FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kreplak, L
   Aebi, U
   Herrmann, H
AF Kreplak, L
   Aebi, U
   Herrmann, H
TI Molecular mechanisms underlying the assembly of intermediate filaments
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Review
DE intermediate filaments; microtubules; cytoskeleton
ID ATOMIC-FORCE MICROSCOPY; PROTEIN-FOLDING MOTIF; HUMAN HAIR KERATINS;
   LIVING CELLS; NUCLEAR LAMINA; HUMAN VIMENTIN; TAIL DOMAIN; IN-VIVO;
   EXPRESSION; REVEALS
C1 German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Herrmann, H (corresponding author), German Canc Res Ctr, Div Cell Biol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
EM h.herrmann@dkfz-heidelberg.de
OI kreplak, laurent/0000-0001-9370-9809
CR Adamson J. Gordon, 1993, Current Opinion in Biotechnology, V4, P428, DOI 10.1016/0958-1669(93)90008-K
   AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293
   BLIKSTAD I, 1983, J CELL BIOL, V96, P1803, DOI 10.1083/jcb.96.6.1803
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   Cerda J, 1998, EUR J CELL BIOL, V77, P175, DOI 10.1016/S0171-9335(98)80105-2
   CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3
   COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   ECKELT A, 1992, EUR J CELL BIOL, V58, P319
   FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450
   Foisner R, 2001, J CELL SCI, V114, P3791
   FRASER RDB, 1976, J MOL BIOL, V108, P435, DOI 10.1016/S0022-2836(76)80129-5
   Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   FUCHS E, 1983, CELL, V34, P332, DOI 10.1016/0092-8674(83)90367-7
   Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501
   Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   HEITLINGER E, 1992, J STRUCT BIOL, V108, P74, DOI 10.1016/1047-8477(92)90009-Y
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   HESS JF, 2004, J BIOL CHEM
   HUIATT TW, 1980, J BIOL CHEM, V255, P6981
   ISHIKAWA H, 1968, J CELL BIOL, V38, P538, DOI 10.1083/jcb.38.3.538
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7
   KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13
   Klapper M, 1997, J CELL SCI, V110, P2519
   KROHNE G, 1987, EMBO J, V6, P3801, DOI 10.1002/j.1460-2075.1987.tb02716.x
   Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874
   Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200
   LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251
   MILLER RK, 1993, J CELL BIOL, V122, P123, DOI 10.1083/jcb.122.1.123
   Mounkes LC, 2004, CURR OPIN CELL BIOL, V16, P322, DOI 10.1016/j.ceb.2004.03.009
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   NGAI J, 1990, CELL, V60, P415, DOI 10.1016/0092-8674(90)90593-4
   Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139
   Nigg E A, 1992, Semin Cell Biol, V3, P245, DOI 10.1016/1043-4682(92)90026-R
   OSBORN M, 1989, LAB INVEST, V61, P585
   Parry DAD, 1995, INTERMEDIATE FILAMEN
   Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159
   QUINLAN RA, 1986, J MOL BIOL, V192, P337, DOI 10.1016/0022-2836(86)90369-4
   ROGERS GE, 1959, ANN NY ACAD SCI, V83, P378
   ROGERS KR, 1995, EUR J CELL BIOL, V66, P136
   Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069
   Sasse B, 1998, J STRUCT BIOL, V123, P56, DOI 10.1006/jsbi.1998.4006
   Schulz G. E., 1979, PRINCIPLES PROTEIN S
   SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929
   STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93
   STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41
   STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161
   Stolz M, 2000, J STRUCT BIOL, V131, P171, DOI 10.1006/jsbi.2000.4301
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   STRELKOV SV, 2004, IN PRESS J MOL BIOL
   STROMER MH, 1987, BIOCHEM J, V246, P75, DOI 10.1042/bj2460075
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Wang H, 2000, J CELL BIOL, V151, P1459, DOI 10.1083/jcb.151.7.1459
   WEBER K, 1984, CANC CELLS, V1
   Wiche G, 1998, J CELL SCI, V111, P2477
   Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707
   Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503
   Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147
NR 69
TC 40
Z9 42
U1 0
U2 19
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD NOV 15
PY 2004
VL 301
IS 1
BP 77
EP 83
DI 10.1016/j.yexcr.2004.08.021
PG 7
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 868IX
UT WOS:000224908400011
PM 15501448
DA 2021-01-25
ER

PT J
AU Liang, Y
   Fotiadis, D
   Maeda, T
   Maeda, A
   Modzelewska, A
   Filipek, S
   Saperstein, DA
   Engel, A
   Palczewski, K
AF Liang, Y
   Fotiadis, D
   Maeda, T
   Maeda, A
   Modzelewska, A
   Filipek, S
   Saperstein, DA
   Engel, A
   Palczewski, K
TI Rhodopsin signaling and organization in heterozygote rhodopsin knockout
   mice
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROTEIN-COUPLED RECEPTORS; 3-DIMENSIONAL STRUCTURE; CA2+-BINDING
   PROTEINS; TARGETED DISRUPTION; CRYSTAL-STRUCTURE; VISUAL PIGMENT; MOUSE
   RETINA; NATIVE RODS; DIMERIZATION; ACTIVATION
AB Rhodopsin ( Rho) resides within internal membrane structures called disc membranes that are found in the rod outer segments (ROS) of photoreceptors in the retina. Rho expression is essential for formation of ROS, which are absent in knockout Rho-/- mice. ROS of mice heterozygous for the Rho gene deletion (Rho+/-) may have a lower Rho density than wild type (WT) membranes, or the ROS structure may be reduced in size due to lower Rho expression. Here, we present evidence that the smaller volume of ROS from heterozygous mice is most likely responsible for observed electrophysiological response differences. In Rho-/- mice as compared with age-matched WT mice, the length of ROS was shorter by 30-40%, and the average diameter of ROS was reduced by similar to20%, as demonstrated by transmission and scanning electron microscopy. Together, the reduction of the volume of ROS was similar to60% in Rho+/- mice. Rho content in the eyes was reduced by similar to43% and 11-cis-retinal content in the eye was reduced by similar to38%, as determined by UV-visible spectroscopy and retinoid analysis, respectively. Transmission electron microscopy of negatively stained disc membranes from Rho+/- mice indicated a typical morphology apart from the reduced size of disc diameter. Power spectra calculated from disc membrane regions on such electron micrographs displayed a diffuse ring at similar to4.5 nm(-1), indicating paracrystallinity of Rho. Atomic force microscopy of WT and Rho+/- disc membranes revealed, in both cases, Rho organized in paracrystalline and raftlike structures. From these data, we conclude that the differences in physiological responses measured in WT and Rho+/- mice are due to structural changes of the whole ROS and not due to a lower density of Rho.
C1 Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.
   Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem, Seattle, WA 98195 USA.
   Univ Basel, ME Muller Inst Microscopy, Biozentrum, CH-4056 Basel, Switzerland.
   Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.
RP Palczewski, K (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.
EM palczews@u.washington.edu
RI Filipek, Slawomir/A-2985-2008
OI Filipek, Slawomir/0000-0003-3147-3858
FU NEI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01
   EY008061, EY08061, P30 EY001730, EY01730] Funding Source: Medline; PHS
   HHSUnited States Public Health Service [3P05F02625] Funding Source:
   Medline; NATIONAL EYE INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, R29EY008061, P30EY001730,
   R01EY008061, R01EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, R01EY008061, R01EY008061,
   P30EY001730, P30EY001730, P30EY001730, R01EY008061, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, R29EY008061, R01EY008061,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, R29EY008061,
   R01EY008061, P30EY001730, R01EY008061, P30EY001730, R01EY008061,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, R01EY008061, R01EY008061,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, R01EY008061,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, R01EY008061,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, R01EY008061,
   P30EY001730, R01EY008061, R01EY008061, P30EY001730, P30EY001730,
   R29EY008061, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   R29EY008061, R01EY008061, P30EY001730, P30EY001730, R29EY008061,
   P30EY001730, P30EY001730] Funding Source: NIH RePORTER
CR Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314
   Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1
   Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X
   Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19
   Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083
   CARRILLO JJ, 2004, IN PRESS MOL PHARM
   CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205
   CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204
   Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b
   Dean MK, 2001, J MED CHEM, V44, P4595, DOI 10.1021/jm010290+
   Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c
   Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611
   Filizola M, 2002, PROTEIN ENG, V15, P881, DOI 10.1093/protein/15.11.881
   Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2003, NATURE, V426, P31, DOI 10.1038/426031a
   Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90
   Hargrave PA, 2001, INVEST OPHTH VIS SCI, V42, P3
   Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027
   Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545
   Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216
   Jang GF, 2001, J BIOL CHEM, V276, P32456, DOI 10.1074/jbc.M104949200
   JAVITCH JA, 2004, IN PRESS MOL PHARM
   Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200
   Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7
   Medina R, 2004, J BIOL CHEM, V279, P39565, DOI 10.1074/jbc.M402446200
   Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998
   Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+
   Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   OHGURO H, 1993, P NATL ACAD SCI USA, V90, P3241, DOI 10.1073/pnas.90.8.3241
   Okada T, 2001, CURR OPIN STRUC BIOL, V11, P420, DOI 10.1016/S0959-440X(00)00227-X
   Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209
   Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399
   Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6
   Palczewski K, 2000, BIOESSAYS, V22, P337, DOI 10.1002/(SICI)1521-1878(200004)22:4<337::AID-BIES4>3.0.CO;2-Z
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d
   Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X
   PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H
   Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5
   Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7
   Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612
   SCHLEGEL W, 1979, J BIOL CHEM, V254, P5168
   Soyer OS, 2003, BIOCHEMISTRY-US, V42, P14522, DOI 10.1021/bi035097r
   STONE WL, 1979, EXP EYE RES, V28, P387, DOI 10.1016/0014-4835(79)90114-3
   Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091
   Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052
   Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297
   Vogel R, 2004, J MOL BIOL, V338, P597, DOI 10.1016/j.jmb.2004.03.006
NR 52
TC 100
Z9 101
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 12
PY 2004
VL 279
IS 46
BP 48189
EP 48196
DI 10.1074/jbc.M408362200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 869BJ
UT WOS:000224957000093
PM 15337746
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Storici, P
   Qiu, J
   Schirmer, T
   Silverman, RB
AF Storici, P
   Qiu, J
   Schirmer, T
   Silverman, RB
TI Mechanistic crystallography. Mechanism of inactivation of
   gamma-aminobutyric acid aminotransferase by
   (1R,3S,4S)-3-amino-4-fluorocyclopentane-1-carboxylic acid as elucidated
   by crystallography
SO BIOCHEMISTRY
LA English
DT Article
ID ANTIEPILEPSY DRUG VIGABATRIN; SERINE O-SULFATE; 4-AMINO-5-HALOPENTANOIC
   ACIDS; GABA-AMINOTRANSFERASE; ETHYNYL-GABA; ENZYME; IDENTIFICATION;
   CHEMISTRY
AB (1R,3S,4S)-3-Amino-4-fluorocyclopentane-1-carboxylic acid (7) was previously shown to be a mechanism-based inactivator of gamma-aminobutyric acid aminotransferase (GABA-AT) [Qiu, J. and Silverman, R. B. (2000) J. Med. Chem. 43, 706-720]. Two mechanisms were considered as reasonable possibilities, a Michael addition mechanism and an enamine mechanism. On the basis of a variety of chemical studies. including tedious radiolabeling experiments, it was concluded that inactivation by 7 proceeds by a Michael addition mechanism. Here, a crystal structure of 7 bound to pig liver GABA-AT is reported, which clearly demonstrates that the adduct formed is derived from an enamine mechanism. This represents another example of how crystallography is an important tool for elucidation of inactivation mechanisms.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   Northwestern Univ, Dept Chem, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.
   Northwestern Univ, Drug Discovery Program, Evanston, IL 60208 USA.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
EM Agman@chem.northwestern.edu
OI storici, paola/0000-0002-2590-3332
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM66132] Funding Source: Medline; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM066132, R01GM066132,
   R01GM066132, R01GM066132] Funding Source: NIH RePORTER
CR BURKE JR, 1991, J AM CHEM SOC, V113, P9329, DOI 10.1021/ja00024a042
   Choi S, 2002, J AM CHEM SOC, V124, P1620, DOI 10.1021/ja011968d
   Cowtan K, 1994, JOINT CCP4 ESF EACBM, V31, P34
   DEBIASE D, 1991, J BIOL CHEM, V266, P20056
   Dietze EC, 1997, CHEM RES TOXICOL, V10, P1097, DOI 10.1021/tx970090u
   Doerge DR, 1995, J MASS SPECTROM, pS136
   Kent UM, 2001, CURR DRUG METAB, V2, P215, DOI 10.2174/1389200013338478
   LIKOS JJ, 1982, BIOCHEMISTRY-US, V21, P4377, DOI 10.1021/bi00261a029
   Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599
   MUMFORD JP, 1994, EPILEPSIA S5, V35, P525
   MUMFORD JP, 2000, NEUROLOGY S1, V55, pS32
   MUMFORD JP, 1998, NEUROLOGY, V51, P627
   NANAVATI SM, 1991, J AM CHEM SOC, V113, P9341, DOI 10.1021/ja00024a043
   Petroff OAC, 1998, MOL NEUROBIOL, V16, P97, DOI 10.1007/BF02740605
   Qiu J, 2000, J MED CHEM, V43, P706, DOI 10.1021/jm9904755
   SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240
   SILVERMAN RB, 1981, BIOCHEMISTRY-US, V20, P1197, DOI 10.1021/bi00508a022
   SILVERMAN RB, 1986, BIOCHEMISTRY-US, V25, P6817, DOI 10.1021/bi00370a013
   SILVERMAN RB, 1987, MECH BASED ENZYME IN, V2
   SILVERMAN RB, 1987, MECH BASED ENZYME IN, V1
   Storici P, 2004, J BIOL CHEM, V279, P363, DOI 10.1074/jbc.M305884200
   Storici P, 1999, BIOCHEMISTRY-US, V38, P8628, DOI 10.1021/bi990478j
   UENO H, 1982, BIOCHEMISTRY-US, V21, P4387, DOI 10.1021/bi00261a030
   Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736
   Yang YJ, 1999, PHARMACOL THERAPEUT, V83, P141, DOI 10.1016/S0163-7258(99)00027-3
   Zechel DL, 1998, BIOCHEM J, V336, P139, DOI 10.1042/bj3360139
   1994, BIOL CRYSTALLOGR D, V50, P760
NR 27
TC 20
Z9 20
U1 1
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD NOV 9
PY 2004
VL 43
IS 44
BP 14057
EP 14063
DI 10.1021/bi0487185
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 868UV
UT WOS:000224939400019
PM 15518554
DA 2021-01-25
ER

PT J
AU Breuza, L
   Halbeisen, R
   Jeno, P
   Otte, S
   Barlowe, C
   Hong, WJ
   Hauri, HP
AF Breuza, L
   Halbeisen, R
   Jeno, P
   Otte, S
   Barlowe, C
   Hong, WJ
   Hauri, HP
TI Proteomics of endoplasmic reticulum-golgi intermediate compartment
   (ERGIC) membranes from brefeldin A-treated HepG2 cells identifies
   ERGIC-32, a new cycling protein that interacts with human Erv46
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID EARLY SECRETORY PATHWAY; CIS-GOLGI; QUALITY-CONTROL; VESICULAR
   TRANSPORT; BINDING PROTEIN; KDEL RECEPTOR; RETROGRADE TRANSPORT;
   MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; RECYCLING PATHWAY
AB Cycling proteins play important roles in the organization and function of the early secretory pathway by participating in membrane traffic and selective transport of cargo between the endoplasmic reticulum ( ER), the intermediate compartment ( ERGIC), and the Golgi. To identify new cycling proteins, we have developed a novel procedure for the purification of ERGIC membranes from HepG2 cells treated with brefeldin A, a drug known to accumulate cycling proteins in the ERGIC. Membranes enriched 110-fold over the homogenate for ERGIC-53 were obtained and analyzed by mass spectrometry. Major proteins corresponded to established and putative cargo receptors and components mediating protein maturation and membrane traffic. Among the uncharacterized proteins, a 32-kDa protein termed ERGIC-32 is a novel cycling membrane protein with sequence homology to Erv41p and Erv46p, two proteins enriched in COPII vesicles of yeast. ERGIC-32 localizes to the ERGIC and partially colocalizes with the human homologs of Erv41p and Erv46p, which mainly localize to the cis-Golgi. ERGIC-32 interacts with human Erv46 (hErv46) as revealed by covalent cross-linking and mistargeting experiments, and silencing of ERGIC-32 by small interfering RNAs increases the turnover of hErv46. We propose that ERGIC-32 functions as a modulator of the hErv41-hErv46 complex by stabilizing hErv46. Our novel approach for the isolation of the ERGIC from BFA-treated cells may ultimately lead to the identification of all proteins rapidly cycling early in the secretory pathway.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Biochem, Hanover, NH 03756 USA.
   Inst Mol & Cell Biol, Singapore 117609, Singapore.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Hans-Peter.Hauri@unibas.ch
RI HONG, Wanjin/E-9927-2010
OI Breuza, Lionel/0000-0002-8075-8625
CR Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200
   Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Bachert C, 2001, MOL BIOL CELL, V12, P3152, DOI 10.1091/mbc.12.10.3152
   BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3
   Barrowman J, 2003, J BIOL CHEM, V278, P19878, DOI 10.1074/jbc.M302406200
   Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224
   Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200
   Bieberich E, 1997, EUR J BIOCHEM, V246, P681, DOI 10.1111/j.1432-1033.1997.t01-1-00681.x
   Blum R, 1999, J CELL SCI, V112, P537
   BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x
   Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2
   CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P574, DOI 10.1016/0003-9861(85)90727-1
   CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685
   Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751
   Duhig T, 1998, GENOMICS, V52, P72, DOI 10.1006/geno.1998.5372
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052
   FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x
   FIEDLER K, 1994, CELL, V77, P625, DOI 10.1016/0092-8674(94)90047-7
   Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396
   Fullekrug J, 1999, J CELL SCI, V112, P2813
   Fullekrug J, 1997, FEBS LETT, V404, P75, DOI 10.1016/S0014-5793(97)00097-5
   Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939
   GRIFFITHS G, 1994, J CELL BIOL, V127, P1557, DOI 10.1083/jcb.127.6.1557
   Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013
   HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41
   Hara-Kuge S, 2002, J BIOL CHEM, V277, P16332, DOI 10.1074/jbc.M112188200
   Hardt B, 2001, BIOL CHEM, V382, P1039, DOI 10.1515/BC.2001.130
   Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hirosawa M, 1999, DNA Res, V6, P329, DOI 10.1093/dnares/6.5.329
   Hui N, 1997, MOL BIOL CELL, V8, P1777
   Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2
   Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Lahtinen U, 1996, J BIOL CHEM, V271, P4031
   Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515
   Linstedt AD, 1997, MOL BIOL CELL, V8, P1073
   LINSTEDT AD, 1995, P NATL ACAD SCI USA, V92, P5102, DOI 10.1073/pnas.92.11.5102
   LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679
   LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W
   Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601
   Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485
   Mezzacasa A, 2002, TRAFFIC, V3, P833, DOI 10.1034/j.1600-0854.2002.31108.x
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nickel W, 2002, J CELL SCI, V115, P3235
   Orci L, 2003, P NATL ACAD SCI USA, V100, P4586, DOI 10.1073/pnas.0730885100
   Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598
   Otte S, 2001, J CELL BIOL, V152, P503, DOI 10.1083/jcb.152.3.503
   PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x
   Prescott AR, 1997, EUR J CELL BIOL, V72, P238
   RAPOSO G, 1995, J CELL BIOL, V131, P1403, DOI 10.1083/jcb.131.6.1403
   REEVES JE, 1995, MOL MEMBR BIOL, V12, P201, DOI 10.3109/09687689509027508
   Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119
   Rowe T, 1998, SCIENCE, V279, P696, DOI 10.1126/science.279.5351.696
   Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.0.CO;2-8
   SARASTE J, 1995, J CELL SCI, V108, P1541
   Satoh M, 1996, J CELL BIOL, V133, P469, DOI 10.1083/jcb.133.2.469
   SCHINDLER R, 1993, EUR J CELL BIOL, V61, P1
   SCHWEIZER A, 1991, J CELL BIOL, V113, P45, DOI 10.1083/jcb.113.1.45
   SCHWEIZER A, 1993, J CELL SCI, V104, P671
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137
   Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127
   Shugrue CA, 1999, J CELL SCI, V112, P4547
   SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323
   Spiro MJ, 2001, GLYCOBIOLOGY, V11, P803, DOI 10.1093/glycob/11.10.803
   Stephens DJ, 2000, J CELL SCI, V113, P2177
   SUBRAMANIAM VN, 1995, J CELL SCI, V108, P2405
   TANG BL, 1993, J CELL BIOL, V120, P325, DOI 10.1083/jcb.120.2.325
   TANG BL, 1995, EUR J CELL BIOL, V68, P199
   TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045
   Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082
   Zhang T, 1999, MOL BIOL CELL, V10, P435, DOI 10.1091/mbc.10.2.435
   Zhang T, 1997, J CELL BIOL, V139, P1157, DOI 10.1083/jcb.139.5.1157
NR 83
TC 78
Z9 86
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 5
PY 2004
VL 279
IS 45
BP 47242
EP 47253
DI 10.1074/jbc.M406644200
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 867HE
UT WOS:000224832400112
PM 15308636
OA Bronze
DA 2021-01-25
ER

PT J
AU Plachta, N
   Bibel, M
   Tucker, KL
   Barde, YA
AF Plachta, N
   Bibel, M
   Tucker, KL
   Barde, YA
TI Developmental potential of defined neural progenitors derived from mouse
   embryonic stem cells
SO DEVELOPMENT
LA English
DT Article
DE neural tube; stem cells; motoneuron; radial glial cells; neurotrophin
   receptors
ID RADIAL GLIA; RECEPTOR EXPRESSION; NEURONAL LINEAGE; SENSORY NEURONS;
   NERVOUS-SYSTEM; IN-VITRO; ES CELLS; DIFFERENTIATION; SPECIFICATION; FATE
AB The developmental potential of a uniform population of neural progenitors was tested by implanting them into chick embryos. These cells were generated from retinoic acid-treated mouse embryonic stem (ES) cells, and were used to replace a segment of the neural tube. At the time of implantation, the progenitors expressed markers defining them as Pax6-positive radial glial (RG) cells, which have recently been shown to generate most pyramidal neurons in the developing cerebral cortex. Six days after implantation, the progenitors generated large numbers of neurons in the spinal cord, and differentiated into interneurons and motoneurons at appropriate locations. They also colonized the host dorsal root ganglia (DRG) and differentiated into neurons, but, unlike stem cell-derived motoneurons, they failed to elongate axons out of the DRG. In addition, they neither expressed the DRG marker Brn3a nor the Trk neurotrophin receptors. Control experiments with untreated ES cells indicated that when colonizing the DRG, these cells did elongate axons and expressed Brn3a, as well as Trk receptors. Our results thus indicate that ES cell-derived progenitors with RG characteristics generate neurons in the spinal cord and the DRG. They are able to respond appropriately to local cues in the spinal cord, but not in the DRG, indicating that they are restricted in their developmental potential.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.
   Heidelberg Univ, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Barde, Yves/F-6019-2011
OI Barde, Yves/0000-0002-7627-461X
CR Anderson DJ, 1999, CURR OPIN NEUROBIOL, V9, P517, DOI 10.1016/S0959-4388(99)00015-X
   Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4
   Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002
   Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809
   Diez del Corral R, 2003, NEURON, V40, P65
   Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2
   FontainePerus J, 1997, DEVELOPMENT, V124, P3025
   Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828
   Huang EJ, 1999, DEVELOPMENT, V126, P2869
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250
   LeDouarin N., 1999, NEURAL CREST
   Ma L, 2003, DEVELOPMENT, V130, P3525, DOI 10.1242/dev.00582
   Malatesta P, 2000, DEVELOPMENT, V127, P5253
   Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8
   McKay SE, 1996, DEVELOPMENT, V122, P715
   Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0
   Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199
   Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006
   Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541
   Renoncourt Y, 1998, MECH DEVELOP, V79, P185, DOI 10.1016/S0925-4773(98)00189-0
   Tucker KL, 2001, NAT NEUROSCI, V4, P29
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302
   Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9
NR 29
TC 59
Z9 59
U1 0
U2 3
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD NOV
PY 2004
VL 131
IS 21
BP 5449
EP 5456
DI 10.1242/dev.01420
PG 8
WC Developmental Biology
SC Developmental Biology
GA 875LQ
UT WOS:000225422200022
PM 15469972
OA Bronze
DA 2021-01-25
ER

PT J
AU Golding, JP
   Tsoni, S
   Dixon, M
   Yee, KT
   Partridge, TA
   Beauchamp, JR
   Gassmann, M
   Zammit, PS
AF Golding, JP
   Tsoni, S
   Dixon, M
   Yee, KT
   Partridge, TA
   Beauchamp, JR
   Gassmann, M
   Zammit, PS
TI Heparin-binding EGF-like growth factor shows transient left-right
   asymmetrical expression in mouse myotome pairs
SO GENE EXPRESSION PATTERNS
LA English
DT Article
DE somite; myotome; mouse; embryo; HB-EGF; EGFr; ErbB1; ErbB4; Myf5;
   left-right asymmetry; iv/iv; situs inversus
ID MUSCLE PROGENITOR CELLS; SKELETAL-MUSCLE; MESSENGER-RNA; MICE; RAT;
   MECHANISMS; CONVERTASE; MIGRATION; INVERSUS; RECEPTOR
AB Heparin-binding EGF-like growth factor (HB-EGF) is a potent mitogen and chemoattractant for diverse cell types including, keratinocytes, fibroblasts and vascular smooth muscle cells. In adult mice, skeletal muscle and endothelial cells prominently express HB-EGF, although analysis of embryonic expression has been limited to studies of heart and kidney development. Here we survey HB-EGF mRNA expression in E7.5-E15 mouse embryos and show that HB-EGF is expressed in branchial arches, limb buds and, transiently, in mature somites between E9.25 and E11. This somitic expression is restricted to the myotomal compartment. Intriguingly, within myotome pairs, the expression of HB-EGF is stronger on the left side of the body, whilst cognate receptors, ErbB1 and ErbB4, are symmetrically expressed in left and right somite pairs. In iv/iv mutant embryos, with inverted left-right body axis, the expression of HB-EGF was also inverted, now being stronger in myotomes on the right side of the body. Thus, the expression of HB-EGF in myotome pairs is regulated by global cues that define the left-right body axis. (C) 2004 Elsevier B.V. All rights reserved.
C1 MRC, Ctr Clin Sci, Muscle Cell Biol Grp, London W12 0NN, England.
   Natl Inst Med Res, Div Neurobiol, London NW7 1AA, England.
   Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.
   Univ Basel, Dept Physiol, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Golding, JP (corresponding author), MRC, Ctr Clin Sci, Muscle Cell Biol Grp, Du Cane Rd, London W12 0NN, England.
EM jon.golding@csc.mrc.ac.uk
RI Golding, Jon/L-2700-2017
OI Golding, Jon/0000-0002-7910-7382; Gassmann, Martin/0000-0001-6201-3032;
   Beauchamp, Jonathan/0000-0003-2067-3088; zammit,
   peter/0000-0001-9562-3072
FU Medical Research CouncilMedical Research Council UK (MRC) [G113/31]
   Funding Source: Medline
CR ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020
   Burdine RD, 2000, GENE DEV, V14, P763
   Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4
   DAHL E, 1995, ANAT EMBRYOL, V191, P267
   DAS SK, 1994, DEVELOPMENT, V120, P1071
   Fumagalli P, 1998, GENOMICS, V47, P238, DOI 10.1006/geno.1997.5078
   GOLDING JP, 2004, IN PRESS DEV DYN
   Grove EA, 1998, DEVELOPMENT, V125, P2315
   HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698
   HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933
   Huang RJ, 2003, DEV BIOL, V255, P30, DOI 10.1016/S0012-1606(02)00051-9
   Hummel K. P., 1959, Journal of Heredity, V50, P9
   Iivanainen E, 2003, FASEB J, V17, P1609, DOI 10.1096/fj.02-0939com
   Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100
   LAYTON WM, 1976, J HERED, V67, P336, DOI 10.1093/oxfordjournals.jhered.a108749
   Meyer D, 1997, DEVELOPMENT, V124, P3575
   Nakagawa T, 1997, KIDNEY INT, V51, P1774, DOI 10.1038/ki.1997.244
   Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342
   Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5
   OTT MO, 1991, DEVELOPMENT, V111, P1097
   RAAB G, 1997, BIOCHIM BIOPHYS ACTA, V1333, P179
   Sporle R, 2001, DEV GENES EVOL, V211, P198, DOI 10.1007/s004270100139
   Stolte D, 2002, ANAT EMBRYOL, V205, P1, DOI 10.1007/s00429-002-0227-z
   Summerbell D, 2000, DEVELOPMENT, V127, P3745
   Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140
   Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225
   Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0
   Takemura T, 2002, KIDNEY INT, V61, P1968, DOI 10.1046/j.1523-1755.2002.00358.x
   TEMIZER DH, 1992, J BIOL CHEM, V267, P24892
   Wang JH, 1999, T NONFERR METAL SOC, V9, P235
NR 30
TC 17
Z9 18
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-133X
J9 GENE EXPR PATTERNS
JI Gene Expr. Patterns
PD NOV
PY 2004
VL 5
IS 1
BP 3
EP 9
DI 10.1016/j.modgep.2004.08.004
PG 7
WC Developmental Biology; Genetics & Heredity
SC Developmental Biology; Genetics & Heredity
GA 874RR
UT WOS:000225368000001
PM 15533812
DA 2021-01-25
ER

PT J
AU Dehio, C
   Sauder, U
   Hiestand, R
AF Dehio, C
   Sauder, U
   Hiestand, R
TI Isolation of Bartonella schoenbuchensis from Lipoptena cervi, a
   blood-sucking arthropod causing deer ked dermatitis
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID SP-NOV.
AB Bartonella schoenbuchensis, which commonly causes bacteremia in ruminants, was isolated from the deer ked Lipoptena cervi and was shown to localize to the midgut of this blood-sucking arthropod, causing deer ked dermatitis in humans. The role of B. schoenbuchensis in the etiology of deer ked dermatitis should be further investigated.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Basel, Interdisciplinary Ctr Microscopy, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR ALEKSEEV E A, 1985, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P56
   ANDERSON B, 1993, J INFECT DIS, V168, P1034, DOI 10.1093/infdis/168.4.1034
   Bermond D, 2002, INT J SYST EVOL MICR, V52, P383, DOI 10.1099/00207713-52-2-383
   Breitschwerdt EB, 2000, CLIN MICROBIOL REV, V13, P428, DOI 10.1128/CMR.13.3.428-438.2000
   Caceres Abraham G., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P485, DOI 10.1590/S0036-46651993000600002
   CHISTYAKOV A F, 1968, Vestnik Dermatologii i Venerologii, V42, P59
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Dehio C, 2001, INT J SYST EVOL MICR, V51, P1557, DOI 10.1099/00207713-51-4-1557
   Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1
   GOTHE R, 1994, PARASITOL RES, V80, P81, DOI 10.1007/BF00932630
   IVANOV V I, 1975, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, V44, P491
   Jacomo V, 2002, CLIN DIAGN LAB IMMUN, V9, P8, DOI 10.1128/CDLI.9.1.8-18.2002
   RANTANEN T, 1982, ACTA DERM-VENEREOL, V62, P307
   REUNALA T, 1980, DUODECIM, V965, P897
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
NR 16
TC 91
Z9 100
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 2004
VL 42
IS 11
BP 5320
EP 5323
DI 10.1128/JCM.42.11.5320-5323.2004
PG 4
WC Microbiology
SC Microbiology
GA 871QV
UT WOS:000225149300059
PM 15528732
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Bar, H
   Strelkov, SV
   Sjoberg, G
   Aebi, U
   Herrmann, H
AF Bar, H
   Strelkov, SV
   Sjoberg, G
   Aebi, U
   Herrmann, H
TI The biology of desmin filaments: how do mutations affect their
   structure, assembly, and organisation?
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Review
DE intermediate filaments; filament assembly; desminopathy; desmin-related
   myopathy
ID INTERMEDIATE-SIZED FILAMENTS; ALPHA-B-CRYSTALLIN; SKELETAL MYOPATHY;
   MYOFIBRILLAR MYOPATHY; SMOOTH-MUSCLE; DE-NOVO; IMMUNOCYTOCHEMICAL
   ANALYSIS; RESTRICTIVE CARDIOMYOPATHY; ATOMIC-STRUCTURE; VIMENTIN-FREE
AB Desmin, the major intermediate filament (IF) protein of muscle, is evolutionarily highly conserved from shark to man. Recently, an increasing number of mutations of the desmin gene has been described to be associated with human diseases such as certain skeletal and cardiac myopathies. These diseases are histologically characterised by intracellular aggregates containing desmin and various associated proteins. Although there is progress regarding our knowledge on the cellular function of desmin within the cytoskeleton, the impact of each distinct mutation is currently not understood at all. In order to get insight into how such mutations affect filament assembly and their integration into the cytoskeleton we need to establish IF structure at atomic detail. Recent progress in determining the dimer structure of the desmin-related IF-protein vimentin allows us to assess how such mutations may affect desmin filament architecture. (C) 2004 Elsevier Inc. All rights reserved.
C1 Deutsch Krebsforschungszentrum, Dept Cell Biol, D-69120 Heidelberg, Germany.
   Heidelberg Univ, Dept Cardiol, D-69115 Heidelberg, Germany.
   Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden.
RP Herrmann, H (corresponding author), Deutsch Krebsforschungszentrum, Dept Cell Biol, D-69120 Heidelberg, Germany.
EM h.herrmann@dkfz-heidelberg.de
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
CR Abraham SC, 1998, HUM PATHOL, V29, P876, DOI 10.1016/S0046-8177(98)90460-9
   Arbustini E, 1998, J AM COLL CARDIOL, V31, P645, DOI 10.1016/S0735-1097(98)00026-6
   ARNOLD HH, 1993, J CELL SCI, V104, P957
   BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293
   Bellin RM, 2001, J BIOL CHEM, V276, P32330, DOI 10.1074/jbc.M104005200
   BERTINI E, 1991, ACTA NEUROPATHOL, V81, P632, DOI 10.1007/BF00296373
   Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137
   BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686
   Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6
   CAPETANAKI YG, 1984, P NATL ACAD SCI-BIOL, V81, P6909, DOI 10.1073/pnas.81.22.6909
   Carlsson L, 2002, ACTA NEUROPATHOL, V104, P493, DOI 10.1007/s00401-002-0583-z
   Carlsson L, 2001, ACTA PHYSIOL SCAND, V171, P341, DOI 10.1046/j.1365-201x.2001.00837.x
   Carlsson L, 2000, HISTOCHEM CELL BIOL, V114, P39
   CARON A, 1993, NEUROMUSCULAR DISORD, V3, P541, DOI 10.1016/0960-8966(93)90112-W
   Choi HJ, 2002, NAT STRUCT BIOL, V9, P612, DOI 10.1038/nsb818
   CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3
   COOKE P, 1976, J CELL BIOL, V68, P539, DOI 10.1083/jcb.68.3.539
   COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y
   Dagvadorj A, 2004, J NEUROL, V251, P143, DOI 10.1007/s00415-004-0289-3
   Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104
   DANTO SI, 1984, J CELL BIOL, V98, P2179, DOI 10.1083/jcb.98.6.2179
   DeBleecker JL, 1996, J NEUROPATH EXP NEUR, V55, P563, DOI 10.1097/00005072-199605000-00009
   Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235
   Djabali K, 1997, J CELL SCI, V110, P2759
   ECKELT A, 1992, EUR J CELL BIOL, V58, P319
   EVANS RM, 1988, EUR J CELL BIOL, V46, P152
   FIDZIANSKA A, 1995, J NEUROL SCI, V131, P88, DOI 10.1016/0022-510X(95)00090-O
   FRAIL DE, 1990, NUCLEIC ACIDS RES, V18, P1910, DOI 10.1093/nar/18.7.1910
   FRANKE WW, 1978, CYTOBIOLOGIE, V17, P392
   FRANKE WW, 1978, P NATL ACAD SCI USA, V75, P5034, DOI 10.1073/pnas.75.10.5034
   FURST DO, 1989, J CELL BIOL, V109, P517, DOI 10.1083/jcb.109.2.517
   GARD DL, 1980, CELL, V19, P263, DOI 10.1016/0092-8674(80)90408-0
   GAWLITTA W, 1981, EUR J CELL BIOL, V26, P83
   GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x
   GEISLER N, 1993, J STRUCT BIOL, V110, P205, DOI 10.1006/jsbi.1993.1023
   GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x
   GOEBEL HH, 1994, REV NEUROL, V150, P452
   Goebel HH, 1997, CURR OPIN NEUROL, V10, P426, DOI 10.1097/00019052-199710000-00012
   GOEBEL HH, 1993, VIRCHOWS ARCH B, V64, P127, DOI 10.1007/BF02915105
   GOEBEL HH, 1995, MUSCLE NERVE, V18, P1306, DOI 10.1002/mus.880181114
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   GOLDFARB LG, 2004, DESMIN MYOPATHY
   GRANGER BL, 1978, CELL, V15, P1253, DOI 10.1016/0092-8674(78)90051-X
   GRANGER BL, 1980, CELL, V22, P727, DOI 10.1016/0092-8674(80)90549-8
   HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   Herrmann H, 1998, Subcell Biochem, V31, P319
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   HERRMANN H, 1989, DEVELOPMENT, V105, P299
   Hijikata T, 1999, J CELL SCI, V112, P867
   Hijikata T, 2003, HISTOCHEM CELL BIOL, V119, P109, DOI 10.1007/s00418-003-0496-5
   Hofmann I, 2000, J CELL SCI, V113, P2471
   HOROWITZ SH, 1994, MUSCLE NERVE, V17, P151, DOI 10.1002/mus.880170204
   Howman EV, 2003, NEUROMUSCULAR DISORD, V13, P42, DOI 10.1016/S0960-8966(02)00181-5
   Huber O, 2003, CELL MOL LIFE SCI, V60, P1872, DOI 10.1007/s00018-003-3050-7
   HUIATT TW, 1980, J BIOL CHEM, V255, P6981
   INAGAKI M, 1988, J BIOL CHEM, V263, P5970
   ISHIKAWA H, 1968, J CELL BIOL, V38, P538, DOI 10.1083/jcb.38.3.538
   KACHINSKY AM, 1995, J HISTOCHEM CYTOCHEM, V43, P843, DOI 10.1177/43.8.7542682
   Kaminska A, 2004, HUM GENET, V114, P306, DOI 10.1007/s00439-003-1057-7
   Karabinos A, 2000, EUR J CELL BIOL, V79, P17, DOI 10.1078/S0171-9335(04)70003-5
   KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x
   Katsouras CS, 2000, INT J CARDIOL, V72, P195, DOI 10.1016/S0167-5273(99)00176-X
   KAUFMAN SJ, 1988, P NATL ACAD SCI USA, V85, P9606, DOI 10.1073/pnas.85.24.9606
   KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0
   Kawajiri A, 2003, MOL BIOL CELL, V14, P1489, DOI 10.1091/mbc.E02-09-0612
   KITAMURA S, 1989, J BIOL CHEM, V264, P5674
   KLYMKOWSKY MW, 1981, NATURE, V291, P249, DOI 10.1038/291249a0
   Kowalczyk AP, 1999, INT REV CYTOL, V185, P237
   Kuisk IR, 1996, DEV BIOL, V174, P1, DOI 10.1006/dbio.1996.0046
   LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0
   LAZARIDES E, 1976, P NATL ACAD SCI USA, V73, P4344, DOI 10.1073/pnas.73.12.4344
   LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X
   LI H, 1993, NUCLEIC ACIDS RES, V21, P335, DOI 10.1093/nar/21.2.335
   Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122
   LOCKARD VG, 1993, J MOL CELL CARDIOL, V25, P303, DOI 10.1006/jmcc.1993.1036
   LYONS GE, 1993, MOL BASIS MORPHOGEN, P155
   LYONS GE, 1992, SEMIN DEV BIOL, V3, P2443
   MAYO ML, 1992, INT J DEV BIOL, V36, P255
   MCCORMICK MB, 1993, J CELL BIOL, V122, P395, DOI 10.1083/jcb.122.2.395
   Melberg A, 1999, ANN NEUROL, V46, P684, DOI 10.1002/1531-8249(199911)46:5<684::AID-ANA2>3.0.CO;2-#
   Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Nakano S, 1996, J NEUROPATH EXP NEUR, V55, P549, DOI 10.1097/00005072-199605000-00008
   NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x
   Nicolao P, 1999, AM J HUM GENET, V64, P788, DOI 10.1086/302281
   OLSON EN, 1989, ONCOGENE, V4, P907
   Park KY, 2000, CLIN GENET, V57, P423, DOI 10.1034/j.1399-0004.2000.570604.x
   Parry DAD, 1995, INTERMEDIATE FILAMEN
   PARRY DAD, 1999, GUIDEBOOK CYTOSKELET, P285
   PORCU M, 1994, CLIN CARDIOL, V17, P277, DOI 10.1002/clc.4960170512
   PRICE MG, 1983, J CELL BIOL, V97, P1860, DOI 10.1083/jcb.97.6.1860
   QUAX W, 1985, CELL, V43, P327, DOI 10.1016/0092-8674(85)90038-8
   QUAX W, 1983, CELL, V35, P215, DOI 10.1016/0092-8674(83)90224-6
   QUAX W, 1985, GENE, V38, P189, DOI 10.1016/0378-1119(85)90217-3
   QUINLAN RA, 1989, J CELL SCI, V93, P71
   RAATS JMH, 1992, EUR J CELL BIOL, V58, P108
   RAATS JMH, 1990, J CELL BIOL, V111, P1971, DOI 10.1083/jcb.111.5.1971
   Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166
   Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626
   RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X
   RICHARDSON FL, 1981, EUR J CELL BIOL, V26, P91
   Riemer D, 1998, J CELL SCI, V111, P2967
   ROGERS KR, 1995, EUR J CELL BIOL, V66, P136
   SASSOON DA, 1993, DEV BIOL, V156, P11, DOI 10.1006/dbio.1993.1055
   SAUK JJ, 1984, J CELL BIOL, V99, P1590, DOI 10.1083/jcb.99.5.1590
   SCHAART G, 1989, DEVELOPMENT, V107, P585
   Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206
   Schroder R, 1999, EUR J CELL BIOL, V78, P288, DOI 10.1016/S0171-9335(99)80062-4
   Schroder R, 2000, LAB INVEST, V80, P455, DOI 10.1038/labinvest.3780051
   SCHWARZ MA, 1990, ANNU REV CELL BIOL, V6, P461, DOI 10.1146/annurev.cellbio.6.1.461
   Schweitzer SC, 2001, J CELL SCI, V114, P1079
   SEJERSEN T, 1993, J CELL SCI, V106, P1291
   Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767
   SJOBERG G, 1994, EXP CELL RES, V214, P447, DOI 10.1006/excr.1994.1281
   SMALL JV, 1977, J CELL SCI, V23, P243
   SMITH TH, 1994, J CELL BIOL, V127, P95, DOI 10.1083/jcb.127.1.95
   STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93
   STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   STROMER MH, 1987, BIOCHEM J, V246, P75, DOI 10.1042/bj2460075
   THORNELL LE, 1985, ANN NY ACAD SCI, V455, P213, DOI 10.1111/j.1749-6632.1985.tb50414.x
   TOKUYASU KT, 1983, J CELL BIOL, V96, P1727, DOI 10.1083/jcb.96.6.1727
   TOKUYASU KT, 1983, J CELL BIOL, V96, P1736, DOI 10.1083/jcb.96.6.1736
   TRAUB P, 1983, J CELL SCI, V63, P43
   VERHOEVEN D, 1988, J PATHOL, V154, P287, DOI 10.1002/path.1711540312
   Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765
   WALKER JH, 1985, EUR J CELL BIOL, V38, P123
   Wang J, 2000, EUR J CELL BIOL, V79, P478, DOI 10.1078/0171-9335-00069
   Wiche G, 1998, J CELL SCI, V111, P2477
   Zachara E, 1997, G Ital Cardiol, V27, P436
   Zhang J, 2001, CLIN GENET, V59, P248, DOI 10.1034/j.1399-0004.2001.590406.x
NR 143
TC 128
Z9 135
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD NOV
PY 2004
VL 148
IS 2
BP 137
EP 152
DI 10.1016/j.jsb.2004.04.003
PG 16
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 866FK
UT WOS:000224759000001
PM 15477095
DA 2021-01-25
ER

PT J
AU Ben-Tekaya, H
   Miura, K
   Pepperkok, R
   Hauri, H
AF Ben-Tekaya, H
   Miura, K
   Pepperkok, R
   Hauri, H
TI Live imaging of retrograde and anterograde traffic reveals the
   stationary nature of the ERGIC
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 04-08, 2004
CL Washington, DC
SP Amer Soc Cell Biol
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   EMBL, Heidelberg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2004
VL 15
SU S
MA 1064
BP 192A
EP 192A
PG 1
WC Cell Biology
SC Cell Biology
GA 864QU
UT WOS:000224648801409
DA 2021-01-25
ER

PT J
AU Smirnov, SP
   McKee, KK
   Ruegg, MA
   Yurchenco, PD
AF Smirnov, SP
   McKee, KK
   Ruegg, MA
   Yurchenco, PD
TI Conjugation of non-neuronal agrin and perlecan proteins to laminin-2
   promotes and stabilizes acetylcholine receptor clusters
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 04-08, 2004
CL Washington, DC
SP Amer Soc Cell Biol
C1 Robert Wood Johnson Med Sch, Piscataway, NJ USA.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2004
VL 15
SU S
MA 2307
BP 416A
EP 416A
PG 1
WC Cell Biology
SC Cell Biology
GA 864QU
UT WOS:000224648803376
DA 2021-01-25
ER

PT J
AU Pagano, A
   Crottet, P
   Prescianotto-Baschong, C
   Spiess, M
AF Pagano, A
   Crottet, P
   Prescianotto-Baschong, C
   Spiess, M
TI In vitro formation of recycling vesicles from endosomes requires adaptor
   protein-1/clathrin and is regulated by Rab4 and the connector rabaptin-5
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID TRANS-GOLGI NETWORK; POLARIZED EPITHELIAL-CELLS; CLATHRIN-COATED
   VESICLES; CANINE KIDNEY-CELLS; ASIALOGLYCOPROTEIN RECEPTOR; ENDOCYTIC
   PATHWAY; PLASMA-MEMBRANE; GAMMA-ADAPTIN; PROTEINS; COMPLEX
AB The involvement of clathrin and associated adaptor proteins in receptor recycling from endosomes back to the plasma membrane is controversial. We have used an in vitro assay to identify the molecular requirements for the formation of recycling vesicles. Cells expressing the asialoglycoprotein receptor H1, a typical recycling receptor, were surface biotinylated and then allowed to endocytose for 10 min. After stripping away surface-biotin, the cells were permeabilized and the cytosol washed away. In a temperature-, cytosol-, and nucleotide-dependent manner, the formation of sealed vesicles containing biotinylated H1 could be reconstituted. Vesicle formation was strongly inhibited upon immunodepletion of adaptor protein (AP)-1, but not of AP-2 or AP-3, from the cytosol, and was restored by readdition of purified AP-1. Vesicle formation was stimulated by supplemented clathrin, but inhibited by brefeldin A, consistent with the involvement of ARF1 and a brefeldin-sensitive guanine nucleotide exchange factor. The GTPase rab4, but not rab5, was required to generate endosome-derived vesicles. Depletion of rabaptin-5/rabex-5, a known interactor of both rab4 and gamma-adaptin, stimulated and addition of the purified protein strongly inhibited vesicle production. The results indicate that recycling is mediated by AP-1/clathrin-coated vesicles and regulated by rab4 and rabaptin-5/rabex-5.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
CR AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x
   Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046
   ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531
   Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790
   BRODSKY FM, 1987, NATURE, V326, P203, DOI 10.1038/326203a0
   CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028
   Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241
   Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309
   Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191
   De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744
   de Wit H, 2001, MOL BIOL CELL, V12, P3703, DOI 10.1091/mbc.12.11.3703
   Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431
   Deneka M, 2003, EMBO J, V22, P2645, DOI 10.1093/emboj/cdg257
   DOXSEY SJ, 1987, CELL, V50, P453, DOI 10.1016/0092-8674(87)90499-5
   DRAPER RK, 1990, SCIENCE, V248, P1539, DOI 10.1126/science.2163108
   Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5
   Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020
   FUHRER C, 1994, J BIOL CHEM, V269, P3277
   Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611
   Gan YB, 2002, NAT CELL BIOL, V4, P605, DOI 10.1038/ncb827
   GEFFEN I, 1993, J BIOL CHEM, V268, P20772
   Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054
   HAINFELD JF, 1987, SCIENCE, V236, P450, DOI 10.1126/science.3563522
   Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279
   Hinners I, 2003, J CELL SCI, V116, P763, DOI 10.1242/jcs.00270
   Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67
   Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1
   Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3
   Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013
   JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283
   JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251
   LEITINGER B, 1995, P NATL ACAD SCI USA, V92, P10109, DOI 10.1073/pnas.92.22.10109
   Lim SN, 2001, MOL BIOL CELL, V12, P981, DOI 10.1091/mbc.12.4.981
   Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201
   Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219
   Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973
   Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015
   Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315
   Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193
   Mohrmann K, 2002, J BIOL CHEM, V277, P10474, DOI 10.1074/jbc.M111237200
   Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.E03-04-0230
   Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9
   Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064
   Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187
   Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123
   Shiba Y, 2002, J BIOCHEM, V131, P327, DOI 10.1093/oxfordjournals.jbchem.a003107
   Simpson F, 1997, J CELL BIOL, V137, P835, DOI 10.1083/jcb.137.4.835
   SPIESS M, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00495a001
   STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5
   Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21
   Sugimoto H, 2002, MOL BIOL CELL, V13, P2374, DOI 10.1091/mbc.E01-10-0096
   TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cellbio.9.1.129
   van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200
   van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380
   van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1
   VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X
   Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941
   Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222
   Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207
   Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055
NR 60
TC 66
Z9 69
U1 0
U2 4
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2004
VL 15
IS 11
BP 4990
EP 5000
DI 10.1091/mbc.E04-04-0355
PG 11
WC Cell Biology
SC Cell Biology
GA 864QQ
UT WOS:000224648400022
PM 15331762
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Kohler, R
   Schafer, K
   Muller, S
   Vignon, G
   Diederichs, K
   Philippsen, A
   Ringler, P
   Pugsley, AP
   Engel, A
   Welte, W
AF Kohler, R
   Schafer, K
   Muller, S
   Vignon, G
   Diederichs, K
   Philippsen, A
   Ringler, P
   Pugsley, AP
   Engel, A
   Welte, W
TI Structure and assembly of the pseudopilin PulG
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID GENERAL SECRETORY PATHWAY; II PROTEIN SECRETION; PILIN-LIKE COMPONENT;
   PSEUDOMONAS-AERUGINOSA; IV PILIN; ESCHERICHIA-COLI; MACROMOLECULAR
   STRUCTURES; NEISSERIA-MENINGITIDIS; KLEBSIELLA-OXYTOCA; OLIGOMERIC RINGS
AB The pseudopilin PulG is one of several essential components of the type II pullulanase secretion machinery (the Pul secreton) of the Gram-negative bacterium Klebsiella oxytoca. The sequence of the N-terminal 25 amino acids of the PulG precursor is hydrophobic and very similar to the corresponding region of type IV pilins. The structure of a truncated PulG (lacking the homologous region), as determined by X-ray crystallography, was found to include part of the long N-terminal alpha-helix and the four internal anti-parallel beta-strands that characterize type IV pilins, but PulG lacks the highly variable loop region with a disulphide bond that is found in the latter. When overproduced, PulG forms flexible pili whose structural features, as visualized by electron microscopy, are similar to those of bacterial type IV pili. The average helical repeat comprises 17 PulG subunits and four helical turns. Electron microscopy and molecular modelling show that PulG probably assembles into left-handed helical pili with the long N-terminal alpha-helix tightly packed in the centre of the pilus. As in the type IV pilins, the hydrophobic N-terminal part of the PulG alpha-helix is necessary for its assembly. Subtle sequence variations within this highly conserved segment seem to determine whether or not a type IV pilin can be assembled into pili by the Pul secreton.
C1 Inst Pasteur, Mol Genet Unit, F-75724 Paris 15, France.
   Univ Konstanz, Dept Biol, D-78457 Constance, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Pugsley, AP (corresponding author), Inst Pasteur, Mol Genet Unit, 25 Rue Dr Roux, F-75724 Paris 15, France.
EM max@pasteur.fr
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I
   BEARD MKM, 1990, J BACTERIOL, V172, P2601, DOI 10.1128/jb.172.5.2601-2607.1990
   Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x
   Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340
   Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003
   Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001
   Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885
   Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9
   DENFERT C, 1987, EMBO J, V6, P3531, DOI 10.1002/j.1460-2075.1987.tb02679.x
   DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0
   Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269
   DUPUY B, 1992, MOL MICROBIOL, V6, P1887, DOI 10.1111/j.1365-2958.1992.tb01361.x
   Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003
   ELLEMAN TC, 1986, J BACTERIOL, V168, P574, DOI 10.1128/jb.168.2.574-580.1986
   ELLEMAN TC, 1987, MOL MICROBIOL, V1, P377, DOI 10.1111/j.1365-2958.1987.tb01945.x
   HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0
   Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7
   Hahn E, 2000, J STRUCT BIOL, V132, P241, DOI 10.1006/jsbi.2000.4323
   Hazes B, 2000, J MOL BIOL, V299, P1005, DOI 10.1006/jmbi.2000.3801
   HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x
   HOYNE PA, 1992, J BACTERIOL, V174, P7321, DOI 10.1128/jb.174.22.7321-7327.1992
   Hu NT, 2002, BIOCHEM J, V365, P205, DOI 10.1042/BJ20020194
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Keizer DW, 2001, J BIOL CHEM, V276, P24186, DOI 10.1074/jbc.M100659200
   Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x
   LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   MICHAELIS S, 1985, J BACTERIOL, V164, P633, DOI 10.1128/JB.164.2.633-638.1985
   Miller J. H., 1992, LAB MANUAL HDB ESCHE, P43
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   Nunn D, 1999, TRENDS CELL BIOL, V9, P402, DOI 10.1016/S0962-8924(99)01634-7
   PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0
   PASLOSKE BL, 1989, J BACTERIOL, V171, P2142, DOI 10.1128/jb.171.4.2142-2147.1989
   PASLOSKE BL, 1988, MOL MICROBIOL, V2, P489, DOI 10.1111/j.1365-2958.1988.tb00055.x
   Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0
   Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263
   Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000
   PUGSLEY AP, 1993, MOL MICROBIOL, V9, P295, DOI 10.1111/j.1365-2958.1993.tb01691.x
   Pugsley AP, 1996, MOL MICROBIOL, V20, P1235, DOI 10.1111/j.1365-2958.1996.tb02643.x
   PUGSLEY AP, 1993, MOL MICROBIOL, V10, P665, DOI 10.1111/j.1365-2958.1993.tb00938.x
   Pugsley AP, 2001, J BACTERIOL, V183, P1312, DOI 10.1128/JB.183.4.1312-1319.2001
   PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993
   Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x
   Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221
   Sauvonnet N, 2000, J BACTERIOL, V182, P848, DOI 10.1128/JB.182.3.848-854.2000
   SAXTON WO, 1979, ULTRAMICROSCOPY, V4, P343, DOI 10.1016/S0304-3991(79)80044-3
   Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678
   Smith PR, 1996, J STRUCT BIOL, V116, P35, DOI 10.1006/jsbi.1996.0007
   SMITH PR, 1974, J PHYS A-MATH GEN, V7, P1627, DOI 10.1088/0305-4470/7/13/017
   STROM MS, 1991, J BIOL CHEM, V266, P1656
   STROM MS, 1993, J BIOL CHEM, V268, P15788
   SUN D, 1991, INFECT IMMUN, V59, P114, DOI 10.1128/IAI.59.1.114-118.1991
   Sun DX, 1997, GENE, V192, P79, DOI 10.1016/S0378-1119(97)00007-3
   TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074
   Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003
   Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408
NR 64
TC 91
Z9 94
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD NOV
PY 2004
VL 54
IS 3
BP 647
EP 664
DI 10.1111/j.1365-2958.2004.04307.x
PG 18
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 862XA
UT WOS:000224523500007
PM 15491357
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Moskes, C
   Burghaus, PA
   Wernli, B
   Sauder, U
   Durrenberger, M
   Kappes, B
AF Moskes, C
   Burghaus, PA
   Wernli, B
   Sauder, U
   Durrenberger, M
   Kappes, B
TI Export of Plasmodium falciparum calcium-dependent protein kinase 1 to
   the parasitophorous vacuole is dependent on three N-terminal membrane
   anchor motifs
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID STAGE-SPECIFIC EXPRESSION; PROTEIN-KINASE; MALARIA PARASITE; INFECTED
   ERYTHROCYTES; MOLECULAR-CLONING; ENDOPLASMIC-RETICULUM;
   LEISHMANIA-MAJOR; HIGHER-PLANTS; AMINO-ACIDS; HOMOLOG
AB Calcium-dependent protein kinases play a pivotal role in calcium signalling in plants and some protozoa, including the malaria parasites. They are found in various subcellular locations, suggesting an involvement in multiple signal transduction pathways. Recently, Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) has been found in the membrane and organelle fraction of the parasite. The kinase contains three motifs for membrane binding at its N-terminus, a consensus sequence for myristoylation, a putative palmitoylation site and a basic motif. Endogenous PfCDPK1 and the in vitro translated kinase were both shown to be myristoylated. The supposed membrane attachment function of the basic cluster was experimentally verified and shown to participate together with N-myristoylation in membrane anchoring of the kinase. Using immunogold electron microscopy, the protein was detected in the parasitophorous vacuole and the tubovesicular system of the parasite. Mutagenesis of the predicted acylated residues and the basic motif confirmed that dual acylation and the basic cluster are required for correct targeting of Aequorea victoria green fluorescent protein to the parasitophorous vacuole, suggesting that PfCDPK1 as the leishmanial hydrophilic acylated surface protein B is a representative of a novel class of proteins whose export is dependent on a 'non-classical' pathway involving N-myristoylation/palmitoylation.
C1 Univ Heidelberg, Inst Hyg, Dept Parasitol, D-69120 Heidelberg, Germany.
   Univ Marburg, FB Biol Zool, Abt Parasitol, D-35032 Marburg, Germany.
   Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Interdisciplinary Ctr Microscopy, CH-4056 Basel, Switzerland.
RP Kappes, B (corresponding author), Univ Heidelberg, Inst Hyg, Dept Parasitol, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.
EM barbara.kappes@urz.uni-heidelberg.de
CR Adisa A, 2001, J CELL SCI, V114, P3377
   Albano FR, 1999, EUR J CELL BIOL, V78, P453, DOI 10.1016/S0171-9335(99)80072-7
   Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9
   Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0
   Burghaus PA, 2001, J BIOL CHEM, V276, P26838, DOI 10.1074/jbc.M100111200
   Busconi L, 1997, BIOCHEM J, V323, P239, DOI 10.1042/bj3230239
   Crabb BS, 2004, METH MOL B, V270, P263
   Crabb BS, 1997, MOL BIOCHEM PARASIT, V90, P131, DOI 10.1016/S0166-6851(97)00143-6
   Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008
   Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850
   Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017
   Farber PM, 1997, MOL BIOCHEM PARASIT, V87, P211, DOI 10.1016/S0166-6851(97)00052-2
   FLINN HM, 1994, MOL BIOCHEM PARASIT, V65, P259, DOI 10.1016/0166-6851(94)90077-9
   Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130
   Gilberger TW, 1997, J BIOL CHEM, V272, P29584, DOI 10.1074/jbc.272.47.29584
   Graeser R, 1996, MOL BIOCHEM PARASIT, V82, P37, DOI 10.1016/0166-6851(96)02716-8
   Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6
   Hayashi M, 2001, J BIOL CHEM, V276, P15249, DOI 10.1074/jbc.M011709200
   Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999
   Kappes B, 1999, PARASITOL TODAY, V15, P449, DOI 10.1016/S0169-4758(99)01527-6
   Kissinger JC, 2001, NUCLEIC ACIDS RES, V29, P66
   Kun JFJ, 1997, MOL BIOCHEM PARASIT, V85, P41, DOI 10.1016/S0166-6851(96)02805-8
   LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287
   Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556
   Li JL, 2000, BBA-GENE STRUCT EXPR, V1491, P341, DOI 10.1016/S0167-4781(00)00032-4
   Lopez-Estrano C, 2003, P NATL ACAD SCI USA, V100, P12402, DOI 10.1073/pnas.2133080100
   Lu SX, 2002, PLANT PHYSIOL, V128, P1008, DOI 10.1104/pp.010770
   Ludwig AA, 2004, J EXP BOT, V55, P181, DOI 10.1093/jxb/erh008
   Martin ML, 2000, PLANT J, V24, P429, DOI 10.1046/j.1365-313x.2000.00889.x
   MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8
   Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6
   Mohrle JJ, 1997, BIOCHEM J, V328, P677
   Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x
   PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283
   PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020
   PIMENTA PFP, 1994, EXP PARASITOL, V79, P468, DOI 10.1006/expr.1994.1108
   Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0
   Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5
   ROBERTS DM, 1992, ANNU REV PLANT PHYS, V43, P375, DOI 10.1146/annurev.pp.43.060192.002111
   Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556
   Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227
   Sambrook J, 1988, MOL CLONING LAB MANU
   Satterlee JS, 1998, J MEMBRANE BIOL, V164, P205, DOI 10.1007/s002329900406
   Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954
   SUETTERLIN BW, 1992, EUR J BIOCHEM, V207, P455, DOI 10.1111/j.1432-1033.1992.tb17071.x
   TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840
   Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794
   WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8
   Wickert H, 2003, MOL BIOCHEM PARASIT, V129, P209, DOI 10.1016/S0166-6851(03)00117-8
   Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636
   ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7
   ZHAO Y, 1992, EUR J BIOCHEM, V207, P305, DOI 10.1111/j.1432-1033.1992.tb17051.x
   ZHAO Y, 1994, BIOCHEMISTRY-US, V33, P3714, DOI 10.1021/bi00178a031
NR 53
TC 78
Z9 81
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD NOV
PY 2004
VL 54
IS 3
BP 676
EP 691
DI 10.1111/j.1365-2958.2004.04313.x
PG 16
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 862XA
UT WOS:000224523500009
PM 15491359
DA 2021-01-25
ER

PT J
AU Jacinto, E
   Loewith, R
   Schmidt, A
   Lin, S
   Ruegg, MA
   Hall, A
   Hall, MN
AF Jacinto, E
   Loewith, R
   Schmidt, A
   Lin, S
   Ruegg, MA
   Hall, A
   Hall, MN
TI Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin
   insensitive
SO NATURE CELL BIOLOGY
LA English
DT Article
ID CELL-GROWTH; TARGET; RAPTOR; INHIBITION; NUTRIENT; ADHESION; CDC42;
   MTOR; ACTIVATION; MECHANISM
AB The target of rapamycin ( TOR) is a highly conserved protein kinase and a central controller of cell growth. In budding yeast, TOR is found in structurally and functionally distinct protein complexes: TORC1 and TORC2. A mammalian counterpart of TORC1 (mTORC1) has been described, but it is not known whether TORC2 is conserved in mammals. Here, we report that a mammalian counterpart of TORC2 (mTORC2) also exists. mTORC2 contains mTOR, mLST8 and mAVO3, but not raptor. Like yeast TORC2, mTORC2 is rapamycin insensitive and seems to function upstream of Rho GTPases to regulate the actin cytoskeleton. mTORC2 is not upstream of the mTORC1 effector S6K. Thus, two distinct TOR complexes constitute a primordial signalling network conserved in eukaryotic evolution to control the fundamental process of cell growth.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
RI Ruegg, Markus/X-7256-2019; Loewith, Robbie/S-6289-2016
OI Ruegg, Markus/0000-0002-4974-9384; Loewith, Robbie/0000-0002-2482-603X;
   Hall, Michael N/0000-0002-2998-0757; Jacinto, Estela/0000-0001-7118-1759
CR Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962
   Azim AC, 2000, METHOD ENZYMOL, V325, P257
   Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999
   Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x
   Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X
   Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095
   Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021
   Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542
   Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   HARRIS TE, 2003, SCI STKE, V15, P1
   Hubberstey A, 1996, J CELL BIOCHEM, V61, P459, DOI 10.1002/(SICI)1097-4644(19960601)61:3<459::AID-JCB13>3.3.CO;2-#
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x
   Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416
   RIDLEY AJ, 1995, METHOD ENZYMOL, V256, P306
   RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Sarkaria JN, 1999, CANCER RES, V59, P4375
   Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Xia Y, 2003, J BIOL CHEM, V278, P13143, DOI 10.1074/jbc.M208500200
NR 30
TC 1442
Z9 1487
U1 3
U2 110
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
EI 1476-4679
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD NOV
PY 2004
VL 6
IS 11
BP 1122
EP U30
DI 10.1038/ncb1183
PG 10
WC Cell Biology
SC Cell Biology
GA 867BI
UT WOS:000224816700018
PM 15467718
DA 2021-01-25
ER

PT J
AU Strelkov, SV
   Schumacher, J
   Burkhard, P
   Aebi, U
   Herrmann, H
AF Strelkov, SV
   Schumacher, J
   Burkhard, P
   Aebi, U
   Herrmann, H
TI Crystal structure of the human lamin a coil 2B dimer: Implications for
   the head-to-tail association of nuclear lamins
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE atomic structure; intermediate filament; nuclear lamins; filament
   assembly; laminopathy
ID DREIFUSS MUSCULAR-DYSTROPHY; CAUSE AUTOSOMAL-DOMINANT;
   INTERMEDIATE-FILAMENTS; DILATED CARDIOMYOPATHY; MOLECULAR ARCHITECTURE;
   ATOMIC-STRUCTURE; ROD DOMAIN; SEGMENT 1A; MUTATIONS; A/C
AB Nuclear intermediate filaments (IFs) are made from fibrous proteins termed lamins that assemble, in association with several transmembrane proteins of the inner nuclear membrane and an unknown number of chromatin proteins, into a filamentous scaffold called the nuclear lamina. In man, three types of lamins with significant sequence identity, i.e. lamin A/C, lamin B1 and B2, are expressed. The molecular characteristics of the filaments they form and the details of the assembly mechanism are still largely unknown. Here we report the crystal structure of the coiled-coil dimer from the second half of coil 2 from human lamin A at 2.2 Angstrom resolution. Comparison to the recently solved structure of the homologous segment of human vimentin reveals a similar overall structure but a different distribution of charged residues and a different pattern of intra- and interhelical salt bridges. These features may explain, at least in part, the differences observed between the lamin and vimentin assembly pathways. Employing a modeled lamin A coil 1A dimer, we propose that the head-to-tail association of two lamin dimers involves strong electrostatic attractions of distinct clusters of negative charge located on the opposite ends of the rod domain with arginine clusters in the head domain and the first segment of the tail domain. Moreover, lamin A mutations, including several in coil 2B, have been associated with human laminopathies. Based on our data most of these mutations are unlikely to alter the structure of the dimer but may affect essential molecular interactions occurring in later stages of filament assembly and lamina formation. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   DKFZ, Div Cell Biol, German Canc Res Ctr, D-69120 Heidelberg, Germany.
RP Strelkov, SV (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sergei-v.strelkov@unibas.ch; h.herrmann@dkfz.de
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799
   Brandenberger R, 1996, J CELL BIOL, V135, P1583, DOI 10.1083/jcb.135.6.1583
   Brodsky GL, 2000, CIRCULATION, V101, P473, DOI 10.1161/01.CIR.101.5.473
   Brown CA, 2001, AM J MED GENET, V102, P359, DOI 10.1002/ajmg.1463
   Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   Charniot JC, 2003, HUM MUTAT, V21, P473, DOI 10.1002/humu.10170
   Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X
   CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3
   COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   di Barletta MR, 2000, AM J HUM GENET, V66, P1407, DOI 10.1086/302869
   Dreger CK, 2002, J STRUCT BIOL, V140, P100, DOI 10.1016/S1047-8477(02)00540-3
   Dreuillet C, 2002, NUCLEIC ACIDS RES, V30, P4634, DOI 10.1093/nar/gkf587
   Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629
   Foisner Roland, 2003, ScientificWorldJournal, V3, P1
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   GALLAGHER SR, 1995, CURRENT PROTOCOLS PR, V2
   GEISLER N, 1985, J MOL BIOL, V182, P173, DOI 10.1016/0022-2836(85)90035-X
   GIEFFERS C, 1991, EUR J CELL BIOL, V55, P191
   GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x
   Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5
   HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   HOGER TH, 1991, EXP CELL RES, V197, P280, DOI 10.1016/0014-4827(91)90434-V
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KAMMERER RA, 1995, J MOL BIOL, V250, P64, DOI 10.1006/jmbi.1995.0358
   Ki CS, 2002, J HUM GENET, V47, P225, DOI 10.1007/s100380200029
   Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3
   LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8
   MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0
   Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   PARRY DAD, 1995, INTERMEDIATE FILAMEN, P1
   PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x
   Reichart B, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-12
   Sasse B, 1997, EUR J BIOCHEM, V250, P30, DOI 10.1111/j.1432-1033.1997.t01-1-00030.x
   Sasse B, 1998, J STRUCT BIOL, V123, P56, DOI 10.1006/jsbi.1998.4006
   Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206
   Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4
   Smith TA, 2004, PROTEINS, V55, P1043, DOI 10.1002/prot.20089
   Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   STRELKOV SV, 2004, IN PRESS METHODS CEL, pCH2
   Stuurman N, 1996, J STRUCT BIOL, V117, P1, DOI 10.1006/jsbi.1996.0064
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Tabellini G, 2002, CELL SIGNAL, V14, P819, DOI 10.1016/S0898-6568(02)00021-9
   TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33
   Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2
   Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102
NR 69
TC 149
Z9 152
U1 0
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD OCT 29
PY 2004
VL 343
IS 4
BP 1067
EP 1080
DI 10.1016/j.jmb.2004.08.093
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 864TP
UT WOS:000224656100022
PM 15476822
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, G
TI Letting go
SO FEBS LETTERS
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, Reinach, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, Reinach, Switzerland.
EM gottfried.schatz@unibas.ch
NR 0
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD OCT 22
PY 2004
VL 576
IS 3
BP 285
EP 286
DI 10.1016/j.febslet.2004.09.043
PG 2
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 866RD
UT WOS:000224789700001
PM 15498548
DA 2021-01-25
ER

PT J
AU Belanger, KD
   Simmons, LA
   Roth, JK
   VanderPloeg, KA
   Lichten, LB
   Fahrenkrog, B
AF Belanger, KD
   Simmons, LA
   Roth, JK
   VanderPloeg, KA
   Lichten, LB
   Fahrenkrog, B
TI The karyopherin Msn5/Kap142 requires Nup82 for nuclear export and
   performs a function distinct from translocation in RPA protein import
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID TRANSCRIPTION FACTOR PHO4; PORE COMPLEX; YEAST NUCLEOPORIN;
   SACCHAROMYCES-CEREVISIAE; TRANSPORT KINETICS; PROTEOMIC ANALYSIS;
   LOCALIZATION; RECEPTOR; SUBSTRATE; NUP116P
AB Protein transport between the nucleus and cytoplasm requires interactions between nuclear pore complex proteins (nucleoporins) and soluble nuclear transport factors (karyopherins, importins, and exportins). Exactly how these interactions contribute to the nucleocytoplasmic transport of substrates remains unclear. Using a synthetic lethal screen with the nucleoporin NUP1, we have identified a conditional allele of NUP82, encoding an essential nuclear pore complex protein in Saccharomyces cerevisiae. This nup82-3 allele also exhibits synthetic genetic interactions with mutants of the karyopherin MSN5. nup82-3 mutants accumulate the Msn5 export substrate Pho4 within the nucleus at nonpermissive temperatures. The nuclear import of the RPA complex subunit Rfa2 is impaired in nup82-3 and in mutants of the karyopherin KAP95, but is not affected by the loss of MSN5. Interestingly, deletion of MSN5 results in retention of Rfa2-GFP within the nucleus under conditions in which it normally diffuses out. These data provide evidence that Nup82 is important for Msn5-mediated nuclear protein export and Kap95-mediated protein import. In addition, Msn5 may play a role independent of import in the localization of Rfa2.
C1 Colgate Univ, Dept Biol, Hamilton, NY 13346 USA.
   Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Belanger, KD (corresponding author), Colgate Univ, Dept Biol, 13 Oak Dr, Hamilton, NY 13346 USA.
EM kbelanger@mail.colgate.edu
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R15GM065107,
   R15GM065107] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS) [R15
   GM065107, GM-65107, R15 GM065107-01] Funding Source: Medline
CR Alepuz PM, 1999, GENETICS, V153, P1219
   Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200
   Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   BELANGER KD, 1994, J CELL BIOL, V126, P619, DOI 10.1083/jcb.126.3.619
   Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475
   Blondel M, 1999, GENE DEV, V13, P2284, DOI 10.1101/gad.13.17.2284
   Booth JW, 1999, J BIOL CHEM, V274, P32360, DOI 10.1074/jbc.274.45.32360
   Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8
   DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X
   ENENKEL C, 1995, J BIOL CHEM, V270, P16499, DOI 10.1074/jbc.270.28.16499
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2
   Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894
   Gleizes PE, 2001, J CELL BIOL, V155, P923, DOI 10.1083/jcb.200108142
   GORLICH D, 1995, NATURE, V377, P246, DOI 10.1038/377246a0
   Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135
   GRANDI P, 1995, J CELL BIOL, V130, P1263, DOI 10.1083/jcb.130.6.1263
   GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x
   Guthrie C., 1991, GUIDE YEAST GENETICS
   Ho AK, 2000, MOL CELL BIOL, V20, P5736, DOI 10.1128/MCB.20.15.5736-5748.2000
   Hurwitz ME, 1998, P NATL ACAD SCI USA, V95, P11241, DOI 10.1073/pnas.95.19.11241
   HURWITZ ME, 1995, J CELL BIOL, V130, P1275, DOI 10.1083/jcb.130.6.1275
   Jullien D, 1999, EMBO J, V18, P4348, DOI 10.1093/emboj/18.15.4348
   Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673
   Kaffman A, 1998, NATURE, V396, P482
   Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001
   Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9
   Maniar HS, 1997, GENETICS, V145, P891
   MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P2008, DOI 10.1073/pnas.92.6.2008
   Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118
   Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9
   OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141
   Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200
   Queralt E, 2003, MOL CELL BIOL, V23, P3126, DOI 10.1128/MCB.23.9.3126-3140.2003
   REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7
   Roberts PM, 1998, METHOD CELL BIOL, V53, P545
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0
   Sambrook J, 1989, MOL CLONING LAB MANU
   Shulga N, 1996, J CELL BIOL, V135, P329, DOI 10.1083/jcb.135.2.329
   Solsbacher J, 2000, MOL CELL BIOL, V20, P8468, DOI 10.1128/MCB.20.22.8468-8479.2000
   Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0
   Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200
   Strom AC, 2001, GENOME BIOL, V2
   Vainberg IE, 2000, MOL CELL BIOL, V20, P3996, DOI 10.1128/MCB.20.11.3996-4005.2000
   Woods R.A., 2001, METH MOL B, V177, P85
   Yoshida K, 2001, J CELL BIOL, V152, P729, DOI 10.1083/jcb.152.4.729
NR 53
TC 10
Z9 10
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 15
PY 2004
VL 279
IS 42
BP 43530
EP 43539
DI 10.1074/jbc.M407641200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 860YY
UT WOS:000224383100023
PM 15294903
OA Other Gold
DA 2021-01-25
ER

PT J
AU Ducreux, S
   Zorzato, F
   Muller, C
   Sewry, C
   Muntoni, F
   Quinlivan, R
   Restagno, G
   Girard, T
   Treves, S
AF Ducreux, S
   Zorzato, F
   Muller, C
   Sewry, C
   Muntoni, F
   Quinlivan, R
   Restagno, G
   Girard, T
   Treves, S
TI Effect of ryanodine receptor mutations on interleukin-6 release and
   intracellular calcium homeostasis in human myotubes from malignant
   hyperthermia-susceptible individuals and patients affected by central
   core disease
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID GENE-EXPRESSION; SARCOPLASMIC-RETICULUM; CA2+; CELLS; ACTIVATION;
   DOMAIN; RODS; LOOP
AB In this study we report for the first time the functional properties of human myotubes isolated from patients harboring the native RYR1 I4898T and R4893W mutations linked to central core disease. We examined two aspects of myotube physiology, namely excitation-contraction and excitation-secretion coupling. Our results show that upon activation of the ryanodine receptor (RYR), myotubes release interleukin-6 (IL-6); this was dependent on de novo protein synthesis and could be blocked by dantrolene and cyclosporine. Myotubes from the two patients affected by central core disease showed a 4-fold increase in the release of the inflammatory cytokine IL-6, compared with cells derived from control or malignant hyperthermia susceptible individuals. All tested myotubes released calcium from intracellular stores upon stimulation via surface membrane depolarization or direct RYR activation by 4-chloro-m-cresol. The functional impact on calcium release of RYR1 mutations linked to central core disease or malignant hyperthermia is different: human myotubes carrying the malignant hyperthermia-linked RYR1 mutation V2168M had a shift in their sensitivity to the RYR agonist 4-chloro-m-cresol to lower concentrations, whereas human myotubes harboring C-terminal mutations linked to central core disease exhibited reduced [Ca2+](i) increase in response to 4-chloro-m-cresol, caffeine, and KCl. Taken together, these results suggest that abnormal release of calcium via mutated RYR enhances the production of the inflammatory cytokine IL-6, which may in turn affect signaling pathways responsible for the trophic status of muscle fibers.
C1 Kantonsspital, Dept Anaesthesia, CH-4031 Basel, Switzerland.
   Kantonsspital, Dept Res, CH-4031 Basel, Switzerland.
   Univ Ferrara, Dipartimento Med Sperimentale & Diagnost, I-44100 Ferrara, Italy.
   Univ Wurzburg, Biozentrum, Inst Humangenet, D-97074 Wurzburg, Germany.
   Dubowitz Neuromuscular Ctr, London W12 0NN, England.
   Robert Jones & Agnes Hunt Orthopaed Hosp NHS Trus, Neuromuscular Ctr, Oswestry SY10 7AG, Shrops, England.
   Azienda Osped S Anna, Dipartimento Patol Clin, SC Genet Mol, I-10126 Turin, Italy.
RP Treves, S (corresponding author), Kantonsspital, Dept Anaesthesia, CH-4031 Basel, Switzerland.
EM susan.treves@unibas.ch
RI DUCREUX, SYLVIE/D-6257-2013
OI DUCREUX, SYLVIE/0000-0003-3207-9537; Treves, Susan/0000-0002-0007-9631
CR Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791
   Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198
   Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850
   Benacquista BL, 2000, BIOPHYS J, V78, P1349, DOI 10.1016/S0006-3495(00)76689-6
   Censier K, 1998, J CLIN INVEST, V101, P1233, DOI 10.1172/JCI993
   Chen SRW, 2002, BIOPHYS J, V82, P2436
   Constantin B, 1996, CELL CALCIUM, V19, P365, DOI 10.1016/S0143-4160(96)90109-8
   Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000
   Denborough M, 1998, LANCET, V352, P1131, DOI 10.1016/S0140-6736(98)03078-5
   Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999
   Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev
   Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677
   FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.biophys.18.1.333
   Friday BB, 2001, J CELL SCI, V114, P303
   GALLANT EM, 1992, AM J PHYSIOL, V262, pC422
   Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9
   Gelfand J.A., 2001, HARRISONS PRINCIPLES, P90
   Girard T, 2001, Hum Mutat, V18, P357, DOI 10.1002/humu.1203
   Girard T, 2001, J BIOL CHEM, V276, P48077, DOI 10.1074/jbc.M107134200
   GONCHAROVA EJ, 1992, DEVELOPMENT, V114, P173
   Gonzalez E, 2003, J PHYSIOL-LONDON, V552, P833, DOI 10.1113/jphysiol.2003.048165
   GREENFIELD JG, 1958, BRAIN, V81, P461, DOI 10.1093/brain/81.4.461
   HAYASHI K, 1989, MUSCLE NERVE, V12, P95, DOI 10.1002/mus.880120203
   Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297
   HerrmannFrank A, 1996, BIOCHEM PHARMACOL, V52, P149, DOI 10.1016/0006-2952(96)00175-X
   Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2
   ISAACS H, 1975, J NEUROL NEUROSUR PS, V38, P1177, DOI 10.1136/jnnp.38.12.1177
   Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D
   Kamdar SJ, 1997, EXP CELL RES, V232, P439, DOI 10.1006/excr.1997.3551
   Kami K, 2000, J HISTOCHEM CYTOCHEM, V48, P1203, DOI 10.1177/002215540004800904
   LARACH MG, 1994, ANESTHESIOLOGY, V80, P771, DOI 10.1097/00000542-199404000-00008
   Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164
   MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759
   McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D
   McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435
   Monnier N, 2000, HUM MOL GENET, V9, P2599, DOI 10.1093/hmg/9.18.2599
   Reid MB, 2001, ACTA PHYSIOL SCAND, V171, P225, DOI 10.1046/j.1365-201x.2001.00824.x
   RIOS E, 1991, PHYSIOL REV, V71, P849
   Santana LF, 2002, J PHYSIOL-LONDON, V544, P57, DOI 10.1113/jphysiol.2002.020552
   Scacheri PC, 2000, NEUROLOGY, V55, P1689, DOI 10.1212/WNL.55.11.1689
   Sewry CA, 2002, NEUROMUSCULAR DISORD, V12, P930, DOI 10.1016/S0960-8966(02)00135-9
   SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004
   SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610
   Sugiura T, 2002, INT IMMUNOL, V14, P917, DOI 10.1093/intimm/dxf062
   TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0
   Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879
   Tong JF, 1999, J BIOL CHEM, V274, P693, DOI 10.1074/jbc.274.2.693
   Treves S, 2002, CELL CALCIUM, V31, P1, DOI 10.1054/ceca.2001.0252
   Wehner M, 2003, CELL CALCIUM, V34, P163, DOI 10.1016/S0143-4160(03)00072-1
   WIETZERBIN J, 1989, ANN NY ACAD SCI, V557, P162
   Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200
   Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200
   Zorzato F, 2003, HUM MOL GENET, V12, P379, DOI 10.1093/hmg/ddg032
   ZORZATO F, 1990, J BIOL CHEM, V265, P2244
   Zumwalt JW, 1999, ENDOCRINOLOGY, V140, P888, DOI 10.1210/en.140.2.888
NR 55
TC 69
Z9 70
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 15
PY 2004
VL 279
IS 42
BP 43838
EP 43846
DI 10.1074/jbc.M403612200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 860YY
UT WOS:000224383100060
PM 15299003
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Noskov, SY
   Berneche, S
   Roux, B
AF Noskov, SY
   Berneche, S
   Roux, B
TI Control of ion selectivity in potassium channels by electrostatic and
   dynamic properties of carbonyl ligands
SO NATURE
LA English
DT Article
ID K+ CHANNEL; CONDUCTION; PERMEATION; ENERGY; FILTER; NA+; SIMULATIONS;
   MUTATIONS; OCCUPANCY; PROTEINS
AB Potassium channels are essential for maintaining a normal ionic balance across cell membranes. Central to this function is the ability of such channels to support transmembrane ion conduction at nearly diffusion-limited rates while discriminating for K+ over Na+ by more than a thousand-fold. This selectivity arises because the transfer of the K+ ion into the channel pore is energetically favoured, a feature commonly attributed to a structurally precise fit between the K+ ion and carbonyl groups lining the rigid and narrow pore(1). But proteins are relatively flexible structures(2,3) that undergo rapid thermal atomic fluctuations larger than the small difference in ionic radius between K+ and Na+. Here we present molecular dynamics simulations for the potassium channel KcsA, which show that the carbonyl groups coordinating the ion in the narrow pore are indeed very dynamic ('liquid-like') and that their intrinsic electrostatic properties control ion selectivity. This finding highlights the importance of the classical concept of field strength(4). Selectivity for K+ is seen to emerge as a robust feature of a flexible fluctuating pore lined by carbonyl groups.
C1 Cornell Univ, Weill Med Coll, Dept Biochem & Struct Biol, New York, NY 10021 USA.
   Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Roux, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem & Struct Biol, 1300 York Ave, New York, NY 10021 USA.
EM benoit.roux@med.cornell.edu
RI Noskov, Sergei/B-3654-2010; Berneche, Simon/L-6389-2013
OI Berneche, Simon/0000-0002-6274-4094; Noskov, Sergei/0000-0001-7769-335X
CR Allen TW, 2000, J CHEM PHYS, V112, P8191, DOI 10.1063/1.481420
   ALLEN TW, IN PRESS J GEN PHYSL
   Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114
   AQVIST J, 1992, J PHYS CHEM-US, V96, P10019
   Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067
   Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364
   EISENMAN G, 1962, Biophys J, V2, P259
   Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c
   HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0
   Hille B, 1999, NAT MED, V5, P1105, DOI 10.1038/13415
   Hille B., 2001, ION CHANNELS EXCITAB
   KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0
   LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671
   LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303
   Loboda A, 2001, BIOPHYS J, V80, P2704, DOI 10.1016/S0006-3495(01)76239-X
   Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080
   Luzhkov VB, 2001, BBA-PROTEIN STRUCT M, V1548, P194, DOI 10.1016/S0167-4838(01)00213-8
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   MARRONE TJ, 1995, J AM CHEM SOC, V117, P779, DOI 10.1021/ja00107a022
   Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000
   NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569
   Nimigean CM, 2002, J GEN PHYSIOL, V120, P323, DOI 10.1085/jgp.20028614
   Pauling L., 1960, NATURE CHEM BOND STR
   Shrivastava IH, 2002, BIOPHYS J, V83, P633, DOI 10.1016/S0006-3495(02)75197-7
   WEEKS JD, 1971, J CHEM PHYS, V54, P5237, DOI 10.1063/1.1674820
   YAMASHITA MM, 1990, P NATL ACAD SCI USA, V87, P5648, DOI 10.1073/pnas.87.15.5648
   Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604
   Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022
   Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009
NR 32
TC 385
Z9 394
U1 5
U2 92
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD OCT 14
PY 2004
VL 431
IS 7010
BP 830
EP 834
DI 10.1038/nature02943
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 861RE
UT WOS:000224435500043
PM 15483608
DA 2021-01-25
ER

PT J
AU Flames, N
   Long, JE
   Garratt, AN
   Fischer, TM
   Gassmann, M
   Birchmeier, C
   Lai, C
   Rubenstein, JLR
   Marin, O
AF Flames, N
   Long, JE
   Garratt, AN
   Fischer, TM
   Gassmann, M
   Birchmeier, C
   Lai, C
   Rubenstein, JLR
   Marin, O
TI Short- and long-range attraction of cortical GABAergic interneurons by
   Neuregulin-1
SO NEURON
LA English
DT Article
ID MEDIAL GANGLIONIC EMINENCE; DEVELOPING CEREBRAL-CORTEX; SCHWANN-CELL
   MOTILITY; AT-RISK HAPLOTYPE; NEOCORTICAL DEVELOPMENT; TANGENTIAL
   MIGRATION; NEURONAL MIGRATION; MAMMARY-GLAND; RADIAL GLIA; SCHIZOPHRENIA
AB Most cortical interneurons arise from the subcortical telencephalon, but the molecules that control their migration remain largely unidentified. Here, we show that different isoforms of Neuregulin-1 are expressed in the developing cortex and in the route that migrating interneurons follow toward the cortex, whereas a population of the migrating interneurons express ErbB4 a receptor for Neuregulin-1. The different isoforms of Neuregulin-1 act as short- and long-range attractants for migrating interneurons, and perturbing ErbB4 function in vitro decreases the number of interneurons that tangentially migrate to the cortex. In vivo, loss of Neuregulin-1/ErbB4 signaling causes an alteration in the tangential migration of cortical interneurons and a reduction in the number of GABAergic interneurons in the postnatal cortex. These observations provide evidence that Neuregulin-1 and its ErbB4 receptor directly control neuronal migration in the nervous system.
C1 CSIC, Inst Neurociencias Alicante, San Juan de Alicante 03550, Spain.
   Univ Miguel Hernandez, San Juan de Alicante 03550, Spain.
   Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA.
   Max Delbrueck Ctr, D-13125 Berlin, Germany.
   Scripps Res Inst, La Jolla, CA 92037 USA.
   Univ Basel, Dept Physiol, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Marin, O (corresponding author), CSIC, Inst Neurociencias Alicante, San Juan de Alicante 03550, Spain.
EM o.marin@umh.es
RI Garratt, Alistair N/D-9893-2013; Flames, Nuria/L-2290-2017; Marin,
   Oscar/F-3856-2012
OI Garratt, Alistair N/0000-0001-9631-3041; Flames,
   Nuria/0000-0003-0961-0609; Marin, Oscar/0000-0001-6264-7027; Gassmann,
   Martin/0000-0001-6201-3032
FU NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [R01MH051561, K02MH001046,
   K02MH001046, K02MH001046, R01MH051561, R01MH051561, R01MH049428,
   K02MH001046, R01MH049428, K02MH001046, R01MH049428, R01MH051561,
   K02MH001046, R01MH049428, R01MH049428, K02MH001046, K02MH001046,
   R01MH049428, R01MH049428, R01MH049428, R01MH049428, R01MH049428,
   R01MH049428, R01MH051561, R01MH049428, R01MH051561, K02MH001046,
   R01MH051561, R01MH051561, R01MH049428, K02MH001046, R01MH049428,
   R01MH049428, R01MH049428, R01MH049428] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Drug Abuse (NIDA) [R01DA012462, R01DA012462, R01DA012462,
   R01DA012462, R01DA012462, R01DA012462] Funding Source: NIH RePORTER;
   NIDA NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Drug Abuse
   (NIDA) [R01DA12462] Funding Source: Medline; NIMH NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [K02MH01046,
   R01MH49428, R01MH51561] Funding Source: Medline
CR Adlkofer K, 2000, GLIA, V29, P104, DOI 10.1002/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2
   Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474
   Anderson SA, 2002, CEREB CORTEX, V12, P702, DOI 10.1093/cercor/12.7.702
   Anderson SA, 2001, DEVELOPMENT, V128, P353
   Ang ESBC, 2003, J NEUROSCI, V23, P5805
   Anton ES, 1997, DEVELOPMENT, V124, P3501
   Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1
   Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5
   Caric D, 2001, DEVELOPMENT, V128, P4203
   Casarosa S, 1999, DEVELOPMENT, V126, P525
   Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749
   Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258
   Corvin AP, 2004, MOL PSYCHIATR, V9, P208, DOI 10.1038/sj.mp.4001412
   DeCarlos JA, 1996, J NEUROSCI, V16, P6146
   Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7
   Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.3.CO;2-X
   GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0
   Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8
   Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3
   Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732
   Jimenez D, 2002, DEV BIOL, V244, P155, DOI 10.1006/dbio.2002.0586
   Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77
   Keverne EB, 1999, BRAIN RES BULL, V48, P467, DOI 10.1016/S0361-9230(99)00025-8
   Lavdas AA, 1999, J NEUROSCI, V19, P7881
   Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754
   Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9
   Li T, 2004, MOL PSYCHIATR, V9, P698, DOI 10.1038/sj.mp.4001485
   Mahanthappa NK, 1996, J NEUROSCI, V16, P4673
   Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058
   Marin O, 2003, DEVELOPMENT, V130, P1889, DOI 10.1242/dev.00417
   Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891
   Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509
   Martinez S, 1999, DEVELOPMENT, V126, P1189
   Mazumdar A, 2001, CANCER RES, V61, P400
   Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038
   MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0
   Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971
   Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5
   Polleux F, 2002, DEVELOPMENT, V129, P3147
   Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1
   Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3
   SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823
   Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100
   Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442
   Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734
   Sussel L, 1999, DEVELOPMENT, V126, P3359
   TAN SS, 1995, DEVELOPMENT, V121, P1029
   TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0
   Tang JX, 2004, MOL PSYCHIATR, V9, P11, DOI 10.1038/sj.mp.4001436
   Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100
   Wichterle H, 2003, P NATL ACAD SCI USA, V100, P727, DOI 10.1073/pnas.242721899
   Wichterle H, 2001, DEVELOPMENT, V128, P3759
   Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131
   Williams NM, 2003, MOL PSYCHIATR, V8, P485, DOI 10.1038/sj.mp.4001348
   Woo TU, 1998, P NATL ACAD SCI USA, V95, P5341, DOI 10.1073/pnas.95.9.5341
   Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377
   Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252
   Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6
NR 58
TC 301
Z9 310
U1 0
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD OCT 14
PY 2004
VL 44
IS 2
BP 251
EP 261
DI 10.1016/j.neuron.2004.09.028
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 864LU
UT WOS:000224635800009
PM 15473965
DA 2021-01-25
ER

PT J
AU Higy, M
   Junne, T
   Spiess, M
AF Higy, M
   Junne, T
   Spiess, M
TI Topogenesis of membrane proteins at the endoplasmic reticulum
SO BIOCHEMISTRY
LA English
DT Editorial Material
ID SIGNAL RECOGNITION PARTICLE; POSITIVELY CHARGED RESIDUES;
   METHIONINE-RICH DOMAIN; ER MEMBRANE; CONDUCTING CHANNEL; TRANSMEMBRANE
   ORIENTATION; SEQUENCE ORIENTATION; NASCENT POLYPEPTIDES;
   MOLECULAR-MECHANISM; SECRETORY PROTEIN
AB Most eukaryotic membrane proteins are cotranslationally integrated into the endoplasmic reticulum membrane by the Sec61 translocation complex. They are targeted to the translocon by hydrophobic signal sequences, which induce the translocation of either their N- or their C-terminal sequence. Signal sequence orientation is largely determined by charged residues flanking the apolar sequence (the positive-inside rule), folding properties of the N-terminal segment, and the hydrophobicity of the signal. Recent in vivo experiments suggest that N-terminal signals initially insert into the translocon head-on to yield a translocated N-terminus. Driven by a local electrical potential, the signal may invert its orientation and translocate the C-terminal sequence. Increased hydrophobicity slows down inversion by stabilizing the initial bound state. In vitro cross-linking studies indicate that signals rapidly contact lipids upon entering the translocon. Together with the recent crystal structure of the homologous SecYEbeta translocation complex of Methanococcus jannaschii, which did not reveal an obvious hydrophobic binding site for signals within the pore, a model emerges in which the translocon allows the lateral partitioning of hydrophobic segments between the aqueous pore and the lipid membrane. Signals may return into the pore for reorientation until translation is terminated. Subsequent transmembrane segments in multispanning proteins behave similarly and contribute to the overall topology of the protein.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Martin.Spiess@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
CR Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200
   Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4
   BELTZER JP, 1991, J BIOL CHEM, V266, P973
   BLOBEL G, 1975, J CELL BIOL, V67, P852, DOI 10.1083/jcb.67.3.852
   BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835
   Bogdanov M, 1999, J BIOL CHEM, V274, P36827, DOI 10.1074/jbc.274.52.36827
   Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2
   BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643
   CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3
   Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x
   DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633
   Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0
   Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250
   Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827
   Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119
   Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599
   Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257
   Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361
   Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0
   GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7
   GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G
   Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074
   Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4
   HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786
   Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3
   Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346
   HIGH S, 1991, J CELL BIOL, V113, P25, DOI 10.1083/jcb.113.1.25
   Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799
   Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755
   Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X
   KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604
   KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0
   Lemberg MK, 2004, FEBS LETT, V564, P213, DOI 10.1016/S0014-5793(04)00192-9
   Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6
   LUTCKE H, 1992, EMBO J, V11, P1543, DOI 10.1002/j.1460-2075.1992.tb05199.x
   Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636
   MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5
   Martoglio B, 1996, TRENDS CELL BIOL, V6, P142, DOI 10.1016/0962-8924(96)10001-5
   Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9
   McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6
   Meacock SL, 2002, MOL BIOL CELL, V13, P4114, DOI 10.1091/mbc.E02-04-0198
   Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0
   MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x
   Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355
   Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2
   Nilsson I, 2000, J BIOL CHEM, V275, P6207, DOI 10.1074/jbc.275.9.6207
   Ota K, 2000, J BIOL CHEM, V275, P29743, DOI 10.1074/jbc.M002468200
   Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y
   PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2
   PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U
   Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200
   SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16
   Sato M, 1998, J BIOL CHEM, V273, P25203, DOI 10.1074/jbc.273.39.25203
   Sato Y, 2003, J BIOL CHEM, V278, P13227, DOI 10.1074/jbc.M300431200
   Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519
   Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881
   STIRLING CJ, 1992, MOL BIOL CELL, V3, P129
   van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218
   van Voorst F, 2000, BIOCHEM J, V347, P601, DOI 10.1042/bj3470601
   vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261
   VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x
   VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635
   VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0
   Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555
   Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925
   WESSELS HP, 1988, CELL, V55, P61, DOI 10.1016/0092-8674(88)90009-8
   ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x
NR 67
TC 109
Z9 113
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD OCT 12
PY 2004
VL 43
IS 40
BP 12716
EP 12722
DI 10.1021/bi048368m
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 860VI
UT WOS:000224371400002
PM 15461443
DA 2021-01-25
ER

PT J
AU Arber, S
   Wong, R
AF Arber, S
   Wong, R
TI Neuronal and glial cell biology - Editorial overview
SO CURRENT OPINION IN NEUROBIOLOGY
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch; wongr@pcg.wustl.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-4388
J9 CURR OPIN NEUROBIOL
JI Curr. Opin. Neurobiol.
PD OCT
PY 2004
VL 14
IS 5
BP 519
EP 521
DI 10.1016/j.conb.2004.08.018
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA 865RU
UT WOS:000224721200001
DA 2021-01-25
ER

PT J
AU Bauer, Y
   Knechtle, P
   Wendland, J
   Helfer, H
   Philippsen, P
AF Bauer, Y
   Knechtle, P
   Wendland, J
   Helfer, H
   Philippsen, P
TI A Ras-like GTPase is involved in hyphal growth guidance in the
   filamentous fungus Ashbya gossypii
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID BUD-SITE SELECTION; CELL POLARITY; NEUROSPORA-CRASSA;
   SACCHAROMYCES-CEREVISIAE; NUCLEAR-DISTRIBUTION; ACTIN CYTOSKELETON;
   NEURITE OUTGROWTH; RHO-GTPASES; PC12 CELLS; CYTOPLASMIC DYNEIN
AB Characteristic features of morphogenesis in filamentous fungi are sustained polar growth at tips of hyphae and frequent initiation of novel growth sites (branches) along the extending hyphae. We have begun to study regulation of this process on the molecular level by using the model fungus Ashbya gossypii. We found that the A. gossypii Ras-like GTPase Rsr1p/Bud1p localizes to the tip region and that it is involved in apical polarization of the actin cytoskeleton, a determinant of growth direction. In the absence of RSR1/BUD1, hyphal growth was severely slowed down due to frequent phases of pausing of growth at the hyphal tip. During pausing events a hyphal tip marker, encoded by the polarisome component AgSPA2, disappeared from the tip as was shown by in vivo time-lapse fluorescence microscopy of green fluorescent protein-labeled AgSpa2p. Reoccurrence of AgSpa2p was required for the resumption of hyphal growth. In the Agrsr1/bud1Delta deletion mutant, resumption of growth occurred at the hyphal tip in a frequently uncoordinated manner to the previous axis of polarity. Additionally, hyphal filaments in the mutant developed aberrant branching sites by mislocalizing AgSpa2p thus distorting hyphal morphology. These results define AgRsr1p/Bud1p as a key regulator of hyphal growth guidance.
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
OI Wendland, Juergen/0000-0001-8350-253X; Knechtle,
   Philipp/0000-0003-0377-9446
CR Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Bidlingmaier S, 2004, J CELL BIOL, V164, P207, DOI 10.1083/jcb.200307065
   Brown JL, 1997, GENE DEV, V11, P2972, DOI 10.1101/gad.11.22.2972
   Bruno KS, 1996, P NATL ACAD SCI USA, V93, P4775, DOI 10.1073/pnas.93.10.4775
   Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4
   CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q
   Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X
   Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   Fowler TJ, 2000, GENETICS, V156, P1585
   GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0
   Goi T, 1999, MOL CELL BIOL, V19, P1731
   Gorfer M, 2001, MOL PLANT MICROBE IN, V14, P135, DOI 10.1094/MPMI.2001.14.2.135
   GOW NAR, 1994, MICROBIOL-SGM, V140, P3193, DOI 10.1099/13500872-140-12-3193
   HAROLD FM, 1995, MICROBIOL-UK, V141, P2765, DOI 10.1099/13500872-141-11-2765
   Heath IB, 1999, FUNGAL GENET BIOL, V28, P79, DOI 10.1006/fgbi.1999.1168
   Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5
   HERSKOWITZ I, 1995, SPRING HARBOR S QUAN
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   Hoshino M, 2003, J CELL BIOL, V163, P1067, DOI 10.1083/jcb.200308070
   Hoshino M, 2002, BIOCHEM BIOPH RES CO, V295, P651, DOI 10.1016/S0006-291X(02)00731-3
   Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068
   Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000
   Kawasaki R, 2003, GENES CELLS, V8, P235, DOI 10.1046/j.1365-2443.2003.00629.x
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Kozminski KG, 2003, MOL BIOL CELL, V14, P4958, DOI 10.1091/mbc.E03-06-0426
   Lee CHJ, 1996, J NEUROSCI, V16, P6784
   Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547
   Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687
   Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5
   Nakamura T, 2002, MOL CELL BIOL, V22, P8721, DOI 10.1128/MCB.22.24.8721-8734.2002
   Nern A, 2000, MOL CELL, V5, P853, DOI 10.1016/S1097-2765(00)80325-1
   Park HO, 2002, J BIOL CHEM, V277, P26721, DOI 10.1074/jbc.C200245200
   Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463
   PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139
   PRINGLE JR, 1995, COLD SPRING HARBOR S
   Riquelme M, 2000, MICROBIOL-UK, V146, P1743, DOI 10.1099/00221287-146-7-1743
   Riquelme M, 2002, FUNGAL GENET BIOL, V37, P171, DOI 10.1016/S1087-1845(02)00506-6
   SAMBROOK J, 1989, MOL CLONING LAB MAN
   Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305
   Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433
   Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000
   Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053
   Spencer ML, 2002, J BIOL CHEM, V277, P20160, DOI 10.1074/jbc.M201092200
   Tinsley JH, 1996, MOL BIOL CELL, V7, P731
   Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2003, EMBO REP, V4, P200, DOI 10.1038/sj.embor.embor727
   Wendland J, 2001, FUNGAL GENET BIOL, V34, P63, DOI 10.1006/fgbi.2001.1290
   Wendland J, 2001, GENETICS, V157, P601
   Wendland J, 2000, J CELL SCI, V113, P1611
   Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x
   WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z
   Yaar L, 1997, MICROBIOL-SGM, V143, P3033, DOI 10.1099/00221287-143-9-3033
   Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2
NR 56
TC 50
Z9 50
U1 0
U2 2
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD OCT
PY 2004
VL 15
IS 10
BP 4622
EP 4632
DI 10.1091/mbc.E04-02-0104
PG 11
WC Cell Biology
SC Cell Biology
GA 858AJ
UT WOS:000224162200024
PM 15282338
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Loretan, K
   Bissiere, S
   Luthi, A
AF Loretan, K
   Bissiere, S
   Luthi, A
TI Dopaminergic modulation of spontaneous inhibitory network activity in
   the lateral amygdala
SO NEUROPHARMACOLOGY
LA English
DT Article
DE amygdala; dopamine; interneuron; IPSC; oscillations; tyrosine kinase
ID FEAR-POTENTIATED STARTLE; ANTAGONIST SCH 23390; BASOLATERAL AMYGDALA;
   GLUTAMATE RECEPTORS; D-1 RECEPTOR; IN-VIVO; RAT-BRAIN; NEURONS; D1;
   ACTIVATION
AB There is converging evidence that dopamine (DA) receptor activation in the lateral amygdala (LA) is required for the acquisition of conditioned fear. Powerful inhibitory circuits exist in the LA shaping the activity of excitatory projection neurons and controlling the induction of associative plasticity, which is thought to underlie fear learning. In vivo and in vitro electrophysiological experiments indicate that DA Suppresses inhibitory transmission triggered by excitatory afferent input. Conversely, DA increase the excitability of inhibitory interneurons in the LA. However, the mechanisms by which DA modulates inhibitory transmission are poorly understood. Using whole-cell recordings from LA projection neurons in coronal mouse brain slices, we found that DA strongly increased the frequency of spontaneous inhibitory postsynaptic Currents (sIPSCs). In addition, DA application induced low-frequency (2-6 Hz) oscillatory activity of inhibitory circuits in the absence of excitatory input. The increase in sIPSC frequency required activation of D1-like receptors. Unlike D1 receptor-mediated transmission in other brain areas, this effect was independent of the cAMP/PKA signal transduction cascade, but involved activation of the protein tyrosine kinase Src. This indicates that DA orchestrates the activity of populations of interneurons in the LA by a D1-dependent, non-cationical signal transduction pathway. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Luthi, A (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.
EM andreas.luthi@fmi.ch
CR Beierlein M, 2000, NAT NEUROSCI, V3, P904
   Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3
   Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058
   BOYSON SJ, 1986, J NEUROSCI, V6, P3177
   Brinley-Reed M, 1999, BRAIN RES, V850, P127, DOI 10.1016/S0006-8993(99)02112-5
   Collins DR, 1999, NEUROSCIENCE, V89, P1025, DOI 10.1016/S0306-4522(98)00396-0
   DAVIS M, 2000, AMYGDALA, P231
   Dunah AW, 2001, J NEUROSCI, V21, P5546
   Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121
   El-Ghundi M, 2001, BRAIN RES, V892, P86, DOI 10.1016/S0006-8993(00)03234-0
   Fi XF, 1996, SYNAPSE, V24, P115, DOI 10.1002/(SICI)1098-2396(199610)24:2<115::AID-SYN3>3.0.CO;2-I
   Freissmuth M, 1999, TRENDS PHARMACOL SCI, V20, P237, DOI 10.1016/S0165-6147(99)01337-1
   Frohardt RJ, 2000, BEHAV NEUROSCI, V114, P227, DOI 10.1037/0735-7044.114.2.227
   Galarreta M, 1999, NATURE, V402, P72
   Gibson JR, 1999, NATURE, V402, P75
   Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1
   Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0
   Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262
   Guarraci FA, 1999, BRAIN RES, V827, P28, DOI 10.1016/S0006-8993(99)01291-3
   Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996
   Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X
   Hopf FW, 2003, J NEUROSCI, V23, P5079
   Inglis FM, 1999, J NEUROCHEM, V72, P1088, DOI 10.1046/j.1471-4159.1999.0721088.x
   Lamont EW, 1998, BRAIN RES, V795, P128, DOI 10.1016/S0006-8993(98)00281-9
   Lang EJ, 1997, J NEUROPHYSIOL, V77, P341
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   Leonard SK, 2003, SYNAPSE, V50, P320, DOI 10.1002/syn.10272
   Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897
   MEADORWOODRUFF JH, 1991, NEUROPSYCHOPHARMACOL, V5, P231
   Missale C, 1998, PHYSIOL REV, V78, P189
   Pape HC, 1998, J NEUROPHYSIOL, V79, P205
   PARE D, 1995, J NEUROPHYSIOL, V74, P1179
   Pare D, 2000, J NEUROSCI, V20, P2701
   Rosenkranz JA, 1999, J NEUROSCI, V19, P11027
   Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a
   Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002
   Rosenkranz JA, 2001, J NEUROSCI, V21, P4090, DOI 10.1523/JNEUROSCI.21-11-04090.2001
   Ruskin DN, 1999, J PHARMACOL EXP THER, V290, P1493
   Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003
   Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818
   Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513
   UNDIE AS, 1994, J NEUROCHEM, V62, P2045
   Weisskopf MG, 1999, J NEUROSCI, V19, P10512
NR 43
TC 42
Z9 42
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0028-3908
EI 1873-7064
J9 NEUROPHARMACOLOGY
JI Neuropharmacology
PD OCT
PY 2004
VL 47
IS 5
BP 631
EP 639
DI 10.1016/j.neuropharm.2004.07.015
PG 9
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 864LI
UT WOS:000224634600001
PM 15458834
DA 2021-01-25
ER

PT J
AU Gnerre, C
   Blattler, S
   Kaufmann, MR
   Looser, R
   Meyer, UA
AF Gnerre, C
   Blattler, S
   Kaufmann, MR
   Looser, R
   Meyer, UA
TI Regulation of CYP3A4 by the bile acid receptor FXR: evidence for
   functional binding sites in the CYP3A4 gene
SO PHARMACOGENETICS
LA English
DT Article
DE CYP3A4; drug metabolism; farnesoid X receptor; gene regulation; GW4064;
   primary bile acids
ID PREGNANE-X-RECEPTOR; ORPHAN NUCLEAR RECEPTOR; CONSTITUTIVE ANDROSTANE
   RECEPTOR; SALT EXPORT PUMP; ACTIVATED RECEPTOR; HORMONE-RECEPTORS;
   LITHOCHOLIC ACID; CYTOCHROMES P450; HUMAN LIVER; INDUCTION
AB CYP3A4, the most abundant cytochrome P450 in human liver, is responsible for the metabolism of numerous xenobiotics and endobiotics. CYP3A4 expression is highly variable and is induced by numerous compounds of exogenous and endogenous origin, including elevated concentrations of secondary bile acids via the pregnane X receptor (PXR). We show that physiological concentrations of the primary bile acid chenodeoxycholic acid regulate the expression of CYP3A4 via the bile acid receptor FXR. Experiments performed in vitro in different cell culture systems, gel-mobility shift assays and experiments performed in vivo in transgenic mice lacking FXR or PXR and treated with the synthetic FXR agonist GW4064 were undertaken to study the implication of FXR in the regulation of CYP3A. Our data provide evidence for the presence of two functional FXR recognition sites located in a 345-bp element within the 5'-flanking region of CYP3A4. Mutational analysis of these sites and experiments in transgenic mice lacking FXR or PXR support the relevance of FXR activation for CYP3A regulation. Thus, whereas elevated concentrations of precursors of bile acids and secondary bile acids induce CYP3A via PXR, primary bile acids can modulate the expression of CYP3A via FXR. These findings may explain elevated CYP3A expression in cholestasis and part of the variability of drug responsiveness and toxicity between individuals. (C) 2004 Lippincott Williams Wilkins.
C1 Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Klingelbergstr 60-70, CH-4056 Basel, Switzerland.
EM urs-a.meyer@unibas.ch
CR Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200
   Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1
   Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898
   Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208
   BREMMELGAARD A, 1980, SCAND J GASTROENTERO, V15, P593, DOI 10.3109/00365528009182221
   Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918
   Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883
   Flockhart DA, 2003, PHARMACOGENOMICS J, V3, P3, DOI 10.1038/sj.tpj.6500144
   Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359
   Goodwin B, 1999, MOL PHARMACOL, V56, P1329
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100
   Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051
   GUO GL, 2003, J BIOL CHEM, V15, P15
   Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   Kliewer SA, 2002, J LIPID RES, V43, P359
   Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200
   Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477
   Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7
   Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587
   OURLIN JC, 2003, MOL ENDOCRINOL, V12, P12
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   PICHARD L, 1991, TRANSPLANT P, V23, P978
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591
   Savas U, 1999, MOL PHARMACOL, V56, P851
   Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200
   Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Stedman C, 2004, J BIOL CHEM, V279, P11336, DOI 10.1074/jbc.M310258200
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   SUMMERFIELD JA, 1976, BIOCHEM J, V154, P507, DOI 10.1042/bj1540507
   Thummel KE, 2001, MOL PHARMACOL, V60, P1399
   Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815
   Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200
   WAXMAN DJ, 1991, ARCH BIOCHEM BIOPHYS, V290, P160, DOI 10.1016/0003-9861(91)90602-F
   Willson TM, 2001, MED RES REV, V21, P513, DOI 10.1002/med.1023
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
NR 45
TC 116
Z9 121
U1 1
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0960-314X
J9 PHARMACOGENETICS
JI Pharmacogenetics
PD OCT
PY 2004
VL 14
IS 10
BP 635
EP 645
DI 10.1097/00008571-200410000-00001
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
GA 865FK
UT WOS:000224687700001
PM 15454728
DA 2021-01-25
ER

PT J
AU Audhya, A
   Loewith, R
   Parsons, AB
   Gao, L
   Tabuchi, M
   Zhou, HL
   Boone, C
   Hall, MN
   Emr, SD
AF Audhya, A
   Loewith, R
   Parsons, AB
   Gao, L
   Tabuchi, M
   Zhou, HL
   Boone, C
   Hall, MN
   Emr, SD
TI Genome-wide lethality screen identifies new PI4,5P2 effectors that
   regulate the actin cytoskeleton
SO EMBO JOURNAL
LA English
DT Article
DE actin; phosphoinositide; polarity; Rho GTPase; TOR
ID SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; PLASMA-MEMBRANE; SECRETORY
   VESICLES; DISTINCT ROLES; BUDDING YEAST; PROTEIN; KINASE; ORGANIZATION;
   COMPLEXES
AB To further understand the roles played by the essential phosphoinositide PI4,5P(2), we have used a synthetic lethal analysis, which systematically combined the mss4(ts) mutation, partially defective in PI4P 5-kinase activity, with each of approximately 4700 deletion mutations. This genomic screening technique uncovered numerous new candidate effectors and regulators of PI4,5P(2) in yeast. In particular, we identified Slm1 (Yil105c), a previously uncharacterized PI4,5P(2) binding protein. Like Mss4, Slm1 and its homolog Slm2 (Ynl047c) were required for actin cytoskeleton polarization and viability. Co-immunoprecipitation experiments revealed that Slm1 interacts with a component of TORC2, a Tor2 kinase-containing complex, which also regulates the actin cytoskeleton. Consistent with these findings, phosphorylation of Slm1 and Slm2 was dependent on TORC2 protein kinase activity, both in vivo and in vitro, and Slm1 localization required both PI4,5P(2) and functional TORC2. Together, these data suggest that Slm1 and Slm2 function downstream of PI4,5P(2) and the TORC2 kinase pathway to control actin cytoskeleton organization.
C1 Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.
   Univ Basel, Biozentrum, Div Biochem, Basel, Switzerland.
   Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada.
   Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada.
   Ludwig Inst Canc Res, La Jolla, CA USA.
RP Emr, SD (corresponding author), Univ Calif San Diego, Sch Med, HHMI, Div Cellular & Mol Med, Cellular & Mol Med Bldg,Rm 318,9500 Gilman Dr,3rd, La Jolla, CA 92093 USA.
EM semr@ucsd.edu
RI Loewith, Robbie/S-6289-2016; Tabuchi, Mitsuaki/E-9544-2010
OI Loewith, Robbie/0000-0002-2482-603X; Zhou, Huilin/0000-0002-1350-4430;
   Hall, Michael N/0000-0002-2998-0757; Tabuchi,
   Mitsuaki/0000-0002-2042-691X
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [CA58689] Funding Source: Medline; NHGRI NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Human Genome Research Institute (NHGRI) [K22 HG002604, K22
   HG002604-02] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689, P01CA058689,
   P01CA058689, P01CA058689, P01CA058689, P01CA058689] Funding Source: NIH
   RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Human Genome Research Institute (NHGRI) [K22HG002604,
   K22HG002604, K22HG002604, K22HG002604] Funding Source: NIH RePORTER
CR Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022
   Audhya A, 2003, EMBO J, V22, P4223, DOI 10.1093/emboj/cdg397
   Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673
   Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5
   Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X
   CIFUENTES ME, 1993, J BIOL CHEM, V268, P11586
   Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3
   Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163
   Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787
   Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481
   GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653
   Hallett MA, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-16
   Helliwell SB, 1998, GENETICS, V148, P99
   Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779
   Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Maniatis T, 1982, MOL CLONING LAB MANU
   Mulholland J, 1997, MOL BIOL CELL, V8, P1481
   Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7
   Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75
   Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6
   Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476
   Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2
   Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899
   Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8
NR 35
TC 105
Z9 109
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD SEP 29
PY 2004
VL 23
IS 19
BP 3747
EP 3757
DI 10.1038/sj.emboj.7600384
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 866CA
UT WOS:000224749300005
PM 15372071
OA Green Published
DA 2021-01-25
ER

PT J
AU Morales-Johansson, H
   Jenoe, P
   Cooke, FT
   Hall, MN
AF Morales-Johansson, H
   Jenoe, P
   Cooke, FT
   Hall, MN
TI Negative regulation of phosphatidylinositol 4,5-bisphosphate levels by
   the INP51-associated proteins TAX4 and IRS4
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CELL-WALL INTEGRITY; GTP-BINDING PROTEIN; KINASE SUBSTRATE EPS15;
   EXCHANGE FACTOR ROM2; 170 KDA ISOFORM; SACCHAROMYCES-CEREVISIAE; ACTIN
   CYTOSKELETON; EH-DOMAIN; 4-PHOSPHATE 5-KINASE; PLASMA-MEMBRANE
AB Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) is an important second messenger in signaling pathways in organisms ranging from yeast to mammals, but the regulation of PI(4,5) P(2) levels remains unclear. Here we present evidence that PI(4,5) P(2) levels in Saccharomyces cerevisiae are down-regulated by the homologous and functionally redundant proteins TAX4 and IRS4. The EPS15 homology domain-containing proteins TAX4 and IRS4 bind and activate the PI(4,5) P(2) 5-phosphatase INP51 via an Asn-Pro-Phe motif in INP51. Furthermore, the INP51-TAX4/IRS4 complex negatively regulates the cell integrity pathway. Thus, TAX4 and IRS4 are novel regulators of PI(4,5) P(2) and PI(4,5)P(2)-dependent signaling. The interaction between TAX4/IRS4 and INP51 is analogous to the association of EPS15 with the 5-phosphatase synaptojanin 1 in mammalian cells, suggesting that EPS15 is an activator of synaptojanin 1.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
   UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
OI Hall, Michael N/0000-0002-2998-0757
CR ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0
   Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5
   BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023
   Benmerah A, 1995, J CELL BIOL, V131, P1831, DOI 10.1083/jcb.131.6.1831
   BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0
   Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235
   BULAWA CE, 1992, MOL CELL BIOL, V12, P1764, DOI 10.1128/MCB.12.4.1764
   CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3
   Cremona O, 2001, J CELL SCI, V114, P1041
   Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163
   DENOBEL JG, 1991, YEAST, V7, P589, DOI 10.1002/yea.320070606
   Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787
   Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613
   Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277
   Faucherre A, 2003, HUM MOL GENET, V12, P2449, DOI 10.1093/hmg/ddg250
   Gagny B, 2000, J CELL SCI, V113, P3309
   Garcia-Rodriguez LJ, 2000, FEBS LETT, V478, P84, DOI 10.1016/S0014-5793(00)01835-4
   GASCARD P, 1993, BIOCHEMISTRY-US, V32, P5941, DOI 10.1021/bi00074a004
   Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935
   Guthrie C, 1991, METHODS ENZYMOLOGY, V194
   Haffner C, 2000, CURR BIOL, V10, P471, DOI 10.1016/S0960-9822(00)00446-2
   Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8
   HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0
   Helliwell SB, 1998, GENETICS, V148, P99
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   HILGEMANN DW, 2001, SCI STKE
   Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779
   Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8
   Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x
   ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983
   Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047
   Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x
   Kaiser CA, 2002, METHOD ENZYMOL, V351, P325
   Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193
   KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559
   LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Loovers HM, 2003, J BIOL CHEM, V278, P5652, DOI 10.1074/jbc.M208396200
   Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8
   Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511
   Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231
   McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0
   Morinaka K, 1999, ONCOGENE, V18, P5915, DOI 10.1038/sj.onc.1202974
   NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x
   Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x
   Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001
   Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183
   Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279
   Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239
   Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694
   Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002
   Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Smith JS, 1999, MOL CELL BIOL, V19, P3184
   Song W, 2003, NEURON, V40, P665, DOI 10.1016/S0896-6273(03)00726-8
   Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476
   Stolz LE, 1998, GENETICS, V148, P1715
   Stolz LE, 1998, J BIOL CHEM, V273, P11852, DOI 10.1074/jbc.273.19.11852
   SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245
   Tang HY, 1996, MOL CELL BIOL, V16, P4897
   Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200
   Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71
   Wendland B, 1998, CURR OPIN CELL BIOL, V10, P513, DOI 10.1016/S0955-0674(98)80067-7
   WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530
   Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517
   YOSHIDA S, 1994, J BIOL CHEM, V269, P1166
NR 71
TC 19
Z9 19
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 17
PY 2004
VL 279
IS 38
BP 39604
EP 39610
DI 10.1074/jbc.M405589200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 852YA
UT WOS:000223791500050
PM 15265867
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Green, JD
   Kreplak, L
   Goldsbury, C
   Blatter, XL
   Stolz, M
   Cooper, GS
   Seelig, A
   Kist-Ler, J
   Aebi, U
AF Green, JD
   Kreplak, L
   Goldsbury, C
   Blatter, XL
   Stolz, M
   Cooper, GS
   Seelig, A
   Kist-Ler, J
   Aebi, U
TI Atomic force microscopy reveals defects within mica supported lipid
   bilayers induced by the amyloidogenic human amylin peptide
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE AFM; membrane; amyloid; Langmuir-Blodgett; interaction
ID GENE-RELATED PEPTIDE; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; POLYPEPTIDE
   IAPP; PRION PROTEIN; PARKINSONS-DISEASE; MEMBRANE; BINDING; MECHANISM;
   NEUROTOXICITY
AB To date, over 20 peptides or proteins have been identified that can form amyloid fibrils in the body and are thought to cause disease. The mechanism by which amyloid peptides cause the cytotoxicity observed and disease is not understood. However, one of the major hypotheses is that amyloid peptides cause membrane perturbation. Hence, we have studied the interaction between lipid bilayers and the 37 amino acid residue polypeptide amylin, which is the primary constituent of the pancreatic amyloid associated with type 2 diabetes. Using a dye release assay we confirmed that the amyloidogenic human amylin peptide causes membrane disruption; however, time-lapse atomic force microscopy revealed that this did not occur by the formation of defined pores. On the contrary, the peptide induced the formation of small defects spreading over the lipid surface. We also found that rat amylin, which has 84% identity with human amylin but cannot form amyloid fibrils, could also induce similar lesions to supported lipid bilayers. The effect, however, for rat amylin but not human amylin, was inhibited under high ionic conditions. These data provide an alternative theory to pore formation, and how amyloid peptides may cause membrane disruption and possibly cytotoxicity. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, ME Miller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Auckland, Fac Sci, Sch Biol Sci, Auckland, New Zealand.
   Univ Auckland, Sch Med, Dept Med, Auckland 1001, New Zealand.
RP Aebi, U (corresponding author), Univ Basel, Biozentrum, ME Miller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM ueli.aebi@unibas.ch
RI Cooper, Garth JS/I-3201-2015
OI Cooper, Garth JS/0000-0001-5241-3163; kreplak,
   laurent/0000-0001-9370-9809
CR Aitken JF, 2003, BIOCHEM J, V374, P779, DOI 10.1042/BJ20030422
   Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u
   BETSHOLTZ C, 1989, FEBS LETT, V251, P261, DOI 10.1016/0014-5793(89)81467-X
   BOETTCHER C, 1961, ANAL CHIM ACTA, V24, P203, DOI 10.1016/0003-2670(61)80041-X
   BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0
   Bremer A, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P277
   Butterfield DA, 2002, NEUROBIOL AGING, V23, P655
   Castle AL, 1998, AM J PHYSIOL-ENDOC M, V275, pE531
   CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343
   Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r
   Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571
   COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163
   COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628
   CORNISH J, 1998, AM J PHYSIOL, V275, pD694
   Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443
   DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5
   Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h
   EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115
   EVANS RW, 1987, BIOCHEM J, V245, P455, DOI 10.1042/bj2450455
   Fang Y, 1997, BBA-BIOMEMBRANES, V1324, P309, DOI 10.1016/S0005-2736(96)00236-2
   FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200
   Harroun TA, 2001, FEBS LETT, V507, P200, DOI 10.1016/S0014-5793(01)02972-6
   Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999
   Hertel C, 1997, P NATL ACAD SCI USA, V94, P9412, DOI 10.1073/pnas.94.17.9412
   Hettiarachchi M, 1997, AM J PHYSIOL-ENDOC M, V273, pE859
   Heymann JB, 2002, J MICROSC-OXFORD, V207, P43, DOI 10.1046/j.1365-2818.2002.01039.x
   Higham CE, 2000, FEBS LETT, V470, P55, DOI 10.1016/S0014-5793(00)01287-4
   Hirakura Y, 2000, AMYLOID, V7, P194, DOI 10.3109/13506120009146834
   Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491
   Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0
   Kanski J, 2002, FREE RADICAL BIO MED, V32, P1205, DOI 10.1016/S0891-5849(02)00821-3
   Kawahara M, 2000, J BIOL CHEM, V275, P14077, DOI 10.1074/jbc.275.19.14077
   Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646
   Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970
   Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   LEIGHTON B, 1988, NATURE, V335, P632, DOI 10.1038/335632a0
   Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com
   LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Malisauskas M, 2003, J MOL BIOL, V330, P879, DOI 10.1016/S0022-2836(03)00551-5
   Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988
   Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g
   Oren Z, 1998, BIOPOLYMERS, V47, P451
   Reviakine I, 2000, LANGMUIR, V16, P1806, DOI 10.1021/la9903043
   Sanghera N, 2002, J MOL BIOL, V315, P1241, DOI 10.1006/jmbi.2001.5322
   SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221
   Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P15297, DOI 10.1021/bi001774v
   Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1
   Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881
   Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7
   YOUNG AA, 1993, AM J PHYSIOL, V264, pE943
NR 60
TC 122
Z9 124
U1 1
U2 29
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 17
PY 2004
VL 342
IS 3
BP 877
EP 887
DI 10.1016/j.jmb.2004.07.052
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 853OX
UT WOS:000223838000014
PM 15342243
DA 2021-01-25
ER

PT J
AU Cordier, F
   Grzesiek, S
AF Cordier, F
   Grzesiek, S
TI Quantitative comparison of the hydrogen bond network of A-state and
   native ubiquitin by hydrogen bond scalar couplings
SO BIOCHEMISTRY
LA English
DT Article
ID MOLTEN-GLOBULE STATE; CHEMICAL-SHIFTS; STRUCTURAL-CHARACTERIZATION;
   BACKBONE DYNAMICS; NMR-SPECTROSCOPY; ALPHA-HELICES; PROTEIN; PEPTIDE;
   (3H)J(NC'); EXCHANGE
AB The backbone hydrogen bond (H-bond) network of the partially folded A-state of ubiquitin (60% methanol, 40% water, pH 2) has been characterized quantitatively by (h3)J(NC), H-bond scalar couplings between the N-15 nuclei of amino acid H-bond donors and the C-13 carbonyl nuclei of the acceptors. Results on (h3)J(NC), couplings and the amide proton (H-1(N)) chemical shifts for the A-state are compared quantitatively to the native state. The (h3)J(NC), correlations of the A-state show intact, nativelike H-bonds of the first P-hairpin beta1/beta2 and the cc-helix, albeit at lower strength, whereas the H-bonds in the C-terminal part change from a pure beta-structure to an all alpha-helical H-N(i)-->O(i-4) connectivity pattern. A residue-specific analysis reveals that the conformations within the conserved secondary structure segments are much more homogeneous in the A-state than in the native state. Thus, the strong asymmetry of IIJNc, couplings and H-1(N) chemical shifts between the interior and exterior sides of the native state alpha-helix vanishes in the A-state. This indicates that the bend of this helix around the native state hydrophobic core is released in the homogeneous solvent environment of the A-state. Similarly, an irregularity in the behavior of H-bond 13-->L 15 in hairpin beta1/beta2, which results from strong contacts to strand beta5 in the native state, is absent in the A-state. These findings rationalize the behavior of the H-1(N) chemical shifts in both states and indicate that the A-state is in many aspects similar to the onset of thermal denaturation of the native state.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Cordier, F (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
EM Florence.Cordier@unibas.ch; Stephan.Grzesiek@unibas.ch
OI Cordier, Florence/0000-0002-5963-7773; Grzesiek,
   Stephan/0000-0003-1998-4225
CR ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598
   ALONSO DOV, 1995, J MOL BIOL, V247, P501, DOI 10.1006/jmbi.1994.0156
   Bagno A, 2000, CHEM-EUR J, V6, P2925
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   BALDWIN RL, 1993, CURR OPIN STRUC BIOL, V3, P84, DOI 10.1016/0959-440X(93)90206-Z
   Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v
   Barfield M, 2001, J AM CHEM SOC, V123, P4014, DOI 10.1021/ja003781c
   BLUNDELL T, 1983, NATURE, V306, P281, DOI 10.1038/306281a0
   BRIGGS MS, 1992, P NATL ACAD SCI USA, V89, P2017, DOI 10.1073/pnas.89.6.2017
   Brutscher B, 1997, BIOCHEMISTRY-US, V36, P13043, DOI 10.1021/bi971538t
   CHAKRABARTI P, 1986, BIOPOLYMERS, V25, P1087, DOI 10.1002/bip.360250609
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   COX JPL, 1993, J MOL BIOL, V234, P483, DOI 10.1006/jmbi.1993.1600
   Englaender S.W., 1996, ENCY NUCL MAGNETIC R, V4, P2415
   Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213
   Grzesiek S, 2001, METHOD ENZYMOL, V338, P111
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052
   HARDING MM, 1991, BIOCHEMISTRY-US, V30, P3120, DOI 10.1021/bi00226a020
   Jaravine VA, 2001, PROTEIN SCI, V10, P943, DOI 10.1110/ps.48501
   Jourdan M, 2001, BIOCHEMISTRY-US, V40, P10317, DOI 10.1021/bi010767j
   Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193
   KUNTZ ID, 1991, J AM CHEM SOC, V113, P1406, DOI 10.1021/ja00004a050
   KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202
   LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802
   OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6
   PAN YQ, 1992, BIOCHEMISTRY-US, V31, P11405, DOI 10.1021/bi00161a019
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Prompers JJ, 2001, J MOL BIOL, V305, P1085, DOI 10.1006/jmbi.2000.4353
   Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X
   PTITSYN OB, 1995, CURR OPIN STRUC BIOL, V5, P74, DOI 10.1016/0959-440X(95)80011-O
   QIAN H, 1992, J PHYS CHEM-US, V96, P3987, DOI 10.1021/j100189a015
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Scheurer C, 1999, J AM CHEM SOC, V121, P8661, DOI 10.1021/ja9917417
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   STOCKMAN BJ, 1993, J BIOMOL NMR, V3, P285, DOI 10.1007/BF00212515
   VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6
   WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056
   Wang YX, 1999, J BIOMOL NMR, V14, P181, DOI 10.1023/A:1008346517302
   WILKINSON KD, 1986, ARCH BIOCHEM BIOPHYS, V250, P390, DOI 10.1016/0003-9861(86)90741-1
   WISHART DS, 1994, J BIOMOL NMR, V4, P171
   Zerella R, 1999, PROTEIN SCI, V8, P1320, DOI 10.1110/ps.8.6.1320
   Zerella R, 2000, PROTEIN SCI, V9, P2142, DOI 10.1110/ps.9.11.2142
   ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042
   ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390
NR 47
TC 32
Z9 32
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD SEP 7
PY 2004
VL 43
IS 35
BP 11295
EP 11301
DI 10.1021/bi049314f
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 851TM
UT WOS:000223708400016
PM 15366939
DA 2021-01-25
ER

PT J
AU Crespo, JL
   Helliwell, SB
   Wiederkehr, C
   Demougin, P
   Fowler, B
   Primig, M
   Hall, MN
AF Crespo, JL
   Helliwell, SB
   Wiederkehr, C
   Demougin, P
   Fowler, B
   Primig, M
   Hall, MN
TI NPR1 kinase and RSP5-BUL1/2 ubiquitin ligase control GLN3-dependent
   transcription in Saccharomyces cerevisiae
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID AMINO-ACID PERMEASE; TOR SIGNALING PATHWAY; INTRACELLULAR TRAFFICKING;
   TRYPTOPHAN PERMEASE; SECRETORY PATHWAY; GENE-EXPRESSION; GATA FACTORS;
   CELL-GROWTH; NITROGEN; YEAST
AB The GATA transcription factors GLN3 and GAT1 activate nitrogen-regulated genes in Saccharomyces cerevisiae. NPR1 is a protein kinase that controls post-Golgi sorting of amino acid permeases. In the presence of a good nitrogen source, TOR ( target of rapamycin) maintains GLN3 and NPR1 phosphorylated and inactive by inhibiting the type 2A-related phosphatase SIT4. We identified NPR1 as a regulator of GLN3. Specifically, loss of NPR1 causes nuclear translocation and activation of GLN3, but not GAT1, in nitrogen-rich conditions. NPR1-mediated inhibition of GLN3 is independent of the phosphatase SIT4. We also demonstrate that the E3/E4 ubiquitin-protein ligase proteins RSP5 and BUL1/2 are required for GLN3 activation under poor nitrogen conditions. Thus, NPR1 and BUL1/2 antagonistically control GLN3-dependent transcription, suggesting a role for regulated ubiquitination in the control of nutrient-responsive transcription.
C1 Univ Basel, Div Biochem, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   Univ Childrens Hosp, CH-4005 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
RI Crespo, Jose L/L-3977-2014; Primig, Michael/G-3175-2013
OI Crespo, Jose L/0000-0003-3514-1025; Primig, Michael/0000-0002-2061-0119;
   Hall, Michael N/0000-0002-2998-0757
CR Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200
   Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200
   Chen EJ, 2002, P NATL ACAD SCI USA, V99, P14837, DOI 10.1073/pnas.232591899
   Coffman JA, 1997, J BACTERIOL, V179, P5609, DOI 10.1128/jb.179.17.5609-5613.1997
   Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1016/S0168-6445(02)00071-2
   COOPER TG, 1990, J BACTERIOL, V172, P1014, DOI 10.1128/jb.172.2.1014-1018.1990
   Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599
   Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002
   CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993
   DAUGHERTY JR, 1993, J BACTERIOL, V175, P64, DOI 10.1128/JB.175.1.64-73.1993
   De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200
   ELBERRY HM, 1993, J BACTERIOL, V175, P4688, DOI 10.1128/JB.175.15.4688-4698.1993
   GILMAN M, 1998, CURRENT PROTOCOLS MO
   Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649
   Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9
   Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282
   RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887
   Roberg KJ, 1997, GENETICS, V147, P1569
   Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469
   Saxena D, 2003, EUKARYOT CELL, V2, P552, DOI 10.1128/EC.2.3.552-559.2003
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200
   Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253
   VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845
NR 32
TC 42
Z9 48
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 3
PY 2004
VL 279
IS 36
BP 37512
EP 37517
DI 10.1074/jbc.M407372200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 849QK
UT WOS:000223554600041
PM 15247235
OA Bronze
DA 2021-01-25
ER

PT J
AU Bohn, E
   Gaentzsch, P
   Reineke, K
   Muller, S
   Krejci, J
   Manncke, B
   Grassl, GG
   Wolf-Watz, H
   Cornelis, GR
   Apfelbacher, M
   Autenrieth, IB
AF Bohn, E
   Gaentzsch, P
   Reineke, K
   Muller, S
   Krejci, J
   Manncke, B
   Grassl, GG
   Wolf-Watz, H
   Cornelis, GR
   Apfelbacher, M
   Autenrieth, IB
TI Targeting of RhoA by YopT induces expression of glucorticoid induced
   leucine zipper
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the DGHM
CY SEP 26-29, 2004
CL Munster, GERMANY
SP DGHM
C1 Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, Tubingen, Germany.
   Umea Univ, Unit Appl Cell & Mol Biol, Umea, Sweden.
   Univ Basel, Biozentrum, Basel, Switzerland.
   LMU Munchen, Max Von Pettenkofer Inst, Munich, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 1438-4221
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD SEP
PY 2004
VL 294
SU 39
BP 97
EP 97
PG 1
WC Microbiology; Virology
SC Microbiology; Virology
GA 861ZA
UT WOS:000224456000034
DA 2021-01-25
ER

PT J
AU Meyer, UA
AF Meyer, UA
TI Pharmacogenetics - five decades of therapeutic lessons from genetic
   diversity
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID HUMAN CYTOCHROME-P-450DB1; POOR METABOLIZERS; DRUG-METABOLISM;
   HUMAN-LIVER; DEBRISOQUINE; POLYMORPHISM; DEFECT; HYDROXYLATION;
   MUTATIONS; IDENTIFICATION
AB Physicians have long been aware of the subtle differences in the responses of patients to medication. The recognition that a part of this variation is inherited, and therefore predictable, created the field of pharmacogenetics fifty years ago. Knowing the gene variants that cause differences among patients has the potential to allow 'personalized' drug therapy and to avoid therapeutic failure and serious side effects.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM Urs-A.Meyer@unibas.ch
CR ALEXANDERSON B, 1969, BMJ-BRIT MED J, V4, P764, DOI 10.1136/bmj.4.5686.764
   BATESON W, 2002, MENDELS PRINCIPLES H
   BERTILSSON L, 1985, THER DRUG MONIT, V7, P478, DOI 10.1097/00007691-198512000-00021
   BERTILSSON L, 1993, LANCET, V341, P63, DOI 10.1016/0140-6736(93)92546-6
   BLUM M, 1991, P NATL ACAD SCI USA, V88, P5237, DOI 10.1073/pnas.88.12.5237
   BONICKE R, 1953, N-S ARCH EX PATH PH, V220, P321
   BREWER GJ, 1971, AM J HUM GENET, V23, P92
   CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a
   Chou WH, 2000, J CLIN PSYCHOPHARM, V20, P246, DOI 10.1097/00004714-200004000-00019
   CLAYMAN CB, 1952, JAMA-J AM MED ASSOC, V149, P1563, DOI 10.1001/jama.1952.72930340022010b
   DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594
   DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057
   EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V16, P183, DOI 10.1007/BF00562059
   EVANS DAP, 1960, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5197.485
   Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526
   Fox AL, 1932, P NATL ACAD SCI USA, V18, P115, DOI 10.1073/pnas.18.1.115
   Garrod A. E., 1931, INBORN FACTORS DIS
   Garrod AE, 1902, LANCET, V2, P1616
   Garrod AE, 1909, INBORN ERRORS METABO
   Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229
   GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0
   GOUGH AC, 1990, NATURE, V347, P773, DOI 10.1038/347773a0
   GUT J, 1984, FEBS LETT, V173, P287, DOI 10.1016/0014-5793(84)80792-9
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   HEIM M, 1990, LANCET, V336, P529, DOI 10.1016/0140-6736(90)92086-W
   HUGHES HB, 1954, AM REV TUBERC PULM, V70, P266
   HUGHES HB, 1953, J PHARMACOL EXP THER, V109, P444
   JOHANSSON I, 1993, P NATL ACAD SCI USA, V90, P11825, DOI 10.1073/pnas.90.24.11825
   KAGIMOTO M, 1990, J BIOL CHEM, V265, P17209
   KAHN GC, 1982, BRIT J CLIN PHARMACO, V13, P637, DOI 10.1111/j.1365-2125.1982.tb01430.x
   KALOW W, 1957, CAN J BIOCHEM PHYS, V35, P1305
   Kalow W, 2001, PHARMACOGENOMICS
   KALOW W, 1962, PHARMACOGENETICS HER
   KIRCHHEINER J, 2000, PHARMACOPSYCHIATR S3, V36, pS235
   KUPFER A, 1984, EUR J CLIN PHARMACOL, V26, P753, DOI 10.1007/BF00541938
   LEHMANN H, 1956, LANCET, V271, P124
   LUZATTO L, 2001, METABOLIC MOL BASIS, V3, P4517
   Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938
   MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1
   Masood E, 1999, NATURE, V398, P545, DOI 10.1038/19126
   MEIER PJ, 1983, GASTROENTEROLOGY, V85, P682
   Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6
   Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269
   MOTULSKY AG, 1957, JAMA-J AM MED ASSOC, V165, P835, DOI 10.1001/jama.1957.72980250010016
   Nebert Daniel W, 2003, Am J Pharmacogenomics, V3, P361, DOI 10.2165/00129785-200303060-00002
   Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314
   PRICEEVANS DA, 1993, CLIN MOL PHARMACOGEN
   Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705
   SCRIVER CR, 1989, GARRODS INBORN FACTO
   Sellers EM, 2003, DRUG DISCOV TODAY, V8, P487, DOI 10.1016/S1359-6446(03)02704-1
   SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240
   SMITH RL, 1986, XENOBIOTICA, V16, P361, DOI 10.3109/00498258609050244
   SNYDER LAURENCE H., 1932, OHIO JOUR SCI, V32, P436
   SullivanKlose TH, 1996, PHARMACOGENETICS, V6, P341, DOI 10.1097/00008571-199608000-00007
   VATSIS KP, 1991, P NATL ACAD SCI USA, V88, P6333, DOI 10.1073/pnas.88.14.6333
   VATSIS KP, 1995, PHARMACOGENETICS, V5, P1, DOI 10.1097/00008571-199502000-00001
   VESELL ES, 1978, HUM GENET, P19
   Vogel F., 1959, ERG INN MED KINDERHK, P52, DOI [10.1007/978-3-642-94744-5_2, DOI 10.1007/978-3-642-94744-5_2]
   WEBER WW, 1997, PHARMACOGENETICS, P334
   Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021
   Williams R. J., 1956, BIOCH INDIVIDUALITY
   Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2
   ZANGER UM, 1988, P NATL ACAD SCI USA, V85, P8256, DOI 10.1073/pnas.85.21.8256
NR 63
TC 228
Z9 242
U1 0
U2 26
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD SEP
PY 2004
VL 5
IS 9
BP 669
EP 676
DI 10.1038/nrg1428
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 850PZ
UT WOS:000223626200016
PM 15372089
DA 2021-01-25
ER

PT J
AU Nicholson, JR
   Dunant, P
   Hofbauer, KG
AF Nicholson, JR
   Dunant, P
   Hofbauer, KG
TI Effect of melanocortin 4-receptor blockade in an animal model of
   cachexia
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 9th International Congress of the World-Muscle-Society
CY SEP 01-04, 2004
CL Goteborg, SWEDEN
SP World Muscle Soc
C1 Univ Basel, MyoContract AG, Biozentrum, Liestal, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP
PY 2004
VL 14
IS 8-9
BP 611
EP 612
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 847ZQ
UT WOS:000223437000214
DA 2021-01-25
ER

PT J
AU Marz, P
   Probst, A
   Lang, S
   Schwager, M
   Rose-John, S
   Otten, U
   Ozbek, S
AF Marz, P
   Probst, A
   Lang, S
   Schwager, M
   Rose-John, S
   Otten, U
   Ozbek, S
TI Ataxin-10, the spinocerebellar ataxia type 10 neurodegenerative disorder
   protein, is essential for survival of cerebellar neurons
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CLINICAL-FEATURES; REPEAT EXPANSION; ATTCT REPEAT; PATHOGENESIS;
   FRATAXIN; REGION
AB Spinocerebellar ataxia (SCA) type 10, an autosomal dominant disease characterized by cerebellar ataxia, is caused by a novel pentanucleotide (ATTCT) repeat expansion in the SCA10 gene. Although clinical features of the disease are well characterized, nothing is known so far about the affected SCA10 gene product, ataxin-10 (Atx-10). We have cloned the rat SCA10 gene and expressed the corresponding protein in HEK293 cells. Atx-10 has an apparent molecular mass of similar to55 kDa and belongs to the family of armadillo repeat proteins. In solution, it tends to form homotrimeric complexes, which associate via a tip-to-tip contact with the concave sides of the molecules facing each other. Atx-10 immunostaining of mouse and human brain sections revealed a predominantly cytoplasmic and perinuclear localization with a clear restriction to olivocerebellar regions. Knock down of SCA10 in primary neuronal cells by small interfering RNAs resulted in an increased apoptosis of cerebellar neurons, arguing for a loss-of-function phenotype in SCA10 patients.
C1 Univ Basel, Inst Physiol, CH-4051 Basel, Switzerland.
   Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland.
   Univ Kiel, Dept Biochem, D-24098 Kiel, Germany.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Marz, P (corresponding author), Univ Basel, Inst Physiol, Vesalgasse 1, CH-4051 Basel, Switzerland.
EM p.maerz@unibas.ch
RI Rose-John, Stefan/A-7998-2010; Ozbek, Suat/D-3701-2014
OI Rose-John, Stefan/0000-0002-7519-3279; Ozbek, Suat/0000-0003-2569-3942
CR ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383
   Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1
   ENGEL J, 1994, METHOD ENZYMOL, V245, P469
   HARDING AE, 1981, J MED GENET, V18, P436, DOI 10.1136/jmg.18.6.436
   Hatzfeld M, 1999, INT REV CYTOL, V186, P179
   Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9
   JUCKER M, 1994, NEUROSCIENCE, V60, P875, DOI 10.1016/0306-4522(94)90269-0
   Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741
   Li FS, 2002, J BIOL CHEM, V277, P45004, DOI 10.1074/jbc.M205259200
   Lin X, 2003, CYTOGENET GENOME RES, V100, P184, DOI 10.1159/000072853
   Margolis RL, 2001, TRENDS MOL MED, V7, P479, DOI 10.1016/S1471-4914(01)02179-7
   Marz P, 1999, GLIA, V26, P191, DOI 10.1002/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-#
   Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911
   Matsuura T, 2004, AM J HUM GENET, V74, P1216, DOI 10.1086/421526
   Paulson H, 2002, LANCET NEUROL, V1, P471, DOI 10.1016/S1474-4422(02)00234-X
   Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6
   Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081
   Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200
   Scheel H, 2003, HUM MOL GENET, V12, P2845, DOI 10.1093/hmg/ddg297
   Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9
   Tapscott SJ, 2000, SCIENCE, V289, P1701, DOI 10.1126/science.289.5485.1701
   Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101
   Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217
   Zoghbi HY, 2000, NEUROBIOL DIS, V7, P523, DOI 10.1006/nbdi.2000.0346
NR 26
TC 36
Z9 38
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 20
PY 2004
VL 279
IS 34
BP 35542
EP 35550
DI 10.1074/jbc.M405865200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 846GJ
UT WOS:000223303400049
PM 15201271
DA 2021-01-25
ER

PT J
AU Martin, G
   Moglich, A
   Keller, W
   Doublie, S
AF Martin, G
   Moglich, A
   Keller, W
   Doublie, S
TI Biochemical and structural insights into substrate binding and catalytic
   mechanism of mammalian poly(A) polymerase
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE poly(A) polymerase; mRNA 3 ' end processing; nucleotidyl transferase;
   substrate specificity; ATP binding
ID CCA-ADDING ENZYME; MESSENGER-RNA POLYADENYLATION; CRYSTAL-STRUCTURES;
   DNA-POLYMERASE; NUCLEOTIDYLTRANSFERASE SUPERFAMILY; TERMINAL
   DEOXYNUCLEOTIDYLTRANSFERASE; KANAMYCIN NUCLEOTIDYLTRANSFERASE;
   MUTATIONAL ANALYSIS; SPECIFICITY FACTOR; ATP
AB Polyadenylation of messenger RNA precursors is an essential process in eukaryotes. Poly(A) polymerase (PAP), a member of the nucleotidyl transferase family that includes DNA polymerase beta, incorporates ATP at the 3' end of mRNAs in a template-independent manner. Although the structures of mammalian and yeast PAPs are known, their mechanism of ATP selection has remained elusive. In a recent bovine PAP structure complexed with an analog of ATP and Mn2+, strictly conserved residues interact selectively with the adenine base, but the nucleotide was found in a "non-productive" conformation. Here we report a second bovine crystal structure, obtained in the presence of Mg2+, where 3'-dATP adopts a "productive" conformation similar to that seen in yeast PAP or DNA polymerase beta. Mutational analysis and activity assays with ATP analogs suggest a role in catalysis for one of the two adenine-binding sites revealed by our structural data. The other site might function to prevent futile hydrolysis of ATP. In order to investigate the role of metals in catalysis we performed steady state kinetics experiments under distributive polymerization conditions. These tests suggest a sequential random mechanism in vitro in the presence of ATP and RNA, without preference for a particular order of binding of the two substrates. In vivo, however, where polyadenylation is processive and the primer does not dissociate from the enzyme, an ordered mechanism with the primer as the leading substrate is more likely. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Vermont, Markey Ctr Mol Genet, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.
RP Doublie, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sdoublie@uvm.edu
OI Doublie, Sylvie/0000-0002-6294-5304; Moglich,
   Andreas/0000-0002-7382-2772
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM62239] Funding Source: Medline; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM062239, R01GM062239,
   R01GM062239, R01GM062239, R01GM062239] Funding Source: NIH RePORTER
CR Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609
   Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4
   Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346
   BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x
   Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Cho HD, 2003, RNA, V9, P970, DOI 10.1261/rna.2110903
   DEIBEL MR, 1980, J BIOL CHEM, V255, P4206
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427
   Denessiouk KA, 2001, PROTEINS, V44, P282, DOI 10.1002/prot.1093
   EDMONDS M, 1982, ENZYMES, V15, P217
   EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T
   Fondufe-Mittendorf YN, 2002, NUCLEIC ACIDS RES, V30, P614, DOI 10.1093/nar/30.2.614
   HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894
   Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070
   Knecht W, 2002, EMBO J, V21, P1873, DOI 10.1093/emboj/21.7.1873
   Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101
   Kyriakopoulou CB, 2001, J BIOL CHEM, V276, P33504, DOI 10.1074/jbc.M104599200
   Lee YJ, 2001, MOL CELLS, V11, P379
   Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7
   Martin G, 1999, PROTEIN SCI, V8, P2380
   Martin G, 2004, RNA, V10, P899, DOI 10.1261/rna.5242304
   Martin G, 1998, RNA, V4, P226
   Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x
   Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193
   McClure W R, 1980, Methods Enzymol, V64, P277
   MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376
   MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672
   Nobeli I, 2001, NUCLEIC ACIDS RES, V29, P4294, DOI 10.1093/nar/29.21.4294
   Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005
   Perumal K, 2001, J BIOL CHEM, V276, P21791, DOI 10.1074/jbc.M101905200
   RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0
   READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622
   Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799
   Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5
   SAKON J, 1993, BIOCHEMISTRY-US, V32, P11977, DOI 10.1021/bi00096a006
   Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812
   Segel IH, 1975, ENZYME KINETICS
   Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583
   THURESSON AC, 1994, P NATL ACAD SCI USA, V91, P979, DOI 10.1073/pnas.91.3.979
   Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001
   WAHLE E, 1991, J BIOL CHEM, V266, P3131
   WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x
   WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039
   WILLIAMS KR, 1977, J BIOL CHEM, V252, P5589
   Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4
   Yue DX, 1998, J BIOL CHEM, V273, P29693, DOI 10.1074/jbc.273.45.29693
   Yue DX, 1996, RNA, V2, P895
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
   Zhelkovsky A, 2004, RNA, V10, P558, DOI 10.1261/rna.5238704
NR 57
TC 41
Z9 42
U1 0
U2 0
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 20
PY 2004
VL 341
IS 4
BP 911
EP 925
DI 10.1016/j.jmb.2004.06.047
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 847FZ
UT WOS:000223379400005
PM 15328606
DA 2021-01-25
ER

PT J
AU Betat, H
   Rammelt, C
   Martin, G
   Morl, M
AF Betat, H
   Rammelt, C
   Martin, G
   Morl, M
TI Exchange of regions between bacterial poly(A) polymerase and the
   CCA-Adding enzyme generates altered specificities
SO MOLECULAR CELL
LA English
DT Article
ID TRANSFER-RNA NUCLEOTIDYLTRANSFERASE; ESCHERICHIA-COLI; MESSENGER-RNA;
   CATALYTIC DOMAIN; BINDING; POLYADENYLATION; DEGRADATION; CLEAVAGE
AB Bacterial poly(A) polymerases (PAP) and tRNA nucleotidyltransferases are highly similar in sequence but display different activities: whereas tRNA nucleotidyltransferase catalyzes the addition of CCA to 3' ends of tRNAs, PAP adds poly(A) tails to a variety of transcripts. Using domain substitution experiments, we show that these enzymes follow a modular concept: exchange of N- and C-terminal regions leads to chimeric enzymes with unexpected activities, indicating that tRNA nucleotidyltransferase carries an "anchor domain" in the C-terminal section that restricts polymerization to three nucleotides. A 27 amino acid region was identified that determines whether poly(A) or CCA is synthesized by the enzyme chimeras. Sequence alignments suggest that the catalytic cores of both enzymes carry identical components involved in nucleotide recognition and incorporation. This seems to be the prerequisite for the observed reprogramming of the catalytic center of PAP to incorporate a sequence of defined length and composition instead of long stretches of A residues.
C1 Max Planck Inst Evolut Anthropol, D-04103 Leipzig, Germany.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Morl, M (corresponding author), Max Planck Inst Evolut Anthropol, Deutscher Pl 6, D-04103 Leipzig, Germany.
EM moerl@eva.mpg.de
OI Morl, Mario/0000-0003-0972-9386
CR Cao GJ, 1997, BIOCHEM BIOPH RES CO, V239, P46, DOI 10.1006/bbrc.1997.7421
   Cho HD, 2003, RNA, V9, P970, DOI 10.1261/rna.2110903
   CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881
   Deutscher M. P., 1982, ENZYMES, V15, P183, DOI [DOI 10.1016/S1874-6047(08)60279-6, 10.1016/S1874-6047(08)60279-6]
   Hopfner KP, 1998, P NATL ACAD SCI USA, V95, P9813, DOI 10.1073/pnas.95.17.9813
   HORTON RM, 1990, BIOTECHNIQUES, V8, P528
   Hou YM, 2000, RNA, V6, P1031, DOI 10.1017/S1355838200000686
   Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741
   Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7
   Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398
   Martin G, 2004, RNA, V10, P899, DOI 10.1261/rna.5242304
   Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x
   McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404
   PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760
   Raynal LC, 1998, J BACTERIOL, V180, P6276
   Raynal LC, 1999, MOL MICROBIOL, V32, P765, DOI 10.1046/j.1365-2958.1999.01394.x
   Raynal LC, 1996, BIOCHIMIE, V78, P390, DOI 10.1016/0300-9084(96)84745-6
   Reichert AS, 2001, BIOL CHEM, V382, P1431, DOI 10.1515/BC.2001.176
   REUVEN NB, 1993, P NATL ACAD SCI USA, V90, P4350, DOI 10.1073/pnas.90.10.4350
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sarkar N, 1997, ANNU REV BIOCHEM, V66, P173, DOI 10.1146/annurev.biochem.66.1.173
   Schurer H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf055
   Schurer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144
   Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197
   SIPPEL AE, 1973, EUR J BIOCHEM, V37, P31, DOI 10.1111/j.1432-1033.1973.tb02953.x
   Sohlberg B, 2003, J BACTERIOL, V185, P7273, DOI 10.1128/JB.185.24.7273-7278.2003
   Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6
   WAHLE E, 1995, BBA-GENE STRUCT EXPR, V1261, P183, DOI 10.1016/0167-4781(94)00248-2
   WILLIAMS KR, 1977, J BIOL CHEM, V252, P5589
   Yehudai-Resheff S, 2000, NUCLEIC ACIDS RES, V28, P1139, DOI 10.1093/nar/28.5.1139
   Yue DX, 1996, RNA, V2, P895
NR 31
TC 38
Z9 38
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD AUG 13
PY 2004
VL 15
IS 3
BP 389
EP 398
DI 10.1016/j.molcel.2004.06.026
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 846JR
UT WOS:000223312300007
PM 15304219
DA 2021-01-25
ER

PT J
AU Punzo, C
   Plaza, S
   Seimiya, M
   Schnupf, P
   Kurata, S
   Jaeger, J
   Gehring, WJ
AF Punzo, C
   Plaza, S
   Seimiya, M
   Schnupf, P
   Kurata, S
   Jaeger, J
   Gehring, WJ
TI Functional divergence between eyeless and twin of eyeless in Drosophila
   melanogaster
SO DEVELOPMENT
LA English
DT Article
DE ey; toy; sey; PD; HD; Drosophila
ID SINE-OCULIS; TRANSCRIPTIONAL ACTIVATOR; MORPHOGENETIC FURROW; EYE
   DEVELOPMENT; HOMEOTIC GENES; COMPOUND EYE; PAX-6 GENE; OF-EYELESS;
   EXPRESSION; HEDGEHOG
AB Pax6 genes encode transcription factors with two DNA-binding domains that are highly conserved during evolution. In Drosophila, two Pax6 genes function in a pathway in which twin of eyeless (toy) directly regulates eyeless (ey), which is necessary for initiating the eye developmental pathway. To investigate the gene duplication of Pax6 that occurred in holometabolous insects like Drosophila and silkworm, we used different truncated forms of toy and small eyes (sey), and tested their capacity to induce ectopic eye development in an ey-independent manner. Even though the Paired domains of TOY and SEY have DNA-binding properties that differ from those of the Paired domain of EY, they all are capable of inducing ectopic eye development in an ey mutant background. We also show that one of the main functional differences between toy and ey lies in the C-terminal region of their protein products, implying differences in their transactivation potential. Furthermore, we show that only the homeodomain (HD) of EY is able to downregulate the expression of Distal-less (Dll), a feature that is required during endogenous eye development. These results suggest distinct functions of the two DNA-binding domains of TOY and EY, and significant evolutionary divergence between the two Drosophila Pax6 genes.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
RI plaza, serge/F-5290-2015; Schnupf, Pamela/G-6040-2017
OI Schnupf, Pamela/0000-0003-4292-1257; Jaeger,
   Johannes/0000-0002-2568-2103; Punzo, Claudio/0000-0001-5207-0041
CR ASHBURNER M, 1989, DROSPHILA LAB MANUAL
   Benassayag C, 2003, DEVELOPMENT, V130, P575, DOI 10.1242/dev.00226
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   CARRIERE C, 1993, MOL CELL BIOL, V13, P7257, DOI 10.1128/MCB.13.12.7257
   Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706
   CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5
   Curtiss J, 2000, DEVELOPMENT, V127, P1325
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   GEHRING WJ, 1966, J EMBRYOL EXP MORPH, V15, P371
   Glardon S, 1998, DEVELOPMENT, V125, P2701
   Gonzalez-Crespo S, 1998, NATURE, V394, P196, DOI 10.1038/28197
   Gorfinkiel N, 1997, GENE DEV, V11, P2259, DOI 10.1101/gad.11.17.2259
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Halder G, 1998, DEVELOPMENT, V125, P2181
   HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0
   Jarrett HW, 2000, ANAL BIOCHEM, V279, P209, DOI 10.1006/abio.2000.4489
   Kenyon KL, 2003, DEV CELL, V5, P403, DOI 10.1016/S1534-5807(03)00243-0
   Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0
   Kronhamn J, 2002, DEVELOPMENT, V129, P1015
   Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(02)08063-7
   Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497
   Lindsley D. L., 1992, GENOME DROSOPHILA ME, P1133
   Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Pichaud F, 2001, CELL, V105, P9, DOI 10.1016/S0092-8674(01)00292-6
   Punzo C, 2002, DEVELOPMENT, V129, P625
   Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122
   STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219
   TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E
   WOLFF T, 1991, DEVELOPMENT, V113, P841
   XU T, 1993, DEVELOPMENT, V117, P1223
   Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131
NR 36
TC 41
Z9 43
U1 0
U2 12
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD AUG
PY 2004
VL 131
IS 16
BP 3943
EP 3953
DI 10.1242/dev.01278
PG 11
WC Developmental Biology
SC Developmental Biology
GA 851OL
UT WOS:000223694300012
PM 15253940
OA Bronze
DA 2021-01-25
ER

PT J
AU Pyrowolakis, G
   Hartmann, B
   Muller, B
   Basler, K
   Affolter, M
AF Pyrowolakis, G
   Hartmann, B
   Muller, B
   Basler, K
   Affolter, M
TI A simple molecular complex mediates widespread BMP-induced repression
   during Drosophila development
SO DEVELOPMENTAL CELL
LA English
DT Article
ID GERMLINE STEM-CELLS; SIGNAL-TRANSDUCTION; NEURAL INDUCTION; DPP;
   TRANSCRIPTION; GENE; BRINKER; BINDING; TARGET; GOOSEBERRY
AB The spatial and temporal control of gene expression during the development of multicellular organisms is regulated to a large degree by cell-cell signaling. We have uncovered a simple mechanism through which Dpp, a TGFbeta/BMP superfamily member in Drosophila, represses many key developmental genes in different tissues. A short DNA sequence, a Dpp-dependent silencer element, is sufficient to confer repression of gene transcription upon Dpp receptor activation and nuclear translocation of Mad and Medea. Transcriptional repression does not require the cooperative action of cell type-specific transcription factors but relies solely on the capacity of the silencer element to interact with Mad and, Medea and to subsequently recruit the zinc finger-containing repressor protein Schnurri. Our findings demonstrate how the Dpp pathway can repress key targets in a simple and tissue-unrestricted manner in vivo and hence provide a paradigm for the inherent capacity of a signaling system to repress transcription upon pathway activation.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland.
RP Basler, K (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM basler@molbiol.unizh.ch; markus.affolter@unibas.ch
RI Mueller, Bruno/E-9888-2017
OI Mueller, Bruno/0000-0003-2664-7219; Basler, Konrad/0000-0003-3534-1529;
   Affolter, Markus/0000-0002-5171-0016
CR Affolter M, 2001, EMBO J, V20, P3298, DOI 10.1093/emboj/20.13.3298
   ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1
   Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502
   Bier E, 1997, CELL, V89, P681, DOI 10.1016/S0092-8674(00)80250-0
   Bouchard M, 2000, DEV BIOL, V222, P135, DOI 10.1006/dbio.2000.9702
   Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2
   Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033
   Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325
   Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597
   Courey AJ, 2001, GENE DEV, V15, P2786
   Dobens LL, 2000, DEVELOPMENT, V127, P745
   Dobens LL, 2000, DEV DYNAM, V218, P80, DOI 10.1002/(SICI)1097-0177(200005)218:1<80::AID-DVDY7>3.0.CO;2-8
   Gerhart J, 1999, TERATOLOGY, V60, P226
   GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6
   Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101
   Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003
   Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906
   Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200
   Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200
   Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261
   LI XL, 1994, EMBO J, V13, P400, DOI 10.1002/j.1460-2075.1994.tb06274.x
   LI XL, 1993, EMBO J, V12, P4499, DOI 10.1002/j.1460-2075.1993.tb06139.x
   Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200
   Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199
   Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383
   Marty T, 2001, DEVELOPMENT, V128, P2833
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786
   Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282
   Raftery LA, 2003, TRENDS GENET, V19, P701, DOI 10.1016/j.tig.2003.10.009
   SEGALAT L, 1994, MECH DEVELOP, V47, P241, DOI 10.1016/0925-4773(94)90042-6
   Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U
   Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026
   STAEHLINGHAMPTON K, 1995, DEVELOPMENT, V121, P3393
   Stathopoulos A, 2002, DEV BIOL, V246, P57, DOI 10.1006/dbio.2002.0652
   THURINGER F, 1993, EMBO J, V12, P2419, DOI 10.1002/j.1460-2075.1993.tb05896.x
   Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328
   Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5
   Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354
   Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1
NR 45
TC 103
Z9 105
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD AUG
PY 2004
VL 7
IS 2
BP 229
EP 240
DI 10.1016/j.devcel.2004.07.008
PG 12
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 847FM
UT WOS:000223378100012
PM 15296719
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Grunenfelder, B
   Tawfilis, S
   Gehrig, S
   Osteras, M
   Eglin, D
   Jenal, U
AF Grunenfelder, B
   Tawfilis, S
   Gehrig, S
   Osteras, M
   Eglin, D
   Jenal, U
TI Identification of the protease and the turnover signal responsible for
   cell cycle-dependent degradation of the Caulobacter FliF motor protein
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID C-TERMINUS; PROTEOLYSIS; RECOGNITION; CLPXP; CHEMORECEPTOR; MUTAGENESIS;
   COMPONENT; PROMOTER; REQUIRES
AB Flagellar ejection is tightly coupled to the cell cycle in Caulobacter crescentus. The MS ring protein FliF, which anchors the flagellar structure in the inner membrane, is degraded coincident with flagellar release. Previous work showed that removal of 26 amino acids from the C terminus of FliF prevents degradation of the protein and interferes with flagellar assembly. To understand FliF degradation in more detail, we identified the protease responsible for FliF degradation and performed a high-resolution mutational analysis of the C-terminal degradation signal of FliF. Cell cycle-dependent turnover of FliF requires an intact clpA gene, suggesting that the ClpAP protease is required for removal of the MS ring protein. Deletion analysis of the entire C-terminal cytoplasmic portion of FRF C confirmed that the degradation signal was contained in the last 26 amino acids that were identified previously. However, only deletions longer than 20 amino acids led to a stable FliF protein, while shorter deletions dispersed over the entire 26 amino acids critical for turnover had little effect on stability. This indicated that the nature of the degradation signal is not based on a distinct primary amino acid sequence. The addition of charged amino acids to the C-terminal end abolished cell cycle-dependent FliF degradation, implying that a hydrophobic tail feature is important for the degradation of FliF. Consistent with this, ClpA-dependent degradation was restored when a short stretch of hydrophobic amino acids was added to the C terminus of stable FliF mutant forms.
C1 Univ Basel, Div Mol Microbiol, Biozentrum, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Div Mol Microbiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   ALLEY MRK, 1993, SCIENCE, V259, P1754, DOI 10.1126/science.8456303
   Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0
   Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q
   Crymes WB, 1999, J BACTERIOL, V181, P3967, DOI 10.1128/JB.181.13.3967-3973.1999
   Defenbaugh DA, 2003, J BIOL CHEM, V278, P52333, DOI 10.1074/jbc.M308724200
   Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA
   Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4
   EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977
   Fischer B, 2002, MOL MICROBIOL, V44, P461, DOI 10.1046/j.1365-2958.2002.02887.x
   Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1
   Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298
   GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531
   Gottesman S, 1999, CURR OPIN MICROBIOL, V2, P142, DOI 10.1016/S1369-5274(99)80025-3
   Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338
   Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465
   Grimaud R, 1998, J BIOL CHEM, V273, P12476, DOI 10.1074/jbc.273.20.12476
   Grunenfelder B, 2003, J BACTERIOL, V185, P1624, DOI 10.1128/JB.185.5.1624-1633.2003
   Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098
   Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348
   Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200
   Jenal U, 2000, FEMS MICROBIOL REV, V24, P177, DOI 10.1016/S0168-6445(99)00035-2
   Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8
   Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x
   Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658
   JOHNSON RC, 1977, GENETICS, V86, P25
   Keiler KC, 2000, P NATL ACAD SCI USA, V97, P7778, DOI 10.1073/pnas.97.14.7778
   Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990
   KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400
   King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652
   Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X
   Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997
   Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298
   Osteras M, 1999, J BACTERIOL, V181, P3039
   POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964
   Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x
   PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3
   Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2
   Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579
   Sambrook J., 2001, MOL CLONING LAB MANU
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   SOMMER JM, 1989, J BACTERIOL, V171, P392, DOI 10.1128/jb.171.1.392-401.1989
   STEPHENS CM, 1993, MOL MICROBIOL, V9, P1169, DOI 10.1111/j.1365-2958.1993.tb01246.x
   Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936
   TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196
   Tsai JW, 2001, J BACTERIOL, V183, P5001, DOI 10.1128/JB.183.17.5001-5007.2001
   VALLEJO AN, 1994, PCR METH APPL, V4, pS123
   Wang LY, 1999, J BACTERIOL, V181, P1211, DOI 10.1128/JB.181.4.1211-1219.1999
   WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630
   Wolf BB, 2002, CURR BIOL, V12, pR177, DOI 10.1016/S0960-9822(02)00736-4
   Wright R, 1996, GENE DEV, V10, P1532, DOI 10.1101/gad.10.12.1532
NR 52
TC 19
Z9 19
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD AUG
PY 2004
VL 186
IS 15
BP 4960
EP 4971
DI 10.1128/JB.186.15.4960-4971.2004
PG 12
WC Microbiology
SC Microbiology
GA 840RJ
UT WOS:000222876700021
PM 15262933
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Burghout, P
   Beckers, F
   de Wit, E
   van Boxtel, R
   Cornelis, GR
   Tommassen, J
   Koster, M
AF Burghout, P
   Beckers, F
   de Wit, E
   van Boxtel, R
   Cornelis, GR
   Tommassen, J
   Koster, M
TI Role of the pilot protein YscW in the biogenesis of the YscC secretin in
   Yersinia enterocolitica
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID OUTER-MEMBRANE PROTEIN; GRAM-NEGATIVE BACTERIA; C-TERMINAL DOMAIN;
   ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; ASSEMBLY PATHWAY; LIPOPROTEIN;
   LOCALIZATION; CHAPERONE; REQUIRES
AB The YscC secretin is a major component of the type III protein secretion system of Yersinia enterocolitica and forms an oligomeric structure in the outer membrane. In a mutant lacking the outer membrane lipoprotein YscW, secretion is strongly reduced, and it has been proposed that YscW plays a role in the biogenesis of the secretin. To study the interaction between the secretin and this putative pilot protein, YscC and YscW were produced in trans in a Y. enterocolitica strain lacking all other components of the secretion machinery. YscW expression increased the yield of oligomeric YscC and was required for its outer membrane localization, confirming the function of YscW as a pilot protein. Whereas the pilot-binding site of other members of the secretin family has been identified in the C terminus, a truncated YscC derivative lacking the C-terminal 96 amino acid residues was functional and stabilized by YscW. Pulse-chase experiments revealed that similar to30 min were required before YscC oligomerization was completed. In the absence of YscW, oligomerization was delayed and the yield of YscC oligomers was strongly reduced. An unlipidated form of the YscW protein was not functional, although it still interacted with the secretin and caused mislocalization of YscC even in the presence of wild-type YscW. Hence, YscW interacts with the unassembled YscC protein and facilitates efficient oligomerization, likely at the outer membrane.
C1 Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands.
   Univ Utrecht, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Tommassen, J (corresponding author), Univ Utrecht, Dept Mol Microbiol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.
EM J.P.M.Tommassen@bio.uu.nl
RI Koster, Margot/D-1261-2011; Tommassen, Jan/I-1690-2016; de Wit,
   Emmie/A-1549-2019
OI Tommassen, Jan/0000-0001-7633-4945; de Wit, Emmie/0000-0002-9763-7758
CR ALLAOUI A, 1995, J BACTERIOL, V177, P4230, DOI 10.1128/jb.177.15.4230-4237.1995
   Bitter W, 2003, ARCH MICROBIOL, V179, P307, DOI 10.1007/s00203-003-0541-8
   BRISSETTE JL, 1990, J MOL BIOL, V211, P565, DOI 10.1016/0022-2836(90)90266-O
   Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x
   CHINA B, 1990, MOL MICROBIOL, V4, P1585, DOI 10.1111/j.1365-2958.1990.tb02070.x
   CONCHAS RF, 1990, GENE, V87, P133, DOI 10.1016/0378-1119(90)90505-L
   CORNELIS G, 1975, J GEN MICROBIOL, V87, P285, DOI 10.1099/00221287-87-2-285
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x
   Daefler S, 1998, MOL MICROBIOL, V28, P1367, DOI 10.1046/j.1365-2958.1998.00908.x
   Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x
   DiGiuseppe PA, 2004, ASM NEWS, V70, P71
   GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883
   Goranson J, 1996, FEMS MICROBIOL LETT, V135, P149
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998
   Jansen C, 2000, EUR J BIOCHEM, V267, P3792, DOI 10.1046/j.1432-1327.2000.01417.x
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAROCHE Y, 1984, PLASMID, V12, P67, DOI 10.1016/0147-619X(84)90069-6
   MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   OSBORN MJ, 1972, J BIOL CHEM, V247, P3962
   Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231
   RAPOZA MP, 1993, J BACTERIOL, V175, P1856, DOI 10.1128/JB.175.6.1856-1859.1993
   REID J, 1988, J BIOL CHEM, V263, P7753
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001
   Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219
   Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F
   TOMMASSEN J, 1983, EMBO J, V2, P1275, DOI 10.1002/j.1460-2075.1983.tb01581.x
   VOSSCHEPERKEUTER GH, 1984, J MOL BIOL, V175, P511, DOI 10.1016/0022-2836(84)90182-7
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   ZINK DL, 1980, NATURE, V283, P224, DOI 10.1038/283224a0
NR 43
TC 66
Z9 69
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD AUG
PY 2004
VL 186
IS 16
BP 5366
EP 5375
DI 10.1128/JB.186.16.5366-5375.2004
PG 10
WC Microbiology
SC Microbiology
GA 844SC
UT WOS:000223179000020
PM 15292137
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Engel, A
AF Engel, A
TI 2D crystals: An approach to assess structure and function of membrane
   proteins
SO PROTEIN SCIENCE
LA English
DT Meeting Abstract
CT 18th Symposium of the Protein-Society
CY AUG 14-18, 2004
CL San Diego, CA
SP Protein Soc, Abbott Lab Fund, Amer Peptide Soc, Amgen, Biogen Idec, DARPA, Eli Lilly & Co, Eli Lilly Res Labs, Biotechnol Discovery Res, Genencor Int, Genentech Inc, Merck Res Labs, Natl Sci Fdn, NIH, New England BioLabs, Novartis Inst Biomed Res, Pfizer Inc, Protein Soc Educ Comm, Protein Soc Young Protein Sci Comm, Roche Pharmaceut, Sunesis Pharmaceut Inc
C1 Univ Basel, Biozentrum, Maurice E Mueller Inst, Basel, Switzerland.
CR Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092
NR 3
TC 0
Z9 0
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI WOODBURY
PA 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD AUG
PY 2004
VL 13
SU 1
MA 39
BP 62
EP 63
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 866TL
UT WOS:000224796100040
DA 2021-01-25
ER

PT J
AU Pokidysheva, E
   Milbradt, AG
   Meier, S
   Renner, C
   Haussinger, D
   Bachinger, HP
   Moroder, L
   Grzesiek, S
   Holstein, TW
   Ozbek, S
   Engel, J
AF Pokidysheva, E
   Milbradt, AG
   Meier, S
   Renner, C
   Haussinger, D
   Bachinger, HP
   Moroder, L
   Grzesiek, S
   Holstein, TW
   Ozbek, S
   Engel, J
TI The structure of the Cys-rich terminal domain of hydra minicollagen,
   which is involved in disulfide networks of the nematocyst wall
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID BASEMENT-MEMBRANE; IV COLLAGEN; PROTEIN; BONDS; LINKAGE; SYSTEM; SWITCH;
   CORAL
AB The minicollagens found in the nematocysts of Hydra constitute a family of invertebrate collagens with unusual properties. They share a common modular architecture with a central collagen sequence ranging from 14 to 16 Gly-X-Y repeats flanked by polyproline/hydroxyproline stretches and short terminal domains that show a conserved cysteine pattern (CXXXCXXXCXXXCXXXCC). The minicollagen cysteine-rich domains are believed to function in a switch of the disulfide connectivity from intra- to intermolecular bonds during maturation of the capsule wall. The solution structure of the C-terminal fragment including a minicollagen cysteine-rich domain of minicollagen-1 was determined in two independent groups by H-1 NMR. The corresponding peptide comprising the last 24 residues of the molecule was produced synthetically and refolded by oxidation under low protein concentrations. Both presented structures are identical in their fold and disulfide connections (Cys(2)-Cys(18), Cys(6)-Cys(14), and Cys(10)-Cys(19)) revealing a robust structural motif that is supposed to serve as the polymerization module of the nematocyst capsule.
C1 Univ Basel, Dept Biol Struct, Biozentrum, CH-4051 Basel, Switzerland.
   Univ Basel, Dept Biophys Chem, Biozentrum, CH-4051 Basel, Switzerland.
   Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   Shriners Hosp Children, Portland, OR 97239 USA.
   Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
   Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany.
RP Grzesiek, S (corresponding author), Univ Basel, Dept Biol Struct, Biozentrum, Klingelbergstr 70, CH-4051 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch; suat.oezbek@unibas.ch
RI Meier, Sebastian/A-4279-2015; Haussinger, Daniel/C-6617-2016; Ozbek,
   Suat/D-3701-2014
OI Meier, Sebastian/0000-0003-3761-3217; Haussinger,
   Daniel/0000-0002-4798-0072; Grzesiek, Stephan/0000-0003-1998-4225;
   Moroder, Luis/0000-0001-9570-5713; Ozbek, Suat/0000-0003-2569-3942
CR Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918
   BATEMAN JF, 1996, MOL COMPONENTS INTER, V2
   BLANQUET R, 1966, SCIENCE, V154, P152, DOI 10.1126/science.154.3745.152
   Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054
   BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Creighton TE, 1997, BIOL CHEM, V378, P731
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443
   ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001
   Engel J, 1997, SCIENCE, V277, P1785, DOI 10.1126/science.277.5333.1785
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   ENGEL U, 2002, J CELL SCI, V115
   FAINZILBER M, 1995, BIOCHEMISTRY-US, V34, P8649, DOI 10.1021/bi00027a014
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Gunwar S, 1998, J BIOL CHEM, V273, P8767, DOI 10.1074/jbc.273.15.8767
   Handford PA, 2000, BBA-MOL CELL RES, V1498, P84, DOI 10.1016/S0167-4889(00)00085-9
   HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186
   Housset D, 2000, ACTA CRYSTALLOGR D, V56, P151, DOI 10.1107/S0907444999014948
   JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208
   Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770
   KORADI R, 1996, J MOL GRAPHICS, V14, P29
   KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   Laederach A, 2002, BIOCHEMISTRY-US, V41, P12359, DOI 10.1021/bi026185z
   LENHOFF HM, 1957, BIOCHIM BIOPHYS ACTA, V26, P204, DOI 10.1016/0006-3002(57)90074-4
   Li PP, 2002, P NATL ACAD SCI USA, V99, P1353, DOI 10.1073/pnas.032668699
   Mandard N, 2002, EUR J BIOCHEM, V269, P1190, DOI 10.1046/j.0014-2956.2002.02760.x
   MEIER S, 2004, IN PRESS FEBS LETT
   Milbradt AG, 2003, BIOCHEMISTRY-US, V42, P2404, DOI 10.1021/bi020628h
   Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100
   Ozbek S, 2002, J BIOL CHEM, V277, P49200, DOI 10.1074/jbc.M209401200
   Ozbek S, 2002, J STRUCT BIOL, V137, P11, DOI 10.1006/jsbi.2002.4436
   Ricard-Blum S, 2000, UNCONVENTIONAL COLLA
   Tamaoki H, 1998, PROTEIN ENG, V11, P649, DOI 10.1093/protein/11.8.649
   VANDERREST M, 1991, FASEB J, V5, P2814
   Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524
   WAGNER DD, 1987, BLOOD, V69, P27
   WANG WQ, 1995, GENE, V152, P195, DOI 10.1016/0378-1119(95)00644-L
   WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783
   Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g
   Wieringa R, 2003, J VIROL, V77, P12996, DOI 10.1128/JVI.77.24.12996-13004.2003
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   ZHANG RM, 1989, J BIOL CHEM, V264, P18472
NR 44
TC 25
Z9 25
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 16
PY 2004
VL 279
IS 29
BP 30395
EP 30401
DI 10.1074/jbc.M403734200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 836CD
UT WOS:000222531900065
PM 15123641
OA Bronze
DA 2021-01-25
ER

PT J
AU Gassmann, M
   Shaban, H
   Vigot, R
   Sansig, G
   Haller, C
   Barbieri, S
   Humeau, Y
   Schuler, V
   Muller, M
   Kinzel, B
   Klebs, K
   Schmutz, M
   Froestl, W
   Heid, J
   Kelly, PH
   Gentry, C
   Jaton, AL
   Van der Putten, H
   Mombereau, C
   Lecourtier, L
   Mosbacher, J
   Cryan, JF
   Fritschy, JM
   Luthi, A
   Kaupmann, K
   Bettler, B
AF Gassmann, M
   Shaban, H
   Vigot, R
   Sansig, G
   Haller, C
   Barbieri, S
   Humeau, Y
   Schuler, V
   Muller, M
   Kinzel, B
   Klebs, K
   Schmutz, M
   Froestl, W
   Heid, J
   Kelly, PH
   Gentry, C
   Jaton, AL
   Van der Putten, H
   Mombereau, C
   Lecourtier, L
   Mosbacher, J
   Cryan, JF
   Fritschy, JM
   Luthi, A
   Kaupmann, K
   Bettler, B
TI Redistribution of GABA(B(1)) protein and atypical GABA(B) responses in
   GABA(B(2))-deficient mice
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE GABA; GPCR; G-protein; heterodimerization; metabotropic; trafficking
ID METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; B-RECEPTOR;
   RAT-BRAIN; ACID(B) RECEPTORS; SPLICE VARIANTS; MESSENGER-RNAS; GB2
   SUBUNITS; K+ CHANNELS; EXPRESSION
AB GABA(B) receptors mediate slow synaptic inhibition in the nervous system. In transfected cells, functional GABA(B) receptors are usually only observed after coexpression of GABA(B(1)) and GABA(B(2)) subunits, which established the concept of heteromerization for G-protein-coupled receptors. In the heteromeric receptor, GABA(B(1)) is responsible for binding of GABA, whereas GABA(B(2)) is necessary for surface trafficking and G-protein coupling. Consistent with these in vitro observations, the GABA(B(1)) subunit is also essential for all GABA(B) signaling in vivo. Mice lacking the GABA(B(1)) subunit do not exhibit detectable electrophysiological, biochemical, or behavioral responses to GABA(B) agonists. However, GABA(B(1)) exhibits a broader cellular expression pattern than GABA(B(2)), suggesting that GABA(B(1)) could be functional in the absence of GABA(B(2)). We now generated GABA(B(2))-deficient mice to analyze whetherGABA(B(1)) has the potential to signal without GABA(B(2)) in neurons. We show that GABA(B(2))(-/-) mice suffer from spontaneous seizures, hyperalgesia, hyperlocomotor activity, and severe memory impairment, analogous to GABA(B(1))(-/-) mice. This clearly demonstrates that the lack of heteromeric GABA(B(1,2)) receptors underlies these phenotypes. To our surprise and in contrast to GABA(B(1))(-/-) mice, we still detect atypical electrophysiological GABA(B) responses in hippocampal slices of GABA(B(2))(-/-) mice. Furthermore, in the absence of GABA(B(2)), the GABA(B(1)) protein relocates from distal neuronal sites to the soma and proximal dendrites. Our data suggest that association of GABA(B(2)) with GABA(B(1)) is essential for receptor localization in distal processes but is not absolutely necessary for signaling. It is therefore possible that functional GABA(B) receptors exist in neurons that naturally lack GABA(B(2)) subunits.
C1 Univ Basel, Biozentrum, Pharmazentrum, Dept Clin Biol Sci, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.
   CNRS, Unite Propre Rech 2356, F-67084 Strasbourg, France.
   Novartis Inst Med Sci, London WC1E 6B9, England.
   Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland.
RP Kaupmann, K (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, Dept Clin Biol Sci, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM klemens.kaupmann@pharma.novartis.com; bernhard.bettler@unibas.ch
RI Cryan, John F./A-6950-2013; shaban, Hamdy/C-1939-2014; bettler,
   bernhard/AAO-8018-2020
OI Cryan, John F./0000-0001-5887-2723; shaban, Hamdy/0000-0003-3760-6113;
   Bettler, Bernhard/0000-0003-0842-8207; Fritschy,
   Jean-Marc/0000-0002-8552-3702; Gassmann, Martin/0000-0001-6201-3032;
   Kaupmann, Klemens/0000-0001-8903-2508
CR Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0
   BETTLER B, 2004, IN PRESS PHYSL REV
   Billinton A, 2000, MOL BRAIN RES, V77, P111, DOI 10.1016/S0169-328X(00)00047-4
   Blanchet C, 2002, P NATL ACAD SCI USA, V99, P4674, DOI 10.1073/pnas.072075399
   Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575
   Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247
   Brucato FH, 1996, NEUROSCIENCE, V74, P331, DOI 10.1016/0306-4522(96)00131-5
   Burman KJ, 2003, BRAIN RES, V970, P35, DOI 10.1016/S0006-8993(02)04269-5
   Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1
   Calver AR, 2001, J NEUROSCI, V21, P1203
   Calver AR, 2002, NEUROSIGNALS, V11, P299, DOI 10.1159/000068257
   Calver AR, 2003, MOL BRAIN RES, V110, P305, DOI 10.1016/S0169-328X(02)00662-9
   Clark JA, 2000, BRAIN RES, V860, P41, DOI 10.1016/S0006-8993(00)01958-2
   D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74
   Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200
   EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385
   Filippov AK, 2000, J NEUROSCI, V20, P2867
   Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x
   Fritschy JM, 1998, J COMP NEUROL, V390, P194
   Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152
   Getova D, 1998, PSYCHOPHARMACOLOGY, V137, P369, DOI 10.1007/s002130050632
   Getova DP, 2001, PSYCHOPHARMACOLOGY, V157, P89, DOI 10.1007/s002130100766
   Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343
   JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5
   Kaupmann K, 1998, NATURE, V396, P683
   Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0
   Kaupmann K, 2003, EUR J NEUROSCI, V18, P2722, DOI 10.1111/j.1460-9568.2003.03013.x
   Kim MO, 2003, DEV BRAIN RES, V143, P47, DOI 10.1016/S0165-3806(03)00099-3
   Kniazeff J, 2002, J NEUROSCI, V22, P7352
   Kulik A, 2003, J NEUROSCI, V23, P11026
   Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771
   Lei WB, 2001, J BIOL CHEM, V276, P16720, DOI 10.1074/jbc.M100207200
   Li SP, 2003, MOL CELLS, V16, P40
   Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5
   Luthi A, 1997, J NEUROPHYSIOL, V77, P221, DOI 10.1152/jn.1997.77.1.221
   MALCANGIO M, 1991, BRIT J PHARMACOL, V103, P1303, DOI 10.1111/j.1476-5381.1991.tb09784.x
   Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698
   Mao JZ, 2004, P NATL ACAD SCI USA, V101, P1087, DOI 10.1073/pnas.0304827101
   Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X
   Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798
   Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498
   Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8
   Martin SC, 2001, GENE, V278, P63, DOI 10.1016/S0378-1119(01)00678-3
   Mohler H, 2001, LIFE SCI, V68, P2297, DOI 10.1016/S0024-3205(01)01018-9
   Nakagawa Y, 1999, EUR J PHARMACOL, V381, P1, DOI 10.1016/S0014-2999(99)00567-1
   Ng TKY, 2001, J COMP NEUROL, V433, P458, DOI 10.1002/cne.1153
   OLPE HR, 1990, EUR J PHARMACOL, V187, P27, DOI 10.1016/0014-2999(90)90337-6
   Pagano A, 2001, J NEUROSCI, V21, P1189
   Patel S, 2001, PAIN, V90, P217, DOI 10.1016/S0304-3959(00)00404-8
   Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995
   Queva S, 2003, BRIT J PHARMACOL, V140, P315, DOI 10.1038/sj.bjp.0705447
   RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409
   Robbins MJ, 2001, J NEUROSCI, V21, P8043
   Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0
   Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2
   Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477
   Sloviter RS, 1999, NEUROPHARMACOLOGY, V38, P1707, DOI 10.1016/S0028-3908(99)00132-X
   Staubli U, 1999, J NEUROSCI, V19, P4609
   Straessle A, 2003, EUR J NEUROSCI, V18, P2213, DOI 10.1046/j.1460-9568.2003.02964.x
   Urwyler S, 2001, MOL PHARMACOL, V60, P963
   VENABLE N, 1990, PSYCHOPHARMACOLOGY, V100, P215, DOI 10.1007/BF02244409
NR 61
TC 176
Z9 188
U1 0
U2 9
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUL 7
PY 2004
VL 24
IS 27
BP 6086
EP 6097
DI 10.1523/JNEUROSCI.5635-03.2004
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 835NR
UT WOS:000222491000006
PM 15240800
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Meier, S
   Haussinger, D
   Pokidysheva, E
   Bachinger, HP
   Grzesiek, S
AF Meier, S
   Haussinger, D
   Pokidysheva, E
   Bachinger, HP
   Grzesiek, S
TI Determination of a high-precision NMR structure of the minicollagen
   cysteine rich domain from Hydra and characterization of its disulfide
   bond formation
SO FEBS LETTERS
LA English
DT Article
DE nematocyst; disulfide bond; Heteronuclear NMR; residual dipolar coupling
ID ENDOPLASMIC-RETICULUM; PROTEIN-STRUCTURE; CHEMICAL-SHIFT; NEMATOCYSTS;
   GLUTATHIONE; ALIGNMENT; COLLAGENS; LINKAGE; SYSTEM; SWITCH
AB A high-precision solution structure of the C-terminal minicollagen cysteine rich domain of Hydra has been determined using modern heteronuclear and weak alignment NMR techniques at natural isotope abundance. The domain consists of only 24 amino acids, six of which are prolines and six are cysteines bonded in disulfide bridges that constrain the structure into a new fold. The redox equilibrium of the structure has been characterized from a titration with glutathione. No local native structures are detectable in the reduced form. Thus, oxidation and folding are tightly coupled. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Basel, Div Struct Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Shriners Hosp Children, Portland, OR 97239 USA.
RP Grzesiek, S (corresponding author), Univ Basel, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Meier, Sebastian/A-4279-2015; Haussinger, Daniel/C-6617-2016
OI Meier, Sebastian/0000-0003-3761-3217; Haussinger,
   Daniel/0000-0002-4798-0072; Grzesiek, Stephan/0000-0003-1998-4225
CR Bass R, 2004, J BIOL CHEM, V279, P5257, DOI 10.1074/jbc.M304951200
   BLANQUET R, 1966, SCIENCE, V154, P152, DOI 10.1126/science.154.3745.152
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Engel J, 1997, SCIENCE, V277, P1785, DOI 10.1126/science.277.5333.1785
   Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   FASMAN GD, 1976, HDB BIOCH MOL BIOL
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341
   HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302
   HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186
   HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   LENHOFF HM, 1957, BIOCHIM BIOPHYS ACTA, V26, P204, DOI 10.1016/0006-3002(57)90074-4
   Ozbek S, 2002, J BIOL CHEM, V277, P49200, DOI 10.1074/jbc.M209401200
   Ozbek S, 2002, J STRUCT BIOL, V137, P11, DOI 10.1006/jsbi.2002.4436
   POKIDYSHEVA E, 2004, IN PRESS J BIOL CHEM
   Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281
   WEBER J, 1990, J BIOL CHEM, V265, P9664
   Welker E, 2001, P NATL ACAD SCI USA, V98, P2312, DOI 10.1073/pnas.041615798
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   ZHANG RM, 1989, J BIOL CHEM, V264, P18472
NR 28
TC 13
Z9 13
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD JUL 2
PY 2004
VL 569
IS 1-3
BP 112
EP 116
DI 10.1016/j.febslet.2004.05.034
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 836IG
UT WOS:000222548500020
PM 15225618
OA Bronze
DA 2021-01-25
ER

PT J
AU Jazwinska, A
   Affolter, M
AF Jazwinska, A
   Affolter, M
TI A family of genes encoding zona pellucida (ZP) domain proteins is
   expressed in various epithelial tissues during Drosophila embryogenesis
SO GENE EXPRESSION PATTERNS
LA English
DT Article
DE Drosophila; zona pellucida; zona pellucida domain; epithelial
   morphogenesis
ID HOMOLOG; IDENTIFICATION; MORPHOGENESIS; ANGIOGENESIS; GROWTH; DUCTIN;
   BINDS; DMBT1
AB Zona pellucida (ZP) domain proteins have been identified in various species from worms to humans. Most of the characterized ZP family members are secreted or remain anchored to the plasma membrane where they play a structural role and/or act as receptors. In humans, several ZP proteins attracted attention because of their abundant expression in certain organs and their relation to various diseases. Here, we compare the molecular architecture and embryonic expression pattern of the 18 genes encoding ZP proteins in Drosophila melanogaster. Only five of these genes have been genetically characterized. All ZP genes are expressed in the embryo in epithelial tissues, such as the foregut, the hindgut, the Malpighian tubules, the salivary glands, the tracheal system, sensory organs and epidermis. Five genes are expressed during oogenesis; two of them are transcribed in the follicular epithelium, but not in the germ line cells. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Jazwinska, Anna/M-8705-2016
OI Jazwinska, Anna/0000-0003-3881-9284; Affolter,
   Markus/0000-0002-5171-0016
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Bandyopadhyay A, 2002, ONCOGENE, V21, P3541, DOI 10.1038/sj.onc.1205439
   Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200
   BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9
   Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X
   Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev
   EPIFANO O, 1995, J BIOL CHEM, V270, P27254, DOI 10.1074/jbc.270.45.27254
   Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097
   Hikita C, 1999, J BIOL CHEM, V274, P17671, DOI 10.1074/jbc.274.25.17671
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   JONES SJM, 1995, MOL GEN GENET, V248, P719, DOI 10.1007/BF02191712
   Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802
   Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972
   Matsushita F, 2000, BIOCHEM BIOPH RES CO, V268, P275, DOI 10.1006/bbrc.2000.2104
   Mollenhauer J, 2000, CANCER RES, V60, P1704
   Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537
   Pak J, 2001, J BIOL CHEM, V276, P9924, DOI 10.1074/jbc.M008610200
   Roch F, 2003, J CELL SCI, V116, P1199, DOI 10.1242/jcs.00298
   Scheele GA, 1996, PANCREAS, V12, P1, DOI 10.1097/00006676-199601000-00001
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   SEBASTIANO M, 1991, DEV BIOL, V146, P519, DOI 10.1016/0012-1606(91)90253-Y
   Spradling Allan C., 1993, P1
   Stoffel W., 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   Tian JD, 1999, P NATL ACAD SCI USA, V96, P829, DOI 10.1073/pnas.96.3.829
   van den Driesche S, 2003, CARDIOVASC RES, V58, P20, DOI 10.1016/S0008-6363(02)00852-0
   Vijayakumar S, 1999, J CELL BIOL, V144, P1057, DOI 10.1083/jcb.144.5.1057
   Waclawek M, 1998, BIOL REPROD, V59, P1230, DOI 10.1095/biolreprod59.5.1230
   Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178
   Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5
   Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6
   Yu RYL, 2000, EMBO J, V19, P3542, DOI 10.1093/emboj/19.14.3542
NR 32
TC 31
Z9 33
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-133X
EI 1872-7298
J9 GENE EXPR PATTERNS
JI Gene Expr. Patterns
PD JUL
PY 2004
VL 4
IS 4
BP 413
EP 421
DI 10.1016/j.modgep.2004.01.003
PG 9
WC Developmental Biology; Genetics & Heredity
SC Developmental Biology; Genetics & Heredity
GA 834TM
UT WOS:000222433800007
PM 15183308
DA 2021-01-25
ER

PT J
AU Burghout, P
   van Boxtel, R
   Van Gelder, P
   Ringler, P
   Muller, SA
   Tommassen, J
   Koster, M
AF Burghout, P
   van Boxtel, R
   Van Gelder, P
   Ringler, P
   Muller, SA
   Tommassen, J
   Koster, M
TI Structure and electrophysiological properties of the YscC secretin from
   the type III secretion system of Yersinia enterocolitica
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID TRANSMISSION ELECTRON-MICROSCOPY; OUTER-MEMBRANE PROTEIN; GRAM-NEGATIVE
   BACTERIA; ENTEROPATHOGENIC ESCHERICHIA-COLI; PHAGE PIV MULTIMER;
   C-TERMINAL DOMAIN; PSEUDOMONAS-AERUGINOSA; NEISSERIA-MENINGITIDIS;
   SUPRAMOLECULAR STRUCTURE; OLIGOMERIC RINGS
AB YscC is the integral outer membrane component of the type III protein secretion machinery of Yersinia enterocolitica and belongs to the family of secretins. This group of proteins forms stable ring-like oligomers in the outer membrane, which are thought to function as transport channels for macromolecules. The YscC oligomer was purified after solubilization from the membrane with a nonionic detergent. Sodium dodecyl sulfate did not dissociate the oligomer, but it caused a change in electrophoretic mobility and an increase in protease susceptibility, indicating partial denaturation of the subunits within the oligomer. The mass of the homo-oligomer, as determined by scanning transmission electron microscopy, was approximately 1 MDa. Analysis of the angular power spectrum from averaged top views of negatively stained YscC oligomers revealed a 13-fold angular order, suggesting that the oligomer consists of 13 subunits. Reconstituted in planar lipid bilayers, the YscC oligomer displayed a constant voltage-independent conductance of approximately 3 nS, thus forming a stable pore. However, in vivo, the expression of YscC did not lead to an increased permeability of the outer membrane. Electron microscopy revealed that the YscC oligomer is composed of three domains, two stacked rings attached to a conical domain. This structure is consistent with the notion that the secretin forms the upper part of the basal body of the needle structure of the type III secreton.
C1 Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands.
   Univ Utrecht, Biomembrane Inst, NL-3584 CH Utrecht, Netherlands.
   Free Univ Brussels VIB, Dept Ultrastruct, B-1050 Brussels, Belgium.
   Univ Basel, Maurice E Muller Inst High Resolut Electron M, Biozentrum, CH-4056 Basel, Switzerland.
RP Tommassen, J (corresponding author), Univ Utrecht, Dept Mol Microbiol, Padualaan 8, NL-3584 CH Utrecht, Netherlands.
EM J.P.M.Tommassen@bio.uu.nl
RI Tommassen, Jan/I-1690-2016; Koster, Margot/D-1261-2011
OI Tommassen, Jan/0000-0001-7633-4945; 
CR ALLAOUI A, 1995, J BACTERIOL, V177, P4230, DOI 10.1128/jb.177.15.4230-4237.1995
   Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340
   BURGHOUT P, IN PRESS J BACTERIOL
   CHINA B, 1990, MOL MICROBIOL, V4, P1585, DOI 10.1111/j.1365-2958.1990.tb02070.x
   Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003
   Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x
   Daefler S, 1998, MOL MICROBIOL, V28, P1367, DOI 10.1046/j.1365-2958.1998.00908.x
   Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x
   Daefler S, 1997, J MOL BIOL, V266, P978, DOI 10.1006/jmbi.1996.0866
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   de Jonge MI, 2002, EUR J BIOCHEM, V269, P5215, DOI 10.1046/j.1432-1033.2002.03228.x
   Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x
   FRANK J, 1981, ULTRAMICROSCOPY, V6, P343, DOI 10.1016/S0304-3991(81)80221-5
   FRENKEN LGJ, 1993, MOL MICROBIOL, V9, P591, DOI 10.1111/j.1365-2958.1993.tb01719.x
   GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883
   Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   HANCOCK REW, 1978, J BACTERIOL, V136, P381, DOI 10.1128/JB.136.1.381-390.1978
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Hasler L, 1997, J STRUCT BIOL, V119, P273, DOI 10.1006/jsbi.1997.3889
   HELLER KB, 1978, J BACTERIOL, V134, P1181, DOI 10.1128/JB.134.3.1181-1183.1978
   Hille B, 1992, IONIC CHANNELS EXCIT
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998
   Jackson MW, 1999, J BACTERIOL, V181, P5126, DOI 10.1128/JB.181.16.5126-5130.1999
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Marciano DK, 1999, SCIENCE, V284, P1516, DOI 10.1126/science.284.5419.1516
   MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   NIKAIDO H, 1985, MICROBIOL REV, V49, P1
   Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9
   Sambrook J, 1989, MOL CLONING LAB MANU
   SAXTON WO, 1979, ULTRAMICROSCOPY, V4, P343, DOI 10.1016/S0304-3991(79)80044-3
   Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876
   TOMMASSEN J, 1983, EMBO J, V2, P1275, DOI 10.1002/j.1460-2075.1983.tb01581.x
   Van Gelder P, 2000, EUR J BIOCHEM, V267, P79, DOI 10.1046/j.1432-1327.2000.00960.x
   VanGelder P, 1997, PROTEIN ENG, V10, P699, DOI 10.1093/protein/10.6.699
   Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408
NR 55
TC 73
Z9 76
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD JUL
PY 2004
VL 186
IS 14
BP 4645
EP 4654
DI 10.1128/JB.186.14.4645-4654.2004
PG 10
WC Microbiology
SC Microbiology
GA 838QM
UT WOS:000222728100026
PM 15231798
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Jaravine, VA
   Cordier, F
   Grzesiek, S
AF Jaravine, VA
   Cordier, F
   Grzesiek, S
TI Quantification of H/D isotope effects on protein hydrogen-bonds by
   (h3)J(NC ') and (1)J(NC ') couplings and peptide group N-15 and C-13 '
   chemical shifts
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE hydrogen-deuterium exchange; protein structure; protein stability;
   hydrogen bond stability; Ubbelohde effect; NMR
ID NUCLEAR-MAGNETIC-RESONANCE; HIGH-RESOLUTION; STAPHYLOCOCCAL NUCLEASE;
   SEQUENTIAL ASSIGNMENT; NMR-SPECTROSCOPY; SCALAR COUPLINGS; EXCHANGE;
   DNA; CRYSTALLOGRAPHY; DEPENDENCIES
AB The effect of hydrogen/deuterium exchange on protein hydrogen bond coupling constants (h3)J(NC') has been investigated in the small globular protein ubiquitin. The couplings across deuterated or protonated hydrogen bonds were measured by a long-range quantitative HA(CACO)NCO experiment. The analysis is combined with a determination of the H-N/D-N isotope effect on the amide group (1)J(NC') couplings and the N-15 and C-13' chemical shifts. On average, H-bond deuteration exchange weakens (h3)J(NC') and strengthens (1)J(NC') couplings. A correlation is found between the size of the N-15 isotope shift, the N-15 chemical shift, and the (h3)J(NC') coupling constants. The data are consistent with a reduction of donor-acceptor overlap as expected from the classical Ubbelohde effect and the common understanding that H-N/D-N exchange leads to a shortening of the N-hydron bond length.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Stephan.Grzesiek@unibas.ch
OI Cordier, Florence/0000-0002-5963-7773; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v
   Barfield M, 2001, J AM CHEM SOC, V123, P4014, DOI 10.1021/ja003781c
   BAX A, 1994, METHOD ENZYMOL, V239, P79
   Benedict H, 1998, J AM CHEM SOC, V120, P2939, DOI 10.1021/ja9719790
   Bevington P. R., 1992, DATA REDUCTION ERROR
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100
   Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X
   Engler N, 2003, P NATL ACAD SCI USA, V100, P10243, DOI 10.1073/pnas.1834279100
   GOMBLER W, 1982, J AM CHEM SOC, V104, P6616, DOI 10.1021/ja00388a023
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P4369, DOI 10.1021/ja00063a068
   HANSEN PE, 1988, PROG NUCL MAG RES SP, V20, P207, DOI 10.1016/0079-6565(88)80002-5
   Harris CM, 2001, EUR J BIOCHEM, V268, P5504, DOI 10.1046/j.1432-1033.2001.02462.x
   HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1
   IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022
   Jameson C. J., 1996, ENCY NUCL MAGNETIC R, V4, P2638
   JAMESON CJ, 1984, J CHEM PHYS, V81, P4300, DOI 10.1063/1.447439
   Jaravine VA, 2000, PROTEIN SCI, V9, P290
   Jelsch C, 2000, P NATL ACAD SCI USA, V97, P3171, DOI 10.1073/pnas.97.7.3171
   JURANIC N, 1995, J AM CHEM SOC, V117, P405, DOI 10.1021/ja00106a046
   Juranic N, 2001, J AM CHEM SOC, V123, P4099, DOI 10.1021/ja015647d
   Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473
   Kojima C, 2000, J BIOMOL NMR, V18, P269, DOI 10.1023/A:1026717101063
   Krantz BA, 2002, NAT STRUCT BIOL, V9, P458, DOI 10.1038/nsb794
   Kreevoy MM, 1999, CAN J CHEM, V77, P733, DOI 10.1139/cjc-77-5-6-733
   LEGON AC, 1988, CHEM PHYS LETT, V147, P484, DOI 10.1016/0009-2614(88)85013-9
   LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022
   MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852
   MARKLEY JL, 1968, SCIENCE, V161, P1249, DOI 10.1126/science.161.3847.1249
   Mittermaier A, 2002, J BIOMOL NMR, V23, P35, DOI 10.1023/A:1015368803552
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   Rosen MK, 1996, J MOL BIOL, V263, P627, DOI 10.1006/jmbi.1996.0603
   Salzmann M, 2000, J AM CHEM SOC, V122, P7543, DOI 10.1021/ja0003268
   Scheurer C, 1999, J AM CHEM SOC, V121, P8661, DOI 10.1021/ja9917417
   Shenderovich IG, 1998, BER BUNSEN PHYS CHEM, V102, P422, DOI 10.1002/bbpc.19981020322
   Shu F, 2000, P NATL ACAD SCI USA, V97, P3872, DOI 10.1073/pnas.060024697
   Smirnov SN, 1996, J AM CHEM SOC, V118, P4094, DOI 10.1021/ja953445+
   SOKOLOV ND, 1994, CHEM PHYS, V181, P305, DOI 10.1016/0301-0104(93)E0436-Y
   TORCHIA DA, 1988, J AM CHEM SOC, V110, P2320, DOI 10.1021/ja00215a063
   TUCHSEN E, 1991, INT J BIOL MACROMOL, V13, P2, DOI 10.1016/0141-8130(91)90002-C
   UBBELOHDE AR, 1955, ACTA CRYSTALLOGR, V8, P71, DOI 10.1107/S0365110X55000340
   WANG AC, 1995, J BIOMOL NMR, V5, P376
NR 46
TC 30
Z9 30
U1 0
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD JUL
PY 2004
VL 29
IS 3
BP 309
EP 318
DI 10.1023/B:JNMR.0000032516.87434.35
PG 10
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 831QX
UT WOS:000222211200008
PM 15213429
DA 2021-01-25
ER

PT J
AU Bariola, PA
   Retelska, D
   Stasiak, A
   Kammerer, RA
   Fleming, A
   Hijri, M
   Franks, S
   Farmer, EE
AF Bariola, PA
   Retelska, D
   Stasiak, A
   Kammerer, RA
   Fleming, A
   Hijri, M
   Franks, S
   Farmer, EE
TI Remorins form a novel family of coiled coil-forming oligomeric and
   filamentous proteins associated with apical, vascular and embryonic
   tissues in plants
SO PLANT MOLECULAR BIOLOGY
LA English
DT Article
DE coiled coil; crosslinking; electron microscopy; filamentous protein;
   plant
ID PLASMA-MEMBRANE; ARABIDOPSIS-THALIANA; GENE; ORGANIZATION; CYTOSKELETON;
   DEFENSE; SIGNALS; GENOME; GROWTH; LEAF
AB Remorins form a superfamily of plant-specific plasma membrane/lipid-raft-associated proteins of unknown structure and function. Using specific antibodies, we localized tomato remorin 1 to apical tissues, leaf primordia and vascular traces. The deduced remorin protein sequence contains a predicted coiled coil-domain, suggesting its participation in protein-protein interactions. Circular dichroisim revealed that recombinant potato remorin contains an alpha-helical region that forms a functional coiled-coil domain. Electron microscopy of purified preparations of four different recombinant remorins, one from potato, two divergent isologs from tomato, and one from Arahidopsis thaliana, demonstrated that the proteins form highly similar filamentous structures. The diameters of the negatively-stained filaments ranged from 4.6-7.4 nm for potato remorin 1, 4.3-6.2 nm for tomato remorin 1, 5.7-7.5 nm for tomato remorin 2, and 5.7-8.0 nm for Arabidopsis Dbp. Highly polymerized remorin 1 was detected in glutaraldehyde-crosslinked tomato plasma membrane preparations and a population of the protein was immunolocalized in tomato root tips to structures associated with discrete regions of the plasma membrane.
C1 Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.
   ID Biomed Washington, Bothell, WA 98011 USA.
   Univ Lausanne, Lab Ultrastruct Anal, CH-1015 Lausanne, Switzerland.
   Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.
   Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland.
   Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.
   Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Farmer, EE (corresponding author), Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.
EM Edward.Farmer@unil.ch
RI Farmer, Edward/H-1635-2011; Stasiak, Andrzej/E-5551-2010
OI Stasiak, Andrzej/0000-0002-0398-1989; Hijri,
   Mohamed/0000-0001-6112-8372; Kammerer, Richard/0000-0003-4570-5197
CR ALLIOTTE T, 1989, PLANT PHYSIOL, V89, P743, DOI 10.1104/pp.89.3.743
   Baskin TI, 1997, PLANT PHYSIOL, V113, P493, DOI 10.1104/pp.113.2.493
   BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cb.09.110193.000331
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315
   Davies E, 2001, PLANT SCI, V160, P185, DOI 10.1016/S0168-9452(00)00365-4
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   FARMER EE, 1991, J BIOL CHEM, V266, P3140
   Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514
   Gardiner J, 2003, PROTOPLASMA, V222, P61, DOI 10.1007/s00709-003-0009-3
   JACINTO T, 1993, PLANT PHYSIOL, V103, P1393, DOI 10.1104/pp.103.4.1393
   Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692
   Kohn WD, 1997, J BIOL CHEM, V272, P2583, DOI 10.1074/jbc.272.5.2583
   KREIS T, 1993, GUIDEBOOK CYTOSKELET
   Lai EC, 2003, J CELL BIOL, V162, P365, DOI 10.1083/jcb.200307087
   Lloyd C, 2002, PLANT CELL, V14, P2319, DOI 10.1105/tpc.141030
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   MCCAULEY MM, 1989, BOT GAZ, V150, P351, DOI 10.1086/337781
   MONGRAND S, 2004, IN PRESS J BIOL CHEM
   Nambara E, 1999, CURR OPIN PLANT BIOL, V2, P388, DOI 10.1016/S1369-5266(99)00010-2
   Reymond P, 1996, PLANT CELL, V8, P2265, DOI 10.1105/tpc.8.12.2265
   Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707
   REYMOND P, 1995, P NATL ACAD SCI USA, V92, P4145, DOI 10.1073/pnas.92.10.4145
   SOGO JM, 1987, ELECTRON MICROS, P61
   SOULAGES JL, 2003, PLANT PHYSIOL, V131, P1
   VANHOLDE K, 1985, PHYS BIOCH
   Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818
   Wasteneys GO, 2002, J CELL SCI, V115, P1345
   WEISS CA, 1993, PLANT CELL, V5, P1513
   Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
NR 31
TC 52
Z9 63
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-4412
J9 PLANT MOL BIOL
JI Plant Mol.Biol.
PD JUL
PY 2004
VL 55
IS 4
BP 579
EP 594
DI 10.1007/s11103-004-1520-4
PG 16
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA 879BB
UT WOS:000225690300010
PM 15604702
DA 2021-01-25
ER

PT J
AU Henry, T
   Pommier, S
   Journet, L
   Bernadac, A
   Gorvel, JP
   Lloubes, R
AF Henry, T
   Pommier, S
   Journet, L
   Bernadac, A
   Gorvel, JP
   Lloubes, R
TI Improved methods for producing outer membrane vesicles in Gram-negative
   bacteria
SO RESEARCH IN MICROBIOLOGY
LA English
DT Article
DE outer membrane vesicles; outer membrane integrity; Tol-Pal proteins;
   colicins; minor coat g3p protein
ID C-TERMINAL DOMAIN; FILAMENTOUS PHAGE INFECTION; COLI-TOL-PAL;
   ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; SHIGELLA-FLEXNERI;
   NEISSERIA-GONORRHOEAE; SALMONELLA-ENTERICA; PROTEIN IMPORT;
   CELL-ENVELOPE
AB Outer membrane vesicle formation occurs during Gram-negative bacterial growth. However, natural production of large amounts of outer membrane vesicles has only been described in a few bacterial genera. The purified vesicles of some bacterial pathogens have shown potential applications in vaccinology and in antibiotic therapy. This study focused on the development of a gene expression system able to induce production of large amounts of outer membrane vesicles. The Tol-Pal system of Escherichia coli, required to maintain outer membrane integrity, is composed of five cell envelope proteins, TolA, TolB, TolQ, TolR and Pal. Tol proteins are parasitized by filamentous bacteriophages and by colicins. The phage infection process and colicin import require, respectively, the N-terminal domain of the minor coat g3p protein and the translocation domain of colicins, with both domains interacting with Tol proteins. In this study, we show that the periplasmic production of either Tol, g3p or colicin domains was able to specifically destabilize the E. coli or Shigella flexneri cell envelope and to induce production of high amounts of vesicles. This technique was further found to work efficiently in Salmonella enterica serovar Typhimurium. (C) 2004 Elsevier SAS. All rights reserved.
C1 CNRS, Inst Biol Struct & Microbiol, UPR 9027, F-13402 Marseille 20, France.
   Ctr Immunol Marseille Luminy, Case 906, F-13288 Marseille 9, France.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Lloubes, R (corresponding author), CNRS, Inst Biol Struct & Microbiol, UPR 9027, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.
EM lloubes@ibsm.enrs-mrs.fr
RI pommier, stephanie/D-1165-2014; Henry, Thomas/G-3160-2013; Gorvel,
   Jean-Pierre/O-1332-2018
OI Henry, Thomas/0000-0002-0687-8565; Gorvel,
   Jean-Pierre/0000-0002-2829-9804; LLOUBES, Roland/0000-0002-9520-1053;
   Journet, Laure/0000-0002-5847-2962
CR Aase A, 2003, VACCINE, V21, P2042, DOI 10.1016/S0264-410X(02)00774-0
   Bakke H, 2001, INFECT IMMUN, V69, P5010, DOI 10.1128/IAI.69.8.5010-5015.2001
   BENEDETTI H, 1991, EMBO J, V10, P1989, DOI 10.1002/j.1460-2075.1991.tb07728.x
   Bernadac A, 1998, J BACTERIOL, V180, P4872, DOI 10.1128/JB.180.18.4872-4878.1998
   Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999
   Bouveret E, 2002, BIOCHIMIE, V84, P413, DOI 10.1016/S0300-9084(02)01423-2
   Bouveret E, 1999, J BACTERIOL, V181, P6306, DOI 10.1128/JB.181.20.6306-6311.1999
   Bouveret E, 1998, MOL MICROBIOL, V27, P143, DOI 10.1046/j.1365-2958.1998.00667.x
   Bouveret E, 1997, MOL MICROBIOL, V23, P909, DOI 10.1046/j.1365-2958.1997.2751640.x
   Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002
   Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x
   CAVARD D, 1986, J MOL BIOL, V187, P449, DOI 10.1016/0022-2836(86)90445-6
   Coster TS, 1999, INFECT IMMUN, V67, P3437, DOI 10.1128/IAI.67.7.3437-3443.1999
   Dennis JJ, 1996, J BACTERIOL, V178, P7059, DOI 10.1128/jb.178.24.7059-7068.1996
   Derouiche R, 1996, EMBO J, V15, P6408, DOI 10.1002/j.1460-2075.1996.tb01032.x
   DORWARD DW, 1989, J BACTERIOL, V171, P4196, DOI 10.1128/JB.171.8.4196-4201.1989
   Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C
   Gaspar JA, 2000, MOL MICROBIOL, V38, P262, DOI 10.1046/j.1365-2958.2000.02094.x
   GHRAYEB J, 1984, EMBO J, V3, P2437, DOI 10.1002/j.1460-2075.1984.tb02151.x
   GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987
   Holst J, 2003, VACCINE, V21, P734, DOI 10.1016/S0264-410X(02)00591-1
   Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489
   Journet L, 2001, MOL MICROBIOL, V42, P331, DOI 10.1046/j.1365-2958.2001.02592.x
   Journet L, 1999, J BACTERIOL, V181, P4476, DOI 10.1128/JB.181.15.4476-4484.1999
   Kadurugamuwa JL, 1999, MICROBIOL-SGM, V145, P2051, DOI 10.1099/13500872-145-8-2051
   Kadurugamuwa JL, 1998, ANTIMICROB AGENTS CH, V42, P1476, DOI 10.1128/AAC.42.6.1476
   KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995
   KATSUI N, 1982, J BACTERIOL, V151, P1523, DOI 10.1128/JB.151.3.1523-1531.1982
   KNOX KW, 1966, J BACTERIOL, V92, P1206, DOI 10.1128/JB.92.4.1206-1217.1966
   Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843
   Kotloff KL, 2002, INFECT IMMUN, V70, P2016, DOI 10.1128/IAI.70.4.2016-2021.2002
   LAZZARONI JC, 1992, MOL MICROBIOL, V6, P735, DOI 10.1111/j.1365-2958.1992.tb01523.x
   LEVENGOODFREYERMUTH SK, 1993, J BACTERIOL, V175, P222, DOI 10.1128/JB.175.1.222-228.1993
   Li ZS, 1998, J BACTERIOL, V180, P5478, DOI 10.1128/JB.180.20.5478-5483.1998
   Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6
   MEYER DH, 1993, INFECT IMMUN, V61, P4933, DOI 10.1128/IAI.61.11.4933-4936.1993
   PAYNE SM, 1977, INFECT IMMUN, V18, P94, DOI 10.1128/IAI.18.1.94-98.1977
   PETTIT RK, 1992, MOL MICROBIOL, V6, P723, DOI 10.1111/j.1365-2958.1992.tb01521.x
   Pucciarelli MG, 2002, MICROBIOL-SGM, V148, P1171, DOI 10.1099/00221287-148-4-1171
   Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6
   ROTHFIELD L, 1969, J MOL BIOL, V44, P477, DOI 10.1016/0022-2836(69)90374-X
   Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113
   SUZUKI H, 1978, MOL GEN GENET, V167, P1
   Tacket CO, 2000, INFECT IMMUN, V68, P1196, DOI 10.1128/IAI.68.3.1196-1201.2000
   Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2
   Walburger A, 2002, MOL MICROBIOL, V44, P695, DOI 10.1046/j.1365-2958.2002.02895.x
   WEBSTER RE, 1991, MOL MICROBIOL, V5, P1005, DOI 10.1111/j.1365-2958.1991.tb01873.x
   YEM D, 1978, J BACTERIOL, V133, P1418
   Zhou L, 1998, FEMS MICROBIOL LETT, V163, P223, DOI 10.1111/j.1574-6968.1998.tb13049.x
NR 49
TC 45
Z9 46
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0923-2508
EI 1769-7123
J9 RES MICROBIOL
JI Res. Microbiol.
PD JUL-AUG
PY 2004
VL 155
IS 6
BP 437
EP 446
DI 10.1016/j.resmic.2004.04.007
PG 10
WC Microbiology
SC Microbiology
GA 843NK
UT WOS:000223090400003
PM 15249060
DA 2021-01-25
ER

PT J
AU Jakob, M
   Demarteau, O
   Suetterlin, R
   Heberer, M
   Martin, I
AF Jakob, M
   Demarteau, O
   Suetterlin, R
   Heberer, M
   Martin, I
TI Chondrogenesis of expanded adult human articular chondrocytes is
   enhanced by specific prostaglandins
SO RHEUMATOLOGY
LA English
DT Article
DE tissue engineering; cartilage repair; cell differentiation; cartilage
   degeneration; joint inflammation
ID IN-VITRO; GENE-EXPRESSION; CARTILAGE; OSTEOARTHRITIS; ARTHRITIS; E-2;
   DIFFERENTIATION; CYCLOOXYGENASE; DEGRADATION; TISSUE
AB Objective. To investigate the effects of the cyclooxygenase-2 (cox-2)-dependent prostaglandins D-2 (PGD(2)), E-2 (PGE(2)) and F(2)alpha (PGF(2)alpha) on the redifferentiation and cartilage matrix production of dedifferentiated articular chondrocytes.
   Methods. Human articular chondrocytes from three adult donors were dedifferentiated by monolayer expansion and induced to redifferentiate by culture as 3D pellets in a defined serum-free medium containing TGF-beta(1) and dexamethasone, without or with further supplementation with PGD(2), PGE(2) or PGF(2)alpha. After 2 weeks, pellets were assessed histologically, immunohistochemically, biochemically and by real-time quantitative reverse transcriptase-polymerase chain reaction.
   Results. All three PGs, but predominantly PGE(2), reduced the staining intensity of pellets for collagen type I, whereas PGD(2) and PGF(2)alpha increased the staining intensity of pellets for collagen type II and glycosaminoglycans (GAG). The GAG/DNA content of pellets was not affected by PGE(2) but was increased 1.5- and 2.1-fold by PGD(2) and PGF(2)alpha respectively. PGE(2) reduced the expression of collagen type I mRNA (9.0-fold), whereas PGD(2) and PGF(2)alpha increased the mRNA expression of collagen type II (6.2- and 4.1-fold respectively) and aggrecan (29.8- and 10.7-fold respectively).
   Conclusion. In contrast to PGE(2), PGD(2) and PGF(2)alpha enhanced chondrogenic differentiation and hyaline cartilage matrix deposition by expanded human articular chondrocytes, and could thus be used to improve in vitro or in vivo cartilage regeneration approaches based on these cells.
C1 Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Surg, CH-4051 Basel, Switzerland.
   Univ Basel Hosp, Dept Res, CH-4051 Basel, Switzerland.
   Univ Basel, Biozentrum, ME Mueller Inst, Basel, Switzerland.
RP Jakob, M (corresponding author), Univ Basel Hosp, Inst Surg Res & Hosp Management, Dept Surg, Hebelstr 20,ZLF,Room 405, CH-4051 Basel, Switzerland.
EM mjakob@uhbs.ch
RI Martin, Ivan/K-9286-2016
OI Martin, Ivan/0000-0001-6493-0432
CR Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950
   Binette F, 1998, J ORTHOP RES, V16, P207, DOI 10.1002/jor.1100160208
   Blanco FJ, 1999, J RHEUMATOL, V26, P1366
   Brooks P, 1999, RHEUMATOLOGY, V38, P779, DOI 10.1093/rheumatology/38.8.779
   DiBattista JA, 1996, MOL CELL ENDOCRINOL, V123, P27, DOI 10.1016/0303-7207(96)03887-7
   Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.0.CO;2-8
   Fahmi H, 2002, J RHEUMATOL, V29, P3
   Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550
   Goldring Mary B., 1996, Am J Ther, V3, P9, DOI 10.1097/00045391-199601000-00003
   Hardy MM, 2002, ARTHRITIS RHEUM, V46, P1789, DOI 10.1002/art.10356
   HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Laufer S, 2003, CURR OPIN RHEUMATOL, V15, P623, DOI 10.1097/00002281-200309000-00017
   Lowe GN, 1996, ENDOCRINOLOGY, V137, P2208, DOI 10.1210/en.137.6.2208
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   Miyamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P644, DOI 10.1016/S1063-4584(03)00118-3
   MOHAMEDALI H, 1995, RHEUMATOL INT, V14, P191, DOI 10.1007/BF00262297
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Roberts S, 2001, ARTHRITIS RHEUM-US, V44, P2586, DOI 10.1002/1529-0131(200111)44:11<2586::AID-ART439>3.0.CO;2-I
   Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148
   Schwartz Z, 1998, ENDOCRINOLOGY, V139, P1825, DOI 10.1210/en.139.4.1825
   Stokes DG, 2002, ARTHRITIS RHEUM, V46, P404, DOI 10.1002/art.10106
NR 22
TC 44
Z9 46
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1462-0324
J9 RHEUMATOLOGY
JI RHEUMATOLOGY
PD JUL
PY 2004
VL 43
IS 7
BP 852
EP 857
DI 10.1093/rheumatology/keh197
PG 6
WC Rheumatology
SC Rheumatology
GA 832LX
UT WOS:000222270100007
PM 15113997
OA Bronze
DA 2021-01-25
ER

PT J
AU Leptin, M
   Affolter, M
AF Leptin, M
   Affolter, M
TI Drosophila gastrulation: Identification of a missing link
SO CURRENT BIOLOGY
LA English
DT Editorial Material
ID TRACHEAL SYSTEM; CELL-MIGRATION; FGF; PATTERN; MESODERM; EMBRYOS;
   ENCODES; GENOME
AB Drosophila gastrulation serves as a model system to elucidate the genetic and molecular mechanisms involved in morphogenetic movements. The ligand of the FGF receptor Heartless, which is involved in mesoderm movement, has now been isolated and shown to be a link between a morphogen gradient and cell behavior.
C1 Univ Cologne, Inst Genet, D-50931 Cologne, Germany.
   Univ Basel, Biozentrum, CH-4053 Basel, Switzerland.
RP Leptin, M (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-50931 Cologne, Germany.
EM mleptin@uni-koeln.de; Markus.Affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016
CR BELMAN M, 1996, GENE DEV, V10, P2993
   Dormann D, 2003, CURR OPIN GENET DEV, V13, P358, DOI 10.1016/S0959-437X(03)00087-X
   Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003
   Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058
   KLAMBT C, 1992, GENE DEV, V6, P1568
   Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912
   Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   RYDER E, 2004, IN PRESS GENETICS
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   SHISHIDO E, 1993, DEVELOPMENT, V117, P751
   Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404
   Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
NR 15
TC 6
Z9 6
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD JUN 22
PY 2004
VL 14
IS 12
BP R480
EP R482
DI 10.1016/j.cub.2004.06.016
PG 3
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 832ZF
UT WOS:000222305500014
PM 15203022
OA Bronze
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, G
TI Postdocs
SO FEBS LETTERS
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM Gottfried.Schatz@unibas.ch
NR 0
TC 1
Z9 1
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD JUN 18
PY 2004
VL 568
IS 1-3
BP 1
EP 3
DI 10.1016/j.febslet.2004.05.013
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 831OX
UT WOS:000222205200001
PM 15196909
OA Bronze
DA 2021-01-25
ER

PT J
AU Walburger, A
   Koul, A
   Ferrari, G
   Nguyen, L
   Prescianotto-Baschong, C
   Huygen, K
   Klebl, B
   Thompson, C
   Bacher, G
   Pieters, J
AF Walburger, A
   Koul, A
   Ferrari, G
   Nguyen, L
   Prescianotto-Baschong, C
   Huygen, K
   Klebl, B
   Thompson, C
   Bacher, G
   Pieters, J
TI Protein kinase G from pathogenic mycobacteria promotes survival within
   macrophages
SO SCIENCE
LA English
DT Article
ID INTRACELLULAR SURVIVAL; PHAGOSOME MATURATION; TUBERCULOSIS PHAGOSOME;
   EARLY ENDOSOMES; MICE; INHIBITORS; BIOGENESIS; SEQUENCE; ARREST; FUSION
AB Pathogenic mycobacteria resist lysosomal delivery after uptake into macrophages, allowing them to survive intracellularly. We found that the eukaryotic-like serine/threonine protein kinase G from pathogenic mycobacteria was secreted within macrophage phagosomes, inhibiting phagosome-lysosome fusion and mediating intracellular survival of mycobacteria. Inactivation of protein kinase G by gene disruption or chemical inhibition resulted in lysosomal localization and mycobacterial cell death in infected macrophages. Besides identifying a target for the control of mycobacterial infections, these findings suggest that pathogenic mycobacteria have evolved eukaryotic-like signal transduction mechanisms capable of modulating host cell trafficking pathways.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Axxima Pharmaceut AG, D-81377 Munich, Germany.
   Inst Pasteur, B-1180 Brussels, Belgium.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Huygen, Kris/0000-0001-7808-0512; Pieters, Jean/0000-0002-5284-9757;
   Nguyen, Liem/0000-0002-1523-1472
CR Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535
   Berthet FX, 1998, SCIENCE, V282, P759, DOI 10.1126/science.282.5389.759
   CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257
   Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   DENIS M, 1990, J LEUKOCYTE BIOL, V47, P25
   Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997
   Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049
   Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Hasan Z, 1998, ELECTROPHORESIS, V19, P1179, DOI 10.1002/elps.1150190719
   Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307
   Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x
   Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038
   McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   Ogawara H, 1999, MICROBIOL-UK, V145, P3343, DOI 10.1099/00221287-145-12-3343
   Russell DG, 1997, PHILOS T ROY SOC B, V352, P1303, DOI 10.1098/rstb.1997.0114
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765
   Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9
   Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1
   Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100
   STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277
   SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x
   Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326
NR 34
TC 385
Z9 408
U1 0
U2 33
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 18
PY 2004
VL 304
IS 5678
BP 1800
EP 1804
DI 10.1126/science.1099384
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 829YU
UT WOS:000222089500045
PM 15155913
DA 2021-01-25
ER

PT J
AU Morlando, M
   Ballarino, M
   Greco, P
   Caffarelli, E
   Dichtl, B
   Bozzoni, I
AF Morlando, M
   Ballarino, M
   Greco, P
   Caffarelli, E
   Dichtl, B
   Bozzoni, I
TI Coupling between snoRNP assembly and 3' processing controls box C/D
   snoRNA biosynthesis in yeast
SO EMBO JOURNAL
LA English
DT Article
DE 3'-end formation; Nop1p; Saccharomyces cerevisiae; snoRNA; snoRNP
   assembly
ID SMALL NUCLEOLAR RNAS; MESSENGER-RNA; POLYMERASE-II; 3'-END FORMATION;
   BINDING-PROTEIN; POLYADENYLATION; CLEAVAGE; SACCHAROMYCES;
   TRANSCRIPTION; SSU72
AB RNA polymerase II transcribes genes encoding proteins and a large number of small stable RNAs. While premRNA 3'-end formation requires a machinery ensuring tight coupling between cleavage and polyadenylation, small RNAs utilize polyadenylation-independent pathways. In yeast, specific factors required for snRNA and snoRNA 3'-end formation were characterized as components of the APT complex that is associated with the core complex of the cleavage/polyadenylation machinery (coreCPF). Other essential factors were identified as independent components: Nrd1p, Nab3p and Sen1p. Here we report that mutations in the conserved box D of snoRNAs and in the snoRNP-specific factor Nop1p interfere with transcription and 3'-end formation of box CID snoRNAs. We demonstrate that Nop1p is associated with box CID snoRNA genes and that it interacts with APT components. These data suggest a mechanism of quality control in which efficient transcription and 3'-end formation occur only when nascent snoRNAs are successfully assembled into functional particles.
C1 Univ Roma La Sapienza, Inst Pasteur Cenci Bolognetti, Dept Genet & Mol Biol, I-00185 Rome, Italy.
   Univ Roma La Sapienza, CNR, Inst Mol Biol & Pathol, Rome, Italy.
   Univ Basel, Dept Cell Biol, Biozentrum, Basel, Switzerland.
RP Bozzoni, I (corresponding author), Univ Roma La Sapienza, Inst Pasteur Cenci Bolognetti, Dept Genet & Mol Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
EM irene.bozzoni@uniromal.it
RI ballarino, monica/AAA-5065-2020
OI Morlando, Mariangela/0000-0002-8327-4423; Dichtl,
   Bernhard/0000-0001-5514-4982; Ballarino, Monica/0000-0002-8595-7105
CR Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399
   Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497
   Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778
   BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329
   BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7
   Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2
   Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298
   Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9
   Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237
   Chanfreau G, 1998, EMBO J, V17, P3726, DOI 10.1093/emboj/17.13.3726
   CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470
   Conrad NK, 2000, GENETICS, V154, P557
   DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632
   delOlmo M, 1997, MOL GEN GENET, V255, P209, DOI 10.1007/s004380050491
   Dheur S, 2003, EMBO J, V22, P2831, DOI 10.1093/emboj/cdg253
   Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4
   Dichtl B, 2001, EMBO J, V20, P3197, DOI 10.1093/emboj/20.12.3197
   Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218
   Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4
   Galardi S, 2002, MOL CELL BIOL, V22, P6663, DOI 10.1128/MCB.22.19.6663-6668.2002
   Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Giorgi C, 2001, EMBO J, V20, P6856, DOI 10.1093/emboj/20.23.6856
   Gross S, 2001, P NATL ACAD SCI USA, V98, P6080, DOI 10.1073/pnas.101046598
   He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203
   Huang YQ, 1996, MOL CELL BIOL, V16, P1534
   Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3
   Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700
   Kyburz A, 2003, NUCLEIC ACIDS RES, V31, P3936, DOI 10.1093/nar/gkg478
   Lafontaine DLJ, 2000, MOL CELL BIOL, V20, P2650, DOI 10.1128/MCB.20.8.2650-2659.2000
   Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X
   Manley JL, 2002, NAT STRUCT BIOL, V9, P790, DOI 10.1038/nsb1102-790
   Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8
   Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002
   Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200
   Ohnacker M, 2000, EMBO J, V19, P37, DOI 10.1093/emboj/19.1.37
   Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999
   Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7
   Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885
   Russnak R, 1996, GENE EXPRESSION, V6, P241
   SCHMITT ME, 1990, MOL CELL BIOL, V20, P1311
   Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003
   Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090
   Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x
   THOMAS BJ, 1989, GENETICS, V123, P725
   TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x
   Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000
   Villa T, 2000, MOL CELL BIOL, V20, P1311, DOI 10.1128/MCB.20.4.1311-1320.2000
   Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9
   Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002
   WENDY MO, 1997, NUCLEIC ACIDS RES, V25, P4619
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
NR 52
TC 36
Z9 36
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JUN 16
PY 2004
VL 23
IS 12
BP 2392
EP 2401
DI 10.1038/sj.emboj.7600254
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 842WT
UT WOS:000223035900007
PM 15167896
OA Green Published
DA 2021-01-25
ER

PT J
AU Podvinec, M
   Handschin, C
   Looser, R
   Meyer, UA
AF Podvinec, M
   Handschin, C
   Looser, R
   Meyer, UA
TI Identification of the xenosensors regulating human 5-aminolevulinate
   synthase
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID DELTA-AMINOLEVULINATE SYNTHASE; PREGNANE-X RECEPTOR; CONSTITUTIVE
   ANDROSTANE RECEPTOR; ORPHAN NUCLEAR RECEPTOR; TRANSCRIPTIONAL
   ACTIVATION; ACID SYNTHASE; RESPONSIVE ENHANCER; XENOBIOTIC RECEPTOR; RAT
   HEPATOCYTES; GENE-EXPRESSION
AB Heme is an essential component of numerous hemoproteins with functions including oxygen transport, energy metabolism, and drug biotransformation. In nonerythropoietic cells, 5-aminolevulinate synthase (ALAS1) is the rate-limiting enzyme in heme biosynthesis. Upon exposure to drugs that induce cytochromes P450 and other drug-metabolizing enzymes, ALAS1 is transcriptionally upregulated, increasing the rate of heme biosynthesis to provide heme for cytochrome P450 hemoproteins. We used a combined in silico-in vitro approach to identify sequences in the ALAS1 gene that mediate direct transcriptional response to xenobiotic challenge. We have characterized two enhancer elements, located 20 and 16 kb upstream of the transcriptional start site. Both elements respond to prototypic inducer drugs and interact with the human pregnane X receptor NR1I2 and the human constitutive androstane receptor NR1I3. Our results suggest that the fundamental mechanism of drug induction is the same for cytochromes P450 and ALAS1. Transcriptional activation of the ALAS1 gene is the first step in the coordinated up-regulation of apoprotein and heme synthesis in response to exogenous and endogenous signals controlling heme levels. Understanding the direct effects of drugs on heme synthesis is of clinical interest, particularly in patients with hepatic porphyrias.
C1 Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM urs-a.meyer@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3
   BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y
   Cable EE, 2000, ARCH BIOCHEM BIOPHYS, V384, P280, DOI 10.1006/abbi.2000.2117
   DEMONTELLANO O, 1995, CYTOCHROME P 450 STR
   Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200
   Fraser DJ, 2002, J BIOL CHEM, V277, P34717, DOI 10.1074/jbc.M204699200
   Goodwin B, 1999, MOL PHARMACOL, V56, P1329
   HAMILTON JW, 1988, BIOCHEM J, V255, P267
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   HAYASHI N, 1983, BIOCHEM BIOPH RES CO, V115, P700, DOI 10.1016/S0006-291X(83)80201-0
   Honkakoski P, 1998, MOL PHARMACOL, V53, P597
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Jover R, 1996, BIOCHEM BIOPH RES CO, V226, P152, DOI 10.1006/bbrc.1996.1325
   LAUDET V, 2002, NUCL RECEPTOR FACT B
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   Li B, 1999, J BIOL CHEM, V274, P17534, DOI 10.1074/jbc.274.25.17534
   Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986
   Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638
   Makinen JM, 2002, MOL PHARMACOL, V62, P366, DOI 10.1124/mol.62.2.366
   MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2
   Meyer UA, 1998, SEMIN LIVER DIS, V18, P43, DOI 10.1055/s-2007-1007139
   MUNAKATA H, 1993, J BIOCHEM, V114, P103, DOI 10.1093/oxfordjournals.jbchem.a124123
   Ourlin JC, 2000, ARCH BIOCHEM BIOPHYS, V373, P375, DOI 10.1006/abbi.1999.1566
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792
   RYAN G, 1989, INT J BIOCHEM, V21, P1025, DOI 10.1016/0020-711X(89)90235-8
   Scassa ME, 1998, EXP CELL RES, V244, P460, DOI 10.1006/excr.1998.4206
   SCHOENHAUT DS, 1989, NUCLEIC ACIDS RES, V17, P7013, DOI 10.1093/nar/17.17.7013
   SRIVASTAVA G, 1988, J BIOL CHEM, V263, P5202
   Stoltz C, 1999, BIOCHEM PHARMACOL, V57, P1073, DOI 10.1016/S0006-2952(98)00367-0
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112
   YOMOGIDA K, 1993, J BIOCHEM-TOKYO, V113, P364, DOI 10.1093/oxfordjournals.jbchem.a124052
NR 40
TC 68
Z9 71
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 15
PY 2004
VL 101
IS 24
BP 9127
EP 9132
DI 10.1073/pnas.0401845101
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 830EQ
UT WOS:000222104900054
PM 15178759
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Boudko, SP
   Strelkov, SV
   Engel, J
   Stetefeld, J
AF Boudko, SP
   Strelkov, SV
   Engel, J
   Stetefeld, J
TI Design and crystal structure of bacteriophage T4 mini-fibritin NCCF
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE bacteriophage T4 fibritin; coiled coil; collar-whisker complex; crystal
   structure; foldon
ID SEGMENTED COILED-COIL; GENE-PRODUCT; SINGLE-CHAIN; PROTEIN;
   STABILIZATION; SURFACE; T4D; WAC
AB Fibritin is a fibrous protein that forms "whiskers" attached to the neck of bacteriophage T4. Whiskers interact with the long tail fibers regulating the assembly and infectivity of the virus. The fibritin trimer includes the N-terminal domain responsible for attachment to the phage particle and for the collar formation, the central domain forming a 500 A long segmented coiled-coil structure, and the C-terminal "foldon" domain. We have designed a "mini" fibritin with most of the coiled-coil domain deleted, and solved its crystal structure. The non-helical N-terminal part represents a new protein fold that tightly interacts with the coiled-coil segment forming a single domain, as revealed by calorimetry. The analysis of the crystal structure and earlier electron microscopy data on the collar-whisker complex suggests the necessity of other proteins to participate in the collar formation. Crystal structure determination of the N-terminal domain of fibritin is the first step towards elucidating the detailed structure and assembly mechanism of the collar-whisker complex. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Boudko, SP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sergei.boudko@unibas.ch
RI Stetefeld, Joerg/H-7630-2017; Strelkov, Sergei V/G-7425-2014
OI Stetefeld, Joerg/0000-0003-1478-3248; Strelkov, Sergei
   V/0000-0001-7189-4652
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BISHOP R J, 1974, Journal of Supramolecular Structure, V2, P196, DOI 10.1002/jss.400020214
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   Boudko SP, 2002, EUR J BIOCHEM, V269, P833, DOI 10.1046/j.1432-1033.2002.02734.x
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102
   CONLEY MP, 1975, P NATL ACAD SCI USA, V72, P3701, DOI 10.1073/pnas.72.9.3701
   COOMBS DH, 1977, J MOL BIOL, V116, P375, DOI 10.1016/0022-2836(77)90076-6
   DEWEY MJ, 1974, J MOL BIOL, V84, P625, DOI 10.1016/0022-2836(74)90120-X
   DICKSON RC, 1970, J MOL BIOL, V53, P461, DOI 10.1016/0022-2836(70)90077-X
   EFIMOV VP, 1995, VIRUS GENES, V10, P173, DOI 10.1007/BF01702598
   EFIMOV VP, 1994, J MOL BIOL, V242, P470, DOI 10.1006/jmbi.1994.1595
   FOLLANSBEE SE, 1974, VIROLOGY, V58, P180, DOI 10.1016/0042-6822(74)90153-6
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kashentseva EA, 2002, CANCER RES, V62, P609
   Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001
   Leiman PG, 2003, CELL MOL LIFE SCI, V60, P2356, DOI 10.1007/s00018-003-3072-1
   Leslie A.G.W., 1992, JOINT CCP4 ESF EAMCB, V26
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   Miroshnikov KA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1346, DOI 10.1023/A:1002888419749
   Miroshnikov KA, 1998, PROTEIN ENG, V11, P329, DOI 10.1093/protein/11.4.329
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   SOBOLEV BN, 1991, J BIOMOL STRUCT DYN, V8, P953, DOI 10.1080/07391102.1991.10507859
   Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X
   Strelkov SV, 1998, ACTA CRYSTALLOGR D, V54, P805, DOI 10.1107/S0907444997018878
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   TERZAGHI BE, 1979, J MOL BIOL, V127, P1, DOI 10.1016/0022-2836(79)90454-6
   Winn MD, 2002, ACTA CRYSTALLOGR D, V58, P1929, DOI 10.1107/S0907444902016116
   WOOD WB, 1979, J MOL BIOL, V127, P15, DOI 10.1016/0022-2836(79)90455-8
   YANAGIDA M, 1970, J MOL BIOL, V51, P411, DOI 10.1016/0022-2836(70)90151-8
   Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002
NR 35
TC 19
Z9 21
U1 0
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUN 11
PY 2004
VL 339
IS 4
BP 927
EP 935
DI 10.1016/j.jmb.2004.04.001
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 827RV
UT WOS:000221919100018
PM 15165860
DA 2021-01-25
ER

PT J
AU Mouratou, B
   Stetefeld, J
AF Mouratou, B
   Stetefeld, J
TI Identification of functionally important residues in the pyridoxal-5
   '-phosphate-dependent catalytic antibody 15A9
SO BIOCHEMISTRY
LA English
DT Article
ID SITE-DIRECTED MUTAGENESIS; TYROSINE PHENOL-LYASE;
   ASPARTATE-AMINOTRANSFERASE; 3-DIMENSIONAL STRUCTURE;
   SUBSTRATE-SPECIFICITY; MOLECULAR EVOLUTION; CRYSTAL-STRUCTURE; FAB
   FRAGMENT; AMINO-ACIDS; ACTIVE-SITE
AB Antibody 15A9 is unique in its ability to catalyze the transamination reaction of hydrophobic D-amino acids with pyridoxal-5'-phosphate (PLP). Both previous chemical modification studies and a three dimensional (3-D) homology model indicated the presence of functionally important tyrosine residues in the antigen-binding cavity of antibody 15A9. To gain further insight into the hapten, ligand binding, and catalytic mechanism of 15A9, all tyrosine residues in the complementarity-determining regions (CDRs) and the single arginine residue in CDR3 of the light chain were subject to an alanine scan. Substitution of Tyr(H33), Tyr(L94), or Arg(L91) abolished the catalytic activity and reduced the affinity for PLP and N-alpha-(5'-phosphopyridoxyl)-amino acids, which are close analogues of covalent PLP-substrate adducts. The Tyr(H100b)Ala mutant possessed no detectable catalytic activity, while its affinity for each ligand was essentially the same as that of the wild-type antibody. The binding affinity for the hapten was drastically reduced by a Tyr(L32)Ala mutation, suggesting that the hydroxyphenyl group of Tyr(L32) participates in the binding of the extended side chain of the hapten. The other Tyr - Ala substitutions affected both binding and catalytic activity only to a minor degree. On the basis of the information obtained from the mutagenesis study, we docked N-alpha-(5'-phosphopyridoxyl)-D-alanine into the antigen-binding site. According to this model, Arg(L91) binds the alpha-carboxylate group of the amino acid substrate and Tyr(H100b) plays an essential role in the catalytic mechanism of antibody 15A9 by facilitating the Calpha/C4' prototropic shift. In addition, the catalytic apparatus of antibody 15A9 revealed several mechanistic features that overlap with those of PLP-dependent enzymes.
C1 Univ Zurich, Biochem Inst, CH-8057 Zurich, Switzerland.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Mouratou, B (corresponding author), Univ Zurich, Biochem Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM mouratou@lebs.cnrs-gif.fr
RI Stetefeld, Joerg/H-7630-2017
OI Stetefeld, Joerg/0000-0003-1478-3248
CR ANTSON AA, 1993, BIOCHEMISTRY-US, V32, P4195, DOI 10.1021/bi00067a006
   Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085
   BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3
   BIZEBARD T, 1994, ACTA CRYSTALLOGR D, V50, P768, DOI 10.1107/S0907444994001903
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   CHEN HY, 1995, BIOCHEMISTRY-US, V34, P12276, DOI 10.1021/bi00038a023
   CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8
   Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005
   Fujii I, 1998, NAT BIOTECHNOL, V16, P463, DOI 10.1038/nbt0598-463
   Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203
   GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580
   Gramatikova SI, 1996, J BIOL CHEM, V271, P30583, DOI 10.1074/jbc.271.48.30583
   Gramatikova SI, 1997, J BIOL CHEM, V272, P9779
   Green BS, 2002, J IMMUNOL METHODS, V269, P3, DOI 10.1016/S0022-1759(02)00220-X
   Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751
   Hotta K, 2000, J MOL BIOL, V302, P1213, DOI 10.1006/jmbi.2000.4503
   Hotta K, 2002, BIOCHEMISTRY-US, V41, P772, DOI 10.1021/bi0158167
   HWANG JK, 1988, NATURE, V334, P270, DOI 10.1038/334270a0
   JACOBSEN JR, 1992, SCIENCE, V256, P365, DOI 10.1126/science.256.5055.365
   Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1
   JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P133
   Kabat E. A., 1991, SEQUENCES PROTEINS I
   KABAT EA, 1977, J BIOL CHEM, V252, P6609
   KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4
   Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497
   LIU HS, 1994, J MOL BIOL, V240, P127, DOI 10.1006/jmbi.1994.1427
   Mahon MM, 1998, FEBS LETT, V427, P74, DOI 10.1016/S0014-5793(98)00397-4
   MATSUO Y, 1957, J AM CHEM SOC, V79, P2011, DOI 10.1021/ja01565a068
   Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129
   METZLER DE, 2001, BIOCHEMISTRY-US, P737
   MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F
   MITCHELL JBO, 1992, J MOL BIOL, V226, P251, DOI 10.1016/0022-2836(92)90137-9
   Miyashita H, 1997, J MOL BIOL, V267, P1247, DOI 10.1006/jmbi.1997.0938
   Mouratou B, 2000, MOL IMMUNOL, V37, P633, DOI 10.1016/S0161-5890(00)00090-0
   Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086
   Peisach D, 1998, BIOCHEMISTRY-US, V37, P4958, DOI 10.1021/bi972884d
   PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045
   RIORDAN JF, 1977, SCIENCE, V195, P884, DOI 10.1126/science.190679
   Romesberg FE, 1998, J AM CHEM SOC, V120, P5160, DOI 10.1021/ja9738992
   ROSE DR, 1993, PROTEIN SCI, V2, P1106, DOI 10.1002/pro.5560020705
   SKERRA A, 1994, GENE, V141, P79, DOI 10.1016/0378-1119(94)90131-7
   SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2
   STEWART JD, 1994, BIOCHEMISTRY-US, V33, P1994, DOI 10.1021/bi00174a004
   STEWART JD, 1994, P NATL ACAD SCI USA, V91, P7404, DOI 10.1073/pnas.91.16.7404
   Sundararaju B, 1997, BIOCHEMISTRY-US, V36, P6502, DOI 10.1021/bi962917+
   Thayer MM, 1999, J MOL BIOL, V291, P329, DOI 10.1006/jmbi.1999.2960
   Vacca RA, 1997, J BIOL CHEM, V272, P21932, DOI 10.1074/jbc.272.35.21932
   WIRSCHING P, 1991, SCIENCE, V252, P680, DOI 10.1126/science.2024120
NR 48
TC 2
Z9 2
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUN 1
PY 2004
VL 43
IS 21
BP 6612
EP 6619
DI 10.1021/bi049874e
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 824BF
UT WOS:000221658000026
PM 15157094
DA 2021-01-25
ER

PT J
AU Akiyama, T
   Gullo, MR
   de Rooij, NF
   Tonin, A
   Hidber, HR
   Frederix, PLTM
   Engel, A
   Staufer, U
AF Akiyama, T
   Gullo, MR
   de Rooij, NF
   Tonin, A
   Hidber, HR
   Frederix, PLTM
   Engel, A
   Staufer, U
TI Development of insulated conductive probes with platinum silicide tips
   for atomic force microscopy in cell biology
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES &
   REVIEW PAPERS
LA English
DT Article; Proceedings Paper
CT 16th International Microprocesses and Nanotechnology Conference
CY OCT 29-31, 2003
CL Tokyo, JAPAN
SP Japan Soc Appl Phys, IEEE Electron Devices Soc, Amer Vacuum Soc, Assoc Super Adv Elect Technologies, IEE Japan
DE AFM; conductive probe; membrane protein; microfabrication; tip
ID CANTILEVER
AB A microfabrication process of a multifunctional probe is introduced for atomic force microscopy and various electrochemical measurements on biological samples in buffer solution. The silicon nitride probes have a spring constant lower than 0.1 N/m and a conductive tip, which is tightly insulated except at the apex. The conductive core of the tip consists of PtxSiy and shows a typical radius of curvature of 15 nm. A simultaneous measurement of topography and electrical current on graphite in air was demonstrated.
C1 Univ Neuchatel, Inst Microtechnol, CH-2007 Neuchatel, Switzerland.
   Univ Basel, Inst Phys, Basel, Switzerland.
   Univ Basel, ME Muller Inst, Biozentrum, Basel, Switzerland.
RP Akiyama, T (corresponding author), Univ Neuchatel, Inst Microtechnol, Rue Jaquet Droz 1, CH-2007 Neuchatel, Switzerland.
EM terunobu.akiyama@unine.ch
RI Staufer, Urs/J-6866-2016; Gullo, Maurizio/B-4383-2012
OI Staufer, Urs/0000-0002-3519-6467; 
CR ALBRECHT TR, 1990, J VAC SCI TECHNOL A, V8, P3386, DOI 10.1116/1.576520
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Kueng A, 2003, APPL PHYS LETT, V82, P1592, DOI 10.1063/1.1559652
   Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021
   Yamamoto T, 1997, J VAC SCI TECHNOL B, V15, P1547, DOI 10.1116/1.589397
NR 6
TC 21
Z9 21
U1 0
U2 13
PU INST PURE APPLIED PHYSICS
PI TOKYO
PA TOYOKAIJI BLDG NO. 12, 6-9-6 SHINBASHI, MINATO-KU, TOKYO, 105, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.
PD JUN
PY 2004
VL 43
IS 6B
BP 3865
EP 3867
DI 10.1143/JJAP.43.3865
PG 3
WC Physics, Applied
SC Physics
GA 837FX
UT WOS:000222615100046
DA 2021-01-25
ER

PT J
AU Gehring, WJ
AF Gehring, WJ
TI Precis of Edwin G. Conklin's JEZ article, "Mosaic development in
   Ascidian eggs"
SO JOURNAL OF EXPERIMENTAL ZOOLOGY PART A-COMPARATIVE EXPERIMENTAL BIOLOGY
LA English
DT Editorial Material
ID CELL LINEAGE ANALYSIS; INTRACELLULAR INJECTION; TRACER ENZYME; EMBRYOS;
   STAGE
C1 Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR CHABRY L, 1887, J ANAT PHYSL, V23, P12
   Cohen A, 1936, J EXP ZOOL, V74, P91, DOI 10.1002/jez.1400740106
   Conklin E, 1905, BIOL BULL-US, V8, P205, DOI 10.2307/1535879
   Conklin E.G., 1905, J ACAD NATL SCI PHIL, P1905, DOI [10.5962/bhl.title.4801, DOI 10.5962/BHL.TITLE.4801]
   Conklin EG, 1905, J EXP ZOOL, V2, P145, DOI 10.1002/jez.1400020202
   CRAMPTON HE, 1897, ANN NY ACAD SCI, V10, P50
   Driesch H, 1891, Z WISS ZOOL, V53, P184
   DRIESCH H, 1895, ARCH ENTW MECH, V1, P338
   Morgan T. H., 1934, EMBRYOLOGY GENETICS, P9
   NISHIDA H, 1985, DEV BIOL, V110, P440, DOI 10.1016/0012-1606(85)90102-2
   NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6
   NISHIDA H, 1983, DEV BIOL, V99, P382, DOI 10.1016/0012-1606(83)90288-9
   NISHIDA H, 1989, DEV BIOL, V132, P355, DOI 10.1016/0012-1606(89)90232-7
   Wilson EB, 1903, ARCH ENTWICKLUNG ORG, V16, P411, DOI 10.1007/BF02152027
NR 14
TC 2
Z9 2
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0022-104X
J9 J EXP ZOOL PART A
JI J. Exp. Zool. Part A
PD JUN 1
PY 2004
VL 301A
IS 6
BP 461
EP 463
DI 10.1002/jez.a.87
PG 3
WC Zoology
SC Zoology
GA 828PP
UT WOS:000221985500001
PM 15181639
DA 2021-01-25
ER

PT J
AU Schwarz, R
   Seelig, J
   Kunnecke, B
AF Schwarz, R
   Seelig, J
   Kunnecke, B
TI Structural properties of perfluorinated linear alkanes: a F-19 and C-13
   NMR study of perfluorononane
SO MAGNETIC RESONANCE IN CHEMISTRY
LA English
DT Article
DE NMR; F-19 NMR; C-13 NMR; perfluorononane; perfluorinated n-alkanes;
   through-space coupling; COSY; quantum chemical modelling
ID NUCLEAR-MAGNETIC-RESONANCE; CHEMICAL-SHIFT CORRELATION; SPIN
   COUPLING-CONSTANTS; SPECTROSCOPY; RELAXATION; SPECTRA; HUMANS
AB Liquid perfluorocarbons exhibit unique physical-chemical characteristics such as extraordinary stability, combined hydrophobia and lipophobia, low surface tension and a capacity to carry large quantities of gas. They have found widespread use in industry, medicine and biology even though the molecular origin of these properties is not fully understood. The objective of the present work was to elucidate the physical behavior of perfluorinated linear alkanes by investigating their intramolecular electronic environment using C-13 and F-19 NMR techniques in combination with theoretical calculations of molecular orbitals. Particular advantage was taken of F-19-F-19 through-space couplings, which led us to propose a molecular model in which delocalized p-electrons of the fluorines cover the entire surface of the molecule in two pairs of intertwined helices. Experimental data are presented for n-perfluorononane and supported by corresponding measurements with shorter and longer perfluorinated alkanes. Copyright (C) 2004 John Wiley Sons, Ltd.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
CR Albeniz AC, 1997, ORGANOMETALLICS, V16, P5416, DOI 10.1021/om970529d
   Albinsson B, 1996, J PHYS CHEM-US, V100, P3418, DOI 10.1021/jp953055+
   AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450
   BAX A, 1981, J MAGN RESON, V42, P501, DOI 10.1016/0022-2364(81)90272-9
   Borodin O, 2002, J PHYS CHEM B, V106, P9912, DOI 10.1021/jp026158i
   Bremser W., 1987, CARBON 13 NMR SPECTR
   BUNN CW, 1954, NATURE, V174, P549, DOI 10.1038/174549a0
   DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024
   Foris A, 2001, MAGN RESON CHEM, V39, P386, DOI 10.1002/mrc.857
   FREEMAN R, 1978, J CHEM SOC CHEM COMM, P684, DOI 10.1039/c39780000684
   FRISCH MJ, 2003, GAUSSIAN 03 G03REVA
   GIAEVER I, 1983, P NATL ACAD SCI-BIOL, V80, P219, DOI 10.1073/pnas.80.1.219
   HAMZA MA, 1981, J MAGN RESON, V42, P227
   HASZELDINE RN, 1950, J CHEM SOC, P3617, DOI 10.1039/jr9500003617
   HASZELDINE RN, 1951, J CHEM SOC, P603, DOI 10.1039/jr9510000603
   Helgaker T, 1999, CHEM REV, V99, P293, DOI 10.1021/cr960017t
   KAJDAS C, 1992, CHEM TECHNOLOGY LUBR
   KIMBER BJ, 1978, NATURE, V271, P184, DOI 10.1038/271184a0
   KUPCE E, 1995, J MAGN RESON SER A, V115, P273, DOI 10.1006/jmra.1995.1179
   LYERLA JR, 1975, J AM CHEM SOC, V98, P1697
   MALLORY FB, 1973, J AM CHEM SOC, V95, P7747, DOI 10.1021/ja00804a034
   MATTREY RF, 1987, AM J ROENTGENOL, V148, P1259, DOI 10.2214/ajr.148.6.1259
   MUSGRAVE WKR, 1949, J CHEM SOC, P3021, DOI 10.1039/jr9490003021
   OVENALL DW, 1977, J MAGN RESON, V25, P361, DOI 10.1016/0022-2364(77)90031-2
   Pecul M, 2003, INT J MOL SCI, V4, P143, DOI 10.3390/i4030143
   PETRAKIS L, 1961, J CHEM PHYS, V35, P1243, DOI 10.1063/1.1732030
   Ribeiro AA, 2003, MAGN RESON CHEM, V41, P107, DOI 10.1002/mrc.1137
   RIESS JG, 1991, BLOOD COMPATIBLE MAT, P237
   ROTLISBERGER U, 1996, J CHEM PHYS, V104, P3692
   Schwarz R, 2002, MAGNET RESON MED, V48, P255, DOI 10.1002/mrm.10207
   SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2
   SOLOMON I, 1959, CR HEBD ACAD SCI, V248, P92
   THOMAS SR, 1986, J COMPUT ASSIST TOMO, V10, P1, DOI 10.1097/00004728-198601000-00001
   VOLD RL, 1968, J CHEM PHYS, V48, P3831, DOI 10.1063/1.1669699
NR 34
TC 18
Z9 18
U1 1
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0749-1581
EI 1097-458X
J9 MAGN RESON CHEM
JI Magn. Reson. Chem.
PD JUN
PY 2004
VL 42
IS 6
BP 512
EP 517
DI 10.1002/mrc.1380
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Spectroscopy
SC Chemistry; Spectroscopy
GA 821UO
UT WOS:000221488600005
PM 15137044
DA 2021-01-25
ER

PT J
AU Chatenay-Rivauday, C
   Cakar, ZP
   Jeno, P
   Kuzmenko, ES
   Fiedler, K
AF Chatenay-Rivauday, C
   Cakar, ZP
   Jeno, P
   Kuzmenko, ES
   Fiedler, K
TI Caveolae: biochemical analysis
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Review
DE plasmalemmal vesicle; mechanosignaling; membrane potential; endothelia;
   compliance
ID BOVINE HEART-MITOCHONDRIA; HETEROTRIMERIC G-PROTEINS; NITRIC-OXIDE
   SYNTHASE; RAT-LIVER MICROSOMES; TRANS-GOLGI-NETWORK; ENDOTHELIAL-CELLS;
   ATP SYNTHASE; ANNEXIN-V; IN-VIVO; EPITHELIAL-CELLS
AB Caveolae appear in a multitude of processes encompassing growth regulation and trafficking. We demonstrate the abundant presence of ESA/reggie-1/flotillin-2, ATP synthase beta subunit and annexin V in endothelial caveolae by immunopurification of caveolae from vascular endothelial membrane. Five proteins are abundant in a caveolin-1 protein complex, analyzed by sucrose gradient velocity sedimentation following octyl-beta-D-glucopyranoside extraction. Caveolin-1 alpha interacts with caveolin-1 beta, caveolin-2, actin, the microsomal form of NADH cytochrome B5 reductase and ESA/reggie-1/flotillin-2 as shown by co-immunoprecipitation. We propose the concept that ATP biosynthesis in caveolae regulates mechanosignaling and is induced by membrane depolarization and a proton gradient. Pressure stimuli and metabolic changes may trigger gene regulation in endothelial cells, involving a nuclear conformer of caveolin-1, shown here with an epitope-specific caveolin-1 antibody, and immediate response of ion channel activity, regulated by ESA/reggie-1/flotillin-2.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Fiedler, K (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM k_fiedler@bluewin.ch
RI Cakar, Z. Petek/A-6152-2019
OI Cakar, Z. Petek/0000-0002-2278-3670; Fiedler, Klaus/0000-0001-9398-1116
CR AGIN D, 1972, FDN MATH BIOL, P253
   Andersen MH, 2002, BIOCHEM BIOPH RES CO, V292, P550, DOI 10.1006/bbrc.2002.6673
   ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909
   Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199
   Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j
   Bankston LA, 1996, J BIOL CHEM, V271, P17132, DOI 10.1074/jbc.271.29.17132
   BERENDES R, 1993, SCIENCE, V262, P427, DOI 10.1126/science.7692599
   Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793
   Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100
   Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012
   Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501
   Bossuyt J, 2002, FEBS LETT, V511, P113, DOI 10.1016/S0014-5793(01)03323-3
   Boyd NL, 2003, AM J PHYSIOL-HEART C, V285, pH1113, DOI 10.1152/ajpheart.00302.2003
   Braet F, 1998, P NATL ACAD SCI USA, V95, P13635, DOI 10.1073/pnas.95.23.13635
   Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011
   Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111
   Bucci M, 2000, NAT MED, V6, P1362
   Busse R, 2003, TRENDS PHARMACOL SCI, V24, P24, DOI 10.1016/S0165-6147(02)00005-6
   Cantor RS, 1999, CHEM PHYS LIPIDS, V101, P45, DOI 10.1016/S0009-3084(99)00054-7
   Cardo-Vila M, 2003, MOL CELL, V11, P1151, DOI 10.1016/S1097-2765(03)00138-2
   Cherepanov DA, 2003, BIOPHYS J, V85, P1307, DOI 10.1016/S0006-3495(03)74565-2
   Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r
   CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421
   Czarny M, 2003, J BIOL CHEM, V278, P4424, DOI 10.1074/jbc.M210375200
   Davis MJ, 1999, PHYSIOL REV, V79, P387
   DELBRUCK R, 1994, EUR J CELL BIOL, V64, P7
   DEMANGE P, 1994, TRENDS BIOCHEM SCI, V19, P272, DOI 10.1016/0968-0004(94)90002-7
   Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587
   Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688
   DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x
   Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980
   Edwards G, 1998, NATURE, V396, P269
   Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708
   Esnault C, 2000, NAT GENET, V24, P363
   FIEDLER K, 1994, EMBO J, V13, P1729, DOI 10.1002/j.1460-2075.1994.tb06437.x
   FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Georgievskii Y, 2002, BIOPHYS J, V82, P2833, DOI 10.1016/S0006-3495(02)75626-9
   Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a
   Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515
   Hamill OP, 2001, PHYSIOL REV, V81, P685
   Henttinen T, 2003, J BIOL CHEM, V278, P24888, DOI 10.1074/jbc.M300779200
   Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349
   Illi B, 2003, CIRC RES, V93, P155, DOI 10.1161/01.RES.0000080933.82105.29
   Inscho EW, 1996, AM J PHYSIOL-RENAL, V271, pF1077
   ISHIBASHI T, 1981, J BIOL CHEM, V256, P2962
   Isshiki M, 2002, J BIOL CHEM, V277, P43389, DOI 10.1074/jbc.M205411200
   JACOBSON BS, 1992, EUR J CELL BIOL, V58, P296
   Kamiya A, 2003, AM J PHYSIOL-HEART C, V285, pH1158, DOI 10.1152/ajpheart.00965.2002
   KIM D, 1989, SCIENCE, V244, P1174, DOI 10.1126/science.2727703
   KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003
   Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S
   LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693
   Li WP, 2001, J CELL SCI, V114, P1397
   Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002
   Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200
   Marchesan D, 2003, J BIOL CHEM, V278, P27293, DOI 10.1074/jbc.M301430200
   Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250
   Megli FM, 1998, BIOCHEMISTRY-US, V37, P10540, DOI 10.1021/bi9801255
   MEGSON AC, 1995, BRIT J PHARMACOL, V115, P1415, DOI 10.1111/j.1476-5381.1995.tb16632.x
   MONIER S, 1995, MOL BIOL CELL, V6, P911
   Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200
   Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798
   Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811
   Mourier T, 2001, MOL BIOL EVOL, V18, P1833, DOI 10.1093/oxfordjournals.molbev.a003971
   Nakamura F, 1996, P NATL ACAD SCI USA, V93, P10465, DOI 10.1073/pnas.93.19.10465
   NARUSE K, 1993, AM J PHYSIOL, V264, pC1037
   Nilius B, 2001, PHYSIOL REV, V81, P1415
   Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975
   Oh P, 1999, J BIOL CHEM, V274, P23144, DOI 10.1074/jbc.274.33.23144
   Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685
   OKAYASU T, 1981, ARCH BIOCHEM BIOPHYS, V206, P21, DOI 10.1016/0003-9861(81)90061-8
   ORDWAY RW, 1989, SCIENCE, V244, P1176, DOI 10.1126/science.2471269
   OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.E02-11-0761
   Parton RG, 1997, J CELL BIOL, V136, P137, DOI 10.1083/jcb.136.1.137
   Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017
   Pasquali C, 1997, ELECTROPHORESIS, V18, P2573, DOI 10.1002/elps.1150181413
   Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784
   PERANEN J, 1993, J HISTOCHEM CYTOCHEM, V41, P447, DOI 10.1177/41.3.8429208
   PIETRINI G, 1988, P NATL ACAD SCI USA, V85, P7246, DOI 10.1073/pnas.85.19.7246
   PRIOR IA, 2003, SCI STKE, pI19
   Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200
   Razani B, 2001, J BIOL CHEM, V276, P38121
   Rizzo V, 1998, J BIOL CHEM, V273, P34724, DOI 10.1074/jbc.273.52.34724
   ROGERS MJ, 1975, J BIOL CHEM, V250, P5713
   Rohra DK, 2003, EUR J PHARMACOL, V465, P141, DOI 10.1016/S0014-2999(03)01490-0
   Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524
   RUNSWICK MJ, 1983, J BIOL CHEM, V258, P3081
   SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407
   Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200
   Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660
   Schnermann J, 2003, ANNU REV PHYSIOL, V65, P501, DOI 10.1146/annurev.physiol.65.050102.085738
   SCHROEDER WT, 1994, J BIOL CHEM, V269, P19983
   Schulte T, 1997, DEVELOPMENT, V124, P577
   Schwiebert LM, 2002, AM J PHYSIOL-CELL PH, V282, pC289, DOI 10.1152/ajpcell.01387.2000
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Smalheiser NR, 1996, MOL BIOL CELL, V7, P1003
   Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X
   Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X
   Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200
   Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325
   Stan RV, 1997, MOL BIOL CELL, V8, P595
   STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565
   Teubl M, 1999, J BIOL CHEM, V274, P29529, DOI 10.1074/jbc.274.41.29529
   Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317
   Trouet D, 1999, J PHYSIOL-LONDON, V520, P113, DOI 10.1111/j.1469-7793.1999.t01-1-00113.x
   TUNON P, 1984, J BIOCHEM BIOPH METH, V9, P171, DOI 10.1016/0165-022X(84)90008-3
   Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702
   Walker JE, 1995, METHOD ENZYMOL, V260, P163, DOI 10.1016/0076-6879(95)60136-8
   Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6
   YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020
   Zsembery A, 2003, J BIOL CHEM, V278, P13398, DOI 10.1074/jbc.M212277200
NR 114
TC 19
Z9 22
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD JUN
PY 2004
VL 31
IS 2
BP 67
EP 84
DI 10.1023/B:MOLE.0000031352.51910.e9
PG 18
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 827YK
UT WOS:000221939400001
PM 15293782
OA Green Published
DA 2021-01-25
ER

PT J
AU Stahlberg, H
   Kutejova, E
   Muchova, K
   Gregorini, M
   Lustig, A
   Muller, SA
   Olivieri, V
   Engel, A
   Wilkinson, AJ
   Barak, I
AF Stahlberg, H
   Kutejova, E
   Muchova, K
   Gregorini, M
   Lustig, A
   Muller, SA
   Olivieri, V
   Engel, A
   Wilkinson, AJ
   Barak, I
TI Oligomeric structure of the Bacillus subtilis cell division protein
   DivIVA determined by transmission electron microscopy
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID TO-POLE OSCILLATION; ESCHERICHIA-COLI; MIND PROTEIN; CHROMOSOME
   SEGREGATION; INHIBITOR MINC; SITE SELECTION; RAPID POLE; FTSZ; RING;
   BACTERIA
AB DivIVA from Bacillus subtilis is a bifunctional protein with distinct roles in cell division and sporulation. During vegetative growth, DivIVA regulates the activity of the MinCD complex, thus helping to direct cell division to the correct mid-cell position. DivIVA fulfils a quite different role during sporulation in B. subtilis when it directs the oriC region of the chromosome to the cell pole before asymmetric cell division. DivIVA is a 19.5 kDa protein with a large part of its structure predicted to form a tropomyosin-like alpha-helical coiled-coil. Here, we present a model for the quaternary structure of DivIVA, based on cryonegative stain transmission electron microscopy images. The purified protein appears as an elongated particle with lateral expansions at both ends producing a form that resembles a 'doggy-bone'. The particle mass estimated from these images agrees with the value of 145 kDa measured by analytical ultracentrifugation suggesting 6- to 8-mers. These DivIVA oligomers serve as building blocks in the formation of higher order assemblies giving rise to strings, wires and, finally, two-dimensional lattices in a time-dependent manner.
C1 Slovak Acad Sci, Inst Mol Biol, Bratislava 84551 45, Slovakia.
   Univ Basel, Biozentrum, Maurice E Muller Inst High Resolut Electron M, CH-4056 Basel, Switzerland.
   York Univ, Dept Chem, York YO1 5OD, N Yorkshire, England.
RP Barak, I (corresponding author), Slovak Acad Sci, Inst Mol Biol, Dubravska Cesta 21, Bratislava 84551 45, Slovakia.
EM imrich.barak@savba.sk
RI Barak, Imrich/H-7285-2019; Stahlberg, Henning/H-1868-2011; Kutejova,
   Eva/K-6550-2014
OI Barak, Imrich/0000-0002-3690-404X; Stahlberg,
   Henning/0000-0002-1185-4592; Kutejova, Eva/0000-0002-0973-679X; Muchova,
   Katarina/0000-0002-5263-7498; Wilkinson, Anthony/0000-0003-4577-9479
CR Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1
   BACKMAN K, 1976, P NATL ACAD SCI USA, V73, P4174, DOI 10.1073/pnas.73.11.4174
   Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0
   Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914
   BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0
   BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813
   Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997
   Daniel RA, 2000, MOL MICROBIOL, V35, P299, DOI 10.1046/j.1365-2958.2000.01724.x
   DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x
   DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719
   Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x
   Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003
   Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x
   Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298
   Hamoen LW, 2003, J BACTERIOL, V185, P693, DOI 10.1128/JB.185.2.693-697.2003
   Harry EJ, 2003, MOL MICROBIOL, V47, P37, DOI 10.1046/j.1365-2958.2003.03253.x
   Harry EJ, 2001, MOL MICROBIOL, V40, P795, DOI 10.1046/j.1365-2958.2001.02370.x
   Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x
   LUPAS A, 1995, J MOL BIOL, V248, P180, DOI 10.1006/jmbi.1995.0210
   Margolin W, 2001, CURR OPIN MICROBIOL, V4, P647, DOI 10.1016/S1369-5274(01)00264-8
   Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419
   Muchova K, 2002, MICROBIOL-SGM, V148, P807, DOI 10.1099/00221287-148-3-807
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Norris V, 2002, BIOCHIMIE, V84, P341, DOI 10.1016/S0300-9084(02)01387-1
   Norris V, 2002, J MOL BIOL, V318, P455, DOI 10.1016/S0022-2836(02)00098-0
   Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999
   Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9
   Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971
   Rowland SL, 2000, J BACTERIOL, V182, P613, DOI 10.1128/JB.182.3.613-619.2000
   Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100
   Stragier P., 2001, BACILLUS SUBTILIS IT, P519
   Thomaides HB, 2001, GENE DEV, V15, P1662, DOI 10.1101/gad.197501
   WHITBY FG, 1992, J MOL BIOL, V227, P441, DOI 10.1016/0022-2836(92)90899-U
   WOLDRINGH CL, 1991, RES MICROBIOL, V142, P309, DOI 10.1016/0923-2508(91)90046-D
   Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x
   Zhang Y, 1998, MOL MICROBIOL, V30, P265, DOI 10.1046/j.1365-2958.1998.01059.x
NR 38
TC 67
Z9 69
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JUN
PY 2004
VL 52
IS 5
BP 1281
EP 1290
DI 10.1111/j.1365-2958.2004.04074.x
PG 10
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 823WJ
UT WOS:000221644200006
PM 15165232
OA Bronze
DA 2021-01-25
ER

PT J
AU Kopp, J
   Schwede, T
AF Kopp, J
   Schwede, T
TI Automated protein structure homology modeling: a progress report
SO PHARMACOGENOMICS
LA English
DT Review
DE automated comparative modeling; homology modeling server; protein model
   database; protein structure; SWISS-MODEL repository
ID STRUCTURE PREDICTION; SWISS-MODEL; SACCHAROMYCES-CEREVISIAE;
   MOLECULAR-DYNAMICS; GENETIC ALGORITHM; CRYSTAL-STRUCTURE; SEQUENCE;
   BINDING; KNOWLEDGE; ALIGNMENT
AB Understanding the molecular function of proteins is greatly enhanced by insights gained from their three-dimensional structures. Since experimental structures are only available for a small fraction of proteins, computational methods for protein structure modeling play an increasingly important role. Comparative protein structure modeling is currently the most accurate method, yielding models suitable for a wide spectrum of applications, such as structure-guided drug development or virtual screening. Stable and reliable automated prediction pipelines have been developed to apply large-scale comparative modeling to whole genomes or entire sequence databases. Model repositories give access to these annotated and evaluated models. In this review, we will discuss recent developments in automated comparative modeling and provide selected examples illustrating the use of homology models.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658
   Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Archer E, 2003, TRENDS PHARMACOL SCI, V24, P36, DOI 10.1016/S0165-6147(02)00009-3
   Bates PA, 2001, PROTEINS, P39
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bradley P, 2003, PROTEINS, V53, P457, DOI 10.1002/prot.10552
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   Contreras-Moreira B, 2003, PROTEINS, V53, P424, DOI 10.1002/prot.10549
   Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126
   Deane CM, 2001, PROTEIN SCI, V10, P599, DOI 10.1110/ps.37601
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Ellis C, 2003, NAT REV DRUG DISCOV, V2, P509
   Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3
   Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543
   Evers A, 2003, J MOL BIOL, V334, P327, DOI 10.1016/j.jmb.2003.09.032
   Fischer D, 2003, PROTEINS, V53, P503, DOI 10.1002/prot.10538
   Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753
   Flohil JA, 2002, PROTEINS, V48, P593, DOI 10.1002/prot.10105
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371
   Golovin A, 2004, NUCLEIC ACIDS RES, V32, pD211, DOI 10.1093/nar/gkh078
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381
   John B, 2004, PROTEIN SCI, V13, P54, DOI 10.1110/ps.03335004
   John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460
   Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897
   Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846
   Kirton SB, 2002, ADV DRUG DELIVER REV, V54, P385, DOI 10.1016/S0169-409X(02)00010-8
   Klebe G, 2000, J MOL MED, V78, P269, DOI 10.1007/s001090000084
   Koehl Patrice, 1999, Nature Structural Biology, V6, P108, DOI 10.1038/5794
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008
   Koretke KK, 2002, PROTEIN SCI, V11, P1575, DOI 10.1110/ps.3590102
   Kubinyi H, 1998, Curr Opin Drug Discov Devel, V1, P4
   Kubinyi H, 1999, J RECEPT SIGNAL TR R, V19, P15, DOI 10.3109/10799899909036635
   Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250
   Lewis DFV, 2003, CHEM-BIOL INTERACT, V145, P281, DOI 10.1016/S0009-2797(03)00021-8
   Lund O, 1997, PROTEIN ENG, V10, P1241, DOI 10.1093/protein/10.11.1241
   Marti-Renom MA, 2002, STRUCTURE, V10, P435, DOI 10.1016/S0969-2126(02)00731-1
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430
   Mordasini T, 2003, CHEMBIOCHEM, V4, P155, DOI 10.1002/cbic.200390026
   Moult J, 2003, PROTEINS, V53, P334, DOI 10.1002/prot.10556
   Moult J, 1996, CURR OPIN BIOTECH, V7, P422, DOI 10.1016/S0958-1669(96)80118-2
   Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Peitsch MC, 1997, ELECTROPHORESIS, V18, P498, DOI 10.1002/elps.1150180326
   Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274
   Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095
   Radivojac P, 2004, PROTEIN SCI, V13, P71, DOI 10.1110/ps.03128904
   Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705
   Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85
   Rychlewski L, 2003, PROTEINS, V53, P542, DOI 10.1002/prot.10535
   Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597
   Sanchez R, 1997, CURR OPIN STRUC BIOL, V7, P206, DOI 10.1016/S0959-440X(97)80027-9
   Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Sunyaev SR, 2004, PROTEINS, V54, P569, DOI 10.1002/prot.10503
   SUTCLIFFE MJ, 1987, PROTEIN ENG, V1, P377, DOI 10.1093/protein/1.5.377
   Tramontano A, 2003, PROTEINS, V53, P352, DOI 10.1002/prot.10543
   Vangrevelinghe E, 2003, J MED CHEM, V46, P2656, DOI 10.1021/jm030827e
   Vila JA, 2003, P NATL ACAD SCI USA, V100, P14812, DOI 10.1073/pnas.2436463100
   Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0
   Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699
   Yang AS, 2000, J MOL BIOL, V301, P665, DOI 10.1006/jmbi.2000.3973
NR 80
TC 76
Z9 78
U1 0
U2 7
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1462-2416
EI 1744-8042
J9 PHARMACOGENOMICS
JI Pharmacogenomics
PD JUN
PY 2004
VL 5
IS 4
BP 405
EP 416
DI 10.1517/14622416.5.4.405
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 831JY
UT WOS:000222191900012
PM 15165176
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, W
TI Biological evolution: Lessons to be learned from microbial population
   biology and genetics
SO RESEARCH IN MICROBIOLOGY
LA English
DT Editorial Material
ID ELEMENTS; GENOMES
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM wemer.arber@unibas.ch
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   ARBER W, 1995, J MOL EVOL, V40, P7, DOI 10.1007/BF00166591
   ARBER W, 1991, J MOL EVOL, V33, P4, DOI 10.1007/BF02100190
   Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x
   ARBER W, 2004, ENCY MOL CELL BIOL M, V5, P331
   BLOT M, 1994, GENETICA, V93, P5, DOI 10.1007/BF01435235
   CAPORALE LH, 1999, ANN NY ACAD SCI, V870
   Forterre P, 2003, RES MICROBIOL, V154, P223, DOI 10.1016/S0923-2508(03)00111-6
   Hofnung M, 1999, RES MICROBIOL, V150, P577, DOI 10.1016/S0923-2508(99)00133-3
   Rowe-Magnus DA, 1999, RES MICROBIOL, V150, P641, DOI 10.1016/S0923-2508(99)00127-8
NR 10
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0923-2508
J9 RES MICROBIOL
JI Res. Microbiol.
PD JUN
PY 2004
VL 155
IS 5
BP 297
EP 300
DI 10.1016/j.resmic.2004.01.009
PG 4
WC Microbiology
SC Microbiology
GA 838TN
UT WOS:000222736200001
PM 15207860
DA 2021-01-25
ER

PT J
AU Martin, G
   Keller, W
AF Martin, G
   Keller, W
TI Sequence motifs that distinguish ATP(CTP): tRNA nucleotidyl transferases
   from eubacterial poly(A) polymerases
SO RNA
LA English
DT Article
DE nucleoticlyl transferase; ATP(CTP): tRNA nucleotidyl transferase;
   poly(A) polymerase; RNA modification; RNA processing
ID CCA-ADDING ENZYME; POLYNUCLEOTIDE PHOSPHORYLASE FUNCTIONS; TRANSFER-RNA
   NUCLEOTIDYLTRANSFERASE; CRYSTAL-STRUCTURE; GENE; DNA; IDENTIFICATION;
   SUPERFAMILY; POLYMERIZATION; CHLOROPLAST
AB ATP(CTP):tRNA nucleotidyl transferases, tRNA maturing enzymes found in all organisms, and eubacterial poly(A) polymerases, enzymes involved in mRNA degradation, are so similar that until now their biochemical functions could not be distinguished by their amino acid sequence. BLAST searches and analysis with the program "Sequence Space" for the prediction of functional residues revealed sequence motifs which define these two protein families. One of the poly(A) polymerase defining motifs specifies a structure that we propose to function in binding the 3' term nus of the RNA substrate. Similar motifs are found in other homopolyribonucleotidyl transferases. Phylogenetic classification of nucleotidyl tranferases from sequenced genomes reveals that eubacterial poly(A) polymerases have evolved relatively recently and are found only in a small group of bacteria and surprisingly also in plants, where they may function in organelles.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Keller, W (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM walter.keller@unibas.ch
CR Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609
   Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4
   Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298
   Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012
   CAO GJ, 1992, P NATL ACAD SCI USA, V89, P10380, DOI 10.1073/pnas.89.21.10380
   CASARI G, 1995, NAT STRUCT BIOL, V2, P171, DOI 10.1038/nsb0295-171
   CHEN JY, 1992, J BIOL CHEM, V267, P14879
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903
   Falquet L, 2003, NUCLEIC ACIDS RES, V31, P3782, DOI 10.1093/nar/gkg547
   HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4
   Keller W, 2002, NATURE, V419, P267, DOI 10.1038/419267a
   Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7
   Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x
   Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193
   Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999
   Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997
   Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268
   Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200
   Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563
   OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994
   Raynal LC, 1998, J BACTERIOL, V180, P6276
   Reichert AS, 2001, BIOL CHEM, V382, P1431, DOI 10.1515/BC.2001.176
   Rott R, 2003, J BIOL CHEM, V278, P15771, DOI 10.1074/jbc.M211571200
   Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812
   Seth M, 2002, BIOCHEMISTRY-US, V41, P4521, DOI 10.1021/bi0120953
   Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197
   STEITZ TA, 1994, SCIENCE, V266, P2022, DOI 10.1126/science.7528445
   Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5
   Tomita K, 2002, J BIOL CHEM, V277, P48192, DOI 10.1074/jbc.M207527200
   Tomita K, 2001, SCIENCE, V294, P1334, DOI 10.1126/science.1063816
   Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999
   Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4
   Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001
   Yue DX, 1996, RNA, V2, P895
   Zhelkovsky A, 1998, MOL CELL BIOL, V18, P5942, DOI 10.1128/MCB.18.10.5942
NR 36
TC 37
Z9 39
U1 1
U2 3
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD JUN
PY 2004
VL 10
IS 6
BP 899
EP 906
DI 10.1261/rna.5242304
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 823PT
UT WOS:000221626100003
PM 15146073
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Dichtl, E
   Aasland, R
   Keller, W
AF Dichtl, E
   Aasland, R
   Keller, W
TI Functions for S-cerevisiae Swd2p in 3 ' end formation of specific mRNAs
   and snoRNAs and global histone 3 lysine 4 methylation
SO RNA
LA English
DT Article
DE 3 ' end formation; RNA polymerase II transcription termination; snoRNAs;
   histone methylation; WD-40 repeat
ID POLYMERASE-II TRANSCRIPTION; SMALL NUCLEOLAR RNAS; POLY(A) SIGNAL;
   POLYADENYLATION FACTOR; PROCESSING FACTORS; EM VISUALIZATION; YEAST
   SNORNA; WD-REPEAT; IN-VIVO; TERMINATION
AB The Saccharomyces cerevisiae WD-40 repeat protein Swd2p associates with two functionally distinct multiprotein complexes: the cleavage and polyadenylation factor (CPF) that is involved in pre-mRNA and snoRNA 3' end formation and the SET1 complex (SET1C) that methylates histone 3 lysine 4. Based on bioinformatic analysis we predict a seven-bladed beta-propeller structure for Swd2p proteins. Northern, transcriptional run-on and in vitro 3' end cleavage analyses suggest that temperature sensitive swd2 strains were defective in 3' end formation of specific mRNAs and snoRNAs. Protein-protein interaction studies support a role for Swd2p in the assembly of 3' end formation complexes. Furthermore, histone 3 lysine 4 di- and tri-methylation were adversely affected and telomeres were shortened in swd2 mutants. Underaccumulation of the Set1p methyltransferase accounts for the observed loss of SET1C activity and suggests a requirement for Swd2p for the stability or assembly of this complex. We also provide evidence that the roles of Swd2p as component of CPF and SET1C are functionally independent. Taken together, our results establish a dual requirement for Swd2p in 3' end formation and histone tail modification.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Univ Bergen, BCCS, Dept Mol Biol, N-5020 Bergen, Norway.
   Univ Bergen, BCCS, Computat Biol Unit, N-5020 Bergen, Norway.
RP Dichtl, E (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM bernhard.dichtl@unibas.ch; walter.keller@unibas.ch
OI Dichtl, Bernhard/0000-0001-5514-4982
CR Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778
   Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2
   Birney E, 1996, NUCLEIC ACIDS RES, V24, P2730, DOI 10.1093/nar/24.14.2730
   Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298
   Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201
   Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237
   CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470
   Dheur S, 2003, EMBO J, V22, P2831, DOI 10.1093/emboj/cdg253
   Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390
   Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4
   Dichtl B, 2001, EMBO J, V20, P3197, DOI 10.1093/emboj/20.12.3197
   Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5
   Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218
   Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055
   He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203
   Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Kessler MM, 1996, J BIOL CHEM, V271, P27167, DOI 10.1074/jbc.271.43.27167
   Kim SJ, 2003, J BIOL CHEM, V278, P41691, DOI 10.1074/jbc.M306304200
   Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3
   Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700
   Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3
   Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1
   Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200
   Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X
   Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398
   MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897
   Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8
   Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002
   MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202
   Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698
   Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200
   Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073
   Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3
   Ohnacker M, 2000, EMBO J, V19, P37, DOI 10.1093/emboj/19.1.37
   Orozco IJ, 2002, J BIOL CHEM, V277, P42899, DOI 10.1074/jbc.M207415200
   Osheim YN, 2002, CHROMOSOMA, V111, P1, DOI 10.1007/s00412-002-0183-7
   Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7
   Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2
   Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7
   Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200
   Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200
   Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137
   Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200
   Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6
   Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080
   Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196
   Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5
   Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003
   Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090
   THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Tran DP, 2001, MOL CELL BIOL, V21, P7495, DOI 10.1128/MCB.21.21.7495-7508.2001
   Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2
   van Helden J, 2000, NUCLEIC ACIDS RES, V28, P1000
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
NR 61
TC 51
Z9 51
U1 0
U2 1
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD JUN
PY 2004
VL 10
IS 6
BP 965
EP 977
DI 10.1261/rna.7090104
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 823PT
UT WOS:000221626100010
PM 15146080
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Bucior, I
   Scheuring, S
   Engel, A
   Burger, MM
AF Bucior, I
   Scheuring, S
   Engel, A
   Burger, MM
TI Carbohydrate-carbohydrate interaction provides adhesion force and
   specificity for cellular recognition
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
DE cell-cell recognition; cell surface proteoglycan;
   carbohydrate-carbohydrate interaction; species specificity; adhesion
   force
ID CIRCULAR PROTEOGLYCANS; SIGNAL-TRANSDUCTION; AGGREGATION FACTOR;
   P-SELECTIN; BINDING; REGENERATION; DISSOCIATION; SPECTROSCOPY;
   INVOLVEMENT; MULTIPLE
AB The adhesion force and specificity in the first experimental evidence for cell-cell recognition in the animal kingdom were assigned to marine sponge cell surface proteoglycans. However, the question whether the specificity resided in a protein or carbohydrate moiety could not yet be resolved. Here, the strength and species specificity of cell-cell recognition could be assigned to a direct carbohydrate-carbohydrate interaction. Atomic force microscopy measurements revealed equally strong adhesion forces between glycan molecules (190-310 piconewtons) as between proteins in antibody-antigen interactions (244 piconewtons). Quantitative measurements of adhesion forces between glycans from identical species versus glycans from different species confirmed the species specificity of the interaction. Glycan-coated beads aggregated according to their species of origin, i.e., the same way as live sponge cells did. Live cells also demonstrated species selective binding to glycans coated on surfaces. These findings confirm for the first time the existence of relatively strong and species-specific recognition between surface glycans, a process that may have significant implications in cellular recognition.
C1 Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   Marine Biol Labs, Woods Hole, MA 02543 USA.
   Univ Basel, ME Muller Inst Microscopy, Biozentrum, CH-4056 Basel, Switzerland.
RP Burger, MM (corresponding author), Novartis Int AG, Novartis Sci Board, WKL-125,13-02, CH-4002 Basel, Switzerland.
EM max.burger@group.novartis.com
RI Scheuring, Simon/L-9843-2018
OI Scheuring, Simon/0000-0003-3534-069X
CR Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6
   Burger M.M., 1979, Life Sciences Research Report, P119
   Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1
   Chon JWM, 2000, J APPL PHYS, V87, P3978, DOI 10.1063/1.372455
   DAMMER U, 1995, SCIENCE, V267, P1173, DOI 10.1126/science.7855599
   de la Fuente JM, 2001, ANGEW CHEM INT EDIT, V40, P2258, DOI 10.1002/1521-3773(20010618)40:12<2257::AID-ANIE2257>3.0.CO;2-S
   EGGENS I, 1989, J BIOL CHEM, V264, P9476
   Feizi T, 1996, AM J RESP CRIT CARE, V154, pS133, DOI 10.1164/ajrccm/154.4_Pt_2.S133
   Feizi T, 2000, GLYCOCONJUGATE J, V17, P553, DOI 10.1023/A:1011022509500
   Fernandez-Busquets X, 2003, CELL MOL LIFE SCI, V60, P88, DOI 10.1007/s000180300006
   Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283
   Galtsoff PS, 1925, J EXP ZOOL, V42, P223, DOI 10.1002/jez.1400420110
   Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727
   Hanley W, 2003, J BIOL CHEM, V278, P10556, DOI 10.1074/jbc.M213233200
   Haseley SR, 2001, P NATL ACAD SCI USA, V98, P9419, DOI 10.1073/pnas.151111298
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   HUMPHREYS T, 1963, DEV BIOL, V8, P27, DOI 10.1016/0012-1606(63)90024-1
   Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89
   Iwabuchi K, 1998, J BIOL CHEM, V273, P9130, DOI 10.1074/jbc.273.15.9130
   Jarchow J, 2000, J STRUCT BIOL, V132, P95, DOI 10.1006/jsbi.2000.4309
   JUMBLATT JE, 1980, BIOCHEMISTRY-US, V19, P1038, DOI 10.1021/bi00546a032
   KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.biochem.60.1.443
   KOJIMA N, 1989, J BIOL CHEM, V264, P20159
   MISEVIC GN, 1987, J BIOL CHEM, V262, P5870
   MISEVIC GN, 1993, J BIOL CHEM, V268, P4922
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   PICKOVER CA, 2001, WONDERS NUMBERS
   Popescu O, 2003, BIOCHIMIE, V85, P181, DOI 10.1016/S0300-9084(03)00063-4
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452
   Saleh OA, 2003, P NATL ACAD SCI USA, V100, P820, DOI 10.1073/pnas.0337563100
   Song Y, 1998, J BIOL CHEM, V273, P2517, DOI 10.1074/jbc.273.5.2517
   SPILLMANN D, 1993, J BIOL CHEM, V268, P13378
   SPILLMANN D, 1995, J BIOL CHEM, V270, P5089, DOI 10.1074/jbc.270.10.5089
   Spillmann D, 1996, J CELL BIOCHEM, V61, P562, DOI 10.1002/(SICI)1097-4644(19960616)61:4<562::AID-JCB9>3.0.CO;2-M
   Stipp CS, 2000, J CELL SCI, V113, P1871
   Tromas C, 2001, ANGEW CHEM INT EDIT, V40, P3052, DOI 10.1002/1521-3773(20010817)40:16<3052::AID-ANIE3052>3.0.CO;2-Q
   Truant S, 2003, INT J CANCER, V104, P683, DOI 10.1002/ijc.11011
   TURNER RS, 1973, NATURE, V244, P509, DOI 10.1038/244509a0
   VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390
   Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204
NR 41
TC 83
Z9 84
U1 4
U2 22
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD MAY 24
PY 2004
VL 165
IS 4
BP 529
EP 537
DI 10.1083/jcb.200309005
PG 9
WC Cell Biology
SC Cell Biology
GA 824AP
UT WOS:000221656200008
PM 15148309
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Caplan, SR
   Walz, D
AF Caplan, SR
   Walz, D
TI Stepping is not necessarily a characteristic of rotary macromolecular
   machines
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of the
   American-Society-for-Biochemistry-and-Molecular-Biology/8th Congress of
   the International-Union-for-Biochemistry-and-Molecular-Biology
CY JUN 12-16, 2004
CL Boston, MA
SP Amer Soc BioChem & Mol Biol, Int Union Biochem & Mol Biol
C1 McGill Univ, Dept Physiol, Montreal, PQ, Canada.
   Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAY 14
PY 2004
VL 18
IS 8
SU S
BP C29
EP C29
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 823UP
UT WOS:000221639100133
DA 2021-01-25
ER

PT J
AU Hall, MN
AF Hall, MN
TI TOR signaling and control of cell growth
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of the
   American-Society-for-Biochemistry-and-Molecular-Biology/8th Congress of
   the International-Union-for-Biochemistry-and-Molecular-Biology
CY JUN 12-16, 2004
CL Boston, MA
SP Amer Soc Biochem & Mol Biol, Int Union Biochem & Mol Biol
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
CR Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
NR 3
TC 0
Z9 0
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAY 14
PY 2004
VL 18
IS 8
SU S
BP C122
EP C122
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 823UP
UT WOS:000221639100563
DA 2021-01-25
ER

PT J
AU Zahringer, U
   Lindner, B
   Knirel, YA
   van den Akker, WMR
   Hiestand, R
   Heine, H
   Dehio, C
AF Zahringer, U
   Lindner, B
   Knirel, YA
   van den Akker, WMR
   Hiestand, R
   Heine, H
   Dehio, C
TI Structure and biological activity of the short-chain lipopolysaccharide
   from Bartonella henselae ATCC 49882(T)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID OUTER-MEMBRANE PROTEINS; NF-KAPPA-B; ENDOTHELIAL-CELLS; LIPID-A;
   BACTERIAL; LEGIONELLA; EXPRESSION; ACID; DECASACCHARIDE; PROLIFERATION
AB The facultative intracellular pathogen Bartonella henselae is responsible for a broad range of clinical manifestations, including the formation of vascular tumors as a result of increased proliferation and survival of colonized endothelial cells. This remarkable interaction with endotoxin-sensitive endothelial cells and the apparent lack of septic shock are considered to be due to a reduced endotoxic activity of the B. henselae lipopolysaccharide. Here, we show that B. henselae ATCC 49882(T) produces a deep-rough-type lipopolysaccharide devoid of O-chain and report on its complete structure and Toll-like receptor-dependent biological activity. The major short-chain lipopolysaccharide was studied by chemical analyses, electrospray ionization, and matrix-assisted laser desorption/ionization mass spectrometry, as well as by NMR spectroscopy after alkaline deacylation. The carbohydrate portion of the lipopolysaccharide consists of a branched trisaccharide containing a glucose residue attached to position 5 of an alpha-(2-->4)-linked 3-deoxy-D-manno-oct-2-ulosonic acid disaccharide. Lipid A is a pentaacylated beta-(1'-->6)-linked 2,3-diamino 2,3-dideoxy-glucose disaccharide 1,4'-bisphosphate with two amide-linked residues each of 3-hydroxydodecanoic and 3-hydroxyhexadecanoic acids and one residue of either 25-hydroxyhexacosanoic or 27-hydroxyoctacosanoic acid that is O-linked to the acyl group at position 2'. The lipopolysaccharide studied activated Toll-like receptor 4 signaling only to a low extent (1,000-10,000-fold lower compared with that of Salmonella enterica sv. Friedenau) and did not activate Toll-like receptor 2. Some unusual structural features of the B. henselae lipopolysaccharide, including the presence of a long-chain fatty acid, which are shared by the lipopolysaccharides of other bacteria causing chronic intracellular infections ( e. g. Legionella and Chlamydia), may provide the molecular basis for low endotoxic potency.
C1 Leibniz Ctr Med & Biosci, Res Ctr Bortsel, D-23845 Borstel, Germany.
   Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Zahringer, U (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Bortsel, D-23845 Borstel, Germany.
EM uzaehr@fz-borstel.de
RI Heine, Holger/H-4552-2012; Lindner, Buko/G-9731-2014; Dehio,
   Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016; Knirel, Yuriy
   A/E-2058-2014
OI Heine, Holger/0000-0001-8128-5068; Dehio, Christoph/0000-0001-7288-1052;
   Dehio, Christoph/0000-0001-7288-1052; 
CR BHAT UR, 1991, J BACTERIOL, V173, P2155, DOI 10.1128/JB.173.7.2155-2159.1991
   BHAT UR, 1991, INT J SYST BACTERIOL, V41, P213
   BOCK K, 1992, CARBOHYD RES, V229, P213, DOI 10.1016/S0008-6215(00)90571-8
   CARRION M, 1990, J BACTERIOL, V172, P1725, DOI 10.1128/jb.172.4.1725-1731.1990
   CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9
   Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0
   Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x
   Girard R, 2003, J CELL SCI, V116, P293, DOI 10.1242/jcs.00212
   Gudlavalleti SK, 2003, J BIOL CHEM, V278, P3957, DOI 10.1074/jbc.M210491200
   Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001
   Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618
   Holst O, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P115
   Karem KL, 2000, MICROBES INFECT, V2, P1193, DOI 10.1016/S1286-4579(00)01273-9
   Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Knirel YA, 1996, CARBOHYD RES, V283, P129, DOI 10.1016/0008-6215(95)00401-7
   Knirel YA, 1995, CARBOHYD RES, V279, P215, DOI 10.1016/0008-6215(95)00274-X
   KOSMA P, 1995, J ENDOTOXIN RES, V0002
   Kyme P, 2003, MICROBIOL-SGM, V149, P621, DOI 10.1099/mic.0.26014-0
   Liberto MC, 2000, MICROBIOLOGICA, V23, P449
   Liberto MC, 2003, DIAGN MICR INFEC DIS, V45, P107
   Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315
   MINNICK MF, 1994, INFECT IMMUN, V62, P2644, DOI 10.1128/IAI.62.6.2644-2648.1994
   Neumeister B, 1998, INFECT IMMUN, V66, P4151
   QUE NLS, 2002, J ENDOTOXIN RES, V8, P156
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   RIETSCHEL ET, 1994, FASEB J, V8, P217
   Rund S, 1999, J BIOL CHEM, V274, P16819, DOI 10.1074/jbc.274.24.16819
   SAWARDEKER JS, 1965, ANAL CHEM, V37, P1602, DOI 10.1021/ac60231a048
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   SONESSON A, 1993, FEMS MICROBIOL LETT, V106, P315, DOI 10.1111/j.1574-6968.1993.tb05982.x
   van den Akker WMR, 1998, MICROBIOL-SGM, V144, P1527, DOI 10.1099/00221287-144-6-1527
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83
   Zahringer U, 1995, Prog Clin Biol Res, V392, P113
   ZAHRINGER U, 1994, ADV CARBOHYD CHEM BI, V50, P211, DOI 10.1016/S0065-2318(08)60152-3
NR 41
TC 67
Z9 69
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 14
PY 2004
VL 279
IS 20
BP 21046
EP 21054
DI 10.1074/jbc.M313370200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 818VY
UT WOS:000221273800061
PM 14766898
OA Other Gold
DA 2021-01-25
ER

PT J
AU Friberg, MA
   Spiess, M
   Rutishauser, J
AF Friberg, MA
   Spiess, M
   Rutishauser, J
TI Degradation of wild-type vasopressin precursor and pathogenic mutants by
   the proteasome
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID NEUROHYPOPHYSEAL DIABETES-INSIPIDUS; NEUROPHYSIN-II GENE; SIGNAL PEPTIDE
   MUTATION; ENDOPLASMIC-RETICULUM; PRION PROTEIN; CELL-LINE; UBIQUITIN;
   IDENTIFICATION; PATHWAY; MEMBRANE
AB Mutations in the gene encoding the antidiuretic hormone arginine vasopressin cause autosomal dominant neurogenic diabetes insipidus. Autoptic data in affected individuals suggest that the neurons expressing mutant vasopressin undergo selective degeneration. Expression studies have shown that the mutants are retained in the endoplasmic reticulum, but how this trafficking defect is linked to neurotoxicity is unknown. One possibility is that unsecreted mutant precursors, or degradation products thereof, are cytotoxic. We therefore investigated the fate of endoplasmic reticulum-retained pathogenic mutants. Our data show that the mutants are retrotranslocated to the cytosol and degraded by the proteasome. In the presence of proteasomal inhibitors, three distinct un- or deglycosylated cytosolic species of vasopressin precursors were stabilized: pre-pro-vasopressin, pro-vasopressin, and an N-terminally truncated form. In addition to the retrotranslocated forms, a fraction of the newly synthesized precursor was not translocated, but was synthesized into the cytosol due to inefficient function of the vasopressin signal peptide. As a result, cytosolic pre-pro-vasopressin and its degradation product were also recovered when wild-type vasopressin was expressed. Cytosolic forms of vasopressin might trigger cytotoxicity in vivo, as has been proposed in the case of prion protein, which also contains an inefficient N-terminal signal peptide.
C1 Univ Basel Hosp, Div Endocrinol Metab & Clin Nutr, CH-4031 Basel, Switzerland.
   Univ Basel Hosp, Dept Med, Med Clin A, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Rutishauser, J (corresponding author), Univ Basel Hosp, Med Clin B, Petersgraben 4, CH-4031 Basel, Switzerland.
EM j.rutishauser@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
CR Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3
   Amizuka N, 2000, BIOCHEM BIOPH RES CO, V273, P621, DOI 10.1006/bbrc.2000.2913
   Belin D, 1996, EMBO J, V15, P468, DOI 10.1002/j.1460-2075.1996.tb00379.x
   BERGERON C, 1991, ACTA NEUROPATHOL, V81, P345, DOI 10.1007/BF00305879
   Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965
   Boson WL, 2003, CLIN ENDOCRINOL, V58, P108, DOI 10.1046/j.1365-2265.2003.01667.x
   BRAVERMAN LE, 1965, ANN INTERN MED, V63, P503, DOI 10.7326/0003-4819-63-3-503
   Bullmann C, 2002, EXP CLIN ENDOCR DIAB, V110, P134, DOI 10.1055/s-2002-29091
   Cescato R, 2000, J NEUROCHEM, V74, P1131
   CHEVRIER D, 1991, MOL CELL ENDOCRINOL, V79, P109, DOI 10.1016/0303-7207(91)90101-W
   CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4
   DiMeglio LA, 2001, MOL GENET METAB, V72, P39, DOI 10.1006/mgme.2000.3117
   Evans DAP, 2000, J NEUROENDOCRINOL, V12, P685
   Fisher EA, 1997, J BIOL CHEM, V272, P20427, DOI 10.1074/jbc.272.33.20427
   Fluck CE, 2001, EUR J ENDOCRINOL, V145, P439, DOI 10.1530/eje.0.1450439
   Gaupp R, 1941, Z GESAMTE NEUROL PSY, V171, P514, DOI 10.1007/BF02880551
   Goder V, 2001, FEBS LETT, V504, P87, DOI 10.1016/S0014-5793(01)02712-0
   Gong LM, 2000, J BIOL CHEM, V275, P14212, DOI 10.1074/jbc.275.19.14212
   GONKING NQ, 1997, J INVEST MED, V45, pA29
   HANHART E, 1940, HDB ERBBIOLOGIE ME 2, V4, P798
   Hansen LK, 1997, TRENDS ENDOCRIN MET, V8, P363, DOI 10.1016/S1043-2760(97)00157-4
   HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786
   Hatsuzawa K, 1997, J BIOCHEM-TOKYO, V121, P270
   Hegde RS, 2003, TRENDS NEUROSCI, V26, P337, DOI 10.1016/S0166-2236(03)00143-7
   Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827
   Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725
   Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107
   Holscher C, 2001, J BIOL CHEM, V276, P13388, DOI 10.1074/jbc.M007331200
   ITO M, 1993, J CLIN INVEST, V91, P2565, DOI 10.1172/JCI116494
   Ito M, 1997, J CLIN INVEST, V99, P1897, DOI 10.1172/JCI119357
   Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200
   Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227
   Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725
   Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619
   Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098
   Mahoney CP, 2002, J CLIN ENDOCR METAB, V87, P870, DOI 10.1210/jc.87.2.870
   Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513
   Nijenhuis M, 1999, J BIOL CHEM, V274, P21200, DOI 10.1074/jbc.274.30.21200
   Olias G, 1996, DNA CELL BIOL, V15, P929, DOI 10.1089/dna.1996.15.929
   Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550
   Rittig S, 1996, AM J HUM GENET, V58, P107
   Rittig S, 2002, J CLIN ENDOCR METAB, V87, P3351, DOI 10.1210/jc.87.7.3351
   Rutishauser J, 1996, J CLIN ENDOCR METAB, V81, P192, DOI 10.1210/jc.81.1.192
   Rutishauser J, 1999, MOL GENET METAB, V67, P89, DOI 10.1006/mgme.1999.2825
   Santiprabhob J, 2002, MOL GENET METAB, V77, P112, DOI 10.1016/S1096-7192(02)00118-X
   SAUSVILLE E, 1985, J BIOL CHEM, V260, P236
   Schubert U, 2000, NATURE, V404, P770
   Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074
   Siggaard C, 1999, J CLIN ENDOCR METAB, V84, P2933, DOI 10.1210/jc.84.8.2933
   VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635
   Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619
   Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383
   Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X
   Zhou MY, 1998, J BIOL CHEM, V273, P24649, DOI 10.1074/jbc.273.38.24649
   Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982
NR 55
TC 25
Z9 25
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 7
PY 2004
VL 279
IS 19
BP 19441
EP 19447
DI 10.1074/jbc.M310249200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 817FX
UT WOS:000221164500009
PM 14996841
OA Bronze
DA 2021-01-25
ER

PT J
AU Gerebtzoff, G
   Li-Blatter, X
   Fischer, H
   Frentzel, A
   Seelig, A
AF Gerebtzoff, G
   Li-Blatter, X
   Fischer, H
   Frentzel, A
   Seelig, A
TI Halogenation of drugs enhances membrane binding and permeation
SO CHEMBIOCHEM
LA English
DT Article
DE chlorine; fluorine; ionization constants; kinetics; thermodynamics
ID BLOOD-BRAIN-BARRIER; PARTITION-COEFFICIENTS; IONIZATION-CONSTANTS;
   LIPID-MEMBRANES; SUBSTANCE-P; PRESSURE; ANTAGONISTS; CONFORMATION;
   MONOLAYERS
AB Halogenation of drugs is commonly used to enhance membrane binding and permeation. We quantify the effect of replacing a hydrogen residue by a chlorine or a trifluoromethyl residue in position C-2 of promazine, perazine, and perphenazine analogues. Moreover, we investigate the influence of the position (C-6 and C-7) of residue CF3 in benzopyranols. The twelve drugs are characterized by surface activity measurements, which yield the cross-sectional area, the air-water partition coefficient, and the critical micelle concentration. By using the first two parameters (A(D) and K-aw) and the appropriate membrane packing density, the lipid-water partition coefficients, are calculated in excellent agreement with the lipid-water partition coefficients measured by means of isothermal titration calorimetry for small unilamellar vesicles of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine. Replacement of a hydrogen residue by a chlorine and a trifluoromethyl residue enhances the free energy of partitioning into the lipid membrane, and average by DeltaG(lw)approximate to-1.3 or -4.5 kJ mol(-1), respectively, and the permeability coefficient by a factor of similar to2 or similar to9, respectively. Despite exhibiting practically identical hydrophobicities, the two benzopyranol analogues differ in their permeability coefficients by almost an order of magnitude; this is due to their different cross-sectional areas at the air-water and lipid-water interfaces.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anna.seelig@unibas.ch
CR BERGMANN R, 1990, J MED CHEM, V33, P2759, DOI 10.1021/jm00172a013
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   CLARKE FH, 1984, J PHARM SCI, V73, P226, DOI 10.1002/jps.2600730221
   CLARKE FH, 1987, J PHARM SCI, V76, P611, DOI 10.1002/jps.2600760806
   COOKSON RF, 1974, CHEM REV, V74, P5, DOI 10.1021/cr60287a002
   DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0
   Fischer H, 2000, CHIMIA, V54, P640
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   Franke U, 1999, J PHARM SCI, V88, P89, DOI 10.1021/js980206m
   FROMHERZ P, 1975, REV SCI INSTRUM, V46, P1380, DOI 10.1063/1.1134025
   GATLIKLANDWOJTO.E, UNPUB
   GOBAS FAPC, 1988, J PHARM SCI, V77, P265, DOI 10.1002/jps.2600770317
   Hanakam F, 1996, BIOCHEMISTRY-US, V35, P11036, DOI 10.1021/bi960789j
   KITAMURA K, 2004, IN PRESS BIOCH BIOPH
   LIBLATTER X, UNPUB
   MANNHOLD R, 1990, QUANT STRUCT-ACT REL, V9, P21, DOI 10.1002/qsar.19900090105
   Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3
   MCLAUGHLIN S, 1989, ANNU REV BIOPHYS BIO, V18, P113, DOI 10.1146/annurev.bb.18.060189.000553
   MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71
   NEWTON DW, 1978, DRUG INTEL CLIN PHAR, V12, P546, DOI 10.1177/106002807801200906
   SEELIG A, 1992, BIOCHEMISTRY-US, V31, P2897, DOI 10.1021/bi00126a008
   SEELIG A, 1990, BIOCHIM BIOPHYS ACTA, V1030, P111, DOI 10.1016/0005-2736(90)90245-J
   SEELIG A, 1994, P NATL ACAD SCI USA, V91, P68, DOI 10.1073/pnas.91.1.68
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   SEELIG A, 2004, IN PRESS MINIREV MED
   SEELIG A, 2002, ENCY PHYS SCI TECHNO
   SEELIG J, 1980, Q REV BIOPHYS, V13, P19, DOI 10.1017/S0033583500000305
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   SEILER P, 1974, EUR J MED CHEM, V9, P473
   Takegami S, 2003, CHEM PHARM BULL, V51, P1056
   TOLLENAERE JP, 1977, EUR J MED CHEM, V12, P199
   True JE, 2003, INORG CHEM, V42, P4437, DOI 10.1021/ic0343298
   Wenk MR, 1997, BIOPHYS J, V73, P2565, DOI 10.1016/S0006-3495(97)78285-7
NR 33
TC 164
Z9 164
U1 1
U2 28
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1439-4227
EI 1439-7633
J9 CHEMBIOCHEM
JI ChemBioChem
PD MAY 3
PY 2004
VL 5
IS 5
BP 676
EP 684
DI 10.1002/cbic.200400017
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 818UR
UT WOS:000221270500012
PM 15122640
DA 2021-01-25
ER

PT J
AU Stolz, M
   Raiteri, R
   Daniels, AU
   VanLandingham, MR
   Baschong, W
   Aebi, U
AF Stolz, M
   Raiteri, R
   Daniels, AU
   VanLandingham, MR
   Baschong, W
   Aebi, U
TI Dynamic elastic modulus of porcine articular cartilage determined at two
   different levels of tissue organization by indentation-type atomic force
   microscopy
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID MECHANICAL-PROPERTIES; SPRING CONSTANT; SCANNING FORCE; STIFFNESS;
   SAMPLES; CONSTITUENTS; FIBROBLASTS; CANTILEVERS; MORPHOLOGY; SURFACES
AB Cartilage stiffness was measured ex vivo at the micrometer and nanometer scales to explore structure-mechanical property relationships at smaller scales than has been done previously. A method was developed to measure the dynamic elastic modulus, \E*\, in compression by indentation-type atomic force microscopy (IT AFM). Spherical indenter tips (radius=similar to2.5 mum) and sharp pyramidal tips (radius=similar to20 nm) were employed to probe micrometer-scale and nanometer-scale response, respectively. \E*\ values were obtained at 3 Hz from 1024 unloading response curves recorded at a given location on subsurface cartilage from porcine femoral condyles. With the microsphere tips, the average modulus was similar to2.6 MPa, in agreement with available millimeter-scale data, whereas with the sharp pyramidal tips, it was typically 100-fold lower. In contrast to cartilage, measurements made on agarose gels, a much more molecularly amorphous biomaterial, resulted in the same average modulus for both indentation tips. From results of AFM imaging of cartilage, the micrometer-scale spherical tips resolved no. ne structure except some chondrocytes, whereas the nanometer-scale pyramidal tips resolved individual collagen fibers and their 67-nm axial repeat distance. These results suggest that the spherical AFM tip is large enough to measure the aggregate dynamic elastic modulus of cartilage, whereas the sharp AFM tip depicts the elastic properties of its. ne structure. Additional measurements of cartilage stiffness following enzyme action revealed that elastase digestion of the collagen moiety lowered the modulus at the micrometer scale. In contrast, digestion of the proteoglycans moiety by cathepsin D had little effect on \E*\ at the micrometer scale, but yielded a clear stiffening at the nanometer scale. Thus, cartilage compressive stiffness is different at the nanometer scale compared to the overall structural stiffness measured at the micrometer and larger scales because of the fine nanometer-scale structure, and enzyme-induced structural changes can affect this scale-dependent stiffness differently.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Genoa, Dept Biophys & Elect Engn, Genoa, Italy.
   Univ Basel, Felix Platter Hosp, Lab Orthoped Biomech, CH-4003 Basel, Switzerland.
   Army Res Lab, Aberdeen Proving Ground, MD USA.
   Univ Basel, Dept Oral Surg, CH-4003 Basel, Switzerland.
RP Aebi, U (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelberstr 70, CH-4056 Basel, Switzerland.
EM ueli.aebi@unibas.ch
CR A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3
   Appleyard RC, 2001, PHYS MED BIOL, V46, P541, DOI 10.1088/0031-9155/46/2/319
   ASPDEN RM, 1991, J BIOMED ENG, V13, P521, DOI 10.1016/0141-5425(91)90102-D
   BADER DL, 1994, BIO-MED MATER ENG, V4, P245
   BUECKLE H, 1973, SCI HARDNESS TESTING
   Capella B, 1997, IEEE ENG MED BIOL, V16, P58, DOI 10.1109/51.582177
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Cohen NP, 1998, J ORTHOP SPORT PHYS, V28, P203, DOI 10.2519/jospt.1998.28.4.203
   Gibson CT, 1996, NANOTECHNOLOGY, V7, P259, DOI 10.1088/0957-4484/7/3/014
   Hay Jennifer L, 2000, ASM HDB, P232, DOI DOI 10.31399/asm.hb.v08.a0003273
   Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X
   Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI [10.1515/crll.1882.92.156, DOI 10.1515/CRLL.1882.92.156]
   HOH JH, 1994, J CELL SCI, V107, P1105
   HORI RY, 1976, J BIOMECH, V9, P259, DOI 10.1016/0021-9290(76)90012-9
   HUES SM, 1993, MRS BULL, V18, P41, DOI 10.1557/S088376940004344X
   Hunziker PR, 2002, CHIMIA, V56, P520, DOI 10.2533/000942902777680234
   Jurvelin JS, 1996, J STRUCT BIOL, V117, P45, DOI 10.1006/jsbi.1996.0068
   KEMPSON GE, 1971, J BIOMECH, V4, P239, DOI 10.1016/0021-9290(71)90030-3
   KEMPSON GE, 1970, BIOCHIM BIOPHYS ACTA, V215, P70, DOI 10.1016/0304-4165(70)90388-0
   LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880
   LINN FC, 1967, J BONE JOINT SURG AM, VA 49, P1079, DOI 10.2106/00004623-196749060-00005
   LUEKE HD, 1991, SPRINGER LEHRBUCH, V5, P200
   LYYRA T, 1995, MED ENG PHYS, V17, P395, DOI 10.1016/1350-4533(95)97322-G
   MAK AF, 1987, J BIOMECH, V20, P703, DOI 10.1016/0021-9290(87)90036-4
   Mankin HJ, 1994, ORTHOPEDIC BASIC SCI
   MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0
   Matzelle TR, 2002, J PHYS CHEM B, V106, P2861, DOI 10.1021/jp0128426
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PERSCH G, 1994, MICROELECTRON ENG, V24, P113, DOI 10.1016/0167-9317(94)90061-2
   PHARR GM, 1992, MRS BULL, V17, P28, DOI 10.1557/S0883769400041634
   PHARR GM, 1992, J MATER RES, V7, P613, DOI 10.1557/JMR.1992.0613
   POPKO J, 1986, Beitraege zur Orthopaedie und Traumatologie, V33, P506
   RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6
   Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176
   Raiteri R, 1998, COLLOID SURFACE A, V136, P191, DOI 10.1016/S0927-7757(97)00339-7
   Randall NX, 1998, SURF COAT TECH, V108, P489, DOI 10.1016/S0257-8972(98)00573-8
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Rotsch C, 1999, P NATL ACAD SCI USA, V96, P921, DOI 10.1073/pnas.96.3.921
   Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8
   Shepherd DET, 1997, P I MECH ENG H, V211, P155, DOI 10.1243/0954411971534278
   Sneddon IN., 1965, INT J ENG SCI, V3, DOI DOI 10.1016/0020-7225(65)90019-4
   Stolz M, 1999, MOL BIOL CELL, V10, p145A
   STOLZ M, 2003, BIOWORLD, V3, P2
   Swanepoel M. W., 1994, Proceedings of the Institution of Mechanical Engineers, Part H (Journal of Engineering in Medicine), V208, P33
   TKACZUK H, 1982, J MED ENG TECHNOL, V6, P104, DOI 10.3109/03091908209040998
   TKACZUK H, 1986, CLIN ORTHOP RELAT R, P301
   Torii A, 1996, MEAS SCI TECHNOL, V7, P179, DOI 10.1088/0957-0233/7/2/010
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   Van Leeuwen T., 1999, DISCOURSE STUD, V1, DOI [https://doi.org/10.1177/1461445699001001005, DOI 10.1177/1461445699001001005]
   Vanlandingham MR, 1997, J MATER SCI LETT, V16, P117, DOI 10.1023/A:1018533708655
   VANLANDINGHAM MR, 1997, S MAT RES SOC PITTSB
   VAWTER DL, 1983, J BIOMECH ENG-T ASME, V105, P194, DOI 10.1115/1.3138405
   Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4
   Walch M, 2000, ULTRAMICROSCOPY, V82, P259, DOI 10.1016/S0304-3991(99)00135-7
   Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006
   WEISENHORN AL, 1993, P SOC PHOTO-OPT INS, V1855, P26, DOI 10.1117/12.146382
   WEISENHORN AL, 1992, PHYS REV B, V45, P11226, DOI 10.1103/PhysRevB.45.11226
NR 58
TC 325
Z9 333
U1 3
U2 113
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD MAY
PY 2004
VL 86
IS 5
BP 3269
EP 3283
DI 10.1016/S0006-3495(04)74375-1
PG 15
WC Biophysics
SC Biophysics
GA 816HW
UT WOS:000221102000057
PM 15111440
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Benabdillah, R
   Mota, LJ
   Lutzelschwab, S
   Demoinet, E
   Cornelis, GR
AF Benabdillah, R
   Mota, LJ
   Lutzelschwab, S
   Demoinet, E
   Cornelis, GR
TI Identification of a nuclear targeting signal in YopM from Yersinia spp.
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE microbial pathogenesis; nuclear localization signal; type III secretion;
   YopM; Yersinia; leucine-rich repeats
ID MAMMALIAN-CELLS; TYROSINE-PHOSPHATASE; VIRULENCE PLASMID; SECRETION
   SYSTEMS; ENDOTHELIAL-CELLS; EUKARYOTIC CELLS; ALPHA PRODUCTION; BINDING
   PROTEIN; FOCAL ADHESIONS; IMPORT PATHWAY
AB YopM is a type III secretion effector from Yersinia which contributes to pathogenicity but whose action still remains unclear. It is an acidic, leucine-rich repeats (LRR) containing protein which migrates to the nucleus of target cells in spite of the fact that it does not contain any classical nuclear localization signal (NLS). Using a yeast approach, we observed that the three first LRRs (LRR1-3) and the 32 C-terminal residues of YopM (YopM(C-ter)) act as NLSs in yeast. Furthermore, by transfection of HEK293T cells, we observed that YopM(C-ter) could direct large recombinant EGFP-LexA-AD proteins into the nucleus of mammalian cells confirming that it contains a NLS. Critical residues for nuclear targeting were identified by site-directed mutagenesis in YOPMC-ter. In addition, we show that YOPMC-ter NLS is crucial for the nuclear targeting of an EGFP-YopM fusion protein. (C) 2004 Elsevier Ltd. All fights reserved.
C1 Univ Basel, Biozentrum, Mol Microbiol Div, CH-4056 Basel, Switzerland.
   Christain Duve Inst Cellular Pathol, Microbial Pathogenesis Unit, B-1200 Brussels, Belgium.
   Univ Catholique Louvain, B-1200 Brussels, Belgium.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Mol Microbiol Div, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Mota, Luis J/B-9497-2008
OI Mota, Luis J/0000-0002-5592-8397
CR Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624
   Albertini M, 1998, J CELL BIOL, V143, P1447, DOI 10.1083/jcb.143.6.1447
   Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x
   Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7
   Bild AH, 2002, EMBO J, V21, P3255, DOI 10.1093/emboj/cdf351
   Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x
   Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Boland A, 1998, MICROB PATHOGENESIS, V25, P343, DOI 10.1006/mpat.1998.0247
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   DAVEY J, 1985, CELL, V40, P667, DOI 10.1016/0092-8674(85)90215-6
   Denecker G, 2002, INFECT IMMUN, V70, P3510, DOI 10.1128/IAI.70.7.3510-3520.2002
   Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973
   Fallman M, 2002, INT J MED MICROBIOL, V291, P501
   Fernandez DH, 2001, PLASMID, V45, P52, DOI 10.1006/plas.2000.1499
   FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2
   Frohlich T, 1998, J CELL SCI, V111, P2353
   Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002
   Guan K L, 1993, Semin Cell Biol, V4, P389, DOI 10.1006/scel.1993.1046
   Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003
   Hines J, 2001, MICROB PATHOGENESIS, V30, P193, DOI 10.1006/mpat.2000.0424
   HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813
   Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998
   ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983
   KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5
   Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840
   LEUNG KY, 1989, J BACTERIOL, V171, P4623, DOI 10.1128/jb.171.9.4623-4632.1989
   LEUNG KY, 1990, INFECT IMMUN, V58, P3262, DOI 10.1128/IAI.58.10.3262-3271.1990
   LOEB JDJ, 1995, P NATL ACAD SCI USA, V92, P7647, DOI 10.1073/pnas.92.17.7647
   McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200
   Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x
   MULDER B, 1989, INFECT IMMUN, V57, P2534, DOI 10.1128/IAI.57.8.2534-2541.1989
   PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0
   Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x
   Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407
   Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307
   Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7
   Rhee Y, 2000, NAT BIOTECHNOL, V18, P433
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988
   Ruckdeschel K, 1997, J BIOL CHEM, V272, P15920, DOI 10.1074/jbc.272.25.15920
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x
   Sauvonnet N, 2002, J BIOL CHEM, V277, P25133, DOI 10.1074/jbc.M203239200
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Seedorf M, 1997, P NATL ACAD SCI USA, V94, P8590, DOI 10.1073/pnas.94.16.8590
   Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3
   Skrzypek E, 2003, INFECT IMMUN, V71, P937, DOI 10.1128/IAI.71.2.937-947.2003
   Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x
   SOMMER L, 1991, CELL, V67, P987, DOI 10.1016/0092-8674(91)90371-5
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777
   Toyotome T, 2001, J BIOL CHEM, V276, P32071, DOI 10.1074/jbc.M101882200
   Venkatesan MM, 2001, INFECT IMMUN, V69, P3271, DOI 10.1128/IAI.69.5.3271-3285.2001
   Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343
   Yoshida K, 2001, J CELL BIOL, V152, P729, DOI 10.1083/jcb.152.4.729
   ZHAO LJ, 1988, CELL, V55, P1005, DOI 10.1016/0092-8674(88)90245-0
   Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289
NR 60
TC 61
Z9 61
U1 0
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD MAY
PY 2004
VL 36
IS 5
BP 247
EP 261
DI 10.1016/j.micpath.2003.12.006
PG 15
WC Immunology; Microbiology
SC Immunology; Microbiology
GA 811KU
UT WOS:000220771600002
PM 15043860
DA 2021-01-25
ER

PT J
AU Petit, V
   Nussbaumer, U
   Dossenbach, C
   Affolter, M
AF Petit, V
   Nussbaumer, U
   Dossenbach, C
   Affolter, M
TI Downstream-of-FGFR is a fibroblast growth factor-specific scaffolding
   protein and recruits corkscrew upon receptor activation
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID TRACHEAL CELL-MIGRATION; SERUM RESPONSE FACTOR; MESODERMAL CELLS;
   TYROSINE KINASE; DROSOPHILA; GENE; HOMOLOG; PATHWAYS; ENCODES; SYSTEM
AB Fibroblast growth factor (FGF) receptor (FGFR) signaling controls the migration of glial, mesodermal, and tracheal cells in Drosophila melanogaster. Little is known about the molecular events linking receptor activation to cytoskeletal rearrangements during cell migration. We have performed a functional characterization of Downstream-of-FGFR (Dof), a putative adapter protein that acts specifically in FGFR signal transduction in Drosophila. By combining reverse genetic, cell culture, and biochemical approaches, we demonstrate that Dof is a specific substrate for the two Drosophila FGFRs. After defining a minimal Dof rescue protein, we identify two regions important for Dof function in mesodermal and tracheal cell migration. The N-terminal 484 amino acids are strictly required for the interaction of Dof with the FGFRs. Upon receptor activation, tyrosine residue 515 becomes phosphorylated and recruits the phosphatase Corkscrew (Csw). Csw recruitment represents an essential step in FGF-induced cell migration and in the activation of the Ras/MAPK pathway. However, our results also indicate that the activation of Ras is not sufficient to activate the migration machinery in tracheal and mesodermal cells. Additional proteins binding either to the FGFRs, to Dof, or to Csw appear to be crucial for a chemotactic response.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Markus.Affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016; PETIT, Valerie/0000-0003-1645-9396
CR Affolter M, 2001, SCIENCE, V292, P1080, DOI 10.1126/science.1060856
   Ahmad SM, 2002, CELL, V109, P651, DOI 10.1016/S0092-8674(02)00744-4
   Battersby A, 2003, J MOL BIOL, V329, P479, DOI 10.1016/S0022-2836(03)00489-3
   Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993
   Boube M, 2001, GENE DEV, V15, P1554, DOI 10.1101/gad.195501
   Dossenbach C, 2001, DEVELOPMENT, V128, P4563
   Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131
   Franch-Marro X, 2000, DEV BIOL, V227, P80, DOI 10.1006/dbio.2000.9890
   Gabay L, 1997, DEVELOPMENT, V124, P3535
   Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103
   Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003
   GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697
   Guillemin K, 1996, DEVELOPMENT, V122, P1353
   Hadari YR, 2001, P NATL ACAD SCI USA, V98, P8578, DOI 10.1073/pnas.161259898
   Hamlet MRJ, 2001, GENETICS, V159, P1073
   Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235
   Imam F, 1999, GENETICS, V152, P307
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4
   Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1
   Michelson AM, 1998, DEVELOPMENT, V125, P4379
   Montagne J, 1996, DEVELOPMENT, V122, P2589
   Nussbaumer U, 2000, MECH DEVELOP, V96, P27, DOI 10.1016/S0925-4773(00)00373-7
   Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0
   ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0
   Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298
   Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000
   Ong SH, 1996, BIOCHEM BIOPH RES CO, V225, P1021, DOI 10.1006/bbrc.1996.1288
   Ornitz DM, 2001, GENOME BIOL, V2
   Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285
   Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165
   REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Saxton TM, 1999, P NATL ACAD SCI USA, V96, P3790, DOI 10.1073/pnas.96.7.3790
   Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/S0092-8674(00)00114-8
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Wang JK, 1996, ONCOGENE, V13, P721
   Xu H, 1998, J BIOL CHEM, V273, P17987, DOI 10.1074/jbc.273.29.17987
   Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83
NR 45
TC 23
Z9 23
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD MAY
PY 2004
VL 24
IS 9
BP 3769
EP 3781
DI 10.1128/MCB.24.9.3769-3781.2004
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 813HL
UT WOS:000220898100018
PM 15082772
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Niehus, E
   Gressmann, H
   Ye, F
   Schlapbach, R
   Dehio, M
   Dehio, C
   Stack, A
   Meyer, TF
   Suerbaum, S
   Josenhans, C
AF Niehus, E
   Gressmann, H
   Ye, F
   Schlapbach, R
   Dehio, M
   Dehio, C
   Stack, A
   Meyer, TF
   Suerbaum, S
   Josenhans, C
TI Genome-wide analysis of transcriptional hierarchy and feedback
   regulation in the flagellar system of Helicobacter pylori
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; CAULOBACTER-CRESCENTUS; CAMPYLOBACTER-JEJUNI;
   GENE-TRANSCRIPTION; RESPONSE REGULATORS; EXPORT APPARATUS;
   ESCHERICHIA-COLI; CELL-CYCLE; MOTILITY; PROTEIN
AB The flagellar system of Helicobacter pylori, which comprises more than 40 mostly unclustered genes, is essential for colonization of the human stomach mucosa. In order to elucidate the complex transcriptional circuitry of flagellar biosynthesis in H. pylori and its link to other cell functions, mutants in regulatory genes governing flagellar biosynthesis (rpoN, flgR, flhA, flhF, HP0244) and whole-genome microarray technology were used in this study. The regulon controlled by RpoN, its activator FlgR (FleR) and the cognate histidine kinase HP0244 (FleS) was characterized on a genome-wide scale for the first time. Seven novel genes (HP1076, HP1233, HP1154/1155, HP0366/367, HP0869) were identified as belonging to RpoN-associated flagellar regulons. The hydrogenase accessory gene HP0869 was the only annotated non-flagellar gene in the RpoN regulon. Flagellar basal body components FlhA and FlhF were characterized as functional equivalents to master regulators in H. pylori, as their absence led to a general reduction of transcripts in the RpoN (class 2) and FliA (class 3) regulons, and of 24 genes newly attributed to intermediate regulons, under the control of two or more promoters. FlhA- and FlhF-dependent regulons comprised flagellar and non-flagellar genes. Transcriptome analysis revealed that negative feedback regulation of the FliA regulon was dependent on the antisigma factor FlgM. FlgM was also involved in FlhA- but not FlhF-dependent feedback control of the RpoN regulon. In contrast to other bacteria, chemotaxis and flagellar motor genes were not controlled by FliA or RpoN. A true master regulator of flagellar biosynthesis is absent in H. pylori, consistent with the essential role of flagellar motility and chemotaxis for this organism.
C1 Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany.
   Max Planck Inst Infect Biol, D-10117 Berlin, Germany.
   Univ Basel, Biozentrum, Dept Mol Microbiol, Basel, Switzerland.
   Hannover Med Sch, Inst Med Microbiol, D-30625 Hannover, Germany.
   Hannover Med Sch, Hosp Epidemiol, D-30625 Hannover, Germany.
RP Josenhans, C (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Josef Schneider Str 2, D-97080 Wurzburg, Germany.
EM cjosenhans@hygiene.uni-wuerzburg.de
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019;
   Schlapbach, Ralph/R-8234-2016; Meyer, Thomas F. F/J-2485-2013
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Meyer, Thomas F. F/0000-0002-6120-8679;
   Schlapbach, Ralph/0000-0002-7488-4262
CR AIZAWA SI, 2000, ENCY MICROBIOLOGY, P380
   Allan E, 2000, J BACTERIOL, V182, P5274, DOI 10.1128/JB.182.18.5274-5277.2000
   Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495
   ANDERSON DK, 1995, MOL GEN GENET, V246, P697, DOI 10.1007/BF00290715
   Beier D, 2000, J BACTERIOL, V182, P2068, DOI 10.1128/JB.182.8.2068-2076.2000
   Beier D, 1997, J BACTERIOL, V179, P4676, DOI 10.1128/jb.179.15.4676-4683.1997
   Beier D, 1998, MOL MICROBIOL, V30, P121, DOI 10.1046/j.1365-2958.1998.01043.x
   Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000
   Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000
   Colland F, 2001, MOL MICROBIOL, V41, P477, DOI 10.1046/j.1365-2958.2001.02537.x
   Dasgupta N, 2002, J BACTERIOL, V184, P5240, DOI 10.1128/JB.184.19.5240-5250.2002
   Dasgupta N, 2000, J BACTERIOL, V182, P357, DOI 10.1128/JB.182.2.357-364.2000
   Dietz P, 2002, J BACTERIOL, V184, P350, DOI 10.1128/JB.184.2.350-362.2002
   Eisenbach M, 1996, MOL MICROBIOL, V20, P903, DOI 10.1111/j.1365-2958.1996.tb02531.x
   FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992
   Forsyth MH, 2002, J BACTERIOL, V184, P4630, DOI 10.1128/JB.184.16.4630-4635.2002
   Foynes S, 2000, INFECT IMMUN, V68, P2016, DOI 10.1128/IAI.68.4.2016-2023.2000
   Fujinaga R, 2001, J Infect Chemother, V7, P148, DOI 10.1007/s101560100027
   GEIS G, 1993, J MED MICROBIOL, V38, P371, DOI 10.1099/00222615-38-5-371
   Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002
   Hendrixson DR, 2003, MOL MICROBIOL, V50, P687, DOI 10.1046/j.1365-2958.2003.03731.x
   Heuermann D, 1998, MOL GEN GENET, V257, P519, DOI 10.1007/s004380050677
   Hirano T, 2003, J BACTERIOL, V185, P2485, DOI 10.1128/JB.185.8.2485-2492.2003
   Jagannathan A, 2001, J BACTERIOL, V183, P2937, DOI 10.1128/JB.183.9.2937-2942.2001
   Jenal U, 2000, FEMS MICROBIOL REV, V24, P177, DOI 10.1016/S0168-6445(99)00035-2
   Jones AC, 1997, J BACTERIOL, V179, P5643, DOI 10.1128/jb.179.17.5643-5647.1997
   Jones SE, 2001, MICROBIOL-SGM, V147, P949, DOI 10.1099/00221287-147-4-949
   Josenhans C, 2000, INFECT IMMUN, V68, P4598, DOI 10.1128/IAI.68.8.4598-4603.2000
   Josenhans C, 2002, MOL MICROBIOL, V43, P307, DOI 10.1046/j.1365-2958.2002.02765.x
   Josenhans C, 2001, HELICOBACTER PYLORI: MOLECULAR AND CELLULAR BIOLOGY, P171
   Karlinsey JE, 2000, CELL, V102, P487, DOI 10.1016/S0092-8674(00)00053-2
   Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531
   Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755
   Kihara M, 2001, J BACTERIOL, V183, P1655, DOI 10.1128/JB.183.5.1655-1662.2001
   Kim JS, 1999, J BACTERIOL, V181, P6969
   Kutsukake K, 1999, GENES GENET SYST, V74, P287, DOI 10.1266/ggs.74.287
   LABIGNEROUSSEL A, 1988, J BACTERIOL, V170, P1704, DOI 10.1128/jb.170.4.1704-1708.1988
   Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699
   McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001
   McGee DJ, 2002, J MED MICROBIOL, V51, P958, DOI 10.1099/0022-1317-51-11-958
   Mehta N, 2003, J BACTERIOL, V185, P726, DOI 10.1128/JB.185.3.726-734.2003
   MENARD R, 1993, J BACTERIOL, V175, P5899
   Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x
   Muir RE, 2001, MOL MICROBIOL, V41, P117, DOI 10.1046/j.1365-2958.2001.02506.x
   Niehus E, 2002, MICROBIOL-SGM, V148, P3827, DOI 10.1099/00221287-148-12-3827
   OTOOLE PW, 1994, MOL MICROBIOL, V14, P691, DOI 10.1111/j.1365-2958.1994.tb01307.x
   Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002
   Pandza S, 2000, MOL MICROBIOL, V36, P414, DOI 10.1046/j.1365-2958.2000.01859.x
   Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x
   Pruss BM, 2001, FEMS MICROBIOL LETT, V197, P91
   Raddatz G, 2001, BIOINFORMATICS, V17, P98, DOI 10.1093/bioinformatics/17.1.98
   Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615
   RITCHINGS BW, 1995, INFECT IMMUN, V63, P4868, DOI 10.1128/IAI.63.12.4868-4876.1995
   Schmitz A, 1997, J BACTERIOL, V179, P987, DOI 10.1128/jb.179.4.987-997.1997
   Spohn G, 1999, J BACTERIOL, V181, P593, DOI 10.1128/JB.181.2.593-599.1999
   Spohn G, 2001, HELICOBACTER PYLORI, P239
   Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003
   THONY B, 1989, FEMS MICROBIOL LETT, V63, P341
   Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483
   Vanet A, 2000, J MOL BIOL, V297, P335, DOI 10.1006/jmbi.2000.3576
   Wu JG, 1997, MOL MICROBIOL, V24, P233, DOI 10.1046/j.1365-2958.1997.3281691.x
NR 61
TC 138
Z9 143
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD MAY
PY 2004
VL 52
IS 4
BP 947
EP 961
DI 10.1111/j.1365-2958.2004.04006.x
PG 15
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 818FQ
UT WOS:000221231400004
PM 15130117
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Tay, AG
   Farhadi, J
   Suetterlin, R
   Pierer, G
   Heberer, M
   Martin, I
AF Tay, AG
   Farhadi, J
   Suetterlin, R
   Pierer, G
   Heberer, M
   Martin, I
TI Cell yield, proliferation, and postexpansion differentiation capacity of
   human ear, nasal, and rib chondrocytes
SO TISSUE ENGINEERING
LA English
DT Article
ID HUMAN ARTICULAR CHONDROCYTES; HUMAN SEPTAL CARTILAGE; GROWTH-FACTORS;
   MECHANICAL-PROPERTIES; AGE-DEPENDENCE; II COLLAGEN; IN-VITRO; TISSUE;
   REDIFFERENTIATION; CULTURE
AB Human ear, nasal, and rib chondrocytes were compared with respect to their suitability to generate autologous cartilage grafts for nonarticular reconstructive surgery. Cells were expanded for two passages in medium containing 10% fetal bovine serum without (control) or with transforming growth factor beta(1) (TGF-beta(1)), fibroblast growth factor 2 (FGF-2), and platelet-derived growth factor bb (PDGF-bb) (TFP). Expanded cells were cultured as three-dimensional pellets in chondrogenic serum-free medium containing insulin, dexamethasone, and TGF-beta(1). Chondrocytes from all three sources were successfully isolated, increased their proliferation rate in response to TFP, and dedifferentiated during passaging. Redifferentiation by ear and nasal, but not rib, chondrocytes was enhanced after TFP expansion, as assessed by the significant increase in glycosaminoglycan (GAG)/DNA content and collagen type II mRNA expression in the resulting pellets. TFP-expanded ear and nasal chondrocytes generated pellets of better quality than rib chondrocytes, as assessed by the significantly higher GAG/DNA content and collagen type II mRNA expression, and by the relative stain intensities for GAG and collagen types I and II. In conclusion, postexpansion cell yields suggest that all three sources investigated could be used to generate autologous grafts of clinically relevant size. However, ear and nasal chondrocytes, if expanded with TFP, display superior postexpansion chondrogenic potential and may be a preferred cell source for cartilage tissue engineering.
C1 Univ Basel Hosp, Dept Surg, Inst Surg Res & Hosp Management, CH-4031 Basel, Switzerland.
   Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.
   Singapore Gen Hosp, Dept Plast Surg, Singapore 0316, Singapore.
   Univ Basel, Biozentrum, ME Mueller Inst, Basel, Switzerland.
RP Martin, I (corresponding author), Univ Basel Hosp, Dept Surg, Inst Surg Res & Hosp Management, Hebelstr 20,ZLF,Room 405, CH-4031 Basel, Switzerland.
EM imartin@uhbs.ch
RI Martin, Ivan/K-9286-2016
OI Martin, Ivan/0000-0001-6493-0432
CR Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950
   Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210
   BUJIA J, 1994, ACTA OTO-LARYNGOL, V114, P539, DOI 10.3109/00016489409126100
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   Mandl EW, 2002, TISSUE ENG, V8, P573, DOI 10.1089/107632702760240490
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   Naumann A, 2002, J HISTOCHEM CYTOCHEM, V50, P1049, DOI 10.1177/002215540205000807
   Ohara K, 1997, PLAST RECONSTR SURG, V99, P1030, DOI 10.1097/00006534-199704000-00017
   QUATELA VC, 1993, ARCH OTOLARYNGOL, V119, P32
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Rotter N, 2002, ARCH BIOCHEM BIOPHYS, V403, P132, DOI 10.1016/S0003-9861(02)00263-1
   Rotter N, 2002, BIOMATERIALS, V23, P3087, DOI 10.1016/S0142-9612(02)00031-5
   Rotter N, 2001, ARCH OTOLARYNGOL, V127, P1248, DOI 10.1001/archotol.127.10.1248
   Saadeh PB, 1999, ANN PLAS SURG, V42, P509, DOI 10.1097/00000637-199905000-00008
   van Osch GJVM, 2001, AM J RHINOL, V15, P187, DOI 10.2500/105065801779954166
   van Osch GJVM, 2001, PLAST RECONSTR SURG, V107, P433, DOI 10.1097/00006534-200102000-00020
   Vunjak-Novakovic G, 1999, J ORTHOP RES, V17, P130, DOI 10.1002/jor.1100170119
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
NR 24
TC 123
Z9 131
U1 1
U2 12
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD MAY
PY 2004
VL 10
IS 5-6
BP 762
EP 770
DI 10.1089/1076327041348572
PG 9
WC Cell & Tissue Engineering
SC Cell Biology
GA 836DC
UT WOS:000222534500011
PM 15265293
DA 2021-01-25
ER

PT J
AU Fotiadis, D
   Liang, Y
   Filipek, S
   Saperstein, DA
   Engel, A
   Palczewski, K
AF Fotiadis, D
   Liang, Y
   Filipek, S
   Saperstein, DA
   Engel, A
   Palczewski, K
TI The G protein-coupled receptor rhodopsin in the native membrane
SO FEBS LETTERS
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Structure, Dynamics and Function of
   Proteins in Biological Membranes
CY OCT 05-10, 2003
CL Monte Verita, Ascona, SWITZERLAND
HO Monte Verita
DE atomic force microscopy; G protein-coupled receptor; membrane protein;
   photoreceptor cell; rhodopsin; transmission electron microscopy
ID ROD OUTER SEGMENTS; METABOTROPIC GLUTAMATE-RECEPTOR; 3-DIMENSIONAL
   STRUCTURE; INVERTEBRATE RHODOPSIN; PROJECTION STRUCTURE;
   SIGNAL-TRANSDUCTION; LATERAL DIFFUSION; GABA(B) RECEPTOR;
   ENERGY-TRANSFER; C5A RECEPTOR
AB The higher-order structure of G protein-coupled receptors (GPCRs) in membranes may involve dimerization and formation of even larger oligomeric complexes. Here, we have investigated the organization of the prototypical GPCR rhodopsin in its native membrane by electron and atomic force micros-copy (AFM). Disc membranes from mice were isolated and observed by AFM at room temperature. In all experimental conditions, rhodopsin forms structural dimers organized in paracrystalline arrays. A semi-empirical molecular model for the rhodopsin paracrystal is presented validating our previously reported results. Finally, we compare our model with other currently available models describing the supramolecular structure of GPCRs in the membrane. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.
   Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.
   Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem, Seattle, WA 98195 USA.
RP Fotiadis, D (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dimitrios.fotiadis@unibas.ch; palczews@u.washington.edu
RI Filipek, Slawomir/A-2985-2008
OI Filipek, Slawomir/0000-0003-3147-3858
FU NEI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [EY08061, P30 EY001730, EY01730, R01 EY008061] Funding Source: Medline;
   NATIONAL EYE INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, R29EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, R01EY008061,
   P30EY001730, R29EY008061, R01EY008061, R01EY008061, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   R01EY008061, R01EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   R01EY008061, R01EY008061, P30EY001730, R29EY008061, P30EY001730,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, R01EY008061,
   R01EY008061, P30EY001730, P30EY001730, R29EY008061, P30EY001730,
   P30EY001730, P30EY001730, R29EY008061, P30EY001730, R01EY008061,
   P30EY001730, R01EY008061, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, R01EY008061,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, R01EY008061, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, R29EY008061,
   P30EY001730, R01EY008061] Funding Source: NIH RePORTER
CR Angers S, 2000, TRENDS PHARMACOL SCI, V21, P326, DOI 10.1016/S0165-6147(00)01518-2
   Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314
   Arimoto R, 2001, BIOPHYS J, V81, P3285, DOI 10.1016/S0006-3495(01)75962-0
   Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1
   Ballesteros J, 2001, Curr Opin Drug Discov Devel, V4, P561
   Ballesteros JA, 2001, MOL PHARMACOL, V60, P1
   Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X
   BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613
   Bhave G, 2003, J BIOL CHEM, V278, P30294, DOI 10.1074/jbc.M303258200
   Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575
   Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200
   Carrillo JJ, 2003, J BIOL CHEM, V278, P42578, DOI 10.1074/jbc.M306165200
   Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b
   Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200
   CONE RA, 1972, NATURE-NEW BIOL, V236, P39
   Davies A, 1996, J STRUCT BIOL, V117, P36, DOI 10.1006/jsbi.1996.0067
   Davies A, 2001, J MOL BIOL, V314, P455, DOI 10.1006/jmbi.2001.5167
   Elliott MH, 2003, BIOCHEMISTRY-US, V42, P7892, DOI 10.1021/bi027162n
   Floyd DH, 2003, J BIOL CHEM, V278, P35354, DOI 10.1074/jbc.M305607200
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2003, NATURE, V426, P31, DOI 10.1038/426031a
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256
   FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500
   George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913
   Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90
   Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200
   Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798
   Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819
   Issafras H, 2002, J BIOL CHEM, V277, P34666, DOI 10.1074/jbc.M202386200
   Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348
   Kajimura N, 2000, J ELECTRON MICROSC, V49, P691, DOI 10.1093/oxfordjournals.jmicro.a023860
   Kaupmann K, 1998, NATURE, V396, P683
   Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200
   Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200
   Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74
   Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564
   Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028
   Lee SP, 2003, BIOCHEMISTRY-US, V42, P11023, DOI 10.1021/bi0345539
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001
   LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457
   Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798
   Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498
   Milligan G, 2003, LIFE SCI, V74, P181, DOI 10.1016/j.lfs.2003.09.005
   Milligan G, 2001, J CELL SCI, V114, P1265
   Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+
   Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7
   Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908
   POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0
   Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5
   Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7
   SAIBIL H, 1976, NATURE, V262, P266, DOI 10.1038/262266a0
   SAIBIL H, 1987, J CELL BIOL, V105, P19, DOI 10.1083/jcb.105.1.19
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   SCHERTLER GFX, 1995, P NATL ACAD SCI USA, V92, P11578, DOI 10.1073/pnas.92.25.11578
   Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200
   Soyer OS, 2003, BIOCHEMISTRY-US, V42, P14522, DOI 10.1021/bi035097r
   Stanasila L, 2003, J BIOL CHEM, V278, P40239, DOI 10.1074/jbc.M306085200
   SUZUKI E, 1993, J ELECTRON MICROSC, V42, P178
   Trettel F, 2003, J BIOL CHEM, V278, P40980, DOI 10.1074/jbc.M306815200
   Van Brocklyn JR, 2002, BBA-MOL CELL BIOL L, V1582, P89, DOI 10.1016/S1388-1981(02)00141-5
   Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100
   Visiers I, 2002, METHOD ENZYMOL, V343, P329
   White JH, 1998, NATURE, V396, P679
NR 67
TC 175
Z9 181
U1 1
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD APR 30
PY 2004
VL 564
IS 3
BP 281
EP 288
DI 10.1016/S0014-5793(04)00194-2
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 817IG
UT WOS:000221170600014
PM 15111110
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Pfeffer, S
   Zavolan, M
   Grasser, FA
   Chien, MC
   Russo, JJ
   Ju, JY
   John, B
   Enright, AJ
   Marks, D
   Sander, C
   Tuschl, T
AF Pfeffer, S
   Zavolan, M
   Grasser, FA
   Chien, MC
   Russo, JJ
   Ju, JY
   John, B
   Enright, AJ
   Marks, D
   Sander, C
   Tuschl, T
TI Identification of virus-encoded microRNAs
SO SCIENCE
LA English
DT Article
ID HOMOLOG; SYSTEM; BCL-2; BHRF1
AB RNA silencing processes are guided by small RNAs that are derived from double-stranded RNA. To probe for function of RNA silencing during infection of human cells by a DNA virus, we recorded the small RNA profile of cells infected by Epstein-Barr virus (EBV). We show that EBV expresses several microRNA (miRNA) genes. Given that miRNAs function in RNA silencing pathways either by targeting messenger RNAs for degradation or by repressing translation, we identified viral regulators of host and/or viral gene expression.
C1 Rockefeller Univ, Lab RNA Mol Biol, New York, NY 10021 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Klin Homburg, Inst Mikrobiol & Hyg, Abt Virol, D-66421 Homburg, Germany.
   Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA.
   Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA.
RP Tuschl, T (corresponding author), Rockefeller Univ, Lab RNA Mol Biol, 1230 York Ave,Box 186, New York, NY 10021 USA.
EM ttuschl@rockefeller.edu
RI Enright, Anton/F-3094-2011; Pfeffer, Sebastien/H-3212-2019; Pal, Deb
   K/F-3318-2011; Sander, Chris/H-1452-2011; Pfeffer,
   Sebastien/A-6512-2010; Zavolan, Mihaela/S-3888-2016
OI Enright, Anton/0000-0002-6090-3100; Pfeffer,
   Sebastien/0000-0002-8458-348X; Sander, Chris/0000-0001-6059-6270;
   Pfeffer, Sebastien/0000-0002-8458-348X; Zavolan,
   Mihaela/0000-0002-8832-2041
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01-GM068476-01] Funding Source: Medline;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM068476,
   R01GM068476, R01GM068476, R01GM068476, R01GM068476] Funding Source: NIH
   RePORTER
CR Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Enright AJ, 2004, GENOME BIOL, V5
   FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   Kieff E, 2001, FIELDS VIROLOGY, P2511
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Middeldorp JM, 2003, CRIT REV ONCOL HEMAT, V45, P1, DOI 10.1016/S1040-8428(02)00078-1
   Murray PG, 1996, BLOOD, V87, P706, DOI 10.1182/blood.V87.2.706.bloodjournal872706
   OUDEJANS JJ, 1995, BLOOD, V86, P1893, DOI 10.1182/blood.V86.5.1893.bloodjournal8651893
   TORSTEINSDOTTIR S, 1989, INT J CANCER, V43, P273, DOI 10.1002/ijc.2910430219
   Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8
   ZHANG CX, 1995, VIROLOGY, V208, P180, DOI 10.1006/viro.1995.1141
NR 13
TC 1111
Z9 1225
U1 1
U2 81
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 30
PY 2004
VL 304
IS 5671
BP 734
EP 736
DI 10.1126/science.1096781
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 816JD
UT WOS:000221105300045
PM 15118162
DA 2021-01-25
ER

PT J
AU Schreiber, SN
   Emter, R
   Hock, MB
   Knutti, D
   Cardenas, J
   Podvinec, M
   Oakeley, EJ
   Kralli, A
AF Schreiber, SN
   Emter, R
   Hock, MB
   Knutti, D
   Cardenas, J
   Podvinec, M
   Oakeley, EJ
   Kralli, A
TI The estrogen-related receptor alpha (ERR alpha) functions in PPAR gamma
   coactivator 1 alpha (PGC-1 alpha)-induced mitochondrial biogenesis
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID SYNTHASE BETA-SUBUNIT; TRANSCRIPTIONAL COACTIVATOR; INSULIN-RESISTANCE;
   RESPONSE ELEMENTS; ORPHAN RECEPTOR; GENE PROMOTER; PGC-1;
   DIFFERENTIATION; EXPRESSION; IDENTIFICATION
AB Estrogen-related receptor alpha (ERRalpha) is one of the first orphan nuclear receptors to be identified, yet its physiological functions are still unclear. We show here that ERRa is an effector of the transcriptional coactivator PGC-1alpha [peroxisome proliferator-activated receptor gamma (PPARgamma) coactivator 1alpha], and that it regulates the expression of genes involved in oxidative phosphorylation and mitochondrial biogenesis. Inhibition of ERRalpha compromises the ability of PGC-1alpha to induce the expression of genes encoding mitochondrial proteins and to increase mitochondrial DNA content. A constitutively active form of ERRalpha is sufficient to elicit both responses. ERRa binding sites are present in the transcriptional control regions of ERRalpha/PGC-1alpha-induced genes and contribute to the transcriptional response to PGC-1alpha. The ERRalpha-regulated genes described here have been reported to be expressed at reduced levels in humans that are insulin-resistant. Thus, changes in ERRa activity could be linked to pathological changes in metabolic disease, such as diabetes.
C1 Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Kralli, A (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM kralli@scripps.edu
CR Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com
   Bjorntorp P, 1967, Diabetologia, V3, P346, DOI 10.1007/BF00429867
   Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905
   Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971
   Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398
   Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96
   Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032
   EVANS MJ, 1989, J BIOL CHEM, V264, P14361
   Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1
   GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0
   Hara K, 2002, DIABETOLOGIA, V45, P740, DOI 10.1007/s00125-002-0803-z
   HARAGUCHI Y, 1994, J BIOL CHEM, V269, P9330
   Harper ME, 2001, BBA-BIOENERGETICS, V1504, P159, DOI 10.1016/S0005-2728(00)00244-9
   Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200
   Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200
   Johnston SD, 1997, MOL ENDOCRINOL, V11, P342, DOI 10.1210/me.11.3.342
   Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100
   Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000
   Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X
   Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698
   Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lenka N, 1998, PROG NUCLEIC ACID RE, V61, P309, DOI 10.1016/S0079-6603(08)60830-2
   Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Moyes CD, 2003, ANNU REV PHYSIOL, V65, P177, DOI 10.1146/annurev.physiol.65.092101.142705
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200
   Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400
   Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401
   Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270
   Vanacker JM, 1998, ONCOGENE, V17, P2429, DOI 10.1038/sj.onc.1202167
   Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   VILLENA JA, 1994, J BIOL CHEM, V269, P32649
   Villena JA, 2002, CELL MOL LIFE SCI, V59, P1934, DOI 10.1007/PL00012516
   Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1
   Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yang C, 1999, CANCER RES, V59, P4519
   Yang NY, 1996, J BIOL CHEM, V271, P5795, DOI 10.1074/jbc.271.10.5795
NR 47
TC 555
Z9 562
U1 0
U2 35
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 27
PY 2004
VL 101
IS 17
BP 6472
EP 6477
DI 10.1073/pnas.0308686101
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 816KD
UT WOS:000221107900028
PM 15087503
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, G
TI My two blues
SO FEBS LETTERS
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM gottfried.schatz@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD APR 23
PY 2004
VL 564
IS 1-2
BP 1
EP 3
DI 10.1016/S0014-5793(04)00330-8
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 815GY
UT WOS:000221032000001
PM 15094033
OA Bronze
DA 2021-01-25
ER

PT J
AU Haussinger, D
   Ahrens, T
   Aberle, T
   Engel, J
   Stetefeld, J
   Grzesiek, S
AF Haussinger, D
   Ahrens, T
   Aberle, T
   Engel, J
   Stetefeld, J
   Grzesiek, S
TI Proteolytic E-cadherin activation followed by solution NMR and X-ray
   crystallography
SO EMBO JOURNAL
LA English
DT Article
DE cellular adhesion; prodomain; protein dynamics; protein structure;
   proteolytic activation
ID CELL-ADHESION; LATERAL DIMERIZATION; HOMOPHILIC ADHESION; STRUCTURAL
   BASIS; CALCIUM; DOMAIN; HOMOASSOCIATION; BINDING
AB Cellular adhesion by classical cadherins depends critically on the exact proteolytic removal of their N-terminal prosequences. In this combined solution NMR and X-ray crystallographic study, the consequences of propeptide cleavage of an epithelial cadherin construct ( domains 1 and 2) were followed at atomic level. At low protein concentration, the N-terminal processing induces docking of the tryptophan-2 side-chain into a binding pocket on the same molecule. At high concentration, cleavage induces dimerization (K-D = 0.72 mM, k(off) = 0.7 s(-1)) and concomitant intermolecular exchange of the betaA-strands and the tryptophan-2 side-chains. Thus, the cleavage represents the switch from a nonadhesive to the functional form of cadherin.
C1 Univ Basel, Biozentrum, Div Biol Struct, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Kiel, Dept Biochem, Kiel, Germany.
RP Stetefeld, J (corresponding author), Univ Basel, Biozentrum, Div Biol Struct, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joerg.stetefeld@unibas.ch; stephan.grzesiek@unibas.ch
RI Stetefeld, Joerg/H-7630-2017; Haussinger, Daniel/C-6617-2016
OI Stetefeld, Joerg/0000-0003-1478-3248; Haussinger,
   Daniel/0000-0002-4798-0072; Grzesiek, Stephan/0000-0003-1998-4225
CR Alattia JR, 1997, FEBS LETT, V417, P405, DOI 10.1016/S0014-5793(97)01333-1
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559
   Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487
   Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Garrido F, 1991, Semin Cancer Biol, V2, P3
   Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3
   He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957
   Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624
   Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Leslie AGW, 1994, MOSFLM USERS GUIDE
   Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402
   Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0
   Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777
   OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937
   Ozawa M, 2002, J BIOL CHEM, V277, P19600, DOI 10.1074/jbc.M202029200
   OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645
   Perret E, 2002, EMBO J, V21, P2537, DOI 10.1093/emboj/21.11.2537
   Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738
   Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4
   Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579
   SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0
   Shapiro L, 1998, CURR OPIN NEUROBIOL, V8, P593, DOI 10.1016/S0959-4388(98)80086-X
   Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1
   Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x
   Troyanovsky RB, 1999, J CELL SCI, V112, P4379
   TURK D, 1992, THESIS TU MUNCHEN MU
NR 33
TC 97
Z9 100
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD APR 21
PY 2004
VL 23
IS 8
BP 1699
EP 1708
DI 10.1038/sj.emboj.7600192
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 821YO
UT WOS:000221499500003
PM 15071499
OA Green Published
DA 2021-01-25
ER

PT J
AU Heerklotz, H
AF Heerklotz, H
TI The microcalorimetry of lipid membranes
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Review
ID PRESSURE PERTURBATION CALORIMETRY; THERMOTROPIC PHASE-BEHAVIOR;
   ISOTHERMAL TITRATION CALORIMETRY; LIQUID-CRYSTALLINE TRANSITION; TROJAN
   PEPTIDE PENETRATIN; SCANNING MICROCALORIMETRY; AMPHIPATHIC PEPTIDES;
   BILAYER-MEMBRANES; BINDING MECHANISM; CURVATURE STRAIN
AB Insight into the forces governing a system is essential for understanding its behaviour and function. Calorimetric investigations provide a wealth of information that is not, or is hardly, available by other methods. This paper reviews calorimetric approaches and assays for the study of lipid vesicles (liposomes) and biological membranes. With respect to the instrumentation, differential scanning calorimetry (DSC), pressure perturbation calorimetry (PPC), isothermal titration calorimetry (ITC) and water sorption calorimetry are considered. Applications of these techniques to lipid systems include the measurement of thermodynamic parameters and a detailed characterization of the thermotropic, barotropic, and lyotropic phase behaviour. The membrane binding or partitioning of solutes (proteins, peptides, drugs, surfactants, ions, etc) can also be quantified. Many calorimetric assays are available for studying the effect of proteins and other additives on membranes, characterizing non-ideal mixing, domain formation, stability, curvature strain, permeability, solubilization, and fusion. Studies of membrane proteins in lipid environments elucidate lipid-protein interactions in membranes. The systems are described in terms of enthalpic and entropic forces, equilibrium constants, heat capacities, partial volume changes etc, shedding light also on the stability of structures and the molecular origin and mechanism of structural changes.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM heiko.heerklotz@unibas.ch
OI Heerklotz, Heiko/0000-0003-4615-7022
CR Albert AD, 1996, BBA-PROTEIN STRUCT M, V1297, P77, DOI 10.1016/0167-4838(96)00102-1
   Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1
   BAKRI A, 1993, THERMOMETRIC APPL NO
   Barreleiro PCA, 2000, J PHYS CHEM B, V104, P7795, DOI 10.1021/jp000636c
   BAUERLE HD, 1991, BIOCHEMISTRY-US, V30, P7203, DOI 10.1021/bi00243a023
   BESCHIASCHVILI G, 1992, BIOCHEMISTRY-US, V31, P10044, DOI 10.1021/bi00156a026
   BHAKOO M, 1988, BIOCHIM BIOPHYS ACTA, V945, P307, DOI 10.1016/0005-2736(88)90493-2
   Binder H, 1999, J COLLOID INTERF SCI, V220, P235, DOI 10.1006/jcis.1999.6501
   Binder H, 2003, PHYS CHEM CHEM PHYS, V5, P5108, DOI 10.1039/b309667j
   Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8
   Binder H, 1999, CHEM PHYS LETT, V304, P329, DOI 10.1016/S0009-2614(99)00355-3
   Binder H, 2000, J PHYS CHEM B, V104, P12049, DOI 10.1021/jp0011802
   BLUME A, 1992, BIOCHEMISTRY-US, V31, P4636, DOI 10.1021/bi00134a014
   BLUME A, 1983, BIOCHEMISTRY-US, V22, P5436, DOI 10.1021/bi00292a027
   BLUME A, 1980, BIOCHEMISTRY-US, V19, P4908, DOI 10.1021/bi00562a032
   BOTTNER M, 1993, BIOPHYS J, V65, P2041, DOI 10.1016/S0006-3495(93)81254-2
   Cevc G., 1985, PHOSPHOLIPID BILAYER
   Cevc G., 1993, PHOSPHOLIPIDS HDB
   CHAPMAN D, 1974, J BIOL CHEM, V249, P2512
   Chellani Mohan, 1999, American Biotechnology Laboratory, V17, P18
   Chen L, 1995, METHOD ENZYMOL, V259, P169
   Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c
   Ebel H, 2001, J PHYS CHEM B, V105, P7353, DOI 10.1021/jp010515s
   Epand RF, 1999, BIOCHEMISTRY-US, V38, P454, DOI 10.1021/bi981893z
   Epand RM, 2002, BIOCHEM J, V365, P841, DOI 10.1042/BJ20020290
   EPAND RM, 1994, BIOPHYS J, V66, P1450, DOI 10.1016/S0006-3495(94)80935-X
   EPAND RM, 1988, BIOCHIM BIOPHYS ACTA, V945, P161, DOI 10.1016/0005-2736(88)90478-6
   FLOGEL M, 1975, BIOCHEMISTRY-US, V14, P2610, DOI 10.1021/bi00683a008
   FOHT PJ, 1995, BIOCHEMISTRY-US, V34, P13811, DOI 10.1021/bi00042a012
   Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.3.CO;2-F
   Giorgione JR, 1998, BIOCHEMISTRY-US, V37, P10956, DOI 10.1021/bi980185a
   Grabitz P, 2002, BIOPHYS J, V82, P299, DOI 10.1016/S0006-3495(02)75395-2
   GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665
   Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9
   Haynie D. T., 2001, BIOL THERMODYNAMICS
   Heerklotz H, 1996, J PHYS CHEM-US, V100, P6764, DOI 10.1021/jp9523534
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8
   Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7
   Heerklotz H, 1997, J PHYS CHEM B, V101, P639, DOI 10.1021/jp962342q
   Heerklotz H, 2002, BIOPHYS J, V82, P1445, DOI 10.1016/S0006-3495(02)75498-2
   Heerklotz H, 2001, BIOPHYS J, V81, P184, DOI 10.1016/S0006-3495(01)75690-1
   Heerklotz H, 2001, BIOPHYS J, V80, P271, DOI 10.1016/S0006-3495(01)76012-2
   HEERKLOTZ H, 1995, CHEM PHYS LETT, V235, P517, DOI 10.1016/0009-2614(95)00139-U
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   HEERKLOTZ H, 2004, PHOSPHOLIPIDS HDB
   Heerklotz HH, 1999, BIOPHYS J, V76, P2606, DOI 10.1016/S0006-3495(99)77413-8
   Heerklotz HH, 1998, BIOCALORIMETRY, P89
   Heerklotz HH, 1998, J PHYS CHEM B, V102, P5363, DOI 10.1021/jp980884x
   Heimburg T, 1999, BIOPHYS J, V76, P2575, DOI 10.1016/S0006-3495(99)77410-2
   HEIMBURG T, 1994, BIOCHEMISTRY-US, V33, P9477, DOI 10.1021/bi00198a013
   Heimburg T, 2001, BIOPHYS J, V80, p502A
   HEYN MP, 1981, BIOCHEMISTRY-US, V20, P7109, DOI 10.1021/bi00528a009
   Hildebrand A, 2002, LANGMUIR, V18, P2836, DOI 10.1021/la011421c
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   Ivanova VP, 2003, BIOPHYS J, V84, P2427, DOI 10.1016/S0006-3495(03)75047-4
   Johann C, 1996, BIOPHYS J, V71, P3215, DOI 10.1016/S0006-3495(96)79515-2
   JOHNSON ML, 1986, METHOD ENZYMOL, V130, P534
   Keller M, 1997, BBA-BIOMEMBRANES, V1326, P178, DOI 10.1016/S0005-2736(97)00022-9
   Kodama M, 1997, BBA-BIOMEMBRANES, V1329, P61, DOI 10.1016/S0005-2736(97)00086-2
   KOYNOVA R, 1995, BBA-LIPID LIPID MET, V1255, P213, DOI 10.1016/0005-2760(94)00202-A
   KOYNOVA R, 1994, CHEM PHYS LIPIDS, V69, P181, DOI 10.1016/0009-3084(94)90001-9
   Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9
   KOYNOVA R, 1994, CHEM PHYS LIPIDS, V69, P1, DOI 10.1016/0009-3084(94)90024-8
   Kujawa P, 2001, MACROMOLECULES, V34, P4130, DOI 10.1021/ma002082h
   LADBROOKE BD, 1969, CHEM PHYS LIPIDS, V3, P304, DOI 10.1016/0009-3084(69)90040-1
   LADBURY JE, 2003, BIOCALORIMETRY, V2
   LANDWEHR A, 1994, BER BUNSEN PHYS CHEM, V98, P214, DOI 10.1002/bbpc.19940980214
   LEE AG, 1977, BIOCHIM BIOPHYS ACTA, V472, P285, DOI 10.1016/0304-4157(77)90001-6
   Leharne SA, 1998, BIOCALORIMETRY, P157
   LEHRMANN R, 1994, BBA-BIOMEMBRANES, V1189, P89, DOI 10.1016/0005-2736(94)90284-4
   Lerchner J, 1999, J THERM ANAL CALORIM, V57, P241, DOI 10.1023/A:1010152517237
   Lin LN, 2002, ANAL BIOCHEM, V302, P144, DOI 10.1006/abio.2001.5524
   LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025
   LIOPOWSKY R, 1995, STRUCTURE DYNAMICS M
   Liu F, 2001, BIOCHEMISTRY-US, V40, P760, DOI 10.1021/bi001942j
   Lobo BA, 2003, BIOPHYS CHEM, V104, P67, DOI 10.1016/S0301-4622(02)00339-3
   Lohner K, 1997, BIOCHEMISTRY-US, V36, P1525, DOI 10.1021/bi961300p
   Machaidze G, 2002, BIOCHEMISTRY-US, V41, P1965, DOI 10.1021/bi015841c
   Majhi PR, 2002, J PHYS CHEM B, V106, P10753, DOI 10.1021/jp025849b
   Mannock DA, 2003, BIOPHYS J, V84, P1038, DOI 10.1016/S0006-3495(03)74920-0
   Markova N, 2001, THERMOCHIM ACTA, V374, P93, DOI 10.1016/S0040-6031(01)00476-2
   Markova N, 2000, J PHYS CHEM B, V104, P8053, DOI 10.1021/jp001020q
   MCMULLEN TPW, 1995, BBA-BIOMEMBRANES, V1234, P90, DOI 10.1016/0005-2736(94)00266-R
   MCMULLEN TPW, 1993, BIOCHEMISTRY-US, V32, P516, DOI 10.1021/bi00053a016
   MORIN PE, 1991, BIOCHEMISTRY-US, V30, P8494, DOI 10.1021/bi00098a030
   MOUNTCASTLE DB, 1978, P NATL ACAD SCI USA, V75, P4906, DOI 10.1073/pnas.75.10.4906
   NEBEL S, 1995, BIOCHEMISTRY-US, V34, P5705, DOI 10.1021/bi00017a001
   Nebel S, 1997, BIOCHEMISTRY-US, V36, P2853, DOI 10.1021/bi961839n
   Nyholm TKM, 2003, BIOPHYS J, V84, P3138, DOI 10.1016/S0006-3495(03)70038-1
   Ollivon M R, 1991, Adv Exp Med Biol, V302, P175
   Opatowski E, 1997, BIOPHYS J, V73, P1448, DOI 10.1016/S0006-3495(97)78177-3
   PARSEGIAN VA, 1995, HDB BIOL PHYS, P644
   Patel DR, 2001, BIOCHEMISTRY-US, V40, P7054, DOI 10.1021/bi010345+
   Pfeiffer H, 2003, BBA-BIOMEMBRANES, V1609, P148, DOI 10.1016/S0005-2736(02)00665-X
   Plotnikov VV, 1997, ANAL BIOCHEM, V250, P237, DOI 10.1006/abio.1997.2236
   PRASAD SK, 1987, CHEM PHYS LIPIDS, V43, P227
   Prenner EJ, 1999, BBA-BIOMEMBRANES, V1417, P211, DOI 10.1016/S0005-2736(99)00004-8
   PRIVALOV G, 1995, ANAL BIOCHEM, V232, P79, DOI 10.1006/abio.1995.9957
   PRUZAN P, 1976, REV SCI INSTRUM, V47, P66, DOI 10.1063/1.1134493
   Randzio SL, 2003, THERMOCHIM ACTA, V398, P75, DOI 10.1016/S0040-6031(02)00366-0
   RANDZIO SL, 1994, REV SCI INSTRUM, V65, P960, DOI 10.1063/1.1144926
   Randzio SL, 1997, J THERM ANAL CALORIM, V48, P573, DOI 10.1007/BF01979504
   Ravoo BJ, 2000, CELL BIOL INT, V24, P787, DOI 10.1006/cbir.2000.0628
   Rexroad J, 2003, J PHARM SCI, V92, P665, DOI 10.1002/jps.10340
   Rowe ES, 1998, BIOCHEMISTRY-US, V37, P2430, DOI 10.1021/bi9721602
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   SEELIG J, 1991, BIOCHEMISTRY-US, V30, P9354, DOI 10.1021/bi00102a031
   Shnyrov VL, 1997, ARCH BIOCHEM BIOPHYS, V341, P89, DOI 10.1006/abbi.1997.9953
   Shnyrov VL, 1997, THERMOCHIM ACTA, V302, P165, DOI 10.1016/S0040-6031(97)00238-4
   Smith AL, 2002, BBA-PROTEIN STRUCT M, V1594, P150, DOI 10.1016/S0167-4838(01)00298-9
   STEFFAN G, 1994, CHEM PHYS LIPIDS, V74, P141, DOI 10.1016/0009-3084(94)90055-8
   Suurkuusk M, 1998, CHEM PHYS LIPIDS, V94, P119, DOI 10.1016/S0009-3084(98)00052-8
   Takahashi H, 1998, THERMOCHIM ACTA, V308, P85, DOI 10.1016/S0040-6031(97)00453-X
   TAMPE R, 1991, BIOCHEMISTRY-US, V30, P4909, DOI 10.1021/bi00234a011
   TERZI E, 1994, BIOCHEMISTRY-US, V33, P7434, DOI 10.1021/bi00189a051
   VANOSDOL WW, 1992, BIOPHYS J, V63, P1011, DOI 10.1016/S0006-3495(92)81674-0
   VANOSDOL WW, 1991, BIOPHYS J, V59, P775, DOI 10.1016/S0006-3495(91)82290-1
   VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021
   Wadso I, 1997, CHEM SOC REV, V26, P79, DOI 10.1039/cs9972600079
   Wang SL, 2004, CHEM PHYS LIPIDS, V129, P21, DOI 10.1016/j.chemphyslip.2003.09.017
   Wenk MR, 1997, BIOPHYS J, V73, P2565, DOI 10.1016/S0006-3495(97)78285-7
   Wenk MR, 1996, J PHARM SCI-US, V85, P228, DOI 10.1021/js950120i
   Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n
   Wenk MR, 1998, BBA-BIOMEMBRANES, V1372, P227, DOI 10.1016/S0005-2736(98)00059-5
   Wenk MR, 1997, J PHYS CHEM B, V101, P5224, DOI 10.1021/jp9707955
   Westh P, 2001, BIOPHYS CHEM, V89, P53, DOI 10.1016/S0301-4622(00)00218-0
   Wieprecht T, 2002, BIOPHYS CHEM, V96, P191, DOI 10.1016/S0301-4622(02)00025-X
   Wieprecht T, 2002, CURR TOP MEMBR, V52, P31
   Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k
   WIESLANDER A, 1982, REV INFECT DIS, V4, pS43
   Winter A, 1996, CHEM PHYS LIPIDS, V81, P21, DOI 10.1016/0009-3084(96)02529-7
   Winter R, 2001, CURR OPIN COLLOID IN, V6, P303, DOI 10.1016/S1359-0294(01)00092-9
   ZHANG FL, 1992, BIOCHEMISTRY-US, V31, P2005, DOI 10.1021/bi00122a016
   Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6
   Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805
NR 139
TC 76
Z9 77
U1 2
U2 56
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
EI 1361-648X
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD APR 21
PY 2004
VL 16
IS 15
BP R441
EP R467
AR PII S0953-8984(04)59359-1
DI 10.1088/0953-8984/16/15/R01
PG 27
WC Physics, Condensed Matter
SC Physics
GA 818VL
UT WOS:000221272500005
DA 2021-01-25
ER

PT J
AU Barde, YA
AF Barde, YA
TI Death of injured neurons caused by the precursor of nerve growth factor
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Editorial Material
ID NEUROTROPHIC FACTOR; ALZHEIMERS-DISEASE; MESSENGER-RNA; CELL-DEATH;
   BRAIN; RECEPTOR; SYSTEM; MICROGLIA; INDUCTION; BDNF
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Barde, Yves/F-6019-2011
OI Barde, Yves/0000-0002-7627-461X
CR Aisen PS, 2002, LANCET NEUROL, V1, P279, DOI 10.1016/S1474-4422(02)00133-3
   Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016
   Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8
   Frade JM, 1996, NATURE, V383, P166
   Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101
   JUNGBLUTH S, 1994, EUR J BIOCHEM, V221, P677, DOI 10.1111/j.1432-1033.1994.tb18780.x
   KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x
   Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7
   Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057
   Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8
   MEYER M, 1992, J CELL BIOL, V119, P45, DOI 10.1083/jcb.119.1.45
   Mowla SJ, 1999, J NEUROSCI, V19, P2069
   Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0
   Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004
   RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899
   Sedel F, 2004, J NEUROSCI, V24, P2236, DOI 10.1523/JNEUROSCI.4464-03.2004
   Taylor AR, 2004, NEURON, V41, P491, DOI 10.1016/S0896-6273(04)00079-0
   Terry AV, 2003, J PHARMACOL EXP THER, V306, P821, DOI 10.1124/jpet.102.041616
   THOENEN H, 1991, ANN NY ACAD SCI, V640, P86
NR 23
TC 9
Z9 9
U1 0
U2 0
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 20
PY 2004
VL 101
IS 16
BP 5703
EP 5704
DI 10.1073/pnas.0401374101
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 814ME
UT WOS:000220978000004
PM 15079062
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Sanchez, IE
   Morillas, M
   Zobeley, E
   Kiefhaber, T
   Glockshuber, R
AF Sanchez, IE
   Morillas, M
   Zobeley, E
   Kiefhaber, T
   Glockshuber, R
TI Fast folding of the two-domain Semliki forest virus capsid protein
   explains co-translational proteolytic activity
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; co-translational folding; semliki Forest virus
   protease; two-domain proteins; prolyl isomerization
ID MECHANISM; KINETICS; ISOMERIZATION; TRANSLOCATION; DENATURATION;
   ALPHAVIRUSES; LYSOZYME; BARRIERS; BEHAVIOR
AB The capsid protein of Semliki Forest virus constitutes the N-terminal part of a large viral polyprotein. It consists of an unstructured basic segment (residues 1-118) and a 149 residue serine protease module (SFVP, residues 119-267) comprised of two P-barrel domains. Previous in vivo and in vitro translation experiments have demonstrated that SFVP folds co-translationally during synthesis of the viral polyprotein and rapidly cleaves itself off the nascent chain. To test whether fast co-translation folding of SFVP is an intrinsic property of the polypeptide chain or whether folding is accelerated by cellular components, we investigated spontaneous folding of recombinant SFVP in vitro. The results show that the majority of unfolded SFVP molecules fold faster than any previously studied two-domain protein (tau = 50 ms), and that folding of the N-terminal domain precedes structure formation of the C-terminal domain. This shows that co-translational folding of SFVP does not require additional cellular components and suggests that rapid folding is the result of molecular evolution towards efficient virus biogenesis. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Biophys Chem Abt, CH-4056 Basel, Switzerland.
   ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.
RP Glockshuber, R (corresponding author), Univ Basel, Biozentrum, Biophys Chem Abt, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch; rudi@mol.biol.ethz.ch
RI Kiefhaber, Thomas/A-3028-2010
OI Sanchez, Ignacio Enrique/0000-0003-4284-9013; Morillas,
   Manuel/0000-0002-6489-6737
CR AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4586, DOI 10.1021/bi00839a053
   BALBACH J, 2000, PROTEIN FOLDING FRON, P212
   BIERI O., 2000, MECH PROTEIN FOLDING, P34
   BOEGE U, 1981, VIROLOGY, V113, P293, DOI 10.1016/0042-6822(81)90156-2
   BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401
   BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026
   Choi HK, 1997, PROTEINS, V27, P345, DOI 10.1002/(SICI)1097-0134(199703)27:3<345::AID-PROT3>3.0.CO;2-C
   CHRUNYK BA, 1990, BIOCHEMISTRY-US, V29, P2149, DOI 10.1021/bi00460a027
   Creighton TE, 1997, BIOL CHEM, V378, P731
   Demeler B, 1998, BIOPHYS J, V74, P444, DOI 10.1016/S0006-3495(98)77802-6
   FISCHER G, 1990, BIOCHEMISTRY-US, V29, P2205, DOI 10.1021/bi00461a001
   Golbik R, 1999, PROTEIN SCI, V8, P1505, DOI 10.1110/ps.8.7.1505
   HAGERMAN PJ, 1976, BIOCHEMISTRY-US, V15, P1462, DOI 10.1021/bi00652a017
   IKAI A, 1973, J MOL BIOL, V73, P145, DOI 10.1016/0022-2836(73)90320-3
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   Jaenicke R, 1999, PROG BIOPHYS MOL BIO, V71, P155, DOI 10.1016/S0079-6107(98)00032-7
   JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3
   KIEFHABER T, 1995, P NATL ACAD SCI USA, V92, P9029, DOI 10.1073/pnas.92.20.9029
   Kiefhaber T, 1995, Methods Mol Biol, V40, P313
   KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8
   Kolb VA, 2000, J BIOL CHEM, V275, P16597, DOI 10.1074/jbc.M002030200
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8
   Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013
   Martin A, 2003, J MOL BIOL, V331, P1131, DOI 10.1016/S0022-2836(03)00864-7
   Martin A, 2003, J MOL BIOL, V329, P599, DOI 10.1016/S0022-2836(03)00433-9
   Moore JW, 1981, KINETICS MECH
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Nicola AV, 1999, NAT CELL BIOL, V1, P341
   Pappenberger G, 2001, NAT STRUCT BIOL, V8, P452, DOI 10.1038/87624
   Parker MJ, 1996, BIOCHEMISTRY-US, V35, P15740, DOI 10.1021/bi961330s
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   RUDOLPH R, 1990, P NATL ACAD SCI USA, V87, P4625, DOI 10.1073/pnas.87.12.4625
   Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   SANCHEZ IE, 2003, BIOPHYS CHEM, V325, P367
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Scherer G, 1998, J AM CHEM SOC, V120, P5568, DOI 10.1021/ja980181t
   Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804
   Schmid Franz X., 1992, P197
   SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Szabo Z. G., 1969, COMPREHENSIVE CHEM K, V2, P1
   Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9
NR 44
TC 31
Z9 31
U1 0
U2 7
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 16
PY 2004
VL 338
IS 1
BP 159
EP 167
DI 10.1016/j.jmb.2004.02.037
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 811HI
UT WOS:000220762600014
PM 15050831
DA 2021-01-25
ER

PT J
AU Heerklotz, H
   Wieprecht, T
   Seelig, J
AF Heerklotz, H
   Wieprecht, T
   Seelig, J
TI Membrane perturbation by the lipopeptide surfactin and detergents as
   studied by deuterium
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID PHOSPHATIDYLCHOLINE MODEL MEMBRANES; MAGNETIC-RESONANCE SPECTROSCOPY;
   FATTY ACYL CHAINS; X-RAY-DIFFRACTION; ANTIMICROBIAL PEPTIDES;
   PHOSPHOLIPID-BILAYERS; TITRATION CALORIMETRY; NEUTRON-DIFFRACTION;
   BACILLUS-SUBTILIS; AMPHIPATHIC PEPTIDES
AB Surfactin is a lipopeptide produced by bacillus subtilis, which has been shown to permeabilize cell and model membranes by all unspecific mechanism often referred to as detergent-like. We have compared the structural effects of surfactin oil lipid membranes with those of two nonionic detergents, C12EO6 and C12EO8, by means of solid-state NMR of selectively deuterated lipids. The detergents exhibit the expected behavior of increasing the lateral pressure in the headgroup region and disordering the acyl chains. In contrast, the strong activity of surfactin to destabilize membranes is not reflected in an extreme disordering of the fatty acyl chains. However, surfactin tilts the acyl chains of the lipid and leads to a reorientation of the lipid headgroup toward the membrane interior. These effects provide evidence for a rather deep insertion of the peptide moiety into the hydrophobic-hydrophilic interface of the membrane. The results are discussed in terms of the molecular parameters governing the activity of a molecule to destabilize lipid membranes and the activity of antibiotic peptides to induce unspecific leakage of membranes.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM heiko.heerklotz@unibas.ch
OI Heerklotz, Heiko/0000-0003-4615-7022
CR ARIMA K, 1968, BIOCHEM BIOPH RES CO, V31, P488, DOI 10.1016/0006-291X(68)90503-2
   Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9
   Beven L, 1997, RES MICROBIOL, V148, P163, DOI 10.1016/S0923-2508(97)87647-4
   BONMATIN JM, 1992, BIOCHIMIE, V74, P825, DOI 10.1016/0300-9084(92)90065-M
   BULDT G, 1978, NATURE, V271, P182, DOI 10.1038/271182a0
   BULDT G, 1979, J MOL BIOL, V134, P673, DOI 10.1016/0022-2836(79)90479-0
   DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2
   Deleu M, 2003, LANGMUIR, V19, P3377, DOI 10.1021/la026543z
   EDWARDS K, 1991, J COLLOID INTERF SCI, V147, P1, DOI 10.1016/0021-9797(91)90129-V
   GALLY HU, 1975, BIOCHEMISTRY-US, V14, P3647, DOI 10.1021/bi00687a021
   Grau A, 1999, BBA-BIOMEMBRANES, V1418, P307, DOI 10.1016/S0005-2736(99)00039-5
   Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9
   HEEKLOTZ H, 2001, J BIOPHYS J, V81, P1547
   Heerklotz H, 1996, J PHYS CHEM-US, V100, P6764, DOI 10.1021/jp9523534
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 1997, J PHYS CHEM B, V101, P639, DOI 10.1021/jp962342q
   Heerklotz H, 2001, BIOPHYS J, V81, P184, DOI 10.1016/S0006-3495(01)75690-1
   Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840
   ISREALACHVILI JN, 1991, INTERMOLECULAR SURFA
   KAMEDA Y, 1974, CHEM PHARM BULL, V22, P938
   Klose G, 1999, J PHYS CHEM B, V103, P3022, DOI 10.1021/jp983528n
   Kracht M, 1999, J ANTIBIOT, V52, P613, DOI 10.7164/antibiotics.52.613
   Kragh-Hansen U, 1998, BIOPHYS J, V75, P2932, DOI 10.1016/S0006-3495(98)77735-5
   Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0
   Lantzsch G, 1996, BIOPHYS CHEM, V58, P289, DOI 10.1016/0301-4622(95)00108-5
   Lohner K, 1999, BBA-BIOMEMBRANES, V1462, P141, DOI 10.1016/S0005-2736(99)00204-7
   LOHNER K, 1997, ADV BIOPH C, V6, P53
   MACDONALD PM, 1991, BIOCHEMISTRY-US, V30, P3558, DOI 10.1021/bi00228a029
   MATSUZAKI K, 1994, BIOCHEMISTRY-US, V33, P3342, DOI 10.1021/bi00177a027
   Matsuzaki K, 1998, BIOCHEMISTRY-US, V37, P11856, DOI 10.1021/bi980539y
   Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2
   OTTEN D, 1995, BIOPHYS J, V68, P584, DOI 10.1016/S0006-3495(95)80220-1
   Otten D, 2000, J PHYS CHEM B, V104, P12119, DOI 10.1021/jp001505e
   SCHERER PG, 1989, BIOCHEMISTRY-US, V28, P7720, DOI 10.1021/bi00445a030
   Schote U, 2002, J PHARM SCI, V91, P856, DOI 10.1002/jps.10071
   SEELIG A, 1975, BIOCHIM BIOPHYS ACTA, V406, P1, DOI 10.1016/0005-2736(75)90037-1
   SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024
   SEELIG A, 2002, ENCY PHYS SCI TECHNO, V9, P335
   SEELIG J, 1978, BIOCHEMISTRY-US, V17, P3310, DOI 10.1021/bi00609a021
   SEELIG J, 1987, BIOCHEMISTRY-US, V26, P7535, DOI 10.1021/bi00398a001
   SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948
   SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457
   THURMOND RL, 1994, J PHYS CHEM-US, V98, P972, DOI 10.1021/j100054a038
   Vollenbroich D, 1997, BIOLOGICALS, V25, P289, DOI 10.1006/biol.1997.0099
   Vollenbroich D, 1997, APPL ENVIRON MICROB, V63, P44, DOI 10.1128/AEM.63.1.44-49.1997
   Wenk MR, 1997, J PHYS CHEM B, V101, P5224, DOI 10.1021/jp9707955
   WENK MR, 1997, J BIOPHYS J, V72, pTH331
   Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268
   Wiese A, 1998, J MEMBRANE BIOL, V162, P127, DOI 10.1007/s002329900350
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
   Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4
   ZACCAI G, 1979, J MOL BIOL, V134, P693, DOI 10.1016/0022-2836(79)90480-7
   1999, BIOCH BIOPHYS ACTA, V1462
NR 53
TC 43
Z9 45
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD APR 15
PY 2004
VL 108
IS 15
BP 4909
EP 4915
DI 10.1021/jp0371938
PG 7
WC Chemistry, Physical
SC Chemistry
GA 810ST
UT WOS:000220724700050
DA 2021-01-25
ER

PT J
AU Dietrich, FS
   Voegeli, S
   Brachat, S
   Lerch, A
   Gates, K
   Steiner, S
   Mohr, C
   Pohlmann, R
   Luedi, P
   Choi, SD
   Wing, RA
   Flavier, A
   Gaffney, TD
   Phillippsen, P
AF Dietrich, FS
   Voegeli, S
   Brachat, S
   Lerch, A
   Gates, K
   Steiner, S
   Mohr, C
   Pohlmann, R
   Luedi, P
   Choi, SD
   Wing, RA
   Flavier, A
   Gaffney, TD
   Phillippsen, P
TI The Ashbya gossypii genome as a tool for mapping the ancient
   Saccharomyces cerevisiae genome
SO SCIENCE
LA English
DT Article
ID SEQUENCE; TRANSFORMATION; DUPLICATION; EVOLUTION; GENES
AB We have sequenced and annotated the genome of the filamentous ascomycete Ashbya gossypii. With a size of only 9.2 megabases, encoding 4718 protein-coding genes, it is the smallest genome of a free-living eukaryote yet characterized. More than 90% of A. gossypii genes show both homology and a particular pattern of synteny with Saccharomyces cerevisiae. Analysis of this pattern revealed 300 inversions and translocations that have occurred since divergence of these two species. It also provided compelling evidence that the evolution of S. cerevisiae included a whole genome duplication or fusion of two related species and showed, through inferred ancient gene orders, which of the duplicated genes lost one copy and which retained both copies.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Duke Univ, Med Ctr, Dept Microbiol & Mol Genet, Durham, NC 27710 USA.
   Syngenta Biotechnol Inc, Res Triangle Pk, NC 27709 USA.
   Clemson Univ, Dept Agron, Clemson, SC 29634 USA.
   Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.
RP Phillippsen, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Peter.philippsen@unibas.ch
RI Wing, Rod A/Z-2885-2019; Lerch, Anita/AAR-4467-2020
OI Wing, Rod A/0000-0001-6633-6226; Lerch, Anita/0000-0003-3062-5901;
   Brachat, Sophie/0000-0002-3398-8225
CR Alberti-Segui C, 2001, J CELL SCI, V114, P975
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   BELL SP, 1995, CELL, V83, P563, DOI 10.1016/0092-8674(95)90096-9
   Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418
   Fischer G, 2000, NATURE, V405, P451
   Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554
   Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546
   KELLIS M, 2004, IN PRESS NATURE
   KNECHTLE P, 1993, MOL BIOL CELL, V14, P4140
   LALO D, 1993, CR ACAD SCI III-VIE, V316, P367
   Philippsen P, 1997, NATURE, V387, P93, DOI 10.1038/387s093
   Stahmann KP, 2000, APPL MICROBIOL BIOT, V53, P509, DOI 10.1007/s002530051649
   STEINER S, 1995, GENETICS, V140, P973
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2001, GENETICS, V157, P601
   Wendland J, 1999, CURR GENET, V35, P618, DOI 10.1007/s002940050460
   Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711
   Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724
   WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z
NR 20
TC 484
Z9 1425
U1 0
U2 29
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 9
PY 2004
VL 304
IS 5668
BP 304
EP 307
DI 10.1126/science.1095781
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 810QS
UT WOS:000220719400051
PM 15001715
DA 2021-01-25
ER

PT J
AU Guthe, S
   Kapinos, L
   Moglich, A
   Meier, S
   Grzesiek, S
   Kiefhaber, T
AF Guthe, S
   Kapinos, L
   Moglich, A
   Meier, S
   Grzesiek, S
   Kiefhaber, T
TI Very fast folding and association of a trimerization domain from
   bacteriophage T4 fibritin
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; protein association; trimeric proteins; prolyl
   isomerization; fast folding
ID SEGMENTED COILED-COIL; ALPHA-CHYMOTRYPSIN; PROTEIN; MECHANISM;
   STABILIZATION; RIBONUCLEASE; REPRESSOR; DIFFUSION; BARRIERS; KINETICS
AB The foldon domain constitutes the C-terminal 30 amino acid residues of the trimeric protein fibritin from bacteriophage T4. Its function is to promote folding and trimerization of fibritin. We investigated structure, stability and folding mechanism of the isolated foldon domain. The domain folds into the same trimeric beta-propeller structure as in fibritin and undergoes a two-state unfolding transition from folded trimer to unfolded monomers. The folding kinetics involve several consecutive reactions. Structure formation in the region of the single beta-hairpin of each monomer occurs on the submillisecond timescale. This reaction is followed by two consecutive association steps with rate constants of 1.9(+/-0.5) x 10(6) M-1 s(-1) and 5.4(+/-0.3) x 10(6) M-1 s(-1) at 0.58 M GdmCl, respectively. This is similar to the fastest reported bimolecular association reactions for folding of dimeric proteins. At low concentrations of protein, folding shows apparent third-order kinetics. At high concentrations of protein, the reaction becomes almost independent of protein concentrations with a half-time of about 3 ms, indicating that a first-order folding step from a partially folded trimer to the native protein (k = 210(+/-20) s(-1)) becomes rate-limiting. Our results suggest that all steps on the folding/ trimerization pathway of the foldon domain are evolutionarily optimized for rapid and specific initiation of trimer formation during fibritin assembly. The results further show that beta-hairpins allow efficient and rapid protein-protein interactions during folding. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010; Meier, Sebastian/A-4279-2015
OI Meier, Sebastian/0000-0003-3761-3217; Grzesiek,
   Stephan/0000-0003-1998-4225; Moglich, Andreas/0000-0002-7382-2772
CR Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   BIERI O., 2000, MECH PROTEIN FOLDING, P34
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   Boudko SP, 2002, EUR J BIOCHEM, V269, P833, DOI 10.1046/j.1432-1033.2002.02734.x
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Gloss LM, 1998, BIOCHEMISTRY-US, V37, P15990, DOI 10.1021/bi981511p
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   Gutfreund H, 1995, KINETICS LIFE SCI
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3
   Kahmann JD, 2003, EMBO J, V22, P1824, DOI 10.1093/emboj/cdg181
   Kiefhaber T, 1995, Methods Mol Biol, V40, P313
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011
   Moore JW, 1981, KINETICS MECH
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Pace C N, 1986, Methods Enzymol, V131, P266
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013
   Seckler R., 2000, MECH PROTEIN FOLDING, P279
   Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X
   TANFORD C, 1968, ADV PROTEIN CHEM, V23, P218
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Wagner C, 1999, P NATL ACAD SCI USA, V96, P6716, DOI 10.1073/pnas.96.12.6716
   Waldburger CD, 1996, P NATL ACAD SCI USA, V93, P2629, DOI 10.1073/pnas.93.7.2629
   WENDT H, 1995, BIOCHEMISTRY-US, V34, P4097, DOI 10.1021/bi00012a028
   ZITZEWITZ JA, 1995, BIOCHEMISTRY-US, V34, P12812, DOI 10.1021/bi00039a042
   Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507
NR 37
TC 62
Z9 63
U1 3
U2 22
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 2
PY 2004
VL 337
IS 4
BP 905
EP 915
DI 10.1016/j.jmb.2004.02.020
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 807QH
UT WOS:000220515500011
PM 15033360
DA 2021-01-25
ER

PT J
AU Seifritz, E
   Di Salle, F
   Esposito, F
   Luthi, A
   Seelig, J
   Dammann, G
AF Seifritz, E
   Di Salle, F
   Esposito, F
   Luthi, A
   Seelig, J
   Dammann, G
TI Functional MRI and Borderline Personality Disorder
SO EUROPEAN PSYCHIATRY
LA English
DT Meeting Abstract
C1 Univ Basel, Dept Psychiat, CH-4003 Basel, Switzerland.
   Univ Naples Federico II, Div Neuroradiol, Naples, Italy.
   Univ Naples 2, Div Neurol 2, Naples, Italy.
   Friedrich Miescher Inst, CH-4002 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0924-9338
J9 EUR PSYCHIAT
JI Eur. Psychiat.
PD APR
PY 2004
VL 19
SU 1
BP 1S
EP 2S
DI 10.1016/j.eurpsy.2004.01.002
PG 2
WC Psychiatry
SC Psychiatry
GA 814AS
UT WOS:000220948200004
DA 2021-01-25
ER

PT J
AU Schmid, MC
   Schulein, R
   Dehio, M
   Denecker, G
   Carena, I
   Dehio, C
AF Schmid, MC
   Schulein, R
   Dehio, M
   Denecker, G
   Carena, I
   Dehio, C
TI The VirB type IV secretion system of Bartonella henselae mediates
   invasion, proinflammatory activation and antiapoptotic protection of
   endothelial cells
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID PROLIFERATION; ERYTHROCYTES; MACROPHAGES; APOPTOSIS; INDUCTION;
   INFECTION; ANTIGEN; OPERON
AB Bartonella henselae is an arthropod-borne zoonotic pathogen causing intraerythrocytic bacteraemia in the feline reservoir host and a broad range of clinical manifestations in incidentally infected humans. Remarkably, B. henselae can specifically colonize the human vascular endothelium, resulting in inflammation and the formation of vasoproliferative lesions known as bacillary angiomatosis and bacillary peliosis. Cultured human endothelial cells provide an in vitro system to study this intimate interaction of B. henselae with the vascular endothelium. However, little is known about the bacterial virulence factors required for this pathogenic process. Recently, we identified the type IV secretion system (T4SS) VirB as an essential pathogenicity factor in Bartonella, required to establish intraerythrocytic infection in the mammalian reservoir. Here, we demonstrate that the VirB T4SS also mediates most of the virulence attributes associated with the interaction of B. henselae during the interaction with human endothelial cells. These include: (i) massive rearrangements of the actin cytoskeleton, resulting in the formation of bacterial aggregates and their internalization by the invasome structure; (ii) nuclear factor kappaB-dependent proinflammatory activation, leading to cell adhesion molecule expression and chemokine secretion, and (iii) inhibition of apoptotic cell death, resulting in enhanced endothelial cell survival. Moreover, we show that the VirB system mediates cytostatic and cytotoxic effects at high bacterial titres, which interfere with a potent VirB-independent mitogenic activity. We conclude that the VirB T4SS is a major virulence determinant of B. henselae, required for targeting multiple endothelial cell functions exploited by this vasculotropic pathogen.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019; Denecker,
   Geertrui/E-8134-2010
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Schmid, Michael/0000-0002-3445-0013;
   Denecker, Geertrui/0000-0002-2515-2911
CR ANDERSON B, 1995, J CLIN MICROBIOL, V33, P2358, DOI 10.1128/JCM.33.9.2358-2365.1995
   Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x
   CONLEY T, 1994, J LAB CLIN MED, V124, P521
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9
   Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1
   Karem KL, 2000, MICROBES INFECT, V2, P1193, DOI 10.1016/S1286-4579(00)01273-9
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315
   Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schmiederer M, 2001, INFECT IMMUN, V69, P6495, DOI 10.1128/IAI.69.10.6495-6502.2001
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919
NR 23
TC 118
Z9 132
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD APR
PY 2004
VL 52
IS 1
BP 81
EP 92
DI 10.1111/j.1365-2958.2003.03964.x
PG 12
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 806HZ
UT WOS:000220426300007
PM 15049812
OA Bronze
DA 2021-01-25
ER

PT J
AU Fahrenkrog, B
   Koser, J
   Aebi, U
AF Fahrenkrog, B
   Koser, J
   Aebi, U
TI The nuclear pore complex: a jack of all trades?
SO TRENDS IN BIOCHEMICAL SCIENCES
LA English
DT Review
ID SACCHAROMYCES-CEREVISIAE NUCLEOPORIN; STRUCTURAL BASIS; IMPORTIN-BETA;
   NUCLEOCYTOPLASMIC TRANSPORT; CAENORHABDITIS-ELEGANS; MESSENGER-RNA;
   PROTEIN GP210; CHROMOSOME-SEGREGATION; CHROMATIN BOUNDARIES; ENVELOPE
   BREAKDOWN
AB The nuclear pore complex (NPC) is the only gateway between the cell nucleus and the cytoplasm, and it mediates all movement between these two compartments. The past few years have witnessed much progress on its structure and molecular architecture, its interaction with soluble transport receptors, and how nucleocytoplasmic transport is regulated by the small GTPase Ran. However, the exact molecular mechanisms underlying nucleocytoplasmic transport and in particular cargo translocation through the NPC are understood only poorly. Recent findings on the interaction between the NPC and transport factors might provide insights into how efficient NPC translocation is accomplished. Moreover, in addition to mediating nucleocytoplasmic transport, the NPC seems to be involved, either directly or indirectly, in many other cellular processes such as chromosome segregation, gene expression, the secretory pathway and apoptosis. Here we review recent findings on these unexpected roles of the NPC.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4066 Basel, Switzerland.
RP Fahrenkrog, B (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4066 Basel, Switzerland.
EM birthe.fahrenkrog@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413
CR AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200
   Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305
   Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085
   Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x
   Behrens P, 2003, APOPTOSIS, V8, P39, DOI 10.1023/A:1021644918117
   Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081
   Bodoor K, 1999, J CELL SCI, V112, P2253
   Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899
   Braun IC, 2002, MOL CELL BIOL, V22, P5405, DOI 10.1128/MCB.22.15.5405-5418.2002
   Brinkmann U, 1998, AM J HUM GENET, V62, P509, DOI 10.1086/301773
   Buendia B, 1999, J CELL SCI, V112, P1743
   Bustamante JO, 2000, PFLUG ARCH EUR J PHY, V439, P433, DOI 10.1007/s004240050960
   Cohen M, 2003, MOL BIOL CELL, V14, P4230, DOI 10.1091/mbc.E03-04-0260
   Cohen M, 2002, J STRUCT BIOL, V140, P232, DOI 10.1016/S1047-8477(02)00516-6
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   DABAUVALLE MC, 1991, J CELL BIOL, V112, P1073, DOI 10.1083/jcb.112.6.1073
   Danker T, 2000, PFLUG ARCH EUR J PHY, V439, P671, DOI 10.1007/s004240050992
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465
   Drummond SP, 2002, J CELL BIOL, V158, P53, DOI 10.1083/jcb.200108145
   Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660
   Favreau C, 2001, EUR J BIOCHEM, V268, P3883, DOI 10.1046/j.1432-1327.2001.02290.x
   Ferrando-May E, 2001, CELL DEATH DIFFER, V8, P495, DOI 10.1038/sj.cdd.4400837
   Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756
   Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3
   Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3
   Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237
   Grant RP, 2003, J MOL BIOL, V326, P849, DOI 10.1016/S0022-2836(02)01474-2
   Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582
   Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275
   Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0
   Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109
   Kerscher O, 2001, GENETICS, V157, P1543
   Kuersten S, 2002, MOL CELL BIOL, V22, P5708, DOI 10.1128/MCB.22.16.5708-5720.2002
   Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4
   Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387
   Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001
   MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254
   Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538
   MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433
   Morrison J, 2003, J MOL BIOL, V333, P587, DOI 10.1016/j.jmb.2003.08.050
   Nanduri J, 2001, MOL CELL, V8, P281, DOI 10.1016/S1097-2765(01)00312-4
   Pai CY, 2002, TRENDS CELL BIOL, V12, P452, DOI 10.1016/S0962-8924(02)02367-X
   Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241
   Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320
   Rollenhagen C, 2003, MOL BIOL CELL, V14, P2104, DOI 10.1091/mbc.E02-06-0372
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007
   Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116
   Ryan KJ, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-17
   Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080
   Schafer C, 2002, P NATL ACAD SCI USA, V99, P7154, DOI 10.1073/pnas.092140799
   Senay C, 2003, J BIOL CHEM, V278, P48395, DOI 10.1074/jbc.M308275200
   Shahin V, 2001, FASEB J, V15, P1895, DOI 10.1096/fj.00-0838com
   Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200
   Theodoropoulos PA, 1999, J CELL SCI, V112, P3049
   Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007
   Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898
   Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6
   Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   WOZNIAK RW, 1992, J CELL BIOL, V119, P1441, DOI 10.1083/jcb.119.6.1441
   Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
   Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288
NR 78
TC 109
Z9 114
U1 0
U2 3
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0968-0004
J9 TRENDS BIOCHEM SCI
JI Trends Biochem.Sci.
PD APR
PY 2004
VL 29
IS 4
BP 175
EP 182
DI 10.1016/j.tibs.2004.02.006
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 815SS
UT WOS:000221062600006
PM 15082311
DA 2021-01-25
ER

PT J
AU Green, JD
   Goldsbury, C
   Kistler, J
   Cooper, GJS
   Aebi, U
AF Green, JD
   Goldsbury, C
   Kistler, J
   Cooper, GJS
   Aebi, U
TI Human amylin oligomer growth and fibril elongation define two distinct
   phases in amyloid formation
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID GENE-RELATED PEPTIDE; ATOMIC-FORCE MICROSCOPY; BETA-PROTEIN; CONGO-RED;
   TRANSGENIC MICE; PARKINSONS-DISEASE; DIABETES-MELLITUS;
   PLAQUE-FORMATION; ALPHA-SYNUCLEIN; IN-VITRO
AB Human amylin (hA), a 37-amino-acid polypeptide, is one of a number of peptides with the ability to form amyloid fibrils and cause disease. It is the main constituent of the pancreatic amyloid deposits associated with type 2 diabetes. Increasing interest in early assembly intermediates rather than the mature fibrils as the cytotoxic agent has led to this study in which the smallest hA oligomers have been captured by atomic force microscopy. These are 2.3 +/- 1.9 nm in height, 23 +/- 14 nm in length, and consist of an estimated 16 hA molecules. Oligomers first grow to a height of about 6 nm before they begin to significantly elongate into fibrils. Congo red inhibits elongation but not the growth in height of hA oligomers. Two distinct phases have thus been identified in hA fibrillogenesis: lateral growth of oligomers followed by longitudinal growth into mature fibrils. These observations suggest that mature fibrils are assembled directly via longitudinal growth of full-width oligomers, making assembly by lateral association of protofibrils appear less likely.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Auckland, Fac Sci, Sch Biol Sci, Auckland 1, New Zealand.
   Univ Auckland, Sch Med, Dept Med, Auckland, New Zealand.
RP Aebi, U (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Ueli.Aebi@unibas.ch
RI Cooper, Garth JS/I-3201-2015
OI Cooper, Garth JS/0000-0001-5241-3163
CR Aitken JF, 2003, BIOCHEM J, V374, P779, DOI 10.1042/BJ20030422
   BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0
   BURGEVIN MC, 1994, NEUROREPORT, V5, P2429, DOI 10.1097/00001756-199412000-00006
   Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304
   Castle AL, 1998, AM J PHYSIOL-ENDOC M, V275, pE531
   Chui DH, 1999, NAT MED, V5, P560
   CLARK A, 1987, LANCET, V2, P231
   Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r
   Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571
   COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163
   COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628
   Cornish J, 1998, AM J PHYSIOL-ENDOC M, V275, pE694
   DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5
   FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0
   Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858
   Harroun TA, 2001, FEBS LETT, V507, P200, DOI 10.1016/S0014-5793(01)02972-6
   Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999
   Hettiarachchi M, 1997, AM J PHYSIOL-ENDOC M, V273, pE859
   Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283
   Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491
   Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646
   Kim YS, 2003, J BIOL CHEM, V278, P10842, DOI 10.1074/jbc.M212540200
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   LEIGHTON B, 1988, NATURE, V335, P632, DOI 10.1038/335632a0
   LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0
   LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243
   Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0
   Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000
   Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462
   Podlisny MB, 1998, BIOCHEMISTRY-US, V37, P3602, DOI 10.1021/bi972029u
   Rhoades E, 2000, BBA-PROTEIN STRUCT M, V1476, P230, DOI 10.1016/S0167-4838(99)00248-4
   Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524
   SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989
   Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899
   YOUNG AA, 1993, AM J PHYSIOL, V264, P943
   Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200
NR 40
TC 127
Z9 128
U1 0
U2 24
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 26
PY 2004
VL 279
IS 13
BP 12206
EP 12212
DI 10.1074/jbc.M312452200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 804YV
UT WOS:000220334900026
PM 14704152
OA Bronze
DA 2021-01-25
ER

PT J
AU Appenzeller-Herzog, C
   Roche, AC
   Nufer, O
   Hauri, HP
AF Appenzeller-Herzog, C
   Roche, AC
   Nufer, O
   Hauri, HP
TI pH-induced conversion of the transport lectin ERGIC-53 triggers
   glycoprotein release
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID GOLGI INTERMEDIATE COMPARTMENT; CARBOHYDRATE-RECOGNITION DOMAIN;
   RECEPTOR-ASSOCIATED PROTEIN; VACUOLAR H+-ATPASE; ENDOPLASMIC-RETICULUM;
   SECRETORY PATHWAY; ASIALOGLYCOPROTEIN RECEPTOR; LEGUMINOUS LECTINS;
   RECYCLING PATHWAY; CRYSTAL-STRUCTURE
AB The recycling mannose lectin ERGIC- 53 operates as a transport receptor by mediating efficient endoplasmic reticulum ( ER) export of some secretory glycoproteins. Binding of cargo to ERGIC- 53 in the ER requires Ca2+. Cargo release occurs in the ERGIC, but the molecular mechanism is unknown. Here we report efficient binding of purified ERGIC- 53 to immobilized mannose at pH 7.4, the pH of the ER, but not at slightly lower pH. pH sensitivity of the lectin was more prominent when Ca2+ concentrations were low. A conserved histidine in the center of the carbohydrate recognition domain was required for lectin activity suggesting it may serve as a molecular pH/Ca2+ sensor. Acidification of cells inhibited the association of ERGIC- 53 with the known cargo cathepsin Z- related protein and dissociation of this glycoprotein in the ERGIC was impaired by organelle neutralization that did not impair the transport of a control protein. The results elucidate the molecular mechanism underlying reversible lectin/ cargo interaction and establish the ERGIC as the earliest low pH site of the secretory pathway.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   CNRS, Ctr Biophys Mol, F-45071 Orleans, France.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Hans-Peter.Hauri@unibas.ch
RI Appenzeller-Herzog, Christian/A-2894-2014
OI Appenzeller-Herzog, Christian/0000-0001-7430-294X
CR Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277
   ANTUSCH D, 1990, J IMMUNOL, V145, P885
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224
   BONIFACINO JS, 1988, J BIOL CHEM, V263, P8965
   BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x
   CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
   Elgavish S, 1998, J MOL BIOL, V277, P917, DOI 10.1006/jmbi.1998.1664
   Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200
   Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200
   Fiedler K, 1996, J CELL SCI, V109, P271
   Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101
   Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200
   Hauri HP, 2000, J CELL SCI, V113, P587
   Itin C, 1996, MOL BIOL CELL, V7, P483
   ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Loris R, 2002, BBA-GEN SUBJECTS, V1572, P198, DOI 10.1016/S0304-4165(02)00309-4
   Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9
   Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200
   Palokangas H, 1998, MOL BIOL CELL, V9, P3561, DOI 10.1091/mbc.9.12.3561
   Pezzati R, 1997, MOL BIOL CELL, V8, P1501
   PIMPANEAU V, 1991, CARBOHYD RES, V213, P95, DOI 10.1016/S0008-6215(00)90601-3
   Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298
   Scheel AA, 1996, BIOCHEMISTRY-US, V35, P10203, DOI 10.1021/bi960807x
   Schrag JD, 2003, TRENDS BIOCHEM SCI, V28, P49, DOI 10.1016/S0968-0004(02)00004-X
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Sharma V, 1997, J MOL BIOL, V267, P433, DOI 10.1006/jmbi.1996.0863
   Solovyova N, 2002, J NEUROSCI METH, V122, P1, DOI 10.1016/S0165-0270(02)00300-X
   Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031
   Velloso LM, 2002, J BIOL CHEM, V277, P15979, DOI 10.1074/jbc.M112098200
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   Warren G, 1999, CELL, V98, P125, DOI 10.1016/S0092-8674(00)81006-5
   Weisz OA, 2003, INT REV CYTOL, V226, P259, DOI 10.1016/S0074-7696(03)01005-2
   WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6
   Wragg S, 1999, J BIOL CHEM, V274, P35400, DOI 10.1074/jbc.274.50.35400
   Wu MM, 2000, METHOD ENZYMOL, V327, P546, DOI 10.1016/S0076-6879(00)27301-1
   Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200
   Ying M, 2000, J CELL SCI, V113, P3623
   ZEUZEM S, 1992, P NATL ACAD SCI USA, V89, P6619, DOI 10.1073/pnas.89.14.6619
   Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153
NR 45
TC 78
Z9 79
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 26
PY 2004
VL 279
IS 13
BP 12943
EP 12950
DI 10.1074/jbc.M313245200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 804YV
UT WOS:000220334900112
PM 14718532
OA Other Gold
DA 2021-01-25
ER

PT J
AU Wiederkehr, C
   Basavaraj, R
   de Menthiere, CS
   Koch, R
   Schlecht, U
   Hermida, L
   Masdoua, B
   Ishii, R
   Cassen, V
   Yamamoto, M
   Lane, C
   Cherry, M
   Lamb, N
   Primig, M
AF Wiederkehr, C
   Basavaraj, R
   de Menthiere, CS
   Koch, R
   Schlecht, U
   Hermida, L
   Masdoua, B
   Ishii, R
   Cassen, V
   Yamamoto, M
   Lane, C
   Cherry, M
   Lamb, N
   Primig, M
TI Database model and specification of GermOnline Release 2.0, a
   cross-species community annotation knowledgebase on germ cell
   differentiation
SO BIOINFORMATICS
LA English
DT Article
ID GENE-EXPRESSION; MEIOSIS
AB Summary: GermOnline is a web-accessible relational database that enables life scientists to make a significant and sustained contribution to the annotation of genes relevant for the fields of mitosis, meiosis, germ line development and gametogenesis across species. This novel approach to genome annotation includes a platform for knowledge submission and curation as well as microarray data storage and visualization hosted by a global network of servers.
   .
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   Inst Human Genet, F-34396 Montpellier, France.
   Univ Tokyo, Dept Biophys & Biochem, Tokyo 1130033, Japan.
   Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.
   Stanford Univ, Stanford, CA 94305 USA.
RP Primig, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM michael.primig@unibas.ch
RI Primig, Michael/G-3175-2013
OI Primig, Michael/0000-0002-2061-0119; Ishii, Ryohei/0000-0003-2486-1393;
   Hermida, Leandro/0000-0003-3887-518X
CR Baxevanis AD, 2003, NUCLEIC ACIDS RES, V31, P1, DOI 10.1093/nar/gkg120
   Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951
   Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539
   Primig M, 2003, NAT GENET, V35, P291, DOI 10.1038/ng1203-291
   Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9
   Schlecht U, 2003, REPRODUCTION, V125, P447, DOI 10.1530/reprod/125.4.447
   SCHLECHT U, 2003, IN PRESS MOL BIOL CE
   Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033
   Wiederkehr C, 2004, NUCLEIC ACIDS RES, V32, pD560, DOI 10.1093/nar/gkh055
   Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299
   Yeh I, 2003, BIOINFORMATICS, V19, P241, DOI 10.1093/bioinformatics/19.2.241
NR 11
TC 8
Z9 9
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD MAR 22
PY 2004
VL 20
IS 5
BP 808
EP U812
DI 10.1093/bioinformatics/bth030
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 807ER
UT WOS:000220485300031
PM 14751982
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Paul, R
   Weiser, S
   Amiot, NC
   Chan, C
   Schirmer, T
   Giese, B
   Jenal, U
AF Paul, R
   Weiser, S
   Amiot, NC
   Chan, C
   Schirmer, T
   Giese, B
   Jenal, U
TI Cell cycle-dependent dynamic localization of a bacterial response
   regulator with a novel di-guanylate cyclase output domain
SO GENES & DEVELOPMENT
LA English
DT Article
DE Caulobacter development; GGDEF domain; protein localization; response
   regulator
ID CAULOBACTER-CRESCENTUS; CELLULOSE SYNTHESIS; SIGNAL-TRANSDUCTION;
   ACETOBACTER-XYLINUM; ADENYLYL-CYCLASE; DIGUANYLIC ACID; TRANSMEMBRANE
   RECEPTORS; SENSORY DOMAINS; GGDEF DOMAIN; PROTEINS
AB Pole development is coordinated with the Caulobacter crescentus cell cycle by two-component signaling proteins. We show that an unusual response regulator, PleD, is required for polar differentiation and is sequestered to the cell pole only when it is activated by phosphorylation. Dynamic localization of PleD to the cell pole provides a mechanism to temporally and spatially control the signaling output of PleD during development. Targeting of PleD to the cell pole is coupled to the activation of a C-terminal guanylate cyclase domain, which catalyzes the synthesis of cyclic di-guanosine monophosphate. We propose that the local action of this novel-type guanylate cyclase might constitute a general regulatory principle in bacterial growth and development.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Structural Biol, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   AMIKAM D, 1989, J BACTERIOL, V171, P6649, DOI 10.1128/jb.171.12.6649-6655.1989
   Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8
   Anantharaman V, 2001, TRENDS BIOCHEM SCI, V26, P579, DOI 10.1016/S0968-0004(01)01968-5
   Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1111/j.1574-6968.1999.tb13650.x
   Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x
   Ausmees N, 1999, MICROBIOL-UK, V145, P1253, DOI 10.1099/13500872-145-5-1253
   Boles BR, 2002, J BACTERIOL, V184, P5946, DOI 10.1128/JB.184.21.5946-5954.2002
   Bomchil N, 2003, J BACTERIOL, V185, P1384, DOI 10.1128/JB.185.4.1384-1390.2003
   Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236
   Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022
   D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002
   DOMINO SE, 1991, METHOD ENZYMOL, V195, P345
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977
   Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177
   Gronewold TMA, 2001, MOL MICROBIOL, V40, P744, DOI 10.1046/j.1365-2958.2001.02428.x
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x
   Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998
   JENAL U, 1994, J MOL BIOL, V243, P227, DOI 10.1006/jmbi.1994.1650
   Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x
   JOHNSON RA, 1991, METHOD ENZYMOL, P3
   Jones HA, 1999, MICROBIOL-SGM, V145, P2117, DOI 10.1099/13500872-145-8-2117
   Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3
   Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6
   Mougel C, 2001, TRENDS BIOCHEM SCI, V26, P582, DOI 10.1016/S0968-0004(01)01969-7
   Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602
   Nikolskaya AN, 2003, J MOL MICROB BIOTECH, V5, P11, DOI 10.1159/000068720
   Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003
   PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443
   Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8
   PONTING CP, 1997, CURR BIOL, V7, P674
   Rhoads AR, 1997, FASEB J, V11, P331
   Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996
   Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991
   ROSS P, 1990, J BIOL CHEM, V265, P18933
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   Smith SO, 2001, J MOL BIOL, V313, P1139, DOI 10.1006/jmbi.2001.5101
   SOMMER JM, 1991, GENETICS, V129, P623
   Spiers AJ, 2002, GENETICS, V161, P33
   STENKAMP RE, 1978, BIOCHEMISTRY-US, V17, P2499, DOI 10.1021/bi00606a007
   Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998
   Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22
   Terwilliger NB, 1998, J EXP BIOL, V201, P1085
   Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7
   Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2
   Zhulin IB, 2003, J BACTERIOL, V185, P285, DOI 10.1128/JB.185.1.285-294.2003
NR 55
TC 423
Z9 438
U1 1
U2 24
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD MAR 15
PY 2004
VL 18
IS 6
BP 715
EP 727
DI 10.1101/gad.289504
PG 13
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 811TM
UT WOS:000220794200011
PM 15075296
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Anderson, TG
   Tan, A
   Ganz, P
   Seelig, J
AF Anderson, TG
   Tan, A
   Ganz, P
   Seelig, J
TI Calorimetric measurement of phospholipid interaction with
   methyl-beta-cyclodextrin
SO BIOCHEMISTRY
LA English
DT Article
ID TITRATION CALORIMETRY; GAMMA-CYCLODEXTRINS; INDUCED HEMOLYSIS;
   CHOLESTEROL; MEMBRANE; VESICLES; ALPHA; MECHANISM; THERMODYNAMICS;
   SOLUBILIZATION
AB Cyclodextrins are able to bind hydrophobic molecules in their interior cavity and as such have received a great deal of attention as carriers of cholesterol, lipophilic drugs, and other sparingly soluble compounds. Despite the importance of these biochemical applications, relatively little is known about the interactions of cyclodextrins with phospholipid membranes. Here we characterize the binding of randomly methylated beta-cyclodextrin (mbetaCD) to 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) using right-angle light scattering and isothermal titration calorimetry. Existing models of lipophile-membrane interactions are inadequate to describe the observed binding; we introduce a modified chemical reaction model in which the chemical activity of the phospholipid is independent of its concentration. We find that an average of four mbetaCD molecules bind to each POPC molecule with an enthalpy of reaction of 46 kJ mol(-1) and an equilibrium constant of 90 M-3. These results are consistent with earlier qualititative observations and suggest that disruption of phospholipid membranes may be minimized if the concentration of mbetaCD is kept below about 15 mM.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
RP Anderson, TG (corresponding author), Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM thomas.anderson@unibas.ch
CR ALMOG S, 1990, BIOCHEMISTRY-US, V29, P4582, DOI 10.1021/bi00471a012
   Baker BM, 1998, METHOD ENZYMOL, V295, P294
   Burnette RR, 2000, J PHARM SCI, V89, P1389
   Cevc G, 1987, PHOSPHOLIPID BILAYER
   Choi YH, 2001, J INCL PHENOM MACRO, V39, P71, DOI 10.1023/A:1008196029391
   Connors KA, 1997, CHEM REV, V97, P1325, DOI 10.1021/cr960371r
   Debouzy JC, 1998, J PHARM SCI, V87, P59, DOI 10.1021/js970180j
   DECAPRIO J, 1992, J LIPID RES, V33, P441
   Fauvelle F, 1997, J PHARM SCI, V86, P935, DOI 10.1021/js9602453
   Garidel P, 2000, LANGMUIR, V16, P5267, DOI 10.1021/la9912390
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA, P357
   KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250
   Legendre JY, 1995, EUR J PHARM SCI, V3, P311, DOI 10.1016/0928-0987(95)00020-0
   Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0
   LI G, 1994, SCIENCE, V264, P249, DOI 10.1126/science.264.5156.249
   MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J
   MARTIN FJ, 1976, BIOCHEMISTRY-US, V15, P321, DOI 10.1021/bi00647a013
   NICHOLS JW, 1982, BIOCHEMISTRY-US, V21, P1720, DOI 10.1021/bi00537a003
   Nishijo J, 1998, CHEM PHARM BULL, V46, P120
   Nishijo J, 2000, CHEM PHARM BULL, V48, P48
   Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X
   Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200
   OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x
   Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816
   Podar K, 2003, J BIOL CHEM, V278, P5794, DOI 10.1074/jbc.M208636200
   Puglisi G, 1996, J COLLOID INTERF SCI, V180, P542, DOI 10.1006/jcis.1996.0335
   Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097
   Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o
   SCHLENK H, 1961, J AM CHEM SOC, V83, P2312, DOI 10.1021/ja01471a022
   Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c
   Tan AM, 2002, BIOPHYS J, V83, P1547, DOI 10.1016/S0006-3495(02)73924-6
   Tanford C., 1980, HYDROPHOBIC EFFECT F
   Tanhuanpaa K, 1999, J BIOL CHEM, V274, P35359, DOI 10.1074/jbc.274.50.35359
   Tanhuanpaa K, 2001, BIOPHYS J, V81, P1501, DOI 10.1016/S0006-3495(01)75804-3
   Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p
   Wenk MR, 1997, J PHYS CHEM B, V101, P5224, DOI 10.1021/jp9707955
   Widom B, 2003, PHYS CHEM CHEM PHYS, V5, P3085, DOI 10.1039/b304038k
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
   Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026
NR 40
TC 63
Z9 63
U1 1
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAR 2
PY 2004
VL 43
IS 8
BP 2251
EP 2261
DI 10.1021/bi0358869
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 777PA
UT WOS:000189185700012
PM 14979721
DA 2021-01-25
ER

PT J
AU Babiak, A
   Schumm, AM
   Wangler, C
   Loukas, M
   Wu, JB
   Dombrowski, S
   Matuschek, C
   Kotzerke, J
   Dehio, C
   Waltenberger, J
AF Babiak, A
   Schumm, AM
   Wangler, C
   Loukas, M
   Wu, JB
   Dombrowski, S
   Matuschek, C
   Kotzerke, J
   Dehio, C
   Waltenberger, J
TI Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic
   stimulus leading to enhancement of regional perfusion
SO CARDIOVASCULAR RESEARCH
LA English
DT Article
DE regional blood flow; ischemia; animal model; growth factor receptors;
   VEGF; arteriogenesis; endothelium; monocytes; collateral arteries
ID ENDOTHELIAL GROWTH-FACTOR; MONOCYTE ACTIVATION; ORF VIRUS; IN-VIVO;
   ANGIOGENESIS; RECEPTOR; EXPRESSION; CELLS; MECHANISMS; HINDLIMB
AB Objective: The process of arteriogenesis is driven by various growth factors including vascular endothelial growth factor (VEGF)-A, which mediates its activity through VEGFR-2 (Flk-1/KDR) on endothelial cells and through VEGFR-1 (Flt-1) on endothelial cells and monocytes. The purpose of this study was to identify which of the VEGF receptors are involved in arteriogenesis in vivo. Methods: Collateral vessel growth was induced by femoral artery ligation in a mouse model of hindlimb ischemia. Following ligation, Balb/c mice were treated with different growth factors (VEGF-A, VEGF-E, PIGF-2, VEGF-E plus PIGF-2 or VEGF-A plus PIGF-2, activating either VEGFR-1, VEGFR-2, or both). After 1 week of treatment, hindlimb perfusion was assessed by perfusion scintigraphy using Tc-99m-MIBI. Results: The strongest improvement of regional perfusion was achieved by simultaneous activation of VEGFR-1 and VEGFR-2, using either VEGF-A or VEGF-A plus PIGF-2, with elevation of relative perfusion in the ischemic limbs from 0.61 to 0.83. The partial restoration in perfusion was associated with morphological changes typical for arteriogenesis. Moreover, specific inhibition of both VEGF-receptors using ZK 202650 resulted in a significant inhibition of arteriogenesis, indicating an active role of the VEGF system in compensatory arteriogenesis. Conclusion: The coordinated activation of both VEGFR-1 and VEGFR-2 represents a more potent arteriogenesic stimulus compared to the isolated activation of either one of these two receptors. These data imply that the activation of both monocytes and endothelial cells is necessary to obtain a maximal VEGF-induced activation of arteriogenesis. (C) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
C1 Univ Hosp Maastricht, Dept Intervent Cardiol, NL-6202 AZ Maastricht, Netherlands.
   Univ Ulm, Med Ctr, Dept Internal Med 2, D-89069 Ulm, Germany.
   Univ Ulm, Med Ctr, Dept Nucl Med, D-89069 Ulm, Germany.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   CARIM, Maastricht, Netherlands.
RP Waltenberger, J (corresponding author), Univ Hosp Maastricht, Dept Intervent Cardiol, P Debyelaan 25, NL-6202 AZ Maastricht, Netherlands.
EM j.waltenberger@cardio.azm.nl
RI Wangler, Carmen/AAB-3557-2020; Dehio, Christoph/AAD-5572-2019; Dehio,
   Christoph/R-8277-2016; Waltenberger, Johannes/I-1813-2013
OI Wangler, Carmen/0000-0003-1161-8669; Dehio,
   Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052;
   Waltenberger, Johannes/0000-0002-2417-9880
CR Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877
   Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629
   Couffinhal T, 1998, AM J PATHOL, V152, P1667
   Couper LL, 1997, CIRC RES, V81, P932
   Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F
   Hiratsuka S, 2001, CANCER RES, V61, P1207
   Mack CA, 1998, J VASC SURG, V27, P699, DOI 10.1016/S0741-5214(98)70236-8
   Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363
   Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074/jbc.273.47.31273
   Persico MG, 1999, CURR TOP MICROBIOL, V237, P31
   Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5
   WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988
   Weber KSC, 1999, ARTERIOSCL THROM VAS, V19, P2085, DOI 10.1161/01.ATV.19.9.2085
   Wise LM, 1999, P NATL ACAD SCI USA, V96, P3071, DOI 10.1073/pnas.96.6.3071
NR 19
TC 54
Z9 56
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0008-6363
EI 1755-3245
J9 CARDIOVASC RES
JI Cardiovasc. Res.
PD MAR 1
PY 2004
VL 61
IS 4
BP 789
EP 795
DI 10.1016/j.cardiores.2003.12.014
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 801WI
UT WOS:000220125600018
PM 14985076
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Pyrowolakis, J
   Hartmann, B
   Muller, B
   Basler, K
   Affolter, M
AF Pyrowolakis, J
   Hartmann, B
   Muller, B
   Basler, K
   Affolter, M
TI Novel properties of the Dpp/BMP signaling pathway in Drosophila
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the Deutschen-Gesellschaft-fur-Zellbiologie
CY MAR 24-27, 2004
CL Berlin, Germany
SP Deutsch Gesell Zellbiol
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Zurich, CH-8006 Zurich, Switzerland.
RI Mueller, Bruno/E-9888-2017
OI Mueller, Bruno/0000-0003-2664-7219
NR 0
TC 0
Z9 0
U1 0
U2 2
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2004
VL 83
SU 54
BP 22
EP 22
PG 1
WC Cell Biology
SC Cell Biology
GA 812EX
UT WOS:000220823900014
DA 2021-01-25
ER

PT J
AU Schlecht, U
   Demougin, P
   Koch, R
   Hermida, L
   Wiederkehr, C
   Descombes, P
   Pineau, C
   Jegou, B
   Primig, M
AF Schlecht, U
   Demougin, P
   Koch, R
   Hermida, L
   Wiederkehr, C
   Descombes, P
   Pineau, C
   Jegou, B
   Primig, M
TI Expression profiling of mammalian male meiosis and gametogenesis
   identifies novel candidate genes for roles in the regulation of
   fertility
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID SERTOLI-CELLS; CHROMOSOME CONDENSATION; SYNAPTONEMAL COMPLEXES; MICE
   LACKING; PROTEIN; SPERMATOGENESIS; TRANSITION; KINASE; GROWTH; MEMBER
AB We report a comprehensive large-scale expression profiling analysis of mammalian male germ cells undergoing mitotic growth, meiosis, and gametogenesis by using high-density oligonucleotide microarrays and highly enriched cell populations. Among 11,955 rat loci investigated, 1268 were identified as differentially transcribed in germ cells at subsequent developmental stages compared with total testis, somatic Sertoli cells as well as brain and skeletal muscle controls. The loci were organized into four expression clusters that correspond to somatic, mitotic, meiotic, and postmeiotic cell types. This work provides information about expression patterns of similar to200 genes known to be important during male germ cell development. Approximately 40 of those are included in a group of 121 transcripts for which we report germ cell expression and lack of transcription in three somatic control cell types. Moreover, we demonstrate the testicular expression and transcriptional induction in mitotic, meiotic, and/or postmeiotic germ cells of 293 as yet uncharacterized transcripts, some of which are likely to encode factors involved in spermatogenesis and fertility. This group also contains potential germ cell-specific targets for innovative contraceptives. A graphical display of the data is conveniently accessible through the GermOnline database at http://www.germonline.org.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   Univ Geneva, CMU, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva 4, Switzerland.
   Univ Rennes 1, INSERM, U435, Grp Etud Reprod Chez Male, F-35042 Rennes, Bretagne, France.
RP Primig, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM michael.primig@unibas.ch
RI Pineau, Charles/D-9185-2013; Jegou, Bernard/I-4742-2015; Primig,
   Michael/G-3175-2013
OI Pineau, Charles/0000-0002-7461-5433; Primig,
   Michael/0000-0002-2061-0119; Hermida, Leandro/0000-0003-3887-518X;
   JEGOU, Bernard/0000-0003-0623-3609
CR Adham IM, 1997, MOL REPROD DEV, V46, P370, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;370::AID-MRD16&gt;3.0.CO;2-2
   Adham IM, 2001, MOL HUM REPROD, V7, P513, DOI 10.1093/molehr/7.6.513
   Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1
   Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   BOWDISH KS, 1994, MOL CELL BIOL, V14, P7909, DOI 10.1128/MCB.14.12.7909
   Cho C, 2001, NAT GENET, V28, P82, DOI 10.1038/88313
   Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699
   Clarke GM, 1998, BASIC COURSE STAT
   COAIACOVO MP, 2002, GENETICS, V162, P113
   Cunningham DB, 1998, DEV BIOL, V204, P345, DOI 10.1006/dbio.1998.9004
   Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399
   Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103
   Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075
   Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811
   Goepfert TM, 2002, CANCER RES, V62, P4115
   Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203
   Gromoll J, 1997, BIOL REPROD, V57, P1312, DOI 10.1095/biolreprod57.6.1312
   Guillaume E, 2001, MOL REPROD DEV, V60, P439, DOI 10.1002/mrd.1108
   Guo TB, 2003, J ANDROL, V24, P332
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Ishibashi K, 2002, BBA-GENE STRUCT EXPR, V1576, P335, DOI 10.1016/S0167-4781(02)00393-7
   Ishibashi K, 1997, BIOCHEM BIOPH RES CO, V237, P714, DOI 10.1006/bbrc.1997.7219
   JEGOU B, 1999, MALE REPROD FUNCTION
   KANATSUSHINOHAR.M, 2003, BIOL REPROD
   KAUFMAN L, 1990, FINDING GROUPS DATA
   Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0
   Kneitz B, 2000, GENE DEV, V14, P1085
   Le Goffic R, 2002, ENDOCRINOLOGY, V143, P1434, DOI 10.1210/en.143.4.1434
   Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319
   Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931
   Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855
   Livera G, 2002, REPRODUCTION, V124, P173, DOI 10.1530/rep.0.1240173
   Lui WY, 2003, BBA-MOL CELL RES, V1593, P121, DOI 10.1016/S0167-4889(02)00348-8
   Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376
   Malathi K, 1997, MOL CELL BIOL, V17, P7230, DOI 10.1128/MCB.17.12.7230
   Mannan AU, 2003, BIOL REPROD, V69, P788, DOI 10.1095/biolreprod.103.017400
   McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059
   Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728
   O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966
   Offenberg HH, 1998, NUCLEIC ACIDS RES, V26, P2572, DOI 10.1093/nar/26.11.2572
   Ouspenski II, 2000, MOL BIOL CELL, V11, P1305, DOI 10.1091/mbc.11.4.1305
   Pang ALY, 2003, J ANDROL, V24, P899
   PAYNE AH, 1990, BIOL REPROD, V42, P399, DOI 10.1095/biolreprod42.3.399
   Persengiev SP, 1996, MOL ENDOCRINOL, V10, P742, DOI 10.1210/me.10.6.742
   Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7
   PINEAU C, 1993, RECENT PROG HORM RES, V48, P539
   PINEAU C, 1993, J ANDROL, V14, P87
   Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539
   Primig M, 2003, NAT GENET, V35, P291, DOI 10.1038/ng1203-291
   Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3
   Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9
   Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6
   Rosok O, 1999, GENOMICS, V61, P44, DOI 10.1006/geno.1999.5922
   Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P422, DOI 10.1210/me.2003-0188
   Schalk JAC, 1998, CHROMOSOMA, V107, P540, DOI 10.1007/s004120050340
   Schlecht U, 2003, REPRODUCTION, V125, P447, DOI 10.1530/reprod/125.4.447
   Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100
   Sha JH, 2002, MOL HUM REPROD, V8, P511, DOI 10.1093/molehr/8.6.511
   Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445
   Shinkai Y, 2002, MOL CELL BIOL, V22, P3276, DOI 10.1128/MCB.22.10.3276-3280.2002
   Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0
   Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561
   Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176
   Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346
   Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199
   TOEBOSCH AMW, 1989, J ENDOCRINOL, V122, P757, DOI 10.1677/joe.0.1220757
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Wiederkehr C, 2004, NUCLEIC ACIDS RES, V32, pD560, DOI 10.1093/nar/gkh055
   WIEDERKEHR C, 2004, IN PRESS BIOINFORMAT
   Wolgemuth DJ, 2002, RECENT PROG HORM RES, V57, P75, DOI 10.1210/rp.57.1.75
   Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683
   Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619
NR 74
TC 103
Z9 116
U1 0
U2 18
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAR
PY 2004
VL 15
IS 3
BP 1031
EP 1043
DI 10.1091/mbc.E03-10-0762
PG 13
WC Cell Biology
SC Cell Biology
GA 800TZ
UT WOS:000220051900010
PM 14718556
OA Green Published
DA 2021-01-25
ER

PT J
AU Goder, V
   Junne, T
   Spiess, M
AF Goder, V
   Junne, T
   Spiess, M
TI Sec61p contributes to signal sequence orientation according to the
   positive-inside rule
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID ENDOPLASMIC-RETICULUM MEMBRANE; ER MEMBRANE; SECRETORY PROTEIN; ANCHOR
   PROTEINS; TRANSMEMBRANE ORIENTATION; CHARGED RESIDUES; TRANSLOCATION;
   RECOGNITION; DOMAIN; DETERMINANTS
AB Protein targeting to the endoplasmic reticulum. is mediated by signal or signal-anchor sequences. They also play an important role in protein topogenesis, because their orientation in the translocon determines whether their N- or C-terminal sequence is translocated. Signal orientation is primarily determined by charged residues flanking the hydrophobic core, whereby the more positive end is predominantly positioned to the cytoplasmic side of the membrane, a phenomenon known as the "positive-inside rule." We tested the role of conserved charged residues of Sec61p, the major component of the translocon in. Saccharomyces cerevisiae, in orienting. signals according to their flanking charges by. site-directed mutagenesis by using diagnostic model proteins. Mutation of R67, R74, or E382 in Sec61p reduced C-terminal translocation of a signal-anchor protein with a positive N-terminal flanking sequence and increased it for signal-anchor proteins with positive C-terminal sequences. These mutations produced a stronger effect on substrates with greater charge difference across the hydrophobic core of the signal. For some of the substrates, a charge mutation in Sec61p had a similar effect as one in the substrate polypeptides. Although these three residues do. not account for the entire charge effect in signal orientation, the results show that Sec61p contributes to the positive-inside rule.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
RI Goder, Veit/F-8092-2016
OI Goder, Veit/0000-0003-0854-4873; Spiess, Martin/0000-0001-7139-0550
CR ANDERSSON H, 1994, EMBO J, V13, P2267, DOI 10.1002/j.1460-2075.1994.tb06508.x
   BELTZER JP, 1991, J BIOL CHEM, V266, P973
   Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x
   DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633
   Eusebio A, 1998, EXP CELL RES, V241, P181, DOI 10.1006/excr.1998.4042
   Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x
   Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361
   GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7
   GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G
   Harley CA, 1998, J BIOL CHEM, V273, P24963, DOI 10.1074/jbc.273.38.24963
   HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786
   Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3
   HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743
   HIGH S, 1993, J BIOL CHEM, V268, P26745
   Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755
   MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5
   MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x
   Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355
   Pilon M, 1998, MOL BIOL CELL, V9, P3455, DOI 10.1091/mbc.9.12.3455
   Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540
   Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9
   Pohlschroder M, 1997, CELL, V91, P563, DOI 10.1016/S0092-8674(00)80443-2
   Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200
   SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16
   SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9
   SPIESS M, 1995, FEBS LETT, V369, P76, DOI 10.1016/0014-5793(95)00551-J
   Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488
   vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261
   VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7
   Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555
   WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511
   WESSELS HP, 1991, METHOD CELL BIOL, V34, P287
   Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590
   Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0
NR 34
TC 84
Z9 84
U1 0
U2 4
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAR
PY 2004
VL 15
IS 3
BP 1470
EP 1478
DI 10.1091/mbc.E03-08-0599
PG 9
WC Cell Biology
SC Cell Biology
GA 800TZ
UT WOS:000220051900049
PM 14668483
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Nordheim, U
   Nicholson, JR
   Senn, C
   Hofbauer, KG
AF Nordheim, U
   Nicholson, JR
   Senn, C
   Hofbauer, KG
TI Stimulation of hypothalamic NPYY2 receptors by peripheral administration
   of PYY3-36 activates central melanocortin pathways
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
CT 45th Spring Meeting of the
   German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology
CY MAR 09-11, 2004
CL Mainz, GERMANY
SP German Soc Exptl & Clin Pharmacol & Toxicol
C1 Univ Basel, Biozentrum Pharmazentrum, Chair Appl Pharmacol, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0028-1298
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD MAR
PY 2004
VL 369
SU 1
MA 324
BP R81
EP R81
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 808UA
UT WOS:000220592800325
DA 2021-01-25
ER

PT J
AU Stetefeld, J
   Alexandrescu, AT
   Maciejewski, MW
   Jenny, M
   Rathgeb-Szabo, K
   Schulthess, T
   Landwehr, R
   Frank, S
   Ruegg, MA
   Kammerer, RA
AF Stetefeld, J
   Alexandrescu, AT
   Maciejewski, MW
   Jenny, M
   Rathgeb-Szabo, K
   Schulthess, T
   Landwehr, R
   Frank, S
   Ruegg, MA
   Kammerer, RA
TI Modulation of agrin function by alternative splicing and Ca2+ binding
SO STRUCTURE
LA English
DT Article
ID ALPHA-DYSTROGLYCAN BINDING; CRYSTAL-STRUCTURE; RECEPTOR; DOMAIN;
   PROTEIN; CALCIUM; HEPARIN; NMR; DYNAMICS; ISOFORMS
AB The aggregation of acetylcholine receptors on postsynaptic membranes is a key step in neuromuscular junction development. This process depends on alternatively spliced forms of the proteoglycan agrin with "B-inserts" of 8, 11, or 19 residues in the protein's globular C-terminal domain, G3. Structures of the neural B8 and B11 forms of agrin-G3 were determined by X-ray crystallography. The structure of G3-B0, which lacks inserts, was determined by NMR. The agrin-G3 domain adopts a beta jellyroll fold. The B insert site is flanked by four loops on one edge of the beta sandwich. The loops form a surface that corresponds to a versatile interaction interface in the family of structurally related LNS proteins. NMR and X-ray data indicate that this interaction interface is flexible in agrin-G3 and that flexibility is reduced by Ca2+ binding. The plasticity of the interaction interface could enable different splice forms of agrin to select between multiple binding partners.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.
   Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06032 USA.
   Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.
RP Alexandrescu, AT (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joerg.stetefeld@unibas.ch; andrei@uconn.edu
RI Ruegg, Markus/X-7256-2019; Stetefeld, Joerg/H-7630-2017
OI Ruegg, Markus/0000-0002-4974-9384; Stetefeld, Joerg/0000-0003-1478-3248;
   Kammerer, Richard/0000-0003-4570-5197
CR Alexandrescu AT, 2001, J BIOMOL NMR, V20, P295, DOI 10.1023/A:1011256008944
   Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459
   BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8
   Borges LS, 2002, J NEUROBIOL, V50, P69, DOI 10.1002/neu.10020
   Brunger A. T., 1992, SYSTEM XRAY CRYSTALL
   Burgess RW, 2002, J NEUROCHEM, V83, P271, DOI 10.1046/j.1471-4159.2002.01102.x
   Campanelli JT, 1996, DEVELOPMENT, V122, P1663
   CHOTHIA C, 1987, COLD SPRING HARB SYM, V52, P399, DOI 10.1101/SQB.1987.052.01.046
   CONSTANTINE KL, 1993, PROTEINS, V15, P290, DOI 10.1002/prot.340150307
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Cornish T, 1999, J CELL SCI, V112, P1213
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0
   Gaggelli E, 1999, EUR J BIOCHEM, V262, P268, DOI 10.1046/j.1432-1327.1999.00420.x
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504
   Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284
   Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3
   Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3
   Hoover CL, 2003, J CELL BIOL, V161, P923, DOI 10.1083/jcb.200301013
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279
   Martin PT, 2002, GLYCOBIOLOGY, V12, p1R, DOI 10.1093/glycob/12.1.1R
   McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q
   Megeath LJ, 1998, J NEUROSCI, V18, P672
   NILGES M, 1991, NATO ADV SCI I A-LIF, V225, P451
   Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3
   Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389
   Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200
   Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839
   Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432
   Tseng CN, 2003, J BIOL CHEM, V278, P17236, DOI 10.1074/jbc.M300282200
   TURK D, 1992, THESIS TU MUNCHEN MU
   Wiltscheck R, 1997, PROTEIN SCI, V6, P1734, DOI 10.1002/pro.5560060814
   Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X
   Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9
NR 43
TC 38
Z9 39
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD MAR
PY 2004
VL 12
IS 3
BP 503
EP 515
DI 10.1016/j.str.2004.02.001
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 821AB
UT WOS:000221430300018
PM 15016366
DA 2021-01-25
ER

PT J
AU Bowers, K
   Lottridge, J
   Helliwell, SB
   Goldthwaite, LM
   Luzio, JP
   Stevens, TH
AF Bowers, K
   Lottridge, J
   Helliwell, SB
   Goldthwaite, LM
   Luzio, JP
   Stevens, TH
TI Protein-protein interactions of ESCRT complexes in the yeast
   Saccharomyces cerevisiae
SO TRAFFIC
LA English
DT Article
DE class E; endosome; ESCRT complexes; multivesicular body; protein
   sorting; vacuole; VPS
ID MULTIVESICULAR BODY PATHWAY; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL
   3-PHOSPHATE; DEUBIQUITINATING ENZYME; CARBOXYPEPTIDASE-Y; VACUOLE
   BIOGENESIS; ENDOCYTIC PATHWAY; DOWN-REGULATION; EBOLA-VIRUS; UBIQUITIN
AB Ten class E Vps proteins in yeast are known components of the ESCRT complexes I, II and III, which are required for the sorting of proteins to the lumenal membranes of multivesicular bodies. We used the yeast 2 hybrid system to analyze the protein-protein interactions of all 17 soluble class E Vps proteins, as well as proteins thought to be required for the ubiquitination and deubiquitination of cargo proteins at multivesicular bodies. We identified novel interactions between yeast ESCRT complex components suggesting that ESCRTI binds to both ESCRTII and ESCRTIII. These interactions were confirmed by GST pull-down experiments. Our data indicate that the link between ESCRTI and ESCRTIII is via Vps28p and Vps37p/Srn2p binding directly to Vps20p, as well as through indirect interactions via ESCRTII. This is in contrast to the situation in mammalian cells where ESCRTI and ESCRTIII interact indirectly via ALIX, the mammalian homologue of yeast proteins Vps31p/Bro1p and Rim20p. Our data also enable us to link all soluble class E Vps proteins to the ESCRT complexes. We propose the formation of a large multimeric complex on the endosome membrane consisting of ESCRTI, ESCRTII, ESCRTIII and other associated proteins.
C1 Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England.
   Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2XY, England.
   Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.
   Univ Basel, Div Biochem, Biozentrum, CH-4056 Basel, Switzerland.
RP Bowers, K (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome Trust,MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.
EM kb123@cam.ac.uk
RI Bowers, Katherine/U-2013-2019
OI Bowers, Katherine/0000-0001-5085-5208; Stevens, Tom/0000-0001-6427-6848
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM038006,
   R01GM038006, R01GM032448, R01GM038006, R01GM032448, R37GM032448,
   R01GM038006, R01GM038006, R01GM032448, R01GM038006, R01GM038006,
   R01GM038006, R01GM038006, R01GM032448, R37GM032448, R01GM038006,
   R01GM038006, R01GM032448, R01GM032448, R01GM032448, R01GM038006,
   R01GM032448, R01GM032448, R37GM032448, R01GM038006, R01GM038006,
   R01GM032448, R01GM038006, R37GM032448, R37GM032448, R01GM038006,
   R01GM038006, R37GM032448, R01GM032448, R01GM038006, R01GM038006,
   R01GM038006, R01GM032448, R01GM032448, R01GM038006, R37GM032448,
   R37GM032448, R01GM032448, R01GM038006, R01GM032448, R01GM038006,
   R37GM032448, R01GM038006, R01GM038006, R01GM038006, R37GM032448,
   R01GM038006, R01GM032448, R01GM038006, R01GM032448, R01GM032448,
   R01GM038006] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [GM38006, GM32448] Funding Source: Medline
CR Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365
   Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982
   Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8
   Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4
   Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x
   BACHEKG, 2003, J CELL BIOL, V162, P435
   BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369
   Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007
   Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815
   Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080
   Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005
   Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277
   Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998
   Burke D, 2000, METHODS YEAST GENETI
   Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5
   Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1
   Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6
   Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001
   Friant S, 2003, DEV CELL, V5, P499, DOI 10.1016/S1534-5807(03)00238-7
   Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946
   Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2
   Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577
   HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x
   Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649
   Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4
   Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380
   Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a
   Howard TL, 2001, J CELL SCI, V114, P2395
   Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498
   James P, 1996, GENETICS, V144, P1425
   Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200
   Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200
   Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200
   Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2
   Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473
   Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136
   Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973
   Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440
   Kranz A, 2001, MOL BIOL CELL, V12, P711, DOI 10.1091/mbc.12.3.711
   Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047
   Luban J, 2001, NAT MED, V7, P1278, DOI 10.1038/nm1201-1278
   MARCUSSON EG, 1994, CELL, V77, P579, DOI 10.1016/0092-8674(94)90219-4
   Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100
   Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313
   Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456
   Nikko E, 2003, J BIOL CHEM, V278, P50732, DOI 10.1074/jbc.M306953200
   NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35
   Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9
   Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395
   ORLOWSKI J, 2003, IN PRESS PFLUGERS AR, DOI DOI 10.1007/S00424-00003-01110-00423
   Paidhungat M, 1998, GENETICS, V148, P1787
   Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x
   Pornillos O, 2002, EMBO J, V21, P2397, DOI 10.1093/emboj/21.10.2397
   Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138
   Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9
   Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2
   RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389
   Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176
   ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644
   ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936
   ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x
   ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schmidt AE, 1999, J BIOL CHEM, V274, P21981, DOI 10.1074/jbc.274.31.21981
   Shaw JD, 2003, TRAFFIC, V4, P479, DOI 10.1034/j.1600-0854.2003.t01-1-00106.x
   Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Springael JY, 2002, FEBS LETT, V517, P103, DOI 10.1016/S0014-5793(02)02586-3
   Springael JY, 1999, J CELL SCI, V112, P1375
   Stauffer DR, 2001, J CELL SCI, V114, P2383
   Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x
   VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198
   Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533
   von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1
   Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001
   Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200
   WOLF DH, 1975, J BACTERIOL, V123, P1150, DOI 10.1128/JB.123.3.1150-1156.1975
   Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751
NR 82
TC 154
Z9 166
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-9219
EI 1600-0854
J9 TRAFFIC
JI Traffic
PD MAR
PY 2004
VL 5
IS 3
BP 194
EP 210
DI 10.1111/j.1600-0854.2004.00169.x
PG 17
WC Cell Biology
SC Cell Biology
GA 776WT
UT WOS:000189142900007
PM 15086794
DA 2021-01-25
ER

PT J
AU Arber, S
AF Arber, S
TI Subplate neurons: bridging the gap to function in the cortex
SO TRENDS IN NEUROSCIENCES
LA English
DT Article
ID VISUAL-CORTEX; CONNECTIONS; PROJECTIONS; NEOCORTEX; COLUMNS; CELLS
AB The importance of subplate neurons in controlling multiple steps of cortex development was recognized more than a decade ago. However, knowledge of the precise function of subplate neurons in the establishment of cortical circuitry has been missing. A recent study has now started to dissect the functional and molecular mechanisms underlying the generation of transient neuronal circuitry in the visual cortex.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 170, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X
CR ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185
   CALLAWAY EM, 1992, J NEUROSCI, V12, P570
   Clancy B, 2001, J COMP NEUROL, V434, P233, DOI 10.1002/cne.1174
   FRIAUF E, 1990, J NEUROSCI, V10, P2601
   Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2
   GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795
   GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0
   Hanganu IL, 2002, J NEUROSCI, V22, P7165
   HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x
   Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152
   Lein ES, 1999, P NATL ACAD SCI USA, V96, P13491, DOI 10.1073/pnas.96.23.13491
   McAllister AK, 1999, P NATL ACAD SCI USA, V96, P13600, DOI 10.1073/pnas.96.24.13600
   MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909
   Robertson RT, 2000, J COMP NEUROL, V426, P632, DOI 10.1002/1096-9861(20001030)426:4<632::AID-CNE10>3.0.CO;2-4
   Sarnat Harvey B, 2002, Semin Pediatr Neurol, V9, P302, DOI 10.1053/spen.2002.32506
   VALVERDE F, 1995, J NEUROSCI, V15, P5014
NR 16
TC 14
Z9 15
U1 0
U2 2
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0166-2236
J9 TRENDS NEUROSCI
JI Trends Neurosci.
PD MAR
PY 2004
VL 27
IS 3
BP 111
EP 113
DI 10.1016/j.tins.2004.01.005
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA 804VR
UT WOS:000220326700001
PM 15046074
DA 2021-01-25
ER

PT J
AU Siebert, CA
   Qian, P
   Fotiadis, D
   Engel, A
   Hunter, CN
   Bullough, PA
AF Siebert, CA
   Qian, P
   Fotiadis, D
   Engel, A
   Hunter, CN
   Bullough, PA
TI Molecular architecture of photosynthetic membranes in Rhodobacter
   sphaeroides: the role of PufX
SO EMBO JOURNAL
LA English
DT Article
DE 2D crystals; cytochrome bc(1) complex; light harvesting complex;
   photosynthesis; reaction centre
ID LIGHT-HARVESTING COMPLEX; ELECTRON-TRANSFER COMPONENTS; PIGMENT PROTEIN
   COMPLEXES; RHODOSPIRILLUM-RUBRUM; CRYSTAL-STRUCTURE; CORE COMPLEX;
   SUPRAMOLECULAR ORGANIZATION; RHODOPSEUDOMONAS-VIRIDIS; ANGSTROM
   RESOLUTION; ALPHA-POLYPEPTIDE
AB The effects of the PufX polypeptide on membrane architecture were investigated by comparing the composition and structures of photosynthetic membranes from PufX(+) and PufX(-) strains of Rhodobacter sphaeroides. We show that this single polypeptide profoundly affects membrane morphology, leading to highly elongated cells containing extended tubular membranes. Purified tubular membranes contain helical arrays composed solely of dimeric RC-LH1-PufX (RC, reaction centre; LH, light harvesting) complexes with apparently open LH1 rings. PufX(-) cells contain crystalline membranes with a pseudo-hexagonal packing of monomeric core complexes. Analysis of purified complexes by electron microscopy and atomic force microscopy shows that LH1 and PufX form a continuous ring of protein around each RC. A model of the tubular membrane is presented with PufX located adjacent to the stained region created by a vacant LH1beta. This arrangement, coupled with a flexible ring, would give the RC Q(B) site transient access to the interstices in the lattice, which might be of functional importance. We discuss the implications of our data for the export of quinol from the RC, for eventual reduction of the cytochrome bc(1) complex.
C1 Univ Sheffield, Krebs Inst Biomol Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Bullough, PA (corresponding author), Univ Sheffield, Krebs Inst Biomol Res, Dept Mol Biol & Biotechnol, Firth Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.
EM p.bullough@sheffield.ac.uk
OI Bullough, Per/0000-0001-8147-1127; Siebert, charles/0000-0002-8126-1979
CR ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P5730, DOI 10.1073/pnas.84.16.5730
   BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15248, DOI 10.1021/bi00046a033
   BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15235, DOI 10.1021/bi00046a032
   Cogdell RJ, 1996, PHOTOSYNTH RES, V48, P55, DOI 10.1007/BF00040996
   Crofts A, 1998, PHOTOSYNTH RES, V55, P357, DOI 10.1023/A:1005940120396
   Crofts AR, 2000, TRENDS MICROBIOL, V8, P105, DOI 10.1016/S0966-842X(99)01693-5
   CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6
   Crofts AR, 2000, TRENDS MICROBIOL, V8, P107, DOI 10.1016/S0966-842X(99)01695-9
   CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0
   DREWS G, 1995, ADV PHOTOSYNTH, V2, P231
   FARCHAUS JW, 1990, J BACTERIOL, V172, P977, DOI 10.1128/jb.172.2.977-985.1990
   FARCHAUS JW, 1992, EMBO J, V11, P2779, DOI 10.1002/j.1460-2075.1992.tb05345.x
   Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200
   Francia F, 1999, BIOCHEMISTRY-US, V38, P6834, DOI 10.1021/bi982891h
   Frese RN, 2000, P NATL ACAD SCI USA, V97, P5197, DOI 10.1073/pnas.090083797
   GOLECKI JR, 1991, J MICROSC-OXFORD, V162, P147, DOI 10.1111/j.1365-2818.1991.tb03125.x
   GOLECKI JR, 1991, FEMS MICROBIOL LETT, V77, P335, DOI 10.1016/0378-1097(91)90576-V
   HUNTER CN, 1988, BIOCHEMISTRY-US, V27, P3459, DOI 10.1021/bi00409a050
   Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410
   Joliot P, 1997, BBA-BIOENERGETICS, V1318, P374, DOI 10.1016/S0005-2728(96)00114-4
   JOLIOT P, 1993, BIOCHIM BIOPHYS ACTA, V1141, P151, DOI 10.1016/0005-2728(93)90039-I
   Joliot P, 1996, PHOTOSYNTH RES, V48, P291, DOI 10.1007/BF00041020
   JOLIOT P, 1989, BIOCHIM BIOPHYS ACTA, V975, P336, DOI 10.1016/S0005-2728(89)80341-X
   JONES MR, 1992, MOL MICROBIOL, V6, P1173, DOI 10.1111/j.1365-2958.1992.tb01556.x
   Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534
   KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x
   Katona G, 2003, J MOL BIOL, V331, P681, DOI 10.1016/S0022-2836(03)00751-4
   Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9
   LILBURN TG, 1992, BIOCHIM BIOPHYS ACTA, V1100, P160
   MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0
   MCGLYNN P, 1994, FEBS LETT, V349, P349, DOI 10.1016/0014-5793(94)00701-2
   McGlynn P, 1996, J BIOL CHEM, V271, P3285, DOI 10.1074/jbc.271.6.3285
   MILLER KR, 1982, NATURE, V300, P53, DOI 10.1038/300053a0
   Pugh RJ, 1998, BBA-BIOENERGETICS, V1366, P301, DOI 10.1016/S0005-2728(98)00131-5
   Qian P, 2003, J BIOL CHEM, V278, P23678, DOI 10.1074/jbc.M302753200
   Recchia PA, 1998, BIOCHEMISTRY-US, V37, P11055, DOI 10.1021/bi980657l
   Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892
   SABATY M, 1994, BBA-BIOENERGETICS, V1187, P313, DOI 10.1016/0005-2728(94)90005-1
   SCHACHMAN HK, 1952, ARCH BIOCHEM BIOPHYS, V38, P245, DOI 10.1016/0003-9861(52)90029-5
   Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100
   SCHEURING S, 2004, IN PRESS J BIOL CHEM
   Stahlberg H, 1998, J MOL BIOL, V282, P819, DOI 10.1006/jmbi.1998.1975
   STARK W, 1984, EMBO J, V3, P777, DOI 10.1002/j.1460-2075.1984.tb01884.x
   Tremmel IG, 2003, BBA-BIOENERGETICS, V1607, P97, DOI 10.1016/j.bbabio.2003.09.004
   VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445
   Vermeglio A, 1999, TRENDS MICROBIOL, V7, P435, DOI 10.1016/S0966-842X(99)01625-X
   Vermeglio A, 2000, TRENDS MICROBIOL, V8, P106, DOI 10.1016/S0966-842X(99)01694-7
   Vermeglio A, 2002, BBA-BIOENERGETICS, V1555, P60, DOI 10.1016/S0005-2728(02)00255-4
   VERMEGLIO A, 1995, ADV PHOTOSYNTH, V2, P279
   Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050
   Walz T, 1997, J MOL BIOL, V265, P107, DOI 10.1006/jmbi.1996.0714
   Westerhuis WHJ, 2002, BIOCHEMISTRY-US, V41, P8698, DOI 10.1021/bi011663b
NR 54
TC 125
Z9 139
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD FEB 25
PY 2004
VL 23
IS 4
BP 690
EP 700
DI 10.1038/sj.emboj.7600092
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 810GZ
UT WOS:000220694100002
PM 14765115
OA Green Published
DA 2021-01-25
ER

PT J
AU Golding, JP
   Sobieszczuk, D
   Dixon, M
   Coles, E
   Christiansen, J
   Wilkinson, D
   Gassmann, M
AF Golding, JP
   Sobieszczuk, D
   Dixon, M
   Coles, E
   Christiansen, J
   Wilkinson, D
   Gassmann, M
TI Roles of erbB4, rhombomere-specific, and rhombomere-independent cues in
   maintaining neural crest-free zones in the embryonic head
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE neural crest; erbB4; mesenchyme; quail Sulf1; chick Sulf1; surface
   ectoderm; cell migration patterning
ID MICE LACKING; CRANIAL MESENCHYME; GENE-EXPRESSION; MOTOR-NEURONS; EPH
   RECEPTORS; HINDBRAIN; MIGRATION; NEUREGULIN; SEGMENTATION; COLLAPSIN-1
AB Within the developing vertebrate head, the migration of neural tube-derived neural crest cells (NCCs) through the cranial mesenchyme is patterned into three streams, with mesenchyme adjacent to rhombomeres (r)3 and r5 maintained NCC-free. The receptor tyrosine kinase erbB4 is expressed within r3 and r5 and is required to maintain the r3-adjacent NCC-free zone in mouse embryos. In this study, we demonstrate that the extent of r3 involvement in patterning mouse NCC migration is restricted to the same dorsolateral region regulated by erbB4. In chick embryos, we show that erb134 signaling similarly maintains the r3-adjacent NCC-free zone. However, although r5 expresses erb134, this is insufficient to maintain the r3-adjacent NCC-free zone in grafting experiments where r5 replaced r3, indicating that erbB4 requires additional factors at the A-P level of r3 to pattern NCC migration. Furthermore, we show that the r5-adjacent NCC-free zone is maintained independently of r5, but requires surface ectoderm. Finally, we demonstrate that avian cranial surface ectoderm is patterned molecularly, with dorsolateral surface ectoderm at the levels of r2/3 and C expressing the sulfatase QSulf1 in quail, or the orthologue CSulf1 in chick. Aberrant NCC migration into r3-adjacent mesenchyme correlated with more focused QSulf1 expression in r2/3 surface ectoderm. (C) 2003 Elsevier Inc. All rights reserved.
C1 Natl Inst Med Res, Div Neurobiol, London NW7 1AA, England.
   Natl Inst Med Res, Div Dev Neurobiol, London NW7 1AA, England.
   Univ Basel, Dept Physiol, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Golding, JP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Clin Sci,Muscle Cell Biol Grp, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.
EM jon.golding@csc.mrc.ac.uk
RI Golding, Jon/L-2700-2017
OI Golding, Jon/0000-0002-7910-7382; Christiansen,
   Jeff/0000-0002-8146-1225; Gassmann, Martin/0000-0001-6201-3032
CR Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X
   Barrow JR, 2000, DEVELOPMENT, V127, P933
   Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168
   Borg JP, 2000, NAT CELL BIOL, V2, P407, DOI 10.1038/35017038
   Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5
   CARPENTER EM, 1993, DEVELOPMENT, V118, P1063
   Christiansen JH, 2001, MECH DEVELOP, V102, P119, DOI 10.1016/S0925-4773(01)00294-5
   Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663
   Dixon M, 1999, MOL CELL NEUROSCI, V13, P237, DOI 10.1006/mcne.1999.0749
   Eickholt BJ, 1999, DEVELOPMENT, V126, P2181
   Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761
   Farlie PG, 1999, DEV BIOL, V213, P70, DOI 10.1006/dbio.1999.9332
   Gale E, 1996, DEVELOPMENT, V122, P783
   Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497
   GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0
   Gavalas A, 1997, DEVELOPMENT, V124, P3693
   Golding JP, 2002, DEVELOPMENT, V129, P1095
   Golding JP, 1999, DEV BIOL, V216, P85, DOI 10.1006/dbio.1999.9497
   Golding JP, 2000, NAT CELL BIOL, V2, P103, DOI 10.1038/35000058
   Grove EA, 1998, DEVELOPMENT, V125, P2315
   Jacob J, 2000, J NEUROSCI, V20, P7664
   Kawasaki T, 2002, DEVELOPMENT, V129, P671
   Kobayashi H, 1997, J NEUROSCI, V17, P8339
   Kulesa PM, 1998, DEV BIOL, V204, P327, DOI 10.1006/dbio.1998.9082
   KURATANI SC, 1993, DEVELOPMENT, V117, P105
   LADOUARIN NM, 1982, NEURAL CREST
   Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726
   LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0
   LUMSDEN A, 1991, DEVELOPMENT, V113, P1281
   Manzanares M, 1999, DEV BIOL, V211, P220, DOI 10.1006/dbio.1999.9318
   Mason I, 1999, METH MOL B, V97, P221, DOI 10.1385/1-59259-270-8:221
   Moens CB, 1996, DEVELOPMENT, V122, P3981
   Nittenberg R, 1997, DEVELOPMENT, V124, P2297
   Rijli FM, 1998, INT J DEV BIOL, V42, P393
   SECHRIST J, 1993, DEVELOPMENT, V118, P691
   SECHRIST J, 1994, DEVELOPMENT, V120, P1777
   Shepherd I, 1996, DEV BIOL, V173, P185, DOI 10.1006/dbio.1996.0016
   Smith A, 1997, CURR BIOL, V7, P561, DOI 10.1016/S0960-9822(06)00255-7
   Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0
   Theil T, 2002, DEVELOPMENT, V129, P1477
   Theil T, 1998, DEVELOPMENT, V125, P443
   Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7
   Trainor PA, 2002, DEVELOPMENT, V129, P433
   Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056
   Ulupinar E, 1999, MOL CELL NEUROSCI, V13, P281, DOI 10.1006/mcne.1999.0747
   Wilkinson DG, 2000, INT REV CYTOL, V196, P177
   Xu QL, 2000, PHILOS T ROY SOC B, V355, P993, DOI 10.1098/rstb.2000.0635
   YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277
NR 48
TC 27
Z9 27
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD FEB 15
PY 2004
VL 266
IS 2
BP 361
EP 372
DI 10.1016/j.ydbio.2003.11.003
PG 12
WC Developmental Biology
SC Developmental Biology
GA 776RA
UT WOS:000189129300011
PM 14738883
DA 2021-01-25
ER

PT J
AU Kaufmann, I
   Martin, G
   Friedlein, A
   Langen, H
   Keller, W
AF Kaufmann, I
   Martin, G
   Friedlein, A
   Langen, H
   Keller, W
TI Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and
   stimulates poly(A) polymerase
SO EMBO JOURNAL
LA English
DT Article
DE cleavage and polyadenylation specificity factor; polyadenylation;
   poly(A) site recognition; pre-mRNA 3 ' end processing; upstream sequence
   elements
ID POLYADENYLATION SPECIFICITY FACTOR; IDIOPATHIC HYPEREOSINOPHILIC
   SYNDROME; UPSTREAM SEQUENCE ELEMENT; PRE-MESSENGER-RNAS; SNRNP-A
   PROTEIN; MAMMALIAN CLEAVAGE; PROCESSING FACTOR; SITE RECOGNITION; 160-KD
   SUBUNIT; FACTOR-I
AB In mammals, polyadenylation of mRNA precursors (pre-mRNAs) by poly( A) polymerase ( PAP) depends on cleavage and polyadenylation specificity factor ( CPSF). CPSF is a multisubunit complex that binds to the canonical AAUAAA hexamer and to U-rich upstream sequence elements on the pre-mRNA, thereby stimulating the otherwise weakly active and nonspecific polymerase to elongate efficiently RNAs containing a poly( A) signal. Based on sequence similarity to the Saccharomyces cerevisiae polyadenylation factor Fip1p, we have identified human Fip1 (hFip1) and found that the protein is an integral subunit of CPSF. hFip1 interacts with PAP and has an arginine-rich RNA-binding motif that preferentially binds to U-rich sequence elements on the pre-mRNA. Recombinant hFip1 is sufficient to stimulate the in vitro polyadenylation activity of PAP in a U-rich element-dependent manner. hFip1, CPSF160 and PAP form a ternary complex in vitro, suggesting that hFip1 and CPSF160 act together in poly( A) site recognition and in cooperative recruitment of PAP to the RNA. These results show that hFip1 significantly contributes to CPSF-mediated stimulation of PAP activity.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   F Hoffmann La Roche & Co Ltd, Roche Genet, CH-4002 Basel, Switzerland.
RP Keller, W (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM walter.keller@unibas.ch
CR Aissouni Y, 2002, J BIOL CHEM, V277, P35808, DOI 10.1074/jbc.M200540200
   Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778
   Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703
   BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x
   BIENROTH S, 1991, J BIOL CHEM, V266, P19768
   Brackenridge S, 2000, MOL CELL BIOL, V20, P2660, DOI 10.1128/MCB.20.8.2660-2669.2000
   BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511
   Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217
   Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390
   Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4
   Dichtl B, 2001, EMBO J, V20, P3197, DOI 10.1093/emboj/20.12.3197
   Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5
   FRIEDMAN DI, 1995, MOL MICROBIOL, V18, P191, DOI 10.1111/j.1365-2958.1995.mmi_18020191.x
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   GILMARTIN GM, 1995, GENE DEV, V9, P72, DOI 10.1101/gad.9.1.72
   Graveley BR, 1996, MOL CELL BIOL, V16, P4942
   Graveley BR, 1996, J VIROL, V70, P1612, DOI 10.1128/JVI.70.3.1612-1617.1996
   Griffin JH, 2003, P NATL ACAD SCI USA, V100, P7830, DOI 10.1073/pnas.0932698100
   Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X
   GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3
   Hans H, 2000, MOL CELL BIOL, V20, P2926, DOI 10.1128/MCB.20.8.2926-2932.2000
   Helming S, 2001, MOL CELL BIOL, V21, P2026, DOI 10.1128/MCB.21.6.2026-2037.2001
   HUMPHREY T, 1987, EMBO J, V6, P4159, DOI 10.1002/j.1460-2075.1987.tb02762.x
   JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183
   JENNY A, 1995, NUCLEIC ACIDS RES, V23, P2629, DOI 10.1093/nar/23.14.2629
   Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514
   Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060
   KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x
   Klasens BIF, 1999, NUCLEIC ACIDS RES, V27, P446, DOI 10.1093/nar/27.2.446
   LACASSE EC, 1995, NUCLEIC ACIDS RES, V23, P1647, DOI 10.1093/nar/23.10.1647
   LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9
   Legendre M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-7
   LUTZ CS, 1994, GENE DEV, V8, P576, DOI 10.1101/gad.8.5.576
   Lutz CS, 1996, GENE DEV, V10, P325, DOI 10.1101/gad.10.3.325
   Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x
   MOREIRA A, 1995, EMBO J, V14, P3809, DOI 10.1002/j.1460-2075.1995.tb00050.x
   Moreira A, 1998, GENE DEV, V12, P2522, DOI 10.1101/gad.12.16.2522
   MURTHY KGK, 1992, J BIOL CHEM, V267, P14804
   MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672
   Phillips C, 1997, NUCLEIC ACIDS RES, V25, P2344, DOI 10.1093/nar/25.12.2344
   Preker PJ, 1997, EMBO J, V16, P4727, DOI 10.1093/emboj/16.15.4727
   PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7
   PRESCOTT J, 1994, MOL CELL BIOL, V14, P4682, DOI 10.1128/MCB.14.7.4682
   Ruegsegger U, 1996, J BIOL CHEM, V271, P6107
   Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583
   Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2
   Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000
   WAHLE E, 1991, J BIOL CHEM, V266, P3131
   Walsh EP, 2002, BIOCHEMISTRY-US, V41, P2409, DOI 10.1021/bi015815e
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
   Zhelkovsky A, 1998, MOL CELL BIOL, V18, P5942, DOI 10.1128/MCB.18.10.5942
NR 51
TC 158
Z9 168
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD FEB 11
PY 2004
VL 23
IS 3
BP 616
EP 626
DI 10.1038/sj.emboj.7600070
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 773KA
UT WOS:000188921900014
PM 14749727
OA Green Published
DA 2021-01-25
ER

PT J
AU Kong, XC
   Barzaghi, P
   Ruegg, MA
AF Kong, XC
   Barzaghi, P
   Ruegg, MA
TI Inhibition of synapse assembly in mammalian muscle in vivo by RNA
   interference
SO EMBO REPORTS
LA English
DT Article
ID UTROPHIN-DEFICIENT MICE; TYROSINE KINASE MUSK; GENE-EXPRESSION;
   NEUROMUSCULAR-JUNCTIONS; AGRIN; CELLS; FIBERS; INDUCTION; SYSTEM
AB The formation of the vertebrate neuromuscular junction (NMJ) requires the receptor tyrosine kinase MuSK and the adaptor molecule rapsyn. Here, we report that the phenotypes of mice deficient in these two molecules can be reproduced by RNA interference (RNAi) in rat muscle in vivo. Specifically, double-stranded RNA (dsRNA) targeting MuSK and rapsyn inhibited the formation of the NMJ in rat muscle fibres in vivo, while dsRNA targeting nonessential proteins did not have any effect. Moreover, plasmids that trigger RNAi to MuSK induced the disassembly of existing NMJs. These results thus demonstrate for the first time the functionality of dsRNA in silencing endogenous genes in adult mammalian muscle in vivo. Moreover, they show that MuSK is also required for the maintenance of the NMJ, offering a mechanistic explanation for the myasthenia gravis caused by auto-antibodies to MuSK.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
CR BENOIST C, 1999, FUNDAMENTAL IMMUNOLO, V1, P367
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000
   Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999
   Chi JT, 2003, P NATL ACAD SCI USA, V100, P6343, DOI 10.1073/pnas.1037853100
   Cohen I, 1997, MOL CELL NEUROSCI, V9, P237, DOI 10.1006/mcne.1997.0623
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883
   DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547
   Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0
   Gehl J, 1999, BIOCHEM BIOPH RES CO, V261, P377, DOI 10.1006/bbrc.1999.1014
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871
   Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520
   Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831
   Jones G, 1999, J NEUROSCI, V19, P3376
   Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944
   McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a
   McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824
   McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908
   Meier T, 1997, J NEUROSCI, V17, P6534
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Moore C, 2001, P NATL ACAD SCI USA, V98, P14655, DOI 10.1073/pnas.251291598
   Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399
   Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100
   Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619
   Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016
   Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836
   Yi CE, 2003, J BIOL CHEM, V278, P934, DOI 10.1074/jbc.M205946200
   Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499
NR 34
TC 100
Z9 100
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD FEB
PY 2004
VL 5
IS 2
BP 183
EP 188
DI 10.1038/sj.embor.7400065
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 779ZX
UT WOS:000189344800016
PM 14749715
OA Green Published
DA 2021-01-25
ER

PT J
AU Mucke, N
   Kreplak, L
   Kirmse, R
   Wedig, T
   Herrmann, H
   Aebi, U
   Langowski, J
AF Mucke, N
   Kreplak, L
   Kirmse, R
   Wedig, T
   Herrmann, H
   Aebi, U
   Langowski, J
TI Assessing the flexibility of intermediate filaments by atomic force
   microscopy
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE statistical analysis; persistence length; surface interaction; electron
   microscopy; atomic force microscopy
ID LIVING ENDOTHELIAL-CELLS; ACTIN FILAMENT; F-ACTIN;
   MECHANICAL-PROPERTIES; CARDIAC MYOCYTES; VIMENTIN; ARCHITECTURE;
   PHALLOIDIN; PROTEINS; INSIGHTS
AB Eukaryotic cells contain three cytoskeletal filament systems that exhibit very distinct assembly properties, supramolecular architectures, dynamic behaviour and mechanical properties. Microtubules and microfilaments are relatively stiff polar structures whose assembly is modulated by the state of hydrolysis of the bound nucleotide. In contrast, intermediate filaments (IFs) are more flexible apolar structures assembled from a similar to 45 nm long coiled-coil dimer as the elementary building block. The differences in flexibility that exist among the three filament systems have been described qualitatively by comparing electron micrographs of negatively stained dehydrated filaments and by directly measuring the persistence length of F-actin filaments (similar to3 - 10 mum) and microtubules (similar to 1 - 8 mm) by various physical methods. However, quantitative data on the persistence length of IFs are still missing.
   Toward this goal, we have carried out atomic force microscopy (AFM) in physiological buffer to characterise the morphology of individual vimentin IFs adsorbed to different solid supports. In addition, we compared these images with those obtained by transmission electron microscopy (TEM) of negatively stained dehydrated filaments. For each support, we could accurately measure the apparent persistence length of the filaments, yielding values ranging between 0.3 mum and 1 mum. Making simple assumptions concerning the adsorption mechanism, we could estimate the persistence length of an IF in a dilute solution to be similar to 1 mum, indicating that the lower measured values reflect constraints induced by the adsorption process of the filaments on the corresponding support.
   Based on our knowledge of the structural organisation and mechanical properties of IFs, we reason that the lower persistence length of IFs compared to that of F-actin filaments is caused by the presence of flexible linker regions within the coiled-coil dimer and by postulating the occurrence of axial slipping between dimers within lFs. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Basel, ME Muller Inst Struct Biol Biozentrum, CH-4056 Basel, Switzerland.
   German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany.
   German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
RP Mucke, N (corresponding author), Univ Basel, ME Muller Inst Struct Biol Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM norbert.muecke@dkfz-heidelberg.de; laurent.kreplak@unibas.ch
RI Langowski, Jorg/A-1843-2011
OI Langowski, Jorg/0000-0001-8600-0666; kreplak,
   laurent/0000-0001-9370-9809
CR AEBI U, 1986, ANN NY ACAD SCI, V483, P100, DOI 10.1111/j.1749-6632.1986.tb34502.x
   AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   Bloom S, 1996, J MOL CELL CARDIOL, V28, P2123, DOI 10.1006/jmcc.1996.0204
   BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261
   BREMER A, 1991, J CELL BIOL, V115, P689, DOI 10.1083/jcb.115.3.689
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   ERICKSON HP, 1989, J MOL BIOL, V206, P465, DOI 10.1016/0022-2836(89)90494-4
   Flory P.J., 1969, STAT MECH CHAIN MOL
   FRASER RDB, 1976, J MOL BIOL, V108, P435, DOI 10.1016/S0022-2836(76)80129-5
   FRONTALI C, 1979, BIOPOLYMERS, V18, P1353, DOI 10.1002/bip.1979.360180604
   Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514
   Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3
   Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995
   Helmke BP, 2003, BIOPHYS J, V84, P2691, DOI 10.1016/S0006-3495(03)75074-7
   Helmke BP, 2001, BIOPHYS J, V80, P184, DOI 10.1016/S0006-3495(01)76006-7
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   Hohenadl M, 1999, BIOPHYS J, V77, P2199, DOI 10.1016/S0006-3495(99)77060-8
   ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   KARRASCH S, 1994, J VAC SCI TECHNOL B, V12, P1474, DOI 10.1116/1.587319
   Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101
   KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106
   Kreplak L, 2002, BIOPHYS J, V82, P2265, DOI 10.1016/S0006-3495(02)75572-0
   Landau L., 1986, THEORY ELASTICITY
   Landau L. D., 1980, STAT PHYS 1
   Liu XM, 2002, BIOPHYS J, V83, P2705, DOI 10.1016/S0006-3495(02)75280-6
   LOCKARD VG, 1993, J MOL CELL CARDIOL, V25, P303, DOI 10.1006/jmcc.1993.1036
   Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1
   Parry DAD, 1995, INTERMEDIATE FILAMEN
   RAMAEKERS FCS, 1982, P NATL ACAD SCI-BIOL, V79, P3208, DOI 10.1073/pnas.79.10.3208
   Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687
   Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776
   STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93
   Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559
   Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Wang H, 2000, J CELL BIOL, V151, P1459, DOI 10.1083/jcb.151.7.1459
   Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503
NR 47
TC 162
Z9 167
U1 1
U2 26
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 30
PY 2004
VL 335
IS 5
BP 1241
EP 1250
DI 10.1016/j.jmb.2003.11.038
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 767YK
UT WOS:000188501300008
PM 14729340
DA 2021-01-25
ER

PT J
AU Niederkofler, V
   Salie, R
   Sigrist, M
   Arber, S
AF Niederkofler, V
   Salie, R
   Sigrist, M
   Arber, S
TI Repulsive guidance molecule (RGM) gene function is required for neural
   tube closure but not retinal topography in the mouse visual system
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE RGM; retinal topography; exencephaly; neural tube closure; GPI; axon
   guidance
ID GANGLION-CELL AXONS; EPH RECEPTOR; IN-VITRO; PROTEIN; ELF-1;
   REGENERATION; PREDICTION; EXPRESSION; PROJECTION; INHIBITOR
AB The establishment of topographic projections in the developing visual system depends on the spatially and temporally controlled expression of axon guidance molecules. In the developing chick tectum, the graded expression of the repulsive guidance molecule (RGM) has been proposed to be involved in controlling the topography of the retinal ganglion cell (RGC) axon termination zones along the anteroposterior axis of the tectum. We now show that there are three mouse proteins homologous to chick RGM displaying similar proteolytic processing but exhibiting differential cell-surface targeting by glycosyl phosphatidylinositol anchor addition. Two members of this gene family (mRGMa and mRGMb) are expressed in complementary patterns in the nervous system, and mRGMa is expressed prominently in the superior colliculus at the time of anteroposterior targeting of RGC axons. The third member of the family (mRGMc) is expressed almost exclusively in skeletal muscles. Functional studies in the mouse reveal a role for mRGMa in controlling cephalic neural tube closure, thus defining an unexpected role for mRGMa in early embryonic development. In contrast, mRGMa mutant mice did not exhibit defects in anteroposterior targeting of RGC axons to their stereotypic termination zones in the superior colliculus.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X
CR Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3
   Brittis PA, 2001, NEURON, V30, P11, DOI 10.1016/S0896-6273(01)00258-6
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3
   Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165
   DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5
   Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069
   Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0
   Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3
   GODEMENT P, 1989, DEVELOPMENT, V106, P313
   GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226
   Harris MJ, 1997, TERATOLOGY, V56, P177, DOI 10.1002/(SICI)1096-9926(199709)56:3<177::AID-TERA1>3.0.CO;2-Z
   Holmberg J, 2000, NATURE, V408, P203
   Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1
   Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X
   Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041
   Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258
   Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6
   Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3
   ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886
   SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823
   Sharom FJ, 2002, BIOCHEM CELL BIOL, V80, P535, DOI 10.1139/O02-146
   SIMON DK, 1992, J NEUROSCI, V12, P1212
   SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   Theiler K., 1989, HOUSE MOUSE ATLAS EM
   WALTER J, 1987, DEVELOPMENT, V101, P909
   Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748
NR 31
TC 149
Z9 155
U1 0
U2 2
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JAN 28
PY 2004
VL 24
IS 4
BP 808
EP 818
DI 10.1523/JNEUROSCI.4610-03.2004
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 768DJ
UT WOS:000188512700005
PM 14749425
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Fotiadis, D
   Qian, P
   Philippsen, A
   Bullough, PA
   Engel, A
   Hunter, CN
AF Fotiadis, D
   Qian, P
   Philippsen, A
   Bullough, PA
   Engel, A
   Hunter, CN
TI Structural analysis of the reaction center light-harvesting complex I
   photosynthetic core complex of Rhodospirillum rubrum using atomic force
   microscopy
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID RHODOBACTER-SPHAEROIDES R-26; PUFX PROTEIN; RHODOPSEUDOMONAS-VIRIDIS;
   ANGSTROM RESOLUTION; TRYPTOPHAN RESIDUES; ANTENNA COMPLEX;
   ENERGY-TRANSFER; LH2; SUBUNITS; MEMBRANE
AB The bacterium Rhodospirillum rubrum contains a simple photosynthetic system, in which the reaction center ( RC) receives energy from the light-harvesting (LH1) complex. We have used high-resolution atomic force microscopy (AFM) to image two-dimensional crystals of the RC-LH1 complex of R. rubrum. The AFM topographs show that the RC-LH1 complex is similar to 94 Angstrom in height, the RC-H subunit protrudes from the cytoplasmic face of the membrane by 40 Angstrom, and it sits 21 Angstrom above the highest point of the surrounding LH1 ring. In contrast, the RC on the periplasmic side is at a lower level than LH1, which protrudes from the membrane by 12 Angstrom. The RC-LH1 complex can adopt an irregular shape in regions of uneven packing forces in the crystal; this reflects a likely flexibility in the natural membrane, which might be functionally important by allowing the export of quinol formed as a result of RC photochemistry. Nanodissection of the RC by the AFM tip removes the RC-H subunit and reveals the underlying RC-L and -M subunits. LH1 complexes completely lacking the RC were also found, providing ideal conditions for imaging both rings of LH1 polypeptides for the first time by AFM. In addition, we demonstrate the ellipticity of the LH1 ring at the cytoplasmic and periplasmic sides of the membrane, in both the presence and absence of the RC. These AFM measurements have been reconciled with previous electron microscopy and NMR data to produce a model of the RC-LH1 complex.
C1 Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Hunter, CN (corresponding author), Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.
EM c.n.hunter@sheffield.ac.uk
OI Bullough, Per/0000-0001-8147-1127
CR ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162
   ARNOUX B, 1989, FEBS LETT, V258, P47, DOI 10.1016/0014-5793(89)81612-6
   BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15248, DOI 10.1021/bi00046a033
   BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15235, DOI 10.1021/bi00046a032
   BEEKMAN LMP, 1994, BIOCHEMISTRY-US, V33, P3143, DOI 10.1021/bi00177a001
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BRUNISHOLZ RA, 1984, H-S Z PHYSIOL CHEM, V365, P689, DOI 10.1515/bchm2.1984.365.2.689
   Conroy MJ, 2000, J MOL BIOL, V298, P83, DOI 10.1006/jmbi.2000.3649
   de Planque MRR, 2003, BIOCHEMISTRY-US, V42, P5341, DOI 10.1021/bi027000r
   DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Forster T, 1965, MODERN QUANTUM CHEMI, P93
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fotiadis D, 1998, J MOL BIOL, V283, P83, DOI 10.1006/jmbi.1998.2097
   Freer A, 1996, STRUCTURE, V4, P449, DOI 10.1016/S0969-2126(96)00050-0
   Gerken U, 2003, BIOCHEMISTRY-US, V42, P10354, DOI 10.1021/bi034969m
   HALL RL, 1978, PHOTOCHEM PHOTOBIOL, V28, P273, DOI 10.1111/j.1751-1097.1978.tb07708.x
   HUNTER CN, 1989, TRENDS BIOCHEM SCI, V14, P72
   Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x
   Katona G, 2003, J MOL BIOL, V331, P681, DOI 10.1016/S0022-2836(03)00751-4
   LILBURN TG, 1992, BIOCHIM BIOPHYS ACTA, V1100, P160
   MONSHOUWER R, 1995, CHEM PHYS LETT, V246, P341, DOI 10.1016/0009-2614(95)01104-H
   OLSEN JD, 1994, P NATL ACAD SCI USA, V91, P7124, DOI 10.1073/pnas.91.15.7124
   Olsen JD, 1997, BIOCHEMISTRY-US, V36, P12625, DOI 10.1021/bi9710481
   Pugh RJ, 1998, BBA-BIOENERGETICS, V1366, P301, DOI 10.1016/S0005-2728(98)00131-5
   Qian P, 2003, J BIOL CHEM, V278, P23678, DOI 10.1074/jbc.M302753200
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100
   Scheuring S, 2003, J MOL BIOL, V325, P569, DOI 10.1016/S0022-2836(02)01241-X
   Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029
   SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213
   Sundstrom V, 1999, J PHYS CHEM B, V103, P2327, DOI 10.1021/jp983722+
   VISSCHER KJ, 1989, PHOTOSYNTH RES, V22, P211, DOI 10.1007/BF00048300
   YEATES TO, 1988, P NATL ACAD SCI USA, V85, P7993, DOI 10.1073/pnas.85.21.7993
NR 36
TC 122
Z9 132
U1 1
U2 19
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 16
PY 2004
VL 279
IS 3
BP 2063
EP 2068
DI 10.1074/jbc.M310382200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 762WT
UT WOS:000188005700061
PM 14578348
OA Bronze
DA 2021-01-25
ER

PT J
AU Portevin, D
   Sousa-D'Auria, CC
   Houssin, C
   Grimaldi, C
   Chami, M
   Daffe, M
   Guilhot, C
AF Portevin, D
   Sousa-D'Auria, CC
   Houssin, C
   Grimaldi, C
   Chami, M
   Daffe, M
   Guilhot, C
TI A polyketide synthase catalyzes the last condensation step of mycolic
   acid biosynthesis in mycobacteria and related organisms
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CORYNEBACTERIUM-GLUTAMICUM; PERMEABILITY BARRIER; CELL-ENVELOPE; GENE;
   TUBERCULOSIS; REPLACEMENT; VIRULENCE; FRACTURE; PLASMID; PROTEIN
AB Mycolic acids are major and specific constituents of the cell envelope of Corynebacterineae, a suborder of bacterial species including several important human pathogens such as Mycobacterium tuberculosis, Mycobacterium, leprae, or Corynebacterium diphtheriae. These long-chain fatty acids are involved in the unusual architecture and impermeability of the cell envelope of these bacteria. The condensase, the enzyme responsible for the final condensation step in mycolic acid biosynthesis, has remained an enigma for decades. By in silico analysis of various mycobacterial genomes, we identified a candidate enzyme, Pks13, that contains the four catalytic domains required for the condensation reaction. Orthologs of this enzyme were found in other Corynebacterineae species. A Corynebacterium glutamicum strain with a deletion in the pks13 gene was shown to be deficient in mycolic acid production whereas it was able to produce the fatty acids precursors. This mutant strain displayed an altered cell envelope structure. We showed that the pks13 gene was essential for the survival of Mycobacterium smegmatis. A conditional M. smegmatis mutant carrying its only copy of pks13 on a thermosensitive plasmid exhibited mycolic acid biosynthesis defect if grown at nonpermissive temperature. These results indicate that Pks13 is the condensase, a promising target for the development of new antimicrobial drugs against Corynebacterineae.
C1 CNRS, Inst Pharmacol & Biol struct, Dept Mecan Mol Infect Mycobacteriennes, F-31077 Toulouse, France.
   Univ Toulouse 3, UMR 5089, F-31077 Toulouse, France.
   CNRS, Inst Genet & Microbiol, Lab Biotechnol Microorgan Interet Ind, F-91405 Orsay, France.
   Univ Paris 11, UMR 8621, F-91405 Orsay, France.
   Univ Basel, Biozentrum, ME Muller Inst MSB, CH-4056 Basel, Switzerland.
RP Guilhot, C (corresponding author), CNRS, Inst Pharmacol & Biol struct, Dept Mecan Mol Infect Mycobacteriennes, 205 Route Narbonne, F-31077 Toulouse, France.
EM guilhot@ipbs.fr
OI Sousa, Celia R/0000-0001-8988-3724; Portevin, Damien/0000-0003-2949-9557
CR AGGERBECK LP, 1986, METHOD ENZYMOL, V128, P457
   Azad AK, 1996, P NATL ACAD SCI USA, V93, P4787, DOI 10.1073/pnas.93.10.4787
   Belisle JT, 1998, METH MOL B, V101, P31, DOI 10.1385/0-89603-471-2:31
   BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333
   CHAMI M, 1995, BIOL CELL, V83, P219, DOI 10.1016/0248-4900(96)81311-6
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   COLLINS MD, 1988, FEMS MICROBIOL LETT, V49, P349
   Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200
   Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131
   Draper P, 1998, Front Biosci, V3, pD1253
   Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x
   Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x
   Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530
   GASTAMBIDEODIER M, 1960, BIOCHEM Z, V333, P285
   Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6
   GUILHOT C, 1992, FEMS MICROBIOL LETT, V98, P181
   JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990
   Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181
   Le Dantec C, 2001, J BACTERIOL, V183, P2157, DOI 10.1128/JB.183.7.2157-2164.2001
   MATHUR M, 1992, J BIOL CHEM, V267, P19388
   Pelicic V, 1996, MOL MICROBIOL, V20, P919, DOI 10.1111/j.1365-2958.1996.tb02533.x
   PEYRET JL, 1993, MOL MICROBIOL, V9, P97, DOI 10.1111/j.1365-2958.1993.tb01672.x
   Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x
   Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365
   QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6
   TAKAYAMA K, 1972, ANTIMICROB AGENTS CH, V2, P29, DOI 10.1128/AAC.2.1.29
   Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000
   WEBB V, 1999, MYCOBACTERIA MOL BIO, V1, P287
   2000, WHO IUATLD GLOBAL PR
NR 30
TC 221
Z9 232
U1 0
U2 23
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 6
PY 2004
VL 101
IS 1
BP 314
EP 319
DI 10.1073/pnas.0305439101
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 761VY
UT WOS:000187937200058
PM 14695899
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Storici, P
   De Biase, D
   Bossa, F
   Bruno, S
   Mozzarelli, A
   Peneff, C
   Silverman, RB
   Schirmer, T
AF Storici, P
   De Biase, D
   Bossa, F
   Bruno, S
   Mozzarelli, A
   Peneff, C
   Silverman, RB
   Schirmer, T
TI Structures of gamma-aminobutyric acid (GABA) aminotransferase, a
   pyridoxal 5 '-phosphate, and [2Fe-2S] cluster-containing enzyme,
   complexed with gamma-ethynyl-GABA and with the antiepilepsy drug
   vigabatrin
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID BRAIN 4-AMINOBUTYRATE AMINOTRANSFERASE; CRYSTAL-STRUCTURE; ACTIVE-SITE;
   CATALYTIC INHIBITOR; RESTRICTED ANALOG; ACETYLENIC GABA; INACTIVATION;
   TRANSAMINASE; MECHANISM; SYNTHASE
AB gamma-Aminobutyric acid aminotransferase (GABA-AT) is a pyridoxal 5'-phosphate-dependent enzyme responsible for the degradation of the inhibitory neurotransmitter GABA. GABA-AT is a validated target for antiepilepsy drugs because its selective inhibition raises GABA concentrations in brain. The antiepilepsy drug, gamma-vinyl-GABA (vigabatrin) has been investigated in the past by various biochemical methods and resulted in several proposals for its mechanisms of inactivation. In this study we solved and compared the crystal structures of pig liver GABA-AT in its native form (to 2.3-Angstrom resolution) and in complex with vigabatrin as well as with the close analogue gamma-ethynyl-GABA (to 2.3 and 2.8 Angstrom, respectively). Both inactivators form a covalent ternary adduct with the active site Lys329 and the pyridoxal 5'-phosphate (PLP) cofactor. The crystal structures provide direct support for specific inactivation mechanisms proposed earlier on the basis of radiolabeling experiments. The reactivity of GABA-AT crystals with the two GABA analogues was also investigated by polarized absorption microspectrophotometry. The spectral data are discussed in relation to the proposed mechanism. Intriguingly, all three structures revealed a [2Fe-2S] cluster of yet unknown function at the center of the dimeric molecule in the vicinity of the PLP cofactors.
C1 Univ Basel, Biozentrum, Div Biol Struct, CH-4056 Basel, Switzerland.
   Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy.
   Univ Roma La Sapienza, Ctr Eccellenza Biol & Med Mol, I-00185 Rome, Italy.
   Univ Parma, Dept Biochem & Mol Biol, I-43100 Parma, Italy.
   Univ Parma, Natl Inst Phys Matter, I-43100 Parma, Italy.
   Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.
   Northwestern Univ, Drug Discovery Program, Evanston, IL 60208 USA.
RP Silverman, RB (corresponding author), Univ Basel, Biozentrum, Div Biol Struct, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Agman@chem.northwestern.edu; tilman.schirmer@unibas.ch
RI Messier, Claude/A-2322-2008; Bruno, Stefano/A-4582-2011; De Biase,
   Daniela/H-3678-2019; Mozzarelli, Andrea/C-3615-2014
OI Messier, Claude/0000-0002-4791-1763; Bruno, Stefano/0000-0002-7890-2472;
   De Biase, Daniela/0000-0003-3536-9927; Mozzarelli,
   Andrea/0000-0003-3762-0062; storici, paola/0000-0002-2590-3332
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS015703, R01NS015703, R01NS015703, R01NS015703, R01NS015703,
   R01NS015703, R01NS015703, R01NS015703, R01NS015703, R01NS015703,
   R01NS015703, R01NS015703, R01NS015703, R01NS015703, R01NS015703,
   R01NS015703] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [NS15703] Funding Source: Medline
CR AOYAGI T, 1990, CHEM PHARM BULL, V38, P1748
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BAKAY RAE, 1981, BRAIN RES, V206, P387, DOI 10.1016/0006-8993(81)90539-4
   BAXTER CF, 1958, J BIOL CHEM, V233, P1135
   BEART PM, 1971, NATURE-NEW BIOL, V234, P80, DOI 10.1038/newbio234080a0
   Beinert H, 1999, CURR OPIN CHEM BIOL, V3, P152, DOI 10.1016/S1367-5931(99)80027-1
   Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653
   BREHM L, 1972, ACTA CHEM SCAND, V26, P1298, DOI 10.3891/acta.chem.scand.26-1298
   BURKE JR, 1991, J AM CHEM SOC, V113, P9329, DOI 10.1021/ja00024a042
   BUTTERWORTH J, 1983, J NEUROCHEM, V41, P440, DOI 10.1111/j.1471-4159.1983.tb04761.x
   Chen DW, 2001, BIOCHEMISTRY-US, V40, P596, DOI 10.1021/bi002265w
   Choi S, 2002, J AM CHEM SOC, V124, P1620, DOI 10.1021/ja011968d
   CHURCHICH JE, 1981, J BIOL CHEM, V256, P1101
   CLARK PA, 1993, J AM CHEM SOC, V115, P1894, DOI 10.1021/ja00058a039
   COOPER AJL, 1985, METHOD ENZYMOL, V113, P80
   Cowtan K, 1994, JOINT CCP4 ESF EACBM, V31, P34
   DEBIASE D, 1992, EUR J BIOCHEM, V208, P351
   DEBIASE D, 1991, J BIOL CHEM, V266, P20056
   Dewey SL, 1998, SYNAPSE, V30, P119, DOI 10.1002/(SICI)1098-2396(199810)30:2<119::AID-SYN1>3.0.CO;2-F
   FAEDER EJ, 1970, BIOCHEMISTRY-US, V9, P4043, DOI 10.1021/bi00823a003
   FOWLER LJ, 1972, BIOCHEM J, V130, P569, DOI 10.1042/bj1300569
   FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034
   GALE D, 1989, INT ECON REV, V30, P3, DOI 10.2307/2526545
   Gidal BE, 1999, ANN PHARMACOTHER, V33, P1277, DOI 10.1345/aph.18376
   GUNNE LM, 1984, NATURE, V309, P347, DOI 10.1038/309347a0
   HOFRICHTER J, 1976, ANNU REV BIOPHYS BIO, V5, P511, DOI 10.1146/annurev.bb.05.060176.002455
   JOHN RA, 1984, BIOCHEM SOC T, V12, P430, DOI 10.1042/bst0120430
   JOHN RA, 1979, BIOCHEM J, V177, P721, DOI 10.1042/bj1770721
   JOHN RA, 1976, BIOCHEM J, V155, P645, DOI 10.1042/bj1550645
   JOHNSTON GA, 1975, J NEUROCHEM, V24, P157, DOI 10.1111/j.1471-4159.1975.tb07642.x
   JOHNSTON GAR, 1977, J PHARM PHARMACOL, V29, P240, DOI 10.1111/j.2042-7158.1977.tb11297.x
   JUNG MJ, 1977, J NEUROCHEM, V28, P717, DOI 10.1111/j.1471-4159.1977.tb10618.x
   JUNG MJ, 1975, BIOCHEM BIOPH RES CO, V67, P301, DOI 10.1016/0006-291X(75)90316-2
   Kalviainen R, 2001, CNS DRUGS, V15, P217
   KARLSSON A, 1974, BIOCHEM PHARMACOL, V23, P3053, DOI 10.1016/0006-2952(74)90281-0
   KING TE, 1967, METHOD ENZYMOL, V10, P631
   KROGSGAARDLARSEN P, 1977, NATURE, V268, P53, DOI 10.1038/268053a0
   KWON OS, 1992, J BIOL CHEM, V267, P7215
   LIPPERT B, 1980, BRAIN RES BULL, V5, P375, DOI 10.1016/0361-9230(80)90060-X
   LIPPERT B, 1977, EUR J BIOCHEM, V74, P441, DOI 10.1111/j.1432-1033.1977.tb11410.x
   Lloyd KG, 1981, NEUROTRANSMITTERS SE, P325
   LOSCHER W, 1986, BIOCHEM PHARMACOL, V35, P3176, DOI 10.1016/0006-2952(86)90408-9
   LOSCHER W, 1982, NEUROPHARMACOLOGY, V21, P803, DOI 10.1016/0028-3908(82)90068-5
   McGeer E. G., 1983, GLUTAMINE GLUTAMATE, P3
   McNamara J. O., 1996, PHARMACOL BASIS THER, P461
   MCPHALEN CA, 1992, J MOL BIOL, V225, P495, DOI 10.1016/0022-2836(92)90935-D
   Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129
   METCALF BW, 1979, BIOCHEM PHARMACOL, V28, P1705, DOI 10.1016/0006-2952(79)90529-X
   MOZZARELLI A, 1989, J BIOL CHEM, V264, P15774
   Mozzarelli A, 1996, ANNU REV BIOPH BIOM, V25, P343
   Mozzarelli A, 2001, ADVANCED FUNCTIONAL MOLECULES AND POLYMERS, VOL 4, P55
   NANAVATI SM, 1991, J AM CHEM SOC, V113, P9341, DOI 10.1021/ja00024a043
   NANAVATI SM, 1989, J MED CHEM, V32, P2413, DOI 10.1021/jm00131a001
   NISHINO N, 1988, JPN J PHARMACOL, V48, P331, DOI 10.1254/jjp.48.331
   Ollagnier-de-Choudens S, 2002, BIOCHEMISTRY-US, V41, P9145, DOI 10.1021/bi0122011
   Paul V, 2000, BRAIN RES BULL, V51, P43, DOI 10.1016/S0361-9230(99)00206-3
   Phillips RS, 2002, J BIOL CHEM, V277, P21592, DOI 10.1074/jbc.M200216200
   RANDO RR, 1977, BIOCHEM BIOPH RES CO, V76, P1276, DOI 10.1016/0006-291X(77)90993-7
   ROGAWSKI MA, 1990, PHARMACOL REV, V42, P223
   SCHON F, 1974, BRAIN RES, V66, P289, DOI 10.1016/0006-8993(74)90147-4
   Shen BW, 1998, J MOL BIOL, V277, P81, DOI 10.1006/jmbi.1997.1583
   Silverman R. B., 2002, ORGANIC CHEM ENZYME
   SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240
   STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016
   Storici P, 1999, BIOCHEMISTRY-US, V38, P8628, DOI 10.1021/bi990478j
   TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040
   Weyand M, 1999, BIOCHEMISTRY-US, V38, P16469, DOI 10.1021/bi9920533
   Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736
NR 68
TC 102
Z9 109
U1 1
U2 14
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 2
PY 2004
VL 279
IS 1
BP 363
EP 373
DI 10.1074/jbc.M305884200
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 757GU
UT WOS:000187555300044
PM 14534310
OA Bronze
DA 2021-01-25
ER

PT J
AU Chan, C
   Amiot, N
   Jenal, U
   Schirmer, T
AF Chan, Carmen
   Amiot, Nicolas
   Jenal, Urs
   Schirmer, Tilman
TI Structure of the response regulator PleD with a novel di-guanylate
   cyclase domain.
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE Response regulator; Multi-domain protein; Di-guanylate cyclase
C1 [Chan, Carmen; Schirmer, Tilman] Univ Basel, Dept Struct Biol, Basel, Switzerland.
   [Jenal, Urs] Univ Basel, Dept Mol Biol, Biozentrum, Basel, Switzerland.
   [Amiot, Nicolas] Univ Basel, Dept Chem, Basel, Switzerland.
EM carmen.chan@unibas.ch
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   Paul R, 2004, GENES DEV
   Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8
NR 4
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2004
VL 60
SU S
MA s1.m8.p7
BP S162
EP S162
DI 10.1107/S0108767304096795
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3TV
UT WOS:000477684600321
OA Bronze
DA 2021-01-25
ER

PT J
AU Garcia, P
   Marino, M
   Mayans, O
AF Garcia, Pilar
   Marino, Marco
   Mayans, Olga
TI Oligomerization events mediated by coiled-coils as kinase regulatory
   mechanism.
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE Kinase activation; Coiled-coil; Oligomerization
C1 [Garcia, Pilar; Marino, Marco; Mayans, Olga] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
EM Olga.Mayans@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2004
VL 60
SU S
MA s1.m5.p4
BP S126
EP S126
DI 10.1107/S010876730409751X
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3TV
UT WOS:000477684600249
OA Bronze
DA 2021-01-25
ER

PT J
AU Mayans, O
   Marino, M
   Deuss, M
   Svergun, D
   Sterner, R
AF Mayans, Olga
   Marino, Marco
   Deuss, Miriam
   Svergun, Dimitri
   Sterner, Reinhard
TI Evolutionary Links in the Metabolic Synthesis and Degradation of
   Nucleotides: Prove and Prejudice.
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE Nucleotide Metabolism; Superfamily Evolution; Phosphoribosyltransferase
C1 [Mayans, Olga; Marino, Marco] Univ Basel, Div Struct Biol, Biozentrum, Basel, Switzerland.
   [Deuss, Miriam; Sterner, Reinhard] Univ Cologne, Inst Biochem, Cologne, Germany.
   [Svergun, Dimitri] EMBL Hamburg Outstn, Hamburg, Germany.
EM Olga.Mayans@unibas.ch
CR Mayans O, 2002, EMBO J, V21, P3245, DOI 10.1093/emboj/cdf298
NR 1
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2004
VL 60
SU S
MA s1.m8.o5
BP S29
EP S29
DI 10.1107/S0108767304099441
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3TV
UT WOS:000477684600057
OA Bronze
DA 2021-01-25
ER

PT J
AU Palanivelu, D
   Agre, P
   Kozono, D
   Lustig, A
   Suda, K
   Schirmer, T
AF Palanivelu, Dinesh
   Agre, Peter
   Kozono, David
   Lustig, Ariel
   Suda, Kitaru
   Schirmer, Tilman
TI Co-axial association of eye lens aquaporin AQP0.
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE Aquaporin; Membrane protein; Cell adhesion
C1 [Palanivelu, Dinesh; Suda, Kitaru; Schirmer, Tilman] Univ Basel, Div Struct Biol, Biozentrum, Basel, Switzerland.
   [Agre, Peter; Kozono, David] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD USA.
   [Agre, Peter; Kozono, David] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA.
   [Lustig, Ariel] Univ Basel, Div Biophys Chem, Biozentrum, Basel, Switzerland.
EM dinesh.palanivelu@unibas.ch
CR Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   ZAMPIGHI GA, 1989, J CELL BIOL, V108, P2255, DOI 10.1083/jcb.108.6.2255
NR 4
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2004
VL 60
SU S
MA s1.m5.p12
BP S130
EP S130
DI 10.1107/S0108767304097430
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3TV
UT WOS:000477684600257
OA Bronze
DA 2021-01-25
ER

PT J
AU Pinotsis, N
   Zou, PJ
   Marino, M
   Lange, S
   Popov, A
   Mavridis, I
   Gautel, M
   Mayans, OM
   Wilmanns, M
AF Pinotsis, Nikos
   Zou, Peijian
   Marino, Marco
   Lange, Stephan
   Popov, Alexander
   Mavridis, Irene
   Gautel, Mathias
   Mayans, Olga M.
   Wilmanns, Matthias
TI Molecular basis of telethonin-mediated linkage of the N-terminus of
   titin within the sarcomeric Z-disc.
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE Muscle sarcomere; Z-disc; Titin; Telethonin
C1 [Pinotsis, Nikos; Zou, Peijian; Popov, Alexander; Mayans, Olga M.; Wilmanns, Matthias] EMBL Hamburg DESY, D-22603 Hamburg, Germany.
   [Marino, Marco; Mayans, Olga M.] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   [Lange, Stephan; Gautel, Mathias] Kings Coll London, Randall Ctr, London SE1 1UL, England.
   [Lange, Stephan; Gautel, Mathias] Kings Coll London, Cardiovasc Div, Muscle Cell Biol, London SE1 1UL, England.
   [Mavridis, Irene] Natl Ctr Sci Res Demokritos, Inst Phys Chem, Athens 15310, Greece.
EM pinotsis@embl-hamburg.de
RI Pinotsis, Nikos/AAD-4013-2019; Gautel, Mathias/AAB-9860-2019
OI Pinotsis, Nikos/0000-0002-5096-257X; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2004
VL 60
SU S
MA s1.m5.o5
BP S21
EP S21
DI 10.1107/S0108767304099593
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3TV
UT WOS:000477684600042
OA Bronze
DA 2021-01-25
ER

PT J
AU Kjellbom, P
   Fotiadis, D
   Larsson, C
   Engel, A
   Johanson, U
   Fraysse, L
   Gustavsson, S
   Sjovall, S
   Alexandersson, E
   Fellert, M
AF Kjellbom, P.
   Fotiadis, D.
   Larsson, C.
   Engel, A.
   Johanson, U.
   Fraysse, L.
   Gustavsson, S.
   Sjovall, S.
   Alexandersson, E.
   Fellert, M.
TI PLANT AQUAPORINS - POST-TRANSLATIONAL REGULATION, SUBSTRATE SPECIFICITY
   AND STRUCTURE
SO ACTA PHYSIOLOGIAE PLANTARUM
LA English
DT Meeting Abstract
C1 [Kjellbom, P.; Larsson, C.; Johanson, U.; Fraysse, L.; Gustavsson, S.; Sjovall, S.; Alexandersson, E.; Fellert, M.] Lund Univ, Dept Plant Biochem, SE-22100 Lund, Sweden.
   [Fotiadis, D.; Larsson, C.] Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
RI Johanson, Urban/D-4344-2015
OI Johanson, Urban/0000-0001-8862-128X
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0137-5881
J9 ACTA PHYSIOL PLANT
JI Acta Physiol. Plant.
PY 2004
VL 26
IS 3
BP 77
EP 77
PG 1
WC Plant Sciences
SC Plant Sciences
GA V80CW
UT WOS:000205415400197
DA 2021-01-25
ER

PT J
AU Nordheim, U
   Hofbauer, KG
AF Nordheim, U
   Hofbauer, KG
TI Stimulation of NPYY2 receptors by PYY3-36 reveals divergent
   cardiovascular effects of endogenous NPY in rats on different dietary
   regimens
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE blood pressure; heart rate; sympathetic nerve activity; neuropeptide Y;
   peptide YY
ID NEUROPEPTIDE-Y; BLOOD-PRESSURE; HYPOTHALAMIC NUCLEI; GUT HORMONE;
   RELEASE
AB In the present experiments the gut hormone peptide YY3-36 (PYY3-36), which inhibits neuropeptide Y (NPY) release, was used as a tool to study the cardiovascular effects of endogenous NPY under different dietary regimens in rats instrumented with a telemetry transmitter. In a first experiment, rats were placed on a standard chow diet ad libitum and in a second experiment on a high-fat diet ad libitum. After 6 wk, PYY3-36 (300 mug/kg) or vehicle was injected intraperitoneally. In a third experiment, PYY3-36 or vehicle was administered after 14 days of 50% restriction of a standard chow diet. In food-restricted rats, PYY3-36 increased mean arterial pressure ( 7 +/- 1 mmHg, mean +/- SE, P < 0.001 vs. saline, 1-way repeated-measures ANOVA with Bonferroni t-test) and heart rate ( 22 +/- 4 beats/min, P < 0.001) during 3 h after administration. Conversely, PYY3-36 did not influence mean arterial pressure ( 0 +/- 1 mmHg) and heart rate (-8 +/- 5 beats/min) significantly in rats on a high-fat diet. Rats fed standard chow diet ad libitum showed an intermediate response ( mean arterial pressure 4 +/- 1 mmHg, P < 0.05, and heart rate 5 +/- 2 beats/min, not significant). Thus, in our studies, divergent cardiovascular responses to PYY3-36 were observed in rats on different dietary regimens. These findings suggest that the cardiovascular effects of PYY3-36 depend on the hypothalamic NPY release, which is increased after chronic food restriction and decreased during a high-fat diet.
C1 Univ Basel, Chair Appl Pharmacol, Biozentrum, CH-4056 Basel, Switzerland.
RP Hofbauer, KG (corresponding author), Univ Basel, Chair Appl Pharmacol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2
   AGUIRRE JA, 1990, NEUROSCI LETT, V118, P5, DOI 10.1016/0304-3940(90)90235-2
   Astrup A, 2001, INT J OBESITY, V25, pS46, DOI [10.1038/sj.ijo.0801698, 10.1038/sj/ijo/0801698]
   Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887
   BECK B, 1990, BRAIN RES, V528, P245, DOI 10.1016/0006-8993(90)91664-3
   BILLINGTON CJ, 1994, AM J PHYSIOL, V266, pR1765
   Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265
   CARTER DA, 1985, PEPTIDES, V6, P421, DOI 10.1016/0196-9781(85)90107-X
   EGAWA M, 1991, AM J PHYSIOL, V260, pR328
   HARLAND D, 1988, NEUROSCI LETT, V85, P239, DOI 10.1016/0304-3940(88)90358-8
   HASHIM MA, 1995, NEUROPEPTIDES, V29, P263, DOI 10.1016/0143-4179(95)90035-7
   Iyengar S, 1999, J PHARMACOL EXP THER, V289, P1031
   Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68
   Kanatani A, 2000, ENDOCRINOLOGY, V141, P1011, DOI 10.1210/en.141.3.1011
   Keire DA, 2002, PEPTIDES, V23, P305, DOI 10.1016/S0196-9781(01)00602-7
   LUNDBERG JM, 1995, BRIT J PHARMACOL, V116, P2971, DOI 10.1111/j.1476-5381.1995.tb15952.x
   MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9
   Malmstrom R E, 1997, Acta Physiol Scand Suppl, V636, P1
   Michel MC, 1998, PHARMACOL REV, V50, P143
   Morton KDR, 1999, REGUL PEPTIDES, V81, P81, DOI 10.1016/S0167-0115(99)00021-X
   Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514
   PedersenBjergaard U, 1996, SCAND J CLIN LAB INV, V56, P497, DOI 10.3109/00365519609088805
   PERNOW J, 1986, ACTA PHYSIOL SCAND, V126, P239, DOI 10.1111/j.1748-1716.1986.tb07811.x
   Rupp H, 1999, AM J PHYSIOL-HEART C, V277, pH1540
   Stricker-Krongrad A, 1997, AM J PHYSIOL-REG I, V273, pR2112
   VANDIJK G, 1994, BRAIN RES, V660, P96, DOI 10.1016/0006-8993(94)90843-5
   VanNess JM, 1999, BRAIN RES, V821, P263, DOI 10.1016/S0006-8993(99)01058-6
   WILDING JPH, 1992, J ENDOCRINOL, V132, P299, DOI 10.1677/joe.0.1320299
   Wilmore JH, 2001, MED SCI SPORT EXER, V33, P107
   Young JB, 1997, OBES RES, V5, P646, DOI 10.1002/j.1550-8528.1997.tb00590.x
NR 30
TC 9
Z9 10
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD JAN 1
PY 2004
VL 286
IS 1
BP R138
EP R142
DI 10.1152/ajpregu.00374.2003
PG 5
WC Physiology
SC Physiology
GA 751BX
UT WOS:000187033900024
PM 14551170
DA 2021-01-25
ER

PT J
AU Dehio, C
AF Dehio, C
TI Molecular and cellular basis of Bartonella pathogenesis
SO ANNUAL REVIEW OF MICROBIOLOGY
LA English
DT Review
DE cell proliferation; antiapoptosis; invasion; endothelial cell;
   erythrocyte; type IV secretion system
ID HUMAN ENDOTHELIAL-CELLS; IV SECRETION SYSTEM; GREEN FLUORESCENT PROTEIN;
   OUTER-MEMBRANE PROTEINS; MUTT MOTIF FAMILY; NF-KAPPA-B; SP-NOV;
   BACILLARY ANGIOMATOSIS; SP. NOV.; ANTIFLAGELLIN ANTIBODIES
AB The genus Bartonella comprises several important human pathogens that cause a wide range of clinical manifestations: cat-scratch disease, trench fever, Carrion's disease, bacteremia with fever, bacillary angiomatosis and peliosis, endocarditis, and neuroretinitis. Common features of bartonellae include transmission by blood-sucking arthropods and the specific interaction with endothelial cells and erythrocytes of their mammalian hosts. For each Bartonella species, the invasion and persistent intracellular colonization of erythrocytes are limited to a specific human or animal reservoir host. In contrast, endothelial cells are target host cells in probably all mammals, including humans. Bartonellae subvert multiple cellular functions of human endothelial cells, resulting in cell invasion, proinflammatory activation, suppression of apoptosis, and stimulation of proliferation, which may cumulate in vasoproliferative tumor growth. This review summarizes our understanding of Bartonella-host cell interactions and the molecular mechanisms of bacterial virulence and persistence. In addition, current controversies and unanswered questions in this area are highlighted.
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR Abbott RC, 1997, COMP IMMUNOL MICROB, V20, P41, DOI 10.1016/S0147-9571(96)00025-2
   ANDERSON B, 1995, J CLIN MICROBIOL, V33, P2358, DOI 10.1128/JCM.33.9.2358-2365.1995
   BARTON AL, 1909, CRON MED LIMA, V26, P7
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P163, DOI 10.1097/00006454-199702000-00002
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P2, DOI 10.1097/00006454-199701000-00003
   BATTERMAN HJ, 1995, INFECT IMMUN, V63, P4553, DOI 10.1128/IAI.63.11.4553-4556.1995
   Battisti JM, 1999, APPL ENVIRON MICROB, V65, P3441
   BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986
   Bermond D, 2002, INT J SYST EVOL MICR, V52, P383, DOI 10.1099/00207713-52-2-383
   Bermond D, 2000, INT J SYST EVOL MICR, V50, P1973, DOI 10.1099/00207713-50-6-1973
   BIRTLES RJ, 1995, INT J SYST BACTERIOL, V45, P1, DOI 10.1099/00207713-45-1-1
   Boulouis HJ, 2001, INFECT IMMUN, V69, P5313, DOI 10.1128/IAI.69.9.5313-5317.2001
   BRENNER DJ, 1993, INT J SYST BACTERIOL, V43, P777, DOI 10.1099/00207713-43-4-777
   Brouqui P, 1996, RES MICROBIOL, V147, P719, DOI 10.1016/S0923-2508(97)85119-4
   Buckles EL, 2000, MICROB PATHOGENESIS, V29, P165, DOI 10.1006/mpat.2000.0381
   Burgess AWO, 1998, MICROB PATHOGENESIS, V25, P157, DOI 10.1006/mpat.1998.0223
   Burgess AWO, 2000, MICROB PATHOGENESIS, V29, P73, DOI 10.1006/mpat.2000.0366
   CARLOS TM, 1994, BLOOD, V84, P2068
   Carroll JA, 2000, INFECT IMMUN, V68, P6750, DOI 10.1128/IAI.68.12.6750-6757.2000
   Cartwright JL, 1999, BIOCHEM BIOPH RES CO, V256, P474, DOI 10.1006/bbrc.1999.0354
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Chamberlin J, 2002, J INFECT DIS, V186, P983, DOI 10.1086/344054
   Chang CC, 2000, EMERG INFECT DIS, V6, P306, DOI 10.3201/eid0603.000313
   Chomel BB, 2003, ANN NY ACAD SCI, V990, P267, DOI 10.1111/j.1749-6632.2003.tb07376.x
   CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995
   Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996
   Chomel BB, 2000, REV SCI TECH OIE, V19, P136, DOI 10.20506/rst.19.1.1204
   Coleman SA, 2001, INFECT IMMUN, V69, P4373, DOI 10.1128/IAI.69.7.4373-4381.2001
   CONLEY T, 1994, J LAB CLIN MED, V124, P521
   Conyers GB, 1999, J BIOL CHEM, V274, P1203, DOI 10.1074/jbc.274.3.1203
   DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993
   de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83
   DEBRE R., 1950, BuL Mem. Soc. Med. Hop., V66, P76
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Dehio C, 2001, INT J SYST EVOL MICR, V51, P1557, DOI 10.1099/00207713-51-4-1557
   Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9
   DEHIO C, 2004, IN PRESS CULTURE BAR
   Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Derrick SC, 2001, BLOOD CELL MOL DIS, V27, P1013, DOI 10.1006/bcmd.2001.0475
   Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137
   Droz S, 1999, J CLIN MICROBIOL, V37, P1117, DOI 10.1128/JCM.37.4.1117-1122.1999
   Ellis BA, 1999, J INFECT DIS, V180, P220, DOI 10.1086/314824
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   GARCIA FU, 1990, AM J PATHOL, V136, P1125
   GARCIA FU, 1992, J INFECT DIS, V165, P1138, DOI 10.1093/infdis/165.6.1138
   GRASSESCHI HA, 1994, CAN J MICROBIOL, V40, P782, DOI 10.1139/m94-123
   Guptill L, 1997, J INFECT DIS, V176, P206, DOI 10.1086/514026
   Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2
   Hacker G, 2002, FEMS MICROBIOL LETT, V211, P1
   Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802
   Heller R, 1999, INT J SYST BACTERIOL, V49, P283, DOI 10.1099/00207713-49-1-283
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Henderson IR, 2000, TRENDS MICROBIOL, V8, P529, DOI 10.1016/S0966-842X(00)01853-9
   Hendrix LR, 2003, ANN NY ACAD SCI, V990, P596, DOI 10.1111/j.1749-6632.2003.tb07433.x
   Hendrix LR, 2000, FEMS MICROBIOL LETT, V182, P119, DOI 10.1111/j.1574-6968.2000.tb08884.x
   Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]
   Iwaki-Egawa S, 1997, FEMS MICROBIOL LETT, V157, P207, DOI 10.1111/j.1574-6968.1997.tb12775.x
   Kempf VAJ, 2002, TRENDS MICROBIOL, V10, P269, DOI 10.1016/S0966-842X(02)02372-7
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kerkhoff FT, 1999, J CLIN MICROBIOL, V37, P4034, DOI 10.1128/JCM.37.12.4034-4038.1999
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   KOEHLER JE, 1994, JAMA-J AM MED ASSOC, V271, P531, DOI 10.1001/jama.271.7.531
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   KORDICK DL, 1995, J CLIN MICROBIOL, V33, P1655, DOI 10.1128/JCM.33.6.1655-1656.1995
   Kordick DL, 1997, J CLIN MICROBIOL, V35, P1813, DOI 10.1128/JCM.35.7.1813-1818.1997
   Kordick DL, 1996, INT J SYST BACTERIOL, V46, P704, DOI 10.1099/00207713-46-3-704
   Kosoy M, 2003, J CLIN MICROBIOL, V41, P645, DOI 10.1128/JCM.41.2.645-650.2003
   Kosoy MY, 2000, COMP IMMUNOL MICROB, V23, P221, DOI 10.1016/S0147-9571(99)00075-2
   Kosoy MY, 1999, J WILDLIFE DIS, V35, P275, DOI 10.7589/0090-3558-35.2.275
   KOSTIANOVSKY M, 1994, ULTRASTRUCT PATHOL, V18, P349, DOI 10.3109/01913129409023203
   Lamas CC, 2003, HEART, V89, P258, DOI 10.1136/heart.89.3.258
   Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0
   Lee AK, 1998, INFECT IMMUN, V66, P3964, DOI 10.1128/IAI.66.8.3964-3967.1998
   Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315
   Maeno N, 2002, SCAND J IMMUNOL, V55, P366, DOI 10.1046/j.1365-3083.2002.01065.x
   Maillard R, 2004, INT J SYST EVOL MICR, V54, P215, DOI 10.1099/ijs.0.02770-0
   Manders SM, 1996, CLIN DERMATOL, V14, P295, DOI 10.1016/0738-081X(96)00015-6
   Marin V, 2001, J IMMUNOL, V167, P3435, DOI 10.4049/jimmunol.167.6.3435
   Matera G, 2003, INT IMMUNOPHARMACOL, V3, P853, DOI 10.1016/S1567-5769(03)00059-6
   McLennan AG, 1999, INT J MOL MED, V4, P79
   Mehock JR, 1998, INFECT IMMUN, V66, P3462, DOI 10.1128/IAI.66.7.3462-3466.1998
   MERNAUGH G, 1992, INFECT IMMUN, V60, P937, DOI 10.1128/IAI.60.3.937-943.1992
   Minnick M F, 2000, Subcell Biochem, V33, P97
   Minnick MF, 2003, INFECT IMMUN, V71, P6933, DOI 10.1128/IAI.71.12.6933-6942.2003
   Minnick MF, 2003, INFECT IMMUN, V71, P814, DOI 10.1128/IAI.71.2.814-821.2003
   MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995
   Mitchell SJ, 1997, CAN J MICROBIOL, V43, P734, DOI 10.1139/m97-106
   MUNK F, 1917, MUENCH MED WOCHENSCH, V64, P1422
   Musso T, 2001, INFECT IMMUN, V69, P5974, DOI 10.1128/IAI.69.10.5974-5980.2001
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   Raoult D, 2001, Lancet Infect Dis, V1, P77, DOI 10.1016/S1473-3099(01)00062-7
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301
   Resto-Ruiz S, 2003, DNA CELL BIOL, V22, P431, DOI 10.1089/104454903767650694
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Riess T, 2003, GENE, V313, P103, DOI 10.1016/S0378-1119(03)00636-X
   Rolain JM, 2002, LANCET, V360, P226, DOI 10.1016/S0140-6736(02)09462-X
   Rolain JM, 2001, J CLIN MICROBIOL, V39, P2978, DOI 10.1128/JCM.39.8.2978-2980.2001
   Sander A, 2000, J CLIN MICROBIOL, V38, P2943, DOI 10.1128/JCM.38.8.2943-2948.2000
   SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmiederer M, 2000, DNA CELL BIOL, V19, P141, DOI 10.1089/104454900314528
   Schmiederer M, 2001, INFECT IMMUN, V69, P6495, DOI 10.1128/IAI.69.10.6495-6502.2001
   SCHMINCKE RA, 1917, MUNCHEN MED WOCHEN, V64, P961
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Seubert A, 2002, INT J MED MICROBIOL, V291, P555
   SLATER LN, 1992, ARCH INTERN MED, V152, P602, DOI 10.1001/archinte.152.3.602
   Sweger D, 2000, CLIN DIAGN LAB IMMUN, V7, P251, DOI 10.1128/CDLI.7.2.251-257.2000
   TAPPERO JW, 1993, JAMA-J AM MED ASSOC, V269, P770, DOI 10.1001/jama.269.6.770
   Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D
   van der Flier M, 2000, INFECT IMMUN, V68, P4792, DOI 10.1128/IAI.68.8.4792-4794.2000
   Verma A, 2000, INFECT IMMUN, V68, P5960, DOI 10.1128/IAI.68.10.5960-5969.2000
   Verma A, 2002, CELL MICROBIOL, V4, P557, DOI 10.1046/j.1462-5822.2002.00217.x
   Verma A, 2001, CELL MICROBIOL, V3, P169, DOI 10.1046/j.1462-5822.2001.00104.x
   VINSON JW, 1961, PATHOL MICROBIOL, V24, P152, DOI 10.1159/000161254
   Watarai MH, 2003, J EXP MED, V198, P5, DOI 10.1084/jem.20021980
   WEISS E, 1982, INT J SYST BACTERIOL, V32, P305, DOI 10.1099/00207713-32-3-305
   Welch DF, 1999, J CLIN MICROBIOL, V37, P2598, DOI 10.1128/JCM.37.8.2598-2601.1999
   Wong AK, 2001, P NATL ACAD SCI USA, V98, P7481, DOI 10.1073/pnas.121192298
   XU YH, 1995, BBA-BIOMEMBRANES, V1234, P173, DOI 10.1016/0005-2736(94)00271-P
   Yeo HJ, 2003, P NATL ACAD SCI USA, V100, P15947, DOI 10.1073/pnas.2535211100
   Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200
   Zimmermann R, 2003, J BACTERIOL, V185, P1739, DOI 10.1128/JB.185.5.1739-1744.2003
NR 128
TC 121
Z9 126
U1 0
U2 17
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0066-4227
EI 1545-3251
J9 ANNU REV MICROBIOL
JI Annu. Rev. Microbiol.
PY 2004
VL 58
BP 365
EP 390
DI 10.1146/annurev.micro.58.030603.123700
PG 26
WC Microbiology
SC Microbiology
GA 873YT
UT WOS:000225318500016
PM 15487942
DA 2021-01-25
ER

PT J
AU Berneche, S
   Roux, B
AF Berneche, S
   Roux, B
TI A gate in the selectivity filter of potassium channels
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the Biophysical Society
CY FEB 14-18, 2004
CL Baltimore, MD
SP Biophys Soc
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Cornell Univ, Weill Med Coll, New York, NY USA.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2004
VL 86
IS 1
SU S
BP 9A
EP 9A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 762KQ
UT WOS:000187971200045
DA 2021-01-25
ER

PT J
AU Anderson, TG
   Seelig, J
AF Anderson, TG
   Seelig, J
TI Use of microcalorimetry to study the mixing of phospholipids in bilayer
   membranes
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the Biophysical Society
CY FEB 14-18, 2004
CL Baltimore, MD
SP Biophys Soc
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2004
VL 86
IS 1
SU S
BP 38A
EP 38A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 762KQ
UT WOS:000187971200191
DA 2021-01-25
ER

PT J
AU Anderson, TG
   Tan, AM
   Ganz, P
   Seelig, J
AF Anderson, TG
   Tan, AM
   Ganz, P
   Seelig, J
TI Calorimetric measurement of phospholipid interaction with
   methyl-[beta]-cyclodextrin
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the Biophysical Society
CY FEB 14-18, 2004
CL Baltimore, MD
SP Biophys Soc
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2004
VL 86
IS 1
SU S
BP 174A
EP 174A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 762KQ
UT WOS:000187971200896
DA 2021-01-25
ER

PT J
AU Ziegler, A
   Seelig, J
AF Ziegler, A
   Seelig, J
TI Interaction of the protein transduction domain of HIV-1 TAT with heparan
   sulfate: Binding mechanism and thermodynamic parameters
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID IMMUNODEFICIENCY-VIRUS TYPE-1; PLASMA-MEMBRANE; BASIC DOMAIN; CELLULAR
   UPTAKE; DELIVERY; PEPTIDE; SURFACE; CELLS; GROWTH; INTERNALIZATION
AB The positively charged protein transduction domain of the HIV-1 TAT protein (TAT-PTD; residues 47 - 57 of TAT) rapidly translocates across the plasma membrane of living cells. This property is exploited for the delivery of proteins, drugs, and genes into cells. The mechanism of this translocation is, however, not yet understood. Recent theories for translocation suggest binding of the protein transduction domain (PTD) to extracellular glycosaminoglycans as a possible mechanism. We have studied the binding equilibrium between TAT-PTD and three different glycosaminoglycans with high sensitivity isothermal titration calorimetry and provide the first quantitative thermodynamic description. The polysulfonated macromolecules were found to exhibit multiple identical binding sites for TAT-PTD with only small differences between the three species as far as the thermodynamic parameters are concerned. Heparan sulfate (HS, molecular weight, 14.2 +/- 2 kDa) has 6.3 +/- 1.0 independent binding sites for TAT-PTD which are characterized by a binding constant K-0 = (6.0 +/- 0.6) x 10(5) M-1 and a reaction enthalpy DeltaH(pep)(0) = -4.6 +/- 1.0 kcal/mol at 28degreesC. The binding affinity, DeltaG(pep)(0), is determined to equal extent by enthalpic and entropic contributions. The HS-TAT-PTD complex formation entails a positive heat capacity change of DeltaC(p)(0) = +135 cal/mol peptide, which is characteristic of a charge neutralization reaction. This is in contrast to hydrophobic binding reactions which display a large negative heat capacity change. The stoichiometry of 6 - 7 TAT-PTD molecules per HS corresponds to an electric charge neutralization. Light scattering data demonstrate a maximum scattering intensity at this stoichiometric ratio, the intensity of which depends on the order of mixing of the two components. The data suggest cross-linking and/or aggregation of HS-TAT-PTD complexes. Two other glycosaminoglycans, namely heparin and chondroitin sulfate B, were also studied with isothermal titration calorimetry. The thermodynamic parameters are K-0 = (6.0 +/- 0.6) x 10(5) M-1 and DeltaH(pep)(0) = - 5.1 +/- 0.7 kcal/ mol for heparin and K-0 = (2.5 +/- 0.5) x 10(5) M-1 and DeltaH(pep)(0) = -3.2 +/- 0.4 kcal/mol for chondroitin sulfate B at 28degreesC. The close thermodynamic similarity of the three binding molecules also implies a close structural relationship. The ubiquitous occurrence of glycosaminoglycans on the cell surface together with their tight and rapid interaction with the TAT protein transduction domain makes complex formation a strong candidate as the primary step of protein translocation.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
EM joachim.seelig@unibas.ch
CR Albini A, 1996, ONCOGENE, V12, P289
   BARILLARI G, 1992, J IMMUNOL, V149, P3727
   BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0
   Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8
   Carey DJ, 1997, BIOCHEM J, V327, P1
   CHURCHER MJ, 1993, J MOL BIOL, V230, P90, DOI 10.1006/jmbi.1993.1128
   CLAVEL F, 1986, NATURE, V324, P691, DOI 10.1038/324691a0
   Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188
   Eguchi A, 2001, J BIOL CHEM, V276, P26204, DOI 10.1074/jbc.M010625200
   FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664
   Fowlkes JL, 1996, J BIOL CHEM, V271, P14676, DOI 10.1074/jbc.271.25.14676
   FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2
   Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1
   Gius D, 1997, INT J RADIAT ONCOL, V39, P160, DOI 10.1016/S0360-3016(97)80609-8
   GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0
   Ho A, 2001, CANCER RES, V61, P474
   Howard TM, 1996, AIDS RES HUM RETROV, V12, P1413, DOI 10.1089/aid.1996.12.1413
   Huang L, 1995, BIOCHEM BIOPH RES CO, V217, P761, DOI 10.1006/bbrc.1995.2838
   LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   LEWIS GN, 1961, THERMODYNAMICS, P524
   Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4
   LONG KS, 1995, BIOCHEMISTRY-US, V34, P8885, DOI 10.1021/bi00027a041
   LUO Y, 1993, J VIROL, V67, P5617, DOI 10.1128/JVI.67.9.5617-5622.1993
   MABROUK K, 1991, FEBS LETT, V289, P13, DOI 10.1016/0014-5793(91)80898-D
   Mai JC, 2002, J BIOL CHEM, V277, P30208, DOI 10.1074/jbc.M204202200
   MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x
   Martinho RG, 1996, MOL BIOL CELL, V7, P1771
   Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x
   Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996
   Orsini MJ, 1996, J NEUROSCI, V16, P2546
   Pooga M, 1998, FASEB J, V12, P67
   Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3
   Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206
   ROY C, 1989, BIOCHEM CELL BIOL, V67, P510, DOI 10.1139/o89-082
   Rusnati M, 1998, J BIOL CHEM, V273, P16027, DOI 10.1074/jbc.273.26.16027
   Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198
   Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313
   SALMINEN MO, 1995, VIROLOGY, V213, P80, DOI 10.1006/viro.1995.1548
   Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200
   Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2
   Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   SODROSKI J, 1985, SCIENCE, V229, P74, DOI 10.1126/science.2990041
   Stein S, 1999, FEBS LETT, V458, P383, DOI 10.1016/S0014-5793(99)01186-2
   TANFORD C, 1961, PHYSICAL CHEM MACROM, P532
   Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498
   Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200
   VANHOLDE KE, 1998, PRINCIPLES PHYS BIOC, P605
   Violini S, 2002, BIOCHEMISTRY-US, V41, P12652, DOI 10.1021/bi026097e
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7
   WEEKS KM, 1990, SCIENCE, V249, P1281, DOI 10.1126/science.2205002
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
   Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805
NR 56
TC 156
Z9 162
U1 0
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2004
VL 86
IS 1
BP 254
EP 263
DI 10.1016/S0006-3495(04)74101-6
PN 1
PG 10
WC Biophysics
SC Biophysics
GA 757MA
UT WOS:000187565000025
PM 14695267
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Noskov, SY
   Berneche, S
   Roux, B
AF Noskov, SY
   Berneche, S
   Roux, B
TI The microscopic origin of ion selectivity in potassium channels.
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 48th Annual Meeting of the Biophysical Society
CY FEB 14-18, 2004
CL Baltimore, MD
SP Biophys Soc
C1 Cornell Univ, Weill Med Coll, New York, NY 10021 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
NR 0
TC 2
Z9 3
U1 0
U2 1
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2004
VL 86
IS 1
SU S
BP 351A
EP 352A
PN 2
PG 2
WC Biophysics
SC Biophysics
GA 762KQ
UT WOS:000187971201808
DA 2021-01-25
ER

PT S
AU Herrmann, H
   Kreplak, L
   Aebi, U
AF Herrmann, H
   Kreplak, L
   Aebi, U
BE Omary, MB
   Coulombe, PA
TI Isolation, characterization, and in vitro assembly of intermediate
   filaments
SO INTERMEDIATE FILAMENT CYTOSKELETON
SE Methods in Cell Biology
LA English
DT Review
ID GEL-ELECTROPHORESIS; SMOOTH-MUSCLE; LAMIN-A; PROTEINS; VIMENTIN; DESMIN;
   IDENTIFICATION; PLECTIN; CYTOSKELETONS; BINDING
C1 German Canc Res Ctr, Div Cell Biol, TP 3, D-69120 Heidelberg, Germany.
   Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Herrmann, H (corresponding author), German Canc Res Ctr, Div Cell Biol, TP 3, D-69120 Heidelberg, Germany.
OI kreplak, laurent/0000-0001-9370-9809
CR ACHTSTAETTER T, 1986, METHOD ENZYMOL, V134, P355
   AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1987, J ELECTRON MICR TECH, V7, P29, DOI 10.1002/jemt.1060070104
   AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Bremer A, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P277
   BUJARD H, 1987, METHOD ENZYMOL, V155, P416
   Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515
   COULOMBE PA, 1990, J CELL BIOL, V111, P3049, DOI 10.1083/jcb.111.6.3049
   COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153
   CRESS AE, 1988, J BIOL CHEM, V263, P19678
   FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430
   FRITZ M, 1995, LANGMUIR, V11, P3529, DOI 10.1021/la00009a040
   GARRELS JI, 1979, J BIOL CHEM, V254, P7961
   GEISLER N, 1982, CELL, V30, P277, DOI 10.1016/0092-8674(82)90033-2
   GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2
   GIEFFERS C, 1991, EUR J CELL BIOL, V55, P191
   GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725
   Haner M, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P292
   HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   HERRMANN H, 1985, J CELL SCI, V73, P87
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   HERRMANN H, 1983, J BIOL CHEM, V258, P4610
   HERRMANN H, 1987, J BIOL CHEM, V262, P1320
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   Hesse M, 2001, J CELL SCI, V114, P2569
   HOFMANN I, 1991, EUR J CELL BIOL, V56, P328
   Hofmann I, 1998, Subcell Biochem, V31, P363
   HUIATT TW, 1980, J BIOL CHEM, V255, P6981
   Janmey P A, 1998, Subcell Biochem, V31, P381
   JANMEY PA, 1991, J BIOCHEM BIOPH METH, V22, P41, DOI 10.1016/0165-022X(91)90080-G
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   Karabinos A, 2003, J MOL BIOL, V325, P241, DOI 10.1016/S0022-2836(02)01240-8
   KARRASCH S, 1993, BIOPHYS J, V65, P2437, DOI 10.1016/S0006-3495(93)81327-4
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MACK JW, 1993, J MOL BIOL, V232, P50, DOI 10.1006/jmbi.1993.1369
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Muller DJ, 1997, J STRUCT BIOL, V119, P149, DOI 10.1006/jsbi.1997.3878
   NAGAI K, 1987, METHOD ENZYMOL, V153, P461
   NELSON WJ, 1983, MOL CELL BIOL, V3, P1146, DOI 10.1128/MCB.3.6.1146
   PYTELA R, 1980, P NATL ACAD SCI-BIOL, V77, P4808, DOI 10.1073/pnas.77.8.4808
   QUAXJEUKEN YEFM, 1983, P NATL ACAD SCI-BIOL, V80, P3548, DOI 10.1073/pnas.80.12.3548
   QUINLAN RA, 1984, J MOL BIOL, V178, P365, DOI 10.1016/0022-2836(84)90149-9
   QUINLAN RA, 1986, J MOL BIOL, V192, P337, DOI 10.1016/0022-2836(86)90369-4
   Regula JT, 2001, MICROBIOL-UK, V147, P1045, DOI 10.1099/00221287-147-4-1045
   RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X
   ROGERS KR, 1995, EUR J CELL BIOL, V66, P136
   STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93
   Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000
   STEINERT P, 1982, METHOD CELL BIOL, V24, P399
   STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   STROMER MH, 1981, EUR J CELL BIOL, V25, P136
   van Amerongen H, 1998, Subcell Biochem, V31, P399
   VORGIAS CE, 1983, PREP BIOCHEM, V13, P227, DOI 10.1080/00327488308064250
   WICHE G, 1983, J CELL BIOL, V97, P887, DOI 10.1083/jcb.97.3.887
   Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522
NR 62
TC 104
Z9 104
U1 0
U2 13
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-679X
BN 0-12-564173-7
J9 METHOD CELL BIOL
JI Methods Cell Biol.
PY 2004
VL 78
BP 3
EP 24
PG 22
WC Cell Biology
SC Cell Biology
GA BBU63
UT WOS:000227909200001
PM 15646613
DA 2021-01-25
ER

PT S
AU Strelkov, SV
   Kreplak, L
   Herrmann, H
   Aebi, U
AF Strelkov, SV
   Kreplak, L
   Herrmann, H
   Aebi, U
BE Omary, MB
   Coulombe, PA
TI Intermediate filament protein structure determination
SO INTERMEDIATE FILAMENT CYTOSKELETON
SE Methods in Cell Biology
LA English
DT Review
ID AMINO-ACID-SEQUENCE; CROSS-LINKING; COILED-COIL; KERATIN FILAMENTS; ROD
   DOMAIN; ARCHITECTURE; VIMENTIN; SCATTERING; DESMIN; ORGANIZATION
C1 Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   German Canc Res Ctr, Div Cell Biol, TP3, D-69120 Heidelberg, Germany.
RP Strelkov, SV (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652; kreplak,
   laurent/0000-0001-9370-9809
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Blundell T. L., 1976, PROTEIN CRYSTALLOGRA
   Brandenberger R, 1996, J CELL BIOL, V135, P1583, DOI 10.1083/jcb.135.6.1583
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   Briki F, 1998, BBA-PROTEIN STRUCT M, V1429, P57, DOI 10.1016/S0167-4838(98)00216-7
   Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   BUJARD H, 1987, METHOD ENZYMOL, V155, P416
   Cantor C.R., 1980, BIOPHYSICAL CHEM
   COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102
   Dhe-Paganon S, 2002, J BIOL CHEM, V18, P18
   DRENTH J, 1995, PRINCIPLES PROTEIN X
   DUCRUIX A, 1992, CRYSTALLIZATION NUCL
   ENGEL A, 1985, J ULTRA MOL STRUCT R, V90, P323, DOI 10.1016/S0022-5320(85)80010-1
   GALLAGHER SR, 1995, CURRENT PROTOCOLS PR, V2
   GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x
   Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995
   GEISLER N, 1992, EUR J BIOCHEM, V206, P841, DOI 10.1111/j.1432-1033.1992.tb16992.x
   GEISLER N, 1981, P NATL ACAD SCI-BIOL, V78, P4120, DOI 10.1073/pnas.78.7.4120
   GOLDMAN AE, 1986, P NATL ACAD SCI USA, V83, P3839, DOI 10.1073/pnas.83.11.3839
   HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   HERRMANN H, 1993, J MOL BIOL, V234, P99, DOI 10.1006/jmbi.1993.1566
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   KAMMERER RA, 1995, J MOL BIOL, V250, P64, DOI 10.1006/jmbi.1995.0358
   Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3
   McPherson A., 1982, PREPARATION ANAL PRO
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   MULLIGAN L, 1991, J STRUCT BIOL, V106, P145, DOI 10.1016/1047-8477(91)90084-A
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Parry DAD, 2002, J STRUCT BIOL, V137, P97, DOI 10.1006/jsbi.2002.4437
   Parry DAD, 2001, J BIOL CHEM, V276, P39253, DOI 10.1074/jbc.M104604200
   PARRY DAD, 1995, INTERMEDIAT FILAMENT
   PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7
   Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069
   SAYERS Z, 1990, J STRUCT BIOL, V103, P212, DOI 10.1016/1047-8477(90)90039-F
   Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   STRELKOV SV, 2004, IN PRESS J MOL BIOL
   Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9
   Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1
   Vachette P, 2003, METHOD ENZYMOL, V374, P584, DOI 10.1016/S0076-6879(03)74024-5
   Watts NR, 2002, J STRUCT BIOL, V137, P109, DOI 10.1006/jsbi.2002.4469
NR 53
TC 19
Z9 19
U1 1
U2 2
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-679X
BN 0-12-564173-7
J9 METHOD CELL BIOL
JI Methods Cell Biol.
PY 2004
VL 78
BP 25
EP 43
PG 19
WC Cell Biology
SC Cell Biology
GA BBU63
UT WOS:000227909200002
PM 15646614
DA 2021-01-25
ER

PT J
AU Fahrenkrog, B
   Sauder, U
   Aebi, U
AF Fahrenkrog, B
   Sauder, U
   Aebi, U
TI The S-cerevisiae HtrA-like protein Nma111p is a nuclear serine protease
   that mediates yeast apoptosis
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE apoptosis; HtrA; Nic96p; nucleus; yeast
ID PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; MESSENGER-RNA; HEAT-SHOCK;
   REGULATES APOPTOSIS; PDZ DOMAINS; IN-SITU; INHIBITOR; FAMILY;
   IDENTIFICATION
AB The yeast S. cerevisiae can undergo programmed cell death that exhibits the typical cellular markers of apoptosis. The mammalian HtrA2 protein was recently reported to mediate apoptosis in a serine-protease-dependent manner owing to its ability to antagonise the inhibitor of apoptosis protein XIAP. Here, we report the identification and characterisation of the S. cerevisiae HtrA-like protein, which we termed Nma111p (for nuclear mediator of apoptosis), as a mediator of yeast apoptosis. Nma111p is a nuclear protein that, under cellular stress conditions (i.e. at elevated temperature or after induction of apoptosis by H2O2), tends to aggregate inside the nucleus without its expression level being upregulated, suggesting that aggregation of Nma111p is correlated to its death-mediating character. Nma111p belongs to the HtrA family of serine proteases and its pro-apoptotic activity depends on its serine-protease activity. Yeast cells that lack Nma111p survive better at 50degreesC than wild-type cells and the cells show no apoptotic hallmarks, such as chromatin condensation and fragmentation, or accumulation of reactive oxygen species, after the induction of apoptosis by H2O2. By contrast, overexpression of Nma111p enhances apoptotic-like cell death. Therefore, Nma111p, like its mammalian homologue HtrA2, mediates apoptosis.
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Fahrenkrog, B (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM birthe.fahrenkrog@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413
CR Ayscough KR, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P477
   BaudinBaillieu A, 1997, YEAST, V13, P353, DOI 10.1002/(SICI)1097-0061(19970330)13:4<353::AID-YEA86>3.0.CO;2-P
   Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5
   Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239
   Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581
   Fahrenkrog B, 2000, MOL BIOL CELL, V11, P3885, DOI 10.1091/mbc.11.11.3885
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425
   GORCZYCA W, 1993, CANCER RES, V53, P1945
   Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x
   Gross A, 2000, MOL CELL BIOL, V20, P3125, DOI 10.1128/MCB.20.9.3125-3136.2000
   Guthrie C., 1991, GUIDE YEAST GENETICS
   HARPER JW, 1993, CELL, V75, P805
   Harris BZ, 2001, J CELL SCI, V114, P3219
   Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200
   Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374
   Hood JK, 1998, J BIOL CHEM, V273, P35142, DOI 10.1074/jbc.273.52.35142
   Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Kissova I, 2000, FEBS LETT, V471, P113, DOI 10.1016/S0014-5793(00)01379-X
   Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008
   Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707
   Ligr M, 2001, MOL BIOL CELL, V12, P2422, DOI 10.1091/mbc.12.8.2422
   LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335
   Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161
   Madeo F, 2002, CURR GENET, V41, P208, DOI 10.1007/s00294-002-0310-2
   Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4
   Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729
   Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757
   Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4
   Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200
   Mazzoni C, 2003, MOL BIOL CELL, V14, P721, DOI 10.1091/mbc.E02-05-0258
   Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x
   Ponting CP, 1997, PROTEIN SCI, V6, P464
   Reed JC, 2000, CELL, V102, P545, DOI 10.1016/S0092-8674(00)00076-3
   ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281
   Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830
   SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365
   Schulz JB, 1996, J NEUROSCI, V16, P4696
   Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5
   Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092
   SKORKOGLONEK J, 1995, GENE, V163, P47, DOI 10.1016/0378-1119(95)00406-V
   Skulachev VP, 2002, FEBS LETT, V528, P23, DOI 10.1016/S0014-5793(02)03319-7
   Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6
   Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0
   Szallies A, 2002, FEBS LETT, V517, P144, DOI 10.1016/S0014-5793(02)02608-X
   Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170
   Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9
   Vainberg IE, 2000, MOL CELL BIOL, V20, P3996, DOI 10.1128/MCB.20.11.3996-4005.2000
   Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200
   Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208
NR 55
TC 166
Z9 174
U1 0
U2 5
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JAN 1
PY 2004
VL 117
IS 1
BP 115
EP 126
DI 10.1242/jcs.00848
PG 12
WC Cell Biology
SC Cell Biology
GA 774XC
UT WOS:000189010800012
PM 14657274
OA Bronze
DA 2021-01-25
ER

PT J
AU Frere, SGA
   Luthi, A
AF Frere, SGA
   Luthi, A
TI Pacemaker channels in mouse thalamocortical neurones are regulated by
   distinct pathways of cAMP synthesis
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
ID ACTIVATED CATION CURRENT; ADENYLYL-CYCLASE ACTIVITY; GABA(B) RECEPTORS;
   I-H; DIFFERENTIAL EXPRESSION; ADRENERGIC-RECEPTORS; MEDIATED
   ENHANCEMENT; OPIOID INHIBITION; POTASSIUM CURRENT; CEREBRAL-CORTEX
AB A crucial aspect of pacemaker current (I-h) function is the regulation by cyclic nucleotides. To assess the endogenous mechanisms controlling cAMP levels in the vicinity of pacemaker channels, I-h regulation by G-protein-coupled neurotransmitter receptors was studied in mouse thalamocortical neurones. Activation of beta-adrenergic receptors with (-)-isoproterenol (Iso) led to a small steady enhancement of I-h amplitude, whereas activation of GABA(B) receptors with (+/-)-Baclofen (Bac) reduced I-h, consistent with an up- and down-regulation of basal cAMP levels, respectively. In contrast, a transient (tau(decay), similar to200 s), supralinear up-regulation Of Ih was observed upon coapplication of Iso and Bac that was larger than that observed with Iso alone. This up-regulation appeared to involve a cAMP synthesis pathway distinct from that recruited by Iso, as it was associated with a reversible acceleration in I-h activation kinetics and an occlusion of modulation by photolytically released cAMP, yet showed an 11 mV as opposed to a 6 mV positive shift in the activation curve and an at least seven-fold increase in duration. GABA, in the presence of the GABA(A) antagonist picrotoxin, mimicked, whereas N-ethylmaleimide, an inhibitor of G(i)-proteins, blocked the up-regulation, supporting a requirement for GABA(B) receptor activation in the potentiation. Activation of synaptic GABA(B) responses via stimulation of inhibitory afferents from the nucleus reticularis potentiated Iso-induced increments in I-h, suggesting that synaptically located receptors couple positively to cAMP synthesis induced by beta-adrenergic receptors. These findings indicate that distinct pathways of cAMP synthesis target the pacemaker current and the recruitment of these may be controlled by GABAergic activity within thalamic networks.
C1 Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, Sect Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
RP Luthi, A (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, Sect Pharmacol & Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anita.luthi@unibas.ch
OI Luthi, Anita/0000-0002-4954-4143
CR Accili EA, 1997, J PHYSIOL-LONDON, V500, P643, DOI 10.1113/jphysiol.1997.sp022049
   ANDRADE R, 1993, NEURON, V10, P83, DOI 10.1016/0896-6273(93)90244-L
   ANHOLT RRH, 1994, TRENDS NEUROSCI, V17, P37, DOI 10.1016/0166-2236(94)90033-7
   ASTONJONES G, 1981, J NEUROSCI, V1, P876
   BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336
   Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0
   Bal T, 2000, J NEUROSCI, V20, P7478
   Belevych AE, 2001, J PHYSIOL-LONDON, V536, P677, DOI 10.1111/j.1469-7793.2001.00677.x
   Bloom F E, 1975, Adv Cyclic Nucleotide Res, V5, P603
   Blumenfeld H, 2000, J NEUROSCI, V20, P5153
   BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0
   Brunton J, 1998, J NEUROSCI, V18, P1671
   Cirelli C, 2000, J NEUROSCI, V20, P9187
   Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211
   Crabtree JW, 1999, CELL MOL LIFE SCI, V56, P683, DOI 10.1007/s000180050462
   Cunningham MD, 1996, BRAIN RES, V720, P220, DOI 10.1016/0006-8993(96)00120-5
   DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0
   DUMAN RS, 1986, J NEUROCHEM, V47, P800
   Fedele E, 1997, NEUROPHARMACOLOGY, V36, P1405, DOI 10.1016/S0028-3908(97)00113-5
   GERBER U, 1994, J NEUROPHYSIOL, V72, P2360
   Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0
   Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145
   HARTZELL HC, 1988, PROG BIOPHYS MOL BIO, V52, P165, DOI 10.1016/0079-6107(88)90014-4
   Hirono M, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn764
   Huguenard JR, 1998, J SLEEP RES, V7, P24, DOI 10.1046/j.1365-2869.7.s1.5.x
   Ihnatovych I, 2002, DEV BRAIN RES, V133, P69, DOI 10.1016/S0165-3806(01)00323-6
   INGRAM SL, 1994, NEURON, V13, P179, DOI 10.1016/0896-6273(94)90468-5
   JIANG ZG, 1993, J PHYSIOL-LONDON, V462, P753, DOI 10.1113/jphysiol.1993.sp019580
   KAANG BK, 1993, NEURON, V10, P427, DOI 10.1016/0896-6273(93)90331-K
   KARBON EW, 1985, MOL PHARMACOL, V27, P53
   Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235
   Knight AR, 1996, NEUROPHARMACOLOGY, V35, P703, DOI 10.1016/S0028-3908(96)00015-9
   Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x
   Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255
   Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7
   Luthi A, 1999, NAT NEUROSCI, V2, P634, DOI 10.1038/10189
   MADISON DV, 1986, J PHYSIOL-LONDON, V372, P245, DOI 10.1113/jphysiol.1986.sp016007
   MAKMAN MH, 1988, BRAIN RES, V445, P303, DOI 10.1016/0006-8993(88)91193-6
   Matsuoka I, 1997, J NEUROCHEM, V68, P498
   McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185
   MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332
   Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8
   Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121
   Olianas MC, 1999, BIOCHEM PHARMACOL, V57, P649, DOI 10.1016/S0006-2952(98)00326-8
   Onali P, 2001, BIOCHEM PHARMACOL, V62, P183, DOI 10.1016/S0006-2952(01)00659-1
   Pan ZZ, 2003, J PHYSIOL-LONDON, V548, P765, DOI 10.1113/jphysiol.2002.037622
   PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026
   Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299
   PAPE HC, 1992, NEURON, V9, P441, DOI 10.1016/0896-6273(92)90182-D
   Pedarzani P, 1996, EUR J NEUROSCI, V8, P2098, DOI 10.1111/j.1460-9568.1996.tb00731.x
   PERKINS JP, 1973, J PHARMACOL EXP THER, V185, P371
   Princivalle AP, 2001, NEUROREPORT, V12, P591, DOI 10.1097/00001756-200103050-00032
   RAINBOW TC, 1984, P NATL ACAD SCI-BIOL, V81, P1585, DOI 10.1073/pnas.81.5.1585
   Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734
   Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x
   Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000
   SATTIN A, 1975, J PHARMACOL EXP THER, V192, P22
   SCHAAD NC, 1989, J NEUROCHEM, V53, P1941, DOI 10.1111/j.1471-4159.1989.tb09265.x
   SCHERER RW, 1989, J NEUROCHEM, V53, P989, DOI 10.1111/j.1471-4159.1989.tb11806.x
   Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391
   SHAPIRO MS, 1994, J NEUROSCI, V14, P7109
   Smith MS, 1998, ANN EMERG MED, V32, P65, DOI 10.1016/S0196-0644(98)70101-5
   Sodickson DL, 1996, J NEUROSCI, V16, P6374
   Svoboda KR, 1998, J NEUROSCI, V18, P7084
   TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6
   TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211
   Uezono Y, 1997, BIOCHEM BIOPH RES CO, V241, P476, DOI 10.1006/bbrc.1997.7738
   Ulens C, 2001, PFLUG ARCH EUR J PHY, V442, P928
   Ulrich D, 1996, J PHYSIOL-LONDON, V493, P845, DOI 10.1113/jphysiol.1996.sp021427
   Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088
   Watts AE, 1996, J NEUROPHYSIOL, V76, P2262
   WINSLOW JW, 1987, J BIOL CHEM, V262, P4501
   WOJCIK WJ, 1989, J NEUROCHEM, V53, P753, DOI 10.1111/j.1471-4159.1989.tb11769.x
   WOJCIK WJ, 1984, MOL PHARMACOL, V25, P24
NR 74
TC 24
Z9 24
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD JAN 1
PY 2004
VL 554
IS 1
BP 111
EP 125
DI 10.1113/jphysiol.2003.050989
PG 15
WC Neurosciences; Physiology
SC Neurosciences & Neurology; Physiology
GA 770XN
UT WOS:000188756800014
PM 14678496
OA Green Published
DA 2021-01-25
ER

PT J
AU Daniel, E
   Lustig, A
   David, MM
   Tsfadia, Y
AF Daniel, E
   Lustig, A
   David, MM
   Tsfadia, Y
TI On the molecular mass of Lumbricus erythrocruorin
SO MICRON
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Invertebrate Dioxygen Binding Proteins
CY SEP 07-12, 2003
CL Univ Mainz, Mainz, GERMANY
HO Univ Mainz
DE molecular mass; earthworm; Lumbricus; erythrocruorin; haemoglobin
ID EXTRACELLULAR HEMOGLOBIN; TERRESTRIS HEMOGLOBIN; QUATERNARY STRUCTURE;
   EARTHWORM; RESOLUTION
AB A critical examination of the published molecular mass of erythrocruorin (Ec) from Lumbricus and related earthworm species reveals that the results do cluster, not at one, but at two values of the molecular mass. One cluster corresponds to similar to 3.6 MDa as predicted from the Vinogradov model for the hexagonal bilayer (HBL) assembly of Lumbricus terrestris EC and as estimated from the crystal structure of HBL at 5.5 A resolution. The other cluster corresponds to similar to 4.4 MDa. However, in contrast to the controversy over the molecular mass, there is a consensus that the sedimentation coefficient of intact L. terrestris Ec is similar to 60S. Drawing on the occurrence of central subunits in Ec of Oenone fulgida and few other annelid species, we propose for the 4.4 MDa molecule a model of HBL supplemented by a central mass. The proposed model abides by D-6 symmetry and is a suitable candidate to represent 60S Lumbricus terrestris Ec. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Tel Aviv Univ, Dept Biochem, IL-69978 Tel Aviv, Israel.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Daniel, E (corresponding author), Tel Aviv Univ, Dept Biochem, IL-69978 Tel Aviv, Israel.
EM danielez@post.tau.ac.il
CR CEJKA Z, 1989, J ULTRA MOL STRUCT R, V102, P71, DOI 10.1016/0889-1605(89)90035-9
   Daniel E, 2003, BBA-PROTEINS PROTEOM, V1649, P1, DOI 10.1016/S1570-9639(03)00023-2
   Lamy JN, 1996, CHEM REV, V96, P3113, DOI 10.1021/cr9600058
   Martin PD, 1996, J MOL BIOL, V255, P154, DOI 10.1006/jmbi.1996.0013
   OWNBY DW, 1993, J BIOL CHEM, V268, P13539
   PILZ I, 1980, INT J BIOL MACROMOL, V2, P279, DOI 10.1016/0141-8130(80)90045-8
   Royer WE, 2000, P NATL ACAD SCI USA, V97, P7107, DOI 10.1073/pnas.97.13.7107
   SCHATZ M, 1995, J STRUCT BIOL, V114, P28, DOI 10.1006/jsbi.1995.1003
   Tsfadia Y, 1999, BBA-PROTEIN STRUCT M, V1433, P217, DOI 10.1016/S0167-4838(99)00134-X
   VANBRUGGEN EF, 1974, BIOCHIM BIOPHYS ACTA, V359, P210, DOI 10.1016/0005-2795(74)90145-7
   Zhu H, 1996, J BIOL CHEM, V271, P30007, DOI 10.1074/jbc.271.47.30007
NR 11
TC 8
Z9 8
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PY 2004
VL 35
IS 1-2
BP 131
EP 132
DI 10.1016/j.micron.2003.10.042
PG 2
WC Microscopy
SC Microscopy
GA 778DG
UT WOS:000189223400041
PM 15036316
DA 2021-01-25
ER

PT J
AU Schmelzle, T
   Beck, T
   Martin, DE
   Hall, MN
AF Schmelzle, T
   Beck, T
   Martin, DE
   Hall, MN
TI Activation of the RAS/cyclic AMP pathway suppresses a TOR deficiency in
   yeast
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID DEPENDENT PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE;
   NUCLEAR-LOCALIZATION; SIGNALING PATHWAY; COUPLED RECEPTOR;
   STRESS-RESPONSE; CELL-GROWTH; CYCLIC-AMP; GENE-EXPRESSION; RAPAMYCIN
AB The TOR (target of rapamycin) and RAS/cyclic AMP (cAMP) signaling pathways are the two major pathways controlling cell growth in response to nutrients in yeast. In this study we examine the functional interaction between TOR and the RAS/cAMP pathway. First, activation of the RAS/cAMP signaling pathway confers pronounced resistance to rapamycin. Second, constitutive activation of the RAS/cAMP pathway prevents several rapamycin-induced responses, such as the nuclear translocation of the transcription factor MSN2 and induction of stress genes, the accumulation of glycogen, the induction of autophagy, the down-regulation of ribosome biogenesis (ribosomal protein gene transcription and RNA polymerase I and III activity), and the down-regulation of the glucose transporter HXT1. Third, many of these TOR-mediated responses are independent of the previously described TOR effectors TAP42 and the type 2A-related protein phosphatase SIT4. Conversely, TOR-controlled TAP42/SIT4-dependent events are not affected by the RAS/cAMP pathway. Finally, and importantly, TOR controls the subcellular localization of both the protein kinase A catalytic subunit TPKI and the RAS/cAMP signaling-related kinase YAK1. Our findings suggest that TOR signals through the RAS/cAMP pathway, independently of TAP42/SIT4. Therefore, the RAS/cAMP pathway may be a novel TOR effector branch.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelberstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
OI Hall, Michael N/0000-0002-2998-0757
CR BARBE E, 1996, MEDITERR POLIT, V1, P25
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0
   Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200
   Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998
   BROACH JR, 1991, TRENDS GENET, V7, P28, DOI 10.1016/0168-9525(91)90018-L
   CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   Chan S, 2001, MODERN PATHOL, V14, p1P
   COLLART MA, 1993, CURRENT PROTOCOLS MO
   Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599
   Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002
   Cutler NS, 2001, MOL BIOL CELL, V12, P4103, DOI 10.1091/mbc.12.12.4103
   De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200
   DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904
   Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4
   Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584
   GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336
   Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135
   Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586
   Griffioen G, 2000, J BIOL CHEM, V275, P1449, DOI 10.1074/jbc.275.2.1449
   Griffioen G, 2002, CURR GENET, V41, P199, DOI 10.1007/s00294-002-0308-9
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920
   Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863
   Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x
   Liu JF, 2001, IEEE SIGNAL PROC LET, V8, P20, DOI 10.1109/97.889639
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Lorenz MC, 2000, GENETICS, V154, P609
   MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x
   Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001
   Moskvina E, 1998, YEAST, V14, P1041, DOI 10.1002/(SICI)1097-0061(199808)14:11<1041::AID-YEA296>3.0.CO;2-4
   NEUMANSILBERBERG FS, 1995, MOL CELL BIOL, V15, P3187
   NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554
   Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55
   Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943
   Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777
   Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556
   Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x
   TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371
   WARD MP, 1994, MOL CELL BIOL, V14, P5619, DOI 10.1128/MCB.14.9.5619
   WARNER JR, 1991, METHOD ENZYMOL, V194, P423
   Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Xia Y, 2003, J BIOL CHEM, V278, P13143, DOI 10.1074/jbc.M208500200
   Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
NR 67
TC 200
Z9 203
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD JAN
PY 2004
VL 24
IS 1
BP 338
EP 351
DI 10.1128/MCB.24.1.338-351.2004
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 757CL
UT WOS:000187531200030
PM 14673167
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Bianchi, MS
   Catalano, PN
   Bonaventura, MM
   Silveyra, P
   Bettler, B
   Libertun, C
   Lux-Lantos, VAR
AF Bianchi, MS
   Catalano, PN
   Bonaventura, MM
   Silveyra, P
   Bettler, B
   Libertun, C
   Lux-Lantos, VAR
TI Effect of androgens on sexual differentiation of pituitary
   gamma-aminobutyric acid receptor subunit GABAB expression
SO NEUROENDOCRINOLOGY
LA English
DT Article
DE gamma-aminobutyric acid; gamma-aminobutyric acid receptors; gonadal
   steroids; gonadotropins; sex dimorphism; excitatory amino acid
   neurotransmitters
ID CENTRAL-NERVOUS-SYSTEM; INTACT MALE RATS; ANTERIOR-PITUITARY; FEMALE
   RATS; LUTEINIZING-HORMONE; POSTNATAL-DEVELOPMENT; PLASMA TESTOSTERONE;
   INHIBITS PROLACTIN; GABA(B)R1 RECEPTOR; GONADAL-STEROIDS
AB Previous work demonstrated a sexually dimorphic ontogenic expression of gamma-aminobutyric acid receptors (GABA(B)R) in rat pituitary. As sex steroids determine sex-specific expression patterns, we now studied the effect of sex hormones on pituitary GABABR expression. GABABR subunits, measured by Western blot and by semi-quantitative RT-PCR and luteinizing hormonen(LH), follicle-stimulating hormone (FSH) and testosterone measured by RIA were determined in two experimental designs: First experimental design: 8- and 15-day-old females (8F, 15F); 8F and 15F treated with 100 mug testosterone propionate (TP) on day 1 of life (8F100TP, 15F100TP), 8- and 15-day-old males (8M, 15M) and 8M and 15M castrated on day 1 (8MC, 15MC). Second experimental design: 8-day-old female and male animals: 8F, 8F100TP, 8F treated with 1 mug/day TP on days 1-4 (8F1TP), 8F treated with the androgen antagonist Flutamide (Flut: 2.5 mg/100 g BW of pregnant mother on days E17-E23) (8F-Flut), 8M, 8MC, 8M treated with Flut as above (8M-Flut) and 8MC-Flut. In these animals, in addition, GABA, glutamate, aspartate and taurine were measured by HPLC in hypothalami and cortex. In the first set of experiments, GABA(B1)R mRNA/protein expression was higher in 8F than in 15F, 8M or 15M. In 8F100TP, GABA(B1)R mRNA/protein decreased to male levels. TP treatment did not alter GABA(B1)R expression in 15F. There was no difference in GABA(B1)R expression between 8M and 15M and neonatal castration did not modify its expression. In the second set of experiments, TP (1 mug) or Flut did not modify GABA(B1)R in 8F, while 100 mug TP continued to decrease GABA(B1)R expression. In 8M, Flut, alone or with castration, increased GABA(B1)R mRNA/protein expression to 8F. Hypothalamic GABA content followed the same pattern as pituitary GABABR expression in 8-day-old animals, suggesting a cross-regulation. With regard to hormonal levels, 100 mug, but not 1 mug TP altered gonadotropins at 8 days, although both treatments effectively androgenized females as evidenced by lack of cycling. We conclude that androgens, acting pre- and postnatally, decrease pituitary GABABR subunit expression. Copyright (C) 2004 S. Karger AG, Basel.
C1 Univ Buenos Aires, CONICET, Inst Biol & Med Expt, Buenos Aires, DF, Argentina.
   Univ Buenos Aires, Sch Med, Dept Physiol, Buenos Aires, DF, Argentina.
   Univ Basel, Biozentrum Pharmazentrum, Dept Clin Biol Sci, Basel, Switzerland.
RP Libertun, C (corresponding author), V de Obligado 2490,C1428ADN, Buenos Aires, DF, Argentina.
EM libertun@dna.uba.ar
RI Silveyra, Patricia/A-7136-2018; bettler, bernhard/AAO-8018-2020
OI Silveyra, Patricia/0000-0001-7083-8915; Bettler,
   Bernhard/0000-0003-0842-8207
CR ALDAHAN MI, 1994, BRAIN RES, V640, P33, DOI 10.1016/0006-8993(94)91854-6
   ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213
   Becu-Villalobos D, 1997, CELL MOL NEUROBIOL, V17, P699, DOI 10.1023/A:1022542221535
   BECUVILLALOBOS D, 1986, DEV BRAIN RES, V25, P111, DOI 10.1016/0165-3806(86)90157-4
   Bianchi M, 2001, NEUROPHARMACOLOGY, V40, P185, DOI 10.1016/S0028-3908(00)00146-5
   Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247
   BOWERY NG, 1996, GABA RECEPTORS, P1
   Brussaard AB, 1999, J PHYSIOL-LONDON, V516, P513, DOI 10.1111/j.1469-7793.1999.0513v.x
   Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1
   Carrer HF, 2002, CELL MOL NEUROBIOL, V22, P479, DOI 10.1023/A:1021825317546
   Casto JM, 2003, PHYSIOL BEHAV, V79, P633, DOI 10.1016/S0031-9384(03)00120-3
   Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171
   Davis AM, 2000, BEHAV NEUROSCI, V114, P923, DOI 10.1037/0735-7044.114.5.923
   Davis AM, 1996, HORM BEHAV, V30, P538, DOI 10.1006/hbeh.1996.0057
   Davis AM, 1999, NEUROSCIENCE, V90, P1471, DOI 10.1016/S0306-4522(98)00511-9
   Davis EC, 1996, NEUROENDOCRINOLOGY, V63, P142, DOI 10.1159/000126950
   De Vries GJ, 2004, ENDOCRINOLOGY, V145, P1063, DOI 10.1210/en.2003-1504
   DEBELJUK L, 1972, ENDOCRINOLOGY, V90, P585, DOI 10.1210/endo-90-2-585
   DEPLAZAS SF, 1982, ENDOCRINOLOGY, V111, P1974, DOI 10.1210/endo-111-6-1974
   DEVILLALOBOS DB, 1984, ENDOCRINOLOGY, V115, P84, DOI 10.1210/endo-115-1-84
   DOHLER KD, 1975, ENDOCRINOLOGY, V97, P898
   DUVILANSKI BH, 1984, NEUROENDOCRINOL LETT, V6, P243
   FITCH RH, 1991, INT J DEV NEUROSCI, V9, P35, DOI 10.1016/0736-5748(91)90070-3
   Fitch RH, 1998, BEHAV BRAIN SCI, V21, P311, DOI 10.1017/S0140525X98001216
   Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x
   Gamel-Didelon K, 2002, NEUROENDOCRINOLOGY, V76, P170, DOI 10.1159/000064523
   Goodarzi MO, 2003, J CLIN ENDOCR METAB, V88, P73, DOI 10.1210/jc.2002-021292
   Gorski RA, 2002, ADV EXP MED BIOL, V511, P57
   Han TM, 2003, J NEUROBIOL, V54, P502, DOI 10.1002/neu.10157
   Isomoto S, 1998, BIOCHEM BIOPH RES CO, V253, P10, DOI 10.1006/bbrc.1998.9706
   JACOBSON CD, 1981, J NEUROSCI, V1, P1142
   JAKUBOWSKI M, 1991, ENDOCRINOLOGY, V128, P2702, DOI 10.1210/endo-128-6-2702
   Jost A., 1973, Recent Progress Hormone Res, V29, P1
   Jussofie A, 1995, DEV NEUROSCI-BASEL, V17, P335, DOI 10.1159/000111303
   Kaupmann K, 1998, NATURE, V396, P683
   Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0
   Lacau de Mengido I M, 1989, Life Sci, V45, P567, DOI 10.1016/0024-3205(89)90041-6
   LIBERTUN C, 1979, P SOC EXP BIOL MED, V161, P28, DOI 10.3181/00379727-161-40482
   Luttge WG, 1970, HORM BEHAV, V1, P265
   LUX VAR, 1986, P SOC EXP BIOL MED, V183, P358
   Lux-Lantos V, 2001, NEUROENDOCRINOLOGY, V73, P334, DOI 10.1159/000054650
   LUXLANTOS V, 1992, NEUROENDOCRINOLOGY, V56, P687, DOI 10.1159/000126294
   Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698
   Mayerhofer Artur, 2001, FASEB Journal, V15, P1089
   MCDONALD PG, 1974, J ENDOCRINOL, V61, P95, DOI 10.1677/joe.0.0610095
   Murray HE, 1999, NEUROENDOCRINOLOGY, V70, P384, DOI 10.1159/000054500
   Ojeda Sergio R., 1994, P363
   Panagiotaropoulos T, 2004, NEUROENDOCRINOLOGY, V80, P181, DOI 10.1159/000082516
   PEETS EA, 1974, ENDOCRINOLOGY, V94, P532, DOI 10.1210/endo-94-2-532
   Perrot-Sinal TS, 2001, BRAIN RES, V922, P201, DOI 10.1016/S0006-8993(01)03167-5
   Pfaff T, 1999, EUR J NEUROSCI, V11, P2874, DOI 10.1046/j.1460-9568.1999.00704.x
   Quadros PS, 2002, J NEUROENDOCRINOL, V14, P761, DOI 10.1046/j.1365-2826.2002.00827.x
   Rao CV, 2004, BIOL REPROD, V71, P579, DOI 10.1095/biolreprod.104.027300
   ReyRoldan EB, 1997, LIFE SCI, V61, P2283, DOI 10.1016/S0024-3205(97)00932-6
   ReyRoldan EB, 1996, LIFE SCI, V58, P1059, DOI 10.1016/0024-3205(96)00059-8
   Romeo RD, 2004, NEUROENDOCRINOLOGY, V79, P125, DOI 10.1159/000077270
   SALLER CF, 1989, J CHROMATOGR-BIOMED, V487, P167, DOI 10.1016/S0378-4347(00)83020-0
   Schousboe A, 1999, NEUROCHEM INT, V34, P373, DOI 10.1016/S0197-0186(99)00044-3
   Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2
   Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200
   SHERIDAN PJ, 1973, J ENDOCRINOL, V57, P33, DOI 10.1677/joe.0.0570033
   Simeone TA, 2003, J CHILD NEUROL, V18, P39, DOI 10.1177/08830738030180012101
   Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745
   Tobet SA, 2002, EUR J NEUROSCI, V16, P373, DOI 10.1046/j.1460-9568.2002.02105.x
   Tobet SA, 1997, CELL MOL NEUROBIOL, V17, P565, DOI 10.1023/A:1022529918810
   TURGEON SM, 1994, NEUROSCIENCE, V62, P601, DOI 10.1016/0306-4522(94)90392-1
   VANDERSCHOOT P, 1992, J REPROD FERTIL, V96, P483
   Verdonck A, 1998, ARCH ORAL BIOL, V43, P551, DOI 10.1016/S0003-9969(98)00030-2
   VINCENT SR, 1982, NEUROENDOCRINOLOGY, V34, P117, DOI 10.1159/000123288
   Waagepetersen HS, 1999, J NEUROCHEM, V73, P1335, DOI 10.1046/j.1471-4159.1999.0731335.x
   WARD IL, 1980, SCIENCE, V207, P328, DOI 10.1126/science.7188648
   WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306
   White JH, 1998, NATURE, V396, P679
   Yoo MJ, 2000, BRAIN RES, V878, P1, DOI 10.1016/S0006-8993(00)02600-7
NR 74
TC 15
Z9 16
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0028-3835
EI 1423-0194
J9 NEUROENDOCRINOLOGY
JI Neuroendocrinology
PY 2004
VL 80
IS 3
BP 129
EP 142
DI 10.1159/000082527
PG 14
WC Endocrinology & Metabolism; Neurosciences
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA 886QW
UT WOS:000226244400001
PM 15591793
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Hulo, N
   Sigrist, CJA
   Le Saux, V
   Langendijk-Genevaux, PS
   Bordoli, L
   Gattiker, A
   De Castro, E
   Bucher, P
   Bairoch, A
AF Hulo, N
   Sigrist, CJA
   Le Saux, V
   Langendijk-Genevaux, PS
   Bordoli, L
   Gattiker, A
   De Castro, E
   Bucher, P
   Bairoch, A
TI Recent improvements to the PROSITE database
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID MULTIPLE SEQUENCE ALIGNMENT
AB The PROSITE database consists of a large collection of biologically meaningful signatures that are described as patterns or profiles. Each signature is linked to documentation that provides useful biological information on the protein family, domain or functional site identified by the signature. The PROSITE web page has been redesigned and several tools have been implemented to help the user discover new conserved regions in their own proteins and to visualize domain arrangements. We also introduced the facility to search PDB with a PROSITE entry or a user's pattern and visualize matched positions on 3D structures. The latest version of PROSITE (release 18.17 of November 30, 2003) contains 1676 entries. The database is accessible at http://www.expasy.org/prosite/.
C1 Univ Geneva, CMU, SIB, CH-1211 Geneva 4, Switzerland.
   Univ Basel, Biozentrum, SIB, CH-4056 Basel, Switzerland.
   Swiss Inst Expt Canc Res, Swiss Inst Bioinformat, CH-1066 Epalinges, Switzerland.
RP Hulo, N (corresponding author), Univ Geneva, CMU, SIB, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.
EM Nicolas.Hulo@isb-sib.ch
RI Langendijk-Genevaux, Petra S/F-6820-2015; Bairoch, Amos/X-7411-2019
OI Langendijk-Genevaux, Petra S/0000-0001-5363-6174; Bairoch,
   Amos/0000-0003-2826-6444; SIGRIST, Christian J. A./0000-0002-4348-0070;
   de Castro, Edouard/0000-0001-5436-7383
CR Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030
   Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235
   Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107
   GRIBSKOV M, 1990, METHOD ENZYMOL, V183, P146
   Hofmann K, 2000, Brief Bioinform, V1, P167, DOI 10.1093/bib/1.2.167
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   Jonassen I, 1997, COMPUT APPL BIOSCI, V13, P509
   Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Pagni M, 2001, Brief Bioinform, V2, P51, DOI 10.1093/bib/2.1.51
   Pagni M, 2001, NUCLEIC ACIDS RES, V29, P148, DOI 10.1093/nar/29.1.148
   SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5
   Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265
   Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
NR 18
TC 300
Z9 316
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 1
PY 2004
VL 32
SI SI
BP D134
EP D137
DI 10.1093/nar/gkh044
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 763HM
UT WOS:000188079000029
PM 14681377
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Wiederkehr, C
   Basavaraj, R
   de Menthiere, CS
   Hermida, L
   Koch, R
   Schlecht, U
   Amon, A
   Brachat, S
   Breitenbach, M
   Briza, P
   Caburet, S
   Cherry, M
   Davis, R
   Deutschbauer, A
   Dickinson, HG
   Dumitrescu, T
   Fellous, M
   Goldman, A
   Grootegoed, JA
   Hawley, R
   Ishii, R
   Jegou, B
   Kaufman, RJ
   Klein, F
   Lamb, N
   Maro, B
   Nasmyth, K
   Nicolas, A
   Orr-Weaver, T
   Philippsen, P
   Pineau, C
   Rabitsch, KP
   Reinke, V
   Roest, H
   Saunders, W
   Schroder, M
   Schedl, T
   Siep, M
   Villeneuve, A
   Wolgemuth, DJ
   Yamamoto, M
   Zickler, D
   Esposito, RE
   Primig, M
AF Wiederkehr, C
   Basavaraj, R
   de Menthiere, CS
   Hermida, L
   Koch, R
   Schlecht, U
   Amon, A
   Brachat, S
   Breitenbach, M
   Briza, P
   Caburet, S
   Cherry, M
   Davis, R
   Deutschbauer, A
   Dickinson, HG
   Dumitrescu, T
   Fellous, M
   Goldman, A
   Grootegoed, JA
   Hawley, R
   Ishii, R
   Jegou, B
   Kaufman, RJ
   Klein, F
   Lamb, N
   Maro, B
   Nasmyth, K
   Nicolas, A
   Orr-Weaver, T
   Philippsen, P
   Pineau, C
   Rabitsch, KP
   Reinke, V
   Roest, H
   Saunders, W
   Schroder, M
   Schedl, T
   Siep, M
   Villeneuve, A
   Wolgemuth, DJ
   Yamamoto, M
   Zickler, D
   Esposito, RE
   Primig, M
TI GermOnline, a cross-species community knowledgebase on germ cell
   differentiation
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE GENOME; GENE-EXPRESSION; TRANSCRIPTIONAL
   PROGRAM; BUDDING YEAST; SPORULATION; ANNOTATION; BIOLOGY; MEIOSIS;
   ELEGANS; SERVER
AB GermOnline provides information and microarray expression data for genes involved in mitosis and meiosis, gamete formation and germ line development across species. The database has been developed, and is being curated and updated, by life scientists in cooperation with bioinformaticists. Information is contributed through an online form using free text, images and the controlled vocabulary developed by the GeneOntology Consortium. Authors provide up to three references in support of their contribution. The database is governed by an international board of scientists to ensure a standardized data format and the highest quality of GermOnline's information content. Release 2.0 provides exclusive access to microarray expression data from Saccharomyces cerevisiae and Rattus norvegicus, as well as curated information on similar to700 genes from various organisms. The focus report pages include links to external databases that contain relevant annotation, microarray expression and proteome data. Conversely, the Saccharomyces Genome Database (SGD), S.cerevisiae GeneDB and Swiss-Prot link to the budding yeast section of GermOnline from their respective locus pages. GermOnline, a fully operational prototype subject-oriented knowledgebase designed for community annotation and array data visualization, is accessible at http://www.germonline.org. The target audience includes researchers who work on mitotic cell division, meiosis, gametogenesis, germ line development, human reproductive health and comparative genomics.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
   Inst Genet Humaine, Montpellier, France.
   MIT, Howard Hughes Med Inst, Cambridge, MA USA.
   Salzburg Univ, A-5020 Salzburg, Austria.
   Hop Cochin, F-75674 Paris, France.
   Stanford Univ, Palo Alto, CA 94304 USA.
   Univ Oxford, Oxford OX1 2JD, England.
   Univ Pittsburgh, Pittsburgh, PA 15260 USA.
   Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England.
   Erasmus Univ, Rotterdam, Netherlands.
   Stowers Inst, Kansas City, KS USA.
   Univ Tokyo, Tokyo, Japan.
   Univ Rennes 1, Bretagne, France.
   Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.
   Univ Vienna, A-1010 Vienna, Austria.
   Inst Mol Pathol, A-1030 Vienna, Austria.
   Inst Curie, Paris, France.
   MIT, Whitehead Inst, Cambridge, MA 02139 USA.
   Yale Univ, New Haven, CT USA.
   Washington Univ, St Louis, MO USA.
   Columbia Univ, New York, NY USA.
   Univ Paris 11, Orsay, France.
   Univ Chicago, Chicago, IL 60637 USA.
RP Primig, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM michael.primig@unibas.ch
RI Maro, Bernard/AAL-2220-2020; Pineau, Charles/D-9185-2013; Siep,
   Michel/AAE-3770-2020; Primig, Michael/G-3175-2013; Briza,
   Peter/D-7309-2012; Caburet, Sandrine/AAH-3435-2019; Jegou,
   Bernard/I-4742-2015
OI Pineau, Charles/0000-0002-7461-5433; Primig,
   Michael/0000-0002-2061-0119; Briza, Peter/0000-0002-4941-6782; Caburet,
   Sandrine/0000-0002-7404-8213; JEGOU, Bernard/0000-0003-0623-3609;
   Brachat, Sophie/0000-0002-3398-8225; Hermida,
   Leandro/0000-0003-3887-518X; Nasmyth, Kim/0000-0001-7030-4403; Ishii,
   Ryohei/0000-0003-2486-1393
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM063310] Funding Source: Medline;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM063310,
   R01GM063310, R01GM063310, R01GM063310, R01GM063310, R01GM063310,
   R01GM063310, R01GM063310, R01GM063310] Funding Source: NIH RePORTER
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Baxevanis AD, 2003, NUCLEIC ACIDS RES, V31, P1, DOI 10.1093/nar/gkg120
   Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095
   Brachat S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r45
   Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23
   Briza P, 2002, YEAST, V19, P403, DOI 10.1002/yea.843
   Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8
   Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699
   Colaiacovo MP, 2002, GENETICS, V162, P113
   Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399
   Enyenihi AH, 2003, GENETICS, V163, P47
   Getz G, 2003, BIOINFORMATICS, V19, P1153, DOI 10.1093/bioinformatics/btg143
   Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935
   Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498
   Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278
   Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008
   Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121
   Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701
   Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951
   Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522
   Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539
   Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3
   Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Stein L, 2001, NAT REV GENET, V2, P493, DOI 10.1038/35080529
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   Weng S, 2003, NUCLEIC ACIDS RES, V31, P216, DOI 10.1093/nar/gkg054
   Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033
   Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299
   Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86
NR 30
TC 24
Z9 25
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 1
PY 2004
VL 32
SI SI
BP D560
EP D567
DI 10.1093/nar/gkh055
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 763HM
UT WOS:000188079000133
PM 14681481
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Nicholson, JR
   Dunant, P
   Hofbauer, KG
AF Nicholson, JR
   Dunant, P
   Hofbauer, KG
TI Melanocortin 4-receptor (MC4-R) blockade in rodent models of cachexia
SO PHARMACOLOGY
LA English
DT Meeting Abstract
CT 10th Symposium of the Austrian-Pharmacological-Society
CY SEP 23-26, 2004
CL Vienna, AUSTRIA
SP Austrian Pharmacolog Soc
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   MyoContract AG, Liestal, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0031-7012
J9 PHARMACOLOGY
JI Pharmacology
PY 2004
VL 72
IS 2
BP 148
EP 148
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 855NQ
UT WOS:000223980900077
DA 2021-01-25
ER

PT J
AU Filipek, S
   Krzysko, KA
   Fotiadis, D
   Liang, Y
   Saperstein, DA
   Engel, A
   Palczewski, K
AF Filipek, S
   Krzysko, KA
   Fotiadis, D
   Liang, Y
   Saperstein, DA
   Engel, A
   Palczewski, K
TI A concept for G protein activation by G protein-coupled receptor dimers:
   the transducin/rhodopsin interface
SO PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
LA English
DT Article
ID ROD OUTER SEGMENTS; ANGSTROM CRYSTAL-STRUCTURE; RESISTANT MEMBRANE
   RAFTS; HETEROTRIMERIC G-PROTEIN; COVALENT CROSS-LINKING; 4TH CYTOPLASMIC
   LOOP; G-BETA-GAMMA; ALPHA-SUBUNIT; 3-DIMENSIONAL STRUCTURE;
   SIGNAL-TRANSDUCTION
AB G protein-coupled receptors (GPCRs) are ubiquitous and essential in modulating virtually all physiological processes. These receptors share a similar structural design consisting of the seven-transmembrane alpha-helical segments. The active conformations of the receptors are stabilized by an agonist and couple to structurally highly conserved heterotrimeric G proteins. One of the most important unanswered questions is how GPCRs couple to their cognate G proteins. Phototransduction represents an excellent model system for understanding G protein signaling, owing to the high expression of rhodopsin in rod photoreceptors and the multidisciplinary experimental approaches used to study this GPCR. Here, we describe how a G protein (transducin) docks on to an oligomeric GPCR (rhodopsin), revealing structural details of this critical interface in the signal transduction process. This conceptual model takes into account recent structural information on the receptor and G protein, as well as oligomeric states of GPCRs.
C1 Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.
   Univ Warsaw, Fac Chem, Warsaw, Poland.
   Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.
   Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem, Seattle, WA 98195 USA.
RP Filipek, S (corresponding author), Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.
RI ; Filipek, Slawomir/A-2985-2008
OI Krzysko, Krystiana Anna/0000-0003-1687-6851; Filipek,
   Slawomir/0000-0003-3147-3858
FU NATIONAL EYE INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [R01EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, R01EY008061, R01EY008061, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, R01EY008061,
   P30EY001730, P30EY001730, P30EY001730, R29EY008061, P30EY001730,
   P30EY001730, R29EY008061, P30EY001730, P30EY001730, R01EY008061,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   R01EY008061, R29EY008061, P30EY001730, P30EY001730, R01EY008061,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, R01EY008061, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   R01EY008061, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, R01EY008061, R29EY008061, P30EY001730,
   R01EY008061, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R29EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, R29EY008061, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, R01EY008061, P30EY001730, R01EY008061,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730] Funding Source: NIH RePORTER; NEI NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [EY08061, EY01730] Funding Source: Medline
CR AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200
   AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095
   AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003
   Acharya S, 1997, J BIOL CHEM, V272, P6519, DOI 10.1074/jbc.272.10.6519
   Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314
   Arimoto R, 2001, BIOPHYS J, V81, P3285, DOI 10.1016/S0006-3495(01)75962-0
   Bai M, 2004, CELL SIGNAL, V16, P175, DOI 10.1016/S0898-6568(03)00128-1
   Balasubramanian N, 2003, CURR BIOL, V13, P1306, DOI 10.1016/S0960-9822(03)00511-6
   Ballesteros JA, 2001, MOL PHARMACOL, V60, P1
   Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X
   Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78
   Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560
   Bissantz C, 2003, J RECEPT SIG TRANSD, V23, P123, DOI 10.1081/RRS-120025192
   Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19
   BROWN PK, 1963, J CELL BIOL, V19, P79, DOI 10.1083/jcb.19.1.79
   Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898
   Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083
   Carrillo JJ, 2003, J BIOL CHEM, V278, P42578, DOI 10.1074/jbc.M306165200
   Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b
   Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200
   Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3
   Coleman DE, 1999, J BIOL CHEM, V274, P16669, DOI 10.1074/jbc.274.24.16669
   COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283
   Elliott MH, 2003, BIOCHEMISTRY-US, V42, P7892, DOI 10.1021/bi027162n
   Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937
   Filipek S, 2003, ANNU REV BIOPH BIOM, V32, P375, DOI 10.1146/annurev.biophys.32.110601.142520
   Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611
   FILIPEK S, UNPUB
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2003, NATURE, V426, P31, DOI 10.1038/426031a
   FOTIADIS D, 2004, IN PRESS FEBS LETT
   Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100
   George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913
   Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90
   Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6
   Gomes I, 2001, J MOL MED, V79, P226, DOI 10.1007/s001090100219
   Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147
   Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669
   HAMM HE, 1991, CELL MOL NEUROBIOL, V11, P563, DOI 10.1007/BF00741446
   Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2
   Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7
   Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831
   Itoh Y, 2001, P NATL ACAD SCI USA, V98, P4883, DOI 10.1073/pnas.051632998
   Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441
   KARNIK SS, 1990, J BIOL CHEM, V265, P17520
   Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270
   KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828
   Kostenis E, 1998, J BIOL CHEM, V273, P17886, DOI 10.1074/jbc.273.28.17886
   LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0
   Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0
   Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348
   Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930
   Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j
   Milligan G, 2003, LIFE SCI, V74, P181, DOI 10.1016/j.lfs.2003.09.005
   Milligan G, 2001, J CELL SCI, V114, P1265
   Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+
   Moepps Barbara, 2003, EMBO Reports, V4, P237, DOI 10.1038/sj.embor.embor777
   Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7
   Okada T, 2001, CURR OPIN STRUC BIOL, V11, P420, DOI 10.1016/S0959-440X(00)00227-X
   Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6
   Overton MC, 2003, J BIOL CHEM, V278, P49369, DOI 10.1074/jbc.M308654200
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   PALCZEWSKI K, 1994, PROTEIN SCI, V3, P1355, DOI 10.1002/pro.5560030901
   Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908
   Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X
   Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5
   Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7
   RODBELL M, 1995, BIOSCIENCE REP, V15, P117, DOI 10.1007/BF01207453
   Rondard P, 2001, P NATL ACAD SCI USA, V98, P6150, DOI 10.1073/pnas.101136198
   Saiz L, 2001, BIOPHYS J, V81, P204, DOI 10.1016/S0006-3495(01)75692-5
   SCHLEGEL W, 1979, J BIOL CHEM, V254, P5168
   Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200
   Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100
   SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0
   Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0
   STONE WL, 1979, EXP EYE RES, V28, P387, DOI 10.1016/0014-4835(79)90114-3
   Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091
   Teller DC, 2003, FEBS LETT, V555, P151, DOI 10.1016/S0014-5793(03)01152-9
   Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052
   Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907
   Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200
   WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1
NR 84
TC 142
Z9 145
U1 0
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1474-905X
J9 PHOTOCH PHOTOBIO SCI
JI Photochem. Photobiol. Sci.
PY 2004
VL 3
IS 6
BP 628
EP 638
DI 10.1039/b315661c
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA 825HL
UT WOS:000221746800020
PM 15170495
DA 2021-01-25
ER

PT B
AU Engel, A
AF Engel, A
BE PifatMrzijak, G
TI Observing structure and dynamics of membrane proteins by high-resolution
   microscopy
SO SUPRAMOLECULAR STRUCTURE AND FUNCTION 8
LA English
DT Proceedings Paper
CT 8th International Summer School in Biophysics - Supramolecular Structure
   and Function
CY SEP 14-26, 2003
CL Rovinj, CROATIA
SP UNESCO Venice Off, UVO ROSTE
ID ATOMIC-FORCE MICROSCOPY; X-RAY-STRUCTURE; ESCHERICHIA-COLI;
   2-DIMENSIONAL CRYSTALLIZATION; ELECTRON CRYSTALLOGRAPHY; ANGSTROM
   RESOLUTION; 2D CRYSTALLIZATION; CRYSTAL-STRUCTURE; LACTOSE PERMEASE;
   MOLECULAR-BASIS
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
CR Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196
   Czajkowsky DM, 1998, FEBS LETT, V430, P51, DOI 10.1016/S0014-5793(98)00461-X
   Czajkowsky DM, 1999, P NATL ACAD SCI USA, V96, P2001, DOI 10.1073/pnas.96.5.2001
   de Groot BL, 2000, J MOL BIOL, V300, P987, DOI 10.1006/jmbi.2000.3913
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a
   Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Fernandez C, 2003, FEBS LETT, V555, P144, DOI 10.1016/S0014-5793(03)01155-4
   Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Fotiadis D, 1998, J MOL BIOL, V283, P83, DOI 10.1006/jmbi.1998.2097
   Fotiadis D, 2001, J BIOL CHEM, V276, P1707, DOI 10.1074/jbc.M009383200
   FOTIADIS D, 2003, IN PRESS J BIOL CHEM
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109
   Hegner M, 2002, CHIMIA, V56, P506, DOI 10.2533/000942902777680090
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619
   Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   JAP BK, 1995, J MOL BIOL, V251, P413, DOI 10.1006/jmbi.1995.0444
   Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1
   KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0
   Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028
   Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   MANNELLA CA, 1984, SCIENCE, V224, P165, DOI 10.1126/science.6322311
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Mou JX, 1996, FEBS LETT, V381, P161, DOI 10.1016/0014-5793(96)00112-3
   MOU JX, 1995, FEBS LETT, V371, P279, DOI 10.1016/0014-5793(95)00906-P
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 1997, EMBO J, V16, P2547, DOI 10.1093/emboj/16.10.2547
   Muller DJ, 2002, METHOD CELL BIOL, V68, P257
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Nollert P, 2001, FEBS LETT, V504, P179, DOI 10.1016/S0014-5793(01)02747-8
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Rief M, 2000, ADV EXP MED BIOL, V481, P129
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   RINGLER P, 2000, 2 DIMENSIONAL CRYSTA
   Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x
   Scheuring S, 2002, EUR BIOPHYS J BIOPHY, V31, P172, DOI 10.1007/s00249-001-0197-8
   Stahlberg H, 2001, FEBS LETT, V504, P166, DOI 10.1016/S0014-5793(01)02746-6
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0
   Werten PJL, 2002, FEBS LETT, V529, P65, DOI 10.1016/S0014-5793(02)03290-8
   Zhuang JP, 1999, J STRUCT BIOL, V125, P63, DOI 10.1006/jsbi.1998.4059
NR 64
TC 1
Z9 1
U1 0
U2 1
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
BN 0-306-48661-X
PY 2004
BP 119
EP 134
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BAZ94
UT WOS:000224339900007
DA 2021-01-25
ER

PT J
AU Humeau, Y
   Shaban, H
   Bissiere, S
   Luthi, A
AF Humeau, Y
   Shaban, H
   Bissiere, S
   Luthi, A
TI Presynaptic induction of heterosynaptic associative plasticity in the
   mammalian brain
SO NATURE
LA English
DT Article
ID LONG-TERM POTENTIATION; LATERAL AMYGDALA; SYNAPTIC TRANSMISSION;
   BASOLATERAL AMYGDALA; NMDA RECEPTORS; DEPRESSION; RAT; LOCALIZATION;
   CORTEX; MEMORY
AB The induction of associative synaptic plasticity in the mammalian central nervous system classically depends on coincident presynaptic and postsynaptic activity(1,2). According to this principle, associative homosynaptic long-term potentiation (LTP) of excitatory synaptic transmission can be induced only if synaptic release occurs during postsynaptic depolarization(1,2). In contrast, heterosynaptic plasticity in mammals is considered to rely on activity-independent, non-associative processes(3-8). Here we describe a novel mechanism underlying the induction of associative LTP in the lateral amygdala ( LA). Simultaneous activation of converging cortical and thalamic afferents specifically induced associative, N-methyl-D-aspartate (NMDA)-receptor-dependent LTP at cortical, but not at thalamic, inputs. Surprisingly, the induction of associative LTP at cortical inputs was completely independent of postsynaptic activity, including depolarization, postsynaptic NMDA receptor activation or an increase in postsynaptic Ca2+ concentration, and did not require network activity. LTP expression was mediated by a persistent increase in the presynaptic probability of release at cortical afferents. Our study shows the presynaptic induction and expression of heterosynaptic and associative synaptic plasticity on simultaneous activity of converging afferents. Our data indicate that input specificity of associative LTP can be determined exclusively by presynaptic properties.
C1 Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Luthi, A (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.
RI shaban, Hamdy/C-1939-2014
OI shaban, Hamdy/0000-0003-3760-6113
CR ABRAHAM WC, 1991, BRAIN RES, V546, P336, DOI 10.1016/0006-8993(91)91498-P
   ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V
   Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191
   Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002
   Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6
   Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058
   Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901
   BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0
   Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x
   FARB CR, 1995, J COMP NEUROL, V362, P86, DOI 10.1002/cne.903620106
   Farb CR, 1999, SYNAPSE, V33, P218, DOI 10.1002/(SICI)1098-2396(19990901)33:3<218::AID-SYN6>3.3.CO;2-T
   GRACY KN, 1995, J COMP NEUROL, V362, P71, DOI 10.1002/cne.903620105
   GUSTAFSSON B, 1990, SEMIN NEUROSCI, V2, P321
   HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2
   Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3
   Humeau Y, 2002, J NEUROSCI, V22, P7968
   Lang EJ, 1997, J NEUROPHYSIOL, V77, P341
   Lang EJ, 1998, NEUROSCIENCE, V83, P877, DOI 10.1016/S0306-4522(97)00420-X
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213
   McDonald AJ, 1996, NEUROSCIENCE, V75, P407, DOI 10.1016/0306-4522(96)00269-2
   Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067
   Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X
   Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a
   Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530
   Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0
   Szinyei C, 2000, J NEUROSCI, V20, P8909
   Tsukamoto M, 2003, J PHYSIOL-LONDON, V546, P665, DOI 10.1113/jphysiol.2002.033803
   Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1
   Weisskopf MG, 1999, J NEUROSCI, V19, P10512
NR 30
TC 185
Z9 187
U1 0
U2 14
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD DEC 18
PY 2003
VL 426
IS 6968
BP 841
EP 845
DI 10.1038/nature02194
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 754QM
UT WOS:000187342000059
PM 14685239
DA 2021-01-25
ER

PT J
AU Seifritz, E
   Esposito, F
   Neuhoff, JG
   Luthi, A
   Mustovic, H
   Dammann, G
   von Bardeleben, U
   Radue, EW
   Cirillo, S
   Tedeschi, G
   Di Salle, F
AF Seifritz, E
   Esposito, F
   Neuhoff, JG
   Luthi, A
   Mustovic, H
   Dammann, G
   von Bardeleben, U
   Radue, EW
   Cirillo, S
   Tedeschi, G
   Di Salle, F
TI Differential sex-independent amygdala response to infant crying and
   laughing in parents versus nonparents
SO BIOLOGICAL PSYCHIATRY
LA English
DT Article
DE audition; functional magnetic resonance imaging; adaptation; social;
   emotion; amygdala
ID MEDIAL PREFRONTAL CORTEX; HUMAN AUDITORY-CORTEX; MATERNAL-BEHAVIOR;
   FUNCTIONAL MRI; HUMAN BRAIN; HORMONAL CHANGES; NEGATIVE BOLD; FMRI DATA;
   EMOTION; ACTIVATION
AB Background: Animal and human studies implicate fore-brain neural circuits in maternal behavior. Here, we hypothesized that human brain response to emotional stimuli relevant for social interactions between infants and adults are modulated by sex- and experience-dependent factors.
   Methods: We used functional magnetic resonance imaging and examined brain response to infant crying and laughing in mothers and fathers of young children and in women and men without children.
   Results: Women but not men, independent of their parental status, showed neural deactivation in the anterior cingulate cortex, as indexed by decreased blood oxygenation level-dependent signal, in response to both infant crying and laughing. The response pattern changed fundamentally with parental experience: in the amygdala and interconnected limbic regions, parents (independent of sex) showed stronger activation from crying, whereas nonparents showed stronger activation from laughing.
   Conclusions: Our data show sex- and experience-dependent modulation of brain response to infant vocalizations. Successful recognition and evaluation of infant vocalizations can be critical for bonding mechanisms and for offspring well-being and survival. Thus, the modulation of responses by experience seems to represent an adaptive mechanism that can be related to reproductive fitness.
C1 Univ Basel, Dept Psychiat, CH-4025 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4025 Basel, Switzerland.
   Univ Basel, Dept Radiol, CH-4025 Basel, Switzerland.
   Univ Naples 2, Div Neurol 2, Naples, Italy.
   Univ Naples 2, Div Neuroradiol, Naples, Italy.
   Univ Naples Federico II, Dept Neurol Sci, Div Neuroradiol, Naples, Italy.
   Coll Wooster, Dept Psychol, Wooster, OH 44691 USA.
RP Seifritz, E (corresponding author), Univ Basel, Dept Psychiat, Wilhelm Kleinstr 27, CH-4025 Basel, Switzerland.
RI Neuhoff, John/A-2955-2016; Esposito, Fabrizio/M-8555-2015
OI Esposito, Fabrizio/0000-0002-5099-9786; cirillo,
   sossio/0000-0002-1821-8070; Neuhoff, John/0000-0003-1123-9044
CR Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X
   Albright TD, 2000, NEURON, V25, pS1, DOI 10.1016/S0896-6273(00)80912-5
   Alexander GM, 2002, EVOL HUM BEHAV, V23, P467, DOI 10.1016/S1090-5138(02)00107-1
   Allen JS, 2002, AM J PHYS ANTHROPOL, V118, P341, DOI 10.1002/ajpa.10092
   Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293
   Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2
   Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078
   Braun K, 2001, NEUROSCIENCE, V103, P861, DOI 10.1016/S0306-4522(01)00074-4
   Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2
   Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749
   Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598
   Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L
   Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148
   Dietrich T, 2001, NEUROIMAGE, V13, P425, DOI 10.1006/nimg.2001.0703
   DIXSON AF, 1982, NATURE, V299, P551, DOI 10.1038/299551a0
   Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358
   Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8
   Fischer H, 2003, BRAIN RES BULL, V59, P387, DOI 10.1016/S0361-9230(02)00940-1
   Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306
   Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402
   George MS, 1996, ARCH NEUROL-CHICAGO, V53, P665, DOI 10.1001/archneur.1996.00550070103017
   Gubernick DJ, 2000, P ROY SOC B-BIOL SCI, V267, P147, DOI 10.1098/rspb.2000.0979
   Gur RC, 2002, CEREB CORTEX, V12, P998, DOI 10.1093/cercor/12.9.998
   Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500
   Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407
   Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002
   Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829
   Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793
   Lang PJ, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   Leger DW, 1996, CHILD DEV, V67, P3238, DOI 10.2307/1131776
   Lorberbaum JP, 1999, DEPRESS ANXIETY, V10, P99, DOI 10.1002/(SICI)1520-6394(1999)10:3<99::AID-DA2>3.0.CO;2-#
   Lorberbaum JP, 2002, BIOL PSYCHIAT, V51, P431, DOI 10.1016/S0006-3223(01)01284-7
   MACLEAN PD, 1985, ARCH GEN PSYCHIAT, V42, P405
   Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161
   Merboldt KD, 2001, NEUROIMAGE, V14, P253, DOI 10.1006/nimg.2001.0802
   MURPHY MR, 1981, SCIENCE, V213, P459, DOI 10.1126/science.7244642
   Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661
   Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004
   Purhonen M, 2001, INT J PSYCHOPHYSIOL, V41, P271, DOI 10.1016/S0167-8760(01)00139-8
   Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X
   RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313
   RADLEY MM, 1999, B2 U FLOR CTR RES PS
   Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800
   Reburn CJ, 1999, HORM BEHAV, V35, P163, DOI 10.1006/hbeh.1998.1509
   Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304
   Sander K, 2003, BRAIN RES PROTOC, V11, P81, DOI 10.1016/S1385-299X(03)00018-7
   Sander K, 2001, COGNITIVE BRAIN RES, V12, P181, DOI 10.1016/S0926-6410(01)00045-3
   Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355
   SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0
   Sheehan T, 2002, NEUROENDOCRINOLOGY, V75, P12, DOI 10.1159/000048217
   Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9
   Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745
   Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688
   Storey AE, 2000, EVOL HUM BEHAV, V21, P79, DOI 10.1016/S1090-5138(99)00042-2
   Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911
   Trainor BC, 2002, P ROY SOC B-BIOL SCI, V269, P823, DOI 10.1098/rspb.2001.1954
   vom Saal F S, 1982, Science, V215, P1270, DOI 10.1126/science.7058349
   Wade AR, 2002, NEURON, V36, P993, DOI 10.1016/S0896-6273(02)01138-8
   Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z
   Ward B.D, 2000, SIMULTANEOUS INFEREN
   Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70
   Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912
   Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933
   Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O
   Wynne-Edwards KE, 2001, HORM BEHAV, V40, P139, DOI 10.1006/hbeh.2001.1699
   Zald DH, 2003, BRAIN RES REV, V41, P88, DOI 10.1016/S0165-0173(02)00248-5
NR 67
TC 232
Z9 238
U1 2
U2 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD DEC 15
PY 2003
VL 54
IS 12
BP 1367
EP 1375
DI 10.1016/S0006-3223(03)00697-8
PG 9
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 753UW
UT WOS:000187249800009
PM 14675800
DA 2021-01-25
ER

PT J
AU Sanchez, IE
   Kiefhaber, T
AF Sanchez, IE
   Kiefhaber, T
TI Origin of unusual Phi-values in protein folding: Evidence against
   specific nucleation sites
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding kinetics; phi-value analysis; rate-equilibrium free
   energy relationships; transition state
ID TRANSITION-STATE; SH3 DOMAIN; RESIDUAL STRUCTURE; HAMMOND BEHAVIOR;
   ENERGY; KINETICS; STABILIZATION; SIMILARITIES; MECHANISM; PATHWAYS
AB phi(f)-value analysis is one of the most common methods to characterize the structure of protein folding transition states. It compares the effects of mutations on the folding kinetics with the respective effects on equilibrium stability. The interpretation of the results usually focuses on a few unusual phi(f)-values, which are either particularly high or which are larger than 1 or smaller than 0. These mutations are believed to affect the most important regions for the folding process. A major uncertainty in experimental phi(f)-values is introduced by the commonly used analysis of only a single mutant at various positions in a protein (two-point analysis). To test the reliability of two-point phi(f)-values we used reference data from three positions in two different proteins at which multiple mutations have been introduced. The results show that two-point phi(f)-values are highly inaccurate if the difference in stability between two variants is less than 7 kJ/mol, corresponding to a 20-fold difference in equilibrium constant. Comparison with reported phi(f)-values for 11 proteins shows that most unusual phi(f)-values are observed in mutants which show changes in protein stability that are too small to allow a reliable analysis. The results argue against specific nucleation sites in protein folding and give a picture of transition states as distorted native states for the major part of a protein or for large substructures. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Dept Biophys Chem, Biozentrum, Klingelberstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Sanchez, Ignacio/A-5658-2009; Kiefhaber, Thomas/A-3028-2010
OI Sanchez, Ignacio Enrique/0000-0003-4284-9013
CR Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   BIERI O., 2000, MECH PROTEIN FOLDING, P34
   Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757
   Chu RA, 2002, BIOCHEMISTRY-US, V41, P7998, DOI 10.1021/bi025872n
   Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f
   Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311
   EVANS PA, 1991, PROTEINS, V9, P248, DOI 10.1002/prot.340090404
   FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013
   FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W
   Friel CT, 2003, J MOL BIOL, V326, P293, DOI 10.1016/S0022-2836(02)01249-4
   Galzitskaya OV, 1999, P NATL ACAD SCI USA, V96, P11299, DOI 10.1073/pnas.96.20.11299
   GOLDENBERG DP, 1989, NATURE, V338, P127, DOI 10.1038/338127a0
   Goldenberg DP, 1999, NAT STRUCT BIOL, V6, P987, DOI 10.1038/14866
   Grantcharova VP, 1998, NAT STRUCT BIOL, V5, P714, DOI 10.1038/1412
   Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586
   Gruebele M, 1998, NAT STRUCT BIOL, V5, P662, DOI 10.1038/1354
   Guerois R, 2000, J MOL BIOL, V304, P967, DOI 10.1006/jmbi.2000.4234
   Horovitz A, 2002, P NATL ACAD SCI USA, V99, P14095, DOI 10.1073/pnas.222303299
   ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616
   Jencks W. P., 1969, CATALYSIS CHEM ENZYM
   JENNINGS PA, 1991, METHOD ENZYMOL, P202
   Kim DE, 2000, J MOL BIOL, V298, P971, DOI 10.1006/jmbi.2000.3701
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Klimov DK, 2001, PROTEINS, V43, P465, DOI 10.1002/prot.1058
   Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618
   Kragelund BB, 1999, NAT STRUCT BIOL, V6, P594
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   KUWAJIMA K, 1989, J MOL BIOL, V206, P547, DOI 10.1016/0022-2836(89)90500-7
   Leffler J.E., 1963, RATES EQUILIBRIA ORG
   LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340
   Li L, 2000, NAT STRUCT BIOL, V7, P336
   MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498
   McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971
   Mok YK, 2001, J MOL BIOL, V307, P913, DOI 10.1006/jmbi.2001.4521
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748
   Northey JGB, 2002, J MOL BIOL, V320, P389, DOI 10.1016/S0022-2836(02)00445-X
   Ozkan SB, 2001, NAT STRUCT BIOL, V8, P765, DOI 10.1038/nsb0901-765
   Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016
   Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   Shoemaker BA, 1999, J MOL BIOL, V287, P675, DOI 10.1006/jmbi.1999.2613
   Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591
   Ventura S, 2002, NAT STRUCT BIOL, V9, P485, DOI 10.1038/nsb799
   Viguera AR, 2002, P NATL ACAD SCI USA, V99, P5349, DOI 10.1073/pnas.072387799
   Villegas V, 1998, J MOL BIOL, V283, P1027, DOI 10.1006/jmbi.1998.2158
NR 47
TC 124
Z9 125
U1 0
U2 10
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 12
PY 2003
VL 334
IS 5
BP 1077
EP 1085
DI 10.1016/j.jmb.2003.10.016
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 752GP
UT WOS:000187153000017
PM 14643667
DA 2021-01-25
ER

PT J
AU Pieters, J
   Ploegh, H
AF Pieters, J
   Ploegh, H
TI Chemical warfare and mycobacterial Defense
SO SCIENCE
LA English
DT Editorial Material
ID PROTEASOME; TUBERCULOSIS; MACROPHAGES; UBIQUITIN; GENES
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
OI Pieters, Jean/0000-0002-5284-9757
CR ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0
   Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187
   Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043
   Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851
   DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300
   Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176
   Ehrt S, 1997, J EXP MED, V186, P1885, DOI 10.1084/jem.186.11.1885
   Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0
   Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049
   Ruan J, 1999, INFECT IMMUN, V67, P3276, DOI 10.1128/IAI.67.7.3276-3283.1999
   Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498
   Via LE, 1998, J CELL SCI, V111, P897
   XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522
NR 14
TC 15
Z9 17
U1 0
U2 2
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD DEC 12
PY 2003
VL 302
IS 5652
BP 1900
EP 1902
DI 10.1126/science.1092873
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 752NL
UT WOS:000187174000036
PM 14671281
DA 2021-01-25
ER

PT J
AU Dingley, AJ
   Steger, G
   Esters, B
   Riesner, D
   Grzesiek, S
AF Dingley, AJ
   Steger, G
   Esters, B
   Riesner, D
   Grzesiek, S
TI Structural characterization of the 69 nucleotide potato spindle tuber
   viroid left-terminal domain by NMR and thermodynamic analysis
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE ConStruct; nucleic acid; PSTVd; RNA structure; thermal stability
ID GRADIENT GEL-ELECTROPHORESIS; IN-SITU HYBRIDIZATION; SECONDARY
   STRUCTURE; SELF-CLEAVAGE; CONFORMATIONAL TRANSITIONS;
   NUCLEOTIDE-SEQUENCE; RNA STRUCTURES; NUCLEIC-ACIDS; PLANT-VIRUS; MINUS
   RNAS
AB The 69 nucleotide left-terminal domain (TO of the potato spindle tuber RNA viroid (PSTVd) constitutes one of its five structural elements. Due to a twofold complementary sequence repeat, two possible conformations are proposed for the T, secondary structure; an elongated-rod and a bifurcated form. In the present study, two TL mutants were designed that remove the symmetry of the sequence repeats and ensure that either the bifurcated or the elongated-rod conformation is thermodynamically favored. Imino H-1 and N-15 resonances were assigned for both mutants and the native TL domain based on H-1-H-1 NOESY and heteronuclear H-1-N-15 HSQC high-resolution NMR spectra. The NMR secondary structure analysis of all constructs establishes unambiguously the elongated-rod form as the secondary structure of the native TL domain. Temperature-gradient gel electrophoresis and UV melting experiments corroborate these results. A combined secondary structure and sequence analysis of TL domains of other Pospiviroidae family members indicates that the elongated-rod form is thermodynamically favored for the vast majority of these viroids. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Dusseldorf, Inst Biol Phys, D-40225 Dusseldorf, Germany.
   Forschungszentrum Julich, Inst Struct Biol IBI 2, D-52425 Julich, Germany.
   Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
RP Dingley, AJ (corresponding author), Univ Dusseldorf, Inst Biol Phys, D-40225 Dusseldorf, Germany.
EM dingley@biochem.ucl.ac.uk; stephan.grzesiek@unibas.ch
RI Dingley, Andrew/G-6427-2013
OI Dingley, Andrew/0000-0002-6838-5803; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Al-Hashimi HM, 2002, J MOL BIOL, V318, P637, DOI 10.1016/S0022-2836(02)00160-2
   Baumstark T, 1997, EMBO J, V16, P599, DOI 10.1093/emboj/16.3.599
   BONFIGLIOLI RG, 1994, PLANT J, V6, P99, DOI 10.1046/j.1365-313X.1994.6010099.x
   BRANCH AD, 1988, P NATL ACAD SCI USA, V85, P9128, DOI 10.1073/pnas.85.23.9128
   BRANCH AD, 1984, SCIENCE, V223, P450, DOI 10.1126/science.6197756
   DAROS JA, 1994, P NATL ACAD SCI USA, V91, P12813, DOI 10.1073/pnas.91.26.12813
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Diener T.O., 1987, VIROIDS
   DIENER TO, 1967, SCIENCE, V158, P378, DOI 10.1126/science.158.3799.378
   DIENER TO, 1991, FASEB J, V5, P2808
   Flores R, 1998, ARCH VIROL, V143, P623, DOI 10.1007/s007050050318
   Flores R, 1999, BIOL CHEM, V380, P849, DOI 10.1515/BC.1999.104
   Flores R, 1997, SEMIN VIROL, V8, P65, DOI 10.1006/smvy.1997.0107
   FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X
   FORSTER AC, 1987, CELL, V49, P211, DOI 10.1016/0092-8674(87)90562-9
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Gast FU, 1996, J MOL BIOL, V262, P652, DOI 10.1006/jmbi.1996.0543
   Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583
   GROSS HJ, 1978, NATURE, V273, P203, DOI 10.1038/273203a0
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052
   HARDERS J, 1989, EMBO J, V8, P3941, DOI 10.1002/j.1460-2075.1989.tb08577.x
   HASELOFF J, 1982, NUCLEIC ACIDS RES, V10, P3681, DOI 10.1093/nar/10.12.3681
   HASHIMOTO J, 1987, NUCLEIC ACIDS RES, V15, P7045, DOI 10.1093/nar/15.17.7045
   HECKER R, 1988, GENE, V72, P59, DOI 10.1016/0378-1119(88)90128-X
   HENCO K, 1979, NUCLEIC ACIDS RES, V6, P3041, DOI 10.1093/nar/6.9.3041
   HERNANDEZ C, 1992, P NATL ACAD SCI USA, V89, P3711, DOI 10.1073/pnas.89.9.3711
   HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163
   HUTCHINS CJ, 1985, PLANT MOL BIOL, V4, P293, DOI 10.1007/BF02418248
   HUTCHINS CJ, 1986, NUCLEIC ACIDS RES, V14, P3627, DOI 10.1093/nar/14.9.3627
   Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7
   JUCKER FM, 1995, BIOCHEMISTRY-US, V34, P14416, DOI 10.1021/bi00044a019
   KEESE P, 1985, P NATL ACAD SCI USA, V82, P4582, DOI 10.1073/pnas.82.14.4582
   Kim I, 2002, J AM CHEM SOC, V124, P9338, DOI 10.1021/ja026647w
   KLUMP H, 1978, NUCLEIC ACIDS RES, V5, P1581, DOI 10.1093/nar/5.5.1581
   KOLTUNOW AM, 1989, INTERVIROLOGY, V30, P194, DOI 10.1159/000150093
   LANGOWSKI J, 1978, NUCLEIC ACIDS RES, V5, P1589, DOI 10.1093/nar/5.5.1589
   LIMA MI, 1994, ARCH VIROL, V138, P385, DOI 10.1007/BF01379142
   LIPPENS G, 1995, J BIOMOL NMR, V5, P327, DOI 10.1007/BF00211762
   LOSS P, 1991, EMBO J, V10, P719, DOI 10.1002/j.1460-2075.1991.tb08002.x
   Luck R, 1999, NUCLEIC ACIDS RES, V27, P4208, DOI 10.1093/nar/27.21.4208
   MARCOS JF, 1992, VIROLOGY, V186, P481, DOI 10.1016/0042-6822(92)90013-F
   MUHLBACH HP, 1979, NATURE, V278, P185, DOI 10.1038/278185a0
   Navarro B, 1997, P NATL ACAD SCI USA, V94, P11262, DOI 10.1073/pnas.94.21.11262
   Navarro JA, 2000, EMBO J, V19, P2662, DOI 10.1093/emboj/19.11.2662
   NIKONOWICZ EP, 1992, NUCLEIC ACIDS RES, V20, P4507, DOI 10.1093/nar/20.17.4507
   NOWAKOWSKI J, 1998, OXFORD HDB NUCL ACID, P567
   Pelchat M, 2000, NUCLEIC ACIDS RES, V28, P179, DOI 10.1093/nar/28.1.179
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577
   QU F, 1993, EMBO J, V12, P2129, DOI 10.1002/j.1460-2075.1993.tb05861.x
   RANDLES JW, 1982, NUCLEIC ACIDS RES, V10, P5569, DOI 10.1093/nar/10.18.5569
   Repsilber D, 1999, RNA, V5, P574, DOI 10.1017/S1355838299982018
   RIESNER D, 1979, J MOL BIOL, V133, P85, DOI 10.1016/0022-2836(79)90252-3
   RIESNER D, 1989, ELECTROPHORESIS, V10, P377, DOI 10.1002/elps.1150100516
   RIESNER D, 1992, ELECTROPHORESIS, V13, P632, DOI 10.1002/elps.11501301129
   RIESNER D, 1985, ANNU REV BIOCHEM, V54, P531, DOI 10.1146/annurev.bi.54.070185.002531
   RIESNER D, 1990, NUCL ACIDS, P194
   RIESNET D, 1991, ADV ELECTROPHORESIS, P169
   ROSENBAUM V, 1987, BIOPHYS CHEM, V26, P235, DOI 10.1016/0301-4622(87)80026-1
   SAMMONS DW, 1981, ELECTROPHORESIS, V2, P135, DOI 10.1002/elps.1150020303
   SCHINDLER IM, 1992, PLANT SCI, V84, P221, DOI 10.1016/0168-9452(92)90138-C
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   SCHUMACHER J, 1983, EMBO J, V2, P1549, DOI 10.1002/j.1460-2075.1983.tb01622.x
   SEMANCIK JS, 1993, J GEN VIROL, V74, P2427, DOI 10.1099/0022-1317-74-11-2427
   SEMANCIK JS, 1987, VIROIDS VIROIS LIKE
   SPIEKER RL, 1990, NUCLEIC ACIDS RES, V18, P3998, DOI 10.1093/nar/18.13.3998
   Spieker RL, 1996, J GEN VIROL, V77, P2631, DOI 10.1099/0022-1317-77-10-2631
   STASYS RA, 1995, FEBS LETT, V358, P182, DOI 10.1016/0014-5793(94)01424-Y
   STEGER G, 1984, J BIOMOL STRUCT DYN, V2, P543
   Symons RH, 1997, NUCLEIC ACIDS RES, V25, P2683, DOI 10.1093/nar/25.14.2683
   SYMONS RH, 1990, SEMIN VIROL, V1, P75
   TINOCO I, 1971, NATURE, V230, P362, DOI 10.1038/230362a0
   Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   WYATT JR, 1991, BIOTECHNIQUES, V11, P764
   Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425
   ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181
NR 77
TC 31
Z9 32
U1 0
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 5
PY 2003
VL 334
IS 4
BP 751
EP 767
DI 10.1016/j.jmb.2003.10.015
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 749KD
UT WOS:000186918300010
PM 14636600
DA 2021-01-25
ER

PT J
AU Journet, L
   Agrain, C
   Broz, P
   Cornelis, GR
AF Journet, L
   Agrain, C
   Broz, P
   Cornelis, GR
TI The needle length of bacterial injectisomes is determined by a molecular
   ruler
SO SCIENCE
LA English
DT Article
ID FLAGELLAR HOOK LENGTH; III SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM;
   SUBSTRATE-SPECIFICITY; SHIGELLA-FLEXNERI; YOP SECRETION; TAIL LENGTH;
   PROTEIN; COMPLEX; YSCP
AB Size determination represents a fundamental requirement for multicomponent biological structures. Some pathogenic bacteria possess a weapon derived from the flagellum. Like the flagellum, this type-III secretion apparatus, called the injectisome, has a transmembrane basal body, but the external component is a needle-like structure instead of a hook and a. lament. Here, we provide evidence that the length of this needle is determined by the size of a protein, YscP, acting as a molecular ruler.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RI Broz, Petr/AAC-7940-2019
OI Broz, Petr/0000-0002-2334-7790; Journet, Laure/0000-0002-5847-2962
CR ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128
   Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1016/S0378-1097(01)00301-9
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   COLLAZO CM, 1995, MOL MICROBIOL, V15, P25, DOI 10.1111/j.1365-2958.1995.tb02218.x
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932
   DUDA RL, 1986, VIROLOGY, V151, P296, DOI 10.1016/0042-6822(86)90051-6
   Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003
   HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0
   KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002
   Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366
   Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000
   Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x
   Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999
   Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2
   Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x
   Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002
NR 23
TC 214
Z9 224
U1 0
U2 16
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD DEC 5
PY 2003
VL 302
IS 5651
BP 1757
EP 1760
DI 10.1126/science.1091422
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 750AX
UT WOS:000186970100046
PM 14657497
DA 2021-01-25
ER

PT J
AU de Monvel, JB
   Scarfone, E
   Le Calvez, S
   Ulfendahl, M
AF de Monvel, JB
   Scarfone, E
   Le Calvez, S
   Ulfendahl, M
TI Image-adaptive deconvolution for three-dimensional deep biological
   imaging
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID WAVELET SHRINKAGE; MICROSCOPY; RESTORATION; LIGHT; COMPENSATION; OPTICS
AB Deconvolution algorithms are widely used in conventional fluorescence microscopy, but they remain difficult to apply to deep imaging systems such as confocal and two-photon microscopy, due to the practical difficulty of measuring the system's point spread function (PSF), especially in biological experiments. Since a separate PSF measurement performed under the design optical conditions of the microscope cannot reproduce the true experimental conditions prevailing in situ, the most natural approach to solve the problem is to extract the PSF from the images themselves. We investigate here the approach of cropping an approximate PSF directly from the images, by exploiting the presence of small structures within the samples under study. This approach turns out to be practical in many cases, allowing significantly better restorations than with a design PSF obtained by imaging fluorescent beads in gel. We demonstrate the advantages of this approach with a number of deconvolution experiments performed both on artificially blurred and noisy test images, and on real confocal images taken within an in vitro preparation of the mouse hearing organ.
C1 Karolinska Inst, Ctr Hearing & Commun Res, Stockholm, Sweden.
   Univ Montpellier, INSERM, Montpellier, France.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP de Monvel, JB (corresponding author), Karolinska Inst, Karolinska Sjukhuset, M1-00 ENT, S-17176 Stockholm, Sweden.
OI Boutet de Monvel, Jacques/0000-0001-6182-3527
CR de Monvel JB, 2001, BIOPHYS J, V80, P2455, DOI 10.1016/S0006-3495(01)76214-5
   DONOHO DL, 1994, BIOMETRIKA, V81, P425, DOI 10.1093/biomet/81.3.425
   Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626
   FUGATE RQ, 1991, NATURE, V353, P144, DOI 10.1038/353144a0
   GIBSON SF, 1991, J OPT SOC AM A, V8, P1601
   GULL SF, 1978, NATURE, V272, P686, DOI 10.1038/272686a0
   Hanley QS, 1999, J MICROSC-OXFORD, V196, P317
   HARDY JW, 1977, J OPT SOC AM, V67, P360, DOI 10.1364/JOSA.67.000360
   HELL S, 1993, J MICROSC-OXFORD, V169, P391, DOI 10.1111/j.1365-2818.1993.tb03315.x
   HIRAOKA Y, 1990, BIOPHYS J, V57, P325, DOI 10.1016/S0006-3495(90)82534-0
   HOLMES TJ, 1988, J OPT SOC AM A, V5, P666, DOI 10.1364/JOSAA.5.000666
   Kam Z., 1997, Bioimaging, V5, P40, DOI 10.1002/1361-6374(199703)5:1<40::AID-BIO4>3.3.CO;2-N
   Kam Z, 2001, P NATL ACAD SCI USA, V98, P3790, DOI 10.1073/pnas.071275698
   Le Calvez S, 2000, J NEUROCYTOL, V29, P645, DOI 10.1023/A:1010831303845
   LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605
   Neil MAA, 2000, J MICROSC-OXFORD, V197, P219
   PAWLEY JB, 1995, HDB BIOL CONFOCAL MI
   PRIMMERMAN CA, 1991, NATURE, V353, P141, DOI 10.1038/353141a0
   Ragazzoni R, 2000, NATURE, V403, P54, DOI 10.1038/47425
   RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055
   Saito N., 1995, Journal of Mathematical Imaging and Vision, V5, P337, DOI 10.1007/BF01250288
NR 21
TC 35
Z9 36
U1 0
U2 6
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD DEC
PY 2003
VL 85
IS 6
BP 3991
EP 4001
DI 10.1016/S0006-3495(03)74813-9
PG 11
WC Biophysics
SC Biophysics
GA 747GX
UT WOS:000186797800052
PM 14645088
OA Green Published
DA 2021-01-25
ER

PT J
AU Russell, AP
   Feilchenfeldt, J
   Schreiber, S
   Praz, M
   Crettenand, A
   Gobelet, C
   Meier, CA
   Bell, DR
   Kralli, A
   Giacobino, JP
   Deriaz, O
AF Russell, AP
   Feilchenfeldt, J
   Schreiber, S
   Praz, M
   Crettenand, A
   Gobelet, C
   Meier, CA
   Bell, DR
   Kralli, A
   Giacobino, JP
   Deriaz, O
TI Endurance training in humans leads to fiber type-specific increases in
   levels of peroxisome proliferator-activated receptor-gamma coactivator-1
   and peroxisome proliferator-activated receptor-alpha in skeletal muscle
SO DIABETES
LA English
DT Article
ID MESSENGER-RNA; INSULIN SENSITIVITY; LIPID-METABOLISM; GENE-EXPRESSION;
   PPAR-GAMMA; EXERCISE; PGC-1; ADAPTATIONS; OXIDATION; RESISTANCE
AB The peroxisome proliferator-activated receptor (PPAR)-gamma coactivator-1 (PGC-1) can induce mitochondria biogenesis and has been implicated in the development of oxidative type I muscle fibers. The PPAR isoforms alpha, beta/delta, and gamma control the transcription of genes involved in fatty acid and glucose metabolism. As endurance training increases skeletal muscle mitochondria and type I fiber content and fatty acid oxidative capacity, our aim was to determine whether these increases could be mediated by possible effects on PGC-1 or PPAR-alpha, -beta/delta, and -gamma. Seven healthy men performed 6 weeks of endurance training and the expression levels of PGG-1 and PPA-R-alpha, -beta/delta, and -gamma mRNA as well as the fiber type distribution of the PGC-1 and PPAR-alpha proteins were measured in biopsies from their vastus lateralis muscle. PGC-1 and PPAR-a mRNA expression increased by 2.7- and 2.2-fold (P < 0.01), respectively, after endurance training. PGC-1 expression was 2.2- and 6-fold greater in the type IIa than in the type I and IIx fibers, respectively. It increased by 2.8-fold in the type IIa fibers and by 1.5-fold in both the type I and IIx fibers after endurance training (P < 0.015). PPAR-alpha was 1.9-fold greater in type I than in the II fibers and increased by 3.0-fold and 1.5-fold in these respective fibers after endurance training (P < 0.001). The increases in PGC-1 and PPAR-alpha levels reported in this study may play an important role in the changes in muscle mitochondria content, oxidative phenotype, and sensitivity to insulin known to be induced by endurance training.
C1 SUVA, Clin Romande Readaptat, CH-1951 Sion, Switzerland.
   Univ Hosp Geneva, Endocrine Unit, Geneva, Switzerland.
   Univ Basel, Biozentrum, Div Biochem, Basel, Switzerland.
   Univ Nottingham, Sch Life & Environm Sci, Nottingham NG7 2RD, England.
   Univ Geneva, Dept Med Biochem, Geneva, Switzerland.
   Scripps Res Inst, Dept Cell Biol, La Jolla, CA USA.
RP Russell, AP (corresponding author), SUVA, Clin Romande Readaptat, Case Postale 352,Av Gd Champsec 90, CH-1951 Sion, Switzerland.
EM aaron.russell@crr-suva.ch
OI Russell, Aaron/0000-0002-7323-9501
CR Andersen JL, 1999, J APPL PHYSIOL, V86, P455
   APPLE FS, 1989, J APPL PHYSIOL, V66, P2717
   Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com
   BERGSTROM J, 1966, SCAND J CLIN LAB INV, V18, P16, DOI 10.3109/00365516609065602
   Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786
   DELA F, 1994, DIABETES, V43, P862, DOI 10.2337/diabetes.43.7.862
   DELA F, 1992, AM J PHYSIOL, V263, pE1134
   Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C
   Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134
   Hara K, 2002, DIABETOLOGIA, V45, P740, DOI 10.1007/s00125-002-0803-z
   Harber MP, 2002, INT J SPORTS MED, V23, P484, DOI 10.1055/s-2002-35067
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831
   Holloszy John O., 1998, Frontiers in Bioscience, V3, pD1011
   Horowitz JF, 2000, AM J PHYSIOL-ENDOC M, V279, pE348
   HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248
   HULTMAN E, 1995, P NUTR SOC, V54, P107, DOI 10.1079/PNS19950041
   Kliewer SA, 1998, CURR OPIN GENET DEV, V8, P576, DOI 10.1016/S0959-437X(98)80014-2
   KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355
   KROTKIEWSKI M, 1994, PRESSE MED, V23, P1393
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Manetta J, 2002, MED SCI SPORT EXER, V34, P423, DOI 10.1097/00005768-200203000-00007
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200
   MURAKAMI T, 1994, AM J PHYSIOL, V267, pE388
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   RODNICK KJ, 1987, AM J PHYSIOL, V253, pE489
   Rodriguez LP, 2002, AM J PHYS MED REHAB, V81, P651, DOI 10.1097/00002060-200209000-00004
   Russell A, 2002, INT J OBESITY, V26, P157, DOI 10.1038/sj.ijo.0801885
   Russell AP, 2003, PFLUG ARCH EUR J PHY, V445, P563, DOI 10.1007/s00424-002-0943-5
   Schiaffino S, 1996, PHYSIOL REV, V76, P371
   Schrauwen P, 2002, DIABETES, V51, P2220, DOI 10.2337/diabetes.51.7.2220
   Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200
   Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888
   Terada S, 2002, BIOCHEM BIOPH RES CO, V296, P350, DOI 10.1016/S0006-291X(02)00881-1
   Tunstall RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66, DOI 10.1152/ajpendo.00475.2001
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Vogt M, 2001, J APPL PHYSIOL, V91, P173
   WADE R, 1990, GENOMICS, V7, P346, DOI 10.1016/0888-7543(90)90168-T
   Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411
NR 42
TC 320
Z9 334
U1 0
U2 24
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD DEC
PY 2003
VL 52
IS 12
BP 2874
EP 2881
DI 10.2337/diabetes.52.12.2874
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 746AH
UT WOS:000186723600002
PM 14633846
OA Bronze
DA 2021-01-25
ER

PT J
AU Di Salle, F
   Esposito, F
   Scarabino, T
   Formisano, E
   Marciano, E
   Saulino, C
   Cirillo, S
   Elefante, R
   Scheffler, K
   Seifritz, E
AF Di Salle, F
   Esposito, F
   Scarabino, T
   Formisano, E
   Marciano, E
   Saulino, C
   Cirillo, S
   Elefante, R
   Scheffler, K
   Seifritz, E
TI fMRI of the auditory system: understanding the neural basis of auditory
   gestalt
SO MAGNETIC RESONANCE IMAGING
LA English
DT Article; Proceedings Paper
CT International School on Magnetic Resonance and Brain Function
CY APR 06-10, 2003
CL ERICE, ITALY
DE functional MRI; auditory cortex
ID HUMAN CEREBRAL-CORTEX; EVENT-RELATED FMRI; SCANNER ACOUSTIC NOISE;
   HUMAN-BRAIN; TONOTOPIC ORGANIZATION; MAGNETIC-FIELDS; SOUND ANALYSIS;
   INFERIOR COLLICULUS; MISMATCH NEGATIVITY; MACAQUE MONKEY
AB Functional magnetic resonance imaging (fMRI) has rapidly become the most widely used imaging method for studying brain functions in humans. This is a result of its extreme flexibility of use and of the astonishingly detailed spatial and temporal information it provides. Nevertheless, until very recently, the study of the auditory system has progressed at a considerably slower pace compared to other functional systems. Several factors have limited fMRI research in the auditory field, including some intrinsic features of auditory functional anatomy and some peculiar interactions between fMRI technique and audition. A well known difficulty arises from the high intensity acoustic noise produced by gradient switching in echo-planar imaging (EPI), as well as in other fMRI sequences more similar to conventional MR sequences. The acoustic noise interacts in an unpredictable way with the experimental stimuli both from a perceptual point of view and in the evoked hemodynamics. To overcome this problem, different approaches have been proposed recently that generally require careful tailoring of the experimental design and the fMRI methodology to the specific requirements posed by the auditory research. The novel methodological approaches can make the fMRI exploration of auditory processing much easier and more reliable, and thus may permit filling the gap with other fields of neuroscience research. As a result, some fundamental neural underpinnings of audition are being clarified, and the way sound stimuli are integrated in the auditory gestalt are beginning to be understood. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Naples Federico II, Dept Neurol Sci, Naples, Italy.
   Univ Naples 2, Div Neurol 2, Naples, Italy.
   Sci Inst Casa Solliev Sofferenza, Dept Neuroradiol, Foggia, Italy.
   Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.
   Univ Naples Federico II, Audiol Unit, Naples, Italy.
   Univ Naples 2, Dept Neuroradiol, Naples, Italy.
   Univ Basel, Magnet Resonance Ctr, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Basel, Dept Psychiat, CH-4003 Basel, Switzerland.
RP Di Salle, F (corresponding author), Univ Naples Federico II, Dept Neurol Sci, Naples, Italy.
EM disalle@unina.it
RI Esposito, Fabrizio/M-8555-2015
OI Esposito, Fabrizio/0000-0002-5099-9786; Scheffler,
   Klaus/0000-0001-6316-8773; MARCIANO, Elio/0000-0001-5055-9150; cirillo,
   sossio/0000-0002-1821-8070
CR ARLINGER S, 1982, ELECTROEN CLIN NEURO, V54, P642, DOI 10.1016/0013-4694(82)90118-3
   Bandettini PA, 1998, MAGNET RESON MED, V39, P410, DOI 10.1002/mrm.1910390311
   BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220
   Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078
   Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480
   BERTRAND O, 1991, ACTA OTO-LARYNGOL, P116
   Bilecen D, 1998, MAGNET RESON MED, V40, P934, DOI 10.1002/mrm.1910400621
   Bilecen D, 1998, HEARING RES, V126, P19, DOI 10.1016/S0378-5955(98)00139-7
   BILECEN D, 1996, P ISMRM NEW YORK, V1, P1841
   BINDER JR, 1994, COGNITIVE BRAIN RES, V2, P31, DOI 10.1016/0926-6410(94)90018-3
   BINDER JR, 1994, ANN NEUROL, V35, P662, DOI 10.1002/ana.410350606
   Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512
   Binder JR, 1997, J NEUROSCI, V17, P353
   Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9
   Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7
   Bushara KO, 1999, NAT NEUROSCI, V2, P759
   CAMPAIN R, 1976, BRAIN LANG, V3, P318, DOI 10.1016/0093-934X(76)90026-2
   Chen GK, 1999, IEEE T BIO-MED ENG, V46, P186, DOI 10.1109/10.740881
   Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278
   Di Salle F, 2001, NEUROIMAGE, V13, P328, DOI 10.1006/nimg.2000.0683
   Duvernoy H., 1999, 3 DIMENSIONAL SECTIO
   Eden GF, 1999, MAGN RESON MED, V41, P13, DOI 10.1002/(SICI)1522-2594(199901)41:1<13::AID-MRM4>3.0.CO;2-T
   Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E
   ELBERLING C, 1982, SCAND AUDIOL, V11, P61, DOI 10.3109/01050398209076201
   Engelien A, 2002, NEUROIMAGE, V16, P944, DOI 10.1006/nimg.2002.1149
   Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698
   Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313
   Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033
   GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312
   Ghika-Schmid F, 1997, EUR NEUROL, V38, P276, DOI 10.1159/000113394
   GLENDENNING KK, 1981, J COMP NEUROL, V197, P673, DOI 10.1002/cne.901970409
   Griffiths TD, 1999, CLIN SCI, V96, P231, DOI 10.1042/CS19980337
   Griffiths TD, 1996, NATURE, V383, P425, DOI 10.1038/383425a0
   Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9
   Grimm C, 1998, ELECTROEN CLIN NEURO, V106, P22, DOI 10.1016/S0013-4694(97)00122-3
   Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M
   Halgren E, 1999, HUM BRAIN MAPP, V7, P29
   Hall DA, 2000, MAGN RESON MED, V43, P601, DOI 10.1002/(SICI)1522-2594(200004)43:4<601::AID-MRM16>3.3.CO;2-I
   Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N
   Hedeen RA, 1997, MAGNET RESON MED, V37, P7, DOI 10.1002/mrm.1910370103
   Hennel F, 1999, MAGNET RESON MED, V42, P6, DOI 10.1002/(SICI)1522-2594(199907)42:1<6::AID-MRM2>3.0.CO;2-D
   HENNEL F, 1998, P ESMRM GEN, V1, P218
   Hennig J., 1993, MAGMA, V1, P39, DOI 10.1007/BF02660372
   Hernandez AE, 2000, BRAIN LANG, V73, P421, DOI 10.1006/brln.1999.2278
   Howard MA, 1996, BRAIN RES, V724, P260, DOI 10.1016/0006-8993(96)00315-0
   Jakob PM, 1998, MAGNET RESON MED, V40, P614, DOI 10.1002/mrm.1910400414
   Jancke L, 1998, NEUROPSYCHOLOGIA, V36, P875, DOI 10.1016/S0028-3932(98)00019-0
   Kaas JH, 1998, AUDIOL NEURO-OTOL, V3, P73, DOI 10.1159/000013783
   Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1
   Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109
   Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623
   KONISHI M, 1988, AUDITORY FUNCTION NE, P721
   KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675
   Lantos G, 1997, NEUROIMAGE, V5, pS174
   LAUTER JL, 1985, HEARING RES, V20, P199, DOI 10.1016/0378-5955(85)90024-3
   Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873
   Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815
   LOVELESS N, 1994, HEARING RES, V81, P91, DOI 10.1016/0378-5955(94)90156-2
   Maddock RJ, 1997, PSYCHIAT RES-NEUROIM, V75, P1, DOI 10.1016/S0925-4927(97)00018-8
   Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058
   MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2
   MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231
   MINCKLER J, 1972, INTRO NEUROSCIENCE
   MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312
   Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340
   Mustovic H, 2003, NEUROIMAGE, V20, P429, DOI 10.1016/S1053-8119(03)00293-3
   Naatanen R, 2003, INT J PSYCHOPHYSIOL, V48, P179, DOI 10.1016/S0167-8760(03)00053-9
   OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868
   PANDYA DN, 1994, J COMP NEUROL, V345, P447, DOI 10.1002/cne.903450311
   PANTEV C, 1988, ELECTROEN CLIN NEURO, V69, P160, DOI 10.1016/0013-4694(88)90211-8
   PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4
   Pavani F, 2002, CURR BIOL, V12, P1584, DOI 10.1016/S0960-9822(02)01143-0
   Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067
   RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330
   Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8
   Ravicz ME, 2000, J ACOUST SOC AM, V108, P1683, DOI 10.1121/1.1310190
   Robson MD, 1998, NEUROIMAGE, V7, P185, DOI 10.1006/nimg.1998.0322
   ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770
   Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056
   SALDANA E, 1992, J COMP NEUROL, V319, P417, DOI 10.1002/cne.903190308
   Saleem KS, 2000, J NEUROSCI, V20, P5083
   Scheffler K, 1999, MAGNET RESON MED, V42, P829, DOI 10.1002/(SICI)1522-2594(199911)42:5<829::AID-MRM2>3.0.CO;2-6
   Scheffler K, 1998, CEREB CORTEX, V8, P156, DOI 10.1093/cercor/8.2.156
   Scheich H, 1998, EUR J NEUROSCI, V10, P803, DOI 10.1046/j.1460-9568.1998.00086.x
   Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0
   Seifritz E, 2003, TRENDS NEUROSCI, V26, P231, DOI 10.1016/S0166-2236(03)00075-4
   Seifritz E, 2002, CURR BIOL, V12, P2147, DOI 10.1016/S0960-9822(02)01356-8
   Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355
   Shah NJ, 1999, J MAGN RESON IMAGING, V9, P19, DOI 10.1002/(SICI)1522-2586(199901)9:1<19::AID-JMRI3>3.0.CO;2-K
   Strainer JC, 1997, AM J NEURORADIOL, V18, P601
   TALAIRACH P, 1988, STEREOTACTIC COPLANA
   TALAVAGE RM, 1996, P ISMRM, V4, P1842
   TALAVAGE RM, 1997, NEUROIMAGE, V5, pS8
   Tanaka H, 2000, NEUROREPORT, V11, P2045, DOI 10.1097/00001756-200006260-00047
   TIITINEN H, 1993, PSYCHOPHYSIOLOGY, V30, P537, DOI 10.1111/j.1469-8986.1993.tb02078.x
   TUOMISTO T, 1983, NUOVO CIMENTO D, V2, P471, DOI 10.1007/BF02455946
   Ulmer JL, 1998, J COMPUT ASSIST TOMO, V22, P480, DOI 10.1097/00004728-199805000-00022
   Ulmer JL, 1998, J COMPUT ASSIST TOMO, V22, P111, DOI 10.1097/00004728-199801000-00021
   VERKINDT C, 1995, EVOKED POTENTIAL, V96, P143, DOI 10.1016/0168-5597(94)00242-7
   VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240
   Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2
   Weeks R, 2000, J NEUROSCI, V20, P2664
   Wessinger CM, 1997, HUM BRAIN MAPP, V5, P18, DOI 10.1002/(SICI)1097-0193(1997)5:1<18::AID-HBM3>3.0.CO;2-Q
   YAMAMOTO T, 1992, ACTA OTO-LARYNGOL, V112, P201, DOI 10.1080/00016489.1992.11665404
   YAMAMOTO T, 1988, P NATL ACAD SCI USA, V85, P8732, DOI 10.1073/pnas.85.22.8732
   Yang YH, 2000, MAGNET RESON MED, V43, P185, DOI 10.1002/(SICI)1522-2594(200002)43:2<185::AID-MRM4>3.0.CO;2-3
   Zatorre RJ, 2003, TRENDS NEUROSCI, V26, P229, DOI 10.1016/S0166-2236(03)00074-2
NR 107
TC 27
Z9 27
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0730-725X
EI 1873-5894
J9 MAGN RESON IMAGING
JI Magn. Reson. Imaging
PD DEC
PY 2003
VL 21
IS 10
BP 1213
EP 1224
DI 10.1016/j.mri.2003.08.023
PG 12
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 763WQ
UT WOS:000188123800013
PM 14725929
DA 2021-01-25
ER

PT J
AU Marenne, MN
   Journet, L
   Mota, LJ
   Cornelis, GR
AF Marenne, MN
   Journet, L
   Mota, LJ
   Cornelis, GR
TI Genetic analysis of the formation of the Ysc-Yop translocation pore in
   macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE type III secretion; translocation pore; LcrV; needle; traffic
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; RECOMBINANT V-ANTIGEN; III SECRETION
   SYSTEM; TARGET-CELL CONTACT; EFFECTOR PROTEINS; PASSIVE-IMMUNITY;
   EPITHELIAL-CELLS; PLASMA-MEMBRANE; REGULATORY ROLE; SUICIDE VECTOR
AB The Ysc-Yop type III secretion (TTS) system allows extracellular Yersinia bacteria, adhering to eukaryotic target cells, to inject Yop effector proteins in the cytosol of these cells. The secretion apparatus, called the injectisome, ends up with a needle-like structure made of YscF. YopN, one of the proteins secreted by the injectisome is thought to act as a plug. YopB, YopD and LcrV, three other proteins secreted by the injectisome and called 'translocators' form a pore allowing translocation of the Yop effectors across the target cell plasma membrane. Here, we tested the role of LcrV, YscF and YopN in the formation of this pore in macrophages by monitoring the release of the low-molecul ar-weight fluorescent dye BCECF (2',7'-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester, 623 Da) and of the high-molecular-weight lactate dehydrogenase (LDH, 135 kDa). BCECF is released through the translocation pore itself provided no Yop effector is trafficking through the channel. In contrast, LDH is released by the osmotic lysis of the target cell that occurs after pore formation. This release is reduced by the GAP activity of YopE. In order to study the role of LcrV, one has to circumvent the regulatory effect of LcrV on the synthesis of YopB and Yopf). We observed here that this regulatory role of LcrV is lost in a yopQ mutant and hence we studied the role of LcrV in a yopQ mutant background. A lcrV, yopQ double mutant was deficient in pore formation while able to produce YopB and YopD. Pore formation was restored by the introduction of lcrV(+) but not yopQ(+) confirming that LcrV itself is directly required for pore formation. Bacteria secreting only YopB, YopD and LcrV could form pores, showing that YopB, YopD and LcrV are sufficient for pore formation provided they are secreted by the same bacterium. LcrV is not involved in secretion of YopB and YopD as suggested previously. Bacteria producing normal Ysc injectisomes, including the YscF needle but no translocators did not form pores, indicating that the needle is not sufficient by itself for pore formation, as was also suggested. yopN mutant bacteria formed needles and released BCECF even if they secreted the effectors. This observation suggests that many translocation pores are not filled in the absence of YopN and thus that YopN might form a link between the needle and the pore, guiding the effectors. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Mol Microbiol Div, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Louvain, Christian De Duve Inst Cellular Pathol, B-1200 Brussels, Belgium.
   Univ Louvain, Fac Med, B-1200 Brussels, Belgium.
RP Cornelis, GR (corresponding author), Univ Basel, Mol Microbiol Div, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Mota, Luis J/B-9497-2008
OI Mota, Luis J/0000-0002-5592-8397; Journet, Laure/0000-0002-5847-2962
CR BERGMAN T, 1991, J BACTERIOL, V173, P1607, DOI 10.1128/jb.173.5.1607-1616.1991
   BHAKDI S, 1989, J EXP MED, V169, P737, DOI 10.1084/jem.169.3.737
   Bodeus M., 1990, RAT HYBRIDOMA RAT MO, P335
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098
   Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000
   Cheng LW, 2001, J BACTERIOL, V183, P5293, DOI 10.1128/JB.183.18.5293-5301.2001
   CHINA B, 1990, MOL MICROBIOL, V4, P1585, DOI 10.1111/j.1365-2958.1990.tb02070.x
   Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932
   Cornelis GR, 1998, J BACTERIOL, V180, P5495, DOI 10.1128/JB.180.21.5495-5504.1998
   Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x
   Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999
   FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x
   Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x
   Francis MS, 2002, CURR OPIN MICROBIOL, V5, P166, DOI 10.1016/S1369-5274(02)00301-6
   Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x
   Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002
   HAKANSSON S, 1993, INFECT IMMUN, V61, P71
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Holmstrom A, 1997, MOL MICROBIOL, V24, P73, DOI 10.1046/j.1365-2958.1997.3211681.x
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x
   Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x
   Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lawton DG, 2002, J BIOL CHEM, V277, P38714, DOI 10.1074/jbc.M203632200
   Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200
   Matson JS, 2001, J BACTERIOL, V183, P5082, DOI 10.1128/JB.183.17.5082-5091.2001
   Matson JS, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-16
   MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988
   MOTIN VL, 1994, INFECT IMMUN, V62, P4192, DOI 10.1128/IAI.62.10.4192-4201.1994
   NAKAJIMA R, 1995, INFECT IMMUN, V63, P3021, DOI 10.1128/IAI.63.8.3021-3029.1995
   NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993
   Neyt C, 1997, J BACTERIOL, V179, P612, DOI 10.1128/jb.179.3.612-619.1997
   Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Nilles ML, 1997, J BACTERIOL, V179, P1307, DOI 10.1128/jb.179.4.1307-1316.1997
   Nilles ML, 1998, J BACTERIOL, V180, P3410, DOI 10.1128/JB.180.13.3410-3420.1998
   PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   PRICE SB, 1989, J BACTERIOL, V171, P5646, DOI 10.1128/jb.171.10.5646-5653.1989
   Roggenkamp A, 1997, INFECT IMMUN, V65, P446, DOI 10.1128/IAI.65.2.446-451.1997
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Sarker MR, 1998, INFECT IMMUN, V66, P2976, DOI 10.1128/IAI.66.6.2976-2979.1998
   Schulte R, 1996, INFECT IMMUN, V64, P2106, DOI 10.1128/IAI.64.6.2106-2113.1996
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315
   SKRZYPEK E, 1993, J BACTERIOL, V175, P3520, DOI 10.1128/jb.175.11.3520-3528.1993
   SKRZYPEK E, 1995, J BACTERIOL, V177, P2530, DOI 10.1128/jb.177.9.2530-2542.1995
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stainier I, 1997, MOL MICROBIOL, V26, P833, DOI 10.1046/j.1365-2958.1997.6281995.x
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Viboud GI, 2003, MOL MICROBIOL, V47, P1305, DOI 10.1046/j.1365-2958.2003.03350.x
   Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x
   Wilson RK, 2001, CELL MICROBIOL, V3, P753, DOI 10.1046/j.1462-5822.2001.00159.x
NR 67
TC 80
Z9 82
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD DEC
PY 2003
VL 35
IS 6
BP 243
EP 258
DI 10.1016/S0882-4010(03)00154-2
PG 16
WC Immunology; Microbiology
SC Immunology; Microbiology
GA 743RR
UT WOS:000186587800002
PM 14580388
DA 2021-01-25
ER

PT J
AU Primig, M
   Wiederkehr, C
   Basavaraj, R
   de Menthiere, CS
   Hermida, L
   Koch, R
   Schlecht, U
   Dickinson, HG
   Fellous, M
   Grootegoed, JA
   Hawley, RS
   Jegou, B
   Maro, B
   Nicolas, A
   Orr-Weaver, T
   Schedl, T
   Villeneuve, A
   Wolgemuth, DJ
   Yamamoto, M
   Zickler, D
   Lamb, N
   Esposito, RE
AF Primig, M
   Wiederkehr, C
   Basavaraj, R
   de Menthiere, CS
   Hermida, L
   Koch, R
   Schlecht, U
   Dickinson, HG
   Fellous, M
   Grootegoed, JA
   Hawley, RS
   Jegou, B
   Maro, B
   Nicolas, A
   Orr-Weaver, T
   Schedl, T
   Villeneuve, A
   Wolgemuth, DJ
   Yamamoto, M
   Zickler, D
   Lamb, N
   Esposito, RE
TI GermOnline, a new cross-species community annotation database on
   germ-line development and gametogenesis
SO NATURE GENETICS
LA English
DT Letter
ID GENOME; MEIOSIS
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
   Inst Genet Humaine, Montpellier, France.
   Univ Oxford, Oxford OX1 2JD, England.
   Hop Cochin, F-75674 Paris, France.
   Erasmus MC, Rotterdam, Netherlands.
   Stowers Inst, Kansas City, MO USA.
   Univ Rennes 1, Bretagne, France.
   Univ Paris 06, Paris, France.
   Inst Curie, Paris, France.
   MIT, Whitehead Inst Biomed Res, Cambridge, MA USA.
   Washington Univ, St Louis, MO USA.
   Stanford Univ, Palo Alto, CA 94304 USA.
   Columbia Univ, New York, NY USA.
   Univ Tokyo, Tokyo, Japan.
   Univ Paris 11, Orsay, France.
   Univ Chicago, Chicago, IL 60637 USA.
RP Primig, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
RI Maro, Bernard/AAL-2220-2020; Primig, Michael/G-3175-2013; Jegou,
   Bernard/I-4742-2015
OI Primig, Michael/0000-0002-2061-0119; Hermida,
   Leandro/0000-0003-3887-518X; Hawley, R. Scott/0000-0002-6478-0494;
   JEGOU, Bernard/0000-0003-0623-3609
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM063310,
   R01GM063310, R01GM063310, R01GM063310, R01GM063310, R01GM063310,
   R01GM063310, R01GM063310, R01GM063310] Funding Source: NIH RePORTER;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM063310] Funding Source: Medline
CR Baxevanis AD, 2003, NUCLEIC ACIDS RES, V31, P1, DOI 10.1093/nar/gkg120
   Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8
   Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334
   Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539
   Schlecht U, 2003, REPRODUCTION, V125, P447, DOI 10.1530/reprod/125.4.447
   Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033
   WIEDERKEHR C, IN PRESS NUCL ACIDS
   Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299
   Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724
   Yeh I, 2003, BIOINFORMATICS, V19, P241, DOI 10.1093/bioinformatics/19.2.241
NR 10
TC 19
Z9 19
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1061-4036
J9 NAT GENET
JI Nature Genet.
PD DEC
PY 2003
VL 35
IS 4
BP 291
EP 292
DI 10.1038/ng1203-291
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA 747DY
UT WOS:000186791000002
PM 14647278
DA 2021-01-25
ER

PT J
AU Handschin, C
   Meyer, UA
AF Handschin, C
   Meyer, UA
TI Induction of drug metabolism: The role of nuclear receptors
SO PHARMACOLOGICAL REVIEWS
LA English
DT Review
ID PREGNANE-X-RECEPTOR; CONSTITUTIVE-ANDROSTANE RECEPTOR;
   PHENOBARBITAL-RESPONSIVE ENHANCER; PROLIFERATOR-ACTIVATED RECEPTOR;
   CYP3A4 GENE-EXPRESSION; LIGAND-BINDING DOMAIN; CHICKEN CYP2H1 GENE; ST
   JOHNS WORT; BARBITURATE-MEDIATED INDUCTION; ENRICHED TRANSCRIPTION
   FACTORS
AB Induction of drug metabolism was described more than 40 years ago. Progress in understanding the molecular mechanism of induction of drug-metabolizing enzymes was made recently when the important roles of the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR), two members of the nuclear receptor superfamily of transcription factors, were discovered to act as sensors for lipophilic xenobiotics, including drugs. CAR and PXR bind as heterodimeric complexes with the retinoid X receptor to response elements in the regulatory regions of the induced genes. PXR is directly activated by xenobiotic ligands, whereas CAR is involved in a more complex and less well understood mechanism of signal transduction triggered by drugs. Most recently, analysis of these xenobiotic-sensing nuclear receptors and their nonmammalian precursors such as the chicken xenobiotic receptor suggests an important role of PXR and CAR also in endogenous pathways, such as cholesterol and bile acid biosynthesis and metabolism. In this review, recent findings regarding xenosensors and their target genes are summarized and are put into an evolutionary perspective in regard to how a living organism has derived a system that is able to deal with potentially toxic compounds it has not encountered before.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM ursa.a.meyer@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR ADESNIK M, 1981, J BIOL CHEM, V256, P340
   Akiyama TE, 2003, BBA-GEN SUBJECTS, V1619, P223, DOI 10.1016/S0304-4165(02)00480-4
   ALTHAUS FR, 1979, J BIOL CHEM, V254, P2148
   Andersin T, 2003, MOL ENDOCRINOL, V17, P234, DOI 10.1210/me.2002-0263
   Auerbach SS, 2003, NUCLEIC ACIDS RES, V31, P3194, DOI 10.1093/nar/gkg419
   Auwerx J, 1999, CELL, V97, P161
   Baader M, 2002, J BIOL CHEM, V277, P15647, DOI 10.1074/jbc.M109882200
   BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544
   BAFFET G, 1995, BIOCHEM BIOPH RES CO, V216, P947, DOI 10.1006/bbrc.1995.2712
   Barwick JL, 1996, MOL PHARMACOL, V50, P10
   BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5
   Beigneux AP, 2002, BIOCHEM BIOPH RES CO, V293, P145, DOI 10.1016/S0006-291X(02)00196-1
   Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200
   Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208
   Bertilsson G, 2001, BIOCHEM BIOPH RES CO, V280, P139, DOI 10.1006/bbrc.2000.4066
   Blizard D, 2001, DRUG METAB DISPOS, V29, P781
   Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195
   Blumberg B, 1998, GENE DEV, V12, P1269, DOI 10.1101/gad.12.9.1269
   Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149
   Bohan A, 2002, SEMIN LIVER DIS, V22, P123, DOI 10.1055/s-2002-30099
   Brigelius-Flohe R, 2003, BIOCHEM BIOPH RES CO, V305, P737, DOI 10.1016/S0006-291X(03)00811-8
   Bulera SJ, 2001, HEPATOLOGY, V33, P1239, DOI 10.1053/jhep.2001.23560
   BURGER HJ, 1990, ARCH BIOCHEM BIOPHYS, V281, P204, DOI 10.1016/0003-9861(90)90433-Y
   Burk O, 2002, J BIOL CHEM, V277, P24280, DOI 10.1074/jbc.M202345200
   Cai Y, 2002, EUR J PHARM SCI, V15, P89, DOI 10.1016/S0928-0987(01)00211-1
   Chang TKH, 2003, DRUG METAB DISPOS, V31, P7, DOI 10.1124/dmd.31.1.7
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Cheng PY, 2001, CURR DRUG METAB, V2, P165, DOI 10.2174/1389200013338676
   Cherrington NJ, 2002, J PHARMACOL EXP THER, V300, P97, DOI 10.1124/jpet.300.1.97
   Choi HS, 1997, J BIOL CHEM, V272, P23565, DOI 10.1074/jbc.272.38.23565
   Choi HS, 1996, J STEROID BIOCHEM, V56, P23, DOI 10.1016/0960-0760(95)00220-0
   CONNEY AH, 1960, J PHARMACOL EXP THER, V130, P1
   Corcos L, 2001, PHARMACOL TOXICOL, V89, P113, DOI 10.1034/j.1600-0773.2001.d01-144.x
   Coumoul X, 2002, BIOCHEM PHARMACOL, V64, P1513, DOI 10.1016/S0006-2952(02)01298-4
   Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170
   Davidson BP, 2001, INT J BIOCHEM CELL B, V33, P1080, DOI 10.1016/S1357-2725(01)00076-0
   DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175
   Dogra SC, 1998, CLIN EXP PHARMACOL P, V25, P1, DOI 10.1111/j.1440-1681.1998.tb02135.x
   Dogra SC, 1997, DNA CELL BIOL, V16, P1407, DOI 10.1089/dna.1997.16.1407
   Dogra SC, 1999, MOL PHARMACOL, V55, P14
   Dogra SC, 1996, ARCH BIOCHEM BIOPHYS, V327, P271, DOI 10.1006/abbi.1996.0121
   DOGRA SC, 1993, ARCH BIOCHEM BIOPHYS, V300, P531, DOI 10.1006/abbi.1993.1073
   Dogra SC, 2003, MOL PHARMACOL, V63, P73, DOI 10.1124/mol.63.1.73
   Dotzlaw H, 1999, CLIN CANCER RES, V5, P2103
   Drocourt L, 2002, J BIOL CHEM, V277, P25125, DOI 10.1074/jbc.M201323200
   Drocourt L, 2001, DRUG METAB DISPOS, V29, P1325
   Duanmu ZB, 2002, DRUG METAB DISPOS, V30, P997, DOI 10.1124/dmd.30.9.997
   Dunkov BC, 1997, DNA CELL BIOL, V16, P1345, DOI 10.1089/dna.1997.16.1345
   Dussault I, 2003, P NATL ACAD SCI USA, V100, P833, DOI 10.1073/pnas.0336235100
   Dussault I, 2002, MOL CELL BIOL, V22, P5270, DOI 10.1128/MCB.22.15.5270-5280.2002
   Dussault I, 2001, J BIOL CHEM, V276, P33309, DOI 10.1074/jbc.C100375200
   Ekins S, 2002, TRENDS PHARMACOL SCI, V23, P49, DOI 10.1016/S0165-6147(02)01977-6
   Ekins S, 2002, DRUG METAB DISPOS, V30, P96, DOI 10.1124/dmd.30.1.96
   Ekins S, 2002, PHARM RES-DORDR, V19, P1788, DOI 10.1023/A:1021429105173
   Enmark E, 1996, MOL ENDOCRINOL, V10, P1293, DOI 10.1210/me.10.11.1293
   Enmark E, 2001, TRENDS PHARMACOL SCI, V22, P611, DOI 10.1016/S0165-6147(00)01859-9
   Falkner KC, 2001, MOL PHARMACOL, V60, P611
   Ferguson SS, 2002, DRUG METAB REV, V34, P111
   Ferguson SS, 2002, MOL PHARMACOL, V62, P737, DOI 10.1124/mol.62.3.737
   Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507
   FONNE R, 1987, PHARMACOL THERAPEUT, V33, P19, DOI 10.1016/0163-7258(87)90022-2
   Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996
   Forman BM, 2001, PHARMACOGENETICS, V11, P551, DOI 10.1097/00008571-200110000-00001
   Fraser DJ, 2002, J BIOL CHEM, V277, P34717, DOI 10.1074/jbc.M204699200
   Frueh FW, 1997, MOL PHARMACOL, V51, P363
   Fukuen S, 2002, BIOCHEM BIOPH RES CO, V298, P433, DOI 10.1016/S0006-291X(02)02469-5
   FULCO AJ, 1991, ANNU REV PHARMACOL, V31, P177
   Galisteo M, 1999, J PHARMACOL EXP THER, V290, P1270
   Ganem LG, 1999, TOXICOL APPL PHARM, V155, P32, DOI 10.1006/taap.1998.8599
   Garcia-Allan C, 2000, J BIOCHEM MOL TOXIC, V14, P65, DOI 10.1002/(SICI)1099-0461(2000)14:2<65::AID-JBT1>3.0.CO;2-#
   Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200
   Gerbal-Chaloin S, 2002, J BIOL CHEM, V277, P209, DOI 10.1074/jbc.M107228200
   Gerhold D, 2001, PHYSIOL GENOMICS, V5, P161
   Gillam Elizabeth M J, 2002, Trends Pharmacol Sci, V23, P355, DOI 10.1016/S0165-6147(02)02092-8
   Gillam EMJ, 2001, TRENDS PHARMACOL SCI, V22, P448, DOI 10.1016/S0165-6147(00)01847-2
   GONZALEZ FJ, 1982, J BIOL CHEM, V257, P5962
   GONZALEZ FJ, 1991, ALCOHOL ALCOHOLISM, P97
   Goodwin B, 2001, MOL PHARMACOL, V60, P427
   Goodwin B, 2002, AM J PHYSIOL-GASTR L, V282, pG926, DOI 10.1152/ajpgi.00044.2002
   Goodwin B, 2002, MOL PHARMACOL, V62, P359, DOI 10.1124/mol.62.2.359
   Goodwin B, 1999, MOL PHARMACOL, V56, P1329
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100
   Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051
   Grun F, 2002, J BIOL CHEM, V277, P43691, DOI 10.1074/jbc.M206553200
   Guo GL, 2002, MOL PHARMACOL, V61, P832, DOI 10.1124/mol.61.4.832
   HAHN CN, 1991, J BIOL CHEM, V266, P17031
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307
   HE JS, 1991, J BIOL CHEM, V266, P7864
   Heath LA, 2000, INT J DEV BIOL, V44, P141
   Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6
   Hirsch-Ernst KI, 2001, MOL PHARMACOL, V59, P1402
   Honkakoski P, 1997, J BIOL CHEM, V272, P14943, DOI 10.1074/jbc.272.23.14943
   Honkakoski P, 1998, MOL PHARMACOL, V53, P597
   Honkakoski P, 1996, J BIOL CHEM, V271, P9746, DOI 10.1074/jbc.271.16.9746
   Honkakoski P, 2003, ANN MED, V35, P172, DOI 10.1080/07853890310008224
   Honkakoski P, 1998, BIOCHEM J, V330, P889, DOI 10.1042/bj3300889
   Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   Honkakoski P, 1998, J BIOCHEM MOL TOXIC, V12, P3
   Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100
   Huss JM, 1998, J BIOL CHEM, V273, P16155, DOI 10.1074/jbc.273.26.16155
   Huss JM, 1996, P NATL ACAD SCI USA, V93, P4666, DOI 10.1073/pnas.93.10.4666
   Hustert E, 2001, DRUG METAB DISPOS, V29, P1454
   Iwahori T, 2003, HEPATOLOGY, V37, P665, DOI 10.1053/jhep.2003.50094
   Jacobs MN, 2003, J STEROID BIOCHEM, V84, P117, DOI 10.1016/S0960-0760(03)00021-9
   Jakoby William B., 1994, P429
   Johnson EF, 1996, FASEB J, V10, P1241
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Jover R, 2002, FASEB J, V16, P1799, DOI 10.1096/fj.02-0195fje
   Kakizaki S, 2002, DRUG METAB DISPOS, V30, P208, DOI 10.1124/dmd.30.2.208
   Kakizaki S, 2003, BBA-GEN SUBJECTS, V1619, P239, DOI 10.1016/S0304-4165(02)00482-8
   Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212
   Karpen SJ, 2002, J HEPATOL, V36, P832, DOI 10.1016/S0168-8278(02)00129-0
   Kassam A, 2000, J BIOL CHEM, V275, P4345, DOI 10.1074/jbc.275.6.4345
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897
   Kawamoto T, 1999, MOL CELL BIOL, V19, P6318
   Kawamura A, 1999, BIOCHEM BIOPH RES CO, V264, P530, DOI 10.1006/bbrc.1999.1544
   Kemper B, 1998, PROG NUCLEIC ACID RE, V61, P25, DOI 10.1016/S0079-6603(08)60824-7
   Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5
   Kim J, 1997, J BIOL CHEM, V272, P29423, DOI 10.1074/jbc.272.47.29423
   Kim J, 2000, NUCLEIC ACIDS RES, V28, P1126, DOI 10.1093/nar/28.5.1126
   Kim Soo-Mi, 2001, BMC Molecular Biology, V2, P1, DOI 10.1186/1471-2199-2-1
   Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Kliewer SA, 2002, J LIPID RES, V43, P359
   Kocarek TA, 1998, MOL PHARMACOL, V54, P474
   Kocarek TA, 2002, MOL PHARMACOL, V62, P1177, DOI 10.1124/mol.62.5.1177
   Kocarek TA, 2002, J PHARMACOL TOXICOL, V47, P177, DOI 10.1016/S1056-8719(03)00002-9
   Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2
   Landes N, 2003, BIOCHEM PHARMACOL, V65, P269, DOI 10.1016/S0006-2952(02)01520-4
   Ledda-Columbano GM, 2003, CARCINOGENESIS, V24, P1059, DOI 10.1093/carcin/bgg063
   Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   Li JX, 2000, GENE DEV, V14, P464
   Li W, 2002, INSECT MOL BIOL, V11, P543, DOI 10.1046/j.1365-2583.2002.00363.x
   LIANG QW, 1995, J BIOL CHEM, V270, P4438, DOI 10.1074/jbc.270.9.4438
   Liddle C, 2002, SEMIN LIVER DIS, V22, P115, DOI 10.1055/s-2002-30098
   Lieber CS, 1997, PHYSIOL REV, V77, P517
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lindblom TH, 2001, CURR BIOL, V11, P864, DOI 10.1016/S0960-9822(01)00236-6
   Liu SQ, 1998, DNA CELL BIOL, V17, P461, DOI 10.1089/dna.1998.17.461
   Liu SQ, 2001, BIOCHEM PHARMACOL, V62, P21, DOI 10.1016/S0006-2952(01)00635-9
   Lowell BB, 2000, NATURE, V404, P652
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Ma Q, 2001, CURR DRUG METAB, V2, P149, DOI 10.2174/1389200013338603
   Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638
   Makinen JM, 2002, MOL PHARMACOL, V62, P366, DOI 10.1124/mol.62.2.366
   MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   Marc N, 2000, EUR J BIOCHEM, V267, P963, DOI 10.1046/j.1432-1327.2000.01083.x
   Masahiko N, 2000, EUR J PHARM SCI, V11, P259, DOI 10.1016/S0928-0987(00)00112-3
   Masuyama H, 2000, MOL ENDOCRINOL, V14, P421, DOI 10.1210/me.14.3.421
   Matsuda H, 2002, BBA-MOL CELL RES, V1593, P93, DOI 10.1016/S0167-4889(02)00345-2
   Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6
   Meyer UA, 1997, ANNU REV PHARMACOL, V37, P269, DOI 10.1146/annurev.pharmtox.37.1.269
   Meyer UA, 1996, J PHARMACOKINET BIOP, V24, P449, DOI 10.1007/BF02353473
   Meyer UA, 1999, DRUG METAB REV, V31, P365, DOI 10.1081/DMR-100101924
   Min GS, 2002, J BIOL CHEM, V277, P34626, DOI 10.1074/jbc.M205239200
   Min GS, 2002, J BIOL CHEM, V277, P26356, DOI 10.1074/jbc.M200051200
   MIYATA M, 1995, ARCH BIOCHEM BIOPHYS, V318, P71, DOI 10.1006/abbi.1995.1206
   Moore JT, 2003, BBA-GEN SUBJECTS, V1619, P235, DOI 10.1016/S0304-4165(02)00481-6
   Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097
   Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200
   Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977
   Morgan ET, 1998, DRUG METAB DISPOS, V26, P1232
   Morgan ET, 2001, DRUG METAB DISPOS, V29, P1366
   Muangmoonchai R, 2001, BIOCHEM J, V355, P71, DOI 10.1042/0264-6021:3550071
   Muller M, 2000, SEMIN LIVER DIS, V20, P323, DOI 10.1055/s-2000-9387
   Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7
   NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.bi.56.070187.004501
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   Nirodi CS, 1996, ARCH BIOCHEM BIOPHYS, V331, P79, DOI 10.1006/abbi.1996.0285
   Nishikawa J, 2000, BIOCHEM BIOPH RES CO, V277, P209, DOI 10.1006/bbrc.2000.3649
   OKEY AB, 1990, PHARMACOL THERAPEUT, V45, P241, DOI 10.1016/0163-7258(90)90030-6
   Ostberg T, 2002, EUR J BIOCHEM, V269, P4896, DOI 10.1046/j.1432-1033.2002.03207.x
   Ourlin JC, 2002, BIOCHEM BIOPH RES CO, V291, P378, DOI 10.1006/bbrc.2002.6464
   Ourlin JC, 2003, MOL ENDOCRINOL, V17, P1693, DOI 10.1210/me.2002-0383
   Owsley E, 2003, BIOCHEM BIOPH RES CO, V304, P191, DOI 10.1016/S0006-291X(03)00551-5
   Paquet Y, 2000, J BIOL CHEM, V275, P38427, DOI 10.1074/jbc.M005776200
   Park YK, 1996, J BIOL CHEM, V271, P23725, DOI 10.1074/jbc.271.39.23725
   Pascussi JM, 2000, MOL PHARMACOL, V58, P361
   Pascussi JM, 2000, MOL PHARMACOL, V58, P1441
   Pascussi JM, 2003, MOL ENDOCRINOL, V17, P42, DOI 10.1210/me.2002-0244
   Pascussi JM, 2001, EUR J BIOCHEM, V268, P6346, DOI 10.1046/j.0014-2956.2001.02540.x
   Pascussi JM, 1999, BIOCHEM BIOPH RES CO, V260, P377, DOI 10.1006/bbrc.1999.0745
   Pascussi JM, 2003, BBA-GEN SUBJECTS, V1619, P243, DOI 10.1016/S0304-4165(02)00483-X
   Pascussi JM, 2000, BIOCHEM BIOPH RES CO, V274, P707, DOI 10.1006/bbrc.2000.3219
   Petersen RA, 2003, BBA-GEN SUBJECTS, V1619, P269, DOI 10.1016/S0304-4165(02)00486-5
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   PRABHU L, 1995, P NATL ACAD SCI USA, V92, P9628, DOI 10.1073/pnas.92.21.9628
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   QUATTROCHI LC, 1995, J BIOL CHEM, V270, P28917, DOI 10.1074/jbc.270.48.28917
   Quattrochi LC, 2001, DRUG METAB DISPOS, V29, P615
   Ramsden R, 1999, GENE, V228, P169, DOI 10.1016/S0378-1119(98)00612-X
   RAMSDEN R, 1993, J BIOL CHEM, V268, P21722
   Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781
   Raucy JL, 2003, DRUG METAB DISPOS, V31, P533, DOI 10.1124/dmd.31.5.533
   REMMER H, 1963, KLIN WOCHENSCHR, V41, P276, DOI 10.1007/BF01483392
   REMMER H, 1972, EUR J CLIN PHARMACOL, V5, P116, DOI 10.1007/BF00561756
   REMMER H, 1958, NATURWISSENSCHAFTEN, V45, P522, DOI 10.1007/BF00707842
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Ripp SL, 2002, DRUG METAB DISPOS, V30, P570, DOI 10.1124/dmd.30.5.570
   Rivera-Rivera I, 2003, BBA-GEN SUBJECTS, V1619, P254, DOI 10.1016/S0304-4165(02)00484-1
   RODRIGUEZ AD, 2002, DRUG DRUG INTERACTIO
   Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421
   Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200
   Roy-Chowdhury J, 2003, DEV CELL, V4, P607, DOI 10.1016/S1534-5807(03)00131-X
   Sakuma T, 1999, DRUG METAB DISPOS, V27, P379
   SALONPAA P, 1994, BIOCHEM BIOPH RES CO, V205, P631, DOI 10.1006/bbrc.1994.2712
   Samudre KR, 2002, BIOCHEM BIOPH RES CO, V292, P312, DOI 10.1006/bbrc.2002.6665
   Savas U, 1999, MOL PHARMACOL, V56, P851
   Savas U, 2000, DRUG METAB DISPOS, V28, P529
   Schmoldt DL, 2001, MANAG FOR ECOSYST, V3, P1
   Schuetz EG, 1998, MOL PHARMACOL, V54, P1113
   Schuetz EG, 2000, DRUG METAB DISPOS, V28, P268
   Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200
   Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336
   Shaw GC, 1998, J BIOL CHEM, V273, P7996, DOI 10.1074/jbc.273.14.7996
   Shaw GC, 2000, CURR MICROBIOL, V40, P47, DOI 10.1007/s002849910009
   SHAW GC, 1993, J BIOL CHEM, V268, P2997
   Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201
   Shiraki T, 2003, J BIOL CHEM, V278, P11344, DOI 10.1074/jbc.M212859200
   Sidhu JS, 1998, J BIOL CHEM, V273, P4769, DOI 10.1074/jbc.273.8.4769
   Sidhu JS, 1996, J PHARMACOL EXP THER, V276, P238
   Sidhu JS, 1997, J PHARMACOL EXP THER, V282, P1122
   Simpson AECM, 1997, GEN PHARMACOL-VASC S, V28, P351, DOI 10.1016/S0306-3623(96)00246-7
   Smirlis D, 2001, J BIOL CHEM, V276, P12822, DOI 10.1074/jbc.M005930200
   Sonoda J, 2003, CURR DRUG METAB, V4, P59, DOI 10.2174/1389200033336739
   Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599
   Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Staudinger JL, 2003, DRUG METAB DISPOS, V31, P523, DOI 10.1124/dmd.31.5.523
   Stieger B, 1998, CURR OPIN CELL BIOL, V10, P462, DOI 10.1016/S0955-0674(98)80059-8
   Stoltz C, 1999, BIOCHEM PHARMACOL, V57, P1073, DOI 10.1016/S0006-2952(98)00367-0
   Stoltz C, 1998, J BIOL CHEM, V273, P8528, DOI 10.1074/jbc.273.14.8528
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172
   Sultana S, 1997, J BIOL CHEM, V272, P8895
   Suzuki H, 2000, SEMIN LIVER DIS, V20, P251, DOI 10.1055/s-2000-8408
   Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912
   Takeshita A, 2002, J BIOL CHEM, V277, P32453, DOI 10.1074/jbc.M111245200
   Thummel KE, 2001, MOL PHARMACOL, V60, P1399
   Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815
   Toell A, 2002, J CELL BIOCHEM, V85, P72, DOI 10.1002/jcb.10104
   TROTTIER E, 1995, GENE, V158, P263, DOI 10.1016/0378-1119(94)00916-G
   Turner R, 2002, NATURE, V418, P740, DOI 10.1038/418740a
   Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000
   Tzameli I, 2001, TRENDS ENDOCRIN MET, V12, P7, DOI 10.1016/S1043-2760(00)00332-5
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   Ueda A, 2002, MOL PHARMACOL, V61, P1284, DOI 10.1124/mol.61.6.1284
   Vidal-Puig A, 2001, NATURE, V413, P125, DOI 10.1038/35093198
   Wan YJY, 2000, MOL CELL BIOL, V20, P4436, DOI 10.1128/MCB.20.12.4436-4444.2000
   Wang HB, 2003, DRUG METAB DISPOS, V31, P620, DOI 10.1124/dmd.31.5.620
   Wang HY, 2003, J BIOL CHEM, V278, P31547, DOI 10.1074/jbc.M212532200
   Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9
   Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762
   Watkins RE, 2003, BIOCHEMISTRY-US, V42, P1430, DOI 10.1021/bi0268753
   Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273
   WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577
   WAXMAN DJ, 1990, BIOCHEM J, V271, P113, DOI 10.1042/bj2710113
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087
   Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112
   Wentworth JM, 2000, J ENDOCRINOL, V166, pR11, DOI 10.1677/joe.0.166R011
   Werck-Reichhart D, 2000, GENOME BIOL, V1
   Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103
   Willson TM, 2001, MED RES REV, V21, P513, DOI 10.1002/med.1023
   Xiao L, 2002, DRUG METAB DISPOS, V30, P951, DOI 10.1124/dmd.30.9.951
   Xie W, 2001, J BIOL CHEM, V276, P37739, DOI 10.1074/jbc.R100033200
   Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116
   Xie W, 2002, DRUG DISCOV TODAY, V7, P509, DOI 10.1016/S1359-6446(02)02251-1
   Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100
   Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
   Xiong H, 2002, DRUG METAB DISPOS, V30, P918, DOI 10.1124/dmd.30.8.918
   Yamamoto Y, 2003, ARCH BIOCHEM BIOPHYS, V409, P207, DOI 10.1016/S0003-9861(02)00456-3
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Yoshinari K, 2001, MOL PHARMACOL, V59, P278
   Zaher H, 1998, BIOCHEM PHARMACOL, V55, P235, DOI 10.1016/S0006-2952(97)00476-0
   Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001
   Zelko I, 2000, BIOCHEM BIOPH RES CO, V277, P1, DOI 10.1006/bbrc.2000.3557
   Zhang H, 1999, ARCH BIOCHEM BIOPHYS, V368, P14, DOI 10.1006/abbi.1999.1307
   Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502
   Zhang J, 2001, PHARMACOGENETICS, V11, P555, DOI 10.1097/00008571-200110000-00003
   Zhou SF, 2003, DRUG METAB REV, V35, P35, DOI 10.1081/DMR-120018248
   Ziegler Daniel M., 1994, P415
NR 295
TC 338
Z9 355
U1 1
U2 47
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0031-6997
EI 1521-0081
J9 PHARMACOL REV
JI Pharmacol. Rev.
PD DEC
PY 2003
VL 55
IS 4
BP 649
EP 673
DI 10.1124/pr.55.4.2
PG 25
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 749GG
UT WOS:000186910700010
PM 14657421
DA 2021-01-25
ER

PT J
AU Most, P
   Boerries, M
   Eicher, C
   Schweda, C
   Ehlermann, P
   Pleger, ST
   Loeffler, E
   Koch, WJ
   Katus, HA
   Schoenenberger, CA
   Remppis, A
AF Most, P
   Boerries, M
   Eicher, C
   Schweda, C
   Ehlermann, P
   Pleger, ST
   Loeffler, E
   Koch, WJ
   Katus, HA
   Schoenenberger, CA
   Remppis, A
TI Extracellular S100A1 protein inhibits apoptosis in ventricular
   cardiomyocytes via activation of the extracellular signal-regulated
   protein kinase 1/2 (ERK1/2)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID DEPENDENT PATHWAY; NEURITE OUTGROWTH; KINASE; CELL; CA2+; MYOCYTES;
   GROWTH; FAMILY; RAS; CONTRACTILITY
AB S100A1 is a Ca2+-binding protein of the EF-hand type that belongs to the S100 protein family. It is specifically expressed in the myocardium at high levels and is considered to be an important regulator of cardiac contractility. Because the S100A1 protein is released into the extracellular space during ischemic myocardial injury, we examined the cardioprotective potential of the extracellular S100A1 protein on ventricular cardiomyocytes in vitro. In this report we show that extracellularly added S100A1 protein is endocytosed into the endosomal compartment of neonatal ventricular cardiomyocytes via a Ca2+-dependent clathrin-mediated process. S100A1 uptake protects neonatal ventricular cardiomyocytes from 2-deoxyglucose and oxidative stress-induced apoptosis in vitro. S100A1-mediated antiapoptotic effects involve specific activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) prosurvival pathway, including activation of phospholipase C, protein kinase C, mitogen-activated protein kinase kinase 1, and ERK1/2. In contrast, neither transsarcolemmal Ca2+ influx via the L-type channel nor protein kinase A activity seems to take part in the S100A1-mediated signaling pathway. In conclusion, this study provides evidence for the S100A1 protein serving as a novel cardioprotective factor in vitro. These findings warrant speculation that injury-dependent release of the S100A1 protein from cardiomyocytes may serve as an intrinsic mechanism to promote survival of the myocardium in vivo.
C1 Univ Heidelberg, D-69115 Heidelberg, Germany.
   Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland.
   Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.
RP Most, P (corresponding author), Univ Heidelberg, Bergheimer Str 58, D-69115 Heidelberg, Germany.
CR Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709
   Alexanian AR, 1999, FASEB J, V13, P1611
   Bianchi R, 1996, BBA-MOL CELL RES, V1313, P258, DOI 10.1016/0167-4889(96)00098-5
   Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062
   Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   Convery MK, 1998, PFLUG ARCH EUR J PHY, V436, P581, DOI 10.1007/s004240050675
   Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200
   Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095
   De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571
   Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296
   Du XJ, 2002, MOL CELL BIOL, V22, P2821, DOI 10.1128/MCB.22.8.2821-2829.2002
   Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200
   Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172
   Hobai IA, 1997, PFLUG ARCH EUR J PHY, V433, P455, DOI 10.1007/s004240050300
   Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6
   Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8
   Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200
   Kiewitz R, 2000, BIOCHEM BIOPH RES CO, V274, P865, DOI 10.1006/bbrc.2000.3229
   Mehrhof FB, 2001, CIRCULATION, V104, P2088, DOI 10.1161/hc4201.097133
   Mikkelsen SE, 2001, J NEUROCHEM, V79, P767, DOI 10.1046/j.1471-4159.2001.00605.x
   Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200
   Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200
   Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598
   Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200
   Parrizas M, 1997, J BIOL CHEM, V272, P154
   Pinson A., 1990, CELL CULTURE TECHNIQ, P20
   Pol A, 1998, FEBS LETT, V441, P34, DOI 10.1016/S0014-5793(98)01517-8
   Rammes A, 1997, J BIOL CHEM, V272, P9496
   Remppis A, 1996, BBA-MOL CELL RES, V1313, P253, DOI 10.1016/0167-4889(96)00097-3
   Remppis Andrew, 2002, Basic Research in Cardiology, V97
   Reppel M, 2002, EUR HEART J, V23, P41
   Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200
   Sheng ZL, 1997, J BIOL CHEM, V272, P5783, DOI 10.1074/jbc.272.9.5783
   Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883
   ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2
NR 36
TC 61
Z9 63
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 28
PY 2003
VL 278
IS 48
BP 48404
EP 48412
DI 10.1074/jbc.M308587200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 746DM
UT WOS:000186731400126
PM 12960148
OA Bronze
DA 2021-01-25
ER

PT J
AU Remigy, HW
   Caujolle-Bert, D
   Suda, K
   Schenk, A
   Chami, M
   Engel, A
AF Remigy, HW
   Caujolle-Bert, D
   Suda, K
   Schenk, A
   Chami, M
   Engel, A
TI Membrane protein reconstitution and crystallization by controlled
   dilution
SO FEBS LETTERS
LA English
DT Article; Proceedings Paper
CT 2nd Nobel Symposium on Membrane Proteins: Structure Function and
   Assembly (126)
CY AUG 22-24, 2003
CL STOCKHOLM, SWEDEN
DE two-dimensional crystallization; lipid-detergent interaction; membrane
   protein solubilization; reconstitution
ID 2-DIMENSIONAL CRYSTALLIZATION; VESICLE TRANSITION; 3-DIMENSIONAL
   STRUCTURE; 2D CRYSTALLIZATION; BILE-SALT; MICELLE; PHOSPHATIDYLCHOLINE;
   DETERGENTS; COMPLEX; IDENTIFICATION
AB Efficient reconstitution of membrane proteins for functional analyses can be achieved by dilution of a ternary mixture containing proteins, lipids and detergents. Once the dilution reaches the point where the free detergent concentration would become lower than the critical micellar concentration, detergent is recruited from the bound detergent pool, and association of proteins and lipids is initiated. Here we show that dilution is also suitable for the assembly of two-dimensional crystals. A device has been designed that allows controlled dilution of a protein-lipid-detergent mixture to induce formation of densely packed or crystalline proteoliposomes. Turbidity is used to monitor the progress of reconstitution on-line, while dilution is achieved by computer-controlled addition of buffer solution in sub-microliter steps. This system has mainly been tested with porin OmpF, a typical beta-barrel protein, and aqua-porin-1, a typical alpha-helical protein. The results demonstrate that large, highly ordered two-dimensional crystals can be produced by the dilution method. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Basel, Bioctr, ME Muller Inst Microscopy Biozentrum, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Bioctr, ME Muller Inst Microscopy Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
OI Schenk, Andreas/0000-0001-9214-2505
CR ALMOG S, 1986, BIOCHEMISTRY-US, V25, P2597, DOI 10.1021/bi00357a048
   AOYAMA K, 1995, ULTRAMICROSCOPY, V57, P345, DOI 10.1016/0304-3991(94)00192-P
   Auer M, 1999, J MOL BIOL, V287, P961, DOI 10.1006/jmbi.1999.2652
   Braun T, 2000, EMBO REP, V1, P183, DOI 10.1093/embo-reports/kvd022
   Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827
   Chami M, 2001, J STRUCT BIOL, V133, P64, DOI 10.1006/jsbi.2001.4344
   CYRKLAFF M, 1995, EMBO J, V14, P1854, DOI 10.1002/j.1460-2075.1995.tb07177.x
   DENKER BM, 1988, J BIOL CHEM, V263, P15634
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   FORD RC, 1990, EMBO J, V9, P3067, DOI 10.1002/j.1460-2075.1990.tb07503.x
   Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   HJELM RP, 1992, J PHYS CHEM-US, V96, P8653, DOI 10.1021/j100200a080
   HOLZENBURG A, 1989, BIOCHEMISTRY-US, V28, P4187, DOI 10.1021/bi00436a010
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   JAP BK, 1995, J MOL BIOL, V251, P413, DOI 10.1006/jmbi.1995.0444
   KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0
   Lambert O, 1998, BIOPHYS J, V74, P918, DOI 10.1016/S0006-3495(98)74015-9
   Lebeau L, 2001, J MOL BIOL, V308, P639, DOI 10.1006/jmbi.2001.4629
   LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7
   Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X
   LICHTENBERG D, 1985, BIOCHIM BIOPHYS ACTA, V821, P470, DOI 10.1016/0005-2736(85)90052-5
   MANNELLA CA, 1984, SCIENCE, V224, P165, DOI 10.1126/science.6322311
   Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   OLLIVON M, 1988, BIOCHEMISTRY-US, V27, P1695, DOI 10.1021/bi00405a047
   RACKER E, 1975, FEBS LETT, V57, P14, DOI 10.1016/0014-5793(75)80141-4
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V
   Rigaud JL, 2000, BBA-BIOMEMBRANES, V1508, P112, DOI 10.1016/S0005-2736(00)00307-2
   Ringler P, 2000, PRACT APPROACH SER, P229
   SCHURTENBERGER P, 1985, J PHYS CHEM-US, V89, P1042, DOI 10.1021/j100252a031
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Tsiotis G, 1996, J MOL BIOL, V259, P241, DOI 10.1006/jmbi.1996.0316
   WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   Zhuang JP, 1999, J STRUCT BIOL, V125, P63, DOI 10.1006/jsbi.1998.4059
NR 40
TC 40
Z9 41
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD NOV 27
PY 2003
VL 555
IS 1
BP 160
EP 169
DI 10.1016/S0014-5793(03)01105-0
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 748NH
UT WOS:000186867600029
PM 14630337
OA Bronze
DA 2021-01-25
ER

PT J
AU Shanshiashvili, LV
   Suknidze, NC
   Machaidze, GG
   Mikeladze, DG
   Ramsden, JJ
AF Shanshiashvili, LV
   Suknidze, NC
   Machaidze, GG
   Mikeladze, DG
   Ramsden, JJ
TI Adhesion and clustering of charge isomers of myelin basic protein at
   model myelin membranes
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE adsorption; association; desorption; multiple sclerosis; OWLS
ID POSTTRANSLATIONAL MODIFICATIONS; MULTIPLE-SCLEROSIS; 3-DIMENSIONAL
   STRUCTURE; ADSORPTION; KINASE; MICROHETEROGENEITY; DEPOSITION;
   PHOSPHORYLATION; DEIMINATION; CITRULLINE
AB The association of myelin basic protein charge isomers with the lipid part of the myelin membrane was investigated at the microscopic (molecular) level in a model membrane system, using optical waveguide lightmode spectrometry to determine with high precision the kinetics of association and dissociation to planar phospholipid membranes under controlled hydrodynamic conditions and over a range of protein concentrations. Detailed analysis of the data revealed a rich and intricate behaviour and clearly showed that the membrane protein affinity is characterized by at least four independent parameters: (i) the association rate coefficient characterizing the protein-membrane interaction energy as the protein approaches the fluid-membrane interface; (ii) the protein-membrane adhesion, i.e., the probability that it will remain at the membrane after arrival; (iii) the protein conformation at the membrane; and (iv) the protein's tendency to cluster at the membrane. Some of these parameters varied in characteristic ways as the bulk solution concentration of the protein was varied, giving further clues to the detailed molecular comportment of the protein. The parameters and their characteristic variations with bulk concentration were markedly different for the different isomers. Implications of these results for neurological disorders involving demyelination, such as multiple sclerosis, are discussed. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
   Georgian Acad Sci, IS Beritashvili Inst Physiol, GE-380060 Tbilisi, Georgia.
   Collegium Basilea, Inst Adv Study, CH-4053 Basel, Switzerland.
RP Ramsden, JJ (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
EM J.Ramsden@unibas.ch
OI Mikeladze, David/0000-0002-3982-7668
CR Atkins CM, 1999, J NEUROCHEM, V73, P1090, DOI 10.1046/j.1471-4159.1999.0731090.x
   Atkins CM, 1997, J NEUROCHEM, V68, P1960
   Beniac DR, 1997, J BIOL CHEM, V272, P4261, DOI 10.1074/jbc.272.7.4261
   Boggs JM, 1997, BIOCHEMISTRY-US, V36, P5065, DOI 10.1021/bi962649f
   Boggs JM, 1999, J NEUROSCI RES, V57, P529, DOI 10.1002/(SICI)1097-4547(19990815)57:4<529::AID-JNR12>3.3.CO;2-S
   Boggs JM, 2000, BIOCHEMISTRY-US, V39, P7799, DOI 10.1021/bi0002129
   BRADY GW, 1981, BIOPHYS J, V34, P345, DOI 10.1016/S0006-3495(81)84853-9
   CHEIFETZ S, 1985, BIOCHEMISTRY-US, V24, P1909, DOI 10.1021/bi00329a016
   CHEIFETZ S, 1984, ARCH BIOCHEM BIOPHYS, V233, P151, DOI 10.1016/0003-9861(84)90611-8
   CHOU FCH, 1976, J BIOL CHEM, V251, P2671
   Csucs G, 1998, J CHEM PHYS, V109, P779, DOI 10.1063/1.476616
   GOW A, 1989, BIOCHEM J, V257, P535, DOI 10.1042/bj2570535
   Guemouri L, 1998, J CHEM PHYS, V109, P3265, DOI 10.1063/1.476917
   HINRICHSEN EL, 1986, J STAT PHYS, V44, P793, DOI 10.1007/BF01011908
   KARTHIGASAN J, 1994, J NEUROCHEM, V62, P1203
   Kim JK, 2003, MOL CELL PROTEOMICS, V2, P453, DOI 10.1074/mcp.M200050-MCP200
   KURRAT R, 1994, J CHEM SOC FARADAY T, V90, P587, DOI 10.1039/ft9949000587
   Luthi PO, 1997, PHYS REV E, V55, P3111, DOI 10.1103/PhysRevE.55.3111
   MARTIN R, 1994, NEUROLOGY, V44, P123, DOI 10.1212/WNL.44.1.123
   Mastronardi FG, 1996, J CLIN INVEST, V97, P349, DOI 10.1172/JCI118422
   MASTRONARDI FG, 1993, J NEUROSCI RES, V36, P315, DOI 10.1002/jnr.490360309
   MURTHY NS, 1984, BIOCHIM BIOPHYS ACTA, V769, P493, DOI 10.1016/0005-2736(84)90335-3
   OMLIN FX, 1982, J CELL BIOL, V95, P242, DOI 10.1083/jcb.95.1.242
   Palma AE, 1997, J NEUROCHEM, V69, P1753
   PEREYRA PM, 1988, NEUROCHEM RES, V13, P583, DOI 10.1007/BF00973301
   Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5382, DOI 10.1021/bi9925571
   Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5374, DOI 10.1021/bi9925569
   Ramsden JJ, 1996, BIOCHEMISTRY-US, V35, P3746, DOI 10.1021/bi952158f
   Ramsden JJ, 1999, PHILOS MAG B, V79, P381, DOI 10.1080/13642819908206414
   Ramsden JJ, 1998, SURF SCI SERIES, V75, P321
   RAMSDEN JJ, 1994, Q REV BIOPHYS, V27, P41, DOI 10.1017/S0033583500002900
   Ramsden JJ, 1999, COLLOID SURFACE B, V14, P77, DOI 10.1016/S0927-7765(99)00026-0
   RAMSDEN JJ, 1993, PHYS REV LETT, V71, P295, DOI 10.1103/PhysRevLett.71.295
   RAMSDEN JJ, 1994, PHYS REV E, V50, P5072, DOI 10.1103/PhysRevE.50.5072
   READHEAD C, 1990, ANN NY ACAD SCI, V605, P280
   Ridsdale RA, 1997, J BIOL CHEM, V272, P4269, DOI 10.1074/jbc.272.7.4269
   SCHAAF P, 1989, J CHEM PHYS, V91, P4401, DOI 10.1063/1.456768
   SCHERER JR, 1987, P NATL ACAD SCI USA, V84, P7938, DOI 10.1073/pnas.84.22.7938
   Seiwa C, 2000, NEUROSCI RES, V37, P21, DOI 10.1016/S0168-0102(00)00100-0
   TARJUS G, 1994, PHYS REV E, V49, P3239, DOI 10.1103/PhysRevE.49.3239
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   TIEFENTHALER K, 1992, ADV BIOSENSORS, V2, P261
   Van Tassel PR, 1998, J COLLOID INTERF SCI, V207, P317, DOI 10.1006/jcis.1998.5781
   WOOD DD, 1989, J BIOL CHEM, V264, P5121
   Wu H, 2003, BIOCHEMISTRY-US, V42, P1129, DOI 10.1021/bi026857l
   Yon M, 1996, J NEUROIMMUNOL, V65, P55, DOI 10.1016/0165-5728(95)00183-2
   Zand R, 1998, BIOCHEMISTRY-US, V37, P2441, DOI 10.1021/bi972347t
NR 47
TC 21
Z9 23
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 2003
VL 419
IS 2
BP 170
EP 177
DI 10.1016/j.abb.2003.09.020
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 744CL
UT WOS:000186610300009
PM 14592460
DA 2021-01-25
ER

PT J
AU Fotiadis, D
   Liang, Y
   Filipek, S
   Saperstein, DA
   Engel, A
   Palczewski, K
AF Fotiadis, D
   Liang, Y
   Filipek, S
   Saperstein, DA
   Engel, A
   Palczewski, K
TI Biophysics - Is rhodopsin dimeric in native rods? Reply
SO NATURE
LA English
DT Editorial Material
ID MEMBRANES; MICROSCOPY; RECEPTORS; DISK
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.
   Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem, Seattle, WA 98195 USA.
   Univ Warsaw, Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.
   Univ Warsaw, Dept Chem, PL-02109 Warsaw, Poland.
RP Fotiadis, D (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
CR Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Kajimura N, 2000, J ELECTRON MICROSC, V49, P691, DOI 10.1093/oxfordjournals.jmicro.a023860
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457
   MILJANICH GP, 1985, J MEMBRANE BIOL, V85, P79, DOI 10.1007/BF01872007
   SUZUKI E, 1993, J ELECTRON MICROSC, V42, P178
NR 7
TC 12
Z9 12
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD NOV 6
PY 2003
VL 426
IS 6962
BP 31
EP 31
DI 10.1038/426031a
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 739WY
UT WOS:000186370800031
DA 2021-01-25
ER

PT J
AU Machaidze, G
   Seelig, J
AF Machaidze, G
   Seelig, J
TI Specific binding of cinnamycin (Ro 09-0198) to phosphatidylethanolamine.
   Comparison between micellar and membrane environments
SO BIOCHEMISTRY
LA English
DT Article
ID RO 09-0198; NONADECAPEPTIDE RO-09-0198; CYCLIC PEPTIDE; DURAMYCIN-B;
   LYSOPHOSPHATIDYLETHANOLAMINE; THERMODYNAMICS; LANTIBIOTICS; RO09-0198;
   MOVEMENT; H-1-NMR
AB Cinnamycin (Ro 09-0198) is a tetracyclic peptide antibiotic that binds specifically to phosphatidylethanolamine (PE). Formation of a complex with phosphatidylethanolamine follows a 1:1 stoichiometry. Using high-sensitivity isothermal titration calorimetry (ITC), we have measured the thermodynamic parameters of complex formation for two different PE environments, namely, PE dissolved either in octyl glucoside (OG) micelles or in a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayer membrane. We have compared diacyl-PE with lyso-PE and have varied the carbon chain length from 6 to 18. Binding requires both a PE headgroup and at least one fatty acyl chain. The optimum chain length for complex formation (n) is eight. Longer chains do not enhance the binding affinity; for shorter chains, the interaction is weakened. The cinnamycin-PE complex has a binding constant K-0 of similar to10(7)-10(8) M-1 in the POPC membrane and only similar to10(6) M-1 in the octyl glucoside micelle. The difference can be attributed to the nonspecific hydrophobic interaction of cinnamycin with the lipid membrane. Complex formation is enthalpy-driven in OG micelles, whereas enthalpy and entropy make equal contributions in bilayer membranes. However, for the optimum chain length (n) of eight, the binding reaction is also completely enthalpy-driven for the bilayer membrane.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
CR ANTONELLI ML, 1994, COLLOID POLYM SCI, V272, P704, DOI 10.1007/BF00659284
   AOKI Y, 1994, J BIOCHEM-TOKYO, V116, P291, DOI 10.1093/oxfordjournals.jbchem.a124522
   BULDT G, 1980, BIOCHEMISTRY-US, V19, P6170
   CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P171, DOI 10.1016/0005-2736(88)90192-7
   CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P180, DOI 10.1016/0005-2736(88)90193-9
   Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867
   Guder A, 2000, BIOPOLYMERS, V55, P62, DOI 10.1002/1097-0282(2000)55:1<62::AID-BIP60>3.3.CO;2-P
   Hosoda K, 1996, J BIOCHEM-TOKYO, V119, P226
   KESSLER H, 1987, HELV CHIM ACTA, V70, P726, DOI 10.1002/hlca.19870700322
   KESSLER H, 1992, BIOPOLYMERS, V32, P427, DOI 10.1002/bip.360320420
   KESSLER H, 1988, HELV CHIM ACTA, V71, P1924, DOI 10.1002/hlca.19880710811
   KESSLER H, 1993, CHEM PEPTIDES PROTEI, P351
   LEWIS GN, 1961, THERMODYNAMICS, P524
   Machaidze G, 2002, BIOCHEMISTRY-US, V41, P1965, DOI 10.1021/bi015841c
   Makino A, 2003, J BIOL CHEM, V278, P3204, DOI 10.1074/jbc.M210347200
   MARKI F, 1991, BIOCHEM PHARMACOL, V42, P2027, DOI 10.1016/0006-2952(91)90604-4
   Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1
   NAVARRO J, 1985, BIOCHEMISTRY-US, V24, P4645, DOI 10.1021/bi00338a025
   PAULA S, 1995, J PHYS CHEM-US, V99, P11742, DOI 10.1021/j100030a019
   PRIVALOV PL, 1989, PURE APPL CHEM, V61, P1097, DOI 10.1351/pac198961061097
   PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191
   SEELIG J, 1976, BIOCHEMISTRY-US, V15, P5199, DOI 10.1021/bi00669a001
   SHIPLEY GG, 1974, J LIPID RES, V15, P124
   TAKEMOTO K, 1979, Patent No. 7911395
   TANFORD F, 1980, HYDROPHOBIC EFFECT F
   WAKAMATSU K, 1990, BIOCHEMISTRY-US, V29, P113, DOI 10.1021/bi00453a013
   WAKAMIYA T, 1988, TETRAHEDRON LETT, V29, P4771, DOI 10.1016/S0040-4039(00)80604-8
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
   ZIMMERMANN N, 1993, EUR J BIOCHEM, V216, P419, DOI 10.1111/j.1432-1033.1993.tb18159.x
NR 29
TC 44
Z9 44
U1 1
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD NOV 4
PY 2003
VL 42
IS 43
BP 12570
EP 12576
DI 10.1021/bi035225b
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 742RD
UT WOS:000186531100016
PM 14580203
DA 2021-01-25
ER

PT J
AU Nufer, O
   Kappeler, F
   Guldbrandsen, S
   Hauri, HP
AF Nufer, O
   Kappeler, F
   Guldbrandsen, S
   Hauri, HP
TI ER export of ERGIC-53 is controlled by cooperation of targeting
   determinants in all three of its domains
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE COPII; endoplasmic reticulurn; ERGIC; oligomeilzation; transport signal
ID GOLGI INTERMEDIATE COMPARTMENT; HELICAL MEMBRANE-PROTEINS;
   AMINO-ACID-COMPOSITION; ENDOPLASMIC-RETICULUM; TRANSPORT VESICLES;
   TRANSMEMBRANE DOMAIN; RECYCLING PATHWAY; SECRETORY PATHWAY;
   EPITHELIAL-CELLS; CYTOPLASMIC TAIL
AB Selective export of proteins from the endoplasmic reticulum (ER) requires transport signals that have not been My characterized. Here, we provide the first complete map of ER export determinants of a type I membrane protein, ERGIC-53, that cycles in the early secretory pathway. ER export requires a phenylalanine motif at the C-terminus, known to mediate coat protein II (COPII) interaction, that is assisted by a glutamine in the cytoplasmic domain. Disulfide bond-stabilized oligomerization is also required. Efficient hexamerization depends on the presence of a polar and two aromatic residues in the transmembrane domain (TND). Oligomerization becomes independent on disulfide bonds when TMD hydrophobicity is increased. ER export is also influenced by TMD length, 21 amino acids being most efficient. When transferred to a signal-less construct, the established targeting motifs reconstitute full transport activity. The results suggest an ER-export mechanism in which transmembrane and luminal determinants mediate oligomerization required for efficient recruitment of ERGIC-53 into budding vesicles via the C-terminal COPII-binding phenylalanine motif.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
CR Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908
   Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875
   Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61
   Ausubel F. A., 1997, CURRENT PROTOCOLS MO
   BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X
   BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8
   Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4
   Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2
   Belden WJ, 2001, J BIOL CHEM, V276, P43040, DOI 10.1074/jbc.M108113200
   Brosig B, 1998, PROTEIN SCI, V7, P1052
   Bulbarelli A, 2002, J CELL SCI, V115, P1689
   BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686
   Butterfield SM, 2002, J AM CHEM SOC, V124, P9751, DOI 10.1021/ja026668q
   Choma C, 2000, NAT STRUCT BIOL, V7, P161
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002
   Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751
   Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796
   Fiedler K, 1997, J BIOL CHEM, V272, P24739, DOI 10.1074/jbc.272.40.24739
   Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396
   Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880
   HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838
   Hauri HP, 2000, J CELL SCI, V113, P587
   Herrmann JM, 1999, TRENDS CELL BIOL, V9, P5, DOI 10.1016/S0962-8924(98)01414-7
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V347, P166
   HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425
   HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4
   Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200
   ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57
   Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8
   JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585
   Kuehn MJ, 1997, CURR OPIN CELL BIOL, V9, P477, DOI 10.1016/S0955-0674(97)80022-1
   Kuehn MJ, 1998, NATURE, V391, P187
   Lahtinen U, 1999, EUR J BIOCHEM, V260, P392, DOI 10.1046/j.1432-1327.1999.00158.x
   LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W
   LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403
   Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X
   Nakamura N, 1998, MOL BIOL CELL, V9, P3493, DOI 10.1091/mbc.9.12.3493
   Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556
   Nufer O, 2002, J CELL SCI, V115, P619
   OHASHI M, 1995, NATURE, V377, P544, DOI 10.1038/377544a0
   PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.bi.56.070187.004145
   Powers J, 2002, MOL BIOL CELL, V13, P880, DOI 10.1091/mbc.01-10-0499
   Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832
   Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027
   SCHINDLER R, 1993, EUR J CELL BIOL, V61, P1
   SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13
   Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698
   Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344
   Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107
   Ubarretxena-Belandia I, 2001, CURR OPIN STRUC BIOL, V11, P370, DOI 10.1016/S0959-440X(00)00217-7
   Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1
   Urena JM, 1999, J CELL SCI, V112, P773
   Votsmeier C, 2001, EMBO J, V20, P6742, DOI 10.1093/emboj/20.23.6742
   WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0
   Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698
   Zhou FX, 2000, NAT STRUCT BIOL, V7, P154
NR 64
TC 78
Z9 81
U1 0
U2 6
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD NOV 1
PY 2003
VL 116
IS 21
BP 4429
EP 4440
DI 10.1242/jcs.00759
PG 12
WC Cell Biology
SC Cell Biology
GA 755GN
UT WOS:000187395300016
PM 13130098
OA Bronze
DA 2021-01-25
ER

PT J
AU Cunningham, MA
   Pipe, SW
   Zhang, B
   Hauri, HP
   Ginsburg, D
   Kaufman, RJ
AF Cunningham, MA
   Pipe, SW
   Zhang, B
   Hauri, HP
   Ginsburg, D
   Kaufman, RJ
TI LMAN1 is a molecular chaperone for the secretion of coagulation factor
   VIII
SO JOURNAL OF THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE endoplasmic reticulum; ERGIC-53; hemophilia; trafficking
ID ENDOPLASMIC-RETICULUM; FACTOR-V; LECTIN ERGIC-53; MAMMALIAN-CELLS; ER;
   COPII; EXPRESSION; DEFICIENCY; TRANSPORT; COMPARTMENT
AB Combined deficiency of both coagulation factors (F)V and VIII is a rare autosomal recessive bleeding disorder caused by null expression of LMAN1 (previously termed ERGIC-53) in a majority of affected individuals. Previously, a requirement for a functional LMAN1 cycling pathway between the ER and Golgi was demonstrated for efficient secretion of FV and FVIII (Moussalli et al. J Biol Chem 1999; 274: 32569), however, the molecular nature of the interaction between LMAN1 and its cargo was not characterized. Using coimmunoprecipitation of LMAN1 and FVIII from transfected HeLa and COS-1cells, we demonstrate an interaction between LMAN1 and FVIII in vivo. The interaction was mediated via high mannose-containing asparagine-linked oligosaccharides that are densely situated within the B domain of FVIII, as well as protein-protein interactions. These results are interpreted based on the recent determination of the crystal structure of the carbohydrate recognition domain of LMAN1.
C1 Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.
   Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI USA.
   Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI USA.
   Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI USA.
   Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, Basel, Switzerland.
RP Kaufman, RJ (corresponding author), Univ Michigan, Sch Med, Howard Hughes Med Inst, MSRB 2,Room 4570,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.
EM kaufmanr@umich.edu
RI Pipe, Steven W./ABC-3843-2020; Zhang, Bin/B-8102-2012
OI Pipe, Steven W./0000-0003-2558-2089; 
FU NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [P01HL057346, P01HL057346,
   R01HL052173, R01HL052173, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   R01HL052173, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, R01HL052173, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, R01HL052173, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, R01HL052173, P01HL057346, P01HL057346, R01HL052173,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, R01HL052173, P01HL057346, R01HL052173, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, R01HL052173, R01HL052173, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, R01HL052173, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, R01HL052173, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   R01HL052173, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, R01HL052173,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   R01HL052173, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, R01HL052173] Funding Source: NIH RePORTER;
   NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01 HL52173, P01 HL057346] Funding Source: Medline
CR Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Campbell JL, 1997, P NATL ACAD SCI USA, V94, P837, DOI 10.1073/pnas.94.3.837
   Herrmann JM, 1999, TRENDS CELL BIOL, V9, P5, DOI 10.1016/S0962-8924(98)01414-7
   Itin C, 1996, MOL BIOL CELL, V7, P483
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L
   KOSCHINSKY ML, 1986, P NATL ACAD SCI USA, V83, P5086, DOI 10.1073/pnas.83.14.5086
   Kuehn MJ, 1998, NATURE, V391, P187
   Moussalli M, 1999, J BIOL CHEM, V274, P32539, DOI 10.1074/jbc.274.46.32539
   Neerman-Arbez M, 1999, BLOOD, V93, P2253
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nichols WC, 1999, BLOOD, V93, P2261
   PITTMAN DD, 1994, BLOOD, V84, P4214, DOI 10.1182/blood.V84.12.4214.bloodjournal84124214
   PITTMAN DD, 1993, METHOD ENZYMOL, V222, P236
   Sambrook J, 1989, MOL CLONING LAB MANU
   Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9
   TOOLE JJ, 1986, P NATL ACAD SCI USA, V83, P5939, DOI 10.1073/pnas.83.16.5939
   Velloso LM, 2002, J BIOL CHEM, V277, P15979, DOI 10.1074/jbc.M112098200
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   WINCHESTER B, 1990, BIOCHEM J, V265, P277, DOI 10.1042/bj2650277
NR 22
TC 43
Z9 47
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1538-7933
EI 1538-7836
J9 J THROMB HAEMOST
JI J. Thromb. Haemost.
PD NOV
PY 2003
VL 1
IS 11
BP 2360
EP 2367
DI 10.1046/j.1538-7836.2003.00415.x
PG 8
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 747UE
UT WOS:000186822600017
PM 14629470
OA Bronze
DA 2021-01-25
ER

PT J
AU Green, J
   Naot, D
   Cooper, G
AF Green, J
   Naot, D
   Cooper, G
TI Hepatocyte nuclear factor 1 negatively regulates amylin gene expression
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE amylin; islet amyloid polypeptide; maturity-onset diabetes of the young;
   maturity-onset diabetes of the young 3; type 2 diabetes; hepatocyte
   nuclear factor 1; transcriptional regulation
ID DEPENDENT DIABETES-MELLITUS; CELL-SPECIFIC PROMOTER; HUMAN INSULIN GENE;
   TRANSCRIPTION FACTOR; GLUCOKINASE GENE; FACTOR-I; UPSTREAM PROMOTER;
   JAPANESE SUBJECTS; PYRUVATE-KINASE; FACTOR 1-ALPHA
AB Maturity-onset diabetes of the young (MODY) is a monogenic subtype of Type 2 diabetes, defined as having an early age of onset, with a dominant inheritance pattern. Hepatocyte nuclear factor I (HNF1), which is encoded by the MODY3 gene, has been shown to bind the insulin promoter. Since the promoters of three pancreas-specific genes involved in glucose homeostasis-insulin, glucokinase, and amylin bind similar transcription factors, we were interested in whether HNF1 could also regulate amylin expression. In the present study, we used the electrophoretic mobility shift assay, to demonstrate that the HNF1 transcription factor can specifically bind to the amylin promoter. Moreover, co-transfection of an HNF1 expression vector with an amylin-CAT reporter plasmid decreased the activity of the amylin promoter by 85%. These data support the hypothesis that the amylin gene is regulated by HNF1 in a negative manner and may explain partially how HNF1 mutations result in diabetes. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Auckland, Sch Med, Dept Med, Auckland 1, New Zealand.
   Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.
RP Green, J (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Cooper, Garth JS/I-3201-2015
OI Cooper, Garth JS/0000-0001-5241-3163; Naot, Dorit/0000-0001-9498-2639
CR Ben-Shushan E, 2001, J BIOL CHEM, V276, P17533, DOI 10.1074/jbc.M009088200
   Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398
   BrethertonWatt D, 1996, BIOCHEM J, V313, P495, DOI 10.1042/bj3130495
   Byrne MM, 1996, DIABETES, V45, P1503, DOI 10.2337/diabetes.45.11.1503
   Campbell SC, 1999, FEBS LETT, V463, P53, DOI 10.1016/S0014-5793(99)01584-7
   Cha JY, 2001, EXP MOL MED, V33, P59, DOI 10.1038/emm.2001.11
   CLARK A, 1995, DIABETES RES CLIN PR, V28, pS39, DOI 10.1016/0168-8227(95)01075-O
   COOPER GJS, 1988, P NATL ACAD SCI USA, V85, P7763, DOI 10.1073/pnas.85.20.7763
   COOPER GJS, 1994, ENDOCR REV, V15, P163, DOI 10.1210/er.15.2.163
   COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628
   DRONSFIELD MJ, 1995, DIABETOLOGIA, V38, pA60
   Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457
   Duncan SA, 1998, SCIENCE, V281, P692, DOI 10.1126/science.281.5377.692
   EMENS LA, 1992, P NATL ACAD SCI USA, V89, P7300, DOI 10.1073/pnas.89.16.7300
   FAJANS SS, 1992, J LAB CLIN MED, V119, P206
   FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0
   GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777
   Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200
   Gregori C, 2002, J BIOL CHEM, V277, P28618, DOI 10.1074/jbc.M204047200
   Hansen SK, 2002, J CLIN INVEST, V110, P827, DOI 10.1172/JCI200215085
   HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B
   Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384
   Kristinsson SY, 2001, DIABETOLOGIA, V44, P2098, DOI 10.1007/s001250100016
   Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109
   KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0
   LEIBIGER B, 1994, BIOL CHEM H-S, V375, P93, DOI 10.1515/bchm3.1994.375.2.93
   LEIBIGER IB, 1994, FEBS LETT, V337, P161, DOI 10.1016/0014-5793(94)80265-3
   LEIGHTON B, 1990, TRENDS BIOCHEM SCI, V15, P295, DOI 10.1016/0968-0004(90)90015-4
   MIQUEROL L, 1994, J BIOL CHEM, V269, P8944
   Mitchell SMS, 2002, DIABETOLOGIA, V45, P1344, DOI 10.1007/s00125-002-0913-7
   NOGUCHI T, 1991, BIOCHEM BIOPH RES CO, V181, P259, DOI 10.1016/S0006-291X(05)81411-1
   Okita K, 1999, BIOCHEM BIOPH RES CO, V263, P566, DOI 10.1006/bbrc.1999.1412
   Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8
   Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548
   Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878
   SHELTON KD, 1992, MOL CELL BIOL, V12, P4578, DOI 10.1128/MCB.12.10.4578
   Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138
   Streeper RS, 1998, P NATL ACAD SCI USA, V95, P9208, DOI 10.1073/pnas.95.16.9208
   Suh DS, 1996, MOL ENDOCRINOL, V10, P1227, DOI 10.1210/me.10.10.1227
   Thomas H, 2001, HUM MOL GENET, V10, P2089, DOI 10.1093/hmg/10.19.2089
   TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902
   Wang HY, 2002, DIABETES, V51, pS333, DOI 10.2337/diabetes.51.2007.S333
   Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701
   Wang M, 1996, MOL ENDOCRINOL, V10, P243, DOI 10.1210/me.10.3.243
   Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875
   Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478
   Yamada S, 1999, DIABETES, V48, P645, DOI 10.2337/diabetes.48.3.645
   Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231
   Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0
   Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0
   Yamakawa K, 2001, ENDOCR RES, V27, P63, DOI 10.1081/ERC-100107170
   Yang Q, 2002, DIABETES, V51, P1785, DOI 10.2337/diabetes.51.6.1785
   Yoshiuchi I, 2001, HUM MUTAT, V18, P345, DOI 10.1002/humu.1196
   Zhang SP, 2002, J MOL BIOL, V324, P271, DOI 10.1016/S0022-2836(02)01044-6
NR 54
TC 2
Z9 4
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 17
PY 2003
VL 310
IS 2
BP 464
EP 469
DI 10.1016/j.bbrc.2003.09.046
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 731UF
UT WOS:000185904300032
PM 14521933
DA 2021-01-25
ER

PT J
AU Peakman, LJ
   Antognozzi, M
   Bickle, TA
   Janscak, P
   Szczelkun, MD
AF Peakman, LJ
   Antognozzi, M
   Bickle, TA
   Janscak, P
   Szczelkun, MD
TI S-adenosyl methionine prevents promiscuous DNA cleavage by the EcoP1I
   type III restriction enzyme
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE restriction endonuclease; protein-DNA interactions; long-range DNA
   communications; allosteric interaction; salt effects
ID 2 RECOGNITION SITES; ADENOSYLMETHIONINE SYNTHETASE; ESCHERICHIA-COLI;
   MODIFICATION SYSTEM; NUCLEIC-ACID; BACTERIOPHAGE P1; HOST-SPECIFICITY;
   ENDONUCLEASE; PURIFICATION; BINDING
AB DNA cleavage by the type III restriction endonuclease EcoP1I was analysed on circular and catenane DNA in a variety of buffers with different salts. In the presence of the cofactor S-adenosyl methionine (AdoMet), and irrespective of buffer, only substrates with two EcoP1I sites in inverted repeat were susceptible to cleavage. Maximal activity was achieved at a Res,Mod, to site ratio of similar to1:1 yet resulted in cleavage at only one of the two sites. In contrast, the outcome of reactions in the absence of AdoMet was dependent upon the identity of the monovalent buffer components, in particular the identity of the cation. With Na+, cleavage was observed only on substrates with two sites in inverted repeat at elevated enzyme to site ratios (> 15:1). However, with K+ every substrate tested was susceptible to cleavage above an enzyme to site ratio of similar to3:1, including a DNA molecule with two directly repeated sites and even a DNA molecule with a single site. Above an enzyme to site ratio of 2:1, substrates with two sites in inverted repeat were cleaved at both cognate sites. The rates of cleavage suggested two separate events: a fast primary reaction for the first cleavage of a pair of inverted sites; and an order-of-magnitude slower secondary reaction for the second cleavage of the pair or for the first cleavage of all other site combinations. EcoP1I enzymes mutated in either the ATPase or nuclease motifs did not produce the secondary cleavage reactions. Thus, AdoMet appears to play a dual role in type III endonuclease reactions: Firstly, as an allosteric activator, promoting DNA association; and secondly, as a "specificity factor", ensuring that cleavage occurs only when two endonucleases bind two recognition sites in a designated orientation. However, given the right conditions, AdoMet is not strictly required for DNA cleavage by a type III enzyme. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Bristol, Dept Biochem, DNA Prot Interact Grp, Bristol BS8 1TD, Avon, England.
   Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England.
   Univ Basel, Biozentrum, Div Microbiol, CH-4056 Basel, Switzerland.
RP Szczelkun, MD (corresponding author), Univ Bristol, Dept Biochem, DNA Prot Interact Grp, Bristol BS8 1TD, Avon, England.
EM mark.szczelkun@bristol.ac.uk
RI Janscak, Pavel/Q-3795-2018; Janscak, Pavel/G-6189-2014
OI Janscak, Pavel/0000-0002-1748-7789; Szczelkun, Mark/0000-0002-2501-6602
CR ANDERSON CF, 1995, ANNU REV PHYS CHEM, V46, P657, DOI 10.1146/annurev.physchem.46.1.657
   BACHI B, 1979, J MOL BIOL, V128, P143, DOI 10.1016/0022-2836(79)90123-2
   Bath AJ, 2002, J BIOL CHEM, V277, P4024, DOI 10.1074/jbc.M108441200
   BERGERAT A, 1990, NUCLEIC ACIDS RES, V18, P4369, DOI 10.1093/nar/18.15.4369
   Bist P, 2001, J MOL BIOL, V310, P93, DOI 10.1006/jmbi.2001.4744
   BLEAM ML, 1980, P NATL ACAD SCI USA, V77, P3085, DOI 10.1073/pnas.77.6.3085
   Bourniquel AA, 2002, BIOCHIMIE, V84, P1047, DOI 10.1016/S0300-9084(02)00020-2
   BROCKES JP, 1972, BIOCHEM J, V127, P1
   BUCHMAN AR, 1981, DNA TUMOR VIRUSES 2, P799
   Cacace MG, 1997, Q REV BIOPHYS, V30, P241, DOI 10.1017/S0033583597003363
   Cesnaviciene E, 2001, J MOL BIOL, V314, P205, DOI 10.1006/jmbi.2001.5049
   Gowers DM, 2003, EMBO J, V22, P1410, DOI 10.1093/emboj/cdg125
   HA JH, 1992, J MOL BIOL, V228, P252, DOI 10.1016/0022-2836(92)90504-D
   HABERMAN A, 1974, J MOL BIOL, V89, P545, DOI 10.1016/0022-2836(74)90035-7
   Halford SE, 2000, NAT STRUCT BIOL, V7, P705, DOI 10.1038/78911
   Halford SE, 2001, BIOCHEM SOC T, V29, P363, DOI 10.1042/BST0290363
   Janscak P, 2001, J MOL BIOL, V306, P417, DOI 10.1006/jmbi.2000.4411
   JANULAITIS A, 1992, NUCLEIC ACIDS RES, V20, P6043, DOI 10.1093/nar/20.22.6043
   Jurenaite-Urbanaviciene S, 2001, NUCLEIC ACIDS RES, V29, P895, DOI 10.1093/nar/29.4.895
   KAUC L, 1978, EUR J BIOCHEM, V92, P417, DOI 10.1111/j.1432-1033.1978.tb12762.x
   KONG H, 1994, J BIOL CHEM, V269, P683
   KRUEGER DH, 1975, J VIROL, V16, P453, DOI 10.1128/JVI.16.2.453-455.1975
   Kunz A, 1998, BIOL CHEM, V379, P617
   LARK C, 1970, J MOL BIOL, V52, P337, DOI 10.1016/0022-2836(70)90034-3
   LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033
   LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006
   Lepikhov K, 2001, NUCLEIC ACIDS RES, V29, P4691, DOI 10.1093/nar/29.22.4691
   LINN S, 1968, P NATL ACAD SCI USA, V59, P1300, DOI 10.1073/pnas.59.4.1300
   LOHMAN TM, 1986, CRIT REV BIOCHEM MOL, V19, P191, DOI 10.3109/10409238609084656
   Lu ZCJ, 2002, J BIOL CHEM, V277, P16624, DOI 10.1074/jbc.M110456200
   MARKHAM GD, 1980, J BIOL CHEM, V255, P9082
   MARKHAM GD, 1986, J BIOL CHEM, V261, P1507
   MATVIENKO NN, 1992, NUCLEIC ACIDS RES, V20, P1803, DOI 10.1093/nar/20.7.1803
   MCQUENEY MS, 1995, J BIOL CHEM, V270, P18277, DOI 10.1074/jbc.270.31.18277
   MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x
   MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0
   MENETSKI JP, 1992, J BIOL CHEM, V267, P10400
   MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0
   Milsom SE, 2001, J MOL BIOL, V311, P515, DOI 10.1006/jmbi.2001.4893
   Mucke M, 2001, J MOL BIOL, V312, P687, DOI 10.1006/jmbi.2001.4998
   MUDD SH, 1958, J BIOL CHEM, V231, P481
   NOBBS TJ, 1995, J MOL BIOL, V252, P399, DOI 10.1006/jmbi.1995.0506
   Nobbs TJ, 1998, J MOL BIOL, V281, P419, DOI 10.1006/jmbi.1998.1966
   Piekarowicz A, 1999, J MOL BIOL, V293, P1055, DOI 10.1006/jmbi.1999.3198
   POWELL LM, 1993, J MOL BIOL, V234, P60, DOI 10.1006/jmbi.1993.1563
   REISER J, 1977, J BIOL CHEM, V252, P451
   RISSER R, 1974, J MOL BIOL, V89, P517, DOI 10.1016/0022-2836(74)90034-5
   Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P418, DOI 10.1093/nar/gkg069
   ROSNER JL, 1973, VIROLOGY, V52, P213, DOI 10.1016/0042-6822(73)90410-8
   Sambrook J., 2001, MOL CLONING LAB MANU
   Sears LE, 1996, NUCLEIC ACIDS RES, V24, P3590, DOI 10.1093/nar/24.18.3590
   SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789
   SZCZELKUN MD, 1995, BIOCHEMISTRY-US, V34, P10724, DOI 10.1021/bi00034a004
   Szczelkun MD, 1996, EMBO J, V15, P1460, DOI 10.1002/j.1460-2075.1996.tb00488.x
   Takusagawa F, 1996, BIOCHEMISTRY-US, V35, P2586, DOI 10.1021/bi952604z
   TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040
   Tucholski J, 1998, GENE, V223, P293, DOI 10.1016/S0378-1119(98)00450-8
   Vipond IB, 1995, MOL BIOTECHNOL, V4, P259, DOI 10.1007/BF02779019
   Vitkute J, 1997, NUCLEIC ACIDS RES, V25, P4444, DOI 10.1093/nar/25.22.4444
   VITOR JMB, 1995, GENE, V157, P109, DOI 10.1016/0378-1119(94)00668-I
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   YUAN R, 1978, J MOL BIOL, V122, P433, DOI 10.1016/0022-2836(78)90420-5
   YUAN R, 1980, J MOL BIOL, V144, P501, DOI 10.1016/0022-2836(80)90334-4
NR 63
TC 31
Z9 31
U1 0
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD OCT 17
PY 2003
VL 333
IS 2
BP 321
EP 335
DI 10.1016/j.jmb.2003.08.042
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 730VZ
UT WOS:000185852000008
PM 14529619
DA 2021-01-25
ER

PT J
AU Knechtle, P
   Dietrich, F
   Philippsen, P
AF Knechtle, P
   Dietrich, F
   Philippsen, P
TI Maximal polar growth potential depends on the polarisome component
   AgSpa2 in the filamentous fungus Ashbya gossypii
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID FLOW-THROUGH CELL; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; ACTIN
   CYTOSKELETON; CANDIDA-ALBICANS; HYPHAL MORPHOGENESIS; NEUROSPORA-CRASSA;
   BUDDING YEAST; BUD-SITE; PROTEIN
AB We used actin staining and videomicroscopy to analyze the development from a spore to a young mycelium in the filamentous ascomycete Ashbya gossypii. The development starts with an initial isotropic growth phase followed by the emergence of germ tubes. The initial tip growth speed of 6-10 mum/h increases during early stages of development. This increase is transiently interrupted in response to the establishment of lateral branches or septa. The hyphal tip growth speed finally reaches a maximum of up to 200 mum/h, and the tips of these mature hyphae have the ability to split into two equally fast-growing hyphae. A search for A. gossypii homologs of polarisome components of the yeast Saccharomyces cerevisiae revealed a remarkable size difference between Spa2p of both organisms, with AgSpa2p being double as long as ScSpa2p due to an extended internal domain. AgSpa2 colocalizes with sites of polarized actin. Using time-lapse videomicroscopy, we show that AgSpa2p-GFP polarization is established at sites of branch initiation and then permanently maintained at hyphal tips. Polarization at sites of septation is transient. During apical branching the existing AgSpa2p-GFP polarization is symmetrically divided. To investigate the function of AgSpa2p, we generated two AgSPA2 mutants, a partial deletion of the internal domain alone, and a complete deletion. The mutations had an impact on the maximal hyphal tip growth speed, on the hyphal diameter, and on the branching pattern. We suggest that AgSpa2p is required for the determination of the area of growth at the hyphal tip and that the extended internal domain plays an important role in this process.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
OI Knechtle, Philipp/0000-0003-0377-9446
CR AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259
   Amberg DC, 1997, MOL BIOL CELL, V8, P729
   Arkowitz RA, 1997, J CELL BIOL, V138, P17, DOI 10.1083/jcb.138.1.17
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Boyce KJ, 2001, J BACTERIOL, V183, P3447, DOI 10.1128/JB.183.11.3447-3457.2001
   Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4
   Christiansen T, 1999, BIOTECHNOL BIOENG, V63, P147, DOI 10.1002/(SICI)1097-0290(19990420)63:2<147::AID-BIT3>3.0.CO;2-M
   DIETRICH F, 2001, 20 INT C YEAST GEN M
   Dietrich FS, 1997, NATURE, V387, P78, DOI 10.1038/387s078
   Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7
   Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718
   Finger FP, 1998, J CELL BIOL, V142, P609, DOI 10.1083/jcb.142.3.609
   Fink G., 1991, METHOD ENZYMOL, V194, P14
   Fujiwara T, 1998, MOL BIOL CELL, V9, P1221, DOI 10.1091/mbc.9.5.1221
   GEHRUNG S, 1990, J CELL BIOL, V111, P1451, DOI 10.1083/jcb.111.4.1451
   GOW NAR, 1982, J GEN MICROBIOL, V128, P2187
   GOW NAR, 1980, CURR MICROBIOL, V4, P357, DOI 10.1007/BF02605377
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Harris SD, 1997, FUNGAL GENET BIOL, V22, P1, DOI 10.1006/fgbi.1997.0990
   Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474
   Harris SD, 1999, GENETICS, V151, P1015
   Hazan I, 2002, MOL BIOL CELL, V13, P134, DOI 10.1091/mbc.01-03-0116
   HEATH IB, 1995, CAN J BOT, V73, pS131, DOI 10.1139/b95-236
   Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   Jackson SL, 2001, NEW PHYTOL, V151, P556, DOI 10.1046/j.0028-646x.2001.00228.x
   John E, 1999, PRENAT NEONAT MED, V4, P63
   KATZ D, 1972, J BACTERIOL, V109, P1097, DOI 10.1128/JB.109.3.1097-1100.1972
   Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000
   LEW DJ, 1995, CURR OPIN GENET DEV, V5, P17, DOI 10.1016/S0959-437X(95)90048-9
   LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305
   LOPEZFRANCO R, 1994, P NATL ACAD SCI USA, V91, P12228, DOI 10.1073/pnas.91.25.12228
   MAIZEL JV, 1981, P NATL ACAD SCI-BIOL, V78, P7665, DOI 10.1073/pnas.78.12.7665
   Momany M, 1999, GENETICS, V151, P557
   Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5
   Momany M, 1997, CELL MOTIL CYTOSKEL, V38, P373, DOI 10.1002/(SICI)1097-0169(1997)38:4<373::AID-CM7>3.0.CO;2-4
   Momany M, 2000, MICROBIOL-UK, V146, P3279, DOI 10.1099/00221287-146-12-3279
   PROSSER JI, 1979, J GEN MICROBIOL, V111, P153, DOI 10.1099/00221287-111-1-153
   Pruyne D, 2000, J CELL SCI, V113, P365
   Pruyne D, 2000, J CELL SCI, V113, P571
   Roemer T, 1998, J CELL SCI, V111, P479
   Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schade D, 2003, FUNGAL GENET BIOL, V40, P65, DOI 10.1016/S1087-1845(03)00064-1
   SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712
   SCHIRMAIER F, 1984, EMBO J, V3, P3311, DOI 10.1002/j.1460-2075.1984.tb02295.x
   SEVILLA MJ, 1986, J GEN MICROBIOL, V132, P3083
   Sharpless KE, 2002, MOL BIOL CELL, V13, P469, DOI 10.1091/mbc.01-07-0356
   Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053
   SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583
   SNYDER M, 1991, J CELL BIOL, V114, P515, DOI 10.1083/jcb.114.3.515
   SNYDER M, 1989, J CELL BIOL, V108, P1419, DOI 10.1083/jcb.108.4.1419
   Spohr A, 1998, BIOTECHNOL BIOENG, V58, P541, DOI 10.1002/(SICI)1097-0290(19980605)58:5<541::AID-BIT11>3.0.CO;2-E
   STEINER S, 1995, GENETICS, V140, P973
   STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trinci A. P. J., 1994, MYCOTA, VI, P175
   TRINCI APJ, 1970, T BRIT MYCOL SOC, V55, P17, DOI 10.1016/S0007-1536(70)80091-2
   Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725
   van Drogen F, 2002, CURR BIOL, V12, P1698, DOI 10.1016/S0960-9822(02)01186-7
   Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Watters MK, 2000, MYCOL RES, V104, P557, DOI 10.1017/S0953756299001598
   Watters MK, 2001, APPL ENVIRON MICROB, V67, P1788, DOI 10.1128/AEM.67.4.1788-1792.2001
   Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2001, FUNGAL GENET BIOL, V34, P63, DOI 10.1006/fgbi.2001.1290
   Wendland J, 2001, GENETICS, V157, P601
   Wendland J, 2000, J CELL SCI, V113, P1611
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
NR 72
TC 72
Z9 77
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD OCT
PY 2003
VL 14
IS 10
BP 4140
EP 4154
DI 10.1091/mbc.E03-03-0167
PG 15
WC Cell Biology
SC Cell Biology
GA 727LU
UT WOS:000185660900017
PM 12937275
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Jazwinska, A
   Ribeiro, C
   Affolter, M
AF Jazwinska, A
   Ribeiro, C
   Affolter, M
TI Epithelial tube morphogenesis during Drosophila tracheal development
   requires Piopio, a luminal ZP protein
SO NATURE CELL BIOLOGY
LA English
DT Article
ID CELLS; GFP; GENE; ARCHITECTURE; EMBRYOS; DOMAIN
AB The formation of branched epithelial networks is fundamental to the development of many organs, such as the lung, the kidney or the vasculature. Little is known about the mechanisms that control cell rearrangements during tubulogenesis and regulate the size of individual tubes. Recent studies indicate that whereas the basal surface of tube cells interacts with the surrounding tissues and helps to shape the ramification pattern of tubular organs, the apical surface has an important role in the regulation of tube diameter and tube growth. Here we report that two proteins, Piopio (Pio) and Dumpy (Dp), containing a zona pellucida (ZP) domain are essential for the generation of the interconnected tracheal network in Drosophila melanogaster. Pio is secreted apically, accumulates in the tracheal lumen and possibly interacts with Dp through the ZP domains. In the absence of Pio and Dp, multicellular tubes do not rearrange through cell elongation and cell intercalation to form narrow tubes with autocellular junctions; instead they are transformed into multicellular cysts, which leads to a severe disruption of the branched pattern. We propose that an extracellular matrix containing Pio and Dp provides a structural network in the luminal space, around which cell rearrangements can take place in an ordered fashion without losing interconnections. Our results suggest that a similar structural role might be attributed to other ZP-domain proteins in the formation of different branched organs.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Markus.Affolter@unibas.ch
RI Jazwinska, Anna/M-8705-2016
OI Jazwinska, Anna/0000-0003-3881-9284; Ribeiro,
   Carlos/0000-0002-9542-7335; Affolter, Markus/0000-0002-5171-0016
CR AFFOLTER M, 1994, DEVELOPMENT, V120, P743
   Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9
   BRAND A, 1995, TRENDS GENET, V11, P324, DOI 10.1016/S0168-9525(00)89091-5
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802
   Lecuit T, 2003, NAT CELL BIOL, V5, P103, DOI 10.1038/ncb0203-103
   Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345
   Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635
   Myat MM, 2002, CELL, V111, P879, DOI 10.1016/S0092-8674(02)01140-6
   O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859
   Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246
   PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9
   Prout M, 1997, GENETICS, V146, P275
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6
   Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178
   Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6
NR 30
TC 130
Z9 131
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
EI 1476-4679
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD OCT
PY 2003
VL 5
IS 10
BP 895
EP 901
DI 10.1038/ncb1049
PG 7
WC Cell Biology
SC Cell Biology
GA 727FM
UT WOS:000185647400015
PM 12973360
DA 2021-01-25
ER

PT J
AU Fahrenkrog, B
   Aebi, U
AF Fahrenkrog, B
   Aebi, U
TI The nuclear pore complex: Nucleocytoplasmic transport and beyond
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID SACCHAROMYCES-CEREVISIAE NUCLEOPORIN; IMPORTIN-BETA; STRUCTURAL BASIS;
   MOLECULAR ARCHITECTURE; MOBILE NUCLEOPORIN; RAN GTPASE; FG REPEAT;
   PROTEIN; DOMAIN; NUP98
AB Over the past two years, it has become evident that there is an unexpected link between nuclear pore complex structure and dynamics, nucleocytoplasmic transport and chromosome segregation. In addition, a tomographic three-dimensional reconstruction of native nuclear pore complexes preserved in thick amorphous ice has unveiled a number of new structural features of this supramolecular machine. These data, together with some of the elementary physical principles that underlie nucleocytoplasmic transport, will be discussed in this review.
C1 Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Fahrenkrog, B (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM birthe.fahrenkrog@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413
CR AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6
   AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X
   ALBERTS B, 1992, CELL, V68, P415, DOI 10.1016/0092-8674(92)90179-G
   Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200
   Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166
   Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200
   Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305
   Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Bickel T, 2002, BIOPHYS J, V83, P3079, DOI 10.1016/S0006-3495(02)75312-5
   Boer JM, 1997, EXP CELL RES, V232, P182, DOI 10.1006/excr.1997.3502
   Bustamante JO, 2000, PFLUG ARCH EUR J PHY, V439, P433, DOI 10.1007/s004240050960
   Campbell MS, 2001, J CELL SCI, V114, P953
   Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375
   Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0
   Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1
   Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Danker T, 1999, P NATL ACAD SCI USA, V96, P13530, DOI 10.1073/pnas.96.23.13530
   Danker T, 2000, PFLUG ARCH EUR J PHY, V439, P671, DOI 10.1007/s004240050992
   Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5
   Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379
   Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465
   DWORETZKY SI, 1988, J CELL BIOL, V107, P1279, DOI 10.1083/jcb.107.4.1279
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Fahrenkrog Birthe, 2002, Results Probl Cell Differ, V35, P25
   Feldherr CM, 1997, J CELL SCI, V110, P3065
   Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698
   Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3
   Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046
   Grant RP, 2003, J MOL BIOL, V326, P849, DOI 10.1016/S0022-2836(02)01474-2
   Grant RP, 2002, NAT STRUCT BIOL, V9, P247, DOI 10.1038/nsb773
   Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582
   Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538
   Hase ME, 2001, MOL BIOL CELL, V12, P2433, DOI 10.1091/mbc.12.8.2433
   Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068
   Jaggi RD, 2003, BIOPHYS J, V84, P665
   JARNIK M, 1991, J STRUCT BIOL, V107, P291, DOI 10.1016/1047-8477(91)90054-Z
   Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109
   Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9
   Kerscher O, 2001, GENETICS, V157, P1543
   Kiseleva E, 1998, J CELL SCI, V111, P223
   Kose S, 1999, J BIOL CHEM, V274, P3946, DOI 10.1074/jbc.274.7.3946
   Kosova B, 2000, J BIOL CHEM, V275, P343, DOI 10.1074/jbc.275.1.343
   Kosztin I, 2002, P NATL ACAD SCI USA, V99, P3575, DOI 10.1073/pnas.052209199
   Kuersten S, 2001, TRENDS CELL BIOL, V11, P497, DOI 10.1016/S0962-8924(01)02144-4
   Kull FJ, 1998, J MUSCLE RES CELL M, V19, P877, DOI 10.1023/A:1005489907021
   LEL EP, 2002, DEV CELL, V2, P261
   Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X
   Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982
   Nemergut ME, 2000, J CELL BIOL, V149, P835, DOI 10.1083/jcb.149.4.835
   Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   Peters R, 2002, J STRUCT BIOL, V140, P268, DOI 10.1016/S1047-8477(02)00525-7
   Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241
   RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3
   Rakowska A, 1998, J MEMBRANE BIOL, V163, P129, DOI 10.1007/s002329900377
   REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320
   Rollenhagen C, 2003, MOL BIOL CELL, V14, P2104, DOI 10.1091/mbc.E02-06-0372
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   ROUT MP, 1993, J CELL BIOL, V109, P2641
   Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116
   Sablin EP, 2001, CURR OPIN STRUC BIOL, V11, P716, DOI 10.1016/S0959-440X(01)00265-2
   Salman H, 2001, P NATL ACAD SCI USA, V98, P7247, DOI 10.1073/pnas.121067698
   Schafer C, 2002, P NATL ACAD SCI USA, V99, P7154, DOI 10.1073/pnas.092140799
   Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31
   Shahin V, 2001, FASEB J, V15, P1895, DOI 10.1096/fj.00-0838com
   Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003
   Siebrasse JP, 2002, EMBO REP, V3, P887, DOI 10.1093/embo-reports/kvf171
   Smith S, 1999, J CELL SCI, V112, P3649
   SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6
   Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839
   Theodoropoulos PA, 1999, J CELL SCI, V112, P3049
   Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88
   Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291
   Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0
   Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   Wang J, 2002, J BIOL CHEM, V277, P46659, DOI 10.1074/jbc.M206407200
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
   Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119
   YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0
   Zimowska G, 2002, EXP CELL RES, V276, P223, DOI 10.1006/excr.2002.5525
   Zimowska G, 1997, J CELL SCI, V110, P927
   Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999
NR 100
TC 304
Z9 311
U1 0
U2 39
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0072
EI 1471-0080
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD OCT
PY 2003
VL 4
IS 10
BP 757
EP 766
DI 10.1038/nrm1230
PG 10
WC Cell Biology
SC Cell Biology
GA 729HA
UT WOS:000185766600011
PM 14570049
DA 2021-01-25
ER

PT J
AU Seifritz, E
   Di Salle, F
   Esposito, F
   Bilecen, D
   Neuhoff, JG
   Scheffler, K
AF Seifritz, E
   Di Salle, F
   Esposito, F
   Bilecen, D
   Neuhoff, JG
   Scheffler, K
TI Sustained blood oxygenation and volume response to repetition
   rate-modulated sound in human auditory cortex
SO NEUROIMAGE
LA English
DT Article
ID HUMAN BRAIN; SENSORY STIMULATION; TEMPORAL ENVELOPE; FUNCTIONAL MRI;
   SIGNAL CHANGES; BALLOON MODEL; STIMULUS RATE; TIME-COURSE; FLOW;
   ACTIVATION
AB The blood oxygen level-dependent (BOLD) signal time course in the auditory cortex is characterized by two components, an initial transient peak and a subsequent sustained plateau with smaller amplitude. Because the T-2* signal detected by functional magnetic resonance imaging (fMRI) depends on at least two counteracting factors, blood oxygenation and volume, we examined whether the reduction in the sustained BOLD signal results from decreased levels of oxygenation or from increased levels of blood volume. We used conventional fMRI to quantify the BOLD signal and fMRI in combination with superparamagnetic contrast agent to quantify blood volume and employed repetition rate-modulated sounds in a silent background to manipulate the response amplitude in the auditory cortex. In the BOLD signal, the initial peak reached 3.3% with pulsed sound and 1.9% with continuous sound, whereas the sustained BOLD signal fell to 2.2% with pulsed sound and to 0.5% with continuous sound, respectively. The repetition rate-dependent reduction in the sustained BOLD amplitude was accompanied by concordant changes in sustained blood volume levels, which, compared to silence, increased by similar to30% with pulsed and by similar to10% with continuous sound. Thus, our data suggest that the reduced amplitude of the sustained BOLD signal reflects stimulus-dependent modulation of blood oxygenation rather than blood volume-related effects. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Basel, Dept Psychiat, CH-4025 Basel, Switzerland.
   Univ Naples Federico II, Dept Neurol Sci, Div Neuroradiol, Naples, Italy.
   Univ Naples 2, Div Neurol 2, I-80138 Naples, Italy.
   Univ Basel, MR Phys, Dept Med Radiol, CH-4025 Basel, Switzerland.
   Coll Wooster, Dept Psychol, Wooster, OH 44691 USA.
   Univ Basel, Biozentrum, Magnet Resonance Ctr, CH-4025 Basel, Switzerland.
RP Seifritz, E (corresponding author), Univ Basel, Dept Psychiat, Wilhelmkleinstr 27, CH-4025 Basel, Switzerland.
EM erich.seifritz@unibas.ch
RI Neuhoff, John/A-2955-2016; Esposito, Fabrizio/M-8555-2015
OI Esposito, Fabrizio/0000-0002-5099-9786; Scheffler,
   Klaus/0000-0001-6316-8773; Neuhoff, John/0000-0003-1123-9044
CR Atzori M, 2001, NAT NEUROSCI, V4, P1230, DOI 10.1038/nn760
   Bandettini PA, 1998, MAGNET RESON MED, V39, P410, DOI 10.1002/mrm.1910390311
   Bandettini PA, 1997, HUM BRAIN MAPP, V5, P93
   BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204
   Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480
   BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051
   Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602
   Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814
   COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341
   Di Salle F, 2001, NEUROIMAGE, V13, P328, DOI 10.1006/nimg.2000.0683
   Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E
   Eggermont JJ, 2002, J NEUROPHYSIOL, V87, P305, DOI 10.1152/jn.00490.2001
   ERNST T, 1994, MAGN RESON MED, V32, P146, DOI 10.1002/mrm.1910320122
   FOX PT, 1984, J NEUROPHYSIOL, V51, P1109
   FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140
   FRAHM J, 1992, JMRI-J MAGN RESON IM, V2, P501, DOI 10.1002/jmri.1880020505
   Fransson P, 1998, MAGNET RESON MED, V39, P912, DOI 10.1002/mrm.1910390608
   Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402
   GaschlerMarkefski B, 1997, MAGN RESON MED, V38, P811, DOI 10.1002/mrm.1910380518
   Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588
   Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N
   Hall DA, 2001, J ACOUST SOC AM, V109, P1559, DOI 10.1121/1.1345697
   Harms MP, 2002, J NEUROPHYSIOL, V88, P1433, DOI 10.1152/jn.2002.88.3.1433
   Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403
   Jancke L, 1999, COGNITIVE BRAIN RES, V8, P117, DOI 10.1016/S0926-6410(99)00012-9
   Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729
   KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675
   Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737
   Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012
   Mandeville JB, 1999, MAGN RESON MED, V42, P944, DOI 10.1002/(SICI)1522-2594(199911)42:5<944::AID-MRM15>3.0.CO;2-W
   Mildner T, 2001, MAGN RESON MED, V46, P891, DOI 10.1002/mrm.1274.abs
   Miller KL, 2001, HUM BRAIN MAPP, V13, P1, DOI 10.1002/hbm.1020
   MUSTOVIC H, 2003, IN PRESS NEUROIMAGE
   Naatanen R., 1992, ATTENTION BRAIN FUNC
   Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001
   OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868
   OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951
   OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3
   PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996
   Recanzone GH, 2000, HEARING RES, V150, P104, DOI 10.1016/S0378-5955(00)00194-5
   Robson MD, 1998, NEUROIMAGE, V7, P185, DOI 10.1006/nimg.1998.0322
   Scheffler K, 1999, MAGNET RESON MED, V42, P829, DOI 10.1002/(SICI)1522-2594(199911)42:5<829::AID-MRM2>3.0.CO;2-6
   Scheffler K, 1998, CEREB CORTEX, V8, P156, DOI 10.1093/cercor/8.2.156
   Seifritz E, 2002, SCIENCE, V297, P1706, DOI 10.1126/science.1074355
   Tanaka H, 2000, NEUROREPORT, V11, P2045, DOI 10.1097/00001756-200006260-00047
   van Zijl PCM, 1998, NAT MED, V4, P159, DOI 10.1038/nm0298-159
   Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108
   Yabe H, 2001, BRAIN RES, V897, P222, DOI 10.1016/S0006-8993(01)02224-7
   Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946
NR 49
TC 9
Z9 9
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1053-8119
J9 NEUROIMAGE
JI Neuroimage
PD OCT
PY 2003
VL 20
IS 2
BP 1365
EP 1370
DI 10.1016/S1053-8119(03)00421-X
PG 6
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 737YV
UT WOS:000186260700067
PM 14568505
DA 2021-01-25
ER

PT J
AU Karelson, G
   Ziegler, A
   Kunnecke, B
   Seelig, J
AF Karelson, G
   Ziegler, A
   Kunnecke, B
   Seelig, J
TI Feeding versus infusion: a novel approach to study the NAA metabolism in
   rat brain
SO NMR IN BIOMEDICINE
LA English
DT Article
DE feeding; C-13-NMR; brain metabolism; tricarboxylic acid cycle; amino
   acids
ID ACETYL-L-ASPARTATE; CYSTEINE SULFINATE DECARBOXYLASE; C-13
   NMR-SPECTROSCOPY; N-ACETYLASPARTATE; IN-VIVO; CEREBRAL METABOLISM;
   LIPID-SYNTHESIS; NERVOUS-SYSTEM; RABBIT BRAIN; ACID
AB Using in vivo C-13-NMR spectroscopy, the energy metabolism in rat brain has commonly been studied via infusion of C-13-labeled substrates on a minute to hour time scale. In the present study, as a novel approach, C-13-enriched animal chow was administered over several days and compared with a 2 h infusion of [U-C-13(6)]-glucose. Rats received chow containing either [U-C-13(6)]-glucose or [U-C-13]-biomass (a mixture of proteins, lipids, DNA, and carbohydrates) during 3 to 5 days. During feeding with C-13-labeled glucose and biomass, in vivo C-13-NMR spectroscopy was carried out daily and revealed slow but successive label incorporation into a large number of metabolites. Lipids and proteins were not significantly 13 C-enriched during a 2 h infusion of C-13-labeled glucose, but became the most prominent resonances in the C-13 feeding experiment. Likewise, feeding with C-13-enriched biomass led to additional C-13-label incorporation into creatine, urea carbons and glycogen. Finally, only the acetyl moiety of N-acetyl-aspartate (NAA) became significantly enriched during the 2h infusion experiment, whereas the aspartyl moiety remained at natural abundance levels. In the feeding experiments, however, label incorporation into all carbons of NAA could be observed. Moreover, isotopomer analysis of brain extracts revealed that the acetyl moiety of NAA in feeding experiments was always more strongly 1 3 C-enriched than its aspartyl moiety, suggesting that the turnover of the acetyl moiety is faster than that of the aspartyl moiety. The different enrichment kinetics of acetyl and aspartyl moiety could be explained by the existence of two different metabolic pathways reflecting the compartmentalised synthesis of NAA. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
CR AGRAWAL HC, 1966, J NEUROCHEM, V13, P607, DOI 10.1111/j.1471-4159.1966.tb11957.x
   Baslow MH, 1997, J MOL NEUROSCI, V9, P109, DOI 10.1007/BF02736855
   Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x
   Baslow MH, 1999, J MOL NEUROSCI, V13, P47, DOI 10.1385/JMN:13:1-2:47
   BEHAR KL, 1986, MAGNET RESON MED, V3, P911, DOI 10.1002/mrm.1910030611
   Bhakoo KK, 2000, J NEUROCHEM, V74, P254, DOI 10.1046/j.1471-4159.2000.0740254.x
   Braissant O, 2001, MOL BRAIN RES, V86, P193, DOI 10.1016/S0169-328X(00)00269-2
   BURRI R, 1991, DEV NEUROSCI-BASEL, V13, P403, DOI 10.1159/000112191
   CERDAN S, 1990, J BIOL CHEM, V265, P12916
   Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x
   Choi IY, 1999, J NEUROCHEM, V73, P1300, DOI 10.1046/j.1471-4159.1999.0731300.x
   Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574
   Choi IY, 2001, J NEUROCHEM, V78, P159
   CHOI IY, 2000, P INT SOC MAGNETIC R, V8, P598
   CLARKE DD, 1975, J NEUROCHEM, V24, P479, DOI 10.1111/j.1471-4159.1975.tb07665.x
   Cunnane SC, 2001, J MOL NEUROSCI, V16, P173, DOI 10.1385/JMN:16:2-3:173
   Dringen R, 1998, J NEUROCHEM, V70, P835
   Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9
   Fillenz M, 1999, ACTA PHYSIOL SCAND, V167, P275
   Gruetter R, 1998, DEV NEUROSCI-BASEL, V20, P380, DOI 10.1159/000017334
   Haber S, 2001, BRAIN RES, V896, P102, DOI 10.1016/S0006-8993(01)02065-0
   HAWKINS RA, 1979, SCIENCE, V205, P325, DOI 10.1126/science.451608
   Huang W, 2000, J PHARMACOL EXP THER, V295, P392
   KAUL R, 1991, J NEUROCHEM, V56, P129, DOI 10.1111/j.1471-4159.1991.tb02571.x
   Kerr SE, 1937, J BIOL CHEM, V117, P217
   KLEEMAN CR, 1962, AM J PHYSIOL, V203, P739
   KUNNECKE B, 1993, NMR BIOMED, V6, P264, DOI 10.1002/nbm.1940060406
   MARCUCCI F, 1966, J NEUROCHEM, V123, P1069
   MARGOLIS RU, 1960, J NEUROCHEM, V5, P379, DOI 10.1111/j.1471-4159.1960.tb13377.x
   MCINTOSH JC, 1965, J NEUROCHEM, V12, P825, DOI 10.1111/j.1471-4159.1965.tb10267.x
   Moreno A, 2001, J NEUROCHEM, V77, P347, DOI 10.1046/j.1471-4159.2001.t01-1-00282.x
   NADLER JV, 1972, J NEUROCHEM, V19, P2091, DOI 10.1111/j.1471-4159.1972.tb05119.x
   NELSON SR, 1968, J NEUROCHEM, V15, P1271, DOI 10.1111/j.1471-4159.1968.tb05904.x
   NOTTERPEK LM, 1994, NEURON, V13, P473, DOI 10.1016/0896-6273(94)90361-1
   OJA SS, 1990, PROG CLIN BIOL RES, V351, P277
   PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539
   Pow DV, 2002, GLIA, V37, P153, DOI 10.1002/glia.10026
   Sager TN, 1999, J NEUROCHEM, V73, P807, DOI 10.1046/j.1471-4159.1999.0730807.x
   SHANK RP, 1993, J NEUROCHEM, V61, P315, DOI 10.1111/j.1471-4159.1993.tb03570.x
   Silver SM, 1996, AM J KIDNEY DIS, V28, P1, DOI 10.1016/S0272-6386(96)90124-9
   SOLIS JM, 1988, NEUROSCI LETT, V91, P53, DOI 10.1016/0304-3940(88)90248-0
   TALLAN HH, 1956, J BIOL CHEM, V219, P257
   TALLAN HH, 1957, J BIOL CHEM, V224, P41
   TAPPAZ M, 1992, NEUROCHEM RES, V17, P849, DOI 10.1007/BF00993260
   TAPPAZ M, 1994, ADV EXP MED BIOL, V359, P257
   TAYLOR DL, 1995, J NEUROCHEM, V65, P275
   TRUCKENMILLER ME, 1985, J NEUROCHEM, V45, P1658, DOI 10.1111/j.1471-4159.1985.tb07240.x
   Tsacopoulos M, 1996, J NEUROSCI, V16, P877
   TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M
   Tyson RL, 1998, NEUROSCI LETT, V251, P181, DOI 10.1016/S0304-3940(98)00527-8
   Waagepetersen HS, 2000, NEUROCHEM INT, V36, P349, DOI 10.1016/S0197-0186(99)00143-6
   Waagepetersen HS, 2001, GLIA, V35, P246, DOI 10.1002/glia.1089
NR 52
TC 12
Z9 12
U1 0
U2 0
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0952-3480
J9 NMR BIOMED
JI NMR Biomed.
PD OCT-NOV
PY 2003
VL 16
IS 6-7
BP 413
EP 423
DI 10.1002/nbm.845
PG 11
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA 754XQ
UT WOS:000187359100008
PM 14679503
DA 2021-01-25
ER

PT J
AU Vohradsky, J
   Janda, I
   Grunenfelder, B
   Berndt, P
   Roder, D
   Langen, H
   Weiser, J
   Jenal, U
AF Vohradsky, J
   Janda, I
   Grunenfelder, B
   Berndt, P
   Roder, D
   Langen, H
   Weiser, J
   Jenal, U
TI Proteome of Caulobacter crescentus cell cycle publicly accessible on
   SWICZ server
SO PROTEOMICS
LA English
DT Article
DE bioinformatics; Caulobacter crescentus; cell cycle; global protein
   analysis
ID IDENTIFICATION
AB Here we present the Swiss-Czech Proteomics Server (SWICZ), which hosts the proteomic database summarizing information about the cell cycle of the aquatic bacterium Caulobacter crescentus. The database provides a searchable tool for easy access of global protein synthesis and protein stability data as examined during the C. crescentus cell cycle. Protein synthesis data collected from five different cell cycle stages were determined for each protein spot as a relative value of the total amount of [S-35]methionine incorporation. Protein stability of pulse-labeled extracts were measured during a chase period equivalent to one cell cycle unit. Quantitative information for individual proteins together with descriptive data such as protein identities, apparent molecular masses and isoelectric points, were combined with information on protein function, genomic context, and the cell cycle stage, and were then assembled in a relational database with a world wide web interface (http://proteom.biomed.cas.cz), which allows the database records to be searched and displays the recovered information. A total of 1250 protein spots were reproducibly detected on two-dimensional gel electropherograms, 295 of which were identified by mass spectroscopy. The database is accessible either through clickable two-dimensional gel electrophoretic maps or by means of a set of dedicated search engines. Basic characterization of the experimental procedures, data processing, and a comprehensive description of the web site are presented. In its current state, the SWICZ proteome database provides a platform for the incorporation of new data emerging from extended functional studies on the C. crescentus proteome.
C1 Acad Sci Czech Republ, Inst Microbiol, Lab Bioinformat, CR-14220 Prague, Czech Republic.
   Univ Basel, Biozentrum, Basel, Switzerland.
   F Hoffmann La Roche & Co Ltd, Pharmaceut Res, Gene Technol, Basel, Switzerland.
RP Vohradsky, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Lab Bioinformat, Videnska 1083, CR-14220 Prague, Czech Republic.
RI Weiser, Jaroslav/AAU-8548-2020; Weiser, jaroslav/I-2078-2013
OI Weiser, jaroslav/0000-0003-3541-4249
CR Berndt P, 1999, ELECTROPHORESIS, V20, P3521, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3521::AID-ELPS3521>3.0.CO;2-8
   BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209
   Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098
   Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x
   JOHNSON RC, 1977, GENETICS, V86, P25
   Kaufman L, 1990, FINDING GROUPS DATA, P199, DOI [10.1002/9780470316801, DOI 10.1002/9780470316801]
   Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298
   Vohradsky J, 1997, ELECTROPHORESIS, V18, P1418, DOI 10.1002/elps.1150180817
NR 10
TC 10
Z9 11
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD OCT
PY 2003
VL 3
IS 10
BP 1874
EP 1882
DI 10.1002/pmic.200300559
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 736JW
UT WOS:000186168500004
PM 14625849
DA 2021-01-25
ER

PT J
AU Foultier, B
   Cornelis, GR
AF Foultier, B
   Cornelis, GR
TI DNA sequence and analysis of the pYV(a127/90) virulence plasmid of
   Yersinia enterocolitica strain A127/90
SO RESEARCH IN MICROBIOLOGY
LA English
DT Article
DE type III secretion; pYV; Syc; Ysc; YlpA
ID OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; PYV PLASMID; PESTIS; TRAT;
   RESISTANCE; SECRETION; ANTIGEN; GENOME
AB The complete nucleotide sequence and organization of the Yersinia enterocolitica strain A127/90 serotype 0:8 biotype 1B virulence plasmid (pYVa127/90) were determined. In contrast to other biotype 1B strains, usually isolated in the USA, strain A127/90 was isolated in Japan. The organization of the genes carried by the 66591-bp pYVa127/90 plasmid is globally similar to that of 67720-bp pYVe8081, the virulence plasmid from 8081, an American isolate of serotype O:8 biotype 1B. Differences are noticeable in the amino acid sequences of the SycH chaperone, the YopM cytotoxin and the plague-protective antigen LcrV. Interestingly, pYVa127/90 contains the entire coding sequence of the YlpA lipoprotein, which is missing from pYVe8081. In addition, we identified five potential new genes. Several vestigial insertion sequence elements appeared to be different between the two plasmids. These observations suggest that both pYV plasmids are from a common ancestor but may have evolved independently following the conquest of two distant ecological niches. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
C1 Univ Catholique Louvain, Microbial Pathogenesis Unit, Christian Duve Inst Cellular Pathol, B-1200 Brussels, Belgium.
   Univ Catholique Louvain, Fac Med, B-1200 Brussels, Belgium.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Catholique Louvain, Microbial Pathogenesis Unit, Christian Duve Inst Cellular Pathol, B-1200 Brussels, Belgium.
CR AGUERO ME, 1984, INFECT IMMUN, V46, P740
   Boland A, 1998, MICROB PATHOGENESIS, V25, P343, DOI 10.1006/mpat.1998.0247
   CHINA B, 1990, MOL MICROBIOL, V4, P1585, DOI 10.1111/j.1365-2958.1990.tb02070.x
   Cornelis GR, 2000, PHILOS T ROY SOC B, V355, P681, DOI 10.1098/rstb.2000.0608
   Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998
   Fu RD, 1998, APPL ENVIRON MICROB, V64, P53
   Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998
   ICHINOHE H, 1991, J CLIN MICROBIOL, V29, P846, DOI 10.1128/JCM.29.4.846-847.1991
   IRIARTE M, 1999, PATHOGENICITY ISLAND, P91
   LAWTON WD, 1963, J IMMUNOL, V91, P179
   Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998
   MOLL A, 1980, INFECT IMMUN, V28, P359
   Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083
   Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998
   Roggenkamp A, 1997, INFECT IMMUN, V65, P446, DOI 10.1128/IAI.65.2.446-451.1997
   SIMONET M, 1990, INFECT IMMUN, V58, P841, DOI 10.1128/IAI.58.3.841-845.1990
   Snellings NJ, 2001, INFECT IMMUN, V69, P4627, DOI 10.1128/IAI.69.7.4627-4638.2001
   Tobe T, 1999, INFECT IMMUN, V67, P5455, DOI 10.1128/IAI.67.10.5455-5462.1999
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
NR 19
TC 12
Z9 25
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0923-2508
J9 RES MICROBIOL
JI Res. Microbiol.
PD OCT
PY 2003
VL 154
IS 8
BP 553
EP 557
DI 10.1016/S0923-2508(03)00147-5
PG 5
WC Microbiology
SC Microbiology
GA 740JL
UT WOS:000186399200004
PM 14527656
DA 2021-01-25
ER

PT J
AU Sharkia, R
   Bonshtien, AL
   Mizrahi, I
   Weiss, C
   Niv, A
   Lustig, A
   Viitanen, PV
   Azem, A
AF Sharkia, R
   Bonshtien, AL
   Mizrahi, I
   Weiss, C
   Niv, A
   Lustig, A
   Viitanen, PV
   Azem, A
TI On the oligomeric state of chloroplast chaperonin 10 and chaperonin 20
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE chloroplast; chaperonin; Cpn60; Cpn10; Cpn20; GroES
ID SUBUNIT BINDING-PROTEIN; ARABIDOPSIS-THALIANA; CO-CHAPERONIN;
   MITOCHONDRIAL CHAPERONIN-10; ESCHERICHIA-COLI; CROSS-LINKING; GROES;
   PURIFICATION; OVEREXPRESSION; NUCLEOTIDES
AB Type I chaperonins are fundamental protein folding machineries that function in eubacteria, mitochondria and chloroplasts. Eubacteria and mitochondria contain chaperonin systems comprised of homo-oligomeric chaperonin 60 tetradecamers and co-chaperonin 10 heptamers. In contrast, the chloroplast chaperonins are heterooligomeric tetradecamers that are composed of two subunit types, alpha and beta. Additionally, chloroplasts contain two structurally distinct co-chaperonins. One, ch-cpn10, is probably similar to the mitochondrial and bacterial co-chaperonins, and is composed of 10 kDa subunits. The other, termed ch-cpn20 is composed of two cpn10-like domains that are held together by a short linker. While the oligomeric structure of ch-cpn10 remains to be elucidated, it was previously suggested that ch-cpn20 forms tetramers in solution, and that this is the functional oligomer. In the present study, we investigated the properties of purified ch-cpn10 and ch-cpn20. Using bifunctional cross-linking reagents, gel filtration chromatography and analytical ultracentrifugation, we show that ch-cpn10 is a heptamer in solution. In contrast, ch-cpn20 forms multiple oligomers that are in dynamic equilibrium with each other and cover a broad spectrum of molecular weights in a concentration-dependent manner. However, upon association with GroEL, only one type of co-chaperonin-GroEL complex is formed. (C) 2003 Elsevier B.V. All rights reserved.
C1 Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   DuPont Co Inc, Dept Cent Res & Dev, Expt Stn, Div Mol Biol, Wilmington, DE 19880 USA.
RP Azem, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.
CR Azem A, 1997, J BIOL CHEM, V272, P20901, DOI 10.1074/jbc.272.33.20901
   AZEM A, 1995, BBA-GEN SUBJECTS, V1243, P151, DOI 10.1016/0304-4165(94)00107-9
   Azem A, 1998, METHOD ENZYMOL, V290, P253, DOI 10.1016/S0076-6879(98)90024-6
   AZEM A, 1993, USE CROSS LINKING BI
   BANEYX F, 1995, J BIOL CHEM, V270, P10695, DOI 10.1074/jbc.270.18.10695
   Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h
   BERTSCH U, 1992, P NATL ACAD SCI USA, V89, P8696, DOI 10.1073/pnas.89.18.8696
   Bertsch U, 1995, PLANT MOL BIOL, V29, P1039, DOI 10.1007/BF00014976
   Braig K, 1998, CURR OPIN STRUC BIOL, V8, P159, DOI 10.1016/S0959-440X(98)80033-X
   Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829
   Eisenstein E, 1998, METHOD ENZYMOL, V290, P119, DOI 10.1016/S0076-6879(98)90011-8
   Harlow E, 1988, ANTIBODIES LAB MANUA
   HEMMINGSEN SM, 1986, PLANT PHYSIOL, V80, P269, DOI 10.1104/pp.80.1.269
   Hendrick JP, 1995, FASEB J, V9, P1559
   Hill JE, 2001, CELL STRESS CHAPERON, V6, P190, DOI 10.1379/1466-1268(2001)006<0190:ATTIAI>2.0.CO;2
   Hirohashi T, 1999, BBA-PROTEIN STRUCT M, V1429, P512, DOI 10.1016/S0167-4838(98)00268-4
   Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0
   Koumoto Y, 2001, J BIOL CHEM, V276, P29688, DOI 10.1074/jbc.M102330200
   Koumoto Y, 1999, PLANT J, V17, P467, DOI 10.1046/j.1365-313X.1999.00388.x
   Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x
   Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0
   MUSGROVE JE, 1987, EUR J BIOCHEM, V163, P529, DOI 10.1111/j.1432-1033.1987.tb10900.x
   Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581
   Viitanen PV, 1998, METHOD ENZYMOL, V290, P218, DOI 10.1016/S0076-6879(98)90021-0
   Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001
NR 25
TC 22
Z9 22
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-9639
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD SEP 23
PY 2003
VL 1651
IS 1-2
BP 76
EP 84
DI 10.1016/S1570-9639(03)00237-1
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 726GT
UT WOS:000185591100009
PM 14499591
DA 2021-01-25
ER

PT J
AU Hoogenboom, BW
   Kadowaki, K
   Revaz, B
   Fischer, O
AF Hoogenboom, BW
   Kadowaki, K
   Revaz, B
   Fischer, O
TI Homogeneous samples of Bi2Sr2CaCu2O8+delta
SO PHYSICA C-SUPERCONDUCTIVITY AND ITS APPLICATIONS
LA English
DT Article
DE High-T-c superconductivity; Bi2Sr2CaCu2O8+delta; inhomogeneity
ID VACUUM TUNNELING SPECTROSCOPY; DENSITY-OF-STATES; INHOMOGENEITY; GAP
AB Recently, much attention has been paid to inhomogeneity in samples of the high-temperature superconductor Bi2Sr2CaCu2O8+delta. In this work it is shown that homogeneous samples can indeed be obtained in the slightly overdoped range. However, the homogeneity critically depends on sample preparation. (C) 2003 Elsevier B.V. All rights, reserved.
C1 Univ Geneva, DPMC, CH-1211 Geneva 4, Switzerland.
   Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RP Hoogenboom, BW (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM bart.hoogenboom@unibas.ch
RI Kadowaki, Kazuo/L-8660-2017
OI Kadowaki, Kazuo/0000-0002-9899-0094; Hoogenboom,
   Bart/0000-0002-8882-4324
CR Bozin ES, 2000, PHYS REV LETT, V84, P5856, DOI 10.1103/PhysRevLett.84.5856
   Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503
   CHANG A, 1992, PHYS REV B, V46, P5692, DOI 10.1103/PhysRevB.46.5692
   Cren T, 2001, EUROPHYS LETT, V54, P84, DOI 10.1209/epl/i2001-00232-4
   Cren T, 2000, PHYS REV LETT, V84, P147, DOI 10.1103/PhysRevLett.84.147
   Ding H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.227001
   EMERY VJ, 1990, PHYS REV LETT, V64, P475, DOI 10.1103/PhysRevLett.64.475
   FISCHER O, 1998, GAP SYMMETRY FLUCTUA
   GENOUD JY, 1996, THESIS U GENEVA
   Hoogenboom BW, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.224502
   Hoogenboom BW, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.267001
   Howald C, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.100504
   KENT AD, 1992, ULTRAMICROSCOPY, V42, P1632, DOI 10.1016/0304-3991(92)90497-8
   Lang KM, 2002, NATURE, V415, P412, DOI 10.1038/415412a
   LIU JX, 1991, PHYS REV LETT, V67, P2195, DOI 10.1103/PhysRevLett.67.2195
   Martin I, 2001, PHYSICA C, V357, P46, DOI 10.1016/S0921-4534(01)00192-7
   Ovchinnikov YN, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.064524
   Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012
   RENNER C, 1990, J VAC SCI TECHNOL A, V8, P330, DOI 10.1116/1.577100
   RENNER C, 1995, PHYS REV B, V51, P9208, DOI 10.1103/PhysRevB.51.9208
   RENNER C, 1994, PHYSICA B, V194, P1689, DOI 10.1016/0921-4526(94)91344-7
   Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149
   Wang ZQ, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.064509
NR 23
TC 18
Z9 18
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0921-4534
EI 1873-2143
J9 PHYSICA C
JI Physica C
PD SEP 15
PY 2003
VL 391
IS 4
BP 376
EP 380
DI 10.1016/S0921-4534(03)01087-6
PG 5
WC Physics, Applied; Physics, Condensed Matter
SC Physics
GA 716PH
UT WOS:000185037200009
DA 2021-01-25
ER

PT J
AU Krieger, F
   Fierz, B
   Bieri, O
   Drewello, M
   Kiefhaber, T
AF Krieger, F
   Fierz, B
   Bieri, O
   Drewello, M
   Kiefhaber, T
TI Dynamics of unfolded polypeptide chains as model for the earliest steps
   in protein folding
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; chain dynamics; intrachain diffusion; triplet-triplet
   transfer; unfolded proteins
ID INTRAMOLECULAR CONTACT FORMATION; TRIPLET ENERGY-TRANSFER; RANDOM COIL;
   KINETICS; SOLVENT; FLUORESCENCE; SIMULATIONS; TRANSITION; MOLECULES;
   XANTHONE
AB The rate of formation of intramolecular interactions in unfolded proteins determines how fast conformational space can be explored during folding. Characterization of the dynamics of unfolded proteins is therefore essential for the understanding of the earliest steps in protein folding. We used triplet-triplet energy transfer to measure formation of intrachain contacts in different unfolded polypeptide chains. The time constants (1/k) for contact formation over short distances are almost independent of chain length, with a maximum value of about 5 ns for flexible glycine-rich chains and of 12 ns for stiffer chains. The rates of contact formation over longer distances decrease with increasing chain length, indicating different rate-limiting steps for motions over short and long chain segments. The effect of the amino acid sequence on local chain dynamics was probed by using a series of host-guest peptides. Formation of local contacts is only sixfold slower around the stiffest amino acid (proline) compared to the most flexible amino acid (glycine). Good solvents for polypeptide chains like EtOH, GdmCl and urea were found to slow intrachain diffusion and to decrease chain stiffness. These data allow us to determine the time constants for formation of the earliest intrachain contacts during protein folding. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Max Planck Arbeitrgrp Enzymol Proteinfaltung, D-06120 Halle An Der Saale, Germany.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Fierz, Beat/H-3143-2012; Kiefhaber, Thomas/A-3028-2010
OI Fierz, Beat/0000-0002-2991-3044; 
CR ANDERSON RW, 1974, J CHEM PHYS, V61, P2500, DOI 10.1063/1.1682369
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   BRANT DA, 1965, J AM CHEM SOC, V87, P2791, DOI 10.1021/ja01091a003
   CAMACHO CJ, 1995, P NATL ACAD SCI USA, V92, P1277, DOI 10.1073/pnas.92.5.1277
   CLOSS GL, 1989, J AM CHEM SOC, V111, P3751, DOI 10.1021/ja00192a044
   DAMSCHEN DE, 1978, J PHYS CHEM-US, V82, P2268, DOI 10.1021/j100510a002
   Eaton WA, 1996, STRUCTURE, V4, P1133, DOI 10.1016/S0969-2126(96)00121-9
   Flory P. J., 1953, PRINCIPLES POLYM CHE
   Flory P.J., 1969, STAT MECH CHAIN MOL
   GARNER A, 1976, J CHEM SOC FARAD T 2, V72, P1010, DOI 10.1039/f29767201010
   Grabner G, 2000, J PHYS CHEM A, V104, P1365, DOI 10.1021/jp992468y
   GRAHAM R, 1978, J CHEM SOC PERK T 1, P876, DOI 10.1039/p19780000876
   Hudgins RR, 2002, J AM CHEM SOC, V124, P556, DOI 10.1021/ja010493n
   JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547
   Klessinger M., 1995, EXCITED STATES PHOTO
   Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v
   Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220
   LAPIDUS LJ, 2001, PHYS REV LETT, DOI UNSP 2581010-1-258101-4
   LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366
   Ley C, 2000, J PHOTOCH PHOTOBIO A, V137, P87, DOI 10.1016/S1010-6030(00)00374-9
   LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802
   MILLER WG, 1967, J MOL BIOL, V23, P67, DOI 10.1016/S0022-2836(67)80067-6
   Murov S. L., 1993, HDB PHOTOCHEMISTRY
   Pace C N, 1986, Methods Enzymol, V131, P266
   Pappu RV, 2000, P NATL ACAD SCI USA, V97, P12565, DOI 10.1073/pnas.97.23.12565
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031
   SCHIMMEL PR, 1967, P NATL ACAD SCI USA, V58, P52, DOI 10.1073/pnas.58.1.52
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   Sporlein S, 2002, P NATL ACAD SCI USA, V99, P7998, DOI 10.1073/pnas.122238799
   SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715
   Wagner PJ, 1999, J AM CHEM SOC, V121, P9626, DOI 10.1021/ja990224l
   WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9
   Yeh IC, 2002, J AM CHEM SOC, V124, P6563, DOI 10.1021/ja025789n
   ZHOU HX, 1991, J CHEM PHYS, V94, P6147, DOI 10.1063/1.460427
   ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390
   Zwanzig R, 1997, P NATL ACAD SCI USA, V94, P148, DOI 10.1073/pnas.94.1.148
NR 37
TC 219
Z9 220
U1 2
U2 26
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 5
PY 2003
VL 332
IS 1
BP 265
EP 274
DI 10.1016/S0022-2836(03)00892-1
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 716ND
UT WOS:000185034400023
PM 12946363
DA 2021-01-25
ER

PT J
AU Bayan, N
   Houssin, C
   Chami, M
   Leblon, G
AF Bayan, N
   Houssin, C
   Chami, M
   Leblon, G
TI Mycomembrane and S-layer: two important structures of Corynebacterium
   glutamicum cell envelope with promising biotechnology applications
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE S-layer; mycolic acid; arabinogalactan; porin
ID MYCOBACTERIUM-TUBERCULOSIS; SURFACE-LAYER; BIOPHYSICAL CHARACTERIZATION;
   PERMEABILITY BARRIER; MYCOLOYL RESIDUES; WALL PERMEABILITY; FORMING
   PROTEIN; FUSION PROTEIN; GENE; PORIN
AB Corynebacteria belong to a distinct Gram-positive group of bacteria including mycobacteria and nocardia, which are characterized by the presence of mycolic acids in their cell wall. These bacteria share the property of having an unusual cell envelope structural organization close to Gram-negative bacteria. In addition to the inner membrane, the cell envelope is constituted of a thick arabinogalactan-peptidoglycan polymer covalently linked to an outer lipid layer, which is mainly composed of mycolic acids and probably organized in an outer membrane like structure. In some species, the cell is covered by a crystalline surface layer composed of a single protein species, which is anchored in the outer membrane like barrier. An increasing number of reports have led to a better understanding of the structure of the cell wall of Corynebacterium glutamicum. These works included the characterization of several cell wall proteins like Slayer protein and porins, genetic and biochemical characterization of mycolic acids biosynthesis, ultrastructural description of the cell envelope, and chemical analysis of its constituents. All these data address new aspects regarding cell wall permeability towards macromolecules and aminoacids but also open new opportunities for biotechnology applications. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Paris 11, Inst Genet & Microbiol, Lab Biotechnol Microorganismes Interet Ind, F-91405 Orsay, France.
   Inst Pasteur, Unite Genet Mol, F-75724 Paris 15, France.
   Univ Basel, Biozentrum, ME Muller Inst Biomech, MSB, CH-4056 Basel, Switzerland.
RP Leblon, G (corresponding author), Univ Paris 11, Inst Genet & Microbiol, Lab Biotechnol Microorganismes Interet Ind, F-91405 Orsay, France.
EM leblon@igmors.u-psud.fr
RI Bayan, Nicolas/AAI-5034-2020
OI Bayan, Nicolas/0000-0001-7760-0811
CR Asselineau Jean, 1998, Frontiers in Bioscience, V3, pE164
   Bahl H, 1997, FEMS MICROBIOL REV, V20, P47, DOI 10.1016/S0168-6445(97)00050-8
   BARKSDALE L, 1977, BACTERIOL REV, V41, P217, DOI 10.1128/MMBR.41.1.217-372.1977
   Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3
   Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420
   Beveridge TJ, 1997, FEMS MICROBIOL REV, V20, P99, DOI 10.1016/S0168-6445(97)00043-0
   Breitwieser A, 2002, PROTEIN ENG, V15, P243, DOI 10.1093/protein/15.3.243
   Chami M, 1997, MOL MICROBIOL, V23, P483, DOI 10.1046/j.1365-2958.1997.d01-1868.x
   CHAMI M, 1995, BIOL CELL, V83, P219, DOI 10.1016/0248-4900(96)81311-6
   COLLINS MD, 1982, J GEN MICROBIOL, V128, P2503
   Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R
   Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131
   DATTA AK, 1993, BIOCHIM BIOPHYS ACTA, V1169, P135, DOI 10.1016/0005-2760(93)90198-I
   DEBRIEL D, 1992, J CLIN MICROBIOL, V30, P1407, DOI 10.1128/JCM.30.6.1407-1417.1992
   Dmitriev BA, 2000, INT J MED MICROBIOL, V290, P251
   Draper P, 1998, Front Biosci, V3, pD1253
   Eggeling L, 2001, J BIOSCI BIOENG, V92, P201, DOI 10.1263/jbb.92.201
   Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070
   Engelhardt H, 2002, J BIOL CHEM, V277, P37567, DOI 10.1074/jbc.M206983200
   GAILLY C, 1982, EUR J BIOCHEM, V125, P83, DOI 10.1111/j.1432-1033.1982.tb06654.x
   Hermann T, 1998, ELECTROPHORESIS, V19, P3217, DOI 10.1002/elps.1150191827
   Hermann T, 2000, ELECTROPHORESIS, V21, P654, DOI 10.1002/(SICI)1522-2683(20000201)21:3<654::AID-ELPS654>3.0.CO;2-1
   Hermann T, 2001, ELECTROPHORESIS, V22, P1712, DOI 10.1002/1522-2683(200105)22:9<1712::AID-ELPS1712>3.0.CO;2-G
   Houssin C, 2002, FEMS MICROBIOL LETT, V217, P71, DOI 10.1016/S0378-1097(02)01035-2
   HUCHENQ A, 1983, BIOCHEMISTRY
   Ilk N, 2002, APPL ENVIRON MICROB, V68, P3251, DOI 10.1128/AEM.68.7.3251-3260.2002
   Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x
   JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990
   JOLIFF G, 1992, MOL MICROBIOL, V6, P2349, DOI 10.1111/j.1365-2958.1992.tb01410.x
   Kartmann B, 1999, J BACTERIOL, V181, P6543, DOI 10.1128/JB.181.20.6543-6546.1999
   KREMER L, 2000, MOL GENETICS MYCOBAC, P203
   Lapujade P, 1999, METAB ENG, V1, P255, DOI 10.1006/mben.1999.0129
   Lee RE, 1997, BBA-LIPID LIPID MET, V1346, P275, DOI 10.1016/S0005-2760(97)00051-9
   Lichtinger T, 2001, EUR J BIOCHEM, V268, P462
   Lichtinger T, 1998, BIOCHEMISTRY-US, V37, P15024, DOI 10.1021/bi980961e
   LIEBL W, 1991, PROKARYOTES, V2, P1157
   Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545
   Marienfeld S, 1997, ANTON LEEUW INT J G, V72, P291, DOI 10.1023/A:1000578811089
   Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x
   MCNEIL MR, 1991, RES MICROBIOL, V142, P451, DOI 10.1016/0923-2508(91)90120-Y
   Mdluli K, 1998, MOL MICROBIOL, V27, P1223, DOI 10.1046/j.1365-2958.1998.00774.x
   Mesnage S, 1999, INFECT IMMUN, V67, P4847, DOI 10.1128/IAI.67.9.4847-4850.1999
   Mesnage S, 1999, J APPL MICROBIOL, V87, P256, DOI 10.1046/j.1365-2672.1999.00880.x
   Minnikin D.E., 1982, BIOL MYCOBACTERIA, P95
   Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4
   Moll D, 2002, P NATL ACAD SCI USA, V99, P14646, DOI 10.1073/pnas.232299399
   Mukhopadhyay S, 1997, J BACTERIOL, V179, P6205, DOI 10.1128/jb.179.19.6205-6207.1997
   Nampoothiri KM, 2002, APPL MICROBIOL BIOT, V58, P89, DOI 10.1007/s00253-001-0861-z
   Nguyen DT, 2001, FEMS MICROBIOL LETT, V201, P145, DOI 10.1016/S0378-1097(01)00254-3
   Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x
   NIEDERWEIS M, 1995, J BACTERIOL, V177, P5716, DOI 10.1128/jb.177.19.5716-5718.1995
   NIKAIDO H, 1993, MOL MICROBIOL, V8, P1025, DOI 10.1111/j.1365-2958.1993.tb01647.x
   PAUL TR, 1992, J BACTERIOL, V174, P6508, DOI 10.1128/JB.174.20.6508-6517.1992
   PEYRET JL, 1993, MOL MICROBIOL, V9, P97, DOI 10.1111/j.1365-2958.1993.tb01672.x
   Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x
   Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365
   Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x
   RASTOGI N, 1986, CURR MICROBIOL, V13, P237, DOI 10.1007/BF01568645
   RASTOGI N, 1991, RES MICROBIOL, V142, P464, DOI 10.1016/0923-2508(91)90121-P
   Raynaud C, 2002, MOL MICROBIOL, V46, P191, DOI 10.1046/j.1365-2958.2002.03152.x
   RICHTER W, 1985, J BASIC MICROB, V25, P527, DOI 10.1002/jobm.3620250818
   Riess FG, 1998, MOL MICROBIOL, V29, P139, DOI 10.1046/j.1365-2958.1998.00914.x
   Salim K, 1997, APPL ENVIRON MICROB, V63, P4392, DOI 10.1128/AEM.63.11.4392-4400.1997
   Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000
   Sara M, 2001, TRENDS MICROBIOL, V9, P47, DOI 10.1016/S0966-842X(00)01905-3
   SAXTON WO, 1986, J MOL BIOL, V20, P251
   Schaffer S, 2001, ELECTROPHORESIS, V22, P4404, DOI 10.1002/1522-2683(200112)22:20<4404::AID-ELPS4404>3.0.CO;2-2
   Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x
   SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329
   Senaratne RH, 1998, J BACTERIOL, V180, P3541, DOI 10.1128/JB.180.14.3541-3547.1998
   Shimakata T, 2000, ARCH BIOCHEM BIOPHYS, V380, P331, DOI 10.1006/abbi.2000.1924
   Sleytr UB, 1997, FEMS MICROBIOL REV, V20, P151, DOI 10.1016/S0168-6445(97)00044-2
   Sleytr UB, 1997, TRENDS BIOTECHNOL, V15, P20, DOI 10.1016/S0167-7799(96)10063-9
   Soual-Hoebeke E, 1999, MICROBIOL-UK, V145, P3399, DOI 10.1099/00221287-145-12-3399
   Stackebrandt E, 1997, INT J SYST BACTERIOL, V47, P479, DOI 10.1099/00207713-47-2-479
   Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x
   TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x
   TRIAS J, 1993, J BIOL CHEM, V14, P283
   Wang L, 2000, J BIOL CHEM, V275, P7224, DOI 10.1074/jbc.275.10.7224
   Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0
NR 80
TC 57
Z9 63
U1 1
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD SEP 4
PY 2003
VL 104
IS 1-3
BP 55
EP 67
DI 10.1016/S0168-1656(03)00163-9
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 721FN
UT WOS:000185306500005
PM 12948629
DA 2021-01-25
ER

PT J
AU Handschin, C
   Podvinec, M
   Meyer, UA
AF Handschin, C
   Podvinec, M
   Meyer, UA
TI In silico approaches, and in vitro and in vivo experiments to predict
   induction of drug metabolism
SO DRUG NEWS & PERSPECTIVES
LA English
DT Review
ID PREGNANE-X-RECEPTOR; CONSTITUTIVE-ANDROSTANE RECEPTOR; ORPHAN NUCLEAR
   RECEPTORS; PROLIFERATOR-ACTIVATED RECEPTOR; REPORTER GENE ASSAY;
   XENOBIOTIC RECEPTOR; PHENOBARBITAL INDUCTION; HORMONE-RECEPTORS; HUMAN
   LIVER; TRANSCRIPTION FACTORS
AB Despite being described more than 40 years ago, the molecular mechanism that regulates hepatic induction of cytochromes P450 and other drug-metabolizing enzymes and drug transporters by xenobiotics has remained enigmatic until recently. A major breakthrough was the discovery of the orphan nuclear receptors pregnane X receptor and constitutive androstane receptor playing key roles as species-specific xenosensors in this induction response. Using this newly acquired knowledge, the human induction response can now be more accurately predicted. This is of considerable clinical importance, since induction of cytochrome P450s and other enzymes can lead to unwanted drug-drug interactions, adverse drug reactions and drug toxicity. In this review, in vitro, in vivo and in silico techniques are discussed that can identify troublesome compounds at an early stage and that can help to design new, safer medicines faster. (C) 2003 Prous Science. All rights reserved.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
EM christoph_handschin@dfci.harvard.edu
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR Akiyama TE, 2003, BBA-GEN SUBJECTS, V1619, P223, DOI 10.1016/S0304-4165(02)00480-4
   Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1
   Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388
   Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149
   Bodin K, 2001, J BIOL CHEM, V276, P38685, DOI 10.1074/jbc.M105127200
   Bodin K, 2002, J BIOL CHEM, V277, P31534, DOI 10.1074/jbc.M201712200
   Burk O, 2002, J BIOL CHEM, V277, P24280, DOI 10.1074/jbc.M202345200
   Corcos L, 2001, PHARMACOL TOXICOL, V89, P113, DOI 10.1034/j.1600-0773.2001.d01-144.x
   DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175
   Drocourt L, 2001, DRUG METAB DISPOS, V29, P1325
   Duarte J, 2002, NUCLEIC ACIDS RES, V30, P364, DOI 10.1093/nar/30.1.364
   Dussault I, 2002, MOL CELL BIOL, V22, P5270, DOI 10.1128/MCB.22.15.5270-5280.2002
   Dussault I, 2001, J BIOL CHEM, V276, P33309, DOI 10.1074/jbc.C100375200
   Eidne KA, 2002, TRENDS ENDOCRIN MET, V13, P415, DOI 10.1016/S1043-2760(02)00669-0
   Ekins S, 2002, TRENDS PHARMACOL SCI, V23, P49, DOI 10.1016/S0165-6147(02)01977-6
   Ekins S, 2002, DRUG METAB DISPOS, V30, P96, DOI 10.1124/dmd.30.1.96
   Ekins S, 2002, PHARM RES-DORDR, V19, P1788, DOI 10.1023/A:1021429105173
   El-Sankary W, 2001, DRUG METAB DISPOS, V29, P1499
   Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996
   Forman BM, 2001, PHARMACOGENETICS, V11, P551, DOI 10.1097/00008571-200110000-00001
   Frueh FW, 1997, MOL PHARMACOL, V51, P363
   Furster C, 1999, BBA-MOL CELL BIOL L, V1437, P46, DOI 10.1016/S0005-2760(98)00175-1
   Gerhold DL, 2002, NAT GENET, V32, P547, DOI 10.1038/ng1042
   Gillam EMJ, 2001, TRENDS PHARMACOL SCI, V22, P448, DOI 10.1016/S0165-6147(00)01847-2
   Glockner R, 2002, TOXICOLOGY, V176, P187, DOI 10.1016/S0300-483X(02)00136-1
   Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163
   Honkakoski P, 1996, J BIOL CHEM, V271, P9746, DOI 10.1074/jbc.271.16.9746
   Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   Honkakoski P, 2001, PHARMACEUT RES, V18, P146, DOI 10.1023/A:1011068015301
   Hustert E, 2001, DRUG METAB DISPOS, V29, P1454
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   Johnson EF, 1996, FASEB J, V10, P1241
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Jones SA, 2002, METHOD ENZYMOL, V357, P161
   Jover R, 2002, FASEB J, V16, P1799, DOI 10.1096/fj.02-0195fje
   Kakizaki S, 2003, BBA-GEN SUBJECTS, V1619, P239, DOI 10.1016/S0304-4165(02)00482-8
   Karpen SJ, 2002, J HEPATOL, V36, P832, DOI 10.1016/S0168-8278(02)00129-0
   Kawamoto T, 1999, MOL CELL BIOL, V19, P6318
   Kemper B, 1998, PROG NUCLEIC ACID RE, V61, P25, DOI 10.1016/S0079-6603(08)60824-7
   Kirton SB, 2002, ADV DRUG DELIVER REV, V54, P385, DOI 10.1016/S0169-409X(02)00010-8
   Kliewer SA, 1999, RECENT PROG HORM RES, V54, P345
   Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038
   Kliewer SA, 2002, J LIPID RES, V43, P359
   Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757
   KOCAREK TA, 1995, DRUG METAB DISPOS, V23, P415
   Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779
   LeCluyse EL, 2001, EUR J PHARM SCI, V13, P343, DOI 10.1016/S0928-0987(01)00135-X
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953
   Liddle C, 2002, SEMIN LIVER DIS, V22, P115, DOI 10.1055/s-2002-30098
   Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363
   Luo G, 2002, DRUG METAB DISPOS, V30, P795, DOI 10.1124/dmd.30.7.795
   Lupp A, 2001, TOXICOLOGY, V161, P53, DOI 10.1016/S0300-483X(01)00333-X
   Ma Q, 2001, CURR DRUG METAB, V2, P149, DOI 10.2174/1389200013338603
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   Masahiko N, 2000, EUR J PHARM SCI, V11, P259, DOI 10.1016/S0928-0987(00)00112-3
   Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6
   Moore JT, 2000, TOXICOLOGY, V153, P1, DOI 10.1016/S0300-483X(00)00300-0
   Moore JT, 2003, BBA-GEN SUBJECTS, V1619, P235, DOI 10.1016/S0304-4165(02)00481-6
   Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097
   Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200
   Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977
   Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   Ourlin JC, 2002, BIOCHEM BIOPH RES CO, V291, P378, DOI 10.1006/bbrc.2002.6464
   Pan J, 2002, XENOBIOTICA, V32, P739, DOI 10.1080/00498250210147115
   Pascussi JM, 2003, BBA-GEN SUBJECTS, V1619, P243, DOI 10.1016/S0304-4165(02)00483-X
   Pelkonen O, 1998, XENOBIOTICA, V28, P1203, DOI 10.1080/004982598238886
   Pelkonen O, 2002, E SCHERING RES FDN W, V37, P105
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   Raucy J, 2002, J PHARMACOL EXP THER, V303, P412, DOI 10.1124/jpet.102.038653
   Repa JJ, 1999, CURR OPIN BIOTECH, V10, P557, DOI 10.1016/S0958-1669(99)00031-2
   Sapone A, 2002, TRENDS PHARMACOL SCI, V23, P260, DOI 10.1016/S0165-6147(02)02047-3
   Savas U, 1999, MOL PHARMACOL, V56, P851
   Schuetz E, 2002, MOL PHARMACOL, V62, P439, DOI 10.1124/mol.62.3.439
   Schuetz EG, 1998, MOL PHARMACOL, V54, P1113
   Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200
   Smith DA, 2000, EUR J PHARM SCI, V11, P185, DOI 10.1016/S0928-0987(00)00107-X
   Sueyoshi T, 2002, METHOD ENZYMOL, V357, P205
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912
   Tucker G T, 2001, Eur J Pharm Sci, V13, P417
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   van Giersbergen PLM, 2002, EUR J PHARMACOL, V450, P115, DOI 10.1016/S0014-2999(02)02075-7
   Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762
   WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087
   Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112
   Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753
   Willson TM, 2001, MED RES REV, V21, P513, DOI 10.1002/med.1023
   Xiao L, 2002, DRUG METAB DISPOS, V30, P951, DOI 10.1124/dmd.30.9.951
   Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116
   Xie W, 2002, DRUG DISCOV TODAY, V7, P509, DOI 10.1016/S1359-6446(02)02251-1
   Young RR, 2002, TOXICOLOGY, V173, P103, DOI 10.1016/S0300-483X(02)00026-4
   Yuan R, 2002, DRUG METAB DISPOS, V30, P1311, DOI 10.1124/dmd.30.12.1311
   Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001
   Zelko I, 2000, BIOCHEM BIOPH RES CO, V277, P1, DOI 10.1006/bbrc.2000.3557
   Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502
   Zhang J, 2001, PHARMACOGENETICS, V11, P555, DOI 10.1097/00008571-200110000-00003
NR 107
TC 7
Z9 10
U1 0
U2 1
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 0214-0934
EI 2013-0139
J9 DRUG NEWS PERSPECT
JI Drug News Perspect.
PD SEP
PY 2003
VL 16
IS 7
BP 423
EP 434
DI 10.1358/dnp.2003.16.7.829354
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 743QM
UT WOS:000186585100003
PM 14668938
DA 2021-01-25
ER

PT J
AU Seubert, A
   Hiestand, R
   de la Cruz, F
   Dehio, C
AF Seubert, A
   Hiestand, R
   de la Cruz, F
   Dehio, C
TI A bacterial conjugation machinery recruited for pathogenesis
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID MULTIPLE SEQUENCE ALIGNMENT; HELICOBACTER-PYLORI CAGA; IV SECRETION
   MACHINERY; GRAM-NEGATIVE BACTERIA; INCW PLASMID R388;
   BARTONELLA-HENSELAE; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI;
   AGROBACTERIUM-TUMEFACIENS; VIRB OPERON
AB Type IV secretion systems (T4SS) are multicomponent transporters of Gram-negative bacteria adapted to functions as diverse as DNA transfer in bacterial conjugation or the delivery of effector proteins into eukaryotic target cells in pathogenesis. The generally modest sequence conservation between T4SS may reflect their evolutionary distance and/or functional divergence. Here, we show that the establishment of intraerythrocytic parasitism by Bartonella tribocorum requires a putative T4SS, which shares an unprecedented level of sequence identity with the Trw conjugation machinery of the broad-host-range antibiotic resistance plasmid R388 (up to 80% amino acid identity for individual T4SS components). The highly conserved T4SS loci are collinear except for the presence of numerous tandem gene duplications in B. tribocorum, which mostly encode variant forms of presumed surface-exposed pilus subunits. Conservation is not only structural, but also functional: R388 mutated in either trwD or trwH encoding essential T4SS components could be trans-complemented for conjugation by the homologues of the B. tribocorum system. Conservation also includes the transcription regulatory circuit: both T4SS loci encode a highly homologous and interchangeable KorA/KorB repressor system that negatively regulates the expression of all T4SS components. This striking example of adaptive evolution reveals the capacity of T4SS to assume dedicated functions in either DNA transfer or pathogenesis over rather short evolutionary distance and implies a novel role for the conjugation systems of widespread broad-host-range plasmids in the evolution of bacterial pathogens.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Cantabria, Dept Biol Mol, Santander 39011, Spain.
   CSIC, CIB, Unidad Asociada, Madrid, Spain.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Dehio, Christoph/R-8277-2016; de la Cruz, Fernando/L-2812-2014; Dehio,
   Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; de la Cruz,
   Fernando/0000-0003-4758-6857; Dehio, Christoph/0000-0001-7288-1052;
   Seubert, Anja/0000-0003-3321-9140
CR Baron C, 2002, MOL MICROBIOL, V43, P1359, DOI 10.1046/j.1365-2958.2002.02816.x
   BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I
   BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990
   BOLLAND S, 1991, THESIS U CANTABRIA S
   Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299
   BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929
   Cao TB, 2001, MICROBIOL-SGM, V147, P3201, DOI 10.1099/00221287-147-12-3201
   Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x
   Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3
   Dang TA, 1999, MOL MICROBIOL, V32, P1239, DOI 10.1046/j.1365-2958.1999.01436.x
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347
   Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x
   Kihara D, 2000, GENOME RES, V10, P731, DOI 10.1101/gr.10.6.731
   Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699
   Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x
   More MI, 1996, J BACTERIOL, V178, P4392, DOI 10.1128/jb.178.15.4392-4399.1996
   Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025
   Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497
   Ohashi N, 2002, INFECT IMMUN, V70, P2128, DOI 10.1128/IAI.70.4.2128-2138.2002
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583
   Sagulenko E, 2001, J BACTERIOL, V183, P5813, DOI 10.1128/JB.183.20.5813-5825.2001
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999
   Schmiederer M, 2001, INFECT IMMUN, V69, P6495, DOI 10.1128/IAI.69.10.6495-6502.2001
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Seubert A, 2003, PLASMID, V49, P44, DOI 10.1016/S0147-619X(02)00103-8
   SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583
   STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987
   Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007
NR 41
TC 96
Z9 102
U1 0
U2 11
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD SEP
PY 2003
VL 49
IS 5
BP 1253
EP 1266
DI 10.1046/j.1365-2958.2003.03650.x
PG 14
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 717UX
UT WOS:000185110100009
PM 12940985
OA Bronze
DA 2021-01-25
ER

PT J
AU Ohnishi, K
   Melchers, F
AF Ohnishi, K
   Melchers, F
TI The nonimmunoglobulin portion of lambda 5 mediates cell-autonomous pre-B
   cell receptor signaling
SO NATURE IMMUNOLOGY
LA English
DT Article
ID SURROGATE LIGHT-CHAIN; MU-HEAVY-CHAIN; BONE-MARROW; REPERTOIRE
   SELECTION; ALLELIC EXCLUSION; DEFICIENT MICE; SURFACE; COMPLEX; MOUSE;
   DIFFERENTIATION
AB The pre-B cell receptor (preBCR), composed of mu immunoglobulin (Ig) and surrogate light chains, signals large 'preB-II' cells to proliferate in the apparent absence of ligands or cooperating cells. We deleted the N-terminal, nonimmunoglobulin (nonlg) portion of lambda5, or mutated seven arginine residues in it to serine residues. PreBCRs with such mutant lambda5 proteins showed increased cell surface representation and a diminished rate of aggregation and internalization. Tyrosine phosphorylation of preBCR complexes containing mutant lambda5 proteins was abolished. These results indicate that the nonIg portion of lambda5, and the seven arginine residues in it, are needed for signal transduction, and that signaling could be cell autonomous. We propose two models to explain the apparently constitutive, ligand-independent signal-transducing capacity of the preBCR.
C1 Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Ohnishi, K (corresponding author), Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.
CR Bradl H, 2001, J IMMUNOL, V167, P6403, DOI 10.4049/jimmunol.167.11.6403
   Ceredig R, 2000, EUR J IMMUNOL, V30, P759, DOI 10.1002/1521-4141(200003)30:3<759::AID-IMMU759>3.0.CO;2-M
   CHAMBERS JD, 1993, J LEUKOCYTE BIOL, V53, P462
   Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862
   FUHRMANN U, 1984, NATURE, V307, P755, DOI 10.1038/307755a0
   Gauthier L, 1999, J IMMUNOL, V162, P41
   GUELPAFONLUPT V, 1994, MOL IMMUNOL, V31, P1099, DOI 10.1016/0161-5890(94)90105-8
   Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8
   Hartley D, 1996, J BIOL CHEM, V271, P21939, DOI 10.1074/jbc.271.36.21939
   Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697
   Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469
   KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0
   KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969
   KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L
   KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0
   LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I
   LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610
   Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1034/j.1600-065X.2000.017510.x
   MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X
   Melchers F, 1999, P NATL ACAD SCI USA, V96, P2571, DOI 10.1073/pnas.96.6.2571
   Minegishi Y, 1999, P NATL ACAD SCI USA, V96, P3041, DOI 10.1073/pnas.96.6.3041
   Muljo SA, 2002, INT IMMUNOL, V14, P577, DOI 10.1093/intimm/dxf023
   Mundt C, 2001, J EXP MED, V193, P435, DOI 10.1084/jem.193.4.435
   OHNISHI K, 1994, J BIOL CHEM, V269, P28347
   Reichlin A, 2001, J EXP MED, V193, P13, DOI 10.1084/jem.193.1.13
   ROLINK A, 1993, J EXP MED, V178, P1263, DOI 10.1084/jem.178.4.1263
   Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23
   Shaffer AL, 1997, J IMMUNOL, V159, P1265
   Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286
   Silverman GJ, 2000, J EXP MED, V192, P87, DOI 10.1084/jem.192.1.87
   TAKEMORI T, 1987, EMBO J, V6, P951, DOI 10.1002/j.1460-2075.1987.tb04844.x
   tenBoekel E, 1997, IMMUNITY, V7, P357
   TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973
   Wasserman R, 1998, J EXP MED, V187, P259, DOI 10.1084/jem.187.2.259
   WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221
   WINKLER TH, 1995, BLOOD, V85, P2045, DOI 10.1182/blood.V85.8.2045.bloodjournal8582045
NR 38
TC 129
Z9 133
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD SEP
PY 2003
VL 4
IS 9
BP 849
EP 856
DI 10.1038/ni959
PG 8
WC Immunology
SC Immunology
GA 715YN
UT WOS:000185002200011
PM 12897780
DA 2021-01-25
ER

PT J
AU Treves, S
   Sewry, C
   Quinlivan, R
   Muntoni, F
   Muller, CR
   Girard, T
   Ducreux, S
   Zorzato, F
AF Treves, S
   Sewry, C
   Quinlivan, R
   Muntoni, F
   Muller, CR
   Girard, T
   Ducreux, S
   Zorzato, F
TI Mutations in the skeletal muscle calcium channel (ryanodine receptor)
   linked to central core disease. Impact on the functional properties of
   the endogenous calcium release channel in cultured human muscle cells
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 8th International Congress of the World-Muscle-Society
CY SEP 03-06, 2003
CL SZEGED, HUNGARY
SP World Muscle Soc
C1 Kantonsspital, Dept Anaesthesie & Forsch, CH-4031 Basel, Switzerland.
   Univ London Imperial Coll Sci Technol & Med, Dubowitz Neuromuscular Unit, London W12 0NN, England.
   Robert Jones & Agnes Hunt Orthopaed Hosp, Neuromuscular Ctr, Oswestry SY10 7AG, Shrops, England.
   Univ Wurzburg, Biozentrum, Inst Human Genet, D-97074 Wurzburg, Germany.
   Univ Ferrara, Dipartimento Med Sperimentale & Diagnost, I-44100 Ferrara, Italy.
RI DUCREUX, SYLVIE/D-6257-2013
OI DUCREUX, SYLVIE/0000-0003-3207-9537
NR 0
TC 0
Z9 0
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP
PY 2003
VL 13
IS 7-8
BP 627
EP 628
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 716AX
UT WOS:000185007600054
DA 2021-01-25
ER

PT J
AU Schamel, WWA
   Kuppig, S
   Becker, B
   Gimborn, K
   Hauri, HP
   Reth, M
AF Schamel, WWA
   Kuppig, S
   Becker, B
   Gimborn, K
   Hauri, HP
   Reth, M
TI A high-molecular-weight complex of membrane proteins BAP29/BAP31 is
   involved in the retention of membrane-bound IgD in the endoplasmic
   reticulum
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CELL ANTIGEN RECEPTOR; IMMUNOGLOBULIN HEAVY-CHAIN; SIGNAL-TRANSDUCTION;
   BINDING-PROTEIN; CYTOPLASMIC DOMAINS; ACCESSORY PROTEINS; SURFACE
   EXPRESSION; MU-TRANSMEMBRANE; ALPHA; BETA
AB B cell antigen receptors (BCRs) are multimeric transmembrane protein complexes comprising membrane-bound immunoglobulins (mIgs) and Ig-alpha/Ig-beta heterodimers. In most cases, transport of migs from the endoplasmic reticulum (ER) to the cell surface requires assembly with the Ig-alpha/Ig-beta subunits. In addition to Ig-alpha/Ig-beta, mIg molecules also bind two ER-resident membrane proteins, BAP29 and BAP31, and the chaperone heavy chain binding protein (BiP). In this article, we show that neither Ig-alpha/Ig-beta nor BAP29/BAP31 nor BiP bind simultaneously to the same mIgD molecule. Blue native PAGE revealed that only a minor fraction of intracellular mIgD is associated with high-molecular-weight BAP29/BAP31 complexes. BAP-binding to mIgs was found to correlate with ER retention of chimeric mIgD molecules. On high-level expression in Drosophila melanogaster S2 cells, mIgD molecules were detected on the cell surface in the absence of Ig-alpha/Ig-beta. This aberrant transport was prevented by coexpression of BAP29 and BAP31. Thus, BAP complexes contribute to ER retention of mIg complexes that are not bound to Ig-alpha/Ig-beta. Furthermore, the mechanism of ER retention of both BAP31 and mIgD is not through retrieval from a post-ER compartment, but true ER retention. In conclusion, BAP29 and BAP31 might be the long sought after retention proteins and/or chaperones that act on transmembrane regions of various proteins.
C1 Univ Freiburg, Dept Mol Immunol, D-79108 Freiburg, Germany.
   Univ Basel, Biozentrum, Dept Pharmacol, CH-4056 Basel, Switzerland.
RP Reth, M (corresponding author), Max Planck Inst Immunobiol, Stubeweg 51, D-79108 Freiburg, Germany.
CR Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x
   Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397
   Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9
   BLUM JH, 1993, J BIOL CHEM, V268, P27236
   BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558
   Breckenridge DG, 2002, P NATL ACAD SCI USA, V99, P4331, DOI 10.1073/pnas.072088099
   BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043
   Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049
   CHERAYIL BJ, 1993, J IMMUNOL, V151, P11
   FLASWINKEL H, 1994, EMBO J, V13, P83, DOI 10.1002/j.1460-2075.1994.tb06237.x
   GRUPP SA, 1993, J BIOL CHEM, V268, P25776
   HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0
   HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829
   Ho SC, 2000, J IMMUNOL, V164, P4713, DOI 10.4049/jimmunol.164.9.4713
   HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x
   KALOFF CR, 1995, IMMUNITY, V2, P629, DOI 10.1016/1074-7613(95)90007-1
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Lambert G, 2001, J BIOL CHEM, V276, P20340, DOI 10.1074/jbc.M011209200
   MATSUUCHI L, 1992, P NATL ACAD SCI USA, V89, P3404, DOI 10.1073/pnas.89.8.3404
   MELNICK J, 1995, IMMUNOL TODAY, V16, P243, DOI 10.1016/0167-5699(95)80167-7
   Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327
   Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444
   O'Hare T, 1999, J IMMUNOL, V163, P11
   PATEL KJ, 1993, CELL, V74, P939, DOI 10.1016/0092-8674(93)90473-4
   RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0
   RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525
   RETH M, 1979, EUR J IMMUNOL, V9, P1004, DOI 10.1002/eji.1830091216
   Reth M, 2000, IMMUNOL REV, V176, P10
   Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6
   SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049
   Sanders CR, 2000, CURR OPIN STRUC BIOL, V10, P438, DOI 10.1016/S0959-440X(00)00112-3
   Schamel WWA, 2000, MOL IMMUNOL, V37, P253, DOI 10.1016/S0161-5890(00)00025-0
   Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0
   SHAW AC, 1990, CELL, V63, P381, DOI 10.1016/0092-8674(90)90171-A
   STEVENS TL, 1994, J IMMUNOL, V152, P4397
   Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27
   TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x
   VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0
   WEISER P, 1994, EUR J IMMUNOL, V24, P665, DOI 10.1002/eji.1830240327
   WIENANDS J, 1991, EUR J IMMUNOL, V21, P2373, DOI 10.1002/eji.1830211012
   Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865
   WIENANDS J, 1990, EMBO J, V9, P449, DOI 10.1002/j.1460-2075.1990.tb08130.x
   WIENANDS J, 1999, B CELL ANTIGEN RECEP
   WILLIAMS GT, 1993, MOL IMMUNOL, V30, P1427, DOI 10.1016/0161-5890(93)90104-J
   WILLIAMS GT, 1990, J EXP MED, V171, P947, DOI 10.1084/jem.171.3.947
   Wu YJ, 1997, J IMMUNOL, V158, P2762
NR 48
TC 66
Z9 68
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 19
PY 2003
VL 100
IS 17
BP 9861
EP 9866
DI 10.1073/pnas.1633363100
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 714QY
UT WOS:000184926000043
PM 12886015
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Morsomme, P
   Prescianotto-Baschong, C
   Riezman, H
AF Morsomme, P
   Prescianotto-Baschong, C
   Riezman, H
TI The ER v-SNAREs are required for GPI-anchored protein sorting from other
   secretory proteins upon exit from the ER
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
DE membrane trafficking; SNARE; protein sorting; GPI; ER to Golgi
ID ENDOPLASMIC-RETICULUM; TRANSPORT VESICLES; MEMBRANE-PROTEIN;
   GOLGI-APPARATUS; COPII VESICLES; LIPID RAFTS; FUSION; YEAST; COMPLEX;
   DOCKING
AB Glycosylphosphatidylinositol (GPI)-anchored proteins exit the ER in distinct vesicles from other secretory proteins, and this sorting event requires the Rab GTPase Ypt1p, tethering factors Uso1p, and the conserved oligomeric Golgi complex. Here we show that proper sorting depended on the vSNAREs, Bos1p, Bet1p, and Sec22p. However, the t-SNARE Sed5p was not required for protein sorting upon ER exit. Moreover, the sorting defect observed in vitro with bos1-1 extracts was also observed in vivo and was visualized by EM. Finally, transport and maturation of the GPI-anchored protein Gas1p was specifically affected in a bos1-1 mutant at semirestrictive temperature. Therefore, we propose that v-SNAREs are part of the cargo protein sorting machinery upon exit from the ER and that a correct sorting process is necessary for proper maturation of GPI-anchored proteins.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Riezman, H (corresponding author), Univ Geneva, Dept Biochem, Sci 2,30 Quai E Ansermet, CH-1211 Geneva, Switzerland.
RI Morsomme, Pierre/AAD-9600-2019
OI Morsomme, Pierre/0000-0001-7780-7230; Riezman,
   Howard/0000-0003-4680-9422
CR Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444
   Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697
   Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156
   Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791
   Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398
   Christoforidis S, 1999, NATURE, V397, P621
   Doering TL, 1996, EMBO J, V15, P182, DOI 10.1002/j.1460-2075.1996.tb00346.x
   Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585
   Kuehn MJ, 1998, NATURE, V391, P187
   Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734
   Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202
   LIAN JP, 1993, CELL, V73, P735, DOI 10.1016/0092-8674(93)90253-M
   LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0
   Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204
   Matsuoka K, 1998, MOL CELL, V2, P703, DOI 10.1016/S1097-2765(00)80168-9
   McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2
   McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1
   Morsomme P, 2002, DEV CELL, V2, P307, DOI 10.1016/S1534-5807(02)00133-8
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27
   Prescianotto-Baschong C, 2002, TRAFFIC, V3, P37, DOI 10.1034/j.1600-0854.2002.30106.x
   SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x
   Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526
   Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200
   Simonsen A, 1998, NATURE, V394, P494
   Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698
   Sutterlin C, 1997, J CELL SCI, V110, P2703
   van IJzendoorn SCD, 2002, DEV CELL, V2, P219, DOI 10.1016/S1534-5807(02)00115-6
   VanRheenen SM, 1999, J CELL BIOL, V147, P729, DOI 10.1083/jcb.147.4.729
   VanRheenen SM, 1998, J CELL BIOL, V141, P1107, DOI 10.1083/jcb.141.5.1107
   VANTUINEN E, 1987, J HISTOCHEM CYTOCHEM, V35, P327, DOI 10.1177/35.3.3546482
   Watanabe R, 2002, J BIOL CHEM, V277, P49538, DOI 10.1074/jbc.M206209200
NR 33
TC 52
Z9 53
U1 0
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0021-9525
J9 J CELL BIOL
JI J. Cell Biol.
PD AUG 4
PY 2003
VL 162
IS 3
BP 403
EP 412
DI 10.1083/jcb.200212101
PG 10
WC Cell Biology
SC Cell Biology
GA 710EM
UT WOS:000184667900006
PM 12885760
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Kammermeier, L
   Spring, J
   Stierwald, M
   Burgunder, JM
   Reichert, H
AF Kammermeier, L
   Spring, J
   Stierwald, M
   Burgunder, JM
   Reichert, H
TI Identification of the Drosophila melanogaster homolog of the human
   spastin gene
SO DEVELOPMENT GENES AND EVOLUTION
LA English
DT Article
DE Drosophila melanogaster; spastin; AAA domain; embryonic CNS
ID PARAPLEGIA; PROTEIN; MUTATIONS; SEQUENCE; DOMAIN
AB The human SPG4 locus encodes the spastin gene, which is responsible for the most prevalent form of autosomal dominant hereditary spastic paraplegia (AD-HSP), a neurodegenerative disorder. Here we identify the predicted gene product CG5977 as the Drosophila homolog of the human spastin gene, with much higher sequence similarities than any other related AAA domain protein in the fly. Furthermore we report a new potential transmembrane domain in the N-terminus of the two homologous proteins. During embryogenesis, the expression pattern of Drosophila spastin becomes restricted primarily to the central nervous system, in contrast to the ubiquitous expression of the vertebrate spastin genes. Given this nervous system-specific expression, it will be important to determine if Drosophila spastin loss-of-function mutations also lead to neurodegeneration.
C1 Univ Basel, Inst Zool, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   Natl Univ Singapore, Singapore 308433, Singapore.
   Natl Inst Neurosci, Singapore 308433, Singapore.
RP Kammermeier, L (corresponding author), Univ Basel, Inst Zool, Biozentrum, Pharmazentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4
   Charvin D, 2003, HUM MOL GENET, V12, P71, DOI 10.1093/hmg/ddg004
   Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9
   Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923
   Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153
   Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472
   Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242
   Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
NR 12
TC 16
Z9 18
U1 0
U2 1
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0949-944X
J9 DEV GENES EVOL
JI Dev. Genes Evol.
PD AUG
PY 2003
VL 213
IS 8
BP 412
EP 415
DI 10.1007/s00427-003-0340-x
PG 4
WC Cell Biology; Evolutionary Biology; Developmental Biology
SC Cell Biology; Evolutionary Biology; Developmental Biology
GA 713TN
UT WOS:000184874500006
PM 12908108
DA 2021-01-25
ER

PT J
AU Ribeiro, C
   Petit, V
   Affolter, M
AF Ribeiro, C
   Petit, V
   Affolter, M
TI Signaling systems, guided cell migration, and organogenesis: insights
   from genetic studies in Drosophila
SO DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE hemocytes; border cells; germ cells; Trachea; receptor tyrosine kinase;
   JAK/STAT; Filopodia; cellular extensions
ID FGF RECEPTOR HOMOLOG; BRANCHING MORPHOGENESIS; MESODERMAL CELLS;
   TRACHEAL SYSTEM; BORDER CELLS; GERM-CELLS; INVASIVE BEHAVIOR; JAK/STAT
   PATHWAY; PROTEIN; ENCODES
AB During development, cells change their position extensively. Although the basic cellular mechanisms involved in cell locomotion have been studied mostly in cultured cells, genetic and molecular approaches using model organisms are starting to shed light on the complex events influencing cell migration during development. Recent technical advances in following and analyzing migrating cells inside the living embryo offer the possibility of understanding how different signaling systems regulate the fundamental cellular processes underlying guided cell migration in vivo. In Drosophila melanogaster, studies of migrating cells have concentrated mainly on hemocytes, germ cells, border cells, and tracheal cells. Interestingly, most of these cells were recently shown to make different cellular extensions and to use receptor tyrosine kinases to sense the chemoattractive signal. This review describes our current understanding of how different signaling networks control guided migration in these four systems and discusses the impact of novel imaging techniques on the study of guided cell migration during development. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, Basel, Switzerland.
OI PETIT, Valerie/0000-0003-1645-9396; Ribeiro, Carlos/0000-0002-9542-7335;
   Affolter, Markus/0000-0002-5171-0016
CR Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Affolter M, 2001, SCIENCE, V292, P1080, DOI 10.1126/science.1060856
   Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5
   Ahmad SM, 2002, CELL, V109, P651, DOI 10.1016/S0092-8674(02)00744-4
   Beccari S, 2002, MECH DEVELOP, V111, P115, DOI 10.1016/S0925-4773(01)00615-3
   Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993
   Boube M, 2000, MECH DEVELOP, V91, P271, DOI 10.1016/S0925-4773(99)00315-9
   Boube M, 2001, GENE DEV, V15, P1554, DOI 10.1101/gad.195501
   Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3
   Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202
   Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361
   Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1
   Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X
   Curtiss J, 2002, NAT CELL BIOL, V4, pE48, DOI 10.1038/ncb0302-e48
   Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5
   Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131
   Englund C, 2002, DEVELOPMENT, V129, P4941
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848
   Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830
   Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003
   GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697
   Gupta T, 2001, DEV CELL, V1, P443, DOI 10.1016/S1534-5807(01)00062-4
   Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7
   Imam F, 1999, GENETICS, V152, P307
   Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103
   JAGLARZ MK, 1995, DEVELOPMENT, V121, P3495
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lichtman JW, 2001, NAT NEUROSCI, V4, P1215, DOI 10.1038/nn754
   Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092
   Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635
   Michelson AM, 1998, DEVELOPMENT, V125, P4379
   MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E
   Montell DJ, 2001, MECH DEVELOP, V105, P19, DOI 10.1016/S0925-4773(01)00393-8
   Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533
   Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5
   Petit V, 2002, INT J DEV BIOL, V46, P125
   REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Rorth P, 2002, TRENDS CELL BIOL, V12, P325, DOI 10.1016/S0962-8924(02)02311-5
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Schober M, 2002, NAT CELL BIOL, V4, pE211, DOI 10.1038/ncb0902-e211
   Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233
   Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9
   Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983
   Starz-Gaiano M, 2001, MECH DEVELOP, V105, P5, DOI 10.1016/S0925-4773(01)00392-6
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   TEPASS U, 1994, DEVELOPMENT, V120, P1829
   Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Vincent S, 1997, DEVELOPMENT, V124, P2741
   Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93
   Wolf C, 2000, GENE DEV, V14, P2140, DOI 10.1101/gad.180900
   Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0
   Zhang N, 1996, GENETICS, V143, P1231
NR 62
TC 27
Z9 28
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD AUG 1
PY 2003
VL 260
IS 1
BP 1
EP 8
DI 10.1016/S0012-1606(03)00211-2
PG 8
WC Developmental Biology
SC Developmental Biology
GA 710KH
UT WOS:000184679000001
PM 12885551
DA 2021-01-25
ER

PT J
AU Engel, A
AF Engel, A
TI Microscopic assessment of membrane protein structure and function
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article; Proceedings Paper
CT 45th Symposium of the Society-for-Histochemistry
CY SEP 18, 2003
CL LES DIABLERETS, SWITZERLAND
SP Soc Histochem
DE 3D electron microscopy; atomic force microscopy; electron diffraction;
   membrane protein crystallization
ID ATOMIC-FORCE MICROSCOPE; RESOLUTION ELECTRON CRYSTALLOGRAPHY; COLI OUTER
   MEMBRANES; NA+-ATP SYNTHASE; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE;
   ANGSTROM RESOLUTION; DEINOCOCCUS-RADIODURANS; SURFACE-LAYER;
   CRYOELECTRON MICROSCOPY
AB Membrane proteins represent an important class of proteins that are encoded by about 40% of all genes, but compared to soluble proteins structural information is sparse. Most of the atomic coordinates currently available are from bacterial membrane proteins and have been obtained by X-ray crystallography. Recent results demonstrate the imaging power of the atomic force microscope and the accuracy of electron crystallography. These methods allow membrane proteins to be studied while embedded in the bilayer, and thus in a functional state. The low signal-to-noise ratio of cryoelectron microscopy is overcome by crystallizing membrane proteins in a two-dimensional protein-lipid membrane, allowing its atomic structure to be determined. In contrast, the high signal-to-noise ratio of atomic force microscopy allows individual protein surfaces to be imaged at subnanometer resolution, and their conformational states to be sampled. This review discusses examples of microscopic membrane protein structure determination and illuminates recent progress.
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
CR Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1
   Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200
   BAUMEISTER W, 1986, J MOL BIOL, V187, P241, DOI 10.1016/0022-2836(86)90231-7
   Bibby TS, 2001, J BIOL CHEM, V276, P43246, DOI 10.1074/jbc.M106541200
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827
   Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220
   Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5
   CONWAY JF, 1993, J STRUCT BIOL, V111, P222, DOI 10.1006/jsbi.1993.1052
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   de Groot BL, 2003, J MOL BIOL, V325, P485, DOI 10.1016/S0022-2836(02)01233-0
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   ENGEL A, 1985, NATURE, V317, P643, DOI 10.1038/317643a0
   Fernandez C, 2001, FEBS LETT, V504, P173, DOI 10.1016/S0014-5793(01)02742-9
   Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860
   Fisher TE, 2000, NAT STRUCT BIOL, V7, P719
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668
   Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821
   Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731
   Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0
   Lancaster CRD, 2001, FEBS LETT, V504, P133, DOI 10.1016/S0014-5793(01)02706-5
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631
   Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1996, J BACTERIOL, V178, P3025
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676
   PETERS J, 1987, J BACTERIOL, V169, P5216, DOI 10.1128/jb.169.11.5216-5223.1987
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7
   Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x
   Scheuring S, 2002, EUR BIOPHYS J BIOPHY, V31, P172, DOI 10.1007/s00249-001-0197-8
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   SCHINDLER H, 1978, P NATL ACAD SCI USA, V75, P3751, DOI 10.1073/pnas.75.8.3751
   Schirmer T, 1999, J MOL BIOL, V294, P1159, DOI 10.1006/jmbi.1999.3326
   Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001
   Sleytr UB, 1997, FEMS MICROBIOL REV, V20, P5, DOI 10.1016/S0168-6445(97)00039-9
   Stahlberg H, 2001, FEBS LETT, V504, P166, DOI 10.1016/S0014-5793(01)02746-6
   Stahlberg H, 2000, J STRUCT BIOL, V132, P133, DOI 10.1006/jsbi.2000.4317
   Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644
   Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   Werten PJL, 2002, FEBS LETT, V529, P65, DOI 10.1016/S0014-5793(02)03290-8
   Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534
NR 68
TC 11
Z9 11
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD AUG
PY 2003
VL 120
IS 2
BP 93
EP 102
DI 10.1007/s00418-003-0560-1
PG 10
WC Cell Biology; Microscopy
SC Cell Biology; Microscopy
GA 712VK
UT WOS:000184818900002
PM 12898277
DA 2021-01-25
ER

PT J
AU Groger, C
   Moglich, A
   Pons, M
   Koch, B
   Hengstenberg, W
   Kalbitzer, HR
   Brunner, E
AF Groger, C
   Moglich, A
   Pons, M
   Koch, B
   Hengstenberg, W
   Kalbitzer, HR
   Brunner, E
TI NMR-spectroscopic mapping of an engineered cavity in the I14A mutant of
   HPr from Staphylococcus carnosus using xenon
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID LASER-POLARIZED XENON; BINDING; PROTEIN; MYOGLOBIN; PRESSURE; SITES
C1 Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany.
   Univ Basel, Div Biophys Chem, Biozentrum Basel, CH-4056 Basel, Switzerland.
   Univ Barcelona, Dept Organ Chem, Barcelona, Spain.
   Ruhr Univ Bochum, Abt Biol Mikroorgan, D-44780 Bochum, Germany.
RP Brunner, E (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany.
RI pons, miquel/C-8657-2011
OI pons, miquel/0000-0002-0586-8322; Kalbitzer, Hans
   Robert/0000-0002-6514-2355; Moglich, Andreas/0000-0002-7382-2772
CR Gorler A, 1999, APPL MAGN RESON, V17, P465
   Gronwald W, 2002, J BIOMOL NMR, V23, P271, DOI 10.1023/A:1020279503261
   Kalbitzer HR, 2000, PROTEIN SCI, V9, P693
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Landon C, 2001, PROTEIN SCI, V10, P762, DOI 10.1110/ps.47001
   Locci E, 2002, CHEMPHYSCHEM, V3, P812, DOI 10.1002/1439-7641(20020916)3:9<812::AID-CPHC812>3.0.CO;2-D
   Locci E, 2001, J MAGN RESON, V150, P167, DOI 10.1006/jmre.2001.2325
   Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117
   MOGLICH A, 2001, THEIS REGENSBURG
   Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523
   Navon G, 1996, SCIENCE, V271, P1848, DOI 10.1126/science.271.5257.1848
   Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.3.CO;2-O
   Quillin ML, 2000, J MOL BIOL, V302, P955, DOI 10.1006/jmbi.2000.4063
   RAIFORD DS, 1979, ANAL CHEM, V51, P2050, DOI 10.1021/ac50048a040
   ROE DC, 1985, J MAGN RESON, V63, P388
   Rubin SM, 2000, P NATL ACAD SCI USA, V97, P9472, DOI 10.1073/pnas.170278897
   Rubin SM, 2002, J MOL BIOL, V322, P425, DOI 10.1016/S0022-2836(02)00739-8
   Rubin SM, 2001, J MAGN RESON, V152, P79, DOI 10.1006/jmre.2001.2389
   Rubin SM, 2001, J AM CHEM SOC, V123, P8616, DOI 10.1021/ja0110325
   SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0
   SCHOENBORN BP, 1965, NATURE, V208, P760, DOI 10.1038/208760a0
   Whittington DA, 2001, BIOCHEMISTRY-US, V40, P3476, DOI 10.1021/bi0022487
NR 22
TC 35
Z9 35
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUL 23
PY 2003
VL 125
IS 29
BP 8726
EP 8727
DI 10.1021/ja030113t
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 702UN
UT WOS:000184243000017
PM 12862458
DA 2021-01-25
ER

PT J
AU Naumann, R
   Walz, D
   Schiller, SM
   Knoll, W
AF Naumann, R
   Walz, D
   Schiller, SM
   Knoll, W
TI Kinetics of valinomycin-mediated K+ ion transport through tethered
   bilayer lipid membranes
SO JOURNAL OF ELECTROANALYTICAL CHEMISTRY
LA English
DT Article
DE biomimetics; tethered bilayer lipid membranes; valinomycin; ion
   transport
ID GOLD SURFACES; THIOLIPIDS; LAYERS
AB Bilayer lipid membranes tethered to planar gold electrodes were prepared, based on a self assembled monolayer (SAM) of 2,3-di-O-phytanyl-sn-glycerol-l-tetraethylene glycol-DL-alpha-lipoic acid ester lipid (DPTL). When the SAM's were exposed to a suspension of liposomes made from diphytanoylphosphodatidyl choline (DPhyPC), tethered lipid bilayers (tBLMs) were formed with good sealing properties. The preformed tBLMs were doped with valinomycin, and the K+ ion concentration in the bathing solution was increased stepwise by adding KCl. Electrical impedance spectra were recorded following every addition. These data were modelled by means of the network simulation program SPICE, using parameter values of the undoped membrane and a kinetic scheme for the K+/valinomycin system, whose rate constants were determined previously in independent measurements. Experimental and simulated data are in reasonable agreement despite some simplifying assumptions used in the SPICE simulations. Experimental data were also fitted to a conventional equivalent circuit, which reveals that the representation of the K+/valinomycin system by an ohmic resistor can be considered as no more than an approximation. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Naumann, R (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
CR Bunjes N, 1997, LANGMUIR, V13, P6188, DOI 10.1021/la970317l
   Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432
   Guidelli R, 2001, J ELECTROANAL CHEM, V504, P1, DOI 10.1016/S0022-0728(01)00382-5
   GUIDELLI R, 2002, COMMUNICATION
   Knoll W, 2000, J Biotechnol, V74, P137, DOI 10.1016/S1389-0352(00)00012-X
   Krishna G, 2001, LANGMUIR, V17, P4858, DOI 10.1021/la001480a
   LANG H, 1994, LANGMUIR, V10, P197, DOI 10.1021/la00013a029
   NAUMANN R, 1995, ANGEW CHEM INT EDIT, V34, P2056, DOI 10.1002/anie.199520561
   Naumann R, 2002, BIOSENS BIOELECTRON, V17, P25, DOI 10.1016/S0956-5663(01)00182-8
   Naumann R, 1999, BIOSENS BIOELECTRON, V14, P651, DOI 10.1016/S0956-5663(99)00036-6
   Peggion C, 2001, LANGMUIR, V17, P6585, DOI 10.1021/la010604w
   Raguse B, 1998, LANGMUIR, V14, P648, DOI 10.1021/la9711239
   Schiller SM, 2003, ANGEW CHEM INT EDIT, V42, P208, DOI 10.1002/anie.200390080
   Sinner EK, 2001, CURR OPIN CHEM BIOL, V5, P705, DOI 10.1016/S1367-5931(01)00269-1
   STARK G, 1971, BIOPHYS J, V11, P981, DOI 10.1016/S0006-3495(71)86272-0
   WALZ D, 1995, BIOELECTROCHEMISTRY, V1, pCH2
   Wiegand G, 2002, J PHYS CHEM B, V106, P4245, DOI 10.1021/jp014337e
NR 17
TC 77
Z9 77
U1 1
U2 27
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0022-0728
J9 J ELECTROANAL CHEM
JI J. Electroanal. Chem.
PD JUL 17
PY 2003
VL 550
BP 241
EP 252
DI 10.1016/S0022-0728(03)00013-5
PG 12
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 711DP
UT WOS:000184724600022
DA 2021-01-25
ER

PT J
AU Deutsch, S
   Rideau, A
   Bochaton-Piallat, ML
   Merla, G
   Geinoz, A
   Gabbiani, G
   Schwede, T
   Matthes, T
   Antonarakis, SE
   Beris, P
AF Deutsch, S
   Rideau, A
   Bochaton-Piallat, ML
   Merla, G
   Geinoz, A
   Gabbiani, G
   Schwede, T
   Matthes, T
   Antonarakis, SE
   Beris, P
TI Asp1424Asn MYH9 mutation results in an unstable protein responsible for
   the phenotypes in May-Hegglin anomaly/Fechtner syndrome
SO BLOOD
LA English
DT Article
ID MYOSIN HEAVY-CHAIN; AUTOSOMAL-DOMINANT MACROTHROMBOCYTOPENIA;
   SINGLE-NUCLEOTIDE POLYMORPHISMS; LEUKOCYTE INCLUSIONS; DNA POOLS;
   CHROMOSOME; DEAFNESS; FECHTNER; GENE; EPSTEIN
AB May-Hegglin anomaly (MHA), Fechtner syndrome (FTNS), Sebastian syndrome (SBS), and Epstein syndrome (EPS) are a group of rare, autosomal dominant disorders characterized by thrombocytopenia, giant platelets, and Dohle-like inclusion bodies, together with variable manifestations of Alport-like symptoms that include high-tone sensorineural deafness, cataracts, and nephritis. These disorders result from mutations in the MYH9 gene, which encodes for the nonmuscle myosin heavy chain A protein (also known as NMMHC-A). To date 20 different mutations have been characterized for this gene, but no clear phenotype-genotype correlation has been established, and very little is known regarding the molecular pathogenesis of this group of diseases. Here, we describe 2 new families with MHA/FTNS phenotypes that have been characterized in terms of their mutations, protein localization in megakaryocytes, protein expression, and mRNA stability. Our findings suggest that, at least for the Asp1424Asn mutation in the MYH9 gene, the phenotypes result from a highly unstable protein. No abnormalities in protein localization or mRNA stability were observed. We hypothesize that haploin-sufficiency of the MYH9 results in a failure to properly reorganize the cytoskeleton in megakaryocytes as required for efficient platelet production. (C) 2003 by The American Society of Hematology.
C1 Univ Hosp Geneva, Div Hematol, CH-1211 Geneva, Switzerland.
   Univ Geneva, Fac Med, Div Med Genet, Geneva, Switzerland.
   Univ Geneva, Fac Med, Dept Pathol, Geneva, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Univ Geneva, Fac Med, Grad Program Mol & Cellular Biol, Geneva, Switzerland.
RP Beris, P (corresponding author), Univ Hosp Geneva, Div Hematol, CH-1211 Geneva, Switzerland.
EM photis.beris@hcuge.ch
RI Schwede, Torsten/A-4650-2008; Antonarakis, Stylianos E/N-8866-2014;
   merla, giuseppe/K-4627-2012
OI Schwede, Torsten/0000-0003-2715-335X; Antonarakis, Stylianos
   E/0000-0001-8907-5823; merla, giuseppe/0000-0001-5078-928X; Deutsch,
   Samuel/0000-0001-9456-7101
CR Alderborn A, 2000, GENOME RES, V10, P1249, DOI 10.1101/gr.10.8.1249
   ANTONARAKIS SE, 2001, METABOLIC MOL BASES, V1, P343
   Arrondel C, 2002, J AM SOC NEPHROL, V13, P65
   BENZONANA G, 1988, CELL MOTIL CYTOSKEL, V11, P260, DOI 10.1002/cm.970110405
   BERNHEIM J, 1976, AM J MED, V61, P145, DOI 10.1016/0002-9343(76)90058-9
   Bochaton-Piallat ML, 2000, INVEST OPHTH VIS SCI, V41, P2336
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775
   COLLER BS, 1981, BLOOD, V58, P279
   Dragich J, 2000, HUM MOL GENET, V9, P2365, DOI 10.1093/hmg/9.16.2365
   ECKSTEIN JD, 1975, ANN INTERN MED, V82, P639, DOI 10.7326/0003-4819-82-5-639
   EPSTEIN CJ, 1972, AM J MED, V52, P299, DOI 10.1016/0002-9343(72)90017-4
   GODWIN HA, 1974, BRIT J HAEMATOL, V26, P117, DOI 10.1111/j.1365-2141.1974.tb00455.x
   Heath KE, 2001, AM J HUM GENET, V69, P1033, DOI 10.1086/324267
   HEGGLIN R, 1945, Helv Med Acta, V12, P439
   Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069
   Kelley MJ, 2000, HUM GENET, V106, P557, DOI 10.1007/s004390050025
   Kunishima S, 1999, HUM GENET, V105, P379, DOI 10.1007/s004390051119
   Kunishima S, 2003, LAB INVEST, V83, P115, DOI 10.1097/01.LAB.0000050960.48774.17
   Kunishima S, 2001, J HUM GENET, V46, P722, DOI 10.1007/s100380170007
   Kunishima S, 2001, BLOOD, V97, P1147, DOI 10.1182/blood.V97.4.1147
   Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5
   LUSHER JM, 1968, BLOOD, V32, P950, DOI 10.1182/blood.V32.6.950.950
   Mansfield PJ, 2000, BLOOD, V95, P2407, DOI 10.1182/blood.V95.7.2407.007k02_2407_2412
   Martignetti JA, 2000, AM J HUM GENET, V66, P1449, DOI 10.1086/302873
   MAUPIN P, 1994, J CELL SCI, V107, P3077
   MAY R, 1909, DEUTSCHES ARCHIV KLI, V96, P1
   Nagasaki A, 2002, J CELL SCI, V115, P2241
   Neve B, 2002, BIOTECHNIQUES, V32, P1138, DOI 10.2144/02325dd03
   Pecci A, 2002, BRIT J HAEMATOL, V117, P164, DOI 10.1046/j.1365-2141.2002.03385.x
   PETERSON LC, 1985, BLOOD, V65, P397
   Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7
   Seri M, 2000, NAT GENET, V26, P103
   Seri M, 2002, HUM GENET, V110, P182, DOI 10.1007/s00439-001-0659-1
   SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6
   SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530
   TOOTHAKER LE, 1991, BLOOD, V78, P1826
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Tsurusawa M, 2000, INT J HEMATOL, V71, P400
   Wasson J, 2002, BIOTECHNIQUES, V32, P1144, DOI 10.2144/02325dd04
NR 40
TC 38
Z9 42
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD JUL 15
PY 2003
VL 102
IS 2
BP 529
EP 534
DI 10.1182/blood-2002-09-2783
PG 6
WC Hematology
SC Hematology
GA 699XY
UT WOS:000184083500026
PM 12649151
DA 2021-01-25
ER

PT J
AU Pozidis, C
   Chalkiadaki, A
   Gomez-Serrano, A
   Stahlberg, H
   Brown, I
   Tampakaki, AP
   Lustig, A
   Sianidis, G
   Politou, AS
   Engel, A
   Panopoulos, NJ
   Mansfield, J
   Pugsley, AP
   Karamanou, S
   Economou, A
AF Pozidis, C
   Chalkiadaki, A
   Gomez-Serrano, A
   Stahlberg, H
   Brown, I
   Tampakaki, AP
   Lustig, A
   Sianidis, G
   Politou, AS
   Engel, A
   Panopoulos, NJ
   Mansfield, J
   Pugsley, AP
   Karamanou, S
   Economou, A
TI Type III protein translocase - Hrcn is a peripheral membrane ATPase that
   is activated by oligomerization
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FLAGELLAR EXPORT APPARATUS; SYRINGAE PV PHASEOLICOLA;
   PSEUDOMONAS-SYRINGAE; SALMONELLA-TYPHIMURIUM; SECRETION SYSTEM; NEEDLE
   COMPLEX; HRP PILUS; MOLECULAR CHARACTERIZATION; SUPRAMOLECULAR
   STRUCTURE; F0F1 ATPASE
AB Type III protein secretion (TTS) is catalyzed by translocases that span both membranes of Gram-negative bacteria. A hydrophilic TTS component homologous to F-1/V-1-ATPases is ubiquitous and essential for secretion. We show that hrcN encodes the putative TTS ATPase of Pseudomonas syringae pathovar phaseolicola and that HrcN is a peripheral protein that assembles in clusters at the membrane. A decahistidinyl HrcN derivative was overexpressed in Escherichia coli and purified to homogeneity in a folded state. Hydrodynamic analysis, cross-linking, and electron microscopy revealed four distinct HrcN forms: I, 48 kDa ( monomer); II, similar to300 kDa ( putative hexamer); III, 575 kDa ( dodecamer); and IV, similar to3.5 MDa. Form III is the predominant form of HrcN at the membrane, and its ATPase activity is dramatically stimulated (> 700-fold) over the basal activity of Form I. We propose that TTS ATPases catalyze protein translocation as activated homo-oligomers at the plasma membrane.
C1 FORTH, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Crete, Greece.
   Univ Crete, Dept Biol, GR-71110 Iraklion, Crete, Greece.
   Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ London, Imperial Coll Wye, Dept Biol Sci, Ashford TN25 5AH, Kent, England.
   Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.
   Inst Pasteur, CNRS, FRE 2364, Mol Genet Unit, F-75724 Paris 15, France.
RP Economou, A (corresponding author), FORTH, Inst Mol Biol & Biotechnol, POB 1527, GR-71110 Iraklion, Crete, Greece.
RI Stahlberg, Henning/H-1868-2011; Karamanou, Spyridoula/H-7485-2018;
   Economou, Anastassios/P-8292-2017
OI Stahlberg, Henning/0000-0002-1185-4592; Karamanou,
   Spyridoula/0000-0002-8803-1404; Economou,
   Anastassios/0000-0002-1770-507X; Tampakaki,
   Anastasia/0000-0003-4439-0920
CR Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856
   Auvray F, 2002, J MOL BIOL, V318, P941, DOI 10.1016/S0022-2836(02)00172-9
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Bogdanove AJ, 1996, J BACTERIOL, V178, P1720, DOI 10.1128/jb.178.6.1720-1730.1996
   Brown IR, 2001, MOL PLANT MICROBE IN, V14, P394, DOI 10.1094/MPMI.2001.14.3.394
   CHANG CN, 1979, P NATL ACAD SCI USA, V76, P1251, DOI 10.1073/pnas.76.3.1251
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Dalal S, 2001, CELL, V104, P5, DOI 10.1016/S0092-8674(01)00186-6
   DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106
   DREYFUS G, 1993, J BACTERIOL, V175, P3131, DOI 10.1128/JB.175.10.3131-3138.1993
   Economou A, 2002, MOL MEMBR BIOL, V19, P159, DOI 10.1080/09687680210152609
   EICHELBERG K, 1994, J BACTERIOL, V176, P4501, DOI 10.1128/JB.176.15.4501-4510.1994
   Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   GROMETELHANAN Z, 1992, J BIOENERG BIOMEMBR, V24, P447, DOI 10.1007/BF00762361
   HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284
   Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x
   Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397
   KAGAWA Y, 1992, J BIOENERG BIOMEMBR, V24, P441, DOI 10.1007/BF00762360
   Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5
   Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x
   Katayama E, 1996, J MOL BIOL, V255, P458, DOI 10.1006/jmbi.1996.0038
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   KING EO, 1954, J LAB CLIN MED, V44, P301
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Li CM, 2002, EMBO J, V21, P1909, DOI 10.1093/emboj/21.8.1909
   LIDELL MC, 1994, MOL PLANT MICROBE IN, V7, P488, DOI 10.1094/MPMI-7-0488
   Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999
   MANSFIELD J, 1994, MOL PLANT MICROBE IN, V7, P726, DOI 10.1094/MPMI-7-0726
   Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x
   Minamino T, 2001, J MOL BIOL, V312, P1027, DOI 10.1006/jmbi.2001.5000
   Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x
   Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878
   Plano GV, 2001, MOL MICROBIOL, V40, P284, DOI 10.1046/j.1365-2958.2001.02354.x
   POSSOT O, 1994, MOL MICROBIOL, V12, P287, DOI 10.1111/j.1365-2958.1994.tb01017.x
   Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247
   RAHME LG, 1991, J BACTERIOL, V173, P575, DOI 10.1128/jb.173.2.575-586.1991
   Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961
   SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5
   Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876
   Tanese N, 1997, METHODS, V12, P224, DOI 10.1006/meth.1997.0475
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509
NR 48
TC 58
Z9 65
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 11
PY 2003
VL 278
IS 28
BP 25816
EP 25824
DI 10.1074/jbc.M301903200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 697AN
UT WOS:000183920200069
PM 12734178
OA Bronze
DA 2021-01-25
ER

PT J
AU Tidcombe, H
   Jackson-Fisher, A
   Mathers, K
   Stern, DF
   Gassmann, M
   Golding, JP
AF Tidcombe, H
   Jackson-Fisher, A
   Mathers, K
   Stern, DF
   Gassmann, M
   Golding, JP
TI Neural and mammary gland defects in ErbB4 knockout mice genetically
   rescued from embryonic lethality
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID RECEPTOR GENE-EXPRESSION; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT;
   NEUROMUSCULAR SYNAPSES; NEURONAL DEVELOPMENT; SIGNALING NETWORK;
   DEVELOPING MOUSE; DIFFERENTIATION; ACTIVATION; HEREGULIN
AB Mice lacking the epidermal growth factor receptor family member ErbB4 exhibit defects in cranial neural crest cell migration but die by embryonic day 11 because of defective heart development. To examine later phenotypes, we rescued the heart defects in ErbB4 mutant mice by expressing ErbB4 under a cardiac-specific myosin promoter. Rescued Erb84 mutant mice reach adulthood and are fertile. However, during pregnancy, mammary lobuloalveoli fail to differentiate correctly and lactation is defective. Rescued mice also display aberrant cranial nerve architecture and increased numbers of large interneurons within the cerebellum.
C1 Univ Basel, Biozentrum, Pharmazentrum, Dept Physiol, CH-4056 Basel, Switzerland.
   Natl Inst Med Res, Div Neurobiol, London NW7 1AA, England.
   Natl Inst Med Res, Div Biol Serv, London NW7 1AA, England.
   Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA.
RP Gassmann, M (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, Dept Physiol, Klingelbergstr 50, CH-4056 Basel, Switzerland.
RI Golding, Jon/L-2700-2017
OI Golding, Jon/0000-0002-7910-7382; Gassmann, Martin/0000-0001-6201-3032
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA080065, R01CA080065, R01CA080065, R01CA080065,
   R01CA080065, R01CA080065, R01CA080065, R01CA080065, R01CA080065,
   R01CA080065, R01CA080065, R01CA080065, R01CA080065, R01CA080065,
   R01CA080065] Funding Source: NIH RePORTER; NCI NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [R01CA80065, R01 CA080065]
   Funding Source: Medline
CR ALTIOK N, 1995, EMBO J, V14, P4258, DOI 10.1002/j.1460-2075.1995.tb00100.x
   Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601
   BUCHMAN VL, 1993, DEVELOPMENT, V118, P989
   Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4
   Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133
   Cheney ML, 1997, ANN OTO RHINOL LARYN, V106, P733, DOI 10.1177/000348949710600903
   Erickson SL, 1997, DEVELOPMENT, V124, P4999
   Fried K, 2002, DEV DYNAM, V224, P356, DOI 10.1002/dvdy.10114
   Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961
   GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0
   Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6
   Golding JP, 1999, DEV BIOL, V216, P85, DOI 10.1006/dbio.1999.9497
   Golding JP, 2000, NAT CELL BIOL, V2, P103, DOI 10.1038/35000058
   Grove EA, 1998, DEVELOPMENT, V125, P2315
   GULICK J, 1991, J BIOL CHEM, V266, P9180
   JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0
   Jones FE, 1996, CELL GROWTH DIFFER, V7, P1031
   Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77
   Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833
   Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998
   LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0
   Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179
   LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0
   MASON S, 1995, BREAST, V4, P11, DOI 10.1016/0960-9776(95)90022-5
   MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0
   Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065
   Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5
   MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012
   Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209
   Ozaki M, 1998, NEUROSCI RES, V30, P351, DOI 10.1016/S0168-0102(98)00013-3
   PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746
   PRATT SG, 1984, OPHTHALMOLOGY, V91, P27
   Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593
   Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3
   Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O
   Sedmera D, 1996, BIOESSAYS, V18, P607, DOI 10.1002/bies.950180714
   SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085
   Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056
   Troyer KL, 2001, J MAMMARY GLAND BIOL, V6, P7, DOI 10.1023/A:1009560330359
   Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538
   Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073
   ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x
NR 42
TC 185
Z9 188
U1 0
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 8
PY 2003
VL 100
IS 14
BP 8281
EP 8286
DI 10.1073/pnas.1436402100
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 702KF
UT WOS:000184222500045
PM 12824469
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Meyer, C
   Meyer, D
   Bickle, TA
   Giese, B
AF Meyer, C
   Meyer, D
   Bickle, TA
   Giese, B
TI Chemical restriction: Strand cleavage by ammonia treatment at
   8-oxoguanine yields biologically active DNA
SO CHEMBIOCHEM
LA English
DT Article
DE chemical restriction; DNA cleavage; nucleotides; polymerase chain
   reaction
ID ESCHERICHIA-COLI; MAMMALIAN-CELLS; ONE-ELECTRON; OXIDATION; MUTAGENESIS;
   8-OXO-7,8-DIHYDRO-2'-DEOXYGUANOSINE; 7,8-DIHYDRO-8-OXOGUANINE;
   INSERTION; PRODUCTS; OPPOSITE
AB Cleavage of DNA single and double strands at an 8-oxoguanine-containing nucleotide occurs in 90% yield if the modified oligonucleotide is treated with NH3 and O-2 at 60degreesC. The mechanism of this oxidative cleavage reaction was studied, and the reaction was applied tot he generation of single stranded overhangs on PCR-amplified DNA that can be ligated. As an example, the lac Z' gene was amplified by PCR with 8-oxoguanine modified primers, restricted by ammonia treatment, ligated into a plasmid vector, transformed in Escherischia coli cells, and screened for blue colonies. This method guarantees efficiencies comparable to the standard cloning procedure with restriction enzymes, and it allows the design of any 3'-overhang independent of the sequence of the cloned DNA.
C1 Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Giese, B (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.
CR Cysewski P, 1998, J CHEM SOC FARADAY T, V94, P3117, DOI 10.1039/a804512g
   Duarte V, 1999, NUCLEIC ACIDS RES, V27, P496, DOI 10.1093/nar/27.2.496
   Hazra TK, 2001, NUCLEIC ACIDS RES, V29, P1967, DOI 10.1093/nar/29.9.1967
   Hickerson RP, 1999, J AM CHEM SOC, V121, P9423, DOI 10.1021/ja991929q
   Hidajat R, 1997, BIOTECHNIQUES, V22, P32, DOI 10.2144/97221bm04
   Huang HX, 1996, DNA CELL BIOL, V15, P589, DOI 10.1089/dna.1996.15.589
   KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034
   KUNKEL TA, 1988, CELL, V53, P837, DOI 10.1016/S0092-8674(88)90189-4
   MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122
   NAEGELI H, 1997, MECH DNA DAMAGE RECO
   *NEW ENGL BIOL INC, 2000, CAT TECHN REF
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   SHIBUTANI S, 1990, J AM CHEM SOC, V112, P5667, DOI 10.1021/ja00170a056
   SUGIYAMA H, 1994, CHEM RES TOXICOL, V7, P637
   Tan XZ, 1999, CARCINOGENESIS, V20, P2287, DOI 10.1093/carcin/20.12.2287
   Torres MC, 1996, CHEM RES TOXICOL, V9, P1313, DOI 10.1021/tx960107t
   Watson DE, 1997, BIOTECHNIQUES, V23, P858, DOI 10.2144/97235st01
   WIADERKIEWICZ R, 1987, NUCLEIC ACIDS RES, V15, P7831, DOI 10.1093/nar/15.19.7831
   WOOD ML, 1992, NUCLEIC ACIDS RES, V20, P6023, DOI 10.1093/nar/20.22.6023
NR 21
TC 7
Z9 7
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1439-4227
J9 CHEMBIOCHEM
JI Chembiochem
PD JUL 7
PY 2003
VL 4
IS 7
BP 610
EP 614
DI 10.1002/cbic.200300587
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 700JT
UT WOS:000184109400007
PM 12851930
DA 2021-01-25
ER

PT J
AU Sprecher, SG
   Galle, S
   Reichert, H
AF Sprecher, SG
   Galle, S
   Reichert, H
TI Substrate specificity and juvenile Faviid predominance of coral
   colonization at the Maldive Islands following the 1998 bleaching event
SO CORAL REEFS
LA English
DT Article
DE coral reefs; coral colonization; coral substrates; juvenile corals
ID MORTALITY; PORITES; ATOLL; REEFS
C1 Univ Basel, Inst Zool, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Reichert, H (corresponding author), Univ Basel, Inst Zool, Biozentrum, Pharmazentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
RI Sprecher, Simon/B-5188-2012
CR BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440
   Edwards AJ, 2001, MAR POLLUT BULL, V42, P7, DOI 10.1016/S0025-326X(00)00200-9
   Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9
   McClanahan TR, 2001, CORAL REEFS, V19, P367, DOI 10.1007/s003380000131
   Mumby PJ, 2001, MAR BIOL, V139, P183
   Naeem I., 1998, CORAL BLEACHING MALD
NR 6
TC 5
Z9 5
U1 0
U2 4
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0722-4028
J9 CORAL REEFS
JI Coral Reefs
PD JUL
PY 2003
VL 22
IS 2
BP 130
EP 132
DI 10.1007/s00338-003-0292-7
PG 3
WC Marine & Freshwater Biology
SC Marine & Freshwater Biology
GA 698VF
UT WOS:000184019500008
DA 2021-01-25
ER

PT J
AU Schmitz, HP
   Heinisch, JJ
AF Schmitz, HP
   Heinisch, JJ
TI Evolution, biochemistry and genetics of protein kinase C in fungi
SO CURRENT GENETICS
LA English
DT Review
DE signal transduction; MAP kinase; yeast; protein domains; regulation;
   fungi
ID CELL INTEGRITY PATHWAY; CYSTEINE-RICH DOMAIN; SACCHAROMYCES-CEREVISIAE;
   KLUYVEROMYCES-LACTIS; FISSION YEAST; SIGNALING PATHWAY;
   CANDIDA-ALBICANS; PHORBOL ESTERS; WHITE COLLAR-1; BINDING-SITE
AB From yeast to humans, protein kinase C is an enzyme of central importance in signal transduction processes. In baker's yeast, Saccharomyces cerevisiae, a single gene encoding Pkclp has been identified. Mutant analyses revealed that Pkclp function is essential to ensure cellular integrity through regulation of a specific MAP kinase cascade. Due to the involvement of different defective mammalian isozymes in various diseases and the model character of simple eukaryotes, increasing attention has been paid to the structure and regulation of the enzymes of fungal origin. This review summarizes the knowledge gathered so far.
C1 Univ Osnabruck, Fachbereich Biol Chem, AG Genet, D-49076 Osnabruck, Germany.
   Univ Basel, Biozentrum Basel, Inst Angew Mikrobiol, Biopharmazentrum, CH-4056 Basel, Switzerland.
RP Heinisch, JJ (corresponding author), Univ Osnabruck, Fachbereich Biol Chem, AG Genet, Barbarastr 11, D-49076 Osnabruck, Germany.
RI Heinisch, Juergen J./G-3801-2017
OI Schmitz, Hans-Peter/0000-0001-5449-4593
CR Akkaraju GR, 2000, BIOCHEM BIOPH RES CO, V279, P103, DOI 10.1006/bbrc.2000.3903
   Ambra R, 2000, FEMS MICROBIOL LETT, V189, P45, DOI 10.1111/j.1574-6968.2000.tb09204.x
   Andrews PD, 2000, J CELL SCI, V113, P2685
   ANTONSSON B, 1994, J BIOL CHEM, V269, P16821
   Aquino-Pinero E, 2002, MED MYCOL, V40, P185, DOI 10.1080/714031095
   Arellano M, 1999, J CELL SCI, V112, P3569
   Arpaia G, 1999, MOL GEN GENET, V262, P314, DOI 10.1007/s004380051089
   Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276
   Baymiller J, 1997, YEAST, V13, P305, DOI 10.1002/(SICI)1097-0061(19970330)13:4<305::AID-YEA91>3.0.CO;2-F
   BELL RM, 1991, J BIOL CHEM, V266, P4661
   Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948
   Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241
   Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8
   Calonge TM, 2000, MOL BIOL CELL, V11, P4393, DOI 10.1091/mbc.11.12.4393
   Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4
   Cho W, 2001, J BIOL CHEM, V276, P32407, DOI 10.1074/jbc.R100007200
   Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0
   Daub M, 1998, MOL CELL BIOL, V18, P6698, DOI 10.1128/MCB.18.11.6698
   Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163
   Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057
   Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698
   Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681
   Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795
   Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x
   Hosotani T, 2001, GENES CELLS, V6, P775, DOI 10.1046/j.1365-2443.2001.00461.x
   Hoyos B, 2002, J BIOL CHEM, V277, P23949, DOI 10.1074/jbc.M110750200
   Hoyos B, 2000, J EXP MED, V192, P835, DOI 10.1084/jem.192.6.835
   Hurley JH, 1997, PROTEIN SCI, V6, P477
   Inagaki M, 1999, MOL CELL BIOL, V19, P8344
   Ishii H, 1998, J MOL MED, V76, P21, DOI 10.1007/s109-1998-8101-y
   Jacoby JJ, 1999, J MOL BIOL, V288, P337, DOI 10.1006/jmbi.1999.2682
   Jacoby JJ, 1997, FEBS LETT, V417, P219, DOI 10.1016/S0014-5793(97)01287-8
   JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140
   Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x
   Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173
   KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335
   KIKKAWA U, 1983, J BIOL CHEM, V258, P1442
   KILEY SC, 1995, J CELL SCI, V108, P1003
   Kirchrath L, 2000, J MOL BIOL, V300, P743, DOI 10.1006/jmbi.2000.3916
   Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042
   LEVIN DE, 1994, CELL MOL BIOL RES, V40, P229
   LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221
   LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q
   Li Y, 2000, MOL CELL BIOL, V20, P3843, DOI 10.1128/MCB.20.11.3843-3851.2000
   LORBERG A, 2003, IN PRESS YEAST
   Madden K, 1997, SCIENCE, V275, P1781, DOI 10.1126/science.275.5307.1781
   MAZZEI GJ, 1993, J BIOL CHEM, V268, P7401
   Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281
   Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811
   Morawetz R, 1996, MOL GEN GENET, V250, P17, DOI 10.1007/BF02191821
   Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312
   Nanduri J, 2001, MOL BIOL CELL, V12, P1835, DOI 10.1091/mbc.12.6.1835
   NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0
   NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x
   Oeser B, 1998, FEMS MICROBIOL LETT, V165, P273, DOI 10.1111/j.1574-6968.1998.tb13157.x
   PALMER RH, 1995, EUR J BIOCHEM, V227, P344, DOI 10.1111/j.1432-1033.1995.tb20395.x
   Paravicini G, 1996, YEAST, V12, P741, DOI 10.1002/(SICI)1097-0061(19960630)12:8<741::AID-YEA967>3.0.CO;2-G
   Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496
   Park H, 2000, GLYCOBIOLOGY, V10, P737, DOI 10.1093/glycob/10.7.737
   Perez P, 2002, J BIOCHEM, V132, P513, DOI 10.1093/oxfordjournals.jbchem.a003250
   Ponting CP, 1996, PROTEIN SCI, V5, P162
   Raitt DC, 2000, EMBO J, V19, P4623, DOI 10.1093/emboj/19.17.4623
   Sayers LG, 2000, GENES CELLS, V5, P17, DOI 10.1046/j.1365-2443.2000.00301.x
   Schmitz HP, 2002, J CELL SCI, V115, P3139
   Schmitz HP, 2001, J MOL BIOL, V311, P1, DOI 10.1006/jmbi.2001.4848
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248
   Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200
   SWINKELS BW, 1993, ANTON LEEUW INT J G, V64, P187, DOI 10.1007/BF00873027
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   TODA T, 1993, EMBO J, V12, P1987, DOI 10.1002/j.1460-2075.1993.tb05848.x
   Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572
   WATANABE M, 1994, J BIOL CHEM, V269, P16829
   WATANABE Y, 1995, MOL CELL BIOL, V15, P5740
   Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615
   ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X
NR 80
TC 43
Z9 44
U1 0
U2 2
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0172-8083
J9 CURR GENET
JI Curr. Genet.
PD JUL
PY 2003
VL 43
IS 4
BP 245
EP 254
DI 10.1007/s00294-003-0403-6
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA 703GM
UT WOS:000184271700003
PM 12736758
DA 2021-01-25
ER

PT J
AU Bazinet, C
   Rollins, JE
AF Bazinet, C
   Rollins, JE
TI Rickettsia-like mitochondrial motility in Drosophila spermiogenesis
SO EVOLUTION & DEVELOPMENT
LA English
DT Article
ID ACTIN-BASED MOTILITY; DENDRITIC ORGANIZATION; LISTERIA-MONOCYTOGENES;
   ARP2/3 COMPLEX; MELANOGASTER; DYNAMICS; INDIVIDUALIZATION; MOVEMENT;
   SPERM; SPERMATOGENESIS
AB Although it is generally accepted that mitochondria and chloroplasts are descended in evolution from bacteria, the potential contributions of their endosymbiont ancestors to specialized cellular pathways in development remain largely unexplored. Here we show that a motile behavior of mitochondria in Drosophila spermiogenesis is strikingly similar to the actin-based "comet tail" motility of several bacteria. A combination of electron and fluorescence microscopy demonstrates major reorganization and movement of mitochondria ahead of, and in close association with, dense conical arrays of actin filaments in the sperm individualization complex, which mediates the resolution of male germline syncytia into separate gametes. Because of several other parallels between the movement of the individualization complex and the motility behavior of some rickettsiae , the bacterial family from which mitochondria are most likely descended, this motility phenomenon is a strong candidate for a true vestige of endosymbiont behavior in contemporary mitochondria. The potential conservation of an ancient endosymbiont motility mechanism within a highly conserved feature of gametogenesis, the resolution of germline syncytia, may indicate a formative role for the endosymbiotic ancestor of mitochondria in the evolution of this developmental pathway.
C1 St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bazinet, C (corresponding author), St Johns Univ, Dept Biol Sci, Jamaica, NY 11439 USA.
EM bazinetc@stjohns.edu
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01 HD36498-01]
   Funding Source: Medline
CR Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094
   Boldogh IR, 2001, P NATL ACAD SCI USA, V98, P3162, DOI 10.1073/pnas.051494698
   Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7
   de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405
   Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137
   Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833
   Fuller Margaret T., 1993, P71
   Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001
   Gouin E, 1999, J CELL SCI, V112, P1697
   Greenspan R. J., 1997, FLY PUSHING THEORY P
   Heinzen RA, 1999, INFECT IMMUN, V67, P4201, DOI 10.1128/IAI.67.8.4201-4207.1999
   Hicks JL, 1999, MOL BIOL CELL, V10, P4341, DOI 10.1091/mbc.10.12.4341
   Margulis L., 1981, SYMBIOSIS CELL EVOLU
   MATTHEWS KA, 1994, DROSOPHILA MELANGOST, P13
   Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406
   Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899
   Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975
   PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614
   ROBERTSON HM, 1988, GENETICS, V118, P461
   Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2
   Santel A, 1998, J CELL SCI, V111, P3299
   Sicheritz-Ponten T, 1998, BBA-BIOENERGETICS, V1365, P545, DOI 10.1016/S0005-2728(98)00099-1
   Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009
   TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597
   TOKUYASU KT, 1972, Z ZELLFORSCH MIK ANA, V124, P479, DOI 10.1007/BF00335253
NR 25
TC 17
Z9 18
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1520-541X
J9 EVOL DEV
JI Evol. Dev.
PD JUL-AUG
PY 2003
VL 5
IS 4
BP 379
EP 385
DI 10.1046/j.1525-142X.2003.03045.x
PG 7
WC Evolutionary Biology; Developmental Biology; Genetics & Heredity
SC Evolutionary Biology; Developmental Biology; Genetics & Heredity
GA 694VY
UT WOS:000183796900006
PM 12823454
DA 2021-01-25
ER

PT J
AU Koenig, BW
   Rogowski, M
   Louis, JM
AF Koenig, BW
   Rogowski, M
   Louis, JM
TI A rapid method to attain isotope labeled small soluble peptides for NMR
   studies
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE E. coli; fusion protein; isotope labeling; NMR; recombinant peptide
ID NUCLEAR-MAGNETIC-RESONANCE; BACTERIALLY EXPRESSED PEPTIDE; RESIDUAL
   DIPOLAR COUPLINGS; CARTILAGE MATRIX PROTEIN; RECEPTOR-BINDING DOMAIN;
   ESCHERICHIA-COLI; MULTIDIMENSIONAL NMR; SECONDARY STRUCTURE; BACKBONE
   DYNAMICS; STRAIN PAK
AB A widely applicable strategy is presented for efficient and rapid production of small water soluble peptides expressed as fusion proteins with the immunoglobulin-binding domain of streptococcal protein G. A simple extraction and purification scheme that includes a protease cleavage step to release the target peptide is described. The yield of authentic target peptide exceeds 10 mg per liter of culture. Production of U-C-13, N-15 and highly deuterated U-C-13, N-15 isotope labeled peptide is demonstrated for the 11 residue S2 peptide, corresponding to the C-terminus of the alpha-subunit of transducin, and the coiled coil trimerization domain from cartilage matrix protein (CMPcc), respectively. Heteronuclear two-dimensional NMR spectra are used for initial peptide characterization.
C1 Res Ctr Julich, Inst Biol Struct, IBI 2, D-52425 Julich, Germany.
   Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.
   Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.
RP Koenig, BW (corresponding author), Res Ctr Julich, Inst Biol Struct, IBI 2, D-52425 Julich, Germany.
RI Koenig, Bernd/B-4315-2008
OI Koenig, Bernd/0000-0002-5300-6276
CR Alexandrescu AT, 1998, PROTEIN SCI, V7, P389
   ARGRAVES WS, 1987, P NATL ACAD SCI USA, V84, P464, DOI 10.1073/pnas.84.2.464
   Campbell AP, 2000, J BIOMOL NMR, V17, P239, DOI 10.1023/A:1008311319998
   CAmpbell AP, 1997, BIOCHEMISTRY-US, V36, P12791, DOI 10.1021/bi9709304
   Campos-Olivas R, 2002, P NATL ACAD SCI USA, V99, P10310, DOI 10.1073/pnas.152342699
   CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2
   Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357
   GOEDDEL DV, 1979, P NATL ACAD SCI USA, V76, P106, DOI 10.1073/pnas.76.1.106
   GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600
   Gross E., 1967, METHOD ENZYMOL, V11, P238
   Huth JR, 1997, PROTEIN SCI, V6, P2359
   ITAKURA K, 1977, SCIENCE, V198, P1056, DOI 10.1126/science.412251
   Jonasson P, 1998, GENE, V210, P203, DOI 10.1016/S0378-1119(98)00026-2
   Jones DH, 2000, BIOCHEMISTRY-US, V39, P1870, DOI 10.1021/bi992495e
   Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755
   Kay LE, 2001, METHOD ENZYMOL, V339, P174, DOI 10.1016/S0076-6879(01)39314-X
   KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088
   Koenig BW, 2000, J BIOMOL NMR, V16, P121, DOI 10.1023/A:1008378523816
   Koenig BW, 2002, CHEMBIOCHEM, V3, P975, DOI 10.1002/1439-7633(20021004)3:10<975::AID-CBIC975>3.0.CO;2-Y
   Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3
   Kohno T, 1998, J BIOMOL NMR, V12, P109, DOI 10.1023/A:1008254603368
   KULIOPULOS A, 1994, J AM CHEM SOC, V116, P4599, DOI 10.1021/ja00090a008
   LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9
   LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187
   Majerle A, 2000, J BIOMOL NMR, V18, P145, DOI 10.1023/A:1008362401928
   MERRIFIELD B, 1995, PEPTIDES SYNTHESIS S, P94
   NAGAI K, 1987, METHOD ENZYMOL, V153, P461
   NI F, 1994, PROG NUCL MAG RES SP, V26, P517, DOI 10.1016/0079-6565(94)80015-4
   Opella SJ, 2001, METHOD ENZYMOL, V339, P285, DOI 10.1016/S0076-6879(01)39319-9
   Ottleben H, 1997, EUR J BIOCHEM, V244, P471, DOI 10.1111/j.1432-1033.1997.00471.x
   Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366
   SANTORO J, 1992, J MAGN RESON, V97, P202, DOI 10.1016/0022-2364(92)90250-B
   Sharon M, 2002, PROTEIN EXPRES PURIF, V24, P374, DOI 10.1006/prep.2001.1577
   SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732
   Tripet B, 1996, PROTEIN ENG, V9, P1029, DOI 10.1093/protein/9.11.1029
   Tugarinov V, 1999, NAT STRUCT BIOL, V6, P331
   Uegaki K, 1996, FEBS LETT, V379, P47, DOI 10.1016/0014-5793(95)01459-4
   VANATALU K, 1993, EUR J BIOCHEM, V216, P315, DOI 10.1111/j.1432-1033.1993.tb18148.x
   VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V
   Walters KJ, 2001, METHOD ENZYMOL, V339, P238, DOI 10.1016/S0076-6879(01)39316-3
   Williamson PTF, 2000, PROTEIN EXPRES PURIF, V19, P271, DOI 10.1006/prep.2000.1246
   Wiltscheck R, 1997, PROTEIN SCI, V6, P1734, DOI 10.1002/pro.5560060814
   Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975
NR 47
TC 38
Z9 39
U1 0
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD JUL
PY 2003
VL 26
IS 3
BP 193
EP 202
DI 10.1023/A:1023887412387
PG 10
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 681NA
UT WOS:000183041200001
PM 12766417
DA 2021-01-25
ER

PT J
AU Dory, D
   Echchannaoui, H
   Letiembre, M
   Ferracin, F
   Pieters, J
   Adachi, Y
   Akashi, S
   Zimmerli, W
   Landmann, R
AF Dory, D
   Echchannaoui, H
   Letiembre, M
   Ferracin, F
   Pieters, J
   Adachi, Y
   Akashi, S
   Zimmerli, W
   Landmann, R
TI Generation and functional characterization of a clonal murine periportal
   Kupffer cell line from H-2K(b)-tsA58 mice
SO JOURNAL OF LEUKOCYTE BIOLOGY
LA English
DT Article
DE mouse; lipopolysaccharide; nitric oxide; phagocytosis
ID MOUSE PERITONEAL-MACROPHAGES; TUMOR-NECROSIS-FACTOR; RAT-LIVER KUPFFER;
   ENDOTHELIAL-CELLS; SCAVENGER RECEPTOR; TRANSGENIC MOUSE; NITRIC-OXIDE;
   IN-VITRO; LIPOPOLYSACCHARIDE-BINDING; MONOCLONAL-ANTIBODY
AB Murine Kupffer cells (KCs) are heterogeneous and survive only for a short time in vitro. Here, a clonal, murine KC fine was generated from transgenic mice, expressing the thermolabile mutant tsA58 of the Simian virus 40 large T antigen under the control of the H-2K(b) promoter. Thirty-three degrees Celsius and 37degreesC but not 39degreesC have been permissive for growth of the clone; it required conditioned media from hepatocytes and endothelial cells for proliferation. In contrast to primary cells, the cells of the clone were uniform, survived detachment, and could therefore be analyzed by cytofluorimetry. The clone, as primary KCs, constitutively expressed nonspecific esterase, peroxidase, MOMA-2, BM8, scavenger receptor A, CD14, and Toll-like receptor 4 (TLR4); the antigen-presenting molecules CD40, CD80, and CD1d; and endocytosed dextran-fluorescein isothiocyanate. It lacked complement, Fc receptors, F4/80 marker, and the phagosomal coat protein tryptophan aspartate-containing coat protein (TACO). The clone exhibited CD14- and TLR4/ MD2-independent, plasma-dependent lipopolysaccharide (LPS) binding, Escherichia coli and Streptococcus pneumoniae phagocytosis, and LPS- and interferon-gamma-induced NO production but no tumor necrosis factor alpha, interleukin (IL)-6, or IL-10 release. The large size, surface-marker expression, and capacity to clear gram-negative and -positive bacteria indicate that the clone was derived from the periportal, large KC subpopulation. The clone allows molecular studies of anti-infective and immune functions of KCs.
C1 Univ Basel Hosp, Div Infect Dis, Res Dept, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Biochem, CH-4003 Basel, Switzerland.
   Tokyo Univ Pharm & Life Sci, Lab Immunopharmacol Microbial Prod, Tokyo, Japan.
   Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Infect Genet, Tokyo, Japan.
RP Landmann, R (corresponding author), Univ Basel Hosp, Div Infect Dis, Res Dept, Hebelstr 20, CH-4031 Basel, Switzerland.
RI Dory, Daniel/ABC-3914-2020; Echchannaoui, Hakim/A-9474-2017
OI Echchannaoui, Hakim/0000-0001-9980-9974; Letiembre,
   Maryse/0000-0003-4619-2979; Pieters, Jean/0000-0002-5284-9757
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [15590431] Funding Source: KAKEN
CR Adachi Y, 1999, J ENDOTOXIN RES, V5, P139, DOI 10.1179/096805199101531642
   ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0
   Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228
   Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471
   Arii S, 2000, J Hepatobiliary Pancreat Surg, V7, P40, DOI 10.1007/s005340050152
   Barber RD, 1997, BBA-MOL CELL RES, V1355, P191, DOI 10.1016/S0167-4889(96)00124-3
   Barber RD, 2000, J NEUROSCI, V20, P3695
   Bellezzo JM, 1996, AM J PHYSIOL-GASTR L, V270, pG956
   BENDELAC A, 1995, SCIENCE, V269, P185, DOI 10.1126/science.7542402
   BIRMELIN M, 1984, EUR J BIOCHEM, V142, P219, DOI 10.1111/j.1432-1033.1984.tb08274.x
   BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430
   Cauwels A, 1999, J IMMUNOL, V162, P4762
   Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x
   Dennis JE, 1996, CONNECT TISSUE RES, V35, P93, DOI 10.3109/03008209609029179
   DERIJKE YB, 1994, J BIOL CHEM, V269, P824
   DING AH, 1988, J IMMUNOL, V141, P2407
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   HEUFF G, 1993, J IMMUNOL METHODS, V159, P115, DOI 10.1016/0022-1759(93)90148-Z
   Hoebe KHN, 2000, VET QUART, V22, P21, DOI 10.1080/01652176.2000.9695018
   HUGHES DA, 1995, EUR J IMMUNOL, V25, P466, DOI 10.1002/eji.1830250224
   Ikejima K, 1999, AM J PHYSIOL-GASTR L, V276, pG591
   ITOH Y, 1992, LIVER, V12, P26
   JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096
   Kanda S, 1996, CELL GROWTH DIFFER, V7, P383
   KNOOK DL, 1976, EXP CELL RES, V99, P444, DOI 10.1016/0014-4827(76)90605-4
   Landmann R, 2000, MICROBES INFECT, V2, P295, DOI 10.1016/S1286-4579(00)00298-7
   Leifeld L, 1999, AM J PATHOL, V154, P1711, DOI 10.1016/S0002-9440(10)65427-2
   Lichtman SN, 1998, AM J PHYSIOL-GASTR L, V275, pG39
   Lohse AW, 1996, GASTROENTEROLOGY, V110, P1175, DOI 10.1053/gast.1996.v110.pm8613007
   MALORNY U, 1986, CELL TISSUE RES, V243, P421
   Matsuura T, 1998, INT J ARTIF ORGANS, V21, P229
   Milosevic N, 2000, EUR J PHARMACOL, V401, P317, DOI 10.1016/S0014-2999(00)00473-8
   Miyakawa K, 1999, ANAL QUANT CYTOL, V21, P329
   Moens U, 1997, VIRUS GENES, V15, P135, DOI 10.1023/A:1007962908248
   Mustafa SB, 1999, HEPATOLOGY, V30, P1206, DOI 10.1002/hep.510300530
   Netea MG, 2002, J INFECT DIS, V185, P1483, DOI 10.1086/340511
   NOBLE M, 1995, TRANSGENIC RES, V4, P215, DOI 10.1007/BF01969114
   OLYNYK JK, 1994, AM J PHYSIOL, V267, pG213
   Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000
   Pradel G, 2001, HEPATOLOGY, V33, P1154, DOI 10.1053/jhep.2001.24237
   Schmalzl F, 1970, Ser Haematol, V3, P93
   Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x
   Sheth K, 2000, SHOCK, V14, P380, DOI 10.1097/00024382-200014030-00024
   SLEYSTER EC, 1982, LAB INVEST, V47, P484
   SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509
   Su GL, 2000, HEPATOLOGY, V31, P932, DOI 10.1053/he.2000.5634
   ten Hagen TL, 1998, LIVER, V18, P299
   tenHagen TLM, 1996, J IMMUNOL METHODS, V193, P81, DOI 10.1016/0022-1759(96)00045-2
   Terpstra V, 2000, BLOOD, V95, P2157, DOI 10.1182/blood.V95.6.2157
   Uwatoku R, 2001, ARCH HISTOL CYTOL, V64, P223, DOI 10.1679/aohc.64.223
   van Oosten M, 1998, INFECT IMMUN, V66, P5107, DOI 10.1128/IAI.66.11.5107-5112.1998
   Wheeler MD, 2001, J LEUKOCYTE BIOL, V69, P622
   Yoshioka M, 1998, VET IMMUNOL IMMUNOP, V66, P301, DOI 10.1016/S0165-2427(98)00206-2
NR 55
TC 22
Z9 23
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0741-5400
J9 J LEUKOCYTE BIOL
JI J. Leukoc. Biol.
PD JUL
PY 2003
VL 74
IS 1
BP 49
EP 59
DI 10.1189/jlb.0302133
PG 11
WC Cell Biology; Hematology; Immunology
SC Cell Biology; Hematology; Immunology
GA 755FB
UT WOS:000187367800008
PM 12832442
OA Bronze
DA 2021-01-25
ER

PT J
AU Schwede, T
   Kopp, J
   Guex, N
   Peitsch, MC
AF Schwede, T
   Kopp, J
   Guex, N
   Peitsch, MC
TI SWISS-MODEL: an automated protein homology-modeling server
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID NEW-GENERATION; PREDICTION; DATABASE; TOOLS
AB SWISS-MODEL (http://swissmodel.expasy.org) is a server for automated comparative modeling of three-dimensional (3D) protein structures. It pioneered the field of automated modeling starting in 1993 and is the most widely-used free web-based automated modeling facility today. In 2002 the server computed 120 000 user requests for 3D protein models. SWISS-MODEL provides several levels of user interaction through its World Wide Web interface: in the 'first approach mode' only an amino acid sequence of a protein is submitted to build a 3D model. Template selection, alignment and model building are done completely automated by the server. In the 'alignment mode', the modeling process is based on a user-defined target-template alignment. Complex modeling tasks can be handled with the 'project mode' using DeepView (Swiss-PdbViewer), an integrated sequence-to-structure workbench. All models are sent back via email with a detailed modeling report. WhatCheck analyses and ANOLEA evaluations are provided optionally. The reliability of SWISS-MODEL is continuously evaluated in the EVA-CM project. The SWISS-MODEL server is under constant development to improve the successful implementation of expert knowledge into an easy-to-use server.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   GlaxoSmithKline, Res Triangle Pk, NC 27709 USA.
   Swiss Inst Bioinformat, Basel, Switzerland.
   Novartis AG, CH-4002 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008; Peitsch, Manuel/J-7416-2017
OI Schwede, Torsten/0000-0003-2715-335X; Kopp, Juergen/0000-0001-5633-7399;
   Peitsch, Manuel/0000-0001-5324-359X
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8
   Bates PA, 2001, PROTEINS, P39
   Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095
   Brenner SE, 2001, NAT REV GENET, V2, P801, DOI 10.1038/35093574
   Eyrich VA, 2001, BIOINFORMATICS, V17, P1242, DOI 10.1093/bioinformatics/17.12.1242
   Flohil JA, 2002, PROTEINS, V48, P593, DOI 10.1002/prot.10105
   Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D
   Koehl Patrice, 1999, Nature Structural Biology, V6, P108, DOI 10.1038/5794
   Kopp E, 2003, FUNC GENOM, V3, P89
   Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250
   Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.3.CO;2-U
   Lund O, 1997, PROTEIN ENG, V10, P1241, DOI 10.1093/protein/10.11.1241
   Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Moult J, 1996, CURR OPIN BIOTECH, V7, P422, DOI 10.1016/S0958-1669(96)80118-2
   Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046
   PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658
   Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274
   Peitsch MC, 2002, BIOINFORMATICS, V18, P934, DOI 10.1093/bioinformatics/18.7.934
   PEITSCH MC, 1993, INT IMMUNOL, V5, P233, DOI 10.1093/intimm/5.2.233
   Sali A, 1999, TRENDS BIOCHEM SCI, V24, pM20, DOI 10.1016/S0968-0004(99)01494-2
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597
   Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2
   SUTCLIFFE MJ, 1987, PROTEIN ENG, V1, P377, DOI 10.1093/protein/1.5.377
   Tramontano A, 2001, PROTEINS, P22, DOI 10.1002/prot.10015
   van Gunsteren W. F., 1996, BIOMOLECULAR SIMULAT
   Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640
   Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068
NR 35
TC 3858
Z9 4218
U1 3
U2 177
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 1
PY 2003
VL 31
IS 13
BP 3381
EP 3385
DI 10.1093/nar/gkg520
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 695LT
UT WOS:000183832900024
PM 12824332
OA Green Accepted, Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Falquet, L
   Bordoli, L
   Ioannidis, V
   Pagni, M
   Jongeneel, CV
AF Falquet, L
   Bordoli, L
   Ioannidis, V
   Pagni, M
   Jongeneel, CV
TI Swiss EMBnet node web server
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID MULTIPLE SEQUENCE ALIGNMENT; PROTEIN SEQUENCES; DATABASE; PROGRAMS;
   FEATURES
AB EMBnet is a consortium of collaborating bioinformatics groups located mainly within Europe (http://www.embnet.org). Each member country is represented by a 'node', a group responsible for the maintenance of local services for their users (e.g. education, training, software, database distribution, technical support, helpdesk). Among these services a web portal with links and access to locally developed and maintained software is essential and different for each node. Our web portal targets biomedical scientists in Switzerland and elsewhere, offering them access to a collection of important sequence analysis tools mirrored from other sites or developed locally. We describe here the Swiss EMBnet node web site (http://www.ch.embnet.org), which presents a number of original services not available anywhere else.
C1 SIB, CH-1066 Epalinges, Switzerland.
   Univ Basel, Biozentrum, SIB, CH-4056 Basel, Switzerland.
   Ludwig Inst Canc Res, Off Informat Technol, CH-1066 Epalinges, Switzerland.
RP Falquet, L (corresponding author), SIB, CH-1066 Epalinges, Switzerland.
EM laurent.falquet@isb-sib.ch
RI Falquet, Laurent/C-2541-2013; Jongeneel, Cornelis V/B-2135-2012
OI Falquet, Laurent/0000-0001-8102-7579; Pagni, Marco/0000-0001-9292-9463;
   Jongeneel, Cornelis Victor/0000-0002-3922-1906; Ioannidis,
   Vassilios/0000-0002-4209-2578
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BRENDEL V, 1992, P NATL ACAD SCI USA, V89, P2002, DOI 10.1073/pnas.89.6.2002
   Christoffels A, 2001, NUCLEIC ACIDS RES, V29, P234, DOI 10.1093/nar/29.1.234
   Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083
   Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617
   Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235
   HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D
   Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138
   Junier T, 2000, BIOINFORMATICS, V16, P178, DOI 10.1093/bioinformatics/16.2.178
   KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264
   Letondal C, 2001, BIOINFORMATICS, V17, P73, DOI 10.1093/bioinformatics/17.1.73
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Pagni M, 2001, NUCLEIC ACIDS RES, V29, P148, DOI 10.1093/nar/29.1.148
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   PEARSON WR, 1990, METHOD ENZYMOL, V183, P63
   Praz V, 2002, NUCLEIC ACIDS RES, V30, P322, DOI 10.1093/nar/30.1.322
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Stoffel W., 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Zdobnov EM, 2002, BIOINFORMATICS, V18, P1149, DOI 10.1093/bioinformatics/18.8.1149
NR 21
TC 10
Z9 10
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 1
PY 2003
VL 31
IS 13
BP 3782
EP 3783
DI 10.1093/nar/gkg547
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 695LT
UT WOS:000183832900109
PM 12824417
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Lee, DL
   Ivaninskii, S
   Burkhard, P
   Hodges, RS
AF Lee, DL
   Ivaninskii, S
   Burkhard, P
   Hodges, RS
TI Unique stabilizing interactions identified in the two-stranded
   alpha-helical coiled-coil: Crystal structure of a cortexillin I/GCN4
   hybrid coiled-coil peptide
SO PROTEIN SCIENCE
LA English
DT Article
DE coiled-coil; protein folding; protein stability; protein
   oligomerization; electrostatics; side-chain packing; circular dichroism
   spectroscopy
ID GCN4 LEUCINE-ZIPPER; AMINO-ACID SUBSTITUTIONS; OLIGOMERIZATION-STATE;
   HYDROPHOBIC CORE; PROTEIN DESIGN; SALT BRIDGES; TRIGGER SITE; ROD
   DOMAIN; PROPENSITY; SPECIFICITY
AB We determined the 1.17 Angstrom resolution X-ray crystal structure of a hybrid peptide based on sequences from coiled-coil regions of the proteins GCN4 and cortexillin I. The peptide forms a parallel homodimeric coiled-coil, with C-alpha backbone geometry similar to GCN4 (rmsd value 0.71 Angstrom). Three stabilizing interactions have been identified: a unique hydrogen bonding-electrostatic network not previously observed in coiled-coils, and two other hydrophobic interactions involving leucine residues at positions e and g from both g-a' and d-e' interchain interactions with the hydrophobic core. This is also the first report of the quantitative significance of these interactions. The GCN4/cortexillin hybrid surprisingly has two interchain Glu-Lys' ion pairs that form a hydrogen bonding network with the Asn residues in the core. This network, which was not observed for the reversed Lys-Glu' pair in GCN4, increases the combined stability contribution of each Glu-Lys' salt bridge across the central Asn15-Asn15' core to similar to0.7 kcal/mole, compared to similar to0.4 kcal mole(-1) from a Glu-Lys' salt bridge on its own. In addition to electrostatic and hydrogen bonding stabilization of the coiled-coil, individual leucine residues at positions e and g in the hybrid peptide also contribute to stability by 0.7 kcal/mole relative to alanine. These interactions are of critical importance to understanding the stability requirements for coiled-coil folding and in modulating the stability of de novo designed macromolecules containing this motif.
C1 Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA.
   Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.
   Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Hodges, RS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Box B121,4200 E 9th Ave, Denver, CO 80262 USA.
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM061855] Funding Source: Medline
CR Acharya A, 2002, BIOCHEMISTRY-US, V41, P14122, DOI 10.1021/bi020486r
   Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w
   Arndt KM, 2002, STRUCTURE, V10, P1235, DOI 10.1016/S0969-2126(02)00838-9
   BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259
   Berger B, 1997, J COMPUT BIOL, V4, P261, DOI 10.1089/cmb.1997.4.261
   BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   Campbell KM, 2002, BIOCHEMISTRY-US, V41, P4866, DOI 10.1021/bi0159276
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   Dieckmann GR, 1998, J MOL BIOL, V280, P897, DOI 10.1006/jmbi.1998.1891
   Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W
   Frank S, 2000, J BIOL CHEM, V275, P11672, DOI 10.1074/jbc.275.16.11672
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462
   Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877
   Hodges R. S., 1972, COLD SPRING HARB SYM, V37, P299
   Kammerer RA, 2001, J BIOL CHEM, V276, P13685, DOI 10.1074/jbc.M010492200
   Kohn WD, 1997, J BIOL CHEM, V272, P2583, DOI 10.1074/jbc.272.5.2583
   Kohn WD, 1998, J MOL BIOL, V283, P993, DOI 10.1006/jmbi.1998.2125
   KOHN WD, 1995, PROTEIN SCI, V4, P237
   Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LAU SYM, 1984, J BIOL CHEM, V259, P3253
   Lee DL, 2001, J MOL BIOL, V306, P539, DOI 10.1006/jmbi.2000.4351
   Litowski JR, 2002, J BIOL CHEM, V277, P37272, DOI 10.1074/jbc.M204257200
   Litowski JR, 1999, J PEPT RES, V54, P1, DOI 10.1034/j.1399-3011.1999.00066.x
   Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.3.CO;2-U
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   McClain DL, 2001, J AM CHEM SOC, V123, P3151, DOI 10.1021/ja004099l
   McPherson A., 1982, PREPARATION ANAL PRO
   Micklatcher C, 1999, CURR OPIN CHEM BIOL, V3, P724, DOI 10.1016/S1367-5931(99)00031-9
   MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0
   Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507
   Myers JK, 1997, P NATL ACAD SCI USA, V94, P2833, DOI 10.1073/pnas.94.7.2833
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pace CN, 1998, BIOPHYS J, V75, P422
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   Phelan P, 2002, BIOCHEMISTRY-US, V41, P2998, DOI 10.1021/bi011920c
   POTEKHIN SA, 1994, PROTEIN ENG, V7, P1097, DOI 10.1093/protein/7.9.1097
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0
   SHELDRICK GM, 1996, METHOD ENZYMOL, V276, P319
   Singh M, 1999, J MOL BIOL, V290, P1031, DOI 10.1006/jmbi.1999.2796
   Steinbok P, 1998, CHILD NERV SYST, V14, P1, DOI 10.1007/s003810050163
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866
   TRIPET B, 2001, PEPTIDES WAVE FUTURE, P365
   Wagschal K, 1999, J MOL BIOL, V285, P785, DOI 10.1006/jmbi.1998.2284
   Wagschal K, 1999, PROTEIN SCI, V8, P2312
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
   Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539
   ZHOU NE, 1994, PROTEIN ENG, V7, P1365, DOI 10.1093/protein/7.11.1365
   Zhu H, 2000, J MOL BIOL, V300, P1377, DOI 10.1006/jmbi.2000.3936
NR 60
TC 29
Z9 29
U1 0
U2 4
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI WOODBURY
PA 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD JUL
PY 2003
VL 12
IS 7
BP 1395
EP 1405
DI 10.1110/ps.0241403
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 694CR
UT WOS:000183756700009
PM 12824486
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Daniel, E
   Lustig, A
   David, MM
   Tsfadia, Y
AF Daniel, E
   Lustig, A
   David, MM
   Tsfadia, Y
TI Towards a resolution of the long-standing controversy regarding the
   molecular mass of extracellular erythrocruorin of the earthworm
   Lumbricus terrestris
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article
DE Lumbricus erythrocruorin; earthworm erythrocruorin; Lumbricus
   hemoglobin; earthworm hemoglobin; molecular mass; central subunit
ID MULTI-HEMOGLOBIN SYSTEM; WORM RIFTIA PACHYPTILA; QUATERNARY STRUCTURE;
   SUBUNIT STRUCTURE; 3-DIMENSIONAL RECONSTRUCTION; ARENICOLA-MARINA;
   ARCHITECTURE; EQUILIBRIUM; STOICHIOMETRY; DISSOCIATION
AB The published molecular mass of erythrocruorin of Lumbricus terrestris and related earthworm species covers a bewildering range of 3.23-4.5 MDa. A critical reexamination reveals that some mass determinations were underestimated and the results do cluster, not at one, but at two values of the molecular mass. One cluster corresponds to similar to 3.6 MDa, as predicted for a stoichiometry of 144 globin and 36 linker chains-the Vinogradov model for the hexagonal bilayer (HBL) assembly of Lumbricus erythrocruorin-and as estimated from the crystal structure of HBL at 5.5 Angstrom resolution [Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7107]. The other cluster corresponds to similar to 4.4 MDa. In addition, a molecular mass of 4.1 MDa, determined by multiangle laser light scattering (MALLS), stands apart of the two clusters, separated from the masses obtained by other methods of molecular mass determination.
   We propose a stoichiometry of 192 globin and 36 linker chains for the 4.4-MDa molecule. The 36 linkers and 144 out of 192 globin chains are identified with the HBL and the remaining 48 globins are allotted equally to the two halves of the axial cavity above and below the central torus of the structure. The proposed model is supported by the occurrence in some annelid species of erythrocruorin with centrally placed subunits [Biochim. Biophys. Acta 359 (1974) 2101, and by the oxidation-dependent shedding of subunits in Lumbricus erythrocruorin. We propose further that the 4.1 MDa determination represents the weight average molecular mass of a population of molecules resulting from a partial dissociation of 4.4-MDa erythrocruorin. This interpretation seems reasonable on the background of the very low protein concentrations (similar to 100 mug/ml and lower) prevailing at the MALLS experiment. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, IL-699978 Tel Aviv, Israel.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Daniel, E (corresponding author), Tel Aviv Univ, Dept Biochem, George S Wise Fac Life Sci, IL-699978 Tel Aviv, Israel.
CR CANTOR CR, 1980, BIOPHYSICAL CHEM, V2
   CEJKA Z, 1989, J ULTRA MOL STRUCT R, V102, P71, DOI 10.1016/0889-1605(89)90035-9
   CEJKA Z, 1991, J STRUCT BIOL, V107, P259, DOI 10.1016/1047-8477(91)90051-W
   CHIANCONE E, 1972, J MOL BIOL, V70, P73, DOI 10.1016/0022-2836(72)90164-7
   CHIANCONE E, 1976, J MOL BIOL, V107, P25
   DARAWSHE S, 1991, EUR J BIOCHEM, V201, P169, DOI 10.1111/j.1432-1033.1991.tb16270.x
   DAVID MM, 1974, J MOL BIOL, V87, P89, DOI 10.1016/0022-2836(74)90561-0
   deHaas F, 1996, J MOL BIOL, V264, P111, DOI 10.1006/jmbi.1996.0627
   deHaas F, 1997, BIOCHEMISTRY-US, V36, P7330, DOI 10.1021/bi970131l
   ELLERTON HD, 1987, COMP BIOCHEM PHYS B, V87, P1011, DOI 10.1016/0305-0491(87)90426-3
   Fujita H, 1962, MATH THEORY SEDIMENT
   GIARDINA B, 1975, J MOL BIOL, V93, P1, DOI 10.1016/0022-2836(75)90355-1
   GROS G, 1978, BIOPHYS J, V22, P453, DOI 10.1016/S0006-3495(78)85499-X
   JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4
   Lamy JN, 1996, CHEM REV, V96, P3113, DOI 10.1021/cr9600058
   Martin PD, 1996, J MOL BIOL, V255, P154, DOI 10.1006/jmbi.1996.0013
   OHTSUKI M, 1983, J ULTRA MOL STRUCT R, V83, P312, DOI 10.1016/S0022-5320(83)90138-7
   OWNBY DW, 1993, J BIOL CHEM, V268, P13539
   Pessen H, 1973, Methods Enzymol, V27, P151
   Pilz I, 1979, Methods Enzymol, V61, P148
   PILZ I, 1980, INT J BIOL MACROMOL, V2, P279, DOI 10.1016/0141-8130(80)90045-8
   PIONETTI JM, 1980, EUR J BIOCHEM, V105, P131, DOI 10.1111/j.1432-1033.1980.tb04482.x
   ROSSIFANELLI MR, 1970, ARCH BIOCHEM BIOPHYS, V141, P278
   ROYER WE, 1988, J BIOL CHEM, V263, P13762
   Royer WE, 2000, P NATL ACAD SCI USA, V97, P7107, DOI 10.1073/pnas.97.13.7107
   SCHATZ M, 1995, J STRUCT BIOL, V114, P28, DOI 10.1006/jsbi.1995.1003
   SHLOM JM, 1973, J BIOL CHEM, V248, P7904
   Svedberg T, 1933, J AM CHEM SOC, V55, P2834, DOI 10.1021/ja01334a033
   Svedberg T, 1940, THE ULTRACENTRIFUGE
   Tanford C., 1961, PHYSICAL CHEM MACROM
   Tsfadia Y, 1999, BBA-PROTEIN STRUCT M, V1433, P217, DOI 10.1016/S0167-4838(99)00134-X
   van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644
   van Heel M., 1989, BIOCHIM BIOPHYS ACTA, V957, P370
   VANBRUGGEN EF, 1974, BIOCHIM BIOPHYS ACTA, V359, P210, DOI 10.1016/0005-2795(74)90145-7
   Vinogradov S. N., 1982, ELECTRON MICROS, P135
   VINOGRADOV SN, 1977, BIOCHIM BIOPHYS ACTA, V492, P136, DOI 10.1016/0005-2795(77)90221-5
   VINOGRADOV SN, 1988, COMP BIOCHEM PHYS B, V91, P577, DOI 10.1016/0305-0491(88)90024-7
   VINOGRADOV SN, 1986, P NATL ACAD SCI USA, V83, P8034, DOI 10.1073/pnas.83.21.8034
   WOOD EJ, 1976, BIOCHEM J, V153, P589, DOI 10.1042/bj1530589
   WYATT PJ, 1993, J CHROMATOGR, V648, P27, DOI 10.1016/0021-9673(93)83285-Z
   YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003
   Zal F, 1996, J BIOL CHEM, V271, P8869, DOI 10.1074/jbc.271.15.8869
   Zal F, 1996, J BIOL CHEM, V271, P8875, DOI 10.1074/jbc.271.15.8875
   Zal F, 1997, EUR J BIOCHEM, V243, P85, DOI 10.1111/j.1432-1033.1997.85_1a.x
   Zhu H, 1996, J BIOL CHEM, V271, P30007, DOI 10.1074/jbc.271.47.30007
   Zhu H, 1996, J BIOL CHEM, V271, P29999, DOI 10.1074/jbc.271.47.29999
NR 46
TC 11
Z9 11
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-9639
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD JUN 26
PY 2003
VL 1649
IS 1
BP 1
EP 15
DI 10.1016/S1570-9639(03)00023-2
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 694RG
UT WOS:000183787400001
PM 12818185
DA 2021-01-25
ER

PT J
AU Liang, Y
   Fotiadis, D
   Filipek, S
   Saperstein, DA
   Palczewski, K
   Engel, A
AF Liang, Y
   Fotiadis, D
   Filipek, S
   Saperstein, DA
   Palczewski, K
   Engel, A
TI Organization of the G protein-coupled receptors rhodopsin and opsin in
   native membranes
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ROD OUTER SEGMENT; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE;
   MONOCLONAL-ANTIBODIES; LATERAL DIFFUSION; DISK MEMBRANES; VISUAL
   PIGMENT; TRANSDUCIN; ARRESTIN; ACTIVATION
AB G protein- coupled receptors ( GPCRs), which constitute the largest and structurally best conserved family of signaling molecules, are involved in virtually all physiological processes. Crystal structures are available only for the detergent-solubilized light receptor rhodopsin. In addition, this receptor is the only GPCR for which the presumed higher order oligomeric state in native membranes has been demonstrated ( Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D. A., Engel, A., and Palczewski, K. ( 2003) Nature 421, 127 - 128). Here, we have determined by atomic force microscopy the organization of rhodopsin in native membranes obtained from wild- type mouse photoreceptors and opsin isolated from photoreceptors of Rpe65 -/- mutant mice, which do not produce the chromophore 11- cis-retinal. The higher order organization of rhodopsin was present irrespective of the support on which the membranes were adsorbed for imaging. Rhodopsin and opsin form structural dimers that are organized in paracrystalline arrays. The intradimeric contact is likely to involve helices IV and V, whereas contacts mainly between helices I and II and the cytoplasmic loop connecting helices V and VI facilitate the formation of rhodopsin dimer rows. Contacts between rows are on the extracellular side and involve helix I. This is the first semi- empirical model of a higher order structure of a GPCR in native membranes, and it has profound implications for the understanding of how this receptor interacts with partner proteins.
C1 Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.
   Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem, Seattle, WA 98195 USA.
   Univ Basel, ME Muller Inst Microscopy, Biozentrum, CH-4056 Basel, Switzerland.
   Warsaw Univ, Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.
   Warsaw Univ, Fac Chem, PL-02109 Warsaw, Poland.
RP Palczewski, K (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.
EM palczews@u.washington.edu
RI Filipek, Slawomir/A-2985-2008
OI Filipek, Slawomir/0000-0003-3147-3858
FU NATIONAL EYE INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, R01EY008061, R03EY013726, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, R01EY008061,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, R01EY008061,
   P30EY001730, R01EY008061, P30EY001730, R01EY008061, P30EY001730,
   R01EY008061, P30EY001730, P30EY001730, R01EY008061, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R29EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R29EY008061, P30EY001730, P30EY001730, R01EY008061,
   R01EY008061, R29EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, R03EY013726,
   R01EY008061, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, R29EY008061,
   R01EY008061, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, R29EY008061, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, R01EY008061, R01EY008061,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, R03EY013726, P30EY001730,
   P30EY001730, R29EY008061, P30EY001730, R01EY008061, R01EY008061] Funding
   Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [R03 EY013726, EY08061, EY 017301, R01 EY008061, P30
   EY001730, EY 13726] Funding Source: Medline
CR ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H
   Arimoto R, 2001, BIOPHYS J, V81, P3285, DOI 10.1016/S0006-3495(01)75962-0
   Ballesteros J, 2001, Curr Opin Drug Discov Devel, V4, P561
   BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613
   BLASIE JK, 1965, J MOL BIOL, V14, P143, DOI 10.1016/S0022-2836(65)80236-4
   BLASIE JK, 1969, J MOL BIOL, V39, P417, DOI 10.1016/0022-2836(69)90136-3
   Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575
   BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201
   BRUCKERT F, 1992, BIOPHYS J, V63, P616, DOI 10.1016/S0006-3495(92)81650-8
   CONE RA, 1972, NATURE-NEW BIOL, V236, P39
   CORLESS JM, 1982, P NATL ACAD SCI-BIOL, V79, P1116, DOI 10.1073/pnas.79.4.1116
   Dean MK, 2001, J MED CHEM, V44, P4595, DOI 10.1021/jm010290+
   DRATZ EA, 1985, BIOCHIM BIOPHYS ACTA, V832, P337, DOI 10.1016/0167-4838(85)90268-7
   Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Gehring WJ, 2002, INT J DEV BIOL, V46, P65
   George SR, 2002, NAT REV DRUG DISCOV, V1, P808, DOI 10.1038/nrd913
   Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147
   Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200
   HAMM HE, 1986, BIOCHEMISTRY-US, V25, P4512, DOI 10.1021/bi00364a010
   HENDERSON R, 1990, PHILOS T ROY SOC B, V326, P379, DOI 10.1098/rstb.1990.0019
   Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   LAIRD DW, 1988, INVEST OPHTH VIS SCI, V29, P419
   Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736
   LIEBMAN PA, 1982, METHOD ENZYMOL, V81, P660
   LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001
   LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457
   MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041
   Marshall GR, 2001, BIOPOLYMERS, V60, P246, DOI 10.1002/1097-0282(2001)60:3<246::AID-BIP10044>3.0.CO;2-V
   MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215
   McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7
   Min KC, 2000, PROTEIN EXPRES PURIF, V20, P514, DOI 10.1006/prep.2000.1326
   Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7
   OHGURO H, 1993, P NATL ACAD SCI USA, V90, P3241, DOI 10.1073/pnas.90.8.3241
   Okada T, 2001, CURR OPIN STRUC BIOL, V11, P420, DOI 10.1016/S0959-440X(00)00227-X
   Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399
   Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6
   PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027
   PALCZEWSKI K, 1988, J BIOL CHEM, V263, P14067
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908
   Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813
   Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7
   SAIBIL H, 1976, NATURE, V262, P266, DOI 10.1038/262266a0
   SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   SCHERTLER GFX, 1995, P NATL ACAD SCI USA, V92, P11578, DOI 10.1073/pnas.92.25.11578
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   Schubert C, 1999, J BIOL CHEM, V274, P21186, DOI 10.1074/jbc.274.30.21186
   Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200
   STRYER L, 1985, BIOPOLYMERS, V24, P29, DOI 10.1002/bip.360240105
   Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091
   Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297
   Wagner HJ, 1998, PROG RETIN EYE RES, V17, P637, DOI 10.1016/S1350-9462(98)00003-2
   Walz T, 1996, J MOL BIOL, V264, P907, DOI 10.1006/jmbi.1996.0686
   WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697
   YEAGER MJ, 1976, BROOKHAVEN SYM BIOL, pR3
NR 60
TC 505
Z9 518
U1 0
U2 47
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 13
PY 2003
VL 278
IS 24
BP 21655
EP 21662
DI 10.1074/jbc.M302536200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 687AT
UT WOS:000183354200044
PM 12663652
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Heerklotz, H
   Szadkowska, H
   Anderson, T
   Seelig, J
AF Heerklotz, H
   Szadkowska, H
   Anderson, T
   Seelig, J
TI The sensitivity of lipid domains to small perturbations demonstrated by
   the effect of triton
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE lipid rafts; sphingomyelin; cholesterol; ITC; enthalpy
ID MEMBRANE DOMAINS; PHASE-EQUILIBRIA; RAFTS; CHOLESTEROL; PROTEINS;
   BILAYERS
AB The hypothesis of lipid rafts describes functional domains in biological membranes. It is often assumed that rafts form by spontaneous de-mixing of certain lipids and that they can be isolated as detergent-resistant membrane particles (DRMs) using the detergent Triton X-100 (TX). Here, we present a model that describes the process of domain formation in membranes in the presence and in the absence of TX We measure the interactions between TX and an equimolar mixture of sphingomyelin (SM), cholesterol (Cho), and 1-palmitoyl-2-oleoyl-3-sn-glycero-phosphatidylcholine (POPC) (1:1:1, mol) by means of isothermal titration calorimetry. Comparison with pure POPC membranes, reveals a very unfavorable interaction between TX and SM/Cho, which causes a substantial tendency to segregate these molecules into separate, DRM-like (SM-rich) and fluid (TX-rich), domains. If rafts are indeed formed by spontaneous de-mixing of PC and SM/Cho, they must be very sensitive, and perturbations caused by techniques used to study rafts could lead to misleading results. If, however, rafts, are much more stable than PC-SM-Cho domains, there must be an unknown raft stabilizer. Subtle changes of such a promoter could serve to modulate raft function. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM heiko.heerklotz@unibas.ch
OI Heerklotz, Heiko/0000-0003-4615-7022
CR Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886
   Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575
   BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J
   Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0
   Edidin M, 2001, TRENDS CELL BIOL, V11, P492, DOI 10.1016/S0962-8924(01)02139-0
   EDIDIN M, 2003, ANNU REV BIOPH BIOM, V16, P16
   Epand RM, 2001, BIOCHEMISTRY-US, V40, P10514, DOI 10.1021/bi010897s
   ESTEP TN, 1979, BIOCHEMISTRY-US, V18, P2112, DOI 10.1021/bi00577a042
   GAWRISCH K, 1995, MOL MEMBR BIOL, V12, P83, DOI 10.3109/09687689509038500
   Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162
   IPSEN JH, 1989, BIOPHYS J, V56, P661, DOI 10.1016/S0006-3495(89)82713-4
   Keller SL, 2000, BIOPHYS J, V79, P2033, DOI 10.1016/S0006-3495(00)76451-4
   LICHTENBERG D, 1985, BIOCHIM BIOPHYS ACTA, V821, P470, DOI 10.1016/0005-2736(85)90052-5
   London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1
   Pike LJ, 2002, BIOCHEMISTRY-US, V41, P2075, DOI 10.1021/bi0156557
   Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097
   Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021
   Wang TY, 2003, BIOPHYS J, V84, P367, DOI 10.1016/S0006-3495(03)74857-7
   YU J, 1973, Journal of Supramolecular Structure, V1, P233, DOI 10.1002/jss.400010308
NR 24
TC 137
Z9 140
U1 1
U2 11
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUN 13
PY 2003
VL 329
IS 4
BP 793
EP 799
DI 10.1016/S0022-2836(03)00504-7
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 691HY
UT WOS:000183601400015
PM 12787678
DA 2021-01-25
ER

PT J
AU Hoogenboom, BW
   Berthod, C
   Peter, M
   Fischer, O
   Kordyuk, AA
AF Hoogenboom, BW
   Berthod, C
   Peter, M
   Fischer, O
   Kordyuk, AA
TI Modeling scanning tunneling spectra of Bi2Sr2CaCu2O8+delta
SO PHYSICAL REVIEW B
LA English
DT Article
ID HIGH-TEMPERATURE SUPERCONDUCTORS; OVERDOPED BI2SR2CACU2O8+DELTA; SPIN
   EXCITATION; GAP; SPECTROSCOPY; PHOTOEMISSION; SCATTERING; PSEUDOGAP;
   RESONANCE; VORTEX
AB Recent angle-resolved photoemission spectroscopy (ARPES) and neutron scattering data have provided ingredients for the interpretation of scanning tunneling spectra on Bi2Sr2CaCu2O8+delta. We analyze the low-temperature tunneling spectra, from oxygen overdoped to underdoped samples, including details about the bilayer splitting and the neutron resonance peak. Two van Hove singularities are identified: the first is integrated in the coherence peaks, the second is heavily broadened at higher binding energy. The shape of the tunneling spectra suggests a strong coupling of the quasiparticles with a collective mode, and a comparison with photoemission shows that the scattering rate in tunneling is an order of magnitude smaller than in ARPES. Finally, the theoretical spectra calculated with an isotropic tunneling matrix element are in better agreement with the experimental data than those obtained with anisotropic matrix elements.
C1 Univ Geneva, DPMC, CH-1211 Geneva 4, Switzerland.
   IFW Dresden, Inst Solid State Res, D-01171 Dresden, Germany.
   Natl Acad Sci Ukraine, Inst Phys Met, UA-03142 Kiev, Ukraine.
RP Hoogenboom, BW (corresponding author), Univ Basel, Inst Biol Struct, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Bart.Hoogenboom@unibas.ch
RI Kordyuk, Alexander A/G-6502-2010
OI Kordyuk, Alexander A/0000-0001-6737-9172; Hoogenboom,
   Bart/0000-0002-8882-4324
CR Abanov A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.177002
   Andersen OK, 1995, J PHYS CHEM SOLIDS, V56, P1573, DOI 10.1016/0022-3697(95)00269-3
   Bok J, 1997, PHYSICA C, V274, P1, DOI 10.1016/S0921-4534(96)00642-9
   Borisenko SV, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.140509
   Chuang YD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.117002
   Cren T, 2000, PHYS REV LETT, V84, P147, DOI 10.1103/PhysRevLett.84.147
   Eschrig M, 2000, PHYS REV LETT, V85, P3261, DOI 10.1103/PhysRevLett.85.3261
   ESCHRIG M, CONDMAT0202083
   Feng DL, 2001, PHYS REV LETT, V86, P5550, DOI 10.1103/PhysRevLett.86.5550
   Fong HF, 1999, NATURE, V398, P588
   Franz M, 1999, PHYS REV B, V60, P3581, DOI 10.1103/PhysRevB.60.3581
   Franz M, 1998, PHYS REV B, V58, P14572, DOI 10.1103/PhysRevB.58.14572
   GROMKO AD, CONDMAT0205385
   HARRISON WA, 1961, PHYS REV, V123, P85, DOI 10.1103/PhysRev.123.85
   He H, 2001, PHYS REV LETT, V86, P1610, DOI 10.1103/PhysRevLett.86.1610
   Hirsch JE, 1999, PHYS REV B, V59, P11962, DOI 10.1103/PhysRevB.59.11962
   Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974
   Hoogenboom BW, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.267001
   HOOGENBOOM BW, 2002, THESIS U GENEVA
   Hudson EW, 1999, SCIENCE, V285, P88, DOI 10.1126/science.285.5424.88
   Johnson PD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.177007
   Kaneko S, 1998, PHYSICA C, V298, P105, DOI 10.1016/S0921-4534(98)00037-9
   Kee HY, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.257002
   Kordyuk AA, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.064504
   Kordyuk AA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.077003
   Kordyuk AA, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.014502
   Kouznetsov K, 1996, PHYS REV B, V54, P3617, DOI 10.1103/PhysRevB.54.3617
   Lanzara A, 2001, NATURE, V412, P510, DOI 10.1038/35087518
   MAHAN GD, 1983, MANY PARTICLE PHYSIC
   Matsuda A, 1999, PHYS REV B, V60, P1377, DOI 10.1103/PhysRevB.60.1377
   Matsuura S, 1998, PHYSICA C, V300, P26, DOI 10.1016/S0921-4534(98)00096-3
   Misra S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.087002
   Miyakawa N, 1999, PHYS REV LETT, V83, P1018, DOI 10.1103/PhysRevLett.83.1018
   Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012
   Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149
   Wei JYT, 1998, PHYS REV B, V57, P3650, DOI 10.1103/PhysRevB.57.3650
   Yusof Z, 1998, PHYS REV B, V58, P514, DOI 10.1103/PhysRevB.58.514
   Zasadzinski JF, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067005
NR 38
TC 56
Z9 56
U1 0
U2 14
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2469-9950
EI 2469-9969
J9 PHYS REV B
JI Phys. Rev. B
PD JUN 11
PY 2003
VL 67
IS 22
AR 224502
DI 10.1103/PhysRevB.67.224502
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 698RB
UT WOS:000184011600070
OA Green Published
DA 2021-01-25
ER

PT J
AU Duckely, M
   Hohn, B
AF Duckely, M
   Hohn, B
TI The VirE2 protein of Agrobacterium tumefaciens: the Yin and Yang of
   T-DNA transfer
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Review
DE Agrobacterium; VirE2; DNA channel
ID SINGLE-STRANDED-DNA; BINDING-PROTEIN; PLANT-CELLS; NUCLEAR-LOCALIZATION;
   ALPHA-HEMOLYSIN; IMPORT; SECRETION; MEMBRANE; CHANNEL; PILUS
AB Agrobacterium tumefaciens has evolved a unique mechanism to solve the problem of transferring DNA across five bilayers; the inner and outer membranes of the bacterium, the plasma membrane of the plant cell and the double membrane formed by the nuclear envelope. The two first and two last seem to be mediated by, respectively, the type IV secretion system in Agrobacterium and the nuclear pore complex in the plant cell, but the mechanism by which the transferred DNA (T-DNA) crosses the plant membrane still remains a mystery. New biophysical experiments suggest that, in addition to its established role as a single-stranded DNA (ssDNA)-binding protein, the VirE2 protein forms a channel in the plant membrane allowing the passage of the T-DNA into the cell. Such a role would be reminiscent of translocator molecules secreted by the type III secretion system of pathogenic bacteria and inserting into the host eukaryotic plasma membrane. The implications for the structure of the protein, its regulation and role in vivo are discussed. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, ME Mueller Inst Microscopy, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4002 Basel, Switzerland.
RP Duckely, M (corresponding author), Univ Basel, Biozentrum, ME Mueller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Ballas N, 1997, P NATL ACAD SCI USA, V94, P10723, DOI 10.1073/pnas.94.20.10723
   Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x
   CHRISTIE PJ, 1988, J BACTERIOL, V170, P2659, DOI 10.1128/jb.170.6.2659-2667.1988
   Citovsky V, 1997, J MOL BIOL, V271, P718, DOI 10.1006/jmbi.1997.1230
   CITOVSKY V, 1989, P NATL ACAD SCI USA, V86, P1193, DOI 10.1073/pnas.86.4.1193
   CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325
   Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077
   DAS A, 1988, P NATL ACAD SCI USA, V85, P2909, DOI 10.1073/pnas.85.9.2909
   Deng WY, 1999, MOL MICROBIOL, V31, P1795, DOI 10.1046/j.1365-2958.1999.01316.x
   Dumas F, 2001, P NATL ACAD SCI USA, V98, P485, DOI 10.1073/pnas.011477898
   Fullner KJ, 1996, SCIENCE, V273, P1107, DOI 10.1126/science.273.5278.1107
   GIETL C, 1987, P NATL ACAD SCI USA, V84, P9006, DOI 10.1073/pnas.84.24.9006
   Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586
   Isberg RR, 2001, NAT STRUCT BIOL, V8, P1006, DOI 10.1038/nsb1201-1006
   Lai EM, 2000, TRENDS MICROBIOL, V8, P361, DOI 10.1016/S0966-842X(00)01802-3
   Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6
   Olson R, 1999, NAT STRUCT BIOL, V6, P134
   Pouliquin P, 1999, BIOPHYS J, V76, P360, DOI 10.1016/S0006-3495(99)77203-6
   Shabala SN, 1998, J MEMBRANE BIOL, V161, P45, DOI 10.1007/s002329900313
   Silhavy TJ, 1997, SCIENCE, V278, P1085, DOI 10.1126/science.278.5340.1085
   Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859
   WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242
   Zhou XR, 1999, J BACTERIOL, V181, P4342, DOI 10.1128/JB.181.14.4342-4352.1999
   Ziemienowicz A, 2001, PLANT CELL, V13, P369, DOI 10.1105/tpc.13.2.369
NR 24
TC 34
Z9 42
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1097
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD JUN 6
PY 2003
VL 223
IS 1
BP 1
EP 6
DI 10.1016/S0378-1097(03)00246-5
PG 6
WC Microbiology
SC Microbiology
GA 692WE
UT WOS:000183682600001
PM 12798992
OA Bronze
DA 2021-01-25
ER

PT J
AU Hoffmann, R
   Melchers, F
AF Hoffmann, R
   Melchers, F
TI A genomic view of lymphocyte development - Opinion
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID GENE-EXPRESSION PROFILES; B-CELL PROLIFERATION; BONE-MARROW;
   OLIGONUCLEOTIDE; DIFFERENTIATION; ACCURACY; PATTERNS
AB RNA expression profiles of consecutive stages of mouse and human B-cell precursors, and of mouse T-cell precursors, from DJ re-arranged states to mature lymphocytes have been generated using high-density oligonucleotide arrays. Approximately 10% of all genes present on the arrays are differentially expressed across all cellular stages of each of the lineages. Approximately half of these are differentially expressed during both T-cell and B-cell differentiation. Many of the genes that are shared are involved in cell cycle regulation and DNA replication, whereas most of the signaling and adhesion molecules and transcription factors are expressed in a lineage-specific manner. Comparable stages of the T-and B-lineage developmental programs share only a few genes. By contrast, homologous genes differentially expressed during both human and mouse B-cell development have very similar expression patterns.
C1 Max Von Pettenkofer Inst, Dept Bacteriol, D-80336 Munich, Germany.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Hoffmann, R (corresponding author), Max Von Pettenkofer Inst, Dept Bacteriol, Pettenkoferstr 9A, D-80336 Munich, Germany.
EM r_hoffmann@m3401.mpk.med.uni-muenchen.de
RI Hoffmann, Reinhard/I-8748-2018
OI Hoffmann, Reinhard/0000-0003-1514-1183
CR Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501
   EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318
   Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862
   Ghia P, 1996, J EXP MED, V184, P2217, DOI 10.1084/jem.184.6.2217
   Ghia P, 1998, IMMUNOL TODAY, V19, P480, DOI 10.1016/S0167-5699(98)01330-9
   Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102
   GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0
   HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0
   Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098
   Hoffmann R, 2003, J IMMUNOL, V170, P1339, DOI 10.4049/jimmunol.170.3.1339
   Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501
   Hoffmann R, 2002, GENOME BIOL, V3
   Ishii M, 2000, GENOMICS, V68, P136, DOI 10.1006/geno.2000.6284
   Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597
   Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625
   Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675
   Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806
   Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5
   Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671
   Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614
   Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0
   Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7
   Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286
   Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907
   VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359
   Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48
NR 34
TC 12
Z9 13
U1 0
U2 2
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
EI 1879-0372
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD JUN
PY 2003
VL 15
IS 3
BP 239
EP 245
DI 10.1016/S0952-7915(03)00047-5
PG 7
WC Immunology
SC Immunology
GA 689GT
UT WOS:000183483800001
PM 12787746
DA 2021-01-25
ER

PT J
AU Hirth, F
   Kammermeier, L
   Frei, E
   Walldorf, U
   Noll, M
   Reichert, H
AF Hirth, F
   Kammermeier, L
   Frei, E
   Walldorf, U
   Noll, M
   Reichert, H
TI An urbilaterian origin of the tripartite brain: developmental genetic
   insights from Drosophila
SO DEVELOPMENT
LA English
DT Article
DE brain development; brain evolution; midbrain/hindbrain boundary; Otx;
   Hox; Pax; Drosophila melanogaster
ID ANTERIOR NEUROECTODERM; NERVOUS-SYSTEM; OTX2; HINDBRAIN; MIDBRAIN;
   ORTHODENTICLE; EXPRESSION; ORGANIZER; SPECIFICATION; FOREBRAIN
AB Studies on expression and function of key developmental control genes suggest that the embryonic vertebrate brain has a tripartite ground plan that consists of a forebrain/midbrain, a hindbrain and an intervening midbrain/hindbrain boundary region, which are characterized by the specific expression of the Otx, Hox and Pax2/5/8 genes, respectively. We show that the embryonic brain of the fruitfly Drosophila melanogaster expresses all three sets of homologous genes in a similar tripartite pattern. Thus, a Pax2/5/8 expression domain is located at the interface of brain-specific otd/Otx2 and unpg/Gbx2 expression domains anterior to Hox expression regions. We identify this territory as the deutocerebral/tritocerebral boundary region in the embryonic Drosophila brain. Mutational inactivation of otd/Otx2 and unpg/Gbx2 result in the loss or misplacement of the brain-specific expression domains of Pax2/5/8 and Hox genes. In addition, otd/Otx2 and unpg/Gbx2 appear to negatively regulate each other at the interface of their brain-specific expression domains. Our studies demonstrate that the deutocerebral/tritocerebral boundary region in the embryonic Drosophila brain displays developmental genetic features similar to those observed for the midbrain/hindbrain boundary region in vertebrate brain development. This suggests that a tripartite organization of the embryonic brain was already established in the last common urbilaterian ancestor of protostomes and deuterostomes.
C1 Univ Basel, Inst Zool, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Pharmazentrum, Inst Zool, CH-4056 Basel, Switzerland.
   Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland.
   Univ Saarland, Dept Anat & Cell Biol, D-66421 Homburg, Germany.
RP Hirth, F (corresponding author), Univ Basel, Inst Zool, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM frank.hirth@unibas.ch
RI Hirth, Frank/B-8384-2015
OI Hirth, Frank/0000-0001-8581-9450
CR ACAMPORA D, 1995, DEVELOPMENT, V121, P3279
   Acampora D, 1999, TRENDS NEUROSCI, V22, P116, DOI 10.1016/S0166-2236(98)01387-3
   Ang SL, 1996, DEVELOPMENT, V122, P243
   Arendt D, 1999, DEVELOPMENT, V126, P2309
   Arendt D, 2001, NATURE, V409, P81, DOI 10.1038/35051075
   BOPP D, 1989, EMBO J, V8, P3447, DOI 10.1002/j.1460-2075.1989.tb08509.x
   Bruce AEE, 1998, DEV BIOL, V201, P101, DOI 10.1006/dbio.1998.8968
   Brusca R.C., 1990, INVERTEBRATES
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   CHAING C, 1995, DEVELOPMENT, V121, P3901
   FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516
   Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066
   Hartmann B, 1998, MOL CELL NEUROSCI, V12, P194, DOI 10.1006/mcne.1998.0716
   Hassanzadeh G, 1998, FEBS LETT, V437, P75, DOI 10.1016/S0014-5793(98)01204-6
   Hirth F, 1999, BIOESSAYS, V21, P677, DOI 10.1002/(SICI)1521-1878(199908)21:8<677::AID-BIES7>3.0.CO;2-8
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   Holland LZ, 1999, CURR OPIN NEUROBIOL, V9, P596, DOI 10.1016/S0959-4388(99)00003-3
   Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7
   Kourakis MJ, 1997, DEV BIOL, V190, P284, DOI 10.1006/dbio.1997.8689
   Li JYH, 2001, DEVELOPMENT, V128, P4979
   Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869
   Martinez S, 1999, DEVELOPMENT, V126, P1189
   Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789
   MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646
   Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1
   NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7
   Pineda D, 2002, DEVELOPMENT, V129, P1423
   Reichert H, 1999, CURR OPIN NEUROBIOL, V9, P589, DOI 10.1016/S0959-4388(99)00002-1
   Reichert H, 2002, INT J DEV BIOL, V46, P81
   Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9
   SIEWING R, 1985, LEHRBUCH ZOOLOGIE
   SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   Wada H, 1998, DEVELOPMENT, V125, P1113
   Wada H, 2001, CURR OPIN NEUROBIOL, V11, P16, DOI 10.1016/S0959-4388(00)00168-9
   Wassarman KM, 1997, DEVELOPMENT, V124, P2923
   Wassef M, 1997, PERSPECT DEV NEUROBI, V5, P3
   WIESCHAUS E, 1992, DEVELOPMENT, V115, P801
   Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516
   Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761
   YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475
NR 42
TC 123
Z9 127
U1 0
U2 13
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD JUN
PY 2003
VL 130
IS 11
BP 2365
EP 2373
DI 10.1242/dev.00438
PG 9
WC Developmental Biology
SC Developmental Biology
GA 691UF
UT WOS:000183623400007
PM 12702651
OA Bronze
DA 2021-01-25
ER

PT J
AU Engering, A
   Kuhn, L
   Fluitsma, D
   Hoefsmit, E
   Pieters, J
AF Engering, A
   Kuhn, L
   Fluitsma, D
   Hoefsmit, E
   Pieters, J
TI Differential post-translational modification of CD63 molecules during
   maturation of human dendritic cells
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE antigen presentation; poly N-acetyl lactosamine addition; dendritic
   cells; tetraspanins; MHC class II
ID MHC CLASS-II; LYSOSOMAL MEMBRANE-GLYCOPROTEINS; INVARIANT CHAIN
   DEGRADATION; B-LYMPHOCYTES; DEVELOPMENTAL REGULATION;
   INTRACELLULAR-TRANSPORT; MULTIVESICULAR BODIES; MANNOSE RECEPTOR;
   PLASMA-MEMBRANE; ANTIGEN
AB The capacity of dendritic cells to initiate T cell responses is related to their ability to redistribute MHC class II molecules from the intracellular MHC class II compartments to the cell surface. This redistribution occurs during dendritic cell development as they are converted from an antigen capturing, immature dendritic cell into an MHC class II-peptide presenting mature dendritic cell. During this maturation, antigen uptake and processing are down-regulated and peptide-loaded class II complexes become expressed in a stable manner on the cell surface. Here we report that the tetraspanin CD63, that associates with intracellularly localized MHC class II molecules in immature dendritic cells, was modified post-translationally by poly N -acetyl lactosamine addition during maturation. This modification of CD63 was accompanied by a change in morphology of MHC class II compartments from typical multivesicular organelles to structures containing densely packed lipid moieties. Post-translational modification of CD63 may be involved in the functional and morphological changes of MHC class II compartments that occur during dendritic cell maturation.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Basel Inst Immunol, Basel, Switzerland.
   Vrije Univ Amsterdam, Dept Cell Biol & Immunol, Amsterdam, Netherlands.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
OI Pieters, Jean/0000-0002-5284-9757
CR AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0
   BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Barois N, 2002, TRAFFIC, V3, P894, DOI 10.1034/j.1600-0854.2002.31205.x
   Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Calafat J, 1997, EUR J HAEMATOL, V58, P56
   CARLSSON Sr, 1990, J BIOL CHEM, V265, P20488
   Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006
   Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775
   Engering A, 2001, INT IMMUNOL, V13, P127, DOI 10.1093/intimm/13.2.127
   Engering AJ, 1998, INT IMMUNOL, V10, P1713, DOI 10.1093/intimm/10.11.1713
   Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941
   Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121
   Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433
   GRIFFITHS GM, 1995, CURR OPIN IMMUNOL, V7, P343, DOI 10.1016/0952-7915(95)80108-1
   Hammond C, 1998, J IMMUNOL, V161, P3282
   Heijnen HFG, 1998, BLOOD, V91, P2313, DOI 10.1182/blood.V91.7.2313.2313_2313_2325
   Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3
   Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508
   JOHNSON JP, 1981, EUR J IMMUNOL, V11, P825, DOI 10.1002/eji.1830111015
   Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071
   Kleijmeer Monique J., 1996, Methods (Orlando), V10, P191, DOI 10.1006/meth.1996.0095
   KOLDOVSKY O, 1971, BIOCHEM J, V125, P697, DOI 10.1042/bj1250697
   Kropshofer H, 2002, NAT IMMUNOL, V3, P61, DOI 10.1038/ni750
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X
   LEE N, 1990, J BIOL CHEM, V265, P20476
   LEFKOVITS I, 1985, USE LARGE SCALE 2 DI
   LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0
   Maecker HT, 1997, FASEB J, V11, P428
   METZELAAR MJ, 1991, J BIOL CHEM, V266, P3239
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099
   Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0
   Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039
   PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213
   PIETERS J, 1993, J CELL SCI, V106, P831
   Pieters J, 2000, ADV IMMUNOL, V75, P159, DOI 10.1016/S0065-2776(00)75004-8
   Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   STOSSEL H, 1990, J EXP MED, V172, P1471, DOI 10.1084/jem.172.5.1471
   Tapper H, 1997, J IMMUNOL, V159, P409
   Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599
   TULP A, 1993, ELECTROPHORESIS, V14, P1295, DOI 10.1002/elps.11501401198
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0
   VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184
   VOG AB, 2002, IMMUNOL REV, V189, P136
   Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821
   WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0
   Yewdell JW, 2002, NATURE, V418, P923, DOI 10.1038/418923a
   Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594
NR 56
TC 34
Z9 35
U1 0
U2 3
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD JUN
PY 2003
VL 270
IS 11
BP 2412
EP 2420
DI 10.1046/j.1432-1033.2003.03609.x
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 681HL
UT WOS:000183030700009
PM 12755696
DA 2021-01-25
ER

PT J
AU Nordheim, U
   Hofbauer, KG
AF Nordheim, U
   Hofbauer, KG
TI Cardiovascular effects of the gut hormone PYY3-36 in normotensive rats
   on a high fat diet or chronic food restriction
SO JOURNAL OF HYPERTENSION
LA English
DT Meeting Abstract
CT 13th European Meeting on Hypertension
CY JUN 13-17, 2003
CL MILAN, ITALY
SP European Soc Hypertens
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0263-6352
J9 J HYPERTENS
JI J. Hypertens.
PD JUN
PY 2003
VL 21
SU 4
BP S298
EP S298
PG 1
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 705QT
UT WOS:000184406701056
DA 2021-01-25
ER

PT J
AU Moller, C
   Fotiadis, D
   Suda, K
   Engel, A
   Kessler, M
   Muller, DJ
AF Moller, C
   Fotiadis, D
   Suda, K
   Engel, A
   Kessler, M
   Muller, DJ
TI Determining molecular forces that stabilize human aquaporin-1
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE aquaporin; atomic force microscopy; force spectroscopy; molecular
   interactions; membrane protein assembly; secondary structure; worm-like
   chain model
ID INTEGRAL MEMBRANE-PROTEIN; WATER PERMEATION; CHANNEL PROTEINS; MIP
   FAMILY; MICROSCOPE; CHIP; IDENTIFICATION; PERMEABILITY; EVOLUTION;
   TRANSPORT
AB Atomic force microscopy (AFM) was used to measure the forces stabilizing human aquaporin-1 (hAQP1), a tetrameric transmembrane protein that forms highly specific water channels. To this end, the AFM tip was attached to the C-terminus of hAQP1 and secondary structure elements were extracted from the membrane while the single-molecule force-extension curve was being recorded. Force peaks, reflecting the unfolding of secondary structure elements, could be interpreted in depth using the atomic model of hAQP1. Different classes of force-extension curves indicated the existence of alternative unfolding pathways for individual proteins. In addition, transmembrane helices at the periphery of the hAQP1 tetramer exhibited smaller extraction forces than helices at the interface between hAQP1 monomers. These results represent the first direct assessment of intermolecular forces defining the oligomeric state of a membrane protein. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Munich, Sekt Phys, Ctr Nanosci CenSC, D-80799 Munich, Germany.
   Tech Univ Dresden, BIOTEC, D-01062 Dresden, Germany.
RP Muller, DJ (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.
EM mueller@mpi-cbg.de
RI Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Booth PJ, 2001, CRIT REV BIOCHEM MOL, V36, P501, DOI 10.1080/20014091074246
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   BUTT HJ, 1995, BIOELECTROCH BIOENER, V38, P191, DOI 10.1016/0302-4598(95)01800-T
   BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   DENKER BM, 1988, J BIOL CHEM, V263, P15634
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   FETTIPLACE R, 1980, PHYSIOL REV, V60, P510
   Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997
   Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N
   Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.0.CO;2-M
   MACEY RI, 1970, BIOCHIM BIOPHYS ACTA, V211, P104, DOI 10.1016/0005-2736(70)90130-6
   Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008
   Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 2002, BIOPHYS J, V83, P3578, DOI 10.1016/S0006-3495(02)75358-7
   Muller DJ, 2002, PROG BIOPHYS MOL BIO, V79, P1, DOI 10.1016/S0079-6107(02)00009-3
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   PAO GM, 1991, MOL MICROBIOL, V5, P33, DOI 10.1111/j.1365-2958.1991.tb01823.x
   Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120
   Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881
   POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110
   Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489
   Schaffer TE, 1996, J APPL PHYS, V80, P3622, DOI 10.1063/1.363308
   SIDEL VW, 1957, J GEN PHYSIOL, V41, P243, DOI 10.1085/jgp.41.2.243
   SMITH BL, 1991, J BIOL CHEM, V266, P6407
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   Zardoya R, 2001, J MOL EVOL, V52, P391, DOI 10.1007/s002390010169
NR 46
TC 51
Z9 52
U1 1
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUN
PY 2003
VL 142
IS 3
BP 369
EP 378
DI 10.1016/S1047-8477(03)00066-2
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 689PK
UT WOS:000183502000006
PM 12781664
DA 2021-01-25
ER

PT J
AU Novotna, J
   Vohradsky, J
   Berndt, P
   Gramajo, H
   Langen, H
   Li, XM
   Minas, W
   Orsaria, L
   Roeder, D
   Thompson, CJ
AF Novotna, J
   Vohradsky, J
   Berndt, P
   Gramajo, H
   Langen, H
   Li, XM
   Minas, W
   Orsaria, L
   Roeder, D
   Thompson, CJ
TI Proteomic studies of diauxic lag in the differentiating prokaryote
   Streptomyces coelicolor reveal a regulatory network of stress-induced
   proteins and central metabolic enzymes
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID ESCHERICHIA-COLI; GENE-EXPRESSION; HEAT-SHOCK;
   MORPHOLOGICAL-DIFFERENTIATION; BACILLUS-SUBTILIS; TRANSCRIPTION
   INITIATION; MULTICELLULAR PROKARYOTE; ANTIBIOTIC BIOSYNTHESIS;
   DEVELOPMENTAL CONTROL; STATISTICAL-ANALYSES
AB Bacteria typically undergo intermittent periods of starvation and adaptation, emulated as diauxic growth in the laboratory. In association with growth arrest elicited by metabolic stress, the differentiating eubacterium Streptomyces coelicolor not only adapts its primary metabolism, but can also activate developmental programmes leading to morphogenesis and antibiotic biosynthesis. Here, we report combined proteomic and metabolomic data of S. coelicolor used to analyse global changes in gene expression during diauxic growth in a defined liquid medium. Cultures initially grew on glutamate, providing the nitrogen source and feeding carbon (as 2-oxoglutarate) into the TCA cycle, followed by a diauxic delay allowing reorientation of metabolism and a second round of growth supported by NH4+, formed during prediauxic phase, and maltose, a glycolytic substrate. Cultures finally entered stationary phase as a result of nitrogen starvation. These four physiological states had previously been defined statistically by their distinct patterns of protein synthesis and heat shock responses. Together, these data demonstrated that the rates of synthesis of heat shock proteins are determined not only by temperature increase but also by the patterns and rates of metabolic flux in certain pathways. Synthesis profiles for metabolic- and stress-induced proteins can now be interpreted by the identification of 204 spots (SWICZ database presented at http://proteom.biomed.cas.cz). Cluster analysis showed that the activity of central metabolic enzymes involved in glycolysis, the TCA cycle, starvation or proteolysis each displayed identifiable patterns of synthesis that logically underlie the metabolic state of the culture. Diauxic lag was accompanied by a structured regulatory programme involving the sequential activation of heat-, salt-, cold- and bacteriostatic antibiotic (pristinamycin I, PI)-induced stimulons. Although stress stimulons presumably provide protection during environmental- or starvation-induced stress, their identities did not reveal any coherent adaptive or developmental functions. These studies revealed interactive regulation of metabolic and stress response systems including some proteins known to support developmental programmes in S. coelicolor.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic.
   F Hoffmann La Roche & Co Ltd, Pharmaceut Res, Gene Technol, CH-4002 Basel, Switzerland.
   Fac Cs Bioquim & Farmaceut, IBR Dept Microbiol, RA-2000 Rosario, Santa Fe, Argentina.
   ETH, Dept Biotechnol, CH-8093 Zurich, Switzerland.
RP Thompson, CJ (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Novotna, Jana/H-6215-2014
CR Barker MM, 2001, J BACTERIOL, V183, P6315, DOI 10.1128/JB.183.21.6315-6323.2001
   Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327
   Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328
   Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a
   BERGMEYER HU, 1983, METHODS ENZYMATIC AN
   Berndt P, 1999, ELECTROPHORESIS, V20, P3521, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3521::AID-ELPS3521>3.0.CO;2-8
   BLANCO G, 1994, MOL MICROBIOL, V12, P375, DOI 10.1111/j.1365-2958.1994.tb01027.x
   BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CASHEL M, 1996, ESCHERICHIA COLI SAL, V1, P1458
   Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x
   Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3
   CHATER KF, 1993, ANNU REV MICROBIOL, V47, P685, DOI 10.1146/annurev.mi.47.100193.003345
   CHATER KF, 1982, GENE, V19, P21, DOI 10.1016/0378-1119(82)90185-8
   CHATTERJEE S, 1981, CAN J MICROBIOL, V27, P639, DOI 10.1139/m81-098
   de Crecy-Lagard V, 1999, MOL MICROBIOL, V32, P505, DOI 10.1046/j.1365-2958.1999.01364.x
   DOULL JL, 1989, FEMS MICROBIOL LETT, V65, P265
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Fischer D, 1998, J BACTERIOL, V180, P6203
   Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241
   GRANOZZI C, 1990, J GEN MICROBIOL, V136, P713, DOI 10.1099/00221287-136-4-713
   GROSSMAN AD, 1985, J MOL BIOL, V186, P357, DOI 10.1016/0022-2836(85)90110-X
   Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098
   Halvorson H., 1966, METHOD ENZYMOL, V8, P559
   Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001
   Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002
   Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5
   HENGGEARONIS R, 1996, ESCHERICHIA COLI SAL, V1, P1497
   Hesketh AR, 2002, MOL MICROBIOL, V46, P917, DOI 10.1046/j.1365-2958.2002.03219.x
   HOLT TG, 1992, MOL MICROBIOL, V6, P969, DOI 10.1111/j.1365-2958.1992.tb02163.x
   HOPE GC, 1974, BIOCHEM J, V144, P403, DOI 10.1042/bj1440403
   Hopwood DA, 1999, MICROBIOL-UK, V145, P2183, DOI 10.1099/00221287-145-9-2183
   Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401
   Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902
   Kelemen GH, 2001, MOL MICROBIOL, V40, P804, DOI 10.1046/j.1365-2958.2001.02417.x
   LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x
   Miguelez EM, 1999, J CELL BIOL, V145, P515, DOI 10.1083/jcb.145.3.515
   MONOD J, 1942, THESIS U PARIS PARIS
   NAGAI H, 1990, J BACTERIOL, V172, P2710, DOI 10.1128/jb.172.5.2710-2715.1990
   Neumann T, 1996, MICROBIOL-UK, V142, P1953, DOI 10.1099/13500872-142-8-1953
   Nguyen KT, 2002, MOL MICROBIOL, V46, P1223, DOI 10.1046/j.1365-2958.2002.03255.x
   Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x
   Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001
   Pope MK, 1996, MOL MICROBIOL, V19, P747, DOI 10.1046/j.1365-2958.1996.414933.x
   Price CW, 2000, BACTERIAL STRESS RESPONSES, P179
   PUGLIA AM, 1995, MOL MICROBIOL, V17, P737, DOI 10.1111/j.1365-2958.1995.mmi_17040737.x
   ROSEMAN S, 1990, J BIOL CHEM, V265, P2993
   SALAHBEY K, 1995, MOL MICROBIOL, V17, P1001, DOI 10.1111/j.1365-2958.1995.mmi_17051001.x
   SCHULTZ JE, 1988, J BACTERIOL, V170, P3903, DOI 10.1128/jb.170.9.3903-3909.1988
   Servant P, 2001, ARCH MICROBIOL, V176, P237, DOI 10.1007/s002030100321
   Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x
   VanBogelen RA, 1999, ELECTROPHORESIS, V20, P2149, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2149::AID-ELPS2149>3.0.CO;2-N
   Viollier PH, 2003, MOL MICROBIOL, V47, P699, DOI 10.1046/j.1365-2958.2003.03302.x
   Viollier PH, 2003, J MOL BIOL, V325, P637, DOI 10.1016/S0022-2836(02)01280-9
   Viollier PH, 2001, J BACTERIOL, V183, P3193, DOI 10.1128/JB.183.10.3193-3203.2001
   Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001
   Vohradsky J, 1997, ELECTROPHORESIS, V18, P1418, DOI 10.1002/elps.1150180817
   Vohradsky J, 2000, J BACTERIOL, V182, P4979, DOI 10.1128/JB.182.17.4979-4986.2000
   Volker U, 1999, J BACTERIOL, V181, P3942
   WEILMALHERBE H, 1951, BIOCHEM J, V49, P286, DOI 10.1042/bj0490286
NR 60
TC 75
Z9 79
U1 0
U2 12
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JUN
PY 2003
VL 48
IS 5
BP 1289
EP 1303
DI 10.1046/j.1365-2958.2003.03529.x
PG 15
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 684FP
UT WOS:000183195000012
PM 12787356
DA 2021-01-25
ER

PT J
AU Eusebio, A
   Oliveri, F
   Barzaghi, P
   Ruegg, MA
AF Eusebio, A
   Oliveri, F
   Barzaghi, P
   Ruegg, MA
TI Expression of mouse agrin in normal, denervated and dystrophic muscle
SO NEUROMUSCULAR DISORDERS
LA English
DT Article
DE mouse; congenital muscular dystrophy; dystrophin; alpha 7 integrin;
   laminin; dy (w)
ID CONGENITAL MUSCULAR-DYSTROPHY; ACETYLCHOLINE-RECEPTOR CLUSTERS;
   ALPHA-7-BETA-1 INTEGRIN; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX;
   SKELETAL-MUSCLE; BASAL LAMINA; DIFFERENTIAL EXPRESSION; BINDING-SITE;
   MUTANT MICE
AB Agrin is a heparan sulfate proteoglycan that is required for the development of postsynaptic specializations at the neuromuscular junction. An alternatively spliced isoform of agrin that lacks this activity is found in basement membranes of several tissues including embryonic muscle. Overexpression of a miniaturized form of this agrin isoform ameliorates the severe muscle dystrophy of lamin alpha2-deficient mice, a mouse model for merosin-deficient congenital muscle dystrophy. Several lines of evidence indicate that this amelioration is based on the high-affinity binding of the mini-agrin to the laminins and to alpha-dystroglycan. Here, we used antibodies raised against mouse agrin to evaluate protein expression in adult muscle of normal and dystrophic mice. We find that expression of agrin in non-synaptic region varies greatly between different muscles in wild-type mice and that its levels are altered in dystrophic muscle. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Dept Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Dept Pharmacol Neurobiol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
CR Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459
   BAO ZZ, 1993, J CELL SCI, V106, P579
   Bixby JL, 2002, J NEUROBIOL, V50, P164, DOI 10.1002/neu.10025
   Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412
   BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189
   Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207
   Burkin DJ, 1998, J CELL BIOL, V143, P1067, DOI 10.1083/jcb.143.4.1067
   Burkin DJ, 2000, J CELL SCI, V113, P2877
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   COOPER H, 1995, CURRENT PROTOCOLS IM, P241
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335
   DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547
   DRAEGER A, 1987, J NEUROL SCI, V81, P19, DOI 10.1016/0022-510X(87)90181-X
   DUCLERT A, 1995, PHYSIOL REV, V75, P339
   ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600
   GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0
   GOODMAN SL, 1989, J CELL BIOL, V109, P799, DOI 10.1083/jcb.109.2.799
   Groffen AJ, 1998, J HISTOCHEM CYTOCHEM, V46, P19, DOI 10.1177/002215549804600104
   Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94
   Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7
   HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H
   IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0
   Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   KRAMER RH, 1991, CELL REGUL, V2, P805
   Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000
   LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Martin PT, 1996, DEV BIOL, V174, P125, DOI 10.1006/dbio.1996.0057
   Martin PT, 1997, DEVELOPMENT, V124, P3909
   Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318
   MCMAHAN UJ, 1990, COLD SH Q B, V55, P407
   Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837
   Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   NARUSAWA M, 1987, J CELL BIOL, V104, P447, DOI 10.1083/jcb.104.3.447
   Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932
   NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471
   OCALAN M, 1988, DEV BIOL, V125, P158, DOI 10.1016/0012-1606(88)90068-1
   OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685
   Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507
   Raats CJI, 1998, J BIOL CHEM, V273, P17832, DOI 10.1074/jbc.273.28.17832
   Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5
   Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1
   SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404
   SONG WK, 1992, J CELL BIOL, V117, P643, DOI 10.1083/jcb.117.3.643
   Tolmachova T, 1999, NUCLEIC ACIDS RES, V27, P3736, DOI 10.1093/nar/27.18.3736
   Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2
   VONDERMARK H, 1991, J BIOL CHEM, V266, P23593
   Yao CC, 1996, J BIOL CHEM, V271, P25598, DOI 10.1074/jbc.271.41.25598
NR 57
TC 37
Z9 37
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUN
PY 2003
VL 13
IS 5
BP 408
EP 415
DI 10.1016/S0960-8966(03)00036-1
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 694QW
UT WOS:000183786300006
PM 12798796
DA 2021-01-25
ER

PT J
AU Lacazette, E
   Le Calvez, S
   Gajendran, N
   Brenner, HR
AF Lacazette, E
   Le Calvez, S
   Gajendran, N
   Brenner, HR
TI A novel pathway for MuSK to induce key genes in neuromuscular synapse
   formation
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
DE agrin; MuSK; synapse formation; skeletal muscle; neuromuscular junction
ID RECEPTOR EPSILON-SUBUNIT; SKELETAL-MUSCLE FIBERS;
   ACETYLCHOLINE-RECEPTOR; TRANSCRIPTION FACTOR; ELECTRICAL-ACTIVITY;
   POSTSYNAPTIC DIFFERENTIATION; SIGNAL-TRANSDUCTION; INNERVATED MUSCLE;
   MAMMALIAN MUSCLE; ADULT MUSCLE
AB At the developing neuromuscular junction the Agrin receptor MUSK is the central organizer of subsynaptic differentiation induced by Agrin from the nerve. The expression of musk itself is also regulated by the nerve, but the mechanisms involved are not known. Here, we analyzed the activation of a musk promoter reporter construct in muscle fibers in vivo and in cultured myotubes, using transfection of multiple combinations of expression vectors for potential signaling components. We show that neuronal Agrin by activating MUSK regulates the expression of musk via two pathways: the Agrin-induced assembly of muscle-derived neuregulin (NRG)-1/ErbB, the pathway thought to regulate acetylcholine receptor (AChR) expression at the synapse, and via a direct shunt involving Agrin-induced activation of Rac. Both pathways converge onto the same regulatory element in the musk promoter that is also thought to confer synapse-specific expression to AChR subunit genes. In this way, a positive feedback signaling loop is established that maintains musk expression at the synapse when impulse transmission becomes functional. The same pathways are used to regulate synaptic expression of AChRepsilon. We propose that the novel pathway stabilizes the synapse early in development, whereas the NRG/ErbB pathway supports maintenance of the mature synapse.
C1 Univ Basel, Dept Physiol Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Brenner, HR (corresponding author), Univ Basel, Dept Physiol Biozentrum, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Lacazette, eric/M-7168-2014
OI , Nadesan/0000-0002-7463-4220; lacazette, eric/0000-0003-1234-5260
CR Alroy I, 1999, MOL CELL BIOL, V19, P1961
   Altiok N, 1997, EMBO J, V16, P717, DOI 10.1093/emboj/16.4.717
   Angus LM, 2001, J BIOL CHEM, V276, P17603, DOI 10.1074/jbc.M100916200
   Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7
   Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037
   Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936
   Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000
   Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4
   Chan RYY, 1999, P NATL ACAD SCI USA, V96, P4627, DOI 10.1073/pnas.96.8.4627
   Cohen NA, 1997, NEUROSCIENCE, V76, P581, DOI 10.1016/S0306-4522(96)00345-4
   d'Exaerde AD, 2002, EMBO REP, V3, P1075, DOI 10.1093/embo-reports/kvf220
   Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1
   Duclert A, 1996, J BIOL CHEM, V271, P17433, DOI 10.1074/jbc.271.29.17433
   DUCLERT A, 1993, P NATL ACAD SCI USA, V90, P3043, DOI 10.1073/pnas.90.7.3043
   Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429
   Fromm L, 2001, BIOCHEMISTRY-US, V40, P5306, DOI 10.1021/bi002649m
   Fromm L, 1998, GENE DEV, V12, P3074, DOI 10.1101/gad.12.19.3074
   GANJU P, 1995, ONCOGENE, V11, P281
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   Gramolini AO, 1998, J BIOL CHEM, V273, P736, DOI 10.1074/jbc.273.2.736
   GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938
   Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911
   Hoffmeyer A, 1998, J BIOL CHEM, V273, P10112, DOI 10.1074/jbc.273.17.10112
   Ip FCF, 2000, MOL CELL NEUROSCI, V16, P661, DOI 10.1006/mcne.2000.0892
   Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654
   Jones G, 1996, P NATL ACAD SCI USA, V93, P5985, DOI 10.1073/pnas.93.12.5985
   Jones G, 1999, J NEUROSCI, V19, P3376
   Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374
   KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617
   KOIKE S, 1995, P NATL ACAD SCI USA, V92, P10624, DOI 10.1073/pnas.92.23.10624
   Leu M, 2003, DEVELOPMENT, V130, P2291, DOI 10.1242/dev.00447
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Loeb JA, 1999, DEVELOPMENT, V126, P781
   Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3
   Meier T, 1997, J NEUROSCI, V17, P6534
   Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x
   Meier T, 1998, J CELL BIOL, V141, P715, DOI 10.1083/jcb.141.3.715
   Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262
   Moore C, 2001, P NATL ACAD SCI USA, V98, P14655, DOI 10.1073/pnas.251291598
   MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012
   RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z
   Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599
   SANES JR, 1991, DEVELOPMENT, V113, P1181
   Sapru MK, 2001, LIFE SCI, V69, P2663, DOI 10.1016/S0024-3205(01)01343-1
   Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1
   Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078
   SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419
   Si JT, 1999, J NEUROSCI, V19, P8498
   TANG JC, 1994, DEVELOPMENT, V120, P1799
   Tansey MG, 1996, J CELL BIOL, V134, P465, DOI 10.1083/jcb.134.2.465
   VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9
   Wang CC, 1998, J ELECTROCERAM, V2, P273, DOI 10.1023/A:1009978607621
   Weiss FU, 1997, J CELL PHYSIOL, V173, P187, DOI 10.1002/(SICI)1097-4652(199711)173:2<187::AID-JCP19>3.3.CO;2-R
   Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
NR 55
TC 60
Z9 61
U1 0
U2 4
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0021-9525
J9 J CELL BIOL
JI J. Cell Biol.
PD MAY 26
PY 2003
VL 161
IS 4
BP 727
EP 736
DI 10.1083/jcb.200210156
PG 10
WC Cell Biology
SC Cell Biology
GA 685WJ
UT WOS:000183286700009
PM 12756238
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Nyfeler, B
   Nufer, O
   Matsui, T
   Mori, K
   Hauri, HP
AF Nyfeler, B
   Nufer, O
   Matsui, T
   Mori, K
   Hauri, HP
TI The cargo receptor ERGIC-53 is a target of the unfolded protein response
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE ATF6; endoplasmic reticulum; ER-Golgi intermediate compartment;
   ERGIC-53; mannose lectin; membrane traffic; unfolded protein response;
   VIP36
ID GLUCOSE-REGULATED PROTEINS; COAGULATION-FACTORS V; NF-Y CBF;
   ENDOPLASMIC-RETICULUM; STRESS-RESPONSE; ER STRESS; LECTIN ERGIC-53;
   ATF6; IDENTIFICATION; BINDING
AB The accumulation of unfolded proteins in the ER triggers a signaling response known as unfolded protein response (UPR). In yeast the UPR affects several hundred genes that encode ER chaperones and proteins operating at later stages of secretion. In mammalian cells the UPR appears to be more limited to chaperones of the ER and genes assumed to be important after cell recovery from ER stress that are not important for secretion. Here, we report that the mRNA of lectin ERGIC-53, a cargo receptor for the transport of glycoproteins from ER to ERGIC, and of its related protein VIP36 is induced by the known inducers of ER stress, tunicamycin and thapsigargin. In parallel, the rate of synthesis of the ERGIC-53 protein was induced by these agents. The response was due to the UPR since it was also triggered by castanospermine, a specific inducer of UPR, and inhibited by genistein. Thapsigargin-induced upregulation of ERGIC-53 could be fully accounted for by the ATF6 pathway of UPR. The results suggest that in mammalian cells the UPR also affects traffic from and beyond the ER. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   Kyoto Univ, Grad Sch Biostudies, Kyoto 6068304, Japan.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Hans-Peter.Hauri@unibas.ch
CR Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Benedetti C, 2000, BIOCHEM BIOPH RES CO, V278, P530, DOI 10.1006/bbrc.2000.3838
   CAO XJ, 1995, J BIOL CHEM, V270, P494, DOI 10.1074/jbc.270.1.494
   Caspersen C, 2000, J BIOL CHEM, V275, P22363, DOI 10.1074/jbc.M001569200
   FIEDLER K, 1994, CELL, V77, P625, DOI 10.1016/0092-8674(94)90047-7
   Fullekrug J, 1999, J CELL SCI, V112, P2813
   Hara-Kuge S, 2002, J BIOL CHEM, V277, P16332, DOI 10.1074/jbc.M112188200
   Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3
   Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787
   Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019
   Higashio H, 2002, BIOCHEM BIOPH RES CO, V296, P568, DOI 10.1016/S0006-291X(02)00923-3
   Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211
   Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9
   Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7
   Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474
   Moussalli M, 1999, J BIOL CHEM, V274, P32539, DOI 10.1074/jbc.274.46.32539
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   NUFER O, 2003, IN PRESS J BIOL CHEM
   Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181
   OKADA T, 2002, BIOCH J, V16
   Pahl HL, 1999, PHYSIOL REV, V79, P683
   PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x
   Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001
   Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2
   Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437
   Sato M, 2002, BIOCHEM BIOPH RES CO, V296, P560, DOI 10.1016/S0006-291X(02)00922-1
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4
   Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1
   VELLOSO LM, 2002, J BIOL CHEM
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   Xian M, 2000, J BIOL CHEM, V275, P20467, DOI 10.1074/jbc.M001054200
   Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7
   Yerushalmi N, 2001, GENE, V265, P55, DOI 10.1016/S0378-1119(01)00347-X
   Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0
   Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000
   Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4
   Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001
   Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741
   Zhou YH, 1998, J NATL CANCER I, V90, P381, DOI 10.1093/jnci/90.5.381
NR 44
TC 22
Z9 23
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 16
PY 2003
VL 304
IS 4
BP 599
EP 604
DI 10.1016/S0006-291X(03)00634-X
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 679GH
UT WOS:000182912000002
PM 12727195
DA 2021-01-25
ER

PT J
AU Nufer, O
   Hauri, HP
AF Nufer, O
   Hauri, HP
TI ER export: Call 14-3-3
SO CURRENT BIOLOGY
LA English
DT Editorial Material
ID ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; INVARIANT CHAIN; RETENTION;
   TRANSPORT; TRAFFICKING; SIGNALS; PHOSPHORYLATION; COMPLEXES; RECEPTOR
AB Forward transport of proteins from the ER to the plasma membrane requires escape from the ER'S retention machinery. Recent studies suggest that 14-3-3 proteins may mediate ER export of potassium channels destined for the plasma membrane by interfering with dibasic-motif-mediated retention.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Nufer, O (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Anderson HA, 1999, J IMMUNOL, V163, P5435
   Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080
   Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4
   Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052
   Hauri HP, 2000, J CELL SCI, V113, P587
   Kuwana T, 1998, P NATL ACAD SCI USA, V95, P1056, DOI 10.1073/pnas.95.3.1056
   LETOURNEUR F, 1995, J CELL BIOL, V129, P971, DOI 10.1083/jcb.129.4.971
   Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7
   MALLABIABARRENA A, 1992, NATURE, V357, P593, DOI 10.1038/357593a0
   O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1
   Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227
   SCHUTZE MP, 1994, EMBO J, V13, P1696, DOI 10.1002/j.1460-2075.1994.tb06434.x
   Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1
   Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27
   Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200
   van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134
   YUAN H, 2003, CURR BIOL       0415
   Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4
NR 18
TC 39
Z9 40
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD MAY 13
PY 2003
VL 13
IS 10
BP R391
EP R393
DI 10.1016/S0960-9822(03)00318-X
PG 3
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 679CK
UT WOS:000182903300008
PM 12747849
DA 2021-01-25
ER

PT J
AU Furtinger, S
   Bettler, B
   Sperk, G
AF Furtinger, S
   Bettler, B
   Sperk, G
TI Altered expression of GABA(B) receptors in the hippocampus after
   kainic-acid-induced seizures in rats
SO MOLECULAR BRAIN RESEARCH
LA English
DT Article
DE GABA(B) receptors; temporal lobe epilepsy; hippocampus; receptor
   downregulation; in situ hybridization; immunocytochemistry
ID TEMPORAL-LOBE EPILEPSY; MESSENGER-RNA EXPRESSION; IN-SITU HYBRIDIZATION;
   ABSENCE SEIZURES; GLUTAMATE-DECARBOXYLASE; INHIBITION; SUBUNITS; MODEL;
   NEURONS; GRANULE
AB Epilepsy is closely related to an altered transmission of GABA, the major inhibitory transmitter in the brain. GABA acts through two classes of receptors, ionotropic GABA(A) receptors and metabotropic GABA(B) receptors. Using in situ hybridization, receptor autoradiography and immunocytochemistry, we now investigated temporal changes in the expression the GABA(B)-1 and GABA(B)-2 subunits (GABA(B)-1R and GABA(B)-1R, respectively) in the hippocampus following kainic-acid-induced seizures. Significant decreases (by about 40%) in mRNA levels of both splice variants (a and b) of GABA(B)-1R and of GABA(B)-2R were observed in the principal cell layer of the hippocampus 6-12 h after kainic acid injection in the rat. Whereas mRNA levels in the granule cell layer returned to basal after 24 It, the decreases persisted in sectors CA1 and CA3, presumably due to progressing neurodegeneration. In the sector CA3, GABA(B)-R mRNA levels and GABA(B)-R1 immunoreactivity partially recovered 30 days after the initial kainic acid seizures indicating receptor upregulation in surviving neurons. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Univ Innsbruck, Dept Pharmacol, A-6020 Innsbruck, Austria.
   Univ Basel, Pharmazentrum, Biozentrum, CH-4056 Basel, Switzerland.
RP Sperk, G (corresponding author), Univ Innsbruck, Dept Pharmacol, Peter Mayr Str 1A, A-6020 Innsbruck, Austria.
EM guenther.sperk@uibk.ac.at
RI bettler, bernhard/AAO-8018-2020
OI Bettler, Bernhard/0000-0003-0842-8207
CR Badran S, 1997, EUR J PHARMACOL, V333, P135, DOI 10.1016/S0014-2999(97)01111-4
   Bettler B, 1998, CURR OPIN NEUROBIOL, V8, P345, DOI 10.1016/S0959-4388(98)80059-7
   Billinton A, 2001, BRIT J PHARMACOL, V132, P475, DOI 10.1038/sj.bjp.0703854
   Billinton A, 2001, MOL BRAIN RES, V86, P84, DOI 10.1016/S0169-328X(00)00271-0
   Billinton A, 2001, TRENDS NEUROSCI, V24, P277, DOI 10.1016/S0166-2236(00)01815-4
   Bischoff S, 1999, J COMP NEUROL, V412, P1
   BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545
   Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661
   Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369
   Clark JA, 2000, BRAIN RES, V860, P41, DOI 10.1016/S0006-8993(00)01958-2
   DAVENPORT CJ, 1990, EXP NEUROL, V109, P180, DOI 10.1016/0014-4886(90)90072-Z
   Durkin MM, 1999, MOL BRAIN RES, V71, P185, DOI 10.1016/S0169-328X(99)00182-5
   FELDBLUM S, 1990, NEURON, V5, P361, DOI 10.1016/0896-6273(90)90172-C
   FISHER RS, 1984, J NEUROSCI, V4, P1312
   FRANCK JE, 1988, J NEUROSCI, V8, P1991
   Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x
   Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152
   Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924
   Haas KZ, 1996, J NEUROSCI, V16, P4250
   HOSFORD DA, 1992, SCIENCE, V257, P398, DOI 10.1126/science.1321503
   HOSFORD DA, 1995, J PHARMACOL EXP THER, V274, P1399
   HOSFORD DA, 1995, J NEUROSCI, V15, P7367
   Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348
   KAMPHUIS W, 1995, MOL BRAIN RES, V31, P33, DOI 10.1016/0169-328X(95)00022-K
   Kapur J, 1995, ANN NEUROL, V38, P893, DOI 10.1002/ana.410380609
   Kaupmann K, 1998, NATURE, V396, P683
   Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0
   Kaupmann K, 1998, P NATL ACAD SCI USA, V95, P14991, DOI 10.1073/pnas.95.25.14991
   KERR DIB, 1995, PHARMACOL THERAPEUT, V67, P187, DOI 10.1016/0163-7258(95)00016-A
   KOKAIA M, 1994, MOL BRAIN RES, V23, P323, DOI 10.1016/0169-328X(94)90242-9
   Kokaia Z, 2001, NEUROSCI LETT, V315, P85, DOI 10.1016/S0304-3940(01)02350-3
   Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74
   LIU Z, 1992, NEUROSCIENCE, V48, P87, DOI 10.1016/0306-4522(92)90340-8
   Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698
   MARESCAUX C, 1992, EPILEPSY RES, P131
   MARKSTEINER J, 1988, NEUROSCIENCE, V26, P379, DOI 10.1016/0306-4522(88)90155-8
   Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995
   Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2
   Schwarzer C, 1997, NEUROSCIENCE, V80, P1001, DOI 10.1016/S0306-4522(97)00145-0
   SCHWARZER C, 1995, NEUROSCIENCE, V69, P705, DOI 10.1016/0306-4522(95)00348-M
   Sloviter RS, 1999, NEUROPHARMACOLOGY, V38, P1707, DOI 10.1016/S0028-3908(99)00132-X
   SNEAD OC, 1992, EUR J PHARMACOL, V213, P343, DOI 10.1016/0014-2999(92)90623-C
   SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6
   SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1
   Tsunashima K, 1997, NEUROSCIENCE, V80, P1019, DOI 10.1016/S0306-4522(97)00144-9
   Vergnes M, 1997, EUR J PHARMACOL, V332, P245, DOI 10.1016/S0014-2999(97)01085-6
   White JH, 1998, NATURE, V396, P679
NR 47
TC 29
Z9 38
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-328X
J9 MOL BRAIN RES
JI Mol. Brain Res.
PD MAY 12
PY 2003
VL 113
IS 1-2
BP 107
EP 115
DI 10.1016/S0169-328X(03)00097-4
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA 685DG
UT WOS:000183245100012
PM 12750012
DA 2021-01-25
ER

PT J
AU Patel, TD
   Kramer, I
   Kucera, J
   Niederkofler, V
   Jessell, TM
   Arber, S
   Snider, WD
AF Patel, TD
   Kramer, I
   Kucera, J
   Niederkofler, V
   Jessell, TM
   Arber, S
   Snider, WD
TI Peripheral NT3 signaling is required for ETS protein expression and
   central patterning of proprioceptive sensory afferents
SO NEURON
LA English
DT Article
ID DORSAL-ROOT GANGLIA; TRANSCRIPTION FACTOR EGR3; MESSENGER-RNA
   EXPRESSION; MOTOR-NEURON POOLS; MICE LACKING; IN-VIVO; NERVOUS-SYSTEM;
   RECEPTOR GENE; TERMINAL ARBORIZATION; NEUROTROPHIN-3
AB To study the role of NT3 in directing axonal projections of proprioceptive dorsal root ganglion (DRG) neurons, NT3(-/-) mice were crossed with mice carrying a targeted deletion of the proapoptotic gene Bax. In Bax(-/-)/NT3(-/-) mice, NT3-dependent neurons survived and expressed the proprioceptive neuronal marker parvalbumin. Initial extension and collateralization of proprioceptive axons into the spinal cord occurred normally, but proprioceptive axons extended only as far as the intermediate spinal cord. This projection defect is similar to the defect in mice lacking the ETS transcription factor ER81 (Arber et al., 2000). Few if any DRG neurons from Sax(-/-)/NT3-/mice expressed ER81 protein. Expression of a NT3 transgene in muscle restored DRG ER81 expression in NTZ3(-/-) mice. Finally, addition of NT3 to DRG explant cultures resulted in induction of ER81 protein. Our data indicate that NT3 mediates the formation of proprioceptive afferent-motor neuron connections via regulation of ER81.
C1 Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   VA Med Ctr, Boston, MA 02130 USA.
   Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.
RP Snider, WD (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.
OI Arber, Silvia/0000-0002-6261-250X
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS031768, R01NS031768, R01NS031768, R01NS031768, F32NS011025,
   R01NS031768, R01NS031768, R01NS031768, R01NS031768, R01NS031768,
   R01NS031768, R01NS031768, R01NS031768, R01NS031768, R01NS031768,
   F32NS011025, F32NS011025, R01NS031768, R01NS031768, R01NS031768,
   R01NS031768, R01NS031768, R01NS031768, R01NS031768, R01NS031768,
   R01NS031768, R01NS031768, R01NS031768, R01NS031768] Funding Source: NIH
   RePORTER; NINDS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [NS31768, NS11025] Funding
   Source: Medline
CR Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   BROWN AG, 1981, ORG SPINAL CORD
   Chen HH, 2002, J NEUROSCI, V22, P3512
   COPRAY JCVM, 1994, DEV BRAIN RES, V81, P57, DOI 10.1016/0165-3806(94)90068-X
   CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6
   Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7
   ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794
   ElShamy WM, 1996, NEURON, V16, P963, DOI 10.1016/S0896-6273(00)80119-1
   ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x
   ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5
   Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5
   FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0
   Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7
   HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925
   KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0
   Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7
   KUCERA J, 1987, ANAT EMBRYOL, V176, P449, DOI 10.1007/BF00310086
   KUCERA J, 1988, NEUROSCI LETT, V95, P88, DOI 10.1016/0304-3940(88)90637-4
   Lentz SI, 1999, J NEUROSCI, V19, P1038
   Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Ma L, 2002, NEURON, V36, P623, DOI 10.1016/S0896-6273(02)01021-8
   Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3
   McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295
   Mendell LM, 1999, J NEUROSCI, V19, P3162
   MU XJ, 1993, J NEUROSCI, V13, P4029
   O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2
   OAKLEY RA, 1995, DEVELOPMENT, V121, P1341
   Oakley RA, 1997, J NEUROSCI, V17, P4262
   Oakley RA, 2002, DEV BIOL, V249, P255, DOI 10.1006/dbio.2002.0775
   Ockel M, 1996, DEVELOPMENT, V122, P301
   Patapoutian A, 1999, SCIENCE, V283, P1180, DOI 10.1126/science.283.5405.1180
   Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5
   Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5
   Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0
   SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E
   SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0
   SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5
   Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4
   TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844
   Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776
   Tourtellotte WG, 1998, NAT GENET, V20, P87
   Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202
   Tucker KL, 2001, NAT NEUROSCI, V4, P29
   Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9
   White FA, 1996, J NEUROSCI, V16, P4662
   White FA, 1998, J NEUROSCI, V18, P1428
   Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0
   WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302
   YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
   Zelena J, 1994, NERVES MECHANORECEPT
NR 59
TC 149
Z9 153
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD MAY 8
PY 2003
VL 38
IS 3
BP 403
EP 416
DI 10.1016/S0896-6273(03)00261-7
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA 677HF
UT WOS:000182800300006
PM 12741988
DA 2021-01-25
ER

PT J
AU Sadowski, M
   Dichtl, B
   Hubner, W
   Keller, W
AF Sadowski, M
   Dichtl, B
   Hubner, W
   Keller, W
TI Independent functions of yeast Pcf11p in pre-mRNA 3 ' end processing and
   in transcription termination
SO EMBO JOURNAL
LA English
DT Article
DE pre-mRNA 3 ' end processing; RNA polymerase IIC-terminal domain;
   transcription termination
ID RNA-POLYMERASE-II; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE;
   POLYADENYLATION FACTOR; POLY(A) SIGNAL; IN-VITRO; EM VISUALIZATION;
   3'-END FORMATION; BRIDGES 2; FACTOR IA
AB Pcf11p, an essential subunit of the yeast cleavage factor IA, is required for pre-mRNA 3' end processing, binds to the C-terminal domain (CTD) of the largest subunit of RNA polymerase II (RNAP II) and is involved in transcription termination. We show that the conserved CTD interaction domain (CID) of Pcf11p is essential for cell viability. Interestingly, the CTD binding and 3' end processing activities of Pcf11p can be functionally uncoupled from each other and provided by distinct Pcf11p fragments in trans. Impaired CTD binding did not affect the 3' end processing activity of Pcf11p and a deficiency of Pcf11p in 3' end processing did not prevent CTD binding. Transcriptional run-on analysis with the CYC1 gene revealed that loss of cleavage activity did not correlate with a defect in transcription termination, whereas loss of CTD binding did. We conclude that Pcf11p is a bifunctional protein and that transcript cleavage is not an obligatory step prior to RNAP II termination.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Keller, W (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RI ; Hubner, Wolfgang/O-7907-2016
OI Dichtl, Bernhard/0000-0001-5514-4982; Hubner,
   Wolfgang/0000-0002-1128-6468; Sadowski, Martin/0000-0002-5267-1442
CR Alen C, 2002, MOL CELL, V10, P1441, DOI 10.1016/S1097-2765(02)00778-5
   Amrani N, 1997, MOL CELL BIOL, V17, P1102, DOI 10.1128/MCB.17.3.1102
   Amrani N, 1997, MOL CELL BIOL, V17, P3694, DOI 10.1128/MCB.17.7.3694
   Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0
   Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298
   Bauren G, 1998, GENE DEV, V12, P2759, DOI 10.1101/gad.12.17.2759
   Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2
   Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298
   Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2
   Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901
   CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440
   Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009
   Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763
   de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895
   Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390
   Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4
   Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5
   Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101
   Gross S, 2001, P NATL ACAD SCI USA, V98, P6080, DOI 10.1073/pnas.101046598
   Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002
   Hirose Y, 1998, NATURE, V395, P93
   Ho CK, 1999, MOL CELL, V3, P405, DOI 10.1016/S1097-2765(00)80468-2
   Kessler MM, 1996, J BIOL CHEM, V271, P27167, DOI 10.1074/jbc.271.43.27167
   Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700
   Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X
   LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306
   McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0
   MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897
   MINVIELLESEBASTIA L, 1994, SCIENCE, V266, P1702, DOI 10.1126/science.7992054
   Ohnacker M, 2000, EMBO J, V19, P37, DOI 10.1093/emboj/19.1.37
   Orozco IJ, 2002, J BIOL CHEM, V277, P42899, DOI 10.1074/jbc.M207415200
   Osheim YN, 2002, CHROMOSOMA, V111, P1, DOI 10.1007/s00412-002-0183-7
   Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7
   Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406
   Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2
   PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1
   Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7
   Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000
   Ryan K, 2002, MOL CELL BIOL, V22, P1684, DOI 10.1128/MCB.22.6.1684-1692.2002
   Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300
   Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583
   Skaar DA, 2002, MOL CELL, V10, P1429, DOI 10.1016/S1097-2765(02)00731-1
   Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699
   TAKAGAKI Y, 1994, NATURE, V372, P471, DOI 10.1038/372471a0
   Tran DP, 2001, MOL CELL BIOL, V21, P7495, DOI 10.1128/MCB.21.21.7495-7508.2001
   Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4
   Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
NR 48
TC 99
Z9 101
U1 1
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0261-4189
J9 EMBO J
JI Embo J.
PD MAY 1
PY 2003
VL 22
IS 9
BP 2167
EP 2177
DI 10.1093/emboj/cdg200
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 674HG
UT WOS:000182630900023
PM 12727883
OA Green Published
DA 2021-01-25
ER

PT J
AU De Paola, V
   Arber, S
   Caroni, P
AF De Paola, V
   Arber, S
   Caroni, P
TI AMPA receptors regulate dynamic equilibrium of presynaptic terminals in
   mature hippocampal networks
SO NATURE NEUROSCIENCE
LA English
DT Article
ID LONG-LASTING POTENTIATION; TERM SYNAPTIC PLASTICITY; DENDRITIC SPINES;
   MOSSY FIBERS; TRANSGENIC MICE; LATE-PHASE; SYNAPSES; SYNAPTOGENESIS;
   PROTEINS; CULTURES
AB The formation and disassembly of synapses in mature neuropil could provide a substrate to encode experience in the brain. Although there is evidence for postsynaptic spine dynamics in mature systems, contributions to circuit rearrangements by presynaptic terminals have remained unclear. We used hippocampal slice cultures from mice expressing spectral variants of green fluorescent protein (GFP) that are targeted to the membrane and/or synaptic vesicles in neuronal subsets to image identified presynaptic terminals. In mature tissues with no net change in synapse numbers, subpopulations of presynaptic terminals appeared and disappeared within 1-3 days. The three terminal types established by mossy fibers had distinct properties. High-frequency stimulation increased the fraction of dynamic terminals for 1-2 days, a process mediated by activation of AMPA receptors, protein kinase A (PKA) and protein synthesis. Thus, synaptic activity can make stable presynaptic terminals become dynamic, providing a candidate mechanism to convert experience into changes in network connectivity.
C1 Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   Univ Basel, Friedrich Miescher Inst, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.
RI de paola, vincenzo/B-4900-2016
OI de paola, vincenzo/0000-0001-9987-8291; Arber,
   Silvia/0000-0002-6261-250X
CR Acsady L, 1998, J NEUROSCI, V18, P3386
   Ahmari SE, 2000, NAT NEUROSCI, V3, P445
   AMARAL DG, 1979, ANAT EMBRYOL, V155, P241, DOI 10.1007/BF00317638
   Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273
   BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145
   Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8
   Bastmeyer M, 1996, J NEUROSCI, V16, P1450
   Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8
   Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5
   Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a
   CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403
   Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3
   CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0
   DAILEY ME, 1994, J NEUROSCI, V14, P1060
   Dailey ME, 1996, J NEUROSCI, V16, P2983
   Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847
   Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978
   Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2
   Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X
   Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3
   Hatada Y, 2000, J NEUROSCI, V20, part. no.
   Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9
   Horch HW, 1999, NEURON, V23, P353
   Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107
   Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1
   Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4
   Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714
   Ma L, 1999, NAT NEUROSCI, V2, P24
   Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717
   Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754
   Mizuhashi S, 2001, J NEUROSCI, V21, P6181
   Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008
   Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175
   Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3
   Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9
   Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004
   Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0
   Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X
   Smart FM, 2000, HIPPOCAMPUS, V10, P542, DOI 10.1002/1098-1063(2000)10:5<542::AID-HIPO4>3.0.CO;2-7
   STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M
   Toni N, 1999, NATURE, V402, P421
   Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x
   Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000
   Wiederkehr A, 1997, EXP CELL RES, V236, P103, DOI 10.1006/excr.1997.3709
   Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598
   Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071
   Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4
   Ziv NE, 2001, CURR OPIN NEUROBIOL, V11, P536, DOI 10.1016/S0959-4388(00)00246-4
NR 48
TC 171
Z9 173
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1097-6256
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD MAY
PY 2003
VL 6
IS 5
BP 491
EP 500
DI 10.1038/nn1046
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 672ZD
UT WOS:000182553200016
PM 12692557
DA 2021-01-25
ER

PT J
AU Savic, N
   Luthi, A
   Gahwiler, BH
   McKinney, RA
AF Savic, N
   Luthi, A
   Gahwiler, BH
   McKinney, RA
TI N-methyl-D-aspartate receptor blockade during development lowers
   long-term potentiation threshold without affecting dynamic range of
   CA3-CA1 synapses
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID HIPPOCAMPUS IN-VITRO; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; SILENT
   SYNAPSES; VISUAL-CORTEX; AREA CA1; UNITARY CA3-CA1; INDUCED LTP;
   DEPRESSION; CONNECTIONS
AB During development, excitatory synapses in the CA1 region of the hippocampus undergo activity-dependent and N-methyl-D-aspartate (NMDA) receptor-dependent long-lasting changes in synaptic efficacy. These bidirectional changes occur between limits that determine the dynamic range within which synapses operate. It is unknown whether the dynamic range itself is also activity-dependent and NMDA receptor-dependent. Here, we show that chronic blockade of NMDA receptors in hippocampal slice cultures during early postnatal development does not affect the dynamic range but results in a lower threshold for the induction of long-term potentiation. Thus, the dynamic range of CA3-CA1 synapses, unlike long-term potentiation threshold, is NMDA receptor-independent, thereby providing functional stability to the hippocampal network during development.
C1 Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland.
   Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Savic, N (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
CR Abraham WC, 2001, P NATL ACAD SCI USA, V98, P10924, DOI 10.1073/pnas.181342098
   Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X
   Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825
   BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982
   BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0
   COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478
   Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6
   Debanne D, 1999, J NEUROSCI, V19, P10664
   Debanne D, 1997, J NEUROPHYSIOL, V77, P2851
   DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148
   DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363
   DUDEK SM, 1993, J NEUROSCI, V13, P2910
   Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0
   FREY U, 1995, NEUROSCIENCE, V67, P799, DOI 10.1016/0306-4522(95)00117-2
   Gahwiler BH, 1998, CULTURING NERVE CELL, P461
   Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013
   HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729
   ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2
   KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1
   Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0
   LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0
   Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1
   Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744
   Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870
   Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213
   Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2
   Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6
   MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C
   MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N
   Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732
   Petralia RS, 1999, NAT NEUROSCI, V2, P31
   Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8
   Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533
   WEXLER EM, 1993, NEUROREPORT, V4, P591, DOI 10.1097/00001756-199305000-00034
   Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850
   Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2
NR 36
TC 15
Z9 15
U1 0
U2 0
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 29
PY 2003
VL 100
IS 9
BP 5503
EP 5508
DI 10.1073/pnas.0831035100
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 673ZY
UT WOS:000182612600096
PM 12702771
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Adams, JC
   Monk, R
   Taylor, AL
   Ozbek, S
   Fascetti, N
   Baumgartner, S
   Engel, J
AF Adams, JC
   Monk, R
   Taylor, AL
   Ozbek, S
   Fascetti, N
   Baumgartner, S
   Engel, J
TI Characterisation of Drosophila thrombospondin defines an early origin of
   pentameric thrombospondins
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE extracellular matrix; cell interactions; heparin-binding; RGD-motif;
   molecular phylogeny
ID OLIGOMERIC MATRIX PROTEIN; MULTIPLE EPIPHYSEAL DYSPLASIA; CELL-BINDING
   DOMAIN; COILED-COIL DOMAIN; EXTRACELLULAR-MATRIX; GENOME SEQUENCE;
   CALCIUM-BINDING; PSEUDOACHONDROPLASIA; MUTATION; COMP
AB Thrombospondins (TSPs) are multidomain oligomers that have complex roles in cell interactions and tissue organisation. The five vertebrate TSPs comprise two subgroups, A and B, that are assembled as trimers or pentamers, respectively. An invertebrate TSP was recently discovered in Drosophila melanogaster, but there is no knowledge of the oligomerisation status or properties of this molecule. We developed by bioinformatics a new dataset containing the single TSP of Drosophila melanogaster and four other newly identified invertebrate TSPs to examine the phylogenetic relationships of TSPs. These analyses clearly indicate pentamerisation as an early attribute of TSPs. We demonstrate experimentally that D. melanogaster TSP is assembled as a pentamer, has heparin-binding activity and is a component of extracellular matrix (ECM). During embryogenesis, the TSP transcript is concentrated at muscle attachment sites and is expressed by a subset of myoblasts and in imaginal discs. These novel results establish TSPs as highly conserved ECM components in both invertebrates and vertebrates and open fresh perspectives on the conservation of structure and biological function within this family (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England.
   UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England.
   Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA.
   Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
   Lund Univ, Dept Cell & Mol Biol, Sect Dev Biol, S-22184 Lund, Sweden.
RP Adams, JC (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.
EM adamsj@ccf.org
RI Ozbek, Suat/D-3701-2014; Baumgartner, Stefan/A-5879-2011; Adams,
   Josephine C/B-1121-2009
OI Baumgartner, Stefan/0000-0001-5320-8321; Adams, Josephine
   C/0000-0002-2225-4947; Ozbek, Suat/0000-0003-2569-3942
CR ADAMS J, 1993, CURR BIOL, V3, P188, DOI 10.1016/0960-9822(93)90270-X
   Adams JC, 2000, DEV DYNAM, V218, P280
   Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25
   Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169
   ADAMS JC, 1995, THROMBOSPONDIN GENE
   Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Adolph KW, 2001, GENE, V269, P177, DOI 10.1016/S0378-1119(01)00441-3
   Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510
   Blair JE, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-7
   Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749
   BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330
   Brown NH, 2000, MATRIX BIOL, V19, P191, DOI 10.1016/S0945-053X(00)00064-0
   Bunch TA, 1998, DEVELOPMENT, V125, P1679
   Campos-Ortega JA, 1985, EMBRYONIC DEV DROSOP
   CARTER WG, 1982, J BIOL CHEM, V257, P13805
   Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199
   CULLEN CF, 1991, TISSUE CELL, V23, P29, DOI 10.1016/0040-8166(91)90064-Z
   CURRIE DA, 1988, DEVELOPMENT, V102, P805
   Dayhoff M., 1978, ATLAS PROTEIN SEQ S3, P345
   Delot E, 1998, J BIOL CHEM, V273, P26692, DOI 10.1074/jbc.273.41.26692
   DOOLITTLE RF, 1992, PROTEIN SCI, V1, P191
   DZOBNOV EM, 2002, SCIENCE, V298, P149
   EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4
   ENGEL J, 1994, DEVELOP, pS35
   Felsenstein J, 1996, METHOD ENZYMOL, V266, P418
   GAO AG, 1994, J BIOL CHEM, V269, P29650
   Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133
   Guo Y, 1998, EMBO J, V17, P5265, DOI 10.1093/emboj/17.18.5265
   Hannah BLA, 2003, J BIOL CHEM, V278, P8929, DOI 10.1074/jbc.M211185200
   HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325
   Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Hou J, 2000, CELL CALCIUM, V27, P309, DOI 10.1054/ceca.2000.0125
   Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989
   Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89
   KOSFELD MD, 1993, J BIOL CHEM, V268, P8808
   Kozlova T, 2000, TRENDS ENDOCRIN MET, V11, P276, DOI 10.1016/S1043-2760(00)00282-4
   LAWLER J, 1993, J MOL EVOL, V36, P509, DOI 10.1007/BF00556355
   Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5
   LAWLER J, 1989, BLOOD, V74, P2022
   LAWLER J, 1985, J BIOL CHEM, V260, P3762
   LAWLER J, 1995, J BIOL CHEM, V270, P2809, DOI 10.1074/jbc.270.6.2809
   LAWLER J, 1988, J CELL BIOL, V118, P693
   Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993
   Maddox BK, 2000, J BIOL CHEM, V275, P11412, DOI 10.1074/jbc.275.15.11412
   Misenheimer TM, 2001, J BIOL CHEM, V276, P45882, DOI 10.1074/jbc.M104218200
   MORGELIN M, 1992, J BIOL CHEM, V267, P6137
   NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649
   OLDBERG A, 1992, J BIOL CHEM, V267, P22346
   ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0
   OROURKE KM, 1992, J BIOL CHEM, V267, P24921
   Ozbek S, 2002, EMBO J, V21, P5960, DOI 10.1093/emboj/cdf628
   QABAR A, 1995, J BIOL CHEM, V270, P12725, DOI 10.1074/jbc.270.21.12725
   ROBINSON J, 1984, J BIOL CHEM, V259, P3818
   Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397
   Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119
   SCHAGGER H, 1998, ANAL BIOCHEM, V173, P201
   SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353
   Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200
   Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910
   Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4
NR 65
TC 46
Z9 47
U1 0
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 25
PY 2003
VL 328
IS 2
BP 479
EP 494
DI 10.1016/S0022-2836(03)00248-1
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 670WB
UT WOS:000182431200014
PM 12691755
DA 2021-01-25
ER

PT J
AU Muller, B
   Hartmann, B
   Pyrowolakis, G
   Affolter, M
   Basler, K
AF Muller, B
   Hartmann, B
   Pyrowolakis, G
   Affolter, M
   Basler, K
TI Conversion of an extracellular Dpp/BMP morphogen gradient into an
   inverse transcriptional gradient
SO CELL
LA English
DT Article
ID DROSOPHILA WING DEVELOPMENT; SIGNAL-TRANSDUCTION; IMAGINAL DISCS;
   BINDING-SITES; DPP TARGETS; BRINKER; GENE; REPRESSION; SCHNURRI; ENCODES
AB Morphogen gradients control body pattern by differentially regulating cellular behavior. Here, we analyze the molecular events underlying the primary response to the Dpp/BMP morphogen in Drosophila. Throughout development, Dpp transduction causes the graded transcriptional downregulation of the brinker (brk) gene. We first provide significance for the brk expression gradient by showing that different Brk levels repress distinct combinations of wing genes expressed at different distances from Dpp-secreting cells. We then dissect the brk regulatory region and identify two separable elements with opposite properties, a constitutive enhancer and a Dpp morphogen-regulated silencer. Furthermore, we present genetic and biochemical evidence that the brk silencer serves as a direct target for a protein complex consisting of the Smad homologs Mad/Medea and the zinc finger protein Schnurri. Together, our results provide the molecular framework for a mechanism by which the extracellular Dpp/BMP morphogen establishes a finely tuned, graded read-out of transcriptional repression.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Mueller, Bruno/E-9888-2017
OI Mueller, Bruno/0000-0003-2664-7219; Basler, Konrad/0000-0003-3534-1529;
   Affolter, Markus/0000-0002-5171-0016
CR Affolter M, 2001, EMBO J, V20, P3298, DOI 10.1093/emboj/20.13.3298
   ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1
   Ashe HL, 2000, DEVELOPMENT, V127, P3305
   Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809
   Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5
   Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2
   DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0
   Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2
   GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5
   Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601
   Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725
   HOCH M, 1993, CURR OPIN GENET DEV, V3, P566, DOI 10.1016/0959-437X(93)90092-4
   Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404
   Hudson JB, 1998, DEVELOPMENT, V125, P1407
   Inoue H, 1998, MOL BIOL CELL, V9, P2145, DOI 10.1091/mbc.9.8.2145
   Jazwinska A, 1999, DEVELOPMENT, V126, P3323
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C
   Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0
   Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906
   Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200
   Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0
   Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261
   Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Morgan T.H., 1897, ROUX ARCH DEV BIOL, V5, P570
   Muller B, 2000, DEVELOPMENT, V127, P2999
   Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9
   Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282
   Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0
   Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379
   SEGALAT L, 1994, MECH DEVELOP, V47, P241, DOI 10.1016/0925-4773(94)90042-6
   SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x
   Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293
   STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2
   STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7
   Sturtevant MA, 1997, DEVELOPMENT, V124, P21
   Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577
   Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7
   Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9
   Torres-Vazquez J, 2000, DEV BIOL, V227, P388, DOI 10.1006/dbio.2000.9900
   Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362
   TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012
   Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433
   WOLPERT L, 1989, DEVELOPMENT, V107, P3
NR 49
TC 136
Z9 138
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0092-8674
J9 CELL
JI Cell
PD APR 18
PY 2003
VL 113
IS 2
BP 221
EP 233
DI 10.1016/S0092-8674(03)00241-1
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 672EP
UT WOS:000182508500011
PM 12705870
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Stoffler, D
   Feja, B
   Fahrenkrog, B
   Walz, J
   Typke, D
   Aebi, U
AF Stoffler, D
   Feja, B
   Fahrenkrog, B
   Walz, J
   Typke, D
   Aebi, U
TI Cryo-electron tomography provides novel insights into nuclear pore
   architecture: Implications for nucleocytoplasmic transport
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE cryo-electron microscopy; electron tomography; nuclear pore complex;
   nucleocytoplasmic transport; 3-D reconstruction
ID INTRANUCLEAR FILAMENTS; MOLECULAR ARCHITECTURE; NUCLEOPORIN NUP153;
   COMPLEX; MICROSCOPY; PROTEIN; IMPORT; ENVELOPE; MACROMOLECULES;
   VISUALIZATION
AB To go beyond the current structural consensus model of the nuclear pore complex (NPC), we performed cryo-electron tomography of fully native NPCs from Xenopus oocyte nuclear envelopes (NEs). The cytoplasmic face of the NPC revealed distinct anchoring sites for the cytoplasmic filaments, whereas the nuclear face was topped with a massive distal ring positioned above the central pore with indications of the anchoring sites for the nuclear basket filaments and putative intranuclear filaments. The rather "spongy"central framework of the NPC was perforated by an elaborate channel and void system, and at the membrane pore interface it exhibited distinct "handles" protruding into the lumen of the NE. The most variable structural moiety of the NPC was a rather tenuous central plug partially obstructing the central pore. Its mobile character was documented by time-lapse atomic force microscopy. Taken together, the new insights we gained into NPC structure support the notion that the NPC acts as a constrained diffusion pore for molecules and particles without retention signal and as an affinity gate for signal-bearing cargoes. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, ME Muller Inst Structural Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Max Planck Inst Biochem, D-82152 Martinsried, Germany.
RP Aebi, U (corresponding author), Univ Basel, ME Muller Inst Structural Biol, Biozentrum, CH-4056 Basel, Switzerland.
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413
CR AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6
   AKEY CW, 1989, J CELL BIOL, V109, P955, DOI 10.1083/jcb.109.3.955
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   CORDES VC, 1993, J CELL BIOL, V123, P1333, DOI 10.1083/jcb.123.6.1333
   Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515
   Danker T, 1999, P NATL ACAD SCI USA, V96, P13530, DOI 10.1073/pnas.96.23.13530
   DIERKSEN K, 1992, ULTRAMICROSCOPY, V40, P71, DOI 10.1016/0304-3991(92)90235-C
   DIERKSEN K, 1993, ULTRAMICROSCOPY, V49, P109, DOI 10.1016/0304-3991(93)90217-L
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Fahrenkrog Birthe, 2002, Results Probl Cell Differ, V35, P25
   Feja B, 1999, J MICROSC-OXFORD, V193, P15, DOI 10.1046/j.1365-2818.1999.00436.x
   Feldherr CM, 1997, J CELL SCI, V110, P3065
   Fukami A, 1965, J Electron Microsc (Tokyo), V14, P112
   Goldberg MW, 1997, J CELL SCI, V110, P409
   GOLDBERG MW, 1992, J CELL BIOL, V119, P1429, DOI 10.1083/jcb.119.6.1429
   Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607
   GREBER UF, 1990, EMBO J, V9, P1495, DOI 10.1002/j.1460-2075.1990.tb08267.x
   Grimm R, 1998, BIOPHYS J, V74, P1031, DOI 10.1016/S0006-3495(98)74028-7
   Grimm R, 1997, BIOPHYS J, V72, P482, DOI 10.1016/S0006-3495(97)78689-2
   Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   JARNIK M, 1991, J STRUCT BIOL, V107, P291, DOI 10.1016/1047-8477(91)90054-Z
   Keminer O, 1999, P NATL ACAD SCI USA, V96, P11842, DOI 10.1073/pnas.96.21.11842
   Kiseleva E, 1997, EUR J CELL BIOL, V74, P407
   Kiseleva E, 1998, J CELL SCI, V111, P223
   Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933
   KOSTER AJ, 1992, ULTRAMICROSCOPY, V46, P207, DOI 10.1016/0304-3991(92)90016-D
   MALIS T, 1988, J ELECTRON MICR TECH, V8, P193, DOI 10.1002/jemt.1060080206
   PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0
   Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729
   Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Pante N, 1997, RNA, V3, P498
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   Rakowska A, 1998, J MEMBRANE BIOL, V163, P129, DOI 10.1007/s002329900377
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771
   SAXTON WO, 1979, ULTRAMICROSCOPY, V4, P343, DOI 10.1016/S0304-3991(79)80044-3
   Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31
   Sheehan B, 1996, J STRUCT BIOL, V116, P99, DOI 10.1006/jsbi.1996.0017
   SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   Walz J, 1997, J STRUCT BIOL, V120, P387, DOI 10.1006/jsbi.1997.3934
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
NR 50
TC 174
Z9 177
U1 0
U2 10
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 18
PY 2003
VL 328
IS 1
BP 119
EP 130
DI 10.1016/S0022-2836(03)00266-3
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 668EK
UT WOS:000182277200010
PM 12684002
DA 2021-01-25
ER

PT J
AU Seifritz, E
   Di Salle, F
   Esposito, F
   Luethi, A
   Seelig, J
   Dammann, G
AF Seifritz, E
   Di Salle, F
   Esposito, F
   Luethi, A
   Seelig, J
   Dammann, G
TI Temporal structure of amygdala response to emotional auditory stimuli in
   patients with borderline personality disorder
SO BIOLOGICAL PSYCHIATRY
LA English
DT Meeting Abstract
CT 58th Annual Convention and Scientific Program of the
   Society-of-Biological-Psychiatry
CY MAY 15-17, 2003
CL SAN FRANCISCO, CALIFORNIA
SP Soc Bio Psychiatry
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Naples Federico II, Div Neuroradiol, Naples, Italy.
   Univ Naples 2, Div Neurol 2, Naples, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD APR 15
PY 2003
VL 53
IS 8
SU S
MA 293
BP 104S
EP 104S
PG 1
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 670XU
UT WOS:000182436000285
DA 2021-01-25
ER

PT J
AU Kahmann, JD
   Sass, HJ
   Allan, MG
   Seto, H
   Thompson, CJ
   Grzesiek, S
AF Kahmann, JD
   Sass, HJ
   Allan, MG
   Seto, H
   Thompson, CJ
   Grzesiek, S
TI Structural basis for antibiotic recognition by the TipA class of
   multidrug-resistance transcriptional regulators
SO EMBO JOURNAL
LA English
DT Article
DE antibiotic recognition; globin fold; heteronuclear NMR; protein
   dynamics; transcriptional regulation
ID THIOSTREPTON-INDUCED GENE; COMPLETE GENOME SEQUENCE;
   STREPTOMYCES-LIVIDANS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE;
   PROTEIN-STRUCTURE; MOLECULAR RECOGNITION; CHEMICAL-SHIFTS; EXPRESSION;
   ALIGNMENT
AB The TipAL protein, a bacterial transcriptional regulator of the MerR family, is activated by numerous cyclic thiopeptide antibiotics. Its C-terminal drug-binding domain, TipAS, defines a subfamily of broadly distributed bacterial proteins including Mta, a central regulator of multidrug resistance in Bacillus subtilis. The structure of apo TipAS, solved by solution NMR [Brookhaven Protein Data Bank entry 1NY9], is composed of a globin-like alpha-helical fold with a deep surface cleft and an unfolded N-terminal region. Antibiotics bind within the cleft at a position that is close to the corresponding heme pocket in myo- and hemoglobin, and induce folding of the N-terminus. Thus the classical globin fold is well adapted not only for accommodating its canonical cofactors, heme and other tetrapyrroles, but also for the recognition of a variety of antibiotics where ligand binding leads to transcriptional activation and drug resistance.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Microbiol, CH-4056 Basel, Switzerland.
   Tokyo Univ Agr, Fac Appl Biosci, Dept Appl Biol & Chem, Tokyo, Japan.
RP Sass, HJ (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM juergen.sass@unibas.ch; charles-j.thompson@unibas.ch;
   stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
CR AHMED M, 1995, J BACTERIOL, V177, P3904, DOI 10.1128/jb.177.14.3904-3910.1995
   AHMED M, 1994, J BIOL CHEM, V269, P28506
   Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   ANDERSON B, 1970, NATURE, V225, P233, DOI 10.1038/225233a0
   Baranova NN, 1999, MOL MICROBIOL, V31, P1549, DOI 10.1046/j.1365-2958.1999.01301.x
   BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3
   Bond CS, 2001, ACTA CRYSTALLOGR D, V57, P755, DOI 10.1107/S0907444901003134
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   Chiu ML, 1996, BIOCHEMISTRY-US, V35, P2332, DOI 10.1021/bi952073e
   Chiu ML, 2001, BIOCHEMISTRY-US, V40, P12950, DOI 10.1021/bi010328k
   Chiu ML, 1999, J BIOL CHEM, V274, P20578, DOI 10.1074/jbc.274.29.20578
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   Eliezer D, 1998, NAT STRUCT BIOL, V5, P148
   Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596
   Godsey MH, 2001, J BIOL CHEM, V276, P47178, DOI 10.1074/jbc.M105819200
   Grkovic S, 2001, SEMIN CELL DEV BIOL, V12, P225, DOI 10.1006/scdb.2000.0248
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052
   GUILFOILE PG, 1991, P NATL ACAD SCI USA, V88, P8553, DOI 10.1073/pnas.88.19.8553
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138
   HILL WE, 1990, RIBOSOME STRUCTURE F
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   HOLMES DJ, 1993, EMBO J, V12, P3183, DOI 10.1002/j.1460-2075.1993.tb05987.x
   KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0
   KLOEK AP, 1993, J BIOL CHEM, V268, P17669
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Laskowski RA, 1996, PROTEIN SCI, V5, P2438
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Miller SM, 1999, ESSAYS BIOCHEM, V34, P17, DOI 10.1042/bse0340017
   Moens L, 1996, MOL BIOL EVOL, V13, P324, DOI 10.1093/oxfordjournals.molbev.a025592
   MURAKAMI T, 1989, J BACTERIOL, V171, P1459, DOI 10.1128/jb.171.3.1459-1466.1989
   PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0
   PLATER R, 1992, GENE, V112, P117, DOI 10.1016/0378-1119(92)90312-D
   Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0
   Porse BT, 1998, J MOL BIOL, V276, P391, DOI 10.1006/jmbi.1997.1541
   Rava PS, 1999, J BACTERIOL, V181, P6152, DOI 10.1128/JB.181.19.6152-6159.1999
   Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281
   SCHIRMER T, 1985, J MOL BIOL, V184, P257, DOI 10.1016/0022-2836(85)90379-1
   Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210
   Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020
   Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2
   Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992
   Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317
   Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217
   WAJCMAN H, 2002, CR BIOL, V325, P1
   Wakasugi K, 1997, BIOPHYS CHEM, V68, P265, DOI 10.1016/S0301-4622(97)80556-X
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6
NR 54
TC 38
Z9 40
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0261-4189
J9 EMBO J
JI Embo J.
PD APR 15
PY 2003
VL 22
IS 8
BP 1824
EP 1834
DI 10.1093/emboj/cdg181
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 666CW
UT WOS:000182159900011
PM 12682015
OA Green Published
DA 2021-01-25
ER

PT J
AU Koeser, J
   Troyanovsky, SM
   Grund, C
   Franke, WW
AF Koeser, J
   Troyanovsky, SM
   Grund, C
   Franke, WW
TI De novo formation of desmosomes in cultured cells upon transfection of
   genes encoding specific desmosomal components
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Review
DE desmosomal assembly; sorting of junctional proteins; desmoplakin;
   plakoglobin; plakophilins; desmogleins; HT-1080
ID INTERMEDIATE-FILAMENT ANCHORAGE; CONSTITUTIVE TRANSMEMBRANE
   GLYCOPROTEIN; JUNCTIONAL PLAQUE PROTEIN; NON-EPIDERMAL DESMOSOMES;
   KIDNEY EPITHELIAL-CELLS; AMINO-ACID-SEQUENCE; ADHERING-JUNCTION;
   PLAKOGLOBIN-BINDING; ADHESION MOLECULES; DESMOPLAKIN-II
AB Desmosomes are cell junctions and cytoskeleton-anchoring structures of epithelia, the myocardium, and dendritic reticulum cells of lymphatic follicles whose major components are known. Using cultured HT-1080 SL-1 fibrosarcoma-derived cells and transfection of cDNAs encoding specific desmosomal components, we have determined a minimum ensemble of proteins sufficient to introduce de novo structures, which, by morphology and functional competence, are indistinguishable from authentic desmosomes. In a more refined analysis, the influence of the desmosomal proteins desmoplakin (Dp), plakoglobin (Pg), and plakophilin 2 (Pp2) on the lateral clustering of the desmosomal transmembrane-glycoprotein desmoglein 2 (Dsg) was examined. We found that for efficient clustering of desmoglein 2 and desmosome structure formation, all three major plaque proteins- desmoplakin, plakoglobin, and plakophilin 2- were necessary. Furthermore, in this cell model, plakophilin 2 was capable of directing desmoplakin to adhaerens junctions (AJ), whereas plakoglobin was crucial for the segregation of desmosomal and AJ components. These results are discussed with respect to the variability in cell junction composition observed in various nonepithelial tissues. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
   Washington Univ, Sch Med, Dept Dermatol, St Louis, MO 63110 USA.
RP Koeser, J (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
EM joachim.koeser@unibas.ch
OI Franke, Werner W./0000-0002-4873-8448
CR Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681
   Angst BD, 2001, J CELL SCI, V114, P625
   BARIBAULT H, 1991, J CELL BIOL, V115, P1675, DOI 10.1083/jcb.115.6.1675
   Bierkamp C, 1999, DEVELOPMENT, V126, P371
   Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346
   BLESSING M, 1989, EMBO J, V8, P117, DOI 10.1002/j.1460-2075.1989.tb03355.x
   Bonne S, 1999, J CELL SCI, V112, P2265
   Bornslaeger EA, 2001, J CELL SCI, V114, P727
   Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985
   Borrmann CM, 2000, ANN NY ACAD SCI, V915, P144
   Brandner JM, 1998, EUR J CELL BIOL, V75, P295, DOI 10.1016/S0171-9335(98)80063-0
   Brandner JM, 1997, DIFFERENTIATION, V62, P119, DOI 10.1046/j.1432-0436.1997.6230119.x
   BUXTON RS, 1993, J CELL BIOL, V121, P481, DOI 10.1083/jcb.121.3.481
   CARTAUD A, 1990, J CELL BIOL, V111, P581, DOI 10.1083/jcb.111.2.581
   Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200
   Chitaev NA, 1996, J CELL BIOL, V133, P359, DOI 10.1083/jcb.133.2.359
   Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193
   COWIN P, 1985, J CELL BIOL, V101, P1442, DOI 10.1083/jcb.101.4.1442
   COWIN P, 1986, CELL, V46, P1063, DOI 10.1016/0092-8674(86)90706-3
   DEMLEHNER MP, 1995, J CELL BIOL, V131, P745, DOI 10.1083/jcb.131.3.745
   DENK H, 1985, EXP CELL RES, V161, P161, DOI 10.1016/0014-4827(85)90500-2
   DRENCKHAHN D, 1986, J CELL BIOL, V102, P1843, DOI 10.1083/jcb.102.5.1843
   Eger A, 1997, J CELL SCI, V110, P1307
   FAIRLEY JA, 1991, J CLIN INVEST, V88, P315, DOI 10.1172/JCI115294
   FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375
   FRANKE WW, 1987, EUR J CELL BIOL, V43, P301
   FRANKE WW, 1987, BIOL CELL, V59, P205, DOI 10.1111/j.1768-322X.1987.tb00532.x
   FRANKE WW, 1982, DIFFERENTIATION, V23, P115, DOI 10.1111/j.1432-0436.1982.tb01274.x
   FRANKE WW, 1989, P NATL ACAD SCI USA, V86, P4027, DOI 10.1073/pnas.86.11.4027
   FRANKE WW, 1987, VIRCHOWS ARCH A, V411, P137, DOI 10.1007/BF00712737
   FRANKE WW, 1981, DIFFERENTIATION, V20, P217, DOI 10.1111/j.1432-0436.1981.tb01178.x
   Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009
   Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5
   GREEN KJ, 1990, J BIOL CHEM, V265, P2603
   GUMBINER BM, 1993, NEURON, V11, P551, DOI 10.1016/0896-6273(93)90068-3
   GUMBINER BM, 1993, J CELL SCI, P155
   HASHIMOTO T, 1993, J CELL SCI, V105, P275
   HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085
   HATZFELD M, 1994, J CELL SCI, V107, P2259
   Hatzfeld M, 1996, J CELL SCI, V109, P2767
   Hatzfeld M, 2000, J CELL BIOL, V149, P209, DOI 10.1083/jcb.149.1.209
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   HIEDA Y, 1989, J CELL BIOL, V109, P1511, DOI 10.1083/jcb.109.4.1511
   Hofmann I, 2000, EUR J BIOCHEM, V267, P4381, DOI 10.1046/j.1432-1327.2000.01483.x
   Hofmann I, 2000, J CELL SCI, V113, P2471
   HORST M, 1991, J BIOL CHEM, V266, P13914
   HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67
   JARVINEN M, 1990, J CELL PHYSIOL, V143, P310, DOI 10.1002/jcp.1041430215
   KAPPRELL HP, 1987, EUR J BIOCHEM, V166, P505, DOI 10.1111/j.1432-1033.1987.tb13543.x
   KAPPRELL HP, 1988, J CELL BIOL, V106, P1679, DOI 10.1083/jcb.106.5.1679
   KELLY DE, 1966, J CELL BIOL, V28, P51, DOI 10.1083/jcb.28.1.51
   Kemler R, 1992, Semin Cell Biol, V3, P149
   KNUDSEN KA, 1992, J CELL BIOL, V118, P671, DOI 10.1083/jcb.118.3.671
   KOCH PJ, 1994, CURR OPIN CELL BIOL, V6, P682, DOI 10.1016/0955-0674(94)90094-9
   KORMAN NJ, 1989, NEW ENGL J MED, V321, P631, DOI 10.1056/NEJM198909073211002
   KOTELIANSKY VE, 1989, J MOL CELL CARDIOL, V21, P23, DOI 10.1016/0022-2828(89)90834-1
   KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049
   Kowalczyk AP, 1999, J BIOL CHEM, V274, P18145, DOI 10.1074/jbc.274.26.18145
   KOWALCZYK AP, 1994, J BIOL CHEM, V269, P31214
   Kowalczyk AP, 1998, J CELL SCI, V111, P3045
   Kowalczyk AP, 1997, J CELL BIOL, V139, P773, DOI 10.1083/jcb.139.3.773
   LEGAN PK, 1994, J CELL BIOL, V126, P507, DOI 10.1083/jcb.126.2.507
   Marcozzi C, 1998, J CELL SCI, V111, P495
   MATTEY DL, 1985, J CELL SCI, V75, P377
   McGrath JA, 1999, BRIT J DERMATOL, V140, P297
   McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240
   McGrath John A., 1999, Journal of Dermatology (Tokyo), V26, P764
   Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495
   Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009
   MOLL R, 1986, LAB INVEST, V54, P4
   MUELLER H, 1983, J MOL BIOL, V163, P647, DOI 10.1016/0022-2836(83)90116-X
   NATHKE IS, 1994, J CELL BIOL, V125, P1341, DOI 10.1083/jcb.125.6.1341
   NIEHRS C, 1992, J BIOL CHEM, V267, P15938
   North AJ, 1999, J CELL SCI, V112, P4325
   Nuber UA, 1996, EUR J CELL BIOL, V71, P1
   OKEEFE EJ, 1989, J BIOL CHEM, V264, P8310
   OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246
   Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534
   Palka HL, 1997, J CELL SCI, V110, P2359
   PASDAR M, 1989, J CELL BIOL, V109, P163, DOI 10.1083/jcb.109.1.163
   PASDAR M, 1988, J CELL BIOL, V106, P677, DOI 10.1083/jcb.106.3.677
   PASDAR M, 1988, J CELL BIOL, V106, P687, DOI 10.1083/jcb.106.3.687
   Pin OY, 1996, J CELL BIOL, V135, P1027, DOI 10.1083/jcb.135.4.1027
   RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z
   ROSE O, 1995, P NATL ACAD SCI USA, V92, P6022, DOI 10.1073/pnas.92.13.6022
   Ruhrberg C, 1997, J CELL BIOL, V139, P1835, DOI 10.1083/jcb.139.7.1835
   Ruhrberg C, 1996, J CELL BIOL, V134, P715, DOI 10.1083/jcb.134.3.715
   Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215
   SACCO PA, 1995, J BIOL CHEM, V270, P20201, DOI 10.1074/jbc.270.34.20201
   SCHAEFER S, 1995, THESIS U HEIDELBERG
   SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103
   SCHMELZ M, 1986, EUR J CELL BIOL, V42, P184
   Schmelz M, 1998, CELL TISSUE RES, V294, P11, DOI 10.1007/s004410051152
   SCHMELZ M, 1986, EUR J CELL BIOL, V42, P177
   SCHMELZ M, 1993, EUR J CELL BIOL, V61, P274
   SCHMID MH, 1994, CRIT REV THER DRUG, V11, P97
   SCHMIDT A, 1994, EUR J CELL BIOL, V65, P229
   Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1007/s002580050282
   Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956
   SHIBAMOTO S, 1995, J CELL BIOL, V128, P949, DOI 10.1083/jcb.128.5.949
   SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625
   SKALLI O, 1994, J CELL BIOL, V125, P159, DOI 10.1083/jcb.125.1.159
   Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229
   STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7
   STAPPENBECK TS, 1994, J BIOL CHEM, V269, P29351
   STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197
   STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691
   TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419
   TAKEICHI M, 1988, CELL DIFFER DEV, V25, P91, DOI 10.1016/0922-3371(88)90104-9
   TROYANOVSKY SM, 1994, J CELL BIOL, V127, P151, DOI 10.1083/jcb.127.1.151
   TROYANOVSKY SM, 1993, CELL, V72, P561, DOI 10.1016/0092-8674(93)90075-2
   TROYANOVSKY SM, 1994, P NATL ACAD SCI USA, V91, P10790, DOI 10.1073/pnas.91.23.10790
   Tselepis C, 1998, P NATL ACAD SCI USA, V95, P8064, DOI 10.1073/pnas.95.14.8064
   TSUKITA S, 1985, J CELL BIOL, V101, P2070, DOI 10.1083/jcb.101.6.2070
   Tsukita Shoichiro, 1992, Current Opinion in Cell Biology, V4, P834, DOI 10.1016/0955-0674(92)90108-O
   Valiron O, 1996, J CELL SCI, V109, P2141
   VIRATA MLA, 1992, P NATL ACAD SCI USA, V89, P544, DOI 10.1073/pnas.89.2.544
   Wahl JK, 1996, J CELL SCI, V109, P1143
   WHEELER GN, 1991, BIOCHEM SOC T, V19, P1060, DOI 10.1042/bst0191060
   WICHE G, 1991, J CELL BIOL, V114, P83, DOI 10.1083/jcb.114.1.83
   Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X
NR 121
TC 53
Z9 54
U1 0
U2 0
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD APR 15
PY 2003
VL 285
IS 1
BP 114
EP 130
DI 10.1016/S0014-4827(03)00016-8
PG 17
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 669NA
UT WOS:000182356300012
PM 12681292
DA 2021-01-25
ER

PT J
AU Meier, M
   Oliveriusova, J
   Kraus, JP
   Burkhard, P
AF Meier, M
   Oliveriusova, J
   Kraus, JP
   Burkhard, P
TI Structural insights into mutations of cystathionine beta-synthase
SO BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Vitamin B6, PQQ, Carbonyl Catalysis and
   Quinoproteins
CY APR 14-19, 2002
CL SOUTHAMPTON, ENGLAND
DE cystathionine beta-synthase; mutation; X-ray crystal structure;
   pyridoxal 5 '-phosphate; heme protein; homocysteine
ID O-ACETYLSERINE SULFHYDRYLASE; MOLECULAR-BASIS; GENE; HOMOCYSTINURIA;
   HOMOCYSTEINE; HEME; DEFICIENCY; BINDING; IDENTIFICATION; METHIONINE
AB Cystathionine beta-synthase (CBS) is a unique heme-containing enzyme that catalyses a pyridoxal 5'-phosphate (PLP)-dependent condensation of serine and homocysteine to give cystathionine. Deficiency of CBS leads to homocystinuria, an inherited disease of sulfur amino acid metabolism characterised by increased levels of homocysteine and methionine and decreased levels of cysteine. Presently, more than 100 CBS mutations have been described which lead to homocystinuria with different degrees of severity in the patients. We have recently solved the crystal structure of a truncated form of this enzyme, which enables us to correlate some of these mutations with the structure. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Biol Struct, CH-4056 Basel, Switzerland.
   Univ Colorado, Sch Med, Dept Pediat & Cellular & Struct Biol, Denver, CO 80262 USA.
RP Burkhard, P (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Biol Struct, Klilngelbergstr 70, CH-4056 Basel, Switzerland.
EM Peter.Burkhard@unibas.ch
RI Meier, Markus/F-2798-2011
OI Meier, Markus/0000-0003-1068-746X
FU NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL065217, R01HL065217,
   R01HL065217, R01HL065217, R01HL065217, R01HL065217, R01HL065217,
   R01HL065217, R01HL065217, R01HL065217] Funding Source: NIH RePORTER;
   NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL65217] Funding Source: Medline; NICHD NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child
   Health & Human Development (NICHD) [P01HD0805] Funding Source: Medline
CR ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x
   Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002
   Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037
   Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449
   Coude M, 1998, J INHERIT METAB DIS, V21, P823, DOI 10.1023/A:1005466601461
   Dawson PA, 1997, EUR J HUM GENET, V5, P15, DOI 10.1159/000484726
   de Franchis R, 1999, HUM MUTAT, V13, P453, DOI 10.1002/(SICI)1098-1004(1999)13:6<453::AID-HUMU4>3.0.CO;2-K
   DEFRANCHIS R, 1994, HUM MOL GENET, V3, P1103, DOI 10.1093/hmg/3.7.1103
   Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3
   Gallagher PM, 1998, MOL GENET METAB, V65, P298, DOI 10.1006/mgme.1998.2771
   Gat-Yablonski G, 2000, Hum Mutat, V16, P372, DOI 10.1002/1098-1004(200010)16:4<372::AID-HUMU12>3.0.CO;2-J
   HU FL, 1993, HUM MOL GENET, V2, P1857, DOI 10.1093/hmg/2.11.1857
   Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597
   Janosik M, 2001, BIOCHEMISTRY-US, V40, P10625, DOI 10.1021/bi010711p
   Kery V, 1999, BIOCHEMISTRY-US, V38, P2716, DOI 10.1021/bi981808n
   KERY V, 1994, J BIOL CHEM, V269, P25283
   Kim CE, 1997, HUM MOL GENET, V6, P2213, DOI 10.1093/hmg/6.13.2213
   Kluijtmans LAJ, 1999, AM J HUM GENET, V65, P59, DOI 10.1086/302439
   Kluijtmans LAJ, 1997, BIOCHEM MOL MED, V62, P23, DOI 10.1006/bmme.1997.2623
   Kozich V, 1997, J INHERIT METAB DIS, V20, P363, DOI 10.1023/A:1005325911665
   KOZICH V, 1993, HUM MOL GENET, V2, P815, DOI 10.1093/hmg/2.6.815
   Kraus JP, 1999, HUM MUTAT, V13, P362
   KRUGER WD, 1995, HUM MOL GENET, V4, P1155, DOI 10.1093/hmg/4.7.1155
   Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089
   Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910
   MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5
   Mudd S.H., 2001, METABOLIC MOL BASES, P2007
   Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o
   Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31
   SEBASTIO G, 1995, AM J HUM GENET, V56, P1324
   Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91
   Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635
   SHIH VE, 1995, AM J HUM GENET, V57, P34
   SKOVBY F, 1984, J BIOL CHEM, V259, P583
   Sperandeo MP, 1996, J INHERIT METAB DIS, V19, P351, DOI 10.1007/BF01799266
   Tsai MY, 1996, CLIN BIOCHEM, V29, P473, DOI 10.1016/0009-9120(96)00045-8
   Tsai MY, 1997, BIOCHEM MOL MED, V61, P9, DOI 10.1006/bmme.1997.2591
NR 37
TC 41
Z9 43
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-9639
EI 1878-1454
J9 BBA-PROTEINS PROTEOM
JI BBA-Proteins Proteomics
PD APR 11
PY 2003
VL 1647
IS 1-2
SI SI
BP 206
EP 213
DI 10.1016/S1570-9639(03)00048-7
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 672XQ
UT WOS:000182549400036
PM 12686134
DA 2021-01-25
ER

PT J
AU Sanchez, IE
   Kiefhaber, T
AF Sanchez, IE
   Kiefhaber, T
TI Hammond behavior versus ground state effects in protein folding:
   Evidence for narrow free energy barriers and residual structure in
   unfolded states
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; Hammond postulate; transition state; unfolded state;
   cross-interaction parameters
ID NUCLEATION-CONDENSATION MECHANISM; PHI-VALUE ANALYSIS; N-TERMINAL
   DOMAIN; TRANSITION-STATE; DENATURED STATE; SH3 DOMAIN; CHYMOTRYPSIN
   INHIBITOR-2; GUANIDINE-HYDROCHLORIDE; MUTATIONAL ANALYSIS;
   ALPHA-CHYMOTRYPSIN
AB Apparent transition state movement upon mutation or changes in solvent conditions is frequently observed in protein folding and is often interpreted in terms of Hammond behavior. This led to the conclusion that barrier regions in protein folding are broad maxima on the free energy landscape. Here, we use the concept of self-interaction and cross-interaction parameters to test experimental data of 21 well-characterized proteins for Hammond behavior. This allows us to characterize the origin of transition state movements along different reaction coordinates. Only one of the 21 proteins shows a small but coherent transition state movement in agreement with the Hammond postulate. In most proteins the structure of the transition state is insensitive to changes in protein stability. The apparent change in the position of the transition state upon mutation, which is frequently observed in phi-value analysis, is in most cases due to ground-state effects caused by structural changes in the unfolded state. This argues for significant residual structure in unfolded polypeptide chains of many proteins. Disruption of these residual interactions by mutation often leads to decreased folding rates, which implies that these interactions are still present in the transition state. The failure to detect Hammond behavior shows that the free energy barriers encountered by a folding polypeptide chain are generally rather narrow and robust maxima for all experimentally explorable reaction coordinates. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Sanchez, Ignacio/A-5658-2009; Kiefhaber, Thomas/A-3028-2010
OI Sanchez, Ignacio Enrique/0000-0003-4284-9013
CR Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   Bieri O, 1999, BIOCHEMISTRY-US, V38, P12460, DOI 10.1021/bi9909703
   Bolhuis PG, 2000, P NATL ACAD SCI USA, V97, P5877, DOI 10.1073/pnas.100127697
   Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757
   CARRA JH, 1994, BIOCHEMISTRY-US, V33, P10842, DOI 10.1021/bi00201a035
   CHENG Y, 1989, SIAM J DISCRETE MATH, V2, P28
   Chiti F, 1999, NAT STRUCT BIOL, V6, P1005
   Chu RA, 2002, BIOCHEMISTRY-US, V41, P7998, DOI 10.1021/bi025872n
   Dalby PA, 1998, J MOL BIOL, V276, P625, DOI 10.1006/jmbi.1997.1546
   Dalby PA, 1998, BIOCHEMISTRY-US, V37, P4674, DOI 10.1021/bi972798d
   Du R, 1998, J CHEM PHYS, V108, P334, DOI 10.1063/1.475393
   EVANS PA, 1991, PROTEINS, V9, P248, DOI 10.1002/prot.340090404
   FARCASIU D, 1975, J CHEM EDUC, V52, P76, DOI 10.1021/ed052p76
   FERSHT AR, 1994, P NATL ACAD SCI USA, V91, P10426, DOI 10.1073/pnas.91.22.10426
   FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869
   FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W
   Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2
   Fulton KF, 1999, J MOL BIOL, V291, P445, DOI 10.1006/jmbi.1999.2942
   Garcia P, 2001, PROTEIN SCI, V10, P1100, DOI 10.1110/ps.52701
   Garcia P, 2002, STRUCTURE, V10, P1173, DOI 10.1016/S0969-2126(02)00804-3
   GOLDENBERG DP, 1989, NATURE, V338, P127, DOI 10.1038/338127a0
   GRANT JS, 1997, J FAMILY NURSING, V3, P36
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   Guerois R, 2000, J MOL BIOL, V304, P967, DOI 10.1006/jmbi.2000.4234
   GUO ZY, 1995, BIOPOLYMERS, V36, P83, DOI 10.1002/bip.360360108
   HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027
   ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873
   Jencks W. P., 1969, CATALYSIS CHEM ENZYM
   JENCKS WP, 1985, CHEM REV, V85, P511, DOI 10.1021/cr00070a001
   Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398
   Kiefhaber T, 1997, BIOCHEMISTRY-US, V36, P5108, DOI 10.1021/bi9702391
   Kim DE, 2000, J MOL BIOL, V298, P971, DOI 10.1006/jmbi.2000.3701
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618
   Kragelund BB, 1999, NAT STRUCT BIOL, V6, P594
   Krantz BA, 2001, NAT STRUCT BIOL, V8, P1042, DOI 10.1038/nsb723
   Kuhlman B, 1998, J MOL BIOL, V284, P1661, DOI 10.1006/jmbi.1998.2246
   Leffler J.E., 1963, RATES EQUILIBRIA ORG
   LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340
   LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173
   LopezHernandez E, 1996, FOLD DES, V1, P43, DOI 10.1016/S1359-0278(96)00011-9
   Luisi DL, 2000, J MOL BIOL, V299, P1091, DOI 10.1006/jmbi.2000.3752
   Main ERG, 1999, J MOL BIOL, V291, P429, DOI 10.1006/jmbi.1999.2941
   Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010
   Martinez JC, 1998, NAT STRUCT BIOL, V5, P721, DOI 10.1038/1418
   MATOUSCHEK A, 1995, BIOCHEMISTRY-US, V34, P13656, DOI 10.1021/bi00041a047
   MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814
   MATOUSCHEK A, 1994, PROTEIN ENG, V7, P1089, DOI 10.1093/protein/7.9.1089
   MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498
   MATTHEWS JM, 1995, BIOCHEMISTRY-US, V34, P6805, DOI 10.1021/bi00020a027
   McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971
   Mok YK, 2001, J MOL BIOL, V307, P913, DOI 10.1006/jmbi.2001.4521
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Myers JK, 1999, BIOCHEMISTRY-US, V38, P6761, DOI 10.1021/bi990088x
   Nauli S, 2001, NAT STRUCT BIOL, V8, P602, DOI 10.1038/89638
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748
   Northey JGB, 2002, J MOL BIOL, V320, P389, DOI 10.1016/S0022-2836(02)00445-X
   Oliveberg M, 1998, J MOL BIOL, V277, P933, DOI 10.1006/jmbi.1997.1612
   Pappenberger G, 2000, P NATL ACAD SCI USA, V97, P17, DOI 10.1073/pnas.97.1.17
   Perl D, 2001, BIOCHEMISTRY-US, V40, P15501, DOI 10.1021/bi011378s
   Plaxco KW, 1998, P NATL ACAD SCI USA, V95, P13591, DOI 10.1073/pnas.95.23.13591
   POHL FM, 1976, FEBS LETT, V65, P293, DOI 10.1016/0014-5793(76)80132-9
   PRIVALOV PL, 1992, J MOL BIOL, V224, P715, DOI 10.1016/0022-2836(92)90555-X
   Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Sari N, 2000, BIOCHEMISTRY-US, V39, P965, DOI 10.1021/bi9920230
   Sato S, 2002, J MOL BIOL, V318, P571, DOI 10.1016/S0022-2836(02)00015-3
   Scalley ML, 1997, P NATL ACAD SCI USA, V94, P10636, DOI 10.1073/pnas.94.20.10636
   Schonbrunner N, 1997, BIOCHEMISTRY-US, V36, P9057, DOI 10.1021/bi970594r
   SERRANO L, 1992, J MOL BIOL, V224, P805, DOI 10.1016/0022-2836(92)90563-Y
   Silow M, 1997, BIOCHEMISTRY-US, V36, P7633, DOI 10.1021/bi970210x
   Taddei N, 2000, J MOL BIOL, V300, P633, DOI 10.1006/jmbi.2000.3870
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   Villegas V, 1998, J MOL BIOL, V283, P1027, DOI 10.1006/jmbi.1998.2158
   Wales DJ, 2001, SCIENCE, V293, P2067, DOI 10.1126/science.1062565
   Wallenhorst WF, 1997, BIOCHEMISTRY-US, V36, P5795, DOI 10.1021/bi9700476
   WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447
   Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523
   Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816
NR 83
TC 124
Z9 124
U1 1
U2 12
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 4
PY 2003
VL 327
IS 4
BP 867
EP 884
DI 10.1016/S0022-2836(03)00171-2
PG 18
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 663FZ
UT WOS:000181996700009
PM 12654269
DA 2021-01-25
ER

PT J
AU Roberts, RJ
   Belfort, M
   Bestor, T
   Bhagwat, AS
   Bickle, TA
   Bitinaite, J
   Blumenthal, RM
   Degtyarev, SK
   Dryden, DTF
   Dybvig, K
   Firman, K
   Gromova, ES
   Gumport, RI
   Halford, SE
   Hattman, S
   Heitman, J
   Hornby, DP
   Janulaitis, A
   Jeltsch, A
   Josephsen, J
   Kiss, A
   Klaenhammer, TR
   Kobayashi, I
   Kong, HM
   Kruger, DH
   Lacks, S
   Marinus, MG
   Miyahara, M
   Morgan, RD
   Murray, NE
   Nagaraja, V
   Piekarowicz, A
   Pingoud, A
   Raleigh, E
   Rao, DN
   Reich, N
   Repin, VE
   Selker, EU
   Shaw, PC
   Stein, DC
   Stoddard, BL
   Szybalski, W
   Trautner, TA
   Van Etten, JL
   Vitor, JMB
   Wilson, GG
   Xu, SY
AF Roberts, RJ
   Belfort, M
   Bestor, T
   Bhagwat, AS
   Bickle, TA
   Bitinaite, J
   Blumenthal, RM
   Degtyarev, SK
   Dryden, DTF
   Dybvig, K
   Firman, K
   Gromova, ES
   Gumport, RI
   Halford, SE
   Hattman, S
   Heitman, J
   Hornby, DP
   Janulaitis, A
   Jeltsch, A
   Josephsen, J
   Kiss, A
   Klaenhammer, TR
   Kobayashi, I
   Kong, HM
   Kruger, DH
   Lacks, S
   Marinus, MG
   Miyahara, M
   Morgan, RD
   Murray, NE
   Nagaraja, V
   Piekarowicz, A
   Pingoud, A
   Raleigh, E
   Rao, DN
   Reich, N
   Repin, VE
   Selker, EU
   Shaw, PC
   Stein, DC
   Stoddard, BL
   Szybalski, W
   Trautner, TA
   Van Etten, JL
   Vitor, JMB
   Wilson, GG
   Xu, SY
TI A nomenclature for restriction enzymes, DNA methyltransferases, homing
   endonucleases and their genes
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID HEMOPHILUS-INFLUENZAE RD; MODIFICATION SYSTEM; NUCLEOTIDE-SEQUENCE;
   RECOGNITION SITES; PURIFICATION; METHYLASES; CLEAVAGE; CLONING; ECOP15I;
   BINDING
AB A nomenclature is described for restriction endonucleases, DNA methyltransferases, homing endonucleases and related genes and gene products. It provides explicit categories for the many different Type II enzymes now identified and provides a system for naming the putative genes found by sequence analysis of microbial genomes.
C1 New England Biolabs Inc, Beverly, MA 01915 USA.
   New York State Dept Hlth, Mol Genet Program, Albany, NY 12201 USA.
   Columbia Univ, New York, NY 10032 USA.
   Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.
   Univ Basel, Biozentrum, Dept Microbiol, CH-4056 Basel, Switzerland.
   Med Coll Ohio, Program Bioinformat & Proteom Genom, Toledo, OH 43699 USA.
   SibEnzyme, Novosibirsk 630090, Russia.
   Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland.
   Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.
   Univ Portsmouth, Sch Biol Sci, Biophys Lab, Portsmouth PO1 2DT, Hants, England.
   Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia.
   Univ Illinois, Coll Med, Urbana, IL 61801 USA.
   Univ Bristol, Sch Med, Dept Biochem, Bristol BS8 1TD, Avon, England.
   Univ Rochester, Dept Biol, Rochester, NY 14627 USA.
   Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.
   Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.
   Inst Biotechnol, LT-2028 Vilnius, Lithuania.
   Univ Giessen, Inst Biochem, D-35392 Giessen, Germany.
   Royal Vet & Agr Univ, Dept Dairy & Food Sci, DK-1958 Frederiksberg C, Denmark.
   Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.
   N Carolina State Univ, Dept Food Sci, Raleigh, NC 27695 USA.
   N Carolina State Univ, Dept Microbiol, Raleigh, NC 27695 USA.
   Univ Tokyo, Inst Med Sci, Dept Mol Biol, Minato Ku, Tokyo 1088639, Japan.
   Humboldt Univ, Inst Virol Charite, D-10098 Berlin, Germany.
   Brookhaven Natl Lab, Upton, NY 11973 USA.
   Univ Massachusetts, Sch Med, Dept Pharmacol, Worcester, MA 01655 USA.
   Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan.
   Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland.
   Indian Inst Sci, Dept Microbiol & Cell Biol, IN-560012 Bangalore, Karnataka, India.
   Warsaw Univ, Inst Microbiol, PL-02096 Warsaw, Poland.
   Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA.
   State Res Ctr Virol & Biotechnol Vektor, Koltsov 633059, Novosibirsk Reg, Russia.
   Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.
   Chinese Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.
   Univ Maryland, Dept Microbiol, College Pk, MD 20742 USA.
   Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.
   Univ Wisconsin, McArdle Lab, Madison, WI 53706 USA.
   Max Planck Inst Mol Genet, D-14195 Berlin, Germany.
   Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.
   Fac Farm Lisboa, P-1500083 Lisbon, Portugal.
RP Roberts, RJ (corresponding author), New England Biolabs Inc, 32 Tozer Rd, Beverly, MA 01915 USA.
EM roberts@neb.com
RI Jeltsch, Albert/O-7404-2014; Gromova, Elizaveta S/I-6305-2012; Kiss,
   Antal/A-1656-2008; Vitor, Jorge/M-3279-2013
OI Jeltsch, Albert/0000-0001-6113-9290; Degtyarev, Sergey
   Kh/0000-0003-1920-8023; Raleigh, Elisabeth A./0000-0003-0745-9925;
   Kobayashi, Ichizo/0000-0002-3854-1879; Vitor, Jorge/0000-0001-6486-3444;
   Roberts, Richard/0000-0002-4348-0169; Blumenthal,
   Robert/0000-0002-0873-0724; Belfort, Marlene/0000-0002-1592-5618; Stein,
   Daniel/0000-0003-3397-5720; Kiss, Antal/0000-0002-7975-3085
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM063790,
   R01GM063790, R01GM063790, R01GM063790, R01GM063790, R01GM063790,
   R01GM063790, R01GM063790, R01GM063790] Funding Source: NIH RePORTER;
   Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [15370099] Funding Source: KAKEN; NIGMS NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01
   GM063790-01A1] Funding Source: Medline
CR Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379
   Belfort Marlene, 2002, P761
   Besnier CE, 2001, EMBO REP, V2, P782, DOI 10.1093/embo-reports/kve175
   BOYER HW, 1971, ANNU REV MICROBIOL, V25, P153, DOI 10.1146/annurev.mi.25.100171.001101
   Dryden DTF, 2001, NUCLEIC ACIDS RES, V29, P3728, DOI 10.1093/nar/29.18.3728
   DUSTERHOFT A, 1991, NUCLEIC ACIDS RES, V19, P1049, DOI 10.1093/nar/19.5.1049
   FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800
   GROMKOVA R, 1973, J BACTERIOL, V114, P1151, DOI 10.1128/JB.114.3.1151-1157.1973
   GUBLER M, 1992, EMBO J, V11, P233, DOI 10.1002/j.1460-2075.1992.tb05046.x
   HENNECKE F, 1991, NATURE, V353, P776, DOI 10.1038/353776a0
   Huai Q, 2001, NAT STRUCT BIOL, V8, P665, DOI 10.1038/90366
   Janscak P, 2001, J MOL BIOL, V306, P417, DOI 10.1006/jmbi.2000.4411
   KARREMAN C, 1990, J BACTERIOL, V172, P266, DOI 10.1128/JB.172.1.266-272.1990
   KELLY TJ, 1970, J MOL BIOL, V51, P393, DOI 10.1016/0022-2836(70)90150-6
   Klein R, 2002, MOL MICROBIOL, V45, P851, DOI 10.1046/j.1365-2958.2002.03064.x
   LOONEY MC, 1989, GENE, V80, P193, DOI 10.1016/0378-1119(89)90284-9
   Mucke M, 2001, J MOL BIOL, V312, P687, DOI 10.1006/jmbi.2001.4998
   Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000
   NOYERWEIDNER M, 1983, J VIROL, V46, P446, DOI 10.1128/JVI.46.2.446-453.1983
   RALEIGH EA, 1986, P NATL ACAD SCI USA, V83, P9070, DOI 10.1073/pnas.83.23.9070
   Reuter M, 1998, J BIOL CHEM, V273, P8294, DOI 10.1074/jbc.273.14.8294
   Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P418, DOI 10.1093/nar/gkg069
   ROY PH, 1973, J MOL BIOL, V81, P427, DOI 10.1016/0022-2836(73)90515-9
   ROY PH, 1973, J MOL BIOL, V81, P445, DOI 10.1016/0022-2836(73)90516-0
   SMITH HO, 1973, J MOL BIOL, V81, P419, DOI 10.1016/0022-2836(73)90152-6
   SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X
   SOHAIL A, 1995, GENE, V157, P227, DOI 10.1016/0378-1119(94)00698-R
   Stankevicius K, 1998, NUCLEIC ACIDS RES, V26, P1084, DOI 10.1093/nar/26.4.1084
   Stewart FJ, 2000, J MOL BIOL, V298, P611, DOI 10.1006/jmbi.2000.3697
   SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C
   SZYBALSKI W, 1988, GENE, V74, P279
   TAO T, 1991, J BACTERIOL, V173, P1367, DOI 10.1128/jb.173.4.1367-1375.1991
   Titheradge AJB, 2001, NUCLEIC ACIDS RES, V29, P4195, DOI 10.1093/nar/29.20.4195
   Xu Y, 2001, P NATL ACAD SCI USA, V98, P12990, DOI 10.1073/pnas.241215698
   YUAN R, 1981, ANNU REV BIOCHEM, V50, P285, DOI 10.1146/annurev.bi.50.070181.001441
NR 35
TC 459
Z9 474
U1 1
U2 68
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 1
PY 2003
VL 31
IS 7
BP 1805
EP 1812
DI 10.1093/nar/gkg274
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 666DE
UT WOS:000182160900001
PM 12654995
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kohli, BM
   Ostermeier, C
AF Kohli, BM
   Ostermeier, C
TI A Rubredoxin based system for screening of protein expression conditions
   and on-line monitoring of the purification process
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
ID ESCHERICHIA-COLI; CLOSTRIDIUM-PASTEURIANUM; GENE; FLUORESCENCE; CLONING;
   SITE; PCR; TAG
AB Rubredoxin (Rub) from Thermotoga maritima, a 6.1-kDa red protein containing an Fe(III)-cysteine(4) center, was evaluated for its usefulness as a colored fusion tag for expression of recombinant proteins in E. coli. Here, we describe the Rub features relevant to accelerating screening for optimal high yield soluble expression conditions and automating the ensuing purification process. Spectroscopic properties and the yield of Rub fused to a typical target protein were compared to analogous GFP and Flavodoxin constructs, showing Rub absorption to be sufficient for structural genomics purposes while being produced at much higher soluble levels than GFP constructs. Based entirely on Rub absorption at 380 nm, both generic and affinity purification of crude cell lysate were performed: thus guided anion exchange purification of a Rub fusion construct as well as automated Ni-NTA purification resulted in pure protein. Rub is stable over a wide range of pH, temperature, and buffer environments, enabling robust purification protocols. Across a variety of fusion constructs, including N- and C-terminal Rub, quantitation via the Rub signal was shown to reliably correlate with analytical HPLC data obtained at 220 nm. We propose the "RubyTag" as an alternative to conventional protein fusion tags, as it combines a specific absorption signal with convenient biochemical and biological properties. Further, it allows direct on-line readout on conventional chromatography systems, holding promise for automated multi-step chromatography. (C) 2002 Elsevier Science (USA). All rights reserved.
C1 Novartis Pharma, CH-4002 Basel, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Ostermeier, C (corresponding author), Novartis Pharma, Lichtstr 35, CH-4002 Basel, Switzerland.
CR Baker KN, 2002, TRENDS BIOTECHNOL, V20, P149, DOI 10.1016/S0167-7799(01)01914-X
   Bengrine A, 1998, BBA-GENE STRUCT EXPR, V1443, P99, DOI 10.1016/S0167-4781(98)00199-7
   Bonomi F, 2000, PROTEIN SCI, V9, P2413, DOI 10.1110/ps.9.12.2413
   Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199
   Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05
   Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102
   HEATH TG, 1993, J CHROMATOGR, V638, P9, DOI 10.1016/0021-9673(93)85002-O
   Jakobs S, 2000, FEBS LETT, V479, P131, DOI 10.1016/S0014-5793(00)01896-2
   MATHIEU I, 1992, BIOCHEM J, V285, P255, DOI 10.1042/bj2850255
   Narahari CR, 2001, BIOTECHNOL PROGR, V17, P150, DOI 10.1021/bp0001415
   Paul R, 2001, PROTEIN EXPRES PURIF, V22, P399, DOI 10.1006/prep.2001.1467
   Price NJ, 2000, PROTEIN EXPRES PURIF, V20, P444, DOI 10.1006/prep.2000.1318
   Raines RT, 2000, METHOD ENZYMOL, V326, P362
   Rodrigues P, 2001, BIOCHEM BIOPH RES CO, V289, P630, DOI 10.1006/bbrc.2001.6016
   Skerra A, 2000, METHOD ENZYMOL, V326, P271
   SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4
   Tooley AJ, 2001, P NATL ACAD SCI USA, V98, P10560, DOI 10.1073/pnas.181340998
   Zeng G, 1998, BIOTECHNIQUES, V25, P206, DOI 10.2144/98252bm05
   Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r
NR 19
TC 9
Z9 10
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD APR
PY 2003
VL 28
IS 2
BP 362
EP 367
DI 10.1016/S1046-5928(02)00704-0
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 673AJ
UT WOS:000182556100020
PM 12699702
DA 2021-01-25
ER

PT J
AU Schreiber, SN
   Knutti, D
   Brogli, K
   Uhlmann, T
   Kralli, A
AF Schreiber, SN
   Knutti, D
   Brogli, K
   Uhlmann, T
   Kralli, A
TI The transcriptional coactivator PGC-1 regulates the expression and
   activity of the orphan nuclear receptor estrogen-related receptor alpha
   (ERR alpha)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CHROMOSOMAL LOCALIZATION; MITOCHONDRIAL BIOGENESIS; HEPATIC
   GLUCONEOGENESIS; GENOMIC ORGANIZATION; GAMMA COACTIVATOR-1; RESPONSE
   ELEMENTS; GENE; ACTIVATION; DIFFERENTIATION; CLONING
AB The estrogen-related receptor a (ERRalpha) is one of the first orphan nuclear receptors identified. Still, we know little about the mechanisms that regulate its expression and its activity. In this study, we show that the transcriptional coactivator PGC-1, which is implicated in the control of energy metabolism, regulates ERRalpha at two levels. First, PGC-1 induces the expression of ERRalpha. Consistent with this induction, levels of ERRalpha mRNA in vivo are highest in PGC-1 expressing tissues, such as heart, kidney, and muscle, and up-regulated in response to signals that induce PGC-1, such as exposure to cold. Second, PGC-1 interacts physically with ERRalpha and enables it to activate transcription. Strikingly, we find that PGC-1 converts ERRalpha from a factor with little or no transcriptional activity to a potent regulator of gene expression, suggesting that ERRalpha is not a constitutively active nuclear receptor but rather one that is regulated by protein ligands, such as PGC-1. Our findings suggest that the two proteins act in a common pathway to regulate processes relating to energy metabolism. In support of this hypothesis, adenovirus-mediated delivery of small interfering RNA for ERRalpha, or of PGC-l mutants that interact selectively with different types of nuclear receptors, shows that PGC-1 can induce the fatty acid oxidation enzyme MCAD (medium-chain acyl-coenzyme A dehydrogenase) in an ERRalpha-dependent manner.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Kralli, A (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905
   Bonnelye E, 1997, MECH DEVELOP, V65, P71, DOI 10.1016/S0925-4773(97)00059-2
   Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971
   Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999
   Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398
   Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977
   Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1
   GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0
   Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689
   Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134
   Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6
   Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618
   Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200
   Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200
   Johnston SD, 1997, MOL ENDOCRINOL, V11, P342, DOI 10.1210/me.11.3.342
   Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000
   Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X
   Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698
   Kraus RJ, 2002, J BIOL CHEM, V277, P24826, DOI 10.1074/jbc.M202952200
   Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200
   Larrouy D, 1999, INT J OBESITY, V23, P1327, DOI 10.1038/sj.ijo.0801106
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lu DS, 2001, CANCER RES, V61, P6755
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181
   Shi HP, 1997, GENOMICS, V44, P52, DOI 10.1006/geno.1997.4850
   Shigeta H, 1997, J MOL ENDOCRINOL, V19, P299, DOI 10.1677/jme.0.0190299
   Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400
   Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200
   Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401
   Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270
   Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764
   Vanacker JM, 1998, ONCOGENE, V17, P2429, DOI 10.1038/sj.onc.1202167
   Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Zhang ZP, 2000, J BIOL CHEM, V275, P20837, DOI 10.1074/jbc.M001880200
NR 42
TC 327
Z9 339
U1 0
U2 12
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 14
PY 2003
VL 278
IS 11
BP 9013
EP 9018
DI 10.1074/jbc.M212923200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 654YF
UT WOS:000181524000020
PM 12522104
OA Bronze
DA 2021-01-25
ER

PT J
AU Pajvani, UB
   Du, XL
   Combs, TP
   Berg, AH
   Rajala, MW
   Schulthess, T
   Engel, J
   Brownlee, M
   Scherer, PE
AF Pajvani, UB
   Du, XL
   Combs, TP
   Berg, AH
   Rajala, MW
   Schulthess, T
   Engel, J
   Brownlee, M
   Scherer, PE
TI Structure-function studies of the adipocyte-secreted hormone
   Acrp30/adiponectin - Implications for metabolic regulation and
   bioactivity
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID COMPLEMENT-RELATED PROTEIN; ADIPOSE-SPECIFIC PROTEIN;
   INSULIN-RESISTANCE; STIMULATING PROTEIN; TNF-ALPHA; OBESITY;
   ADIPONECTIN; PLASMA; TISSUE; EXPRESSION
AB Acrp30/adiponectin is an adipocyte-specific secretory protein that has recently been implicated as a mediator of systemic insulin sensitivity with liver and muscle as target organs. Acrp30 is found as two forms in serum, as a lower molecular weight trimer-dimer and a high molecular weight complex. Little is know about the regulation and significance of these Acrp30 complexes in serum and about the events that lead to the generation of the bioactive ligand. Here, we show that there is a profound sexual dimorphism of Acrp30 levels and complex distribution in serum. Female mice display significantly higher levels of the high molecular weight complex in serum than males. In both females and males, levels of the high molecular weight complex are significantly reduced in response to a systemic increase of insulin. The ratio of the two complexes is restored upon normalization of glucose levels. Structurally, we show that oligomer formation of Acrp30 critically depends on disulfide bond formation mediated by Cys-39. Mutation of Cys-39 results in trimers that are subject to proteolytic cleavage in the collagenous domain. Surprisingly, Acrp30(C39S) or wild-type Acrp30 treated with dithiothreitol are significantly more bioactive than the higher order oligomeric forms of the protein with respect to reduction of serum glucose levels. Furthermore, treatment of primary hepatocytes with trimeric and higher order forms of Acrp30 confirms that the increased bioactivity seen in vivo is reflected in an augmented potency to reduce glucose output in the presence of gluconeogenic stimuli. Combined, these results shed new light on the regulation of this complex protein and suggest a new model for in vivo activation of the protein, implicating a serum reductase activity.
C1 Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Dept Pathol & Med, Bronx, NY 10461 USA.
   Yeshiva Univ Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Scherer, PE (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
RI Scherer, Philipp E/K-7819-2012
OI Scherer, Philipp E/0000-0003-0680-3392
FU NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [F32DK061228, R01DK055758, R01DK055758,
   R01DK055758, F32DK061228, R01DK055758, R01DK055758, R01DK055758,
   R01DK055758, R01DK055758, R01DK055758, R01DK055758, R01DK055758,
   R01DK055758, R01DK055758, R01DK055758, R01DK055758, R01DK055758,
   R01DK055758, R01DK055758, R01DK055758, R01DK055758, R01DK055758,
   R01DK055758, R01DK055758] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288, T32GM007288, T32GM007288, T32GM007288,
   T32GM007288, T32GM007288] Funding Source: NIH RePORTER; NIDDK NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [1R01-DK55758, DK61228] Funding
   Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [T32-GM07288] Funding Source:
   Medline
CR Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   BrownAugsburger P, 1996, J BIOL CHEM, V271, P13724, DOI 10.1074/jbc.271.23.13724
   BrownAugsburger P, 1996, J BIOL CHEM, V271, P18912, DOI 10.1074/jbc.271.31.18912
   CIANFLONE K, 1994, BIOCHEMISTRY-US, V33, P9489, DOI 10.1021/bi00198a014
   Clayton PE, 1997, CLIN ENDOCRINOL, V46, P727, DOI 10.1046/j.1365-2265.1997.2081026.x
   Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120
   Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/en.143.3.998
   Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321
   COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705
   ENGEL J, 1994, METHOD ENZYMOL, V245, P469
   Frias JP, 2001, DIABETES, V50, P1344, DOI 10.2337/diabetes.50.6.1344
   Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798
   Hansen S, 1998, IMMUNOBIOLOGY, V199, P165, DOI 10.1016/S0171-2985(98)80025-9
   Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008
   Hevener A, 2002, DIABETES, V51, P1907, DOI 10.2337/diabetes.51.6.1907
   Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697
   Lay AJ, 2002, J BIOL CHEM, V277, P9062, DOI 10.1074/jbc.M111531200
   Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587
   Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770
   Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803
   Sato C, 2001, J BIOL CHEM, V276, P28849, DOI 10.1074/jbc.M104148200
   SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233
   SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746
   Shuldiner AR, 2001, NEW ENGL J MED, V345, P1345, DOI 10.1056/NEJM200111013451814
   SPIEGELMAN BM, 1993, CELL, V73, P625, DOI 10.1016/0092-8674(93)90243-J
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200
   Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815
   Zhang LQ, 2001, J BIOL CHEM, V276, P19214, DOI 10.1074/jbc.M010191200
NR 36
TC 822
Z9 869
U1 1
U2 34
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 14
PY 2003
VL 278
IS 11
BP 9073
EP 9085
DI 10.1074/jbc.M207198200
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 654YF
UT WOS:000181524000028
PM 12496257
OA Bronze
DA 2021-01-25
ER

PT J
AU Strelkov, SV
   Herrmann, H
   Aebi, U
AF Strelkov, SV
   Herrmann, H
   Aebi, U
TI Molecular architecture of intermediate filaments
SO BIOESSAYS
LA English
DT Review
ID COILED-COIL; CRYSTAL-STRUCTURE; ATOMIC-STRUCTURE; KERATIN; SEQUENCE;
   DYNAMICS; PROTEIN; DIMER; VIMENTIN; DOMAIN
AB Together with microtubules and actin microfilaments, similar to11 nm wide intermediate filaments (IFs) constitute the integrated, dynamic filament network present in the cytoplasm of metazoan cells. This network is critically involved in division, motility and other cellular processes. While the structures of microtubules and microfilaments are known in atomic detail, IF architecture is presently much less understood. The elementary 'building block' of IFs is a highly elongated, rod-like dimer based on an alpha-helical coiled-coil structure. Assembly of cytoplasmic IF proteins, such as vimentin, begins with a lateral association of dimers into tetramers and gradually into the so-called unit-length filaments (ULFs). Subsequently ULFs start to anneal longitudinally, ultimately yielding mature IFs after a compaction step. For nuclear lamins, however, assembly starts with a head-to-tail association of dimers. Recently, X-ray crystallographic data were obtained for several fragments of the vimentin dimer. Based on the dimer structure, molecular models of the tetramer and the entire filament are now a possibility.
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   German Canc Res Ctr, D-6900 Heidelberg, Germany.
RP Strelkov, SV (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sergei-v.strelkov@unibas.ch
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293
   Briki F, 1998, BBA-PROTEIN STRUCT M, V1429, P57, DOI 10.1016/S0167-4838(98)00216-7
   Bubb MR, 2002, J BIOL CHEM, V277, P20999, DOI 10.1074/jbc.M201371200
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3
   CRICK FHC, 1952, NATURE, V170, P882, DOI 10.1038/170882b0
   Dhe-Paganon S, 2002, J BIOL CHEM, V18, P18
   FitzGerald P. G., 2002, J BIOL CHEM, V16, P16
   FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x
   Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995
   GEISLER N, 1992, EUR J BIOCHEM, V206, P841, DOI 10.1111/j.1432-1033.1992.tb16992.x
   Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6
   Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971
   HATZFELD M, 1992, J CELL BIOL, V116, P157, DOI 10.1083/jcb.116.1.157
   HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   Herrmann H, 1998, Subcell Biochem, V31, P319
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   Hesse M, 2001, J CELL SCI, V114, P2569
   Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465
   NORTH ACT, 1994, PROTEINS, V20, P174, DOI 10.1002/prot.340200207
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Parry DAD, 2001, J BIOL CHEM, V276, P39253, DOI 10.1074/jbc.M104604200
   Schliwa M., 1986, CYTOSKELETON CELL BI, V13
   Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438
   SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929
   STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Steinmetz MO, 1998, J MOL BIOL, V278, P703, DOI 10.1006/jmbi.1998.1717
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Watts NR, 2002, J STRUCT BIOL, V137, P109, DOI 10.1006/jsbi.2002.4469
   WEBER K, 1985, ANN NY ACAD SCI, V455, P126, DOI 10.1111/j.1749-6632.1985.tb50408.x
   Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503
NR 48
TC 181
Z9 185
U1 1
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD MAR
PY 2003
VL 25
IS 3
BP 243
EP 251
DI 10.1002/bies.10246
PG 9
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 650RH
UT WOS:000181276700007
PM 12596228
DA 2021-01-25
ER

PT J
AU Wedig, T
   Mucke, N
   Aebi, U
   Herrmann, H
AF Wedig, T
   Mucke, N
   Aebi, U
   Herrmann, H
TI Functional analysis of the vimentin oligomerization and filament
   formation
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Deutschen-Gesellschaft-fur-Zellbiologie/Gesellschaft-fur-Entwicklungsbio
   logie
CY MAR 26-29, 2003
CL BONN, GERMANY
SP Deutsch Gesell Zellbiol, Gesell Entwicklungsbiol
C1 DKFZ, Div Cell Biol, Heidelberg, Germany.
   DKFZ, Div Biophys Macromol, Heidelberg, Germany.
   Univ Basel, Biozentrum, ME Muller Inst, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2003
VL 82
SU 53
BP 103
EP 104
PG 2
WC Cell Biology
SC Cell Biology
GA 663QL
UT WOS:000182016200239
DA 2021-01-25
ER

PT J
AU Schumacher, J
   Strelkov, SV
   Aebi, U
   Mucke, N
   Herrmann, H
AF Schumacher, J
   Strelkov, SV
   Aebi, U
   Mucke, N
   Herrmann, H
TI Investigating the molecular assembly properties of human recombinant
   lamin A and B1
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Deutschen-Gesellschaft-fur-Zellbiologie/Gesellschaft-fur-Entwicklungsbio
   logie
CY MAR 26-29, 2003
CL BONN, GERMANY
SP Deutsch Gesell Zellbiol, Gesell Entwicklungsbiol
C1 German Canc Res Ctr, Div Cell Biol, D-6900 Heidelberg, Germany.
   Univ Basel, Biozentrum, ME Mueller Inst, CH-4003 Basel, Switzerland.
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
NR 0
TC 0
Z9 0
U1 0
U2 0
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2003
VL 82
SU 53
BP 108
EP 108
PG 1
WC Cell Biology
SC Cell Biology
GA 663QL
UT WOS:000182016200252
DA 2021-01-25
ER

PT J
AU Grunenfelder, B
   Gehrig, S
   Jenal, U
AF Grunenfelder, B
   Gehrig, S
   Jenal, U
TI Role of the cytoplasmic C terminus of the FliF motor protein in
   flagellar assembly and rotation
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID CELL-CYCLE CONTROL; MS RING COMPLEX; CAULOBACTER-CRESCENTUS;
   SALMONELLA-TYPHIMURIUM; BASAL BODY; EXPORT APPARATUS; BACTERIAL
   FLAGELLUM; RESPONSE REGULATOR; ESCHERICHIA-COLI; SWITCH COMPLEX
AB Twenty-six FliF monomers assemble into the MS ring, a central motor component of the bacterial flagellum that anchors the structure in the inner membrane. Approximately 100 amino acids at the C terminus of FliF are exposed to the cytoplasm and, through the interaction with the FliG switch protein, a component of the flagellar C ring, are essential for the assembly of the motor. In this study, we have dissected the entire cytoplasmic C terminus of the Caulobacter crescentus FliF protein by high-resolution mutational analysis and studied the mutant forms with regard to the assembly, checkpoint control, and function of the flagellum. Only nine amino acids at the very C terminus of FliF are essential for flagellar assembly. Deletion or substitution of about 10 amino acids preceding the very C terminus of FliF resulted in assembly-competent but nonfunctional flagella, making these the first fliF mutations described so far with a Fla(+) but Mot(-) phenotype. Removal of about 20 amino acids further upstream resulted in functional flagella, but cells carrying these mutations were not able to spread efficiently on semisolid agar plates. At least 61 amino acids located between the functionally relevant C terminus and the second membrane-spanning domain of FliF were not required for flagellar assembly and performance. A strict correlation was found between the ability of FliF mutant versions to assemble into a flagellum, flagellar class III gene expression, and a block in cell division. Motile suppressors could be isolated for nonmotile mutants but not for mutants lacking a flagellum. Several of these suppressor mutations were localized to the 5' region of the fliG gene. These results provide genetic support for a model in which only a short stretch of amino acids at the immediate C terminus of FliF is required for flagellar assembly through stable interaction with the FliG switch protein.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA
   EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977
   Fan F, 1997, MOL MICROBIOL, V26, P1035, DOI 10.1046/j.1365-2958.1997.6412010.x
   FRANCIS NR, 1992, P NATL ACAD SCI USA, V89, P6304, DOI 10.1073/pnas.89.14.6304
   FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079
   GOBER JW, 1992, MOL BIOL CELL, V3, P913
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   HOMMA M, 1987, P NATL ACAD SCI USA, V84, P7483, DOI 10.1073/pnas.84.21.7483
   Jenal U, 2000, FEMS MICROBIOL REV, V24, P177, DOI 10.1016/S0168-6445(99)00035-2
   JENAL U, 1994, J MOL BIOL, V243, P227, DOI 10.1006/jmbi.1994.1650
   Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x
   Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658
   JOHNSON RC, 1977, GENETICS, V86, P25
   Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000
   Kihara M, 2001, J BACTERIOL, V183, P1655, DOI 10.1128/JB.183.5.1655-1662.2001
   KUBORI T, 1992, J MOL BIOL, V226, P433, DOI 10.1016/0022-2836(92)90958-M
   Kubori T, 1997, J BACTERIOL, V179, P813, DOI 10.1128/jb.179.3.813-817.1997
   LARSEN SH, 1974, P NATL ACAD SCI USA, V71, P1239, DOI 10.1073/pnas.71.4.1239
   Lloyd SA, 1996, J BACTERIOL, V178, P223, DOI 10.1128/jb.178.1.223-231.1996
   Lux R, 2000, J MOL BIOL, V298, P577, DOI 10.1006/jmbi.2000.3703
   Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999
   MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023
   MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060
   Marykwas DL, 1996, J MOL BIOL, V256, P564, DOI 10.1006/jmbi.1996.0109
   Miller J., 1972, EXPT MOL GENETICS, P352
   Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999
   Mohr CD, 1996, J BACTERIOL, V178, P675, DOI 10.1128/jb.178.3.675-682.1996
   Muir RE, 2001, MOL MICROBIOL, V41, P117, DOI 10.1046/j.1365-2958.2001.02506.x
   OOSAWA K, 1994, J BACTERIOL, V176, P3683, DOI 10.1128/JB.176.12.3683-3691.1994
   POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964
   RAMAKRISHNAN G, 1994, J BACTERIOL, V176, P7587, DOI 10.1128/JB.176.24.7587-7600.1994
   ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413
   Sambrook J., 2001, MOL CLONING LAB MANU
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SHAPIRO L, 1995, CELL, V80, P525, DOI 10.1016/0092-8674(95)90505-7
   SILVERMAN M, 1974, NATURE, V249, P73, DOI 10.1038/249073a0
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   SOMMER JM, 1989, J BACTERIOL, V171, P392, DOI 10.1128/jb.171.1.392-401.1989
   SOSINSKY GE, 1992, P NATL ACAD SCI USA, V89, P4801, DOI 10.1073/pnas.89.11.4801
   Tang H, 1996, J MOL BIOL, V261, P209, DOI 10.1006/jmbi.1996.0453
   Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335
   UENO T, 1992, J MOL BIOL, V227, P672, DOI 10.1016/0022-2836(92)90216-7
   VALLEJO AN, 1994, PCR METH APPL, V4, P123
   Wu JG, 1997, MOL MICROBIOL, V24, P233, DOI 10.1046/j.1365-2958.1997.3281691.x
NR 45
TC 34
Z9 34
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD MAR
PY 2003
VL 185
IS 5
BP 1624
EP 1633
DI 10.1128/JB.185.5.1624-1633.2003
PG 10
WC Microbiology
SC Microbiology
GA 648KU
UT WOS:000181151200018
PM 12591880
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Lei, EP
   Stern, CA
   Fahrenkrog, B
   Krebber, H
   Moy, TI
   Aebi, U
   Silver, PA
AF Lei, EP
   Stern, CA
   Fahrenkrog, B
   Krebber, H
   Moy, TI
   Aebi, U
   Silver, PA
TI Sac3 is an mRNA export factor that localizes to cytoplasmic fibrils of
   nuclear pore complex
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID MESSENGER-RNA EXPORT; ATTACHED INTRANUCLEAR FILAMENTS; HNRNP-LIKE
   PROTEINS; SACCHAROMYCES-CEREVISIAE; POLY(A)(+) RNA; RIBOSOMAL-SUBUNIT;
   BINDING PROTEIN; IN-VIVO; FUNCTIONAL-CHARACTERIZATION; MOLECULAR
   ARCHITECTURE
AB In eukaryotes, mRNAs are transcribed in the nucleus and exported to the cytoplasm for translation to occur. Messenger RNAs complexed with proteins referred to as ribonucleoparticles are recognized for nuclear export in part by association with Mex67, a key Saccharomyces cerevisiae mRNA export factor and homolog of human TAP/NXF1. Mex67, along with its cofactor Mtr2, is thought to promote ribonucleoparticle translocation by interacting directly with components of the nuclear pore complex (NPC). Herein, we show that the nuclear pore-associated protein Sac3 functions in mRNA export. Using a mutant allele of MTR2 as a starting point, we have identified a mutation in SAC3 in a screen for synthetic lethal interactors. Loss of function of SAC3 causes a strong nuclear accumulation of mRNA and synthetic lethality with a number of mRNA export mutants. Furthermore, Sac3 can be coimmunoprecipitated with Mex67, Mtr2, and other factors involved in mRNA export. Immunoelectron microscopy analysis shows that Sac3 localizes exclusively to cytoplasmic fibrils of the NPC. Finally, Mex67 accumulates at the nuclear rim when SAC3 is mutated, suggesting that Sac3 functions in Mex67 translocation through the NPC.
C1 Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
   Dana Farber Canc Inst, Boston, MA 02115 USA.
   Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413
CR Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994
   BAILER AJ, 1998, BELLE NEWSLETTER, V6, P2
   Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2
   Bauer A, 1996, J CELL SCI, V109, P1575
   Bauer A, 1996, YEAST, V12, P965, DOI 10.1002/(SICI)1097-0061(199608)12:10<965::AID-YEA999>3.0.CO;2-Q
   Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475
   Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515
   Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8
   Damelin M, 2002, BIOPHYS J, V83, P3626, DOI 10.1016/S0006-3495(02)75363-0
   ELLEDGE SJ, 1988, GENE, V70, P303, DOI 10.1016/0378-1119(88)90202-8
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   FLACH J, 1994, MOL CELL BIOL, V14, P8399, DOI 10.1128/MCB.14.12.8399
   Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3
   GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939
   Heath CV, 1995, J CELL BIOL, V131, P1677, DOI 10.1083/jcb.131.6.1677
   Henry MF, 1996, MOL CELL BIOL, V16, P3668
   Herold A, 2001, RNA, V7, P1768
   Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057
   Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778
   Hurt E, 2000, J BIOL CHEM, V275, P8361, DOI 10.1074/jbc.275.12.8361
   Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389
   Hurwitz ME, 1998, P NATL ACAD SCI USA, V95, P11241, DOI 10.1073/pnas.95.19.11241
   HURWITZ ME, 1995, J CELL BIOL, V130, P1275, DOI 10.1083/jcb.130.6.1275
   Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699
   Jones AL, 2000, P NATL ACAD SCI USA, V97, P3224, DOI 10.1073/pnas.050432997
   Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593
   KOLLING R, 1993, MOL GEN GENET, V237, P359
   Kosova B, 2000, J BIOL CHEM, V275, P343, DOI 10.1074/jbc.275.1.343
   KRAEMER DM, 1995, J BIOL CHEM, V270, P19017, DOI 10.1074/jbc.270.32.19017
   Krebber H, 1999, GENE DEV, V13, P1994, DOI 10.1101/gad.13.15.1994
   Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233
   Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401
   Lei EP, 2002, DEV CELL, V2, P261, DOI 10.1016/S1534-5807(02)00134-X
   LEVESQUE L, 2001, J BIOL CHEM, V28, P28
   LI O, 1995, MOL BIOL CELL, V6, P401
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118
   Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0
   Murphy R, 1996, MOL BIOL CELL, V7, P1921
   NOVICK P, 1989, GENETICS, V121, P659
   RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826
   SCHMITZ N, 1999, P ASCO S, V5, P18
   Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256
   SINGLETON DR, 1995, J CELL SCI, V108, P265
   Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2
   Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663
   Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0
   Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777
   Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6
   Strahm Y, 1999, EMBO J, V18, P5761, DOI 10.1093/emboj/18.20.5761
   Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839
   Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695
   Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410
   Strawn LA, 2001, J BIOL CHEM, V276, P6445, DOI 10.1074/jbc.M008311200
   Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078
   Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427
   Teixeira MT, 1997, EMBO J, V16, P5086, DOI 10.1093/emboj/16.16.5086
   Tseng SSL, 1998, EMBO J, V17, P2651, DOI 10.1093/emboj/17.9.2651
   WENTE SR, 1993, J CELL BIOL, V123, P275, DOI 10.1083/jcb.123.2.275
   WENTE SR, 1992, J CELL BIOL, V119, P705, DOI 10.1083/jcb.119.4.705
   Wiegand HL, 2002, MOL CELL BIOL, V22, P245, DOI 10.1128/MCB.22.1.245-256.2002
   WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173
   WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Yan C, 1997, EMBO J, V16, P3572, DOI 10.1093/emboj/16.12.3572
   Zenklusen D, 2001, MOL CELL BIOL, V21, P4219, DOI 10.1128/MCB.21.13.4219-4232.2001
NR 68
TC 56
Z9 56
U1 0
U2 4
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAR
PY 2003
VL 14
IS 3
BP 836
EP 847
DI 10.1091/mbc.E02-08-0520
PG 12
WC Cell Biology
SC Cell Biology
GA 655XV
UT WOS:000181578700002
PM 12631707
OA Green Published
DA 2021-01-25
ER

PT J
AU Aldridge, P
   Paul, R
   Goymer, P
   Rainey, P
   Jenal, U
AF Aldridge, P
   Paul, R
   Goymer, P
   Rainey, P
   Jenal, U
TI Role of the GGDEF regulator PleD in polar development of Caulobacter
   crescentus
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID HISTIDINE PROTEIN-KINASE; SIGNAL-TRANSDUCTION SYSTEMS; CYCLIC DIGUANYLIC
   ACID; BACTERIAL-CELL CYCLE; RESPONSE REGULATOR; ACETOBACTER-XYLINUM;
   CELLULOSE SYNTHESIS; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; DOMAIN
AB Several members of the two-component signal transduction family have been implicated in the control of polar development in Caulobacter crescentus:PleC and DivJ, two polarly localized histidine sensor kinases; and the response regulators DivK and PleD. The PleD protein was shown previously to be required during the swarmer-to-stalked cell transition for flagellar ejection and efficient stalk biogenesis. Here, we present data indicating that PleD also controls the onset of motility and a cell density switch immediately preceding cell division. Constitutively active alleles of pleD or wspR, an orthologue from Pseudomonas fluorescens, almost completely suppressed C. crescentus motility and inhibited the increase in swarmer cell density during cell differentiation. The observation that these alleles also had a dominant-negative effect on motility in a pleC divJ and a pleC divK mutant background indicated that PleD is located downstream of the other components in the signal transduction cascade, which controls the activity of the flagellar motor. In addition, the presence of a constitutive pleD or wspR allele resulted in a doubling of the average stalk length. Together, this is consistent with a model in which the active form of PleD, PleDsimilar toP, negatively controls aspects of differentiation in the late predivisional cell, whereas it acts positively on polar development during the swarmer-to-stalked cell transition. In agreement with such a model, we found that DivJ, which localizes to the stalked pole during cell differentiation, positively controlled the in vivo phosphorylation status of PleD, and the swarmer pole-specific PleC kinase modulated this status in a negative manner. Furthermore, domain switch experiments demonstrated that the WspR GGDEF output domain from P. fluorescens is active in C. crescentus, favouring a more general function for this novel signalling domain over a specific role such as DNA or protein interaction. Possible roles for PleD and its C-terminal output domain in modulating the polar cell surface of C. crescentus are discussed.
C1 Univ Basel, Div Mol Microbiol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.
   Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England.
   Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.
RP Jenal, U (corresponding author), Univ Basel, Div Mol Microbiol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM urs.Jenal@unibas.ch
RI Rainey, Paul/A-3207-2008
OI Rainey, Paul/0000-0003-0879-5795; Goymer, Patrick/0000-0002-2789-9373
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1
   Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x
   Ausmees N, 1999, MICROBIOL-UK, V145, P1253, DOI 10.1099/13500872-145-5-1253
   Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263
   Brun YV, 2000, PROKARYOTIC DEVELOPMENT, P297
   Burton GJ, 1997, J BACTERIOL, V179, P5849, DOI 10.1128/jb.179.18.5849-5853.1997
   D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002
   Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s
   Dieffenbach C.W., 1995, PCR PRIMER LAB MANUA
   Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4
   Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Galperin MY, 2001, FEMS MICROBIOL LETT, V205, P17, DOI 10.1111/j.1574-6968.2001.tb10919.x
   Gronewold TMA, 2001, MOL MICROBIOL, V40, P744, DOI 10.1046/j.1365-2958.2001.02428.x
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x
   Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998
   Jenal U, 2002, CURR OPIN MICROBIOL, V5, P558, DOI 10.1016/S1369-5274(02)00378-8
   KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370
   Lan CY, 1998, J BACTERIOL, V180, P171, DOI 10.1128/JB.180.1.171-174.1998
   Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Ohta N, 1996, TRENDS MICROBIOL, V4, P326, DOI 10.1016/0966-842X(96)10050-0
   OHTA N, 1992, P NATL ACAD SCI USA, V89, P10297, DOI 10.1073/pnas.89.21.10297
   Osteras M, 2000, CURR OPIN MICROBIOL, V3, P171, DOI 10.1016/S1369-5274(00)00071-0
   PAO GM, 1995, J MOL EVOL, V40, P136, DOI 10.1007/BF00167109
   Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8
   PONTING CP, 1997, CURR BIOL, V7, P674
   Romling U, 2000, MOL MICROBIOL, V36, P10, DOI 10.1046/j.1365-2958.2000.01822.x
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991
   ROSS P, 1990, J BIOL CHEM, V265, P18933
   Sambrook J, 1989, MOL CLONING LAB MANU
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   Smit J, 2000, CAN J MICROBIOL, V46, P339, DOI 10.1139/cjm-46-4-339
   SOMMER JM, 1989, J BACTERIOL, V171, P392, DOI 10.1128/jb.171.1.392-401.1989
   SOMMER JM, 1991, GENETICS, V129, P623
   Sourjik V, 1996, MOL MICROBIOL, V22, P427, DOI 10.1046/j.1365-2958.1996.1291489.x
   Spiers AJ, 2002, GENETICS, V161, P33
   Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998
   TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993
   WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630
   Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2
   Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068
   Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9
   Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x
NR 51
TC 175
Z9 178
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD MAR
PY 2003
VL 47
IS 6
BP 1695
EP 1708
DI 10.1046/j.1365-2958.2003.03401.x
PG 14
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 652HF
UT WOS:000181373200016
PM 12622822
OA Bronze
DA 2021-01-25
ER

PT J
AU Nordheim, U
   Dokladny, K
   Hofbauer, KG
AF Nordheim, U
   Dokladny, K
   Hofbauer, KG
TI Is the stimulation of central melanocortin receptors a feasible
   anti-obesity approach?
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
CT 44th Meeting of the
   Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und
   -Toxikologie/20th Gesellschaft-fur-Umwelt-Mutationsforschung
CY MAR 17-20, 2003
CL MAINZ, GERMANY
SP Deutsch Gesell Exptl & Klin Pharm & Toxikol, Gesell Umwelt-Mutat Forsch
C1 Univ Basel, Chair Appl Pharmacol, Biozentrum, Pharmazentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0028-1298
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD MAR
PY 2003
VL 367
SU 1
MA 393
BP R102
EP R102
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 670XN
UT WOS:000182435500404
DA 2021-01-25
ER

PT J
AU Senn, C
   Hangartner, C
   Dokladny, K
   Hofbauer, KG
AF Senn, C
   Hangartner, C
   Dokladny, K
   Hofbauer, KG
TI Comparison of the effects, of pharmacological blockade and
   down-regulation (knock-down) of melanocortin 4 - Receptors on food
   intake in rats
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
CT 44th Meeting of the
   Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und
   -Toxikologie/20th Gesellschaft-fur-Umwelt-Mutationsforschung
CY MAR 17-20, 2003
CL MAINZ, GERMANY
SP Deutsch Gesell Exptl & Klin Pharm & Toxikol, Gesell Umwelt-Mutat Forsch
C1 Univ Basel, Biozentrum Pharmazentrum, Chair Appl Pharmacol, Basel, Switzerland.
   Novartis Pharma AG, BU Transplantat, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0028-1298
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD MAR
PY 2003
VL 367
SU 1
MA 71
BP R21
EP R21
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 670XN
UT WOS:000182435500082
DA 2021-01-25
ER

PT J
AU Stetefeld, J
   Frank, S
   Jenny, M
   Schulthess, T
   Kammerer, RA
   Boudko, S
   Landwehr, R
   Okuyama, K
   Engel, J
AF Stetefeld, J
   Frank, S
   Jenny, M
   Schulthess, T
   Kammerer, RA
   Boudko, S
   Landwehr, R
   Okuyama, K
   Engel, J
TI Collagen stabilization at atomic level: Crystal structure of designed
   (GlyProPro)(10)foldon
SO STRUCTURE
LA English
DT Article
DE collagen folding; collagen stability; foldon; protein design; hetero
   assembly; NC domain
ID TRIPLE-HELIX; BACTERIOPHAGE-T4 FIBRITIN; MOLECULAR-STRUCTURE; NC1
   DOMAIN; PEPTIDE; MODEL; COIL; TRIMERIZATION; NUCLEATION; PARAMETERS
AB In a designed fusion protein the trimeric domain foldon from bacteriophage T4 fibritin was connected to the C terminus of the collagen model peptide (GlyProPro)(10) by a short Gly-Ser linker to facilitate formation of the three-stranded collagen triple helix. Crystal structure analysis at 2.6 Angstrom resolution revealed conformational changes within the interface of both domains compared with the structure of the isolated molecules. A striking feature is an angle of 62.5degrees between the symmetry axis of the foldon trimer and the axis of the triple helix. The melting temperature of (GlyProPro)10 in the designed fusion protein (GlyProPro)(10)foldon is higher than that of isolated (GlyProPro)(10), which suggests an entropic stabilization compensating for the destabilization at the interface.
C1 Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   Tokyo Univ Agr & Technol, Fac Technol, Koganei, Tokyo 1848588, Japan.
RP Stetefeld, J (corresponding author), Univ Basel, Dept Biophys Chem, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joerg.stetefeld@unibas.ch
RI Stetefeld, Joerg/H-7630-2017
OI Stetefeld, Joerg/0000-0003-1478-3248; Kammerer,
   Richard/0000-0003-4570-5197
CR BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BATEMAN JF, 1996, EXTRACELLULAR MATRIX, V2, P22
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602
   Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   BRASS A, 1992, FEBS LETT, V303, P126, DOI 10.1016/0014-5793(92)80503-9
   Brodsky B, 1999, P INDIAN AS-CHEM SCI, V111, P13
   BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   CRICK FHC, 1955, NATURE, V176, P780, DOI 10.1038/176780a0
   DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   Engel J, 2000, MATRIX BIOL, V19, P283, DOI 10.1016/S0945-053X(00)00075-5
   ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881
   Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p
   Leslie AGW, 1994, MOSFLM USERS GUIDE
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7
   Okuyama K, 1999, P INDIAN AS-CHEM SCI, V111, P19
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   Snellman A, 2000, EMBO J, V19, P5051, DOI 10.1093/emboj/19.19.5051
   Strelkov SV, 1998, ACTA CRYSTALLOGR D, V54, P805, DOI 10.1107/S0907444997018878
   Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499
   TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x
   Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8
   TURK D, 1992, THESIS TU MUNCHEN MU
   YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040
NR 38
TC 66
Z9 69
U1 1
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD MAR
PY 2003
VL 11
IS 3
BP 339
EP 346
AR PII S0969-2126(03)00025-X
DI 10.1016/S0969-2126(03)00025-X
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 655FC
UT WOS:000181539800014
PM 12623021
DA 2021-01-25
ER

PT J
AU Feldman, MF
   Cornelis, GR
AF Feldman, MF
   Cornelis, GR
TI The multitalented type III chaperones: all you can do with 15 kDa
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Review
DE type III secretion; chaperones; bacterial pathogenesis; Yersinia; SycE
ID YERSINIA-ENTEROCOLITICA; SHIGELLA-FLEXNERI; SALMONELLA-TYPHIMURIUM;
   SECRETION PATHWAY; EUKARYOTIC CELLS; HOST-CELLS; PROTEIN; YOPE; SYSTEM;
   SYCE
AB Despite the fact that type III chaperones were discovered approximately 10 years ago, the precise role of most of them is still mysterious. A panoply of functions has been proposed for the members of this family of proteins. Type III chaperones have been suggested to act as anti-aggregation and stabilizing factors. They have also been proposed to keep their substrates in unfolded or partially folded structures, set a hierarchy on secretion, and participate in the regulation of the transcription of the type III substrates. Here, we review this enigmatic family of proteins, and discuss the experimental data supporting the roles proposed for type III chaperones. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Catholique Louvain, Christian De Duve Inst Cellular & Mol Pathol, B-1200 Brussels, Belgium.
   Univ Catholique Louvain, Fac Med, B-1200 Brussels, Belgium.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Feldman, Mario/A-2637-2014
OI Feldman, Mario/0000-0003-4497-0976
CR Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1016/S0378-1097(01)00301-9
   Andersson K, 1999, INFECT IMMUN, V67, P2567, DOI 10.1128/IAI.67.5.2567-2574.1999
   Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0
   Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974
   Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000
   Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4
   Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x
   Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077
   Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850
   Day JB, 2000, INFECT IMMUN, V68, P6466, DOI 10.1128/IAI.68.11.6466-6471.2000
   Driessen AJM, 2001, TRENDS MICROBIOL, V9, P193, DOI 10.1016/S0966-842X(01)01980-1
   Evdokimov AG, 2002, PROTEIN SCI, V11, P401, DOI 10.1110/ps.34102
   Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x
   FORSBERG A, 1990, J BACTERIOL, V172, P1547, DOI 10.1128/jb.172.3.1547-1555.1990
   Francis MS, 2002, CURR OPIN MICROBIOL, V5, P166, DOI 10.1016/S1369-5274(02)00301-6
   Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x
   FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x
   Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Li CM, 2002, EMBO J, V21, P1909, DOI 10.1093/emboj/21.8.1909
   LUO Y, 2001, NAT STRUCT BIOL, V29, P29
   Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x
   MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7
   Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x
   Niebuhr K, 2000, MOL MICROBIOL, V38, P8, DOI 10.1046/j.1365-2958.2000.02041.x
   Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x
   Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x
   Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073
   Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x
NR 38
TC 113
Z9 117
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1097
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD FEB 28
PY 2003
VL 219
IS 2
BP 151
EP 158
DI 10.1016/S0378-1097(03)00042-9
PG 8
WC Microbiology
SC Microbiology
GA 655RY
UT WOS:000181567500001
PM 12620614
OA Green Published
DA 2021-01-25
ER

PT J
AU Karlsson, M
   Fotiadis, D
   Sjovall, S
   Johansson, I
   Hedfalk, K
   Engel, A
   Kjellbom, P
AF Karlsson, M
   Fotiadis, D
   Sjovall, S
   Johansson, I
   Hedfalk, K
   Engel, A
   Kjellbom, P
TI Reconstitution of water channel function of an aquaporin overexpressed
   and purified from Pichia pastoris
SO FEBS LETTERS
LA English
DT Article
DE aquaporin; overexpression; electron microscopy; mass spectrometry;
   reconstitution; Pichia pastoris
ID MAJOR INTRINSIC PROTEINS; LEAF PLASMA-MEMBRANES; RESOLUTION;
   PURIFICATION; EXPRESSION; TRANSPORT; PLANTS; FORMS
AB The aquaporin PM28A is one of the major integral proteins in spinach leaf plasma membranes. Phosphorylation/ dephosphorylation of Ser274 at the C-terminus and of Ser115 in the first cytoplasmic loop has been shown to regulate the water channel activity of PM28A when expressed in Xenopus oocytes. To understand the mechanisms of the phosphorylation-mediated gating of the channel the structure of PM28A is required. In a first step we have used the methylotrophic yeast Pichia pastoris for expression of the pm28a gene. The expressed protein has a molecular mass of 32462 Da as determined by matrix-assisted laser desorption ionization-mass spectrometry, forms tetramers as revealed by electron microscopy and is functionally active when reconstituted in proteoliposomes. PM28A was efficiently solubilized from urea- and alkali-stripped Pichia membranes by octyl-beta-D-thioglueopyranoside resulting in a final yield of 25 mg of purified protein per liter of cell culture. (C) 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Lund Univ, Dept Plant Biochem, S-22100 Lund, Sweden.
   Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Chalmers Univ Technol, Dept Mol Biotechnol, S-40530 Gothenburg, Sweden.
RP Kjellbom, P (corresponding author), Lund Univ, Dept Plant Biochem, Box 124, S-22100 Lund, Sweden.
RI Hedfalk, Kristina/A-8244-2010
CR BEARDEN JC, 1978, BIOCHIM BIOPHYS ACTA, V533, P525, DOI 10.1016/0005-2795(78)90398-7
   Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425
   Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206
   DILSIZ N, 1995, BIOCHEM J, V305, P753, DOI 10.1042/bj3050753
   Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800
   Fotiadis D, 2001, J BIOL CHEM, V276, P1707, DOI 10.1074/jbc.M009383200
   Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202
   FRANK J, 1981, SCIENCE, V214, P1353, DOI 10.1126/science.7313694
   Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796
   Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187
   Johanson U, 2002, MOL BIOL EVOL, V19, P456, DOI 10.1093/oxfordjournals.molbev.a004101
   Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358
   Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4
   Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451
   Johansson I, 1996, PLANT CELL, V8, P1181, DOI 10.1105/tpc.8.7.1181
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   MENENDEZ A, 1995, ANAL BIOCHEM, V230, P308, DOI 10.1006/abio.1995.1479
   Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   SHI LB, 1994, J BIOL CHEM, V269, P10417
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7
   van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644
   Werten PJL, 2001, FEBS LETT, V504, P200, DOI 10.1016/S0014-5793(01)02703-X
   Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r
NR 28
TC 71
Z9 74
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD FEB 27
PY 2003
VL 537
IS 1-3
BP 68
EP 72
DI 10.1016/S0014-5793(03)00082-6
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 651DA
UT WOS:000181304100013
PM 12606033
OA Bronze
DA 2021-01-25
ER

PT J
AU Pappenberger, G
   Bachmann, A
   Muller, R
   Aygun, H
   Engels, JW
   Kiefhaber, T
AF Pappenberger, G
   Bachmann, A
   Muller, R
   Aygun, H
   Engels, JW
   Kiefhaber, T
TI Kinetic mechanism and catalysis of a native-state prolyl isomerization
   reaction
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding kinetics; prolyl cis-trans isomerization; native-state
   heterogeneity; tendamistat; cyclophilin
ID RIBONUCLEASE-A; PROTEIN; TENDAMISTAT; PHOSPHORYLATION; THERMODYNAMICS;
   CONFORMATIONS; INTERMEDIATE
AB Folding of tendamistat is a rapid two-state process for the majority of the unfolded molecules. In fluorescence-monitored refolding kinetics about 8% of the unfolded molecules fold slowly (lambda = 0.083 s(-1)), limited by peptidyl-prolyl cis-trans isomerization. This is significantly less than expected from the presence of three trans prolyl-peptide bonds in the native state. In interrupted refolding experiments we detected an additional very slow folding reaction (lambda = 0.008 s(-1) at pH 2) with an amplitude of about 12%. This reaction is caused by the interconversion of a highly structured intermediate to native tendamistat. The intermediate has essentially native spectroscopic properties and about 2% of it remain populated in equilibrium after folding is complete. Catalysis by human cyclophilin 18 identifies this very slow reaction as a prolyl isomerization reaction. This shows that prolyl-isomerases are able to efficiently catalyze native state isomerization reactions, which allows them to influence biologically important regulatory conformational transitions. Folding kinetics of the proline variants P7A, P9A, P50A and P7A/P9A show that the very slow reaction is due to isomerization of the Glu6-Pro7 and Ala8-Pro9 peptide bonds, which are located in a region that makes strong backbone and side-chain interactions to both beta-sheets. In the P50A variant the very slow isomerization. reaction is still present but native state heterogeneity is not observed any more, indicating a long-range destabilizing effect on the alternative native state relative to N. These results enable us to include all prolyl and non-prolyl peptide bond isomerization reactions in the folding mechanism of tendamistat and to characterize the kinetic mechanism and the energetics of a native-state prolyl isomerization reaction. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Biophys Chem Abt, CH-4056 Basel, Switzerland.
   Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol, D-60439 Frankfurt, Germany.
   BioSpring GMBH, D-60386 Frankfurt, Germany.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Biophys Chem Abt, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010; Engels, Joachim W/A-9224-2012
CR Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x
   CHAZIN WJ, 1989, P NATL ACAD SCI USA, V86, P2195, DOI 10.1073/pnas.86.7.2195
   Chiti F, 1999, J BIOL CHEM, V274, P20151, DOI 10.1074/jbc.274.29.20151
   COOK KH, 1979, P NATL ACAD SCI USA, V76, P6157, DOI 10.1073/pnas.76.12.6157
   ELOVE GA, 1994, BIOCHEMISTRY-US, V33, P6925, DOI 10.1021/bi00188a023
   Feng YQ, 1997, PROTEIN SCI, V6, P1777, DOI 10.1002/pro.5560060821
   Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548
   FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0
   GOTO Y, 1982, J MOL BIOL, V156, P891, DOI 10.1016/0022-2836(82)90146-2
   GRATHWOHL C, 1976, BIOPOLYMERS, V15, P2025, DOI 10.1002/bip.1976.360151012
   HAASLAUTERBACH S, 1993, APPL MICROBIOL BIOT, V38, P719, DOI 10.1007/BF00167134
   HURLE MR, 1991, PROTEIN ENG, V4, P451, DOI 10.1093/protein/4.4.451
   KIEFHABER T, 1992, PROTEIN SCI, V1, P1162, DOI 10.1002/pro.5560010910
   KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024
   KIEFHABER T, 1995, P NATL ACAD SCI USA, V92, P9029, DOI 10.1073/pnas.92.20.9029
   KIEFHABER T, 1992, J MOL BIOL, V224, P231, DOI 10.1016/0022-2836(92)90586-9
   KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8
   KIEFHABER T, 1992, PROTEINS, V12, P171, DOI 10.1002/prot.340120210
   KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0
   LANG K, 1989, THESIS U REGENSBURG
   LILIE H, 1995, J MOL BIOL, V248, P190, DOI 10.1006/jmbi.1995.0211
   MARKLEY JL, 1970, P NATL ACAD SCI USA, V65, P645, DOI 10.1073/pnas.65.3.645
   Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9
   Pappenberger G, 2001, NAT STRUCT BIOL, V8, P452, DOI 10.1038/87624
   PFLUGRATH JW, 1986, J MOL BIOL, V189, P383, DOI 10.1016/0022-2836(86)90520-6
   Plaxco KW, 1998, BIOCHEMISTRY-US, V37, P2529, DOI 10.1021/bi972075u
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Reimer U, 2002, BIOPHYS CHEM, V96, P203, DOI 10.1016/S0301-4622(02)00013-3
   Reimer U., 1998, PROTEIN FOLDING FRON, V279, P449
   RENNER M, 1992, J MOL BIOL, V223, P769, DOI 10.1016/0022-2836(92)90988-V
   Roussanne MC, 1998, J BONE MINER RES, V13, P354, DOI 10.1359/jbmr.1998.13.3.354
   RUDOLPH R, 1992, PROTEIN SCI, V1, P654, DOI 10.1002/pro.5560010511
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   SCHINDLER T, 1995, NAT STRUCT BIOL, V2, P663, DOI 10.1038/nsb0895-663
   SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013
   Schonbrunner N, 1997, J MOL BIOL, V268, P526, DOI 10.1006/jmbi.1997.0960
   SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P11195, DOI 10.1021/bi00092a032
   Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z
   Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3
NR 42
TC 28
Z9 28
U1 1
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD FEB 7
PY 2003
VL 326
IS 1
BP 235
EP 246
DI 10.1016/S0022-2836(02)01373-6
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 645UK
UT WOS:000180997600020
PM 12547205
DA 2021-01-25
ER

PT J
AU Bonenfant, D
   Schmelzle, T
   Jacinto, E
   Crespo, JL
   Mini, T
   Hall, MN
   Jenoe, P
AF Bonenfant, D
   Schmelzle, T
   Jacinto, E
   Crespo, JL
   Mini, T
   Hall, MN
   Jenoe, P
TI Quantitation of changes in protein phosphorylation: A simple method
   based on stable isotope labeling and mass spectrometry
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID TOR-SIGNALING PATHWAY; PHOSPHATIDYLINOSITOL KINASE HOMOLOG; TRYPTOPHAN
   PERMEASE; YEAST; RAPAMYCIN; ELECTROSPRAY; PROGRESSION; EXPRESSION;
   NUTRIENTS; TAP42
AB Reversible protein phosphorylation plays an important role in many cellular processes. However, a simple and reliable method to measure changes in the extent of phosphorylation is lacking. Here, we present a method to quantitate the changes in phosphorylation occurring in a protein in response to a stimulus. The method consists of three steps: (i) enzymatic digestion in (H2O)-O-16 or isotopically enriched (H2O)-O-18 to label individual pools of differentially phosphorylated proteins; (h) affinity selection of phosphopeptides from the combined digests by immobilized metal-affinity chromatography; and (iii) dephosphorylation with alkaline phosphatase to allow for quantitation of changes of phosphorylation by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. We applied this strategy to the analysis of the yeast nitrogen permease reactivator protein kinase involved in the target of rapamycin signaling pathway. Alteration in the extent of phosphorylation at Ser-353 and Ser-357 could be easily assessed and quantitated both in wild-type yeast cells treated with rapamycin and in cells lacking the S1T4 phosphatase responsible for dephosphorylating nitrogen permease reactivator protein. The method described here is simple and allows quantitation of relative changes in the level of phosphorylation in signaling proteins, thus yielding information critical for understanding the regulation of complex protein phosphorylation cascades.
C1 Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
RP Jenoe, P (corresponding author), Univ Basel, Biozentrum, Dept Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Crespo, Jose L/L-3977-2014
OI Crespo, Jose L/0000-0003-3514-1025; Hall, Michael N/0000-0002-2998-0757;
   Jacinto, Estela/0000-0001-7118-1759
CR Annan RS, 1996, ANAL CHEM, V68, P3413, DOI 10.1021/ac960221g
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904
   Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301
   Goshe MB, 2001, ANAL CHEM, V73, P2578, DOI 10.1021/ac010081x
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   McLachlin DT, 2001, CURR OPIN CHEM BIOL, V5, P591, DOI 10.1016/S1367-5931(00)00250-7
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591
   Oda Y, 2001, NAT BIOTECHNOL, V19, P379, DOI 10.1038/86783
   Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Radimerski T, 2000, BIOCHEMISTRY-US, V39, P5766, DOI 10.1021/bi9927484
   Resing KA, 1997, METHOD ENZYMOL, V283, P29
   Schlosser A, 2001, ANAL CHEM, V73, P170, DOI 10.1021/ac000826j
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   Schnolzer M, 1996, ELECTROPHORESIS, V17, P945, DOI 10.1002/elps.1150170517
   Yao XD, 2001, ANAL CHEM, V73, P2836, DOI 10.1021/ac001404c
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
   Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777
NR 26
TC 87
Z9 97
U1 0
U2 6
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 4
PY 2003
VL 100
IS 3
BP 880
EP 885
DI 10.1073/pnas.232735599
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 642ZU
UT WOS:000180838100023
PM 12540831
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Heerklotz, H
   Seelig, J
AF Heerklotz, H
   Seelig, J
TI Sphingomyelin hates triton.
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the Biophysical-Society
CY MAR 01-05, 2003
CL SAN ANTONIO, TEXAS
SP Biophys Soc, Axon Instruments, ALA Sci Instruments
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 2003
VL 84
IS 2
SU S
BP 326A
EP 326A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 682ZW
UT WOS:000183123801593
DA 2021-01-25
ER

PT J
AU Heerklotz, H
AF Heerklotz, H
TI Squeezing proteins, lipids, surfactants or solvents in a
   microcalorimeter.
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the Biophysical-Society
CY MAR 01-05, 2003
CL SAN ANTONIO, TEXAS
SP Biophys Soc, Axon Instruments, ALA Sci Instruments
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 2003
VL 84
IS 2
SU S
BP 370A
EP 370A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 682ZW
UT WOS:000183123801811
DA 2021-01-25
ER

PT J
AU Dehio, C
AF Dehio, C
TI Recent progress in understanding Bartonella-induced vascular
   proliferation
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID HUMAN ENDOTHELIAL-CELLS; BACILLARY ANGIOMATOSIS; IN-VITRO; HENSELAE;
   BACILLIFORMIS; INFECTION; ACTIVATION; PATHOGENS; ERYTHROCYTES; MOLECULES
AB The ability to induce endothelial cell proliferation is a common feature of human pathogenic Bartonella species. Recent data have indicated that bartonellae can provoke angioproliferation by at least two independent mechanisms: directly, by triggering proliferation and inhibiting apoptosis of endothelial cells; and indirectly, by stimulating a paracrine angiogenic loop of vascular endothelial growth factor production by infected macrophages. A NF-kappaB-mediated acute inflammatory reaction of the Bartonella-infected endothelium appears to be critical for the recruitment of monocytes/macrophages and the initiation and maintenance of a paracrine angiogenic loop. Given that bartonellae effectively adhere to and invade endothelial cells, their ability to trigger angioproliferation might represent a dedicated pathogenic strategy for expanding the bacterial host cell habitat.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR Brouqui P, 1996, RES MICROBIOL, V147, P719, DOI 10.1016/S0923-2508(97)85119-4
   Coleman SA, 2001, INFECT IMMUN, V69, P4373, DOI 10.1128/IAI.69.7.4373-4381.2001
   CONLEY T, 1994, J LAB CLIN MED, V124, P521
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9
   Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   GARCIA FU, 1990, AM J PATHOL, V136, P1125
   GARCIA FU, 1992, J INFECT DIS, V165, P1138, DOI 10.1093/infdis/165.6.1138
   Hacker G, 2002, FEMS MICROBIOL LETT, V211, P1
   Karem KL, 2000, MICROBES INFECT, V2, P1193, DOI 10.1016/S1286-4579(00)01273-9
   Kempf VAJ, 2002, TRENDS MICROBIOL, V10, P269, DOI 10.1016/S0966-842X(02)02372-7
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   KOSTIANOVSKY M, 1994, ULTRASTRUCT PATHOL, V18, P349, DOI 10.3109/01913129409023203
   Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0
   Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315
   Maeno N, 2002, SCAND J IMMUNOL, V55, P366, DOI 10.1046/j.1365-3083.2002.01065.x
   Manders SM, 1996, CLIN DERMATOL, V14, P295, DOI 10.1016/0738-081X(96)00015-6
   Marin V, 2001, J IMMUNOL, V167, P3435, DOI 10.4049/jimmunol.167.6.3435
   Musso T, 2001, INFECT IMMUN, V69, P5974, DOI 10.1128/IAI.69.10.5974-5980.2001
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Seubert A, 2002, INT J MED MICROBIOL, V291, P555
   Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D
   van der Flier M, 2000, INFECT IMMUN, V68, P4792, DOI 10.1128/IAI.68.8.4792-4794.2000
   Verma A, 2000, INFECT IMMUN, V68, P5960, DOI 10.1128/IAI.68.10.5960-5969.2000
   Verma A, 2002, CELL MICROBIOL, V4, P557, DOI 10.1046/j.1462-5822.2002.00217.x
   Verma A, 2001, CELL MICROBIOL, V3, P169, DOI 10.1046/j.1462-5822.2001.00104.x
   Wong AK, 2001, P NATL ACAD SCI USA, V98, P7481, DOI 10.1073/pnas.121192298
NR 31
TC 55
Z9 59
U1 0
U2 1
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD FEB
PY 2003
VL 6
IS 1
BP 61
EP 65
DI 10.1016/S1369-5274(03)00006-7
PG 5
WC Microbiology
SC Microbiology
GA 668NT
UT WOS:000182300600010
PM 12615221
DA 2021-01-25
ER

PT J
AU Benassayag, C
   Plaza, S
   Callaerts, P
   Clements, J
   Romeo, Y
   Gehring, WJ
   Cribbs, DL
AF Benassayag, C
   Plaza, S
   Callaerts, P
   Clements, J
   Romeo, Y
   Gehring, WJ
   Cribbs, DL
TI Evidence for a direct functional antagonism of the selector genes
   proboscipedia and eyeless in Drosophila head development
SO DEVELOPMENT
LA English
DT Article
DE Hox; Pax6; proboscipedia; maxillary palps; protein-protein;
   differentiation
ID HOMEOBOX-CONTAINING GENE; DNA-BINDING SPECIFICITY; HOX PROTEINS; EYES
   ABSENT; SINE OCULIS; COOPERATIVE INTERACTIONS; NASAL DEVELOPMENT; POINT
   MUTATION; HOMEOTIC GENES; PAIRED DOMAIN
AB Diversification of Drosophild segmental and cellular identities both require the combinatorial function of homeodomain-containing transcription factors. Ectopic expression of the mouthparts selector proboscipedia (pb) directs a homeotic antenna-to-maxillary palp transformation. It also induces a dosage-sensitive eye loss that we used to screen for dominant Enhancer mutations. Four such Enhancer mutations were alleles of the eyeless (ey) gene that encode truncated EY proteins. Apart from eye loss, these new eyeless alleles lead to defects in the adult olfactory appendages: the maxillary palps and antennae. In support of these observations, both ey and pb are expressed in cell subsets of the prepupal maxillary primordium of the antennal imaginal disc, beginning early in pupal development. Transient co-expression is detected early after this onset, but is apparently resolved to yield exclusive groups of cells expressing either PB or EY proteins. A combination of in vivo and in vitro approaches indicates that PB suppresses EY transactivation activity via protein-protein contacts of the PB homeodomain and EY Paired domain. The direct functional antagonism between PB and EY proteins suggests a novel crosstalk mechanism integrating known selector functions in Drosophila head morphogenesis.
C1 CNRS, Ctr Dev Biol, F-31062 Toulouse 04, France.
   Inst Explorat Fonct Genome, F-31062 Toulouse, France.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.
   Univ Toulouse 3, CNRS, IBCG, F-31062 Toulouse, France.
RP Cribbs, DL (corresponding author), CNRS, Ctr Dev Biol, 118 Route Narbonne,Batiment 4R3, F-31062 Toulouse 04, France.
EM cribbs@cict.fr
RI Romeo, Yves/AAC-1669-2021; Callaerts, Patrick/I-8118-2013; plaza,
   serge/F-5290-2015
OI Clements, Jason/0000-0002-8901-784X
CR Abramovich C, 2000, J BIOL CHEM, V275, P26172, DOI 10.1074/jbc.M001323200
   Abzhanov A, 2001, DEVELOPMENT, V128, P2803
   Aplin AC, 1997, MECH DEVELOP, V62, P51, DOI 10.1016/S0925-4773(96)00649-1
   Benassayag C, 1997, MECH DEVELOP, V63, P187, DOI 10.1016/S0925-4773(97)00040-3
   Bendall AJ, 1999, DEVELOPMENT, V126, P4965
   BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7
   BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4
   Botas J, 1993, CURR OPIN CELL BIOL, V5, P1015, DOI 10.1016/0955-0674(93)90086-6
   Boube M, 1998, INT J DEV BIOL, V42, P431
   BOURBON HM, 1995, J BIOL CHEM, V270, P11130, DOI 10.1074/jbc.270.19.11130
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483
   Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N
   Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9
   CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8
   CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5
   CRIBBS DL, 1995, EMBO J, V14, P767, DOI 10.1002/j.1460-2075.1995.tb07055.x
   CRIBBS DL, 1992, EMBO J, V11, P1437, DOI 10.1002/j.1460-2075.1992.tb05188.x
   DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555
   Fitzsimmons D, 1996, GENE DEV, V10, P2198, DOI 10.1101/gad.10.17.2198
   FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7
   GAINES P, 1995, BRAZ J MED BIOL RES, V28, P161
   GARCIABELLIDO A, 1977, AM ZOOL, V17, P613
   GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8
   GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.bi.63.070194.002415
   GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463
   Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505
   Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077
   GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433
   HALDER G, 1995, CURR OPIN GENET DEV, V5, P602, DOI 10.1016/0959-437X(95)80029-8
   Halder G, 1998, DEVELOPMENT, V125, P2181
   HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0
   HOGAN BLM, 1988, DEVELOPMENT, V103, P115
   Jiao RJ, 2001, DEVELOPMENT, V128, P3307
   JOHNSON FB, 1995, P NATL ACAD SCI USA, V92, P739, DOI 10.1073/pnas.92.3.739
   Jun S, 1998, P NATL ACAD SCI USA, V95, P13720, DOI 10.1073/pnas.95.23.13720
   Jun S, 1996, DEVELOPMENT, V122, P2639
   JURGENS G, 1993, DEV DROSOPHILA MELAN, P687
   KAPOUN AM, 1995, DEVELOPMENT, V121, P2127
   Kataoka K, 2001, J BIOL CHEM, V276, P819, DOI 10.1074/jbc.M007643200
   KAUFMAN TC, 1978, GENETICS, V90, P579
   Kronhamn J, 2002, DEVELOPMENT, V129, P1015
   Kurusu M, 2000, P NATL ACAD SCI USA, V97, P2140, DOI 10.1073/pnas.040564497
   LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5
   Lewis E. B., 1968, DROS INFORM SERV, V43, P193
   MANAK JR, 1994, DEVELOPMENT, P61
   MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   MIKKOLA II, 2000, J BIOL CHEM, V7, P7
   MORATA G, 1993, CURR OPIN GENET DEV, V3, P606, DOI 10.1016/0959-437X(93)90096-8
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Noveen A, 2000, DEVELOPMENT, V127, P3475
   Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833
   Percival-Smith A, 1997, DEVELOPMENT, V124, P5049
   Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032
   Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802
   Plaza S, 1997, CELL GROWTH DIFFER, V8, P1115
   PULTZ MA, 1988, GENE DEV, V2, P901, DOI 10.1101/gad.2.7.901
   Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   RAUSKOLB C, 1993, CELL, V74, P1101, DOI 10.1016/0092-8674(93)90731-5
   Roch F, 2000, DEVELOPMENT, V127, P97
   SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879
   SEROUDE L, 1994, NUCLEIC ACIDS RES, V22, P4356, DOI 10.1093/nar/22.20.4356
   Smith DP, 1996, CURR OPIN NEUROBIOL, V6, P500, DOI 10.1016/S0959-4388(96)80056-0
   SMOLIKUTLAUT SM, 1990, GENETICS, V124, P357
   STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585
   STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9
   STUART ET, 1994, ANNU REV GENET, V28, P219, DOI 10.1146/annurev.ge.28.120194.001251
   TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6
   VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6
   Zimmerman JE, 2000, GENETICS, V154, P237
NR 72
TC 24
Z9 25
U1 0
U2 3
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD FEB
PY 2003
VL 130
IS 3
BP 575
EP 586
DI 10.1242/dev.00226
PG 12
WC Developmental Biology
SC Developmental Biology
GA 645KX
UT WOS:000180975700014
PM 12490563
OA Bronze
DA 2021-01-25
ER

PT J
AU Hoffmann, R
   Bruno, L
   Seidl, T
   Rolink, A
   Melchers, F
AF Hoffmann, R
   Bruno, L
   Seidl, T
   Rolink, A
   Melchers, F
TI Rules for gene usage inferred from a comparison of large-scale gene
   expression profiles of T and B lymphocyte development
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID BONE-MARROW; CELL DEVELOPMENT; RECEPTOR; REPERTOIRE; SELECTION;
   IMMATURE; ONSET; CHAIN; BETA; TCR
AB Ribonucleic acid expression profiles of seven consecutive stages of mouse thymocyte development were generated on high density oligonucleotide arrays. Previously known expression patterns of several genes were confirmed. Ten percent (1,304 of more than 13,000) of the monitored genes were found with 99% confidence to be differentially expressed across all T cell developmental stages. When compared with 1,204 genes differentially expressed in five consecutive B lineage developmental stages of bone marrow, >40% (546 genes) appeared to be shared by both lineages. However, when four pools of functionally distinct cell stages were compared between B and T cell development, DJ-rearranged precursor cells and resting immature precursor cells before and after surface Ag receptor expression shared less than 10%, mature resting lymphocytes between 15 and 20%, and only cycling precursors responding to precursor lymphocyte receptor deposition shared >50% of these differentially expressed genes. Three general rules emerge from these results: 1) proliferation of cells at comparable stages is in majority executed by the same genes; 2) intracellular signaling and intercellular communication are effected largely by different genes; and 3) most genes are not used strictly at comparable, but rather at several, stages, possibly in different functional contexts.
C1 Max Von Pettenkofer Inst, Dept Bacteriol, D-80336 Munich, Germany.
   Basel Inst Immunol, Basel, Switzerland.
   Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England.
   Univ Basel, Pharmazentrum, Dept Immunol, Basel, Switzerland.
   Univ Basel, Dept Cell Biol, Biozentrum, Basel, Switzerland.
RP Hoffmann, R (corresponding author), Max Von Pettenkofer Inst, Dept Bacteriol, Pettenkoferstr 9A, D-80336 Munich, Germany.
EM R_hoffmann@m3401.mpk.med.uni-muenchen.de
RI Hoffmann, Reinhard/I-8748-2018; Seidl, Thomas/B-5713-2014
OI Hoffmann, Reinhard/0000-0003-1514-1183; Seidl,
   Thomas/0000-0003-0889-7054
CR BENOIST C, 1999, FUNDAMENTAL IMMUNOLO, P183
   Campbell KS, 1999, CURR OPIN IMMUNOL, V11, P256, DOI 10.1016/S0952-7915(99)80042-9
   Dominguez O, 2000, EMBO J, V19, P1731, DOI 10.1093/emboj/19.7.1731
   EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Ghebrehiwet B, 2001, IMMUNOL REV, V180, P65, DOI 10.1034/j.1600-065X.2001.1800106.x
   GODFREY DI, 1994, J IMMUNOL, V152, P4783
   GRAWUNDER U, 1995, IMMUNITY, V3, P601, DOI 10.1016/1074-7613(95)90131-0
   HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0
   Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501
   Hoffmann R, 2002, GENOME BIOL, V3
   Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774
   Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639
   KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0
   Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625
   Lang J, 1997, J EXP MED, V186, P1513, DOI 10.1084/jem.186.9.1513
   Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098
   Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905
   Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675
   Luo L, 1999, NAT MED, V5, P355
   Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806
   Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1034/j.1600-065X.2000.017510.x
   Melchers F., 1999, FUNDAMENTAL IMMUNOLO, p183 ~224
   ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257
   Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23
   Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004
   Sleckman BP, 2000, MOL CELL BIOL, V20, P4405, DOI 10.1128/MCB.20.12.4405-4410.2000
   TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150
   Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907
   tenBoekel E, 1997, IMMUNITY, V7, P357
   von Boehmer H, 1998, IMMUNOL REV, V165, P111
   Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359
   Yu W, 1999, NATURE, V400, P682
NR 33
TC 49
Z9 49
U1 0
U2 2
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD FEB 1
PY 2003
VL 170
IS 3
BP 1339
EP 1353
DI 10.4049/jimmunol.170.3.1339
PG 15
WC Immunology
SC Immunology
GA 639XM
UT WOS:000180655500028
PM 12538694
OA Bronze
DA 2021-01-25
ER

PT J
AU Viollier, PH
   Kelemen, GH
   Dale, GE
   Nguyen, KT
   Buttner, MJ
   Thompson, CJ
AF Viollier, PH
   Kelemen, GH
   Dale, GE
   Nguyen, KT
   Buttner, MJ
   Thompson, CJ
TI Specialized osmotic stress response systems involve multiple SigB-like
   sigma factors in Streptomyces coelicolor
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID BACILLUS-SUBTILIS; RNA-POLYMERASE; ESCHERICHIA-COLI; HEAT-SHOCK;
   MORPHOLOGICAL-DIFFERENTIATION; MULTICELLULAR PROKARYOTE; ANTIBIOTIC
   BIOSYNTHESIS; PROPER DIFFERENTIATION; DEVELOPMENTAL CONTROL; PROMOTER
   RECOGNITION
AB Whereas in Bacillus subtilis, a general stress response stimulon under the control of a single sigma factor (SigB) is induced by different physiological and environmental stresses (heat, salt or ethanol shock), in Streptomyces coelicolor, these environmental stresses induce independent sets of proteins, and its genome encodes nine SigB paralogues. To investigate possible functions of multiple sigB-like genes in S. coelicolor, Pctc, a promoter routinely used to assay SigB activity in vivo, was analysed as a heterologous reporter. The fact that Pctc was activated by osmotic shock, but not by heat or ethanol, confirmed that stress response system(s) could operate independently in S. coelicolor. Pctc was also induced transiently during growth of liquid cultures, presumably by nutritional signals. We purified an RNA polymerase holoenzyme from crude extracts that catalysed specific transcription of Pctc in vitro. Its sigma subunit was identified as a product of the sigH gene, which is co-transcribed downstream of a putative antisigma factor gene (prsH). Although the sigH function was not needed for normal colony morphology, prsH was conditionally required for both aerial hyphae formation and regulation of antibiotic biosynthesis. Levels of two different sigH-encoded proteins were growth phase dependent but not significantly changed by osmotic stress, implying the important roles of post-translational regulatory elements such as PrsH. In addition, synthesis of three other SigH-like proteins was induced by osmotic stress, but not by ethanol or heat. Two of them were genetically assigned to sigH homologous loci sigI and sigJ and shown to be independently regulated. This family of SigH-like proteins displayed different osmotic response kinetics. Thus, in contrast to many other bacteria, S. coelicolor uses an osmotic sensory system that can co-ordinate the activity of multiple paralogues to control the relative activity of promoters within the same stress stimulon. Such specialized stress response systems may reflect adaptive functions needed for colonial differentiation.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England.
RP Thompson, CJ (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Kelemen, Gabriella/G-8486-2011; Nguyen, Kien/F-9234-2019
OI Buttner, Mark/0000-0002-3505-2981; Nguyen, Kien/0000-0003-2685-3928;
   Viollier, Patrick/0000-0002-5249-9910
CR ALTENBUCHNER J, 1992, METHOD ENZYMOL, V216, P457
   ANGELL S, 1994, MOL GEN GENET, V244, P135, DOI 10.1007/BF00283514
   Babcock MJ, 1997, GENE, V196, P31, DOI 10.1016/S0378-1119(97)00179-0
   BENSON AK, 1993, P NATL ACAD SCI USA, V90, P2330, DOI 10.1073/pnas.90.6.2330
   BENSON AK, 1993, J BACTERIOL, V175, P1929, DOI 10.1128/JB.175.7.1929-1935.1993
   BENSON AK, 1993, J BACTERIOL, V175, P2347, DOI 10.1128/JB.175.8.2347-2356.1993
   Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a
   Bianchi AA, 1999, MOL MICROBIOL, V34, P1029, DOI 10.1046/j.1365-2958.1999.01664.x
   BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2
   BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0
   BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993
   BROWN KL, 1992, MOL MICROBIOL, V6, P1133, DOI 10.1111/j.1365-2958.1992.tb01551.x
   BRUTON CJ, 1995, MOL MICROBIOL, V18, P89, DOI 10.1111/j.1365-2958.1995.mmi_18010089.x
   BUTTNER MJ, 1988, CELL, V52, P599, DOI 10.1016/0092-8674(88)90472-2
   BUTTNER MJ, 1985, J MOL BIOL, V185, P177, DOI 10.1016/0022-2836(85)90189-5
   Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3
   CHATER KF, 1982, GENE, V19, P21, DOI 10.1016/0378-1119(82)90185-8
   Chater KF, 1998, MICROBIOL-UK, V144, P1465, DOI 10.1099/00221287-144-6-1465
   Cho EJ, 1996, NUCLEIC ACIDS RES, V24, P4565, DOI 10.1093/nar/24.22.4565
   Cho YH, 2000, MOL MICROBIOL, V35, P150, DOI 10.1046/j.1365-2958.2000.01685.x
   Cho YH, 2001, MOL MICROBIOL, V42, P205, DOI 10.1046/j.1365-2958.2001.02622.x
   DOULL JL, 1989, FEMS MICROBIOL LETT, V65, P265
   Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1016/S0378-1097(97)00392-3
   Folcher M, 2001, J BIOL CHEM, V276, P1479, DOI 10.1074/jbc.M007690200
   Gehring AM, 2001, J BACTERIOL, V183, P5991, DOI 10.1128/JB.183.20.5991-5996.2001
   GRANOZZI C, 1990, J GEN MICROBIOL, V136, P713, DOI 10.1099/00221287-136-4-713
   GROSS CA, 1996, ESCHERICHIA COLI SAL, V1, P1382
   HALDENWANG WG, 1995, MICROBIOL REV, V59, P1
   Hecker M, 1998, MOL MICROBIOL, V29, P1129, DOI 10.1046/j.1365-2958.1998.00977.x
   Hecker M, 1996, MOL MICROBIOL, V19, P417, DOI 10.1046/j.1365-2958.1996.396932.x
   Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002
   Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5
   HILLEMANN D, 1991, NUCLEIC ACIDS RES, V19, P727, DOI 10.1093/nar/19.4.727
   HOBBS G, 1992, J BACTERIOL, V174, P1487, DOI 10.1128/jb.174.5.1487-1494.1992
   Huang XJ, 1998, J BACTERIOL, V180, P3765, DOI 10.1128/JB.180.15.3765-3770.1998
   IGO MM, 1986, J MOL BIOL, V191, P615, DOI 10.1016/0022-2836(86)90449-3
   IKEDA H, 1984, MOL GEN GENET, V196, P501, DOI 10.1007/BF00436199
   INGRAM C, 1989, J BACTERIOL, V171, P6617, DOI 10.1128/jb.171.12.6617-6624.1989
   Kang CM, 1998, MOL MICROBIOL, V30, P189, DOI 10.1046/j.1365-2958.1998.01052.x
   KELEMEN GH, 1995, MOL MICROBIOL, V17, P221, DOI 10.1111/j.1365-2958.1995.mmi_17020221.x
   Kelemen GH, 1998, J BACTERIOL, V180, P2515, DOI 10.1128/JB.180.9.2515-2521.1998
   Kelemen GH, 1996, MOL MICROBIOL, V21, P593, DOI 10.1111/j.1365-2958.1996.tb02567.x
   Kelemen GH, 2001, MOL MICROBIOL, V40, P804, DOI 10.1046/j.1365-2958.2001.02417.x
   Kieser T., 2000, PRACTICAL STREPTOMYC
   Kormanec J, 1999, FEMS MICROBIOL LETT, V172, P153, DOI 10.1111/j.1574-6968.1999.tb13463.x
   Kormanec J, 2000, FEMS MICROBIOL LETT, V189, P31, DOI 10.1111/j.1574-6968.2000.tb09202.x
   Martin MC, 1997, J BACTERIOL, V179, P7784, DOI 10.1128/jb.179.24.7784-7789.1997
   MAZODIER P, 1989, J BACTERIOL, V171, P3583, DOI 10.1128/jb.171.6.3583-3585.1989
   MCBRIDE MJ, 1987, J BACTERIOL, V169, P5002, DOI 10.1128/jb.169.11.5002-5007.1987
   Muffler A, 1997, J BACTERIOL, V179, P445
   Nguyen KT, 2002, MOL MICROBIOL, V46, P1223, DOI 10.1046/j.1365-2958.2002.03255.x
   Paget MSB, 2001, MOL MICROBIOL, V39, P1036, DOI 10.1046/j.1365-2958.2001.02298.x
   Petersohn A, 1999, J BACTERIOL, V181, P5718, DOI 10.1128/JB.181.18.5718-5724.1999
   POTUCKOVA L, 1995, MOL MICROBIOL, V17, P37, DOI 10.1111/j.1365-2958.1995.mmi_17010037.x
   Price CW, 2000, BACTERIAL STRESS RESPONSES, P179
   PUGLIA AM, 1995, MOL MICROBIOL, V17, P737, DOI 10.1111/j.1365-2958.1995.mmi_17040737.x
   RAY C, 1985, J BACTERIOL, V163, P610, DOI 10.1128/JB.163.2.610-614.1985
   Sambrook J, 1989, MOL CLONING LAB MANU
   Servant P, 2001, ARCH MICROBIOL, V176, P237, DOI 10.1007/s002030100321
   Sevcikova B, 2002, FEMS MICROBIOL LETT, V209, P229, DOI 10.1111/j.1574-6968.2002.tb11136.x
   Sevcikova B, 2001, ARCH MICROBIOL, V177, P98, DOI 10.1007/s00203-001-0367-1
   SUN DX, 1991, J BACTERIOL, V173, P3831, DOI 10.1128/JB.173.12.3831-3845.1991
   SUN DX, 1989, GENE DEV, V3, P141, DOI 10.1101/gad.3.2.141
   Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x
   TATTI KM, 1984, J MOL BIOL, V175, P285, DOI 10.1016/0022-2836(84)90349-8
   THOMPSON CJ, 1982, J BACTERIOL, V151, P668, DOI 10.1128/JB.151.2.668-677.1982
   VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I
   Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x
   Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001
   VIOLLIER PH, 2003, IN PRESS J MOL BIOL
   Vohradsky J, 2000, J BACTERIOL, V182, P4979, DOI 10.1128/JB.182.17.4979-4986.2000
   VOLKER U, 1994, MICROBIOL-UK, V140, P741, DOI 10.1099/00221287-140-4-741
   WESTPHELING J, 1985, NATURE, V313, P22, DOI 10.1038/313022a0
NR 73
TC 62
Z9 64
U1 0
U2 6
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD FEB
PY 2003
VL 47
IS 3
BP 699
EP 714
DI 10.1046/j.1365-2958.2003.03302.x
PG 16
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 641ZJ
UT WOS:000180776700008
PM 12535070
OA Bronze
DA 2021-01-25
ER

PT J
AU Jacinto, E
   Hall, MN
AF Jacinto, E
   Hall, MN
TI TOR signalling in bugs, brain and brawn
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID P70 S6 KINASE; PROTEIN PHOSPHATASE 2A; SKELETAL-MUSCLE HYPERTROPHY;
   RTG-DEPENDENT MITOCHONDRIA; MAMMALIAN-CELL SIZE; AMINO-ACID; TRANSLATION
   INITIATION; CATALYTIC SUBUNIT; PHOSPHOINOSITIDE 3-KINASE; DROSOPHILA
   HOMOLOG
AB TOR-a highly conserved atypical protein kinase and the 'target of rapamycin', an immunosuppressant and anti-cancer drug-controls cell growth. TOR controls the growth of proliferating yeast, fly and mammalian cells in response to nutrients. Recent findings, however, indicate that TOR also controls the growth of non-proliferating cells, such as neurons and muscle cells. Furthermore, TOR, by associating with regulatory proteins and inhibiting phosphatases, controls the activity of multiphosphorylated effectors.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
OI Jacinto, Estela/0000-0001-7118-1759; Hall, Michael N/0000-0002-2998-0757
CR Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999
   Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7
   Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5
   ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115
   Anthony JC, 2000, J NUTR, V130, P2413
   Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120
   Backman SA, 2002, CURR OPIN NEUROBIOL, V12, P516, DOI 10.1016/S0959-4388(02)00354-9
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320
   Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225
   Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014
   Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99
   Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0
   CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574
   Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g
   Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2
   Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599
   Cruz MC, 1999, MOL CELL BIOL, V19, P4101
   Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518
   DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904
   Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2
   Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584
   Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015
   Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802
   Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244
   Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847
   Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201
   Gingras AC, 2001, GENE DEV, V15, P2852
   Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244
   Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7
   Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   Hengstschlager M, 2001, ARCH DERMATOL RES, V293, P383, DOI 10.1007/s004030100250
   Huang Shile, 2002, Curr Opin Investig Drugs, V3, P295
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546
   Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507
   Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020
   KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50
   Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x
   Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698
   Liu ZC, 2001, EMBO J, V20, P7209, DOI 10.1093/emboj/20.24.7209
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6
   Luke MM, 1996, MOL CELL BIOL, V16, P2744
   Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9
   Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5
   Marx SO, 2001, CIRCULATION, V104, P852, DOI 10.1161/01.CIR.104.8.852
   McDaniel ML, 2002, DIABETES, V51, P2877, DOI 10.2337/diabetes.51.10.2877
   Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899
   Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571
   Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126
   Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624
   Musaro A, 1999, NATURE, V400, P581
   Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427
   Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700
   Olson EN, 2000, CELL, V101, P689, DOI 10.1016/S0092-8674(00)80880-6
   Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599
   Pende M, 2000, NATURE, V408, P994
   Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438
   Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098
   Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6
   Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707
   Raymond CR, 2002, NEUROSCIENCE, V109, P531, DOI 10.1016/S0306-4522(01)00500-0
   Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200
   Rintelen F, 2001, P NATL ACAD SCI USA, V98, P15020, DOI 10.1073/pnas.011318098
   Roberg KJ, 1997, GENETICS, V147, P1569
   Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9
   Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473
   Sekulic A, 2000, CANCER RES, V60, P3504
   Semsarian C, 1999, NATURE, V400, P576
   Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6
   Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058
   Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002
   SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133
   Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200
   Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299
   Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4
   Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899
   Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762
   Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293
   Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026
   Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261
   Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200
   Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
   Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000
NR 117
TC 466
Z9 492
U1 1
U2 27
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1471-0072
EI 1471-0080
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD FEB
PY 2003
VL 4
IS 2
BP 117
EP 126
DI 10.1038/nrm1018
PG 10
WC Cell Biology
SC Cell Biology
GA 642KG
UT WOS:000180802200014
PM 12563289
DA 2021-01-25
ER

PT J
AU Viollier, PH
   Weihofen, A
   Folcher, M
   Thompson, CJ
AF Viollier, PH
   Weihofen, A
   Folcher, M
   Thompson, CJ
TI Post-transcriptional regulation of the Streptomyces coelicolor stress
   responsive sigma factor, SigH, involves translational control,
   proteolytic processing, and an anti-sigma factor homolog
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE stress; regulation; translation; development; SigH
ID ANTISIGMA FACTOR SPOIIAB; BACILLUS-SUBTILIS; ESCHERICHIA-COLI;
   RNA-POLYMERASE; ANTIBIOTIC BIOSYNTHESIS; CONJUGAL TRANSFER; CLONING
   VECTORS; GENE-EXPRESSION; A3(2); DIFFERENTIATION
AB The sigH gene encodes a sigma factor whose transcription is controlled by stress regulatory systems and the developmental program in Streptomyces coelicolor. Here, we describe developmentally regulated post-transcriptional control systems for SigH. sigH is expressed as three primary translation products, SigH-sigma(37), SigH-sigma(51), and SigH-sigma(52). In vitro, SigH-sigma(52) was comparable to SigH-sigma(37) in its ability to associate with RNA polymerase core enzyme and specifically initiate transcription in vitro. While SigH-sigma(51/52) were the primary gene products observed throughout early phases of growth, their abundance decreased during later stages in liquid or solid phase cultures while levels of shorter, C-terminally encoded products increased. These included SigH-sigma(37), a product of the downstream translational initiation site, as well as two proteolytic derivatives of SigH-sigma(51/52) (34 kDa and 38 kDa). Accumulation of SigH-sigma(37) and processing of SigH-sigma(51/52) into these stable 34 kDa and 38 kDa derivatives correlated with morphological changes on solid medium and physiological maturation in liquid medium. SigH-sigma(51/52) processing did not occur on medium non-permissive for aerial mycelium formation or in one particular developmental mutant (brgA). The proteolytic activity could be detected in vitro using crude extracts of stationary phase cultures, but was absent from exponential phase cultures. prsH, the gene upstream of sigH having sequence similarity to known anti-sigma factors, 51 was able to bind to, and thus presumably inactivate SigH-sigma(52), SigH-sigma(51), and SigH-sigma(37). We have shown elsewhere that prsH was conditionally required for colonial development. Thus, while at least one transcriptional regulator is known to bring about the accumulation of sigH mRNA at different times and different locations in colonies, the post-transcriptional processes described here regulate the activity of different SigH isoforms and program their temporal accumulation pattern, i.e. the elimination of SigH-sigma(51/52) and accumulation of SigH-sigma(37)-like proteins, as a function of development. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
   Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.
   ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland.
RP Thompson, CJ (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Weihofen, Andreas/A-1566-2011
OI Weihofen, Andreas/0000-0001-6265-9087; Viollier,
   Patrick/0000-0002-5249-9910
CR Babcock MJ, 1997, GENE, V196, P31, DOI 10.1016/S0378-1119(97)00179-0
   Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439
   BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2
   BUTTNER MJ, 1988, CELL, V52, P599, DOI 10.1016/0092-8674(88)90472-2
   Campbell EA, 2000, J MOL BIOL, V300, P17, DOI 10.1006/jmbi.2000.3838
   Chater KF, 2000, PROKARYOTIC DEVELOPMENT, P33
   Chater KF, 1998, MICROBIOL-UK, V144, P1465, DOI 10.1099/00221287-144-6-1465
   Decatur AL, 1996, GENE DEV, V10, P2348, DOI 10.1101/gad.10.18.2348
   Errington J, 1996, TRENDS GENET, V12, P31, DOI 10.1016/0168-9525(96)81386-2
   Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1016/S0378-1097(97)00392-3
   Gaidenko TA, 1998, J BACTERIOL, V180, P3730, DOI 10.1128/JB.180.14.3730-3733.1998
   Garsin DA, 1998, J MOL BIOL, V284, P557, DOI 10.1006/jmbi.1998.2201
   GRANOZZI C, 1990, J GEN MICROBIOL, V136, P713, DOI 10.1099/00221287-136-4-713
   HALDENWANG WG, 1995, MICROBIOL REV, V59, P1
   Hecker M, 1998, MOL MICROBIOL, V29, P1129, DOI 10.1046/j.1365-2958.1998.00977.x
   Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5
   Hopwood D.A., 1985, GENETIC MANIPULATION
   HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4
   Johnson BD, 1997, J BIOL CHEM, V272, P31029, DOI 10.1074/jbc.272.49.31029
   Kelemen GH, 2001, MOL MICROBIOL, V40, P804, DOI 10.1046/j.1365-2958.2001.02417.x
   Kellner EM, 1996, MOL MICROBIOL, V21, P913, DOI 10.1046/j.1365-2958.1996.461408.x
   Kormanec J, 2000, FEMS MICROBIOL LETT, V189, P31, DOI 10.1111/j.1574-6968.2000.tb09202.x
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   LYDIATE DJ, 1985, GENE, V35, P223, DOI 10.1016/0378-1119(85)90001-0
   MAZODIER P, 1989, J BACTERIOL, V171, P3583, DOI 10.1128/jb.171.6.3583-3585.1989
   Muffler A, 1996, EMBO J, V15, P1333, DOI 10.1002/j.1460-2075.1996.tb00475.x
   Price CW, 2000, BACTERIAL STRESS RESPONSES, P179
   Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765
   Sambrook J, 1989, MOL CLONING LAB MANU
   Shima J, 1996, J BACTERIOL, V178, P3785, DOI 10.1128/jb.178.13.3785-3790.1996
   SMOKVINA T, 1990, GENE, V94, P53, DOI 10.1016/0378-1119(90)90467-6
   STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2
   STRAGIER P, 1996, ANNU REV GENET, V30, P241
   Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x
   THOMPSON CJ, 1980, NATURE, V286, P525, DOI 10.1038/286525a0
   Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001
   VIOLLIER PH, 2003, IN PRESS MOL MICROBI
   Vohradsky J, 2000, J BACTERIOL, V182, P4979, DOI 10.1128/JB.182.17.4979-4986.2000
   WESTPHELING J, 1985, NATURE, V313, P22, DOI 10.1038/313022a0
   WRIGHT F, 1992, GENE, V113, P55, DOI 10.1016/0378-1119(92)90669-G
   Zhang B, 1998, J BACTERIOL, V180, P2434, DOI 10.1128/JB.180.9.2434-2441.1998
NR 41
TC 32
Z9 32
U1 0
U2 1
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 24
PY 2003
VL 325
IS 4
BP 637
EP 649
DI 10.1016/S0022-2836(02)01280-9
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 638AA
UT WOS:000180544800004
PM 12507469
DA 2021-01-25
ER

PT J
AU Ahrens, T
   Lambert, M
   Pertz, O
   Sasak, T
   Schulthess, T
   Mege, RM
   Timpl, R
   Engel, J
AF Ahrens, T
   Lambert, M
   Pertz, O
   Sasak, T
   Schulthess, T
   Mege, RM
   Timpl, R
   Engel, J
TI Homoassociation of VE-cadherin follows a mechanism common to "classical"
   cadherins
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE VE-cadherin; N-cadherin; oligomerization domains; homoassociation; cell
   adhesion
ID VASCULAR ENDOTHELIAL-CADHERIN; IN-VIVO; EXTRACELLULAR-MATRIX;
   CALCIUM-BINDING; CELL-ADHESION; LEUKOCYTE TRANSMIGRATION;
   MEMBRANE-PROTEIN; STRUCTURAL BASIS; BETA-CATENIN; N-CADHERIN
AB Vascular endothelial cadherin (VE-cadherin/cadherin5) is specifically expressed in adherens junctions of endothelial cells and exerts important functions in cell-cell adhesion as well as signal transduction. To analyze the mechanism of VE-cadherin homoassociation, the ectodomains CAD1-5 were connected by linker sequences to the N terminus of the coiled-coil domain of cartilage matrix protein (CMP). The chimera VECADCMP were expressed in mammalian cells. The trimeric coiled-coil domain leads to high intrinsic domain concentrations and multivalency promoting self-association. Ca"-dependent homophilic association of VECADCMP was detected in solid phase assays and crosslinking experiments. A striking analogy to homoassociation of type 1 ("classical") cadherins like E, N or P-cadherin was observed when interactions in VECADCMP and between these trimeric proteins were analyzed by electron microscopy. Ca2+-dependent ring-like and double ring-like arrangements suggest interactions between domains 1 and 2 of the ectodomains, which may be correlated with lateral and adhesive contacts in the adhesion process. Association to complexes composed of two VECADCMP molecules was also demonstrated by chemical cross-linking. No indication for an antiparallel association of VECAD ectodomains to hexameric complexes as proposed by Legrand et al. was found. Instead the data suggest that homoassociation of VE-cadherin follows the conserved mechanism of type I cadherins. (C) 2003 Elsevier Science Ltd. All rights reserved
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Paris 06, INSERM, Inst Fer Moulin, U440, F-75005 Paris, France.
   Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.
   Max Planck Inst Biochem, D-82152 Martinsried, Germany.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Mege, Rene Marc/M-9569-2013
OI Mege, Rene-Marc/0000-0001-8128-5543; pertz, olivier/0000-0001-8579-4919
CR Ahrens T, 2002, J BIOL CHEM, V277, P19455, DOI 10.1074/jbc.M200606200
   Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697
   Bibert S, 2002, J BIOL CHEM, V277, P12790, DOI 10.1074/jbc.M111597200
   Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559
   Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783
   Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630
   BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229
   Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487
   Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7
   Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143
   Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815
   Corps E, 2001, J BIOL CHEM, V276, P30862, DOI 10.1074/jbc.M101712200
   Dames SA, 1998, NAT STRUCT BIOL, V5, P687, DOI 10.1038/1382
   Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7
   Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308
   ENGEL J, 1994, METHOD ENZYMOL, V245, P469
   Frank S, 2002, J BIOL CHEM, V277, P19071, DOI 10.1074/jbc.M202146200
   FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777
   Gotsch U, 1997, J CELL SCI, V110, P583
   Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3
   Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798
   Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589
   KISS I, 1989, J BIOL CHEM, V264, P8126
   Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624
   Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   Lambert M, 2000, J CELL SCI, V113, P2207
   LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511
   LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203
   Leckband D, 2000, CURR OPIN CELL BIOL, V12, P587, DOI 10.1016/S0955-0674(00)00136-8
   Legrand P, 2001, J BIOL CHEM, V276, P3581, DOI 10.1074/jbc.M002667200
   Matsuyoshi N, 1997, P ASSOC AM PHYSICIAN, V109, P362
   Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0
   Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777
   Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605
   Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738
   POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x
   SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6
   Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579
   SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0
   Shaw SK, 2001, J IMMUNOL, V167, P2323, DOI 10.4049/jimmunol.167.4.2323
   Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159
   Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820
   SUZUKI S, 1991, CELL REGUL, V2, P261
   Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542
   Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1
   Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x
   van Buul JD, 2002, J IMMUNOL, V168, P588, DOI 10.4049/jimmunol.168.2.588
   Vittet D, 1997, P NATL ACAD SCI USA, V94, P6273, DOI 10.1073/pnas.94.12.6273
   Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8
   Yagi T, 2000, GENE DEV, V14, P1169
   Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0
NR 52
TC 25
Z9 25
U1 0
U2 1
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 24
PY 2003
VL 325
IS 4
BP 733
EP 742
DI 10.1016/S0022-2836(02)01286-X
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 638AA
UT WOS:000180544800011
PM 12507476
DA 2021-01-25
ER

PT J
AU Karabinos, A
   Schunemann, J
   Meyer, M
   Aebi, U
   Weber, K
AF Karabinos, A
   Schunemann, J
   Meyer, M
   Aebi, U
   Weber, K
TI The single nuclear lamin of Caenorhabditis elegans forms in vitro stable
   intermediate filaments and paracrystals with a reduced axial periodicity
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE Ciona intestinalis; Caenorhabditis elegans; intermediate filament;
   lamin; paracrystals
ID CEPHALOCHORDATE BRANCHIOSTOMA; KERATIN FILAMENTS; COILED-COIL; TAIL
   DOMAIN; PROTEINS; EXPRESSION; GENE; INVITRO; ORGANIZATION; COMPLEXES
AB The lamins of the tunicate Ciona intestinalis and the nematode Caenorhabditis elegans show unusual sequence features when compared to the more than 35 metazoan lamin sequences currently known. We therefore analyzed the in vitro assembly of these two lamins by electron microscopy using chicken lamin B2 as a control. While lamin dimers usually appear as a rod carrying two globules at one end, these globules are absent from Ciona lamin, which lacks the central 105-residue region of the tail domain. The deletion of 14 residues or two heptads from the coiled coil rod domain of the single C. elegans lamin results in a 1.5-nm shortening of the dimer rod. Similarly, the paracrystals assembled from the C. elegans lamin exhibit a 3.1-nm reduction of the true axial repeat compared to that of chicken lamin B2 paracrystals. We speculate that the banding pattern in the C. elegans lamin paracrystals arises from a relative stagger between dimers and/or a positioning of the globular tail domain relative to the central rod that is distinct from that observed in chicken lamin B2 paracrystals. Here we show that a nuclear lamin can assemble in vitro into 10-nm intermediate filaments (IFs). C. elegans lamin in low ionic strength Tris-buffers at a pH of 7.2-7.4 provides a stable population of lamin IFs. Some implications of this filament formation are discussed. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Max Planck Inst Biophys Chem, Dept Biochem, D-37077 Gottingen, Germany.
   Univ Basel, Biozentrum, M E Muller Inst Microscopy, CH-4056 Basel, Switzerland.
RP Weber, K (corresponding author), Max Planck Inst Biophys Chem, Dept Biochem, Fassberg 11, D-37077 Gottingen, Germany.
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   Erber A, 1999, J MOL EVOL, V49, P260, DOI 10.1007/PL00006548
   FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450
   FOWLER WE, 1983, J ULTRA MOL STRUCT R, V83, P319, DOI 10.1016/S0022-5320(83)90139-9
   FRANKE WW, 1982, BIOL CELL, V46, P257
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x
   GRUENBAUM Y, 1988, J CELL BIOL, V106, P585, DOI 10.1083/jcb.106.3.585
   HANER M, 1997, CELL BIOL LAB HDB, V3, P292
   HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199
   HEITLINGER E, 1992, J STRUCT BIOL, V108, P74, DOI 10.1016/1047-8477(92)90009-Y
   Heitor M. V., 1991, Industrial Metrology, V2, P1
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Hutchison CJ, 2001, J CELL SCI, V114, P9
   Karabinos A, 1998, FEBS LETT, V437, P15, DOI 10.1016/S0014-5793(98)01190-9
   Karabinos A, 2000, EUR J CELL BIOL, V79, P17, DOI 10.1078/S0171-9335(04)70003-5
   Klapper M, 1997, J CELL SCI, V110, P2519
   Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3
   Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937
   MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0
   MOIR RD, 1990, FEBS LETT, V268, P301, DOI 10.1016/0014-5793(90)81032-J
   MOIR RD, 1991, J CELL SCI, V99, P363
   Parry DAD, 1995, INTERMEDIATE FILAMEN
   Riemer D, 2000, GENE, V255, P317, DOI 10.1016/S0378-1119(00)00323-1
   RIEMER D, 1993, EUR J CELL BIOL, V62, P214
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sasse B, 1997, EUR J BIOCHEM, V250, P30, DOI 10.1111/j.1432-1033.1997.t01-1-00030.x
   Sasse B, 1998, J STRUCT BIOL, V123, P56, DOI 10.1006/jsbi.1998.4006
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   VORBURGER K, 1989, J MOL BIOL, V208, P405, DOI 10.1016/0022-2836(89)90505-6
   Wang J, 2000, EUR J CELL BIOL, V79, P478, DOI 10.1078/0171-9335-00069
NR 34
TC 61
Z9 63
U1 0
U2 2
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 10
PY 2003
VL 325
IS 2
BP 241
EP 247
DI 10.1016/S0022-2836(02)01240-8
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 637MB
UT WOS:000180514700001
PM 12488092
OA Green Published
DA 2021-01-25
ER

PT J
AU Sanchez, IE
   Kiefhaber, T
AF Sanchez, IE
   Kiefhaber, T
TI Evidence for sequential barriers and obligatory intermediates in
   apparent two-state protein folding
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; folding pathways; transition state; non-linear free
   energy relationships; chevron plots
ID TRANSITION-STATE; ENERGY LANDSCAPE; ALPHA-CHYMOTRYPSIN; 3-STATE MODEL;
   BETA-SHEET; KINETICS; DOMAIN; STABILITY; EXTRAPOLATION; RIBONUCLEASE
AB Many small proteins fold fast and without detectable intermediates. This is frequently taken as evidence against the importance of partially folded states, which often transiently accumulate during folding of larger proteins. To get insight into the properties of free energy barriers in protein folding we analyzed experimental data from 23 proteins that were reported to show non-linear activation free-energy relationships. These non-linearities are generally interpreted in terms of broad transition barrier regions with a large number of energetically similar states. Our results argue against the presence of a single broad barrier region. They rather indicate that the non-linearities are caused by sequential folding pathways with consecutive distinct barriers and a few obligatory high-energy intermediates. In contrast to a broad barrier model the sequential model gives a consistent picture of the folding barriers for different variants of the same protein and when folding of a single protein is analyzed under different solvent conditions. The sequential model is also able to explain changes from linear to non-linear free energy relationships and from apparent two-state folding to folding through populated intermediates upon single point mutations or changes in the experimental conditions. These results suggest that the apparent discrepancy between two-state and multi-state folding originates in the relative stability of the intermediates, which argues for the importance of partially folded states in protein folding. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010; Sanchez, Ignacio/A-5658-2009
OI Sanchez, Ignacio Enrique/0000-0003-4284-9013
CR ABKEVICH VI, 1994, J CHEM PHYS, V101, P6052, DOI 10.1063/1.467320
   Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   Burton RE, 1997, NAT STRUCT BIOL, V4, P305, DOI 10.1038/nsb0497-305
   Chiti F, 1999, NAT STRUCT BIOL, V6, P380
   Chu RA, 2002, J MOL BIOL, V315, P759, DOI 10.1006/jmbi.2001.5240
   Clarke J, 1997, J MOL BIOL, V270, P771, DOI 10.1006/jmbi.1997.1147
   Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548
   Ferguson N, 2001, J MOL BIOL, V307, P393, DOI 10.1006/jmbi.2000.4492
   Fersht AR, 2000, P NATL ACAD SCI USA, V97, P14121, DOI 10.1073/pnas.260502597
   Garcia-Mira MM, 2001, BIOPHYS J, V81, P3489, DOI 10.1016/S0006-3495(01)75980-2
   GORSKI SA, 1908, J MOL BIOL, P849
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027
   Houliston RS, 2002, BIOCHEMISTRY-US, V41, P1182, DOI 10.1021/bi0115838
   IKAI A, 1973, J MOL BIOL, V73, P145, DOI 10.1016/0022-2836(73)90320-3
   Isaacson RL, 1999, P NATL ACAD SCI USA, V96, P11247, DOI 10.1073/pnas.96.20.11247
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010
   Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873
   JENCKS WP, 1980, ACCOUNTS CHEM RES, V13, P161, DOI 10.1021/ar50150a001
   Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193
   Kiefhaber T, 1997, BIOCHEMISTRY-US, V36, P5108, DOI 10.1021/bi9702391
   KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8
   KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631
   Laurents DV, 2000, BIOCHEMISTRY-US, V39, P13963, DOI 10.1021/bi001388d
   LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340
   Main ERG, 1999, J MOL BIOL, V291, P429, DOI 10.1006/jmbi.1999.2941
   MATOUSCHEK A, 1995, BIOCHEMISTRY-US, V34, P13656, DOI 10.1021/bi00041a047
   MATOUSCHEK A, 1994, PROTEIN ENG, V7, P1089, DOI 10.1093/protein/7.9.1089
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Oliveberg M, 1998, J MOL BIOL, V277, P933, DOI 10.1006/jmbi.1997.1612
   Otzen DE, 2002, J MOL BIOL, V317, P613, DOI 10.1006/jmbi.2002.5423
   Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j
   Park SH, 1999, NAT STRUCT BIOL, V6, P943, DOI 10.1038/13311
   Perl D, 2002, BIOPHYS CHEM, V96, P173, DOI 10.1016/S0301-4622(02)00024-8
   Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229
   PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5
   Portman JJ, 1998, PHYS REV LETT, V81, P5237, DOI 10.1103/PhysRevLett.81.5237
   Prieto J, 1997, J MOL BIOL, V268, P760, DOI 10.1006/jmbi.1997.0984
   Rodriguez HM, 2000, PROTEIN SCI, V9, P1993, DOI 10.1110/ps.9.10.1993
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260
   Silow M, 1997, BIOCHEMISTRY-US, V36, P7633, DOI 10.1021/bi970210x
   STANIFORTH RA, 1993, BIOCHEMISTRY-US, V32, P3842, DOI 10.1021/bi00066a003
   Taddei N, 1999, BIOCHEMISTRY-US, V38, P2135, DOI 10.1021/bi9822630
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   Tang KS, 1999, J MOL BIOL, V285, P1869, DOI 10.1006/jmbi.1998.2420
   Tsai J, 1997, PROTEIN SCI, V6, P2606
   TSONG TY, 1972, J MOL BIOL, V63, P453, DOI 10.1016/0022-2836(72)90440-8
   Wagner C, 1999, P NATL ACAD SCI USA, V96, P6716, DOI 10.1073/pnas.96.12.6716
   Wallenhorst WF, 1997, BIOCHEMISTRY-US, V36, P5795, DOI 10.1021/bi9700476
   Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030
   WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447
NR 53
TC 214
Z9 215
U1 0
U2 17
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 10
PY 2003
VL 325
IS 2
BP 367
EP 376
DI 10.1016/S0022-2836(02)01230-5
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 637MB
UT WOS:000180514700010
PM 12488101
DA 2021-01-25
ER

PT J
AU Fotiadis, D
   Liang, Y
   Filipek, S
   Saperstein, DA
   Engel, A
   Palczewski, K
AF Fotiadis, D
   Liang, Y
   Filipek, S
   Saperstein, DA
   Engel, A
   Palczewski, K
TI Atomic-force microscopy: Rhodopsin dimers in native disc membranes
SO NATURE
LA English
DT Article
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.
   Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem, Seattle, WA 98195 USA.
RP Fotiadis, D (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
EM palczews@u.washington.edu
RI Filipek, Slawomir/A-2985-2008
OI Filipek, Slawomir/0000-0003-3147-3858
CR Dean MK, 2001, J MED CHEM, V44, P4595, DOI 10.1021/jm010290+
   McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7
   Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Papermaster DS, 2002, INVEST OPHTH VIS SCI, V43, P1300
   Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7
NR 6
TC 593
Z9 610
U1 3
U2 69
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JAN 9
PY 2003
VL 421
IS 6919
BP 127
EP 128
DI 10.1038/421127a
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 633DR
UT WOS:000180267200027
PM 12520290
DA 2021-01-25
ER

PT J
AU Meier, S
   Haussinger, D
   Jensen, P
   Rogowski, M
   Grzesiek, S
AF Meier, S
   Haussinger, D
   Jensen, P
   Rogowski, M
   Grzesiek, S
TI High-accuracy residual H-1(N)-C-13 and H-1(N)-H-1(N) dipolar couplings
   in perdeuterated proteins
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID 2D
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RI Jensen, Pernille Rose/J-8648-2016; Haussinger, Daniel/C-6617-2016;
   Meier, Sebastian/A-4279-2015
OI Jensen, Pernille Rose/0000-0003-4359-848X; Haussinger,
   Daniel/0000-0002-4798-0072; Meier, Sebastian/0000-0003-3761-3217;
   Grzesiek, Stephan/0000-0003-1998-4225
CR DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416
   LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022
   Tian F, 2000, J BIOMOL NMR, V18, P23, DOI 10.1023/A:1008384904380
   Tolman JR, 2001, CURR OPIN STRUC BIOL, V11, P532, DOI 10.1016/S0959-440X(00)00245-1
   TORCHIA DA, 1988, J AM CHEM SOC, V110, P2320, DOI 10.1021/ja00215a063
   Wu ZR, 2002, J AM CHEM SOC, V124, P9672, DOI 10.1021/ja026845n
   Yang DW, 1999, J BIOMOL NMR, V14, P333, DOI 10.1023/A:1008314803561
   ZHU G, 1993, J MAGN RESON SER A, V104, P353, DOI 10.1006/jmra.1993.1235
NR 10
TC 32
Z9 34
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JAN 8
PY 2003
VL 125
IS 1
BP 44
EP 45
DI 10.1021/ja028740q
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 632MQ
UT WOS:000180227400019
PM 12515503
DA 2021-01-25
ER

PT J
AU Markovic-Housley, Z
   Degano, M
   Lamba, D
   von Roepenack-Lahaye, E
   Clemens, S
   Susani, M
   Ferreira, F
   Scheiner, O
   Breiteneder, H
AF Markovic-Housley, Z
   Degano, M
   Lamba, D
   von Roepenack-Lahaye, E
   Clemens, S
   Susani, M
   Ferreira, F
   Scheiner, O
   Breiteneder, H
TI Crystal structure of a hypoallergenic isoform of the major birch pollen
   allergen Bet v 1 and its likely biological function as a plant steroid
   carrier
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE birch pollen allergen; crystal structure; plant pathogenesis-related
   proteins; plant steroid carriers; brassinosteroid
ID PATHOGENESIS-RELATED PROTEINS; BET V 1; GINSENG CALLUSES;
   CROSS-REACTIVITY; POTENTIAL USE; X-RAY; BRASSINOSTEROIDS; FAMILY;
   RIBONUCLEASE; MEMBERS
AB Bet v 1l is a naturally occurring hypoallergenic isoform of the major birch pollen allergen Bet v 1. The Bet v 1 protein belongs to the ubiquitous family of pathogenesis-related plant proteins (PR-10), which are produced in defense-response to various pathogens. Although the allergenic properties of PR-10 proteins have been extensively studied, their biological function in plants is not known. The crystal structure of Bet v 1l in complex with deoxycholate has been determined to a resolution of 1.9 Angstrom using the method of molecular replacement. The structure reveals a large hydrophobic Y-shaped cavity that spans the protein and is partly occupied by two deoxycholate molecules which are bound in tandem and only partially exposed to solvent. This finding indicates that the hydrophobic cavity may have a role in facilitating the transfer of apolar ligands. The structural similarity of deoxycholate and brassinosteroids (BRs) ubiquitous plant steroid hormones, prompted the mass spectrometry (MS) study in order to examine whether BRs can bind to Bet v 1l. The MS analysis of a mixture of Bet v 1l and BRs revealed a specific non-covalent interaction of Bet v 1l with brassinolide and 24-epicastasterone. Together, our findings are consistent with a general plant-steroid carrier function for Bet v 1 and related PR-10 proteins. The role of BRs transport in PR-10 proteins may be of crucial importance in the plant defense response to pathological situations as well as in growth and development. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Dibit Fdn San Raffaele, Biocrystallog Unit, I-20132 Milan, Italy.
   Natl Res Council Basovizza TS, Ist Cristallog, I-34012 Padriciano, TS, Italy.
   Int Ctr Genet Engn & Biotechnol, I-34012 Padriciano, TS, Italy.
   Inst Plant Biochem, D-06120 Halle An Der Saale, Germany.
   BIOMAY, A-1030 Vienna, Austria.
   Salzburg Univ, Dept Genet & Gen Biol, A-5020 Salzburg, Austria.
   Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria.
RP Markovic-Housley, Z (corresponding author), Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
EM zora.housley@unibas.ch
RI Lamba, Doriano/L-9808-2018; Ferreira, Fatima/AAB-4321-2019; Clemens,
   Stephan/A-5107-2009; Ferreira, Fatima/E-4889-2011; Lamba,
   Doriano/B-2961-2011; Degano, Massimo/K-4669-2018
OI Lamba, Doriano/0000-0001-6859-7868; Ferreira,
   Fatima/0000-0003-0989-2335; Clemens, Stephan/0000-0003-0570-1060;
   Ferreira, Fatima/0000-0003-0989-2335; Lamba,
   Doriano/0000-0001-6859-7868; Degano, Massimo/0000-0002-0787-1883
CR AGARWAL MK, 1993, FEBS LETT, V322, P207, DOI 10.1016/0014-5793(93)81570-P
   Akdis CA, 2000, INT ARCH ALLERGY IMM, V121, P261, DOI 10.1159/000024352
   Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726
   Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115
   Biesiadka J, 2002, J MOL BIOL, V319, P1223, DOI 10.1016/S0022-2836(02)00385-6
   Breiteneder H, 2000, J ALLERGY CLIN IMMUN, V106, P27, DOI 10.1067/mai.2000.106929
   BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Bufe A, 1996, PLANTA, V199, P413, DOI 10.1007/BF00195733
   CHACKO S, 1995, J MOL BIOL, V245, P261, DOI 10.1006/jmbi.1994.0022
   Clouse S, 2001, CURR BIOL, V11, pR904, DOI 10.1016/S0960-9822(01)00549-8
   Clouse SD, 1996, PLANT J, V10, P1, DOI 10.1046/j.1365-313X.1996.10010001.x
   Ferreira F, 1998, FASEB J, V12, P231
   Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599
   FRISTENSKY B, 1988, PLANT MOL BIOL, V11, P713, DOI 10.1007/BF00017470
   Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040
   GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0
   Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9
   HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773
   He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360
   HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671
   HoffmannSommergruber K, 1997, GENE, V197, P91, DOI 10.1016/S0378-1119(97)00246-1
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   KUTSCHABSKY L, 1990, Z CHEM, V30, P136
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398
   MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396
   Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331
   Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200
   MOISEYEV GP, 1994, PLANTA, V193, P470, DOI 10.1007/BF00201828
   Moiseyev GP, 1997, FEBS LETT, V407, P207, DOI 10.1016/S0014-5793(97)00337-2
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622
   Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2
   SWOBODA I, 1995, J BIOL CHEM, V270, P2607, DOI 10.1074/jbc.270.6.2607
   Swoboda I, 1996, PHYSIOL PLANTARUM, V96, P433, DOI 10.1111/j.1399-3054.1996.tb00455.x
   TAKATSUTO S, 1994, J CHROMATOGR A, V658, P3, DOI 10.1016/0021-9673(94)85202-2
   Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408
   Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213
   Wen J, 1997, MOL PHYLOGENET EVOL, V8, P317, DOI 10.1006/mpev.1997.0447
   YAZAKI K, 1995, PLANT PHYSIOL, V108, P1331, DOI 10.1104/pp.108.3.1331
   Yokota T, 1997, TRENDS PLANT SCI, V2, P137, DOI 10.1016/S1360-1385(97)01017-0
   ZUREK DM, 1994, PLANT PHYSIOL, V104, P161, DOI 10.1104/pp.104.1.161
NR 46
TC 225
Z9 239
U1 0
U2 36
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 3
PY 2003
VL 325
IS 1
BP 123
EP 133
DI 10.1016/S0022-2836(02)01197-X
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 641HN
UT WOS:000180739500009
PM 12473456
DA 2021-01-25
ER

PT B
AU Heerklotz, H
   Winter, R
   Royer, C
   Seelig, J
AF Heerklotz, H
   Winter, R
   Royer, C
   Seelig, J
BE Winter, R
TI Pressure perturbation calorimetry
SO ADVANCES IN HIGH PRESSURE BIOSCIENCE AND BIOTECHNOLOGY II, PROCEEDINGS
LA English
DT Proceedings Paper
CT 2nd International Conference on High Pressure Bioscience and
   Biotechnology
CY SEP 16-19, 2002
CL DORTMUND, GERMANY
SP Univ Dortmund, Gesell Freunde, Boehringer Ingelheim GmbH, High Pressure Res Ctr, UnipressEquipment, Hi Tech Ltd
AB Pressure perturbation calorimetry is a new technique that measures the heat response of a sample to small pressure jumps of about 5 bar under isothermal conditions. This information allows one to deduce the isobaric thermal expansion of the partial volume of a sample. Volume changes accompanying thermotropic transitions can be determined precisely and conveniently. Such transitions include the chain melting in lipid bilayers, transitions of the topology and order in lipid/detergent systems, protein unfolding and many others. Thermal expansion of solutes in general and the volume changes upon structural transitions are related to changes in intrinsic packing and changes in solvation.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8
   Heerklotz H, 2002, BIOPHYS J, V82, P1445, DOI 10.1016/S0006-3495(02)75498-2
   Kujawa P, 2001, MACROMOLECULES, V34, P4130, DOI 10.1021/ma002082h
   Lin LN, 2002, ANAL BIOCHEM, V302, P144, DOI 10.1006/abio.2001.5524
NR 4
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 3-540-00977-9
PY 2003
BP 477
EP 480
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Food Science & Technology;
   Physics, Applied
SC Biochemistry & Molecular Biology; Biophysics; Food Science & Technology;
   Physics
GA BX46K
UT WOS:000185351300086
DA 2021-01-25
ER

PT S
AU Gatfield, J
   Pieters, J
AF Gatfield, John
   Pieters, Jean
BE Alt, FW
TI Molecular mechanisms of host-pathogen interaction: Entry and survival of
   mycobacteria in macrophages
SO ADVANCES IN IMMUNOLOGY, VOL 81
SE Advances in Immunology
LA English
DT Review
ID NITRIC-OXIDE SYNTHASE; RECEPTOR-MEDIATED PHAGOCYTOSIS; LYSOSOMAL
   MEMBRANE-GLYCOPROTEINS; LEGIONELLA-PNEUMOPHILA DOTA; BONE-MARROW
   MACROPHAGES; PHENOLIC GLYCOLIPID-I; TUMOR-NECROSIS-FACTOR; ACTIN STRESS
   FIBERS; OUTER ARM DYNEIN; FC-GAMMA-RII
C1 Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
RP Gatfield, J (corresponding author), Univ Basel, Biozentrum, Dept Biochem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0
   Adam T, 1996, EMBO J, V15, P3315, DOI 10.1002/j.1460-2075.1996.tb00696.x
   ADAMS DO, 1992, MACROPHAGE, P75
   Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Agranoff D, 1999, J EXP MED, V190, P717, DOI 10.1084/jem.190.5.717
   Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627
   ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601
   Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432
   AlvarezDominguez C, 1996, J BIOL CHEM, V271, P13834, DOI 10.1074/jbc.271.23.13834
   AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0
   Andrew DP, 1998, EUR J IMMUNOL, V28, P1959, DOI 10.1002/(SICI)1521-4141(199806)28:06<1959::AID-IMMU1959>3.0.CO;2-4
   ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130
   Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Asnagli H, 2001, CURR OPIN IMMUNOL, V13, P242, DOI 10.1016/S0952-7915(00)00210-7
   Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999
   Balsam LB, 1998, J IMMUNOL, V160, P5058
   Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727
   Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0
   BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x
   Bednarek SY, 1995, CELL, V83, P1183, DOI 10.1016/0092-8674(95)90144-2
   BELLINGERKAWAHARA C, 1990, J EXP MED, V172, P1201, DOI 10.1084/jem.172.4.1201
   BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498
   Bentrup KHZ, 1999, J BACTERIOL, V181, P7161
   BERGQUIST PR, 1986, EXP BIOL, V45, P111
   Berke G, 1997, Curr Opin Hematol, V4, P32
   BERON W, 1995, TRENDS CELL BIOL, V5, P100, DOI 10.1016/S0962-8924(00)88958-8
   BERTON G, 1992, J CELL BIOL, V116, P1007, DOI 10.1083/jcb.116.4.1007
   BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0
   Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   BLOOM BR, 1992, NATURE, V358, P538, DOI 10.1038/358538b0
   Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P64, DOI 10.1016/S0952-7915(99)00052-7
   Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923
   BORNIG H, 1974, ACTA HISTOCHEM, V50, P110
   Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853
   Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458
   BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333
   Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732
   BROWN MS, 1990, NATURE, V343, P508, DOI 10.1038/343508a0
   Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000
   Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x
   Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717
   Carroll MC, 1998, ANNU REV IMMUNOL, V16, P545, DOI 10.1146/annurev.immunol.16.1.545
   CARTER PB, 1974, INFECT IMMUN, V9, P851, DOI 10.1128/IAI.9.5.851-857.1974
   Caruso AM, 1999, J IMMUNOL, V162, P5407
   Chan J, 1996, P NATL ACAD SCI USA, V93, P14857, DOI 10.1073/pnas.93.25.14857
   CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995
   CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991
   CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765
   Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1
   CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P
   Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454
   CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257
   Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917
   Colonna M, 2000, IMMUNOL TODAY, V21, P428, DOI 10.1016/S0167-5699(00)01697-2
   COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243
   COOPER NR, 1985, ADV IMMUNOL, V37, P151, DOI 10.1016/S0065-2776(08)60340-5
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cossart P, 2001, CURR OPIN IMMUNOL, V13, P96, DOI 10.1016/S0952-7915(00)00188-6
   Cosson P, 1997, CURR OPIN CELL BIOL, V9, P484, DOI 10.1016/S0955-0674(97)80023-3
   Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487
   Cox JS, 1999, NATURE, V402, P79
   Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0
   CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991
   Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027
   Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997
   Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131
   Dai WJ, 1997, J IMMUNOL, V158, P5297
   DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300
   DASILVA RP, 1989, J IMMUNOL, V143, P617
   DAVIS BD, 1990, MICROBIOLOGY
   Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523
   de Jong R, 1998, SCIENCE, V280, P1435
   De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252
   deChastellier C, 1997, EUR J CELL BIOL, V74, P49
   DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x
   DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x
   DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163
   Dell'Angelica EC, 1999, J BIOL CHEM, V274, P7278, DOI 10.1074/jbc.274.11.7278
   DENECKER G, 2001, J BIOL CHEM, V14, P14
   DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6
   Desjardins M, 1997, J EXP MED, V185, P2061, DOI 10.1084/jem.185.12.2061
   DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677
   Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521
   DOWNING JF, 1995, P NATL ACAD SCI USA, V92, P4848, DOI 10.1073/pnas.92.11.4848
   DRABIKOWSKI W, 1973, BIOCHIM BIOPHYS ACTA, V291, P61, DOI 10.1016/0005-2736(73)90060-6
   Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137
   Drees B, 2000, J BIOL CHEM, V275, P22503, DOI 10.1074/jbc.M001698200
   Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x
   DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W
   DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863
   Eggleton P, 1999, CURR OPIN IMMUNOL, V11, P28, DOI 10.1016/S0952-7915(99)80006-5
   Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9
   Ehrt S, 1997, J EXP MED, V186, P1885, DOI 10.1084/jem.186.11.1885
   Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941
   Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998
   EZEKOWITZ RAB, 1991, NATURE, V351, P155, DOI 10.1038/351155a0
   EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785
   FALK K, 1994, IMMUNOGENETICS, V39, P230
   Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50
   FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435
   Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718
   FLESCH I, 1987, J IMMUNOL, V138, P4408
   FLESCH IEA, 1991, INFECT IMMUN, V59, P3213, DOI 10.1128/IAI.59.9.3213-3218.1991
   FLORY CM, 1992, J LEUKOCYTE BIOL, V51, P225
   FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249
   Flynn JL, 1998, J IMMUNOL, V160, P1796
   FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013
   FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2
   Forsyth CB, 1998, J IMMUNOL, V161, P6198
   FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0
   FREHEL C, 1986, ANN INST PASTEUR MIC, V137B, P239, DOI 10.1016/S0769-2609(86)80115-6
   Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001
   Gadjeva M, 2001, CURR OPIN IMMUNOL, V13, P74, DOI 10.1016/S0952-7915(00)00185-0
   Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0
   GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544
   GARCIADELPORTILLO F, 1995, J CELL BIOL, V129, P81, DOI 10.1083/jcb.129.1.81
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   GAYNOR CD, 1995, J IMMUNOL, V155, P5343
   Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000
   Geese M, 2000, J CELL SCI, V113, P1415
   Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978
   GEOFFROY C, 1987, INFECT IMMUN, V55, P1641, DOI 10.1128/IAI.55.7.1641-1646.1987
   GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0
   Glas R, 1998, NATURE, V392, P618
   Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849
   Gold ES, 2000, IMMUNITY, V12, P285, DOI 10.1016/S1074-7613(00)80181-8
   GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0
   Gomes MS, 1999, J IMMUNOL, V162, P6734
   Gomes MS, 1999, INFECT IMMUN, V67, P3199, DOI 10.1128/IAI.67.7.3199-3206.1999
   GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111
   GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q
   Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5
   Gouin E, 1999, J CELL SCI, V112, P1697
   GREENBERG S, 1995, TRENDS CELL BIOL, V5, P93, DOI 10.1016/S0962-8924(00)88957-6
   GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253
   Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737
   Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321
   Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y
   HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0
   Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558
   Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7
   Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7
   HART DNJ, 1993, IMMUNOLOGY, V79, P616
   Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x
   Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431
   Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996
   Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123
   Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x
   Heufler C, 1996, EUR J IMMUNOL, V26, P659, DOI 10.1002/eji.1830260323
   HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315
   HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x
   Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787
   Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1
   Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108
   HORWITZ MA, 1984, CELL, V36, P27, DOI 10.1016/0092-8674(84)90070-9
   HORWITZ MA, 1984, J CELL BIOL, V99, P1936, DOI 10.1083/jcb.99.6.1936
   Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x
   HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301
   Hurme R, 1999, ADV CELL MOL BIOL ME, V6, P59, DOI 10.1016/S1874-5172(99)80006-6
   Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780
   ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z
   Ishibashi Y, 1990, FEMS Microbiol Immunol, V2, P75
   Jabado N, 2000, J EXP MED, V192, P1237, DOI 10.1084/jem.192.9.1237
   JAMES SL, 1990, J IMMUNOL, V145, P2686
   JANEWAY CA, 1989, COLD SH Q B, V54, P1
   JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126
   Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556
   Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573
   Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810
   KABHA K, 1995, INFECT IMMUN, V63, P847, DOI 10.1128/IAI.63.3.847-852.1995
   KAGAYA K, 1989, INFECT IMMUN, V57, P609, DOI 10.1128/IAI.57.2.609-615.1989
   KANASEKI T, 1969, J CELL BIOL, V42, P202, DOI 10.1083/jcb.42.1.202
   KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x
   Kaufmann SHE, 2000, NAT MED, V6, P955, DOI 10.1038/79631
   KAUFMANN SHE, 1988, SPRINGER SEMIN IMMUN, V10, P337, DOI 10.1007/BF02053845
   KELLY AP, 1991, NATURE, V353, P571, DOI 10.1038/353571a0
   KERN I, 1995, INT IMMUNOL, V7, P1295, DOI 10.1093/intimm/7.8.1295
   KERY V, 1992, ARCH BIOCHEM BIOPHYS, V298, P49, DOI 10.1016/0003-9861(92)90092-B
   KIENER PA, 1993, J BIOL CHEM, V268, P24442
   KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4
   KING SM, 1995, J CELL BIOL, V131, P399, DOI 10.1083/jcb.131.2.399
   Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117
   KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009
   Kropshofer H, 1996, EMBO J, V15, P6144, DOI 10.1002/j.1460-2075.1996.tb01002.x
   Krutzik SR, 2001, CURR OPIN IMMUNOL, V13, P104, DOI 10.1016/S0952-7915(00)00189-8
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733
   LANZAVECCHIA A, 1987, IMMUNOL REV, V99, P39, DOI 10.1111/j.1600-065X.1987.tb01171.x
   Le Page C, 2000, Rev Immunogenet, V2, P374
   LEE RT, 1992, ARCH BIOCHEM BIOPHYS, V299, P129, DOI 10.1016/0003-9861(92)90254-T
   Lefkowitz DL, 1997, IMMUNOL CELL BIOL, V75, P136, DOI 10.1038/icb.1997.18
   Lehner PJ, 1996, CURR OPIN IMMUNOL, V8, P59, DOI 10.1016/S0952-7915(96)80106-3
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6
   Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917
   LeVine AM, 1997, J IMMUNOL, V158, P4336
   LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S
   LI QW, 1994, J BIOL CHEM, V269, P31777
   Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254
   Lim A, 1999, J BACTERIOL, V181, P2252, DOI 10.1128/JB.181.7.2252-2256.1999
   Linehan SA, 2000, MICROBES INFECT, V2, P279, DOI 10.1016/S1286-4579(00)00300-2
   Loisel TP, 1999, NATURE, V401, P613
   Ma Y, 1999, P NATL ACAD SCI USA, V96, P371, DOI 10.1073/pnas.96.2.371
   Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3
   MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243
   MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4
   MARODI L, 1993, J CLIN INVEST, V91, P2596, DOI 10.1172/JCI116498
   Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215
   Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987
   Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219
   MAURIN M, 1992, J INFECT DIS, V166, P1097, DOI 10.1093/infdis/166.5.1097
   May RC, 2000, NAT CELL BIOL, V2, P246
   Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x
   MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0
   MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311
   Menard R, 1996, P NATL ACAD SCI USA, V93, P1254, DOI 10.1073/pnas.93.3.1254
   Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3
   Meresse S, 1999, NAT CELL BIOL, V1, pE183
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   Miyakawa Y, 1996, INFECT IMMUN, V64, P926, DOI 10.1128/IAI.64.3.926-932.1996
   Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385
   MONACO JJ, 1995, J LEUKOCYTE BIOL, V57, P543
   MOSSER DM, 1987, NATURE, V327, P329, DOI 10.1038/327329b0
   Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881
   MURRAY HW, 1992, J INFECT DIS, V165, P513, DOI 10.1093/infdis/165.3.513
   NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042
   NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0
   Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   NORTH RJ, 1974, INFECT IMMUN, V10, P66, DOI 10.1128/IAI.10.1.66-71.1974
   Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800
   Oh YK, 1996, INFECT IMMUN, V64, P319, DOI 10.1128/IAI.64.1.319-325.1996
   Ozeki Y, 1997, INFECT IMMUN, V65, P1793, DOI 10.1128/IAI.65.5.1793-1799.1997
   Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497
   Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x
   Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x
   PEARSE BMF, 1975, J MOL BIOL, V97, P93, DOI 10.1016/S0022-2836(75)80024-6
   Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X
   Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500
   PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0
   Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186
   Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967
   Pieters J, 1999, ADV CELL MOL BIOL ME, V5, P379, DOI 10.1016/S1874-5172(99)80041-8
   PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213
   Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5
   PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077
   PIZON V, 1994, J CELL SCI, V107, P1661
   Plow EF, 1997, J CLIN INVEST, V99, P1145, DOI 10.1172/JCI119267
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   PRASAD HK, 1987, J EXP MED, V165, P239, DOI 10.1084/jem.165.1.239
   Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2
   PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865
   Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5
   RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2
   RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95
   Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436
   Rammensee H G, 1993, Chem Immunol, V57, P113
   RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241
   Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148
   Rhodes D A, 1999, Rev Immunogenet, V1, P21
   RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8
   RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7
   Riezman H, 1997, CELL, V91, P731, DOI 10.1016/S0092-8674(00)80461-4
   ROBINSON MS, 1989, J CELL BIOL, V108, P833, DOI 10.1083/jcb.108.3.833
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x
   ROSS SC, 1984, MEDICINE, V63, P243, DOI 10.1097/00005792-198409000-00001
   Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x
   Roy CR, 1997, INFECT IMMUN, V65, P571, DOI 10.1128/IAI.65.2.571-578.1997
   RUSSELL DG, 1995, TRENDS CELL BIOL, V5, P125, DOI 10.1016/S0962-8924(00)88963-1
   Russell DG, 1996, J IMMUNOL, V156, P4764
   RUSSELL DG, 1992, J CELL SCI, V103, P1193
   Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2
   Schaible UE, 1998, J IMMUNOL, V160, P1290
   Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Schild H, 2000, NATURE, V404, P709, DOI 10.1038/35008165
   Schlesinger LS, 1996, J IMMUNOL, V157, P4568
   SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771
   Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5
   SCHNEEMANN M, 1993, J INFECT DIS, V167, P1358, DOI 10.1093/infdis/167.6.1358
   SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243
   Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4
   Schorey JS, 1997, SCIENCE, V277, P1091, DOI 10.1126/science.277.5329.1091
   SCHREIBER S, 1993, J IMMUNOL, V151, P4973
   Schubert U, 2000, NATURE, V404, P770
   SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X
   SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509
   Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x
   Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363
   Shang XZ, 1998, EUR J IMMUNOL, V28, P1970, DOI 10.1002/(SICI)1521-4141(199806)28:06<1970::AID-IMMU1970>3.0.CO;2-H
   Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0
   Shibata Y, 1997, J IMMUNOL, V159, P2462
   SIBLEY LD, 1988, INFECT IMMUN, V56, P1232, DOI 10.1128/IAI.56.5.1232-1236.1988
   SILVERSTEIN SC, 1995, TRENDS CELL BIOL, V5, P141, DOI 10.1016/S0962-8924(00)88967-9
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460
   SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0
   SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2
   Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0
   SPARGO BJ, 1991, P NATL ACAD SCI USA, V88, P737, DOI 10.1073/pnas.88.3.737
   SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0
   Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9
   St John G, 2001, P NATL ACAD SCI USA, V98, P9901
   STAHL PD, 1978, P NATL ACAD SCI USA, V75, P1399, DOI 10.1073/pnas.75.3.1399
   Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x
   STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643
   Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121
   STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543
   STURA EA, 1992, J MOL BIOL, V228, P975, DOI 10.1016/0022-2836(92)90881-J
   STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277
   SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x
   Sugita M, 2000, TRAFFIC, V1, P295, DOI 10.1034/j.1600-0854.2000.010401.x
   SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413
   Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412
   Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0
   Swanson JA, 1999, J CELL SCI, V112, P307
   SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4
   SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995
   TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0
   Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3
   Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7
   Tenner AJ, 1999, CURR OPIN IMMUNOL, V11, P34, DOI 10.1016/S0952-7915(99)80007-7
   TENNER AJ, 1995, IMMUNITY, V3, P485, DOI 10.1016/1074-7613(95)90177-9
   Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544
   TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597
   Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   TONEGAWA S, 1988, BIOSCIENCE REP, V8, P3, DOI 10.1007/BF01128968
   TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.immunol.7.1.601
   TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Ulrichs T, 2000, Rev Immunogenet, V2, P416
   VACHULA M, 1989, J IMMUNOL, V142, P1696
   van Leeuwen FN, 1999, NAT CELL BIOL, V1, P242, DOI 10.1038/12068
   Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51
   VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0
   Via LE, 1998, J CELL SCI, V111, P897
   Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326
   VIDAL S, 1995, J LEUKOCYTE BIOL, V58, P382
   Vogel JP, 1999, CURR OPIN MICROBIOL, V2, P30, DOI 10.1016/S1369-5274(99)80005-8
   VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167
   WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1
   WARDLE EN, 1987, LIVER, V7, P63
   Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105
   WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0
   WHEELER PR, 1988, J GEN MICROBIOL, V134, P2111
   WILKERSON CG, 1995, J CELL BIOL, V129, P169, DOI 10.1083/jcb.129.1.169
   Wilmott RW, 2000, CURR OPIN PEDIATR, V12, P187, DOI 10.1097/00008480-200006000-00002
   Xia Y, 1999, J IMMUNOL, V162, P2281
   XU SM, 1994, J IMMUNOL, V153, P2568
   Yamamoto Y, 1997, INFECT IMMUN, V65, P1077, DOI 10.1128/IAI.65.3.1077-1082.1997
   Yang RB, 1998, NATURE, V395, P284
   ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407
   Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271
NR 365
TC 18
Z9 19
U1 0
U2 2
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0065-2776
BN 0-12-022481-X
J9 ADV IMMUNOL
JI Adv.Immunol.
PY 2003
VL 81
BP 45
EP +
DI 10.1016/S0065-2776(03)81002-7
PG 54
WC Immunology
SC Immunology
GA BEL40
UT WOS:000237769700002
PM 14711053
DA 2021-01-25
ER

PT J
AU Melchers, F
AF Melchers, F
TI The actions of BAFF in B-lymphocyte maturation and its effects on the
   development of autoimmune disease
SO ARTHRITIS RESEARCH & THERAPY
LA English
DT Meeting Abstract
CT 3rd World Congress of the Global-Arthritis-Research-Network (GARN)
CY SEP 14-17, 2003
CL Miyakazi, JAPAN
C1 Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1478-6354
J9 ARTHRITIS RES THER
JI Arthritis Res. Ther.
PY 2003
VL 5
SU 3
MA 16
BP S6
EP S6
DI 10.1186/ar817
PG 1
WC Rheumatology
SC Rheumatology
GA 801SX
UT WOS:000220116700018
OA DOAJ Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Sanchez, IE
   Kiefhaber, T
AF Sanchez, IE
   Kiefhaber, T
TI Non-linear rate-equilibrium free energy relationships and Hammond
   behavior in protein folding
SO BIOPHYSICAL CHEMISTRY
LA English
DT Article
DE protein folding kinetics; transition state; rate-equilibrium
   relationships; Hammond postulate; cross-interaction parameters; folding
   intermediates
ID PHYSICAL ORGANIC-CHEMISTRY; TRANSITION-STATE; DENATURED STATE;
   CHYMOTRYPSIN INHIBITOR-2; GUANIDINE-HYDROCHLORIDE; RESIDUAL STRUCTURE;
   SH3 DOMAIN; POINT MUTATIONS; BINDING SITES; BETA-SHEET
AB Non-linear rate-equilibrium relationships upon mutation or changes in solvent conditions are frequently observed in protein folding reactions and are usually interpreted in terms of Hammond behavior. Here we first give a general overview over the concept of transition state movements in chemical reactions and discuss its application to protein folding. We then show examples for genuine Hammond behavior and for apparent transition state movements caused by other effects like changes in the rate-limiting step of the folding reaction or ground state effects, i.e. structural changes in either the native state or the unfolded state. These examples show that apparent transition state movements can easily be mistaken for Hamniond behavior. We describe experimental tests using self- and cross-interaction parameters to distinguish between structural changes in a single transition state following Hammond behavior and apparent transition state movements caused by other effects. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Sanchez, Ignacio/A-5658-2009; Kiefhaber, Thomas/A-3028-2010
OI Sanchez, Ignacio Enrique/0000-0003-4284-9013
CR Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   CHEN BL, 1989, BIOCHEMISTRY-US, V28, P691, DOI 10.1021/bi00428a042
   Choy WY, 2001, J MOL BIOL, V308, P1011, DOI 10.1006/jmbi.2001.4750
   Dalby PA, 1998, BIOCHEMISTRY-US, V37, P4674, DOI 10.1021/bi972798d
   Evans MG, 1935, T FARADAY SOC, V31, P0875, DOI 10.1039/tf9353100875
   EVANS PA, 1991, PROTEINS, V9, P248, DOI 10.1002/prot.340090404
   Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604
   FARCASIU D, 1975, J CHEM EDUC, V52, P76, DOI 10.1021/ed052p76
   FERSHT AR, 1994, P NATL ACAD SCI USA, V91, P10426, DOI 10.1073/pnas.91.22.10426
   FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W
   Garcia P, 2001, PROTEIN SCI, V10, P1100, DOI 10.1110/ps.52701
   Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586
   HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027
   IKAI A, 1973, J MOL BIOL, V73, P165, DOI 10.1016/0022-2836(73)90321-5
   ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616
   JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010
   Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873
   JENCKS DA, 1977, J AM CHEM SOC, V99, P7948, DOI 10.1021/ja00466a030
   JENCKS WP, 1985, CHEM REV, V85, P511, DOI 10.1021/cr00070a001
   JOHNSON CD, 1975, CHEM REV, V75, P755, DOI 10.1021/cr60298a004
   Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398
   Kim DE, 2000, J MOL BIOL, V298, P971, DOI 10.1006/jmbi.2000.3701
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618
   Krantz BA, 2000, NAT STRUCT BIOL, V7, P62
   Krantz BA, 2001, NAT STRUCT BIOL, V8, P1042, DOI 10.1038/nsb723
   KUWAJIMA K, 1989, J MOL BIOL, V206, P547, DOI 10.1016/0022-2836(89)90500-7
   LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340
   LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173
   Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3
   MATOUSCHEK A, 1995, BIOCHEMISTRY-US, V34, P13656, DOI 10.1021/bi00041a047
   MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814
   MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498
   MATTHEWS JM, 1995, BIOCHEMISTRY-US, V34, P6805, DOI 10.1021/bi00020a027
   Mok YK, 2001, J MOL BIOL, V307, P913, DOI 10.1006/jmbi.2001.4521
   MULLER P, 1994, PURE APPL CHEM, V66, P1077, DOI 10.1351/pac199466051077
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Oliveberg M, 1998, J MOL BIOL, V277, P933, DOI 10.1006/jmbi.1997.1612
   Pace C N, 1986, Methods Enzymol, V131, P266
   Pappenberger G, 2000, P NATL ACAD SCI USA, V97, P17, DOI 10.1073/pnas.97.1.17
   Perl D, 2002, BIOPHYS CHEM, V96, P173, DOI 10.1016/S0301-4622(02)00024-8
   PLANCK M, 1887, ANN PHYS CHEM, V32, P462
   Plaxco KW, 1998, P NATL ACAD SCI USA, V95, P13591, DOI 10.1073/pnas.95.23.13591
   POHL FM, 1976, FEBS LETT, V65, P293, DOI 10.1016/0014-5793(76)80132-9
   SANCHO J, 1991, J MOL BIOL, V221, P1007, DOI 10.1016/0022-2836(91)80188-Z
   Sari N, 2000, BIOCHEMISTRY-US, V39, P965, DOI 10.1021/bi9920230
   Sato S, 2000, PROTEIN SCI, V9, P1601, DOI 10.1110/ps.9.8.1601
   Schonbrunner N, 1997, J MOL BIOL, V268, P526, DOI 10.1006/jmbi.1997.0960
   SCHONBRUNNER N, 1997, BIOCHEMISTRY-US, V36, P6057
   Silow M, 1997, BIOCHEMISTRY-US, V36, P7633, DOI 10.1021/bi970210x
   Smith CK, 1996, PROTEIN SCI, V5, P2009, DOI 10.1002/pro.5560051007
   Tan YJ, 1996, J MOL BIOL, V264, P377, DOI 10.1006/jmbi.1996.0647
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   Teilum K, 2000, J MOL BIOL, V301, P1307, DOI 10.1006/jmbi.2000.4003
   THORNTON ER, 1967, J AM CHEM SOC, V89, P2915, DOI 10.1021/ja00988a020
   Wales DJ, 2001, SCIENCE, V293, P2067, DOI 10.1126/science.1062565
   Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523
   Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816
NR 59
TC 45
Z9 46
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-4622
J9 BIOPHYS CHEM
JI Biophys. Chem.
PY 2003
VL 100
IS 1-3
SI SI
BP 397
EP 407
AR PII S0301-4622(02)00294-6
DI 10.1016/S0301-4622(02)00294-6
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA 661GR
UT WOS:000181883300036
PM 12646379
DA 2021-01-25
ER

PT J
AU Jones, FE
   Golding, JP
   Gassmann, M
AF Jones, Frank E.
   Golding, Jon P.
   Gassmann, Martin
TI ErbB4 Signaling During Breast and Neural Development Novel Genetic
   Models Reveal Unique ErbB4 Activities
SO CELL CYCLE
LA English
DT Article
DE gene targeting; erbB receptors; mammary gland; cerebellum; interneuron
AB The erbB4 gene encodes one of the four members of the mammalian ErbB family of transmembrane tyrosine kinases. The ErbB4 protein plays a role as a receptor for the neuregulins, a large group of structurally related molecules and a few other epidermal growth factor (EGF)-related polypeptides, such as heparin-binding EGF, betacellulin and epiregulin. The importance of this receptor tyrosine kinase in development has been demonstrated by the generation of mice with a targeted inactivation of the erbB4 gene. Such mice die by embryonic day eleven due to defective trabeculation in the heart, precluding analysis of phenotypes at later stages in development and in the adult. Now, using two unique genetic approaches our laboratories succeeded in overcoming this obstacle. In the first approach, the heart defects of ErbB4 null mutant mice were rescued by transgenic expression of an ErbB4 cDNA under a cardiac-specific myosin promoter. This allowed the generation of ErbB4 mutants that develop into adulthood and are fertile. In the second approach, the role of ErbB4 during mammary gland development was specifically addressed by Cre-mediated deletion of both erbB4 alleles within the mammary epithelium. Bellow we discuss the progress made studying these genetic models in understanding the physiological roles of ErbB4 with a focus on the mammary gland and the nervous system.
C1 [Jones, Frank E.] Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, Dept Struct & Cellular Biol, New Orleans, LA 70118 USA.
   [Golding, Jon P.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC, Ctr Clin Sci, Hammersmith Hosp Campus, London W12 0NN, England.
   [Gassmann, Martin] Univ Basel, Dept Physiol, Biozentrum Pharmazentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
RP Gassmann, M (corresponding author), Univ Basel, Dept Physiol, Biozentrum Pharmazentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Martin.Gassmann@unibas.ch
RI Golding, Jon/L-2700-2017
OI Golding, Jon/0000-0002-7910-7382
FU National Cancer Institute/National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [1RO1CA95783-01]; NATIONAL
   CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA095783, R01CA095783, R01CA095783, R01CA095783,
   R01CA095783, R01CA095783, R01CA095783, R01CA095783, R01CA095783,
   R01CA095783, R01CA095783, R01CA095783, R01CA095783, R01CA095783,
   R01CA095783] Funding Source: NIH RePORTER
FX Work was supported by: National Cancer Institute/National Institutes of
   Health grant 1RO1CA95783-01.
CR Beuvink I, 2000, J BIOL CHEM, V275, P10247, DOI 10.1074/jbc.275.14.10247
   Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601
   Carrasco E, 2003, DEV BRAIN RES, V140, P1, DOI 10.1016/S0165-3806(02)00539-4
   Cheney ML, 1997, ANN OTO RHINOL LARYN, V106, P733, DOI 10.1177/000348949710600903
   Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J
   Erickson SL, 1997, DEVELOPMENT, V124, P4999
   Farlie PG, 1999, DEV BIOL, V213, P70, DOI 10.1006/dbio.1999.9332
   Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961
   GAO WQ, 1994, DEVELOPMENT, V120, P1059
   Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497
   Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035
   GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0
   Geurts FJ, 2001, NEUROSCIENCE, V104, P499, DOI 10.1016/S0306-4522(01)00058-6
   Golding JP, 2000, NAT CELL BIOL, V2, P103, DOI 10.1038/35000058
   HAUSMANN B, 1985, J COMP NEUROL, V232, P511, DOI 10.1002/cne.902320408
   Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9
   Jones FE, 1999, ONCOGENE, V18, P3481, DOI 10.1038/sj.onc.1202698
   Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77
   Kew TY, 2000, BRIT J CANCER, V82, P1163, DOI 10.1054/bjoc.1999.1057
   Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167
   Li L, 2002, ONCOGENE, V21, P4900, DOI 10.1038/sj.onc.1205634
   Liesi P, 2003, J NEUROSCI RES, V72, P290, DOI 10.1002/jnr.10573
   Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179
   Long W, 2003, DEVELOPMENT, V3, P3
   Luetteke NC, 1999, DEVELOPMENT, V126, P2739
   Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109
   Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065
   Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5
   Nakagawa T, 1998, DEV BRAIN RES, V108, P263, DOI 10.1016/S0165-3806(98)00057-1
   Ozaki M, 1998, NEUROSCI RES, V30, P351, DOI 10.1016/S0168-0102(98)00013-3
   Ozaki M, 2000, J NEUROSCI RES, V59, P612
   Ozaki M, 1997, NATURE, V390, P691
   Polleux F, 2002, DEVELOPMENT, V129, P3147
   PRATT SG, 1984, OPHTHALMOLOGY, V91, P27
   Rieff HI, 1999, J NEUROSCI, V19, P10757
   Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3
   Schroeder JA, 1998, CELL GROWTH DIFFER, V9, P451
   Srinivasan R, 2000, CANCER RES, V60, P1483
   Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0
   Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100
   Trainor PA, 2002, DEVELOPMENT, V129, P433
   Wang RA, 2003, J CELL BIOL, V161, P583, DOI [10.1083/jcb.200212066, 10.1083/JCB.200212066]
   Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538
   Yamashita H, 2001, MOL CELL ENDOCRINOL, V183, P151, DOI 10.1016/S0303-7207(01)00546-9
   YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215
   Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073
   Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252
   Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702
   Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7
NR 49
TC 26
Z9 28
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PY 2003
VL 2
IS 6
BP 555
EP 559
DI 10.4161/cc.2.6.598
PG 5
WC Cell Biology
SC Cell Biology
GA V43PC
UT WOS:000209692300016
PM 14504474
OA Bronze
DA 2021-01-25
ER

PT J
AU Affolter, M
   Bellusci, S
   Itoh, N
   Shilo, B
   Thiery, JP
   Werb, Z
AF Affolter, M
   Bellusci, S
   Itoh, N
   Shilo, B
   Thiery, JP
   Werb, Z
TI Tube or not tube: Remodeling epithelial tissues by branching
   morphogenesis
SO DEVELOPMENTAL CELL
LA English
DT Review
ID TRACHEAL CELL-MIGRATION; BHLH-PAS PROTEIN; MOLECULAR MECHANISMS;
   TRANSCRIPTION FACTOR; GENETIC-CONTROL; MAMMARY-GLAND; DROSOPHILA; FGF;
   ENCODES; MIDLINE
AB Branching morphogenesis involves the restructuring of epithelial tissues into complex and organized ramified tubular networks. Early rounds of branching are controlled genetically in a hardwired fashion in many organs, whereas later, branching is stochastic, responding to environmental cues. We discuss this sequential process from formation of an organ anlage and invagination of the epithelium to branch initiation and outgrowth in several model systems including Drosophila trachea and mammalian lung, mammary gland, and kidney.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   Childrens Hosp Los Angeles, Dev Biol Program, Los Angeles, CA 90027 USA.
   Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan.
   Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.
   Inst Curie, F-75248 Paris 05, France.
   Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch; zena@itsa.ucsf.edu
RI Thiery, Jean Paul/M-9387-2019
OI Shilo, Ben Zion/0000-0003-4903-8889; Affolter,
   Markus/0000-0002-5171-0016
CR Affolter M, 2001, SCIENCE, V292, P1080, DOI 10.1126/science.1060856
   ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123
   Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076
   Beitel GJ, 2000, DEVELOPMENT, V127, P3271
   Bellusci S, 1996, DEVELOPMENT, V122, P1693
   Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471
   Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0
   Chen CK, 1998, DEVELOPMENT, V125, P4959
   Chihara T, 2000, DEVELOPMENT, V127, P4433
   Curtiss J, 2002, NAT CELL BIOL, V4, pE48, DOI 10.1038/ncb0302-e48
   Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2
   DECELIS JF, 1995, DEVELOPMENT, V121, P3405
   Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI200113171
   Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312
   Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8
   Hirai Y, 2001, J CELL BIOL, V153, P785, DOI 10.1083/jcb.153.4.785
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Hovey RC, 2002, J MAMMARY GLAND BIOL, V7, P17, DOI 10.1023/A:1015766322258
   Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103
   Kheradmand F, 2002, J CELL SCI, V115, P839
   Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615
   Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215
   Llimargas M, 2000, DEVELOPMENT, V127, P4407
   Llimargas M, 1999, DEV GENES EVOL, V209, P174, DOI 10.1007/s004270050241
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6
   Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1
   O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859
   Ohshiro T, 1997, DEVELOPMENT, V124, P3975
   PAGEMCCAW A, 2002, MOL BIOL CELL S, V13
   Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Simian M, 2001, DEVELOPMENT, V128, P3117
   Sonnenfeld M, 1997, DEVELOPMENT, V124, P4571
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   VELTMAAT J, 2003, IN PRESS DIFFERENTIA
   Vincent S, 1997, DEVELOPMENT, V124, P2741
   Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1
   Weaver M, 2000, DEVELOPMENT, V127, P2695
   Weaver M, 1999, DEVELOPMENT, V126, P4005
   Welm B, 2002, CURR BIOL, V12, pR209, DOI 10.1016/S0960-9822(02)00752-2
   Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93
   Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431
   Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079
   Zelzer E, 2000, BIOESSAYS, V22, P219, DOI 10.1002/(SICI)1521-1878(200003)22:3<219::AID-BIES3>3.0.CO;2-A
NR 49
TC 210
Z9 214
U1 1
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD JAN
PY 2003
VL 4
IS 1
BP 11
EP 18
DI 10.1016/S1534-5807(02)00410-0
PG 8
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 643LD
UT WOS:000180862000006
PM 12530959
DA 2021-01-25
ER

PT J
AU Meyer, UA
   Baader, M
   Fraser, D
   Gnerre, C
   Handschin, C
   Oscarson, M
   Podvinee, M
AF Meyer, UA
   Baader, M
   Fraser, D
   Gnerre, C
   Handschin, C
   Oscarson, M
   Podvinee, M
TI In vivo, in vitro, and in silico approaches to study induction of drug
   metabolism
SO DRUG METABOLISM REVIEWS
LA English
DT Meeting Abstract
CT 8th European Meeting of the
   International-Society-for-the-Study-of-Xenobiotics (ISSX)
CY APR 27-MAY 01, 2003
CL DIJON, FRANCE
SP Int Soc Study Xenobiotics
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
NR 0
TC 1
Z9 1
U1 0
U2 2
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0360-2532
J9 DRUG METAB REV
JI Drug Metab. Rev.
PY 2003
VL 35
SU 1
MA 18
BP 9
EP 9
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 665NW
UT WOS:000182128400018
DA 2021-01-25
ER

PT J
AU Foultier, B
   Troisfontaines, P
   Vertommen, D
   Marenne, MN
   Rider, M
   Parsot, C
   Cornelis, GR
AF Foultier, B
   Troisfontaines, P
   Vertommen, D
   Marenne, MN
   Rider, M
   Parsot, C
   Cornelis, GR
TI Identification of substrates and chaperone from the Yersinia
   enterocolitica 1B Ysa type III secretion system
SO INFECTION AND IMMUNITY
LA English
DT Article
ID HIGH-PATHOGENICITY ISLAND; SHIGELLA-FLEXNERI; TRANSLOCATORS YOPB;
   VIRULENCE PLASMID; EFFECTOR PROTEIN; IPAC INVASINS; FUNCTIONAL
   CONSERVATION; MACROPHAGE APOPTOSIS; EPITHELIAL-CELLS; ENTRY
AB All pathogenic Yersinia enterocolitica strains carry the pYV plasmid encoding the Ysc-Yop type III secretion (TTS) system, which operates at 37degreesC. In addition, biovar 1B Y. enterocolitica strains possess a second, chromosomally encoded, TTS system called Ysa, which operates, at least in vitro, under low-temperature and high-salt (LTHS) conditions. Six open reading frames, sycB, yspB, yspC, yspD, yspA, and acpY, neighbor the ysa genes encoding the Ysa TTS apparatus. Here we show that YspA, YspB, YspC, and YspD are secreted by the Ysa TTS system under LTHS conditions. SycB is a chaperone for YspB and YspC and stabilizes YspB. YspB, YspC, and SycB share some similarity with TTS substrates and the chaperone encoded by the Mxi-Spa locus of Shigella flexneri and SPI-1 of Salmonella enterica. In addition, Ysa also secretes the pYV-encoded YopE under LTHS conditions, indicating that YopE is a potential effector of both Y. enterocolitica TTS systems. YspC could also be secreted by S.flexneri, but no functional complementation of ipaC was observed, which indicates that despite their similarity the Ysa and the Mxi-Spa systems are not interchangeable. When expressed from the yopE promoter, YspB and YspC could also be secreted via the Ysc injectisome. However, they could not form detectable pores in eukaryotic target cells and could not substitute for YopB and YopD for translocation of Yop effectors.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Catholic Univ Louvain, Microbial Pathogenesis Unit, B-1200 Brussels, Belgium.
   Catholic Univ Louvain, Hormone & Metab Res Unit, B-1200 Brussels, Belgium.
   Catholic Univ Louvain, Christian De Duve Inst Cellular Pathol, B-1200 Brussels, Belgium.
   Catholic Univ Louvain, Fac Med, B-1200 Brussels, Belgium.
   Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris, France.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Vertommen, Didier/0000-0001-7648-8282
CR BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x
   Carniel E, 1996, J BACTERIOL, V178, P6743, DOI 10.1128/jb.178.23.6743-6751.1996
   Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x
   Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516
   CORNELIS G, 1987, REV INFECT DIS, V9, P64
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104
   Demers B, 1998, EMBO J, V17, P2894, DOI 10.1093/emboj/17.10.2894
   Foultier B, 2002, J MOL EVOL, V55, P37, DOI 10.1007/s00239-001-0089-7
   Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x
   GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011
   Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x
   HANSKI C, 1989, INFECT IMMUN, V57, P673, DOI 10.1128/IAI.57.3.673-678.1989
   HERMANT D, 1995, MOL MICROBIOL, V17, P781, DOI 10.1111/j.1365-2958.1995.mmi_17040781.x
   HIGH N, 1992, EMBO J, V11, P1991, DOI 10.1002/j.1460-2075.1992.tb05253.x
   ICHINOHE H, 1991, J CLIN MICROBIOL, V29, P846, DOI 10.1128/JCM.29.4.846-847.1991
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0
   ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0
   KANEKO S, 1987, J CLIN MICROBIOL, V25, P454, DOI 10.1128/JCM.25.2.454-455.1987
   KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Lafleur L, 1979, Contrib Microbiol Immunol, V5, P298
   MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9
   MARJAI E, 1987, ACTA MICROBIOL HUNG, V34, P97
   Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x
   Menard R, 1996, P NATL ACAD SCI USA, V93, P1254, DOI 10.1073/pnas.93.3.1254
   MENARD R, 1993, J BACTERIOL, V175, P5899
   MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7
   MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x
   Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x
   MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845
   Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Page AL, 1999, CELL MICROBIOL, V1, P183, DOI 10.1046/j.1462-5822.1999.00019.x
   Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x
   PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x
   PORTNOY DA, 1981, INFECT IMMUN, V31, P775, DOI 10.1128/IAI.31.2.775-782.1981
   Rakin A, 1999, INFECT IMMUN, V67, P5265, DOI 10.1128/IAI.67.10.5265-5274.1999
   ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988
   SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986
   SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982
   Sansonetti PJ, 1996, INFECT IMMUN, V64, P2752, DOI 10.1128/IAI.64.7.2752-2764.1996
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   SASAKAWA C, 1989, MOL MICROBIOL, V3, P1191, DOI 10.1111/j.1365-2958.1989.tb00269.x
   SASAKAWA C, 1988, J BACTERIOL, V170, P2480, DOI 10.1128/jb.170.6.2480-2484.1988
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126
   Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073
   TACKET CO, 1985, AM J EPIDEMIOL, V121, P705, DOI 10.1093/aje/121.5.705
   TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597
   Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51
   VENKATESAN MM, 1988, P NATL ACAD SCI USA, V85, P9317, DOI 10.1073/pnas.85.23.9317
   WASSEF JS, 1989, INFECT IMMUN, V57, P858, DOI 10.1128/IAI.57.3.858-863.1989
   Wauters G, 1987, Contrib Microbiol Immunol, V9, P14
   Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519
   Young BM, 2002, J BACTERIOL, V184, P5563, DOI 10.1128/JB.184.20.5563-5571.2002
   Young BM, 2002, J BACTERIOL, V184, P1324, DOI 10.1128/JB.184.5.1324-1334.2002
   ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0
   ZYCHLINSKY A, 1994, MOL MICROBIOL, V11, P619, DOI 10.1111/j.1365-2958.1994.tb00341.x
NR 65
TC 32
Z9 32
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD JAN
PY 2003
VL 71
IS 1
BP 242
EP 253
DI 10.1128/IAI.71.1.242-253.2003
PG 12
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 632EZ
UT WOS:000180212000030
PM 12496172
OA Green Published, Bronze
DA 2021-01-25
ER

PT S
AU Herrmann, H
   Hesse, M
   Reichenzeller, M
   Aebi, U
   Magin, TM
AF Herrmann, H
   Hesse, M
   Reichenzeller, M
   Aebi, U
   Magin, TM
BE Jeon, KW
TI Functional complexity of intermediate filament cytoskeletons: From
   structure to assembly to gene ablation
SO INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 223
SE INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY
LA English
DT Review
DE multigene family; intermediate filaments; IF assembly; diseases
ID FIBRILLARY ACIDIC PROTEIN; EPIDERMOLYSIS-BULLOSA SIMPLEX;
   AMYOTROPHIC-LATERAL-SCLEROSIS; HEAVY NEUROFILAMENT SUBUNIT; INNER
   NUCLEAR-MEMBRANE; MICE LACKING VIMENTIN; HUMAN KERATIN-18 GENE; HUMAN
   HAIR KERATINS; MOTOR-NEURON DEATH; MYOTUBES IN-VIVO
C1 German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
   Univ Bonn, Inst Physiol Chem, Div Cellular Biochem, D-53115 Bonn, Germany.
   Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Herrmann, H (corresponding author), German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
CR ABE M, 1990, J CELL BIOL, V111, P1197, DOI 10.1083/jcb.111.3.1197
   Abumuhor IA, 1998, J STRUCT BIOL, V123, P187, DOI 10.1006/jsbi.1998.4040
   AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Agbulut O, 2001, CELL MOTIL CYTOSKEL, V49, P51, DOI 10.1002/cm.1020
   Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157
   ALBERS KM, 1995, J CELL BIOL, V128, P157, DOI 10.1083/jcb.128.1.157
   Ameen NA, 2001, J CELL SCI, V114, P563
   Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143
   Arin MJ, 2001, J CELL BIOL, V152, P645, DOI 10.1083/jcb.152.3.645
   Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3
   ASKANAS V, 1990, NEUROLOGY, V40, P949, DOI 10.1212/WNL.40.6.949
   BADER BL, 1990, DIFFERENTIATION, V45, P109, DOI 10.1111/j.1432-0436.1990.tb00464.x
   BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293
   BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964
   BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191
   BARTNIK E, 1989, EUR J CELL BIOL, V50, P17
   Batta K, 2000, BRIT J DERMATOL, V143, P621, DOI 10.1046/j.1365-2133.2000.03722.x
   Bawden CS, 2001, J INVEST DERMATOL, V116, P157, DOI 10.1046/j.1523-1747.2001.00215.x
   Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41
   Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000
   BECKER B, 1995, BIOCHEM BIOPH RES CO, V213, P796, DOI 10.1006/bbrc.1995.2200
   Bellin RM, 1999, J BIOL CHEM, V274, P29493, DOI 10.1074/jbc.274.41.29493
   Berton TR, 2000, GENESIS, V26, P160, DOI 10.1002/(SICI)1526-968X(200002)26:2<160::AID-GENE20>3.0.CO;2-#
   Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346
   BLESSING M, 1987, EMBO J, V6, P567, DOI 10.1002/j.1460-2075.1987.tb04792.x
   BLESSING M, 1993, J CELL BIOL, V120, P743, DOI 10.1083/jcb.120.3.743
   BLIKSTAD I, 1983, J CELL BIOL, V96, P1803, DOI 10.1083/jcb.96.6.1803
   BLOUIN R, 1992, DIFFERENTIATION, V52, P45, DOI 10.1111/j.1432-0436.1992.tb00498.x
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799
   Boriek AM, 2001, AM J PHYSIOL-CELL PH, V280, pC46
   Borrmann CM, 2000, ANN NY ACAD SCI, V915, P144
   BOWDEN PE, 1995, NAT GENET, V10, P363, DOI 10.1038/ng0795-363
   Bray D., 2001, CELL MOVEMENTS MOL M
   Brenner M, 2001, NAT GENET, V27, P117
   Bridger JM, 1998, J CELL SCI, V111, P1241
   Brock J, 1996, CELL MOTIL CYTOSKEL, V35, P358, DOI 10.1002/(SICI)1097-0169(1996)35:4<358::AID-CM7>3.0.CO;2-2
   Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640
   Brown MJ, 2001, J IMMUNOL, V167, P641, DOI 10.4049/jimmunol.167.2.641
   BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   Candi E, 1998, P NATL ACAD SCI USA, V95, P2067, DOI 10.1073/pnas.95.5.2067
   Cao TY, 2001, J CELL BIOL, V152, P651, DOI 10.1083/jcb.152.3.651
   Capetanaki Y, 1998, Subcell Biochem, V31, P463
   Carlsson L, 2000, HISTOCHEM CELL BIOL, V114, P39
   CARTAUD A, 1989, J CELL BIOL, V109, P1745, DOI 10.1083/jcb.109.4.1745
   Carter J, 1998, J BIOL CHEM, V273, P5101, DOI 10.1074/jbc.273.9.5101
   Carthew RW, 2001, CURR OPIN CELL BIOL, V13, P244, DOI 10.1016/S0955-0674(00)00204-0
   CARY RB, 1994, DIFFERENTIATION, V56, P31, DOI 10.1046/j.1432-0436.1994.56120031.x
   CARY RB, 1994, J CELL BIOL, V126, P445, DOI 10.1083/jcb.126.2.445
   CASANOVA L, 1995, J CELL SCI, V108, P811
   Casanova ML, 1999, J CLIN INVEST, V103, P1587, DOI 10.1172/JCI5343
   Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5
   Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17
   Celebi JT, 1999, J INVEST DERMATOL, V113, P848, DOI 10.1046/j.1523-1747.1999.00762.x
   CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574
   CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3
   CHING GY, 1993, J CELL BIOL, V122, P1323, DOI 10.1083/jcb.122.6.1323
   CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4
   Chu YW, 1996, AM J PATHOL, V148, P63
   CHU YW, 1993, P NATL ACAD SCI USA, V90, P4261, DOI 10.1073/pnas.90.9.4261
   Cleveland DW, 1996, NEUROLOGY, V47, pS54, DOI 10.1212/WNL.47.4_Suppl_2.54S
   Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3
   Clubb BH, 2000, BIOCHEM BIOPH RES CO, V273, P183, DOI 10.1006/bbrc.2000.2916
   Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8
   COHLBERG JA, 1995, J BIOL CHEM, V270, P9334, DOI 10.1074/jbc.270.16.9334
   COLLIN C, 1992, EXP CELL RES, V202, P132, DOI 10.1016/0014-4827(92)90412-2
   COLLIN C, 1992, DIFFERENTIATION, V51, P137, DOI 10.1111/j.1432-0436.1992.tb00690.x
   Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J
   COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3
   CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3
   Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x
   Corden LD, 1998, HUM MUTAT, V11, P279, DOI 10.1002/(SICI)1098-1004(1998)11:4<279::AID-HUMU5>3.3.CO;2-5
   COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M
   Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626
   COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153
   Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5
   Covello SP, 1998, BRIT J DERMATOL, V139, P475
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x
   Dalpe G, 1999, DEV BIOL, V210, P367, DOI 10.1006/dbio.1999.9263
   DEIONGHE P, 2001, ANN NEUROL, V49, P245
   DENK H, 1979, P NATL ACAD SCI USA, V76, P4112, DOI 10.1073/pnas.76.8.4112
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   DORING V, 1990, EMBO J, V9, P4073, DOI 10.1002/j.1460-2075.1990.tb07629.x
   Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705
   DWORETZKY SI, 1988, J CELL BIOL, V107, P1279, DOI 10.1083/jcb.107.4.1279
   ECKELT A, 1992, EUR J CELL BIOL, V58, P319
   Eckes B, 1998, J CELL SCI, V111, P1897
   Eckes B, 2000, J CELL SCI, V113, P2455
   Eger A, 1997, J CELL SCI, V110, P1307
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727
   Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195
   Elliott CE, 1997, GENOMICS, V42, P115, DOI 10.1006/geno.1997.4724
   Erber A, 1999, J MOL EVOL, V49, P260, DOI 10.1007/PL00006548
   EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1
   Famulok M, 1999, CURR TOP MICROBIOL, V243, P123
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   FERRARI S, 1986, MOL CELL BIOL, V6, P3614, DOI 10.1128/MCB.6.11.3614
   FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757
   Fisk HA, 1997, J CELL BIOL, V138, P485, DOI 10.1083/jcb.138.3.485
   Foisner R, 2001, J CELL SCI, V114, P3791
   Foisner R, 1996, MOL BIOL CELL, V7, P273
   FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723
   FRANKE WW, 1982, DIFFERENTIATION, V23, P115, DOI 10.1111/j.1432-0436.1982.tb01274.x
   FRANKE WW, 1981, BIOL CELL, V41, P173
   FRANKE WW, 1982, BIOL CELL, V46, P257
   FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x
   FRANKE WW, 1987, CELL, V48, P3, DOI 10.1016/0092-8674(87)90345-X
   FRANZ JK, 1986, P NATL ACAD SCI USA, V83, P6475, DOI 10.1073/pnas.83.17.6475
   FRAPPIER T, 1987, EUR J BIOCHEM, V169, P651, DOI 10.1111/j.1432-1033.1987.tb13657.x
   Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517
   Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x
   FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X
   Fuchs E, 1996, ANNU REV GENET, V30, P197, DOI 10.1146/annurev.genet.30.1.197
   Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011
   Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501
   Fujimoto W, 1998, J AM ACAD DERMATOL, V38, P1007, DOI 10.1016/S0190-9622(98)70170-7
   Fujiwara S, 2001, J BIOL CHEM, V276, P13340, DOI 10.1074/jbc.M011386200
   Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009
   Galou M, 1997, BIOL CELL, V89, P85, DOI 10.1016/S0248-4900(99)80068-9
   Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669
   GARD AL, 1985, J NEUROIMMUNOL, V8, P359, DOI 10.1016/S0165-5728(85)80073-4
   GEERTS A, 1991, HEPATOLOGY, V13, P1193, DOI 10.1016/0270-9139(91)92491-P
   Geerts A, 2001, HEPATOLOGY, V33, P177, DOI 10.1053/jhep.2001.21045
   Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417
   GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x
   GEISLER N, 1993, J STRUCT BIOL, V110, P205, DOI 10.1006/jsbi.1993.1023
   Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995
   GEISLER N, 1981, J MOL BIOL, V151, P565, DOI 10.1016/0022-2836(81)90011-5
   GEORGATOS SD, 1987, J CELL BIOL, V105, P117, DOI 10.1083/jcb.105.1.117
   GEORGATOS SD, 1987, P NATL ACAD SCI USA, V84, P6780, DOI 10.1073/pnas.84.19.6780
   GEORGATOS SD, 1987, J CELL BIOL, V105, P105, DOI 10.1083/jcb.105.1.105
   GERHART J, 1997, CELLS EMBRYOLOGY EVO
   Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130
   GILL SR, 1990, J CELL BIOL, V111, P2005, DOI 10.1083/jcb.111.5.2005
   GOLDMAN JE, 1983, SCIENCE, V221, P1082, DOI 10.1126/science.6308771
   Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971
   Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502
   GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4
   Grant SGN, 2001, TRENDS BIOTECHNOL, V19, pS49, DOI 10.1016/S0167-7799(01)01799-1
   Green Kathleen J., 1992, Journal of Dermatology (Tokyo), V19, P765
   Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271
   GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X
   Harborth J, 2001, J CELL SCI, V114, P4557
   HATZFELD M, 1990, J CELL SCI, V97, P317
   HATZFELD M, 1994, J CELL SCI, V107, P1959
   HATZFELD M, 1992, J CELL BIOL, V116, P157, DOI 10.1083/jcb.116.1.157
   HATZFELD M, 1985, J CELL BIOL, V101, P1826, DOI 10.1083/jcb.101.5.1826
   Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   HERRMANN H, 1983, J BIOL CHEM, V258, P4610
   HERRMANN H, 1987, J BIOL CHEM, V262, P1320
   HERRMANN H, 1989, DEVELOPMENT, V105, P279
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   HERRMANN H, 1993, J MOL BIOL, V234, P99, DOI 10.1006/jmbi.1993.1566
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   Herrmann H, 1998, Subcell Biochem, V31, P319
   Herrmann H, 1999, PROTOPLASMA, V209, P157, DOI 10.1007/BF01453444
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   HERRMANN H, 1999, GUIDEBOOK CYTOSKELET, P313
   HERRMANN H, 1998, SUBCELLULAR BIOCH, V31
   Hesse M, 2001, J CELL SCI, V114, P2569
   Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060
   Hijikata T, 1999, J CELL SCI, V112, P867
   HIRANO A, 1991, ADV NEUROL, V56, P91
   Hirokawa N, 1998, J CELL BIOL, V143, P1, DOI 10.1083/jcb.143.1.1
   Hofemeister H, 2000, MOL BIOL CELL, V11, P3233, DOI 10.1091/mbc.11.9.3233
   HOFMANN I, 1992, J CELL SCI, V101, P687
   Hofmann I, 2000, J CELL SCI, V113, P2471
   HOGER TH, 1991, EUR J CELL BIOL, V54, P150
   HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327
   HUIATT TW, 1980, J BIOL CHEM, V255, P6981
   HUME WJ, 1976, J CELL SCI, V22, P149
   Hut PHL, 2000, J INVEST DERMATOL, V114, P616, DOI 10.1046/j.1523-1747.2000.00928.x
   Hutchison CJ, 2001, J CELL SCI, V114, P9
   Hutton E, 1998, J CELL BIOL, V143, P487, DOI 10.1083/jcb.143.2.487
   Ikeda A, 2002, NAT GENET, V30, P401, DOI 10.1038/ng838
   Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078
   Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610
   IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5
   Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x
   ISHIKAWA H, 1968, J CELL BIOL, V38, P538, DOI 10.1083/jcb.38.3.538
   JACKSON BW, 1980, DIFFERENTIATION, V17, P161, DOI 10.1111/j.1432-0436.1980.tb01093.x
   JACKSON BW, 1981, DIFFERENTIATION, V20, P203, DOI 10.1111/j.1432-0436.1981.tb01177.x
   Jacomy H, 1999, J NEUROCHEM, V73, P972, DOI 10.1046/j.1471-4159.1999.0730972.x
   Jonkman MF, 1996, J INVEST DERMATOL, V107, P764, DOI 10.1111/1523-1747.ep12365805
   Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5
   Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6
   JULIEN JP, 1986, MOL BRAIN RES, V1, P243, DOI 10.1016/0169-328X(86)90030-6
   Kalinin A, 2001, J CELL SCI, V114, P3069
   Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998
   KARTENBECK J, 1984, J CELL BIOL, V98, P1072, DOI 10.1083/jcb.98.3.1072
   KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x
   KAUFMAN SJ, 1988, P NATL ACAD SCI USA, V85, P9606, DOI 10.1073/pnas.85.24.9606
   Kay L, 1997, BBA-BIOENERGETICS, V1322, P41, DOI 10.1016/S0005-2728(97)00071-6
   Kirfel J, 2002, DIFFERENTIATION, V70, P56, DOI 10.1046/j.1432-0436.2002.700106.x
   Klapper M, 1997, J CELL SCI, V110, P2519
   Kofron M, 1997, DEVELOPMENT, V124, P1553
   Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052
   Kordeli E, 1998, J CELL SCI, V111, P2197
   KORDELI E, 1986, J CELL BIOL, V102, P748, DOI 10.1083/jcb.102.3.748
   KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910
   KOSZKA C, 1985, EUR J CELL BIOL, V38, P149
   KOUKLIS PD, 1993, J CELL SCI, V106, P919
   KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049
   Kowalczyk AP, 1999, INT REV CYTOL, V185, P237
   KREIS TE, 1983, CELL, V32, P1125, DOI 10.1016/0092-8674(83)90296-9
   Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892
   Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108
   KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303
   Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023
   Ku NO, 1997, J CLIN INVEST, V99, P19, DOI 10.1172/JCI119127
   Ku NO, 2001, NEW ENGL J MED, V344, P1580, DOI 10.1056/NEJM200105243442103
   KULESH DA, 1988, MOL CELL BIOL, V8, P1540, DOI 10.1128/MCB.8.4.1540
   Kupriyanov S, 1998, BIOCHEM CELL BIOL, V76, P1017, DOI 10.1139/bcb-76-6-1017
   LACOUR JP, 1991, BRIT J DERMATOL, V125, P535, DOI 10.1111/j.1365-2133.1991.tb14790.x
   Lampe PD, 1998, J CELL BIOL, V143, P1735, DOI 10.1083/jcb.143.6.1735
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   LANE EB, 1983, NATURE, V303, P701, DOI 10.1038/303701a0
   LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0
   Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874
   Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200
   LANGLEY RC, 1986, J CELL BIOCHEM, V30, P101, DOI 10.1002/jcb.240300202
   LANGLEY RC, 1987, CELL MOTIL CYTOSKEL, V8, P165, DOI 10.1002/cm.970080208
   LAZARIDES E, 1976, P NATL ACAD SCI USA, V73, P4344, DOI 10.1073/pnas.73.12.4344
   LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251
   LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0
   LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337
   LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1
   Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155
   LEE VMY, 1988, P NATL ACAD SCI USA, V85, P7384, DOI 10.1073/pnas.85.19.7384
   LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001
   LEUBE RE, 1988, J CELL BIOL, V106, P1249, DOI 10.1083/jcb.106.4.1249
   Leung CL, 2001, J CELL SCI, V114, P3409
   Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461
   Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122
   Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4
   LIESKA N, 1985, J CELL BIOL, V101, P802, DOI 10.1083/jcb.101.3.802
   Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937
   Livingston RJ, 2001, J INVEST DERMATOL, V116, P970, DOI 10.1046/j.1523-1747.2001.01324.x
   LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329
   Loranger A, 1997, AM J PATHOL, V151, P1673
   LOTSCH D, 2000, THESIS U HEIDELBERG
   Machesney M, 1998, AM J PATHOL, V152, P1133
   MACK JW, 1993, J MOL BIOL, V232, P50, DOI 10.1006/jmbi.1993.1369
   MAGIN TM, 1990, EUR J CELL BIOL, V53, P333
   Magin TM, 2000, PROTOPLASMA, V211, P140, DOI 10.1007/BF01304482
   Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441
   Magin TM, 2000, J CELL SCI, V113, P4231
   Magro CM, 1997, J AM ACAD DERMATOL, V37, P27, DOI 10.1016/S0190-9622(97)70208-1
   Makino T, 2001, J BIOL CHEM, V276, P47445, DOI 10.1074/jbc.M107512200
   Martys JL, 1999, MOL BIOL CELL, V10, P1289, DOI 10.1091/mbc.10.5.1289
   Marx A, 2000, CELL MOL BIOL, V46, P949
   McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361
   McGowan K, 1998, Subcell Biochem, V31, P173
   McGowan KM, 2000, J INVEST DERMATOL, V114, P1101, DOI 10.1046/j.1523-1747.2000.00986.x
   McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240
   MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118
   Menet V, 2000, GLIA, V31, P267, DOI 10.1002/1098-1136(200009)31:3<267::AID-GLIA80>3.0.CO;2-N
   Meng JJ, 1997, J BIOL CHEM, V272, P21495, DOI 10.1074/jbc.272.34.21495
   Mersiyanova IV, 2000, AM J HUM GENET, V67, P37, DOI 10.1086/302962
   Mertens C, 1999, DIFFERENTIATION, V64, P277, DOI 10.1007/s002580050281
   Messing A, 1998, AM J PATHOL, V152, P391
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Michel M, 1996, J CELL SCI, V109, P1017
   Mills GB, 2001, J NATL CANCER I, V93, P1437, DOI 10.1093/jnci/93.19.1437
   Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198
   Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   MING ME, 1994, J INVEST DERMATOL, V103, P780, DOI 10.1111/1523-1747.ep12413024
   MISCHKE D, 1987, J INVEST DERMATOL, V88, P191, DOI 10.1111/1523-1747.ep12525329
   Mizuno Y, 2001, P NATL ACAD SCI USA, V98, P6156, DOI 10.1073/pnas.111153298
   Mizuno Y, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-8
   MOLL I, 1994, PHOTODERMATOL PHOTO, V10, P26
   MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7
   Moll R, 1998, Subcell Biochem, V31, P205
   MUELLER H, 1983, J MOL BIOL, V163, P647, DOI 10.1016/0022-2836(83)90116-X
   NAVARRO JM, 1995, J BIOL CHEM, V270, P21362, DOI 10.1074/jbc.270.36.21362
   Newey SE, 2001, J BIOL CHEM, V276, P6645, DOI 10.1074/jbc.M008305200
   NGAI J, 1990, CELL, V60, P415, DOI 10.1016/0092-8674(90)90593-4
   Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9
   Niki T, 1999, HEPATOLOGY, V29, P520, DOI 10.1002/hep.510290232
   OSBORN M, 1989, LAB INVEST, V61, P585
   OSHEA JM, 1979, BIOCHEM BIOPH RES CO, V89, P972, DOI 10.1016/0006-291X(79)91873-4
   Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2
   OSHIMA RG, 1983, DEV BIOL, V99, P447, DOI 10.1016/0012-1606(83)90294-4
   Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381
   Paladini RD, 1999, J CELL BIOL, V146, P1185, DOI 10.1083/jcb.146.5.1185
   Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035
   Paramio JM, 1999, MOL CELL BIOL, V19, P3086
   Paramio JM, 2001, MOL CELL BIOL, V21, P7449, DOI 10.1128/MCB.21.21.7449-7459.2001
   Parry DAD, 1995, INTERMEDIATE FILAMEN
   PARRY DAD, 1999, GUIDEBOOK CYTOSKELET, P285
   Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159
   PAULIN D, 1980, EXP CELL RES, V130, P297, DOI 10.1016/0014-4827(80)90006-3
   PAULSON RB, 1985, J CRAN GENET DEV BIO, V5, P59
   PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x
   PEKRY M, 2001, PROG BRAIN RES, V132, P23
   Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775
   POLLANEN MS, 1994, ACTA NEUROPATHOL, V88, P1, DOI 10.1007/BF00294352
   Porter RM, 2000, LAB INVEST, V80, P1701, DOI 10.1038/labinvest.3780180
   Porter RM, 1998, J BIOL CHEM, V273, P32265, DOI 10.1074/jbc.273.48.32265
   Porter RM, 1998, J INVEST DERMATOL, V110, P951, DOI 10.1046/j.1523-1747.1998.00218.x
   Porter RM, 1996, J CELL BIOL, V132, P925, DOI 10.1083/jcb.132.5.925
   POTTEN CS, 1987, VIRCHOWS ARCH B, V53, P279, DOI 10.1007/BF02890254
   Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159
   PRICE MG, 1987, J CELL BIOL, V104, P1325, DOI 10.1083/jcb.104.5.1325
   PYTELA R, 1980, P NATL ACAD SCI-BIOL, V77, P4808, DOI 10.1073/pnas.77.8.4808
   PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8
   Quinlan R, 1995, PROTEIN PROFILE, V2, P801
   Quinlan R, 1999, NAT MED, V5, P25, DOI 10.1038/4704
   Quinlan R, 2001, NAT GENET, V27, P10, DOI 10.1038/83657
   QUINLAN RA, 1986, J MOL BIOL, V192, P337, DOI 10.1016/0022-2836(86)90369-4
   Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557
   Reichenzeller M, 2000, J STRUCT BIOL, V129, P175, DOI 10.1006/jsbi.2000.4224
   Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626
   Relchelt J, 2002, J CELL SCI, V115, P2639
   RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X
   RHODES G, 1993, CRYSTALLOGRAPHY MADE
   Riemer D, 1998, J CELL SCI, V111, P2967
   RITTLING SR, 1987, MOL CELL BIOL, V7, P3908, DOI 10.1128/MCB.7.11.3908
   ROGERS KR, 1995, EUR J CELL BIOL, V66, P136
   Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069
   Rogers MA, 2000, J INVEST DERMATOL, V114, P464, DOI 10.1046/j.1523-1747.2000.00910.x
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   ROSENBERG M, 1988, MOL CELL BIOL, V8, P722, DOI 10.1128/MCB.8.2.722
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Rothnagel JA, 1999, DIFFERENTIATION, V65, P119, DOI 10.1046/j.1432-0436.1999.6520119.x
   ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128
   RUEGER DC, 1981, J BIOL CHEM, V256, P606
   RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563
   Ruhrberg C, 1997, CURR OPIN GENET DEV, V7, P392, DOI 10.1016/S0959-437X(97)80154-2
   Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215
   Ruud P, 1999, INT J CANCER, V80, P119, DOI 10.1002/(SICI)1097-0215(19990105)80:1<119::AID-IJC22>3.0.CO;2-X
   Sanchez I, 2000, J CELL BIOL, V151, P1013, DOI 10.1083/jcb.151.5.1013
   SAVTCHENKO ES, 1990, GENOMICS, V7, P394, DOI 10.1016/0888-7543(90)90174-S
   Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206
   Schliwa M., 1986, CELL BIOL MONOGRAPHS, V13
   SCHMIDT ML, 1991, AM J PATHOL, V139, P53
   Schroder R, 1999, EUR J CELL BIOL, V78, P288, DOI 10.1016/S0171-9335(99)80062-4
   Schroder R, 1997, EUR J CELL BIOL, V74, P165
   SCHULZ GE, 1979, PRINCIPLES PROTEIN S, P1
   SCHWARZ MA, 1990, ANNU REV CELL BIOL, V6, P461, DOI 10.1146/annurev.cellbio.6.1.461
   Schweitzer SC, 2001, J CELL SCI, V114, P1079
   SEALOCK R, 1989, SYNAPSE, V3, P315, DOI 10.1002/syn.890030404
   SEJERSEN T, 1993, J CELL SCI, V106, P1291
   SHAMSHER MK, 1995, HUM MOL GENET, V4, P1875, DOI 10.1093/hmg/4.10.1875
   SHAW G, 1982, NATURE, V298, P277, DOI 10.1038/298277a0
   SHENK MA, 1993, TRENDS BIOCHEM SCI, V18, P459
   Smith EA, 1998, J CELL BIOL, V141, P1229, DOI 10.1083/jcb.141.5.1229
   Smith FJD, 1999, PRENATAL DIAG, V19, P941, DOI 10.1002/(SICI)1097-0223(199910)19:10<941::AID-PD663>3.0.CO;2-W
   Smith FJD, 1999, BRIT J DERMATOL, V141, P1010, DOI 10.1046/j.1365-2133.1999.03198.x
   Smith M, 1998, JNMS-J NEUROMUSC SYS, V6, P17
   Smith WL, 1999, ACAD RADIOL, V6, P1, DOI 10.1016/S1076-6332(99)80054-3
   SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929
   Sprecher E, 2001, J INVEST DERMATOL, V116, P511, DOI 10.1046/j.1523-1747.2001.01292.x
   STAPPENBECK TS, 1992, J CELL BIOL, V116, P1197, DOI 10.1083/jcb.116.5.1197
   STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93
   Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000
   STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2
   STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702
   STEINERT PM, 1993, J BIOL CHEM, V268, P2878
   Steinert PM, 1997, J BIOL CHEM, V272, P2021, DOI 10.1074/jbc.272.3.2021
   STEINERT PM, 1981, ELECTRON MICROS, V1, P126
   STEVEN AC, 1982, P NATL ACAD SCI-BIOL, V79, P3101, DOI 10.1073/pnas.79.10.3101
   Stone JD, 2001, J NEUROSCI, V21, P2278
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Stumptner C, 2001, J HEPATOL, V34, P665, DOI 10.1016/S0168-8278(00)00099-4
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913
   Suzuki N, 1998, P NATL ACAD SCI USA, V95, P5027, DOI 10.1073/pnas.95.9.5027
   Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991
   TAKAHASHI K, 1994, J CELL BIOL, V127, P505, DOI 10.1083/jcb.127.2.505
   Takahashi K, 1998, GENOMICS, V53, P170, DOI 10.1006/geno.1998.5476
   TAKAHASHI K, 1995, J BIOL CHEM, V270, P18581, DOI 10.1074/jbc.270.31.18581
   Tamai Y, 2000, J CELL BIOL, V151, P563, DOI 10.1083/jcb.151.3.563
   Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7
   Terasaki M, 2001, MOL BIOL CELL, V12, P503, DOI 10.1091/mbc.12.2.503
   Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675
   Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446
   TIDBALL JG, 1992, EXP CELL RES, V199, P206, DOI 10.1016/0014-4827(92)90425-8
   TIOVOLA DM, 2000, AM J PHYSIOL-GASTR L, V279, pG1343
   Titeux M, 2001, EUR J BIOCHEM, V268, P6435, DOI 10.1046/j.0014-2956.2001.02594.x
   Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374
   Toivola DM, 1998, HEPATOLOGY, V28, P116, DOI 10.1002/hep.510280117
   Toivola DM, 2000, EXP CELL RES, V255, P156, DOI 10.1006/excr.1999.4787
   TOKUYASU KT, 1983, J CELL BIOL, V96, P1736, DOI 10.1083/jcb.96.6.1736
   TOKUYASU KT, 1983, J CELL BIOL, V97, P562, DOI 10.1083/jcb.97.2.562
   TOKUYASU KT, 1985, J CELL BIOL, V100, P1157, DOI 10.1083/jcb.100.4.1157
   TOKUYASU KT, 1984, J CELL BIOL, V98, P1961, DOI 10.1083/jcb.98.6.1961
   Tomkins J, 1998, NEUROREPORT, V9, P3967, DOI 10.1097/00001756-199812010-00036
   Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901
   TRAUB P, 1985, INTERMEDIAT FILAMENT
   Troy TC, 1999, J CELL PHYSIOL, V180, P409, DOI 10.1002/(SICI)1097-4652(199909)180:3<409::AID-JCP12>3.0.CO;2-V
   TROYANOVSKY SM, 1992, EUR J CELL BIOL, V59, P127
   van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134
   van Roessel P, 2002, NAT CELL BIOL, V4, pE15, DOI 10.1038/ncb0102-e15
   Vlcek S, 2001, CELL MOL LIFE SCI, V58, P1758, DOI 10.1007/PL00000815
   Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889
   WASEEM A, 1990, New Biologist, V2, P464
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Wawersik M, 2000, MOL BIOL CELL, V11, P3315, DOI 10.1091/mbc.11.10.3315
   Wawersik MJ, 2001, MOL BIOL CELL, V12, P3439, DOI 10.1091/mbc.12.11.3439
   WEBER K, 1984, CANCER CELL, V1, P153
   WEBER K, 1999, GUIDEBOOK CYTOSKELET, P291
   WICHE G, 1991, J CELL BIOL, V114, P83, DOI 10.1083/jcb.114.1.83
   Wiche G, 1998, J CELL SCI, V111, P2477
   WICHE G, 1983, J CELL BIOL, V97, P887, DOI 10.1083/jcb.97.3.887
   WICHE G, 1981, COLD SPRING HARB SYM, V46, P475
   Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631
   Wilson KL, 2000, TRENDS CELL BIOL, V10, P125, DOI 10.1016/S0962-8924(99)01708-0
   Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6
   Windoffer R, 1999, J CELL SCI, V112, P4521
   Windoffer R, 2001, CELL MOTIL CYTOSKEL, V50, P33, DOI 10.1002/cm.1039
   Winter H, 1998, J INVEST DERMATOL, V111, P955, DOI 10.1046/j.1523-1747.1998.00456.x
   Winter H, 2001, HUM GENET, V108, P37, DOI 10.1007/s004390000439
   Wojcik SM, 1999, DIFFERENTIATION, V65, P97, DOI 10.1046/j.1432-0436.1999.6520097.x
   Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000
   Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079
   Wong P, 2000, J CELL BIOL, V150, P921, DOI 10.1083/jcb.150.4.921
   WONG PC, 1995, J CELL BIOL, V130, P1413, DOI 10.1083/jcb.130.6.1413
   Xu GM, 2001, J BIOL CHEM, V276, P46544, DOI 10.1074/jbc.M107828200
   XU ZS, 1993, J CELL SCI, P101
   Yabe JT, 2000, CELL MOTIL CYTOSKEL, V45, P249, DOI 10.1002/(SICI)1097-0169(200004)45:4<249::AID-CM1>3.0.CO;2-M
   Yabe JT, 1999, J CELL SCI, V112, P3799
   Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503
   Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147
   ZACKROFF RV, 1979, P NATL ACAD SCI USA, V76, P6226, DOI 10.1073/pnas.76.12.6226
   Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8
   Zhang JS, 2001, GENE CHROMOSOME CANC, V30, P123, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1070>3.0.CO;2-W
NR 439
TC 145
Z9 149
U1 0
U2 10
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0074-7696
BN 0-12-364627-8
J9 INT REV CYTOL
JI Int.Rev.Cytol.
PY 2003
VL 223
BP 83
EP +
PG 106
WC Cell Biology
SC Cell Biology
GA BW35F
UT WOS:000181665000003
PM 12641211
DA 2021-01-25
ER

PT J
AU Gehring, W
   Rosbash, M
AF Gehring, W
   Rosbash, M
TI The coevolution of blue-light photoreception and circadian rhythms
SO JOURNAL OF MOLECULAR EVOLUTION
LA English
DT Article; Proceedings Paper
CT Meeting on Evolution, Genomics and Bioinformatics
CY JUN 13-16, 2002
CL SORRENTO, ITALY
SP MURST, UNESCO Reg Bur Sci Europe, Academia Europaea, Int Soc Mol Evolut, Soc Mol Biol & Evolut
DE cryptochromes; circadian rhythms; UV avoidance; photolyases
ID DIEL VERTICAL MIGRATION; RETINAL GANGLION-CELLS; RETINOHYPOTHALAMIC
   TRACT; ULTRAVIOLET-RADIATION; DNA PHOTOLYASE; DAPHNIA-MAGNA; DROSOPHILA;
   CLOCK; CRYPTOCHROME; MELANOPSIN
AB Sunlight is a primary source of energy for life. However, its UV component causes DNA damage. We suggest that the strong UV component of sunlight contributed to the selective pressure for the evolution of the specialized photoreceptor cryptochrome from photolyases involved in DNA repair and propose that early metazoans avoided irradiation by descending in the oceans during the daytime. We suggest further that it is not coincidental that blue-light photoreception evolved in an aquatic environment, since only blue light can penetrate to substantial depths in water. These photoreceptors were then also critical for sensing the decreased luminescence that signals the coming of night and the time to return to the surface. The oceans and the 24-h light-dark cycle therefore provided an optimal setting for an early evolutionary relationship between blue-light photoreception and circadian rhythmicity.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA.
RP Gehring, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262
   BODEN BRIAN P., 1967, SYMP ZOOL SOC LONDON, V19, P15
   BOGOROV BG, 1946, J MAR RES, V6, P25
   Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760
   CUSHING DH, 1951, BIOL REV, V26, P158, DOI 10.1111/j.1469-185X.1951.tb00645.x
   CUVIER G, 1829, REGNE ANIMAL, V4, P164
   Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499
   Egan ES, 1999, J NEUROSCI, V19, P3665
   Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558
   Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2
   FLEISCHMANN EM, 1989, LIMNOL OCEANOGR, V34, P1623, DOI 10.4319/lo.1989.34.8.1623
   Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768
   Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002
   Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609
   Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X
   HUNTSMAN A. G, 1924, CONTRIB CAN BIOL, V2, P82
   KLUGH A. BROOKER, 1930, CANADIAN JOUR RES, V2, P312
   Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094
   Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4
   Lampert Winfried, 1993, Advances in Limnology, V39, P79
   Leech DM, 2001, LIMNOL OCEANOGR, V46, P416, DOI 10.4319/lo.2001.46.2.0416
   Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235
   Nybakken J. W., 2001, MARINE BIOL ECOLOGIC
   OHMAN MD, 1990, ECOL MONOGR, V60, P257, DOI 10.2307/1943058
   Okano S, 1999, PHOTOCHEM PHOTOBIOL, V69, P108
   PENNINGTON JT, 1986, J EXP MAR BIOL ECOL, V104, P69, DOI 10.1016/0022-0981(86)90098-5
   PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P17
   Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a
   Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000
   Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31
   SANCAR A, 1994, BIOCHEMISTRY-US, V33, P2, DOI 10.1021/bi00167a001
   Schopf J.W., 1983, P361
   Selby CP, 1999, PHOTOCHEM PHOTOBIOL, V69, P105, DOI 10.1111/j.1751-1097.1999.tb05313.x
   Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597
   SMITH KC, 1990, J COMP PHYSIOL A, V166, P597
   Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4
   Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293
   Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498
   Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109
   van der Horst GTJ, 1999, NATURE, V398, P627
NR 40
TC 66
Z9 67
U1 2
U2 27
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0022-2844
J9 J MOL EVOL
JI J. Mol. Evol.
PY 2003
VL 57
SU 1
BP S286
EP S289
DI 10.1007/s00239-003-0038-8
PG 4
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA 740HB
UT WOS:000186396000030
PM 15008426
DA 2021-01-25
ER

PT S
AU Bartoccioni, E
   Marino, M
   Evoli, A
   Ruegg, MA
   Scuderi, F
   Provenzano, C
AF Bartoccioni, E
   Marino, M
   Evoli, A
   Ruegg, MA
   Scuderi, F
   Provenzano, C
BE Agius, MA
   Richman, DP
   Fairclough, RH
   Maselli, RA
TI Identification of disease-specific autoantibodies in seronegative
   myasthenia gravis
SO MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE
   OF THE NEUROMUSCULAR JUNCTION
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Myasthenia Gravis and Related Disorders
CY MAY, 2002
CL KEY BISCAYNE, FLORIDA
SP New York Acad Sci, Myasthenia Gravis Fdn Amer Inc
DE myasthenia gravis; muscle-specific kinase; MuSK; seronegative
   myasthenia; autoantibody; autoimmunity
ID ACETYLCHOLINE-RECEPTOR; ANTIBODIES
C1 Catholic Univ, Inst Gen Pathol, I-00168 Rome, Italy.
   Catholic Univ, Inst Neurol, I-00168 Rome, Italy.
   Univ Basel, Biozentrum, CH-4051 Basel, Switzerland.
RP Bartoccioni, E (corresponding author), Catholic Univ, Inst Gen Pathol, Largo Francesco Vito 1, I-00168 Rome, Italy.
RI Provenzano, Carlo/D-4573-2012; Ruegg, Markus/X-7256-2019
OI Provenzano, Carlo/0000-0001-5476-5517; Ruegg,
   Markus/0000-0002-4974-9384; MARINO, Mariapaola/0000-0001-9155-6378
CR Blaes F, 2000, ANN NEUROL, V47, P504, DOI 10.1002/1531-8249(200004)47:4<504::AID-ANA14>3.0.CO;2-Q
   Evoli A, 1996, NEUROMUSCULAR DISORD, V6, P155, DOI 10.1016/0960-8966(96)00009-0
   Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520
   MOSSMAN S, 1986, LANCET, V1, P116
   PROVENZANO C, 1988, J NEUROL NEUROSUR PS, V51, P1228, DOI 10.1136/jnnp.51.9.1228
   Scuderi F, 2002, LAB INVEST, V82, P1139, DOI 10.1097/01.LAB.0000028144.48023.9B
NR 6
TC 1
Z9 1
U1 0
U2 2
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-396-3
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2003
VL 998
BP 356
EP 358
DI 10.1196/annals.1254.041
PG 3
WC Biochemistry & Molecular Biology; Immunology; Multidisciplinary
   Sciences; Neurosciences
SC Biochemistry & Molecular Biology; Immunology; Science & Technology -
   Other Topics; Neurosciences & Neurology
GA BX68C
UT WOS:000186107400040
PM 14592896
DA 2021-01-25
ER

PT J
AU Gemperle, AY
   Enz, A
   Pozza, MF
   Luthi, A
   Olpe, HR
AF Gemperle, AY
   Enz, A
   Pozza, MF
   Luthi, A
   Olpe, HR
TI Effects of clozapine, haloperidol and iloperidone on neurotransmission
   and synaptic plasticity in prefrontal cortex and their accumulation in
   brain tissue: An in vitro study
SO NEUROSCIENCE
LA English
DT Review
DE antipsychotic drugs; prelimbic cortex; schizophrenia; LTP; NMDA
   receptor; tissue concentration
ID LONG-TERM POTENTIATION; METHYL-D-ASPARTATE; ATYPICAL
   ANTIPSYCHOTIC-DRUGS; NEOCORTICAL NEURONS INVITRO; CORTICAL PYRAMIDAL
   NEURONS; PRIMARY VISUAL-CORTEX; RAT MOTOR CORTEX; NMDA RECEPTOR;
   IN-VITRO; SCHIZOPHRENIC-PATIENTS
AB The mode of action of the antipsychotic drugs clozapine, haloperidol and iloperidone was investigated in layer V of prefrontal cortex slices using extracellular field potential, intracellular sharp-electrode as well as whole-cell voltage clamp recording techniques. Intracellular investigations on a broad range of concentrations I revealed that the typical neuroleptic haloperidol at higher concentrations significantly depressed the excitatory postsynaptic component induced by electrical stimulation of layer II. This was not seen with the atypical neuroleptics clozapine and iloperidone. None of the three compounds had any effect on the resting membrane potential, spike amplitude or input resistance at relevant concentrations. Synaptic plasticity was assessed by means of extracellular field potential recordings. Clozapine significantly facilitated the potentiation of synaptic transmission, whereas haloperidol and iloperidone showed no effects. In line with its facilitating effect on synaptic plasticity, it could be demonstrated by whole-cell voltage clamp recordings that clozapine increased N-methyl-D-aspartic acid receptor-mediated excitatory postsynaptic currents in the majority of prefrontal cortical neurones. These investigations were made with neuroleptic drugs applied to the bath in the micromolar concentration range in order to approach clinical brain concentrations that are reached after administration of therapeutic doses. The drug concentrations reached in the slices after the experiments were assessed by means of high-pressure liquid chromatography coupled with mass-spectrometric detection. Surprisingly, drug accumulation in the in vitro preparation was of similar degree as reported in vivo.
   In conclusion, the typical neuroleptic haloperidol significantly depressed excitatory synaptic transmission in layer V neurones of the prefrontal cortex. In contrast, the two atypical neuroleptics, iloperidone and clozapine revealed no depressing effects. This feature of the atypical neuroleptics might be beneficial since a hypofunctionality of this brain area is thought to be linked with the pathophysiology of schizophrenia. Additionally, clozapine facilitated long-term potentiation, which might be linked with the clinically observed beneficial effects on certain cognitive parameters. The clozapine-induced increase of N-methyl-D-aspartic acid receptor-mediated currents suggests that clozapine facilitates the, induction of long-term potentiation. Furthermore, the present study points to the importance of considering the significant accumulation of neuroleptic drugs in in vitro studies. (C) 2003 IBRO. Published by Elsevier Science Ltd. All rights reserved.
C1 Novartis Pharma AG, Nervous Syst Res, CH-4002 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Olpe, HR (corresponding author), Novartis Pharma AG, Nervous Syst Res, CH-4002 Basel, Switzerland.
CR Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0
   ARONIADOU VA, 1993, J NEUROPHYSIOL, V70, P1553
   Arvanov VL, 1997, J PHARMACOL EXP THER, V283, P226
   Arvanov VL, 1999, J PHARMACOL EXP THER, V289, P1000
   BALDESSARINI RJ, 1993, NEUROPSYCHOPHARMACOL, V9, P117, DOI 10.1038/npp.1993.50
   BALDESSARINI RJ, 1988, ARCH GEN PSYCHIAT, V45, P79
   Banerjee SP, 1995, NEUROREPORT, V6, P2500, DOI 10.1097/00001756-199512150-00014
   BEAR MF, 1992, J NEUROPHYSIOL, V67, P841
   CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M
   CASSENS G, 1990, SCHIZOPHRENIA BULL, V16, P477, DOI 10.1093/schbul/16.3.477
   Ceci A, 1999, NEUROSCIENCE, V93, P107, DOI 10.1016/S0306-4522(99)00123-2
   CLEGHORN JM, 1990, SCHIZOPHR RES, V3, P211, DOI 10.1016/0920-9964(90)90038-9
   COHEN BM, 1992, PSYCHOPHARMACOLOGY, V108, P338, DOI 10.1007/BF02245121
   CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302
   CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D
   CORBETT R, 1995, PSYCHOPHARMACOLOGY, V120, P67, DOI 10.1007/BF02246146
   CUTMORE TRH, 1990, SCHIZOPHR RES, V3, P173, DOI 10.1016/0920-9964(90)90035-6
   DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474
   FLETCHER EJ, 1994, EUR J PHARM-MOLEC PH, V267, P249, DOI 10.1016/0922-4106(94)90178-3
   FLETCHER EJ, 1993, EUR J PHARMACOL, V235, P291, DOI 10.1016/0014-2999(93)90148-B
   Friedman JI, 1999, BIOL PSYCHIAT, V45, P1, DOI 10.1016/S0006-3223(98)00287-X
   GELLMAN RL, 1994, NEUROSCIENCE, V58, P515, DOI 10.1016/0306-4522(94)90077-9
   HABLITZ JJ, 1990, J NEUROPHYSIOL, V64, P1282
   HAGGER C, 1993, BIOL PSYCHIAT, V34, P702, DOI 10.1016/0006-3223(93)90043-D
   HALLER E, 1990, AM J PSYCHIAT, V147, P1069
   Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031
   HESS G, 1994, NEUROSCIENCE, V61, P225, DOI 10.1016/0306-4522(94)90226-7
   Hirota K, 2001, BRIT J PHARMACOL, V134, P1461, DOI 10.1038/sj.bjp.0704409
   HIRSCH JC, 1990, J PHYSIOL-LONDON, V427, P31, DOI 10.1113/jphysiol.1990.sp018159
   HIRSCH JC, 1991, EXP BRAIN RES, V85, P621
   Ichikawa J, 1999, EUR ARCH PSY CLIN N, V249, P90
   Jardemark KE, 2000, NEUROSCIENCE, V100, P1, DOI 10.1016/S0306-4522(00)00253-0
   KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
   KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416
   Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201, DOI 10.1093/oxfordjournals.schbul.a033374
   KERKERIAN L, 1987, J NEUROCHEM, V48, P1301, DOI 10.1111/j.1471-4159.1987.tb05661.x
   Kornhuber J, 1999, AM J PSYCHIAT, V156, P885, DOI 10.1176/ajp.156.6.885
   KORPI ER, 1995, N-S ARCH PHARMACOL, V352, P365
   Kuroki T, 1999, J PHARMACOL EXP THER, V288, P774
   LANGDON RB, 1990, J NEUROPHYSIOL, V64, P1484
   LAROCHE S, 1990, NEUROSCI LETT, V114, P184, DOI 10.1016/0304-3940(90)90069-L
   Laroche S, 2000, HIPPOCAMPUS, V10, P438
   Lavin A, 1998, J NEUROSCI, V18, P10566
   LAWTHO D, 1994, NEUROSCI RES, V21, P151, DOI 10.1016/0168-0102(94)90157-0
   LAWTHO D, 1995, NEUROSCI LETT, V188, P125, DOI 10.1016/0304-3940(95)11414-R
   Lee MA, 1999, SCHIZOPHR RES, V37, P1, DOI 10.1016/S0920-9964(98)00145-5
   Leveque JC, 2000, J NEUROSCI, V20, P4011
   Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2
   Lewis DA, 2000, BRAIN RES BULL, V52, P309, DOI 10.1016/S0361-9230(99)00243-9
   LIDSKY TI, 1993, NEUROSCI LETT, V163, P155, DOI 10.1016/0304-3940(93)90370-Z
   Lidsky TI, 1997, BRAIN RES, V764, P46, DOI 10.1016/S0006-8993(97)00423-X
   MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F
   MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782
   McCoy L, 1996, NEUROSCI LETT, V213, P137, DOI 10.1016/0304-3940(96)12834-2
   McGurk SR, 1999, J CLIN PSYCHIAT, V60, P24
   Medalia A, 1988, Arch Clin Neuropsychol, V3, P249, DOI 10.1016/0887-6177(88)90018-2
   Meltzer HY, 1999, SCHIZOPHRENIA BULL, V25, P233, DOI 10.1093/oxfordjournals.schbul.a033376
   MELTZER HY, 1991, PHARMACOL REV, V43, P587
   Michel FJ, 2000, NEUROPHARMACOLOGY, V39, P1536, DOI 10.1016/S0028-3908(99)00239-7
   Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228
   MITCHELL V, 1992, CLIN EXP PHARM PHY S, V21, P49
   MOGHADDAM B, 1990, J NEUROCHEM, V54, P1755, DOI 10.1111/j.1471-4159.1990.tb01230.x
   Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8
   Morris SH, 1999, J NEUROPHYSIOL, V82, P1927
   NAMBA T, 1994, BRAIN RES, V638, P36, DOI 10.1016/0006-8993(94)90630-0
   NICOLL A, 1992, NEUROSCI LETT, V143, P5, DOI 10.1016/0304-3940(92)90220-2
   NOWICKY AV, 1993, J NEUROPHYSIOL, V70, P1255
   OHMORI T, 1991, LIFE SCI, V48, P283, DOI 10.1016/0024-3205(91)90356-G
   Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1
   Otmakhova NA, 1999, J NEUROSCI, V19, P1437
   PACIA SV, 1994, NEUROLOGY, V44, P2247, DOI 10.1212/WNL.44.12.2247
   PEHEK EA, 1994, J NEUROCHEM, V63, P2118
   PENCEK TL, 1978, J PHARMACOL EXP THER, V204, P400
   PENITSORIA J, 1987, BRAIN RES, V425, P263, DOI 10.1016/0006-8993(87)90509-9
   Richelson E, 2000, LIFE SCI, V68, P29, DOI 10.1016/S0024-3205(00)00911-5
   SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731
   SCHMUTZ M, 1991, Epilepsia, V32, P59
   Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798
   SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203
   SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205
   Sharma T, 1999, BRIT J PSYCHIAT, V174, P44, DOI 10.1192/S0007125000298103
   SHARMA T, 2000, CURR OPINION CPNS IN, V2, P40
   Shi WX, 1997, SYNAPSE, V26, P415, DOI 10.1002/(SICI)1098-2396(199708)26:4<415::AID-SYN9>3.0.CO;2-9
   Shim SS, 1999, NEUROCHEM INT, V34, P167, DOI 10.1016/S0197-0186(98)00085-0
   SQUIRES RF, 1991, NEUROCHEM RES, V16, P1099, DOI 10.1007/BF00966587
   Squires RF, 1997, NEUROCHEM RES, V22, P151, DOI 10.1023/A:1027359422433
   Squires RF, 1998, NEUROCHEM RES, V23, P1283, DOI 10.1023/A:1020796200769
   Squires RF, 1999, NEUROCHEM RES, V24, P659, DOI 10.1023/A:1021052409140
   Steckler T, 1998, PROG NEUROBIOL, V54, P313, DOI 10.1016/S0301-0082(97)00061-0
   STIP E, 1996, CAN J PSYCHIAT, V41, P27
   SUTOR B, 1989, J NEUROPHYSIOL, V61, P621
   Tarazi FI, 1996, PSYCHOPHARMACOLOGY, V128, P371, DOI 10.1007/s002130050147
   TARAZI FI, 1995, SCHIZOPHR RES, V15, P168
   TSUNEIZUMI T, 1992, BIOL PSYCHIAT, V32, P817, DOI 10.1016/0006-3223(92)90085-E
   TZAVARA E, 1995, NEUROCHEM RES, V20, P17, DOI 10.1007/BF00995147
   VANBREDERODE JFM, 1992, NEUROSCIENCE, V50, P315, DOI 10.1016/0306-4522(92)90426-3
   Varela JA, 1997, J NEUROSCI, V17, P7926
   Vickery RM, 1997, J NEUROPHYSIOL, V78, P3039
   Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452
   Wang RY, 1998, BRAIN RES, V779, P309, DOI 10.1016/S0006-8993(97)01174-8
   Wang RY, 1998, NEUROPSYCHOPHARMACOL, V19, P74
   Weigmann H, 1999, EUR NEUROPSYCHOPHARM, V9, P253, DOI 10.1016/S0924-977X(98)00036-4
   WEINBERGER DR, 1994, J NEUROPSYCH CLIN N, V6, P419
   WESTLINDDANIELSSON A, 1992, EUR J PHARMACOL, V224, P57, DOI 10.1016/0014-2999(92)94818-G
   Yang CR, 1996, J NEUROSCI, V16, P1904
   Zhang WN, 1999, NEUROREPORT, V10, P2533, DOI 10.1097/00001756-199908200-00018
NR 106
TC 39
Z9 39
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4522
J9 NEUROSCIENCE
JI Neuroscience
PY 2003
VL 117
IS 3
BP 681
EP 695
DI 10.1016/S0306-4522(02)00769-8
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA 656TJ
UT WOS:000181624300016
PM 12617972
DA 2021-01-25
ER

PT J
AU Akiyama, T
   Staufer, U
   de Rooij, NF
   Frederix, P
   Engel, A
AF Akiyama, T
   Staufer, U
   de Rooij, NF
   Frederix, P
   Engel, A
TI Symmetrically arranged quartz tuning fork with soft cantilever for
   intermittent contact mode atomic force microscopy
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID RESOLUTION; SENSOR; LIQUID
AB A self-sensing and -actuating probe for dynamic mode atomic force microscopy (AFM) based on a commercial quartz tuning fork and a microfabricated cantilever is presented. The U-shaped cantilever, exhibiting a sharp tip, is combined with the tuning fork in a symmetrical arrangement, such that each of the two legs of the cantilever is fixed to one of the prongs of the tuning fork. The tuning fork is used as an oscillatory force sensor. Its frequency and amplitude govern that of the tip vibration, while the cantilever determines the spring constant of the whole probe. The frequency of the tip vibration for AFM operations can be much higher than the resonance frequency of the cantilever. A probe comprising a silicon nitride cantilever (0.1 N/m) is used to image monoatomic terraces of graphite in the intermittent contact mode. A much softer cantilever (0.01 N/m) is used to analyze the topography of a microelectronic chip in the same mode. Moreover, a bacterial surface layer hexagonally packed intermediate layer of Deinococcus radiodurans is imaged in a buffer solution. The tip vibration was again generated by the tuning fork while the sample interaction was measured using the standard optical detection scheme in this experiment. These probes are suited for batch fabrication and assembly and, therefore, enlarge the applications for the tuning fork based AFM. (C) 2003 American Institute of Physics.
C1 Univ Neuchatel, Inst Microtechnol, CH-2007 Neuchatel, Switzerland.
   Univ Basel, Maurice E Muller Inst, Biozentrum, CH-4056 Basel, Switzerland.
RP Akiyama, T (corresponding author), Univ Neuchatel, Inst Microtechnol, Rue Jaquet Droz 1, CH-2007 Neuchatel, Switzerland.
EM terunobu.akiyama@unine.ch
RI Staufer, Urs/J-6866-2016
OI Staufer, Urs/0000-0002-3519-6467
CR Akiyama T, 2001, MICROELECTRON ENG, V57-8, P769, DOI 10.1016/S0167-9317(01)00482-8
   ALBRECHT TR, 1990, J VAC SCI TECHNOL A, V8, P3386, DOI 10.1116/1.576520
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Edwards H, 1997, J APPL PHYS, V82, P980, DOI 10.1063/1.365936
   Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067
   Giessibl FJ, 1998, APPL PHYS LETT, V73, P3956, DOI 10.1063/1.122948
   Giessibl FJ, 1999, APPL SURF SCI, V140, P352, DOI 10.1016/S0169-4332(98)00553-4
   Gottlich H, 2000, REV SCI INSTRUM, V71, P3104, DOI 10.1063/1.1304881
   GUNTHER P, 1989, APPL PHYS B-PHOTO, V48, P89, DOI 10.1007/BF00694423
   Hodges AR, 2001, REV SCI INSTRUM, V72, P3880, DOI 10.1063/1.1405799
   Kageshima M, 2002, APPL SURF SCI, V188, P440, DOI 10.1016/S0169-4332(01)00975-8
   KARRAI K, 1995, APPL PHYS LETT, V66, P1842, DOI 10.1063/1.113340
   King GM, 2001, APPL PHYS LETT, V79, P1712, DOI 10.1063/1.1402960
   Moller C, 1999, BIOPHYS J, V77, P1150, DOI 10.1016/S0006-3495(99)76966-3
   Murdfield T, 1996, J VAC SCI TECHNOL B, V14, P877, DOI 10.1116/1.589166
   PUTMAN CAJ, 1994, APPL PHYS LETT, V64, P2454, DOI 10.1063/1.111597
   Rensen WHJ, 2000, APPL PHYS LETT, V77, P1557, DOI 10.1063/1.1308058
   Rensen WHJ, 1999, APPL PHYS LETT, V75, P1640, DOI 10.1063/1.124780
   Rozhok S, 2002, SOLID STATE COMMUN, V121, P683, DOI 10.1016/S0038-1098(02)00035-2
   Rychen J, 1999, REV SCI INSTRUM, V70, P2765, DOI 10.1063/1.1149842
   SARID D, 1991, SCANNING FORCE MICRO
   Serebryakov DV, 2002, REV SCI INSTRUM, V73, P1795, DOI 10.1063/1.1462038
   Todorovic M, 1998, J APPL PHYS, V83, P6229, DOI 10.1063/1.367642
   Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039
   1999, Patent No. 5877412
NR 25
TC 36
Z9 40
U1 2
U2 25
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0034-6748
EI 1089-7623
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD JAN
PY 2003
VL 74
IS 1
BP 112
EP 117
DI 10.1063/1.1523631
PN 1
PG 6
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 636JL
UT WOS:000180451300017
DA 2021-01-25
ER

PT S
AU Lorberg, A
   Hall, MN
AF Lorberg, A
   Hall, MN
BE Thomas, G
   Sabatini, DM
   Hall, MN
TI TOR: The first 10 years
SO TOR-TARGET OF RAPAMYCIN
SE Current Topics in Microbiology and Immunology
LA English
DT Review
ID P70 S6 KINASE; AMINO-ACID AVAILABILITY; EXCHANGE FACTOR ROM2;
   PIK-RELATED KINASES; CELL-GROWTH; SACCHAROMYCES-CEREVISIAE; SIGNALING
   PATHWAY; TRANSCRIPTION FACTORS; RAPAMYCIN TOR; TRANSLATION INITIATION
AB TOR was discovered and christened 10 years ago. On the occasion of this anniversary, we revisit the discovery of TOR and chronicle subsequent breakthroughs in S. cerevisiae that contributed to an understanding of TOR function in yeast and higher eukaryotes. In particular, we discuss findings that led to the realization that the function of TOR is to control cell growth in response to nutrients.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Lorberg, A (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
RI Thomas, George/K-9235-2014
OI Thomas, George/0000-0003-3518-8149
CR Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531
   Alarcon CM, 1996, GENE DEV, V10, P279, DOI 10.1101/gad.10.3.279
   Albig AR, 2001, MOL BIOL CELL, V12, P3428, DOI 10.1091/mbc.12.11.3428
   BARBE E, 1996, MEDITERR POLIT, V1, P25
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x
   Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235
   BIERER BE, 1990, SCIENCE, V250, P556, DOI 10.1126/science.1700475
   BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320
   Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0
   CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947
   CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574
   CHOI JP, 1996, EUROPEAN J POLITICAL, V12, P273, DOI DOI 10.1016/0176-2680(95)00017-8
   Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000
   Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599
   Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200
   Cruz MC, 1999, MOL CELL BIOL, V19, P4101
   Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0
   DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904
   Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584
   Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802
   Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948
   HEITMAN J, 1992, NEW BIOL, V4, P448
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Helliwell SB, 1998, GENETICS, V148, P99
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   Huang Shile, 2002, Curr Opin Investig Drugs, V3, P295
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507
   Kawai M, 2001, CURR GENET, V39, P166
   KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kimball SR, 2002, CURR OPIN CLIN NUTR, V5, P63, DOI 10.1097/00075197-200201000-00012
   Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Kuruvilla FG, 2001, P NATL ACAD SCI USA, V98, P7283, DOI 10.1073/pnas.121186898
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6
   Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815
   Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904
   Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002
   STAN R, 1994, J BIOL CHEM, V269, P32027
   Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6
   Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261
   Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200
   Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
   Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000
   ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6
NR 72
TC 49
Z9 51
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0070-217X
BN 3-540-00534-X
J9 CURR TOP MICROBIOL
JI Curr.Top.Microbiol.Immunol.
PY 2003
VL 279
BP 1
EP 18
PG 18
WC Immunology; Microbiology
SC Immunology; Microbiology
GA BX80E
UT WOS:000186475100001
DA 2021-01-25
ER

PT J
AU Meyer, UA
   Gut, J
AF Meyer, UA
   Gut, J
TI Genomics and the prediction of xenobiotic toxicity
SO TOXICOLOGY
LA English
DT Article; Proceedings Paper
CT 9th International Congress of Toxicology (ICT IX)
CY JUL 08-12, 2001
CL QUEENSLAND, AUSTRALIA
DE adverse drug reactions; genetic polymorphisms; pharmacogenetics;
   toxicogenetics; xenobiotics; single nucleotide polymorphisms
ID ADVERSE DRUG-REACTIONS; NUCLEAR RECEPTORS; PHARMACOGENOMICS;
   HEPATOTOXICITY; ACETAMINOPHEN; NRF2; MICE
AB The systematic identification and functional analysis of human genes is revolutionizing the study of disease processes and the development and rational use of drugs. It increasingly enables medicine to make reliable assessments of the individual risk to acquire a particular disease, raises the number and specificity of drug targets and explains interindividual. variation of the effectiveness and toxicity of drugs. Mutant alleles at a single gene locus for more than 20 drug metabolizing enzymes are some of the best studied individual risk factors for adverse drug reactions and xenobiotic toxicity. Increasingly, genetic polymorphisms of transporter and receptor systems are also recognized as causing interindividual variation in drug response and drug toxicity. However, pharmacogenetic and toxicogenetic factors rarely act alone; they produce a phenotype in concert with other variant genes and with environmental factors. Environmental factors may affect gene expression in many ways. For instance, numerous drugs induce their own and the metabolism of other xenobiotics by interacting with nuclear receptors such as AhR, PPAR, PXR and CAR. Genomics is providing the information and technology to analyze these complex situations to obtain individual genotypic and gene expression information to assess the risk of toxicity. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4506 Basel, Switzerland.
   TheraSTrat, CH-4123 Allschwil, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Div Pharmacol Neurobiol, Biozentrum, Klingelbergstr 50-70, CH-4506 Basel, Switzerland.
CR BEUTLER E, 1992, ANNU REV MED, V43, P47, DOI 10.1146/annurev.med.43.1.47
   Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098
   Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169
   Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487
   GUT J, 1995, TOXICOLOGY, V97, P199, DOI 10.1016/0300-483X(94)03010-Y
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403
   Kalow W, 2001, PHARMACOGENOMICS
   Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776
   Ku NO, 1996, J CLIN INVEST, V98, P1034, DOI 10.1172/JCI118864
   Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200
   McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101
   Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6
   Park BE, 1998, CHEM RES TOXICOL, V11, P969, DOI 10.1021/tx980058f
   Park BK, 2001, TOXICOL LETT, V120, P281, DOI 10.1016/S0378-4274(01)00280-6
   Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728
   Taylor JA, 1998, CANCER RES, V58, P3603
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
NR 18
TC 20
Z9 22
U1 0
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD DEC 27
PY 2002
VL 181
BP 463
EP 466
AR PII S0300-483X(02)00452-3
DI 10.1016/S0300-483X(02)00452-3
PG 4
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 639TX
UT WOS:000180646400078
PM 12505353
DA 2021-01-25
ER

PT J
AU Funato, K
   Vallee, B
   Riezman, H
AF Funato, K
   Vallee, B
   Riezman, H
TI Biosynthesis and trafficking of sphingolipids in the yeast Saccharomyces
   cerevisiae
SO BIOCHEMISTRY
LA English
DT Article
ID LONG-CHAIN BASES; FATTY-ACID ELONGATION; INOSITOL PHOSPHORYLCERAMIDE
   SYNTHASE; SERINE PALMITOYLTRANSFERASE ACTIVITY; ENDOPLASMIC-RETICULUM;
   GOLGI-APPARATUS; SPHINGOID BASE; HEAT-STRESS; INTERORGANELLE TRANSPORT;
   SUBCELLULAR-LOCALIZATION
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Riezman, H (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva, Switzerland.
OI Vallee, Beatrice/0000-0002-5161-354X; Riezman,
   Howard/0000-0003-4680-9422
CR Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x
   Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043
   Beaudoin F, 2002, J BIOL CHEM, V277, P11481, DOI 10.1074/jbc.M111441200
   BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980
   BEELER T, 1994, J BIOL CHEM, V269, P7279
   Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688
   Beeler TJ, 1997, MOL GEN GENET, V255, P570, DOI 10.1007/s004380050530
   Boujaoude LC, 2001, J BIOL CHEM, V276, P35258, DOI 10.1074/jbc.M105442200
   Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507
   BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991
   Cliften P, 1996, MICROBIOL-SGM, V142, P477, DOI 10.1099/13500872-142-3-477
   Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908
   Dickson RC, 1997, J BIOL CHEM, V272, P29620, DOI 10.1074/jbc.272.47.29620
   Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196
   Duax WL, 1996, CURR OPIN STRUC BIOL, V6, P813, DOI 10.1016/S0959-440X(96)80012-1
   Dunn TM, 1998, YEAST, V14, P311, DOI 10.1002/(SICI)1097-0061(19980315)14:4<311::AID-YEA220>3.0.CO;2-B
   Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673
   Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033
   Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200
   Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597
   Gaigg B, 2001, MOL BIOL CELL, V12, P1147, DOI 10.1091/mbc.12.4.1147
   GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2
   Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062
   Grilley MM, 2000, METHOD ENZYMOL, V311, P9
   Grote E, 2000, MOL BIOL CELL, V11, P4051, DOI 10.1091/mbc.11.12.4051
   Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655
   Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704
   HashidaOkado T, 1996, MOL GEN GENET, V251, P236
   HECHTBERGER P, 1994, EUR J BIOCHEM, V225, P641, DOI 10.1111/j.1432-1033.1994.00641.x
   HECHTBERGER P, 1995, FEBS LETT, V367, P201, DOI 10.1016/0014-5793(95)00567-S
   HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765
   Heidler SA, 2000, BBA-MOL BASIS DIS, V1500, P147, DOI 10.1016/S0925-4439(99)00097-6
   HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751
   Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566
   Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998
   KIHARA A, 2002, J BIOL CHEM, V28, P28
   Kim S, 2000, GENETICS, V156, P1519
   Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001
   Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135
   Lanterman MM, 1998, BIOCHEM J, V332, P525, DOI 10.1042/bj3320525
   Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267
   Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150
   MANDON EC, 1992, J BIOL CHEM, V267, P11144
   Mao CG, 1999, BIOCHEM J, V342, P667, DOI 10.1042/0264-6021:3420667
   Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690
   Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876
   Mao CG, 2000, METHOD ENZYMOL, V311, P223
   Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200
   Michel C, 1997, FEBS LETT, V416, P153, DOI 10.1016/S0014-5793(97)01187-3
   Mitchell AG, 1997, J BIOL CHEM, V272, P28281, DOI 10.1074/jbc.272.45.28281
   Monaghan E, 2002, YEAST, V19, P659, DOI 10.1002/yea.864
   Morin-Ganet MN, 2000, TRAFFIC, V1, P56, DOI 10.1034/j.1600-0854.2000.010109.x
   MUKHERJEE JJ, 1990, BIOCHIM BIOPHYS ACTA, V1037, P24, DOI 10.1016/0167-4838(90)90097-Y
   Muniz M, 2000, EMBO J, V19, P10, DOI 10.1093/emboj/19.1.10
   Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437
   NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899
   Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809
   Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376
   PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992
   PINTO WJ, 1992, J BACTERIOL, V174, P2575, DOI 10.1128/jb.174.8.2575-2581.1992
   PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902
   PUOTI A, 1991, J BIOL CHEM, V266, P21051
   Qie LX, 1997, J BIOL CHEM, V272, P16110, DOI 10.1074/jbc.272.26.16110
   Reggiori F, 1997, EMBO J, V16, P3506, DOI 10.1093/emboj/16.12.3506
   Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087
   Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200
   Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417
   Sivadon P, 1997, YEAST, V13, P747, DOI 10.1002/(SICI)1097-0061(19970630)13:8<747::AID-YEA137>3.0.CO;2-L
   Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999
   Skrzypek MS, 1998, J BIOL CHEM, V273, P2829, DOI 10.1074/jbc.273.5.2829
   Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880
   Stukey J, 1997, PROTEIN SCI, V6, P469
   SWAIN E, 2002, J BIOL CHEM, V10, P10
   TAKITA Y, 1995, MOL GEN GENET, V246, P269, DOI 10.1007/BF00288599
   Tanida I, 1996, FEBS LETT, V379, P38, DOI 10.1016/0014-5793(95)01478-0
   Toke DA, 1996, J BIOL CHEM, V271, P18413, DOI 10.1074/jbc.271.31.18413
   VANMEER G, 2002, J BIOL CHEM, V13, P13
   Voelker DR, 2000, BBA-MOL CELL BIOL L, V1486, P97, DOI 10.1016/S1388-1981(00)00051-2
   Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045
   Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235
   Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667
   Young ME, 2002, MOL CELL BIOL, V22, P927, DOI 10.1128/MCB.22.3.927-934.2002
   Yuan DS, 1997, J BIOL CHEM, V272, P25787, DOI 10.1074/jbc.272.41.25787
   Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824
   Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6
   ZHAO C, 1994, J BIOL CHEM, V269, P21480
NR 86
TC 52
Z9 53
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD DEC 24
PY 2002
VL 41
IS 51
BP 15105
EP 15114
DI 10.1021/bi026616d
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 628UN
UT WOS:000180015100001
PM 12484746
DA 2021-01-25
ER

PT J
AU Ozbek, S
   Pertz, O
   Schwager, M
   Lustig, A
   Holstein, T
   Engel, J
AF Ozbek, S
   Pertz, O
   Schwager, M
   Lustig, A
   Holstein, T
   Engel, J
TI Structure/function relationships in the minicollagen of hydra
   nematocysts
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MINI-COLLAGENS
AB The minicollagens found in the inner layer of the Hydra nematocyst walls are the smallest collagens known with 12-16 Gly-X-Y repeats. Minicollagen-1, the best characterized member of this protein family so far, consists of a central collagen triple helix of 12 nm in length flanked at both ends by a polyproline stretch and a conserved cysteine-rich domain. The cysteine-rich tails are proposed to function in the assembly of soluble minicollagen trimers to high molecular structures by a switch of the disulfide linkage from intramolecular to intermolecular bonds. In this study, we investigate the trimeric nature of minicollagen-1 and its capacity to form disulfide-linked polymers in vitro. A fusion protein of minicollagen-1 with maltose-binding protein is secreted as a soluble trimer with only intrachain and no interchain disulfide bridges as confirmed by melting the collagen triple helix under reducing and non-reducing conditions. The conversion of minicollagen-1 trimers to monomers takes place between 40 and 55 degreesC with the melting point being similar to45 degreesC. Oxidative reshuffling of the minicollagen-1 trimers leads to the formation of high molecular aggregates, which upon reduction show distinct polytrimeric states. Minicollagen trimers in isolated nematocyst capsules proved to be sensitive to SDS and were engaged in polymeric structures with additional cross-links that were resistant to reducing agent.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.
   Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Ozbek, Suat/D-3701-2014
OI Ozbek, Suat/0000-0003-2569-3942; pertz, olivier/0000-0001-8579-4919
CR Anderluh G, 2000, BBA-PROTEIN STRUCT M, V1476, P372, DOI 10.1016/S0167-4838(99)00237-X
   BAILEY AJ, 1971, FEBS LETT, V18, P154, DOI 10.1016/0014-5793(71)80433-7
   BLANQUET R, 1966, SCIENCE, V154, P152, DOI 10.1126/science.154.3745.152
   Engel J, 1997, SCIENCE, V277, P1785, DOI 10.1126/science.277.5333.1785
   Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   HO SN, 1990, DNA PROTEIN ENG TECH, V2, P50
   HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186
   HOLSTEIN T, 1981, J ULTRA MOL STRUCT R, V75, P276, DOI 10.1016/S0022-5320(81)80085-8
   HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402
   Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   LENHOFF HM, 1957, BIOCHIM BIOPHYS ACTA, V26, P204, DOI 10.1016/0006-3002(57)90074-4
   Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   Ozbek S, 2002, J STRUCT BIOL, V137, P11, DOI 10.1006/jsbi.2002.4436
   RIGBY BJ, 1975, NATURE, V253, P277, DOI 10.1038/253277a0
   SCHROEDER LA, 1981, LIMNOL OCEANOGR, V24, P1092
   SKAER RJ, 1973, J CELL SCI, V13, P371
   Szczepanek S, 2002, J CELL SCI, V115, P745
   WAGNER DD, 1987, BLOOD, V69, P27
   WEBER J, 1990, TOXICON, V28, P403, DOI 10.1016/0041-0101(90)90078-L
   WEBER J, 1990, J BIOL CHEM, V265, P9664
NR 23
TC 28
Z9 28
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 20
PY 2002
VL 277
IS 51
BP 49200
EP 49204
DI 10.1074/jbc.M209401200
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 629AU
UT WOS:000180028900013
PM 12368276
OA Bronze
DA 2021-01-25
ER

PT J
AU Watanabe, R
   Funato, K
   Venkataramam, K
   Futerman, AH
   Riezman, H
AF Watanabe, R
   Funato, K
   Venkataramam, K
   Futerman, AH
   Riezman, H
TI Sphingolipids are required for the stable membrane association of
   glycosylphosphatidylinositol-anchored proteins in yeast
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID INOSITOL PHOSPHORYLCERAMIDE SYNTHASE; FATTY-ACID ELONGATION;
   SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE;
   GOLGI-APPARATUS; CERAMIDE SYNTHESIS; CELL-SURFACE; LIPID RAFTS;
   TRANSPORT
AB Ongoing sphingolipid synthesis is specifically required in vivo for the endoplasmic reticulum (ER) to Golgi transport of glycosylphosphatidylinositol (GPI)-anchored proteins. However, the sphingolipid intermediates that are required for transport nor their role(s) have been identified. Using stereoisomers of dihydrosphingosine, together with specific inhibitors and a mutant defective for sphingolipid synthesis, we now show that ceramides and/or inositol sphingolipids are indispensable for GPI-anchored protein transport. Furthermore, in the absence of sphingolipid synthesis, a significant fraction of GPI-anchored proteins is no longer associated tightly with the ER membrane. The loose membrane association is neither because of the lack of a GPI-anchor nor because of prolonged ER retention of GPI-anchored proteins. These results indicate that ceramides and/or inositol sphingolipids are required to stabilize the association of GPI-anchored proteins with membranes. They could act either by direct involvement as membrane components or as substrates for the remodeling of GPI lipid moieties.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.
RP Riezman, H (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva, Switzerland.
OI Riezman, Howard/0000-0003-4680-9422; Watanabe,
   Reika/0000-0002-7427-7702; Futerman, Anthony/0000-0003-0013-0115
CR Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697
   Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129
   Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043
   Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111
   David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167
   Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27
   Doering TL, 1996, EMBO J, V15, P182, DOI 10.1002/j.1460-2075.1996.tb00346.x
   FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365
   Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834
   Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783
   Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033
   Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998
   Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655
   Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704
   Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186
   HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x
   JIANG Y, 1993, NATURE, V366, P84, DOI 10.1038/366084a0
   LESTER RL, 1993, ADV LIPID RES, V26, P253
   Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267
   MANDALA SM, 1995, J ANTIBIOT, V48, P349, DOI 10.7164/antibiotics.48.349
   Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690
   Morsomme P, 2002, DEV CELL, V2, P307, DOI 10.1016/S1534-5807(02)00133-8
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437
   NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27
   Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376
   RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55
   Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417
   SIPOS G, 1994, EMBO J, V13, P2789, DOI 10.1002/j.1460-2075.1994.tb06572.x
   Sipos G, 1997, EMBO J, V16, P3494, DOI 10.1093/emboj/16.12.3494
   Skrzypek M, 1997, J BACTERIOL, V179, P1513, DOI 10.1128/jb.179.5.1513-1520.1997
   Sutterlin C, 1997, J CELL SCI, V110, P2703
   Venkataraman K, 2001, BBA-MOL CELL BIOL L, V1530, P219, DOI 10.1016/S1388-1981(01)00085-3
   WANG E, 1991, J BIOL CHEM, V266, P14486
   Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200
   Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824
   Zhong WY, 1999, FEBS LETT, V463, P241, DOI 10.1016/S0014-5793(99)01633-6
NR 38
TC 81
Z9 82
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 20
PY 2002
VL 277
IS 51
BP 49538
EP 49544
DI 10.1074/jbc.M206209200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 629AU
UT WOS:000180028900058
PM 12393888
OA Bronze
DA 2021-01-25
ER

PT J
AU Hippenmeyer, S
   Shneider, NA
   Birchmeier, C
   Burden, SJ
   Jessell, TM
   Arber, S
AF Hippenmeyer, S
   Shneider, NA
   Birchmeier, C
   Burden, SJ
   Jessell, TM
   Arber, S
TI A role for Neuregulin1 signaling in muscle spindle differentiation
SO NEURON
LA English
DT Article
ID ETS TRANSCRIPTION FACTOR; PERIPHERAL NERVOUS-SYSTEM; NICOTINIC
   ACETYLCHOLINE-RECEPTOR; LIM HOMEOBOX GENES; PROPRIOCEPTIVE AFFERENTS;
   NEUROMUSCULAR SYNAPSE; SELECTIVE EXPRESSION; MOTOR INNERVATION; SENSORY
   NEURONS; MICE LACKING
AB The maturation of synaptic structures depends on inductive interactions between axons and their prospective targets. One example of such an interaction is the influence of proprioceptive sensory axons on the differentiation of muscle spindles. We have monitored the expression of three transcription factors, Egr3, Pea3, and Erm, that delineate early muscle spindle development in an assay of muscle spindle-inducing signals. We provide genetic evidence that Neuregulin1 (Nrg1) is required for proprioceptive afferent-evoked induction of muscle spindle differentiation in the mouse. Ig-Nrg1 isoforms are preferentially expressed by proprioceptive sensory neurons and are sufficient to induce muscle spindle differentiation in vivo, whereas CRD-Nrg1 isoforms are broadly expressed in sensory and motor neurons but are not required for muscle spindle induction.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Columbia Univ, Dept Neurol, New York, NY 10032 USA.
   Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA.
   Columbia Univ, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.
   Max Delbruck Ctr Mol Med, Dept Med Genet, D-13122 Berlin, Germany.
   Skirball Inst, Mol Neurobiol Program, New York, NY 10011 USA.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Shneider, Neil/ABF-5751-2020
OI Shneider, Neil/0000-0002-3223-7366; Hippenmeyer,
   Simon/0000-0003-2279-1061; Arber, Silvia/0000-0002-6261-250X; Burden,
   Steven/0000-0002-3550-6891
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS027963, R01NS029071, R01NS027963, R01NS029071, R01NS029071,
   R01NS029071, R01NS029071, R01NS027963, R01NS029071, R01NS027963,
   R01NS027963, R01NS027963, R01NS027963, R01NS027963, R01NS029071,
   R01NS029071, R01NS029071, R01NS029071, R01NS027963, R01NS029071,
   R01NS029071, R01NS027963, R01NS029071, R01NS027963, R01NS027963,
   R01NS029071, R01NS027963, R01NS029071, R01NS029071, R01NS027963,
   R01NS027963, R01NS029071, R01NS029071, R01NS027963, R01NS029071,
   R01NS029071, R01NS027963, R01NS027963] Funding Source: NIH RePORTER;
   NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01 NS029071-16, R01 NS029071-14, R01
   NS029071-13S1, R01 NS029071-13, R01 NS027963-13, NS29071, R01
   NS029071-15] Funding Source: Medline
CR Andrechek ER, 2002, MOL CELL BIOL, V22, P4714, DOI 10.1128/MCB.22.13.4714-4722.2002
   Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9
   Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820
   Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000
   Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5
   Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4
   Chen HH, 2002, J NEUROSCI, V22, P3512
   COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9
   Ernfors P, 2001, CELL MOL LIFE SCI, V58, P1036, DOI 10.1007/PL00000918
   ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5
   Farinas I, 1999, MICROSC RES TECHNIQ, V45, P233, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<233::AID-JEMT7>3.0.CO;2-Y
   FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0
   Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429
   Fromm L, 1998, J PHYSIOLOGY-PARIS, V92, P173, DOI 10.1016/S0928-4257(98)80005-3
   Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.3.CO;2-X
   Hidalgo A, 2001, DEV CELL, V1, P679, DOI 10.1016/S1534-5807(01)00074-0
   Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0
   HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q
   Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6
   Huang Z, 1998, DEVELOPMENT, V125, P3753
   HUNT CC, 1990, PHYSIOL REV, V70, P643
   Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2
   KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8
   KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0
   Kopp DM, 1997, J NEUROSCI, V17, P6697
   KOZEKA K, 1981, DEV BIOL, V87, P133, DOI 10.1016/0012-1606(81)90067-1
   Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833
   KUCERA J, 1993, ANAT EMBRYOL, V187, P397
   KUCERA J, 1994, ANAT EMBRYOL, V190, P273
   Kucera J, 2002, DEV DYNAM, V223, P389, DOI 10.1002/dvdy.10066
   KUCERA J, 1992, ANAT EMBRYOL, V186, P301
   Liebl DJ, 1997, J NEUROSCI, V17, P9113
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Loeb JA, 1999, DEVELOPMENT, V126, P781
   Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717
   Maier A, 1997, INT J DEV BIOL, V41, P1
   Matsuo S, 2000, NEUROSCIENCE, V95, P209
   Mendell LM, 2001, J PHYSIOL-LONDON, V533, P91, DOI 10.1111/j.1469-7793.2001.0091b.x
   Meyer D, 1997, DEVELOPMENT, V124, P3575
   MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0
   O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5
   O'Hagan RC, 1998, ONCOGENE, V16, P301, DOI 10.1038/sj.onc.1201547
   Ozaki M, 1997, NATURE, V390, P691
   Parkinson DB, 2002, MOL CELL NEUROSCI, V20, P154, DOI 10.1006/mcne.2002.1109
   Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599
   SANES JR, 1991, DEVELOPMENT, V113, P1181
   Sapru MK, 1998, P NATL ACAD SCI USA, V95, P1289, DOI 10.1073/pnas.95.3.1289
   Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1
   Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078
   SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823
   Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076
   Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X
   Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4
   Sweeney C, 2001, J BIOL CHEM, V276, P22685, DOI 10.1074/jbc.M100602200
   Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1
   Tourtellotte WG, 1998, NAT GENET, V20, P87
   Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202
   TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2
   Verdi JM, 1996, NEURON, V16, P515, DOI 10.1016/S0896-6273(00)80071-9
   Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4
   Walro JM, 1999, TRENDS NEUROSCI, V22, P180, DOI 10.1016/S0166-2236(98)01339-3
   Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
   Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7
   ZELENA J, 1994, NERVES MECHANORECEPT, P1
   ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x
NR 70
TC 113
Z9 114
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD DEC 19
PY 2002
VL 36
IS 6
BP 1035
EP 1049
DI 10.1016/S0896-6273(02)01101-7
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA 628TA
UT WOS:000180011600008
PM 12495620
DA 2021-01-25
ER

PT J
AU Haussinger, D
   Ahrens, T
   Sass, HJ
   Pertz, O
   Engel, J
   Grzesiek, S
AF Haussinger, D
   Ahrens, T
   Sass, HJ
   Pertz, O
   Engel, J
   Grzesiek, S
TI Calcium-dependent homoassociation of E-cadherin by NMR spectroscopy:
   Changes in mobility, conformation and mapping of contact regions
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein; shift mapping; residual dipolar coupling; dynamics; anisotropy
ID CELL-CELL-ADHESION; RESONANCE ASSIGNMENTS; ROTATIONAL DIFFUSION;
   EXTRACELLULAR DOMAIN; HOMOPHILIC ADHESION; BACKBONE DYNAMICS; STRUCTURAL
   BASIS; BINDING; MACROMOLECULES; ALIGNMENT
AB Cadherins are calcium-dependent cell surface proteins that mediate homophilic cellular adhesion. The calcium-induced oligomerization of the N-terminal two domains of epithelial cadherin (ECAD12) was followed by NMR spectroscopy in solution over a large range of protein (10 muM-5 mM) and calcium (0-5 mM) concentrations. Several spectrally distinct states could be distinguished that correspond to a calcium-free monomeric form, a calcium-bound monomeric form, and to calcium-bound higher oligomeric forms. Chemical shift changes between these different states define calcium-binding residues as well as oligomerization contacts. Information about the relative orientation and mobility of the ECAD12 domains in the various states was obtained from weak alignment and N-15 relaxation experiments. The data indicate that the calcium-free ECAD12 monomer adopts a flexible, kinked conformation that occludes the dimer interface observed in the ECAD12 crystal structure. In contrast, the calcium-bound monomer is already in a straight, non-flexible conformation where this interface is accessible. This mechanism provides a rational for the calcium-induced adhesiveness. Oligomerization induces chemical shift changes in an area of domain CAD1 that is centered at residue Trp-2. These shift changes extend to almost the entire surface of domain CAD1 at high (5 mM) protein concentrations. Smaller additional clusters of shift perturbations are observed around residue A80 in CAM and K160 in CAD2. According to weak alignment and relaxation data, the symmetry of a predominantly dimeric solution aggregate at 0.6 mM ECAD12 differs from the approximate C2-symmetry of the crystalline dimer. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Haussinger, Daniel/C-6617-2016
OI Haussinger, Daniel/0000-0002-4798-0072; pertz,
   olivier/0000-0001-8579-4919; Grzesiek, Stephan/0000-0003-1998-4225
CR Alattia JR, 2000, J BIOMOL NMR, V16, P181, DOI 10.1023/A:1008306727354
   Alattia JR, 1997, FEBS LETT, V417, P405, DOI 10.1016/S0014-5793(97)01333-1
   Alattia JR, 1999, CELL MOL LIFE SCI, V55, P359, DOI 10.1007/s000180050297
   Angst BD, 2001, J CELL SCI, V114, P629
   Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697
   Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559
   Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487
   Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143
   Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823
   Clore GM, 2002, J MAGN RESON, V154, P329, DOI 10.1006/jmre.2001.2489
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624
   Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4
   Leckband D, 2000, CURR OPIN CELL BIOL, V12, P587, DOI 10.1016/S0955-0674(00)00136-8
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073
   Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0
   NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z
   NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   Overduin M, 1996, J BIOMOL NMR, V7, P173
   OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937
   OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645
   Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738
   POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0
   Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820
   Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542
   TAKEICHI M, 1987, TRENDS GENET, V3, P213, DOI 10.1016/0168-9525(87)90238-1
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020
   Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x
   Troyanovsky RB, 1999, J CELL SCI, V112, P4379
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   WAGNER G, 1994, CURR OPIN STRUC BIOL, V4, P841, DOI 10.1016/0959-440X(94)90265-8
NR 46
TC 72
Z9 72
U1 0
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 6
PY 2002
VL 324
IS 4
BP 823
EP 839
DI 10.1016/S0022-2836(02)01137-3
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 625PR
UT WOS:000179825300020
PM 12460580
DA 2021-01-25
ER

PT J
AU Jenal, U
   Stephens, C
AF Jenal, U
   Stephens, C
TI The Caulobacter cell cycle: timing, spatial organization and checkpoints
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID DEPENDENT POLAR LOCALIZATION; DNA-REPLICATION; CHROMOSOME-REPLICATION;
   DYNAMIC LOCALIZATION; REGULATOR CONTROLS; HISTIDINE KINASE; FLAGELLAR
   GENE; DIVISION; TRANSCRIPTION; PROTEINS
AB In Caulobacter crescentus, a complex regulatory network integrates temporal and spatial information to control the ordered progression of the cell cycle, and to synchronize cell proliferation with development. Periodicity includes the timed synthesis, activation or destruction of key regulatory proteins, which activate a large number of genes at the appropriate time of the cell cycle. Checkpoints serve to couple cell division and polar development to the replication and segregation state of the chromosome. Asymmetrically positioned regulatory components are involved in the sequential positioning of polar organelles. New work sheds light on the spatial organization of cellular components involved in cell cycle progression and polar differentiation, and starts to define the molecular nature of checkpoints involved in cell cycle control and development.
C1 Univ Basel, Biozentrum, CH-4054 Basel, Switzerland.
   Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4054 Basel, Switzerland.
EM urs.jenal@unibas.ch; cstephens@scu.edu
CR Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2
   Clarke DJ, 2000, BIOESSAYS, V22, P351, DOI 10.1002/(SICI)1521-1878(200004)22:4<351::AID-BIES5>3.0.CO;2-W
   Crymes WB, 1999, J BACTERIOL, V181, P3967, DOI 10.1128/JB.181.13.3967-3973.1999
   Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648
   Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4
   Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4
   Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664
   England JC, 2001, CURR OPIN MICROBIOL, V4, P674, DOI 10.1016/S1369-5274(01)00268-5
   Errington J, 2001, CURR OPIN MICROBIOL, V4, P660, DOI 10.1016/S1369-5274(01)00266-1
   Fischer B, 2002, MOL MICROBIOL, V44, P461, DOI 10.1046/j.1365-2958.2002.02887.x
   Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098
   Guillet V, 2002, J BIOL CHEM, V277, P42003, DOI 10.1074/jbc.M204789200
   Harry EJ, 2001, MOL MICROBIOL, V40, P795, DOI 10.1046/j.1365-2958.2001.02370.x
   HINZ AJ, 2002, IN PRESS MOL MICROBI
   Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9
   Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998
   Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658
   Jensen RB, 2002, NAT REV MOL CELL BIO, V3, P167, DOI 10.1038/nrm758
   Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661
   Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144
   Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699
   Liu GW, 2001, MOL MICROBIOL, V40, P909, DOI 10.1046/j.1365-2958.2001.02434.x
   MARCZYNSKI GT, 1995, GENE DEV, V9, P1543, DOI 10.1101/gad.9.12.1543
   Margolin W, 2001, CURR OPIN MICROBIOL, V4, P647, DOI 10.1016/S1369-5274(01)00264-8
   Martin ME, 2000, CURR OPIN MICROBIOL, V3, P589, DOI 10.1016/S1369-5274(00)00145-4
   Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x
   Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8
   Mohr CD, 1998, J BACTERIOL, V180, P2175, DOI 10.1128/JB.180.8.2175-2185.1998
   Muir RE, 2002, MOL MICROBIOL, V43, P597, DOI 10.1046/j.1365-2958.2002.02728.x
   Muir RE, 2001, MOL MICROBIOL, V41, P117, DOI 10.1046/j.1365-2958.2001.02506.x
   Muir RE, 2001, MOL MICROBIOL, V39, P1623, DOI 10.1046/j.1365-2958.2001.02351.x
   Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298
   Ohta N, 2000, PROKARYOTIC DEVELOPMENT, P341
   Quardokus EM, 2002, MOL MICROBIOL, V45, P605, DOI 10.1046/j.1365-2958.2002.03040.x
   Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2
   Rothfield LI, 2001, CELL, V106, P13, DOI 10.1016/S0092-8674(01)00432-9
   Shapiro L, 2000, CELL, V100, P89, DOI 10.1016/S0092-8674(00)81686-4
   Siam R, 2000, EMBO J, V19, P1138, DOI 10.1093/emboj/19.5.1138
   Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223
   Stephens C, 2001, CURR BIOL, V11, pR222, DOI 10.1016/S0960-9822(01)00110-5
   STEPHENS CM, 1995, J BACTERIOL, V177, P1662, DOI 10.1128/jb.177.7.1662-1669.1995
   STEPHENS CM, 1993, MOL MICROBIOL, V9, P1169, DOI 10.1111/j.1365-2958.1993.tb01246.x
   Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454
   Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999
   WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630
   Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2
   Wortinger M, 2000, EMBO J, V19, P4503, DOI 10.1093/emboj/19.17.4503
   Wright R, 1996, GENE DEV, V10, P1532, DOI 10.1101/gad.10.12.1532
   Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068
   Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443
   Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005
NR 51
TC 28
Z9 28
U1 0
U2 1
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD DEC
PY 2002
VL 5
IS 6
BP 558
EP 563
DI 10.1016/S1369-5274(02)00378-8
PG 6
WC Microbiology
SC Microbiology
GA 627TT
UT WOS:000179952800004
PM 12457698
DA 2021-01-25
ER

PT J
AU Meier, S
   Haussinger, D
   Grzesiek, S
AF Meier, S
   Haussinger, D
   Grzesiek, S
TI Charged acrylamide copolymer gels as media for weak alignment
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE dipolar couplings; electroosmosis; electrostatic alignment;
   polyelectrolyte; TipAS; ubiquitin
ID PHYSIOLOGICAL SALT-SOLUTIONS; POLYACRYLATE HYDROGELS; NMR;
   MACROMOLECULES; RESOLUTION; COUPLINGS; PROTEINS; FIELD
AB The use of mechanically strained acrylamide/acrylate copolymers is reported as a new alignment medium for biomacromolecules. Compared to uncharged, strained polyacrylamide gels, the negative charges of the acrylamide/acrylate copolymer strongly alter the alignment tensor and lead to pronounced electroosmotic swelling. The swelling itself can be used to achieve anisotropic, mechanical strain. The method is demonstrated for the alignment of TipAS, a 17 kDa antibiotic resistance protein, as well as for human ubiquitin, where alignment tensors with an A(ZZ,NH) of up to 60 Hz are achieved at a gel concentration of 2% (w/v). The alignment can be modulated by the variation of pH, ionic strength, and gel concentration. The high mechanical stability of the swollen gels makes it possible to obtain alignment at polymer concentrations of less than 1% (w/v).
C1 Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
RI Haussinger, Daniel/C-6617-2016; Meier, Sebastian/A-4279-2015
OI Haussinger, Daniel/0000-0002-4798-0072; Meier,
   Sebastian/0000-0003-3761-3217; Grzesiek, Stephan/0000-0003-1998-4225
CR Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594
   Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   Flory P. J., 1953, PRINCIPLES POLYM CHE
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   HOLMES DJ, 1993, EMBO J, V12, P3183, DOI 10.1002/j.1460-2075.1993.tb05987.x
   Horkay F, 2000, BIOMACROMOLECULES, V1, P84, DOI 10.1021/bm9905031
   Horkay F, 2001, BIOMACROMOLECULES, V2, P195, DOI 10.1021/bm0056153
   KATCHALSKY A, 1951, J POLYM SCI, V7, P571, DOI 10.1002/pol.1951.120070513
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279
   Trempe JF, 2002, J BIOMOL NMR, V22, P83, DOI 10.1023/A:1013832422428
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   VERMAAS D, 1948, RECL TRAV CHIM PAY B, V67, P983
   VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6
NR 18
TC 57
Z9 58
U1 0
U2 14
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD DEC
PY 2002
VL 24
IS 4
BP 351
EP 356
DI 10.1023/A:1021609207024
PG 6
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 625HC
UT WOS:000179810200007
PM 12522299
DA 2021-01-25
ER

PT J
AU Crespo, JL
   Hall, MN
AF Crespo, JL
   Hall, MN
TI Elucidating TOR signaling and rapamycin action: lessons from
   Saccharomyces cerevisiae
SO MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
LA English
DT Review
ID P70 S6 KINASE; PROTEIN PHOSPHATASE 2A; AMINO-ACID; MAMMALIAN TARGET;
   TRANSLATION INITIATION; GENE-EXPRESSION; CELL-CYCLE; MESSENGER-RNA;
   CATALYTIC SUBUNIT; FISSION YEAST
AB TOR (target of rapamycin) is a phosphatidylinositol kinase-related protein kinase that controls cell growth in response to nutrients. Rapamycin is an immunosuppressive and anticancer drug that acts by inhibiting TOR. The modes of action of TOR and rapamycin are remarkably conserved from S. cerevisiae to humans. The current understanding of TOR and rapamycin is derived largely from studies with S. cerevisiae. In this review, we discuss the contributions made by S. cerevisiae to understanding rapamycin action and TOR function.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
RI Crespo, Jose L/L-3977-2014
OI Crespo, Jose L/0000-0003-3514-1025; Hall, Michael N/0000-0002-2998-0757
CR Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001
   Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401
   Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531
   Albig AR, 2001, MOL BIOL CELL, V12, P3428, DOI 10.1091/mbc.12.11.3428
   ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115
   Banholzer R, 1997, MOL CELL BIOL, V17, P3254, DOI 10.1128/MCB.17.6.3254
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x
   Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597
   Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264
   Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0
   BIERER BE, 1990, SCIENCE, V250, P556, DOI 10.1126/science.1700475
   BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320
   Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0
   Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99
   Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432
   CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012
   Calder PC, 1999, AMINO ACIDS, V17, P227, DOI 10.1007/BF01366922
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   Carvalho J, 2001, J BIOL CHEM, V276, P25359, DOI 10.1074/jbc.M103050200
   Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323
   CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947
   Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792
   CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574
   CHOI JP, 1996, EUROPEAN J POLITICAL, V12, P273, DOI DOI 10.1016/0176-2680(95)00017-8
   CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q
   CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349
   Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000
   Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599
   Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200
   Cruz MC, 1999, MOL CELL BIOL, V19, P4101
   Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001
   Cutler NS, 2001, MOL BIOL CELL, V12, P4103, DOI 10.1091/mbc.12.12.4103
   Danaie P, 1999, BIOCHEM J, V340, P135, DOI 10.1042/0264-6021:3400135
   De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200
   Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518
   Dennis PB, 1996, MOL CELL BIOL, V16, P6242
   Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0
   DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904
   Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2
   Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015
   FERRARI S, 1993, J BIOL CHEM, V268, P16091
   Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196
   Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987
   Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201
   Gingras AC, 2001, GENE DEV, V15, P2852
   Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422
   Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586
   GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x
   GRENSON M, 1983, EUR J BIOCHEM, V133, P135, DOI 10.1111/j.1432-1033.1983.tb07438.x
   Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0
   Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128
   Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   Harris DM, 1999, PLANT PHYSIOL, V121, P609, DOI 10.1104/pp.121.2.609
   HEITMAN J, 1991, P NATL ACAD SCI USA, V88, P1948, DOI 10.1073/pnas.88.5.1948
   HEITMAN J, 1992, NEW BIOL, V4, P448
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Helliwell SB, 1998, GENETICS, V148, P99
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002
   Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33
   Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091
   Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661
   Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185
   Hosoi H, 1998, MOL PHARMACOL, V54, P815
   Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x
   Iiboshi Y, 1999, BIOCHEM BIOPH RES CO, V260, P534, DOI 10.1006/bbrc.1999.0920
   Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092
   Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546
   Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   JOHNSTON RJ, 1987, POLIT GEOGR QUART, V6, P7, DOI 10.1016/0260-9827(87)90027-9
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   KAFKEWITZ D, 1983, AM J CLIN NUTR, V37, P1025
   Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507
   Kawai M, 2001, CURR GENET, V39, P166
   KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50
   KILBERG MS, 1994, FASEB J, V8, P13
   Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1
   KOLTIN Y, 1991, MOL CELL BIOL, V11, P1718, DOI 10.1128/MCB.11.3.1718
   Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   KUO CJ, 1992, NATURE, V358, P70, DOI 10.1038/358070a0
   Kuruvilla FG, 2001, P NATL ACAD SCI USA, V98, P7283, DOI 10.1073/pnas.121186898
   Leicht M, 1996, CELL GROWTH DIFFER, V7, P1199
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z
   LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38
   LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721
   LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531
   MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283
   MAHAJAN PB, 1994, INT J IMMUNOPHARMACO, V16, P711, DOI 10.1016/0192-0561(94)90091-4
   Mahalingam M, 1996, MOL CELL BIOL, V16, P405
   Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X
   Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899
   Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671
   Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571
   Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624
   Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1
   Nasmyth K, 1993, CURR OPIN CELL BIOL, V5, P166, DOI 10.1016/0955-0674(93)90099-C
   Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700
   PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0
   Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002
   Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416
   Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438
   Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522
   Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182
   Raught B, 2000, COLD SPRING HARBOR M, V39, P245
   Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434
   Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161
   SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815
   Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904
   SCHREIBER SL, 1992, CELL, V70, P365, DOI 10.1016/0092-8674(92)90158-9
   Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772
   Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473
   Sekulic A, 2000, CANCER RES, V60, P3504
   Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6
   Shigemitsu K, 1999, J BIOL CHEM, V274, P1058, DOI 10.1074/jbc.274.2.1058
   SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511
   Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556
   SOPHIANOPOULOU V, 1995, FEMS MICROBIOL REV, V16, P53, DOI 10.1016/0168-6445(94)00091-C
   STAN R, 1994, J BIOL CHEM, V269, P32027
   STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450
   Stromhaug PE, 2001, TRAFFIC, V2, P524, DOI 10.1034/j.1600-0854.2001.20802.x
   Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085
   TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301
   Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200
   Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x
   Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6
   TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E
   TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x
   VANDENBOL M, 1987, EUR J BIOCHEM, V164, P607, DOI 10.1111/j.1432-1033.1987.tb11170.x
   VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721
   vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076
   Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370
   Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261
   Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7
   Weisman R, 2001, J BIOL CHEM, V276, P24736, DOI 10.1074/jbc.M102090200
   Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200
   WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9
   WIEDERRECHT G, 1991, P NATL ACAD SCI USA, V88, P1029, DOI 10.1073/pnas.88.3.1029
   Xu G, 1998, J BIOL CHEM, V273, P28178, DOI 10.1074/jbc.273.43.28178
   YAGLOM J, 1995, MOL CELL BIOL, V15, P731
   Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
   Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000
   Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013
   ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6
NR 171
TC 254
Z9 262
U1 1
U2 27
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1092-2172
EI 1098-5557
J9 MICROBIOL MOL BIOL R
JI Microbiol. Mol. Biol. Rev.
PD DEC
PY 2002
VL 66
IS 4
BP 579
EP +
DI 10.1128/MMBR.66.4.579-591.2002
PG 14
WC Microbiology
SC Microbiology
GA 623BQ
UT WOS:000179683700001
PM 12456783
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Nguyen, KT
   Willey, JM
   Nguyen, LD
   Nguyen, LT
   Viollier, PH
   Thompson, CJ
AF Nguyen, KT
   Willey, JM
   Nguyen, LD
   Nguyen, LT
   Viollier, PH
   Thompson, CJ
TI A central regulator of morphological differentiation in the
   multicellular bacterium Streptomyces coelicolor
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID AERIAL MYCELIUM FORMATION; BACILLUS-SUBTILIS; EXTRACELLULAR
   COMPLEMENTATION; ANTIBIOTIC BIOSYNTHESIS; INTEGRATIVE VECTORS;
   MYXOCOCCUS-XANTHUS; GENE-EXPRESSION; RNA-POLYMERASE; A-FACTOR;
   SPORULATION
AB In the multicellular bacterium Streptomyces coelicolor, functions of developmental (bald) genes are required for the biosynthesis of SapB, a hydrophobic peptidic morphogen that facilitates aerial hyphae formation. Here, we show that aerial hyphal growth and SapB biosynthesis could be activated independently from the normal developmental cascade by providing unprogrammed expression of functionally interactive genes within the ram cluster. ramC, ramS and ramR were essential for normal growth of aerial hyphae, and ramR, a response regulator gene, was a key activator of development. The ramR gene restored growth of aerial hyphae and SapB formation in all bald strains tested (albeit only weakly in the bldC mutant), many of which are characterized by physiological defects. Disruption of the ramR gene abolished SapB biosynthesis and severely delayed growth of aerial hyphae. Transcription of ramR was developmentally controlled, and RamR function in vivo depended on its putative phosphorylation site (D53). We identified and mapped RamR targets immediately upstream of the region encoding ramC and ramS, a putative operon. Overexpression of ramR in the wild-type strain increased SapB levels and caused a distinctive wrinkled surface topology. Based on these results, we propose that phenotypes of bald mutations reflect an early stage in the Streptomyces developmental programme similar to the spo0 mutations in the unicellular bacterium Bacillus subtilis, and that RamR has analogies to Spo0A, the Bacillus response regulator that integrates physiological signals before triggering endospore formation.
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
   Hofstra Univ, Dept Biol, Hempstead, NY 11550 USA.
RP Thompson, CJ (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Nguyen, Kien/F-9234-2019
OI Nguyen, Kien/0000-0003-2685-3928; Nguyen, Liem/0000-0002-1523-1472;
   Willey, Joanne/0000-0003-4544-4417; Viollier,
   Patrick/0000-0002-5249-9910
CR ALTENBUCHNER J, 1992, METHOD ENZYMOL, V216, P457
   Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a
   Bibb MJ, 2000, J BACTERIOL, V182, P4606, DOI 10.1128/JB.182.16.4606-4616.2000
   BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2
   Cervin MA, 1999, MOL MICROBIOL, V31, P597, DOI 10.1046/j.1365-2958.1999.01200.x
   Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3
   CHATER KF, 1993, ANNU REV MICROBIOL, V47, P685, DOI 10.1146/annurev.mi.47.100193.003345
   de Crecy-Lagard V, 1999, MOL MICROBIOL, V32, P505, DOI 10.1046/j.1365-2958.1999.01364.x
   Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401
   Hopwood DA, 1999, MICROBIOL-UK, V145, P2183, DOI 10.1099/00221287-145-9-2183
   HORINOUCHI S, 1994, MOL MICROBIOL, V12, P859, DOI 10.1111/j.1365-2958.1994.tb01073.x
   INGRAM C, 1989, J BACTERIOL, V171, P6617, DOI 10.1128/jb.171.12.6617-6624.1989
   IRETON K, 1995, P NATL ACAD SCI USA, V92, P2845, DOI 10.1073/pnas.92.7.2845
   KATZ E, 1983, J GEN MICROBIOL, V129, P2703
   Keijser BJF, 2002, J BACTERIOL, V184, P4420, DOI 10.1128/JB.184.16.4420-4429.2002
   Keijser BJF, 2000, J MOL MICROB BIOTECH, V2, P565
   Kelemen GH, 2001, MOL MICROBIOL, V40, P804, DOI 10.1046/j.1365-2958.2001.02417.x
   Kieser T., 2000, PRACTICAL STREPTOMYC
   MA HT, 1994, J BACTERIOL, V176, P3800, DOI 10.1128/JB.176.12.3800-3811.1994
   MACNEIL DJ, 1988, J BACTERIOL, V170, P5607, DOI 10.1128/jb.170.12.5607-5612.1988
   MANIATIS T, 1982, MOL CLONING LAB MANU
   Miguelez EM, 1999, J CELL BIOL, V145, P515, DOI 10.1083/jcb.145.3.515
   Molle V, 2000, MOL MICROBIOL, V36, P1265, DOI 10.1046/j.1365-2958.2000.01977.x
   MOTAMEDI H, 1995, GENE, V160, P25, DOI 10.1016/0378-1119(95)00191-8
   MULLER T, 1991, J MICROSC-OXFORD, V161, P73
   Nodwell JR, 1999, GENETICS, V151, P569
   Nodwell JR, 1996, MOL MICROBIOL, V22, P881, DOI 10.1046/j.1365-2958.1996.01540.x
   Nodwell JR, 1998, J BACTERIOL, V180, P1334, DOI 10.1128/JB.180.5.1334-1337.1998
   O'Connor TJ, 2002, MOL MICROBIOL, V45, P45, DOI 10.1046/j.1365-2958.2002.03004.x
   PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443
   Pope MK, 1996, MOL MICROBIOL, V19, P747, DOI 10.1046/j.1365-2958.1996.414933.x
   Quisel JD, 2000, J BACTERIOL, V182, P3446, DOI 10.1128/JB.182.12.3446-3451.2000
   Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x
   ROUAULT MHB, 1997, GENE, V190, P315
   Ryding NJ, 1999, J BACTERIOL, V181, P5419, DOI 10.1128/JB.181.17.5419-5425.1999
   Ryding NJ, 1998, MOL MICROBIOL, V29, P343, DOI 10.1046/j.1365-2958.1998.00939.x
   SMOKVINA T, 1990, GENE, V94, P53, DOI 10.1016/0378-1119(90)90467-6
   SPIEGELMAN G, 1990, J BACTERIOL, V172, P5011, DOI 10.1128/jb.172.9.5011-5019.1990
   Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297
   STRAUCH MA, 1993, CURR OPIN GENET DEV, V3, P203, DOI 10.1016/0959-437X(93)90024-J
   Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x
   Tillotson RD, 1998, MOL MICROBIOL, V30, P595, DOI 10.1046/j.1365-2958.1998.01093.x
   UDO H, 1995, GENE DEV, V9, P972, DOI 10.1101/gad.9.8.972
   Ueda K, 2002, J BACTERIOL, V184, P1488, DOI 10.1128/JB.184.5.1488-1492.2002
   Ueda K, 1998, J BACTERIOL, V180, P5085, DOI 10.1128/JB.180.19.5085-5093.1998
   UEDA K, 1993, J BACTERIOL, V175, P2006, DOI 10.1128/JB.175.7.2006-2016.1993
   Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001
   WILLEY J, 1993, GENE DEV, V7, P895, DOI 10.1101/gad.7.5.895
   WILLEY J, 1991, CELL, V65, P641, DOI 10.1016/0092-8674(91)90096-H
   Wosten HAB, 2000, MICROBIOL-UK, V146, P767, DOI 10.1099/00221287-146-4-767
   Zhang WD, 1996, MOL MICROBIOL, V20, P435, DOI 10.1111/j.1365-2958.1996.tb02630.x
NR 51
TC 59
Z9 63
U1 0
U2 6
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD DEC
PY 2002
VL 46
IS 5
BP 1223
EP 1238
DI 10.1046/j.1365-2958.2002.03255.x
PG 16
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 620TK
UT WOS:000179548400003
PM 12453210
DA 2021-01-25
ER

PT J
AU Ozbek, S
   Engel, J
   Stetefeld, J
AF Ozbek, S
   Engel, J
   Stetefeld, J
TI Storage function of cartilage oligomeric matrix protein: the crystal
   structure of the coiled-coil domain in complex with vitamin D-3
SO EMBO JOURNAL
LA English
DT Article
DE hydrophobic pore; vitamin D-3 storage; X-ray crystallography
ID 1,25-DIHYDROXYVITAMIN D-3; NUCLEAR RECEPTOR; BINDING PROTEIN; HORMONE;
   MUTATIONS; GROWTH; PSEUDOACHONDROPLASIA; TRANSPORT; RETINOL; SYSTEM
AB The five-stranded coiled-coil domain of cartilage oligomeric matrix protein (COMPcc) forms a continuous axial pore with binding capacities for hydrophobic compounds, including prominent cell signalling molecules. Here, we report the X-ray structure of the COMPcc domain in complex with vitamin D-3 at 1.7 Angstrom resolution. The COMPcc pentamer harbours two molecules of the steroid hormone precursor in a planar s-trans conformation of the conjugated triene, with the aliphatic tails lying along the molecule axis. A hydrophilic ring of five GIn54 side chains divides the channel into two hydrophobic compartments in which the bound vitamin D-3 pair is fixed in a head-to-head orientation. Vitamin D-3 binding induces a volumetric increase of the cavities of similar to30% while the main chain distances of the pentamer are retained. This adaptation to the bulky ring systems of the ligands is accomplished by a rotamer re-orientation of beta-branched side chains that form the knobs into holes of the coiled-coil structure. Compared with binding of vitamin D and retinoic acid by their classical receptors, COMP exerts a distinct mechanism of interaction mainly defined by the pattern of hydrophobic core residues.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Ozbek, S (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Suat.Oezbek@unibas.ch
RI Ozbek, Suat/D-3701-2014; Stetefeld, Joerg/H-7630-2017
OI Stetefeld, Joerg/0000-0003-1478-3248; Ozbek, Suat/0000-0003-2569-3942
CR Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Baran DT, 2000, J CELL BIOCHEM, V78, P34, DOI 10.1002/(SICI)1097-4644(20000701)78:1<34::AID-JCB4>3.3.CO;2-Q
   Beer TM, 2001, CANCER-AM CANCER SOC, V91, P2431, DOI 10.1002/1097-0142(20010615)91:12<2431::AID-CNCR1278>3.3.CO;2-V
   BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545
   BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200
   Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238
   DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6
   EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4
   Efimov VP, 1996, PROTEINS, V24, P259, DOI 10.1002/(SICI)1097-0134(199602)24:2<259::AID-PROT13>3.0.CO;2-M
   Ekman S, 1997, CALCIFIED TISSUE INT, V60, P547, DOI 10.1007/s002239900278
   Farquharson C, 1998, EUR J CELL BIOL, V76, P110, DOI 10.1016/S0171-9335(98)80023-X
   Gal-Moscovici A, 2000, CLIN NEPHROL, V53, P362
   Guo Y, 1998, EMBO J, V17, P5265, DOI 10.1093/emboj/17.18.5265
   Hara K, 2001, ANTICANCER RES, V21, P321
   Haussler MR, 1997, J ENDOCRINOL, V154, pS57
   Head JF, 2002, BIOCHEMISTRY-US, V41, P9015, DOI 10.1021/bi026054y
   Hecht JT, 1998, MATRIX BIOL, V17, P625, DOI 10.1016/S0945-053X(98)90113-5
   HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325
   HEDBOM E, 1992, J BIOL CHEM, V267, P6132
   Kleerekoper M, 2001, J CLIN PHARMACOL, V41, P239, DOI 10.1177/00912700122010050
   LESLIE AGW, 1994, MOSFLM USERS GUIDE M
   Maeda S, 2001, MATRIX BIOL, V20, P87, DOI 10.1016/S0945-053X(01)00123-8
   Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761
   Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156
   MORGELIN M, 1992, J BIOL CHEM, V267, P6137
   Muller G, 1998, CONNECT TISSUE RES, V39, P233, DOI 10.3109/03008209809021499
   Nemere I, 2000, AM J PHYSIOL-ENDOC M, V279, pE614
   Nemere I, 2000, AM J PHYSIOL-ENDOC M, V278, pE1104
   NEVILLE PF, 1966, BIOCHEMISTRY-US, V5, P2201, DOI 10.1021/bi00871a007
   Norman AW, 2001, J STEROID BIOCHEM, V76, P49, DOI 10.1016/S0960-0760(00)00145-X
   Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8
   Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998
   OLDBERG A, 1992, J BIOL CHEM, V267, P22346
   OROURKE KM, 1992, J BIOL CHEM, V267, P24921
   QABAR A, 1995, J BIOL CHEM, V270, P12725, DOI 10.1074/jbc.270.21.12725
   Ray R, 1996, P SOC EXP BIOL MED, V212, P305, DOI 10.3181/00379727-212-44020
   Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X
   Rosner W, 1999, J STEROID BIOCHEM, V69, P481, DOI 10.1016/S0960-0760(99)00070-9
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   Shen ZX, 1995, MATRIX BIOL, V14, P773, DOI 10.1016/S0945-053X(05)80020-4
   Smith RKW, 1997, MATRIX BIOL, V16, P255, DOI 10.1016/S0945-053X(97)90014-7
   Suwinska K, 1996, ACTA CRYSTALLOGR B, V52, P550, DOI 10.1107/S0108768195017071
   Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002
   Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200
   Tocchini-Valentini G, 2001, P NATL ACAD SCI USA, V98, P5491, DOI 10.1073/pnas.091018698
   TURK D, 1992, THESIS TU MUNCHEN MU
   van de Kerkhof PCM, 2001, SKIN PHARMACOL APPL, V14, P129, DOI 10.1159/000056342
   Verboven C, 2002, NAT STRUCT BIOL, V9, P131, DOI 10.1038/nsb754
   WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719
   Willnow TE, 2002, CURR OPIN LIPIDOL, V13, P255, DOI 10.1097/00041433-200206000-00004
NR 53
TC 50
Z9 52
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD NOV 15
PY 2002
VL 21
IS 22
BP 5960
EP 5968
DI 10.1093/emboj/cdf628
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 618YZ
UT WOS:000179446900002
PM 12426368
OA Green Published
DA 2021-01-25
ER

PT J
AU Hahn, E
   Wild, P
   Hermanns, U
   Sebbel, P
   Glockshuber, R
   Haner, M
   Taschner, N
   Burkhard, P
   Aebi, U
   Muller, SA
AF Hahn, E
   Wild, P
   Hermanns, U
   Sebbel, P
   Glockshuber, R
   Haner, M
   Taschner, N
   Burkhard, P
   Aebi, U
   Muller, SA
TI Exploring the 3D molecular architecture of Escherichia coli type 1 pili
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE pilus; FimH; immuno-gold labeling; scanning transmission; electron
   microscopy; 3D model
ID TRANSMISSION ELECTRON-MICROSCOPY; BORDETELLA-PERTUSSIS FIMBRIAE;
   PAPD-LIKE CHAPERONES; HOST DEFENSES; FIMH ADHESIN; PROTEIN; BIOGENESIS;
   ENTEROBACTERIACEAE; LOCALIZATION; SEQUENCE
AB An integrated approach combining information gained by Fourier transformation, linear Markham superposition (real space) and mass-per-length measurement by scanning transmission electron microscopy was used to analyze the helical structure of the rod-like type 1 pili expressed by uropathogenic Escherichia coli strain W3110. The 3D reconstruction calculated from the experimental data showed the pili to be 6.9 nm wide, right-handed helical tubes with a 19.31(+/-0.34) nm long helical repeat comprising 27 FimA monomers associated head-to-tail in eight turns of the genetic one-start helix. Adjacent turns of the genetic helix are connected via three binding sites making the pilus rod rather stiff. In situ immuno-electron microscopy experiments showed the minor subunit, (FimH) mediating pilus adhesion to bladder epithelial cells to be the distal protein of the pilus tip, which had a spring-like appearance at higher magnification. The subunits FimG and FimF connect FimH to the FimA rod, the sequential orientation being FimA-FimF-FimG-FimH. The electron density map calculated at 18 A resolution from an atomic model of the pilus rod (built using the pilin domain FimH together with the G1 strand of FimC as a template for FimA and applying the optimal helical parameters determined to the head-to-tail interaction model for pilus assembly) was practically identical with that of the actual 3D reconstruction. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Fed Inst Technol, Inst Mol Biol, CH-8093 Zurich, Switzerland.
   Univ Zurich, Inst Vet Anat, CH-8057 Zurich, Switzerland.
RP Muller, SA (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
CR ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0
   [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760
   Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897
   BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405
   BASCHONG W, 1988, J ULTRA MOL STRUCT R, V99, P189, DOI 10.1016/0889-1605(88)90063-8
   BEACHEY EH, 1988, AM REV RESPIR DIS, V138, P45
   BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x
   BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1016/S0022-2836(84)71582-8
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   BRINTON CC, 1965, T NEW YORK ACAD SCI, V27, P1003, DOI 10.1111/j.2164-0947.1965.tb02342.x
   BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0
   Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061
   Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004
   Hahn E, 2000, J STRUCT BIOL, V132, P241, DOI 10.1006/jsbi.2000.4323
   HAMILTON RC, 1994, MICRON, V25, P613, DOI 10.1016/0968-4328(94)90024-8
   Henn C, 1996, J STRUCT BIOL, V116, P86, DOI 10.1006/jsbi.1996.0015
   JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081
   KLEMM P, 1987, MOL GEN GENET, V208, P439, DOI 10.1007/BF00328136
   KLEMM P, 1984, EUR J BIOCHEM, V143, P395, DOI 10.1111/j.1432-1033.1984.tb08386.x
   KLEMM P, 1990, MOL GEN GENET, V220, P334
   KLEMM P, 1994, FIMBRIAE ADHESION GE, P9
   KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0
   KUEHN MJ, 1994, FIMBRIAE ADHESION GE, P37
   LINDBERG F, 1987, NATURE, V328, P84, DOI 10.1038/328084a0
   Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105
   MIN G, 2002, J MOL BIOL, V317, P701
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494
   Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829
   ORNDORFF PE, 1984, J BACTERIOL, V159, P736, DOI 10.1128/JB.159.2.736-744.1984
   Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058
   Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348
   Saulino ET, 2000, P NATL ACAD SCI USA, V97, P9240, DOI 10.1073/pnas.160070497
   Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2
   SIMONS BL, 1994, FEMS MICROBIOL LETT, V118, P83, DOI 10.1111/j.1574-6968.1994.tb06807.x
   SLOT JW, 1985, EUR J CELL BIOL, V38, P87
   Smith PR, 1996, J STRUCT BIOL, V116, P35, DOI 10.1006/jsbi.1996.0007
   SMITH PR, 1974, J PHYS A-MATH GEN, V7, P1627, DOI 10.1088/0305-4470/7/13/017
   Smyth C. J., 1994, P399
   Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922
   Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999
   STEVEN AC, 1986, J BACTERIOL, V167, P968, DOI 10.1128/jb.167.3.968-974.1986
   TAYLOR KA, 1981, J MOL BIOL, V147, P297, DOI 10.1016/0022-2836(81)90442-3
   Thanassi DG, 1998, CURR OPIN MICROBIOL, V1, P223, DOI 10.1016/S1369-5274(98)80015-5
   Thanassi DG, 1998, P NATL ACAD SCI USA, V95, P3146, DOI 10.1073/pnas.95.6.3146
NR 49
TC 169
Z9 173
U1 1
U2 30
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD NOV 8
PY 2002
VL 323
IS 5
BP 845
EP 857
DI 10.1016/S0022-2836(02)01005-7
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 616MX
UT WOS:000179308500006
PM 12417198
DA 2021-01-25
ER

PT J
AU Bourniquel, AA
   Bickle, TA
AF Bourniquel, AA
   Bickle, TA
TI Complex restriction enzymes: NTP-driven molecular motors
SO BIOCHIMIE
LA English
DT Review
DE restriction-modification systems modification-dependent; GTP-dependent;
   restriction enzymes; endonuclease; motor proteins
ID ESCHERICHIA-COLI K-12; ECOP15I DNA METHYLTRANSFERASE; LARGE STRUCTURAL
   DISTORTION; ORIENTED RECOGNITION SITES; ATOMIC-FORCE MICROSCOPY;
   ADENOSYL-L-METHIONINE; I RESTRICTION; MODIFICATION SYSTEMS;
   NUCLEOTIDE-SEQUENCE; ECOKI METHYLTRANSFERASE
AB Survival is assuredly the prime directive for all living organisms either as individuals or as a species. One of the main challenges encountered by bacterial populations is the danger of bacteriophage attacks, since infection of a single bacterium may rapidly propagate, decimating the entire population. In order to protect themselves against this acute threat, bacteria have developed an array of defence mechanisms, which range from preventing the infection itself via interference with bacteriophage adsorption to the cell surface and prevention of phage DNA injection, to degradation of the injected phage DNA. This last defence mechanism is catalysed by the bacterial restriction-modification (R-M) systems, and in particular, by nucleoside 5'-triphosphate (NTP)-dependent restriction enzymes, e.g. type I and type III R-M systems or the modification-dependent endonucleases. Type I and type III restriction systems have dual properties. They may either act as methylases and protect the host's own DNA against restriction by methylating specific residues, or they catalyse ATP-dependent endonuclease activity so that invading foreign DNA lacking the host-specific methylation is degraded. These defence mechanism systems are further complemented by the presence of methylation-dependent, GTP-dependent endonucleases, that restricts specifically methylated DNA. Although all three types of endonucleases are structurally very different, they share a common functional mechanism. They recognise and bind to specific DNA sequences but do not cleave DNA within those target sites. They belong to the general class of DNA motor proteins, which use the free energy associated with nucleoside 5'-triphosphate hydrolysis to translocate DNA so that the subsequent DNA cleavage event occurs at a distance from the endonuclease recognition site. Moreover, DNA cleavage appears to be a random process triggered upon stalling of the DNA translocation process and requiring dimerisation of the bound endonucleases for a concerted break of both DNA strands. In this review, we present a detailed description and analysis of the functional mechanism of the three known NTP-dependent restriction systems: type I and type III restriction-modification enzymes, as well as the methylation-dependent McrBC endonuclease. (C) 2002 Editions scientifiques et medicales Elsevier SAS and Societe francaise de biochimie et biologie moleculaire. All rights reserved.
C1 Univ Basel, Dept Mol Microbiol, Biozentrum, CH-4056 Basel, Switzerland.
RP Bourniquel, AA (corresponding author), Univ Basel, Dept Mol Microbiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM aude.bourniquel@unibas.ch
CR ABADJIEVA A, 1993, NUCLEIC ACIDS RES, V21, P4435, DOI 10.1093/nar/21.19.4435
   AHAMD I, 1994, J MOL BIOL, V242, P378, DOI 10.1006/jmbi.1994.1588
   Ahmad I, 1996, J MOL BIOL, V259, P229, DOI 10.1006/jmbi.1996.0315
   AHMAD I, 1995, GENE, V157, P143, DOI 10.1016/0378-1119(95)00671-R
   ARBER W, 1962, J MOL BIOL, V5, P18, DOI 10.1016/S0022-2836(62)80058-8
   Berge T, 2000, BIOPHYS J, V79, P479, DOI 10.1016/S0006-3495(00)76309-0
   BERTANI G, 1953, J BACTERIOL, V65, P113, DOI 10.1128/JB.65.2.113-121.1953
   BICKLE TA, 1978, P NATL ACAD SCI USA, V75, P3099, DOI 10.1073/pnas.75.7.3099
   BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993
   Bickle TA, 1993, NUCLEASES, P89
   Bist P, 2001, J MOL BIOL, V310, P93, DOI 10.1006/jmbi.2001.4744
   Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570
   BLUMENTHAL RM, 1985, J BACTERIOL, V164, P501, DOI 10.1128/JB.164.2.501-509.1985
   BULLAS LR, 1976, J GEN MICROBIOL, V95, P166, DOI 10.1099/00221287-95-1-166
   BURCKHARDT J, 1981, J MOL BIOL, V153, P425, DOI 10.1016/0022-2836(81)90287-4
   COWAN GM, 1989, CELL, V56, P103, DOI 10.1016/0092-8674(89)90988-4
   Davies GP, 1999, J MOL BIOL, V290, P565, DOI 10.1006/jmbi.1999.2908
   Davies GP, 1998, NUCLEIC ACIDS RES, V26, P4828, DOI 10.1093/nar/26.21.4828
   Davies GP, 1999, J MOL BIOL, V292, P787, DOI 10.1006/jmbi.1999.3081
   DILA D, 1990, J BACTERIOL, V172, P4888, DOI 10.1128/jb.172.9.4888-4900.1990
   Dreier J, 1996, J MOL BIOL, V264, P722, DOI 10.1006/jmbi.1996.0672
   Dreier J, 1996, J MOL BIOL, V257, P960, DOI 10.1006/jmbi.1996.0215
   Dryden DTF, 2001, NUCLEIC ACIDS RES, V29, P3728, DOI 10.1093/nar/29.18.3728
   DRYDEN DTF, 1993, J BIOL CHEM, V268, P13228
   Dybvig K, 1998, P NATL ACAD SCI USA, V95, P13923, DOI 10.1073/pnas.95.23.13923
   Ellis DJ, 1999, NAT STRUCT BIOL, V6, P15
   ESKIN B, 1972, J BIOL CHEM, V247, P6183
   Firman K, 2000, EMBO J, V19, P2094, DOI 10.1093/emboj/19.9.2094
   FULLERPACE FV, 1984, P NATL ACAD SCI-BIOL, V81, P6095, DOI 10.1073/pnas.81.19.6095
   GANN AAF, 1987, MOL MICROBIOL, V1, P13, DOI 10.1111/j.1365-2958.1987.tb00521.x
   Garcia LR, 1999, P NATL ACAD SCI USA, V96, P12430, DOI 10.1073/pnas.96.22.12430
   Gast FU, 1997, BIOL CHEM, V378, P975, DOI 10.1515/bchm.1997.378.9.975
   GLOVER SW, 1983, MOL GEN GENET, V190, P65, DOI 10.1007/BF00330325
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713
   GORBALENYA AE, 1991, FEBS LETT, V291, P277, DOI 10.1016/0014-5793(91)81301-N
   GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3
   GUBLER M, 1992, EMBO J, V11, P233, DOI 10.1002/j.1460-2075.1992.tb05046.x
   HEITMAN J, 1987, J BACTERIOL, V169, P3243, DOI 10.1128/jb.169.7.3243-3250.1987
   HUMBELIN M, 1988, J MOL BIOL, V200, P23, DOI 10.1016/0022-2836(88)90330-0
   IIDA S, 1983, J MOL BIOL, V165, P1, DOI 10.1016/S0022-2836(83)80239-3
   Janscak P, 1999, NUCLEIC ACIDS RES, V27, P2638, DOI 10.1093/nar/27.13.2638
   Janscak P, 1999, EMBO J, V18, P2638, DOI 10.1093/emboj/18.9.2638
   Janscak P, 2000, J MOL BIOL, V295, P1089, DOI 10.1006/jmbi.1999.3414
   Janscak P, 1996, J MOL BIOL, V257, P977, DOI 10.1006/jmbi.1996.0217
   Janscak P, 2001, J MOL BIOL, V306, P417, DOI 10.1006/jmbi.2000.4411
   KANNAN P, 1989, J MOL BIOL, V209, P335, DOI 10.1016/0022-2836(89)90001-6
   KELLEHER JE, 1991, J MOL BIOL, V221, P431, DOI 10.1016/0022-2836(91)80064-2
   KIM YG, 1994, J BIOL CHEM, V269, P31978
   KISS A, 1985, NUCLEIC ACIDS RES, V13, P6403, DOI 10.1093/nar/13.18.6403
   Kjeldgaard M, 1996, FASEB J, V10, P1347
   KRUGER T, 1992, GENE, V114, P1, DOI 10.1016/0378-1119(92)90700-Y
   KRUGER T, 1995, EMBO J, V14, P2661, DOI 10.1002/j.1460-2075.1995.tb07264.x
   LURIA SE, 1952, J BACTERIOL, V64, P557, DOI 10.1128/JB.64.4.557-569.1952
   MacWilliams MP, 1996, EMBO J, V15, P4775, DOI 10.1002/j.1460-2075.1996.tb00855.x
   MEISEL A, 1995, EMBO J, V14, P2958, DOI 10.1002/j.1460-2075.1995.tb07296.x
   MEISEL A, 1992, NATURE, V355, P467, DOI 10.1038/355467a0
   MEISTER J, 1993, EMBO J, V12, P4585, DOI 10.1002/j.1460-2075.1993.tb06147.x
   Mernagh DR, 1996, NUCLEIC ACIDS RES, V24, P4853, DOI 10.1093/nar/24.24.4853
   Mucke M, 2001, J MOL BIOL, V312, P687, DOI 10.1006/jmbi.2001.4998
   MURRAY NE, 1993, MOL MICROBIOL, V9, P133, DOI 10.1111/j.1365-2958.1993.tb01675.x
   Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000
   NAGARAJA V, 1985, J MOL BIOL, V182, P579, DOI 10.1016/0022-2836(85)90243-8
   NAGARAJA V, 1985, NATURE, V316, P371, DOI 10.1038/316371a0
   Neuwald AF, 1999, GENOME RES, V9, P27
   NOYERWEIDNER M, 1986, MOL GEN GENET, V205, P469, DOI 10.1007/BF00338084
   O'Neill M, 1998, EMBO J, V17, P7118, DOI 10.1093/emboj/17.23.7118
   O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x
   Panne D, 1998, EMBO J, V17, P5477, DOI 10.1093/emboj/17.18.5477
   Panne D, 1999, J MOL BIOL, V290, P49, DOI 10.1006/jmbi.1999.2894
   Panne D, 2001, EMBO J, V20, P3210, DOI 10.1093/emboj/20.12.3210
   PATEL J, 1992, GENE, V112, P21, DOI 10.1016/0378-1119(92)90298-4
   Pieper U, 1997, J MOL BIOL, V272, P190, DOI 10.1006/jmbi.1997.1228
   Pieper U, 2002, BIOCHEMISTRY-US, V41, P5236, DOI 10.1021/bi0156862
   Pieper U, 2002, BIOCHEMISTRY-US, V41, P5245, DOI 10.1021/bi015687u
   Pieper U, 1999, J MOL BIOL, V292, P547, DOI 10.1006/jmbi.1999.3103
   Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x
   POWELL LM, 1993, J MOL BIOL, V234, P60, DOI 10.1006/jmbi.1993.1563
   Powell LM, 1998, J MOL BIOL, V283, P947, DOI 10.1006/jmbi.1998.2142
   Powell LM, 1998, J MOL BIOL, V283, P963, DOI 10.1006/jmbi.1998.2143
   POWELL LM, 1995, NUCLEIC ACIDS RES, V23, P967, DOI 10.1093/nar/23.6.967
   PRICE C, 1989, J MOL BIOL, V205, P115, DOI 10.1016/0022-2836(89)90369-0
   PRICE C, 1987, EMBO J, V6, P1493, DOI 10.1002/j.1460-2075.1987.tb02391.x
   RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x
   RALEIGH EA, 1986, P NATL ACAD SCI USA, V83, P9070, DOI 10.1073/pnas.83.23.9070
   RALEIGH EA, 1989, GENETICS, V122, P279
   Redaschi N, 1996, ESCHERICHIA COLI SAL, P773
   Reddy YVR, 1998, J BIOL CHEM, V273, P23866, DOI 10.1074/jbc.273.37.23866
   Reddy YVR, 2000, J MOL BIOL, V298, P597, DOI 10.1006/jmbi.2000.3673
   REVEL HR, 1983, BACTERIOPHAGE T, V4, P156
   Roberts RJ, 2001, NUCLEIC ACIDS RES, V29, P268, DOI 10.1093/nar/29.1.268
   ROSS TK, 1989, J BACTERIOL, V171, P1974, DOI 10.1128/jb.171.4.1974-1981.1989
   ROSS TK, 1989, MOL GEN GENET, V216, P402, DOI 10.1007/BF00334382
   Schouler C, 1998, MOL MICROBIOL, V28, P169, DOI 10.1046/j.1365-2958.1998.00787.x
   SHARP PM, 1992, P NATL ACAD SCI USA, V89, P9836, DOI 10.1073/pnas.89.20.9836
   Sitaraman R, 1997, MOL MICROBIOL, V26, P109, DOI 10.1046/j.1365-2958.1997.5571938.x
   Stewart FJ, 1998, BIOL CHEM, V379, P611
   Stewart FJ, 2000, J MOL BIOL, V298, P611, DOI 10.1006/jmbi.2000.3697
   STUDIER FW, 1988, P NATL ACAD SCI USA, V85, P4677, DOI 10.1073/pnas.85.13.4677
   Sturrock SS, 1997, NUCLEIC ACIDS RES, V25, P3408, DOI 10.1093/nar/25.17.3408
   SUGISAKI H, 1981, GENE, V16, P73
   SURI B, 1985, J MOL BIOL, V186, P77, DOI 10.1016/0022-2836(85)90258-X
   SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A
   Szczelkun MD, 1996, EMBO J, V15, P6335, DOI 10.1002/j.1460-2075.1996.tb01023.x
   Szczelkun MD, 2002, BIOCHEMISTRY-US, V41, P2067, DOI 10.1021/bi011824b
   TAYLOR I, 1993, NUCLEIC ACIDS RES, V21, P4929, DOI 10.1093/nar/21.21.4929
   TAYLOR I, 1992, NUCLEIC ACIDS RES, V20, P179, DOI 10.1093/nar/20.2.179
   Taylor IA, 1996, J MOL BIOL, V258, P62, DOI 10.1006/jmbi.1996.0234
   Thorpe PH, 1997, NUCLEIC ACIDS RES, V25, P1694, DOI 10.1093/nar/25.9.1694
   Tyndall C, 1997, MOL MICROBIOL, V23, P729, DOI 10.1046/j.1365-2958.1997.2531622.x
   Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3
   Wah DA, 1998, P NATL ACAD SCI USA, V95, P10564, DOI 10.1073/pnas.95.18.10564
   Weiserova M, 1998, BIOL CHEM, V379, P585
   Weiserova M, 2000, J MOL BIOL, V304, P301, DOI 10.1006/jmbi.2000.4219
   WILLCOCK DF, 1994, EMBO J, V13, P3902, DOI 10.1002/j.1460-2075.1994.tb06701.x
   YUAN R, 1975, NATURE, V256, P556, DOI 10.1038/256556a0
   Zinkevich V, 1997, NUCLEIC ACIDS RES, V25, P503, DOI 10.1093/nar/25.3.503
NR 116
TC 79
Z9 79
U1 0
U2 13
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD NOV
PY 2002
VL 84
IS 11
BP 1047
EP 1059
AR PII S0300-9084(02)00020-2
DI 10.1016/S0300-9084(02)00020-2
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 657QT
UT WOS:000181678400002
PM 12595133
DA 2021-01-25
ER

PT J
AU Heerklotz, H
AF Heerklotz, H
TI Triton promotes domain formation in lipid raft mixtures
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID DIFFERENTIAL SCANNING CALORIMETRY; NUCLEAR MAGNETIC-RESONANCE; MEMBRANE
   DOMAINS; TITRATION CALORIMETRY; CONDENSED COMPLEXES; ANCHORED PROTEINS;
   AQUEOUS-SOLUTIONS; PHASE-EQUILIBRIA; MODEL MEMBRANES; CELL-MEMBRANES
AB Biological membranes are supposed to contain functional domains (lipid rafts) made up in particular of sphingomyelin and cholesterol, glycolipids, and certain proteins. It is often assumed that the application of the detergent Triton at 4degreesC allows the isolation of these rafts as a detergent-resistant membrane fraction. The current study aims to clarify whether and how Triton changes the domain properties. To this end, temperature-dependent transitions in vesicles of an equimolar mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, egg sphingomyelin, and cholesterol were monitored at different Triton concentrations by differential scanning calorimetry and pressure perturbation calorimetry. Transitions initiated by the addition of Triton to the lipid mixture were studied by isothermal titration calorimetry, and the structure was investigated by P-31-NMR. The results are discussed in terms of liquid-disordered (Id) and -ordered (to) bilayer and micellar (mic) phases, and the typical sequence encountered with increasing Triton content or decreasing temperature is Id, Id + Io, Id + Io + mic, and Io + mic. That means that addition of Triton may create ordered domains in a homogeneous fluid membrane, which are, in turn, Triton resistant upon subsequent membrane solubilization. Hence, detergent-resistant membranes should not be assumed to resemble biological rafts in size, structure, composition, or even existence. Functional rafts may not be steady phenomena; they might form, grow, cluster or break up, shrink, and vanish according to functional requirements, regulated by rather subtle changes in the activity of membrane disordering or ordering compounds.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
OI Heerklotz, Heiko/0000-0003-4615-7022
CR Ahmed SN, 1997, BIOCHEMISTRY-US, V36, P10944, DOI 10.1021/bi971167g
   Anderson TG, 2001, BIOPHYS J, V81, P2774, DOI 10.1016/S0006-3495(01)75920-6
   Blume A, 1988, PHYSICAL PROPERTIES, P71
   Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575
   CHAPMAN D, 1974, J BIOL CHEM, V249, P2512
   Chellani Mohan, 1999, American Biotechnology Laboratory, V17, P18
   Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9
   Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698
   Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0
   ESTEP TN, 1979, BIOCHEMISTRY-US, V18, P2112, DOI 10.1021/bi00577a042
   Gandhavadi M, 2002, BIOPHYS J, V82, P1469, DOI 10.1016/S0006-3495(02)75501-X
   GONI FM, 1986, EUR J BIOCHEM, V160, P659, DOI 10.1111/j.1432-1033.1986.tb10088.x
   Grabitz P, 2002, BIOPHYS J, V82, P299, DOI 10.1016/S0006-3495(02)75395-2
   Heerklotz H, 2002, BIOPHYS J, V82, P1445, DOI 10.1016/S0006-3495(02)75498-2
   HEERKLOTZ H, 1995, CHEM PHYS LETT, V235, P517, DOI 10.1016/0009-2614(95)00139-U
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162
   IPSEN JH, 1989, BIOPHYS J, V56, P661, DOI 10.1016/S0006-3495(89)82713-4
   Jacobson K, 1999, TRENDS CELL BIOL, V9, P87, DOI 10.1016/S0962-8924(98)01495-0
   Kresheck GC, 2001, J PHYS CHEM B, V105, P4380, DOI 10.1021/jp004022j
   Kresheck GC, 2000, LANGMUIR, V16, P3067, DOI 10.1021/la990895x
   Lin LN, 2002, ANAL BIOCHEM, V302, P144, DOI 10.1006/abio.2001.5524
   London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1
   MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J
   Majhi PR, 2001, LANGMUIR, V17, P3844, DOI 10.1021/la001660k
   Miao L, 2002, BIOPHYS J, V82, P1429, DOI 10.1016/S0006-3495(02)75497-0
   MOURITSEN OG, 1994, CHEM PHYS LIPIDS, V73, P3, DOI 10.1016/0009-3084(94)90171-6
   Nielsen M, 2000, EUROPHYS LETT, V52, P368, DOI 10.1209/epl/i2000-00448-8
   Nyholm T, 2001, LANGMUIR, V17, P4724, DOI 10.1021/la001263+
   Pantaler E, 2000, BBA-BIOMEMBRANES, V1509, P397, DOI 10.1016/S0005-2736(00)00322-9
   Patra SK, 1999, J LIPOSOME RES, V9, P247, DOI 10.3109/08982109909024788
   Plotnikov VV, 1997, ANAL BIOCHEM, V250, P237, DOI 10.1006/abio.1997.2236
   Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097
   SANKARAM MB, 1991, P NATL ACAD SCI USA, V88, P8686, DOI 10.1073/pnas.88.19.8686
   SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130
   Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150
   Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892
   SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Sot J, 2002, LANGMUIR, V18, P2828, DOI 10.1021/la011381c
   THEWALT JL, 1992, BIOPHYS J, V63, P1176, DOI 10.1016/S0006-3495(92)81681-8
   VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021
   Wang TY, 2001, BIOPHYS J, V81, P2762, DOI 10.1016/S0006-3495(01)75919-X
   YU J, 1973, Journal of Supramolecular Structure, V1, P233, DOI 10.1002/jss.400010308
NR 45
TC 426
Z9 437
U1 2
U2 46
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD NOV
PY 2002
VL 83
IS 5
BP 2693
EP 2701
DI 10.1016/S0006-3495(02)75278-8
PG 9
WC Biophysics
SC Biophysics
GA 611NP
UT WOS:000179024500033
PM 12414701
OA Green Published
DA 2021-01-25
ER

PT J
AU Schwyzer, L
   Mateos, JM
   Abegg, M
   Rietschin, L
   Heeb, L
   Thompson, SM
   Luthi, A
   Gahwiler, BH
   McKinney, RA
AF Schwyzer, L
   Mateos, JM
   Abegg, M
   Rietschin, L
   Heeb, L
   Thompson, SM
   Luthi, A
   Gahwiler, BH
   McKinney, RA
TI Physiological and morphological plasticity induced by chronic treatment
   with NT-3 or NT-4/5 in hippocampal slice cultures
SO EUROPEAN JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE CA1; CA3; injury; neurotrophins; plasticity
ID MESSENGER-RNA EXPRESSION; GLUTAMATERGIC SYNAPTIC TRANSMISSION; CORTICAL
   DENDRITIC GROWTH; NEUROTROPHIC FACTOR; RECEPTOR ACTIVATION; INHIBITORY
   SYNAPSES; ADULT HIPPOCAMPUS; NEURONAL-ACTIVITY; RAT HIPPOCAMPUS; BRAIN
AB Expression of neurotrophins (NTs) and their receptors is elevated in the adult CNS under several neuropathological conditions. We have investigated the anatomical and electrophysiological consequences of chronic NT-3 or NT-4/5 treatment on established organotypic hippocampal slice cultures maintained in vitro for > 14 days. Both NT-3 and NT-4/5 increased spontaneous, action potential-dependent excitatory synaptic activity (sEPSCs), but only NT-3 increased inhibitory synaptic activity (sIPSCs) in CA3 pyramidal cells. Both NTs strongly promoted spontaneous synaptic bursting activity. Spontaneous bursts of EPSCs were observed after either NT treatment but only NT-3-treated cultures exhibited an increase in spontaneous bursts of IPSCs. In addition, sIPSC bursts were eliminated by blocking glutamatergic excitation. The frequency of miniature inhibitory postsynaptic currents, but not miniature excitatory postsynaptic currents, was also increased by both NT-3 and NT-4/5. Furthermore, NT-3 and NT-4/5 induced an up-regulation of the growth-associated protein GAP-43, suggesting that neurotrophins may be able to induce axonal reorganization in established neuronal networks. CA1 pyramidal cells exhibited slight alterations in dendritic branching after NT-4/5, but not NT-3 treatment. We conclude that chronic treatment with NT-3 or NT-4/5 can affect an established hippocampal network by elevating spontaneous inhibitory and excitatory synaptic activity and inducing coordinated pre- and postsynaptic structural changes.
C1 Univ Zurich, Inst Brain Res, CH-8057 Zurich, Switzerland.
   Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.
   Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4003 Basel, Switzerland.
RP McKinney, RA (corresponding author), Univ Zurich, Inst Brain Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM mckinney@hifo.unizh.ch
RI Thompson, Scott M/K-8921-2015
CR Alcantara S, 1997, J NEUROSCI, V17, P3623
   BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107
   BECK KD, 1993, J NEUROSCI, V13, P4001
   BENGZON J, 1993, NEUROSCIENCE, V53, P433, DOI 10.1016/0306-4522(93)90207-V
   Binder DK, 1999, J NEUROSCI, V19, P4616
   Binder DK, 1999, J NEUROSCI, V19, P1424
   Bolton MM, 2000, J NEUROSCI, V20, P3221, DOI 10.1523/JNEUROSCI.20-09-03221.2000
   BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223
   Cohen-Cory S, 1999, J NEUROSCI, V19, P9996
   Desai NS, 1999, LEARN MEMORY, V6, P284
   Drake CT, 1999, J NEUROSCI, V19, P8009
   Elmer E, 1998, NEUROSCIENCE, V83, P351, DOI 10.1016/S0306-4522(97)00387-4
   Frerking M, 1998, J NEUROPHYSIOL, V80, P3383
   Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3
   GALL C, 1991, EPILEPSY RES, P225
   GALL CM, 1993, EXP NEUROL, V124, P150, DOI 10.1006/exnr.1993.1186
   Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216
   HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405
   Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428
   ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q
   KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457
   KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341
   Kobayashi NR, 1997, J NEUROSCI, V17, P9583
   Kraushaar U, 2000, J NEUROSCI, V20, P5594
   Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667
   LESSMANN V, 1994, NEUROREPORT, V6, P21
   LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074
   Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744
   Marty S, 2000, J NEUROSCI, V20, P8087
   Marty S, 1996, J NEUROSCI, V16, P675
   MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X
   McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295
   McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5
   McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1
   McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990
   McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548
   PATEL MN, 1995, NEUROSCIENCE, V69, P763, DOI 10.1016/0306-4522(95)00281-M
   REINIS S, 1992, J NEUROSCI METH, V43, P1, DOI 10.1016/0165-0270(92)90061-H
   ROCAMORA N, 1993, NEUROSCIENCE, V53, P905, DOI 10.1016/0306-4522(93)90475-U
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Seil FJ, 2000, PROG BRAIN RES, V128, P219
   SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733
   SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303
   SUZUKI F, 1995, NEUROSCIENCE, V64, P665, DOI 10.1016/0306-4522(94)00463-F
   THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593
   Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256
   ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037
NR 47
TC 22
Z9 23
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0953-816X
EI 1460-9568
J9 EUR J NEUROSCI
JI Eur. J. Neurosci.
PD NOV
PY 2002
VL 16
IS 10
BP 1939
EP 1948
DI 10.1046/j.1460-9568.2002.02259.x
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 620MU
UT WOS:000179537800013
PM 12453058
DA 2021-01-25
ER

PT J
AU Groppe, JC
   Greenwald, J
   Wiater, E
   Rodriguez-Leon, J
   Economides, AN
   Kwiatkowski, W
   Baban, K
   Affolter, M
   Vale, WW
   Izpisua Belmonte, JC
   Choe, S
AF Groppe, JC
   Greenwald, J
   Wiater, E
   Rodriguez-Leon, J
   Economides, AN
   Kwiatkowski, W
   Baban, K
   Affolter, M
   Vale, WW
   Izpisua Belmonte, JC
   Choe, S
TI Structural basis of BMP signalling inhibition by Noggin, a novel cystine
   knot protein
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 Salk Inst Biol Studies, La Jolla, CA 92037 USA.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Gulbenkian Inst Sci, Oeiras, Portugal.
   Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA.
RI Leon, Joaquin Maria Rodriguez/S-9814-2019; Leon, Joaquin Maria
   Rodriguez/C-6957-2013
OI Leon, Joaquin Maria Rodriguez/0000-0002-9582-5480; Leon, Joaquin Maria
   Rodriguez/0000-0002-9582-5480
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 27
BP 6A
EP 6A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569100028
DA 2021-01-25
ER

PT J
AU Lemmon, SK
   Henry, K
   Chang, J
   Newpher, T
   D'Hondt, K
   Riezman, H
AF Lemmon, SK
   Henry, K
   Chang, J
   Newpher, T
   D'Hondt, K
   Riezman, H
TI Role of clathrin and Scd5p in actin organization and endocytosis in
   yeast
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 29
BP 6A
EP 6A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569100030
DA 2021-01-25
ER

PT J
AU Kreplak, L
   Muecke, N
   Wedig, T
   Buerki, A
   Herrmann, H
   Aebi, U
AF Kreplak, L
   Muecke, N
   Wedig, T
   Buerki, A
   Herrmann, H
   Aebi, U
TI Probing the assembly pathway and the polymorphism of vimentin
   intermediate filaments by time-lapse atomic force microscopy
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 Univ Basel, Biozentrum, M E Mueller Inst, CH-4003 Basel, Switzerland.
   German Canc Res Ctr, D-6900 Heidelberg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 339
BP 60A
EP 61A
PG 2
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569100339
DA 2021-01-25
ER

PT J
AU Freidekind, O
   Wedig, T
   Zimbelmann, R
   Muecke, N
   Broehl, D
   Magin, TM
   Aebi, U
   Herrmann, H
AF Freidekind, O
   Wedig, T
   Zimbelmann, R
   Muecke, N
   Broehl, D
   Magin, TM
   Aebi, U
   Herrmann, H
TI The effect of mutations in the evolutionarily conserved IF consensus
   motif of coil 1A on assembly of vimentin and of keratin 8/18
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 German Canc Res Ctr, D-6900 Heidelberg, Germany.
   Univ Bonn, Inst Physiol Chem, D-5300 Bonn, Germany.
   Univ Basel, Biozentrum, M E Mueller Inst, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 342
BP 61A
EP 61A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569100342
DA 2021-01-25
ER

PT J
AU Wedig, T
   Muecke, N
   Aebi, U
   Herrmann, H
AF Wedig, T
   Muecke, N
   Aebi, U
   Herrmann, H
TI Functional analysis of the vimentin oligomerization and filament
   formation
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 German Canc Res Ctr, D-6900 Heidelberg, Germany.
   Univ Basel, Biozentrum, M E Mueller Inst, CH-4003 Basel, Switzerland.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 340
BP 61A
EP 61A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569100340
DA 2021-01-25
ER

PT J
AU Goldsbury, C
   Aebi, U
   Frey, P
AF Goldsbury, C
   Aebi, U
   Frey, P
TI Assembly and structure of Alzheimer's A-beta amyloid-like fibrils
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 DESY, Max Planck Unit Struct Mol Biol, Mandelkow Grp, D-2000 Hamburg, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4003 Basel, Switzerland.
   Novartis Pharma AG, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 781
BP 139A
EP 139A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569100780
DA 2021-01-25
ER

PT J
AU Fiedler, K
AF Fiedler, K
TI Caveolae in mechanotransduction
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 1306
BP 232A
EP 232A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569101305
DA 2021-01-25
ER

PT J
AU Jacinto, T
AF Jacinto, T
TI The TOR complex: Characterization of two highly conserved TOR
   interactors in mammalian cells
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 1637
BP 291A
EP 292A
PG 2
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569101636
DA 2021-01-25
ER

PT J
AU Gladfelter, AS
   Hungerbuehler, K
   Philippsen, P
AF Gladfelter, AS
   Hungerbuehler, K
   Philippsen, P
TI Cell cycle regulation in the filamentous, multinuclear fungus Ashbya
   gossypii
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 1674
BP 298A
EP 298A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569101673
DA 2021-01-25
ER

PT J
AU De Marco, V
   Burkhard, P
   de Marco, A
   Goldie, KN
   Vernos, I
   Hoenger, A
AF De Marco, V
   Burkhard, P
   de Marco, A
   Goldie, KN
   Vernos, I
   Hoenger, A
TI Structural investigations into the coiled-coil region essential for
   proper heterodimerization and complex stability of the heterotrimeric
   kinesin-II Xklp3A/B
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 European Mol Biol Lab, Struct Biol Programme, Heidelberg, Germany.
   European Mol Biol Lab, Prot Express & Purificat Facil, Heidelberg, Germany.
   European Mol Biol Lab, Cell Biol & Biophys Programme, Heidelberg, Germany.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 1820
BP 323A
EP 323A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569101819
DA 2021-01-25
ER

PT J
AU Strelkov, SV
   Schumacher, J
   Herrmann, H
   Aebi, U
   Burkhard, P
AF Strelkov, SV
   Schumacher, J
   Herrmann, H
   Aebi, U
   Burkhard, P
TI Dissecting higher-order oligomers formed by the nuclear lamins at atomic
   detail
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 Univ Basel, Biozentrum, ME Mueller Inst, CH-4003 Basel, Switzerland.
   German Canc Res Ctr, D-6900 Heidelberg, Germany.
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 2147
BP 381A
EP 381A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569102146
DA 2021-01-25
ER

PT J
AU Pagano, A
   Spiess, M
AF Pagano, A
   Spiess, M
TI An in vitro assay for endosomal budding of recycling receptors
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 2910
BP 517A
EP 517A
PG 1
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569102909
DA 2021-01-25
ER

PT J
AU Dichtl, B
   Blank, D
   Ohnacker, M
   Friedlein, A
   Roeder, D
   Langen, H
   Keller, W
AF Dichtl, B
   Blank, D
   Ohnacker, M
   Friedlein, A
   Roeder, D
   Langen, H
   Keller, W
TI A role for SSU72 in balancing RNA polymerase II transcription elongation
   and termination
SO MOLECULAR CELL
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; POLYADENYLATION FACTOR; FUNCTIONAL
   INTERACTION; PROCESSING FACTORS; SITE SELECTION; YEAST; PROTEIN; DOMAIN;
   CLEAVAGE; COMPLEX
AB Interactions of pre-mRNA 3' end factors and the CTD of RNA polymerase II (RNAP II) are required for transcription termination and 3' end processing. Here, we demonstrate that Ssu72p is stably associated with yeast cleavage and polyadenylation factor CPF and provide evidence that it bridges the CPF subunits Pta1p and Ydh1p/Cft2p, the general transcription factor TFIIB, and RNAP II via Rpb2p. Analyses of ssu72-2 mutant cells in the absence and presence of the nuclear exosome component Rrp6p revealed defects in RNAP II transcription elongation and termination. 6-azauracil, that reduces transcription elongation rates, suppressed the ssu72-2 growth defect at 33degreesC. The sum of our analyses suggests a negative influence of Ssu72p on RNAP II during transcription that affects the commitment to either elongation or termination.
C1 Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Roche Genet F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland.
RP Dichtl, B (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM bernhard.dichtl@unibas.ch; walter.keller@unibas.ch
OI Dichtl, Bernhard/0000-0001-5514-4982
CR Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0
   Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298
   Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2
   Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633
   Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298
   Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2
   CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470
   Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901
   Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763
   Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390
   EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735
   Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218
   Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101
   Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998
   Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357
   Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110
   Hirose Y, 1998, NATURE, V395, P93
   Kessler MM, 1996, J BIOL CHEM, V271, P27167, DOI 10.1074/jbc.271.43.27167
   Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700
   Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X
   McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0
   McNeil JB, 1998, GENE DEV, V12, P2510, DOI 10.1101/gad.12.16.2510
   Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398
   Minvielle-Sebastia L, 1998, EMBO J, V17, P7454, DOI 10.1093/emboj/17.24.7454
   Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698
   OCONNOR JP, 1992, MOL CELL BIOL, V12, P3843, DOI 10.1128/MCB.12.9.3843
   Ohnacker M, 2000, EMBO J, V19, P37, DOI 10.1093/emboj/19.1.37
   Pappas DL, 2000, MOL CELL BIOL, V20, P8343, DOI 10.1128/MCB.20.22.8343-8351.2000
   Powell W, 1996, J BIOL CHEM, V271, P6866, DOI 10.1074/jbc.271.12.6866
   PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7
   PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1
   Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7
   Rasmussen TP, 1998, MOL CELL BIOL, V18, P6885, DOI 10.1128/MCB.18.12.6885
   Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000
   Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137
   RUSSELL RA, 1995, IEEE ROBOT AUTOM MAG, V2, P3, DOI 10.1109/100.414920
   Ryan K, 2002, MOL CELL BIOL, V22, P1684, DOI 10.1128/MCB.22.6.1684-1692.2002
   Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583
   Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090
   Sun ZW, 1996, MOL CELL BIOL, V16, P1557
   Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0
   Vo LTA, 2001, MOL CELL BIOL, V21, P8346, DOI 10.1128/MCB.21.24.8346-8356.2001
   Walsh EP, 2002, BIOCHEMISTRY-US, V41, P2409, DOI 10.1021/bi015815e
   Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472
   Wu WH, 1999, GENETICS, V153, P643
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
NR 48
TC 123
Z9 124
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD NOV
PY 2002
VL 10
IS 5
BP 1139
EP 1150
DI 10.1016/S1097-2765(02)00707-4
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 619AJ
UT WOS:000179450600021
PM 12453421
OA Green Published
DA 2021-01-25
ER

PT J
AU Schulein, R
   Dehio, C
AF Schulein, R
   Dehio, C
TI The VirB/VirD4 type IV secretion system of Bartonella is essential for
   establishing intraerythrocytic infection
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID AGROBACTERIUM-TUMEFACIENS VIRB; GRAM-NEGATIVE BACTERIA; PATHOGEN
   XYLELLA-FASTIDIOSA; ESSENTIAL VIRULENCE PROTEIN; PERTUSSIS TOXIN
   SECRETION; HELICOBACTER-PYLORI CAGA; BORDETELLA-PERTUSSIS;
   ENDOTHELIAL-CELLS; BRUCELLA-ABORTUS; ESCHERICHIA-COLI
AB Bartonellae are pathogenic bacteria uniquely adapted to cause intraerythrocytic infection in their human or animal reservoir host(s). Experimental infection of rats by Bartonella tribocorum revealed the initial colonization of a yet unidentified niche outside of circulating blood. This primary niche periodically seeds bacteria into the bloodstream, resulting in the invasion and persistent intracellular colonisation of erythrocytes. Here, this animal model was used for a genetic analysis of the virB locus (virB2-11) and the downstream located virD4 gene, which together encode a putative type IV secretion system (T4SS). A generic method for marker-less gene replacement allowed the generation of non-polar in-frame deletions in either virB4 or virD4. Both mutants were unable to cause bacteraemia, whereas complementation with the full-length genes in trans completely restored infectivity. Segregation analysis of the complementation plasmids further denoted that VirB4 and VirD4 are required at an early stage of the infection course before the onset of intraerythrocytic bacteraemia. This analysis of defined mutants in an in vivo model identified components of the VirB/VirD4 T4SS as the first bona fide pathogenicity factors in Bartonella.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094
   BARNETT MJ, 2001, P NATL ACAD SCI USA, V31, P31
   Battisti JM, 1999, APPL ENVIRON MICROB, V65, P3441
   BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994
   BERGER BR, 1993, J BACTERIOL, V175, P1723, DOI 10.1128/JB.175.6.1723-1734.1993
   Chen LS, 2002, J BACTERIOL, V184, P4838, DOI 10.1128/JB.184.17.4838-4845.2002
   Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x
   CHRISTIE PJ, 1989, P NATL ACAD SCI USA, V86, P9677, DOI 10.1073/pnas.86.24.9677
   Coleman SA, 2001, INFECT IMMUN, V69, P4373, DOI 10.1128/IAI.69.7.4373-4381.2001
   Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x
   COVACCI A, 1993, MOL MICROBIOL, V8, P429, DOI 10.1111/j.1365-2958.1993.tb01587.x
   Craig-Mylius KA, 1999, FEMS MICROBIOL LETT, V179, P479, DOI 10.1016/S0378-1097(99)00447-4
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Delrue RM, 2001, CELL MICROBIOL, V3, P487, DOI 10.1046/j.1462-5822.2001.00131.x
   DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398
   DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347
   Farizo KM, 2000, INFECT IMMUN, V68, P4049, DOI 10.1128/IAI.68.7.4049-4054.2000
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   FULLNER KJ, 1994, MOL GEN GENET, V245, P704, DOI 10.1007/BF00297277
   Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966
   Gomis-Ruth FX, 2002, RES MICROBIOL, V153, P199, DOI 10.1016/S0923-2508(02)01313-X
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x
   Kahrs AF, 1995, GENE, V167, P53, DOI 10.1016/0378-1119(95)00671-0
   Karem KL, 2000, MICROBES INFECT, V2, P1193, DOI 10.1016/S1286-4579(00)01273-9
   KAWAMUKAI M, 1989, J BACTERIOL, V171, P4525, DOI 10.1128/JB.171.8.4525-4529.1989
   KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   KOMANO T, 1991, RES MICROBIOL, V142, P269, DOI 10.1016/0923-2508(91)90040-H
   Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315
   Maguina C, 2000, INFECT DIS CLIN N AM, V14, P1, DOI 10.1016/S0891-5520(05)70215-4
   Marques MV, 2001, PLASMID, V45, P184, DOI 10.1006/plas.2000.1514
   Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P7321, DOI 10.1073/pnas.93.14.7321
   O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x
   Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   PRIDMORE RD, 1987, GENE, V56, P309, DOI 10.1016/0378-1119(87)90149-1
   Rambow-Larsen AA, 2002, J BACTERIOL, V184, P2863, DOI 10.1128/JB.184.11.2863-2869.2002
   RATET P, 1988, GENE, V63, P41, DOI 10.1016/0378-1119(88)90544-6
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schmiederer M, 2000, DNA CELL BIOL, V19, P141, DOI 10.1089/104454900314528
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559
   SEUBERT A, 2002, IN PRESS PLASMID
   Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000
   SIMON R, 1986, METHOD ENZYMOL, V118, P640
   Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003
   Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263
   STIBITZ S, 1986, GENE, V50, P133, DOI 10.1016/0378-1119(86)90318-5
   Watarai M, 2002, MICROBIOL-SGM, V148, P1439, DOI 10.1099/00221287-148-5-1439
   WEISS AA, 1993, P NATL ACAD SCI USA, V90, P2970, DOI 10.1073/pnas.90.7.2970
   Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804
   Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x
NR 60
TC 105
Z9 109
U1 0
U2 5
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD NOV
PY 2002
VL 46
IS 4
BP 1053
EP 1067
DI 10.1046/j.1365-2958.2002.03208.x
PG 15
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 618CQ
UT WOS:000179400900013
PM 12421311
DA 2021-01-25
ER

PT J
AU Feldman, MF
   Muller, S
   Wuest, E
   Cornelis, GR
AF Feldman, MF
   Muller, S
   Wuest, E
   Cornelis, GR
TI SycE allows secretion of YopE-DHFR hybrids by the Yersinia
   enterocolitica type III Ysc system
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID CHAPERONE-LIKE PROTEIN; ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE;
   SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; PRECURSOR PROTEIN; EUKARYOTIC
   CELLS; PLASMA-MEMBRANE; HELA-CELLS; TRANSLOCATION
AB The Ysc type III secretion system allows Yersinia enterocolitica to translocate virulence proteins, called Yop effectors, into the cytosol of eukaryotic cells. Some of the Yop effectors possess an individual chaperone called a Syc protein. The first 15 amino acids of the YopE effector constitute a secretion signal that is sufficient to promote secretion of several reporter proteins. Residues 15-50 of YopE comprise the minimal binding domain for the SycE chaperone. In this study, we investigated the secretion by the Ysc system of several YopE-DHFR hybrid proteins with different folding properties, and evaluated the role of SycE, the cognate chaperone of YopE, in this context. We have analysed the secretion of hybrids containing 16 (YopE(16)), 52 (YopE(52)) and 80 (the complete region covered by the chaperone, YopE(80)) amino acids of YopE or full-length YopE (YopE(FL)) with wild-type DHFR and two mutants with altered folding properties. The hybrids containing DHFRDelta77, the mutant whose folding properties are the most drastically affected, could be secreted in all the conditions tested, even in the absence of the chaperone SycE. In contrast, DHFRwt could only be secreted fused to the first 52 amino acids of YopE, and its secretion was strictly dependent on SycE. The hybrids YopE(80)-DHFRwt and YopE(FL)-DHFRwt were not secreted. YopE(FL)-DHFRwt completely jammed the channel in an SycE-dependent fashion. Our experiments indicate that, in order to be secreted, proteins must be unfolded or only partially folded, and that TSS chaperones could keep their substrates in a secretion-competent conformation, probably by preventing their folding. In addition, they show that the secretion apparatus can reject folded proteins if they are not deeply engaged into the injectisome.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Catholique Louvain, Christian de Duve Int Cellular Pathol, Microbial Pathogenesis Unit, B-1200 Brussels, Belgium.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 30-50, CH-4056 Basel, Switzerland.
RI Feldman, Mario/A-2637-2014
OI Feldman, Mario/0000-0003-4497-0976
CR Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140
   Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974
   Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098
   Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000
   Cheng LW, 1999, J BIOL CHEM, V274, P22102, DOI 10.1074/jbc.274.31.22102
   Clark AC, 1999, J MOL BIOL, V285, P1765, DOI 10.1006/jmbi.1998.2402
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850
   Driessen AJM, 2001, TRENDS MICROBIOL, V9, P193, DOI 10.1016/S0966-842X(01)01980-1
   EILERS M, 1986, NATURE, V322, P228, DOI 10.1038/322228a0
   Evdokimov AG, 2002, PROTEIN SCI, V11, P401, DOI 10.1110/ps.34102
   FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   HEIDORN JV, 1986, J BASIC MICROB, V26, P621, DOI 10.1002/jobm.3620261011
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Hynds PJ, 1998, J BIOL CHEM, V273, P34868, DOI 10.1074/jbc.273.52.34868
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   Kopytek SJ, 2000, ANTIMICROB AGENTS CH, V44, P3210, DOI 10.1128/AAC.44.11.3210-3212.2000
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Lee VT, 2002, J BACTERIOL, V184, P3740, DOI 10.1128/JB.184.13.3740-3745.2002
   LUO Y, 2001, NAT STRUCT BIOL, V29, P29
   MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7
   MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991
   NARAYANA N, 1995, NAT STRUCT BIOL, V2, P1018, DOI 10.1038/nsb1195-1018
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   OEFNER C, 1988, EUR J BIOCHEM, V174, P377, DOI 10.1111/j.1432-1033.1988.tb14108.x
   Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x
   Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006
   PUGSLEY AP, 1992, P NATL ACAD SCI USA, V89, P12058, DOI 10.1073/pnas.89.24.12058
   Salvador N, 2000, J BIOL CHEM, V275, P27447
   SASSO SP, 1994, BBA-PROTEIN STRUCT M, V1207, P74, DOI 10.1016/0167-4838(94)90053-1
   Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996
   SCHLENSTEDT G, 1990, J BIOL CHEM, V265, P13960
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073
   STUEBER D, 1984, EMBO J, V3, P3143, DOI 10.1002/j.1460-2075.1984.tb02271.x
   Teichmann U, 1996, J BIOL CHEM, V271, P10137, DOI 10.1074/jbc.271.17.10137
   Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000
   VESTWEBER D, 1988, EMBO J, V7, P1147, DOI 10.1002/j.1460-2075.1988.tb02924.x
   WALTON PA, 1995, MOL BIOL CELL, V6, P675
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   Wattiau P, 1996, MOL MICROBIOL, V20, P255, DOI 10.1111/j.1365-2958.1996.tb02614.x
   WIENHUES U, 1991, J CELL BIOL, V115, P1601, DOI 10.1083/jcb.115.6.1601
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x
   Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x
NR 52
TC 65
Z9 67
U1 0
U2 1
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD NOV
PY 2002
VL 46
IS 4
BP 1183
EP 1197
DI 10.1046/j.1365-2958.2002.03241.x
PG 15
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 618CQ
UT WOS:000179400900023
PM 12421321
OA Bronze
DA 2021-01-25
ER

PT J
AU Meyer, RP
   Podvinec, M
   Meyer, UA
AF Meyer, RP
   Podvinec, M
   Meyer, UA
TI Cytochrome P450CYP1A1 accumulates in the cytosol of kidney and brain and
   is activated by heme
SO MOLECULAR PHARMACOLOGY
LA English
DT Article
ID RAT-BRAIN; DRUG-METABOLISM; EXPRESSION; PURIFICATION; TISSUE;
   MYELOPEROXIDASE; MICROSOMES; PITUITARY; SEQUENCES; PHENYTOIN
AB Cytochrome P450 CYP1A1 is expressed in most tissues. In brain and kidney, its function remains unclear because its enzymatic activity is barely measurable. Here, we report on the localization of CYP1A1 in the cytosol of kidney and brain, as revealed by immunoblotting with anti-CYP1A1 antibodies and by 7-ethoxyresorufin deethylation (EROD). Hematin (8 muM) added in vitro to cytosol increased the EROD-activity 10-fold in brain olfactory bulb and 7-fold in kidney, presumably by reconstitution of apocytochrome. Succinylacetone, an inhibitor of heme biosynthesis, increased the ratio of cytosolic to microsomal EROD activity of transiently expressed CYP1A1 in COS-1 cells from 1:1 to nearly 6:1. This indicates a strong decrease of microsomal activity with increasing succinylacetone concentration. CYP1A1 activities correlated with CYP1A1 protein assessed by immunoblotting. We conclude that the availability of heme is a limiting factor of P450 function in extrahepatic tissue. Our data further suggest that reduced availability of heme limits the incorporation of P450s into brain endoplasmic reticulum. These observations are important when assessing the function of P450s in extrahepatic tissue.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
RP Meyer, UA (corresponding author), Neurozentrum, Res Unit, Dept Neuropathol, Breisacher Str 64, D-79106 Freiburg, Germany.
EM meyeralf@ukl.uni-freiburg.de
CR BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1050
   BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7
   Carvalho H, 1997, BIOCHEM J, V328, P827, DOI 10.1042/bj3280827
   CORREIA MA, 1975, P NATL ACAD SCI USA, V72, P400, DOI 10.1073/pnas.72.1.400
   Correia MA, 1995, CYTOCHROME P450 STRU, P607
   CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
   da Silva JL, 2001, KIDNEY INT, V59, P1448, DOI 10.1046/j.1523-1755.2001.0590041448.x
   deGroot MJ, 1996, CHEM RES TOXICOL, V9, P1079, DOI 10.1021/tx960003i
   Doostzadeh J, 1996, EUR J BIOCHEM, V242, P641, DOI 10.1111/j.1432-1033.1996.0641r.x
   GIGER U, 1983, FEBS LETT, V153, P335, DOI 10.1016/0014-5793(83)80637-1
   Gu J, 1998, J PHARMACOL EXP THER, V285, P1287
   Hedlund E, 1996, MOL PHARMACOL, V50, P342
   Huang P, 2000, TOXICOL APPL PHARM, V169, P159, DOI 10.1006/taap.2000.9064
   Ingi T, 1996, J NEUROSCI, V16, P5621
   ISCAN M, 1990, BIOCHEM BIOPH RES CO, V169, P858, DOI 10.1016/0006-291X(90)91972-U
   JOSEPH P, 1994, P NATL ACAD SCI USA, V91, P8413, DOI 10.1073/pnas.91.18.8413
   KEMPF AC, 1995, ARCH BIOCHEM BIOPHYS, V321, P277, DOI 10.1006/abbi.1995.1396
   KIMURA S, 1984, J BIOL CHEM, V259, P705
   Lohr JW, 1998, PHARMACOL REV, V50, P107
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Meyer RP, 2001, EXP NEUROL, V167, P376, DOI 10.1006/exnr.2000.7553
   Meyer UA, 1998, SEMIN LIVER DIS, V18, P43, DOI 10.1055/s-2007-1007139
   NASLUND BMA, 1988, MOL PHARMACOL, V33, P31
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   Neunaber R, 1999, COMP BIOCHEM PHYS B, V124, P89, DOI 10.1016/S0305-0491(99)00104-2
   OMIECINSKI CJ, 1980, MOL PHARMACOL, V17, P225
   OMIECINSKI CJ, 1978, BIOCHEM BIOPH RES CO, V83, P1004, DOI 10.1016/0006-291X(78)91495-X
   PARK SS, 1982, CANCER RES, V42, P1798
   PINNIX IB, 1994, ARCH BIOCHEM BIOPHYS, V312, P447, DOI 10.1006/abbi.1994.1331
   Poinas A, 2002, EUR J BIOCHEM, V269, P1243, DOI 10.1046/j.1432-1033.2002.02764.x
   REED CJ, 1988, BIOCHEM J, V253, P569, DOI 10.1042/bj2530569
   Riedl AG, 1998, MOVEMENT DISORD, V13, P212, DOI 10.1002/mds.870130204
   Rosenbrock H, 1999, J NEUROENDOCRINOL, V11, P597
   Rosenbrock H, 2001, J NEUROCHEM, V76, P332, DOI 10.1046/j.1471-4159.2001.00011.x
   SCHILTER B, 1993, MOL PHARMACOL, V44, P990
   SHAHI GS, 1991, NEUROSCI LETT, V127, P247, DOI 10.1016/0304-3940(91)90804-3
   Strobel HW, 1997, DRUG METAB REV, V29, P1079, DOI 10.3109/03602539709002244
   TAYLOR KL, 1990, BIOCHEMISTRY-US, V29, P1533, DOI 10.1021/bi00458a026
   Vijayasarathy C, 1999, EUR J BIOCHEM, V266, P191, DOI 10.1046/j.1432-1327.1999.00843.x
   Volk B, 1995, TOXICOL LETT, V82-3, P655, DOI 10.1016/0378-4274(95)03511-7
   Warner M, 1998, Arch Toxicol Suppl, V20, P455
   Yang YF, 1997, FEMS MICROBIOL LETT, V154, P347, DOI 10.1016/S0378-1097(97)00352-2
NR 42
TC 49
Z9 49
U1 0
U2 1
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0026-895X
EI 1521-0111
J9 MOL PHARMACOL
JI Mol. Pharmacol.
PD NOV
PY 2002
VL 62
IS 5
BP 1061
EP 1067
DI 10.1124/mol.62.5.1061
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 606QR
UT WOS:000178745100012
PM 12391268
DA 2021-01-25
ER

PT J
AU Engel, U
   Oezbek, S
   Engel, R
   Petri, B
   Lottspeich, F
   Holstein, TW
AF Engel, U
   Oezbek, S
   Engel, R
   Petri, B
   Lottspeich, F
   Holstein, TW
TI Nowa, a novel protein with minicollagen Cys-rich domains, is involved in
   nematocyst formation in Hydra
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE minicollagen Cys-rich domain; CTLD; nematocyst; microtubules; assembly
ID ELECTROPHORESIS; COLLAGENS; ATTENUATA; HYDROZOA
AB The novel protein Nowa was identified in nematocysts, explosive organelles of Hydra, jellyfish, corals and other Cnidaria. Biogenesis of these organelles is complex and involves assembly of proteins inside a post-Golgi vesicle to form a double-layered capsule with a long tubule. Nowa is the major component of the outer wall, which is formed very early in morphogenesis. The high molecular weight glycoprotein has a modular structure with an N-terminal sperm coating glycoprotein domain, a central C-type lectin-like domain, and an eightfold repeated cysteine-rich domain at the C-terminus. Interestingly, the cysteine-rich domains are homologous to the cysteine-rich domains of minicollagens. We have previously shown that the cysteines of these minicollagen cysteine-rich domains undergo an isomerization process from intra- to intermolecular disulfide bonds, which mediates the crosslinking of minicollagens to networks in the inner wall of the capsule. The minicollagen cysteine-rich domains present in both proteins provide a potential link between Nowa in the outer wall and minicollagens in the inner wall. We propose a model for nematocyst formation that integrates cytoskeleton rearrangements around the post-Golgi vesicle and protein assembly inside the vesicle to generate a complex structure that is stabilized by intermolecular disulfide bonds.
C1 Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Munich, Inst Zool, D-80333 Munich, Germany.
   Max Planck Inst Biochem, D-82152 Martinsried, Germany.
RP Holstein, TW (corresponding author), Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany.
EM holstein@bio.tu-darmstadt.de
RI Engel, Ulrike/E-5456-2014; Engel, Ulrike/AAO-7719-2020
OI Engel, Ulrike/0000-0002-6953-6845; Ozbek, Suat/0000-0003-2569-3942
CR Anderluh G, 2000, BBA-PROTEIN STRUCT M, V1476, P372, DOI 10.1016/S0167-4838(99)00237-X
   DAVID CN, 1974, J CELL SCI, V16, P359
   DAVID CN, 1973, ROUX ARCH DEV BIOL, V171, P259, DOI 10.1007/BF00577724
   DAVID CN, 1974, AM ZOOL, V14, P537
   DRICKAMER K, 1988, J BIOL CHEM, V263, P9557
   Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3
   Drickamer K., 1989, Ciba Foundation Symposium, P45
   ECKERSKORN C, 1989, CHROMATOGRAPHIA, V28, P92, DOI 10.1007/BF02290390
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   Frohman Michael A., 1995, P381
   GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913
   HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186
   HOLSTEIN T, 1981, J ULTRA MOL STRUCT R, V75, P276, DOI 10.1016/S0022-5320(81)80085-8
   HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402
   HOLSTEIN TW, 1990, NATURE, V346, P21, DOI 10.1038/346021b0
   HOLSTEIN TW, 1990, DEV BIOL, V142, P392, DOI 10.1016/0012-1606(90)90360-U
   Koch AW, 1998, J CELL SCI, V111, P1545
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   Llera AS, 2001, J BIOL CHEM, V276, P7312, DOI 10.1074/jbc.M008573200
   LOOMIS WF, 1956, J EXP ZOOL, V132, P555, DOI 10.1002/jez.1401320309
   Mariscal R.N., 1974, COELENTERATE BIOL RE, P129, DOI DOI 10.1016/B978-0-12-512150-7.50008-6
   Reidling JC, 2000, J BIOL CHEM, V275, P10323, DOI 10.1074/jbc.275.14.10323
   Sambrook J, 1989, MOL CLONING LAB MANU
   Shulman JM, 1999, TRENDS CELL BIOL, V9, pM60, DOI 10.1016/S0968-0004(99)01490-5
   SLAUTTERBACK DB, 1959, J BIOPHYS BIOCHEM CY, V5, P441, DOI 10.1083/jcb.5.3.441
   Szczepanek S, 2002, J CELL SCI, V115, P745
   Szyperski T, 1998, P NATL ACAD SCI USA, V95, P2262, DOI 10.1073/pnas.95.5.2262
   Technau U, 1999, DEVELOPMENT, V126, P999
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   USAMI Y, 1993, P NATL ACAD SCI USA, V90, P928, DOI 10.1073/pnas.90.3.928
   Watson G.M., 1988, P143
   WATSON GM, 1984, J ULTRA MOL STRUCT R, V87, P159, DOI 10.1016/S0022-5320(84)80075-1
   WEBER J, 1987, COMP BIOCHEM PHYS B, V88, P855, DOI 10.1016/0305-0491(87)90255-0
   WEBER J, 1990, J BIOL CHEM, V265, P9664
   WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241
NR 35
TC 56
Z9 58
U1 0
U2 13
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD OCT 15
PY 2002
VL 115
IS 20
BP 3923
EP 3934
DI 10.1242/jcs.00084
PG 12
WC Cell Biology
SC Cell Biology
GA 614GK
UT WOS:000179179800008
PM 12244130
OA Bronze
DA 2021-01-25
ER

PT J
AU Nemes, C
   Ramsden, JJ
   Rozlosnik, N
AF Nemes, C
   Ramsden, JJ
   Rozlosnik, N
TI The unfolding of native laminin investigated by atomic force microscopy
SO PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS
LA English
DT Article
DE mechanical denaturation; protein modules; worm-like chain
ID TITIN; BINDING; ELASTICITY; MOLECULES; TENASCIN; DNA
AB Atomic force microscopy has been used to directly measure the forces required to unfold individual domains of the extracellular matrix protein laminin. The approach-retraction cycles display a characteristic saw-tooth motif. Tooth heights and separations were used to establish a statistical relation between domain unfolding force and domain extension. The extensible domains of laminin require an unfolding force intermediate between previously established values for a-helical and beta-sheet domains in other proteins. The relationship between unfolding force and extension for a given domain is not smooth; discrete steps are observed, interpreted as originating from the modularity of the protein structure. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4003 Basel, Switzerland.
   Collegium Basilea, Inst Adv Study, Basel, Switzerland.
RP Rozlosnik, N (corresponding author), Riso Natl Lab, Danish Polymer Ctr, POB 49, DK-4000 Roskilde, Denmark.
EM noemi.rozlosnik@risoe.dk
RI Rozlosnik, Noemi/A-3090-2012
CR Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x
   BECK K, 1990, FASEB J, V4, P148
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   FISCHER D, 1995, J BIOL CHEM, V270, P3378, DOI 10.1074/jbc.270.7.3378
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   Kellermayer MSZ, 2001, BIOPHYS J, V80, P852, DOI 10.1016/S0006-3495(01)76064-X
   Kellermayer MSZ, 1998, J STRUCT BIOL, V122, P197, DOI 10.1006/jsbi.1998.3988
   LINGARD PA, 1997, PHYS REV E, V56, P4497
   Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008
   Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   PAULSSON M, 1988, J BIOL CHEM, V263, P5425
   PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x
   RAMSDEN JJ, 1993, BIOPOLYMERS, V33, P475, DOI 10.1002/bip.360330313
   Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0
   Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764
   Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466
NR 17
TC 4
Z9 4
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4371
J9 PHYSICA A
JI Physica A
PD OCT 15
PY 2002
VL 313
IS 3-4
BP 578
EP 586
AR PII S0378-4371(02)00984-6
DI 10.1016/S0378-4371(02)00984-6
PG 9
WC Physics, Multidisciplinary
SC Physics
GA 617JF
UT WOS:000179358000023
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, W
TI Roots, strategies and prospects of functional genomics
SO CURRENT SCIENCE
LA English
DT Article
ID DEOXYRIBONUCLEIC-ACID; MICROBIAL EVOLUTION; DNA-POLYMERASE; MUTAGENESIS
AB This essay traces,the historical development of classical and molecular genetics from their early roots to the actual research strategies and their prospects. Attention is also given to the risk. evaluation of genetic engineering by comparing designed genetic alterations with the spontaneous genetic variation known to form the substrate for biological evolution.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Werner.Arber@unibas.ch
CR ARBER W, 1991, J MOL EVOL, V33, P4, DOI 10.1007/BF02100190
   Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x
   ARBER W, 1965, ANNU REV MICROBIOL, V19, P365, DOI 10.1146/annurev.mi.19.100165.002053
   Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137
   BERG P, 1981, SCIENCE, V213, P296, DOI 10.1126/science.6264595
   LEDERBERG J, 1947, GENETICS, V32, P505
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   MOONEY HA, 1990, SCOPE 44 INTRO GENET
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2
   SHORTLE D, 1981, ANNU REV GENET, V15, P265, DOI 10.1146/annurev.ge.15.120181.001405
   SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X
   SMITH M, 1985, ANNU REV GENET, V19, P423, DOI 10.1146/annurev.genet.19.1.423
   WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   ZINDER ND, 1952, J BACTERIOL, V64, P679, DOI 10.1002/path.1700640402
NR 16
TC 3
Z9 3
U1 0
U2 1
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD OCT 10
PY 2002
VL 83
IS 7
BP 826
EP 828
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 605EC
UT WOS:000178662800019
DA 2021-01-25
ER

PT J
AU Henn-Sax, M
   Thoma, R
   Schmidt, S
   Hennig, M
   Kirschner, K
   Sterner, R
AF Henn-Sax, M
   Thoma, R
   Schmidt, S
   Hennig, M
   Kirschner, K
   Sterner, R
TI Two (beta alpha)(8)-barrel enzymes of histidine and tryptophan
   biosynthesis have similar reaction mechanisms and common strategies for
   protecting their labile substrates
SO BIOCHEMISTRY
LA English
DT Article
ID PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; ESCHERICHIA-COLI;
   THERMOTOGA-MARITIMA; DIRECTED EVOLUTION; DIVERGENT EVOLUTION; PHOSPHATE
   SYNTHASE; ADAPTATION; PROTEINS; PURIFICATION; QUANTITATION
AB The enzymes N'-[(5'-phosphoribosyl)formimino]-5-aminoimidazole-4-carboxamideribonucleotide isomerase (HisA) and phosphoribosylanthranilate isomerase (TrpF) are sugar isomerases that are involved in histidine and tryptophan biosynthesis, respectively. Both enzymes have the (betaalpha)(8)-barrel fold and catalyze Amadori rearrangements of a thermolabile aminoaldose into the corresponding aminoketose. To identify those amino acids that are essential for catalysis, conserved residues at the active sites of both HisA and TrpF from the hyperthermophile Thermotoga maritima were replaced by site-directed mutagenesis, and the purified variants were investigated by steady-state enzyme kinetics. Aspartate 8, aspartate 127, and threonine 164 appeared to be important for the HisA reaction, whereas cysteine 7 and aspartate 126 appeared to be important for the TrpF reaction. On the basis of these results and the X-ray structure of a complex between TrpF and a bound product analogue, a reaction mechanism involving general acid-base catalysis and a Schiff base intermediate is proposed for both enzymes. A comparison of the HisA and TrpF enzymes from T. maritima and Escherichia coli showed that, at the physiological temperatures of 80 and 37 degreesC, respectively, the enzymes from the hyperthermophile have significantly higher catalytic efficiencies than the corresponding enzymes from mesophiles. These results suggest that HisA and TrpF have similar chemical reaction mechanisms and use the same strategy to prevent the loss of their thermolabile substrates.
C1 Univ Cologne, Inst Biochem, D-50674 Cologne, Germany.
   Univ Gottingen, Inst Mikrobiol & Genet, Abt Mol Genet & Praparat Mol Biol, D-37077 Gottingen, Germany.
   Univ Basel, Biozentrum, Biophys Chem Abt, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Abt Strukturbiol, CH-4056 Basel, Switzerland.
   F Hoffmann La Roche & Cie AG, CH-4070 Basel, Switzerland.
   European Mol Biol Lab, D-69117 Heidelberg, Germany.
RP Sterner, R (corresponding author), Univ Cologne, Inst Biochem, Otto Fischer Str 12-14, D-50674 Cologne, Germany.
EM Reinhard.Sterner@Uni-Koeln.de
RI Sterner, Reinhard/ABI-6781-2020
OI Sterner, Reinhard/0000-0001-8177-8460
CR Babbitt PC, 2001, ADV PROTEIN CHEM, V55, P1, DOI 10.1016/S0065-3233(01)55001-9
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Barik S, 1998, CURR INNOV MOL BIOL, V5, P25
   Beismann-Driemeyer S, 2001, J BIOL CHEM, V276, P20387, DOI 10.1074/jbc.M102012200
   BISSWANGER H, 1979, BIOCHEMISTRY-US, V18, P5946, DOI 10.1021/bi00593a029
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152
   CREIGHTON T E, 1970, Biochemical Journal, V120, P699
   CREIGHTON TE, 1966, J BIOL CHEM, V241, P4616
   Dabrowski S, 1998, PROTEIN EXPRES PURIF, V14, P131, DOI 10.1006/prep.1998.0945
   DAVISSON VJ, 1994, J ORG CHEM, V59, P137, DOI 10.1021/jo00080a022
   EBERHARD M, 1990, COMPUT APPL BIOSCI, V6, P213
   EDER J, 1991, THESIS U BASEL BASEL
   EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715
   GERBER PR, 1992, BIOPOLYMERS, V32, P1003, DOI 10.1002/bip.360320811
   Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209
   Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809
   Henn-Sax M, 2001, BIOL CHEM, V382, P1315, DOI 10.1515/BC.2001.163
   Hennig M, 2002, J MOL BIOL, V319, P757, DOI 10.1016/S0022-2836(02)00378-9
   Hennig M, 1997, BIOCHEMISTRY-US, V36, P6009, DOI 10.1021/bi962718q
   Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5
   HOMMEL U, 1995, BIOCHEMISTRY-US, V34, P5429, DOI 10.1021/bi00016a014
   Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149
   ISBELL HS, 1958, J ORG CHEM, V23, P1309, DOI 10.1021/jo01103a019
   Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962
   JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397
   KIRSCHNER K, 1987, METHOD ENZYMOL, V142, P386
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546
   LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158
   LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004
   MARGOLIE.MN, 1966, J BIOL CHEM, V241, P3262
   MATNEY TS, 1964, BIOCHEM BIOPH RES CO, V17, P278, DOI 10.1016/0006-291X(64)90397-3
   Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i
   Miyazaki K, 2000, J MOL BIOL, V297, P1015, DOI 10.1006/jmbi.2000.3612
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622
   Rosenthal JA, 1999, BIOCHEMISTRY-US, V38, P7847, DOI 10.1021/bi990045g
   RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019
   SAKAR G, 1990, BIOTECHNIQUES, V8, P404
   SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052
   Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006
   Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174
   STOLL VS, 1990, METHOD ENZYMOL, V182, P24
   Thoma R, 1999, FEBS LETT, V454, P1, DOI 10.1016/S0014-5793(99)00757-7
   Thoma R, 2000, STRUCTURE, V8, P265, DOI 10.1016/S0969-2126(00)00106-4
   Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056
   VOGEL HJ, 1956, J BIOL CHEM, V218, P97
   Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0
   Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406
NR 53
TC 50
Z9 54
U1 2
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD OCT 8
PY 2002
VL 41
IS 40
BP 12032
EP 12042
DI 10.1021/bi026092h
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 601XF
UT WOS:000178473600011
PM 12356303
DA 2021-01-25
ER

PT J
AU Schoenenberger, CA
   Bischler, N
   Fahrenkrog, B
   Aebi, U
AF Schoenenberger, CA
   Bischler, N
   Fahrenkrog, B
   Aebi, U
TI Actin's propensity for dynamic filament patterning
SO FEBS LETTERS
LA English
DT Review
DE actin; branching; bundling; dimer; nucleus
ID ARP2/3 COMPLEX; CROSS-LINKING; F-ACTIN; CRYSTAL-STRUCTURE; BINDING
   PROTEIN; NUCLEAR; POLYMERIZATION; PARACRYSTALS; PURIFICATION; NETWORKS
AB Actin, through its various forms of assembly, provides the basic framework for cell motility, cell shape and intracellular organization in all eukaryotic cells. Many other cellular processes, for example endocytosis and cytokinesis, are also associated with dynamic changes of the actin cytoskeleton. Important prerequisites for actin's functional diversity are its intrinsic ability to rapidly assemble and disassemble filaments and its spatially and temporally well-controlled supramolecular organization. A large number of proteins that interact with actin, collectively referred to as actin-binding proteins (ABPs), carefully orchestrate different scenarios. Since its isolation in 1994 [Machesky, L.M. et al. (1994) J. Cell Biol. 127, 107-115], the Arp2/3 complex containing the actin-related proteins Arp2 and Arp3 has evolved to be one of the main players in the assembly and maintenance of many actin-based structures in the cell (for review see (Borths, E.L. and Welch, M.D. (2002) Structure 10, 131-135; May, R.C. (2001) Cell Mol. Life Sci. 58, 1607-1626; Pollard, T.D. et al. (2000) Rev. Biophys. Biomol. Struct. 29, 545-576; Welch, M.D. (1999) Trends Cell Biol. 11, 423-427]). In particular, when it comes to the assembly of the intricate branched actin network at the leading edge of lamellipodia, the Arp2/3 complex seems to have received all the attention in recent years. In parallel, but not so much in the spotlight, several reports showed that actin on its own can assume different conformations [Bubb, M.R. et al. (2002) J. Biol. Chem. 277, 20999-21006; Schoenenberger, C.-A. et al. (1999) Microsc. Res. Tech. 47, 38-50; Steinmetz, M.O. et al. (1998) J. Mol. Biol. 278, 793-811; Steinmetz, M.O. et al. (1997) J. Cell Biol. 138, 559-574; Millonig, R., Salvo, H. and Aebi, U. (1988) J. Cell Biol. 106, 785-796] through which it drives its supramolecular patterning, and which ultimately generate its functional diversity. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Schoenenberger, CA (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM cora-ann.schoenenberger@unibas.ch; ueli.aebi@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413
CR AEBI U, 1980, NATURE, V288, P296, DOI 10.1038/288296a0
   AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340
   Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398
   Blanchoin L, 2000, NATURE, V404, P1007
   Borths EL, 2002, STRUCTURE, V10, P131, DOI 10.1016/S0969-2126(02)00712-8
   Boujemaa-Paterski R, 2001, BIOCHEMISTRY-US, V40, P11390, DOI 10.1021/bi010486b
   BREMER A, 1991, J CELL BIOL, V115, P689, DOI 10.1083/jcb.115.3.689
   BROWN SS, 1979, J CELL BIOL, V80, P499, DOI 10.1083/jcb.80.2.499
   Bubb MR, 2002, J BIOL CHEM, V277, P20999, DOI 10.1074/jbc.M201371200
   Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061
   Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6
   Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x
   ELZINGA M, 1984, P NATL ACAD SCI-BIOL, V81, P6599, DOI 10.1073/pnas.81.21.6599
   FAULSTICH H, 1992, FEBS LETT, V302, P201, DOI 10.1016/0014-5793(92)80440-R
   FOWLER WE, 1982, J CELL BIOL, V93, P452, DOI 10.1083/jcb.93.2.452
   Fujiwara I, 2002, BIOCHEM BIOPH RES CO, V293, P1550, DOI 10.1016/S0006-291X(02)00421-7
   GILBERT HR, 1983, BIOCHEM BIOPH RES CO, V111, P404, DOI 10.1016/0006-291X(83)90320-0
   Gonsior SM, 1999, J CELL SCI, V112, P797
   Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201
   HANSON J, 1973, PROC R SOC SER B-BIO, V183, P39, DOI 10.1098/rspb.1973.0003
   HARTWIG JH, 1986, J CELL BIOL, V103, P1007, DOI 10.1083/jcb.103.3.1007
   HESTERKAMP T, 1993, EUR J BIOCHEM, V218, P507, DOI 10.1111/j.1432-1033.1993.tb18403.x
   Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895
   HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0
   KNIGHT P, 1978, BIOCHEM J, V175, P1023, DOI 10.1042/bj1751023
   LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628
   MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107
   May RC, 2001, CELL MOL LIFE SCI, V58, P1607, DOI 10.1007/PL00000800
   MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785
   MOCKRIN SC, 1981, J BIOL CHEM, V256, P8228
   Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181
   Mullins RD, 1999, CURR OPIN STRUC BIOL, V9, P244
   Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507
   Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975
   Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799
   Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545
   Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333
   Schoenenberger CA, 1999, MICROSC RES TECHNIQ, V47, P38, DOI 10.1002/(SICI)1097-0029(19991001)47:1<38::AID-JEMT4>3.0.CO;2-5
   Steinmetz MO, 2000, J MOL BIOL, V303, P171, DOI 10.1006/jmbi.2000.4129
   Steinmetz MO, 1998, J MOL BIOL, V278, P703, DOI 10.1006/jmbi.1998.1717
   Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559
   Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009
   Svitkina TM, 1999, TRENDS BIOCHEM SCI, V24, P432, DOI 10.1016/S0968-0004(99)01461-9
   Tang JX, 1999, BIOPHYS J, V76, P2208, DOI 10.1016/S0006-3495(99)77376-5
   TILNEY LG, 1992, J CELL BIOL, V118, P71, DOI 10.1083/jcb.118.1.71
   Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025
   Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7
   Yarmola EG, 2000, J BIOL CHEM, V275, P28120
   YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409
NR 49
TC 29
Z9 29
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD OCT 2
PY 2002
VL 529
IS 1
BP 27
EP 33
AR PII S0014-5793(02)03267-2
DI 10.1016/S0014-5793(02)03267-2
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 601VC
UT WOS:000178468300006
PM 12354608
OA Bronze
DA 2021-01-25
ER

PT J
AU Werten, PJL
   Remigy, HW
   de Groot, BL
   Fotiadis, D
   Philippsen, A
   Stahlberg, H
   Grubmuller, H
   Engel, A
AF Werten, PJL
   Remigy, HW
   de Groot, BL
   Fotiadis, D
   Philippsen, A
   Stahlberg, H
   Grubmuller, H
   Engel, A
TI Progress in the analysis of membrane protein structure and function
SO FEBS LETTERS
LA English
DT Review
DE membrane protein expression; two-dimensional crystallization; atomic
   force microscopy; three-dimensional electron microscopy; molecular
   dynamics simulation
ID ATOMIC-FORCE MICROSCOPE; CRYO-ELECTRON MICROSCOPY; LIGHT-HARVESTING
   COMPLEX; ANGSTROM RESOLUTION; 3-DIMENSIONAL STRUCTURE; WATER CHANNEL;
   2-DIMENSIONAL CRYSTALS; 2D CRYSTALLIZATION; HUMAN AQUAPORIN-1; SINGLE
   MOLECULES
AB Structural information on membrane proteins is sparse, yet they represent an important class of proteins that is encoded by about 30% of all genes. Progress has primarily been achieved with bacterial proteins, but efforts to solve the structure of eukaryotic membrane proteins are also increasing. Most of the structures currently available have been obtained by exploiting the power of X-ray crystallography. Recent results, however, have demonstrated the accuracy of electron crystallography and the imaging power of the atomic force microscope. These instruments allow membrane proteins to be studied while embedded in the bi-layer, and thus in a functional state. The low signal-to-noise ratio of cryo-electron microscopy is overcome by crystallizing membrane proteins in a two-dimensional protein-lipid membrane, allowing its atomic structure to be determined. In contrast, the high signal-to-noise ratio of atomic force microscopy allows individual protein surfaces to be imaged at subnanometer resolution, and their conformational states to be sampled. This review summarizes the steps in membrane protein structure determination and illuminates recent progress. (C) 2002 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Max Planck Inst Biophys Chem, Theoret Mol Biophys Grp, D-37077 Gottingen, Germany.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
CR Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1
   ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827
   Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220
   Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5
   CONWAY JF, 1993, J STRUCT BIOL, V111, P222, DOI 10.1006/jsbi.1993.1052
   de Groot BL, 2000, J MOL BIOL, V300, P987, DOI 10.1006/jmbi.2000.3913
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860
   Fisher TE, 2000, NAT STRUCT BIOL, V7, P719
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Fotiadis D, 2001, J BIOL CHEM, V276, P1707, DOI 10.1074/jbc.M009383200
   Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202
   Frank J, 2000, METHOD ENZYMOL, V317, P276
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Fujiyoshi Y, 2002, CURR OPIN STRUC BIOL, V12, P509, DOI 10.1016/S0959-440X(02)00355-X
   Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668
   Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328
   Hasler L, 1998, J STRUCT BIOL, V121, P162, DOI 10.1006/jsbi.1998.3960
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821
   Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0
   Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299
   Jensen MO, 2001, STRUCTURE, V9, P1083, DOI 10.1016/S0969-2126(01)00668-2
   Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   KISTLER J, 1994, J CELL BIOL, V126, P1047, DOI 10.1083/jcb.126.4.1047
   KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0
   Lancaster CRD, 2001, FEBS LETT, V504, P133, DOI 10.1016/S0014-5793(01)02706-5
   Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X
   Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   Lundstrom K, 2000, INTERVIROLOGY, V43, P247, DOI 10.1159/000053992
   Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631
   Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676
   Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198
   RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V
   Rosenbusch JP, 2001, J STRUCT BIOL, V136, P144, DOI 10.1006/jsbi.2001.4431
   Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x
   Scheuring S, 2002, EUR BIOPHYS J BIOPHY, V31, P172, DOI 10.1007/s00249-001-0197-8
   Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029
   Stahlberg H, 2001, FEBS LETT, V504, P166, DOI 10.1016/S0014-5793(01)02746-6
   Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047
   Sui HX, 2000, ACTA CRYSTALLOGR D, V56, P1198, DOI 10.1107/S0907444900008143
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778
   Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9
   van Heel M, 2000, CURR OPIN STRUC BIOL, V10, P259, DOI 10.1016/S0959-440X(00)00077-4
   van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644
   VANHOEK AN, 1992, J BIOL CHEM, V267, P18267
   Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039
   Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512
   Werten PJL, 2001, FEBS LETT, V504, P200, DOI 10.1016/S0014-5793(01)02703-X
   Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534
   ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002
NR 72
TC 65
Z9 69
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD OCT 2
PY 2002
VL 529
IS 1
BP 65
EP 72
AR PII S0014-5793(02)03290-8
DI 10.1016/S0014-5793(02)03290-8
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 601VC
UT WOS:000178468300013
PM 12354615
DA 2021-01-25
ER

PT J
AU Tronche, F
   Casanova, E
   Turiault, M
   Sahly, I
   Kellendonk, C
AF Tronche, F
   Casanova, E
   Turiault, M
   Sahly, I
   Kellendonk, C
TI When reverse genetics meets physiology: the use of site-specific
   recombinases in mice
SO FEBS LETTERS
LA English
DT Review
DE recombinase; Cre-loxP; mutation; transgenesis; mouse
ID MEDIATED CASSETTE EXCHANGE; EMBRYONIC STEM-CELLS; CRE RECOMBINASE;
   MAMMALIAN-CELLS; CHROMOSOMAL TRANSLOCATION; GLUCOCORTICOID RECEPTOR;
   TARGETED INTEGRATION; LOXP RECOMBINATION; DNA RECOMBINATION; TRANSGENIC
   MICE
AB The use of site-specific recombinases enables the precise introduction of defined genetic mutations into the mouse genome. In theory, any deletion, point mutation, inversion or translocation can be modeled in mice. Because gene targeting is controlled both spatially and temporally, the function of a given gene can be studied in the desired cell types and at a specific time point. This 'genetic dissection' allows to define gene function in development, physiology or behavior. In this review, we focus on the technical possibilities of Cre and other site-specific recombinases but also discuss their limitations. (C) 2002 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
C1 Coll France, CNRS FRE2401, Inst Biol, F-75231 Paris 5, France.
   Univ Basel, Biozentrum, Pharmazentrum, Dept Physiol, Basel, Switzerland.
   Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.
RP Tronche, F (corresponding author), Coll France, CNRS FRE2401, Inst Biol, 11 Pl Marcelin Berthelot, F-75231 Paris 5, France.
EM francois.tronche@college-de-france.fr
RI Kellendonk, Christoph/O-7229-2018; Casanova, Emilio/Y-6553-2019;
   TRONCHE, Francois/F-3895-2011
OI Kellendonk, Christoph/0000-0003-3302-2188; Casanova,
   Emilio/0000-0001-7992-5361; 
CR Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299
   Araki K, 1997, NUCLEIC ACIDS RES, V25, P868, DOI 10.1093/nar/25.4.868
   Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2
   Bouhassira EE, 1997, BLOOD, V90, P3332, DOI 10.1182/blood.V90.9.3332
   Brocard J, 1998, NUCLEIC ACIDS RES, V26, P4086, DOI 10.1093/nar/26.17.4086
   Brown SDM, 2001, CURR OPIN GENET DEV, V11, P268, DOI 10.1016/S0959-437X(00)00189-1
   Buchholz F, 2000, EMBO REP, V1, P133, DOI 10.1093/embo-reports/kvd027
   Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047
   Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657
   Cao TY, 2001, J CELL BIOL, V152, P651, DOI 10.1083/jcb.152.3.651
   Christ N, 2002, J MOL BIOL, V319, P305, DOI 10.1016/S0022-2836(02)00327-3
   Cohen-Tannoudji M, 2000, MECH DEVELOP, V90, P29, DOI 10.1016/S0925-4773(99)00226-9
   Dobie K, 1997, TRENDS GENET, V13, P127, DOI 10.1016/S0168-9525(97)01097-4
   Feng YQ, 1999, J MOL BIOL, V292, P779, DOI 10.1006/jmbi.1999.3113
   Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56
   Gopaul Deshmukh N., 1999, Current Opinion in Structural Biology, V9, P14, DOI 10.1016/S0959-440X(99)80003-7
   GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642
   Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925
   Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a
   Hartung M, 1998, J BIOL CHEM, V273, P22884, DOI 10.1074/jbc.273.36.22884
   Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861
   HOCHMAN L, 1983, VIROLOGY, V131, P11, DOI 10.1016/0042-6822(83)90528-7
   Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099
   Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324
   Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E
   Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307
   KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125
   Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068
   LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232
   Langer SJ, 2002, NUCLEIC ACIDS RES, V30, P3067, DOI 10.1093/nar/gkf421
   Lauth M, 2000, GENESIS, V27, P153, DOI 10.1002/1526-968X(200008)27:4<153::AID-GENE40>3.0.CO;2-B
   Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223
   Lindeberg J, 2002, J NEUROSCI RES, V68, P248, DOI 10.1002/jnr.10213
   Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788
   Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798
   Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136
   Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6
   Minamino T, 2001, CIRC RES, V88, P587, DOI 10.1161/01.RES.88.6.587
   Moon AM, 2000, DEVELOPMENT, V127, P989
   Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B
   Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4
   Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391
   ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861
   Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699
   Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498
   Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440
   Ringrose L, 1997, EUR J BIOCHEM, V248, P903, DOI 10.1111/j.1432-1033.1997.00903.x
   Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630
   Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973
   Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593
   SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166
   Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297
   Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427
   Shaikh AC, 2000, J MOL BIOL, V302, P27, DOI 10.1006/jmbi.2000.3967
   Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023
   Siegal ML, 2000, METH MOL B, V136, P487
   Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7
   SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   Stoll SM, 2002, J BACTERIOL, V184, P3657, DOI 10.1128/JB.184.13.3657-3663.2002
   Tannour-Louet M, 2002, HEPATOLOGY, V35, P1072, DOI 10.1053/jhep.2002.33164
   Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703
   Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064
   Weber P, 2001, EUR J NEUROSCI, V14, P1777, DOI 10.1046/j.0953-816x.2001.01803.x
   Wunderlich FT, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e47
   Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859
   Zhang Y, 1996, NUCLEIC ACIDS RES, V24, P543, DOI 10.1093/nar/24.4.543
   Zheng BH, 1999, NAT GENET, V22, P375, DOI 10.1038/11949
   Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000
NR 70
TC 35
Z9 35
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD OCT 2
PY 2002
VL 529
IS 1
BP 116
EP 121
AR PII S0014-5793(02)03266-0
DI 10.1016/S0014-5793(02)03266-0
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 601VC
UT WOS:000178468300020
PM 12354622
OA Bronze
DA 2021-01-25
ER

PT J
AU Girard, T
   Treves, S
   Censier, K
   Mueller, CR
   Zorzato, F
   Urwyler, A
AF Girard, T
   Treves, S
   Censier, K
   Mueller, CR
   Zorzato, F
   Urwyler, A
TI Phenotyping malignant hyperthermia susceptibility by measuring
   halothane-induced changes in myoplasmic calcium concentration in
   cultured human skeletal muscle cells
SO BRITISH JOURNAL OF ANAESTHESIA
LA English
DT Article
DE anaesthesia; anaesthetics volatile, halothane; ions, calcium; muscle,
   skeletal, myoblasts
ID VITRO CONTRACTURE TEST; RYANODINE-RECEPTOR; IDENTIFICATION; MUTATIONS;
   DIAGNOSIS
AB Background. Malignant hyperthermia (MH) is a potentially lethal disease triggered by volatile anaesthetics and succinylcholine in genetically predisposed individuals. Because of the heterogenetic nature of MH, a simple genetic-based diagnostic test is not feasible and diagnosis requires an invasive open muscle biopsy followed by the in vitro contracture test (IVCT). Our aim was to establish if measurements of halothane-induced increases in intracellular calcium ion concentration [Ca2+](i) in cultured human skeletal muscle cells can be used to phenotype MH susceptibility and if different mutations in the ryanodine receptor (RYRI) gene affect halothane-induced increases in [Ca2+](i).
   Methods. Primary cultures of human skeletal muscle cells were established from 54 individuals diagnosed by the IVCT according to the protocol of the European MH Group as: MH susceptible (n=22), MH negative (n=18) or MH equivocal (n=14). All individuals were screened for the presence of the most common mutations in the RYR1 gene. [Ca2+](i) was measured by fluorescent digital microscopy using fura-2/AM in 10 cells from each patient at five different halothane concentrations.
   Results. The halothane-induced increase in [Ca2+](i) differed significantly between the three diagnostic groups. Different mutations of the RYR1 gene did not have a specific impact on halothane-induced increases in [Ca2+](i).
   Conclusions. Measurements of [Ca2+](i) in human skeletal muscle cells can be used to phenotype MH susceptibility; however, we did not observe a specific effect of any mutation in the RYR1 gene on the halothane-induced increase in [Ca2+](i).
C1 Univ Basel, Dept Anaesthesiol, Kantonsspital, CH-4031 Basel, Switzerland.
   Univ Basel, Dept Res, Kantonsspital, CH-4031 Basel, Switzerland.
   Univ Wurzburg, Inst Human Genet, Biozentrum, D-97074 Wurzburg, Germany.
   Univ Ferrara, Dept Expt & Diagnost Med, Gen Pathol Sect, I-44100 Ferrara, Italy.
RP Girard, T (corresponding author), Univ Basel, Dept Anaesthesiol, Kantonsspital, CH-4031 Basel, Switzerland.
RI Girard, Timothy/I-3008-2019
OI Girard, Timothy/0000-0002-9833-4871; Treves, Susan/0000-0002-0007-9631
CR Bendixen D, 1997, ACTA ANAESTH SCAND, V41, P480, DOI 10.1111/j.1399-6576.1997.tb04727.x
   Censier K, 1998, J CLIN INVEST, V101, P1233, DOI 10.1172/JCI993
   Denborough M, 1998, LANCET, V352, P1131, DOI 10.1016/S0140-6736(98)03078-5
   DENBOROUGH MA, 1960, LANCET, V2, P45
   ELLIS FR, 1984, BRIT J ANAESTH, V56, P1267
   FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346
   Girard T, 2001, Hum Mutat, V18, P357, DOI 10.1002/humu.1203
   GRONERT GA, 2000, ANESTHESIA, P1033
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   IAIZZO PA, 1988, PFLUG ARCH EUR J PHY, V411, P648, DOI 10.1007/BF00580861
   Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D
   LARACH MG, 1994, ANESTHESIOLOGY, V80, P771, DOI 10.1097/00000542-199404000-00008
   MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759
   Manning BM, 1998, AM J HUM GENET, V62, P599, DOI 10.1086/301748
   MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0
   MICKELSON JR, 1988, J BIOL CHEM, V263, P9310
   ORDING H, 1988, BRIT J ANAESTH, V60, P287, DOI 10.1093/bja/60.3.287
   Ording H, 1997, ACTA ANAESTH SCAND, V41, P955, DOI 10.1111/j.1399-6576.1997.tb04820.x
   PUSCHEL K, 1978, ANAESTHESIST, V27, P488
   Robinson RL, 1997, HUM MOL GENET, V6, P953, DOI 10.1093/hmg/6.6.953
   Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332
   Urwyler A, 2001, BRIT J ANAESTH, V86, P283, DOI 10.1093/bja/86.2.283
NR 22
TC 22
Z9 22
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-0912
J9 BRIT J ANAESTH
JI Br. J. Anaesth.
PD OCT
PY 2002
VL 89
IS 4
BP 571
EP 579
DI 10.1093/bja/aef237
PG 9
WC Anesthesiology
SC Anesthesiology
GA 602JX
UT WOS:000178503100009
PM 12393358
OA Bronze
DA 2021-01-25
ER

PT J
AU Wendland, J
   Philippsen, P
AF Wendland, J
   Philippsen, P
TI An IQGAP-related protein, encoded by AgCYK1, is required for septation
   in the filamentous fungus Ashbya gossypii
SO FUNGAL GENETICS AND BIOLOGY
LA English
DT Article
DE septation; cytokinesis; morphogenesis; actin; GFP; IQGAP; secretion
ID ACTIN-RING FORMATION; ASPERGILLUS-NIDULANS; CONTRACTILE RING; ACTOMYOSIN
   RING; FISSION YEAST; CELL POLARITY; HYPHAL TIPS; CYTOKINESIS; STRAINS;
   GROWTH
AB In filamentous ascomycetes hyphae are compartmentalized by septation in which the cytoplasm of the compartments are interconnected via septal pores. Thus, septation in filamentous fungi is different from cytokinesis in yeast like fungi. We have identified an Ashbya gossypii orthologue of the Saccharomyces cerevisiae CYK1 gene which belongs to the IQGAP-protein family. In contrast to S cerevisiae disruption of AgCYK1 yields viable mutant strains that exhibit wildtype-like polarized hyphal growth rates. In the Agcyk1 mutant cortical actin patches localize to growing hyphal tips like wildtype, however, mutant hyphae are totally devoid of actin rings at presumptive septal sites. Septation in wildtype results in the formation of chitin rings. Agcyk1 mutant hyphae are aseptate and do not accumulate chitin in their cell walls. Agcyk1 mutant strains are completely asporogenous indicating that septation is essential for the formation of sporangia in A. gossypii. AgCyk1p-GFP localizes to sites of future septation as a ring prior to chitin depositioning. Furthermore, decrease in Cyk1p-ring diameter was found to be a prerequisite for the accumulation of chitin and septum formation. (C) 2002 Elsevier Science (USA). All rights reserved.
C1 Univ Jena, Dept Microbiol, D-07745 Jena, Germany.
   Hans Knoll Inst Nat Prod Res, Jena, Germany.
   Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4003 Basel, Switzerland.
RP Wendland, J (corresponding author), Univ Jena, Dept Microbiol, Winzerlaer Str 10, D-07745 Jena, Germany.
EM juergen.wendland@uni-jena.de
OI Wendland, Juergen/0000-0001-8350-253X
CR Alberti-Segui C, 2001, J CELL SCI, V114, P975
   ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   BARTNICK.S, 1972, J GEN MICROBIOL, V73, P487, DOI 10.1099/00221287-73-3-487
   Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301
   Brachmann CB, 1998, YEAST, V14, P115
   Bruno KS, 2001, MOL MICROBIOL, V42, P3, DOI 10.1046/j.1365-2958.2001.02605.x
   Chang F, 1996, CELL, V84, P191, DOI 10.1016/S0092-8674(00)80973-3
   Eng K, 1998, CURR BIOL, V8, P611, DOI 10.1016/S0960-9822(98)70248-9
   Epp JA, 1997, CURR BIOL, V7, P921, DOI 10.1016/S0960-9822(06)00411-8
   FISHKIND DJ, 1995, CURR OPIN CELL BIOL, V7, P23, DOI 10.1016/0955-0674(95)80041-7
   GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408
   Gould KL, 1997, GENE DEV, V11, P2939, DOI 10.1101/gad.11.22.2939
   Hales KG, 1999, CURR OPIN CELL BIOL, V11, P717, DOI 10.1016/S0955-0674(99)00042-3
   Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474
   HARRIS SD, 1994, GENETICS, V136, P517
   Jedd G, 2000, NAT CELL BIOL, V2, P226
   Kaminskyj SGW, 2000, FUNGAL GENET BIOL, V31, P105, DOI 10.1006/fgbi.2000.1238
   Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355
   Machesky LM, 1998, CURR BIOL, V8, pR202, DOI 10.1016/S0960-9822(98)70125-3
   Maeting I, 1999, FEBS LETT, V444, P15, DOI 10.1016/S0014-5793(99)00017-4
   Pruyne D, 2000, J CELL SCI, V113, P571
   Shannon KB, 2000, CURR BIOL, V10, P727, DOI 10.1016/S0960-9822(00)00539-X
   Shannon KB, 1999, MOL BIOL CELL, V10, P283, DOI 10.1091/mbc.10.2.283
   Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Staehlin LA, 1996, CELL, V84, P821, DOI 10.1016/S0092-8674(00)81060-0
   Tenney K, 2000, FUNGAL GENET BIOL, V31, P205, DOI 10.1006/fgbi.2000.1230
   Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2001, GENETICS, V157, P601
   Wendland J, 2000, J CELL SCI, V113, P1611
   Wolkow TD, 1996, J CELL SCI, V109, P2179
NR 33
TC 27
Z9 27
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1087-1845
EI 1096-0937
J9 FUNGAL GENET BIOL
JI Fungal Genet. Biol.
PD OCT
PY 2002
VL 37
IS 1
BP 81
EP 88
AR PII S1087-1845(02)00034-8
DI 10.1016/S1087-1845(02)00034-8
PG 8
WC Genetics & Heredity; Mycology
SC Genetics & Heredity; Mycology
GA 596MY
UT WOS:000178169700009
PM 12223192
DA 2021-01-25
ER

PT J
AU Oscarson, M
   McLellan, RA
   Asp, V
   Ledesma, M
   Ruiz, MLB
   Sinues, B
   Rautio, A
   Ingelman-Sundberg, M
AF Oscarson, M
   McLellan, RA
   Asp, V
   Ledesma, M
   Ruiz, MLB
   Sinues, B
   Rautio, A
   Ingelman-Sundberg, M
TI Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that
   causes reduced CYP2A6 activity
SO HUMAN MUTATION
LA English
DT Article
DE cytochrome P450; CYP2A6; coumarin; allele; unequal crossover; carcinogen
ID CYTOCHROME-P450 2A6 CYP2A6; COUMARIN 7-HYDROXYLATION; HUMAN LIVER;
   (+)-CIS-3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE HYDROCHLORIDE;
   INTERINDIVIDUAL VARIABILITY; POLYMORPHIC METABOLISM;
   GENETIC-POLYMORPHISM; NICOTINE METABOLISM; IDENTIFICATION; DELETION
AB The human CYP2A6 enzyme metabolizes certain drugs and pre-carcinogens and appears to be the most important enzyme for nicotine metabolism. At present, more than 10 different allelic variants are known that cause abolished or decreased enzyme activity. Genetic polymorphism in this gene might be of particular importance for an individual's need for nicotine and for susceptibility to lung and/or liver cancer. We have identified a new CYP2A6 allele (CYP2A6*12) which carries an unequal crossover between the CYP2A6 and CYP2A7 genes in intron 2. This results in a hybrid allele where the 5' regulatory region and exons 1-2 are of CYP2A7 origin and exons 3-9 are of CYP2A6 origin, resulting in 10 amino acid substitutions compared to the CYP2A6*1 allele. Phenotyping with the CYP2A6 substrate coumarin indicates that it causes reduced CYP2A6 activity in vivo. Furthermore, when expressed in mammalian COS-1 cells, the enzyme variant catalyzed 7-hydroxylation of coumarin at a rate approximately 60% of that of the wild-type enzyme. The CYP2A6*12 allele was present at an allele frequency of 2.2% among Spaniards, but was absent in Chinese.
C1 Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden.
   Univ Zaragoza, Dept Physiol & Pharmacol, Zaragoza, Spain.
   Univ Oulu, Dept Pharmacol & Toxicol, Oulu, Finland.
RP Ingelman-Sundberg, M (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
EM magnus.ingelman-sundberg@imm.ki.se
RI Bernal, Maria Luisa/F-9556-2016
OI Bernal, Maria Luisa/0000-0002-8222-1418
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM060548,
   R01GM060548, R01GM060548, R01GM060548] Funding Source: NIH RePORTER;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [1-R01 GM60548-01A2] Funding Source: Medline
CR ANDERSSON S, 1989, J BIOL CHEM, V264, P8222
   CAMUS AM, 1993, MOL CARCINOGEN, V7, P268, DOI 10.1002/mc.2940070410
   Chen GF, 1999, PHARMACOGENETICS, V9, P327, DOI 10.1097/00008571-199906000-00007
   CHOLERTON S, 1992, TRENDS PHARMACOL SCI, V13, P434, DOI 10.1016/0165-6147(92)90140-2
   FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651
   Gilmore J, 2001, BIOCHEM PHARMACOL, V62, P669, DOI 10.1016/S0006-2952(01)00720-1
   Hadidi H, 1998, EUR J CLIN PHARMACOL, V54, P437, DOI 10.1007/s002280050489
   Hadidi H, 1997, FOOD CHEM TOXICOL, V35, P903, DOI 10.1016/S0278-6915(97)00066-5
   Hoffman SMG, 1995, J MOL EVOL, V41, P894
   Ingelman-Sundberg M, 1999, DRUG METAB REV, V31, P449, DOI 10.1081/DMR-100101930
   Ingelman-Sundberg M, 2000, PHARMACOGENETICS, V10, P91, DOI 10.1097/00008571-200002000-00012
   ISCAN M, 1994, EUR J CLIN PHARMACOL, V47, P315
   JOHANSSON I, 1991, EUR J CLIN PHARMACOL, V40, P553
   JOHANSSON I, 1994, MOL PHARMACOL, V46, P452
   Kitagawa K, 2001, J BIOL CHEM, V276, P17830, DOI 10.1074/jbc.M009432200
   Kitagawa K, 1999, BIOCHEM BIOPH RES CO, V262, P146, DOI 10.1006/bbrc.1999.1182
   Koskela S, 1999, BIOCHEM PHARMACOL, V57, P1407, DOI 10.1016/S0006-2952(99)00015-5
   Kusano K, 2001, J BIOCHEM, V129, P259, DOI 10.1093/oxfordjournals.jbchem.a002853
   Kwon JT, 2001, PHARMACOGENETICS, V11, P317, DOI 10.1097/00008571-200106000-00006
   MILES JS, 1990, BIOCHEM J, V267, P365, DOI 10.1042/bj2670365
   Miyamoto M, 1999, BIOCHEM BIOPH RES CO, V261, P658, DOI 10.1006/bbrc.1999.1089
   Nakajima M, 2001, CLIN PHARMACOL THER, V69, P72, DOI 10.1067/mcp.2001.112688
   Nunoya K, 1999, J PHARMACOL EXP THER, V289, P437
   Nunoya K, 1998, PHARMACOGENETICS, V8, P239, DOI 10.1097/00008571-199806000-00006
   Oscarson M, 1999, FEBS LETT, V460, P321, DOI 10.1016/S0014-5793(99)01364-2
   Oscarson M, 1999, FEBS LETT, V448, P105, DOI 10.1016/S0014-5793(99)00359-2
   Oscarson M, 1998, FEBS LETT, V438, P201, DOI 10.1016/S0014-5793(98)01297-6
   Oscarson M, 2001, DRUG METAB DISPOS, V29, P91
   Pasanen M, 1997, TOXICOLOGY, V123, P177, DOI 10.1016/S0300-483X(97)00119-4
   Pelkonen O, 2000, TOXICOLOGY, V144, P139, DOI 10.1016/S0300-483X(99)00200-0
   Pitarque M, 2001, BIOCHEM BIOPH RES CO, V284, P455, DOI 10.1006/bbrc.2001.4990
   Rao YS, 2000, MOL PHARMACOL, V58, P747
   Raunio H, 2001, BRIT J CLIN PHARMACO, V52, P357, DOI 10.1046/j.0306-5251.2001.01500.x
   RAUTIO A, 1992, PHARMACOGENETICS, V2, P227, DOI 10.1097/00008571-199210000-00005
   RUIZ MLB, 1999, PHARMACOGENETICS, V5, P657
   SALONPAA P, 1993, EUR J PHARM-ENVIRON, V248, P95, DOI 10.1016/0926-6917(93)90030-T
   Shimada T, 1996, XENOBIOTICA, V26, P395, DOI 10.3109/00498259609046718
   Soucek P, 1999, J CHROMATOGR B, V734, P23
   YAMANO S, 1990, BIOCHEMISTRY-US, V29, P1322, DOI 10.1021/bi00457a031
   YUN CH, 1991, MOL PHARMACOL, V40, P679
NR 40
TC 76
Z9 80
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD OCT
PY 2002
VL 20
IS 4
BP 275
EP 283
DI 10.1002/humu.10126
PG 9
WC Genetics & Heredity
SC Genetics & Heredity
GA 600WW
UT WOS:000178415600006
PM 12325023
DA 2021-01-25
ER

PT J
AU Narimatsu, S
   Takemi, C
   Tsuzuki, D
   Kataoka, H
   Yamamoto, S
   Shimada, N
   Suzuki, S
   Satoh, T
   Meyer, UA
   Gonzalez, FJ
AF Narimatsu, S
   Takemi, C
   Tsuzuki, D
   Kataoka, H
   Yamamoto, S
   Shimada, N
   Suzuki, S
   Satoh, T
   Meyer, UA
   Gonzalez, FJ
TI Stereoselective metabolism of bufuralol racemate and enantiomers in
   human liver microsomes
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article
ID BUNITROLOL 4-HYDROXYLATION; HYDROXYLATION; ENANTIOSELECTIVITY;
   INHIBITORS; ENZYMES
AB A new HPLC method was developed using a chiral column to efficiently separate four 1"-hydroxybufuralol (1"-OH-BF) diastereomers that are major metabolites of bufuralol (BF). Employing this method, we examined diastereomer selectivity in the formation of 1"-OH-BF from BF racemate or enantiomers in four individual samples of human liver microsomes. Three different human liver microsomes showed a selectivity of 1"R-OH <1"S-OH for BF enantiomers, which was similar to that of recombinant CYP2D6 expressed in insect cell microsomes, whereas one human liver microsomal fraction yielded a selectivity of 1"R-OH > 1"S-OH for BF enantiomers, which was similar to those of recombinant CYP2C19 expressed in insect cell microsomes. Recombinant CYP1A2 and CYP3A4 showed a selectivity similar to that of CYP2D6, but their BF 1"-hydroxylase activities were much lower than those of CYP2D6. In inhibition studies, quinidine, a known CYP2D6 inhibitor, markedly inhibited BF 1"-hydroxylation in the fractions of human liver microsomes that showed the CYP2D6-type selectivity. Furthermore, omeprazole, a known CYP2C19 inhibitor, efficiently suppressed the formation of 1"-OH-BF diastereomers from BF in the microsomal fraction that showed the CYP2C19-type selectivity. From these results, we concluded that the diastereomer selectivity in the formation of 1"-OH-BF from BF differs between CYP2D6 and CYP2C19, both of which can be determinant enzymes in the diastereoselective 1"-hydroxylation of BF in human liver microsomes.
C1 Okayama Univ, Fac Pharmaceut Sci, Lab Hlth Chem, Okayama 7008530, Japan.
   Okayama Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Okayama 7008530, Japan.
   Daiichi Pure Chem, Tokyo, Japan.
   Biomed Res Inst, Chiba, Japan.
   Univ Basel, Biozentrum, Basel, Switzerland.
   NCI, NIH, Bethesda, MD 20892 USA.
RP Narimatsu, S (corresponding author), Okayama Univ, Fac Pharmaceut Sci, Lab Hlth Chem, 1-1-1 Tsushima Naka, Okayama 7008530, Japan.
RI Kataoka, Hiroyuki/F-1810-2015
OI Kataoka, Hiroyuki/0000-0003-2315-6051
CR Cosme J, 2000, J BIOL CHEM, V275, P2545, DOI 10.1074/jbc.275.4.2545
   GONZALEZ FJ, 1996, CYTOCHROMES P450 MET, P183
   HAMILTON TC, 1977, ARZNEIMITTEL-FORSCH, V27, P1410
   Ko JW, 1997, DRUG METAB DISPOS, V25, P853
   KRONBACH T, 1987, ANAL BIOCHEM, V162, P24, DOI 10.1016/0003-2697(87)90006-6
   MACHIN PJ, 1985, J MED CHEM, V28, P1648, DOI 10.1021/jm00149a018
   Mankowski DC, 1999, DRUG METAB DISPOS, V27, P1024
   Mei Q, 1999, J PHARMACOL EXP THER, V291, P749
   MEIER UT, 1985, ANAL BIOCHEM, V151, P286, DOI 10.1016/0003-2697(85)90177-0
   MEYER UA, 1997, ANN REV PHARM TOXICO, V37, P268
   Narimatsu S, 2000, CHEM-BIOL INTERACT, V127, P73, DOI 10.1016/S0009-2797(00)00174-5
   NARIMATSU S, 1994, ANAL BIOCHEM, V222, P256, DOI 10.1006/abio.1994.1482
   Narimatsu S, 1999, CHIRALITY, V11, P1, DOI 10.1002/(SICI)1520-636X(1999)11:1<1::AID-CHIR1>3.0.CO;2-E
   Narimatsu S, 1996, BIOL PHARM BULL, V19, P1429
   Narimatsu S, 1996, J PHARM PHARMACOL, V48, P1185, DOI 10.1111/j.2042-7158.1996.tb03918.x
   NEWTON DJ, 1995, DRUG METAB DISPOS, V23, P154
   PETER R, 1990, CHEM RES TOXICOL, V3, P566, DOI 10.1021/tx00018a012
   RELLING MV, 1990, J PHARMACOL EXP THER, V252, P442
   RILEY RJ, 1995, DRUG METAB DISPOS, V23, P922
   WEERAWARNA SA, 1991, J MED CHEM, V34, P3091, DOI 10.1021/jm00114a019
   YAMAZAKI H, 1994, MOL PHARMACOL, V46, P568
NR 21
TC 19
Z9 20
U1 0
U2 3
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0022-3565
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD OCT
PY 2002
VL 303
IS 1
BP 172
EP 178
DI 10.1124/jpet.102.036533
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 594EE
UT WOS:000178035100023
PM 12235248
DA 2021-01-25
ER

PT J
AU Raska, I
   Aebi, U
AF Raska, I
   Aebi, U
TI EMBO Workshop "The Functional Organization of the Cell Nucleus" held in
   Prague, Czech Republic, April 18 to 21, 2002
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Editorial Material
C1 Acad Sci Czech Republ, Inst Expt Med, Dept Cell Biol, Prague, Czech Republic.
   Charles Univ, Gene Express Lab, Fac Med 1, Prague, Czech Republic.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Raska, I (corresponding author), Acad Sci Czech Republ, Inst Expt Med, Dept Cell Biol, Prague, Czech Republic.
RI Raska, Ivan/H-2326-2017
OI Raska, Ivan/0000-0002-2583-5595
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD OCT-DEC
PY 2002
VL 140
IS 1-3
BP 1
EP 2
AR PII S1047-8477(02)00615-9
DI 10.1016/S1047-8477(02)00615-9
PG 2
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 627VW
UT WOS:000179957700001
PM 12490147
DA 2021-01-25
ER

PT J
AU Pederson, T
   Aebi, U
AF Pederson, T
   Aebi, U
TI Actin in the nucleus: what form and what for?
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT EMBO Workshop on Functional Organization of the Cell Nucleus
CY APR 18-21, 2002
CL PRAGUE, CZECH REPUBLIC
SP EMBO
ID MESSENGER-RNA; NUCLEOCYTOPLASMIC TRANSPORT; SACCHAROMYCES-CEREVISIAE;
   DIMETHYL-SULFOXIDE; BINDING-PROTEIN; LAEVIS OOCYTES; LIVING CELLS;
   MYOSIN-I; MOVEMENT; BUNDLES
AB Actin is an abundant protein in most nonmuscle cells. It has often been observed in isolated nuclei, yet cytoplasmic contamination was of course initially regarded as the most plausible origin. Numerous studies on nuclear actin appeared in the 1970s and 1980s, but the picture remained rather muddy. The viewpoint at that time was that actin-shown to move freely between cytoplasm and nucleus-was a mere "thermodynamic wanderer," transiently occupying the nucleus. More recently, evidence has been mounting that actin's presence in the nucleus is not simply governed by the laws of diffusion. The same holds true for the finding of various actin-related proteins in the nucleus, and the case for nuclear myosin, specifically myosin I, is now quite convincing, Moreover, the first intimations of functional roles of nuclear actin are now emerging. Here we examine the overall subject from cell biological and chemical perspectives. The major issue is no longer the presence of actin in the nucleus but rather its supramolecular organization, intranuclear locations, and, of course, functions. These issues interface with recent findings that reveal a surprisingly diverse repertoire of actin conformations and oligomer and polymer forms beyond monomeric G-actin and polymeric F-actin. We present ideas for advancing the nuclear actin field and call for a renewed attack on this major problem in cell biology. (C) 2002 Elsevier Science (USA). All rights reserved.
C1 Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Pederson, T (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 377 Plantat St, Worcester, MA 01605 USA.
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM060551,
   R01GM021595, R01GM060551, R01GM021595, R01GM060551, R01GM021595,
   R01GM060551, R01GM021595, R01GM021595, R01GM021595, R01GM021595,
   R01GM021595, R01GM021595, R01GM021595, R01GM021595, R01GM021595,
   R01GM021595, R01GM021595, R01GM021595] Funding Source: NIH RePORTER;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM-60551, GM-21595] Funding Source: Medline
CR ANKENBAUER T, 1989, NATURE, V342, P822, DOI 10.1038/342822a0
   BREMER A, 1992, Current Opinion in Cell Biology, V4, P20, DOI 10.1016/0955-0674(92)90054-G
   Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8
   CLARK TG, 1977, CELL, V12, P883, DOI 10.1016/0092-8674(77)90152-0
   CLARK TG, 1979, CELL, V18, P1101, DOI 10.1016/0092-8674(79)90223-X
   ENGELHARDT WA, 1982, ANNU REV BIOCHEM, V51, P1, DOI 10.1146/annurev.bi.51.070182.000245
   FUKUI Y, 1979, EXP CELL RES, V120, P451, DOI 10.1016/0014-4827(79)90412-9
   FUKUI Y, 1978, J CELL BIOL, V76, P146, DOI 10.1083/jcb.76.1.146
   Gonsior SM, 1999, J CELL SCI, V112, P797
   GOUNON P, 1981, J CELL BIOL, V88, P410, DOI 10.1083/jcb.88.2.410
   Harata M, 2000, J BIOCHEM, V128, P665, DOI 10.1093/oxfordjournals.jbchem.a022799
   Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595
   Harata M, 2002, NUCLEIC ACIDS RES, V30, P1743, DOI 10.1093/nar/30.8.1743
   Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895
   Howard J., 2001, MECH MOTOR PROTEINS
   Kimura T, 2000, GENES CELLS, V5, P289, DOI 10.1046/j.1365-2443.2000.00326.x
   MCELROY WD, 1957, CHEM BASIS HEREDITY, P64
   MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785
   Nowak G, 1997, J BIOL CHEM, V272, P17176, DOI 10.1074/jbc.272.27.17176
   Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507
   OSBORN M, 1980, EXP CELL RES, V129, P103, DOI 10.1016/0014-4827(80)90335-3
   Pedersen A, 2001, ORAL DIS, V7, P1
   Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799
   Pederson T, 2000, NAT CELL BIOL, V2, pE73, DOI 10.1038/35010501
   Pederson T, 2001, CELL, V104, P635, DOI 10.1016/S0092-8674(02)01455-1
   PEDERSON T, 1977, BIOCHEMISTRY-US, V16, P2771, DOI 10.1021/bi00631a029
   Pederson T, 1999, FASEB J, V13, pS238
   Pederson T, 1998, J MOL BIOL, V277, P147, DOI 10.1006/jmbi.1997.1618
   Pederson T., 1998, CELLS LAB MANUAL
   Percipalle P, 2002, NUCLEIC ACIDS RES, V30, P1725, DOI 10.1093/nar/30.8.1725
   Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229
   Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337
   Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043
   Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5
   Politz JC, 2000, J STRUCT BIOL, V129, P252, DOI 10.1006/jsbi.2000.4227
   POLITZ JC, 2002, GENOME BIOL, V3
   RIMM DL, 1989, J CELL BIOL, V109, P585, DOI 10.1083/jcb.109.2.585
   RUNGGER D, 1979, NATURE, V282, P320, DOI 10.1038/282320a0
   SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X
   SCHINDLER M, 1986, J CELL BIOL, V102, P859, DOI 10.1083/jcb.102.3.859
   Steinmetz MO, 1998, J MOL BIOL, V278, P703, DOI 10.1006/jmbi.1998.1717
   Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559
   Steinmetz MO, 1997, J STRUCT BIOL, V119, P295, DOI 10.1006/jsbi.1997.3873
   Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635
   Zhang SS, 2002, J BIOL CHEM, V277, P843, DOI 10.1074/jbc.M109393200
   Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5
NR 46
TC 161
Z9 170
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD OCT-DEC
PY 2002
VL 140
IS 1-3
BP 3
EP 9
AR PII S1047-8477(02)00528-2
DI 10.1016/S1047-8477(02)00528-2
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 627VW
UT WOS:000179957700002
PM 12490148
DA 2021-01-25
ER

PT J
AU Cornelis, GR
AF Cornelis, GR
TI The Yersinia YSC-YOP 'type III' weaponry
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID PROTEIN-TYROSINE-PHOSPHATASE; SUBSTRATE-BINDING DOMAIN; TARGET-CELL
   CONTACT; N-TERMINAL DOMAIN; V-ANTIGEN; VIRULENCE FACTOR; NEEDLE COMPLEX;
   MESSENGER-RNA; KAPPA-B; SIGNAL-TRANSDUCTION
AB 'Type III secretion '- the mechanism by which some pathogenic bacteria inject proteins straight into the cytosol of eukaryotic cells to 'anaesthetize' or 'enslave' them - was discovered in 1994. Important progress has been made in this area during the past few years: the bacterial organelles responsible for this secretion - called 'injectisomes'-have been visualized, the structures of some of the bacterial protein 'effectors' have been determined, and considerable progress has been made in understanding the intracellular action of the effectors. Type III secretion is key to the pathogenesis of bacteria from the Yersinia genus.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Louvain, Christian de Duvel Inst Cellular Pathol, Brussels, Belgium.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
CR Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1016/S0378-1097(01)00301-9
   ALLAOUI A, 1995, MOL MICROBIOL, V18, P343, DOI 10.1111/j.1365-2958.1995.mmi_18020343.x
   Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140
   Anderson DM, 1999, CURR OPIN MICROBIOL, V2, P18, DOI 10.1016/S1369-5274(99)80003-4
   Andersson K, 1999, INFECT IMMUN, V67, P2567, DOI 10.1128/IAI.67.5.2567-2574.1999
   Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x
   Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7
   Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974
   Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4
   Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x
   Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x
   Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730
   Black DS, 1998, MOL MICROBIOL, V29, P1263, DOI 10.1046/j.1365-2958.1998.01014.x
   BLISKA JB, 1995, INFECT IMMUN, V63, P681, DOI 10.1128/IAI.63.2.681-685.1995
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Boquet P, 2000, MICROBES INFECT, V2, P837, DOI 10.1016/S1286-4579(00)90369-1
   Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098
   Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000
   BURROWS TW, 1956, BRIT J EXP PATHOL, V37, P481
   Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   CORNELIS GR, 1989, MOL MICROBIOL, V3, P1455, DOI 10.1111/j.1365-2958.1989.tb00129.x
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Denecker G, 2002, INFECT IMMUN, V70, P3510, DOI 10.1128/IAI.70.7.3510-3520.2002
   Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200
   Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200
   Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973
   Evdokimov AG, 2001, ACTA CRYSTALLOGR D, V57, P793, DOI 10.1107/S0907444901004875
   FALLMAN M, 1995, INFECT IMMUN, V63, P3117
   FELDMAN MF, IN PRESS MOL MICROBI
   Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999
   FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x
   Foultier B, 2002, J MOL EVOL, V55, P37, DOI 10.1007/s00239-001-0089-7
   Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0
   GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994
   Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002
   GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336
   GUAN KL, 1991, J BIOL CHEM, V266, P17026
   Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x
   Hamid N, 1999, MICROB PATHOGENESIS, V27, P231, DOI 10.1006/mpat.1999.0301
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200
   LEUNG KY, 1990, INFECT IMMUN, V58, P3262, DOI 10.1128/IAI.58.10.3262-3271.1990
   Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x
   Macnab RM, 2000, SCIENCE, V290, P2086, DOI 10.1126/science.290.5499.2086
   Meijer LK, 2000, CELL MICROBIOL, V2, P231, DOI 10.1046/j.1462-5822.2000.00049.x
   MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7
   MICHIELS T, 1991, J BACTERIOL, V173, P4994, DOI 10.1128/jb.173.16.4994-5009.1991
   MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385
   Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127
   Montagna LG, 2001, J BIOL CHEM, V276, P5005, DOI 10.1074/jbc.M009045200
   MULDER B, 1989, INFECT IMMUN, V57, P2534, DOI 10.1128/IAI.57.8.2534-2541.1989
   NAKAJIMA R, 1995, INFECT IMMUN, V63, P3021, DOI 10.1128/IAI.63.8.3021-3029.1995
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Nilles ML, 1998, J BACTERIOL, V180, P3410, DOI 10.1128/JB.180.13.3410-3420.1998
   Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594
   Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920
   Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361
   Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x
   Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083
   Persson C, 1999, MOL MICROBIOL, V33, P828, DOI 10.1046/j.1365-2958.1999.01529.x
   Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231
   Rakin A, 1995, CONTRIB TO MICROBIOL, V13, P244
   Ramamurthi KS, 2002, J BACTERIOL, V184, P3321, DOI 10.1128/JB.184.12.3321-3328.2002
   Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5
   ROBINSBROWNE RM, 1985, INFECT IMMUN, V47, P774, DOI 10.1128/IAI.47.3.774-779.1985
   ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x
   Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069
   Ruckdeschel K, 1997, J BIOL CHEM, V272, P15920, DOI 10.1074/jbc.272.25.15920
   Ruckdeschel K, 2001, J IMMUNOL, V166, P1823, DOI 10.4049/jimmunol.166.3.1823
   RUSSEL M, 1994, SCIENCE, V265, P612, DOI 10.1126/science.8036510
   SALMOND GPC, 1993, TRENDS BIOCHEM SCI, V18, P7, DOI 10.1016/0968-0004(93)90080-7
   Sarker MR, 1998, INFECT IMMUN, V66, P2976, DOI 10.1128/IAI.66.6.2976-2979.1998
   Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x
   Sauvonnet N, 2002, J BIOL CHEM, V277, P25133, DOI 10.1074/jbc.M203239200
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Schulte R, 1996, INFECT IMMUN, V64, P2106, DOI 10.1128/IAI.64.6.2106-2113.1996
   Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3
   SIMONET M, 1990, INFECT IMMUN, V58, P841, DOI 10.1128/IAI.58.3.841-845.1990
   Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315
   SKRZYPEK E, 1993, J BACTERIOL, V175, P3520, DOI 10.1128/jb.175.11.3520-3528.1993
   SKRZYPEK E, 1995, J BACTERIOL, V177, P2530, DOI 10.1128/jb.177.9.2530-2542.1995
   Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x
   Smith CL, 2001, MOL MICROBIOL, V42, P967, DOI 10.1046/j.0950-382x.2001.02711.x
   Sorg I, 2001, INFECT IMMUN, V69, P7535, DOI 10.1128/IAI.69.12.7535-7543.2001
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986
   Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793
   Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373
   VISSER LG, 1995, INFECT IMMUN, V63, P2570, DOI 10.1128/IAI.63.7.2570-2575.1995
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343
   ZHANG ZY, 1992, J BIOL CHEM, V267, P23759
   Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289
NR 119
TC 333
Z9 342
U1 1
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0072
EI 1471-0080
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD OCT
PY 2002
VL 3
IS 10
BP 742
EP 752
DI 10.1038/nrm932
PG 11
WC Cell Biology
SC Cell Biology
GA 599DX
UT WOS:000178319800015
PM 12360191
DA 2021-01-25
ER

PT J
AU Ruegg, M
AF Ruegg, M
TI Therapeutic approach for merosin-deficient congenital muscular dystrophy
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 7th International Congress of the World-Muscle-Society
CY OCT 02-05, 2002
CL ROTTERDAM, NETHERLANDS
SP World Muscle Soc
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2002
VL 12
IS 7-8
BP 781
EP 781
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 602HA
UT WOS:000178498800273
DA 2021-01-25
ER

PT J
AU de los Arcos, T
   Oelhafen, P
   Aebi, U
   Hefti, A
   Duggelin, M
   Mathys, D
   Guggenheim, R
AF de los Arcos, T
   Oelhafen, P
   Aebi, U
   Hefti, A
   Duggelin, M
   Mathys, D
   Guggenheim, R
TI Preparation and characterization of TiN-Ag nanocomposite films
SO VACUUM
LA English
DT Article; Proceedings Paper
CT 7th European Vacuum Conference (EVC-7)/3rd European Topical Conference
   on Hard Coatings (ETCHC-3)
CY SEP 17-20, 2001
CL MADRID, SPAIN
SP Spanish Vacuum Soc
DE magnetron co-sputtering; TiN films; nanocomposite films; Ag clusters
ID HYDROGENATED CARBON-FILMS; REACTIVELY SPUTTERED TIN; ALUMINUM NITRIDE
   FILMS; PHOTOELECTRON-SPECTROSCOPY; TITANIUM; DEPOSITION; TEMPERATURE;
   MORPHOLOGY; PLASMA; METAL
AB Thin nanostructured films of TiN-Ag are deposited by a plasma vapour process consisting of co-sputtering of Ti and Ag from three magnetrons in an Ar-N-2 gas mixture. The coatings are characterized by in situ photoelectron spectroscopy, energy-filtered transmission electron microscopy and scanning electron microscopy. The dependence of the film structure and silver cluster distribution on total silver content, substrate biasing and substrate temperature was investigated. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Inst Phys, CH-4056 Basel, Switzerland.
   Univ Basel, ME Muller Inst, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, SEM Lab, Pharmazentrum, CH-4056 Basel, Switzerland.
RP de los Arcos, T (corresponding author), Univ Basel, Inst Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.
CR Adams D, 1998, THIN SOLID FILMS, V332, P235, DOI 10.1016/S0040-6090(98)01094-3
   Babonneau D, 1998, SURF SCI, V409, P358, DOI 10.1016/S0039-6028(98)00280-5
   Babonneau D, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.195401
   BABONNEAU D, 1999, THESIS U POITIERS, P67
   Braic M, 1999, VACUUM, V53, P41, DOI 10.1016/S0042-207X(98)00419-9
   BUCHER JP, 1984, THIN SOLID FILMS, V122, P63, DOI 10.1016/0040-6090(84)90379-1
   Du HL, 1996, SURF COAT TECH, V81, P151, DOI 10.1016/0257-8972(95)02536-7
   Gampp R, 1995, MATER RES SOC SYMP P, V388, P305, DOI 10.1557/PROC-388-305
   Geng J, 1999, J APPL PHYS, V86, P3460, DOI 10.1063/1.371229
   GRANQVIST CG, 1976, J APPL PHYS, V47, P2200, DOI 10.1063/1.322870
   Groudeva-Zotova S, 2000, SURF COAT TECH, V127, P144, DOI 10.1016/S0257-8972(00)00569-7
   HIBBS MK, 1984, THIN SOLID FILMS, V122, P115, DOI 10.1016/0040-6090(84)90003-8
   LEMPERIERE G, 1984, THIN SOLID FILMS, V111, P339, DOI 10.1016/0040-6090(84)90326-2
   MARECHAL N, 1995, P TOP S ADV IN FILMS, V15, P659
   PETROV I, 1992, J VAC SCI TECHNOL A, V10, P265, DOI 10.1116/1.578074
   Schuler A, 1999, PHYS REV B, V60, P16164, DOI 10.1103/PhysRevB.60.16164
   Schuler A, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.115413
   Schuler A, 2001, J VAC SCI TECHNOL A, V19, P922, DOI 10.1116/1.1359532
   TAMURA M, 1991, SURF COAT TECH, V49, P194, DOI 10.1016/0257-8972(91)90054-Z
   Yashar P, 1998, J VAC SCI TECHNOL A, V16, P2913, DOI 10.1116/1.581439
NR 20
TC 36
Z9 37
U1 0
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD SEP 26
PY 2002
VL 67
IS 3-4
BP 463
EP 470
AR PII S0042-207X(02)00232-4
DI 10.1016/S0042-207X(02)00232-4
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 607RA
UT WOS:000178803500026
DA 2021-01-25
ER

PT J
AU Fraser, DJ
   Podvinec, M
   Kaufmann, MR
   Meyer, UA
AF Fraser, DJ
   Podvinec, M
   Kaufmann, MR
   Meyer, UA
TI Drugs mediate the transcriptional activation of the 5-aminolevulinic
   acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear
   receptor (CXR)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; CYTOCHROME-P450
   GENES; SIGNALING PATHWAY; HEME; INDUCTION; CAR; BINDING; PXR;
   HEPATOCYTES
AB Heme is an essential component in oxygen transport and metabolism in living systems. In non-erythropoietic cells, 5-aminolevulinate synthase (ALAS1) is the first and rate-limiting enzyme in the heme biosynthesis pathway. ALAS1 expression and heme levels are increased in vivo by drugs and other chemical inducers of cytochrome P450 hemoproteins through mechanisms that are poorly understood. In the present studies, a chicken genomic cosmid library was employed to isolate a major portion of the ALAS1 gene. Two drug-responsive enhancer sequences, 176 and 167 base pairs in length, were identified in the W-flanking region of the gene in reporter gene assays in the hepatoma cell line LMH. The relative potency of inducers to activate these enhancers corresponds to induction of ALAS1 mRNA levels in LMH cells. Analysis of putative transcription factor binding sites within the enhancers revealed DR5 and DR4 type recognition sequences for nuclear receptors. Drug activation of the enhancer elements was reduced at least 60% after mutagenesis of individual nuclear receptor binding sites and was virtually eliminated following alteration of both recognition sites within the respective elements. Electrophoretic mobility shift assays and transactivation studies demonstrate direct interactions between the nuclear receptor binding sites and the recently described chicken xenobiotic-sensing receptor, (CXR) implicating drug activation mechanisms for ALAS1 similar to those found in inducible cytochrome(s) P450. This is the first report describing direct transcriptional activation of ALAS1 by drugs via drug-responsive enhancer sequences.
C1 Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Fraser, DJ (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Baader M, 2002, J BIOL CHEM, V277, P15647, DOI 10.1074/jbc.M109882200
   Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208
   Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195
   BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y
   Cable EE, 2000, ARCH BIOCHEM BIOPHYS, V384, P280, DOI 10.1006/abbi.2000.2117
   Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996
   Gerbal-Chaloin S, 2002, J BIOL CHEM, V277, P209, DOI 10.1074/jbc.M107228200
   GRANICK S, 1975, J BIOL CHEM, V250, P9215
   Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173
   HAMILTON JW, 1988, BIOCHEM J, V255, P267
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652
   IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149
   Jover R, 1996, BIOCHEM BIOPH RES CO, V226, P152, DOI 10.1006/bbrc.1996.1325
   Jover R, 2000, EUR J BIOCHEM, V267, P7128, DOI 10.1046/j.1432-1327.2000.01815.x
   Kim J, 2001, J BIOL CHEM, V276, P7559, DOI 10.1074/jbc.M008090200
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448
   Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195
   LopezRodriguez C, 1997, J BIOL CHEM, V272, P29120, DOI 10.1074/jbc.272.46.29120
   MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7
   MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2
   Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200
   Paquet Y, 2000, J BIOL CHEM, V275, P38427, DOI 10.1074/jbc.M005776200
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878
   RUPP RAW, 1990, NUCLEIC ACIDS RES, V18, P2607, DOI 10.1093/nar/18.9.2607
   Sassa S, 2000, INT J HEMATOL, V71, P1
   Savas U, 1999, MOL PHARMACOL, V56, P851
   Steinmetz ACU, 2001, ANNU REV BIOPH BIOM, V30, P329, DOI 10.1146/annurev.biophys.30.1.329
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   Varone CL, 1999, ARCH BIOCHEM BIOPHYS, V372, P261, DOI 10.1006/abbi.1999.1470
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
NR 36
TC 42
Z9 42
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 20
PY 2002
VL 277
IS 38
BP 34717
EP 34726
DI 10.1074/jbc.M204699200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 595PB
UT WOS:000178117000010
PM 12121995
OA Bronze
DA 2021-01-25
ER

PT J
AU Desrivieres, S
   Cooke, FT
   Morales-Johansson, H
   Parker, PJ
   Hall, MN
AF Desrivieres, S
   Cooke, FT
   Morales-Johansson, H
   Parker, PJ
   Hall, MN
TI Calmodulin controls organization of the actin cytoskeleton via
   regulation of phosphatidylinositol (4,5)-bisphosphate synthesis in
   Saccharomyces cerevisiae
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE CMD1; MSS4; PtdIns(4)P 5-kinase; PtdIns(4,5)P-2; Saccharomyces
   cerevisiae
ID PLECKSTRIN HOMOLOGY DOMAINS; PROTEIN-KINASE-C; ADP-RIBOSYLATION
   FACTOR-1; CELL-WALL INTEGRITY; 4-PHOSPHATE 5-KINASE; YEAST CALMODULIN;
   ACID PHOSPHOLIPIDS; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; ENDOCYTOSIS
AB Phosphoinositides regulate a wide range of cellular processes, including proliferation, survival, cytoskeleton remodelling and membrane trafficking, yet the mechanisms controlling the kinases, phosphatases and lipases that modulate phosphomositide levels are poorly understood. In the present study, we describe a mechanism controlling MSS4, the sole phosphatidylinositol (4)-phosphate 5-kinase in Saccharomyces cerevisiae. Mutations in MSS4 and CMD1, encoding the small Ca2+-binding protein calmodulin, confer similar phenotypes, including loss of viability and defects in endocytosis and in organization of the actin cytoskeleton. Overexpression of MSS4 suppresses the growth and actin defects of cmd1-226, a temperature-sensitive calmodulin mutant which is defective in the organization of the actin cytoskeleton. Finally, the cmd1-226 mutant exhibits reduced levels of phosphatidylinositol (4,5)-bisphosphate. These findings suggest that calmodulin positively controls MSS4 activity and thereby the actin cytoskeleton.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
   Lincolns Inn Fields Labs, Canc Res UK London Res Inst, Prot Phosphorylat Lab, London WC2A 3PX, England.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
RI Parker, Peter/D-5192-2013; Desrivieres, Sylvane/B-7399-2011
OI Desrivieres, Sylvane/0000-0002-9120-7060; Hall, Michael
   N/0000-0002-2998-0757; parker, peter/0000-0002-6218-2933
CR Andrews PD, 2000, J CELL SCI, V113, P507
   BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023
   BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0
   Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9
   D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255
   Davis JN, 1997, MOL CELL BIOL, V17, P7398, DOI 10.1128/MCB.17.12.7398
   Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163
   Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787
   DULIC V, 1991, METHOD ENZYMOL, V194, P697
   Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755
   GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103
   Geli MI, 1998, EMBO J, V17, P635, DOI 10.1093/emboj/17.3.635
   Godi A, 1999, NAT CELL BIOL, V1, P280
   Guthrie C., 1991, GUIDE YEAST GENETICS, V194
   Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393
   HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0
   Helliwell SB, 1998, GENETICS, V148, P99
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058
   Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779
   Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8
   Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611
   Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741
   JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125
   JENKINS GH, 1994, J BIOL CHEM, V269, P11547
   Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0
   Jurado LA, 1999, PHYSIOL REV, V79, P661
   Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193
   Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999
   KUBLER E, 1994, EMBO J, V13, P5539, DOI 10.1002/j.1460-2075.1994.tb06891.x
   LEVIN DE, 1994, CELL MOL BIOL RES, V40, P229
   Levitan IB, 1999, NEURON, V22, P645, DOI 10.1016/S0896-6273(00)80722-9
   MADAULE P, 1987, P NATL ACAD SCI USA, V84, P779, DOI 10.1073/pnas.84.3.779
   Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511
   Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231
   Mizunuma M, 1998, NATURE, V392, P303
   MORITZ A, 1992, J BIOL CHEM, V267, P7207
   Nakamura T, 1996, MOL GEN GENET, V251, P211
   NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x
   OHYA Y, 1994, GENETICS, V138, P1041
   OHYA Y, 1994, SCIENCE, V263, P963, DOI 10.1126/science.8310294
   Okano H, 1998, J BIOL CHEM, V273, P26375, DOI 10.1074/jbc.273.41.26375
   Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621
   Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059
   RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758
   RANDAZZO PA, 1994, J BIOL CHEM, V269, P16519
   Randazzo PA, 1997, J BIOL CHEM, V272, P7688
   Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305
   Singer-Kruger B, 1998, J CELL SCI, V111, P3347
   STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0
   STOSSEL TP, 1989, J BIOL CHEM, V264, P18261
   TERUI T, 1994, J BIOL CHEM, V269, P28130
   Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804
   Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013
   Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002
NR 57
TC 37
Z9 37
U1 0
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD SEP 15
PY 2002
VL 366
BP 945
EP 951
DI 10.1042/BJ20020429
PN 3
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 598DA
UT WOS:000178258900028
PM 12079494
OA Green Published
DA 2021-01-25
ER

PT J
AU Sankala, M
   Brannstrom, A
   Schulthess, T
   Bergmann, U
   Morgunova, E
   Engel, J
   Tryggvason, K
   Pikkarainen, T
AF Sankala, M
   Brannstrom, A
   Schulthess, T
   Bergmann, U
   Morgunova, E
   Engel, J
   Tryggvason, K
   Pikkarainen, T
TI Characterization of recombinant soluble macrophage scavenger receptor
   MARCO
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID EXTRACELLULAR-MATRIX COMPONENTS; ELECTRON-MICROSCOPY; ESCHERICHIA-COLI;
   IMMUNE-RESPONSE; INNATE IMMUNITY; HOST-DEFENSE; IN-VITRO; COLLAGEN;
   BINDING; BACTERIA
AB MARCO is a type II transmembrane protein of the class A scavenger receptor family. It has a short N-terminal cytoplasmic domain, a transmembrane domain, and a large extracellular part composed of a 75-residue long spacer domain, a 270-residue collagenous domain, and a 99-residue long scavenger receptor cysteine-rich (SRCR) domain. Previous studies have indicated a role for this receptor in anti-microbial host defense functions. In this work we have produced the extracellular part of MARCO as a recombinant protein, and analyzed its binding properties. The production of this protein, soluble MARCO (sMARCO), has made it possible for the first time to study MARCO and its binding properties in a cell-free system. Using circular dichroism analyses, a protease-sensitive assay, and rotary shadowing electron microscopy, sMARCO was shown to have a triple-helical collagenous structure. Rotary shadowing also demonstrated that the molecules often associate with each other via the globes. sMARCO was found to bind avidly both heat-killed and living bacteria. Lipopolysaccharide, an important component of the outer membrane of Gram-negative bacteria, was shown to be a ligand of MARCO. Studies with different bacterial strains indicated that the O-side chain of lipopolysaccharide is not needed for the bacterial recognition. Finally, the C-terminal SRCR domain was also produced as a recombinant protein, and its bacteria-binding capability was studied. Although the transfection experiments with transmembrane MARCO variants have indicated a crucial role for this domain in bacterial binding, the monomeric domain exhibited low, barely detectable bacteria-binding activity. Thus, it is possible that cooperation between the SRCR domain and the collagenous domain is needed for high-affinity bacterial binding, or that the SRCR domain has to be in a trimeric form to effectively bind to bacteria.
C1 Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Oulu, Dept Biochem, F-90570 Oulu, Finland.
RP Bergmann, U (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden.
RI Morgunova, Ekaterina/G-2479-2018
OI Morgunova, Ekaterina/0000-0002-7754-9021
CR Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228
   Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675
   Areida SK, 2001, J BIOL CHEM, V276, P1594, DOI 10.1074/jbc.M008709200
   Brannstrom A, 2002, BIOCHEM BIOPH RES CO, V290, P1462, DOI 10.1006/bbrc.2002.6378
   BULLAS LR, 1983, J BACTERIOL, V156, P471, DOI 10.1128/JB.156.1.471-474.1983
   Elomaa O, 1998, J BIOL CHEM, V273, P4530, DOI 10.1074/jbc.273.8.4530
   ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6
   ENGEL J, 1994, METHOD ENZYMOL, V245, P469
   ENGEL J, 1987, METHOD ENZYMOL, V145, P3
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547
   GOLDBERG JB, 1992, P NATL ACAD SCI USA, V89, P10716, DOI 10.1073/pnas.89.22.10716
   GORDON S, 1995, BIOESSAYS, V17, P977, DOI 10.1002/bies.950171111
   Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669
   Ito S, 1999, ARCH HISTOL CYTOL, V62, P83, DOI 10.1679/aohc.62.83
   KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   Kronman C, 2000, J BIOL CHEM, V275, P29488, DOI 10.1074/jbc.M004298200
   Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5
   MIDDLETON RB, 1993, BIOCHEM J, V296, P511, DOI 10.1042/bj2960511
   Mushegian A, 2001, J CELL BIOL, V155, P705, DOI 10.1083/jcb.200107040
   Nakamura K, 2001, BIOCHEM BIOPH RES CO, V280, P1028, DOI 10.1006/bbrc.2000.4210
   Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497
   Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000
   PIEZ KA, 1970, BIOCHEMISTRY-US, V9, P4134, DOI 10.1021/bi00823a016
   PIKAAR JC, 1995, J INFECT DIS, V172, P481, DOI 10.1093/infdis/172.2.481
   Pikkarainen T, 1999, J BIOL CHEM, V274, P10975, DOI 10.1074/jbc.274.16.10975
   ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0
   Schulte S, 1998, J BIOL CHEM, V273, P1551, DOI 10.1074/jbc.273.3.1551
   Snellman A, 2000, J BIOL CHEM, V275, P8936, DOI 10.1074/jbc.275.12.8936
   Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0
   Tasanen K, 2000, J BIOL CHEM, V275, P3093, DOI 10.1074/jbc.275.5.3093
   Thomas CA, 2000, J EXP MED, V191, P147, DOI 10.1084/jem.191.1.147
   Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8
   van der Laan LJW, 1999, J IMMUNOL, V162, P939
   vanderLaan LJW, 1997, IMMUNOL LETT, V57, P203, DOI 10.1016/S0165-2478(97)00077-1
NR 36
TC 56
Z9 59
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 6
PY 2002
VL 277
IS 36
BP 33378
EP 33385
DI 10.1074/jbc.M204494200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 591BC
UT WOS:000177859000127
PM 12097327
OA Bronze
DA 2021-01-25
ER

PT J
AU Voros, J
   Ramsden, JJ
   Csucs, G
   Szendro, I
   De Paul, SM
   Textor, M
   Spencer, ND
AF Voros, J
   Ramsden, JJ
   Csucs, G
   Szendro, I
   De Paul, SM
   Textor, M
   Spencer, ND
TI Optical grating coupler biosensors
SO BIOMATERIALS
LA English
DT Article
DE optical grating coupler biosensors; adsorption kinetics; cell-surface
   interactions; protein-DNA interactions; lipid bilayers; surface
   modification
ID GUIDE LIGHTMODE SPECTROSCOPY; MARCKS-RELATED PROTEIN; METAL-OXIDE
   SURFACES; LIPID BILAYERS; SERUM-ALBUMIN; REAL-TIME; ADSORPTION; BINDING;
   SENSORS; ELLIPSOMETRY
AB By incorporating a grating in a planar optical waveguide one creates a device with which the spectrum of guided lightmodes can be measured. When the surface of the waveguide is exposed to different solutions, the peaks in the spectrum shift due to molecular interactions with the surface. Optical waveguide lightmode spectroscopy (OWLS) is a highly sensitive technique that is capable of real-time monitoring of these interactions. Since this integrated optical method is based on the measurement of the polarizability density (i.e., refractive index) in the vicinity of the waveguide surface, radioactive, fluorescent or other kinds of labeling are not required. In addition, measurement of at least two guided modes enables the absolute mass of adsorbed Molecules to be determined. In this article, the technique will be described in some detail, and applications from different areas will be discussed. Selected examples will be presented to demonstrate how monitoring the modification of different metal oxides with polymers and the response of the coated oxides to biofluids help in the design of novel biomaterials: how OWLS is useful for accurate bioaffinity sensing. which is a key issue in the development of new drugs; and how the quantitative study of protein-DNA/RNA and cell-surface interactions can enhance the understanding of processes in molecular and cellular biology. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 ETH Mat, Surface Sci & Technol Lab, Zurich, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
   ETH Zurich, Dept Mat, Biomech Lab, Zurich, Switzerland.
   MicroVacuum Ltd, Budapest, Hungary.
RP Voros, J (corresponding author), ETH Mat, Surface Sci & Technol Lab, Zurich, Switzerland.
RI Spencer, Nicholas/M-9647-2019; Textor, Marcus/A-6200-2012; Spencer,
   NIcholas D./A-5843-2008
OI Spencer, Nicholas/0000-0002-7873-7905; Textor,
   Marcus/0000-0002-0178-1801; Spencer, NIcholas D./0000-0002-7873-7905;
   Voros, Janos/0000-0001-6054-6230
CR Ball V, 1998, BIOPOLYMERS, V46, P489
   Benesch J, 2000, COLLOID SURFACE B, V18, P71, DOI 10.1016/S0927-7765(99)00136-8
   Bier FF, 1997, SENSOR ACTUAT B-CHEM, V38, P78, DOI 10.1016/S0925-4005(97)80174-8
   BJORLING M, 1992, MACROMOLECULES, V25, P3956
   Brusatori MA, 2001, THESIS WAYNE STATE U
   Csucs G, 1998, BBA-BIOMEMBRANES, V1369, P61, DOI 10.1016/S0005-2736(97)00209-5
   Csucs G, 1998, BBA-BIOMEMBRANES, V1369, P304, DOI 10.1016/S0005-2736(97)00233-2
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Guemouri L, 2000, J CHEM PHYS, V113, P8183, DOI 10.1063/1.1314861
   HEYSEL S, 1995, PROTEIN SCI, V4, P2532, DOI 10.1002/pro.5560041210
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9
   Horvath R, 2001, BIOSENS BIOELECTRON, V16, P17, DOI 10.1016/S0956-5663(00)00123-8
   Huang NP, 2002, LANGMUIR, V18, P220, DOI 10.1021/la010913m
   Huetz P, 1995, ACS SYM SER, V602, P334
   Hug TS, 2001, BIOSENS BIOELECTRON, V16, P865, DOI 10.1016/S0956-5663(01)00204-4
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISREALS R, 1995, MACROMOLECULES, V28, P1626
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   KOJIMA M, 1991, BIOMATERIALS, V12, P21
   Kurrat R, 1998, COLLOID SURFACE B, V11, P187, DOI 10.1016/S0927-7765(98)00039-3
   Kurrat R, 1997, REV SCI INSTRUM, V68, P2172, DOI 10.1063/1.1148069
   Kurrat R, 1997, J COLLOID INTERF SCI, V185, P1, DOI 10.1006/jcis.1996.4528
   KURRAT R, 1998, ADSORPTION BIOMOLECU
   LAVALLE P, 2000, MEMOCS S
   Lelah M.D., 1986, POLYURETHANES MED
   LEONARD EF, 1987, BLOOD CONTACT NATURA
   LUKOSZ W, 1983, OPT LETT, V8, P537, DOI 10.1364/OL.8.000537
   LUKOSZ W, 1991, BIOSENS BIOELECTRON, V6, P215, DOI 10.1016/0956-5663(91)80006-J
   LUKOSZ W, 1995, SENSOR ACTUAT B-CHEM, V29, P37, DOI 10.1016/0925-4005(95)01661-9
   Michielin O, 1999, J AM CHEM SOC, V121, P6523, DOI 10.1021/ja990239j
   Mosbach K, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P205
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Piehler J, 1997, APPL OPTICS, V36, P6554, DOI 10.1364/AO.36.006554
   Ramsden JJ, 1996, BIOCHEMISTRY-US, V35, P3746, DOI 10.1021/bi952158f
   Ramsden JJ, 1998, BIOSENS BIOELECTRON, V13, P593, DOI 10.1016/S0956-5663(98)00014-1
   Ramsden JJ, 1999, PHILOS MAG B, V79, P381, DOI 10.1080/13642819908206414
   RAMSDEN JJ, 1995, CYTOMETRY, V19, P97, DOI 10.1002/cyto.990190202
   Ramsden JJ, 1997, J MOL RECOGNIT, V10, P109, DOI 10.1002/(SICI)1099-1352(199705/06)10:3<109::AID-JMR361>3.0.CO;2-D
   RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813
   Ramsden JJ, 1999, COLLOID SURFACE B, V14, P77, DOI 10.1016/S0927-7765(99)00026-0
   Ramsden JJ, 1996, SENSOR MATER, V8, P469
   RAMSDEN JJ, 1993, BIOPOLYMERS, V33, P475, DOI 10.1002/bip.360330313
   Ramsden JJ, 1996, SENSOR ACTUAT B-CHEM, V30, P107, DOI 10.1016/0925-4005(95)01762-K
   RAMSDEN JJ, 1993, EXPERIENTIA, V49, P688, DOI 10.1007/BF01923952
   RAMSDEN JJ, 1995, GLYCOCONJUGATE J, V12, P113, DOI 10.1007/BF00731354
   RAMSDEN JJ, 1993, BIOCHEMISTRY-US, V32, P523, DOI 10.1021/bi00053a017
   Ramsden JJ, 1996, BIOSENS BIOELECTRON, V11, P523, DOI 10.1016/0956-5663(96)86789-3
   Ramsden JJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P241, DOI 10.1006/abbi.1999.1451
   RAMSDEN JJ, 1998, KINETICS PROTEIN ADS, P337
   ROBINSON G, 1995, SENSOR ACTUAT B-CHEM, V29, P31, DOI 10.1016/0925-4005(95)01660-0
   Ruiz L, 1999, J BIOMAT SCI-POLYM E, V10, P931, DOI 10.1163/156856299X00540
   SZENDRO I, 2001, SPIES S INT OPT SAN
   Talbot J, 1996, ADSORPTION, V2, P89, DOI 10.1007/BF00127102
   Textor M, 2000, LANGMUIR, V16, P3257, DOI 10.1021/la990941t
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   Vergeres G, 2000, ARCH BIOCHEM BIOPHYS, V378, P45, DOI 10.1006/abbi.2000.1809
   Voros J, 2000, BIOSENS BIOELECTRON, V15, P423, DOI 10.1016/S0956-5663(00)00102-0
   Widmer MR, 2001, TRIBOL LETT, V10, P111, DOI 10.1023/A:1009074228662
   YOLDAS BE, 1982, APPL OPTICS, V21, P2960, DOI 10.1364/AO.21.002960
NR 62
TC 319
Z9 324
U1 3
U2 76
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2002
VL 23
IS 17
BP 3699
EP 3710
AR PII S0142-9612(02)00103-5
DI 10.1016/S0142-9612(02)00103-5
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 568BM
UT WOS:000176522600019
PM 12109695
DA 2021-01-25
ER

PT J
AU Tan, AM
   Ziegler, A
   Steinbauer, B
   Seelig, J
AF Tan, AM
   Ziegler, A
   Steinbauer, B
   Seelig, J
TI Thermodynamics of sodium dodecyl sulfate partitioning into lipid
   membranes
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID TITRATION CALORIMETRY; SOLUBILIZATION; BINDING; DETERGENTS; LIPOSOMES;
   PHOSPHATIDYLCHOLINE; BILAYERS; VESICLES; MICELLE; TEMPERATURE
AB The partition equilibria of sodium dodecyl sulfate (SDS) and lithium dodecyl sulfate between water and bilayer membranes were investigated with isothermal titration calorimetry and spectroscopic methods (light scattering, P-31-nuclear magnetic resonance) in the temperature range of 28degreesC to 56degreesC. The partitioning of the dodecyl sulfate anion (DS-) into the bilayer membrane is energetically favored by an exothermic partition enthalpy of DeltaH(D)(0) = -6.0 kcal/mol at 28degreesC. This is in contrast to nonionic detergents where DeltaH(D)(0) is usually positive. The partition enthalpy decreases linearly with increasing temperature and the molar heat capacity is DeltaC(P)(0) = -50 +/- 3 cal mol(-1) K-1. The partition isotherm is nonlinear if the bound detergent is plotted versus the free detergent concentration in bulk solution. This is caused by the electrostatic repulsion between the DS- ions inserted into the membrane and those free in solution near the membrane surface. The surface concentration of DS- immediately above the plane of binding was hence calculated with the Gouy-Chapman theory, and a strictly linear relationship was obtained between the surface concentration and the extent of DS- partitioning. The surface partition constant K describes the chemical equilibrium in the absence of electrostatic effects. For the SDS-membrane equilibrium K was found to be 1.2 x 10(4) M-1 to 6 x 10(4) M-1 for the various systems and conditions investigated, very similar to data available for nonionic detergents of the same chain length. The membrane-micelle phase diagram was also studied. Complete membrane solubilization requires a ratio of 2.2 mol SDS bound per mole of total lipid at 56degreesC. The corresponding equilibrium concentration of SDS free in solution is C-D,f(sol) similar to 1.7 mM and is slightly below the critical micelles concentration (CMC) = 2.1 mM (at 56degreesC and 0.11 M buffer). Membrane saturation occurs at - 0.3 mol SDS per mol lipid and the equilibrium SDS concentration is C-D,f(sat) similar to 2.2 mM +/- 0.6 mM. SDS translocation across the bilayer is slow at ambient temperature but increases at high temperatures.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR ALMOG S, 1990, BIOCHEMISTRY-US, V29, P4582, DOI 10.1021/bi00471a012
   ALTENBACH C, 1984, BIOCHEMISTRY-US, V23, P3913, DOI 10.1021/bi00312a019
   AVEYARD C, 1973, INTRO PRINCIPLES SUR
   BECKER R, 1975, BIOCHEMISTRY-US, V14, P1835, DOI 10.1021/bi00680a005
   BESCHIASCHVILI G, 1992, BIOCHEMISTRY-US, V31, P10044, DOI 10.1021/bi00156a026
   Cantor C.R., 1980, BIOPHYSICAL CHEM
   Chatterjee A, 2001, J PHYS CHEM B, V105, P12823, DOI 10.1021/jp0123029
   Cocera M, 2001, CHEM PHYS LIPIDS, V110, P19, DOI 10.1016/S0009-3084(00)00205-X
   Cocera M, 1999, LANGMUIR, V15, P6609, DOI 10.1021/la9906929
   Cocera M, 2000, LANGMUIR, V16, P4068, DOI 10.1021/la991650n
   Gazzara JA, 1997, J LIPID RES, V38, P2147
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   Kragh-Hansen U, 1998, BIOPHYS J, V75, P2932, DOI 10.1016/S0006-3495(98)77735-5
   LASCH J, 1995, BBA-REV BIOMEMBRANES, V1241, P269, DOI 10.1016/0304-4157(95)00010-O
   LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7
   Lopez O, 1998, LANGMUIR, V14, P4671, DOI 10.1021/la980219f
   Lopez O, 1999, ARCH BIOCHEM BIOPHYS, V367, P153, DOI 10.1006/abbi.1999.1267
   MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J
   Majhi PR, 2001, LANGMUIR, V17, P3844, DOI 10.1021/la001660k
   MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71
   MYSELS KJ, 1959, J PHYS CHEM-US, V63, P1696, DOI 10.1021/j150580a032
   Nebel S, 1997, BIOCHEMISTRY-US, V36, P2853, DOI 10.1021/bi961839n
   PAULA S, 1995, J PHYS CHEM-US, V99, P11742, DOI 10.1021/j100030a019
   RICHIERI GV, 1995, J BIOL CHEM, V270, P15076, DOI 10.1074/jbc.270.25.15076
   SCHURTENBERGER P, 1985, J PHYS CHEM-US, V89, P1042, DOI 10.1021/j100252a031
   Tanford C., 1980, HYDROPHOBIC EFFECT F
   Wenk MR, 1997, BIOPHYS J, V73, P2565, DOI 10.1016/S0006-3495(97)78285-7
   Wenk MR, 1997, BIOPHYS J, V72, P1719, DOI 10.1016/S0006-3495(97)78818-0
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
NR 30
TC 55
Z9 55
U1 0
U2 13
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD SEP
PY 2002
VL 83
IS 3
BP 1547
EP 1556
DI 10.1016/S0006-3495(02)73924-6
PG 10
WC Biophysics
SC Biophysics
GA 589RQ
UT WOS:000177774500029
PM 12202379
OA Green Published
DA 2021-01-25
ER

PT J
AU Niimi, T
   Clements, J
   Gehring, WJ
   Callaerts, P
AF Niimi, T
   Clements, J
   Gehring, WJ
   Callaerts, P
TI Dominant-negative form of the Pax6 homolog eyeless for tissue-specific
   loss-of-function studies in the developing eye and brain in Drosophila
SO GENESIS
LA English
DT Article
ID MUSHROOM BODIES; GENE; EXPRESSION; DACHSHUND; MESODERM
C1 Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.
   Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
RP Callaerts, P (corresponding author), Univ Houston, Dept Biol & Biochem, 369 Sci & Res,Bldg 2, Houston, TX 77204 USA.
RI Callaerts, Patrick/I-8118-2013
OI Niimi, Teruyuki/0000-0003-3981-0177; Clements, Jason/0000-0002-8901-784X
FU NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [R01MH059763, R01MH059763,
   R01MH059763, R01MH059763] Funding Source: NIH RePORTER; NIMH NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [MH59763] Funding Source: Medline
CR BRAND AH, 1993, DEVELOPMENT, V118, P401
   Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N
   Conlon FL, 1996, DEVELOPMENT, V122, P2427
   Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104
   Glavic A, 2001, DEV DYNAM, V222, P368, DOI 10.1002/dvdy.1189
   GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F
   Gross JM, 2001, DEV BIOL, V239, P132, DOI 10.1006/dbio.2001.0426
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564
   Kurusu M, 2000, P NATL ACAD SCI USA, V97, P2140, DOI 10.1073/pnas.040564497
   Noveen A, 2000, DEVELOPMENT, V127, P3475
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
NR 13
TC 9
Z9 10
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 1526-954X
J9 GENESIS
JI Genesis
PD SEP-OCT
PY 2002
VL 34
IS 1-2
BP 74
EP 75
DI 10.1002/gene.10140
PG 2
WC Developmental Biology; Genetics & Heredity
SC Developmental Biology; Genetics & Heredity
GA 600VR
UT WOS:000178412900014
PM 12324952
OA Bronze
DA 2021-01-25
ER

PT J
AU Hofbauer, K
AF Hofbauer, K
TI Molecular pathways to obesity
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article; Proceedings Paper
CT Fribourg Obesity Research Conference (FORC)
CY SEP 21, 2001
CL UNIV FRIBOURG, FRIBOURG, SWITZERLAND
SP Swiss Physiol Soc, Swiss Soc Nutr Res, Swiss Assoc Study Obes, Serono Fdn Advancement Med Sci, Knoll AG, Roche Pharma AG, Novartis Pharma, Nestle SA, Obtech Med AG
HO UNIV FRIBOURG
DE energy balance; genetics; evolution; pharmacotherapy; pathophysiology;
   adipocytes; uncoupling protein; leptin; neuropeptide Y; melanocortin
ID ACTIVATED RECEPTOR-GAMMA; MELANIN-CONCENTRATING HORMONE; DIET-INDUCED
   OBESITY; EARLY-ONSET OBESITY; FOOD-INTAKE; ADIPOSE-TISSUE; MICE LACKING;
   BODY-WEIGHT; FEEDING-BEHAVIOR; ENERGY-BALANCE
AB Obesity results from a chronic imbalance between energy intake and energy expenditure. Environmental factors, such as the increased availability of high caloric food or the decreased need for physical activity, contribute to its development and their influence is amplified by genetic predisposition. In recent years remarkable progress has been made in the understanding of the pathophysiology of obesity. Although most of the insights into the regulation of energy balance have been obtained in rodent models, the rare clinical cases of monogenic obesity provided evidence for the importance of several of these mechanisms in humans. The identification of leptin as a factor originating from adipose tissue and informing the brain about the status of energy reserves firmly established the concept of long-term regulation of body fat stores. The disappointing therapeutic results with leptin in obese patients could be explained by the fact that during evolution this hormone developed rather as a starvation signal than as an adiposity signal. It is conceivable that the pharmacological interference with mechanisms downstream of leptin, for example with the melanocortin pathway, might be therapeutically more promising. The discovery of new molecular mechanisms involved in the regulation of the differentiation and proliferation of adipocytes and the elucidation of their paracrine and endocrine functions have changed the traditional view of adipose tissue as an inert depot for triglycerides. The identification of new uncoupling proteins could modify the current concepts of the regulation of thermogenesis in humans. The remarkable progress in the identification of novel targets involved in the regualtion of energy balance should have a positive impact on the search for new antiobesity agents.
C1 Univ Basel, Pharmazentrum, Biozentrum, Chair Appl Pharmacol, CH-4056 Basel, Switzerland.
RP Hofbauer, K (corresponding author), Univ Basel, Pharmazentrum, Biozentrum, Chair Appl Pharmacol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR Ahima RS, 2000, FRONT NEUROENDOCRIN, V21, P263, DOI 10.1006/frne.2000.0197
   Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413
   Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0
   Ahima RS, 2001, TRENDS MOL MED, V7, P205, DOI 10.1016/S1471-4914(01)01989-X
   Ailhaud G, 2000, INT J OBESITY, V24, pS1, DOI 10.1038/sj.ijo.0801267
   Ailhaud G, 1997, J ENDOCRINOL, V155, P201, DOI 10.1677/joe.0.1550201
   AKABAYASHI A, 1994, MOL BRAIN RES, V21, P55, DOI 10.1016/0169-328X(94)90377-8
   Anand A, 2000, NAT GENET, V24, P377
   Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3
   Barsh GS, 2000, NATURE, V404, P644
   Benoit SC, 2000, J NEUROSCI, V20, P3442, DOI 10.1523/JNEUROSCI.20-09-03442.2000
   Birnbaumer M, 2001, CARDIOVASC RES, V51, P409, DOI 10.1016/S0008-6363(01)00337-6
   Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059
   Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0
   Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143
   Boss O, 1998, J BIOL CHEM, V273, P5, DOI 10.1074/jbc.273.1.5
   Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059
   Boutin P, 2001, BEST PRACT RES CL EN, V15, P391, DOI 10.1053/beem.2001.0153
   BRAY GA, 2000, J OBES RELAT METAB D, V24, pS8
   Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122
   Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105
   Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518
   Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501
   Campbell RE, 2001, NEUROENDOCRINOLOGY, V74, P106, DOI 10.1159/000054676
   Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X
   Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254
   Chiesi M, 2001, TRENDS PHARMACOL SCI, V22, P247, DOI 10.1016/S0165-6147(00)01664-3
   Clapham JC, 2001, PHARMACOL THERAPEUT, V89, P81, DOI 10.1016/S0163-7258(00)00105-4
   Clement K, 1998, NATURE, V392, P398
   Collins P, 2001, BRIT J CLIN PHARMACO, V51, P13, DOI 10.1046/j.1365-2125.2001.01294.x
   Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503
   Criscione L, 1998, J CLIN INVEST, V102, P2136, DOI 10.1172/JCI4188
   El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842
   Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0
   Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704
   Fajas L, 2001, J MOL ENDOCRINOL, V27, P1, DOI 10.1677/jme.0.0270001
   Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5
   Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0
   Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397
   Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204
   Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112
   Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376
   Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901
   Gerald C, 1996, NATURE, V382, P168, DOI 10.1038/382168a0
   Glazer G, 2001, ARCH INTERN MED, V161, P1814, DOI 10.1001/archinte.161.15.1814
   Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199
   Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273
   Grant FD, 2000, EXP PHYSIOL, V85, p203S, DOI 10.1111/j.1469-445X.2000.tb00025.x
   Hagan MM, 2000, AM J PHYSIOL-REG I, V279, pR47
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   Hileman SM, 2000, J CLIN ENDOCR METAB, V85, P804, DOI 10.1210/jc.85.2.804
   Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371
   Hofbauer KG, 2002, TRENDS ECOL EVOL, V17, P328, DOI 10.1016/S0169-5347(02)02515-6
   Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6
   Hwa JJ, 1999, AM J PHYSIOL-REG I, V277, pR1428
   Inui A, 2000, PHARMACOL REV, V52, P35
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68
   Kalra SP, 2001, P NATL ACAD SCI USA, V98, P4279, DOI 10.1073/pnas.091101498
   Kanatani A, 2001, MOL PHARMACOL, V59, P501
   Kanatani A, 2000, BIOCHEM BIOPH RES CO, V272, P169, DOI 10.1006/bbrc.2000.2696
   Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3
   Kopelman PG, 2000, NATURE, V404, P635
   Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932
   Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509
   Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298
   Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803
   Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200
   LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001
   Lev-Ran A, 1999, DIABETES REV, V7, P1
   Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725
   Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850
   Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0
   Lowell BB, 2000, NATURE, V404, P652
   Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660
   MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101
   Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014
   Mantzoros CS, 2000, ANN NY ACAD SCI, V900, P174, DOI 10.1111/j.1749-6632.2000.tb06228.x
   Marks DL, 2001, RECENT PROG HORM RES, V56, P359, DOI 10.1210/rp.56.1.359
   Marsh DJ, 1998, NAT MED, V4, P718, DOI 10.1038/nm0698-718
   Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070
   Massiera F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje
   Matarese G, 2000, EUR CYTOKINE NETW, V11, P7
   Mercer JG, 2001, NEUROSCI BIOBEHAV R, V25, P101, DOI 10.1016/S0149-7634(00)00053-1
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523
   Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI12954
   Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135
   Palmiter RD, 1998, RECENT PROG HORM RES, V53, P163
   Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150
   Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722
   Pinel JPJ, 2000, AM PSYCHOL, V55, P1105, DOI 10.1037//0003-066X.55.10.1105
   Ravussin E, 2000, EUR J PHARMACOL, V410, P131, DOI 10.1016/S0014-2999(00)00811-6
   ROBERTSON GL, 1995, ENDOCRIN METAB CLIN, V24, P549, DOI 10.1016/S0889-8529(18)30031-8
   Robinson SW, 2000, ANNU REV GENET, V34, P687, DOI 10.1146/annurev.genet.34.1.687
   SAHU A, 1993, TRENDS ENDOCRIN MET, V4, P217, DOI 10.1016/1043-2760(93)90125-X
   Saito Y, 2000, TRENDS ENDOCRIN MET, V11, P299, DOI 10.1016/S1043-2760(00)00290-3
   Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6
   Salton SRJ, 2000, NEURON, V25, P265, DOI 10.1016/S0896-6273(00)80892-2
   Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199
   Schaffhauser AO, 1997, DIABETES, V46, P1792, DOI 10.2337/diabetes.46.11.1792
   Schwartz MW, 2000, NATURE, V404, P661
   Shimada M, 1998, NATURE, V396, P670
   Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492
   Stearns SC, 1999, EVOLUTION IN HEALTH AND DISEASE, P3
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Styne DM, 2001, PEDIATR CLIN N AM, V48, P823, DOI 10.1016/S0031-3955(05)70344-8
   Tang-Christensen M, 1998, J ENDOCRINOL, V159, P307, DOI 10.1677/joe.0.1590307
   Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093
   Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5
   Tissenbaum HA, 1998, GENETICS, V148, P703
   Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128
   Van der Ploeg LHT, 2000, CURR OPIN CHEM BIOL, V4, P452, DOI 10.1016/S1367-5931(00)00114-9
   Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199
   Wauters M, 2000, EUR J ENDOCRINOL, V143, P293, DOI 10.1530/eje.0.1430293
   Way JM, 2001, J BIOL CHEM, V276, P25651, DOI 10.1074/jbc.C100189200
   Weyer C, 1999, DIABETES METAB, V25, P11
   Wieland HA, 2000, EXPERT OPIN INV DRUG, V9, P1327, DOI 10.1517/13543784.9.6.1327
   Williams G, 2000, P NUTR SOC, V59, P385, DOI 10.1017/S0029665100000434
   Wisse BE, 2001, LANCET, V358, P857, DOI 10.1016/S0140-6736(01)06037-8
   Woods SC, 2000, ANNU REV PSYCHOL, V51, P255, DOI 10.1146/annurev.psych.51.1.255
   Wu ZD, 1999, CURR OPIN CELL BIOL, V11, P689, DOI 10.1016/S0955-0674(99)00037-X
   Yaswen L, 1999, NAT MED, V5, P1066
   YEN TT, 1994, FASEB J, V8, P479
   ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753
   Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391
   ZUANA OD, 2001, INT J OBESITY, V25, P84
NR 132
TC 76
Z9 78
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD SEP
PY 2002
VL 26
SU 2
BP S18
EP S27
DI 10.1038/sj.ijo.0802124
PG 10
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 591VH
UT WOS:000177900600004
PM 12174325
OA Bronze
DA 2021-01-25
ER

PT J
AU Dutzler, R
   Schirmer, T
   Karplus, M
   Fischer, S
AF Dutzler, R
   Schirmer, T
   Karplus, M
   Fischer, S
TI Translocation mechanism of long sugar chains across the maltoporin
   membrane channel
SO STRUCTURE
LA English
DT Article
DE CPR; maltodextrins; permeation; reaction path; register shift
ID ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; STRUCTURAL BASIS;
   OUTER-MEMBRANE; PROTEIN; TRANSPORT; DYNAMICS; SPECIFICITY; BINDING;
   PROGRAM
AB Maltoporin allows permeation of long maltodextrin chains. It tightly binds the amphiphilic sugar, offering both hydrophobic interactions with a helical lane of aromatic residues and H bonds with ionic side chains. The minimum-energy path of maltohexaose translocation is obtained by the conjugate peak refinement method, which optimizes a continuous string of conformers without applying constraints. This reveals that the protein is passive while the sugar glides screw-like along the aromatic lane. Near instant switching of sugar hydroxyl H bond partners results in two small energy barriers (of similar to4 kcal/mol each) during register shift by one glucosyl unit, in agreement with a kinetic analysis of experimental dissociation rates for varying sugar chain lengths. Thus, maltoporin functions like an efficient translocation "enzyme," and the slow rate of the register shift (similar to1/ms) is due to high collisional friction.
C1 Univ Strasbourg 1, Inst Le Bel, Chim Phys Lab, F-67000 Strasbourg, France.
   Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Univ Heidelberg, IWR Biocomp, D-69120 Heidelberg, Germany.
   Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.
RP Karplus, M (corresponding author), Univ Strasbourg 1, Inst Le Bel, Chim Phys Lab, F-67000 Strasbourg, France.
CR AJAY MMA, 1995, J MED CHEM, V38, P4953
   ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385
   BASHFORD D, 1988, PROTEINS, V4, P211, DOI 10.1002/prot.340040308
   BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137
   Blondel A, 1999, J MOL BIOL, V291, P101, DOI 10.1006/jmbi.1999.2879
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   CHOI C, 1991, J CHEM PHYS, V94, P751, DOI 10.1063/1.460343
   DEATH A, 1993, J BACTERIOL, V175, P1475, DOI 10.1128/JB.175.5.1475-1483.1993
   Dumas F, 2000, J BIOL CHEM, V275, P19747, DOI 10.1074/jbc.M000268200
   Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0
   Fischer S, 1998, J PHYS CHEM B, V102, P1797, DOI 10.1021/jp972948u
   FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J
   FISCHER S, 1993, BIOCHEMISTRY-US, V32, P13830, DOI 10.1021/bi00213a011
   Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37
   HUMPHREY W, 1996, J MOL GRAPH MODEL, V14, P33, DOI DOI 10.1016/0263-7855(96)00018-5
   Hunenberger PH, 1999, BIOCHEMISTRY-US, V38, P2358, DOI 10.1021/bi982064g
   Jap BK, 1996, PHYSIOL REV, V76, P1073
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665
   LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F
   MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396
   Meyer JEW, 1997, J MOL BIOL, V266, P761, DOI 10.1006/jmbi.1996.0823
   Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515
   NIKAIDO H, 1992, SCIENCE, V258, P936, DOI 10.1126/science.1279804
   ROSENBUSCH JP, 1996, HDB BIOL PHYS, V2, P599
   Roux B, 1999, BIOPHYS CHEM, V78, P1, DOI 10.1016/S0301-4622(98)00226-9
   ROUX B, 1991, J PHYS CHEM-US, V95, P4856, DOI 10.1021/j100165a049
   SCHIEPEK G, 1995, PSYCHOTHERAPIE FORUM, V3, P1
   Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946
   Schulz GE, 1996, CURR OPIN STRUC BIOL, V6, P485, DOI 10.1016/S0959-440X(96)80113-8
   Schwartz M, 1987, ESCHERICHIA COLI SAL, P1482
   SIMONSON T, 1997, J PHYS CHEM-US, V41, P8347
   SOPKOVA J, 2000, BIOCHEMISTRY-US, V39, P14065
   Verma CS, 1996, J PHYS CHEM-US, V100, P2510, DOI 10.1021/jp952574+
   Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224
NR 37
TC 46
Z9 46
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0969-2126
J9 STRUCTURE
JI Structure
PD SEP
PY 2002
VL 10
IS 9
BP 1273
EP 1284
AR PII S0969-2126(02)00811-0
DI 10.1016/S0969-2126(02)00811-0
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 594CH
UT WOS:000178030800015
PM 12220498
DA 2021-01-25
ER

PT J
AU van Giersbergen, PLM
   Gnerre, C
   Treiber, A
   Dingemanse, J
   Meyer, UA
AF van Giersbergen, PLM
   Gnerre, C
   Treiber, A
   Dingemanse, J
   Meyer, UA
TI Bosentan, a dual endothelin receptor antagonist, activates the pregnane
   X nuclear receptor
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE bosentan; glibenclamide; pregnane X receptor; cytochrome P450 enzyme
   induction
ID XENOBIOTIC RECEPTOR; HUMAN HEPATOCYTES; PHARMACOKINETICS; INDUCTION;
   EXCRETION; GENE; PXR; 6-BETA-HYDROXYCORTISOL; OMEPRAZOLE; INDUCERS
AB Recent clinical studies have shown that bosentan, a dual endothelin receptor antagonist, decreases the exposure to various substrates of cytochrome P450 (CYP) isoenzymes 2C9 and 3A4. The aim of the study was to investigate the effect of bosentan, its metabolites and glibenclamide on the activity of the pregnane X receptor, a nuclear receptor that regulates the transcription of CYP3A4. CV-1 monkey kidney cells were transiently transfected with a luciferase reporter plasmid containing three copies of the ER6 response element of CYP3A4 and the human or mouse pregnane X receptor. Subsequently, the cells were incubated with the test compounds and the activity of luciferase determined. Bosentan activated the human pregnane X receptor with an EC50 of 19-9 muM, whereas rifampicin had an EC50 value of 1.9 muM. Ro 47-8634 (4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-hydroxy-phenoxy)-2,2'-bipyrimidin-4-yl]-benzenesulfonamide), a metabolite of bosentan, and glibenclamide also activated the pregnane X receptor. The findings provide a molecular mechanism for the interactions observed between bosentan and several drugs. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Actel Pharmaceut Ltd, Dept Clin Pharmacol, CH-4123 Allschwil, Switzerland.
   Actel Pharmaceut Ltd, Dept Preclin Pharmacokinet & Metab, CH-4123 Allschwil, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP van Giersbergen, PLM (corresponding author), Actel Pharmaceut Ltd, Dept Clin Pharmacol, Gewerbestr 18, CH-4123 Allschwil, Switzerland.
EM paul.vangiersbergen@actelion.com
CR Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208
   Binet I, 2000, KIDNEY INT, V57, P224, DOI 10.1046/j.1523-1755.2000.00838.x
   Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195
   BORCHERDING SM, 1992, ARCH INTERN MED, V152, P711, DOI 10.1001/archinte.152.4.711
   Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X
   CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228
   CURIPEDROSA R, 1994, J PHARMACOL EXP THER, V269, P384
   DIAZ D, 1990, GASTROENTEROLOGY, V99, P737, DOI 10.1016/0016-5085(90)90963-2
   Dingemanse J, 2002, BRIT J CLIN PHARMACO, V53, p547P, DOI 10.1046/j.1365-2125.2002.16138.x
   Ellahham SH, 2000, CLIN CARDIOL, V23, P803, DOI 10.1002/clc.4960231128
   Fattinger K, 2001, CLIN PHARMACOL THER, V69, P223, DOI 10.1067/mcp.2001.114667
   Flockhart DA, 2000, CHILD ADOL PSYCH CL, V9, P43
   Fuhr U, 2000, CLIN PHARMACOKINET, V38, P493, DOI 10.2165/00003088-200038060-00003
   GED C, 1989, BRIT J CLIN PHARMACO, V28, P373, DOI 10.1111/j.1365-2125.1989.tb03516.x
   Gerbal-Chaloin S, 2002, J BIOL CHEM, V277, P209, DOI 10.1074/jbc.M107228200
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   ISOM HC, 1984, P NATL ACAD SCI-BIOL, V81, P6378, DOI 10.1073/pnas.81.20.6378
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Jonsson A, 2000, EUR J CLIN PHARMACOL, V56, P711, DOI 10.1007/s002280000214
   KIOWSKI W, 1995, LANCET, V346, P732, DOI 10.1016/S0140-6736(95)91504-4
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Kyrklund C, 2000, CLIN PHARMACOL THER, V68, P592, DOI 10.1067/mcp.2000.111414
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   Michalets EL, 1998, PHARMACOTHERAPY, V18, P84
   Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200
   OHNHAUS EE, 1979, EUR J CLIN PHARMACOL, V15, P139, DOI 10.1007/BF00609878
   PICHARD L, 1990, DRUG METAB DISPOS, V18, P595
   Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200
   Smith DA, 2000, EUR J PHARM SCI, V11, P185, DOI 10.1016/S0928-0987(00)00107-X
   van Giersbergen PLM, 2002, CLIN PHARMACOL THER, V71, P253, DOI 10.1067/mcp.2002.122473
   Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Weber C, 1999, J CLIN PHARMACOL, V39, P703, DOI 10.1177/00912709922008344
   Weber C, 1999, DRUG METAB DISPOS, V27, P810
   Weber C, 1999, J CLIN PHARMACOL, V39, P847, DOI 10.1177/00912709922008380
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
NR 36
TC 28
Z9 28
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD AUG 23
PY 2002
VL 450
IS 2
BP 115
EP 121
AR PII S0014-2999(02)02075-7
DI 10.1016/S0014-2999(02)02075-7
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 592LL
UT WOS:000177939100001
PM 12206849
DA 2021-01-25
ER

PT J
AU Handschin, C
   Podvinec, M
   Amherd, R
   Looser, R
   Ourlin, JC
   Meyer, UA
AF Handschin, C
   Podvinec, M
   Amherd, R
   Looser, R
   Ourlin, JC
   Meyer, UA
TI Cholesterol and bile acids regulate xenosensor signaling in
   drug-mediated induction of cytochromes P450
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ORPHAN NUCLEAR RECEPTOR; PREGNANE-X RECEPTOR; CONSTITUTIVE ANDROSTANE
   RECEPTOR; CHICKEN XENOBIOTIC RECEPTOR; HUMAN LIVER-MICROSOMES; RAT
   HEPATOCYTES; TRANSCRIPTIONAL ACTIVATION; ANTIEPILEPTIC DRUGS; HORMONE
   RECEPTORS; LITHOCHOLIC ACID
AB Cytochromes P450 (CYP) constitute the major enzymatic system for metabolism of xenobiotics. Here we demonstrate that transcriptional activation of CYPs by the drug-sensing nuclear receptors pregnane X receptor, constitutive androstane receptor, and the chicken xenobiotic receptor (CXR) can be modulated by endogenous cholesterol and bile acids. Bile acids induce the chicken drug-activated CYP2H1 via CXR, whereas the hydroxylated metabolites of bile acids and oxysterols inhibit drug induction. The cholesterol-sensing liver X receptor competes with CXR, pregnane X receptor, or constitutive androstane receptor for regulation of drug-responsive enhancers from chicken CYP2H1, human CYP3A4, or human CYP2B6, respectively. Thus, not only cholesterol 7alpha-hydroxylase (CYP7A1), but also drug-inducible CYPs, are diametrically affected by these receptors. Our findings reveal new insights into the increasingly complex network of nuclear receptors regulating lipid homeostasis and drug metabolism.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR ANDERSSON M, 1994, BBA-LIPID LIPID MET, V1214, P79, DOI 10.1016/0005-2760(94)90012-4
   Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1
   Aynaci FM, 2001, J CHILD NEUROL, V16, P367
   BACK P, 1987, PHARMACOL THERAPEUT, V33, P153, DOI 10.1016/0163-7258(87)90044-1
   BLOUIN RA, 1993, ARCH BIOCHEM BIOPHYS, V303, P313, DOI 10.1006/abbi.1993.1289
   Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149
   Cancado ELR, 1998, AM J GASTROENTEROL, V93, P1510, DOI 10.1111/j.1572-0241.1998.00472.x
   Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7
   Dussault I, 2001, J BIOL CHEM, V276, P33309, DOI 10.1074/jbc.C100375200
   EIRIS JM, 1995, NEUROLOGY, V45, P1155, DOI 10.1212/WNL.45.6.1155
   Fischer S, 1996, CLIN CHIM ACTA, V251, P173, DOI 10.1016/0009-8981(96)06305-X
   Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588
   Furster C, 1999, BBA-MOL CELL BIOL L, V1437, P46, DOI 10.1016/S0005-2760(98)00175-1
   Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200
   Goodwin B, 1999, MOL PHARMACOL, V56, P1329
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Kocarek TA, 1998, MOL PHARMACOL, V54, P474
   KOCAREK TA, 1993, TOXICOL APPL PHARM, V120, P298, DOI 10.1006/taap.1993.1115
   Kocarek TA, 1998, BIOCHEM PHARMACOL, V55, P1435, DOI 10.1016/S0006-2952(97)00658-8
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7
   Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352
   Ourlin JC, 2002, BIOCHEM BIOPH RES CO, V291, P378, DOI 10.1006/bbrc.2002.6464
   Penzak SR, 2000, SCAND J INFECT DIS, V32, P111
   Plewka A, 1996, EXP TOXICOL PATHOL, V48, P249, DOI 10.1016/S0940-2993(96)80009-1
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524
   Savas U, 1999, MOL PHARMACOL, V56, P851
   Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200
   Schwaninger M, 2000, J NEUROL, V247, P687, DOI 10.1007/s004150070111
   Sehayek E, 2001, J LIPID RES, V42, P1250
   Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7
   Song C, 2000, STEROIDS, V65, P423, DOI 10.1016/S0039-128X(00)00127-6
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   SUDJANASUGIAMAN E, 1994, J LIPID RES, V35, P319
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172
   SUMMERFIELD JA, 1976, BIOCHEM J, V154, P507, DOI 10.1042/bj1540507
   Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912
   THOMAS KD, 1984, ISRAEL J MED SCI, V20, P240
   Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700
   Verrotti A, 1997, J PAEDIATR CHILD H, V33, P242, DOI 10.1111/j.1440-1754.1997.tb01588.x
   Watanabe M, 1996, MED SCI RES, V24, P257
   WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112
   Wietholtz H, 1996, J HEPATOL, V24, P713, DOI 10.1016/S0168-8278(96)80268-6
   Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116
   Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
   Yilmaz E, 2001, ACTA NEUROL BELG, V101, P217
NR 59
TC 52
Z9 53
U1 0
U2 8
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 16
PY 2002
VL 277
IS 33
BP 29561
EP 29567
DI 10.1074/jbc.M202739200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 585DW
UT WOS:000177509300029
PM 12045201
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Ziegler, S
   Burki, K
   Skoda, RC
AF Ziegler, S
   Burki, K
   Skoda, RC
TI A 2-kb c-mpl promoter fragment is sufficient to direct expression to the
   megakaryocytic lineage and sites of embryonic hematopoiesis in
   transgenic mice
SO BLOOD
LA English
DT Article
ID GROWTH-FACTOR; THROMBOPOIETIN; RECEPTOR; CLONING; STIMULATION; MEMBER;
   LIGAND
AB Thrombopoietin receptor c-mpl is expressed on hematopoietic progenitors and cells of the megakaryocytic lineage. The c-mpi promoter may, therefore, be useful for directing the expression of transgenes. We tested whether a 2-kb genomic DNA fragment comprising the putative c-mpl regulatory elements and most of the 5'-untranslated region of mouse c-mpi is able to direct the expression of a reporter gene to hematopoietic cells in transgenic mice. As a reporter gene we used the human placental alkaline phosphatase (PLAP). In adult transgenic mice, PLAP expression was specifically detected in megakaryocytes and platelets. Embryos showed PLAID reporter gene expression already in the yolk sac at embryonic day 6.5 (E6.5) and in blood islands at E7.5. At E9.5, expression was found in blood vessels of the yolk sac and the embryo proper, followed by high levels of expression in the fetal liver at E11.5. Expression in E6.5 yolk sac is compatible with a function of c-mpl and its ligand, thrombopoietin, in the earliest stages of embryonic hematopoiesis. (C) 2002 by The American Society of Hematology.
C1 Univ Basel, Biozentrum, DKF2, Heidelberg, Germany.
   Univ Zurich, Lab Anim Sci, Zurich, Switzerland.
RP Skoda, RC (corresponding author), Univ Basel Hosp, Dept Res Expt Hematol, Hebelstr 20, CH-4031 Basel, Switzerland.
EM radek.skoda@unibas.ch
CR BARTLEY TD, 1994, CELL, V77, P1117, DOI 10.1016/0092-8674(94)90450-2
   Brizzi MF, 1999, CIRC RES, V84, P785
   Cardier JE, 1998, BLOOD, V91, P923, DOI 10.1182/blood.V91.3.923.923_923_929
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Deprimo SE, 1996, TRANSGENIC RES, V5, P459, DOI 10.1007/BF01980211
   DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0
   HARLOW E, 1988, ANTIBOIDES LAB MANUA
   Kaushansky K, 1999, ANN NY ACAD SCI, V872, P314, DOI 10.1111/j.1749-6632.1999.tb08475.x
   KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0
   Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126
   KRIEG PA, 1987, METHOD ENZYMOL, V155, P397
   LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0
   Perlingeiro RCR, 2001, BLOOD, V98, p71A
   SKODA RC, 1993, EMBO J, V12, P2645, DOI 10.1002/j.1460-2075.1993.tb05925.x
   SOUYRI M, 1990, CELL, V63, P1137, DOI 10.1016/0092-8674(90)90410-G
   Stoffel R, 1996, BLOOD, V87, P567, DOI 10.1182/blood.V87.2.567.bloodjournal872567
   VIGON I, 1993, ONCOGENE, V8, P2607
   Xie XD, 2001, BLOOD, V98, p72A
NR 18
TC 12
Z9 13
U1 0
U2 0
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD AUG 1
PY 2002
VL 100
IS 3
BP 1072
EP 1074
DI 10.1182/blood-2002-01-0281
PG 3
WC Hematology
SC Hematology
GA 578LA
UT WOS:000177118000047
PM 12130527
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Fujiyoshi, Y
   Mitsuoka, K
   de Groot, BL
   Philippsen, A
   Grubmuller, H
   Agre, P
   Engel, A
AF Fujiyoshi, Y
   Mitsuoka, K
   de Groot, BL
   Philippsen, A
   Grubmuller, H
   Agre, P
   Engel, A
TI Structure and function of water channels
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Review
ID ELECTRON CRYSTALLOGRAPHY; 3-DIMENSIONAL STRUCTURE; AQUAPORIN CHIP;
   GLYCEROL; SELECTIVITY; PERMEATION; CONDUCTION; MECHANISM; DYNAMICS;
   PROTEIN
AB Aquaporins comprise a family of water-transporting membrane proteins. All aquaporins are efficient water transporters, while sustaining strict selectivity, even against protons, thereby maintaining the proton gradient across the cell membrane. Recently solved structures of these membrane channels have helped us to understand this remarkable property. The structure of the Escherichia coli glycerol facilitator GlpF at 2,2 A resolution has enabled the refinement of a low-resolution human aquaporin-1 structure. This latter structure has recently been confirmed by the 2.2 Angstrom structure of bovine aquaporin-1. Further insights, particularly with respect to the dynamics of water permeation and the filter mechanism, have come from recent molecular dynamics simulations.
C1 Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.
   AIST, Biol Informat Res Ctr, Tokyo 1350064, Japan.
   Max Planck Inst Biophys Chem, Theoret Mol Biophys Grp, D-37077 Gottingen, Germany.
   Univ Basel, ME Muller Inst Microscopy, Biozentrum, CH-4056 Basel, Switzerland.
   Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.
   Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.
RP Fujiyoshi, Y (corresponding author), Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.
EM yoshi@em.biophys.kyoto-u.ac.jp
RI Fujiyoshi, Yoshinori/E-5989-2012
OI Fujiyoshi, Yoshinori/0000-0002-8070-1493
CR Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818
   Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098
   Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220
   Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299
   Jensen MO, 2001, STRUCTURE, V9, P1083, DOI 10.1016/S0969-2126(01)00668-2
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   Kong YF, 2001, P NATL ACAD SCI USA, V98, P14345, DOI 10.1073/pnas.251507998
   Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Ostermeier C, 1996, CURR OPIN STRUC BIOL, V6, P460, DOI 10.1016/S0959-440X(96)80110-2
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198
   SIDEL VW, 1957, J GEN PHYSIOL, V41, P243, DOI 10.1085/jgp.41.2.243
   SMITH BL, 1991, J BIOL CHEM, V266, P6407
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512
   Zhu FQ, 2001, FEBS LETT, V504, P212, DOI 10.1016/S0014-5793(01)02749-1
NR 26
TC 197
Z9 225
U1 2
U2 50
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
EI 1879-033X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD AUG
PY 2002
VL 12
IS 4
BP 509
EP 515
DI 10.1016/S0959-440X(02)00355-X
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 586EF
UT WOS:000177571100013
PM 12163075
OA Green Published
DA 2021-01-25
ER

PT J
AU Grosdent, N
   Maridonneau-Parini, I
   Sory, MP
   Cornelis, GR
AF Grosdent, N
   Maridonneau-Parini, I
   Sory, MP
   Cornelis, GR
TI Role of Yops and adhesins in resistance of Yersinia enterocolitica to
   phagocytosis
SO INFECTION AND IMMUNITY
LA English
DT Article
ID RECEPTOR-MEDIATED PHAGOCYTOSIS; NF-KAPPA-B; TYROSINE PHOSPHATASE;
   MAMMALIAN-CELLS; PROTEIN-KINASE; HUMAN GRANULOCYTES; VIRULENCE PLASMID;
   EPITHELIAL-CELLS; EFFECTOR PROTEIN; BINDING PROTEIN
AB Yersinia enterocolitica is a pathogen endowed with two adhesins, Inv and YadA, and with the Ysc type III secretion system, which allows extracellular adherent bacteria to inject Yop effectors into the cytosol of animal target cells. We tested the influence of all of these virulence determinants on opsonic and nonopsonic phagocytosis by PU5-1.8 and J774 mouse macrophages, as well as by human polymorphonuclear leukocytes (PMNs). The adhesins contributed to phagocytosis in the absence of opsonins but not in the presence of opsonins. In agreement with previous results, YadA counteracted opsonization. In every instance, the Ysc-Yop system conferred a significant level of resistance to phagocytosis. Nonopsonized single-mutant bacteria lacking either YopE, -H, -T, or -O were phagocytosed significantly more by J774 cells and by PMNs. Opsonized bacteria were phagocytosed more than nonopsonized bacteria, and mutant bacteria lacking either YopH, -T, or -O were phagocytosed significantly more by J774 cells and by PMNs than were wild-type (WT) bacteria. Opsonized mutants lacking only YopE were phagocytosed significantly more than were WT bacteria by PMNs but not by J774 cells. Thus, YopH, -T, and -O were involved in all of the phagocytic processes studied here but YopE did not play a clear role in guarding against opsonic phagocytosis by J774. Mutants lacking YopP and YopM were, in every instance, as resistant as WT bacteria. Overexpression of YopE, -H, -T, or -O alone did not confer resistance to phagocytosis, although it affected the cytoskeleton. These results show that YopH, YopT, YopO, and, in some instances, YopE act synergistically to increase the resistance of Y. enterocolitica to phagocytosis by macrophages and PMNs.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   CNRS UMR 5089, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France.
   Univ Catholique Louvain, Fac Med, B-1200 Brussels, Belgium.
   Univ Catholique Louvain, Christian de Duve Inst Cellular Pathol, Microbial Pathogenesis Unit, B-1200 Brussels, Belgium.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelberstr 50-70, CH-4056 Basel, Switzerland.
RI Maridonneau-Parini, Isabelle/F-1985-2011
OI Maridonneau-Parini, Isabelle/0000-0003-0189-0976
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627
   Andersson K, 1999, INFECT IMMUN, V67, P2567, DOI 10.1128/IAI.67.5.2567-2574.1999
   Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x
   Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x
   Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999
   Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x
   Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x
   Black DS, 1998, MOL MICROBIOL, V29, P1263, DOI 10.1046/j.1365-2958.1998.01014.x
   BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993
   BLISKA JB, 1995, INFECT IMMUN, V63, P681, DOI 10.1128/IAI.63.2.681-685.1995
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098
   BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893
   Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717
   CHINA B, 1993, INFECT IMMUN, V61, P3129, DOI 10.1128/IAI.61.8.3129-3136.1993
   CHINA B, 1994, INFECT IMMUN, V62, P1275, DOI 10.1128/IAI.62.4.1275-1281.1994
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998
   Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200
   Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199
   Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200
   Evdokimov AG, 2001, ACTA CRYSTALLOGR D, V57, P793, DOI 10.1107/S0907444901004875
   FALLMAN M, 1995, INFECT IMMUN, V63, P3117
   Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955
   Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x
   Hamid N, 1999, MICROB PATHOGENESIS, V27, P231, DOI 10.1006/mpat.1999.0301
   HEESEMANN J, 1987, FEMS MICROBIOL LETT, V40, P37, DOI 10.1016/0378-1097(87)90512-X
   HEESEMANN J, 1985, J CLIN MICROBIOL, V22, P168, DOI 10.1128/JCM.22.2.168-175.1985
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7
   ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z
   Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   KAPPERUD G, 1987, INFECT IMMUN, V55, P2247, DOI 10.1128/IAI.55.9.2247-2254.1987
   Le Cabec V, 2000, INFECT IMMUN, V68, P4736, DOI 10.1128/IAI.68.8.4736-4745.2000
   LEUNG KY, 1989, J BACTERIOL, V171, P4623, DOI 10.1128/jb.171.9.4623-4632.1989
   LIAN CJ, 1985, INFECT IMMUN, V49, P145, DOI 10.1128/IAI.49.1.145-151.1985
   LIAN CJ, 1987, INFECT IMMUN, V55, P1176, DOI 10.1128/IAI.55.5.1176-1183.1987
   McGee K, 2001, FEBS LETT, V509, P59, DOI 10.1016/S0014-5793(01)03139-8
   MICHIELS T, 1991, J BACTERIOL, V173, P4994, DOI 10.1128/jb.173.16.4994-5009.1991
   MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   N'Diaye EN, 1998, J IMMUNOL, V161, P4983
   Neyt C, 1997, J BACTERIOL, V179, P612, DOI 10.1128/jb.179.3.612-619.1997
   Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920
   PEPE JC, 1993, P NATL ACAD SCI USA, V90, P6473, DOI 10.1073/pnas.90.14.6473
   Persson C, 1999, MOL MICROBIOL, V33, P828, DOI 10.1046/j.1365-2958.1999.01529.x
   Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307
   PILZ D, 1992, INFECT IMMUN, V60, P189, DOI 10.1128/IAI.60.1.189-195.1992
   PORTNOY DA, 1981, INFECT IMMUN, V31, P775, DOI 10.1128/IAI.31.2.775-782.1981
   REISNER BS, 1992, INFECT IMMUN, V60, P5242, DOI 10.1128/IAI.60.12.5242-5252.1992
   Roggenkamp A, 1996, INFECT IMMUN, V64, P2506, DOI 10.1128/IAI.64.7.2506-2514.1996
   ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991
   ROSQVIST R, 1988, INFECT IMMUN, V56, P2139, DOI 10.1128/IAI.56.8.2139-2143.1988
   ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x
   Ruckdeschel K, 1996, INFECT IMMUN, V64, P724, DOI 10.1128/IAI.64.3.724-733.1996
   Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Schulte R, 2000, FASEB J, V14, P1471, DOI 10.1096/fj.14.11.1471
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Visser LG, 1996, INFECT IMMUN, V64, P1653, DOI 10.1128/IAI.64.5.1653-1658.1996
   VISSER LG, 1995, INFECT IMMUN, V63, P2570, DOI 10.1128/IAI.63.7.2570-2575.1995
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   Wiedemann A, 2001, CELL MICROBIOL, V3, P693, DOI 10.1046/j.1462-5822.2001.00149.x
   Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289
NR 69
TC 159
Z9 164
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD AUG
PY 2002
VL 70
IS 8
BP 4165
EP 4176
DI 10.1128/IAI.70.8.4165-4176.2002
PG 12
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 574VC
UT WOS:000176909400023
PM 12117925
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Henry, KR
   D'Hondt, K
   Chang, JS
   Newpher, T
   Huang, K
   Hudson, RT
   Riezman, H
   Lemmon, SK
AF Henry, KR
   D'Hondt, K
   Chang, JS
   Newpher, T
   Huang, K
   Hudson, RT
   Riezman, H
   Lemmon, SK
TI Scd5p and clathrin function are important for cortical actin
   organization, endocytosis, and localization of Sla2p in yeast
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Review
ID RECEPTOR-MEDIATED ENDOCYTOSIS; PROTEIN-PROTEIN INTERACTIONS;
   CYCLASE-ASSOCIATED PROTEIN; CHAIN-DEFICIENT YEAST;
   SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; INTERNALIZATION STEP; ARP2/3
   COMPLEX; BUDDING YEAST; CYTOSKELETON ORGANIZATION
AB SCD5 was identified as a multicopy suppressor of clathrin HC-deficient yeast. SCD5 is essential, but an scd5-Delta338 mutant, expressing Scd5p with a C-terminal truncation of 338 amino acids, is temperature sensitive for growth. Further studies here demonstrate that scd5-Delta338 affects receptor-mediated and fluid-phase endocytosis and normal actin organization. The scd5-Delta338 mutant contains larger and depolarized cortical actin patches and a prevalence of G-actin bars. scd5-Delta338 also displays synthetic negative genetic interactions with mutations in several other proteins important for cortical actin organization and endocytosis. Moreover, Scd5p colocalizes with cortical actin. Analysis has revealed that clathrin-deficient yeast also have a major defect in cortical actin organization and accumulate G-actin. Overexpression of SCD5 partially suppresses the actin defect of clathrin mutants, whereas combining scd5-Delta338 with a clathrin mutation exacerbates the actin and endocytic phenotypes. Both Scd5p and yeast clathrin physically associate with Sla2p, a homologue of the mammalian huntingtin interacting protein HIP1 and the related HIP1R. Furthermore, Sla2p localization at the cell cortex is dependent on Scd5p and clathrin function. Therefore, Scd5p and clathrin are important for actin organization and endocytosis, and Sla2p may provide a critical link between clathrin and the actin cytoskeleton in yeast, similar to HIP1(R) in animal cells.
C1 Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Genet Program, Cleveland, OH 44106 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Lemmon, SK (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.
EM skl@po.cwru.edu
RI Chang, Ji Suk/N-1957-2017
OI Lemmon, Sandra/0000-0002-8022-130X; Riezman, Howard/0000-0003-4680-9422
FU NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [T32DK007319, T32DK007319, T32DK007319,
   T32DK007319, T32DK007319, T32DK007319, T32DK007319, T32DK007319,
   T32DK007319, T32DK007319, T32DK007319, T32DK007319, T32DK007319,
   T32DK007319, T32DK007319, T32DK007319, T32DK007319, T32DK007319,
   T32DK007319, T32DK007319, T32DK007319, T32DK007319, T32DK007319,
   T32DK007319, T32DK007319, T32DK007319, T32DK007319, T32DK007319] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM055796, R01GM055796, R01GM055796,
   R01GM055796, R01GM055796, F31GM020082, R01GM055796, R01GM055796,
   R01GM055796, R01GM055796, F31GM020082, R01GM055796, F32GM017370,
   R01GM055796, F31GM020082, R01GM055796, R01GM055796, R01GM055796,
   R01GM055796, R01GM055796, R01GM055796, R01GM055796, R01GM055796,
   F32GM017370, F32GM017370, R01GM055796, R01GM055796] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Aging (NIA) [T32AG000105, T32AG000105, T32AG000105,
   T32AG000105, T32AG000105, T32AG000105, T32AG000105, T32AG000105,
   T32AG000105, T32AG000105, T32AG000105, T32AG000105, T32AG000105,
   T32AG000105, T32AG000105, T32AG000105, T32AG000105, T32AG000105,
   T32AG000105, T32AG000105, T32AG000105, T32AG000105] Funding Source: NIH
   RePORTER; NIA NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) [T32 AG000105, T32 AG00105] Funding Source: Medline;
   NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [T32 DK7319-23, T32 DK007319]
   Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [F31 GM020082, R01
   GM055796, R01 GM55796, F31 GM20082, F32 GM017370, F32 GM17370] Funding
   Source: Medline
CR ADAMS AEM, 1991, NATURE, V354, P404, DOI 10.1038/354404a0
   ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934
   ADAMS AEM, 1991, METHOD ENZYMOL, V194, P729
   Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x
   Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399
   Ayscough KR, 1999, MOL BIOL CELL, V10, P1061, DOI 10.1091/mbc.10.4.1061
   Baggett JJ, 2001, TRAFFIC, V2, P297, DOI 10.1034/j.1600-0854.2001.002005297.x
   Balguerie A, 1999, J CELL SCI, V112, P2529
   BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070
   BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023
   Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111
   Bennett EM, 2001, TRAFFIC, V2, P851, DOI 10.1046/j.1398-9219.2001.x
   BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0
   BOTSTEIN D, 1997, MOL CELLULAR BIOL YE, V3, P1
   Breton AM, 2001, YEAST, V18, P1053, DOI 10.1002/yea.755
   Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517
   Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555
   Cope MJTV, 1999, J CELL BIOL, V144, P1203, DOI 10.1083/jcb.144.6.1203
   COTTON R G H, 1992, Current Opinion in Biotechnology, V3, P24, DOI 10.1016/0958-1669(92)90121-X
   D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255
   David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331
   Dell'Angelica EC, 2001, TRENDS CELL BIOL, V11, P315, DOI 10.1016/S0962-8924(01)02043-8
   DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4
   Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479
   Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057
   DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0
   DRUBIN DG, 1988, J CELL BIOL, V107, P2551, DOI 10.1083/jcb.107.6.2551
   DULIC V, 1991, METHOD ENZYMOL, V194, P697
   Duncan MC, 2001, NAT CELL BIOL, V3, P687, DOI 10.1038/35083087
   Engqvist-Goldstein AEY, 2001, J CELL BIOL, V154, P1209, DOI 10.1083/jcb.200106089
   Engqvist-Goldstein AEY, 1999, J CELL BIOL, V147, P1503, DOI 10.1083/jcb.147.7.1503
   FAZI B, 2001, J BIOL CHEM, V19, P5290
   Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051
   Freeman NL, 1996, MOL CELL BIOL, V16, P548
   Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x
   Gagny B, 2000, J CELL SCI, V113, P3309
   Gaidarov I, 1999, NAT CELL BIOL, V1, P1
   GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408
   Goodson HV, 1996, J CELL BIOL, V133, P1277, DOI 10.1083/jcb.133.6.1277
   Gurunathan S, 2002, EMBO J, V21, P602, DOI 10.1093/emboj/21.4.602
   Guthrie C., 1991, GUIDE YEAST GENETICS
   HARPER JW, 1993, CELL, V75, P805
   Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077
   Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8
   HOLTZMAN DA, 1993, J CELL BIOL, V122, P635, DOI 10.1083/jcb.122.3.635
   Huang KM, 1997, J CELL SCI, V110, P899
   Iannolo G, 1997, CANCER RES, V57, P240
   Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047
   James P, 1996, GENETICS, V144, P1425
   Kalchman MA, 1997, NAT GENET, V16, P44, DOI 10.1038/ng0597-44
   Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351
   KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x
   KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367
   Legendre-Guillemin V, 2002, J BIOL CHEM, V277, P19897, DOI 10.1074/jbc.M112310200
   LEMMON SK, 1990, GENETICS, V124, P27
   LEMMON SK, 1987, SCIENCE, V238, P504, DOI 10.1126/science.3116672
   Lila T, 1997, MOL BIOL CELL, V8, P367
   LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1
   Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521
   McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679
   MCCLARY JA, 1989, BIOTECHNIQUES, V7, P282
   McMahon HT, 1999, CURR BIOL, V9, pR332, DOI 10.1016/S0960-9822(99)80206-1
   McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0
   Metzler M, 2001, J BIOL CHEM, V276, P39271, DOI 10.1074/jbc.C100401200
   Mishra SK, 2001, J BIOL CHEM, V276, P46230, DOI 10.1074/jbc.M108177200
   MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381
   MULHOLLAND J, 1997, MOL BIOL CELL, V8, P1781
   MUNN AL, 1995, MOL BIOL CELL, V6, P1721
   Nelson KK, 1996, MOL BIOL CELL, V7, P245
   NELSON KK, 1993, MOL CELL BIOL, V13, P521, DOI 10.1128/MCB.13.1.521
   NOVICK P, 1985, CELL, V40, P405, DOI 10.1016/0092-8674(85)90154-0
   PAYNE GS, 1988, J CELL BIOL, V106, P1453, DOI 10.1083/jcb.106.5.1453
   Pishvaee B, 2000, NAT CELL BIOL, V2, P958, DOI 10.1038/35046619
   PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565
   PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732
   Pruyne D, 2000, J CELL SCI, V113, P365
   Pruyne D, 2000, J CELL SCI, V113, P571
   Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111
   Ramjaun AR, 1998, J NEUROCHEM, V70, P2369
   RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55
   Schaerer-Brodbeck C, 2000, MOL BIOL CELL, V11, P1113, DOI 10.1091/mbc.11.4.1113
   SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x
   SEEGER M, 1992, J CELL BIOL, V118, P531, DOI 10.1083/jcb.118.3.531
   Seki N, 1998, J HUM GENET, V43, P268, DOI 10.1007/s100380050087
   SIKORSKI RS, 1989, GENETICS, V122, P19
   SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452
   Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199
   Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q
   TAN PK, 1993, J CELL BIOL, V123, P1707, DOI 10.1083/jcb.123.6.1707
   Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000
   Tang HY, 1996, MOL CELL BIOL, V16, P4897
   Tang Q, 1997, BIOSPECTROSCOPY, V3, P17, DOI 10.1002/(SICI)1520-6343(1997)3:1<17::AID-BSPY2>3.3.CO;2-P
   Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907
   Tu JL, 1996, MOL CELL BIOL, V16, P4199
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2
   Venturi GM, 2000, GENETICS, V155, P69
   VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1
   Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C
   Waelter S, 2001, HUM MOL GENET, V10, P1807, DOI 10.1093/hmg/10.17.1807
   Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487
   Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71
   Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485
   Wendland B, 1999, EMBO J, V18, P4383, DOI 10.1093/emboj/18.16.4383
   Wesp A, 1997, MOL BIOL CELL, V8, P2291, DOI 10.1091/mbc.8.11.2291
   Yang S, 1997, J CELL BIOL, V136, P111, DOI 10.1083/jcb.136.1.111
   Yang S, 1999, MOL BIOL CELL, V10, P2265, DOI 10.1091/mbc.10.7.2265
   Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759
   Zeng GS, 1999, J CELL BIOL, V144, P71, DOI 10.1083/jcb.144.1.71
NR 109
TC 53
Z9 55
U1 0
U2 3
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD AUG
PY 2002
VL 13
IS 8
BP 2607
EP 2625
DI 10.1091/mbc.E02-01-0012
PG 19
WC Cell Biology
SC Cell Biology
GA 583PM
UT WOS:000177416300007
PM 12181333
OA Green Published
DA 2021-01-25
ER

PT J
AU Heese-Peck, A
   Pichler, H
   Zanolari, B
   Watanabe, R
   Daum, G
   Riezman, H
AF Heese-Peck, A
   Pichler, H
   Zanolari, B
   Watanabe, R
   Daum, G
   Riezman, H
TI Multiple functions of sterols in yeast endocytosis
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID GPI-ANCHORED PROTEINS; ALPHA-FACTOR RECEPTOR; VACUOLAR H+-ATPASE;
   SACCHAROMYCES-CEREVISIAE; INTERNALIZATION STEP; PLASMA-MEMBRANE; GOLGI
   TRANSPORT; CELL BIOLOGY; LIPID RAFTS; CHOLESTEROL
AB Sterols are essential factors for endocytosis in animals and yeast. To investigate the sterol structural requirements for yeast endocytosis, we created a variety of ergDelta mutants, each accumulating a distinct set of sterols different from ergosterol. Mutant erg2Deltaerg6Delta and erg3Deltaerg6Delta cells exhibit a strong internalization defect of the a-factor receptor (Ste2p). Specific sterol structures are necessary for pheromone-dependent receptor hyperphosphorylation, a prerequisite for internalization. The lack of phosphorylation is not due to a defect in Ste2p localization or in ligand-receptor interaction. Contrary to most known endocytic factors, sterols seem to function in internalization independently of actin. Furthermore, sterol structures are required at a postinternalization step of endocytosis. ergDelta cells were able to take up the membrane marker FM4-64, but exhibited defects in FM4-64 movement through endosomal compartments to the vacuole. Therefore, there are at least two roles for sterols in endocytosis. Based on sterol analysis, the sterol structural requirements for these two processes were different, suggesting that sterols may have distinct functions at different places in the endocytic pathway. Interestingly, sterol structures unable to support endocytosis allowed transport of the glycosylphosphatidylinositol-anchored protein Gas1p from the endoplasmic reticulum to Golgi compartment.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria.
RP Riezman, H (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM howard.riezman@unibas.ch
RI Pichler, Harald/B-5398-2013
OI Pichler, Harald/0000-0001-6043-2137; Riezman, Howard/0000-0003-4680-9422
CR Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697
   BARD M, 1977, LIPIDS, V12, P645, DOI 10.1007/BF02533759
   BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070
   BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506
   Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8
   Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111
   CHANG WJ, 1992, J CELL BIOL, V118, P63, DOI 10.1083/jcb.118.1.63
   Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0
   D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255
   Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y
   Deckert M, 1996, J CELL BIOL, V133, P791, DOI 10.1083/jcb.133.4.791
   DULIC V, 1991, METHOD ENZYMOL, V194, P697
   Feng Y, 2000, MOL CELL BIOL, V20, P5350, DOI 10.1128/MCB.20.14.5350-5359.2000
   Feng Y, 2000, MOL CELL BIOL, V20, P563, DOI 10.1128/MCB.20.2.563-574.2000
   Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834
   Geli MI, 1998, EMBO J, V17, P635, DOI 10.1093/emboj/17.3.635
   Geli MI, 1998, J CELL SCI, V111, P1031
   Grimmer S, 2000, MOL BIOL CELL, V11, P4205, DOI 10.1091/mbc.11.12.4205
   HEINIGER HJ, 1976, NATURE, V263, P515, DOI 10.1038/263515a0
   Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4
   Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349
   Hicke L, 1997, MOL BIOL CELL, V8, P13
   HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x
   JENNESS DD, 1983, CELL, V35, P521, DOI 10.1016/0092-8674(83)90186-1
   Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035
   KEESLER GA, 1992, ARCH BIOCHEM BIOPHYS, V296, P474, DOI 10.1016/0003-9861(92)90600-2
   KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922
   KONOPKA JB, 1988, CELL, V54, P609, DOI 10.1016/S0092-8674(88)80005-9
   KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x
   Lombardi R, 2001, J BIOL CHEM, V276, P6016, DOI 10.1074/jbc.M008735200
   Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   Munn AL, 1999, MOL BIOL CELL, V10, P3943, DOI 10.1091/mbc.10.11.3943
   MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373
   MUNN AL, 1995, MOL BIOL CELL, V6, P1721
   Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905
   PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199
   RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55
   RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1
   Riezman H, 1998, SEMIN CELL DEV BIOL, V9, P129, DOI 10.1006/scdb.1997.0217
   Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961
   ROTHMAN JH, 1989, J CELL BIOL, V109, P93, DOI 10.1083/jcb.109.1.93
   Schaerer-Brodbeck C, 2000, MOL BIOL CELL, V11, P1113, DOI 10.1091/mbc.11.4.1113
   Schmidt A, 1999, NATURE, V401, P133
   Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187
   Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721
   SMITH SJ, 1993, YEAST, V9, P1177, DOI 10.1002/yea.320091104
   Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775
   Sutterlin C, 1997, J CELL SCI, V110, P2703
   Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9
   TROCHA PJ, 1976, ARCH BIOCHEM BIOPHYS, V174, P45, DOI 10.1016/0003-9861(76)90322-2
   VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779
   Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C
   WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539
   Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397
   Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200
   Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824
NR 57
TC 124
Z9 126
U1 0
U2 14
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD AUG
PY 2002
VL 13
IS 8
BP 2664
EP 2680
DI 10.1091/mbc.E02-04-0186
PG 17
WC Cell Biology
SC Cell Biology
GA 583PM
UT WOS:000177416300011
PM 12181337
OA Green Published
DA 2021-01-25
ER

PT J
AU Sauvonnet, N
   Lambermont, I
   van der Bruggen, P
   Cornelis, GR
AF Sauvonnet, N
   Lambermont, I
   van der Bruggen, P
   Cornelis, GR
TI YopH prevents monocyte chemoattractant protein 1 expression in
   macrophages and T-cell proliferation through inactivation of the
   phosphatidylinositol 3-kinase pathway
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID FORKHEAD TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION PATHWAY;
   GLYCOGEN-SYNTHASE KINASE-3; KAPPA-B ACTIVATION; PHOSPHOINOSITIDE
   3-KINASE; YERSINIA-ENTEROCOLITICA; TYROSINE-PHOSPHATASE; TRANSLOCATORS
   YOPB; EFFECTOR PROTEIN; VIRULENCE FACTOR
AB Phosphatidylinositol 3-kinase (PI 3-kinase) and its target protein kinase B (Akt) are involved in various processes including internalization, chemotaxis and proliferation. We analysed the activation of Akt in J774 macrophages infected with virulent (pYV (+)) or avirulent (pYV(-)) Yersinia enterocolitica. During the early stage of infection with pYV(+) and pYV(-) bacteria, Akt and its targets, glycogen synthase kinase 3 (GSK-3) and forkhead transcription factor (FKHRL1), became phosphorylated. This phosphorylation induction was inhibited by wortmannin and thus dependent on PI 3-kinase. When infection was carried out with pYV(+) bacteria but not with pYV(-) bacteria, Akt and its targets became dephosphorylated at later time points. Using single knock-out mutants in bacterial effector genes, we have determined that the tyrosine phosphatase YopH was responsible for the inactivation of the PI 3-kinase cascade. In macrophages, this inactivation correlated with the downregulation of mRNA coding for monocyte chemoattractant protein 1 (MCP-1), suggesting that YopH inhibits recruitment of macrophages to lymph nodes. We also analysed the effects of Y. enterocolitica infection on the proliferation of T lymphocytes. Consistent with the observation that YopH inactivated the Akt pathway, YopH inhibited PI 3-kinase-dependent secretion of interleukin 2 and proliferation. These data reveal a new effect of YopH in Yersinia pathogenesis.
C1 Christian de Duve Inst Cellular Pathol, Microbial Pathogenesis Unit, Brussels, Belgium.
   Univ Catholique Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium.
   Univ Catholique Louvain, Cellular Genet Unit, B-1200 Brussels, Belgium.
   Univ Basel, Biozentrum, CH-8056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Christian de Duve Inst Cellular Pathol, Microbial Pathogenesis Unit, Brussels, Belgium.
CR Acuto O, 2000, ANNU REV IMMUNOL, V18, P165, DOI 10.1146/annurev.immunol.18.1.165
   Alberta JA, 1999, J BIOL CHEM, V274, P31062, DOI 10.1074/jbc.274.43.31062
   Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797
   Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x
   Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Celli J, 2001, EMBO J, V20, P1245, DOI 10.1093/emboj/20.6.1245
   Chaux P, 1999, J IMMUNOL, V163, P2928
   CHEN HC, 1994, P NATL ACAD SCI USA, V91, P10148, DOI 10.1073/pnas.91.21.10148
   Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998
   CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0
   Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905
   DEL PL, 1997, SCIENCE, V278, P687
   Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200
   Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000
   Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200
   Eder AM, 1998, J BIOL CHEM, V273, P28025, DOI 10.1074/jbc.273.43.28025
   FALLMAN M, 1995, INFECT IMMUN, V63, P3117
   GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994
   Gerszten RE, 2001, J BIOL CHEM, V276, P26846, DOI 10.1074/jbc.M011235200
   GROSDENT N, 2002, IN PRESS INFECT IMMU, V70
   GUAN KL, 1990, SCIENCE, V249, P553, DOI 10.1126/science.2166336
   Hamid N, 1999, MICROB PATHOGENESIS, V27, P231, DOI 10.1006/mpat.1999.0301
   Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997
   Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393
   Li EG, 2000, J BIOL CHEM, V275, P14729, DOI 10.1074/jbc.275.19.14729
   Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713
   MULLNER EW, 1997, MANUAL IMMUNOLOGICAL, V1, P407
   MULLNER EW, 1997, MANUAL IMMUNOLOGICAL, V1, P389
   Murao K, 2000, BIOCHEM BIOPH RES CO, V276, P791, DOI 10.1006/bbrc.2000.3497
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Ohteki T, 2000, J EXP MED, V192, P99, DOI 10.1084/jem.192.1.99
   Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920
   Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361
   Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Sarker MR, 1998, INFECT IMMUN, V66, P2976, DOI 10.1128/IAI.66.6.2976-2979.1998
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Schulte R, 1998, MED MICROBIOL IMMUN, V187, P53, DOI 10.1007/s004300050074
   Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x
   Sotsios Y, 2000, IMMUNOL REV, V177, P217, DOI 10.1034/j.1600-065X.2000.17712.x
   van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150
   Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343
   Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289
NR 52
TC 61
Z9 65
U1 0
U2 8
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD AUG
PY 2002
VL 45
IS 3
BP 805
EP 815
DI 10.1046/j.1365-2958.2002.03053.x
PG 11
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 577XF
UT WOS:000177087600020
PM 12139625
OA Bronze
DA 2021-01-25
ER

PT J
AU Roh, DH
   Bowers, B
   Riezman, H
   Cabib, E
AF Roh, DH
   Bowers, B
   Riezman, H
   Cabib, E
TI Rho1p mutations specific for regulation of beta(1 -> 3)glucan synthesis
   and the order of assembly of the yeast cell wall (vol 44, pg 1167, 2002)
SO MOLECULAR MICROBIOLOGY
LA English
DT Correction
C1 NIDDK, Lab Biochem & Genet, Bethesda, MD 20892 USA.
   NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cabib, E (corresponding author), NIDDK, Lab Biochem & Genet, Bldg 8,Room 403, Bethesda, MD 20892 USA.
EM enricoc@bdg10.niddk.nih.gov
CR Roh DH, 2002, MOL MICROBIOL, V44, P1167, DOI 10.1046/j.1365-2958.2002.02955.x
NR 1
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD AUG
PY 2002
VL 45
IS 4
BP 1175
EP 1175
DI 10.1046/j.1365-2958.2002.02927.x-i1
PG 1
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 585KJ
UT WOS:000177523700025
OA Bronze
DA 2021-01-25
ER

PT J
AU Giaever, G
   Chu, AM
   Ni, L
   Connelly, C
   Riles, L
   Veronneau, S
   Dow, S
   Lucau-Danila, A
   Anderson, K
   Andre, B
   Arkin, AP
   Astromoff, A
   El Bakkoury, M
   Bangham, R
   Benito, R
   Brachat, S
   Campanaro, S
   Curtiss, M
   Davis, K
   Deutschbauer, A
   Entian, KD
   Flaherty, P
   Foury, F
   Garfinkel, DJ
   Gerstein, M
   Gotte, D
   Guldener, U
   Hegemann, JH
   Hempel, S
   Herman, Z
   Jaramillo, DF
   Kelly, DE
   Kelly, SL
   Kotter, P
   LaBonte, D
   Lamb, DC
   Lan, N
   Liang, H
   Liao, H
   Liu, L
   Luo, CY
   Lussier, M
   Mao, R
   Menard, P
   Ooi, SL
   Revuelta, JL
   Roberts, CJ
   Rose, M
   Ross-Macdonald, P
   Scherens, B
   Schimmack, G
   Shafer, B
   Shoemaker, DD
   Sookhai-Mahadeo, S
   Storms, RK
   Strathern, JN
   Valle, G
   Voet, M
   Volckaert, G
   Wang, CY
   Ward, TR
   Wilhelmy, J
   Winzeler, EA
   Yang, YH
   Yen, G
   Youngman, E
   Yu, KX
   Bussey, H
   Boeke, JD
   Snyder, M
   Philippsen, P
   Davis, RW
   Johnston, M
AF Giaever, G
   Chu, AM
   Ni, L
   Connelly, C
   Riles, L
   Veronneau, S
   Dow, S
   Lucau-Danila, A
   Anderson, K
   Andre, B
   Arkin, AP
   Astromoff, A
   El Bakkoury, M
   Bangham, R
   Benito, R
   Brachat, S
   Campanaro, S
   Curtiss, M
   Davis, K
   Deutschbauer, A
   Entian, KD
   Flaherty, P
   Foury, F
   Garfinkel, DJ
   Gerstein, M
   Gotte, D
   Guldener, U
   Hegemann, JH
   Hempel, S
   Herman, Z
   Jaramillo, DF
   Kelly, DE
   Kelly, SL
   Kotter, P
   LaBonte, D
   Lamb, DC
   Lan, N
   Liang, H
   Liao, H
   Liu, L
   Luo, CY
   Lussier, M
   Mao, R
   Menard, P
   Ooi, SL
   Revuelta, JL
   Roberts, CJ
   Rose, M
   Ross-Macdonald, P
   Scherens, B
   Schimmack, G
   Shafer, B
   Shoemaker, DD
   Sookhai-Mahadeo, S
   Storms, RK
   Strathern, JN
   Valle, G
   Voet, M
   Volckaert, G
   Wang, CY
   Ward, TR
   Wilhelmy, J
   Winzeler, EA
   Yang, YH
   Yen, G
   Youngman, E
   Yu, KX
   Bussey, H
   Boeke, JD
   Snyder, M
   Philippsen, P
   Davis, RW
   Johnston, M
TI Functional profiling of the Saccharomyces cerevisiae genome
SO NATURE
LA English
DT Article
ID YEAST GENOME; EXPRESSION; DELETION; GENES
AB Determining the effect of gene deletion is a fundamental approach to understanding gene function. Conventional genetic screens exhibit biases, and genes contributing to a phenotype are often missed. We systematically constructed a nearly complete collection of gene-deletion mutants (96% of annotated open reading frames, or ORFs) of the yeast Saccharomyces cerevisiae. DNA sequences dubbed 'molecular bar codes' uniquely identify each strain, enabling their growth to be analysed in parallel and the fitness contribution of each gene to be quantitatively assessed by hybridization to high-density oligonucleotide arrays. We show that previously known and new genes are necessary for optimal growth under six well-studied conditions: high salt, sorbitol, galactose, pH 8, minimal medium and nystatin treatment. Less than 7% of genes that exhibit a significant increase in messenger RNA expression are also required for optimal growth in four of the tested conditions. Our results validate the yeast gene-deletion collection as a valuable resource for functional genomics.
C1 Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.
   Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.
   Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.
   Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.
   Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.
   Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.
   McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada.
   Rosetta Inpharmat Inc, Kirkland, WA 98034 USA.
   Catholic Univ Louvain, FYSA, B-1348 Louvain, Belgium.
   Free Univ Brussels, Lab Physiol Cellulaire, Gosselies, Belgium.
   Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Howard Hughes Med Inst, Berkeley, CA 94720 USA.
   Free Univ Brussels, IRMW, B-1070 Brussels, Belgium.
   Univ Salamanca, CSIC, Inst Microbiol & Bioquim, Dept Genet & Microbiol, E-37007 Salamanca, Spain.
   Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Padua, Dept Biol, I-35121 Padua, Italy.
   Goethe Univ Frankfurt, Inst Microbiol, EUROSCARF, D-60439 Frankfurt, Germany.
   Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.
   NCI, Ctr Canc Res, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA.
   Univ Dusseldorf, Inst Mikrobiol, D-40225 Dusseldorf, Germany.
   Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales.
   Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada.
   Katholieke Univ Leuven, Lab Gene Technol, B-3001 Heverlee, Belgium.
RP Davis, RW (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.
EM dbowe@cmgm.stanford.edu
RI Youngman, Elaine/O-7449-2019; Johnston, Mark/R-6156-2019; Campanaro,
   Stefano/I-5657-2019; Revuelta, Jose Luis/ABG-1502-2020; Arkin,
   Adam/M-9941-2019; Johnston, Mark/K-3543-2019; Entian,
   Karl-Dieter/D-3080-2011; Flaherty, Patrick/A-1720-2011; Winzeler,
   Elizabeth/AAP-6752-2020; Arkin, Adam P/A-6751-2008; Guldener,
   Ulrich/G-5227-2012; Storms, Reginald/B-2405-2013; Andre,
   Bruno/D-1725-2010; Revuelta, Jose L/C-2324-2012; BENITO,
   ROCIO/B-4271-2017
OI Revuelta, Jose Luis/0000-0001-7838-5308; Arkin,
   Adam/0000-0002-4999-2931; Johnston, Mark/0000-0002-4932-7229; Winzeler,
   Elizabeth/0000-0002-4049-2113; Arkin, Adam P/0000-0002-4999-2931;
   Guldener, Ulrich/0000-0001-5052-8610; Revuelta, Jose
   L/0000-0001-7838-5308; BENITO, ROCIO/0000-0001-9781-4198; VALLE,
   GIORGIO/0000-0003-4377-5685; Brachat, Sophie/0000-0002-3398-8225;
   Menard, Patrice/0000-0001-8844-3727; CAMPANARO,
   STEFANO/0000-0002-9431-1648; LUCAU-DANILA, Anca/0000-0002-9379-6241;
   Boeke, Jef/0000-0001-5322-4946
CR BENZER S, 1961, P NATL ACAD SCI USA, V47, P403, DOI 10.1073/pnas.47.3.403
   Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517
   GUTHRIE C, 1991, GUIDE YEAST GENETICS, P12
   Hamer L, 2001, P NATL ACAD SCI USA, V98, P5110, DOI 10.1073/pnas.091094198
   HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4
   Jones E., 1982, MOL BIOL YEAST SACCH, P181
   Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859
   Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37
   Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147
   Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1
   Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074
   Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2
   Ross-Macdonald P, 1999, NATURE, V402, P413
   Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939
   SHERMAN F, 1986, METHODS YEAST GENETI, P145
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   WACH A, 1996, EUROFAN
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200
   Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423
NR 22
TC 2837
Z9 3992
U1 9
U2 289
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUL 25
PY 2002
VL 418
IS 6896
BP 387
EP 391
DI 10.1038/nature00935
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 576MU
UT WOS:000177009700029
PM 12140549
DA 2021-01-25
ER

PT J
AU Feng, K
   Zhou, XH
   Oohashi, T
   Morgelin, M
   Lustig, A
   Hirakawa, S
   Ninomiya, Y
   Engel, J
   Rauch, U
   Fassler, R
AF Feng, K
   Zhou, XH
   Oohashi, T
   Morgelin, M
   Lustig, A
   Hirakawa, S
   Ninomiya, Y
   Engel, J
   Rauch, U
   Fassler, R
TI All four members of the Ten-m/Odz family of transmembrane proteins form
   dimers
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PAIR-RULE GENE; COLLAGEN-VI; ODD OZ; EXPRESSION; TISSUES; TENASCIN;
   HOMOLOGS; LAMININ; BINDING; VIRUS
AB Ten-m/Odz/teneurins are a new family of four distinct type II transmembrane molecules. Their extracellular domains are composed of an array of eight consecutive EGF modules followed by a large globular domain. Two of the eight modules contain only 5 instead of the typical 6 cysteine residues and have the capability to dimerize in a covalent, disulfide-linked fashion. The structural properties of the extracellular domains of all four mouse Ten-m proteins have been analyzed using secreted, recombinant molecules produced by mammalian HEK-293 cells. Electron microscopic analysis supported by analytical ultracentrifugation data revealed that the recombinant extracellular domains of all Ten-m proteins formed homodimers. SDS-PAGE analysis under non-reducing conditions as well as negative staining after partial denaturation of the molecules indicated that the globular COOH-terminal domains of Ten-m1 and -m4 contained subdomains with a pronounced stability against denaturing agents, especially when compared with the homologous domains of Ten-m2 and -m3. Co-transfection experiments of mammalian cells with two different extracellular domains revealed that Ten-m molecules have also the ability to form heterodimers, a property that, combined with alternative splicing events, allows the formation of a multitude of molecules with different characteristics from a limited set of genes.
C1 Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   Lund Univ, Sect Connect Tissue Biol, Dept Expt Pathol, S-22185 Lund, Sweden.
   Lund Univ, Sect Connect Tissue Biol, Dept Cell & Mol Biol, S-22185 Lund, Sweden.
   Okayama Univ, Sch Med, Dept Mol Biol & Biochem, Okayama 700, Japan.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Fassler, R (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.
RI Oohashi, Toshitaka/B-1599-2011
CR BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8
   BAUMGARTNER S, 1994, EMBO J, V13, P3728, DOI 10.1002/j.1460-2075.1994.tb06682.x
   Ben-Zur T, 2000, DEV BIOL, V217, P107, DOI 10.1006/dbio.1999.9532
   Brandau O, 1999, HUM MOL GENET, V8, P2407, DOI 10.1093/hmg/8.13.2407
   ENGEL J, 1987, METHOD ENZYMOL, V145, P3
   JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972
   KISHIRO Y, 1995, CELL STRUCT FUNCT, V20, P151, DOI 10.1247/csf.20.151
   Kohfeldt E, 1996, EUR J BIOCHEM, V238, P333, DOI 10.1111/j.1432-1033.1996.0333z.x
   LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8
   Levine A, 1997, DEV DYNAM, V209, P1, DOI 10.1002/(SICI)1097-0177(199705)209:1<1::AID-AJA1>3.0.CO;2-M
   MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x
   Mieda M, 1999, MECH DEVELOP, V87, P223, DOI 10.1016/S0925-4773(99)00155-0
   Minet AD, 1999, J CELL SCI, V112, P2019
   Minet AD, 2000, GENE, V257, P87, DOI 10.1016/S0378-1119(00)00388-7
   Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563
   Otaki JM, 1999, DEV BIOL, V212, P165, DOI 10.1006/dbio.1999.9310
   RALSON G, 1993, INTRO ANAL ULTRACENT
   Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503
   Tucker RP, 2000, MECH DEVELOP, V98, P187, DOI 10.1016/S0925-4773(00)00444-5
   Tucker RP, 2001, DEV DYNAM, V220, P27, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1084>3.0.CO;2-B
   Van Holde K., 1971, PHYSICAL BIOCH, P98
   Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619
   WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0
   Zhang Y, 2000, J BIOL CHEM, V275, P32628, DOI 10.1074/jbc.M002594200
NR 24
TC 63
Z9 70
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 19
PY 2002
VL 277
IS 29
BP 26128
EP 26135
DI 10.1074/jbc.M203722200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 574UV
UT WOS:000176908700040
PM 12000766
OA Bronze
DA 2021-01-25
ER

PT J
AU Muller, DJ
   Hand, GM
   Engel, A
   Sosinsky, GE
AF Muller, DJ
   Hand, GM
   Engel, A
   Sosinsky, GE
TI Conformational changes in surface structures of isolated connexin 26 gap
   junctions
SO EMBO JOURNAL
LA English
DT Article
DE calcium; connexon; intercellular communication; ion channel structure;
   membrane protein structure
ID ATOMIC-FORCE MICROSCOPY; 3-DIMENSIONAL STRUCTURE; MEMBRANE; CALCIUM;
   RESOLUTION; PERMEABILITY; BIOMOLECULES; HEMICHANNELS; ELECTRON
AB Gap junction channels mediate communication between adjacent cells. Using atomic force microscopy (AFM), we have imaged conformational changes of the cytoplasmic and extracellular surfaces of native connexin 26 gap junction plaques. The cytoplasmic domains of the gap junction surface, imaged at submolecular resolution, form a hexameric pore protruding from the membrane bilayer. Exhibiting an intrinsic flexibility, these cytoplasmic domains, comprising the C-terminal connexin end, reversibly collapse by increasing the forces applied to the AFM stylus. The extracellular connexon surface was imaged after dissection of the gap junction with the AFM stylus. Upon injection of Ca2+ into the buffer solution, the extracellular channel entrance reduced its diameter from 1.5 to 0.6 nm, a conformational change that is fully reversible and specific among the divalent cations tested. Ca2+ had a profound effect on the cytoplasmic surface also, inducing the formation of microdomains. Consequently, the plaque height increased by 0.6 nm to 18 nm. This suggests that calcium ions induce conformational changes affecting the structure of both the hemichannels and the intact channels forming cell-cell contacts.
C1 Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.
   Tech Univ Dresden, BIOTEC, D-8027 Dresden, Germany.
   Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Dept Neurosci, La Jolla, CA 92093 USA.
   Univ Calif San Diego, San diego Supercomp Ctr, La Jolla, CA 92093 USA.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Muller, DJ (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.
EM mueller@mpi-cbg.de; gsosinsky@ucsd.edu
RI Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665
FU NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050,
   P41RR004050, P41RR004050, P41RR004050, P41RR004050, P41RR004050] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM065937, R01GM065937, R01GM065937,
   R01GM065937, R01GM065937, R01GM065937, R01GM065937, R01GM065937,
   R01GM065937, R01GM065937, R01GM065937, R01GM065937, R01GM065937,
   R01GM065937] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR) [P41 RR004050,
   RR04050] Funding Source: Medline; NIGMS NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01 GM065937]
   Funding Source: Medline
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497
   Czajkowsky DM, 1998, FEBS LETT, V430, P51, DOI 10.1016/S0014-5793(98)00461-X
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   Delmar M, 2000, CURR TOP MEMBR, V49, P223
   DEMELLO WC, 1975, J PHYSIOL-LONDON, V250, P231, DOI 10.1113/jphysiol.1975.sp011051
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Engel A, 1997, CURR OPIN STRUC BIOL, V7, P279, DOI 10.1016/S0959-440X(97)80037-1
   Engel A, 1999, TRENDS CELL BIOL, V9, P77, DOI 10.1016/S0962-8924(98)01415-9
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Fotiadis D, 1998, J MOL BIOL, V283, P83, DOI 10.1006/jmbi.1998.2097
   FRANK J, 1988, J MICROSC-OXFORD, V150, P99, DOI 10.1111/j.1365-2818.1988.tb04602.x
   FRANK J, 1981, SCIENCE, V214, P1353, DOI 10.1126/science.7313694
   GHOSHROY S, 1995, J MEMBRANE BIOL, V146, P15
   Hand GM, 2002, J MOL BIOL, V315, P587, DOI 10.1006/jmbi.2001.5262
   HOH JH, 1993, BIOPHYS J, V65, P149, DOI 10.1016/S0006-3495(93)81074-9
   HOH JH, 1991, SCIENCE, V253, P1405, DOI 10.1126/science.1910206
   Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101
   LAL R, 1995, AM J PHYSIOL-CELL PH, V268, pC968
   Lal R, 2001, MICROSC RES TECHNIQ, V52, P273, DOI 10.1002/1097-0029(20010201)52:3<273::AID-JEMT1013>3.0.CO;2-M
   LAZRAK A, 1993, BIOPHYS J, V65, P2002, DOI 10.1016/S0006-3495(93)81242-6
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019
   LOEWENST.WR, 1966, ANN NY ACAD SCI, V137, P441, DOI 10.1111/j.1749-6632.1966.tb50175.x
   LOEWENSTEIN WR, 1967, J GEN PHYSIOL, V50, P1865, DOI 10.1085/jgp.50.7.1865
   MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629
   Moller C, 2000, J MOL BIOL, V301, P869, DOI 10.1006/jmbi.2000.3995
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292
   Muller DJ, 1999, J MOL BIOL, V285, P1903, DOI 10.1006/jmbi.1998.2441
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Muller DJ, 1998, FEBS LETT, V430, P105, DOI 10.1016/S0014-5793(98)00623-1
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   OLIVEIRACASTRO GM, 1971, J MEMBRANE BIOL, V5, P51, DOI 10.1007/BF01870825
   PERACCHIA C, 1978, NATURE, V271, P669, DOI 10.1038/271669a0
   PERACCHIA C, 1994, MEMBRANE CHANNELS MO, P361
   Perkins G, 1997, BIOPHYS J, V72, P533, DOI 10.1016/S0006-3495(97)78693-4
   Perkins GA, 1998, J MOL BIOL, V277, P171, DOI 10.1006/jmbi.1997.1580
   Pfahnl A, 1999, PFLUG ARCH EUR J PHY, V437, P345, DOI 10.1007/s004240050788
   PUTMAN CAJ, 1992, SPIE, V1639, P198
   Rottingen JA, 2000, ACTA PHYSIOL SCAND, V169, P203
   SAXTON WO, 1984, ULTRAMICROSCOPY, V13, P57, DOI 10.1016/0304-3991(84)90057-3
   SAXTON WO, 1992, ULTRAMICROSCOPY, V46, P287, DOI 10.1016/0304-3991(92)90020-K
   SAXTON WO, 1979, ULTRAMICROSCOPY, V4, P343, DOI 10.1016/S0304-3991(79)80044-3
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   SCHABERT FA, 1994, BIOPHYS J, V67, P2394, DOI 10.1016/S0006-3495(94)80726-X
   SCHWARZ UD, 1994, J MICROSC-OXFORD, V173, P183, DOI 10.1111/j.1365-2818.1994.tb03441.x
   SOSINSKY GE, 1992, ELECTRON MICROSC REV, V5, P59, DOI 10.1016/0892-0354(92)90005-B
   SOSINSKY GE, 1988, BIOPHYS J, V53, P709, DOI 10.1016/S0006-3495(88)83152-7
   Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836
   Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176
   UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7
   UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0
   UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0
   UNWIN PNT, 1983, J CELL BIOL, V97, P1459, DOI 10.1083/jcb.97.5.1459
   Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076
   Yeager M, 1998, J STRUCT BIOL, V121, P231, DOI 10.1006/jsbi.1998.3972
   ZHANG JT, 1994, J MEMBRANE BIOL, V139, P15
NR 63
TC 193
Z9 205
U1 2
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JUL 15
PY 2002
VL 21
IS 14
BP 3598
EP 3607
DI 10.1093/emboj/cdf365
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 572PT
UT WOS:000176784700005
PM 12110573
OA Green Published
DA 2021-01-25
ER

PT J
AU Sauvonnet, N
   Pradet-Balade, B
   Garcia-Sanz, JA
   Cornelis, GR
AF Sauvonnet, N
   Pradet-Balade, B
   Garcia-Sanz, JA
   Cornelis, GR
TI Regulation of mRNA expression in macrophages after Yersinia
   enterocolitica infection - Role of different Yop effectors
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID INITIATION-FACTOR 2B; GENE-EXPRESSION; PHOSPHOINOSITIDE 3-KINASE;
   PLASMINOGEN-ACTIVATOR; EPITHELIAL-CELLS; UP-REGULATION; MAP KINASE;
   PROTEIN; VIRULENCE; APOPTOSIS
AB The Yop virulon, which comprises a complete type III secretion system and secreted proteins, allows bacteria from the genus Yersinia to resist the nonspecific immune response of the host. This virulon, which is encoded by a plasmid called pYV in Yersinia enterocolitica, enables extracellular bacteria to inject six Yop effectors (YopE, -H, -T, -O, -P, -M) into the host cell. To investigate the role of YopP, YopM, and the other pYV-encoded factors on the expression of the host cell genes, we characterized the transcriptome alterations in infected mouse macrophages using the microarray technique. PU5-1.8 macrophages were infected either with an avirulent (pYV(-)), a wild type (pYV(+)), or two knockout (yopP(-) and yopM(-)) mutants of Y. enterocolitica. Expression alterations in response to Y. enterocolitica infection were monitored for 6657 genes. Among those, 857 genes were affected, 339 of which were specifically regulated by the action of the Yop virulon. Further analysis of those 339 genes allowed identification of specific targets of YopP, YopM, or the other pYV-encoded factors. According to these results, the main action of the Yop virulon is to counteract the host cell pro-inflammatory response to the infection. YopP participates to this inhibition, whereas another pYV-encoded factor appears to also be involved in this down-regulation. Besides, YopM was found to induce the regulation of genes involved in cell cycle and cell growth, revealing for the first time an in vitro effect for YopM. In addition to YopM, other pYV factors distinct from YopP affected the expression of genes involved in cycling. In conclusion, these results provide new insight into the mechanisms of Yersinia pathogenicity by identifying the changes in host genes expression after infection and highlight the concerted actions of the different Yop effectors.
C1 Christian de Duve Inst Cellular Biol, Microbial Pathogenesis Unit, B-1200 Brussels, Belgium.
   Catholic Univ Louvain, B-1200 Brussels, Belgium.
   Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Inst Pasteur, Unite Biol Interact Cellulaires, F-75015 Paris, France.
EM guy.cornelis@unibas.ch
RI Garcia-Sanz, Jose A./AAA-2956-2019; Garcia-Sanz, Jose A/E-7684-2011
OI Garcia-Sanz, Jose A./0000-0002-1153-6025; Garcia-Sanz, Jose
   A/0000-0002-1153-6025
CR Alberta JA, 1999, J BIOL CHEM, V274, P31062, DOI 10.1074/jbc.274.43.31062
   Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059
   Belcher CE, 2000, P NATL ACAD SCI USA, V97, P13847, DOI 10.1073/pnas.230262797
   Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200
   Bies J, 1996, ONCOGENE, V12, P355
   Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695
   Cohen P, 2000, J BIOL CHEM, V275, P11181, DOI 10.1074/jbc.275.15.11181
   Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998
   Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200
   Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0
   Dube PH, 2001, P NATL ACAD SCI USA, V98, P10880, DOI 10.1073/pnas.191214498
   Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200
   Dunn SE, 2001, CANCER RES, V61, P1367
   Eckmann L, 2000, J BIOL CHEM, V275, P14084, DOI 10.1074/jbc.275.19.14084
   Gale M, 1998, MOL CELL BIOL, V18, P859, DOI 10.1128/MCB.18.2.859
   Gaudry CA, 2001, J BIOL CHEM, V276, P24871, DOI 10.1074/jbc.M102731200
   GRAHAM IL, 1989, J IMMUNOL, V142, P2352
   GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263
   Grigoryev S, 1996, J BIOL CHEM, V271, P28521, DOI 10.1074/jbc.271.45.28521
   HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   Horikawa I, 2001, J CELL BIOCHEM, V82, P415, DOI 10.1002/jcb.1169
   Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993
   Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108
   Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393
   Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9
   Lefai E, 2001, BIOCHEM J, V360, P117, DOI 10.1042/0264-6021:3600117
   LEUNG KY, 1990, INFECT IMMUN, V58, P3262, DOI 10.1128/IAI.58.10.3262-3271.1990
   Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401
   Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   MULLNER EW, 1997, IMMUNOLOGY METHODS M, V1, P389
   MULLNER EW, 1997, IMMUNOLOGY METHODS M, V1, P407
   Niinobu T, 2000, AM J PHYSIOL-CELL PH, V279, pC504
   Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920
   Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239
   Panetta R, 1999, BIOCHEM BIOPH RES CO, V259, P550, DOI 10.1006/bbrc.1999.0817
   Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002
   Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307
   Quevedo C, 2000, J BIOL CHEM, V275, P19192, DOI 10.1074/jbc.M000238200
   Ridgway P, 2000, J CELL SCI, V113, P2647
   Ruckdeschel K, 2001, J IMMUNOL, V166, P1823, DOI 10.4049/jimmunol.166.3.1823
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Seipel K, 1999, J CELL SCI, V112, P1825
   Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315
   Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x
   Subrahmanyam YVBK, 2001, BLOOD, V97, P2457, DOI 10.1182/blood.V97.8.2457
   Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343
   Yao X, 1999, P NATL ACAD SCI USA, V96, P6850, DOI 10.1073/pnas.96.12.6850
   Zavizion B, 1997, J INFECT DIS, V176, P1637, DOI 10.1086/517345
   Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289
NR 56
TC 53
Z9 57
U1 0
U2 9
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 12
PY 2002
VL 277
IS 28
BP 25133
EP 25142
DI 10.1074/jbc.M203239200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 571YP
UT WOS:000176747000039
PM 12006597
OA Other Gold
DA 2021-01-25
ER

PT J
AU Egger, B
   Leemans, R
   Loop, T
   Kammermeier, L
   Fan, Y
   Radimerski, T
   Strahm, MC
   Certa, U
   Reichert, H
AF Egger, B
   Leemans, R
   Loop, T
   Kammermeier, L
   Fan, Y
   Radimerski, T
   Strahm, MC
   Certa, U
   Reichert, H
TI Gliogenesis in Drosophila: genome-wide analysis of downstream genes of
   glial cells missing in the embryonic nervous system
SO DEVELOPMENT
LA English
DT Article
DE glial cells missing; glial cell; nervous system; oligonucleotide
   microarray; gene expression; Drosophila
ID ZINC-FINGER PROTEIN; PAIR-RULE GENE; TRANSCRIPTION FACTORS; NEURONAL
   LINEAGE; MIDLINE GLIA; STEM-CELLS; EXPRESSION; MELANOGASTER; CNS; FATE
AB In Drosophila, the glial cells missing (gcm) gene encodes a transcription factor that controls the determination of glial versus neuronal fate. In gcm mutants, presumptive glial cells are transformed into neurons and, conversely, when gcm is ectopically misexpressed, presumptive neurons become glia. Although gcm is thought to initiate glial cell development through its action on downstream genes that execute the glial differentiation program, little is known about the identity of these genes. To identify gcm downstream genes in a comprehensive manner, we used genome-wide oligonucleotide arrays to analyze differential gene expression in wild-type embryos versus embryos in which gcm is misexpressed throughout the neuroectoderm. Transcripts were analyzed at two defined temporal windows during embryogenesis. During the first period of initial gcm action on determination of glial cell precursors, over 400 genes were differentially regulated. Among these are numerous genes that encode other transcription factors, which underscores the master regulatory role of gcm in gliogenesis. During a second later period, when glial cells had already differentiated, over 1200 genes were differentially regulated. Most of these genes, including many genes for chromatin remodeling factors and cell cycle regulators, were not differentially expressed at the early stage, indicating that the genetic control of glial fate determination is largely different from that involved in maintenance of differentiated cells. At both stages, glial-specific genes were upregulated and neuron-specific genes were downregulated, supporting a model whereby gcm promotes glial development by activating glial genes, while simultaneously repressing neuronal genes. In addition, at both stages, numerous genes that were not previously known to be involved in glial development were differentially regulated and, thus, identified as potential new downstream targets of gcm. For a subset of the differentially regulated genes, tissue-specific in vivo expression data were obtained that confirmed the transcript profiling results. This first genome-wide analysis of gene expression events downstream of a key developmental transcription factor presents a novel level of insight into the repertoire of genes that initiate and maintain cell fate choices in CNS development.
C1 Univ Basel, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
   F Hoffmann La Roche & Co Ltd, Roche Bioinformat, CH-4070 Basel, Switzerland.
   F Hoffmann La Roche & Co Ltd, Genet Pharmaceut Div, CH-4070 Basel, Switzerland.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
RI Egger, Boris/N-3493-2019; Egger, Boris/B-7227-2012
OI Egger, Boris/0000-0001-8551-9140; Egger, Boris/0000-0001-8551-9140
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912
   Akiyama-Oda Y, 2000, DEV BIOL, V222, P429, DOI 10.1006/dbio.2000.9727
   Akiyama-Oda Y, 1998, DEV GENES EVOL, V208, P578, DOI 10.1007/s004270050217
   Akiyama-Oda Y, 1999, DEVELOPMENT, V126, P1967
   ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123
   Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45
   BAUMGARTNER S, 1994, EMBO J, V13, P3728, DOI 10.1002/j.1460-2075.1994.tb06682.x
   Bernardoni R, 1998, DEVELOPMENT, V125, P3189
   Bernardoni R, 1997, DEV BIOL, V191, P118
   Bernardoni R, 1999, DEV BIOL, V216, P265, DOI 10.1006/dbio.1999.9511
   Bhat KM, 2000, DEVELOPMENT, V127, P655
   Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122
   BOUROUIS M, 1989, NATURE, V341, P442, DOI 10.1038/341442a0
   CAMPBELL G, 1994, DEVELOPMENT, V120, P2957
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   CONDRON BG, 1994, NEURON, V13, P541, DOI 10.1016/0896-6273(94)90024-8
   Connell-Crowley L, 2000, CURR BIOL, V10, P599, DOI 10.1016/S0960-9822(00)00487-5
   Cubadda Y, 1997, GENE DEV, V11, P3083, DOI 10.1101/gad.11.22.3083
   DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008
   DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731
   Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3
   Follette PJ, 1997, CURR OPIN GENET DEV, V7, P17, DOI 10.1016/S0959-437X(97)80104-9
   Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039
   FRANK DJ, 1995, J BIOL CHEM, V270, P6292, DOI 10.1074/jbc.270.11.6292
   Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Giesen K, 1997, DEVELOPMENT, V124, P2307
   Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2
   HACKER U, 1992, P NATL ACAD SCI USA, V89, P8754, DOI 10.1073/pnas.89.18.8754
   Hahn M, 1996, EMBO J, V15, P3077, DOI 10.1002/j.1460-2075.1996.tb00670.x
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   Hojo M, 2000, DEVELOPMENT, V127, P2515
   HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3
   ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499
   Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9
   JENNINGS B, 1994, DEVELOPMENT, V120, P3537
   JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5
   Jones BW, 2001, BIOESSAYS, V23, P877, DOI 10.1002/bies.1129
   Kammermeier L, 2001, MECH DEVELOP, V103, P71, DOI 10.1016/S0925-4773(01)00328-8
   KANIA A, 1993, NEURON, V11, P673, DOI 10.1016/0896-6273(93)90078-6
   Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598
   KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9
   KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212
   KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9
   Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146
   Lee KS, 1997, MOL CELLS, V7, P374
   LEEMANS R, 2002, GENOME BIOL, V2
   LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8
   LIAMAZARES S, 1991, GENE DEV, V5, P2153
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   Long AR, 1998, MECH DEVELOP, V76, P33, DOI 10.1016/S0925-4773(98)00110-5
   LUNDELL MJ, 1992, DEV BIOL, V154, P84, DOI 10.1016/0012-1606(92)90050-Q
   Malatesta P, 2000, DEVELOPMENT, V127, P5253
   MONTALTAHE H, 2002, GENOME BIOL, V3
   NG SC, 1989, DEVELOPMENT, V105, P629
   Noordermeer JN, 1998, NEURON, V21, P991, DOI 10.1016/S0896-6273(00)80618-2
   Ohno K, 1998, GENE, V217, P177, DOI 10.1016/S0378-1119(98)00358-8
   Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6
   Oishi I, 1997, J BIOL CHEM, V272, P11916, DOI 10.1074/jbc.272.18.11916
   PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056
   Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4
   Prokopenko SN, 2000, GENETICS, V156, P1691
   Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6
   ROARK M, 1995, GENE DEV, V9, P2384, DOI 10.1101/gad.9.19.2384
   Sanchez-Soriano N, 2000, DEV BIOL, V220, P307, DOI 10.1006/dbio.2000.9648
   Schmidt JG, 1997, J NEUROL REHABIL, V11, P189
   Scholz H, 1997, MECH DEVELOP, V64, P137
   SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P625
   Shishido E, 1997, DEVELOPMENT, V124, P2119
   Soriano NS, 1998, DEVELOPMENT, V125, P3989
   Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   THERIANOS S, 1995, DEVELOPMENT, V121, P3849
   Vincent S, 1996, DEVELOPMENT, V122, P131
   Wech I, 1999, DEV GENES EVOL, V209, P370, DOI 10.1007/s004270050266
   Wegner M, 2001, TRENDS GENET, V17, P286, DOI 10.1016/S0168-9525(01)02275-2
   Zilian O, 1999, DEVELOPMENT, V126, P5409
NR 78
TC 65
Z9 67
U1 0
U2 2
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD JUL
PY 2002
VL 129
IS 14
BP 3295
EP 3309
AR UNSP DEV2836
PG 15
WC Developmental Biology
SC Developmental Biology
GA 581ZP
UT WOS:000177325500002
PM 12091301
DA 2021-01-25
ER

PT J
AU Rolink, AG
   Tschopp, J
   Schneider, P
   Melchers, F
AF Rolink, AG
   Tschopp, J
   Schneider, P
   Melchers, F
TI BAFF is a survival and maturation factor for mouse B cells
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE BAFF; immature B cell; mature B cells; maturation; survival
ID NECROSIS-FACTOR FAMILY; HEAT-STABLE ANTIGEN(HI); AUTOIMMUNE-DISEASE; TNF
   RECEPTOR; LYMPHOCYTE-B; A/WYSNJ MICE; BONE-MARROW; TACI; MEMBER; BLYS
AB Human B cell-activating factor (BAFF) induces mouse surface IgM(+) B cells of the immature type from bone marrow and of them immature types 1 and 2 from spleen, as well as of the mature type from spleen to increased longevity in tissue culture. BAFF does so polyclonally and without inducing proliferation in any of these B cell subpopulations. BAFF induces phenotypic and functional maturation of immature to mature B cells so that all immature cells loose C1qRp (AA4.1, 493) expression and type 1 immature cells up-regulate IgD, CD21 and CD23. Immature B cells of types 1 and 2, upon pre-incubation with BAFF, change their reactiveness to Ig-specific antibodies so that they no longer enter apoptosis but now proliferate. However, BAFF does not seem to overcome negative selection of developing immature B cells in vitro.
C1 Univ Basel, Dept Immunol, Basel, Switzerland.
   Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland.
   Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
RP Rolink, AG (corresponding author), Univ Basel, Dept Immunol, Basel, Switzerland.
EM Antonius.Rolink@unibas.ch
OI Schneider, Pascal/0000-0003-0677-9409
CR Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834
   ALLMAN DM, 1992, J IMMUNOL, V149, P2533
   ALLMAN DM, 1993, J IMMUNOL, V151, P4431
   Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453
   ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0
   FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781
   GRAS MP, 1995, INT IMMUNOL, V7, P1093, DOI 10.1093/intimm/7.7.1093
   Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115
   Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2
   Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697
   King LB, 2000, IMMUNOL REV, V176, P86
   Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6
   Lentz VM, 1996, J IMMUNOL, V157, P598
   Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75
   Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697
   Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2
   MELCHERS F, 1998, FUNDAMENTAL IMMUNOLO, P183
   MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506
   MILLER DJ, 1992, EUR J IMMUNOL, V22, P373, DOI 10.1002/eji.1830220213
   Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260
   Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978
   NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0
   Neuberger MS, 1997, CELL, V90, P971, DOI 10.1016/S0092-8674(00)80362-1
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   Norsworthy PJ, 1999, MAMM GENOME, V10, P789, DOI 10.1007/s003359901093
   Petrenko O, 1999, IMMUNITY, V10, P691, DOI 10.1016/S1074-7613(00)80068-0
   Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23
   Rolink AG, 2001, CURR OPIN IMMUNOL, V13, P202, DOI 10.1016/S0952-7915(00)00205-3
   Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q
   Rolink AG, 1999, IMMUNITY, V10, P619, DOI 10.1016/S1074-7613(00)80061-8
   Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964
   Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747
   Schneider P, 2001, J EXP MED, V194, P1691, DOI 10.1084/jem.194.11.1691
   Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497
   Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680
   SPRENT J, 1993, CURR OPIN IMMUNOL, V5, P433, DOI 10.1016/0952-7915(93)90065-Z
   Thomas-Vaslin V, 1989, Int Immunol, V1, P237, DOI 10.1093/intimm/1.3.237
   Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129
   Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965
   von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3
   Wang H, 2001, NAT IMMUNOL, V2, P632, DOI 10.1038/89782
   Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200
   Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137
   Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001
   Yan MH, 2000, NAT IMMUNOL, V1, P37
NR 45
TC 161
Z9 174
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD JUL
PY 2002
VL 32
IS 7
BP 2004
EP 2010
DI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5
PG 7
WC Immunology
SC Immunology
GA 573WL
UT WOS:000176855000023
PM 12115621
OA Bronze
DA 2021-01-25
ER

PT J
AU Denecker, G
   Totemeyer, S
   Mota, LJ
   Troisfontaines, P
   Lambermont, I
   Youta, C
   Stainier, I
   Ackermann, M
   Cornelis, GR
AF Denecker, G
   Totemeyer, S
   Mota, LJ
   Troisfontaines, P
   Lambermont, I
   Youta, C
   Stainier, I
   Ackermann, M
   Cornelis, GR
TI Effect of low- and high-virulence Yersinia enterocolitica strains on the
   inflammatory response of human umbilical vein endothelial cells
SO INFECTION AND IMMUNITY
LA English
DT Article
ID NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; HIGH-PATHOGENICITY ISLAND;
   OUTER-MEMBRANE PROTEINS; III SECRETION; INDUCED APOPTOSIS; EUKARYOTIC
   CELLS; DOWN-REGULATION; SUICIDE VECTOR; YOP VIRULON
AB Pathogenic strains of Yersinia spp. inject a set of Yop effector proteins into eukaryotic cells by using a plasmid-encoded type III secretion system. In this study, we analyzed the inflammatory response of human umbilical vein endothelial cells (HUVECs) after infection with different Yersinia enterocolitica strains. We found that both expression of intercellular adhesion molecule I and release of the cytokines interleukin-6 (IL-6) and IL-8 by HUVECs are downregulated in a YopP-dependent way, demonstrating that YopP plays a major role in the inflammatory response of these cells. Infection of HUVECs with several low-virulence (biotype 2, 3, and 4) and high-virulence (biotype 1B) Y. enterocolitica strains showed that biotype III isolates are more efficient in inhibiting the inflammatory response than low-virulence Y. enterocolitica strains and that this effect depends on the time of contact. We extended the results of Ruckdeschel et al. and found that on the basis of the presence or absence of arginine-143 of YopP (K. Ruckdeschel, K. Richter, O. Mannel, and J. Heesemann, Infect. Immun. 69:7652-7662, 2001) all the Y. enterocolitica strains used fell into two groups, which correlate with the low- and high-virulence phenotypes. In addition, we found that high-virulence strains inject more YopP into the cytosol of eukaryotic target cells than do low-virulence strains.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Catholique Louvain, Christian Duve Inst Cellular & Mol Pathol, B-1200 Brussels, Belgium.
   Univ Catholique Louvain, Fac Med, B-1200 Brussels, Belgium.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Denecker, Geertrui/E-8134-2010; Mota, Luis J/B-9497-2008; Ackermann,
   Martin/V-4554-2017; Totemeyer, Sabine/H-1188-2011
OI Mota, Luis J/0000-0002-5592-8397; Ackermann, Martin/0000-0003-0087-4819;
   Totemeyer, Sabine/0000-0001-9781-2475; Denecker,
   Geertrui/0000-0002-2515-2911
CR Autenrieth IB, 1996, J MED MICROBIOL, V44, P285, DOI 10.1099/00222615-44-4-285
   Bach S, 1999, INFECT IMMUN, V67, P5091, DOI 10.1128/IAI.67.10.5091-5099.1999
   BEUSCHER HU, 1995, INFECT IMMUN, V63, P1270, DOI 10.1128/IAI.63.4.1270-1277.1995
   Bliska JB, 2000, TRENDS MICROBIOL, V8, P205, DOI 10.1016/S0966-842X(00)01738-8
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 2000, PHILOS T ROY SOC B, V355, P681, DOI 10.1098/rstb.2000.0608
   Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Cornelis GR, 2001, NAT MED, V7, P21, DOI 10.1038/83298
   Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x
   DELOR I, 1990, INFECT IMMUN, V58, P2983, DOI 10.1128/IAI.58.9.2983-2988.1990
   Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200
   FOULTIER B, IN PRESS J MOL EVOL
   GAEDE KI, 1995, INFECT IMMUN, V63, P714, DOI 10.1128/IAI.63.2.714-719.1995
   GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994
   GRUTZKAU A, 1990, GUT, V31, P1011, DOI 10.1136/gut.31.9.1011
   Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x
   HEESEMANN J, 1984, INFECT IMMUN, V46, P105, DOI 10.1128/IAI.46.1.105-110.1984
   ICHINOHE H, 1991, J CLIN MICROBIOL, V29, P846, DOI 10.1128/JCM.29.4.846-847.1991
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Mantovani A, 1997, IMMUNOL TODAY, V18, P231, DOI 10.1016/S0167-5699(97)81662-3
   MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385
   Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127
   NAKAJIMA R, 1995, INFECT IMMUN, V63, P3021, DOI 10.1128/IAI.63.8.3021-3029.1995
   NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993
   Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594
   Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920
   Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x
   Palmer LE, 1999, INFECT IMMUN, V67, P708, DOI 10.1128/IAI.67.2.708-716.1999
   PORTNOY DA, 1981, INFECT IMMUN, V31, P775, DOI 10.1128/IAI.31.2.775-782.1981
   Rakin A, 1999, INFECT IMMUN, V67, P5265, DOI 10.1128/IAI.67.10.5265-5274.1999
   Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069
   Ruckdeschel K, 2001, INFECT IMMUN, V69, P7652, DOI 10.1128/IAI.69.12.7652-7662.2001
   Ruckdeschel K, 2001, J IMMUNOL, V166, P1823, DOI 10.4049/jimmunol.166.3.1823
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Schmidt A, 1999, EUR J IMMUNOL, V29, P1149, DOI 10.1002/(SICI)1521-4141(199904)29:04<1149::AID-IMMU1149>3.0.CO;2-H
   Schulte R, 1996, INFECT IMMUN, V64, P2106, DOI 10.1128/IAI.64.6.2106-2113.1996
   Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315
   Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1988, MICROB PATHOGENESIS, V4, P431, DOI 10.1016/0882-4010(88)90028-9
   STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986
NR 49
TC 41
Z9 47
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD JUL
PY 2002
VL 70
IS 7
BP 3510
EP 3520
DI 10.1128/IAI.70.7.3510-3520.2002
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 564ET
UT WOS:000176302600024
PM 12065490
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Wei, S
   Marches, F
   Daniel, B
   Sonda, S
   Heidenreich, K
   Curiel, T
AF Wei, S
   Marches, F
   Daniel, B
   Sonda, S
   Heidenreich, K
   Curiel, T
TI Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block
   intracellular Toxoplasma gondii replication
SO INTERNATIONAL JOURNAL FOR PARASITOLOGY
LA English
DT Article
DE Toxoplasma gondii; protozoan parasite; mitogen activated protein kinase;
   replication; drug therapy
ID ACQUIRED-IMMUNODEFICIENCY-SYNDROME; LOW-DENSITY-LIPOPROTEIN; HUMAN
   T-CELLS; GROWTH-FACTOR; ENCEPHALITIS; PARASITE; PATHWAY; AIDS; HOST;
   DRUGS
AB Toxoplasma gondii is a medically important, obligate intracellular parasite. Little is known regarding factors that regulate its replication within cells. Such knowledge would further understanding of T. gondii pathogenesis, and might lead to novel therapeutic strategies. Mitogen-activated protein kinases (MAPKs) govern diverse cellular processes including proliferation and differentiation. We now show that treatment of T. gondii-infected cells with SB203580 or SB202190, substituted pyridinylimidazoles that are potent inhibitors of human p38 MAPK, inhibits intracellular T. gondii replication. Several independent experimental approaches suggest that the anti-proliferative effects of pyridinylimidazoles depend on direct action on tachyzoites, not the host cell: (i) selective inhibition of host p38 MAPK using recombinant adenoviruses had little effect on tachyzoite replication, (ii) pyridinylimidazole-treated tachyzoites developed abnormal morphology suggesting defective parasite division, and (iii) pyridinylimidazole-resistant mutant tachyzoites were developed through culture in progressively higher drug concentrations. We hypothesise that pyridinylimidazoles target a human p38 MAPK homologue in tachyzoites that regulates their replication. Phylogenetic data suggest that T. gondii likely encodes a p38 MAPK homologue, but such a homologue is absent from the incomplete Toxoplasma genomic data base. As all eukaryotic pathogens, including agents of malaria, leishmaniasis and trypanosomiasis encode endogenous MAPKs, drugs inhibiting endogenous MAPK activation may represent a novel, potentially broadly-acting class of antiparasitic agents. Pyridinylimidazoles also represent tools to elucidate factors governing intracellular tachyzoite replication. (C) 2002 Australian Society for Parasitology Inc. Published by Elsevier Science Ltd. All rights reserved.
C1 Tulane Univ, Sch Med, New Orleans, LA 70112 USA.
   Baylor Inst Immunol Res, Dallas, TX 75204 USA.
   Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
   Univ Colorado, Hlth Sci Ctr, Denver, CO 80220 USA.
   Denver Vet Affairs, Med Ctr, Denver, CO 80220 USA.
RP Curiel, T (corresponding author), Tulane Univ, Sch Med, 1430 Tulane Ave,SL78, New Orleans, LA 70112 USA.
CR ALBRECHT H, 1995, SCAND J INFECT DIS, V27, P71, DOI 10.3109/00365549509018976
   Berens RL, 1998, J INFECT DIS, V177, P1128, DOI 10.1086/517411
   Boehm JC, 1996, J MED CHEM, V39, P3929, DOI 10.1021/jm960415o
   CARR A, 1992, ANN INTERN MED, V117, P106, DOI 10.7326/0003-4819-117-2-106
   Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000
   Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X
   CURIEL TJ, 1993, J IMMUNOL, V151, P2024
   Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8
   GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241
   Gomez-Marin JE, 1998, PARASITE IMMUNOL, V20, P631, DOI 10.1046/j.1365-3024.1998.00194.x
   Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998
   Heidenreich KA, 1996, J BIOL CHEM, V271, P9891, DOI 10.1074/jbc.271.17.9891
   Khan AA, 1997, ANTIMICROB AGENTS CH, V41, P893, DOI 10.1128/AAC.41.5.893
   Koprak S, 1999, CELL IMMUNOL, V192, P87, DOI 10.1006/cimm.1998.1448
   KRUG EC, 1989, J BIOL CHEM, V264, P10601
   Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X
   Leu CM, 2000, ONCOGENE, V19, P1665, DOI 10.1038/sj.onc.1203452
   LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211
   PORTER SB, 1992, NEW ENGL J MED, V327, P1643, DOI 10.1056/NEJM199212033272306
   RENOLD C, 1992, MEDICINE, V71, P224, DOI 10.1097/00005792-199207000-00005
   Robert-Gangneux F, 2000, PARASITE, V7, P95, DOI 10.1051/parasite/2000072095
   Roisin MP, 2000, PARASITOL RES, V86, P588, DOI 10.1007/PL00008535
   SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509
   Singh RP, 1999, J BIOL CHEM, V274, P19593, DOI 10.1074/jbc.274.28.19593
   Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200
   Verhagen CE, 2000, J EXP MED, V192, P517, DOI 10.1084/jem.192.4.517
   Wei S, 2002, INFECT IMMUN, V70, P1750, DOI 10.1128/IAI.70.4.1750-1760.2002
   Wiese M, 1998, EMBO J, V17, P2619, DOI 10.1093/emboj/17.9.2619
   York RD, 1998, NATURE, V392, P622
NR 29
TC 36
Z9 40
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7519
J9 INT J PARASITOL
JI Int. J. Parasit.
PD JUL
PY 2002
VL 32
IS 8
BP 969
EP 977
AR PII S0020-7519(02)00061-9
DI 10.1016/S0020-7519(02)00061-9
PG 9
WC Parasitology
SC Parasitology
GA 577XE
UT WOS:000177087500004
PM 12076626
DA 2021-01-25
ER

PT J
AU Foultier, B
   Troisfontaines, P
   Muller, S
   Opperdoes, FR
   Cornelis, GR
AF Foultier, B
   Troisfontaines, P
   Muller, S
   Opperdoes, FR
   Cornelis, GR
TI Characterization of the ysa pathogenicity locus in the chromosome of
   Yersinia enterocolitica and phylogeny analysis of type III secretion
   systems
SO JOURNAL OF MOLECULAR EVOLUTION
LA English
DT Article
DE type III secretion; Ysa; Ysp; Syc; Phylogeny; virulence
ID GRAM-NEGATIVE BACTERIA; SALMONELLA-TYPHIMURIUM; PROTEIN SECRETION;
   SHIGELLA-FLEXNERI; YOP SECRETION; MOLECULAR CHARACTERIZATION;
   NUCLEOTIDE-SEQUENCE; PLASMA-MEMBRANE; NEEDLE COMPLEX; HOST-CELLS
AB Several Gram negative bacteria use a complex system called "type III secretion system" (TTSS) to engage their host. The archetype of TTSS is the plasmid-encoded "Yop virulon" shared by the three species of pathogenic Yersinia (Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica). A second TTSS, called Ysa (for Yersinia secretion apparatus) was recently described in Y. enterocolitica 8081, a strain from serotype O:8. In this study, we describe the, ysa locus from A127/90, another strain of serotype O:8, and we extend the sequence to several new genes encoding Ysp proteins which are the substrates of this secretion system, and a putative chaperone SycB. According to the deduced protein sequences, the ysa system from A127/90 is identical to that of 8081. It is different from the chromosome-encoded TTSS of Y. pestis but is instead closely related to the Mxi-Spa TTSS of Shigella and to the SPI-1 encoded TTSS of Salmonella enterica. We further demonstrated that the ysa locus is only present in biotype IB strains of Y. enterocolitica. Including this new Ysa system, a phylogenetic analysis of the 26 known TTSSs was carried out, based on the sequence analysis of three conserved proteins. All the TTSSs fall into five different clusters. The phylogenetic tree of these TTSSs is completely different from the evolutionary tree based on 16S RNA, indicating that TTSSs have been distributed by horizontal transfer.
C1 Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, Microbial Pathogenesis Unit, B-3000 Louvain, Belgium.
   Catholic Univ Louvain, Fac Med, B-3000 Louvain, Belgium.
   Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, Trop Dis Unit, B-3000 Louvain, Belgium.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Catholic Univ Louvain, Christian de Duve Inst Cellular Pathol, Microbial Pathogenesis Unit, B-3000 Louvain, Belgium.
RI Opperdoes, Frederik R/C-8897-2018; Opperdoes, Fred/N-9922-2019
OI Opperdoes, Frederik R/0000-0003-1984-3764; Opperdoes,
   Fred/0000-0003-1984-3764
CR BAUDRY B, 1988, MICROB PATHOGENESIS, V4, P345, DOI 10.1016/0882-4010(88)90062-9
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Bogdanove AJ, 1996, MOL MICROBIOL, V20, P681, DOI 10.1046/j.1365-2958.1996.5731077.x
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Carniel E, 1996, J BACTERIOL, V178, P6743, DOI 10.1128/jb.178.23.6743-6751.1996
   Carniel E, 2001, MICROBES INFECT, V3, P561, DOI 10.1016/S1286-4579(01)01412-5
   COLLAZO CM, 1995, MOL MICROBIOL, V15, P25, DOI 10.1111/j.1365-2958.1995.tb02218.x
   Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998
   DENFERT C, 1989, J BIOL CHEM, V264, P17462
   Ffrench-Constant RH, 2000, APPL ENVIRON MICROB, V66, P3310, DOI 10.1128/AEM.66.8.3310-3329.2000
   Freiberg C, 1997, NATURE, V387, P394, DOI 10.1038/387394a0
   GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883
   Hacker J, 1999, PATHOGENICITY ISLAND
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x
   Hardt WD, 1998, P NATL ACAD SCI USA, V95, P2574, DOI 10.1073/pnas.95.5.2574
   HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105
   HERMANT D, 1995, MOL MICROBIOL, V17, P781, DOI 10.1111/j.1365-2958.1995.mmi_17040781.x
   Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998
   ICHINOHE H, 1991, J CLIN MICROBIOL, V29, P846, DOI 10.1128/JCM.29.4.846-847.1991
   IRIARTE M, 1999, PATHOGENICITY ISLAND
   Kerr JR, 1999, MICROB PATHOGENESIS, V27, P349, DOI 10.1006/mpat.1999.0307
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635
   Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999
   MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8
   MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800
   Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083
   Parsot C, 1994, Curr Top Microbiol Immunol, V192, P217
   PLANO GV, 1995, J BACTERIOL, V177, P3843, DOI 10.1128/jb.177.13.3843-3854.1995
   PLANO GV, 1991, J BACTERIOL, V173, P7293, DOI 10.1128/jb.173.22.7293-7303.1991
   PLANO GV, 1993, J BACTERIOL, V175, P3536, DOI 10.1128/jb.175.11.3536-3545.1993
   RAKIN A, 1999, PATHOGENICITY ISLAND
   ROSGVIST R, 1994, EMBO J, V13, P964
   Rosqvist R, 1995, CONTRIB TO MICROBIOL, V13, P230
   SASAKAWA C, 1993, J BACTERIOL, V175, P32
   Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000
   WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
NR 55
TC 80
Z9 84
U1 0
U2 3
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0022-2844
J9 J MOL EVOL
JI J. Mol. Evol.
PD JUL
PY 2002
VL 55
IS 1
BP 37
EP 51
DI 10.1007/s00239-001-0089-7
PG 15
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA 563EP
UT WOS:000176243200004
PM 12165841
DA 2021-01-25
ER

PT J
AU Agre, P
   King, LS
   Yasui, M
   Guggino, WB
   Ottersen, OP
   Fujiyoshi, Y
   Engel, A
   Nielsen, S
AF Agre, P
   King, LS
   Yasui, M
   Guggino, WB
   Ottersen, OP
   Fujiyoshi, Y
   Engel, A
   Nielsen, S
TI Aquaporin water channels - from atomic structure to clinical medicine
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Review
ID INTEGRAL MEMBRANE-PROTEIN; KIDNEY COLLECTING DUCT; MAJOR INTRINSIC
   PROTEIN; MOLECULAR CHARACTERIZATION; COMPLEX TISSUES; MULLER CELLS;
   EXPRESSION; CLONING; TRANSPORT; LOCALIZATION
AB The water permeability of biological membranes has been a longstanding problem in physiology, but the proteins responsible for this remained unknown until discovery of the aquaporin I (AQP1) water channel protein. AQP1 is selectively permeated by water driven by osmotic gradients. The atomic structure of human AQP1 has recently been defined. Each subunit of the tetramer contains an individual aqueous pore that permits single-file passage of water molecules but interrupts the hydrogen bonding needed for passage of protons. At least 10 mammalian aquaporins have been identified, and these are selectively permeated by water (aquaporins) or water plus glycerol (aquaglyceroporins). The sites of expression coincide closely with the clinical phenotypes - ranging from congenital cataracts to nephrogenic diabetes insipidus. More than 200 members of the aquaporin family have been found in plants, microbials, invertebrates and vertebrates, and their importance to the physiology of these organisms is being uncovered.
C1 Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD USA.
   Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA.
   Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA.
   Johns Hopkins Sch Med, Dept Physiol, Baltimore, MD USA.
   Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway.
   Kyoto Univ, Fac Sci, Dept Biophys, Kyoto 606, Japan.
   Univ Basel, Biozentrum, ME Muller Inst Microscopy, Basel, Switzerland.
   Univ Aarhus, Water & Salt Res Ctr, Aarhus, Denmark.
RP Agre, P (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD USA.
EM pagre@jhmi.edu
RI Yasui, Masato/L-3312-2013; Fujiyoshi, Yoshinori/E-5989-2012
OI Fujiyoshi, Yoshinori/0000-0002-8070-1493
CR Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158
   Agre P, 1997, BIOL CELL, V89, P255, DOI 10.1016/S0248-4900(97)83377-1
   AGRE P, 1987, J BIOL CHEM, V262, P17497
   AGRE P, 1993, AM J PHYSIOL, V265, pF463
   Agre P, 1998, P NATL ACAD SCI USA, V95, P9061, DOI 10.1073/pnas.95.16.9061
   Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659
   Beroukas T, 2001, LANCET, V358, P1875, DOI 10.1016/S0140-6736(01)06900-8
   Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538
   Bichet DG, 1998, AM J MED, V105, P431, DOI 10.1016/S0002-9343(98)00301-5
   Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421
   Delporte C, 1996, J BIOL CHEM, V271, P22070, DOI 10.1074/jbc.271.36.22070
   DENKER BM, 1988, J BIOL CHEM, V263, P15634
   EBIHARA L, 1989, SCIENCE, V243, P1194, DOI 10.1126/science.2466337
   ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663
   ECHEVARRIA M, 1994, P NATL ACAD SCI USA, V91, P10997, DOI 10.1073/pnas.91.23.10997
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Francis P, 2000, HUM MOL GENET, V9, P2329, DOI 10.1093/oxfordjournals.hmg.a018925
   Frigeri A, 1998, J CLIN INVEST, V102, P695, DOI 10.1172/JCI2545
   Frigeri A, 2001, FASEB J, V15, P90, DOI 10.1096/fj.00-0260com
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0
   GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9
   Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247
   Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332
   Han ZQ, 1998, J BIOL CHEM, V273, P6001, DOI 10.1074/jbc.273.11.6001
   HASEGAWA H, 1994, J BIOL CHEM, V269, P5497
   Hatakeyama S, 2001, BIOCHEM BIOPH RES CO, V287, P814, DOI 10.1006/bbrc.2001.5661
   Heitman J, 2000, NAT GENET, V26, P258, DOI 10.1038/81532
   Hohmann S, 2000, TRENDS MICROBIOL, V8, P33, DOI 10.1016/S0966-842X(99)01645-5
   Hurley PT, 2001, AM J PHYSIOL-GASTR L, V280, pG701
   Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782
   ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269
   Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052
   KATSURA T, 1995, P NATL ACAD SCI USA, V92, P7212, DOI 10.1073/pnas.92.16.7212
   King LS, 1996, J CLIN INVEST, V97, P2183, DOI 10.1172/JCI118659
   King LS, 2001, NEW ENGL J MED, V345, P175, DOI 10.1056/NEJM200107193450304
   King LS, 2002, P NATL ACAD SCI USA, V99, P1059, DOI 10.1073/pnas.022626499
   King LS, 1997, AM J PHYSIOL-CELL PH, V273, pC1541
   Kishida K, 2000, J BIOL CHEM, V275, P20896, DOI 10.1074/jbc.M001119200
   Kong YF, 2001, P NATL ACAD SCI USA, V98, P14345, DOI 10.1073/pnas.251507998
   Krane CM, 2001, J BIOL CHEM, V276, P23413, DOI 10.1074/jbc.M008760200
   Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367
   Kwon TH, 2001, SEMIN NEPHROL, V21, P231, DOI 10.1053/snep.2001.21647
   LeCaherec F, 1996, EUR J BIOCHEM, V241, P707, DOI 10.1111/j.1432-1033.1996.00707.x
   Lee MD, 1996, J BIOL CHEM, V271, P8599, DOI 10.1074/jbc.271.15.8599
   Leitch V, 2001, P NATL ACAD SCI USA, V98, P2894, DOI 10.1073/pnas.041616498
   Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899
   Ma TH, 1996, GENOMICS, V35, P543, DOI 10.1006/geno.1996.0396
   Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071
   MA TH, 1994, J BIOL CHEM, V269, P21845
   Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256
   Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984
   Maunsbach AB, 1997, J AM SOC NEPHROL, V8, P358
   MOON C, 1993, J BIOL CHEM, V268, P15772
   MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010
   Mulders SM, 1998, J CLIN INVEST, V102, P57, DOI 10.1172/JCI2605
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5
   Nagelhus EA, 1998, J NEUROSCI, V18, P2506
   Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198
   Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099
   NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275
   NIELSEN S, 1995, KIDNEY INT, V48, P1057, DOI 10.1038/ki.1995.389
   NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663
   Nielsen S, 1997, J NEUROSCI, V17, P171
   Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549
   NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371
   NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013
   Pallone TL, 1997, AM J PHYSIOL-RENAL, V272, pF587
   PRESTIDGE BR, 1994, INT J RADIAT ONCOL, V28, P17, DOI 10.1016/0360-3016(94)90136-8
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   PRESTON GM, 1994, J BIOL CHEM, V269, P1668
   PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540
   PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110
   Promeneur D, 2000, AM J PHYSIOL-RENAL, V279, pF1014
   RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908
   RAO Y, 1990, NATURE, V345, P163, DOI 10.1038/345163a0
   Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981
   Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198
   Santoni V, 2000, CURR OPIN PLANT BIOL, V3, P476, DOI 10.1016/S1369-5266(00)00116-3
   Schreiber R, 1999, J BIOL CHEM, V274, P11811, DOI 10.1074/jbc.274.17.11811
   Schrier RW, 1998, MOL GENET METAB, V65, P255, DOI 10.1006/mgme.1998.2765
   SMITH BL, 1994, J CLIN INVEST, V94, P1043, DOI 10.1172/JCI117418
   SMITH BL, 1991, J BIOL CHEM, V266, P6407
   SON GY, 2001, J BIOL CHEM, V276, P41288
   Song YL, 2002, J PHYSIOL-LONDON, V541, P561, DOI 10.1113/jphysiol.2001.020180
   Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73
   Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778
   Tsubota K, 2001, LANCET, V357, P688, DOI 10.1016/S0140-6736(00)04140-4
   Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737
   Van Dort HM, 2001, J BIOL CHEM, V276, P46968, DOI 10.1074/jbc.M107855200
   Verkman AS, 2000, CURR OPIN NEPHROL HY, V9, P517, DOI 10.1097/00041552-200009000-00010
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   Yamamoto T, 1998, KIDNEY INT, V54, P1041, DOI 10.1046/j.1523-1755.1998.00123.x
   Yang BX, 2001, J BIOL CHEM, V276, P624, DOI 10.1074/jbc.M008664200
   Yasui M, 1999, NATURE, V402, P184
   Yasui M, 1999, P NATL ACAD SCI USA, V96, P5808, DOI 10.1073/pnas.96.10.5808
   Yasui M, 1997, J PHYSIOL-LONDON, V505, P3, DOI 10.1111/j.1469-7793.1997.003bc.x
   ZAMPIGHI GA, 1989, J CELL BIOL, V108, P2255, DOI 10.1083/jcb.108.6.2255
   ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042
   ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002
   ZELINSKI T, 1990, GENOMICS, V6, P623
   Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631
NR 111
TC 751
Z9 806
U1 6
U2 180
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD JUL 1
PY 2002
VL 542
IS 1
BP 3
EP 16
DI 10.1113/jphysiol.2002.020818
PG 14
WC Neurosciences; Physiology
SC Neurosciences & Neurology; Physiology
GA 578VM
UT WOS:000177141800002
PM 12096044
OA Green Published
DA 2021-01-25
ER

PT J
AU Rodriguez-Maranon, MJ
   Bush, RM
   Peterson, EM
   Schirmer, T
   de la Maza, LM
AF Rodriguez-Maranon, MJ
   Bush, RM
   Peterson, EM
   Schirmer, T
   de la Maza, LM
TI Prediction of the membrane-spanning beta-strands of the major outer
   membrane protein of Chlamydia
SO PROTEIN SCIENCE
LA English
DT Article
DE Chlamydia; major outer-membrane protein (MOMP); porin; topology model
ID OMPF PORIN; POSITIVE SELECTION; CELL-ENVELOPE; TRACHOMATIS; ANTIBODIES;
   SEQUENCE; IDENTIFICATION; EPITOPES; VACCINE; NEUTRALIZATION
AB There is preliminary experimental evidence indicating that the major outer-membrane protein (MOMP) of Chlamydia is a porin. We tested this hypothesis for the MOMP of the mouse pneumonitis serovar of Chlamydia trachomatis using two secondary structure prediction methods. First, an algorithm that calculates the mean hydrophobicity of one side of putative beta-strands predicted the positions of 16 transmembrane segments, a structure common to known porins. Second, outer loops typical of porins were assigned using an artificial neural network trained to predict the topology of bacterial outer-membrane proteins with a predominance of beta-strands. A topology model based on these results locates the four variable domains (VDs) of the MOMP on the outer loops and the five constant domains on beta-strands and the periplasmic turns. This model is consistent with genetic analysis and immunological and biochemical data that indicate the VDs are surface exposed. Furthermore, it shows significant homology with the consensus porin model of the program FORESST, which contrasts a proposed secondary structure against a data set of 349 proteins of known structure. Analysis of the MOMP of other chlamydial species corroborated our predicted model.
C1 Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA.
   Univ Calif Irvine, Dept Ecol & Evolut Biol, Irvine, CA 92697 USA.
   Univ Basel, Biozentrum, Div Struct Biol, Basel, Switzerland.
RP de la Maza, LM (corresponding author), Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA.
EM lmdelama@uci.edu
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI032248, R01AI044474, R01AI032248, R01AI032248, R01AI044474,
   R01AI044474, R01AI044474, R01AI032248, R01AI032248, R01AI032248,
   R01AI044474, R01AI032248, R01AI032248, R01AI032248, R01AI032248,
   R01AI044474, R01AI032248, R01AI032248, R01AI044474, R01AI032248,
   R01AI032248, R01AI044474, R01AI032248, R01AI032248] Funding Source: NIH
   RePORTER; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI032248, AI 44474, AI
   32248, R01 AI044474] Funding Source: Medline
CR ANDERSEN AA, 1991, J CLIN MICROBIOL, V29, P707, DOI 10.1128/JCM.29.4.707-711.1991
   BAEHR W, 1988, P NATL ACAD SCI USA, V85, P4000, DOI 10.1073/pnas.85.11.4000
   BAGHIAN A, 1990, INFECT IMMUN, V58, P1379, DOI 10.1128/IAI.58.5.1379-1383.1990
   BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984
   BRUNHAM R, 1994, J CLIN INVEST, V94, P458, DOI 10.1172/JCI117347
   BRUNHAM RC, 1987, J INFECT DIS, V155, P749, DOI 10.1093/infdis/155.4.749
   Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057
   Bush RM, 2001, NAT REV GENET, V2, P387, DOI 10.1038/35072023
   Bush RM, 2001, INT J SYST EVOL MICR, V51, P203, DOI 10.1099/00207713-51-1-203
   CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981
   CALDWELL HD, 1982, INFECT IMMUN, V38, P745, DOI 10.1128/IAI.38.2.745-754.1982
   CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343
   Christiansen G, 1999, AM HEART J, V138, pS491, DOI 10.1016/S0002-8703(99)70283-8
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   DELAMAZA MA, 1995, VACCINE, V13, P119, DOI 10.1016/0264-410X(95)80022-6
   Destenaves B, 2000, CURR OPIN CHEM BIOL, V4, P440, DOI 10.1016/S1367-5931(00)00101-0
   Di Francesco V, 1999, BIOINFORMATICS, V15, P131, DOI 10.1093/bioinformatics/15.2.131
   Diederichs K, 1998, PROTEIN SCI, V7, P2413, DOI 10.1002/pro.5560071119
   Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629
   Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415
   EVERETT KDE, 1995, J BACTERIOL, V177, P877, DOI 10.1128/jb.177.4.877-882.1995
   FITCH WM, 1993, MOL BIOL EVOL, V10, P892
   Geetha V, 1999, PROTEIN ENG, V12, P527, DOI 10.1093/protein/12.7.527
   HACKSTADT T, 1985, J BACTERIOL, V161, P25, DOI 10.1128/JB.161.1.25-31.1985
   HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877
   HATCH TP, 1981, J BACTERIOL, V146, P426, DOI 10.1128/JB.146.1.426-429.1981
   Hatch TP, 1996, J BACTERIOL, V178, P1
   Hughes ES, 2001, INFECT IMMUN, V69, P1671, DOI 10.1128/IAI.69.3.1671-1678.2001
   JEANTEUR D, 1991, MOL MICROBIOL, V5, P2153, DOI 10.1111/j.1365-2958.1991.tb02145.x
   JEANTEUR D, 1994, BACTERIAL CELL WALL, P363
   Klebe G, 2000, J MOL MED, V78, P269, DOI 10.1007/s001090000084
   KREUSCH A, 1994, PROTEIN SCI, V3, P58
   KUO CC, 1987, INFECT IMMUN, V55, P1324, DOI 10.1128/IAI.55.5.1324-1328.1987
   MCCAFFERTY MC, 1995, INFECT IMMUN, V63, P2387, DOI 10.1128/IAI.63.6.2387-2389.1995
   Moulder JW, 1984, BERGEYS MANUAL SYSTE, V1, P729
   Mygind P, 1998, J BACTERIOL, V180, P5784, DOI 10.1128/JB.180.21.5784-5787.1998
   Nigg Clara, 1942, SCIENCE, V95, P49, DOI 10.1126/science.95.2454.49-a
   Pal S, 1997, INFECT IMMUN, V65, P3361, DOI 10.1128/IAI.65.8.3361-3369.1997
   Pal S, 1996, INFECT IMMUN, V64, P5341, DOI 10.1128/IAI.64.12.5341-5348.1996
   Pal S, 1997, VACCINE, V15, P575, DOI 10.1016/S0264-410X(97)00206-5
   Pal S, 1999, VACCINE, V18, P752, DOI 10.1016/S0264-410X(99)00032-8
   PAL S, 1993, J GEN MICROBIOL, V139, P1565, DOI 10.1099/00221287-139-7-1565
   PETERSON EM, 1991, INFECT IMMUN, V59, P4147, DOI 10.1128/IAI.59.11.4147-4153.1991
   PETERSON EM, 1988, INFECT IMMUN, V56, P885, DOI 10.1128/IAI.56.4.885-891.1988
   PETERSON EM, 1988, J BACTERIOL, V170, P1389, DOI 10.1128/jb.170.3.1389-1392.1988
   Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c
   Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k
   QU ZH, 1993, INFECT IMMUN, V61, P1365, DOI 10.1128/IAI.61.4.1365-1370.1993
   RAULSTON JE, 1995, MOL MICROBIOL, V15, P607, DOI 10.1111/j.1365-2958.1995.tb02370.x
   Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676
   Schachter J, 1978, HUMAN CHLAMYDIAL INF
   Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946
   SCHIRMER T, 1993, PROTEIN SCI, V2, P1361, DOI 10.1002/pro.5560020820
   Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2
   SCHULZ GE, 1994, BACTERIAL CELL WALL, P343
   SMITH NH, 1995, MOL BIOL EVOL, V12, P363
   Stephens R. S, 1999, CHLAMYDIA INTRACELLU
   STEPHENS RS, 1987, J BACTERIOL, V169, P3879, DOI 10.1128/jb.169.9.3879-3885.1987
   Stephens RS, 2000, J INFECT DIS, V181, pS521, DOI 10.1086/315631
   SU H, 1988, INFECT IMMUN, V56, P2094, DOI 10.1128/IAI.56.8.2094-2100.1988
   SU H, 1990, INFECT IMMUN, V58, P1017, DOI 10.1128/IAI.58.4.1017-1025.1990
   VANDERLEY P, 1991, INFECT IMMUN, V59, P2963, DOI 10.1128/IAI.59.9.2963-2971.1991
   VILLENEUVE A, 1994, MICROBIOL-UK, V140, P2481, DOI 10.1099/13500872-140-9-2481
   WANG SP, 1984, MED VIROLOGY, V3, P87
   WARD ME, 1992, J INFECTION, V25, P11, DOI 10.1016/0163-4453(92)91882-C
   WELTE W, 1991, BIOCHIM BIOPHYS ACTA, V1080, P271, DOI 10.1016/0167-4838(91)90013-P
   Wolf K, 2001, INFECT IMMUN, V69, P3082, DOI 10.1128/IAI.69.5.3082-3091.2001
   Wyllie S, 1998, INFECT IMMUN, V66, P5202, DOI 10.1128/IAI.66.11.5202-5207.1998
   Yamaguchi-Kabata Y, 2000, J VIROL, V74, P4335, DOI 10.1128/JVI.74.9.4335-4350.2000
NR 69
TC 33
Z9 36
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0961-8368
EI 1469-896X
J9 PROTEIN SCI
JI Protein Sci.
PD JUL
PY 2002
VL 11
IS 7
BP 1854
EP 1861
DI 10.1110/ps.3650102
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 564QJ
UT WOS:000176324800029
PM 12070338
OA Green Published
DA 2021-01-25
ER

PT J
AU Hofbauer, KG
   Huppertz, C
AF Hofbauer, KG
   Huppertz, C
TI Pharmacotherapy and evolution
SO TRENDS IN ECOLOGY & EVOLUTION
LA English
DT Review
ID ESSENTIAL-HYPERTENSION; RECOMBINANT LEPTIN; HUMAN OBESITY; THERAPY;
   DISEASE; WEIGHT; PHARMACOGENOMICS; ANGIOTENSIN; PERSPECTIVE
AB The therapeutic effects of a drug are the result of its action on a specific molecular target combined with the counterregulatory responses of the organism that aim to restore the affected parameters to previous values. The regulatory systems that control the steady state have evolved under natural selection, but because natural selection is a slow process and cannot foresee future developments, these systems are not always adjusted optimally to current conditions. Their activation can therefore reduce or prevent the desired effects of a drug and can even produce adverse effects. Recent examples from the treatment of obesity and arterial hypertension provide new insight to the contribution of such ancient counterregulatory responses to the therapeutic effects of modem pharmacotherapy. This widens the scope of the rapidly growing field of evolutionary medicine, because it demonstrates that evolutionary principles apply not only to the pathogenesis of human diseases, but also to their treatment.
C1 Univ Basel, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   Novartis Pharma AG, Pharma Res, CH-4002 Basel, Switzerland.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413
   Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0
   Bond RA, 2001, TRENDS PHARMACOL SCI, V22, P273, DOI 10.1016/S0165-6147(00)01711-9
   Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558
   BRUNNER HR, 1980, AM J MED, V69, P739, DOI 10.1016/0002-9343(80)90444-1
   Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904
   Carretero OA, 2000, CIRCULATION, V101, P446, DOI 10.1161/01.CIR.101.4.446
   Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329
   Chiesi M, 2001, TRENDS PHARMACOL SCI, V22, P247, DOI 10.1016/S0165-6147(00)01664-3
   CODY RJ, 1983, HYPERTENSION, V5, P36
   Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503
   Eaton SB, 1999, EVOLUTION IN HEALTH AND DISEASE, P251
   EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505
   Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204
   Fernandez-Real JM, 1999, DIABETOLOGIA, V42, P1367, DOI 10.1007/s001250051451
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Francis Gary S., 2001, American Journal of Medicine, V110, p37S
   Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376
   Gavras H, 2001, HYPERTENSION, V37, P342, DOI 10.1161/01.HYP.37.2.342
   GUYTON AC, 2000, MED PHYSL
   Hardman JG, 2001, GOODMAN GILMANS PHAR
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   James G. D., 1990, HYPERTENSION PATHOPH, P137
   Kalow W, 2001, CLIN PHARMACOL THER, V70, P1, DOI 10.1067/mcp.2001.116714
   Kaplan NM, 2000, DRUGS, V59, P21, DOI 10.2165/00003495-200059002-00003
   Kopelman PG, 2000, NATURE, V404, P635
   Kurokawa K, 2001, NEPHRON, V89, P369, DOI 10.1159/000046105
   LARAGH JH, 1990, HYPERTENSION PATHOPH
   Lev-Ran A, 2001, DIABETES-METAB RES, V17, P347, DOI 10.1002/dmrr.230
   Lippi G, 2000, QJM-MON J ASSOC PHYS, V93, P75, DOI 10.1093/qjmed/93.2.75
   Lowell BB, 2000, NATURE, V404, P652
   Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014
   McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   NEEL JV, 1962, AM J HUM GENET, V14, P353
   ODEA K, 1991, PHILOS T ROY SOC B, V334, P233, DOI 10.1098/rstb.1991.0112
   Reinhardt HW, 2000, NEWS PHYSIOL SCI, V15, P319
   Schwartz MW, 2000, NATURE, V404, P661
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Stearns SC, 1999, EVOLUTION IN HEALTH AND DISEASE, P3
   Stearns SC, 2001, Q REV BIOL, V76, P417, DOI 10.1086/420539
   Stini WA, 1998, COLLEGIUM ANTROPOL, V22, P411
   Strassmann BI, 1999, EVOLUTION IN HEALTH AND DISEASE, P91
   Stryer L., 1995, BIOCHEMISTRY-US, P603
   TARAZI RC, 1970, CIRCULATION, V41, P709, DOI 10.1161/01.CIR.41.4.709
   WENDORF M, 1991, DIABETES, V40, P161, DOI 10.2337/diabetes.40.2.161
NR 46
TC 8
Z9 8
U1 0
U2 3
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0169-5347
EI 1872-8383
J9 TRENDS ECOL EVOL
JI Trends Ecol. Evol.
PD JUL
PY 2002
VL 17
IS 7
BP 328
EP 334
AR PII S0169-5347(02)02515-6
DI 10.1016/S0169-5347(02)02515-6
PG 7
WC Ecology; Evolutionary Biology; Genetics & Heredity
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity
GA 564UK
UT WOS:000176331800013
DA 2021-01-25
ER

PT J
AU Landwojtowicz, E
   Nervi, P
   Seelig, A
AF Landwojtowicz, E
   Nervi, P
   Seelig, A
TI Real-time monitoring of P-glycoprotein activation in living cells
SO BIOCHEMISTRY
LA English
DT Article
ID MULTIDRUG-RESISTANCE; ATPASE ACTIVITY; SUBSTRATE RECOGNITION;
   BROAD-SPECIFICITY; CATALYTIC CYCLE; PLASMA-MEMBRANE; CYCLOSPORINE-A;
   ALTERED PH(I); TUMOR-CELLS; TRANSPORTER
AB Extracellular acidification rates (ECARs) in response to eight different drugs activating or inhibiting the ATPase of P-glycoprotein (Pgp) were measured in real time by means of a Cytosensor microphysiometer in MDR1-transfected and corresponding wild-type cell lines, i.e., pig kidney cells (LLC-MDR1 and LLC-PK1) and mouse embryo fibroblasts (NIH-MIDR-G185 and NIH3T3). The ECARs showed a bell-shaped dependence on drug concentration (log scale) in transfected cells but were negligibly small in wild-type cells. The activation profiles (ECARs vs concentration) were analyzed in terms of a model assuming activation of Pgp-ATPase with one and inhibition with two drug molecules bound. The kinetic constants [concentration of half-maximum activation (inhibition), K(i), and the maximum (minimum) transporter activity, V(i)] were in qualitative and quantitative agreement with those determined earlier for Pgp-ATPase activation monitored by phosphate release in inside-out cellular vesicles and in purified reconstituted systems, respectively. Furthermore, the ECARs correlated with the expression level of P-p in the two different cell lines and were reduced in a concentration-dependent manner by cyclosporin A:, a potent inhibitor of the Pgp-ATPase. In contrast, treatment of cells with inhibitors of the Na(+)/H(+) or the Cl-/HCO(3)(-) exchanger did not reduce the ECARs. The micro-pH measurements provide for the first time direct evidence for a tight coupling between the rate of extracellular proton extrusion and intracellular phosphate release upon P-p-ATPase activation. They support a Pgp-mediated transport of protons from the site of ATP hydrolysis to the cell surface. Measurement of the ECARs could thus constitute a new method to conveniently analyze the kinetics of Pgp-ATPase activation in living cells.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4003 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4003 Basel, Switzerland.
EM Anna.Seelig@unibas.ch
CR ALTENBERG GA, 1993, P NATL ACAD SCI USA, V90, P9735, DOI 10.1073/pnas.90.20.9735
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361
   Ayesh S, 1996, BBA-MOL BASIS DIS, V1316, P8, DOI 10.1016/0925-4439(96)00008-7
   BESCHIASCHVILI G, 1992, BIOCHEMISTRY-US, V31, P10044, DOI 10.1021/bi00156a026
   Borst P, 1997, TRENDS GENET, V13, P217, DOI 10.1016/S0168-9525(97)01112-8
   CARDARELLI CO, 1995, CANCER RES, V55, P1086
   Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793
   Chen Y, 2000, J CELL BIOL, V148, P863, DOI 10.1083/jcb.148.5.863
   Chen Y, 2001, CANCER RES, V61, P7763
   Dawson R.M., 1986, DATA BIOCH RES
   Essodaigui M, 1998, BIOCHEMISTRY-US, V37, P2243, DOI 10.1021/bi9718043
   Hafner F, 2000, BIOSENS BIOELECTRON, V15, P149, DOI 10.1016/S0956-5663(00)00069-5
   Hait W N, 1989, Cancer Commun, V1, P35
   HAMILTON G, 1993, ANTICANCER RES, V13, P2059
   Hoffman MM, 1997, BIOCHEMISTRY-US, V36, P11153, DOI 10.1021/bi970530g
   Hoffman MM, 1996, J GEN PHYSIOL, V108, P295, DOI 10.1085/jgp.108.4.295
   HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2
   Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200
   Krupka RM, 1999, J MEMBRANE BIOL, V172, P129, DOI 10.1007/s002329900591
   Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P147, DOI 10.1016/S0925-4439(97)00025-2
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Litman T, 1998, CELL PHYSIOL BIOCHEM, V8, P138, DOI 10.1159/000016277
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   OWICKI JC, 1992, BIOSENS BIOELECTRON, V7, P255, DOI 10.1016/0956-5663(92)87004-9
   PARCE JW, 1989, SCIENCE, V246, P243, DOI 10.1126/science.2799384
   Raggers RJ, 2000, TRAFFIC, V1, P226, DOI 10.1034/j.1600-0854.2000.010305.x
   Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u
   RAVIV Y, 1990, J BIOL CHEM, V265, P3975
   Robinson LJ, 1996, BIOCHEM PHARMACOL, V52, P1081, DOI 10.1016/0006-2952(96)81736-9
   ROEPE PD, 1993, BIOCHEMISTRY-US, V32, P11042, DOI 10.1021/bi00092a014
   Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q
   Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456
   Santai CT, 1999, BIOCHEMISTRY-US, V38, P4227, DOI 10.1021/bi981930m
   Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200
   SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214
   Schmid D, 1999, BIOCHEM PHARMACOL, V58, P1447, DOI 10.1016/S0006-2952(99)00229-4
   Seelig A, 2000, INT J CLIN PHARM TH, V38, P111
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x
   SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381
   SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497
   SKOVSGAARD T, 1990, PEZ FDN SYM, P209
   Smit JW, 1998, J PHARMACOL EXP THER, V286, P321
   THIEBAUT F, 1990, J HISTOCHEM CYTOCHEM, V38, P685, DOI 10.1177/38.5.1692055
   TOCANNE JF, 1990, BIOCHIM BIOPHYS ACTA, V1031, P111, DOI 10.1016/0304-4157(90)90005-W
   van Veen HW, 2001, J MOL MICROB BIOTECH, V3, P185
   vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7
   Weisburg JH, 1999, J BIOL CHEM, V274, P10877, DOI 10.1074/jbc.274.16.10877
   Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i
NR 53
TC 33
Z9 33
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUN 25
PY 2002
VL 41
IS 25
BP 8050
EP 8057
DI 10.1021/bi025720s
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 564QA
UT WOS:000176324000023
PM 12069596
DA 2021-01-25
ER

PT J
AU Emter, R
   Heese-Peck, A
   Kralli, A
AF Emter, R
   Heese-Peck, A
   Kralli, A
TI ERG6 and PDR5 regulate small lipophilic drug accumulation in yeast cells
   via distinct mechanisms
SO FEBS LETTERS
LA English
DT Article
DE drug resistance; ATP-binding cassette transporter; sterol; small
   lipophilic molecule transport; yeast
ID SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; GENETIC-ANALYSIS;
   TRANSPORTER; STEROL; MEMBRANE; MUTANTS; FAMILY; SUSCEPTIBILITY;
   IDENTIFICATION
AB Diagnosis and circumvention of multi-drug resistance requires an understanding of the underlying cellular mechanisms. In the model organism Saccharomyces cerevisiae, deletions of PDR5 or ERG6 increase sensitivity to many small lipophilic drugs. Pdr5p is a plasma membrane ATP-binding cassette transporter that actively exports drugs, thereby lowering their intracellular levels. The mechanism by which ERG6, an enzyme in sterol biosynthesis, affects drug accumulation is less clear. We show here that ERG6 limits the rate of passive drug diffusion across the membrane, without affecting Pdr5p-mediated drug export. Consistent with their action by distinct mechanisms, PDR5 and ERG6 effects on drug accumulation are additive. (C) 2002 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Kralli, A (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR ARSENAULT AL, 1988, BIOCHIM BIOPHYS ACTA, V938, P315, DOI 10.1016/0005-2736(88)90169-1
   BALZI E, 1995, J BIOENERG BIOMEMBR, V27, P71, DOI 10.1007/BF02110333
   BARD M, 1978, J BACTERIOL, V135, P1146, DOI 10.1128/JB.135.3.1146-1148.1978
   Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1
   Borst P, 1999, BBA-BIOMEMBRANES, V1461, P347, DOI 10.1016/S0005-2736(99)00167-4
   EGNER R, 1995, MOL CELL BIOL, V15, P5879
   Egner R, 1998, MOL BIOL CELL, V9, P523, DOI 10.1091/mbc.9.2.523
   Ferte J, 2000, EUR J BIOCHEM, V267, P277, DOI 10.1046/j.1432-1327.2000.01046.x
   Fleckenstein A, 1999, YEAST, V15, P133
   GABER RF, 1989, MOL CELL BIOL, V9, P3447, DOI 10.1128/MCB.9.8.3447
   GARABEDIAN MJ, 1999, NUCL RECEPTORS PRACT, V207, P233
   Georgopapadakou NH, 1998, CURR OPIN MICROBIOL, V1, P547, DOI 10.1016/S1369-5274(98)80087-8
   Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135
   GRAHAM TR, 1993, EMBO J, V12, P869, DOI 10.1002/j.1460-2075.1993.tb05727.x
   Jensen-Pergakes KL, 1998, ANTIMICROB AGENTS CH, V42, P1160, DOI 10.1128/AAC.42.5.1160
   Kaur R, 1999, MICROBIOL-UK, V145, P809, DOI 10.1099/13500872-145-4-809
   Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543
   KRALLI A, 1995, P NATL ACAD SCI USA, V92, P4701, DOI 10.1073/pnas.92.10.4701
   Li XM, 2000, MOL BIOL CELL, V11, P1989, DOI 10.1091/mbc.11.6.1989
   Mahe Y, 1996, J BIOL CHEM, V271, P25167, DOI 10.1074/jbc.271.41.25167
   Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242
   Munn AL, 1999, MOL BIOL CELL, V10, P3943, DOI 10.1091/mbc.10.11.3943
   PRENDERGAST JA, 1995, YEAST, V11, P537, DOI 10.1002/yea.320110603
   SHAH N, 1993, J BIOL CHEM, V268, P5345
   SIKORSKI RS, 1989, GENETICS, V122, P19
   SIMON S, 1994, P NATL ACAD SCI USA, V91, P1128, DOI 10.1073/pnas.91.3.1128
   SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497
   Sitcheran R, 2000, GENETICS, V156, P963
   Urbina JA, 1997, ANTIMICROB AGENTS CH, V41, P1428, DOI 10.1128/AAC.41.7.1428
   van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934
   van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5
   VOGEL JP, 1993, J BIOL CHEM, V268, P3040
   WELIHINDA AA, 1994, BBA-BIOMEMBRANES, V1193, P107, DOI 10.1016/0005-2736(94)90339-5
NR 33
TC 60
Z9 60
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD JUN 19
PY 2002
VL 521
IS 1-3
BP 57
EP 61
AR PII S0014-5793(02)02818-1
DI 10.1016/S0014-5793(02)02818-1
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 566TD
UT WOS:000176443600013
PM 12067726
DA 2021-01-25
ER

PT J
AU Hennig, M
   Darimont, BD
   Jansonius, JN
   Kirschner, K
AF Hennig, M
   Darimont, BD
   Jansonius, JN
   Kirschner, K
TI The catalytic mechanism of indole-3-glycerol phosphate syntase: Crystal
   structures of complexes of the enzyme from Sulfolobus solfataricus with
   substrate analogue, substrate, and product
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE ligand complexes; X-ray structural analysis; (beta alpha)(8)-barrel;
   catalytic mechanism; tryptophan biosynthesis
ID PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; INDOLEGLYCEROL-PHOSPHATE;
   BIFUNCTIONAL ENZYME; 3-DIMENSIONAL STRUCTURE; POSSIBLE DETERMINANTS;
   THERMOTOGA-MARITIMA; ESCHERICHIA-COLI; SYNTHASE; BIOSYNTHESIS;
   CONVERSION
AB Indoleglycerol phosphate synthase catalyzes the ring closure of an N-alkylated anthranilate to a 3-alkyl indole derivative, a reaction requiring Lewis acid catalysis in vitro. Here, we investigated the enzymatic reaction mechanism through X-ray crystallography of complexes of the hyperthermostable enzyme from Sulfolobus solfataricus with the substrate 1-(o-carboxyphenylamino) 1-deoxyribulose 5-phosphate, a substrate analogue and the product indole-3-glycerol phosphate. The substrate and the substrate analogue are bound to the active site in a similar, extended conformation between the previously identified phosphate binding site and a hydrophobic pocket for the anthranilate moiety. This binding mode is unproductive, because the carbon atoms that are to be joined are too far apart. The indole ring of the bound product resides in a second hydrophobic pocket adjacent to that of the anthranilate moiety of the substrate. Although the hydrophobic moiety of the substrate moves during catalysis from one hydrophobic pocket to the other, the triosephosphate moiety remains rigidly bound to the same set of hydrogen-bonding residues. Simultaneously, the catalytically important residues Lys53, Lys110 and Glu159 maintain favourable distances to the atoms of the ligand undergoing covalent changes. On the basis of these data, the structures of two putative catalytic intermediates were modelled into the active site. This new structural information and the modelling studies provide further insight into the mechanism of enzyme-catalyzed indole synthesis. The charged e-amino group of Lys110 is the general acid, and the carboxylate group of Glu159 is the general base. Lys53 guides the substrate undergoing conformational transitions during catalysis, by forming a salt-bridge to the carboxylate group of its anthranilate moiety. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Hennig, M (corresponding author), Hoffmann La Roche Ag, Pharma Res Discovery Technol, Xray Crystallog 65 308, CH-4070 Basel, Switzerland.
EM michael.hennig@roche.com
CR ANDREOTTI G, 1994, BBA-PROTEIN STRUCT M, V1208, P310, DOI 10.1016/0167-4838(94)90118-X
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BISSWANGER H, 1979, BIOCHEMISTRY-US, V18, P5946, DOI 10.1021/bi00593a029
   Brown R.T., 1979, COMPREHENSIVE ORGANI, V4, P411
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   COHN W, 1979, BIOCHEMISTRY-US, V18, P5953, DOI 10.1021/bi00593a030
   Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518
   EBERHARD M, 1989, FEBS LETT, V245, P219, DOI 10.1016/0014-5793(89)80225-X
   EBERHARD M, 1995, BIOCHEMISTRY-US, V34, P5419, DOI 10.1021/bi00016a013
   ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071
   GERBER PR, 1992, BIOPOLYMERS, V32, P1003, DOI 10.1002/bip.360320811
   Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2
   Hennig M, 1997, BIOCHEMISTRY-US, V36, P6009, DOI 10.1021/bi962718q
   HOMMEL U, 1995, BIOCHEMISTRY-US, V34, P5429, DOI 10.1021/bi00016a014
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KIRSCHNER K, 1987, METHOD ENZYMOL, V142, P386
   Knochel TR, 1996, J MOL BIOL, V262, P502, DOI 10.1006/jmbi.1996.0531
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i
   NICHOLS BP, 1996, ESCHERICHIA COLI SAL, V2, P2638
   PARRY RJ, 1972, CHEM HETEROCYCLIC CO, V25, P1
   PRIESTLE JP, 1987, P NATL ACAD SCI USA, V84, P5690, DOI 10.1073/pnas.84.16.5690
   READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622
   SMITH OH, 1962, METHOD ENZYMOL, V5, P794, DOI 10.1016/S0076-6879(62)05315-X
   SMITH OH, 1960, J BIOL CHEM, V235, P2051
   Stehlin C, 1997, FEBS LETT, V403, P268, DOI 10.1016/S0014-5793(97)00066-5
   Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006
   WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7
   YANOFSKY C, 1955, SCIENCE, V121, P138, DOI 10.1126/science.121.3135.138
   YANOFSKY C, 1956, J BIOL CHEM, V223, P171
NR 30
TC 47
Z9 50
U1 0
U2 16
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUN 7
PY 2002
VL 319
IS 3
BP 757
EP 766
DI 10.1016/S0022-2836(02)00378-9
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 565QB
UT WOS:000176380000013
PM 12054868
DA 2021-01-25
ER

PT J
AU Rolink, AG
   Schaniel, C
   Bruno, L
   Melchers, F
AF Rolink, AG
   Schaniel, C
   Bruno, L
   Melchers, F
TI In vitro and in vivo plasticity of Pax5-deficient pre-B I cells
SO IMMUNOLOGY LETTERS
LA English
DT Article; Proceedings Paper
CT 11th Symposium on Signals and Signal Processing in the Immune System
CY SEP 02-06, 2001
CL PECS, HUNGARY
DE mice; Pax-5; cells
ID HEMATOPOIETIC STEM-CELL; MOUSE; MICE; DIFFERENTIATION; IDENTIFICATION;
   RECONSTITUTION; PROGENITORS; COMMITMENT; INVITRO; INVIVO
AB In mice deficient for the transcription factor Pax-5, B cell development is blocked at the pre-B I cell stage. Like wild type, Pax-5(-/-) pre-B I cells can be grown long-term in vitro in the presence of stromal cells and IL-7. However, unlike their wild type in vitro grown counterparts, Pax-5(-/-) pre-B I cells posses an extraordinary developmental plasticity showing hematopoeitic stem cell features such as multipotency and self renewing capacity. Here we review and discuss this in vitro and in vivo plasticity of Pax-5(-/-) pre-B I cells. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Basel Inst Immunol, CH-4005 Basel, Switzerland.
   Univ Basel, Dept Immunol, CH-4056 Basel, Switzerland.
   Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.
   Inst Canc Res, Chester Beatty Labs, Gene Funct & Regulat Lab, London SW3 6JB, England.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Rolink, AG (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.
RI Schaniel, Chrisoph/C-9655-2012; Schaniel, Christoph/P-3836-2019
OI Schaniel, Christoph/0000-0002-1343-4858
CR Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599
   FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0
   JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220
   Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5
   MELCHERS F, 1998, FUNDAMENTAL IMMUNOLO, P183
   MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0
   Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476
   Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319
   Nutt SL, 1999, NATURE, V401, P556
   Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242
   Reininger L, 1996, J EXP MED, V184, P853, DOI 10.1084/jem.184.3.853
   REININGER L, 1992, J EXP MED, V176, P1343, DOI 10.1084/jem.176.5.1343
   Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7
   ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x
   Rolink AG, 2000, IMMUNOL REV, V175, P104, DOI 10.1111/j.1600-065X.2000.imr017512.x
   Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164
   Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472
   SCHANIEL C, 2002, IN PRESS BLOOD, V99
   SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788
   SPENCKER T, 1995, BIOCHEM BIOPH RES CO, V216, P540, DOI 10.1006/bbrc.1995.2656
   TANAKA T, 1994, EUR J IMMUNOL, V24, P1544, DOI 10.1002/eji.1830240713
   URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
NR 23
TC 15
Z9 16
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
J9 IMMUNOL LETT
JI Immunol. Lett.
PD JUN 3
PY 2002
VL 82
IS 1-2
SI SI
BP 35
EP 40
AR PII S0165-2478(02)00016-0
DI 10.1016/S0165-2478(02)00016-0
PG 6
WC Immunology
SC Immunology
GA 560AN
UT WOS:000176059200006
PM 12008032
DA 2021-01-25
ER

PT J
AU Scheuring, S
   Muller, DJ
   Stahlberg, H
   Engel, HA
   Engel, A
AF Scheuring, S
   Muller, DJ
   Stahlberg, H
   Engel, HA
   Engel, A
TI Sampling the conformational space of membrane protein surfaces with the
   AFM
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Article
DE loops; beta-turns; membrane protein; two-dimensional crystal; energy
   landscape
ID ATOMIC-FORCE MICROSCOPY; ELECTRON CRYSTALLOGRAPHY; ANGSTROM RESOLUTION;
   PURPLE MEMBRANE; LIPID BILAYERS; BACTERIORHODOPSIN; TOPOGRAPHS;
   SPECTROSCOPY; AQUAPORIN-1; TOXIN
AB The atomic force microscope acquires topographs of single native membrane proteins at subnanometer resolution. Owing to the high signal-to-noise ratio, such images allow the conformational space of membrane protein surfaces to be sampled. This is demonstrated by topographs of porin OrnpF, aquaporin-Z, and bacteriorhodopsin, all recorded at a lateral resolution of <7 &ANGS; and a vertical resolution of &SIM;1 &ANGS;. The amplitudes of the domain movements were estimated from a large number of single molecule topographs and the corresponding energy landscapes calculated. To visualize the motion of protein domains, movies were generated by similarity ranking of the observed protein configurations. Electronic supplementary material to this paper can be obtained by using the Springer Link server located at http://dx.doi.org/10.1007/s00249-001-0197-8.
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
   Univ Basel, Dept Phys & Astron, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Stahlberg, Henning/H-1868-2011; Muller, Daniel J/A-5967-2010; Scheuring,
   Simon/L-9843-2018
OI Stahlberg, Henning/0000-0002-1185-4592; Muller, Daniel
   J/0000-0003-3075-0665; Scheuring, Simon/0000-0003-3534-069X
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   Czajkowsky DM, 1998, FEBS LETT, V430, P51, DOI 10.1016/S0014-5793(98)00461-X
   Czajkowsky DM, 1999, P NATL ACAD SCI USA, V96, P2001, DOI 10.1073/pnas.96.5.2001
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   HOENGER A, 1990, J STRUCT BIOL, V103, P185, DOI 10.1016/1047-8477(90)90022-5
   KARRASCH S, 1994, P NATL ACAD SCI USA, V91, P836, DOI 10.1073/pnas.91.3.836
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   Miles M, 1997, SCIENCE, V277, P1845, DOI 10.1126/science.277.5333.1845
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Mou JX, 1996, BIOPHYS J, V71, P2213, DOI 10.1016/S0006-3495(96)79422-5
   MOU JX, 1995, J MOL BIOL, V248, P507, DOI 10.1006/jmbi.1995.0238
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292
   MULLER DJ, 1995, BIOPHYS J, V68, P1681
   Muller DJ, 1999, J MOL BIOL, V285, P1903, DOI 10.1006/jmbi.1998.2441
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Muller DJ, 2000, BBA-BIOENERGETICS, V1460, P27, DOI 10.1016/S0005-2728(00)00127-4
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Oesterhelt D, 1974, Methods Enzymol, V31, P667
   PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676
   Reviakine I, 1998, J STRUCT BIOL, V121, P356, DOI 10.1006/jsbi.1998.4003
   Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031
   Sass HJ, 1997, EMBO J, V16, P1484, DOI 10.1093/emboj/16.7.1484
   SAXTON WO, 1979, ULTRAMICROSCOPY, V4, P343, DOI 10.1016/S0304-3991(79)80044-3
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   SCHABERT FA, 1994, BIOPHYS J, V67, P2394, DOI 10.1016/S0006-3495(94)80726-X
   Scheuring S, 2000, J MOL BIOL, V299, P1271, DOI 10.1006/jmbi.2000.3811
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029
   Seelert H, 2000, NATURE, V405, P418
   Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047
   UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7
   Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039
   WALZ T, 1995, NAT STRUCT BIOL, V2, P730, DOI 10.1038/nsb0995-730
NR 37
TC 50
Z9 54
U1 0
U2 15
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0175-7571
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD JUN
PY 2002
VL 31
IS 3
BP 172
EP 178
DI 10.1007/s00249-001-0197-8
PG 7
WC Biophysics
SC Biophysics
GA 573KD
UT WOS:000176827900002
PM 12029329
DA 2021-01-25
ER

PT J
AU Jung, D
   Podvinec, M
   Meyer, UA
   Mangelsdorf, DJ
   Fried, M
   Meier, PJ
   Kullak-Ublick, GA
AF Jung, D
   Podvinec, M
   Meyer, UA
   Mangelsdorf, DJ
   Fried, M
   Meier, PJ
   Kullak-Ublick, GA
TI Human organic anion transporting polypeptide 8 promoter is
   transactivated by the farnesoid X receptor/bile acid receptor
SO GASTROENTEROLOGY
LA English
DT Article
ID ORPHAN NUCLEAR RECEPTORS; CONSTITUTIVE ANDROSTANE RECEPTOR; SALT EXPORT
   PUMP; BILE-ACID; HUMAN LIVER; GENOMIC ORGANIZATION; ACTIVATED RECEPTOR;
   PROTEIN GENE; MOUSE-LIVER; REAL-TIME
AB Background & Aims: OATP8 (gene symbol: SLC21A8) is a multispecific uptake system for organic anions, xenobiotics, and peptides expressed at the basolateral (sinusoidal) membrane of human hepatocytes. We Investigated whether OATP8 gene expression is regulated by the nuclear receptors farnesold X receptor/bile acid receptor (FXR/BAR; NR1H4), pregnane X receptor (PXR), or liver X receptor (LXR). Methods: OATP8 promoter function was studied In reporter assays. OATP8 expression In cells was quantitated by real-time polymerase chain reaction. Results: The bile acid chenodeoxycholic acid (CDCA), a ligand of FXR/BAR, but not clotrimazole or 25-hydroxycholesterol, ligands of PXR or LXR, respectively, Induced OATP8 promoter activity. An Inverted hexanucleotide repeat motif (IR-1 element) In the promoter sequence was shown by electrophoretic mobility shift assays to bind the FXR (9-cis-retinoic acid receptor [RXRalpha]) heterodimer. Targeted mutagenesis of the IR-1 element abolished inducibility of the OATP8 promoter by CDCA, confirming its role as a bile acid response element. CDCA treatment Increased OATP8 messenger RNA levels In human hepatoma cells, suggesting a physiologic role for FXR-mediated OATP8 gene regulation. Conclusions: OATP8 gene expression Is regulated by bile acids via FXR/BAR. Induction of OATP8 could serve to maintain hepatic extraction of xenobiotics and peptides In conditions of Increased Intracellular bile acids.
C1 Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.
   Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.
   Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
   Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX USA.
   Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX USA.
RP Kullak-Ublick, GA (corresponding author), Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.
OI Mangelsdorf, David/0000-0002-4355-0796
CR Abe T, 2001, GASTROENTEROLOGY, V120, P1689, DOI 10.1053/gast.2001.24804
   Abe T, 1999, J BIOL CHEM, V274, P17159, DOI 10.1074/jbc.274.24.17159
   Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200
   Arrese MA, 2000, GASTROENTEROLOGY, V118, pA934, DOI 10.1016/S0016-5085(00)85874-6
   Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169
   Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0
   Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Fickert P, 2001, GASTROENTEROLOGY, V121, P170, DOI 10.1053/gast.2001.25542
   FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8
   Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161
   Ismair MG, 2001, GASTROENTEROLOGY, V121, P1185, DOI 10.1053/gast.2001.28704
   Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0
   JAVITT NB, 1989, J BIOL CHEM, V264, P10384
   Jung D, 2001, J BIOL CHEM, V276, P37206, DOI 10.1074/jbc.M103988200
   Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200
   Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156
   Kullak-Ublick GA, 2000, SEMIN LIVER DIS, V20, P273, DOI 10.1055/s-2000-9426
   Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176
   Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638
   Lee JM, 2000, GASTROENTEROLOGY, V118, P163, DOI 10.1016/S0016-5085(00)70425-2
   Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137
   Li LQ, 1998, J BIOL CHEM, V273, P16184, DOI 10.1074/jbc.273.26.16184
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7
   Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200
   Ogura K, 2000, BIOCHEM BIOPH RES CO, V272, P563, DOI 10.1006/bbrc.2000.2830
   Oswald M, 2001, LIVER, V21, P247, DOI 10.1034/j.1600-0676.2001.021004247.x
   Ourlin JC, 2000, ARCH BIOCHEM BIOPHYS, V373, P375, DOI 10.1006/abbi.1999.1566
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Satlin LM, 1997, J BIOL CHEM, V272, P26340, DOI 10.1074/jbc.272.42.26340
   SEOL WG, 1995, MOL ENDOCRINOL, V9, P72, DOI 10.1210/me.9.1.72
   SHI XY, 1995, J BIOL CHEM, V270, P25591, DOI 10.1074/jbc.270.43.25591
   Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871
   Shneider BL, 1997, HEPATOLOGY, V25, P1176, DOI 10.1002/hep.510250521
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707
   Urizar NL, 2000, J BIOL CHEM, V275, P39313, DOI 10.1074/jbc.M007998200
   Walker NJ, 2001, J BIOCHEM MOL TOXIC, V15, P121, DOI 10.1002/jbt.8
   Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5
NR 52
TC 115
Z9 117
U1 0
U2 4
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD JUN
PY 2002
VL 122
IS 7
BP 1954
EP 1966
DI 10.1053/gast.2002.33583
PG 13
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 563WQ
UT WOS:000176280300028
PM 12055601
DA 2021-01-25
ER

PT J
AU Van Gelder, P
   Dumas, F
   Bartoldus, I
   Saint, N
   Prilipov, A
   Winterhalter, M
   Wang, YF
   Philippsen, A
   Rosenbusch, JP
   Schirmer, T
AF Van Gelder, P
   Dumas, F
   Bartoldus, I
   Saint, N
   Prilipov, A
   Winterhalter, M
   Wang, YF
   Philippsen, A
   Rosenbusch, JP
   Schirmer, T
TI Sugar transport through maltoporin of Escherichia coli: Role of the
   greasy slide
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID OUTER-MEMBRANE; SALMONELLA-TYPHIMURIUM; RATE CONSTANTS; LAMB CHANNEL;
   TRANSLOCATION; MUTANTS; REVEAL; PORINS
AB The lining of the maltodextrin-specific maltoporin (LamB) channel exhibits a string of aromatic residues, the greasy slide, part of which has been shown previously by crystallography to be involved in substrate binding. To probe the functional role of the greasy slide, alanine scanning mutagenesis has been performed on the six greasy slide residues and Y118 at the channel constriction. The mutants were characterized by an in vivo uptake assay and sugar-induced-current-noise analysis. Crystallographic analysis of the W74A mutant showed no perturbation of the structure. All mutants showed considerably decreased maltose uptake rates in vivo (<10% of the wild-type value), indicating the functional importance of the investigated residues. Substitutions at the channel center revealed appreciably increased (up to 100-fold) in vitro half-saturation concentrations for maltotriose and maltohexaose binding to the channel. Sugar association rates, however, were significantly affected also by the mutations at either end of the slide (W74A, W358A, and F227A), an effect which became most apparent upon nonsymmetrical sugar addition. The kinetic data are discussed on the basis of an asymmetric one-site two-barrier model, which suggests that, at low substrate concentrations, as are found under physiological conditions, only the heights of the extracellular and periplasmic barriers, which are reduced by the presence of the greasy slide, determine the efficiency of this facilitated diffusion channel.
C1 Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Div Microbiol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Div Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch
RI Saint, Nathalie/S-5286-2016
OI Saint, Nathalie/0000-0001-5219-9486; Winterhalter,
   Mathias/0000-0002-1604-3318; Dumas, Fabrice/0000-0002-9164-4527
CR AGTERBERG M, 1990, VACCINE, V8, P85, DOI 10.1016/0264-410X(90)90184-N
   ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BENZ R, 1992, BIOCHIM BIOPHYS ACTA, V1104, P299, DOI 10.1016/0005-2736(92)90044-M
   BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137
   Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998
   BRUNGER AT, 1992, X PLOR MANUAL VERSIO
   Dumas F, 2000, J BIOL CHEM, V275, P19747, DOI 10.1074/jbc.M000268200
   Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0
   Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37
   Hilty C, 2001, PHYS REV LETT, V86, P5624, DOI 10.1103/PhysRevLett.86.5624
   Jordy M, 1996, J MOL BIOL, V259, P666, DOI 10.1006/jmbi.1996.0348
   KELLER TA, 1994, BIOCHEM BIOPH RES CO, V199, P767, DOI 10.1006/bbrc.1994.1295
   Meyer JEW, 1997, J MOL BIOL, V266, P761, DOI 10.1006/jmbi.1996.0823
   NEKOLLA S, 1994, BIOPHYS J, V66, P1388, DOI 10.1016/S0006-3495(94)80929-4
   NIKAIDO H, 1985, MICROBIOL REV, V49, P1
   Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1016/S0378-1097(98)00151-7
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCHIEPEK G, 1995, PSYCHOTHERAPIE FORUM, V3, P1
   Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946
   Van Gelder P, 2000, EUR J BIOCHEM, V267, P79, DOI 10.1046/j.1432-1327.2000.00960.x
   Van Gelder P, 2001, PROTEIN ENG, V14, P943, DOI 10.1093/protein/14.11.943
NR 22
TC 32
Z9 33
U1 1
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JUN
PY 2002
VL 184
IS 11
BP 2994
EP 2999
DI 10.1128/JB.184.11.2994-2999.2002
PG 6
WC Microbiology
SC Microbiology
GA 552AP
UT WOS:000175596400018
PM 12003940
OA Green Published, Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Bleves, S
   Marenne, MN
   Detry, G
   Cornelis, GR
AF Bleves, S
   Marenne, MN
   Detry, G
   Cornelis, GR
TI Up-regulation of the Yersinia enterocolitica yop regulon by deletion of
   the flagellum master operon flhDC
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID ESCHERICHIA-COLI; TRANSCRIPTIONAL ACTIVATOR; VIRULENCE PLASMID; III
   SECRETION; SUPRAMOLECULAR STRUCTURE; SUICIDE VECTOR; GENE; TEMPERATURE;
   HOST; EXPRESSION
AB The Yop virulon enables extracellularly located Yersinia, in close contact with a eukaryotic target cell, to inject bacterial toxic proteins directly into the cytosol of this cell. Several Ysc proteins. forming the Yop secretion apparatus, display homology with proteins of the flagellar basal body. To determine whether this relationship could extend to the regulatory pathways, we analyzed the influence of flhDC, the master regulatory operon of the flagellum, on the yop regulon. In an flhDC mutant, the yop regulon was up-regulated. The transcription of virF and the steady-state level of the transcriptional activator VirF were enhanced. yop transcription was increased at 37degreesC and could also be detected at a low temperature. Yop secretion was increased at 37degreesC and occurred even at a low temperature. The Ysc secretion machinery was thus functional at room temperature in the absence of flagella. implying that in wild-type bacteria, Flhb and/or FlhC, or the product or a gene downstream of flhDC. represses the yop regulon. In agreement with this notion, increased expression of flhDC in wild-type bacteria resulted in the oversecretion of flagellins at room temperature and in decreased Yop secretion at 37degreesC.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Louvain, Christian Duve Inst Cellular Pathol, B-1200 Brussels, Belgium.
   Univ Louvain, Fac Med, B-1200 Brussels, Belgium.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelberstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Detry, Gautier/0000-0003-2947-5563
CR BARTLETT DH, 1988, J BACTERIOL, V170, P1575, DOI 10.1128/jb.170.4.1575-1581.1988
   BERTIN P, 1994, J BACTERIOL, V176, P5537, DOI 10.1128/JB.176.17.5537-5540.1994
   Bleves S, 2000, MICROBES INFECT, V2, P1451, DOI 10.1016/S1286-4579(00)01300-9
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   CORNELIS G, 1989, J BACTERIOL, V171, P254, DOI 10.1128/jb.171.1.254-262.1989
   Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998
   CORNELIS GR, 1991, MOL MICROBIOL, V5, P1023, DOI 10.1111/j.1365-2958.1991.tb01875.x
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   DEROUVROIT CL, 1992, MOL MICROBIOL, V6, P395, DOI 10.1111/j.1365-2958.1992.tb01483.x
   Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033
   FOULTIER B, IN PRESS J MOL EVOL
   Furness RB, 1997, J BACTERIOL, V179, P5585, DOI 10.1128/jb.179.17.5585-5588.1997
   Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000
   GIVSKOV M, 1995, MOL MICROBIOL, V15, P445, DOI 10.1111/j.1365-2958.1995.tb02258.x
   Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x
   IRIARTE M, 1995, J BACTERIOL, V177, P2299, DOI 10.1128/jb.177.9.2299-2304.1995
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Kapatral V, 1996, MOL MICROBIOL, V19, P1061, DOI 10.1046/j.1365-2958.1996.452978.x
   KAPATRAL V, 1995, MOL MICROBIOL, V17, P49, DOI 10.1111/j.1365-2958.1995.mmi_17010049.x
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994
   Liu XY, 1996, MOL MICROBIOL, V21, P613, DOI 10.1111/j.1365-2958.1996.tb02569.x
   Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000
   Macnab R., 1996, ESCHERICHIA COLI SAL, P123
   MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991
   MIKULSKIS AV, 1994, MOL MICROBIOL, V14, P905, DOI 10.1111/j.1365-2958.1994.tb01326.x
   MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   Pruss BM, 1996, J BACTERIOL, V178, P668
   Rohde JR, 1999, J BACTERIOL, V181, P4198, DOI 10.1128/JB.181.14.4198-4204.1999
   ROHDE JR, 1994, MOL MICROBIOL, V12, P187, DOI 10.1111/j.1365-2958.1994.tb01008.x
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Shaw W V, 1975, Methods Enzymol, V43, P737
   SKURNIK M, 1984, J BACTERIOL, V158, P1033, DOI 10.1128/JB.158.3.1033-1036.1984
   SKURNIK M, 1992, J BACTERIOL, V174, P2047, DOI 10.1128/jb.174.6.2047-2051.1992
   SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4
   Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Young BM, 2002, J BACTERIOL, V184, P1324, DOI 10.1128/JB.184.5.1324-1334.2002
   Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999
   Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456
   Young GM, 2000, INFECT IMMUN, V68, P4323, DOI 10.1128/IAI.68.7.4323-4326.2000
NR 44
TC 46
Z9 49
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JUN
PY 2002
VL 184
IS 12
BP 3214
EP 3223
DI 10.1128/JB.184.12.3214-3223.2002
PG 10
WC Microbiology
SC Microbiology
GA 557QG
UT WOS:000175918800008
PM 12029037
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Roh, DH
   Bowers, B
   Riezman, H
   Cabib, E
AF Roh, DH
   Bowers, B
   Riezman, H
   Cabib, E
TI Rho1p mutations specific for regulation of beta(1 -> 3)glucan synthesis
   and the order of assembly of the yeast cell wall
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID GTP-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE;
   ALPHA-AGGLUTININ; CROSS-LINKING; KINASE-C; MUTANTS; CHITIN;
   BETA-1,6-GLUCAN; IDENTIFICATION
AB In the yeast Saccharomyces cerevisiae , the GTP-binding protein Rho1 is required for beta(1-->3)glucan synthase activity, for activation of protein kinase C and the cell integrity pathway and for progression in G1, cell polarization and exocytosis. A genetic screen for cells that become permeabilized at non-permissive temperature was used to isolate in vitro -generated mutants of Rho1p. After undergoing a battery of tests, several of them appeared to be specifically defective in the beta(1-->3)glucan synthesis function of Rho1p. At the non-permissive temperature (37degreesC), the mutants developed defects in the cell wall, especially at the tip of new buds. In the yeast cell wall, beta(1-->6)glucan is linked to both beta(1-->3)glucan and mannoprotein, as well as occasionally to chitin. We have used the rho1 mutants to study the order of assembly of the cell wall components. The incorporation of [(14) C]-glucose into beta(1-->3)glucan at 37degreesC was decreased or abolished in the mutants. Concomitantly, a partial defect in the incorporation of label into cell wall mannoproteins and beta(1-->6)glucan was observed. In contrast, YW3458, an inhibitor of glycosylphosphatidylinositol anchor formation, prevented mannoprotein incorporation, whereas the beta(1-->3)-beta(1-->6)glucan complex was synthesized at almost normal levels. As beta(1-->3)glucan can be synthesized in vitro or in vivo independently, we conclude that the order of addition in vivo is beta(1-->3)glucan, beta(1-->6)glucan, mannoprotein. Previous observations indicate that chitin is the last component to be incorporated into the complex.
C1 NIDDKD, Lab Biochem & Genet, Bethesda, MD 20892 USA.
   NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cabib, E (corresponding author), NIDDKD, Lab Biochem & Genet, Bldg 8,Room 403, Bethesda, MD 20892 USA.
OI Riezman, Howard/0000-0003-4680-9422
FU NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [ZIADK024945, Z01DK024945, ZIADK024945,
   ZIADK024945, Z01DK024945, Z01DK024945, Z01DK024945, Z01DK024945,
   Z01DK024945, Z01DK024945, Z01DK024945, Z01DK024945, ZIADK024945,
   Z01DK024945, Z01DK024945] Funding Source: NIH RePORTER
CR Ausubel F. A., 1997, CURRENT PROTOCOLS MO
   BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984
   BORN IJ, 1998, BIOCHIM BIOPHYS ACTA, V1425, P419
   CABIB E, 1975, J BACTERIOL, V124, P1604, DOI 10.1128/JB.124.3.1604-1606.1975
   Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200
   Crotti LB, 2001, ANAL BIOCHEM, V292, P8, DOI 10.1006/abio.2001.5051
   Drgonova J, 1999, J CELL BIOL, V146, P373, DOI 10.1083/jcb.146.2.373
   Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277
   Fraering P, 2001, MOL BIOL CELL, V12, P3295, DOI 10.1091/mbc.12.10.3295
   Georgopapadakou Nafsika H., 1995, Trends in Microbiology, V3, P98, DOI 10.1016/S0966-842X(00)88890-3
   Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029
   Guthrie C., 1991, GUIDE YEAST GENETICS
   Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656
   ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983
   Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x
   KAMADA Y, 1996, J BIOL CHEM, V271, P9173
   Kapteyn JC, 1999, MOL MICROBIOL, V31, P1835, DOI 10.1046/j.1365-2958.1999.01320.x
   Kapteyn JC, 1997, J BACTERIOL, V179, P6279, DOI 10.1128/JB.179.20.6279-6284.1997
   Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337
   Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x
   KOLLAR R, 1995, J BIOL CHEM, V270, P1170, DOI 10.1074/jbc.270.3.1170
   Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762
   KREGER DR, 1975, J GEN MICROBIOLOGY, V0092
   LEIDICH SD, 1994, J BIOL CHEM, V269, P10193
   LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X
   LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221
   Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998
   LU CF, 1995, J CELL BIOL, V128, P333, DOI 10.1083/jcb.128.3.333
   LU CF, 1994, MOL CELL BIOL, V14, P4825, DOI 10.1128/MCB.14.7.4825
   Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5
   Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511
   MAZUR P, 1995, MOL CELL BIOL, V15, P5671
   MOL PC, 1994, J BIOL CHEM, V269, P31267
   Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999
   MOUNTAIN HA, 1991, YEAST, V7, P873, DOI 10.1002/yea.320070814
   Mrsa V, 1997, YEAST, V13, P1145
   MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202
   NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x
   Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279
   Ram AFJ, 1998, FEMS MICROBIOL LETT, V162, P249, DOI 10.1016/S0378-1097(98)00130-X
   RAM AFJ, 1994, NEW APPROACH ISOLATI
   Rose M.D., 1990, METHODS YEAST GENETI
   Saka A, 2001, J BIOL CHEM, V276, P46165, DOI 10.1074/jbc.M103805200
   Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x
   SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111
   SHEMATEK EM, 1980, J BIOL CHEM, V255, P888
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639
   Sutterlin C, 1997, EMBO J, V16, P6374, DOI 10.1093/emboj/16.21.6374
   TORRES L, 1991, MOL MICROBIOL, V5, P2845, DOI 10.1111/j.1365-2958.1991.tb01993.x
   VANTUINEN E, 1987, J HISTOCHEM CYTOCHEM, V35, P327, DOI 10.1177/35.3.3546482
   YAMOCHI W, 1994, J CELL BIOL, V125, P1077, DOI 10.1083/jcb.125.5.1077
   Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013
   ZLOTNIK H, 1984, J BACTERIOL, V159, P1018, DOI 10.1128/JB.159.3.1018-1026.1984
NR 54
TC 29
Z9 33
U1 0
U2 2
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JUN
PY 2002
VL 44
IS 5
BP 1167
EP 1183
DI 10.1046/j.1365-2958.2002.02955.x
PG 17
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 556GQ
UT WOS:000175841400005
PM 12068804
OA Bronze
DA 2021-01-25
ER

PT J
AU Ahrens, T
   Pertz, O
   Haussinger, D
   Fauser, C
   Schulthess, T
   Engel, J
AF Ahrens, T
   Pertz, O
   Haussinger, D
   Fauser, C
   Schulthess, T
   Engel, J
TI Analysis of heterophilic and homophilic interactions of cadherins using
   the c-jun/c-fos dimerization domains
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CELL-ADHESION MOLECULES; CRYSTAL-STRUCTURE; CLASSIC CADHERINS;
   CALCIUM-BINDING; LEUCINE ZIPPERS; STREP-TAG; PROTEINS; PURIFICATION;
   ULTRASTRUCTURE; SPECIFICITIES
AB Cadherin-mediated cell-cell adhesion is initiated by cis dimerization of cadherin ectodomains at the cell surface followed by an antiparallel trans interaction of dimers on opposing cells. To resolve open questions concerning the molecular details and specificity of cis and trans interactions, ectodomains of E- and P-cadherin were analyzed by chemical cross-linking and by electron microscopy. At the high intrinsic concentration created by artificial oligomerization the N-terminal cadherin (CAD)-domain of P-cadherin are forming ring-like cis dimers. At 2 mm Ca2+-associated rings involving two cis dimers indicate trans contacts in electron micrographs. cis and trans interactions were further analyzed by heterodimerization of the ectodomains of E-cadherin (ECAD) and P-cadherin (PCAD) through the leucine zipper domains of c-Jun and c-Fos. ECADJun/ECADFos dimers predominantly form ring-like cis dimers at 1 mm Ca2+ and double-ringed trans contacts above 2 mm Ca2+. The Ca2+-dependent tetrameric trans contacts of ECADJun/ECADFos dimers are also detectable after chemical cross-linking. Only cis contacts but no trans interactions are observed for heterodimers of ECADFos and the Trp-2 to Ala mutant ECADW2AJun arguing for a decisive role of Trp-2 in trans but not cis interaction. Neither cis nor trans interaction was found for heterodimers of ECADJun and PCADFos suggesting that specificity for homophilic interactions already exists at the level of cis dimerization.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Haussinger, Daniel/C-6617-2016
OI Haussinger, Daniel/0000-0002-4798-0072; pertz,
   olivier/0000-0001-8579-4919
CR Angst BD, 2001, J CELL SCI, V114, P629
   Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697
   BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088
   BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349
   Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783
   CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408
   Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143
   Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+
   ENGEL J, 1994, METHOD ENZYMOL, V245, P469
   Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0
   GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   INUZUKA H, 1991, NEURON, V7, P69, DOI 10.1016/0896-6273(91)90075-B
   Jun CD, 2001, J BIOL CHEM, V276, P29019, DOI 10.1074/jbc.M103394200
   Kalandadze A, 1996, J BIOL CHEM, V271, P20156, DOI 10.1074/jbc.271.33.20156
   Klingelhofer J, 2000, J CELL SCI, V113, P2829
   Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   KOSTELNY SA, 1992, J IMMUNOL, V148, P1547
   Leckband D, 2000, CURR OPIN CELL BIOL, V12, P587, DOI 10.1016/S0955-0674(00)00136-8
   Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761
   Miyaguchi K, 2000, J STRUCT BIOL, V132, P169, DOI 10.1006/jsbi.2000.4244
   MURPHYERDOSH C, 1995, J CELL BIOL, V129, P1379, DOI 10.1083/jcb.129.5.1379
   NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z
   NOSE A, 1987, EMBO J, V6, P3655, DOI 10.1002/j.1460-2075.1987.tb02698.x
   NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6
   OLDBERG A, 1992, J BIOL CHEM, V267, P22346
   OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872
   Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738
   POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x
   SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6
   Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231
   Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765
   Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579
   SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0
   Shapiro L, 1998, CURR OPIN NEUROBIOL, V8, P593, DOI 10.1016/S0959-4388(98)80086-X
   Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820
   Skerra A, 2000, METHOD ENZYMOL, V326, P271
   TAKEICHI M, 1988, DEVELOPMENT, V102, P639
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1
   Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x
   VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183
   VOLK T, 1987, CELL, V50, P987, DOI 10.1016/0092-8674(87)90525-3
NR 44
TC 34
Z9 34
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 31
PY 2002
VL 277
IS 22
BP 19455
EP 19460
DI 10.1074/jbc.M200606200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 557EH
UT WOS:000175894800030
PM 11909859
DA 2021-01-25
ER

PT J
AU Voss, TS
   Mini, T
   Jenoe, P
   Beck, HP
AF Voss, TS
   Mini, T
   Jenoe, P
   Beck, HP
TI Plasmodium falciparum possesses a cell cycle-regulated short type
   replication protein A large subunit encoded by an unusual transcript
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SINGLE-STRANDED-DNA; SIMIAN VIRUS-40 DNA; STAGE-SPECIFIC EXPRESSION;
   POLYMERASE-ALPHA; BINDING-PROTEIN; MALARIA PARASITE; FACTOR-A; MOLECULAR
   CHARACTERIZATION; CRITHIDIA-FASCICULATA; FUNCTIONAL DOMAINS
AB DNA replication in Plasmodium parasites takes place at multiple distinct points during their complex life cycle in the mosquito and vertebrate hosts. Although several parasite proteins involved in DNA replication have been described, the various mechanisms engaged in DNA metabolism of this major pathogen remain largely unexplored. As a step toward understanding this complex network, we describe the identification of Plasmodium falciparum replication protein A large subunit (pfRPA1) through affinity purification and mass spectral analysis of a purified 55-kDa factor. Gel retardation experiments revealed that pfRPA is the major single-stranded DNA binding activity in parasite protein extracts. The activity was expressed in a cell cycle-dependent manner with peak activities in late trophozoites and schizonts, thus correlating with the beginning of chromosomal DNA replication. Accordingly, the pfrpa1 message was detected in parasites 20-24 h post-invasion which is in agreement with the expression of other P. falciparum DNA replication genes. Our results show that pfRPA1 is encoded by an unusual 6.5-kb transcript containing a single open reading frame of which only the C-terminal 42% of the deduced protein sequence shows homologies to other reported RPA1s. Like the orthologues of other protozoan parasites, pfRPA1 lacks the N-terminal protein interaction domain and is thus remarkably smaller than the RPA1s of higher eukaryotes.
C1 Swiss Trop Inst, Dept Med Parasitol & Infect Biol, CH-4051 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Beck, HP (corresponding author), Swiss Trop Inst, Dept Med Parasitol & Infect Biol, Socinstr 59, CH-4051 Basel, Switzerland.
OI Beck, Hans-Peter/0000-0001-8326-4834
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993
   Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964
   Braun KA, 1997, BIOCHEMISTRY-US, V36, P8443, DOI 10.1021/bi970473r
   BRILL SJ, 1989, NATURE, V342, P92, DOI 10.1038/342092a0
   BROWN GW, 1994, MOL BIOCHEM PARASIT, V63, P135, DOI 10.1016/0166-6851(94)90016-7
   BROWN GW, 1992, P NATL ACAD SCI USA, V89, P10227, DOI 10.1073/pnas.89.21.10227
   Brush GS, 1995, METHOD ENZYMOL, V262, P522
   Carlton J, 2000, PARASITOL TODAY, V16, P409, DOI 10.1016/S0169-4758(00)01781-6
   CHAVALITSHEWINKOON P, 1993, MOL BIOCHEM PARASIT, V61, P243, DOI 10.1016/0166-6851(93)90070-E
   CHEESMAN S, 1994, NUCLEIC ACIDS RES, V22, P2547, DOI 10.1093/nar/22.13.2547
   Cheesman S, 1998, MOL BIOCHEM PARASIT, V92, P39, DOI 10.1016/S0166-6851(97)00223-5
   Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289
   DORNREITER I, 1992, EMBO J, V11, P769, DOI 10.1002/j.1460-2075.1992.tb05110.x
   DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0
   ERDILE LF, 1991, J BIOL CHEM, V266, P12090
   FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x
   FIRMENICH AA, 1995, MOL CELL BIOL, V15, P1620
   FOX BA, 1993, MOL BIOCHEM PARASIT, V61, P37, DOI 10.1016/0166-6851(93)90156-R
   FOX BA, 1991, MOL BIOCHEM PARASIT, V49, P289, DOI 10.1016/0166-6851(91)90072-E
   GarciaMaya MM, 1997, FEBS LETT, V413, P181, DOI 10.1016/S0014-5793(97)00897-1
   Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126
   GEORGAKI A, 1992, FEBS LETT, V308, P240, DOI 10.1016/0014-5793(92)81283-R
   GEORGAKI A, 1993, NUCLEIC ACIDS RES, V21, P3659, DOI 10.1093/nar/21.16.3659
   Gomes XV, 1996, BIOCHEMISTRY-US, V35, P10558, DOI 10.1021/bi9607517
   HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0
   HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F
   HOPPESEYLER F, 1991, NUCLEIC ACIDS RES, V19, P5080, DOI 10.1093/nar/19.18.5080
   Horrocks P, 1996, MOL BIOCHEM PARASIT, V79, P177, DOI 10.1016/0166-6851(96)02657-6
   INSELBURG J, 1984, MOL BIOCHEM PARASIT, V10, P79, DOI 10.1016/0166-6851(84)90020-3
   Ishiai M, 1996, J BIOL CHEM, V271, P20868, DOI 10.1074/jbc.271.34.20868
   JAIKARIA NS, 1993, MOL BIOCHEM PARASIT, V57, P269, DOI 10.1016/0166-6851(93)90203-A
   KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757
   KILBEY BJ, 1993, NUCLEIC ACIDS RES, V21, P239, DOI 10.1093/nar/21.2.239
   KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050
   Kim DK, 1996, J BIOL CHEM, V271, P15124, DOI 10.1074/jbc.271.25.15124
   Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0
   LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287
   LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B
   LI WB, 1989, NUCLEIC ACIDS RES, V17, P9621, DOI 10.1093/nar/17.23.9621
   LI WB, 1991, MOL BIOCHEM PARASIT, V46, P229, DOI 10.1016/0166-6851(91)90047-A
   Lin YL, 1996, J BIOL CHEM, V271, P17190, DOI 10.1074/jbc.271.29.17190
   LONGHESE MP, 1994, MOL CELL BIOL, V14, P7884, DOI 10.1128/MCB.14.12.7884
   Martin D, 2000, MOL BIOCHEM PARASIT, V110, P93, DOI 10.1016/S0166-6851(00)00260-7
   Matsunaga T, 1996, J BIOL CHEM, V271, P11047, DOI 10.1074/jbc.271.19.11047
   MCCUTCHAN TF, 1984, SCIENCE, V225, P808, DOI 10.1126/science.6382604
   MELENDY T, 1993, J BIOL CHEM, V268, P3389
   Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996
   POLLACK Y, 1982, NUCLEIC ACIDS RES, V10, P539, DOI 10.1093/nar/10.2.539
   RIDLEY RG, 1991, NUCLEIC ACIDS RES, V19, P6731, DOI 10.1093/nar/19.24.6731
   Scaife J.G., 1988, Genetic Engineering, V7, P57
   SEROUSSI E, 1993, J BIOL CHEM, V268, P7147
   Stahl DC, 1996, J AM SOC MASS SPECTR, V7, P532, DOI 10.1016/1044-0305(96)00057-8
   TOSH K, 1995, GENE, V163, P151, DOI 10.1016/0378-1119(95)00376-H
   Tosh K, 1999, EXP PARASITOL, V91, P126, DOI 10.1006/expr.1998.4362
   TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0
   Treuner K, 1996, J MOL BIOL, V259, P104, DOI 10.1006/jmbi.1996.0305
   TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x
   TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961
   TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950
   Voss TS, 2000, MOL BIOCHEM PARASIT, V107, P103, DOI 10.1016/S0166-6851(00)00176-6
   WEBER JL, 1987, GENE, V52, P103, DOI 10.1016/0378-1119(87)90399-4
   White JH, 1996, PARASITOL TODAY, V12, P151, DOI 10.1016/0169-4758(96)10005-3
   WHITE JH, 1993, NUCLEIC ACIDS RES, V21, P3643, DOI 10.1093/nar/21.16.3643
   WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834
   Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61
   WOLD MS, 1989, J BIOL CHEM, V264, P2801
   WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523
   YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020
   Zhu G, 1999, FEMS MICROBIOL LETT, V176, P367, DOI 10.1111/j.1574-6968.1999.tb13685.x
NR 70
TC 42
Z9 44
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 17
PY 2002
VL 277
IS 20
BP 17493
EP 17501
DI 10.1074/jbc.M200100200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 553PR
UT WOS:000175685100015
PM 11880371
OA Bronze
DA 2021-01-25
ER

PT J
AU Fotiadis, D
   Suda, K
   Tittmann, P
   Jeno, P
   Philippsen, A
   Muller, DJ
   Gross, H
   Engel, A
AF Fotiadis, D
   Suda, K
   Tittmann, P
   Jeno, P
   Philippsen, A
   Muller, DJ
   Gross, H
   Engel, A
TI Identification and structure of a putative Ca2+-binding domain at the C
   terminus of AQP1
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE aquaporin-1; atomic force microscopy; calcium-binding protein; electron
   microscopy; mass spectrometry
ID CHIP28 WATER CHANNEL; INTEGRAL MEMBRANE-PROTEIN; ATOMIC-FORCE
   MICROSCOPE; CALCIUM-FREE CALMODULIN; AQUAPORIN CHIP; ELECTRON
   CRYSTALLOGRAPHY; 3-DIMENSIONAL STRUCTURE; RESOLUTION; PROJECTION;
   TRANSPORT
AB Aquaporin-1 (AQP1) is the first functionally identified aquaporin of a growing family of membrane water channels found in all forms of life. Recently, a possible secondary function as a cyclic guanosine monophosphate (cGMP) gated ion channel was attributed to AQP1. We have reconstituted purified protein from bovine and human red blood cell membranes into highly ordered 2D crystals. The topography of both AQP1s was determined by electron microscopy from freeze-dried, unidirectionally metal-shadowed 2D crystals as well as from surface topographs of native crystals recorded in buffer solution with the atomic force microscope (AFM). In spite of the high level of sequence homology between bovine and human AQP1, the surfaces showed distinct differences. Alignment of both sequences and comparison of the acquired surface topographies with the atomic model of human AQP1 revealed the topographic changes on the surface of bovine AQP1 to be induced by a few amino acid substitutions. A striking degree of sequence homology was found between the carboxyl-terminal domains of AQP1s from different organisms and EF-hands from Ca2+-binding proteins belonging to the calmodulin superfamily, suggesting the existence of a Ca2+-binding site at the C terminus of AQP1 instead of the putative cGMP-binding site reported previously. To unveil its position on the acquired surface topographies, 2D crystals of AQP1 were digested with carboxypeptidase Y, which cleaves off the intracellular C terminus. Difference maps of AFM topographs between the native and the peptidase-treated AQP1s showed the carboxylic tail to be close to the 4-fold symmetry axis of the tetramer. SDS-PAGE and matrix-assisted laser desorption/ionisation mass spectrometry of native and decarboxylated bovine and human AQP1 revealed that the EF-hand motif found at the C terminus of AQP1 was partially resistant to peptidase digestion. The importance of the C-terminal domain is implicated by structural instability of decarboxylated AQP1. A possible role of the C terminus and calcium in translocation of AQP1 in cholangiocytes from intracellular vesicles to the plasma membrane and in triggering its fusion is discussed. Functional studies are now required to identify the physiological role of the Ca2+-binding site. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, ME Muller Inst Microscopy, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Fed Inst Technol, Inst Appl Phys, CH-8093 Zurich, Switzerland.
   Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
   Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
RP Engel, A (corresponding author), Univ Basel, ME Muller Inst Microscopy, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
RI Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665
CR Anthony TL, 2000, MOL PHARMACOL, V57, P576
   BENREZZAK O, 1994, DIGESTION, V55, P78, DOI 10.1159/000201129
   Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425
   Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   DENKER BM, 1988, J BIOL CHEM, V263, P15634
   FOROOD B, 1993, P NATL ACAD SCI USA, V90, P838, DOI 10.1073/pnas.90.3.838
   FRANK J, 1978, ULTRAMICROSCOPY, V3, P283, DOI 10.1016/S0304-3991(78)80038-2
   FRANK J, 1981, SCIENCE, V214, P1353, DOI 10.1126/science.7313694
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Fuchs K. H., 1995, Bioimaging, V3, P12, DOI 10.1002/1361-6374(199503)3:1<12::AID-BIO2>3.3.CO;2-U
   Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800
   Gross H., 1990, P 12 INT C EL MICR S, P510
   Gunasekaran K, 1998, J MOL BIOL, V275, P917, DOI 10.1006/jmbi.1997.1505
   Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   JAP BK, 1995, J MOL BIOL, V251, P413, DOI 10.1006/jmbi.1995.0444
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235
   KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768
   Kwon TH, 2001, SEMIN NEPHROL, V21, P231, DOI 10.1053/snep.2001.21647
   Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263
   Ma TH, 2001, AM J PHYSIOL-CELL PH, V280, pC126
   MACEY RI, 1970, BIOCHIM BIOPHYS ACTA, V211, P104, DOI 10.1016/0005-2736(70)90130-6
   Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984
   MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084
   MITRA AK, 1995, NAT STRUCT BIOL, V2, P726, DOI 10.1038/nsb0995-726
   MITRA AK, 1994, BIOCHEMISTRY-US, V33, P12735, DOI 10.1021/bi00209a001
   Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275
   Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120
   PATIL RV, 1994, BIOCHEM BIOPH RES CO, V204, P861, DOI 10.1006/bbrc.1994.2539
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   PRESTON GM, 1994, J BIOL CHEM, V269, P1668
   PRESTON GM, 1993, J BIOL CHEM, V268, P17
   PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110
   Prieto J, 1997, J MOL BIOL, V274, P276, DOI 10.1006/jmbi.1997.1322
   Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198
   ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7
   Saparov SM, 2001, J BIOL CHEM, V276, P31515, DOI 10.1074/jbc.M104267200
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   SCHABERT FA, 1994, BIOPHYS J, V67, P2394, DOI 10.1016/S0006-3495(94)80726-X
   SMITH BL, 1991, J BIOL CHEM, V266, P6407
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x
   UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7
   VANHOEK AN, 1991, J BIOL CHEM, V266, P16633
   VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   WALZ T, 1995, NAT STRUCT BIOL, V2, P730, DOI 10.1038/nsb0995-730
   Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512
   Walz T, 1996, J MOL BIOL, V264, P907, DOI 10.1006/jmbi.1996.0686
   Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606
   Zardoya R, 2001, J MOL EVOL, V52, P391, DOI 10.1007/s002390010169
   ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042
   ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002
NR 62
TC 53
Z9 54
U1 1
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 17
PY 2002
VL 318
IS 5
BP 1381
EP 1394
DI 10.1016/S0022-2836(02)00143-2
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 554ZU
UT WOS:000175767900017
PM 12083525
DA 2021-01-25
ER

PT J
AU Crespo, JL
   Powers, T
   Fowler, B
   Hall, MN
AF Crespo, JL
   Powers, T
   Fowler, B
   Hall, MN
TI The TOR-controlled transcription activators GLN3, RTG1, and RTG3 are
   regulated in response to intracellular levels of glutamine
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID PHOSPHATIDYLINOSITOL KINASE HOMOLOG; P70 S6 KINASE;
   SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAY; NUCLEAR-LOCALIZATION;
   GENE-EXPRESSION; YEAST; RAPAMYCIN; MITOCHONDRIA; PROGRESSION
AB The essential, rapamycin-sensitive TOR kinases regulate a diverse set of cell growth-related readouts in response to nutrients. Thus, the yeast TOR proteins function as nutrient sensors, in particular as sensors of nitrogen and possibly carbon. However, the nutrient metabolite(s) that acts upstream of TOR is unknown. We investigated the role of glutamine, a preferred nitrogen source and a key intermediate in yeast nitrogen metabolism, as a possible regulator of TOR. We show that the glutamine synthetase inhibitor L-methionine sulfoximine (MSX) specifically provokes glutamine depletion in yeast cells. MSX-induced glutamine starvation caused nuclear localization and activation of the TOR-inhibited transcription factors GLN3, RTG1, and RTG3, all of which mediate glutamine synthesis. The MSX-induced nuclear localization of GLN3 required the TOR-controlled, type 2A-related phosphatase SIT4. Other TOR-controlled transcription factors, GAT1/NIL1, MSN2, MSN4, and an unknown factor involved in the expression of ribosomal protein genes, were not affected by glutamine starvation. These findings suggest that the TOR pathway senses glutamine. Furthermore, as glutamine starvation affects only a subset of TOR-controlled transcription factors, TOR appears to discriminate between different nutrient conditions to elicit a response appropriate to a given condition.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
   Univ Calif Davis, Div Biol Sci, Sect Mol & Cellular Biol, Davis, CA 95616 USA.
   Univ Calif Davis, Div Biol Sci, Ctr Genet & Dev, Davis, CA 95616 USA.
   Univ Basel, Childrens Hosp, CH-4005 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Crespo, Jose L/L-3977-2014
OI Crespo, Jose L/0000-0003-3514-1025; Hall, Michael N/0000-0002-2998-0757
CR Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   BENJAMIN PM, 1989, MOL GEN GENET, V217, P370, DOI 10.1007/BF02464906
   Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   COFFMAN JA, 1995, J BACTERIOL, V177, P6910, DOI 10.1128/jb.177.23.6910-6918.1995
   Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586
   Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110
   Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z
   Liu ZC, 1999, MOL CELL BIOL, V19, P6720
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   MAGASANIK B, 1992, MOL CELLULAR BIOL YE, V2, P283
   MANNING JM, 1969, BIOCHEMISTRY-US, V8, P2681, DOI 10.1021/bi00834a066
   MITCHELL AP, 1983, J BIOL CHEM, V258, P119
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103
   Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6
   SHERMAN F, 1991, P3
   Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556
   STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450
   Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
NR 29
TC 226
Z9 227
U1 0
U2 17
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 14
PY 2002
VL 99
IS 10
BP 6784
EP 6789
DI 10.1073/pnas.102687599
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 552TZ
UT WOS:000175637300049
PM 11997479
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Rutishauser, J
   Spiess, M
AF Rutishauser, J
   Spiess, M
TI Endoplasmic reticulum storage diseases
SO SWISS MEDICAL WEEKLY
LA English
DT Review
DE endoplasmic reticulum; storage disease; quality control; protein
   folding; protein degradation
ID TRANSMEMBRANE CONDUCTANCE REGULATOR; NEPHROGENIC DIABETES-INSIPIDUS;
   CYSTIC-FIBROSIS GENE; GOLGI INTERMEDIATE COMPARTMENT; PREPROPARATHYROID
   HORMONE GENE; MISFOLDED SECRETORY PROTEIN; SIGNAL PEPTIDE;
   INTRACELLULAR-TRANSPORT; MOLECULAR CHAPERONES; TRANSCRIPTION FACTOR
AB The endoplasmic reticulum represents the cell's quality control site for accurate folding of secretory and membrane proteins. Quality control is achieved through the association of ER chaperones with unfolded or misfolded polypeptide chains. In the ER stress response, upregulation of chaperones occurs as a consequence of misfolded proteins accumulating in the ER lumen; if these proteins fail to assume their native structure, they are retained in the ER and targeted for degradation by the proteasome. ER storage diseases (ERSDs) are a group of genetically based disorders in which mutant proteins fail to pass the ER quality control. Because all eukaryotic cells contain the ER, the clinical phenotype of ERSDs is very heterogeneous. Disease may result from the mere lack of the mutant protein in question and/or nay be caused indirectly by toxic effects of the misfolded protein or aggregates thereof on the cell. Additionally, the cell's reaction to the ER stress may include signaling pathways which are ultimately detrimental.
   Experimentally, ERSDs serve as models to study the cellular reactions to a variety of perturbations. In particular, understanding the links between ER stress and cell degeneration may give valuable insights into the pathogenesis of other diseases where the accumulation of indigestible toxic material leads to cell injury.
C1 Univ Basel Hosp, Med Clin A, Dept Med, CH-4031 Basel, Switzerland.
   Univ Basel Hosp, Div Endocrinol Metab & Clin Nutr, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Biochem, Basel, Switzerland.
RP Rutishauser, J (corresponding author), Univ Basel Hosp, Med Clin A, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland.
EM j.rutishauser@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
CR Akabas MH, 2000, J BIOL CHEM, V275, P3729, DOI 10.1074/jbc.275.6.3729
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   ARNOLD A, 1990, J CLIN INVEST, V86, P1084, DOI 10.1172/JCI114811
   BARTLETT JD, 1992, J BIOL CHEM, V267, P20465
   BERGERON C, 1991, ACTA NEUROPATHOL, V81, P345, DOI 10.1007/BF00305879
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326
   Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965
   Bichet DG, 1998, CONT ENDOCRINOL, V6, P167
   BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835
   Cabral CM, 2000, J BIOL CHEM, V275, P25015, DOI 10.1074/jbc.M910172199
   CARLSON JA, 1989, J CLIN INVEST, V83, P1183, DOI 10.1172/JCI113999
   CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736
   Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459
   Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111
   CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8
   CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615
   Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727
   Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002
   Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4
   DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920
   DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421
   DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0
   DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551
   Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485
   Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882
   ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202
   ERIKSSON S, 1975, NEW ENGL J MED, V292, P176, DOI 10.1056/NEJM197501232920403
   Fagioli C, 2001, J BIOL CHEM, V276, P40962, DOI 10.1074/jbc.M107456200
   French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917
   Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101
   Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399
   Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443
   Halaban R, 2000, P NATL ACAD SCI USA, V97, P5889, DOI 10.1073/pnas.97.11.5889
   Hansen LK, 1997, TRENDS ENDOCRIN MET, V8, P363, DOI 10.1016/S1043-2760(97)00157-4
   Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384
   Inaba S, 2001, J CLIN ENDOCR METAB, V86, P381, DOI 10.1210/jc.86.1.381
   ITO M, 1991, J CLIN INVEST, V87, P725, DOI 10.1172/JCI115052
   Ito M, 1997, J CLIN INVEST, V99, P1897, DOI 10.1172/JCI119357
   Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200
   Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303
   JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4
   Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799
   Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731
   Katsumi A, 1996, BLOOD, V87, P4164, DOI 10.1182/blood.V87.10.4164.bloodjournal87104164
   KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460
   Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517
   Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909
   KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29
   Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173
   Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052
   LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006
   LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642
   LE AQ, 1994, J BIOL CHEM, V269, P7514
   Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702
   LEHRMAN MA, 1987, J BIOL CHEM, V262, P401
   LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311
   Lin L, 2001, J BIOL CHEM, V276, P33893, DOI 10.1074/jbc.M105226200
   LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0
   MedeirosNeto G, 1996, J CLIN INVEST, V98, P2838, DOI 10.1172/JCI119112
   Mulders SM, 1997, J AM SOC NEPHROL, V8, P242
   Mulders SM, 1998, J CLIN INVEST, V102, P57, DOI 10.1172/JCI2605
   MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4
   Muresan Z, 1997, J BIOL CHEM, V272, P26095, DOI 10.1074/jbc.272.42.26095
   Muresan Z, 1998, MOL ENDOCRINOL, V12, P458, DOI 10.1210/me.12.3.458
   NAGAI I, 1984, ACTA ENDOCRINOL-COP, V105, P318, DOI 10.1530/acta.0.1050318
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Olias G, 1996, DNA CELL BIOL, V15, P929, DOI 10.1089/dna.1996.15.929
   OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203
   Pahl HL, 1999, PHYSIOL REV, V79, P683
   PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x
   Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6
   Pasel K, 2000, J CLIN ENDOCR METAB, V85, P1703, DOI 10.1210/jc.85.4.1703
   PASYK EA, 1995, J BIOL CHEM, V270, P12347, DOI 10.1074/jbc.270.21.12347
   PERLMUTTER DH, 1989, J CLIN INVEST, V84, P1555, DOI 10.1172/JCI114332
   Pier GB, 2000, P NATL ACAD SCI USA, V97, P8822, DOI 10.1073/pnas.97.16.8822
   Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540
   PIND S, 1994, J BIOL CHEM, V269, P12784
   Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6
   Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363
   Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791
   RACCHI M, 1993, J BIOL CHEM, V268, P5735
   RIORDAN JR, 1989, SCIENCE, V245, P1066
   Rutishauser J, 1996, J CLIN ENDOCR METAB, V81, P192, DOI 10.1210/jc.81.1.192
   Sadeghi H, 1997, MOL ENDOCRINOL, V11, P1806, DOI 10.1210/me.11.12.1806
   Schubert U, 2000, NATURE, V404, P770
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Seppen J, 1996, FEBS LETT, V390, P294, DOI 10.1016/0014-5793(96)00677-1
   Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001
   Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7
   Siggaard C, 1999, J CLIN ENDOCR METAB, V84, P2933, DOI 10.1210/jc.84.8.2933
   Sunthornthepvarakul T, 1999, J CLIN ENDOCR METAB, V84, P3792, DOI 10.1210/jc.84.10.3792
   Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303
   Tamarappoo BK, 1999, J BIOL CHEM, V274, P34825, DOI 10.1074/jbc.274.49.34825
   Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200
   Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1
   Trombetta ES, 2000, J CELL BIOL, V148, P1123, DOI 10.1083/jcb.148.6.1123
   TSUKAGUCHI H, 1995, J CLIN INVEST, V96, P2043, DOI 10.1172/JCI118252
   Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619
   WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6
   WATZKE HH, 1991, J CLIN INVEST, V88, P1685, DOI 10.1172/JCI115484
   Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0
   Wine JJ, 1999, J CLIN INVEST, V103, P309, DOI 10.1172/JCI6222
   Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3
   WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014
   Yang BX, 2001, J BIOL CHEM, V276, P2775, DOI 10.1074/jbc.M008216200
   YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480
   Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1
   Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982
NR 110
TC 94
Z9 98
U1 0
U2 7
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
EI 1424-3997
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD MAY 4
PY 2002
VL 132
IS 17-18
BP 211
EP 222
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA 576LJ
UT WOS:000177006300001
PM 12087487
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Baader, M
   Gnerre, C
   Stegeman, JJ
   Meyer, UA
AF Baader, M
   Gnerre, C
   Stegeman, JJ
   Meyer, UA
TI Transcriptional activation of cytochrome P450CYP2C45 by drugs is
   mediated by the chicken xenobiotic receptor (CXR) interacting with a
   phenobarbital response enhancer unit
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CONSTITUTIVE ANDROSTANE RECEPTOR; ORPHAN NUCLEAR RECEPTOR; PREGNANE-X
   RECEPTOR; GENE; IDENTIFICATION; INDUCTION; EXPRESSION; ELEMENT; CYP2H1;
   UPDATE
AB Cytochromes P450 (CYP)-2C enzymes fulfill an important role in xenobiotic metabolism and therefore have extensively been studied in rodents and humans. However, no CYP2C genes have been described in avian species to date. In this paper, we report the cloning, functional analysis, and regulation of chicken CYP2C45. The sequence shares up to 58% amino acid identity with CYP2Cs in other species. The overexpression of CYP2C45 in chicken hepatoma cells leghorn male hepatoma (LMH) led to increased scoparone metabolism. CYP2C45 regulation was studied in LMH cells at the mRNA level and in reporter gene assays using a construct containing 2.6 kb of its 5'-flanking region. Exposure of LMH cells to phenobarbital or metyrapone led to a 95- or 210-fold increase in CYP2C45 mRNA and a 140- or 290-fold increase in reporter gene expression, respectively. A phenobarbital response enhancer unit (PBRU) of 239 bp containing a DR-4 nuclear receptor binding site was identified within the 2.6-kb fragment. Site-specific mutation of the DR-4 revealed the requirement of this motif for CYP2C45 induction by drugs. The chicken xenobiotic receptor CXR interacted with the PBRU in electromobility shift and transactivation assays. Furthermore, the related nuclear receptors, mouse PXR and mouse CAR, transactivated this enhancer element, suggesting evolutionary conservation of nuclear receptor-DNA interactions in CYP2C induction.
C1 Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Urs-A.Meyer@unibas.ch
FU NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS)
   [P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381,
   P42ES007381, P42ES007381, P42ES007381, P42ES007381, P42ES007381] Funding
   Source: NIH RePORTER; NIEHS NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Environmental Health Sciences (NIEHS) [P42 ES07381] Funding
   Source: Medline
CR Czerniak R, 2001, INT J TOXICOL, V20, P161, DOI 10.1080/109158101317097746
   Gerbal-Chaloin S, 2001, DRUG METAB DISPOS, V29, P242
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149
   IOANNIDES C, 1996, HUMAN CYP2C, P162
   JAISWAL AK, 1990, NUCLEIC ACIDS RES, V18, P4237, DOI 10.1093/nar/18.14.4237
   Kemper B, 1998, PROG NUCLEIC ACID RE, V61, P25, DOI 10.1016/S0079-6603(08)60824-7
   Kim J, 2001, J BIOL CHEM, V276, P7559, DOI 10.1074/jbc.M008090200
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Klose TS, 1999, J BIOCHEM MOL TOXIC, V13, P289, DOI 10.1002/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N
   LeCluyse EL, 2001, CHEM-BIOL INTERACT, V134, P283, DOI 10.1016/S0009-2797(01)00163-6
   LEVY RH, 1995, EPILEPSIA, V36, pS8, DOI 10.1111/j.1528-1157.1995.tb06007.x
   Masahiko N, 2000, EUR J PHARM SCI, V11, P259, DOI 10.1016/S0928-0987(00)00112-3
   McGinnity DF, 2000, DRUG METAB DISPOS, V28, P1327
   Meyer RP, 2001, BIOCHEM BIOPH RES CO, V285, P32, DOI 10.1006/bbrc.2001.5111
   Michalets EL, 1998, PHARMACOTHERAPY, V18, P84
   MOREL F, 1990, EUR J BIOCHEM, V191, P437, DOI 10.1111/j.1432-1033.1990.tb19140.x
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   Okey AB, 1992, PHARMACOGENETICS DRU, P549
   Ourlin JC, 2000, ARCH BIOCHEM BIOPHYS, V373, P375, DOI 10.1006/abbi.1999.1566
   Pereira TM, 1998, DNA CELL BIOL, V17, P39, DOI 10.1089/dna.1998.17.39
   Quattrochi LC, 2001, DRUG METAB DISPOS, V29, P615
   RETTIE AE, 1992, CHEM RES TOXICOL, V5, P54, DOI 10.1021/tx00025a009
   Schuetz JD, 1996, MOL PHARMACOL, V49, P63
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Warrington JS, 2000, DRUG METAB DISPOS, V28, P392
   YASUMORI T, 1993, PHARMACOGENETICS, V3, P291, DOI 10.1097/00008571-199312000-00003
NR 34
TC 27
Z9 28
U1 0
U2 10
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 3
PY 2002
VL 277
IS 18
BP 15647
EP 15653
DI 10.1074/jbc.M109882200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 550PA
UT WOS:000175510400058
PM 11867618
OA Bronze
DA 2021-01-25
ER

PT J
AU Hellstern, S
   Sasaki, T
   Fauser, C
   Lustig, A
   Timpl, R
   Engel, J
AF Hellstern, S
   Sasaki, T
   Fauser, C
   Lustig, A
   Timpl, R
   Engel, J
TI Functional studies on recombinant domains of Mac-2-binding protein
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MAC-2 BINDING-PROTEIN; CYSTEINE-RICH DOMAIN; RING-LIKE STRUCTURES;
   EXTRACELLULAR-MATRIX; CRYSTAL-STRUCTURE; CALCIUM-BINDING; BTB/POZ
   DOMAIN; ANTIGEN; SUPERFAMILY; ONCOPROTEIN
AB Mac-2-binding protein (M2BP) is a secreted glycoprotein suggested to have a role in host defense. It forms linear and ring-shaped oligomers, with each ring segment being composed of two monomers. We have produced recombinant human M2BP fragments comprising domains 1 and 2 (M2BP-1,2) and domains 3 and 4 (M2BP-3,4) in 293 human kidney cells to characterize structural and functional properties of M2BP. Both fragments were obtained in a native and glycosylated form, as analyzed by CD spectroscopy, trypsin susceptibility, and enzymatic deglycosylation. These results strongly suggest that both fragments are autonomous folding units. All three potential N-glycosylation sites in M2BP-1,2 and all four in M2BP-3,4 were found to be occupied. M2BP-1,2 expressed in tunicamycin-treated cells contained no glycosyl residues, indicating that O-glycosylation is not occurring. Ultracentrifugation revealed that M2BP-1,2 is homogeneously dimeric in the nanomolar range reflecting the properties of intact M2BP. Domain 2 (BTB/POZ domain) is thus identified as the dimerization domain of M2BP, because it has been formerly shown that recombinant domain 1 is monomeric. M2BP-3,4 showed a concentration-dependent self-association, and aggregates of different size and shape were shown by electron microscopy. In contrast to this irregular aggregation of M2BP-3,4, it has been formerly shown that a fragment comprising domains 2-4 still has the ability to form ring-like structures, although the rings are protein-filled, and thus domain 2 appears to be indispensable for ring formation. Solid phase assays showed that M2BP-3,4 contains binding sites for galectin-3, nidogen, and collagens V and VI, whereas M2BP-1,2 is inactive in binding. Both fragments showed no cell adhesive activity in contrast to native M2BP, suggesting that a concerted binding action and/or multivalent interactions of rings are necessary for cell attachment.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Max Planck Inst Biochem, D-82152 Martinsried, Germany.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123
   ENGEL J, 1994, METHOD ENZYMOL, V245, P469
   HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106
   Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669
   IACOBELLI S, 1988, BREAST CANCER RES TR, V11, P19, DOI 10.1007/BF01807554
   INOHARA H, 1994, BIOCHEM BIOPH RES CO, V201, P1366, DOI 10.1006/bbrc.1994.1854
   Inohara H, 1996, CANCER RES, V56, P4530
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   KOTHS K, 1993, J BIOL CHEM, V268, P14245
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li XM, 1997, J BIOL CHEM, V272, P27324, DOI 10.1074/jbc.272.43.27324
   Li XM, 1999, CANCER RES, V59, P5275
   LONGO G, 1993, BRIT J HAEMATOL, V85, P207, DOI 10.1111/j.1365-2141.1993.tb08674.x
   Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000
   Muller SA, 1999, J MOL BIOL, V291, P801, DOI 10.1006/jmbi.1999.2996
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x
   POWELL TJ, 1995, J IMMUNOTHER, V17, P209, DOI 10.1097/00002371-199505000-00003
   RALSTON G, 1993, INTRO ANAL ULTRACENT
   ROSENBERG I, 1991, J BIOL CHEM, V266, P18731
   Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x
   Trahey M, 1999, P NATL ACAD SCI USA, V96, P3006, DOI 10.1073/pnas.96.6.3006
   ULLRICH A, 1994, J BIOL CHEM, V269, P18401
NR 25
TC 38
Z9 39
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 3
PY 2002
VL 277
IS 18
BP 15690
EP 15696
DI 10.1074/jbc.M200386200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 550PA
UT WOS:000175510400064
PM 11867635
OA Bronze
DA 2021-01-25
ER

PT J
AU Burkhard, P
   Ivaninskii, S
   Lustig, A
AF Burkhard, P
   Ivaninskii, S
   Lustig, A
TI Improving coiled-coil stability by optimizing ionic interactions
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein de novo design; protein oligomerization; coiled coil; protein
   folding; ionic interactions
ID GCN4 LEUCINE-ZIPPER; INTERHELICAL SALT BRIDGES; OLIGOMERIZATION-STATE;
   PROTEIN DESIGN; CORTEXILLIN-I; TRIGGER SITE; ACID; PAIRS; DIMERIZATION;
   SPECIFICITY
AB alpha-Helical coiled coils are a common protein oligomerization motif stabilized mainly by hydrophobic interactions occurring along the coiled-coil interface. We have recently designed and solved the structure of a two-heptad repeat coiled-coil peptide that is stabilized further by a complex network of inter- and intrahelical salt-bridges in addition to the hydrophobic interactions. Here, we extend and improve the de novo design of this two heptad-repeat peptide by four newly designed peptides characterized by different types of ionic interactions. The contribution of these different types of ionic interactions to coiled-coil stability are analyzed by CD spectroscopy and analytical ultracentrifugation. We show that all peptides are highly alpha-helical and two of them are 100% dimeric under physiological conditions. Furthermore, we have solved the X-ray structure of the most stable of these peptides and the rational design principles are verified by comparing this structure to the structure of the parent peptide. We show that by combining the most favorable inter- and intrahelical salt-bridge arrangements it is possible to design coiled-coil oligomerization domains with improved stability properties. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Burkhard, P (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Baltzer L, 1999, BIOORGAN MED CHEM, V7, P83, DOI 10.1016/S0968-0896(98)00218-1
   BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4
   Cohen C, 1998, J STRUCT BIOL, V122, P180, DOI 10.1006/jsbi.1998.3983
   CRICK FCH, ACTA CRYSTALLOG, V6, P68
   FAGAIN C, 1995, BBA-PROTEIN STRUCT M, V1252, P1, DOI 10.1016/0167-4838(95)00133-F
   Gonzalez L, 1996, NAT STRUCT BIOL, V3, P510, DOI 10.1038/nsb0696-510
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462
   HUYGHUESDESPOINTES BMP, 1993, PROTEIN SCI, V2, P80
   Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419
   Kammerer RA, 2001, J BIOL CHEM, V276, P13685, DOI 10.1074/jbc.M010492200
   Kohn WD, 1998, J MOL BIOL, V283, P993, DOI 10.1006/jmbi.1998.2125
   Kortemme T, 1998, SCIENCE, V281, P253, DOI 10.1126/science.281.5374.253
   Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762
   Lavigne P, 1996, SCIENCE, V271, P1136, DOI 10.1126/science.271.5252.1136
   Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.3.CO;2-U
   Lumb KJ, 1996, SCIENCE, V271, P1137, DOI 10.1126/science.271.5252.1137
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   MERUTKA G, 1991, BIOCHEMISTRY-US, V30, P1591, DOI 10.1021/bi00220a021
   MORGAN CS, 1998, PROTEIN SCI, V7, P85
   MUNOZ V, 1995, CURR OPIN BIOTECH, V6, P382, DOI 10.1016/0958-1669(95)80066-2
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653
   OTWINOWSKI Z, 1997, PROCESSING XRAY DIFF, P307
   Severin K, 1997, NATURE, V389, P706
   SHELDRICK GM, 1997, SHELXL HIGH RESOLUTI, P319
   Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121
   Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883
   Struthers MD, 1996, SCIENCE, V271, P342, DOI 10.1126/science.271.5247.342
   Tripet B, 1997, J BIOL CHEM, V272, P8946
   Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866
   Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48
   Turbedsky K, 1998, MOL BIOL CELL, V9, p144A
   Wagschal K, 1999, PROTEIN SCI, V8, P2312
NR 38
TC 86
Z9 87
U1 0
U2 23
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 3
PY 2002
VL 318
IS 3
BP 901
EP 910
DI 10.1016/S0022-2836(02)00114-6
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 554ZR
UT WOS:000175767700024
PM 12054832
DA 2021-01-25
ER

PT J
AU Bachmann, A
   Segel, D
   Kiefhaber, T
AF Bachmann, A
   Segel, D
   Kiefhaber, T
TI Test for cooperativity in the early kinetic intermediate in lysozyme
   folding
SO BIOPHYSICAL CHEMISTRY
LA English
DT Article
ID LACTALBUMIN MOLTEN GLOBULE; X-RAY-SCATTERING; EGG-WHITE LYSOZYME;
   ALPHA-LACTALBUMIN; HEN LYSOZYME; DOMAIN PROTEINS; HEAT-CAPACITY;
   CYTOCHROME-C; APOMYOGLOBIN; STATE
AB During the folding of many proteins, collapsed globular states are formed prior to the native structure. The role of these states for the folding process has been widely discussed. Comparison with properties of synthetic homo and heteropolymers had suggested that the initial collapse represented a shift of the ensemble of unfolded conformations to more compact states without major energy barriers. We investigated the folding/unfolding transition of a collapsed state, which transiently populates early in lysozyme folding. This state forms within the dead-time of stopped-flow mixing and it has been shown to be significantly more compact and globular than the denaturant-induced unfolded state. We used the GdmCl-dependence of the dead-time signal change to characterize the unfolding transition of the burst phase intermediate, Fluorescence and far-UV CD give identical unfolding curves. arguing for a cooperative two-state folding/unfolding transition between unfolded and collapsed lysozyme. These results show that collapse leads to a distinct state in the folding process, which is separated from the ensemble of unfolded molecules by a significant energy barrier. NMR, fluorescence and small angle X-ray scattering data further show that some local interactions in unfolded lysozyme exist at denaturant concentrations above the coil-collapse transition. These interactions might play a crucial role in the kinetic partitioning between fast and slow folding pathways. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, Biophys Chem Abt, CH-4056 Basel, Switzerland.
   Stanford Univ, Dept Phys, Stanford, CA 94305 USA.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Biophys Chem Abt, Klingelberstr 70, CH-4056 Basel, Switzerland.
RI Kiefhaber, Thomas/A-3028-2010
CR BAUER DR, 1980, MACROMOLECULES, V13, P392, DOI 10.1021/ma60074a036
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   CHAFFOTTE AF, 1992, BIOCHEMISTRY-US, V31, P9694, DOI 10.1021/bi00155a024
   DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4
   Eaton WA, 1996, STRUCTURE, V4, P1133, DOI 10.1016/S0969-2126(96)00121-9
   ELIEZER D, 1995, SCIENCE, V270, P487, DOI 10.1126/science.270.5235.487
   EVANS PA, 1991, PROTEINS, V9, P248, DOI 10.1002/prot.340090404
   FLORY PJ, 1969, STAT METHODS CHAIN M
   GINSBURG ANN, 1965, BIOCHEMISTRY, V4, P2159, DOI 10.1021/bi00886a033
   Glatter O, 1982, SMALL ANGLE XRAY SCA
   Ha JH, 1998, NAT STRUCT BIOL, V5, P730, DOI 10.1038/1436
   Hennig M, 1999, J MOL BIOL, V288, P705, DOI 10.1006/jmbi.1999.2722
   Hill T.L., 1974, Progress Biophys Molec Biol, V28, P267, DOI 10.1016/0079-6107(74)90020-0
   ITZHAKI LS, 1994, BIOCHEMISTRY-US, V33, P5212, DOI 10.1021/bi00183a026
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   Jaenicke R, 1999, PROG BIOPHYS MOL BIO, V71, P155, DOI 10.1016/S0079-6107(98)00032-7
   JAENICKE R, 1991, BIOCHEMISTRY-US, V30, P3147, DOI 10.1021/bi00227a001
   JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610
   Kay MS, 1996, NAT STRUCT BIOL, V3, P439, DOI 10.1038/nsb0596-439
   KIEFHABER T, 1995, P NATL ACAD SCI USA, V92, P9029, DOI 10.1073/pnas.92.20.9029
   KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631
   KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331
   KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202
   KUWAJIMA K, 1985, BIOCHEMISTRY-US, V24, P874, DOI 10.1021/bi00325a010
   Luo YZ, 1997, NAT STRUCT BIOL, V4, P925, DOI 10.1038/nsb1197-925
   Luo YZ, 1999, P NATL ACAD SCI USA, V96, P11283, DOI 10.1073/pnas.96.20.11283
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6
   PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7
   RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0
   RENNER M, 1992, J MOL BIOL, V223, P769, DOI 10.1016/0022-2836(92)90988-V
   Rothwarf DM, 1996, BIOCHEMISTRY-US, V35, P13797, DOI 10.1021/bi9608119
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Sauder JM, 1998, FOLD DES, V3, P293, DOI 10.1016/S1359-0278(98)00040-6
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   Segel DJ, 1998, BIOCHEMISTRY-US, V37, P12443, DOI 10.1021/bi980535t
   Segel DJ, 1999, J MOL BIOL, V288, P489, DOI 10.1006/jmbi.1999.2703
   Shastry MCR, 1998, NAT STRUCT BIOL, V5, P385, DOI 10.1038/nsb0598-385
   SUN ST, 1980, J CHEM PHYS, V73, P5971, DOI 10.1063/1.440156
   TANFORD C, 1973, J MOL BIOL, V73, P185, DOI 10.1016/0022-2836(73)90322-7
   THOMSON JA, 1989, J BIOL CHEM, V264, P11614
   Tsuruta H, 1998, J APPL CRYSTALLOGR, V31, P672, DOI 10.1107/S0021889898002702
   WAKATSUKI S, 1992, REV SCI INSTRUM, V63, P1736, DOI 10.1063/1.1143332
   Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030
   WILLIAMS C, 1981, ANNU REV PHYS CHEM, V32, P433, DOI 10.1146/annurev.pc.32.100181.002245
   Wu LC, 1998, J MOL BIOL, V280, P175, DOI 10.1006/jmbi.1998.1825
   WU LC, 1995, NAT STRUCT BIOL, V2, P281, DOI 10.1038/nsb0495-281
NR 47
TC 30
Z9 31
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-4622
J9 BIOPHYS CHEM
JI Biophys. Chem.
PD MAY 2
PY 2002
VL 96
IS 2-3
BP 141
EP 151
AR PII S0301-4622(02)00020-0
DI 10.1016/S0301-4622(02)00020-0
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA 560AX
UT WOS:000176060000007
PM 12034436
DA 2021-01-25
ER

PT J
AU Wieprecht, T
   Beyermann, M
   Seelig, J
AF Wieprecht, T
   Beyermann, M
   Seelig, J
TI Thermodynamics of the coil-alpha-helix transition of amphipathic
   peptides in a membrane environment: the role of vesicle curvature
SO BIOPHYSICAL CHEMISTRY
LA English
DT Article
DE helix-coil transition; amphipathic peptide; peptide-membrane
   interaction; titration calorimetry; magainin
ID LIPID-MEMBRANES; MITOCHONDRIAL PRESEQUENCES; UNILAMELLAR VESICLES;
   MAGAININ-2 AMIDE; ENTHALPY CHANGE; PORE FORMATION; BINDING; WATER;
   MECHANISM; INSERTION
AB The binding of peptides or proteins to a bilayer membrane is often coupled with a random coil --> a-helix transition. Knowledge of the energetics of this membrane-induced folding event is essential for the understanding of the mechanism of membrane activity. In a recent study [Wieprecht et al., J. Mol. Biol. 294 (1999) 785-794], we have developed an approach which allows an analysis of the energetics of membrane-induced folding. We have systematically varied the helix content of the amphipathic peptide magainin-2-amide by synthesizing analogs where two adjacent amino acid residues were substituted by their corresponding D-enantiomers and have measured their binding to small unilamellar vesicles (SUVs). Correlation of the binding parameters with the helicitics allowed the evaluation of the thermodynamic parameters of helix formation. Since SUVs (30 nm in diameter) are characterized by a non-ideal lipid packing due to their high membrane curvature, we have now extended our studies to large unilamellar vesicles (LUVs) (100 nm in diameter) with a lipid packing close to planar membranes. While the free energy of binding was similar for SUVs and LUVs, the binding enthalpies and entropies were distinctly different for the two membrane systems. The thermodynamic parameters of the coil-helix transition were nevertheless not affected by the vesicle size. Helix formation at the membrane surface of LUVs (SUVs) was characterized by an enthalpy change of -0.8 (-0.7) kcal/mol per residue, an entropy change of -2.3 (-1.9) cal/mol K per residue, and a free energy change of -0.12 (-0.14) kcal/mol per residue. Helix formation accounted for similar to50% of the free energy of binding underlining its major role as a driving force for membrane-binding. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Inst Mol Pharmacol, D-10315 Berlin, Germany.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248
   Aveyard Robert, 1973, INTRO PRINCIPLES SUR
   BESCHIASCHVILI G, 1992, BIOCHEMISTRY-US, V31, P10044, DOI 10.1021/bi00156a026
   BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008
   CANTOR CR, 1980, BIOPHYSICAL CHEM, V1
   CHOU PY, 1971, BIOPOLYMERS, V10, P657, DOI 10.1002/bip.360100406
   DEBER CM, 1995, BIOPOLYMERS, V37, P295, DOI 10.1002/bip.360370503
   Gazzara JA, 1997, J LIPID RES, V38, P2147
   Gazzara JA, 1997, J LIPID RES, V38, P2134
   Hammen PK, 1996, BIOCHEMISTRY-US, V35, P3772, DOI 10.1021/bi951848g
   Heerklotz H, 2001, BIOPHYS J, V81, P1547, DOI 10.1016/S0006-3495(01)75808-0
   HERMANS J, 1966, J PHYS CHEM-US, V70, P510, DOI 10.1021/j100874a031
   KELLER RCA, 1992, BIOCHEMISTRY-US, V31, P1672, DOI 10.1021/bi00121a014
   Ladokhin AS, 1999, J MOL BIOL, V285, P1363, DOI 10.1006/jmbi.1998.2346
   Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133
   MARTIN I, 1994, J VIROL, V68, P1139, DOI 10.1128/JVI.68.2.1139-1148.1994
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71
   OOI T, 1991, P NATL ACAD SCI USA, V88, P2859, DOI 10.1073/pnas.88.7.2859
   RIALDI G, 1966, J AM CHEM SOC, V88, P5719, DOI 10.1021/ja00976a007
   ROISE D, 1988, J BIOL CHEM, V263, P4509
   ROTHEMUND S, 1995, BIOCHEMISTRY-US, V34, P12954, DOI 10.1021/bi00040a005
   SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523
   SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304
   SCHOLTZ JM, 1991, P NATL ACAD SCI USA, V88, P2854, DOI 10.1073/pnas.88.7.2854
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5
   van Klompenburg W, 1998, J MEMBRANE BIOL, V162, P1, DOI 10.1007/s002329900336
   Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n
   Wieprecht T, 2000, BIOPHYS CHEM, V85, P187, DOI 10.1016/S0301-4622(00)00120-4
   Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268
   Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k
   Wieprecht T, 1996, BIOCHEMISTRY-US, V35, P10844, DOI 10.1021/bi960362c
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P15297, DOI 10.1021/bi001774v
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
NR 36
TC 85
Z9 86
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-4622
J9 BIOPHYS CHEM
JI Biophys. Chem.
PD MAY 2
PY 2002
VL 96
IS 2-3
BP 191
EP 201
AR PII S0301-4622(02)00025-X
DI 10.1016/S0301-4622(02)00025-X
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA 560AX
UT WOS:000176060000011
PM 12034440
DA 2021-01-25
ER

PT J
AU Abicht, A
   Stucka, R
   Schmidt, C
   Briguet, A
   Hopfner, S
   Song, IH
   Pongratz, D
   Muller-Felber, W
   Ruegg, MA
   Lochmuller, H
AF Abicht, A
   Stucka, R
   Schmidt, C
   Briguet, A
   Hopfner, S
   Song, IH
   Pongratz, D
   Muller-Felber, W
   Ruegg, MA
   Lochmuller, H
TI A newly identified chromosomal microdeletion and an N-box mutation of
   the AChR epsilon gene cause a congenital myasthenic syndrome
SO BRAIN
LA English
DT Article
DE acetylcholine receptor; congenital myasthenic syndrome; epsilon subunit;
   gene deletion; promoter mutation
ID GA-BINDING-PROTEIN; ACETYLCHOLINE-RECEPTOR; SUBUNIT GENE; TRANSCRIPTION
   FACTOR; SYNAPTIC EXPRESSION; GAMMA-SUBUNIT; MUSCLE-FIBERS; INNERVATED
   MUSCLE; AGRIN; PROMOTER
AB Congenital myasthenic syndromes (CMSs) are frequently caused by mutations of the coding region of the acetylcholine receptor epsilon subunit (AChR) gene leading to a reduced expression of the acetylcholine receptor (AChR) at the postsynaptic membrane. Two recent observations have linked two different N-box mutations of the human AChRepsilon promoter to a clinical CMS phenotype. N-boxes are regulatory sequence elements of mammalian promoters that confer synapse-specific expression of several genes, including the AChR subunit genes. Here, we report on a novel point mutation (epsilon-154G-->A) in the N-box of the AChRepsilon promoter in a German CMS pedigree. Semiquantitative analysis of AChRepsilon mRNA levels in the patient's muscle indicated significantly impaired AChRepsilon expression. We provide additional evidence of a pathogenic role for this mutation using the mutated promoter (epsilon-154G-->A) driving a heterologous gene (luciferase) in rat skeletal muscle. We show that agrin-induced gene expression is significantly reduced by the N-box mutant (mt) compared with the wild-type (wt) promoter. Refined haplotype analysis and direct sequencing revealed maternal inheritance of the mutant AChRepsilon promoter (epsilon-154G-->A) together with paternal inheritance of a chromosomal microdeletion (Delta1290 bp) encompassing the promoter and the first two exons of the AChRepsilon gene in the index patient. In conclusion, we provide genetic and functional evidence that a mutation of the AChRepsilon subunit promoter (epsilon-154G-->A) causes CMS due to the reduction of gene expression in skeletal muscle. Moreover, this is the first report of a chromosomal microdeletion affecting an AChR gene. This type of mutation may be missed in standard screening techniques of CMS patients.
C1 Genznetrum Munchen, D-81377 Munich, Germany.
   Univ Munich, Friedrich Baur Inst, Munich, Germany.
   Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4003 Basel, Switzerland.
RP Lochmuller, H (corresponding author), Genznetrum Munchen, Feodor Lynen Str 25, D-81377 Munich, Germany.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Lochmuller, Hanns/0000-0003-2324-8001
CR Abicht A, 1999, NEUROLOGY, V53, P1564, DOI 10.1212/WNL.53.7.1564
   BEESON D, 1993, EUR J BIOCHEM, V215, P229, DOI 10.1111/j.1432-1033.1993.tb18027.x
   Beeson D, 1998, ANN NY ACAD SCI, V841, P181, DOI 10.1111/j.1749-6632.1998.tb10924.x
   Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000
   Chan RYY, 1999, P NATL ACAD SCI USA, V96, P4627, DOI 10.1073/pnas.96.8.4627
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Croxen R, 2001, BRAIN, V124, P1362, DOI 10.1093/brain/124.7.1362
   DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547
   Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059
   Duclert A, 1996, J BIOL CHEM, V271, P17433, DOI 10.1074/jbc.271.29.17433
   DURR I, 1994, EUR J BIOCHEM, V224, P353, DOI 10.1111/j.1432-1033.1994.00353.x
   Engel A E, 2001, Neuromuscul Disord, V11, P315, DOI 10.1016/S0960-8966(00)00189-9
   Engel AG, 1999, ARCH NEUROL-CHICAGO, V56, P163, DOI 10.1001/archneur.56.2.163
   Engel AG, 1994, MYOLOGY, P1798
   Fromm L, 1998, GENE DEV, V12, P3074, DOI 10.1101/gad.12.19.3074
   Gramolini AO, 1998, J BIOL CHEM, V273, P736, DOI 10.1074/jbc.273.2.736
   Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223
   Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654
   Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075
   KOIKE S, 1995, P NATL ACAD SCI USA, V92, P10624, DOI 10.1073/pnas.92.23.10624
   Meier T, 1997, J NEUROSCI, V17, P6534
   Mendell JR, 2001, NEUROLOGY, V56, pA79
   Nichols P, 1999, ANN NEUROL, V45, P439, DOI 10.1002/1531-8249(199904)45:4<439::AID-ANA4>3.0.CO;2-W
   Ohno K, 1999, NEUROMUSCULAR DISORD, V9, P131, DOI 10.1016/S0960-8966(99)00007-3
   Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654
   Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017
   OUDET C, 1992, HUM MOL GENET, V1, P599, DOI 10.1093/hmg/1.8.599
   ROTH D, 1988, ILLEGITIMATE RECOMBI
   Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5
   SANES JR, 1991, DEVELOPMENT, V113, P1181
   Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078
   Si JT, 1997, J BIOL CHEM, V272, P10367
   Stucka R, 2000, NEUROMUSCULAR DISORD, V10, P213, DOI 10.1016/S0960-8966(99)00112-1
   Vincent A, 2000, EUR J BIOCHEM, V267, P6717, DOI 10.1046/j.1432-1033.2000.01785.x
NR 34
TC 24
Z9 25
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD MAY
PY 2002
VL 125
BP 1005
EP 1013
DI 10.1093/brain/awf095
PN 5
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 552NR
UT WOS:000175626900009
PM 11960891
OA Bronze
DA 2021-01-25
ER

PT J
AU Ribeiro, C
   Ebner, A
   Affolter, M
AF Ribeiro, C
   Ebner, A
   Affolter, M
TI In vivo Imaging reveals different cellular functions for FGF and Dpp
   signaling in tracheal branching morphogenesis
SO DEVELOPMENTAL CELL
LA English
DT Article
ID GENETIC-CONTROL; DROSOPHILA EMBRYOS; FUSION PROTEIN; MIGRATION; SYSTEM;
   RECEPTOR; DISTINCT; ENCODES; HOMOLOG; FATES
AB In the developing tracheal system of Drosophila melanogaster, six major branches arise by guided cell migration from a sac-like structure. The chemoattractant Branchless/FGF (BnI) appears to guide cell migration and is essential for the formation of all tracheal branches, while Decapentaplegic (Dpp) signaling is strictly required for the formation of a subset of branches, the dorsal and ventral branches. Using in vivo confocal video microscopy, we find that the two signaling systems affect different cellular functions required for branching morphogenesis. BnI/FGF signaling affects the formation of dynamic filopodia, possibly controlling cytoskeletal activity and motility as such, and Dpp controls cellular functions allowing branch morphogenesis and outgrowth.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
OI Affolter, Markus/0000-0002-5171-0016; Ribeiro,
   Carlos/0000-0002-9542-7335
CR Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5
   Beitel GJ, 2000, DEVELOPMENT, V127, P3271
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Chen CK, 1998, DEVELOPMENT, V125, P4959
   Cooper JA, 2000, CURR OPIN CELL BIOL, V12, P97, DOI 10.1016/S0955-0674(99)00062-9
   Gabay L, 1997, DEVELOPMENT, V124, P3535
   Guillemin K, 1996, DEVELOPMENT, V122, P1353
   Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9
   Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Llimargas M, 1997, DEVELOPMENT, V124, P3273
   Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635
   Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975
   PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9
   Petit V, 2002, INT J DEV BIOL, V46, P125
   Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Sheetz MP, 1999, BIOCHEM SOC SYMP, V65, P233
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362
   Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Vincent S, 1997, DEVELOPMENT, V124, P2741
   Wappner P, 1997, DEVELOPMENT, V124, P4707
NR 27
TC 126
Z9 127
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA
SN 1534-5807
J9 DEV CELL
JI Dev. Cell
PD MAY
PY 2002
VL 2
IS 5
BP 677
EP 683
DI 10.1016/S1534-5807(02)00171-5
PG 7
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 552CW
UT WOS:000175601600019
PM 12015974
DA 2021-01-25
ER

PT J
AU Hafezi, F
   Iseli, HP
   Wenzel, A
   Grimm, C
   Gehring, W
   Reme, CE
AF Hafezi, F
   Iseli, HP
   Wenzel, A
   Grimm, C
   Gehring, W
   Reme, CE
TI PAX6 expression in the senile mammalian retina: A role for the
   maintenance of retinal structure?
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology
CY MAY 05-10, 2002
CL FT LAUDERDALE, FLORIDA
SP Assoc Res Vis & Ophthalmol
C1 Univ Clin Zurich, Dept Ophthalmol, Zurich, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAY
PY 2002
VL 43
SU 2
MA 3923
BP U1127
EP U1127
PG 1
WC Ophthalmology
SC Ophthalmology
GA 709CG
UT WOS:000184606701074
DA 2021-01-25
ER

PT J
AU Hofmann, I
   Schnolzer, M
   Kaufmann, I
   Franke, WW
AF Hofmann, I
   Schnolzer, M
   Kaufmann, I
   Franke, WW
TI Symplekin, a constitutive protein of karyo- and cytoplasmic particles
   involved in mRNA biogenesis in Xenopus laevis oocytes
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID POLYADENYLATION SPECIFICITY FACTOR; BETA-CATENIN; NUCLEAR PROTEINS;
   BINDING-PROTEIN; TIGHT JUNCTION; CAJAL BODIES; FUNCTIONAL INTERACTION;
   POLY(A) POLYMERASE; COILED BODIES; CLEAVAGE
AB Symplekin is a dual location protein that has been localized to the cytoplasmic plaques of tight junctions but also occurs in the form of interchromatin particles in the karyoplasm. Here we report the identification of two novel and major symplekin-containing protein complexes in both the karyo- and the cytoplasm of Xenopus laevis oocytes. Buffer-extractable fractions from the karyoplasm of stage IV-VI oocytes contain an 115 particle, prepared by immunoselection and sucrose gradient centrifugation, in which symplekin is associated with the subunits of the cleavage and polyadenylation specificity factor (CPSF). Moreover, in immunofluorescence microscopy nuclear symplekin colocalizes with protein CPSF-100 in the "Cajal bodies." However, symplekin is also found in cytoplasmic extracts of enucleated oocytes and egg extracts, where it occurs in I IS as well as in ca. 65S particles, again in association with CPSF-100. This suggests that, in X. laevis oocytes, symplekin is possibly involved in both processes, 3'-end processing of pre-mRNA in the nucleus and regulated polyadenylation in the cytoplasm. We discuss the possible occurrence of similar symplekin-containing particles involved in mRNA metabolism in the nucleus and cytoplasm of other kinds of cells, also in comparison with the nuclear forms of other dual location proteins in nuclei and cell junctions.
C1 German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
   German Canc Res Ctr, Prot Anal Facil, D-69120 Heidelberg, Germany.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Hofmann, I (corresponding author), German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
EM i.hofmann@dkfz.de
OI Franke, Werner W./0000-0002-4873-8448
CR ANKENBAUER T, 1989, NATURE, V342, P822, DOI 10.1038/342822a0
   Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024
   Behrens J, 2000, ANN NY ACAD SCI, V910, P21
   Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0
   BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x
   BIENROTH S, 1991, J BIOL CHEM, V266, P19768
   BOHMANN K, 1995, J CELL BIOL, V131, P817, DOI 10.1083/jcb.131.4.817
   Bonne S, 1999, J CELL SCI, V112, P2265
   BONNER WM, 1975, J CELL BIOL, V64, P421, DOI 10.1083/jcb.64.2.421
   BONNER WM, 1975, J CELL BIOL, V64, P431, DOI 10.1083/jcb.64.2.431
   BORRMANN C, 2000, THESIS U HEIDELBERG
   Borrmann CM, 2000, ANN NY ACAD SCI, V915, P144
   CACERES JF, 1997, EUKARYOTIC MRNA PROC, P174
   Cordes VC, 1996, CELL TISSUE RES, V284, P177, DOI 10.1007/s004410050578
   CORDES VC, 1993, J CELL BIOL, V123, P1333, DOI 10.1083/jcb.123.6.1333
   Daniel JM, 1999, MOL CELL BIOL, V19, P3614
   de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6
   de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895
   DEROBERTIS EM, 1978, NATURE, V272, P254, DOI 10.1038/272254a0
   Dickson KS, 1999, MOL CELL BIOL, V19, P5707
   Dickson KS, 2001, J BIOL CHEM, V276, P41810, DOI 10.1074/jbc.M103030200
   DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203
   EVANS JP, 1991, METHOD CELL BIOL, V36, P133
   FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959
   Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273
   Gall JG, 1999, MOL BIOL CELL, V10, P4385, DOI 10.1091/mbc.10.12.4385
   Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779
   HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9
   HERRMANN H, 1989, DEVELOPMENT, V105, P279
   Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895
   Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7
   Hubner S, 2001, INT REV CYTOL, V208, P207
   HUGLE B, 1985, CELL, V41, P615, DOI 10.1016/S0092-8674(85)80034-9
   JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183
   Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514
   Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.3.CO;2-X
   KARNOVSKY A, 1995, P NATL ACAD SCI USA, V92, P4522, DOI 10.1073/pnas.92.10.4522
   Keon BH, 1996, J CELL BIOL, V134, P1003, DOI 10.1083/jcb.134.4.1003
   Kim JW, 2001, MECH DEVELOP, V109, P111, DOI 10.1016/S0925-4773(01)00514-7
   KLEINSCHMIDT JA, 1982, CELL, V29, P799, DOI 10.1016/0092-8674(82)90442-1
   KLEINSCHMIDT JA, 1983, J CELL BIOL, V97, P838, DOI 10.1083/jcb.97.3.838
   Krauss SW, 1997, J CELL BIOL, V137, P275, DOI 10.1083/jcb.137.2.275
   KROHNE G, 1980, P NATL ACAD SCI-BIOL, V77, P1034, DOI 10.1073/pnas.77.2.1034
   KROHNE G, 1980, EXP CELL RES, V129, P167, DOI 10.1016/0014-4827(80)90341-9
   KROHNE G, 1983, METHOD ENZYMOL, V96, P597
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lallena MJ, 1998, J CELL SCI, V111, P1963
   LEE KAW, 1990, METHOD ENZYMOL, V181, P20
   Macdonald P, 2001, CURR OPIN CELL BIOL, V13, P326, DOI 10.1016/S0955-0674(00)00215-5
   Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517
   Mariner DJ, 2000, J CELL SCI, V113, P1481
   Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0
   Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081
   Mertens C, 2001, P NATL ACAD SCI USA, V98, P7795, DOI 10.1073/pnas.141219498
   Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009
   Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9
   Morgan GT, 2000, J STRUCT BIOL, V129, P258, DOI 10.1006/jsbi.2000.4231
   MURTHY KGK, 1992, J BIOL CHEM, V267, P14804
   Nakamura T, 2000, P NATL ACAD SCI USA, V97, P7284, DOI 10.1073/pnas.97.13.7284
   PETERS JM, 1994, J BIOL CHEM, V269, P7709
   PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x
   Preker PJ, 1997, EMBO J, V16, P4727, DOI 10.1093/emboj/16.15.4727
   RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0
   Regula JT, 2000, ELECTROPHORESIS, V21, P3765, DOI 10.1002/1522-2683(200011)21:17<3765::AID-ELPS3765>3.0.CO;2-6
   Ruegsegger U, 1996, J BIOL CHEM, V271, P6107
   SCALENGHE F, 1978, CHROMOSOMA, V66, P299, DOI 10.1007/BF00328531
   Schmidt A, 1999, DIFFERENTIATION, V64, P291, DOI 10.1007/s002580050282
   Schmidt A, 1997, CELL TISSUE RES, V290, P481, DOI 10.1007/s004410050956
   Schmidt-Zachmann MS, 1998, MOL BIOL CELL, V9, P143, DOI 10.1091/mbc.9.1.143
   SCHMIDTZACHMANN MS, 1987, EMBO J, V6, P1881, DOI 10.1002/j.1460-2075.1987.tb02447.x
   Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1
   Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0
   Stevenson BR, 1998, ANNU REV CELL DEV BI, V14, P89, DOI 10.1146/annurev.cellbio.14.1.89
   Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000
   TUMA RS, 1993, J CELL BIOL, V122, P767, DOI 10.1083/jcb.122.4.767
   Ueki K, 1997, SOMAT CELL MOLEC GEN, V23, P229, DOI 10.1007/BF02721375
   WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x
   WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J
   Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1111/j.1574-6976.1999.tb00400.x
   Wickens M, 2000, COLD SPRING HARBOR M, V39, P295
   Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443
   Zhao J, 1999, MOL CELL BIOL, V19, P7733
NR 82
TC 63
Z9 69
U1 0
U2 3
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAY
PY 2002
VL 13
IS 5
BP 1665
EP 1676
DI 10.1091/mbc.01-12-0567
PG 12
WC Cell Biology
SC Cell Biology
GA 555VA
UT WOS:000175812900019
PM 12006661
OA Green Published
DA 2021-01-25
ER

PT J
AU Scheuring, S
   Stahlberg, H
   Chami, M
   Houssin, C
   Rigaud, JL
   Engel, A
AF Scheuring, S
   Stahlberg, H
   Chami, M
   Houssin, C
   Rigaud, JL
   Engel, A
TI Charting and unzipping the surface layer of Corynebacterium glutamicum
   with the atomic force microscope
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID RESOLUTION AFM TOPOGRAPHS; ESCHERICHIA-COLI; DEINOCOCCUS-RADIODURANS;
   CELL-WALL; S-LAYERS; ELECTRON-MICROSCOPY; PROTEIN; DOMAINS;
   ORGANIZATION; ELASTICITY
AB Bacterial surface layers (S-layers) are extracellular protein networks that act as molecular sieves and protect a large variety of archaea and bacteria from hostile environments. Atomic force microscopy (AFM) was used to asses the S-layer of Corynebacterium glutamicum formed of PS2 proteins that assemble into hexameric complexes within a hexagonal lattice. Native and trypsin-treated S-layers were studied. Using the AFM stylus as a nanodissector, native arrays that adsorbed to mica as double layers were separated. All surfaces of native and protease-digested S-layers were imaged at better than 1 nm lateral resolution. Difference maps of the topographies of native and proteolysed samples revealed the location of the cleaved C-terminal fragment and the sidedness of the S-layer. Because the corrugation depths determined from images of both sides span the total thickness of the S-layer, a three-dimensional reconstruction of the S-layer could be calculated. Lattice defects visualized at 1 nm resolution revealed the molecular boundaries of PS2 proteins. The combination of AFM imaging and single molecule force spectroscopy allowed the mechanical properties of the Corynebacterium glutamicum S-layer to be examined. The results provide a basis for understanding the amazing stability of this protective bacterial surface coat.
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Inst Curie, CNRS, UMR 768, F-75231 Paris 05, France.
   LRC CEA 8, F-75231 Paris 05, France.
   Univ Paris 11, Lab Biol Mol Cornyebacteries, CNRS, URA 1354, F-91405 Orsay, France.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Stahlberg, Henning/H-1868-2011; Scheuring, Simon/L-9843-2018
OI Stahlberg, Henning/0000-0002-1185-4592; Scheuring,
   Simon/0000-0003-3534-069X
CR Bahl H, 1997, FEMS MICROBIOL REV, V20, P47, DOI 10.1016/S0168-6445(97)00050-8
   BAUMEISTER W, 1986, J MOL BIOL, V187, P241, DOI 10.1016/0022-2836(86)90231-7
   BAUMEISTER W, 1988, BIOPHYS CHEM, V29, P39, DOI 10.1016/0301-4622(88)87023-6
   BAUMEISTER W, 1986, FEMS MICROBIOL LETT, V36, P119
   BAUMEISTER W, 1989, CAN J MICROBIOL, V35, P215, DOI 10.1139/m89-034
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   Chami M, 1997, MOL MICROBIOL, V23, P483, DOI 10.1046/j.1365-2958.1997.d01-1868.x
   CHAMI M, 1995, BIOL CELL, V83, P219, DOI 10.1016/0248-4900(96)81311-6
   Czajkowsky DM, 1998, FEBS LETT, V430, P51, DOI 10.1016/S0014-5793(98)00461-X
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   ENGEL A, 1982, P NATL ACAD SCI-BIOL, V79, P4050, DOI 10.1073/pnas.79.13.4050
   Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   HOH JH, 1991, SCIENCE, V253, P1405, DOI 10.1126/science.1910206
   KARRASCH S, 1994, P NATL ACAD SCI USA, V91, P836, DOI 10.1073/pnas.91.3.836
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1996, J BACTERIOL, V178, P3025
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   PETERS J, 1986, J BACTERIOL, V167, P1048, DOI 10.1128/jb.167.3.1048-1054.1986
   PEYRET JL, 1993, MOL MICROBIOL, V9, P97, DOI 10.1111/j.1365-2958.1993.tb01672.x
   Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 2000, ADV EXP MED BIOL, V481, P129
   Saxton W O, 1986, J Mol Biol, V187, P251, DOI 10.1016/0022-2836(86)90232-9
   SAXTON WO, 1979, ULTRAMICROSCOPY, V4, P343, DOI 10.1016/S0304-3991(79)80044-3
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   SCHABERT FA, 1994, BIOPHYS J, V67, P2394, DOI 10.1016/S0006-3495(94)80726-X
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029
   Seelert H, 2000, NATURE, V405, P418
   SLEYTR UB, 1988, J BACTERIOL, V170, P2891, DOI 10.1128/jb.170.7.2891-2897.1988
   Sleytr UB, 1997, FEMS MICROBIOL REV, V20, P5, DOI 10.1016/S0168-6445(97)00039-9
   SLEYTR UB, 1993, J APPL BACTERIOL, V74, pS21, DOI 10.1111/j.1365-2672.1993.tb04339.x
   Sleytr UB, 1997, FEMS MICROBIOL REV, V20, P151, DOI 10.1016/S0168-6445(97)00044-2
   SLEYTR UB, 1983, ANNU REV MICROBIOL, V37, P311, DOI 10.1146/annurev.mi.37.100183.001523
   SMITH BL, 1991, J BIOL CHEM, V266, P6407
   WANG EZ, 1993, J BACTERIOL, V175, P4979, DOI 10.1128/JB.175.16.4979-4984.1993
NR 45
TC 58
Z9 60
U1 0
U2 10
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD MAY
PY 2002
VL 44
IS 3
BP 675
EP 684
DI 10.1046/j.1365-2958.2002.02864.x
PG 10
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 549VF
UT WOS:000175466900007
PM 11994150
DA 2021-01-25
ER

PT J
AU Vogel, LK
   Sahkri, S
   Sjostrom, H
   Noren, O
   Spiess, M
AF Vogel, LK
   Sahkri, S
   Sjostrom, H
   Noren, O
   Spiess, M
TI Secretion of antithrombin is converted from nonpolarized to apical by
   exchanging its amino terminus for that of apically secreted family
   members
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CORTICOSTEROID-BINDING GLOBULIN; POLARIZED MDCK CELLS; CANINE
   KIDNEY-CELLS; INFLUENZA-VIRUS HEMAGGLUTININ; HUMAN AMINOPEPTIDASE-N;
   EPITHELIAL-CELLS; SORTING SIGNAL; TRANSMEMBRANE DOMAIN; CYTOPLASMIC
   TAIL; MEMBRANE-PROTEIN
AB The three members of the serpin family, corticosteroid binding globulin, alpha1-antitrypsin, and C1 inhibitor are secreted apically from Madin-Darby canine kidney (MDCK) cells, whereas two homologous family members, antithrombin and plasminogen activator inhibitor-1, are secreted in a nonpolarized fashion. cDNAs coding for chimeras composed of complementary portions of an apically targeted serpin and a nonsorted serpin were generated, expressed in MDCK cells, and the ratio between apical and basolateral secretion was analyzed. These experiments identified an amino-terminal sequence of corticosteroid binding globulin (residues 1-19) that is sufficient to direct a chimera with antithrombin mainly to the apical side. A deletion/mutagenesis analysis showed that no individual amino acid is absolutely required for the apical. targeting ability of amino acids 1-30 of corticosteroid binding globulin. The corresponding amino-terminal sequences of alpha1-antitrypsin and C1 inhibitor were also sufficient to confer apical sorting. Based on our results we suggest that the apical. targeting ability is encoded in the conformation of the protein.
C1 Univ Copenhagen, Panum Inst, Biochem Lab C, Dept Med Biochem & Genet, DK-2200 Copenhagen N, Denmark.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Vogel, LK (corresponding author), Univ Copenhagen, Panum Inst, Biochem Lab C, Dept Med Biochem & Genet, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.
OI Spiess, Martin/0000-0001-7139-0550
CR AVVAKUMOV GV, 1995, J STEROID BIOCHEM, V53, P515, DOI 10.1016/0960-0760(95)00099-L
   BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018
   Cescato R, 2000, J NEUROCHEM, V74, P1131
   Chuang JZ, 1998, J CELL BIOL, V142, P1245, DOI 10.1083/jcb.142.5.1245
   CORBEIL D, 1992, J BIOL CHEM, V267, P2798
   Dunbar LA, 2000, J CELL BIOL, V148, P769, DOI 10.1083/jcb.148.4.769
   Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5
   GILARDI P, 1990, FEBS LETT, V267, P60, DOI 10.1016/0014-5793(90)80287-S
   GOTTLIEB TA, 1986, P NATL ACAD SCI USA, V83, P2100, DOI 10.1073/pnas.83.7.2100
   HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153
   KITAGAWA Y, 1994, EXP CELL RES, V213, P449, DOI 10.1006/excr.1994.1222
   Kuhn U, 2000, BIOCHEM BIOPH RES CO, V270, P631, DOI 10.1006/bbrc.2000.2469
   KUNDU A, 1994, J VIROL, V68, P1812, DOI 10.1128/JVI.68.3.1812-1818.1994
   Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996
   Larsen JE, 1999, FEBS LETT, V451, P19, DOI 10.1016/S0014-5793(99)00526-8
   Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51
   Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X
   Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497
   Martin-Belmonte F, 2000, J BIOL CHEM, V275, P41074, DOI 10.1074/jbc.M005429200
   Marzolo MP, 1997, P NATL ACAD SCI USA, V94, P1834, DOI 10.1073/pnas.94.5.1834
   MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2
   MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M
   MUSTO NA, 1993, EXP CELL RES, V209, P271, DOI 10.1006/excr.1993.1311
   ROBINSON PA, 1985, J ENDOCRINOL, V104, P269, DOI 10.1677/joe.0.1040269
   Rodionov DG, 2000, J BIOL CHEM, V275, P8279, DOI 10.1074/jbc.275.12.8279
   Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8
   Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501
   SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0
   SHEFFIELD WP, 1992, BLOOD, V79, P2330
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Sun AQ, 1998, AM J PHYSIOL-GASTR L, V275, pG1045
   Sun AQ, 2001, J BIOL CHEM, V276, P6825, DOI 10.1074/jbc.M008797200
   TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cellbio.9.1.129
   URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735
   VOGEL LK, 1995, J BIOL CHEM, V270, P22933, DOI 10.1074/jbc.270.39.22933
   Vogel LK, 2000, FEBS LETT, V473, P297, DOI 10.1016/S0014-5793(00)01548-9
   VOGEL LK, 1992, J BIOL CHEM, V267, P2794
   VOGEL LK, 1992, FEBS LETT, V308, P14, DOI 10.1016/0014-5793(92)81039-O
   VOGEL LK, 1993, FEBS LETT, V330, P293, DOI 10.1016/0014-5793(93)80891-W
   WEISZ OA, 1992, J BIOL CHEM, V267, P22282
   WESSELS HP, 1989, J BIOL CHEM, V264, P17
   Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929
NR 42
TC 5
Z9 5
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 19
PY 2002
VL 277
IS 16
BP 13883
EP 13888
DI 10.1074/jbc.M107997200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 543HR
UT WOS:000175096000071
PM 11839735
OA Bronze
DA 2021-01-25
ER

PT J
AU Kressler, D
   Schreiber, SN
   Knutti, D
   Kralli, A
AF Kressler, D
   Schreiber, SN
   Knutti, D
   Kralli, A
TI The PGC-1-related protein PERC is a selective coactivator of estrogen
   receptor alpha
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID NUCLEAR-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; HORMONE RECEPTORS; GAMMA
   COACTIVATOR-1; RESPONSE ELEMENTS; PROMOTER-CONTEXT; ACTIVATION; BINDING;
   IDENTIFICATION; DOMAINS
AB Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) is a tissue-specific coactivator that enhances the activity of many nuclear receptors and coordinates transcriptional programs important for energy metabolism. We describe here a novel PGC-1-related coactivator that is expressed in a similar tissue-specific manner as PGC-1, with the highest levels in heart and skeletal muscle. In contrast to PGC-1, the new coactivator shows high receptor specificity. It enhances potently the activity of estrogen receptor (ER) alpha, while having only small effects on other receptors. Because of its nuclear receptor selectivity, we have termed the new protein PERC (PGC-1 related Estrogen Receptor Coactivator). We show here that the coactivation function of PERC relies on a bipartite transcriptional activation domain and two LXXLL motifs that interact with the AF2 domain of ERalpha in an estrogen-dependent manner. PERC and PGC-1 are likely to have different functions in ER signaling. Whereas PERC acts selectively on ERalpha and not on the second estrogen receptor ERbeta, PGC-1 coactivates strongly both Ells. Moreover, PERC and PGC-1 show distinct preferences for enhancing ERalpha in different promoter contexts. Finally, PERC enhances the ERalpha-mediated response to the partial agonist tamoxifen, while PGG-1 modestly represses it. The two coactivators are likely to mediate distinct, tissue-specific responses to estrogens.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Kralli, A (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anastasia.kralli@unibas.ch
RI Kressler, Dieter/C-2218-2012
OI Kressler, Dieter/0000-0003-4855-3563
CR Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001
   BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x
   Cooke PS, 2001, MOL CELL ENDOCRINOL, V178, P147, DOI 10.1016/S0303-7207(01)00414-2
   Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358
   DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x
   Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343
   Driscoll MD, 1998, J BIOL CHEM, V273, P29321, DOI 10.1074/jbc.273.45.29321
   Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977
   Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747
   Freedman LP, 1999, J CELL BIOCHEM, P103
   Glass CK, 2000, GENE DEV, V14, P121
   Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677
   Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200
   Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750
   Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149
   Jung DJ, 2002, J BIOL CHEM, V277, P1229, DOI 10.1074/jbc.M110417200
   Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000
   Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X
   Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698
   Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920
   LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Li DS, 1999, MOL CELL BIOL, V19, P7191
   Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200
   Loven MA, 2001, J BIOL CHEM, V276, P45282, DOI 10.1074/jbc.M106211200
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   McDonnell DP, 1999, TRENDS ENDOCRIN MET, V10, P301, DOI 10.1016/S1043-2760(99)00177-0
   MCDONNELL DP, 1995, MOL ENDOCRINOL, V9, P659, DOI 10.1210/me.9.6.659
   Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306
   Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9
   Nilsson S, 2001, PHYSIOL REV, V81, P1535
   Nolte RT, 1998, NATURE, V395, P137
   Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270
   Norris JD, 1998, J BIOL CHEM, V273, P6679, DOI 10.1074/jbc.273.12.6679
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200
   Scheidegger KJ, 2000, J BIOL CHEM, V275, P38921, DOI 10.1074/jbc.M004691200
   Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657
   Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984
   Suen CS, 1998, J BIOL CHEM, V273, P27645, DOI 10.1074/jbc.273.42.27645
   Takeshita A, 1998, J BIOL CHEM, V273, P21554, DOI 10.1074/jbc.273.34.21554
   Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200
   TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7
   Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652
   TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21
   Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097
   Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605
   Wong CW, 2001, BIOCHEMISTRY-US, V40, P6756, DOI 10.1021/bi010379h
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297
   Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922
   Yahata T, 2001, GENE DEV, V15, P2598, DOI 10.1101/gad.906301
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
NR 58
TC 171
Z9 177
U1 0
U2 9
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 19
PY 2002
VL 277
IS 16
BP 13918
EP 13925
DI 10.1074/jbc.M201134200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 543HR
UT WOS:000175096000075
PM 11854298
OA Bronze
DA 2021-01-25
ER

PT J
AU Kochs, G
   Haener, M
   Aebi, U
   Haller, O
AF Kochs, G
   Haener, M
   Aebi, U
   Haller, O
TI Self-assembly of human MxA GTPase into highly ordered dynamin-like
   oligomers
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID DEPENDENT CONFORMATIONAL CHANGE; ANTIVIRAL ACTIVITY; INFLUENZA-VIRUS;
   ALUMINUM FLUORIDE; TARGET STRUCTURES; BINDING PROTEINS; TRANSGENIC MICE;
   THOGOTO-VIRUS; DOMAINS; RESISTANCE
AB Human MxA protein is a member of the interferon-induced Mx protein family and an important component of the innate host defense against RNA viruses. The Mx family belongs to a superfamily of large GTPases that also includes the dynamins and the interferon-regulated guanylate-binding proteins. A common feature of these large GTPases is their ability to form high molecular weight oligomers. Here we determined the capacity of MxA to self-assemble into homo-oligomers in vitro. We show that recombinant MxA protein assembles into long filamentous structures with a diameter of about 20 nm at physiological salt concentration as demonstrated by sedimentation assays and electron microscopy. In the presence of guanosine nucleotides the filaments rearranged into rings and more compact helical arrays. Our data indicate that binding and hydrolysis of GTP induce conformational changes in MxA that may be essential for viral target recognition and antiviral activity.
C1 Univ Freiburg, Inst Med Mikrobiol & Hyg, Abt Virol, D-79008 Freiburg, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
RP Kochs, G (corresponding author), Univ Freiburg, Inst Med Mikrobiol & Hyg, Abt Virol, D-79008 Freiburg, Germany.
CR Ahmadian MR, 1997, FEBS LETT, V408, P315, DOI 10.1016/S0014-5793(97)00422-5
   ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B
   Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030
   COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283
   Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2
   Di Paolo C, 1999, J BIOL CHEM, V274, P32071, DOI 10.1074/jbc.274.45.32071
   Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7
   FRESE M, 1995, J VIROL, V69, P3904, DOI 10.1128/JVI.69.6.3904-3909.1995
   Gu XJ, 1996, EMBO J, V15, P695, DOI 10.1002/j.1460-2075.1996.tb00405.x
   Haller O, 1998, REV SCI TECH OIE, V17, P220, DOI 10.20506/rst.17.1.1084
   Hefti HP, 1999, J VIROL, V73, P6984, DOI 10.1128/JVI.73.8.6984-6991.1999
   Hinshaw JE, 1999, CURR OPIN STRUC BIOL, V9, P260, DOI 10.1016/S0959-440X(99)80036-0
   HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0
   Janzen C, 2000, J VIROL, V74, P8202, DOI 10.1128/JVI.74.17.8202-8206.2000
   Kochs G, 1998, METHODS, V15, P255, DOI 10.1006/meth.1998.0629
   Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370
   McNiven MA, 1998, CELL, V94, P151, DOI 10.1016/S0092-8674(00)81414-2
   MELEN K, 1992, J BIOL CHEM, V267, P25898
   MELEN K, 1994, J BIOL CHEM, V269, P2009
   Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676
   NAKAYAMA M, 1993, J BIOL CHEM, V268, P15033
   Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813
   Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277
   Park JM, 1998, EMBO J, V17, P859, DOI 10.1093/emboj/17.4.859
   PAVLOVIC J, 1995, J VIROL, V69, P4506, DOI 10.1128/JVI.69.7.4506-4510.1995
   PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990
   PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993
   Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403
   Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997
   Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617
   RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512
   ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U
   Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5
   Schumacher B, 1998, J BIOL CHEM, V273, P28365, DOI 10.1074/jbc.273.43.28365
   SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518
   Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x
   Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024
   SIMON A, 1991, J VIROL, V65, P968, DOI 10.1128/JVI.65.2.968-971.1991
   Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351
   Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942
   SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0
   STAEHELI P, 1985, MOL CELL BIOL, V5, P2150, DOI 10.1128/MCB.5.8.2150
   Staeheli Peter, 1993, Trends in Cell Biology, V3, P268, DOI 10.1016/0962-8924(93)90055-6
   Stowell MHB, 1999, NAT CELL BIOL, V1, P27
   Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6
   Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377
   van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1
   Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107
   Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310
   Wittinghofer A, 1997, CURR BIOL, V7, pR682, DOI 10.1016/S0960-9822(06)00355-1
   Zhang ZM, 2000, J BIOL CHEM, V275, P8779, DOI 10.1074/jbc.275.12.8779
NR 51
TC 72
Z9 73
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 19
PY 2002
VL 277
IS 16
BP 14172
EP 14176
DI 10.1074/jbc.M200244200
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 543HR
UT WOS:000175096000106
PM 11847228
OA Bronze
DA 2021-01-25
ER

PT J
AU Schaniel, C
   Gottar, M
   Roosnek, E
   Melchers, F
   Rolink, AG
AF Schaniel, C
   Gottar, M
   Roosnek, E
   Melchers, F
   Rolink, AG
TI Extensive in vivo self-renewal, long-term reconstitution capacity, and
   hematopoietic multipotency of Pax5-deficient precursor B-cell clones
SO BLOOD
LA English
DT Article
ID STEM-CELLS; TELOMERE LENGTH; IN-VIVO; PROLIFERATIVE CAPACITY;
   FLOW-CYTOMETRY; MOUSE; DIFFERENTIATION; FIBROBLASTS; COMMITMENT; INVITRO
AB Self-renewal, pluripotency, and long-term reconstitution are defining characteristics of single hematopoietic stem cells. Pax5(-/-) precursor B cells apparently possess similar characteristics. Here, using serial transplantations, with in vitro recloning and growth of the bone marrow-homed donor cells occurring after all transplantations, we analyzed the extent of self-renewal and hematopoietic multipotency of Pax5(-/-) precursor B-cell clones. Moreover, telomere length and telomerase activity in these clones was analyzed at various time points. Thus far, 5 successive transplantations have been performed. Clones transplanted for the fifth time, which have proliferated for more than 150 cell divisions in vitro, still repopulate the bone marrow with precursor B cells and reconstitute these recipients with lymphoid and myeloid cells. During this extensive proliferation, Pax5(-/-) precursor B cells shorten their telomeres at 70 to 90 base pairs per division. Their telomerase activity remains at 3% of that of HEK293 cancer cells during all serial In vivo transplantations/in vitro expansions. Together, these data show that Pax5(-/-) precursor B-cell clones possess extensive in vivo self-renewal capacity, long-term reconstitution capacity, and hematopoietic multipotency, with their telomeres shortening at the normal rate. (C) 2002 by The American Society of Hematology.
C1 Basel Inst Immunol, Basel, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Univ Geneva, Hop Cantonal, Unite Immunol Transplantat, Geneva, Switzerland.
RP Schaniel, C (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Rm 216, Princeton, NJ 08544 USA.
RI Schaniel, Chrisoph/C-9655-2012; Schaniel, Christoph/P-3836-2019
OI Schaniel, Christoph/0000-0002-1343-4858
CR ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120
   CUDKOWICZ G, 1964, NATURE, V201, P165, DOI 10.1038/201165a0
   GRELDER C, 1996, ANNU REV BIOCHEM, V65, P337
   HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B
   HARRISON DE, 1988, P NATL ACAD SCI USA, V85, P822, DOI 10.1073/pnas.85.3.822
   HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hodes RJ, 1999, J EXP MED, V190, P153, DOI 10.1084/jem.190.2.153
   JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4
   MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x
   MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X
   Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7
   Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011
   Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476
   Nutt SL, 1999, NATURE, V401, P556
   OGDEN DA, 1976, TRANSPLANTATION, V22, P287, DOI 10.1097/00007890-197609000-00010
   Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242
   REINCKE U, 1982, SCIENCE, V215, P1619, DOI 10.1126/science.7071580
   ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x
   Rolink AG, 2000, IMMUNOL REV, V175, P104, DOI 10.1111/j.1600-065X.2000.imr017512.x
   Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164
   ROSS EAM, 1982, J EXP MED, V155, P432, DOI 10.1084/jem.155.2.432
   Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743
   Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472
   SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104
   SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788
   SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810
   URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5
   VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
NR 35
TC 46
Z9 46
U1 0
U2 3
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD APR 15
PY 2002
VL 99
IS 8
BP 2760
EP 2766
DI 10.1182/blood.V99.8.2760
PG 7
WC Hematology
SC Hematology
GA 539JJ
UT WOS:000174866500017
PM 11929764
DA 2021-01-25
ER

PT J
AU Cardoso, I
   Goldsbury, CS
   Muller, SA
   Olivieri, V
   Wirtz, S
   Damas, AM
   Aebi, U
   Saraiva, MJ
AF Cardoso, I
   Goldsbury, CS
   Muller, SA
   Olivieri, V
   Wirtz, S
   Damas, AM
   Aebi, U
   Saraiva, MJ
TI Transthyretin fibrillogenesis entails the assembly of monomers: A
   molecular model for in vitro assembled transthyretin amyloid-like
   fibrils
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE AFM, atomic force microscopy; amyloid fibrils; TEM, transmission
   electron microscopy; TTR, transthyretin; STEM, scanning transmission
   electron microscopy
ID TRANSMISSION ELECTRON-MICROSCOPY; STRUCTURAL-ANALYSIS; X-RAY;
   AMYLOIDOGENICITY; PROTOFILAMENT; DENATURATION; VARIANT; L55P
AB Extracellular accumulation of transthyretin (TTR) variants in the form of fibrillar amyloid deposits is the pathological hallmark of familial amyloidotic polyneuropathy (FAP). The TTR Leu55Pro variant occurs in the most aggressive forms of this disease. Inhibition of TTR wild-type (WT) and particularly TTR Leu55Pro fibril formation is of interest as a potential therapeutic strategy and requires a thorough understanding of the, fibril assembly mechanism. To this end, we report on the in vitro assembly properties as observed by transmission electron microscopy (TEM), atomic force microscopy (AFM) and quantitative scanning transmission electron microscopy (STEM) for both TTR WT fibrils produced by acidification, and TTR Leu55Pro fibrils assembled at physiological pH. The morphological features and dimensions of TTR WT and TTR Leu55Pro fibrils were similar, with up to 300 nm long, 8 nm wide fibrils being the most prominent species in both cases. Other species were evident; 4-5 nm wide fibrils, 9-10 nm wide fibrils and oligomers of various sizes. STEM mass-per-length (MPL) measurements revealed discrete fibril types with masses of 9.5 and 14.0( +/-1.4) KDa/nm for TTR WT fibrils and 13.7, 18.5 and 23.2(+/-1.5) kDa/nm for TTR Leu55Pro fibrils. These MPL values are consistent with a model in which fibrillar TTR structures are composed of two, three, four or five elementary protofilaments, with each protofilament being a vertical stack of structurally modified TTR monomers assembled with the 2.9 nm axial monomer-monomer spacing indicated by X-ray fibre diffraction data. Ex vivo TTR amyloid fibrils were examined. From their morphological appearance compared to these, the in vitro assembled TTR WT and Leu55Pro fibrils examined may represent immature fibrillar species. The in vitro system operating at physiological pH for TTR Leu55Pro and the model presented for the molecular arrangement of TTR monomers within fibrils may, therefore, describe early fibril assembly events in vivo. (C) 2002 Elsevier Science Ltd.
C1 Univ Porto, Amyloid Unit, Inst Mol & Cell Biol, P-4100 Oporto, Portugal.
   Univ Porto, Mol Struct Unit, Inst Mol & Cell Biol, P-4100 Oporto, Portugal.
   Univ Porto, Inst Biomed Sci Abel Salazar, P-4100 Oporto, Portugal.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Saraiva, MJ (corresponding author), Univ Porto, Amyloid Unit, Inst Mol & Cell Biol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
RI Saraiva, Maria Joao/K-3907-2013; Cardoso, Isabel/K-3903-2013
OI Saraiva, Maria Joao/0000-0002-3360-6899; Cardoso,
   Isabel/0000-0003-2472-7055
CR Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508
   Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9
   BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6
   Chaney MO, 1998, PROTEIN ENG, V11, P761, DOI 10.1093/protein/11.9.761
   COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036
   EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673
   Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   Ferrao-Gonzales AD, 2000, P NATL ACAD SCI USA, V97, P6445, DOI 10.1073/pnas.97.12.6445
   FURUYA H, 1991, BIOCHEMISTRY-US, V30, P2415, DOI 10.1021/bi00223a017
   Inouye H, 1998, AMYLOID, V5, P163, DOI 10.3109/13506129809003842
   JACOBSON DR, 1992, HUM GENET, V89, P353
   Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+
   Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c
   Lazo ND, 1998, BIOCHEMISTRY-US, V37, P1731, DOI 10.1021/bi971016d
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Malinchik SB, 1998, BIOPHYS J, V74, P537, DOI 10.1016/S0006-3495(98)77812-9
   MCCUTCHEN SL, 1993, BIOCHEMISTRY-US, V32, P12119, DOI 10.1021/bi00096a024
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200
   Redondo C, 2000, BIOCHEM J, V348, P167, DOI 10.1042/0264-6021:3480167
   Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132
   Sebastian PJ, 1998, SOL ENERG MAT SOL C, V55, P1
   Sebastiao MP, 2000, BIOCHEM J, V351, P273, DOI 10.1042/0264-6021:3510273
   Serag AA, 2001, BIOCHEMISTRY-US, V40, P9089, DOI 10.1021/bi010655s
   SERPELL LC, 1995, J MOL BIOL, V254, P113, DOI 10.1006/jmbi.1995.0604
   SHIRAHAMA T, 1967, J CELL BIOL, V33, P679, DOI 10.1083/jcb.33.3.679
NR 27
TC 91
Z9 92
U1 0
U2 7
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 12
PY 2002
VL 317
IS 5
BP 683
EP 695
DI 10.1006/jmbi.2002.5441
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 545EA
UT WOS:000175202300004
PM 11955017
DA 2021-01-25
ER

PT J
AU Min, GW
   Stolz, M
   Zhou, G
   Liang, FX
   Sebbel, P
   Stoffler, D
   Glockshuber, R
   Sun, TT
   Aebi, U
   Kong, XP
AF Min, GW
   Stolz, M
   Zhou, G
   Liang, FX
   Sebbel, P
   Stoffler, D
   Glockshuber, R
   Sun, TT
   Aebi, U
   Kong, XP
TI Localization of uroplakin Ia, the urothelial receptor for bacterial
   adhesin FimH, on the six inner domains of the 16 nm urothelial plaque
   particle
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE asymmetric unit membrane; bladder epithelium; uroplakin; urinary tract
   infection; bacterial adhesin
ID UROPATHOGENIC ESCHERICHIA-COLI; ASYMMETRIC UNIT MEMBRANE;
   URINARY-BLADDER; 3-DIMENSIONAL STRUCTURE; PLASMA-MEMBRANE;
   DIFFERENTIATION; PROTEINS; EPITHELIUM; SUBUNITS; ENTEROBACTERIACEAE
AB The binding of uropathogenic Escherichia coli to the urothelial surface is a critical initial event for establishing urinary tract infection, because it prevents the bacteria from being removed by micturition and it triggers bacterial invasion as well as host cell defense. This binding is mediated by the FimH adhesin located at the tip of the bacterial type 1-fimbrium and its urothelial receptor, uroplakin la (UPIa). To localize the UPIa receptor on the 16 nm particles that form two-dimensional crystals of asymmetric unit membrane (AUM) covering >90 % of the apical urothelial surface, A.. resolution 3-D model of the mouse 16 nm AUM we constructed a 15, particle by negative staining and electron crystallography. Similar to previous lower-resolution models of bovine and pig AUM particles, the mouse16 nm AUM particle consists of six inner and six outer domains that are interconnected to form a twisted ribbon-like structure. Treatment of urothelial plaques with 0.02-0.1 % (v/v) Triton X-100 allowed the stain to penetrate into the membrane, revealing parts of the uroplakin transmembrane moiety with an overall diameter of 14 nm, which was much bigger than the 11 nm value determined earlier by quick-freeze deepetch. Atomic force microscopy of native, unfixed mouse and bovine urothelial plaques confirmed the overall structure of the luminal 16 nm AUM particle that was raised by 6.5 nm above the luminal membrane surface and, in addition, revealed a circular, 0.5 nm high, cytoplasmic protrusion of similar to14 nm diameter. Finally, a difference map calculated from the mouse urothelial plaque images collected in the presence and absence of recombinant bacterial FimH/FimC complex revealed the selective binding of FimH to the six inner domains of the 16 nm AUM particle. These results indicate that the 16 nm AUM particle is anchored by a similar to14 nm diameter transmembrane stalk, and suggest that bacterial binding to UPIa that resides within the six inner domains of the 16 nm AUM particle may preferentially trigger transmembrane signaling involved in bacterial invasion and host cell defense. (C) 2002 Elsevier Science Ltd.
C1 NYU, Sch Med, Struct Biol Program, Skirball Inst Biomol Med,Dept Biochem, New York, NY 10016 USA.
   Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA.
   NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA.
   NYU, Sch Med, Dept Urol, New York, NY 10016 USA.
   ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.
   Scripps Res Inst, La Jolla, CA 92307 USA.
RP Kong, XP (corresponding author), NYU, Sch Med, Struct Biol Program, Skirball Inst Biomol Med,Dept Biochem, New York, NY 10016 USA.
RI ; Sun, Tung-Tien/J-4425-2015
OI Liang, Fengxia/0000-0003-0037-4590; Kong,
   Xiang-Peng/0000-0001-5773-2681; Sun, Tung-Tien/0000-0002-6841-1063
FU NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R01DK039753, P01DK052206, R01DK039753,
   P01DK052206, R01DK039753, R01DK039753, P01DK052206, P01DK052206,
   R01DK039753, P01DK052206, R01DK039753, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, R01DK039753, R01DK039753,
   P01DK052206, R01DK039753, P01DK052206, R01DK039753, P01DK052206,
   P01DK052206, R01DK039753, P01DK052206, R01DK057269, P01DK052206,
   P01DK052206, R01DK039753, P01DK052206, P01DK052206, R01DK057269,
   P01DK052206, P01DK052206, R01DK057269, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, R01DK057269,
   P01DK052206, R01DK039753, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, R01DK039753, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, R01DK039753, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, R01DK039753,
   P01DK052206, P01DK052206, R01DK039753, R01DK039753, P01DK052206,
   P01DK052206, R01DK039753, R01DK039753, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, R01DK057269, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, R01DK039753, P01DK052206] Funding Source: NIH RePORTER;
   NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [DK52206, DK57269, DK39753] Funding
   Source: Medline
CR ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0
   AEBI U, 1977, P NATL ACAD SCI USA, V74, P5514, DOI 10.1073/pnas.74.12.5514
   AGARD DA, 1983, J MOL BIOL, V167, P849, DOI 10.1016/S0022-2836(83)80114-4
   BEACHEY EH, 1981, J INFECT DIS, V143, P325, DOI 10.1093/infdis/143.3.325
   Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933
   BRISSON A, 1983, J MOL BIOL, V166, P21, DOI 10.1016/S0022-2836(83)80048-5
   BUHLE EL, 1984, J ULTRA MOL STRUCT R, V89, P165, DOI 10.1016/S0022-5320(84)80012-X
   Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   Engel A, 1999, TRENDS CELL BIOL, V9, P77, DOI 10.1016/S0962-8924(98)01415-9
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   HICKS RM, 1965, J CELL BIOL, V26, P25, DOI 10.1083/jcb.26.1.25
   HICKS RM, 1974, PHILOS T ROY SOC B, V268, P23, DOI 10.1098/rstb.1974.0013
   Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961
   JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304
   KOSS LG, 1969, LAB INVEST, V21, P154
   KUBALEK E, 1987, J CELL BIOL, V105, P9, DOI 10.1083/jcb.105.1.9
   Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607
   Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867
   Liang FX, 1999, DIFFERENTIATION, V65, P59, DOI 10.1046/j.1432-0436.1999.6510059.x
   Liang FX, 2001, BIOCHEM J, V355, P13, DOI 10.1042/0264-6021:3550013
   LIN Q, 1994, INT J REMOTE SENS, V15, P1775, DOI 10.1080/01431169408954208
   Maecker HT, 1997, FASEB J, V11, P428
   Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803
   Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494
   Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336
   PORTER KR, 1963, INTRO FINE STRUCTURE
   ROBERTSON JD, 1980, J CELL BIOL, V86, P514, DOI 10.1083/jcb.86.2.514
   STAEHELIN LA, 1972, J CELL BIOL, V53, P73, DOI 10.1083/jcb.53.1.73
   Sun TT, 1999, ADV EXP MED BIOL, V462, P7
   Sun TT, 1996, MOL BIOL REP, V23, P3, DOI 10.1007/BF00357068
   TAYLOR KA, 1984, J ULTRA MOL STRUCT R, V87, P23, DOI 10.1016/S0022-5320(84)90113-8
   VERGARA J, 1969, J MOL BIOL, V46, P593, DOI 10.1016/0022-2836(69)90200-9
   WALZ T, 1995, J MOL BIOL, V248, P887, DOI 10.1006/jmbi.1995.0269
   WARREN RC, 1970, NATURE, V227, P280, DOI 10.1038/227280b0
   WU XR, 1993, J CELL SCI, V106, P31
   WU XR, 1995, J BIOL CHEM, V270, P29752
   WU XR, 1994, J BIOL CHEM, V269, P13716
   WU XR, 1990, J BIOL CHEM, V265, P19170
   YU J, 1994, J CELL BIOL, V125, P171, DOI 10.1083/jcb.125.1.171
   Zhang ZT, 1999, CANCER RES, V59, P3512
   Zhang ZT, 2001, ONCOGENE, V20, P1973, DOI 10.1038/sj.onc.1204315
   Zhou G, 2001, J CELL SCI, V114, P4095
   1994, ACTA CRYSTALLOG D, V50, P760
NR 46
TC 62
Z9 62
U1 0
U2 4
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 12
PY 2002
VL 317
IS 5
BP 697
EP 706
DI 10.1006/jmbi.2002.5442
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 545EA
UT WOS:000175202300005
PM 11955018
DA 2021-01-25
ER

PT J
AU Cordier, F
   Grzesiek, S
AF Cordier, F
   Grzesiek, S
TI Temperature-dependence properties as studied by of protein hydrogen bond
   high-resolution NMR
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE scalar coupling; ubiquitin; chemical shift; secondary structure;
   hydrogen exchange
ID NUCLEAR-MAGNETIC-RESONANCE; MODEL-FREE APPROACH; SCALAR COUPLINGS;
   CHEMICAL-SHIFTS; BACKBONE DYNAMICS; BASE-PAIRS; RELAXATION; (3H)J(NC');
   DNA; MACROMOLECULES
AB The temperature-dependence of a large number of NMR parameters describing hydrogen bond properties in the protein ubiquitin was followed over a range from 5 to 65degreesC. The parameters comprise hydrogen bond (H-bond) scalar couplings, (h3)J(NC'), chemical shifts, amide proton exchange rates, N-15 relaxation parameters as well as covalent (1)J(NC') and (1)J(NH) couplings. A global weakening of the (h3)J(NC') coupling with increasing temperature is accompanied by a global upfield shift of the amide protons and a decrease of the sequential (1)J(NC') couplings. If interpreted as a linear increase of the (NO)-O-... distance, the change in (h3)J(NC') corresponds to an average linear thermal expansion coefficient for the NH --> O hydrogen bonds of 1.7 x 10(-4)/K, which is in good agreement with Overall volume expansion coefficients observed for proteins. A residue-specific analysis reveals that not all hydrogen bonds are affected to the same extent by the thermal expansion. The end of beta-sheet beta1/beta5 at hydrogen bond E64 --> Q2 appears as the most thermolabile, whereas the adjacent hydrogen bond I3 --> L15 connecting beta-strands beta1 and beta2 is even stabilized slightly at higher temperatures. Additional evidence for the stabilization of the beta1/beta2 beta-hairpin at higher temperatures is found in reduced hydrogen exchange rates for strand end residue V17 This reduction corresponds to a stabilizing change in free energy of 9.7 kJ/mol for the beta1/beta2 hairpin. The result can be linked to the finding that the beta1/beta2 hairpin behaves as an autonomously folding unit in the A-state of ubiquitin under changed solvent conditions. For several amide groups the temperature-dependencies of the amide exchange rates and H-bond scalar couplings are uncorrelated. Therefore, amide exchange rates are not a sole function of the hydrogen bond "strength" as given by the electronic overlap of donors and acceptors, but are clearly dependent on other blocking mechanisms. (C) 2002 Elsevier Science Ltd.
C1 Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM Stephan.Grzesiek@unibas.ch
OI Cordier, Florence/0000-0002-5963-7773; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Bagno A, 2000, CHEM-EUR J, V6, P2925
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   Barfield M, 2001, J AM CHEM SOC, V123, P4014, DOI 10.1021/ja003781c
   BARFIELD M, 2002, IN PRESS J AM CHEM S
   Brutscher B, 1997, BIOCHEMISTRY-US, V36, P13043, DOI 10.1021/bi971538t
   Case DA, 2000, CURR OPIN STRUC BIOL, V10, P197, DOI 10.1016/S0959-440X(00)00068-3
   Cordier F, 2000, J MOL BIOL, V304, P497, DOI 10.1006/jmbi.2000.4274
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   Czernek J, 2001, J AM CHEM SOC, V123, P11079, DOI 10.1021/ja011618r
   Dingley AJ, 2000, J BIOMOL NMR, V16, P279, DOI 10.1023/A:1008307115641
   Dingley AJ, 1999, J AM CHEM SOC, V121, P6019, DOI 10.1021/ja9908321
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Englaender S.W., 1996, ENCY NUCL MAGNETIC R, V4, P2415
   Fersht A., 1985, ENZYME STRUCTURE MEC
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P627
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   Grzesiek S, 2001, METHOD ENZYMOL, V338, P111
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052
   GRZESIEK S, 1995, J AM CHEM SOC, V117, P9594, DOI 10.1021/ja00142a040
   HINZ HJ, 1994, BIOPHYS CHEM, V52, P275, DOI 10.1016/0301-4622(94)00098-5
   Jaravine VA, 2001, PROTEIN SCI, V10, P943, DOI 10.1110/ps.48501
   Jeffrey G.A., 1991, HYDROGEN BONDING BIO
   Juranic N, 2001, J AM CHEM SOC, V123, P4099, DOI 10.1021/ja015647d
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kojima C, 2000, J BIOMOL NMR, V18, P269, DOI 10.1023/A:1026717101063
   Li H, 2000, J BIOMOL NMR, V18, P207, DOI 10.1023/A:1026537609584
   LIDE DR, 1999, CRC HDB CHEM PHYSICS
   LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Lohr F, 2000, J AM CHEM SOC, V122, P9289, DOI 10.1021/ja001345k
   Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852
   Mishima M, 2000, J AM CHEM SOC, V122, P5883, DOI 10.1021/ja000005w
   PARDI A, 1983, EUR J BIOCHEM, V137, P445, DOI 10.1111/j.1432-1033.1983.tb07848.x
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Scheurer C, 1999, J AM CHEM SOC, V121, P8661, DOI 10.1021/ja9917417
   Seemann H, 2001, J MOL BIOL, V307, P1091, DOI 10.1006/jmbi.2001.4517
   Shenderovich IG, 1998, BER BUNSEN PHYS CHEM, V102, P422, DOI 10.1002/bbpc.19981020322
   VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6
   WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056
   Wang YX, 1999, J BIOMOL NMR, V14, P181, DOI 10.1023/A:1008346517302
   ZHANG YZ, 1995, THESIS U PENNSYLVANI
   ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042
   ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390
NR 49
TC 111
Z9 115
U1 1
U2 25
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 12
PY 2002
VL 317
IS 5
BP 739
EP 752
DI 10.1006/jmbi.2002.5446
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 545EA
UT WOS:000175202300008
PM 11955021
DA 2021-01-25
ER

PT J
AU DoubliZ, S
   Martin, G
   Keller, W
AF DoubliZ, S
   Martin, G
   Keller, W
TI Structural examination of a template-in dependent RNA polymerase.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Burlington, VT 05405 USA.
   Univ Basel, Dept Cell Biol, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 7
PY 2002
VL 223
MA 167-PHYS
BP C44
EP C44
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 564CE
UT WOS:000176296801615
DA 2021-01-25
ER

PT J
AU Ebner, A
   Kiefer, FN
   Ribeiro, C
   Petit, V
   Nussbaumer, U
   Affolter, M
AF Ebner, A
   Kiefer, FN
   Ribeiro, C
   Petit, V
   Nussbaumer, U
   Affolter, M
TI Tracheal development in Drosophila melanogaster as a model system for
   studying the development of a branched organ
SO GENE
LA English
DT Article; Proceedings Paper
CT Workshop on Comparative Development Biology
CY APR 17-23, 2001
CL NAPLES, ITALY
DE branching morphogenesis; cell migration; trachea; transcription; empty
   spiracles; sulfotransferase; proteoglycan
ID MEDIATED ENHANCER DETECTION; DOMAIN TRANSCRIPTION FACTOR;
   GENETIC-CONTROL; CELL-MIGRATION; VENTRAL VEINLESS; EMPTY SPIRACLES;
   THICK VEINS; DPP; EXPRESSION; RECEPTOR
AB The development of the tracheal system of Drosophila melanogaster represents a paradigm for studying the molecular mechanisms involved in the formation of a branched tubular network. Tracheogenesis has been characterized at the morphological, cellular and genetic level and a series of successive, but linked events have been described as the basis for the formation of the complex network of tubules which extend over the entire organism. Tracheal cells stop to divide early in the process of tracheogenesis and the formation of the interconnected network requires highly controlled cell migration events and cell shape changes. A number of genes involved in these two processes have been identified but in order to obtain a more complete view of branching morphogenesis, many more genes carrying essential functions have to be isolated and characterized. Here, we provide a progress report on our attempts to identify further genes expressed in the tracheal system. We show that empty spiracles (ems), a head gap gene, is required for the formation of a specific tracheal branch, the visceral branch. We also identified a Sulfotransferase and a Multiple Inositol Polyphosphate phosphatase that are strongly upregulated in tracheal cells and discuss their possible involvement in tracheal development. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016; PETIT,
   Valerie/0000-0003-1645-9396; Ribeiro, Carlos/0000-0002-9542-7335
CR AFFOLTER M, 1994, DEVELOPMENT, V120, P3105
   Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5
   ANDERSON MG, 1995, GENE DEV, V9, P123, DOI 10.1101/gad.9.1.123
   Beitel GJ, 2000, DEVELOPMENT, V127, P3271
   BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288
   BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273
   Boube M, 2001, GENE DEV, V15, P1554, DOI 10.1101/gad.195501
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Chen CK, 1998, DEVELOPMENT, V125, P4959
   Chi HB, 1999, GENOMICS, V56, P324, DOI 10.1006/geno.1998.5736
   Chihara T, 2000, DEVELOPMENT, V127, P4433
   DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940
   DECELIS JF, 1995, DEVELOPMENT, V121, P3405
   Englund C, 1999, DEVELOPMENT, V126, P1505
   Glazer L, 2001, DEVELOPMENT, V128, P1599
   Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103
   Jazwinska A, 1999, DEVELOPMENT, V126, P3323
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157
   Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215
   Lander AD, 2000, J CELL BIOL, V148, P227, DOI 10.1083/jcb.148.2.227
   Lin XH, 1999, DEVELOPMENT, V126, P3715
   Llimargas M, 2000, DEVELOPMENT, V127, P4407
   Llimargas M, 1997, DEVELOPMENT, V124, P3273
   Manning G., 1993, DEV DROSOPHILA MELAN, V1, P609
   Marty T, 2001, DEVELOPMENT, V128, P2833
   Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635
   OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123
   Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013
   RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9
   Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Vincent S, 1997, DEVELOPMENT, V124, P2741
   VINCENT S, 1999, IN PRESS MOL CELL, V3, P540
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Wappner P, 1997, DEVELOPMENT, V124, P4707
   Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93
   WILSON C, 1989, GENE DEV, V3, P1301, DOI 10.1101/gad.3.9.1301
   Zelzer E, 2000, BIOESSAYS, V22, P219, DOI 10.1002/(SICI)1521-1878(200003)22:3<219::AID-BIES3>3.0.CO;2-A
NR 46
TC 9
Z9 9
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD APR 3
PY 2002
VL 287
IS 1-2
BP 55
EP 66
AR PII S0378-1119(01)00895-2
DI 10.1016/S0378-1119(01)00895-2
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA 553JB
UT WOS:000175671100008
PM 11992723
DA 2021-01-25
ER

PT J
AU Rolink, AG
   Melchers, F
AF Rolink, AG
   Melchers, F
TI BAFFIed B cells survive and thrive: roles of BAFF in B-cell development
SO CURRENT OPINION IN IMMUNOLOGY
LA English
DT Review
ID NECROSIS-FACTOR FAMILY; TNF RECEPTOR SUPERFAMILY; ANTIGEN RECEPTOR;
   A/WYSNJ MICE; LYMPHOCYTE STIMULATOR; AUTOIMMUNE-DISEASE; MATURATION
   ANTIGEN; KAPPA-B; MEMBER; APRIL
AB Interactions of BAFF (B-cell activating factor) with BAFF-R, one of three BAFF-binding receptors that are preferentially expressed on B cells, are essential for B-cell development, because defects in either the ligand or the receptor arrest progression from immature type-1 B cells to type-2 cells and mature cells; B1 B cells are unaffected. Transgenic BAFF overexpression leads to B-cell hyperplasia and autoimmune disease. In vitro, BAFF increases survival of immature and mature B cells; immature B cells also mature polyclonally to mature B cells, without proliferation. Upon GAFF-influenced differentiation, immature B cells change their surface-IgM signal transduction machinery and proliferate rather than undergoing apoptosis.
C1 Univ Basel, Dept Immunol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Melchers, F (corresponding author), Univ Basel, Dept Immunol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM fritz.melchers@unibas.ch
CR Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7
   Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305
   Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453
   Chambers CA, 1997, CURR OPIN IMMUNOL, V9, P396, DOI 10.1016/S0952-7915(97)80087-8
   Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953
   Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100
   GRAS MP, 1995, INT IMMUNOL, V7, P1093, DOI 10.1093/intimm/7.7.1093
   Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115
   Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2
   Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185
   Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322
   Hoag KA, 2000, IMMUNOGENETICS, V51, P924, DOI 10.1007/s002510000223
   HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B
   Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697
   Laabi Y, 2000, SCIENCE, V289, P883, DOI 10.1126/science.289.5481.883
   LAABI Y, 1994, NUCLEIC ACIDS RES, V22, P1147, DOI 10.1093/nar/22.7.1147
   Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6
   Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359
   Lentz VM, 1998, J IMMUNOL, V160, P3743
   Lentz VM, 1996, J IMMUNOL, V157, P598
   Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697
   Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2
   Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1034/j.1600-065X.2000.017510.x
   Melchers F., 1999, FUNDAMENTAL IMMUNOLO, p183 ~224
   MILLER DJ, 1991, EUR J IMMUNOL, V21, P1123, DOI 10.1002/eji.1830210506
   MILLER DJ, 1992, EUR J IMMUNOL, V22, P373, DOI 10.1002/eji.1830220213
   MONROE JG, 1989, J EXP MED, V169, P1059, DOI 10.1084/jem.169.3.1059
   Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260
   Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978
   Neuberger MS, 1997, CELL, V90, P971, DOI 10.1016/S0092-8674(00)80362-1
   Potter M, 2000, CURR TOP MICROBIOL, V252, P307
   Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677
   ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x
   Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q
   Rolink AG, 1999, IMMUNITY, V10, P619, DOI 10.1016/S1074-7613(00)80061-8
   Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964
   Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747
   Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497
   Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680
   SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7
   Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129
   Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965
   von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3
   vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138
   Wang H, 2001, NAT IMMUNOL, V2, P632, DOI 10.1038/89782
   Wang J, 2000, EUR J IMMUNOL, V30, P155, DOI 10.1002/1521-4141(200001)30:1<155::AID-IMMU155>3.3.CO;2-O
   Ware Carl F., 1998, P549
   Ware CF, 2000, J EXP MED, V192, pF35, DOI 10.1084/jem.192.11.F35
   Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200
   Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137
   Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001
   Yan MH, 2000, NAT IMMUNOL, V1, P37
   Yoshida T, 2000, INT IMMUNOL, V12, P517, DOI 10.1093/intimm/12.4.517
NR 53
TC 98
Z9 104
U1 0
U2 2
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0952-7915
EI 1879-0372
J9 CURR OPIN IMMUNOL
JI Curr. Opin. Immunol.
PD APR
PY 2002
VL 14
IS 2
BP 266
EP 275
DI 10.1016/S0952-7915(02)00332-1
PG 10
WC Immunology
SC Immunology
GA 524RK
UT WOS:000174026500018
PM 11869903
DA 2021-01-25
ER

PT J
AU Hoepfner, D
   Schaerer, F
   Brachat, A
   Wach, A
   Philippsen, P
AF Hoepfner, D
   Schaerer, F
   Brachat, A
   Wach, A
   Philippsen, P
TI Reorientation of mispositioned spindles in short astral microtubule
   mutant Spc72 Delta is dependent on spindle pole body outer plaque and
   Kar3 motor protein
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID GAMMA-TUBULIN COMPLEX; YEAST SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE;
   BUDDING YEAST; NUCLEAR MIGRATION; CYTOPLASMIC MICROTUBULES; BINDING
   PROTEIN; CELL CORTEX; ORIENTATION; COMPONENT
AB Nuclear migration and positioning in Saccharomyces cerevisiae depend on long astral microtubules emanating from the spindle pole bodies (SPBs). Herein, we show by in vivo fluorescence microscopy that cells lacking Spc72, the SPB receptor of the cytoplasmic gamma-tubulin complex, can only generate very short (<1 mu m) and unstable astral microtubules. Consequently, nuclear migration to the bud neck and orientation of the anaphase spindle along the mother-bud axis are absent in these cells. However, SPC72 deletion is not lethal because elongated but misaligned spindles can frequently reorient in mother cells, permitting delayed but otherwise correct nuclear segregation. High-resolution time-lapse sequences revealed that this spindle reorientation was most likely accomplished by cortex interactions of the very short astral microtubules. In addition, a set of double mutants suggested that reorientation was dependent on the SPB outer plaque and the astral microtubule motor function of Kar3 but not Kip2/Kip3/Dhc1, or the cortex components Kar9/Num1. Our observations suggest that Spc72 is required for astral microtubule formation at the SPB half-bridge and for stabilization of astral microtubules at the SPB outer plaque. In addition, our data exclude involvement of Spc72 in spindle formation and elongation functions.
C1 Univ Basel, Biozentrum, Lehrstuhl Angew Mikrobiol, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Lehrstuhl Angew Mikrobiol, CH-4056 Basel, Switzerland.
EM peter.philipssen@unibas.ch
CR Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809
   Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X
   Brachat A, 1998, MOL BIOL CELL, V9, P977, DOI 10.1091/mbc.9.5.977
   BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376
   BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975
   Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629
   Chen XYP, 1998, J CELL BIOL, V141, P1169, DOI 10.1083/jcb.141.5.1169
   Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335
   Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041
   DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023
   ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172
   FARKASOVSKY M, 1995, J CELL BIOL, V131, P1003, DOI 10.1083/jcb.131.4.1003
   Fink G., 1991, METHOD ENZYMOL, V194, P14
   Geissler S, 1996, EMBO J, V15, P3899, DOI 10.1002/j.1460-2075.1996.tb00764.x
   Gruneberg U, 2000, EMBO J, V19, P6475, DOI 10.1093/emboj/19.23.6475
   Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997
   HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H
   HYMAN AA, 1989, J CELL BIOL, V109, P1185, DOI 10.1083/jcb.109.3.1185
   JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409
   Kilmartin JV, 1996, EMBO J, V15, P4592, DOI 10.1002/j.1460-2075.1996.tb00837.x
   Knop M, 1998, EMBO J, V17, P3952, DOI 10.1093/emboj/17.14.3952
   Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550
   Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985
   Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W
   Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870
   LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096
   Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219
   MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E
   Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949
   Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377
   MOENS PB, 1971, J CELL BIOL, V50, P344, DOI 10.1083/jcb.50.2.344
   Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663
   Nguyen T, 1998, MOL BIOL CELL, V9, P2201, DOI 10.1091/mbc.9.8.2201
   PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414
   PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583
   Pereira G, 1999, EMBO J, V18, P4180, DOI 10.1093/emboj/18.15.4180
   Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317
   ROUT MP, 1990, J CELL BIOL, V111, P1913, DOI 10.1083/jcb.111.5.1913
   Sambrook J, 1989, MOL CLONING LAB MANU
   Saunders W, 1997, J CELL BIOL, V137, P417, DOI 10.1083/jcb.137.2.417
   Schaerer F, 2001, MOL BIOL CELL, V12, P2519, DOI 10.1091/mbc.12.8.2519
   SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712
   Segal M, 2000, MOL BIOL CELL, V11, P3689, DOI 10.1091/mbc.11.11.3689
   Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985
   Soues S, 1998, J CELL SCI, V111, P2809
   Spang A, 1996, J CELL BIOL, V134, P429, DOI 10.1083/jcb.134.2.429
   Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574
   Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687
   SULLIVAN DS, 1992, J CELL BIOL, V119, P379, DOI 10.1083/jcb.119.2.379
   Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993
   Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271
   Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949
   Yin HW, 2000, NATURE, V406, P1013
NR 57
TC 15
Z9 15
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD APR
PY 2002
VL 13
IS 4
BP 1366
EP 1380
DI 10.1091/mbc.01-07-0338
PG 15
WC Cell Biology
SC Cell Biology
GA 547DU
UT WOS:000175318400022
PM 11950945
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Funato, K
AF Funato, K
TI Sphingolipid biosynthesis and traffic in yeast
SO SEIKAGAKU
LA Japanese
DT Review
ID SACCHAROMYCES-CEREVISIAE; SYNTHASE; LAG1P
C1 Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
CR Dickson RC, 1999, BBA-MOL CELL BIOL L, V1438, P305, DOI 10.1016/S1388-1981(99)00068-2
   Dickson RC, 1999, BBA-GEN SUBJECTS, V1426, P347, DOI 10.1016/S0304-4165(98)00135-4
   Funato K, 2001, J CELL BIOL, V155, P949, DOI 10.1083/jcb.200105033
   Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597
   Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655
   HECHTBERGER P, 1994, EUR J BIOCHEM, V225, P641, DOI 10.1111/j.1432-1033.1994.00641.x
   HECHTBERGER P, 1995, FEBS LETT, V367, P201, DOI 10.1016/0014-5793(95)00567-S
   Holthuis JCM, 2001, PHYSIOL REV, V81, P1689
   Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135
   Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267
   Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200
   PUOTI A, 1991, J CELL BIOL, V113, P515, DOI 10.1083/jcb.113.3.515
   Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417
   Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824
NR 14
TC 0
Z9 0
U1 0
U2 1
PU JAPANESE BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN
SN 0037-1017
J9 SEIKAGAKU
JI Seikagaku
PD APR
PY 2002
VL 74
IS 4
BP 317
EP 321
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 546KD
UT WOS:000175272500007
PM 12030035
DA 2021-01-25
ER

PT J
AU Boudko, S
   Frank, S
   Kammerer, RA
   Stetefeld, J
   Schulthess, T
   Landwehr, R
   Lustig, A
   Bachinger, HP
   Engel, J
AF Boudko, S
   Frank, S
   Kammerer, RA
   Stetefeld, J
   Schulthess, T
   Landwehr, R
   Lustig, A
   Bachinger, HP
   Engel, J
TI Nucleation and propagation of the collagen triple helix in single-chain
   and trimerized peptides: Transition from third to first order kinetics
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE collagen-like peptides; oligomerization domain; foldon; disulfide
   cross-link; intrinsic concentration
ID IV COLLAGEN; COILED-COIL; NC1 DOMAIN; ISOMERIZATION; PROTEINS; CIS; NMR;
   IDENTIFICATION; CONVERSION; SEQUENCE
AB The kinetics of triple helix formation from single non-crosslinked peptide chains were studied for the collagen models (ProProGly)(10) and (ProHypGly)(10) in a broad concentration range and compared with those in nucleated trimers. At very low peptide concentrations the reaction order is 3 but decreases at higher concentrations. For (ProProGly)10 the third order rate constant is 800 M(-2) s(-1) at 7degreesC, which corresponds to a very long half time of 15 hours at 60 muM chain concentration. For (ProHypGly)10 the rate constant is about 1000-fold higher, which is consistent with the stabilizing effect of 4-hydroxyproline in collagens. The concentration dependence of the reaction order is explained by a nucleation mechanism in which a very unstable dimer is in fast equilibrium with the monomeric chains and addition of the third chain occurs in a rate-limiting step. At high concentrations nucleation is faster than propagation of helix formation and propagation becomes rate-limiting. To test this hypothesis an artificial nucleus was introduced by fusion of (ProProGly)10 with the trimeric foldon domain of T4 phage or the crosslinking domain of collagen III GlyProProGlyProCysCysGlyGlyGly. These domains were recombinantly attached to the C terminus of (GlyProPro)(10) and link the three chains in a similar way to the C-terminal propeptide domain in collagen III. This results in a local intrinsic chain concentration of about 1 M. A first order reaction is observed for the folding of the triple helix in (GlyProPro)(10)foldon with a half time of 8.3 minutes, which approximately matches the rate of folding from single chains at 1 M peptide concentration. A high activation energy of 54 kJ/mol is found for this reaction, whereas the temperature dependence of the nucleation step is close to zero, confirming earlier findings on natural collagens that cis-trans isomerization of peptide bonds is the rate-limiting step in propagation. (C) 2002 Elsevier Science Ltd.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.
   Shriners Hosp Children, Res Ctr, Portland, OR 97201 USA.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
EM juergen.engel@unib.as.ch
RI Stetefeld, Joerg/H-7630-2017
OI Stetefeld, Joerg/0000-0003-1478-3248; Kammerer,
   Richard/0000-0003-4570-5197
CR Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668
   Areida SK, 2001, J BIOL CHEM, V276, P1594, DOI 10.1074/jbc.M008709200
   BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x
   BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200
   BUCKNER P, 1978, EUR J BIOCHEM, V90, P595
   Buevich AV, 2000, BIOCHEMISTRY-US, V39, P4299, DOI 10.1021/bi992584r
   BURJANADZE TV, 1992, BIOPOLYMERS, V32, P941, DOI 10.1002/bip.360320805
   DAVIS JM, 1989, J BIOL CHEM, V264, P8956
   DAVIS MT, 1995, ANAL CHEM, V67, P4549, DOI 10.1021/ac00120a019
   DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x
   Durr E, 2000, PROTEIN SCI, V9, P1410
   Efimov VP, 1996, PROTEINS, V24, P259, DOI 10.1002/(SICI)1097-0134(199602)24:2<259::AID-PROT13>3.0.CO;2-M
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137
   Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Goodman M, 1996, J AM CHEM SOC, V118, P5156, DOI 10.1021/ja954132h
   Hardy E, 1997, ANAL BIOCHEM, V244, P28, DOI 10.1006/abio.1996.9719
   HARRINGT.WF, 1970, BIOCHEMISTRY-US, V9, P3714, DOI 10.1021/bi00821a010
   Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602
   Kersteen EA, 2001, BIOPOLYMERS, V59, P24, DOI 10.1002/1097-0282(200107)59:1<24::AID-BIP1002>3.0.CO;2-N
   Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200
   Mechling DE, 1996, J BIOL CHEM, V271, P13781, DOI 10.1074/jbc.271.23.13781
   Netzer KO, 1998, PROTEIN SCI, V7, P1340, DOI 10.1002/pro.5560070610
   Ottl J, 1999, J AM CHEM SOC, V121, P653, DOI 10.1021/ja983456d
   PIEZ KA, 1964, BIOCHEMISTRY-US, V3, P908, DOI 10.1021/bi00895a009
   PIEZ KA, 1970, BIOCHEMISTRY-US, V9, P4134, DOI 10.1021/bi00823a016
   PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   SARKAR SK, 1984, P NATL ACAD SCI-BIOL, V81, P4800, DOI 10.1073/pnas.81.15.4800
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Snellman A, 2000, EMBO J, V19, P5051, DOI 10.1093/emboj/19.19.5051
   SREERAMA N, 1995, BIOCHEMISTRY-US, V34, P7288, DOI 10.1021/bi00021a047
   SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8
   Van Holde K. E., 1985, PHYSICAL BIOCH, P93
   Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V
   Zhang Y, 1999, J BIOL CHEM, V274, P22409, DOI 10.1074/jbc.274.32.22409
NR 44
TC 78
Z9 80
U1 0
U2 14
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAR 29
PY 2002
VL 317
IS 3
BP 459
EP 470
DI 10.1006/jmbi.2002.5439
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 542QM
UT WOS:000175055900010
PM 11922677
DA 2021-01-25
ER

PT J
AU Strelkov, SV
   Herrmann, H
   Geisler, N
   Wedig, T
   Zimbelmann, R
   Aebi, U
   Burkhard, P
AF Strelkov, SV
   Herrmann, H
   Geisler, N
   Wedig, T
   Zimbelmann, R
   Aebi, U
   Burkhard, P
TI Conserved segments 1A and 2B of the intermediate filament dimer: their
   atomic structures and role in filament assembly
SO EMBO JOURNAL
LA English
DT Article
DE atomic structure; coiled coil; intermediate filaments; vimentin; X-ray
   crystallography
ID X-RAY-STRUCTURE; COILED-COIL; ROD DOMAIN; DYNAMICS; KERATIN; VIMENTIN;
   SEQUENCE; REFINEMENT; MOLECULES; NETWORK
AB Intermediate filaments (IFs) are key components of the cytoskeleton in higher eukaryotic cells. The elementary IF 'building block' is an elongated coiled-coil dimer consisting of four consecutive alpha-helical segments. The segments 1A and 2B include highly conserved sequences and are critically involved in IF assembly. Based on the crystal structures of three human vimentin fragments at 1.4-2.3 Angstrom resolution (PDB entries 1gk4, 1gk6 and 1gk7), we have established the molecular organization of these two segments. The fragment corresponding to segment 1A forms a single, amphipatic alpha-helix, which is compatible with a coiled-coil geometry. While this segment might yield a coiled coil within an isolated dimer, monomeric 1A helices are likely to play a role in specific dimer-dimer interactions during IF assembly. The 2B segment reveals a double-stranded coiled coil, which unwinds near residue Phe351 to accommodate a 'stutter'. A fragment containing the last seven heptads of 2B interferes heavily with IF assembly and also transforms mature vimentin filaments into a new kind of structure. These results provide the first insight into the architecture and functioning of IFs at the atomic level.
C1 Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
   Max Planck Inst Biophys Chem, Div Biochem & Cell Biol, D-37070 Gottingen, Germany.
RP Strelkov, SV (corresponding author), Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sergei-v.strelkov@unibas.ch
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
CR AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Brown JH, 1996, PROTEINS, V26, P134
   BRUNGER AT, 1993, Q REV BIOPHYS, V26, P49, DOI 10.1017/S0033583500003966
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   Cohen M, 2001, TRENDS BIOCHEM SCI, V26, P41, DOI 10.1016/S0968-0004(00)01727-8
   CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3
   Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501
   GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x
   GEISLER N, 1992, EUR J BIOCHEM, V206, P841, DOI 10.1111/j.1432-1033.1992.tb16992.x
   Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6
   Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971
   HATZFELD M, 1994, J CELL SCI, V107, P1959
   HATZFELD M, 1992, J CELL BIOL, V116, P157, DOI 10.1083/jcb.116.1.157
   HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   Herrmann H, 1998, Subcell Biochem, V31, P319
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   MCCORMICK MB, 1993, J CELL BIOL, V122, P395, DOI 10.1083/jcb.122.2.395
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   NORTH ACT, 1994, PROTEINS, V20, P174, DOI 10.1002/prot.340200207
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Parry DAD, 1995, INTERMEDIATE FILAMEN
   Schliwa M., 1986, CELL BIOL MONOGRAPHS, V13
   SMITH TA, 2002, IN PRESS J STRUCT BI
   Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Steinmetz MO, 1998, J MOL BIOL, V278, P703, DOI 10.1006/jmbi.1998.1717
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   STRELKOV SV, 2002, IN PRESS J STRUCT BI
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Turkenburg JP, 1996, CURR OPIN STRUC BIOL, V6, P604, DOI 10.1016/S0959-440X(96)80025-X
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   WEBER K, 1985, ANN NY ACAD SCI, V455, P126, DOI 10.1111/j.1749-6632.1985.tb50408.x
   Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006
   Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539
NR 52
TC 209
Z9 213
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD MAR 15
PY 2002
VL 21
IS 6
BP 1255
EP 1266
DI 10.1093/emboj/21.6.1255
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 531CR
UT WOS:000174398900003
PM 11889032
OA Green Published
DA 2021-01-25
ER

PT J
AU Knochel, T
   Pappenberger, A
   Jansonius, JN
   Kirschner, K
AF Knochel, T
   Pappenberger, A
   Jansonius, JN
   Kirschner, K
TI The crystal structure of indoleglycerol-phosphate synthase from
   Thermotoga maritima - Kinetic stabilization by salt bridges
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; SULFOLOBUS-SOLFATARICUS;
   BIFUNCTIONAL ENZYME; 3-DIMENSIONAL STRUCTURE; POSSIBLE DETERMINANTS;
   THERMAL-STABILITY; PROTEIN STABILITY; ESCHERICHIA-COLI;
   HYPERTHERMOPHILE; DESIGN
AB The crystal structure of the thermostable indoleglycerol-phosphate synthase from Thermotoga maritima (tIGPS) was determined at 2.5 Angstrom resolution. It was compared with the structures of the thermostable sIGPS from Sulfolobus solfataricus and of the thermolabile eIGPS from Escherichia coli. The main chains of the three (betaalpha)(8)-barrel proteins superimpose closely, and the packing of side chains in the beta-barrel cores, as well as the architecture of surface loops, is very similar. Both thermostable proteins have, however, 17 strong salt bridges, compared with only 10 in eIGPS. The number of additional salt bridges in tIGPS and sIGPS correlates well with their reduced rate of irreversible thermal inactivation at 90 degreesC. Only 3 of 17 salt bridges in tIGPS and sIGPS are topologically conserved. The major difference between the two proteins is the preference for interhelical salt bridges in sIGPS and intrahelical ones in tIGPS. The different implementation of salt bridges in the closely related proteins suggests that the stabilizing effect of salt bridges depends rather on the sum of their individual contributions than on their location. This observation is consistent with a protein unfolding mechanism where the simultaneous breakdown of all salt bridges is the rate-determining step.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Knochel, T (corresponding author), Pfizer Global Res & Dev, IPC 636,Ramsgate Rd, Sandwich CT13 9NJ, Kent, England.
EM thorsten_knoechel@sandwich.pfizer.com
CR Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5
   BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3369, DOI 10.1021/bi9721795
   CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4
   Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152
   Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82
   Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518
   del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M
   EBERHARD M, 1995, BIOCHEMISTRY-US, V34, P5419, DOI 10.1021/bi00016a013
   Grimsley GR, 1999, PROTEIN SCI, V8, P1843, DOI 10.1110/ps.8.9.1843
   Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578
   HEINZ DW, 1994, PROTEIN ENG, V7, P301, DOI 10.1093/protein/7.3.301
   Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2
   Hennig M, 1997, BIOCHEMISTRY-US, V36, P6009, DOI 10.1021/bi962718q
   HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7
   Hough DW, 1999, CURR OPIN CHEM BIOL, V3, P39, DOI 10.1016/S1367-5931(99)80008-8
   HUBBARD SJ, 1994, PROTEIN ENG, V7, P613, DOI 10.1093/protein/7.5.613
   Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8
   JONES TA, 1985, METHOD ENZYMOL, V115, P157
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867
   KIEFHABER T, 1995, NATURE, V375, P513, DOI 10.1038/375513a0
   Knochel TR, 1996, J MOL BIOL, V262, P502, DOI 10.1006/jmbi.1996.0531
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218
   Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179
   Loladze VV, 1999, BIOCHEMISTRY-US, V38, P16419, DOI 10.1021/bi992271w
   Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470
   MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334
   Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i
   Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709
   Mueller U, 2000, J MOL BIOL, V297, P975, DOI 10.1006/jmbi.2000.3602
   Nagano N, 1999, PROTEIN SCI, V8, P2072, DOI 10.1110/ps.8.10.2072
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   Perl D, 2000, NAT STRUCT BIOL, V7, P380
   PRIESTLE JP, 1987, P NATL ACAD SCI USA, V84, P5690, DOI 10.1073/pnas.84.16.5690
   Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
   RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086
   Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121
   Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006
   STERNER R, 1995, EMBO J, V14, P4395, DOI 10.1002/j.1460-2075.1995.tb00118.x
   Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174
   Strop P, 2000, PROTEIN SCI, V9, P1391, DOI 10.1110/ps.9.7.1391
   Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7
   Thoma R, 2000, STRUCTURE, V8, P265, DOI 10.1016/S0969-2126(00)00106-4
   WILMANNS M, 1991, BIOCHEMISTRY-US, V30, P9161, DOI 10.1021/bi00102a006
   WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7
   Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810
   Yamagata Y, 2001, J BIOL CHEM, V276, P11062, DOI 10.1074/jbc.M009987200
NR 56
TC 22
Z9 22
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 8
PY 2002
VL 277
IS 10
BP 8626
EP 8634
DI 10.1074/jbc.M109517200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 528WR
UT WOS:000174268000128
PM 11741953
OA Bronze
DA 2021-01-25
ER

PT J
AU Mayr-Wohlfart, U
   Waltenberger, J
   Hausser, H
   Kessler, S
   Gunther, KP
   Dehio, C
   Puhl, W
   Brenner, RE
AF Mayr-Wohlfart, U
   Waltenberger, J
   Hausser, H
   Kessler, S
   Gunther, KP
   Dehio, C
   Puhl, W
   Brenner, RE
TI Vascular endothelial growth factor stimulates chemotactic migration of
   primary human osteoblasts
SO BONE
LA English
DT Article
DE chemotaxis; vascular endothelial growth factor (VEGF); bone
   morphogenetic protein (BMP); cell migration; human osteoblast; VEGF
   receptors
ID HUMAN-BONE; 1,25-DIHYDROXYVITAMIN D-3; RECEPTOR FLT-1; FACTOR VEGF;
   FACTOR-BETA; CELLS; EXPRESSION; KDR; ANGIOGENESIS; CARTILAGE
AB Recent studies have indicated a critical role for Vascular endothelial growth factor (VEGF) during the process of endochondral ossification, in particular in coupling cartilage resorption with bone formation. Therefore, we studied the chemoattractive and proliferative properties of human VEGF-A on primary human osteoblasts (PHO) and compared these data with the effects of human basic fibroblast growth factor (bFGF) and human bone morphogenetic protein-2 (BMP-2). Furthermore, initial experiments were carried out to characterize VEGF-binding proteins on osteoblastic cells possibly involved in the response. For the first time, to our knowledge, we could demonstrate a chemoattractive effect of VEGF-A, but not VEGF-E, on primary human osteoblasts. The effect of VEGF-A was dose-dependent and did not reach a maximum within the concentration range tested (up to 10 ng/mL). The maximal effect observed was a chemotactic index (CI) of 2 at a concentration of 10 ng/mL. bFGF and BMP-2 exhibited maxima at 1.0 ng/mL with CI values of 2.5 and 2, respectively. In addition to its effect on cell migration, VEGF-A stimulated cell proliferation by up to 70%. Reverse transcription-polymerase chain reaction (RTPCR) analysis revealed the expression of VEGF receptors VEGFR-1 (Flt-1), VEGFR-2 (Kdr), and VEGFR-3 (Flt-4), as well as neuropilin-1 and -2. An in vitro kinase assay failed to demonstrate activation of VEGFR-2 upon stimulation with either VEGF-E or VEGF-A, consistent with the idea that the effect of VEGF-A on primary human osteoblasts is mediated via VEGFR-I. Taken together, our data establish that human osteoblasts respond to VEGF-A, suggesting a functional role for this growth factor in bone formation and remodeling. (Bone 30:472-477; 2002) (C) 2002 by Elsevier Science Inc. All rights reserved.
C1 Univ Ulm, Div Biochem Joint & Connect Tissue Dis, Orthopaed Dept RKU, D-89081 Ulm, Germany.
   Univ Ulm, Med Ctr, Dept Internal Med 2, Ulm, Germany.
   Univ Basel, Biozentrum, Dept Mol Microbiol, Basel, Switzerland.
RP Brenner, RE (corresponding author), Univ Ulm, Div Biochem Joint & Connect Tissue Dis, Orthopaed Dept RKU, D-89081 Ulm, Germany.
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016;
   Waltenberger, Johannes/I-1813-2013
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Waltenberger,
   Johannes/0000-0002-2417-9880
CR Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336
   BRIGHTON CT, 1991, J BONE JOINT SURG AM, V73A, P832, DOI 10.2106/00004623-199173060-00006
   CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490
   Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629
   DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256
   FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/0022-1759(80)90211-2
   Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2
   Ferrara N, 1996, Curr Opin Nephrol Hypertens, V5, P35, DOI 10.1097/00041552-199601000-00008
   Garcia-Ramirez M, 2000, J BONE MINER RES, V15, P534, DOI 10.1359/jbmr.2000.15.3.534
   Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467
   Goad DL, 1996, ENDOCRINOLOGY, V137, P2262, DOI 10.1210/en.137.6.2262
   GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311
   HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258
   Horner A, 1999, J ANAT, V194, P519, DOI 10.1046/j.1469-7580.1999.19440519.x
   HUGHES FJ, 1992, BONE MINER, V19, P63, DOI 10.1016/0169-6009(92)90844-4
   KASPERK C, 1995, J CLIN ENDOCR METAB, V80, P2511, DOI 10.1210/jc.80.8.2511
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   Kroll J, 1999, BIOCHEM BIOPH RES CO, V265, P636, DOI 10.1006/bbrc.1999.1729
   Kroll J, 2000, Z KARDIOL, V89, P206, DOI 10.1007/s003920050472
   Kubler NR, 1998, INT J ORAL MAX SURG, V27, P305, DOI 10.1016/S0901-5027(05)80621-6
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0
   Larrivee B, 2000, INT J MOL MED, V5, P447
   LIND M, 1995, APMIS, V103, P140, DOI 10.1111/j.1699-0463.1995.tb01089.x
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Mayr-Wohlfart U, 2001, J BONE JOINT SURG BR, V83B, P144, DOI 10.1302/0301-620X.83B1.10219
   MENSING H, 1983, EUR J CELL BIOL, V29, P268
   Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   MORIKE M, 1995, J MOL MED, V73, P571, DOI 10.1007/BF00195142
   PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303
   PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P825
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661
   SADDEH PB, 1999, AM J PHYSIOL, V277, pC628
   Siggelkow H, 1999, J CELL BIOCHEM, V75, P22, DOI 10.1002/(SICI)1097-4644(19991001)75:1<22::AID-JCB3>3.3.CO;2-Y
   TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2
   TSUKAMOTO T, 1991, BIOCHEM BIOPH RES CO, V175, P745, DOI 10.1016/0006-291X(91)91629-Q
   Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647
   WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Wang DS, 1996, J BONE MINER RES, V11, P472
   ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387
NR 42
TC 321
Z9 360
U1 0
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD MAR
PY 2002
VL 30
IS 3
BP 472
EP 477
AR PII S8756-3282(01)00690-1
DI 10.1016/S8756-3282(01)00690-1
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 529YP
UT WOS:000174329100004
PM 11882460
DA 2021-01-25
ER

PT J
AU Morsomme, P
   Riezman, H
AF Morsomme, P
   Riezman, H
TI The Rab GTPase Ypt1p and tethering factors couple protein sorting at the
   ER to vesicle targeting to the Golgi apparatus
SO DEVELOPMENTAL CELL
LA English
DT Article
ID MEMBRANE-PROTEIN; ENDOPLASMIC-RETICULUM; ALKALINE-PHOSPHATASE; TRANSPORT
   VESICLES; CELL-SURFACE; LIPID RAFTS; COMPLEX; COPII; DOCKING; DELIVERY
AB GPI-anchored proteins exit the ER in distinct vesicles from other secretory proteins, and this sorting event can be reproduced in vitro. When extracts from a uso1 mutant were used, the sorting of GPI-anchored proteins from other secretory proteins was defective. Complementation with purified Uso1p restored sorting. The Rab GTPase Ypt1p and the tethering factors Sec34p and Sec35p, but not Bet3p, a member of the TRAPP complex, were also required for protein sorting upon ER exit. Therefore, the Ypt1 p tethering complex couples protein sorting in the ER to vesicle targeting to the Golgi apparatus. Sorting of GPI-anchored proteins from other secretory proteins was also observed in vivo. The sorting defect observed in vitro with uso1 and ypt1 mutants was reproduced in vivo.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Riezman, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM howard.riezman@unibas.ch
RI Morsomme, Pierre/AAD-9600-2019
OI Morsomme, Pierre/0000-0001-7780-7230; Riezman,
   Howard/0000-0003-4680-9422
CR Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444
   Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697
   Barlowe C, 2000, TRAFFIC, V1, P371, DOI 10.1034/j.1600-0854.2000.010501.x
   BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4
   Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097
   Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862
   Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156
   Carroll KS, 2001, SCIENCE, V292, P1373, DOI 10.1126/science.1056791
   Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398
   Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2
   Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017
   Cowles CR, 1997, EMBO J, V16, P2769, DOI 10.1093/emboj/16.10.2769
   Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37
   Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071
   HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297
   Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585
   Kuehn MJ, 1998, NATURE, V391, P187
   Lafont F, 1999, P NATL ACAD SCI USA, V96, P3734, DOI 10.1073/pnas.96.7.3734
   Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202
   Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1
   LIAN JP, 1993, CELL, V73, P735, DOI 10.1016/0092-8674(93)90253-M
   LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0
   Matsuoka K, 1998, MOL CELL, V2, P703, DOI 10.1016/S1097-2765(00)80168-9
   McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   NAIR J, 1990, J CELL BIOL, V110, P1897, DOI 10.1083/jcb.110.6.1897
   NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27
   Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967
   Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531
   Price A, 2000, J CELL BIOL, V148, P1223, DOI 10.1083/jcb.148.6.1223
   Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494
   Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3
   SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x
   Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526
   Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698
   Sutterlin C, 1997, J CELL SCI, V110, P2703
   VanRheenen SM, 1999, J CELL BIOL, V147, P729, DOI 10.1083/jcb.147.4.729
   VanRheenen SM, 1998, J CELL BIOL, V141, P1107, DOI 10.1083/jcb.141.5.1107
   WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495
   Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9
   Whyte JRC, 2001, DEV CELL, V1, P527, DOI 10.1016/S1534-5807(01)00063-6
   Yamakawa H, 1996, J STRUCT BIOL, V116, P356, DOI 10.1006/jsbi.1996.0053
   Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055
NR 44
TC 87
Z9 89
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD MAR
PY 2002
VL 2
IS 3
BP 307
EP 317
DI 10.1016/S1534-5807(02)00133-8
PG 11
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 548KV
UT WOS:000175387900010
PM 11879636
DA 2021-01-25
ER

PT J
AU Bermond, D
   Boulouis, HJ
   Heller, R
   Van Laere, G
   Monteil, H
   Chomel, BB
   Sander, A
   Dehio, C
   Piemont, Y
AF Bermond, D
   Boulouis, HJ
   Heller, R
   Van Laere, G
   Monteil, H
   Chomel, BB
   Sander, A
   Dehio, C
   Piemont, Y
TI Bartonella bovis Bermond et al. sp nov and Bartonella capreoli sp nov.,
   isolated from European ruminants
SO INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
LA English
DT Article
DE Bartonella capreoli; Bartonella bovis; ruminants; citrate synthase gene;
   16S rDNA
ID MULTIPLE SEQUENCE ALIGNMENT; HENSELAE SP-NOV; BORRELIA-BURGDORFERI;
   ROCHALIMAEA-HENSELAE; BABESIA-MICROTI; BLOOD; WILD; INFECTION;
   IDENTIFICATION; CLUSTAL
AB Two novel species of Bartonella isolated from European ruminants are described. Bartonella capreoli sp. nov. was isolated from the blood of roe-deer (Capreolus capreolus) captured in Chize, France. The type strain is IBS 193(T) (= CIP 106691(T) = CCUG 43827(T)). It is distinct from another European ruminant isolate that originated from a cow from a French herd of 430 dairy cattle. The latter isolate belongs to a novel species named Bartonella bovis Bermond et al sp. nov. The type strain is strain 91-4(T) (= CIP 106692(T) CCUG 43828(T)). The two bacteria appeared as small, fastidious, aerobic, oxidase-negative, Gram-negative rods. Their biochemical properties were similar to those of members of the genus Bartonella. The sequences of the 16S rRNA and citrate synthase genes obtained from the two type strains were highly related to sequences of the different Bartonella species. Hybridization values when testing type strains of recognized Bartonella species, obtained with the nuclease/trichloroacetic acid method, support the creation of two novel species.
C1 Univ Strasbourg, Inst Bacteriol, Fac Med, Hop Univ Strasbourg, F-67000 Strasbourg, France.
   Ecole Natl Vet, INRA AFSSA ENVA, UMR 956, Microbiol IIAC, F-94704 Maisons Alfort, France.
   Off Natl Chasse, Reserve Faune Chize, F-79360 Beauvoir Sur Niort, France.
   Univ Basel, Biozentrum, Abt Mol Mikrobiol, Basel, Switzerland.
   Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.
   Inst Med Mikrobiol & Hyg, D-79104 Freiburg, Germany.
RP Bermond, D (corresponding author), Univ Strasbourg, Inst Bacteriol, Fac Med, Hop Univ Strasbourg, 3 Rue Koeberle, F-67000 Strasbourg, France.
EM delphine.bermond@medecine.u-strasbg.fr
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR BAKER JA, 1946, J EXP MED, V84, P37, DOI 10.1084/jem.84.1.37
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P163, DOI 10.1097/00006454-199702000-00002
   BERGMANS AMC, 1996, THESIS UTRECHT U NET
   Bermond D, 2000, INT J SYST EVOL MICR, V50, P1973, DOI 10.1099/00207713-50-6-1973
   Birtles RJ, 1996, INT J SYST BACTERIOL, V46, P891, DOI 10.1099/00207713-46-4-891
   BIRTLES RJ, 1995, INT J SYST BACTERIOL, V45, P1, DOI 10.1099/00207713-45-1-1
   Breitschwerdt EB, 2000, CLIN MICROBIOL REV, V13, P428, DOI 10.1128/CMR.13.3.428-438.2000
   BREITSCHWERDT EB, 1995, J CLIN MICROBIOL, V33, P154, DOI 10.1128/JCM.33.1.154-160.1995
   BROCKLESBY DW, 1970, VET REC, V87, P761, DOI 10.1136/vr.87.24.761
   Chang CC, 2000, EMERG INFECT DIS, V6, P306, DOI 10.3201/eid0603.000313
   CHOMEL BB, 1999, J MICROBIOL METH, V37, P280
   DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993
   Dehio C, 2001, INT J SYST EVOL MICR, V51, P1557, DOI 10.1099/00207713-51-4-1557
   DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y
   Donatien A, 1934, B SOC PATHOL EXO, V7, P652
   Droz S, 1999, J CLIN MICROBIOL, V37, P1117, DOI 10.1128/JCM.37.4.1117-1122.1999
   Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X
   Fussenegger M, 1996, MOL MICROBIOL, V19, P1357, DOI 10.1111/j.1365-2958.1996.tb02479.x
   GRIMONT PAD, 1980, CURR MICROBIOL, V4, P325, DOI 10.1007/BF02605371
   Heller R, 1999, INT J SYST BACTERIOL, V49, P283, DOI 10.1099/00207713-49-1-283
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   HELLER R, 1999, J MICOBIOL METHODS, V37, P279
   HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7
   Hofmeister EK, 1998, J INFECT DIS, V177, P409, DOI 10.1086/514201
   KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0
   Lawson PA, 1996, MED MICROBIOL LETT, V5, P64
   Lotze John C., 1942, AMER JOUR VET RES, V3, P312
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   REGNERY RL, 2000, P 15 M AM SOC RICK A, P16
   RIEGEL P, 1994, J CLIN MICROBIOL, V32, P1860, DOI 10.1128/JCM.32.8.1860-1865.1994
   RIEGEL P, 1995, J CLIN MICROBIOL, V33, P2244, DOI 10.1128/JCM.33.9.2244-2249.1995
   Schouls LM, 1999, J CLIN MICROBIOL, V37, P2215, DOI 10.1128/JCM.37.7.2215-2222.1999
   SKERMAN VBD, 1980, INT J SYST BACTERIOL, V30, P225, DOI 10.1099/00207713-30-1-225
   STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   VINSON JW, 1961, PATHOL MICROBIOL, V24, P152, DOI 10.1159/000161254
   WEINMAN DR, 1968, INFECT BLOOD DIS MAN, P3
   Welch DF, 1999, J CLIN MICROBIOL, V37, P2598, DOI 10.1128/JCM.37.8.2598-2601.1999
   WELCH DF, 1992, J CLIN MICROBIOL, V30, P275, DOI 10.1128/JCM.30.2.275-280.1992
   WELCH DF, 1993, J CLIN MICROBIOL, V31, P2381, DOI 10.1128/JCM.31.9.2381-2386.1993
NR 40
TC 85
Z9 88
U1 0
U2 4
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 1466-5026
EI 1466-5034
J9 INT J SYST EVOL MICR
JI Int. J. Syst. Evol. Microbiol.
PD MAR
PY 2002
VL 52
BP 383
EP 390
DI 10.1099/00207713-52-2-383
PN 2
PG 8
WC Microbiology
SC Microbiology
GA 533ER
UT WOS:000174516900006
PM 11931146
OA Bronze
DA 2021-01-25
ER

PT J
AU Murphy, M
   Nuoffer, SS
   Bickle, TA
AF Murphy, M
   Nuoffer, SS
   Bickle, TA
TI Lack of regulation of the modification-dependent restriction enzyme
   McrBC in Escherichia coli
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID CLP PROTEASE; I RESTRICTION; ALLEVIATION; ENDONUCLEASE; PROTEOLYSIS;
   INDUCTION; SEQUENCE; DNA
AB Restriction alleviation (RA) by the type I restriction enzyme EcoKI is caused by treatments that damage DNA. RA is due to proteolysis of the EcoKI HsdR subunit by the ClpXP ATP-dependent protease. Here we show that the modification-dependent enzyme McrBC is not subject to RA, although it is moderately sensitive to ClpAP.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Bickle, TA (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR BACHMANN BJ, 1987, ESCHERICHIA COLI SAL, P1190
   DHARMALINGAM K, 1980, MOL GEN GENET, V178, P51, DOI 10.1007/BF00267212
   Doronina VA, 2001, MOL MICROBIOL, V39, P416, DOI 10.1046/j.1365-2958.2001.02232.x
   EFIMOVA EP, 1988, MOL GEN GENET, V214, P317, DOI 10.1007/BF00337728
   GEUSKENS V, 1992, EMBO J, V11, P5121, DOI 10.1002/j.1460-2075.1992.tb05619.x
   GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618
   HIOM K, 1991, BIOCHIMIE, V73, P399, DOI 10.1016/0300-9084(91)90106-B
   KELLEHER JE, 1994, J BACTERIOL, V176, P5888, DOI 10.1128/jb.176.19.5888-5896.1994
   Makovets S, 1999, P NATL ACAD SCI USA, V96, P9757, DOI 10.1073/pnas.96.17.9757
   MAURIZI MR, 1990, J BIOL CHEM, V265, P12536
   Osteras M, 1999, J BACTERIOL, V181, P3039
   Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x
   REVEL HR, 1983, BACTERIOPHAGE T, V4, P156
   SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A
   THOMS B, 1982, MOL GEN GENET, V186, P111, DOI 10.1007/BF00422921
NR 15
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD MAR
PY 2002
VL 184
IS 6
BP 1794
EP 1795
DI 10.1128/JB.184.6.1794-1795.2002
PG 2
WC Microbiology
SC Microbiology
GA 526LK
UT WOS:000174131800035
PM 11872734
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Bourniquel, AA
   Casey, MG
   Mollet, B
   Pridmore, RD
AF Bourniquel, AA
   Casey, MG
   Mollet, B
   Pridmore, RD
TI DNA sequence and functional analysis of Lactobacillus delbrueckii subsp
   lactis plasmids pN42 and pJBL2
SO PLASMID
LA English
DT Article
DE Lactobacillus delbrueckii subsp lactis; lactic acid bacteria; plasmid;
   replication; type I R-M system; transformation
ID LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION;
   BACILLUS-SUBTILIS; REPLICATION; SPECIFICITY; HELICASE; CLONING;
   RECOMBINATION; RECOGNITION
AB The plasmids pN42 and pJBL2 were isolated from the Lactobacillus delbrueckii subsp. lactis strains NCC88 and JCL414. DNA sequence determination and bioinformatic analysis revealed a strikingly conserved genetic organization containing five major. highly conserved open reading frames (ORFs). Transformation studies indicated that ORF2 (consisting of a primase fused to a replicative DNA helicase), ori, and ORF3 constitute the minimal requirements for replication of pN42 in the heterologous host Lactococcus lactis. The ORF1's are predicted to encode type I restriction-modification (R-M) system HsdS subunits with different specificities on either plasmid, suggesting that these plasmids may be involved in host defense by expanding their host R-M system repertoire. These plasmids constitute the basis for the construction of novel L. delbrueckii vectors. (C) 2002 Elsevier Science (USA).
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
   Swiss Fed Dairy Res Inst, FAM, Dept Biochem, CH-3003 Bern, Switzerland.
   Nestec Ltd, Nestle Res Ctr, Mol Biol Grp, CH-1000 Lausanne 26, Switzerland.
RP Pridmore, RD (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM david.pridmore@rdls.nestle.com
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x
   CASEY MG, 1989, NETH MILK DAIRY J, V43, P279
   Caspi R, 2001, EMBO J, V20, P3262, DOI 10.1093/emboj/20.12.3262
   CHEN JD, 1988, GENE, V64, P155, DOI 10.1016/0378-1119(88)90489-1
   Datta HJ, 1999, P NATL ACAD SCI USA, V96, P73, DOI 10.1073/pnas.96.1.73
   DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387
   Emond E, 2001, APPL ENVIRON MICROB, V67, P1700, DOI 10.1128/AEM.67.4.1700-1709.2001
   FULLERPACE FV, 1984, P NATL ACAD SCI-BIOL, V81, P6095, DOI 10.1073/pnas.81.19.6095
   GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713
   GOUGH JA, 1983, J MOL BIOL, V166, P1, DOI 10.1016/S0022-2836(83)80047-3
   HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989
   Madsen A, 2000, PLASMID, V44, P196, DOI 10.1006/plas.2000.1478
   MARIANS KJ, 1996, ESCHERICHIA COLI SAL, P749
   MESSER W, 1996, ESCHERICHIA COLI SAL, P1579
   Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000
   NAGARAJA V, 1985, NATURE, V316, P371, DOI 10.1038/316371a0
   O'Sullivan D, 2000, MOL MICROBIOL, V36, P866, DOI 10.1046/j.1365-2958.2000.01901.x
   OSULLIVAN DJ, 1993, APPL ENVIRON MICROB, V59, P2730, DOI 10.1128/AEM.59.8.2730-2733.1993
   PLATTEEUW C, 1994, APPL ENVIRON MICROB, V60, P587, DOI 10.1128/AEM.60.2.587-593.1994
   Ratnakar PVAL, 1996, P NATL ACAD SCI USA, V93, P5522, DOI 10.1073/pnas.93.11.5522
   SAKAMOTO Y, 1995, MICROBIOL-UK, V141, P641, DOI 10.1099/13500872-141-3-641
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Schouler C, 1998, MOL MICROBIOL, V28, P169, DOI 10.1046/j.1365-2958.1998.00787.x
   SEEGERS JFML, 1994, MICROBIOL-UK, V140, P1291, DOI 10.1099/00221287-140-6-1291
   Seegers JFML, 2000, MICROBIOL-UK, V146, P435, DOI 10.1099/00221287-146-2-435
   Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x
   SEITZ H, 2001, EMBO J, V11, P1003
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
NR 29
TC 7
Z9 10
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-619X
EI 1095-9890
J9 PLASMID
JI Plasmid
PD MAR
PY 2002
VL 47
IS 2
BP 153
EP 157
DI 10.1006/plas.2001.1560
PG 5
WC Genetics & Heredity; Microbiology
SC Genetics & Heredity; Microbiology
GA 550DW
UT WOS:000175489200010
PM 11982337
DA 2021-01-25
ER

PT J
AU Ourlin, JC
   Handschin, C
   Kaufmann, M
   Meyer, UA
AF Ourlin, JC
   Handschin, C
   Kaufmann, M
   Meyer, UA
TI A link between cholesterol levels and phenobarbital induction of
   cytochromes P450
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE cytochrome P450; phenobarbital; squalestatin; cholesterol homeostasis;
   sterols; bile acids; CYP2H1; CYP3A37; drug induction
ID ORPHAN NUCLEAR RECEPTORS; CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X
   RECEPTOR; LITHOCHOLIC ACID; EXPRESSION; GENE; RAT; CHOLESTASIS;
   METABOLISM; CYP2H1
AB Squalestatin1 (SQ1), a potent inhibitor of squalene synthase produced a dose-dependent induction of cytochromes P450 CYP2H1 and CYP3A37 mRNAs in chicken hepatoma cells. The effect of SQ1 was completely reversed by 25-hydroxycholesterol. Bile acids elicited an induction of CYP3A37 and CYP2H1 mRNA. Bile acids also reduced the phenobarbital induction of CYP2H1 but not of CYP3A37 mRNA. The effects of SQ1 and its reversal by 25-hydroxycholesterol and the effects of bile acids were reproduced in reporter gene assays with a phenobarbital-responsive enhancer unit of CYP2H1. These data suggest that an endogenous molecule related to cholesterol homeostasis regulates induction of drug-inducible CYPs. (C) 2002 Elsevier Science (USA).
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Urs-A.Meyer@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1
   Aynaci FM, 2001, J CHILD NEUROL, V16, P367
   BACK P, 1987, PHARMACOL THERAPEUT, V33, P153, DOI 10.1016/0163-7258(87)90044-1
   Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5
   Cancado ELR, 1998, AM J GASTROENTEROL, V93, P1510, DOI 10.1111/j.1572-0241.1998.00472.x
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0
   Kemper B, 1998, PROG NUCLEIC ACID RE, V61, P25, DOI 10.1016/S0079-6603(08)60824-7
   Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757
   Kocarek TA, 1998, MOL PHARMACOL, V54, P474
   KOCAREK TA, 1993, TOXICOL APPL PHARM, V120, P298, DOI 10.1006/taap.1993.1115
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Meyer UA, 1999, DRUG METAB REV, V31, P365, DOI 10.1081/DMR-100101924
   Ourlin JC, 2000, ARCH BIOCHEM BIOPHYS, V373, P375, DOI 10.1006/abbi.1999.1566
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Plewka A, 1996, EXP TOXICOL PATHOL, V48, P249, DOI 10.1016/S0940-2993(96)80009-1
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001
   Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Stevens L., 1996, AVIAN BIOCH MOL BIOL
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   Watanabe M, 1996, MED SCI RES, V24, P257
   WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
NR 30
TC 24
Z9 25
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 22
PY 2002
VL 291
IS 2
BP 378
EP 384
DI 10.1006/bbrc.2002.6464
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 524AY
UT WOS:000173990800028
PM 11846416
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Onuma, Y
   Takahashi, S
   Asashima, M
   Kurata, S
   Gehring, WJ
AF Onuma, Y
   Takahashi, S
   Asashima, M
   Kurata, S
   Gehring, WJ
TI Conservation of Pax 6 function and upstream activation by Notch
   signaling in eye development of frogs and flies
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID HOMEOBOX-CONTAINING GENE; SINE OCULIS; ECTOPIC EYES; EYELESS GENE;
   XENOPUS-EMBRYOS; CELL FATE; DROSOPHILA; EXPRESSION; EVOLUTION; ANIRIDIA
AB Loss of Pax 6 function leads to an eyeless phenotype in both mammals and insects, and ectopic expression of both the Drosophila and the mouse gene leads to the induction of ectopic eyes in Drosophila, which suggested to us that Pax 6 might be a universal master control gene for eye morphogenesis. Here, we report the reciprocal experiment in which the IRNAs of the Drosophila Pax 6 homologs, eyeless and twin of eyeless, are transferred into a vertebrate embryo; i.e., early Xenopus embryos at the 2- and 16-cell stages. In both cases, ectopic eye structures are formed. To understand the genetic program specifying eye morphogenesis, we have analyzed the regulatory mechanisms of Pax 6 expression that initiates eye development. Previously, we have demonstrated that Notch signaling regulates the expression of eyeless and twin of eyeless in Drosophila. Here, we show that in Xenopus, activation of Notch signaling also induces eye-related gene expression, including Pax 6, in isolated animal caps. In Xenopus embryos, the activation of Notch signaling causes eye duplications and proximal eye defects, which are also induced by overexpression of eyeless and twin of eyeless. These findings indicate that the gene regulatory cascade is similar in vertebrates and invertebrates.
C1 Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.
   Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan.
   Univ Tokyo, Core Res Evolut Sci & Technol Project, Meguro Ku, Tokyo 1538902, Japan.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Kurata, S (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.
RI Onuma, Yasuko/L-7083-2018
OI Onuma, Yasuko/0000-0002-9330-194X
CR Altmann CR, 1997, DEV BIOL, V185, P119, DOI 10.1006/dbio.1997.8573
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Bernier G, 2000, MECH DEVELOP, V93, P59, DOI 10.1016/S0925-4773(00)00271-9
   Bonini NM, 1997, DEVELOPMENT, V124, P4819
   Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0
   Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483
   Callaerts P, 1999, P NATL ACAD SCI USA, V96, P558, DOI 10.1073/pnas.96.2.558
   Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X
   Chow RL, 1999, DEVELOPMENT, V126, P4213
   COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Gehring WJ, 1996, GENES CELLS, V1, P11, DOI 10.1046/j.1365-2443.1996.11011.x
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232
   HALDER G, 1995, CURR OPIN GENET DEV, V5, P602, DOI 10.1016/0959-437X(95)80029-8
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Halder G, 1998, DEVELOPMENT, V125, P2181
   Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564
   HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0
   HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0
   Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.0.CO;2-E
   Hollemann T, 1998, DEVELOPMENT, V125, P2425
   JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328
   Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0
   KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057
   Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497
   Li HS, 1997, DEVELOPMENT, V124, P603
   Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0
   Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649
   Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475
   Mathers PH, 2000, CELL MOL LIFE SCI, V57, P186, DOI 10.1007/PL00000683
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   OLIVER G, 1996, MECH DEVELOP, V60, P223
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Pineda D, 2000, P NATL ACAD SCI USA, V97, P4525, DOI 10.1073/pnas.97.9.4525
   Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0
   Seimiya M, 2000, DEVELOPMENT, V127, P1879
   Shen WP, 1997, DEVELOPMENT, V124, P45
   Spemann H., 1938, EMBRYONIC DEV INDUCT
   STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380
   TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6
   WALTHER C, 1991, DEVELOPMENT, V113, P1435
   Xu PX, 1999, DEVELOPMENT, V126, P383
   YOUNOSSIHARTENSTEIN A, 1993, ROUX ARCH DEV BIOL, V203, P60, DOI 10.1007/BF00539891
NR 46
TC 93
Z9 101
U1 0
U2 8
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 19
PY 2002
VL 99
IS 4
BP 2020
EP 2025
DI 10.1073/pnas.022626999
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 524UK
UT WOS:000174031100050
PM 11842182
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Arbuzova, A
   Schmitz, AAP
   Vergeres, G
AF Arbuzova, A
   Schmitz, AAP
   Vergeres, G
TI Cross-talk unfolded: MARCKS proteins
SO BIOCHEMICAL JOURNAL
LA English
DT Review
DE actin; calmodulin; membranes; PIP2; PKC
ID C-KINASE SUBSTRATE; MYRISTOYL-ELECTROSTATIC SWITCH; PLECKSTRIN HOMOLOGY
   DOMAIN; ABNORMAL BRAIN-DEVELOPMENT; MAJOR SPECIFIC SUBSTRATE;
   NEURAL-TUBE DEFECTS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE;
   MEMBRANE-BINDING; PLASMA-MEMBRANE; BOVINE BRAIN
AB The proteins of the MARCKS (myristoylated alanine-rich C kinase substrate) family were first identified as prominent substrates of protein kinase C (PKC). Since then, these proteins have been implicated in the regulation of brain development and postnatal survival, cellular migration and adhesion, as well as endo-, exo- and phago-cytosis, and neurosecretion. The effector domain of MARCKS proteins is phosphorylated by PKC, binds to calmodulin and contributes to membrane binding. This multitude of mutually exclusive interactions allows cross-talk between the signal transduction pathways involving PKC and calmodulin. This review focuses on recent, mostly biophysical and biochemical results renewing interest in this protein family. MARCKS membrane binding is now understood at the molecular level. From a structural point of view, there is a consensus emerging that MARCKS proteins are 'natively unfolded'. Interestingly, domains similar to the effector domain have been discovered in other proteins. Furthermore, since the effector domain enhances the polymerization of actin in vitro, MARCKS proteins have been proposed to mediate regulation of the actin cytoskeleton. However, the recent observations that MARCKS might serve to sequester phosphatidylinositol 4,5-bisphosphate in the plasma membrane of unstimulated cells suggest an alternative model for the control of the actin cytoskeleton. While myristoylation is classically considered to be a co-translational, irreversible event, new reports on MARCKS proteins suggest a more dynamic picture of this protein modification. Finally, studies with mice lacking MARCKS proteins have investigated the functions of these proteins during embryonic development in the intact organism.
C1 ZLB Bioplasma AG, Preclin Dev, CH-3000 Bern 22, Switzerland.
   SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Vergeres, G (corresponding author), ZLB Bioplasma AG, Preclin Dev, Wankdorfstr 10, CH-3000 Bern 22, Switzerland.
OI Schmitz, Arndt/0000-0002-7104-6191; Arbuzova, Anna/0000-0003-2462-147X
CR ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O
   ADEREM AA, 1988, NATURE, V332, P362, DOI 10.1038/332362a0
   ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046
   ALLEN LAH, 1995, EMBO J, V14, P1109, DOI 10.1002/j.1460-2075.1995.tb07094.x
   ALLEN LAH, 1995, J EXP MED, V182, P829, DOI 10.1084/jem.182.3.829
   Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j
   Arbuzova A, 1998, BBA-REV BIOMEMBRANES, V1376, P369, DOI 10.1016/S0304-4157(98)00011-2
   Bahr G, 1998, BIOCHEMISTRY-US, V37, P16252, DOI 10.1021/bi981765a
   BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9
   Bhatnagar RS, 1997, TRENDS CELL BIOL, V7, P14, DOI 10.1016/S0962-8924(97)10044-7
   BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501
   BLACKSHEAR PJ, 1992, GENOMICS, V14, P168, DOI 10.1016/S0888-7543(05)80300-3
   Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353
   Braun T, 2000, BIOCHIMIE, V82, P705, DOI 10.1016/S0300-9084(00)01154-8
   Bubb MR, 1999, J BIOL CHEM, V274, P36472, DOI 10.1074/jbc.274.51.36472
   CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512
   Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0
   Chang S, 1996, J BIOL CHEM, V271, P1174, DOI 10.1074/jbc.271.2.1174
   Chen JM, 1996, P NATL ACAD SCI USA, V93, P6275, DOI 10.1073/pnas.93.13.6275
   Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6
   CLARKE PR, 1993, FEBS LETT, V336, P37, DOI 10.1016/0014-5793(93)81604-X
   Corradin S, 1999, J BIOL CHEM, V274, P25411, DOI 10.1074/jbc.274.36.25411
   Corradin S, 1999, J BIOL CHEM, V274, P16782, DOI 10.1074/jbc.274.24.16782
   Cremona O, 2001, J CELL SCI, V114, P1041
   Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0
   Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X
   GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4
   Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039
   GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0
   HINRICHSEN RD, 1993, P NATL ACAD SCI USA, V90, P1585, DOI 10.1073/pnas.90.4.1585
   Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8
   IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175
   JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125
   Jin TQ, 2001, J BIOL CHEM, V276, P12879, DOI 10.1074/jbc.M010513200
   KIM JY, 1994, J BIOL CHEM, V269, P28214
   KIM JY, 1994, BIOPHYS J, V67, P227, DOI 10.1016/S0006-3495(94)80473-4
   LAUMAS S, 1989, P NATL ACAD SCI USA, V86, P3021, DOI 10.1073/pnas.86.9.3021
   Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455
   LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472
   Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001
   MANENTI S, 1994, J BIOL CHEM, V269, P8309
   MANENTI S, 1993, J BIOL CHEM, V268, P6878
   Manenti S, 1999, BIOCHEM J, V340, P775, DOI 10.1042/0264-6021:3400775
   MANENTI S, 1992, J BIOL CHEM, V267, P22310
   Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231
   Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6
   Matsubara M, 1998, FEBS LETT, V421, P203, DOI 10.1016/S0014-5793(97)01557-3
   Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731
   MCILHINNEY RAJ, 1990, BIOCHEM J, V271, P681, DOI 10.1042/bj2710681
   MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8
   MCLAUGHLIN S, 2002, IN PRESS ANN REV BIO
   McNamara RK, 1998, J COMP NEUROL, V397, P337
   McNamara RK, 1998, P NATL ACAD SCI USA, V95, P14517, DOI 10.1073/pnas.95.24.14517
   MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061
   Michielin O, 1999, J AM CHEM SOC, V121, P6523, DOI 10.1021/ja990239j
   Michielin O, 1998, BBA-BIOMEMBRANES, V1375, P110, DOI 10.1016/S0005-2736(98)00141-2
   Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7
   MURRAY D, 2002, IN PRESS CURRENT TOP
   Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4
   Myat MM, 1998, CURR BIOL, V8, P677, DOI 10.1016/S0960-9822(98)70273-8
   Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0
   Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200
   OUIMET CC, 1990, J NEUROSCI, V10, P1683
   PAWSON AJ, 1998, CURR TOPICS MICRO BI, V228, P1
   PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0
   PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020
   Porumb T, 1997, EUR BIOPHYS J BIOPHY, V25, P239, DOI 10.1007/s002490050036
   Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5
   Qin ZH, 1996, BIOCHEMISTRY-US, V35, P2917, DOI 10.1021/bi9521452
   Qin ZH, 1996, BIOCHEMISTRY-US, V35, P13272, DOI 10.1021/bi961747y
   Ramsden JJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P241, DOI 10.1006/abbi.1999.1451
   Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3
   ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211
   Rossi EA, 1999, J BIOL CHEM, V274, P27201, DOI 10.1074/jbc.274.38.27201
   Schleiff E, 1996, J BIOL CHEM, V271, P26794, DOI 10.1074/jbc.271.43.26794
   SCHMITZ A, 1997, NATO ASI SER H, V101, P127
   Schmitz AAP, 1998, BIOCHEMISTRY-US, V37, P9520, DOI 10.1021/bi973063b
   Schmitz AAP, 1999, ANAL BIOCHEM, V268, P343, DOI 10.1006/abio.1998.3080
   Schmitz AAP, 2000, ARCH BIOCHEM BIOPHYS, V380, P380, DOI 10.1006/abbi.2000.1925
   Sechi AS, 2000, J CELL SCI, V113, P3685
   SEKI K, 1995, ARCH BIOCHEM BIOPHYS, V316, P673, DOI 10.1006/abbi.1995.1090
   Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797
   Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095
   Spizz G, 1997, J BIOL CHEM, V272, P23833, DOI 10.1074/jbc.272.38.23833
   Spizz G, 1996, J BIOL CHEM, V271, P553, DOI 10.1074/jbc.271.1.553
   Spizz G, 2001, J BIOL CHEM, V276, P32264, DOI 10.1074/jbc.M103960200
   Stull JT, 2001, J BIOL CHEM, V276, P2311, DOI 10.1074/jbc.R000030200
   STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944
   Stumpo DJ, 1998, GENOMICS, V49, P253, DOI 10.1006/geno.1998.5247
   Swierczynski SL, 1996, J BIOL CHEM, V271, P23424, DOI 10.1074/jbc.271.38.23424
   SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436
   Swierczynski SL, 1996, DEV BIOL, V179, P135, DOI 10.1006/dbio.1996.0246
   Takasaki A, 1999, J BIOL CHEM, V274, P11848, DOI 10.1074/jbc.274.17.11848
   Tall EG, 2000, CURR BIOL, V10, P743, DOI 10.1016/S0960-9822(00)00541-8
   Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556
   TANIGUCHI H, 1993, J BIOL CHEM, V268, P9960
   TANIGUCHI H, 1994, J BIOL CHEM, V269, P18299
   Taniguchi H, 1999, BIOPHYS CHEM, V82, P129, DOI 10.1016/S0301-4622(99)00112-X
   THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0
   Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8
   Ulrich A, 2000, P NATL ACAD SCI USA, V97, P5191, DOI 10.1073/pnas.090500397
   Underhill DM, 1998, J BIOL CHEM, V273, P33619, DOI 10.1074/jbc.273.50.33619
   Vergeres G, 1998, BIOCHEM J, V330, P5, DOI 10.1042/bj3300005
   VERGERES G, 1995, J BIOL CHEM, V270, P19879, DOI 10.1074/jbc.270.34.19879
   Vergeres G, 2000, ARCH BIOCHEM BIOPHYS, V378, P45, DOI 10.1006/abbi.2000.1809
   VERGERES G, 1995, NATO ASI SER, V92, P125
   VERGHESE GM, 1994, J BIOL CHEM, V269, P9361
   Victor K, 1999, BIOCHEMISTRY-US, V38, P12527, DOI 10.1021/bi990847b
   Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200
   Watson DG, 1996, J NEUROCHEM, V67, P767
   Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
   Wohnsland F, 2000, J STRUCT BIOL, V131, P217, DOI 10.1006/jsbi.2000.4299
   Wohnsland F, 2000, BIOPHYS CHEM, V85, P169, DOI 10.1016/S0301-4622(00)00113-7
   Wohnsland F, 2000, J BIOL CHEM, V275, P20873, DOI 10.1074/jbc.M910298199
   Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110
   Wu M, 1996, P NATL ACAD SCI USA, V93, P2110, DOI 10.1073/pnas.93.5.2110
   WU WCS, 1982, P NATL ACAD SCI-BIOL, V79, P5249, DOI 10.1073/pnas.79.17.5249
   Yamauchi E, 1998, J BIOL CHEM, V273, P4367, DOI 10.1074/jbc.273.8.4367
   Yarmola EG, 2001, J BIOL CHEM, V276, P22351, DOI 10.1074/jbc.M101457200
   2000, TRENDS CELL BIOL, V10, P428
NR 125
TC 265
Z9 271
U1 0
U2 19
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON W1N 3AJ, ENGLAND
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD FEB 15
PY 2002
VL 362
BP 1
EP 12
DI 10.1042/0264-6021:3620001
PN 1
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 524AU
UT WOS:000173990400001
PM 11829734
OA Green Published
DA 2021-01-25
ER

PT J
AU Streit, A
   Kohler, R
   Marty, T
   Belfiore, M
   Takacs-Vellai, K
   Vigano, MA
   Schnabel, R
   Affolter, M
   Muller, F
AF Streit, A
   Kohler, R
   Marty, T
   Belfiore, M
   Takacs-Vellai, K
   Vigano, MA
   Schnabel, R
   Affolter, M
   Muller, F
TI Conserved regulation of the Caenorhabditis elegans labial/Hox1 gene
   ceh-13
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE C. elegans; Drosophila; HOM; Hox genes; ceh-13; labial; transcriptional
   regulation; autoregulation; Wnt pathway
ID C-ELEGANS; HOMEOBOX GENES; HOX GENES; DROSOPHILA-ENDODERM; EXPRESSION;
   WINGLESS; INDUCTION; POLARITY; MESODERM; EMBRYOS
AB Caenorhabditis elegans contains a set of six cluster-type homeobox (Hox) genes that are required during larval development. Some of them, but unlike in flies not all of them, are also required during embryogenesis. It has been suggested that the control of the embryonic expression of the worm Hox genes might differ from that of other species by being regulated in a lineal rather than a regional mode. Here, we present a trans-species analysis of the cis-regulatory region of ceh-13, the worm ortholog of the Drosophila labial and the vertebrate Hox1 genes, and find that the molecular mechanisms that regulate its expression may be similar to what has been found in species that follow a regulative, non-cell-autonomous mode of development. We have identified two enhancer fragments that are involved in different aspects of the embryonic ceh-13 expression pattern. We show that important features of comma-stage expression depend on an autoregulatory input that requires ceh-13 and ceh-20 functions. Our data show that the molecular nature of Hox1 class gene autoregulation has been conserved between worms, flies, and vertebrates. The second regulatory sequence is sufficient to drive correct early embryonic expression of ceh-13. Interestingly, this enhancer fragment acts as a response element of the Wnt/WG signaling pathway in Drosophila embryos. (C) 2002 Elsevier Science (USA).
C1 Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   TU Braunschweig, Inst Genet, D-38106 Braunschweig, Germany.
RP Muller, F (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.
OI Takacs-Vellai, Krisztina/0000-0002-4472-0363; vigano, maria
   alessandra/0000-0003-2009-0384; Affolter, Markus/0000-0002-5171-0016
CR BAKER NE, 1988, DEVELOPMENT, V102, P489
   Bienz M, 1997, CURR OPIN GENET DEV, V7, P683, DOI 10.1016/S0959-437X(97)80017-2
   BIENZ M, 1994, TRENDS GENET, V10, P22, DOI 10.1016/0168-9525(94)90015-9
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   BRENNER S, 1974, GENETICS, V77, P71
   Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0
   Brunschwig K, 1999, DEVELOPMENT, V126, P1537
   BURGLIN TR, 1992, NAT GENET, V1, P319, DOI 10.1038/ng0892-319
   BURGLIN TR, 1991, NATURE, V351, P703, DOI 10.1038/351703a0
   Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173
   BURGLIN TR, 1989, NATURE, V341, P239, DOI 10.1038/341239a0
   BURGLIN TR, 1993, CURR OPIN GENET DEV, V3, P615, DOI 10.1016/0959-437X(93)90097-9
   Chan SK, 1996, EMBO J, V15, P2476, DOI 10.1002/j.1460-2075.1996.tb00605.x
   Chan SK, 1997, DEVELOPMENT, V124, P2007
   Cowing D, 1996, NATURE, V382, P353, DOI 10.1038/382353a0
   DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5
   DUBOULE D, 1994, DEVELOPMENT, P135
   FIRE A, 1990, NUCLEIC ACIDS RES, V18, P4269, DOI 10.1093/nar/18.14.4269
   FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F
   GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.bi.63.070194.002415
   Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402
   HOPPLER S, 1995, EMBO J, V14, P5016, DOI 10.1002/j.1460-2075.1995.tb00184.x
   IMMERGLUCK K, 1990, CELL, V62, P261, DOI 10.1016/0092-8674(90)90364-K
   JIN Y, 1999, C ELEGANS PRACTICAL, P69
   Kaletta T, 1997, NATURE, V390, P294, DOI 10.1038/36869
   Kenyon CJ, 1997, COLD SPRING HARB SYM, V62, P293, DOI 10.1101/SQB.1997.062.01.036
   Korswagen HC, 2000, NATURE, V406, P527, DOI 10.1038/35020099
   KRUMLAUF R, 1992, BIOESSAYS, V14, P245, DOI 10.1002/bies.950140408
   Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4
   LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0
   Liu J, 2000, DEVELOPMENT, V127, P5179
   Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5
   MartinBermudo MD, 1997, EMBO J, V16, P4184, DOI 10.1093/emboj/16.14.4184
   Marty T, 2001, DEVELOPMENT, V128, P2833
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x
   Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8
   POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X
   Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8
   Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9
   Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0
   Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033
   Ryoo HD, 1999, DEVELOPMENT, V126, P5137
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schnabel R, 1997, NATURE, V385, P588, DOI 10.1038/385588a0
   Stiernagle T., 1999, C ELEGANS PRACTICAL, P51
   SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4
   Szuts D, 1998, GENE DEV, V12, P2022, DOI 10.1101/gad.12.13.2022
   Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9
   Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4
   TREMML G, 1992, DEVELOPMENT, V116, P447
   Van Auken K, 2000, P NATL ACAD SCI USA, V97, P4499, DOI 10.1073/pnas.97.9.4499
   vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X
   Waltzer L, 2001, EMBO J, V20, P137, DOI 10.1093/emboj/20.1.137
   Wittmann C, 1997, DEVELOPMENT, V124, P4193
   Yang X, 2000, DEVELOPMENT, V127, P3695
   Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1
NR 57
TC 45
Z9 47
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD FEB 15
PY 2002
VL 242
IS 2
BP 96
EP 108
DI 10.1006/dbio.2001.0544
PG 13
WC Developmental Biology
SC Developmental Biology
GA 524CW
UT WOS:000173995300003
PM 11820809
DA 2021-01-25
ER

PT J
AU Kloks, CPAM
   Spronk, CAEM
   Lasonder, E
   Hoffmann, A
   Vuister, GW
   Grzesiek, S
   Hilbers, CW
AF Kloks, CPAM
   Spronk, CAEM
   Lasonder, E
   Hoffmann, A
   Vuister, GW
   Grzesiek, S
   Hilbers, CW
TI The solution structure and DNA-binding properties of the cold-shock
   domain of the human Y-box protein YB-1
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE cold-shock; OB-fold; Y-box protein; single-stranded DNA binding;
   solution structure
ID BACILLUS-SUBTILIS; GENE-5 PROTEIN; MESSENGER-RNA; CRYSTAL-STRUCTURE;
   ESCHERICHIA-COLI; NMR STRUCTURE; BACTERIOPHAGE-M13; IDENTIFICATION;
   TRANSCRIPTION; RECOGNITION
AB The human Y-box protein 1 (YB-1) is a member of the Y-box protein family, a class of proteins involved in transcriptional and translational regulation of a wide range of genes. Here, we report the solution structure of the cold-shock domain (CSD) of YB-1, which is thought to be responsible for nucleic acid binding. It is the first structure solved of a eukaryotic member of the cold-shock protein family and consists of a closed five-stranded anti-parallel beta-barrel capped by a long flexible loop. The structure of CSD is similar to the OB-fold and a comparison with bacterial cold-shock proteins shows that its structural properties are conserved from bacteria to man. Our data suggests the presence of a DNA-binding site consisting of a patch of positively charged and aromatic residues on the surface of the beta-barrel. Further, it is shown that CSD, which has a preference for binding single-stranded pyrimidine-rich sequences, binds weakly and hardly specifically to DNA. Binding affinities reported for intact YB-1 indicate that domains other than the CSD play a role in DNA binding of YB-1. (C) 2002 Elsevier Science Ltd.
C1 Univ Nijmegen, Lab Biophys Chem, NSR Ctr Mol Struct Design & Synth, NL-6525 ED Nijmegen, Netherlands.
   Univ Nijmegan, Lab Mol Biol, NL-6525 ED Nijmegen, Netherlands.
   Forschungszentrum, D-52425 Julich, Germany.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hilbers, CW (corresponding author), Univ Nijmegen, Lab Biophys Chem, NSR Ctr Mol Struct Design & Synth, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.
OI Vuister, Geerten/0000-0001-6172-5097; Grzesiek,
   Stephan/0000-0003-1998-4225; Lasonder, Edwin/0000-0003-2582-3444
CR ALMA NCM, 1982, EUR J BIOCHEM, V122, P319, DOI 10.1111/j.1432-1033.1982.tb05883.x
   Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0
   BOUVET P, 1995, J BIOL CHEM, V270, P28297
   BRUNGER AT, 1993, XPLOR VERSION 3 1 SY
   BULSINK H, 1985, J BIOMOL STRUCT DYN, V3, P227, DOI 10.1080/07391102.1985.10508413
   BULSINK H, 1986, EUR J BIOCHEM, V157, P329, DOI 10.1111/j.1432-1033.1986.tb09672.x
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322
   DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   HORWITZ EM, 1994, J BIOL CHEM, V269, P14130
   JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R
   JONES PG, 1994, MOL MICROBIOL, V11, P811, DOI 10.1111/j.1365-2958.1994.tb00359.x
   Kloks CPAM, 1998, J BIOMOL NMR, V12, P463, DOI 10.1023/A:1008309216938
   Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kremer W, 2001, EUR J BIOCHEM, V268, P2527, DOI 10.1046/j.1432-1327.2001.02127.x
   Ladomery M, 1997, BIOESSAYS, V19, P903, DOI 10.1002/bies.950191010
   LANDSMAN D, 1992, NUCLEIC ACIDS RES, V20, P2861, DOI 10.1093/nar/20.11.2861
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601
   MACDONALD GH, 1995, J BIOL CHEM, V270, P3527, DOI 10.1074/jbc.270.8.3527
   Matsumoto K, 1996, J BIOL CHEM, V271, P22706, DOI 10.1074/jbc.271.37.22706
   MURRAY MT, 1992, P NATL ACAD SCI USA, V89, P11, DOI 10.1073/pnas.89.1.11
   MURRAY MT, 1994, BIOCHEMISTRY-US, V33, P13910, DOI 10.1021/bi00250a046
   MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x
   Nambiar A, 1998, J VIROL, V72, P900, DOI 10.1128/JVI.72.2.900-909.1998
   Nambiar A, 1998, BBA-GENE STRUCT EXPR, V1395, P1, DOI 10.1016/S0167-4781(97)00141-3
   NEWKIRK K, 1994, P NATL ACAD SCI USA, V91, P5114, DOI 10.1073/pnas.91.11.5114
   Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336
   Persson B, 1997, ANAL BIOCHEM, V246, P34, DOI 10.1006/abio.1996.9988
   RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403
   Rietman BH, 1996, EUR J BIOCHEM, V238, P706, DOI 10.1111/j.1432-1033.1996.0706w.x
   SCHINDELIN H, 1994, P NATL ACAD SCI USA, V91, P5119, DOI 10.1073/pnas.91.11.5119
   SCHINDELIN H, 1993, NATURE, V364, P164, DOI 10.1038/364164a0
   SCHNUCHEL A, 1993, NATURE, V364, P169, DOI 10.1038/364169a0
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   Spronk CAEM, 1999, STRUCT FOLD DES, V7, P1483, DOI 10.1016/S0969-2126(00)88339-2
   Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027
   TAFURI SR, 1993, J BIOL CHEM, V268, P24255
   TAFURI SR, 1992, NEW BIOL, V4, P349
   VANDUYNHOVEN JPM, 1990, FEBS LETT, V261, P1, DOI 10.1016/0014-5793(90)80621-O
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024
   VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V
   Whitehead B, 1997, J BIOMOL NMR, V9, P313, DOI 10.1023/A:1018687127330
   Wolffe Alan P., 1995, Science Progress, V78, P301
   WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407
   WOLFFE AP, 1994, TRENDS BIOCHEM SCI, V19, P240, DOI 10.1016/0968-0004(94)90148-1
NR 49
TC 87
Z9 98
U1 0
U2 11
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD FEB 15
PY 2002
VL 316
IS 2
BP 317
EP 326
DI 10.1006/jmbi.2001.5334
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 526BG
UT WOS:000174108100010
PM 11851341
DA 2021-01-25
ER

PT J
AU Machaidze, G
   Ziegler, A
   Seelig, J
AF Machaidze, G
   Ziegler, A
   Seelig, J
TI Specific binding of Ro 09-0198 (cinnamycin) to phosphatidylethanotamine:
   A thermodynamic analysis
SO BIOCHEMISTRY
LA English
DT Article
ID MAGNETIC-RESONANCE; NONADECAPEPTIDE RO-09-0198; TITRATION CALORIMETRY;
   CYCLIC PEPTIDE; MEMBRANES; SPECTROSCOPY; RO09-0198; VESICLES
AB Ro 09-0198 (cinnamycin) is a tetracyclic peptide antibiotic that is used to monitor the transbilayer movement of phosphatidylethanolamine (PE) in biological membranes during cell division and apoptosis. The molecule is one of the very rare examples where a small peptide binds specifically to a particular lipid. In model membranes and biological membranes containing phosphatidylethanolamine, Ro 09-0198 forms a 1:1 complex with this lipid. We have measured the thermodynamic parameters of complex formation with high sensitivity isothermal titration calorimetry and have investigated the structural consequences with deuterium and phosphorus solid-state NMR. Complex formation is characterized by a large binding constant, K-0, of 10(7) to 10(8) M-1, depending on the experimental conditions. The reaction enthalpy, DeltaHdegrees, varies between zero at 10 degreesC to strongly exothermic -10 kcal/mol at 50 degreesC. For large vesicles with a diameter of similar to100 nm, DeltaHdegrees decreases linearly with temperature and the molar heat capacity of complex formation can be evaluated as DeltaC(P)degrees -245 cal/mol, indicating a hydrophobic binding mechanism. The free energy of binding is DeltaGdegrees -10.5 kcal/mol and shows only little temperature dependence. The constancy of DeltaGdegrees together with the distinct temperature-dependence of DeltaHdegrees provide evidence for an entropy-enthalpy compensation mechanism: at 10 degreesC, complex formation is completely entropy-driven, at 50 degreesC it is enthalpy-driven. Varying the PE fatty acid chain-length between 6 and 18 carbon atoms produces similar binding constants and DeltaHdegrees values. Addition of Ro 09-0198 to PE containing bilayers eliminates the typical bilayer structure and produces H-2- and P-31-NMR spectra characteristic of slow isotropic tumbling. This reorganization of the lipid matrix is not limited to PE but also includes other lipids.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
CR AOKI Y, 1994, J BIOCHEM-TOKYO, V116, P291, DOI 10.1093/oxfordjournals.jbchem.a124522
   Breukink E, 2000, BIOCHEMISTRY-US, V39, P10247, DOI 10.1021/bi000915q
   Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361
   Calderone CT, 2001, J AM CHEM SOC, V123, P6262, DOI 10.1021/ja003016y
   CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P171, DOI 10.1016/0005-2736(88)90192-7
   CHOUNG SY, 1988, BIOCHIM BIOPHYS ACTA, V940, P180, DOI 10.1016/0005-2736(88)90193-9
   CLARKE RJ, 1988, ADV CARBOHYD CHEM BI, V46, P205, DOI 10.1016/S0065-2318(08)60167-5
   DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2
   Guder A, 2000, BIOPOLYMERS, V55, P62, DOI 10.1002/1097-0282(2000)55:1<62::AID-BIP60>3.3.CO;2-P
   HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580
   Hosoda K, 1996, J BIOCHEM-TOKYO, V119, P226
   KESSLER H, 1987, HELV CHIM ACTA, V70, P726, DOI 10.1002/hlca.19870700322
   KESSLER H, 1988, HELV CHIM ACTA, V71, P1924, DOI 10.1002/hlca.19880710811
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   PRIVALOV PL, 1989, PURE APPL CHEM, V61, P1097, DOI 10.1351/pac198961061097
   SEELIG J, 1978, BIOCHEMISTRY-US, V17, P3310, DOI 10.1021/bi00609a021
   SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948
   SY D, 1993, BIOELECTROCH BIOENER, V32, P295, DOI 10.1016/0302-4598(93)80053-W
   TAKEMOTO K, 1979, Patent No. 7911395
   Umeda M, 1999, CHEM PHYS LIPIDS, V101, P81, DOI 10.1016/S0009-3084(99)00057-2
   WAKAMIYA T, 1988, TETRAHEDRON LETT, V29, P4771, DOI 10.1016/S0040-4039(00)80604-8
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
   YANG SF, 1967, J BIOL CHEM, V242, P477
   ZHANG BL, 1993, J AM CHEM SOC, V115, P9353, DOI 10.1021/ja00073a087
NR 26
TC 47
Z9 47
U1 0
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 12
PY 2002
VL 41
IS 6
BP 1965
EP 1971
DI 10.1021/bi015841c
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 520NF
UT WOS:000173787400031
PM 11827543
DA 2021-01-25
ER

PT J
AU Bixby, JL
   Baerwald-De la Torre, K
   Wang, C
   Rathjen, FG
   Ruegg, MA
AF Bixby, JL
   Baerwald-De la Torre, K
   Wang, C
   Rathjen, FG
   Ruegg, MA
TI A neuronal inhibitory domain in the N-terminal half of agrin
SO JOURNAL OF NEUROBIOLOGY
LA English
DT Article
DE agrin; neurite outgrowth; integrins; NCAMs; motor neurons
ID CELL-ADHESION MOLECULE; HEPARAN-SULFATE PROTEOGLYCAN;
   EXTRACELLULAR-MATRIX MOLECULES; ADULT-RAT BRAIN; NEURITE OUTGROWTH;
   ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR-JUNCTION; ALPHA-DYSTROGLYCAN;
   IN-VITRO; IMMUNOGLOBULIN SUPERFAMILY
AB Agrin is required for appropriate pre- and postsynaptic differentiation of neuromuscular junctions. While agrin's ability to orchestrate postsynaptic differentiation is well documented, more recent experiments have suggested that agrin is also a "stop signal" for the presynaptic neuron, and that agrin has actions on neurons in the CNS. To elucidate the neuronal activities of agrin and to define the receptor(s) responsible for these functions, we have examined adhesions of neurons and their neurite-outgrowth responses to purified agrin in vitro. We find that both full-length agrin and the C-terminal 95 kDa of agrin (agrin c95), which is sufficient to induce postsynaptic differentiation, are adhesive for chick ciliary ganglion (CG) and fore-brain neurons. Consistent with previous findings, our results show that N-CAM binds to full-length agrin, and suggest that alpha-dystroglycan is a neuronal receptor for agrin c95. In neurite outgrowth assays, full-length agrin inhibited both laminin- and N-cadherin-induced neurite growth from CG neurons. The N-terminal 150 kDa fragment of agrin, but not agrin c95, inhibited neurite outgrowth, indicating that domains in the N-terminal portion of agrin are sufficient for this function. Adhesion assays using protein-coated beads and agrin-expressing cells revealed differential interactions of agrin with members of the immunoglobulin superfamily of cell adhesion molecules. However, none of these, including NCAM, appeared to be critical for neuronal adhesion. In summary, our results suggest that the N-terminal half of agrin is involved in agrin's ability to inhibit neurite outgrowth. Our results further suggest that neither alpha-dystroglycan nor N-CAM, two known binding proteins for agrin, mediate this effect. (C) 2002 John Wiley Sons. Inc.
C1 Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA.
   Univ Miami, Sch Med, Neurosci Program, Miami, FL 33101 USA.
   Max Delbruck Centrum Mol Med, D-13122 Berlin, Germany.
   Univ Basel, Dept Pharmacol, Biozentrum, CH-4056 Basel, Switzerland.
RP Bixby, JL (corresponding author), Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, POB 016189 R-189, Miami, FL 33101 USA.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Bixby, John/0000-0003-1633-5318
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS036773, R01NS036773, R01NS036773, R01NS036773, R01NS036773]
   Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS) [NS 36773]
   Funding Source: Medline
CR Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7
   BIXBY JL, 1990, J CELL BIOL, V111, P2725, DOI 10.1083/jcb.111.6.2725
   BIXBY JL, 1995, J NEUROBIOL, V26, P262, DOI 10.1002/neu.480260210
   BIXBY JL, 1987, DEV BIOL, V119, P363, DOI 10.1016/0012-1606(87)90041-8
   BIXBY JL, 1992, J NEUROBIOL, V23, P468, DOI 10.1002/neu.480230503
   BIXBY JL, 1990, J CELL BIOL, V110, P1253, DOI 10.1083/jcb.110.4.1253
   BIXBY JL, 1993, J NEUROSCI, V13, P3421
   BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cellbio.7.1.117
   BIXBY JL, 1987, P NATL ACAD SCI USA, V84, P2555, DOI 10.1073/pnas.84.8.2555
   Bowen DC, 1996, J NEUROSCI, V16, P3791
   BRUMMENDORF T, 1995, PROTEIN PROFILE, V2, P963
   Brummendorf T, 1996, CURR OPIN NEUROBIOL, V6, P584, DOI 10.1016/S0959-4388(96)80089-4
   Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593
   BURG MA, 1995, J NEUROSCI RES, V41, P49, DOI 10.1002/jnr.490410107
   Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   Burkin DJ, 1998, J CELL BIOL, V143, P1067, DOI 10.1083/jcb.143.4.1067
   Burkin DJ, 2000, J CELL SCI, V113, P2877
   Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4
   Campagna JA, 1997, EUR J NEUROSCI, V9, P2269, DOI 10.1111/j.1460-9568.1997.tb01645.x
   Chang D, 1997, DEV BIOL, V181, P21, DOI 10.1006/dbio.1996.8435
   Cohen NA, 1997, NEUROSCIENCE, V76, P581, DOI 10.1016/S0306-4522(96)00345-4
   Cole GJ, 1996, PERSPECT DEV NEUROBI, V3, P359
   Cornish T, 1999, J CELL SCI, V112, P1213
   Cotman SL, 1999, EXP CELL RES, V249, P54, DOI 10.1006/excr.1999.4463
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335
   DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547
   Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   GRUMET M, 1988, J CELL BIOL, V106, P487, DOI 10.1083/jcb.106.2.487
   Halfter W, 1997, J COMP NEUROL, V383, P1
   Hilgenberg LGW, 1999, J NEUROSCI, V19, P7384, DOI 10.1523/JNEUROSCI.19-17-07384.1999
   HOCH W, 1994, EMBO J, V13, P2814, DOI 10.1002/j.1460-2075.1994.tb06575.x
   Ip FCF, 2000, MOL CELL NEUROSCI, V16, P661, DOI 10.1006/mcne.2000.0892
   Jacobson C, 1998, J NEUROSCI, V18, P6340
   Ji RR, 1998, J NEUROSCI, V18, P9695
   KLIGMAN D, 1982, BRAIN RES, V250, P93, DOI 10.1016/0006-8993(82)90955-6
   KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113
   LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753
   MA E, 1994, J NEUROSCI, V14, P2943
   Martin PT, 1997, DEVELOPMENT, V124, P3909
   Matsumura K, 1997, J BIOL CHEM, V272, P13904, DOI 10.1074/jbc.272.21.13904
   MCMAHAN UJ, 1990, COLD SH Q B, V55, P407
   Meier T, 1996, EMBO J, V15, P2625, DOI 10.1002/j.1460-2075.1996.tb00622.x
   Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716
   Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932
   OCONNOR LT, 1994, J NEUROSCI, V14, P1141
   OToole JJ, 1996, P NATL ACAD SCI USA, V93, P7369, DOI 10.1073/pnas.93.14.7369
   Parkhomovskiy N, 2000, MOL CELL NEUROSCI, V15, P380, DOI 10.1006/mcne.2000.0835
   Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605
   PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K
   REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.ne.14.030191.002531
   Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5
   STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3
   STOECKLI ET, 1991, J CELL BIOL, V112, P449, DOI 10.1083/jcb.112.3.449
   Storms SD, 1996, CELL ADHES COMMUN, V3, P497, DOI 10.3109/15419069609081026
   Storms SD, 1998, J BIOL CHEM, V273, P27124, DOI 10.1074/jbc.273.42.27124
   TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5
   Volkmer H, 1996, J CELL BIOL, V135, P1059, DOI 10.1083/jcb.135.4.1059
   Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083
   Wang J, 1999, MOL CELL NEUROSCI, V14, P370, DOI 10.1006/mcne.1999.0789
NR 65
TC 35
Z9 35
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0022-3034
J9 J NEUROBIOL
JI J. Neurobiol.
PD FEB 5
PY 2002
VL 50
IS 2
BP 164
EP 179
DI 10.1002/neu.10025
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA 515GN
UT WOS:000173487200007
PM 11793362
DA 2021-01-25
ER

PT J
AU Hauptmann, G
   Soll, I
   Gerster, T
AF Hauptmann, G
   Soll, I
   Gerster, T
TI The early embryonic zebrafish forebrain is subdivided into molecularly
   distinct transverse and longitudinal domains
SO BRAIN RESEARCH BULLETIN
LA English
DT Article; Proceedings Paper
CT 3rd European Conference on Comparative Neurobiology
CY APR 19-21, 2001
CL MURCIA, SPAIN
SP HEFAME Fdn, Spanish Soc Neurosci, Univ Murcia
DE alar/basal boundary; Danio rerio; diencephalon; longitudinal brain axis;
   neuromeres; prosomeres
ID EXPRESSION PATTERNS; HOMEOBOX GENE; VERTEBRATE; BRAIN; ORGANIZATION;
   PLATE
AB During early developmental stages, the embryonic vertebrate brain is still relatively simple with few morphological landmarks that would indicate subdivisions in the prosencephalic primordium. To better understand the early organization of the rostral brain of a lower vertebrate, we investigated the embryonic development and regionalization of the fore- and midbrain of a small teleost, the zebrafish (Danio redo), We used regulatory gene expression patterns to trace putative prosomeric domains to the beginning of the pharyngula period, when morphological manifestations of prosomeres are not immediately evident. We directly compared the expression domains of members of the dlx, emx, fgf, hh, lim, nkx, otx, pax, POU, winged helix and wnt regulatory gene families in the rostral brain by means of two-color whole-mount in situ hybridization. This allowed us to define precisely abutting expression borders of neighboring expression domains of different genes. Our analysis shows that the genes examined are expressed in anteroposteriorly and dorsoventrally restricted domains, and share expression borders at stereotypic positions within the fore- and midbrain. The arrangement of the various expression domains identified four major longitudinal subdivisions, which extend in parallel to the bent longitudinal rostral brain axis. Furthermore, we identified a series of eight transverse diencephalic domains which may indicate a prosomeric organization of the rostral zebrafish brain. (C) 2002 Elsevier Science Inc.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Hauptmann, G (corresponding author), Univ Freiburg, Inst Biol Zool 1, Hauptstr 1, D-79104 Freiburg, Germany.
EM hauptman@uni-freiburg.de
OI Hauptmann, Giselbert/0000-0002-1205-1011
CR AKIMENKO MA, 1994, J NEUROSCI, V14, P3475
   BARTH KA, 1995, DEVELOPMENT, V121, P1755
   FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0
   FJOSE A, 1994, DEVELOPMENT, V120, P71
   Furthauer M, 1997, DEVELOPMENT, V124, P4253
   Hauptmann G, 2000, MECH DEVELOP, V91, P105, DOI 10.1016/S0925-4773(99)00277-4
   HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T
   Hauptmann G, 1996, DEVELOPMENT, V122, P1769
   Higashijima S, 1997, DEV BIOL, V192, P211, DOI 10.1006/dbio.1997.8760
   KRAUSS S, 1992, DEVELOPMENT, V116, P249
   KRAUSS S, 1991, NATURE, V353, P267, DOI 10.1038/353267a0
   KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4
   LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0
   MOLVEN A, 1991, EMBO J, V10, P799, DOI 10.1002/j.1460-2075.1991.tb08012.x
   MORI H, 1994, MOL BRAIN RES, V27, P221, DOI 10.1016/0169-328X(94)90004-3
   MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9
   Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179
   PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6
   Rohr KB, 1999, MECH DEVELOP, V85, P147, DOI 10.1016/S0925-4773(99)00044-1
   RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711
   Seo HC, 1998, MECH DEVELOP, V70, P49, DOI 10.1016/S0925-4773(97)00175-5
   Shimamura K, 1995, DEVELOPMENT, V121, P3923
   STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436
   Toyama R, 1997, DEV DYNAM, V209, P406, DOI 10.1002/(SICI)1097-0177(199708)209:4<406::AID-AJA8>3.3.CO;2-T
   Westerfield M., 1995, ZEBRAFISH BOOK GUIDE
   Wullimann MF, 1999, ANAT EMBRYOL, V199, P329, DOI 10.1007/s004290050232
NR 26
TC 51
Z9 51
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD FEB-MAR
PY 2002
VL 57
IS 3-4
BP 371
EP 375
AR PII S0361-9230(01)00691-8
DI 10.1016/S0361-9230(01)00691-8
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA 537HH
UT WOS:000174752500026
PM 11922991
DA 2021-01-25
ER

PT J
AU Pitarque, M
   von Richter, O
   Oscarson, M
   Ingelman-Sundberg, M
AF Pitarque, M
   von Richter, O
   Oscarson, M
   Ingelman-Sundberg, M
TI Functional characterization of the 5 '-flanking region of CYP2A6 and its
   genetic polymorphisms.
SO CLINICAL PHARMACOLOGY & THERAPEUTICS
LA English
DT Meeting Abstract
C1 Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.
   Univ Basel, Biozentrum, Basel, Switzerland.
RI von Richter, Oliver/O-6412-2016
OI von Richter, Oliver/0000-0002-5262-9922
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0009-9236
J9 CLIN PHARMACOL THER
JI Clin. Pharmacol. Ther.
PD FEB
PY 2002
VL 71
IS 2
BP P41
EP P41
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 527GP
UT WOS:000174178600149
DA 2021-01-25
ER

PT J
AU Boudko, SP
   Londer, YY
   Letarov, AV
   Sernova, NV
   Engel, J
   Mesyanzhinov, VV
AF Boudko, SP
   Londer, YY
   Letarov, AV
   Sernova, NV
   Engel, J
   Mesyanzhinov, VV
TI Domain organization, folding and stability of bacteriophage T4 fibritin,
   a segmented coiled-coil protein
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE bacteriophage; foldon; microcalorimetry; protein engineering; segmented
   coded coil
ID REGION; WAC
AB Fibritin is a segmented coiled-coil homotrimer of the 486-residue product of phage T4 gene wac. This protein attaches to a phage particle by the N-terminal region and forms fibrous whiskers of 530 Angstrom. which perform a chaperone function during virus assembly. The short C-terminal region has beta-annulus-like structure. We engineered a set of fibritin deletion mutants sequentially truncated from the N-termini, and the mutants were studied by differential scanning calorimetry (DSC) and CD measurements, The analysis of DSC curves indicates that full-length fibritin exhibits three thermal-heat-absorption peaks centred at 321 K (DeltaH = 1390 kJ.mol trimer(-1)), at 336 K (DeltaH = 7600 kJ.mol trimer(-1)), and at 345 K (DeltaH = 515 kJ.mol trimer(-1)). These transitions were assigned to the N-terniinal, segmented coiled-coil, and C-terminal functional domains, respectively. The coiled-coil region, containing 13 segments, melts co-operatively as a single domain with a mean enthalpy DeltaH(res) = 21 kJ.mol residue(-1). The ratio of DeltaH(VH)/DeltaH(cal) for the coiled-coil part of the 120, 182-, 258- and 281-residue per monomer mutants, truncated from the N-termini, and for full-length fibritin are 0.91, 0.88, 0.42, 0.39, and 0.13. respectively. This gives an indication of the decrease of the 'all-or-none' character of the transition with increasing protein size. The deletion of the 12-residue-long loop in the 120-residue fibritin increases the thermal stability of the coiled-coil region. According to CD data, full-length fibritin and all the mutants truncated from the N-termini refold properly after heat denaturation. In contrast, fibritin XN, which is deleted for the C-terminal domain, forms aggregates inside the cell. The XN protein can be partially refolded by dilution from urea and does not refold after heat denaturation. These results confirm that the C-terminal domain is essential for correct fibritin assembly both in vivo and in vitro and acts as a foldon.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Howard Hughes Med Inst, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.
RP Mesyanzhinov, VV (corresponding author), Howard Hughes Med Inst, Shemyakin Ovchinnikov Inst Bioorgan Chem, Miklukho Maklaya St 16-10, Moscow 117997, Russia.
EM vvm@ibch.ru
CR Ausubel F. M., 1992, SHORT PROTOCOLS MOL
   Bosshard HR, 2001, BIOCHEMISTRY-US, V40, P3544, DOI 10.1021/bi002161l
   COHEN C, 1994, SCIENCE, V263, P488, DOI 10.1126/science.8290957
   Cohen C, 1998, J STRUCT BIOL, V122, P180, DOI 10.1006/jsbi.1998.3983
   CONLEY MP, 1975, P NATL ACAD SCI USA, V72, P3701, DOI 10.1073/pnas.72.9.3701
   COOMBS DH, 1977, J MOL BIOL, V116, P375, DOI 10.1016/0022-2836(77)90076-6
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   EFIMOV VP, 1994, J MOL BIOL, V242, P470, DOI 10.1006/jmbi.1994.1595
   Engel J, 2000, MATRIX BIOL, V19, P283, DOI 10.1016/S0945-053X(00)00075-5
   ENGEL J, 1970, ANGEW CHEM INT EDIT, V9, P389, DOI 10.1002/anie.197003891
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0
   Inaba K, 2000, J MOL BIOL, V302, P219, DOI 10.1006/jmbi.2000.4024
   KAMMERER RA, 1995, J MOL BIOL, V250, P64, DOI 10.1006/jmbi.1995.0358
   Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   LETAROV AV, 1999, THESIS ACAD MED SCI
   Londer YY, 1999, BIOORG KHIM+, V25, P257
   LONDER YY, 1999, THESIS RUSSIAN ACAD
   LUMB KJ, 1995, SCIENCE, V268, P436, DOI 10.1126/science.7716550
   LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013
   *MICR INC, 1998, DSC DAT AN OR TUT GU
   Miroshnikov KA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P1346, DOI 10.1023/A:1002888419749
   Panchenko AR, 1996, P NATL ACAD SCI USA, V93, P2008, DOI 10.1073/pnas.93.5.2008
   Privalov P L, 1986, Methods Enzymol, V131, P4
   PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3
   SOBOLEV BN, 1991, J BIOMOL STRUCT DYN, V8, P953, DOI 10.1080/07391102.1991.10507859
   Strelkov SV, 1998, ACTA CRYSTALLOGR D, V54, P805, DOI 10.1107/S0907444997018878
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   TERZAGHI BE, 1979, J MOL BIOL, V127, P1, DOI 10.1016/0022-2836(79)90454-6
   WAKASUGI K, 1994, J BIOL CHEM, V269, P18750
   YANAGAWA H, 1993, J BIOL CHEM, V268, P5861
   YU MH, 1984, P NATL ACAD SCI-BIOL, V81, P6584, DOI 10.1073/pnas.81.21.6584
NR 36
TC 28
Z9 29
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD FEB
PY 2002
VL 269
IS 3
BP 833
EP 841
DI 10.1046/j.1432-1033.2002.02734.x
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 525FW
UT WOS:000174059100011
PM 11846809
DA 2021-01-25
ER

PT J
AU Ivens, A
   Mayans, O
   Szadkowski, H
   Jurgens, C
   Wilmanns, M
   Kirschner, K
AF Ivens, A
   Mayans, O
   Szadkowski, H
   Jurgens, C
   Wilmanns, M
   Kirschner, K
TI Stabilization of a (beta alpha)(8)-barrel protein by an engineered
   disulfide bridge
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE indoleglycerol phosphate synthase; (beta/alpha)(8)-barrel proteins;
   stabilizing disulfide bonds; protein engineering.
ID INDOLEGLYCEROL-PHOSPHATE SYNTHASE; ESCHERICHIA-COLI; BIFUNCTIONAL
   ENZYME; CATALYTIC-ACTIVITY; FOLDING PATHWAY; STABILITY; ISOMERASE;
   BONDS; SITE
AB The aim of this study was to increase the stability of the thermolabile (betaalpha)(8)-barrel enzyme indoleglycerol phosphate synthase from Escherichia coli by the introduction of disulfide bridges. For the design of such variants, we selected two out of 12 candidates, in which newly introduced cysteines potentially form optimal disulfide bonds. These variants avoid short-range connections, substitutions near catalytic residues, and crosslinks between the new and the three parental cysteines. The variant linking residues 3 and 189 fastens the N-terminus to the (betaalpha)(8)-barrel. The rate of thermal inactivation at 50degreesC of this variant with a closed disulfide bridge is 65-fold slower than that of the reference dithiol form, but only 13-fold slower than that of the parental protein. The near-ultraviolet CD spectrum, the reactivity of parental buried cysteines with Ellman's reagent as well as the decreased turnover number indicate that the protein structure is rigidified. To confirm these data, we have solved the X-ray structure to 2.1-Angstrom resolution. The second variant was designed to crosslink the terminal modules betaalpha1 and betaalpha8. However, not even the dithiol form acquired the native fold, possibly because one of the targeted residues is solvent-inaccessible in the parental protein.
C1 Univ Cologne, Inst Biochem, D-50674 Cologne, Germany.
   EMBL, DESY, Hamburg, Germany.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Ivens, A (corresponding author), Univ Cologne, Inst Biochem, Otto Fischer Str 12-14, D-50674 Cologne, Germany.
EM andreas.ivens@uni-koeln.de
RI Mayans, Olga/A-3954-2008
OI Wilmanns, Matthias/0000-0002-4643-5435; Mayans, Olga/0000-0001-6876-8532
CR Altamirano MM, 2000, NATURE, V403, P617, DOI 10.1038/35001001
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BALLERY N, 1993, BIOCHEMISTRY-US, V32, P708, DOI 10.1021/bi00053a040
   BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002
   BISSWANGER H, 1979, BIOCHEMISTRY-US, V18, P5946, DOI 10.1021/bi00593a029
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022
   Cornish-Bowden A, 1995, FUNDAMENTALS ENZYME
   DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015
   Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518
   DARIMONT B, 1994, THESIS U BASEL
   del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M
   EBERHARD M, 1995, BIOCHEMISTRY-US, V34, P5419, DOI 10.1021/bi00016a013
   EBERHARD M, 1990, THESIS U BASEL
   EDER J, 1992, BIOCHEMISTRY-US, V31, P4437, DOI 10.1021/bi00133a008
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2
   HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4
   KIRSCHNER K, 1987, METHOD ENZYMOL, V142, P386
   KOPETZKI E, 1989, MOL GEN GENET, V216, P149, DOI 10.1007/BF00332244
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Mansfeld J, 1997, J BIOL CHEM, V272, P11152, DOI 10.1074/jbc.272.17.11152
   Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i
   Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PERRY LJ, 1986, BIOCHEMISTRY-US, V25, P733, DOI 10.1021/bi00351a034
   POLLITT S, 1983, J BACTERIOL, V153, P27, DOI 10.1128/JB.153.1.27-32.1983
   RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49
   Sambrook J, 1989, MOL CLONING LAB MANU
   SARKAR G, 1990, BIOTECHNIQUES, V8, P404
   Shaw A, 1996, CURR OPIN STRUC BIOL, V6, P546, DOI 10.1016/S0959-440X(96)80122-9
   SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95
   Stehlin C, 1997, FEBS LETT, V403, P268, DOI 10.1016/S0014-5793(97)00066-5
   Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   WAKARCHUK WW, 1994, PROTEIN ENG, V7, P1379, DOI 10.1093/protein/7.11.1379
   WILMANNS M, 1990, PROTEIN ENG, V3, P173, DOI 10.1093/protein/3.3.173
   WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7
NR 40
TC 22
Z9 23
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD FEB
PY 2002
VL 269
IS 4
BP 1145
EP 1153
DI 10.1046/j.1432-1033.2002.02745.x
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 526XD
UT WOS:000174154400013
PM 11856350
OA Bronze
DA 2021-01-25
ER

PT J
AU Cornelis, GR
AF Cornelis, GR
TI The Yersinia Ysc-Yop virulence apparatus
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article; Proceedings Paper
CT 10th European Workshop Conference on Bacterial Protein Toxins (ETOX 10)
CY JUN 24-29, 2001
CL BHON, BELGIUM
DE pathogenesis; type III secretion; effectors; Yersinia; injectisome
ID PROTEIN-TYROSINE-PHOSPHATASE; CHAPERONE-LIKE PROTEIN; NF-KAPPA-B; III
   SECRETION; TRANSLOCATORS YOPB; EUKARYOTIC CELLS; MAMMALIAN-CELLS;
   BINDING PROTEIN; DOWN-REGULATION; MESSENGER-RNA
AB The Yop virulon is an integrated system allowing extracellular Yersinia adhering at the surface of a target cell to inject an array of bacterial effectors into the eukaryotic cytosol. It consists of a type III secretion apparatus, called the Ysc injectisome and an array of proteins secreted by this apparatus, called Yops. The injectisome is made of about 25 Ysc proteins. The proximal part of the injectisome resembles the basal body of the flagellum while the most distal part is made of a secretin and a small needle protruding from the bacterial surface. Three of the Yops, namely YopB, YopD and LcrV, are required for the translocation of the others across the target cell membrane. They form some kind of a pore in the target cell membrane. Four Yop effectors, YopE, YopT, YpkA and YopH disturb the cytoskeleton dynamics by targeting monomeric GTPases of the Rho family. YopP downregulates the onset of the inflammatory response by blocking the NF-kappaB and MAPK pathways. Strong arguments indicate that it is a SUMO protease. Finally, YopM has been shown to travel to the nucleus of the target cell.
C1 Catholic Univ Louvain, Microbial Pathogenesis Unit, Christian De Duve Inst Cellular Pathol ICP, B-1200 Brussels, Belgium.
   Catholic Univ Louvain, Fac Med, B-1200 Brussels, Belgium.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
CR Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140
   Anderson DM, 1999, CURR OPIN MICROBIOL, V2, P18, DOI 10.1016/S1369-5274(99)80003-4
   Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x
   Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7
   Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x
   Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730
   Black DS, 1998, MOL MICROBIOL, V29, P1263, DOI 10.1046/j.1365-2958.1998.01014.x
   Black DS, 2001, MOL MICROBIOL, V39, P822, DOI 10.1046/j.1365-2958.2001.02270.x
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000
   Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Day JB, 2000, INFECT IMMUN, V68, P6466, DOI 10.1128/IAI.68.11.6466-6471.2000
   Day JB, 2000, J BACTERIOL, V182, P1834, DOI 10.1128/JB.182.7.1834-1843.2000
   Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x
   Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200
   Deng WL, 1999, J BACTERIOL, V181, P2298, DOI 10.1128/JB.181.7.2298-2301.1999
   Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200
   Fekkes P, 1999, MICROBIOL MOL BIOL R, V63, P161, DOI 10.1128/MMBR.63.1.161-173.1999
   Fields KA, 1999, INFECT IMMUN, V67, P4801, DOI 10.1128/IAI.67.9.4801-4813.1999
   Francis MS, 1998, MOL MICROBIOL, V29, P799, DOI 10.1046/j.1365-2958.1998.00973.x
   FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x
   GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0
   GUAN KL, 1991, J BIOL CHEM, V266, P17026
   Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x
   Hamid N, 1999, MICROB PATHOGENESIS, V27, P231, DOI 10.1006/mpat.1999.0301
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   Iriarte M, 1999, J BACTERIOL, V181, P675, DOI 10.1128/JB.181.2.675-680.1999
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   Jackson MW, 1999, J BACTERIOL, V181, P5126, DOI 10.1128/JB.181.16.5126-5130.1999
   Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x
   Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200
   LEUNG KY, 1990, INFECT IMMUN, V58, P3262, DOI 10.1128/IAI.58.10.3262-3271.1990
   Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x
   Meijer LK, 2000, CELL MICROBIOL, V2, P231, DOI 10.1046/j.1462-5822.2000.00049.x
   MENARD R, 1993, J BACTERIOL, V175, P5899
   Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x
   MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999
   Montagna LG, 2001, J BIOL CHEM, V276, P5005, DOI 10.1074/jbc.M009045200
   Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Nilles ML, 1998, J BACTERIOL, V180, P3410, DOI 10.1128/JB.180.13.3410-3420.1998
   Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594
   Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920
   Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x
   Palmer LE, 1999, INFECT IMMUN, V67, P708, DOI 10.1128/IAI.67.2.708-716.1999
   Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999
   Payne PL, 1998, J BACTERIOL, V180, P3882, DOI 10.1128/JB.180.15.3882-3890.1998
   Persson C, 1999, MOL MICROBIOL, V33, P828, DOI 10.1046/j.1365-2958.1999.01529.x
   Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991
   ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x
   Ruckdeschel K, 1998, J EXP MED, V187, P1069, DOI 10.1084/jem.187.7.1069
   Ruckdeschel K, 1997, J BIOL CHEM, V272, P15920, DOI 10.1074/jbc.272.25.15920
   Ruckdeschel K, 2001, J IMMUNOL, V166, P1823, DOI 10.4049/jimmunol.166.3.1823
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Sarker MR, 1998, INFECT IMMUN, V66, P2976, DOI 10.1128/IAI.66.6.2976-2979.1998
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Schulte R, 1996, INFECT IMMUN, V64, P2106, DOI 10.1128/IAI.64.6.2106-2113.1996
   Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x
   Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343
   Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289
NR 76
TC 60
Z9 62
U1 0
U2 7
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 1438-4221
EI 1618-0607
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD FEB
PY 2002
VL 291
IS 6-7
BP 455
EP 462
PG 8
WC Microbiology; Virology
SC Microbiology; Virology
GA 529KA
UT WOS:000174297600009
PM 11890544
DA 2021-01-25
ER

PT J
AU Seubert, A
   Schulein, R
   Dehio, C
AF Seubert, A
   Schulein, R
   Dehio, C
TI Bacterial persistence within erythrocytes: A unique pathogenic strategy
   of Bartonella spp.
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article; Proceedings Paper
CT 10th European Workshop Conference on Bacterial Protein Toxins (ETOX 10)
CY JUN 24-29, 2001
CL BHON, BELGIUM
DE Bartonella; arthropod vector; erythrocyte; cell invasion; persistence;
   type IV secretion
ID GREEN FLUORESCENT PROTEIN; HUMAN ENDOTHELIAL-CELLS;
   EXPERIMENTAL-INFECTION; 17-KILODALTON ANTIGEN; EXPANDING SPECTRUM;
   HENSELAE; BACILLIFORMIS; EXPRESSION; INVASION; QUINTANA
AB The genus Bartonella comprises human-specific and zoonotic pathogens responsible for a wide range of clinical manifestations, including Carrion's disease, trench fever, cat scratch disease, bacillary angiomatosis and peliosis, endocarditis and bacteremia. These arthropod-borne pathogens typically parasitise erythrocytes in their mammalian reservoir host(s), resulting in a long-lasting haemotropic infection. We have studied the process of Bartonella erythrocyte parasitism by tracking green fluorescent protein-expressing bacteria in the blood of experimentally infected animals. Following intravenous infection, bacteria colonise a yet enigmatic primary niche, from where they are seeded into the blood stream in regular intervals of similar tofive days. Bacteria invade mature erythrocytes, replicate temporarily and persist in this unique intracellular niche for the remaining life span of the infected erythrocytes. A triggered antibody response typically results in an abrogation of bacteremia within 3 months of infection, likely by blocking new waves of bacterial invasion into erythrocytes. The recent establishment of genetic tools for Bartonella spp. permitted us to identify several putative pathogenicity determinants. Application of differential fluorescence induction technology resulted in the isolation of bacterial genes differentially expressed during infection in vitro and in vivo, including an unknown family of autotransporter proteins as well as a novel type TV secretion system homologous to the conjugation system of E. coli plasmid R388. Mutational analysis of a previously described type IV secretion system displaying homology to the virB locus of Agrobacterium tumefaciens provided the first example of an essential pathogenicity locus in Bartonella. Though required for establishing haemotropic infection, it remains to be demonstrated if this type IV secretion system is necessary for colonisation of the primary niche or for the subsequent colonisation of erythrocytes.
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Seubert, Anja/0000-0003-3321-9140
CR Abbott RC, 1997, COMP IMMUNOL MICROB, V20, P41, DOI 10.1016/S0147-9571(96)00025-2
   ANDERSON B, 1995, J CLIN MICROBIOL, V33, P2358, DOI 10.1128/JCM.33.9.2358-2365.1995
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P163, DOI 10.1097/00006454-199702000-00002
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P2, DOI 10.1097/00006454-199701000-00003
   BATTERMAN HJ, 1995, INFECT IMMUN, V63, P4553, DOI 10.1128/IAI.63.11.4553-4556.1995
   Battisti JM, 1999, APPL ENVIRON MICROB, V65, P3441
   BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986
   Brouqui P, 1996, RES MICROBIOL, V147, P719, DOI 10.1016/S0923-2508(97)85119-4
   Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x
   Coleman SA, 2001, INFECT IMMUN, V69, P4373, DOI 10.1128/IAI.69.7.4373-4381.2001
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9
   Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   Guptill L, 1997, J INFECT DIS, V176, P206, DOI 10.1086/514026
   Henderson IR, 2000, TRENDS MICROBIOL, V8, P529, DOI 10.1016/S0966-842X(00)01853-9
   Hendrix LR, 2000, FEMS MICROBIOL LETT, V182, P119, DOI 10.1111/j.1574-6968.2000.tb08884.x
   HILL EM, 1992, INFECT IMMUN, V60, P4051, DOI 10.1128/IAI.60.10.4051-4058.1992
   Karem KL, 2000, MICROBES INFECT, V2, P1193, DOI 10.1016/S1286-4579(00)01273-9
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   Kosoy MY, 2000, COMP IMMUNOL MICROB, V23, P221, DOI 10.1016/S0147-9571(99)00075-2
   Kosoy MY, 1999, J WILDLIFE DIS, V35, P275, DOI 10.7589/0090-3558-35.2.275
   Lee AK, 1998, INFECT IMMUN, V66, P3964, DOI 10.1128/IAI.66.8.3964-3967.1998
   Maguina C, 2000, INFECT DIS CLIN N AM, V14, P1, DOI 10.1016/S0891-5520(05)70215-4
   Mehock JR, 1998, INFECT IMMUN, V66, P3462, DOI 10.1128/IAI.66.7.3462-3466.1998
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   Ramakrishnan L, 2000, SCIENCE, V288, P1436, DOI 10.1126/science.288.5470.1436
   Schmiederer M, 2000, DNA CELL BIOL, V19, P141, DOI 10.1089/104454900314528
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Sweger D, 2000, CLIN DIAGN LAB IMMUN, V7, P251, DOI 10.1128/CDLI.7.2.251-257.2000
   Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007
   Valdivia RH, 1998, CURR OPIN MICROBIOL, V1, P359, DOI 10.1016/S1369-5274(98)80042-8
   Verma A, 2000, INFECT IMMUN, V68, P5960, DOI 10.1128/IAI.68.10.5960-5969.2000
NR 36
TC 41
Z9 42
U1 0
U2 10
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 1438-4221
EI 1618-0607
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD FEB
PY 2002
VL 291
IS 6-7
BP 555
EP 560
PG 6
WC Microbiology; Virology
SC Microbiology; Virology
GA 529KA
UT WOS:000174297600023
PM 11890558
DA 2021-01-25
ER

PT J
AU Nufer, O
   Guldbrandsen, S
   Degen, M
   Kappeler, F
   Paccaud, JP
   Tani, K
   Hauri, HP
AF Nufer, O
   Guldbrandsen, S
   Degen, M
   Kappeler, F
   Paccaud, JP
   Tani, K
   Hauri, HP
TI Role of cytoplasmic C-terminal amino acids of membrane proteins in ER
   export
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE COPII; endoplasmic reticulum; ERGIC-53; transport signal; C-terminal
   valine
ID TO-GOLGI TRANSPORT; FACTOR-VIII DEFICIENCY; COMBINED FACTOR-V;
   ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT; SECRETORY PATHWAY;
   SACCHAROMYCES-CEREVISIAE; MAMMALIAN HOMOLOGS; RECYCLING PATHWAY; VESICLE
   FORMATION
AB Export of membrane proteins from the ER is believed to be selective and require transport signals, but the identity of such signals has remained elusive. The recycling type I membrane protein ERGIC-53 carries a C-terminal diphenylalanine motif that is required for efficient ER export. Here we show that this motif can be functionally substituted by a single phenylalanine or tyrosine at position -2, two leucines or isoleucines at position -1 and -2 or a single valine at position -1. These motifs are common among mammalian type I membrane proteins. A single G terminal valine, but none of the other motifs, accelerates transport of inefficiently exported reporter constructs and hence operates as an export signal. The valine signal is position, but not context, dependent. All transport motifs mediate COPII binding in vitro with distinct preferences for the COPII subunits Sec23p, Sec24Bp, Sec24Cp and p125. These results suggest that cytoplasmic C-terminal amino-acid motifs, either alone or in conjunction with other transport determinants, accelerate ER export of numerous type I and probably polytopic membrane proteins by mediating interaction with COPII coat components.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Geneva, Sch Med, Dept Morphol, CH-1211 Geneva, Switzerland.
   Tokyo Univ Pharm & Life Sci, Tokyo 1920392, Japan.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RI Degen, Martin/H-5791-2013
OI Degen, Martin/0000-0002-4356-3714
CR Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875
   Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213
   Ausubel F. A., 1997, CURRENT PROTOCOLS MO
   BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X
   BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4
   Briley GP, 1997, MOL BIOL CELL, V8, P1619
   Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751
   Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3
   Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200
   ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57
   Kaiser C, 2000, P NATL ACAD SCI USA, V97, P3783, DOI 10.1073/pnas.97.8.3783
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Kuehn MJ, 1997, CURR OPIN CELL BIOL, V9, P477, DOI 10.1016/S0955-0674(97)80022-1
   Kuehn MJ, 1998, NATURE, V391, P187
   Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983
   Lahtinen U, 1999, EUR J BIOCHEM, V260, P392, DOI 10.1046/j.1432-1327.1999.00158.x
   LODISH HF, 1988, J BIOL CHEM, V263, P2107
   Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X
   Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9
   Mizoguchi T, 2000, BIOCHEM BIOPH RES CO, V279, P144, DOI 10.1006/bbrc.2000.3846
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Nakamura N, 1998, MOL BIOL CELL, V9, P3493, DOI 10.1091/mbc.9.12.3493
   Neerman-Arbez M, 1999, BLOOD, V93, P2253
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nichols WC, 1999, BLOOD, V93, P2261
   Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556
   Paccaud JP, 1996, MOL BIOL CELL, V7, P1535
   Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833
   PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303
   Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1
   Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001
   Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659
   Sambrook J, 1989, MOL CLONING LAB MANU
   SARASTE J, 1991, J CELL SCI, V100, P415
   Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7
   Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526
   SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13
   Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413
   Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973
   Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698
   STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011
   Stephens DJ, 2000, J CELL SCI, V113, P2177
   Tang BL, 2000, J BIOL CHEM, V275, P13597, DOI 10.1074/jbc.275.18.13597
   Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505
   Urena JM, 1999, J CELL SCI, V112, P773
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8
NR 54
TC 116
Z9 116
U1 0
U2 7
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD FEB 1
PY 2002
VL 115
IS 3
BP 619
EP 628
PG 10
WC Cell Biology
SC Cell Biology
GA 525GC
UT WOS:000174059700017
PM 11861768
DA 2021-01-25
ER

PT J
AU Freigang, J
   Diederichs, K
   Schafer, KP
   Welte, W
   Paul, R
AF Freigang, J
   Diederichs, K
   Schafer, KP
   Welte, W
   Paul, R
TI Crystal structure of oxidized flavodoxin, an essential protein in
   Helicobacter pylori
SO PROTEIN SCIENCE
LA English
DT Article
ID SITE-DIRECTED MUTAGENESIS; GEL-ELECTROPHORESIS; PYRUVATE-FLAVODOXIN;
   ANGSTROM RESOLUTION; ANACYSTIS-NIDULANS; OVERLAP EXTENSION;
   GASTRIC-CARCINOMA; ESCHERICHIA-COLI; REDOX POTENTIALS; BINDING-SITE
AB The redox protein flavodoxin has been shown earlier to be reduced by the pyruvate-oxidoreductase (POR) enzyme complex of Helicobacter pylori, and also was proposed to be involved in the pathogenesis of gastric mucosa-associated lymphoid-tissue lymphoma (MALToma). Here, we report its X-ray structure, which is similar to flavodoxins of other bacteria and cyanobacteria. However, H. pylori flavodoxin has an alanine residue near the isoalloxazine ring of its cofactor flavin mononucleotide (FMN), while the other previously crystallized flavodoxins have a larger hydrophobic residue at this position. This creates a solute filled hole near the FMN cofactor of H. pylori flavodoxin. We also show that flavodoxin is essential for the survival of H. pylori, and conclude that its structure can be used as a starting point for the modeling of an inhibitor for the interaction between the POR-enzyme complex and flavodoxin.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany.
   Byk Gulden Lomberg GmbH, Dept Mol Biol, D-78403 Constance, Germany.
RP Paul, R (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
CR Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495
   BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Chang CS, 1999, GASTROENTEROLOGY, V117, P82, DOI 10.1016/S0016-5085(99)70553-6
   DIEDERICHS K, 1995, PROTEINS, V23, P187, DOI 10.1002/prot.340230208
   Drennan CL, 1999, J MOL BIOL, V294, P711, DOI 10.1006/jmbi.1999.3151
   FUKUYAMA K, 1992, J MOL BIOL, V225, P775, DOI 10.1016/0022-2836(92)90400-E
   GUOGUANG L, 1998, MAPS MULTIPLE ALIGNM
   HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x
   Herrmann L, 1999, MOL MICROBIOL, V33, P524, DOI 10.1046/j.1365-2958.1999.01496.x
   HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Hoover DM, 1997, PROTEIN SCI, V6, P2525
   Hoover DM, 1999, J MOL BIOL, V294, P725, DOI 10.1006/jmbi.1999.3152
   HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4
   HUGHES NJ, 1995, J BACTERIOL, V177, P3953, DOI 10.1128/jb.177.14.3953-3959.1995
   Hughes NJ, 1998, J BACTERIOL, V180, P1119, DOI 10.1128/JB.180.5.1119-1128.1998
   JANCARIK J, 1991, J MOL BIOL, V221, P31, DOI 10.1016/0022-2836(91)90798-B
   KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075
   Kaihovaara P, 1998, J ANTIMICROB CHEMOTH, V41, P171, DOI 10.1093/jac/41.2.171
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Lostao A, 1997, BIOCHEMISTRY-US, V36, P14334, DOI 10.1021/bi971384h
   Lostao A, 2000, J BIOL CHEM, V275, P9518, DOI 10.1074/jbc.275.13.9518
   Ludwig ML, 1997, BIOCHEMISTRY-US, V36, P1259, DOI 10.1021/bi962180o
   Mayhew SG, 1996, BIOCHEM SOC T, V24, P122, DOI 10.1042/bst0240122
   MAYHEW SG, 1975, FLAVODOXINS ELECT TR
   Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u
   NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604
   OSBORNE C, 1991, J BACTERIOL, V173, P1729, DOI 10.1128/jb.173.5.1729-1737.1991
   PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603
   Paul R, 2001, PROTEIN EXPRES PURIF, V22, P399, DOI 10.1006/prep.2001.1467
   RAO ST, 1992, PROTEIN SCI, V1, P1413, DOI 10.1002/pro.5560011103
   Romero A, 1996, EUR J BIOCHEM, V239, P190, DOI 10.1111/j.1432-1033.1996.0190u.x
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x
   Shiesh SC, 2000, DIGEST DIS SCI, V45, P781, DOI 10.1023/A:1005460130305
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   SWENSON RP, 1994, BIOCHEMISTRY-US, V33, P8505, DOI 10.1021/bi00194a015
   Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   VERVOORT J, 1994, METHOD ENZYMOL, V243, P188
   Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411
   WATENPAUGH KD, 1973, P NATL ACAD SCI USA, V70, P3857, DOI 10.1073/pnas.70.12.3857
   WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F
NR 45
TC 58
Z9 59
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD FEB
PY 2002
VL 11
IS 2
BP 253
EP 261
DI 10.1110/ps.28602
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 512ZD
UT WOS:000173352700008
PM 11790835
OA Green Published
DA 2021-01-25
ER

PT J
AU Peek, R
   Kammerer, RA
   Frank, S
   Otte-Holler, I
   Westphal, JR
AF Peek, R
   Kammerer, RA
   Frank, S
   Otte-Holler, I
   Westphal, JR
TI The angiopoietin-like factor cornea-derived transcript 6 is a putative
   morphogen for human cornea
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HUMAN-MELANOMA; MOLECULAR-CLONING; VASCULAR DENSITY; NUDE-MICE; IN-VIVO;
   EXPRESSION; INVITRO; PROTEIN; DEPOSITION; LIVER
AB The human cornea-specific protein cornea-derived transcript 6 (CDT6) is a member of the angiopoietin gene family. We report the structural and functional characterization of CDT6. We demonstrate that CDT6 is a secreted protein that folds into disulfide-linked homotetramers by coiled-coil interactions. The finding that CDT6 is expressed at high levels in the avascular corneal stromal layer suggested that the protein, similar to certain angiopoietins, acts as a negative regulator of angiogenesis. To test this hypothesis and to assay the effect of the protein on a growing tissue with high vascular density, CDT6 was expressed in a mouse xenograft model. Expression of CDT6 led to a reduction in tumor growth and aberrant blood vessel formation by inducing massive fibrosis. Interestingly, expression of CDT6 also resulted in the deposition of extracellular matrix components typical for the mature corneal stromal layer. These observations strongly suggest a role as morphogen for CDT6 in inducing a corneal phenotype in vivo.
C1 Netherlands Ophthalm Res Inst, Dept Mol Immunol, NL-1105 BA Amsterdam, Netherlands.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Nijmegen, Ctr Med, Dept Pathol, NL-6500 HB Nijmegen, Netherlands.
RP Peek, R (corresponding author), Netherlands Ophthalm Res Inst, Dept Mol Immunol, POB 12141, NL-1100 AC Amsterdam, Netherlands.
RI Westphal, J.R./L-4754-2015; Peek, Ron/D-4041-2016; Otte-Holler,
   Irene/N-5708-2015
OI Peek, Ron/0000-0003-2134-3371; Kammerer, Richard/0000-0003-4570-5197
CR AYCOCK RS, 1989, CONNECT TISSUE RES, V23, P19, DOI 10.3109/03008208909103901
   BIRK DE, 1990, J CELL SCI, V95, P649
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041
   Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   Fujimaki T, 1999, CORNEA, V18, P109
   Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602
   Kim I, 2000, J BIOL CHEM, V275, P18550, DOI 10.1074/jbc.M910084199
   Kim I, 1999, FEBS LETT, V443, P353, DOI 10.1016/S0014-5793(99)00008-3
   Kim I, 1999, J BIOL CHEM, V274, P26523, DOI 10.1074/jbc.274.37.26523
   KLYCE SD, 1988, CORNEA, P3
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   Lupas A, 1996, METHOD ENZYMOL, V266, P513
   MADRI JA, 1980, HUM PATHOL, V11, P353, DOI 10.1016/S0046-8177(80)80031-1
   Magro Gaetano, 1997, General and Diagnostic Pathology, V143, P203
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   MCLAUGHLIN JS, 1989, J CELL SCI, V94, P371
   Mindan FJP, 1997, CLIN TRANSPLANT, V11, P426
   Nishida K, 1996, INVEST OPHTH VIS SCI, V37, P1800
   Paczek L, 1996, Ann Transplant, V1, P41
   Peek R, 1998, INVEST OPHTH VIS SCI, V39, P1782
   Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196
   SCOTT JE, 1992, J ANAT, V180, P155
   Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904
   Van der Laak JAWM, 1998, J PATHOL, V184, P136, DOI 10.1002/(SICI)1096-9896(199802)184:2<136::AID-PATH970>3.0.CO;2-9
   VANMUIJEN GNP, 1991, INT J CANCER, V48, P85
   VANMUIJEN GNP, 1991, CLIN EXP METASTAS, V9, P259, DOI 10.1007/BF01753729
   VLEMING LJ, 1995, CLIN NEPHROL, V44, P211
   Westphal JR, 2000, INT J CANCER, V86, P768, DOI 10.1002/(SICI)1097-0215(20000615)86:6<768::AID-IJC3>3.3.CO;2-5
   Westphal JR, 1997, BRIT J CANCER, V76, P561, DOI 10.1038/bjc.1997.427
NR 31
TC 40
Z9 41
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 4
PY 2002
VL 277
IS 1
BP 686
EP 693
DI 10.1074/jbc.M105746200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 508KU
UT WOS:000173087900090
PM 11682471
OA Bronze
DA 2021-01-25
ER

PT J
AU Stahlberg, H
   Engel, A
   Philippsen, A
AF Stahlberg, H
   Engel, A
   Philippsen, A
TI Assessing the structure of membrane proteins: combining different
   methods gives the full picture
SO BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE
LA English
DT Article; Proceedings Paper
CT 12th Annual CSBMCB/SCBBMC Winternational Symposium
CY MAR 21-24, 2002
CL BANFF, CANADA
SP CSBMCB, SCBBMC
DE AQP1; GlpF; F-ATPase; XRD; electron crystallography; AFM
ID FILE WATER CHAIN; ATP SYNTHASE; ESCHERICHIA-COLI; SUBUNIT-C; ELECTRON
   CRYSTALLOGRAPHY; CROSS-LINKING; CHANNEL; AQUAPORIN-1; PROTON; MECHANISM
AB The rotor stoichiometry of F-ATPases has been revealed by the combined approaches of X-ray diffraction (XRD), electron crystallography, and atomic force microscopy (AFM). XRD showed the rotor from the yeast mitochondrial F-ATPase to contain 10 subunits. AFM was used to visualize the tetradecameric chloroplast rotors, and electron crystallography and AFM together revealed the rotors from Ilyobacter tartaricus to be composed of 11 subunits. While biochemical methods had determined an approximate stoichiometric value, precise measurements and new insights into a species-dependent rotor stoichiometry became available by applying the three structural tools together. The structures of AQP1, a water channel, and GlpF, a glycerol channel, were determined by electron crystallography and XRD. The combination of both of these structural tools with molecular dynamics simulations gave a differentiated description of the mechanisms determining the selectivity of water and glycerol channels. This illustrates that the combination of different methods in structural biology reveals more than each method alone.
C1 Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
CR ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098
   Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785
   Engel A, 2002, INT REV CYTOL, V215, P75
   Ferguson SJ, 2000, CURR BIOL, V10, pR804, DOI 10.1016/S0960-9822(00)00765-X
   FERGUSON SJ, 1982, ANNU REV BIOCHEM, V51, P185, DOI 10.1146/annurev.bi.51.070182.001153
   Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Fujiyoshi Y, 2002, CURR OPIN STRUC BIOL, V12, P509, DOI 10.1016/S0959-440X(02)00355-X
   Grotthuss CJDD, 1806, ANN CHIM PHYS, V58, P54
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   Jones PC, 1998, J BIOL CHEM, V273, P29701, DOI 10.1074/jbc.273.45.29701
   Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4
   Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263
   Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579
   Muller DJ, 2001, FEBS LETT, V504, P219, DOI 10.1016/S0014-5793(01)02708-9
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Panke O, 1997, BBA-BIOENERGETICS, V1322, P183, DOI 10.1016/S0005-2728(97)00079-0
   Pomes R, 1996, BIOPHYS J, V71, P19, DOI 10.1016/S0006-3495(96)79211-1
   Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224
   Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198
   Schemidt RA, 1998, J BACTERIOL, V180, P3205, DOI 10.1128/JB.180.12.3205-3208.1998
   Seelert H, 2000, NATURE, V405, P418
   Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129
   Stahlberg H, 2000, J STRUCT BIOL, V132, P133, DOI 10.1006/jsbi.2000.4317
   Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047
   Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700
   Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778
   VanWalraven HS, 1996, FEBS LETT, V379, P309, DOI 10.1016/0014-5793(95)01536-1
   Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512
NR 39
TC 7
Z9 7
U1 1
U2 6
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA
SN 0829-8211
J9 BIOCHEM CELL BIOL
JI Biochem. Cell Biol.
PY 2002
VL 80
IS 5
BP 563
EP 568
DI 10.1139/O02-160
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 674WL
UT WOS:000182660100009
PM 12440697
DA 2021-01-25
ER

PT J
AU Walz, D
   Caplan, SR
AF Walz, D
   Caplan, SR
TI Bacterial flagellar motor and H+/ATP synthase: two proton-driven rotary
   molecular devices with different functions
SO BIOELECTROCHEMISTRY
LA English
DT Article; Proceedings Paper
CT 26th International Symposium on Bioelectrochemistry and Bioenergetics
CY 2001
CL BRATISLAVA, SLOVAKIA
DE torque generation; proton turbine; Brownian ratchet
ID ATP SYNTHASE; ENERGY TRANSDUCTION; ELASTIC ENERGY; MECHANISM; ROTATION;
   TORQUE
AB Both the bacterial flagellar motor and the H+/ATP synthase are membrane-bound macromolecular complexes in which the movement of protons through channels across the membrane is coupled to the rotation of a part of the complex around an axis perpendicular to the membrane. Despite this similarity, the two devices are designed for quite different functions. The flagellar motor is responsible for a practically smooth rotation of the flagellar filament in order to propel the cell. Smooth rotation is not essential for the H+/ATP synthase, which accumulates torque by twisting a rod-shaped structure. Possible mechanisms for generating torque in the two devices are presented, based on the models which have been proposed. The performances of the various mechanisms are discussed. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.
   McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada.
RP Walz, D (corresponding author), Univ Basel, Biozentrum, Klinger Bergstr 70, CH-4056 Basel, Switzerland.
CR Berg HC, 2000, PHILOS T R SOC B, V355, P491, DOI 10.1098/rstb.2000.0590
   BERG HC, 1983, MOBILITY RECOGNITION, P485
   Berry RM, 2000, PHILOS T ROY SOC B, V355, P503, DOI 10.1098/rstb.2000.0591
   CAPLAN SR, 1993, INT REV CYTOL, V147, P97, DOI 10.1016/S0074-7696(08)60767-6
   Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5
   Elston T, 1998, NATURE, V391, P510
   Elston TC, 1997, BIOPHYS J, V73, P703, DOI 10.1016/S0006-3495(97)78104-9
   Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8
   KIHARA M, 1989, J BACTERIOL, V171, P3247, DOI 10.1128/jb.171.6.3247-3257.1989
   LAUGER P, 1988, BIOPHYS J, V53, P53
   MEISTER M, 1989, BIOPHYS J, V55, P905, DOI 10.1016/S0006-3495(89)82889-9
   Nakamoto RK, 1999, ANNU REV BIOPH BIOM, V28, P205, DOI 10.1146/annurev.biophys.28.1.205
   Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200
   Panke O, 1999, BBA-BIOENERGETICS, V1412, P118, DOI 10.1016/S0005-2728(99)00059-6
   Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233
   SCHUSTER CS, 1994, ANNU REV BIOPH BIOM, V23, P509
   Walz D, 2000, BIOPHYS J, V78, P626, DOI 10.1016/S0006-3495(00)76622-7
NR 17
TC 11
Z9 11
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1567-5394
J9 BIOELECTROCHEMISTRY
JI Bioelectrochemistry
PD JAN
PY 2002
VL 55
IS 1-2
BP 89
EP 92
AR PII S1567-5394(01)00162-1
DI 10.1016/S1567-5394(01)00162-1
PG 4
WC Biochemistry & Molecular Biology; Biology; Biophysics; Electrochemistry
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Biophysics; Electrochemistry
GA 571KA
UT WOS:000176715500023
PM 11786348
DA 2021-01-25
ER

PT S
AU Markovic-Housley, Z
   Schirmer, T
AF Markovic-Housley, Z
   Schirmer, T
BE Teeri, TT
   Svensson, B
   Gilbert, HJ
   Feizi, T
TI Structural evidence for substrate assisted catalytic mechanism of bee
   venom hyaluronidase, a major allergen of bee venom
SO CARBOHYDRATE BIOENGINEERING: INTERDISCIPLINARY APPROACHES
SE Royal Society of Chemistry Special Publications
LA English
DT Proceedings Paper
CT 4th Carbohydrate Bioengineering Meeting
CY JUN 10-13, 2001
CL ROYAL INST TECHNOL, STOCKHOLM, SWEDEN
SP Bo Rydin Fdn Sci Res, Swedish Natl Sci Res Council, Swedish Council Forestry & Agr Res, Appl Biosyst, Genencor Int Inc, Neose Technologies Inc, Micromass AB, Novozymes, Eka Chm, Ezaki Glio Co Ltd, Amano Enzyme Inc, Nihon Shokuhin Kako Co Ltd, Nagase Biochem Ltd, Ozeki Corp
HO ROYAL INST TECHNOL
ID CRYSTAL-STRUCTURE; SEQUENCE; CLASSIFICATION; PURIFICATION; HYDROLYSIS;
   CHITOBIASE; CHITINASE; PROTEIN; CELLS
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Markovic-Housley, Z (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
CR Arming S, 1997, EUR J BIOCHEM, V247, P810, DOI 10.1111/j.1432-1033.1997.t01-1-00810.x
   Brameld KA, 1998, J MOL BIOL, V280, P913, DOI 10.1006/jmbi.1998.1890
   Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9
   CRAMER JA, 1994, BBA-GEN SUBJECTS, V1200, P315, DOI 10.1016/0304-4165(94)90173-2
   Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945
   Eads JC, 1997, STRUCTURE, V5, P47, DOI 10.1016/S0969-2126(97)00165-2
   Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599
   Frost GI, 1997, BIOCHEM BIOPH RES CO, V236, P10, DOI 10.1006/bbrc.1997.6773
   GMACHL M, 1993, P NATL ACAD SCI USA, V90, P3569, DOI 10.1073/pnas.90.8.3569
   Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695
   HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309
   Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375
   KEMENY DM, 1984, EUR J BIOCHEM, V139, P217, DOI 10.1111/j.1432-1033.1984.tb07997.x
   LAURENT TC, 1992, FASEB J, V6, P2397
   LAURENT TC, 1989, CIBA FDN S, V143
   Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466
   Lo Leggio L, 1999, PROTEINS, V36, P295
   Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6
   Meyer K, 1971, ENZYMES, V5, P307, DOI 10.1016/S1874-6047(08)60094-3
   Mikami B, 1999, BIOCHEMISTRY-US, V38, P7050, DOI 10.1021/bi9829377
   MIKAMI B, 1994, BIOCHEMISTRY-US, V33, P7779, DOI 10.1021/bi00191a005
   PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7
   PRIMAKOFF P, 1988, NATURE, V335, P543, DOI 10.1038/335543a0
   ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893
   Soldatova LN, 1998, J ALLERGY CLIN IMMUN, V101, P691, DOI 10.1016/S0091-6749(98)70179-4
   SPEZIO M, 1993, BIOCHEMISTRY-US, V32, P9906, DOI 10.1021/bi00089a006
   TAKAGAKI K, 1994, BIOCHEMISTRY-US, V33, P6503, DOI 10.1021/bi00187a017
   Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638
   Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i
   VALENTA R, 1994, ALLERGY CLIN IMMUNOL, V6, P165
   VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003
   White A, 1997, CURR OPIN STRUC BIOL, V7, P645, DOI 10.1016/S0959-440X(97)80073-5
NR 32
TC 1
Z9 1
U1 0
U2 0
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND
SN 0260-6291
BN 0-85404-826-X
J9 ROY SOC CH
PY 2002
IS 275
BP 19
EP 27
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry,
   Medicinal
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA BU26R
UT WOS:000175525300003
DA 2021-01-25
ER

PT J
AU Hegner, M
   Engel, A
AF Hegner, M
   Engel, A
TI Single molecule imaging and manipulation
SO CHIMIA
LA English
DT Article
DE atomic force microscope; membrane proteins; molecular motors; optical
   tweezers; single molecules
ID ATOMIC-FORCE MICROSCOPY; ESCHERICHIA-COLI; OPTICAL TWEEZERS;
   HIGH-RESOLUTION; DNA; SPECTROSCOPY; TRANSITION; SURFACES; SYSTEM; TAIL
AB The atomic force microscope (AFM) and optical tweezers are tools that allow-single biomolecules to be imaged and manipulated. Progress in instrumentation, sample preparation, and image acquisition conditions make novel applications of these tools possible. Biological membranes can be imaged in their native state at a lateral resolution of 0.4-1 nm and a vertical resolution of 0.1-0.2 nm. Function-related conformational changes are resolved to a similar resolution, complementing atomic structure data acquired by other methods. The unique capability of the AFM to observe single proteins directly allows the interaction of proteins forming functional assemblies to be assessed. Single molecule force spectroscopy combined with single molecule imaging provides unprecedented possibilities to analyze intra- and intermolecular forces. Optical tweezers expand the range of measurable forces to those produced by molecular motors. Combined with fluorescence measurements, optical tools give insights into fundamental biological processes such as the molecular conversion of chemical into mechanical energy.
C1 Univ Basel, Biozentrum, NCCR Nanoscale Sci, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Inst Phys, NCCR Nanoscale Sci, CH-4056 Basel, Switzerland.
RP Hegner, M (corresponding author), Univ Basel, Biozentrum, NCCR Nanoscale Sci, ME Muller Inst Struct Biol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Martin.Hegner@unibas.ch; Andreas.Engel@unibas.ch
OI Hegner, Martin/0000-0003-1514-3437
CR AFZAL RS, 1992, REV SCI INSTRUM, V63, P2157, DOI 10.1063/1.1143833
   Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z
   ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288
   ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653
   ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0
   ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072
   Czajkowsky DM, 1998, J MOL BIOL, V276, P325, DOI 10.1006/jmbi.1997.1535
   Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Fotiadis D, 1998, J MOL BIOL, V283, P83, DOI 10.1006/jmbi.1998.2097
   Galligan E, 2001, J CHEM PHYS, V114, P3208, DOI 10.1063/1.1340675
   Grange W, 2002, REV SCI INSTRUM, V73, P2308, DOI 10.1063/1.1477608
   Han WH, 1997, NATURE, V386, P563, DOI 10.1038/386563a0
   HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795
   Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109
   Hegner M., 2000, Single Molecules, V1, P139, DOI 10.1002/1438-5171(200006)1:2<139::AID-SIMO139>3.3.CO;2-3
   Heymann B, 2000, PHYS REV LETT, V84, P6126, DOI 10.1103/PhysRevLett.84.6126
   Husale S, 2002, SINGLE MOL, V3, P91, DOI 10.1002/1438-5171(200206)3:2/3<91::AID-SIMO91>3.0.CO;2-R
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P3342, DOI 10.1063/1.1144449
   Leitz G, 2002, BIOPHYS J, V82, P2224, DOI 10.1016/S0006-3495(02)75568-9
   Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152
   Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689
   Moller C, 1999, BIOPHYS J, V77, P1150, DOI 10.1016/S0006-3495(99)76966-3
   MOU JX, 1995, J MOL BIOL, V248, P507, DOI 10.1006/jmbi.1995.0238
   MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 1997, EMBO J, V16, P2547, DOI 10.1093/emboj/16.10.2547
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Muller DJ, 2000, BBA-BIOENERGETICS, V1460, P27, DOI 10.1016/S0005-2728(00)00127-4
   Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1
   PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x
   Scheuring S, 2002, EUR BIOPHYS J BIOPHY, V31, P172, DOI 10.1007/s00249-001-0197-8
   Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029
   Schumakovitch I, 2002, BIOPHYS J, V82, P517, DOI 10.1016/S0006-3495(02)75416-7
   Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581
   Strunz T, 1999, P NATL ACAD SCI USA, V96, P11277, DOI 10.1073/pnas.96.20.11277
   SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335
   TIBANYENDA N, 1984, EUR J BIOCHEM, V139, P19, DOI 10.1111/j.1432-1033.1984.tb07970.x
   Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039
   Viani MB, 1999, REV SCI INSTRUM, V70, P4300, DOI 10.1063/1.1150069
   Williams MC, 2002, CURR OPIN STRUC BIOL, V12, P330, DOI 10.1016/S0959-440X(02)00340-8
   Wuite GJL, 2000, NATURE, V404, P103
NR 50
TC 5
Z9 5
U1 0
U2 2
PU SWISS CHEMICAL SOC
PI BERN
PA SCHWARZTORSTRASSE 9, CH-3007 BERN, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2002
VL 56
IS 10
BP 506
EP 514
DI 10.2533/000942902777680090
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 610LJ
UT WOS:000178961300006
DA 2021-01-25
ER

PT J
AU Hunziker, PR
   Stolz, M
   Aebi, U
AF Hunziker, PR
   Stolz, M
   Aebi, U
TI Nanotechnology in medicine: Moving from the bench to the bedside
SO CHIMIA
LA English
DT Article
DE arthroscopy; atomic force microscopy; biochemical testing; drug
   targeting; medical implants; medicine; nanoscience
ID ATOMIC-FORCE MICROSCOPY; ARTICULAR-CARTILAGE; PROTEIN; AGE
AB While living matter is composed of a large number of biological nanomachines, it has been recognized early in the history of nanotechnology that medicine could be a prime field for application. Now that nanotechnology has gone beyond its infancy, its mature arsenal of tools, methods and materials is ready for applications outside physics. While true clinical applications of nanotechnology are still practically non-existent at the current time, a significant number of promising medical projects is at an advanced experimental stage. Tools based on the atomic force microscope will not only allow improved imaging of living matter but can also serve as functional probes and will even serve as sensitive sensors for a broad range of molecules of medical interest. New immunological tests based on microcontact printing and microfluidics will significantly improve medical laboratory diagnosis. New materials, including nanotubes and fullerenes, nanocontainers and other self-assembled structures may improve mechanical properties and biocompatibility of implants and will allow new approaches in drug targeting.
C1 Univ Basel Hosp, Med Intens Care Unit, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Hunziker, PR (corresponding author), Univ Basel Hosp, Med Intens Care Unit, Petersgraben 5, CH-4031 Basel, Switzerland.
CR A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3
   ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   Baller MK, 2000, ULTRAMICROSCOPY, V82, P1, DOI 10.1016/S0304-3991(99)00123-0
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Bernard A, 2001, ANAL CHEM, V73, P8, DOI 10.1021/ac0008845
   Cohen NP, 1998, J ORTHOP SPORT PHYS, V28, P203, DOI 10.2519/jospt.1998.28.4.203
   DREXLER KE, 1986, ENG CREATION
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   Graff A, 2002, P NATL ACAD SCI USA, V99, P5064, DOI 10.1073/pnas.062654499
   Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X
   Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956
   KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   MCDEVITT CA, 1976, J BONE JOINT SURG BR, V58, P94
   Michel B, 2001, IBM J RES DEV, V45, P697, DOI 10.1147/rd.455.0697
   Nowak KJ, 1999, NAT GENET, V23, P208
   ROTH V, 1980, J BONE JOINT SURG AM, V62, P1102, DOI 10.2106/00004623-198062070-00007
   Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8
   Sauer M, 2001, ADV MATER, V13, P1649, DOI 10.1002/1521-4095(200111)13:21<1649::AID-ADMA1649>3.0.CO;2-E
   Simonsson T, 2001, BIOL CHEM, V382, P621, DOI 10.1515/BC.2001.073
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stolz M, 2000, J STRUCT BIOL, V131, P171, DOI 10.1006/jsbi.2000.4301
   Thalhammer S, 1997, J STRUCT BIOL, V119, P232, DOI 10.1006/jsbi.1997.3869
   Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483
NR 25
TC 8
Z9 8
U1 0
U2 15
PU NEW SWISS CHEMICAL SOC
PI BASEL
PA C/O NOVARTIS AG, K-25 1 45, CH-4002 BASEL, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2002
VL 56
IS 10
BP 520
EP 526
DI 10.2533/000942902777680234
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 610LJ
UT WOS:000178961300008
DA 2021-01-25
ER

PT J
AU Upalakalin, JN
   Hemo, I
   Dehio, C
   Keshet, E
   Benjamin, LE
AF Upalakalin, JN
   Hemo, I
   Dehio, C
   Keshet, E
   Benjamin, LE
TI Survival mechanisms of VEGF and PIGF during microvascular remodeling
SO COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
LA English
DT Article; Proceedings Paper
CT Cold Spring Harbor Symposium on Quantitiative Biology
CY 2002
CL COLD SPRING HARBOR, NEW YORK
SP Aventis Pharma AG, Bristol Mayers Squibb Co, Eli Lilly & Co, GlaxoSmithKline, Novartis Pharma AG, Pfizer Inc, Abbott Lab, Amersham Biosci Inc, Amgen Inc, Appl Biosyst, Bio Ventures Inc, Chugai Pharmaceut Co Ltd, Cogene Bio Tech Ventures Ltd, Diagnost Products Corp, Forest Lab, Genentech Inc, Hoffmann Rache Inc, Johnson & Johnson Pharmaceut, Res & Dev L L C, Kyowa Hakko Kogyo Co Ltd, Merck Res Lab, New England BioLab Inc, OSI Pharmaceut Inc, Pall Corp, Pharmacia Corp, ResGen Inc, Schering Plough Res Inst, Wyeth Genet Inst
ID ENDOTHELIAL GROWTH-FACTOR; SIGNAL-TRANSDUCTION PATHWAYS; OXYGEN-INDUCED
   RETINOPATHY; BLOOD-VESSEL FORMATION; NITRIC-OXIDE SYNTHASE; FACTOR
   MESSENGER-RNA; SMOOTH-MUSCLE CELLS; PDGF-B; FACTOR GENE; RETINAL
   NEOVASCULARIZATION
C1 Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.
   Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Upalakalin, JN (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA.
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR Adini A, 2002, CANCER RES, V62, P2749
   ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024
   Bachelder RE, 2001, CANCER RES, V61, P5736
   Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761
   Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028
   Benjamin LE, 1998, DEVELOPMENT, V125, P1591
   BERSE B, 1992, MOL BIOL CELL, V3, P211
   Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389
   Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7
   Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127
   Desai J, 1999, BIOL REPROD, V60, P887, DOI 10.1095/biolreprod60.4.887
   Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224
   Donnini S, 1999, J PATHOL, V189, P66, DOI 10.1002/(SICI)1096-9896(199909)189:1<66::AID-PATH390>3.0.CO;2-X
   Dragovich T, 1998, ONCOGENE, V17, P3207, DOI 10.1038/sj.onc.1202587
   Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Fisher SA, 2000, CIRC RES, V87, P856, DOI 10.1161/01.RES.87.10.856
   Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3
   Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
   Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349
   Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6
   Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218
   Fulton D, 1999, NATURE, V400, P792, DOI 10.1038/23523
   Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313
   Gerber HP, 1999, DEVELOPMENT, V126, P1149
   Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200
   Guo NH, 1997, CANCER RES, V57, P1735
   HATTORI K, 2002, NAT MED, V1, P1
   Hellstrom M, 1999, DEVELOPMENT, V126, P3047
   Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298
   Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994
   Holash J, 1999, ONCOGENE, V18, P5356, DOI 10.1038/sj.onc.1203035
   IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761
   Ilan N, 1998, J CELL SCI, V111, P3621
   Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889
   Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5
   Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897
   Khaliq A, 1996, GROWTH FACTORS, V13, P243, DOI 10.3109/08977199609003225
   KIM SH, 1993, J PHYS SOC JPN, V62, P1, DOI 10.1143/JPSJ.62.1
   Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0
   LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875
   LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333
   Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242
   Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731
   Mazure NM, 1997, BLOOD, V90, P3322, DOI 10.1182/blood.V90.9.3322
   McLeod DS, 1996, INVEST OPHTH VIS SCI, V37, P300
   Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6
   Millauer B, 1996, CANCER RES, V56, P1615
   Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892
   Neufeld G, 1999, FASEB J, V13, P9
   Nomura M, 1998, J NEURO-ONCOL, V40, P123, DOI 10.1023/A:1006198422718
   Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4
   O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455
   Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6
   Papetti M, 2002, AM J PHYSIOL-CELL PH, V282, pC947, DOI 10.1152/ajpcell.00389.2001
   Patan S, 2000, J NEURO-ONCOL, V50, P1, DOI 10.1023/A:1006493130855
   PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905
   Pietsch T, 1997, ACTA NEUROPATHOL, V93, P109, DOI 10.1007/s004010050591
   Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200
   Reinmuth N, 2001, FASEB J, V15, P1239
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Robbins SG, 1998, GROWTH FACTORS, V16, P1
   SENGER DR, 1986, CANCER RES, V46, P5629
   Seo MS, 1999, AM J PATHOL, V154, P1743, DOI 10.1016/S0002-9440(10)65430-2
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   Sim BKL, 1997, CANCER RES, V57, P1329
   Simpson DAC, 1999, BIOCHEM BIOPH RES CO, V262, P333, DOI 10.1006/bbrc.1999.1201
   SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101
   Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6
   Sone H, 1999, LIFE SCI, V65, P2573, DOI 10.1016/S0024-3205(99)00526-3
   STEIN I, 1995, MOL CELL BIOL, V15, P5363
   Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112
   STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995
   Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899
   Varner Judith A., 1996, P69
   Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096
   Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375
NR 82
TC 6
Z9 6
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI WOODBURY
PA 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA
SN 0091-7451
J9 COLD SPRING HARB SYM
JI Cold Spring Harbor Symp. Quant. Biol.
PY 2002
VL 67
BP 181
EP 187
DI 10.1101/sqb.2002.67.181
PG 7
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 694NM
UT WOS:000183780700024
PM 12858539
DA 2021-01-25
ER

PT J
AU Montalta-He, H
   Leemans, R
   Loop, T
   Strahm, M
   Certa, U
   Primig, M
   Acampora, D
   Simeone, A
   Reichert, H
AF Montalta-He, Haiqiong
   Leemans, Ronny
   Loop, Thomas
   Strahm, Martin
   Certa, Ulrich
   Primig, Michael
   Acampora, Dario
   Simeone, Antonio
   Reichert, Heinrich
TI Evolutionary conservation of otd/Otx2 transcription factor action: a
   genome-wide microarray analysis in Drosophila
SO GENOME BIOLOGY
LA English
DT Article
AB Background: Homeobox genes of the orthodenticle (otd)/Otx family have conserved roles in the embryogenesis of head and brain. Gene replacement experiments show that the Drosophila otd gene and orthologous mammalian Otx genes are functionally equivalent, in that overexpression of either gene in null mutants of Drosophila or mouse can restore defects in cephalic and brain development. This suggests that otd and Otx genes control a comparable subset of downstream target genes in either organism. Here we use quantitative transcript imaging to analyze this equivalence of otd and Otx gene action at a genomic level.
   Results: Oligonucleotide arrays representing 13,400 annotated Drosophila genes were used to study differential gene expression in flies in which either the Drosophila otd gene or the human Otx2 gene was overexpressed. Two hundred and eighty-seven identified transcripts showed highly significant changes in expression levels in response to otd overexpression, and 682 identified transcripts showed highly significant changes in expression levels in response to Otx2 overexpression. Among these, 93 showed differential expression changes following overexpression of either otd or Otx2, and for 90 of these, comparable changes were observed under both experimental conditions. We postulate that these transcripts are common downstream targets of the fly otd gene and the human Otx2 gene in Drosophila.
   Conclusion: Our experiments indicate that approximately one third of the otd-regulated transcripts also respond to overexpression of the human Otx2 gene in Drosophila. These common otd/ Otx2 downstream genes are likely to represent the molecular basis of the functional equivalence of otd and Otx2 gene action in Drosophila.
C1 [Montalta-He, Haiqiong; Leemans, Ronny; Loop, Thomas; Reichert, Heinrich] Univ Basel, Inst Zool, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Certa, Ulrich] F Hoffmann La Roche Ltd, Roche Genet Pharmaceut Div, CH-4070 Basel, Switzerland.
   [Strahm, Martin] F Hoffmann La Roche Ltd, Roche Bioinformat, CH-4070 Basel, Switzerland.
   [Acampora, Dario; Simeone, Antonio] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England.
RP Reichert, H (corresponding author), Univ Basel, Inst Zool, Biozentrum, Pharmazentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch
RI Acampora, Dario/C-2156-2013; Simeone, Antonio/ABG-5269-2020; Primig,
   Michael/G-3175-2013
OI Simeone, Antonio/0000-0003-2693-9836; Primig,
   Michael/0000-0002-2061-0119
FU SNSFSwiss National Science Foundation (SNSF); F. Hoffmann-La
   RocheHoffmann-La Roche
FX We thank Jan Mous, Adrian Roth, Michel Tessier, Monika Seiler, and Reto
   Brem for essential contributions and helpful advice. We are particularly
   grateful to Clemens Broger and Martin Neeb (F. Hoffman-La Roche) for
   allowing us to use their RACE-A CHIP analysis software and to Volker
   Schmid and Natalie Yanze for help with the light cycler. We especially
   thank Reinhold Koch for contributions to standardizing the description
   of the statistics. We thank all members of our laboratory, especially
   Boris Egger, Frank Hirth and Martin Mueller for constant and encouraging
   discussions, and Lars Kammermeier for help with the photography. This
   research was supported by grants from the SNSF and by F. Hoffmann-La
   Roche.
CR ACAMPORA D, 1995, DEVELOPMENT, V121, P3279
   Acampora D, 1999, TRENDS NEUROSCI, V22, P116, DOI 10.1016/S0166-2236(98)01387-3
   Acampora D, 1998, DEVELOPMENT, V125, P1691
   Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218
   Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Ang SL, 1996, DEVELOPMENT, V122, P243
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Barbosa V, 2000, GENE DEV, V14, P3126, DOI 10.1101/gad.182800
   Bate M, 1993, DEV DROSOPHILA MELAN
   Benos PV, 2001, GENOME RES, V11, P710, DOI 10.1101/gr.173801
   Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9
   Boncinelli E, 2001, TRENDS GENET, V17, P633, DOI 10.1016/S0168-9525(01)02418-0
   Boyl PP, 2001, DEVELOPMENT, V128, P2989
   COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0
   CRIBBS DL, 1995, EMBO J, V14, P767, DOI 10.1002/j.1460-2075.1995.tb07055.x
   Crow JF, 1999, SCIENCE, V283, P1651, DOI 10.1126/science.283.5408.1651
   Dobie KW, 1999, CURR OPIN GENET DEV, V9, P206, DOI 10.1016/S0959-437X(99)80031-8
   Feger G, 1999, GENE, V227, P149, DOI 10.1016/S0378-1119(98)00596-4
   FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165
   FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516
   FINKELSTEIN R, 1994, TRENDS GENET, V10, P310, DOI 10.1016/0168-9525(94)90033-7
   FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0
   Galliot B, 2000, TRENDS GENET, V16, P1, DOI 10.1016/S0168-9525(99)01888-0
   Gao Q, 1996, MECH DEVELOP, V56, P3, DOI 10.1016/0925-4773(96)00504-7
   Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85
   GROSSNIKLAUS U, 1994, DEVELOPMENT, V120, P3155
   Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2
   Hartmann B, 2000, MECH DEVELOP, V90, P143, DOI 10.1016/S0925-4773(99)00237-3
   HECK MMS, 1993, J CELL BIOL, V123, P665, DOI 10.1083/jcb.123.3.665
   Holland LZ, 1999, CURR OPIN NEUROBIOL, V9, P596, DOI 10.1016/S0959-4388(99)00003-3
   HOPPLER S, 1994, CELL, V76, P689, DOI 10.1016/0092-8674(94)90508-8
   Kablar B, 1996, MECH DEVELOP, V55, P145, DOI 10.1016/0925-4773(96)00497-2
   KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W
   Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001
   LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797
   Leemans R, 2000, P NATL ACAD SCI USA, V97, P12138, DOI 10.1073/pnas.210066997
   Leemans R, 2001, GENOME BIOL, V2
   Leuzinger S, 1998, DEVELOPMENT, V125, P1703
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675
   Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5
   MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646
   Nagao T, 1998, P NATL ACAD SCI USA, V95, P3737, DOI 10.1073/pnas.95.7.3737
   Nasiadka A, 1999, DEVELOPMENT, V126, P1515
   *NCBI, NCBI GEN EXP OMN
   Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534
   Philp AV, 1998, TRENDS CELL BIOL, V8, P150, DOI 10.1016/S0962-8924(98)01245-8
   Prokopenko SN, 2000, GENETICS, V156, P1691
   Regel R, 1998, INSECT BIOCHEM MOLEC, V28, P309, DOI 10.1016/S0965-1748(97)00108-2
   Reichert H, 2001, PHILOS T R SOC B, V356, P1533, DOI 10.1098/rstb.2001.0972
   ROYET J, 1995, DEVELOPMENT, V121, P3561
   Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204
   Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270
   SCHMIDTOTT U, 1994, P NATL ACAD SCI USA, V91, P8363, DOI 10.1073/pnas.91.18.8363
   Sharman AC, 1998, TRENDS GENET, V14, P211, DOI 10.1016/S0168-9525(98)01488-7
   SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x
   SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x
   SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0
   Su TT, 1998, CURR BIOL, V8, pR687, DOI 10.1016/S0960-9822(98)70436-1
   Suda Y, 1996, GENES CELLS, V1, P1031, DOI 10.1046/j.1365-2443.1996.900288.x
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   THOR S, 1995, NEURON, V15, P975, DOI 10.1016/0896-6273(95)90084-5
   Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A
   Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9
   Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4
   WALTER MF, 1990, DEV GENET, V11, P270, DOI 10.1002/dvg.1020110405
   WIESCHAUS E, 1992, DEVELOPMENT, V115, P801
   Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817
   Zakin L, 2000, P NATL ACAD SCI USA, V97, P14388, DOI 10.1073/pnas.011513398
   Zimowska G, 1997, J CELL SCI, V110, P927
NR 70
TC 14
Z9 15
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PY 2002
VL 3
IS 4
AR 0015.1
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA V12DW
UT WOS:000207580900009
OA DOAJ Gold
DA 2021-01-25
ER

PT S
AU Gehring, W
   Michaut, L
AF Gehring, W
   Michaut, L
BE Yoshikawa, H
   Ogasawara, N
   Satoh, N
TI Deciphering the eye morphogenetic pathway
SO GENOME SCIENCE: TOWARDS A NEW PARADIGM?
SE INTERNATIONAL CONGRESS SERIES
LA English
DT Proceedings Paper
CT Symposium on Genome Science - Towards a New Paradigm
CY JUN 03-05, 2002
CL TOKYO, JAPAN
SP Uehara Memorial Fdn
ID EYELESS GENE; PAX GENE; DROSOPHILA; EVOLUTION; ENHANCER; EXPRESSION;
   INDUCTION; UPSTREAM; TWIN
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Gehring, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Gehring WJ, 2002, INT J DEV BIOL, V46, P65
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   Groger H, 2000, MECH DEVELOP, V94, P157, DOI 10.1016/S0925-4773(00)00286-0
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564
   KOZMIK Z, 2002, COLD SPRING HARB M E, P61
   Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497
   LEWIS EB, 1992, JAMA-J AM MED ASSOC, V267, P1524, DOI 10.1001/jama.267.11.1524
   Miller DJ, 2000, P NATL ACAD SCI USA, V97, P4475, DOI 10.1073/pnas.97.9.4475
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Punzo C, 2002, DEVELOPMENT, V129, P625
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0531-5131
BN 0-444-51083-4
J9 INT CONGR SER
PY 2002
VL 1246
BP 83
EP 89
AR PII S0531-5131(02)01129-9
DI 10.1016/S0531-5131(02)01129-9
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA BW21N
UT WOS:000181204800009
DA 2021-01-25
ER

PT S
AU Hauri, HP
   Nufer, O
   Breuza, L
   Ben Tekaya, H
   Liang, L
AF Hauri, HP
   Nufer, O
   Breuza, L
   Ben Tekaya, H
   Liang, L
BE Drickamer, K
   Dell, A
TI Lectins and protein traffic early in the secretory pathway
SO GLYCOGENOMICS: THE IMPACT OF GENOMICS AND INFORMATICS ON GLYCOBIOLOGY
SE Biochemical Society Symposia
LA English
DT Article; Proceedings Paper
CT Annual Symposium of the Biochemistry-Society
CY DEC, 2001
CL UNIV YORK, YORK, ENGLAND
SP Biochem Soc
HO UNIV YORK
ID TO-GOLGI TRANSPORT; CARBOXYL-TERMINAL VALINE; COAGULATION-FACTORS V;
   ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; PROTGF-ALPHA; ER; ERGIC-53;
   DYNAMICS; IDENTIFICATION
AB Lectins of the early secretory pathway are involved in selective transport of newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type I membrane protein ERGIC-53 (ERGIC protein of 53 kDa), a marker for the ERGIC, which functions as a cargo receptor to facilitate export of an increasing number of glycoproteins with different characteristics from the ER. Two ERGIC-53-related proteins, VIP36 (vesicular integral membrane protein 36) and a novel ERGIC-53-like protein, ERGL, arc also found in the early secretory pathway. ERGL may act as a regulator of ERGIC-53. Studies of ERGIC-53 continue to provide new insights into the organization and dynamics of the early secretory pathway. Analysis of the cycling of ERGIC-53 uncovered a complex interplay of trafficking signals and revealed novel cytoplasmic ER-export motifs that interact with COP-II coat proteins. These motifs arc common to type I and polytopic membrane proteins including presenilin I and presenilin 2. The results support the notion that protein export from the ER is selective.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
OI Breuza, Lionel/0000-0002-8075-8625
CR Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19
   Briley GP, 1997, MOL BIOL CELL, V8, P1619
   Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9
   Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8
   Dahm T, 2001, MOL BIOL CELL, V12, P1481, DOI 10.1091/mbc.12.5.1481
   Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882
   FIEDLER K, 1994, CELL, V77, P625, DOI 10.1016/0092-8674(94)90047-7
   Fullekrug J, 1999, J CELL SCI, V112, P2813
   Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013
   Hara-Kuge S, 1999, GLYCOBIOLOGY, V9, P833, DOI 10.1093/glycob/9.8.833
   HAURI H-P, 1992, Current Opinion in Cell Biology, V4, P600, DOI 10.1016/0955-0674(92)90078-Q
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3
   Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200
   Itin C, 1996, MOL BIOL CELL, V7, P483
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557
   Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X
   Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281
   Moussalli M, 1999, J BIOL CHEM, V274, P32539, DOI 10.1074/jbc.274.46.32539
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nufer O, 2002, J CELL SCI, V115, P619
   Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459
   Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001
   SARASTE J, 1991, J CELL SCI, V100, P415
   Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7
   Schiller JH, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055385
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185
   Stephens DJ, 2000, J CELL SCI, V113, P2177
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Urena JM, 1999, J CELL SCI, V112, P773
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   Yerushalmi N, 2001, GENE, V265, P55, DOI 10.1016/S0378-1119(01)00347-X
NR 36
TC 28
Z9 28
U1 0
U2 4
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FL, 90 HIGH HOLBORN, LONDON, WC1V 6LJ, ENGLAND
SN 0067-8694
BN 1-85578-154-9
J9 BIOCHEM SOC SYMP
JI Biochem. Soc. Symp.
PY 2002
VL 69
BP 73
EP 82
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BV88X
UT WOS:000180303400006
PM 12655775
DA 2021-01-25
ER

PT J
AU Bourniquel, AA
   Mollet, B
AF Bourniquel, AA
   Mollet, B
TI Purification and characterization of the 3-phosphoglycerate kinase from
   the thermophile Lactobacillus delbrueckii subsp lactis
SO INTERNATIONAL DAIRY JOURNAL
LA English
DT Article
DE 3-phosphoglycerate kinase; PGK; Glycolysis; Lactobacillus delbrueckii
   subsp lactis; lactic acid bacteria
ID BACTERIUM THERMOTOGA-MARITIMA; PHOSPHOGLYCERATE KINASE; TRIOSEPHOSPHATE
   ISOMERASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE;
   BACILLUS-STEAROTHERMOPHILUS; METHANOTHERMUS-FERVIDUS; INTRACELLULAR PH;
   SEQUENCE; CLONING; GENE
AB The 3-phosphoglycerate kinase (PGK) of the thermophile Lactobacillus delbrueckii subsp. lactis was purified to homogeneity and found to be a monomeric enzyme with a molecular weight of 45 kDa. PGK is a Michaelis-Menten type enzyme with a K-m = 0.7 mM for ATP and a K-m = 2.6 mm for 3-phosphoglycerate. pH tolerance of PGK was found to be oriented towards acidic conditions with an optimum at pH 6.8 and a plateau of 90% of the total activity between pH 6.0 and 7.4. The optimum temperature for PGK activity is 45degreesC, which is consistent with the value expected for a thermophilic bacterium with an optimal growth temperature of 45degreesC. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Nestec Ltd, Nestle Res Ctr, CH-1000 Lausanne, Switzerland.
   Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
RP Mollet, B (corresponding author), Nestec Ltd, Nestle Res Ctr, Vers Chez Les Blanc,CP 44, CH-1000 Lausanne, Switzerland.
CR ADAM H, 1965, METHOD ENZYMAT AN, P539
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P3
   BOURNIQUEL AA, 2002, UNPUB INT DAIRY J
   Branny P, 1998, MICROBIOL-SGM, V144, P905, DOI 10.1099/00221287-144-4-905
   DALESSIO G, 1971, J BIOL CHEM, V246, P4319
   DAVIES GJ, 1991, GENE, V109, P39, DOI 10.1016/0378-1119(91)90586-Z
   DELLEY M, 1990, APPL ENVIRON MICROB, V56, P1967, DOI 10.1128/AEM.56.6.1967-1970.1990
   Early CN, 1998, EUR BIOPHYS J BIOPHY, V27, P409, DOI 10.1007/s002490050148
   FABRY S, 1990, GENE, V91, P19, DOI 10.1016/0378-1119(90)90157-M
   Grattinger M, 1998, J MOL BIOL, V280, P525, DOI 10.1006/jmbi.1998.1861
   HESS D, 1995, EUR J BIOCHEM, V233, P227, DOI 10.1111/j.1432-1033.1995.227_1.x
   KOBAYASHI H, 1986, J BIOL CHEM, V261, P627
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MORI N, 1986, FEBS LETT, V204, P313, DOI 10.1016/0014-5793(86)80835-3
   NANNEN NL, 1991, J DAIRY SCI, V74, P741, DOI 10.3168/jds.S0022-0302(91)78219-2
   PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   Sambrook J, 1989, MOL CLONING LAB MANU
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHLAPFER BS, 1992, GENE, V122, P53, DOI 10.1016/0378-1119(92)90031-J
   SCHURIG H, 1995, EMBO J, V14, P442, DOI 10.1002/j.1460-2075.1995.tb07020.x
   Siegumfeldt H, 2000, APPL ENVIRON MICROB, V66, P2330, DOI 10.1128/AEM.66.6.2330-2335.2000
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
NR 23
TC 2
Z9 5
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0958-6946
J9 INT DAIRY J
JI Int. Dairy J.
PY 2002
VL 12
IS 9
BP 723
EP 728
AR PII S0958-6946(02)00069-9
DI 10.1016/S0958-6946(02)00069-9
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA 602XN
UT WOS:000178529900002
DA 2021-01-25
ER

PT J
AU Bourniquel, AA
   Desiere, F
   Mollet, B
AF Bourniquel, AA
   Desiere, F
   Mollet, B
TI Purification and characterization of the pyruvate kinase of
   lactobacillus delbrueckii subsp lactis
SO INTERNATIONAL DAIRY JOURNAL
LA English
DT Article
DE pyruvate kinase; Lactobacillus delbrueckii subsp lactis; lactic acid
   bacteria; glycolysis; ATP production
ID ESCHERICHIA-COLI; BACILLUS-LICHENIFORMIS; STREPTOCOCCUS-LACTIS;
   MOLECULAR-CLONING; GENES; DNA; PHOSPHOFRUCTOKINASE; PHOSPHORYLATION;
   BULGARICUS; CONSTITUTE
AB Lactic acid bacteria have evolved in a very rich and specific medium, milk, and have in the course of adaptation discarded nonessential metabolic processes. Thus, Lactobacillus delbrueckii subsp. lactis lacking both the citric cycle and the pentose-phosphate pathway relies mainly on glycolysis for ATP production and in particular, the reaction catalyzed by pyruvate kinase (PYK). In this study, we purified and characterized L. delbrueckii lactis PYK and studied its role in metabolic regulation. L. delbrueckii lactis (PYK) is a classical homotetramer and a V-type allosteric enzyme. Positive effectors are fructose 1,6-bisphosphate (K-a = 2.2 mm), as well as fructose 6-phosphate and glucose 6-phosphate, which were found to be 1.3- and 1.6-fold more efficient activators than fructose 1,6-bisphosphate, respectively. L. delbrueckii lactis PYK is inhibited by inorganic phosphate, high concentrations of phosphoenolpyruvate and ATP (EC50 = 0. 75 mm). An ATP-binding motif identified on the 134-amino acid C-terminal extension of the enzyme might be involved in ATP regulation of L. delbrueckii lactis PYK. This extension also encodes a protein domain with homologies to the enzyme I of the Escherichia coli sugar-PTS system suggesting that the PYK might be involved in L. delbrueckii lactis sugar transport metabolism. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
RP Mollet, B (corresponding author), Nestec Ltd, Nestle Res Ctr, Vers Chez Les Blanc,POB 44, CH-1000 Lausanne 26, Switzerland.
CR ABBE K, 1982, J BACTERIOL, V149, P299, DOI 10.1128/JB.149.1.299-305.1982
   AINSWORTH S, 1973, BIOCHEM J, V13, P223
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P3
   AXEL RC, 1993, HIGH INST S, V2, P1
   Branny P, 1996, J BACTERIOL, V178, P4727, DOI 10.1128/jb.178.15.4727-4730.1996
   CARDENAS JM, 1982, METHOD ENZYMOL, P140
   COLLINS LB, 1974, J BACTERIOL, V120, P52, DOI 10.1128/JB.120.1.52-58.1974
   DELLEY M, 1990, APPL ENVIRON MICROB, V56, P1967, DOI 10.1128/AEM.56.6.1967-1970.1990
   DIESTERHAFT M, 1972, BIOCHIM BIOPHYS ACTA, V268, P373, DOI 10.1016/0005-2744(72)90332-4
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   HALL ER, 1978, INT J BIOCHEM, V9, P785, DOI 10.1016/0020-711X(78)90027-7
   KONINGS WN, 1989, CRC CR REV MICROBIOL, V16, P419, DOI 10.3109/10408418909104474
   LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033
   LEBRAS G, 1993, BIOCHIMIE, V75, P797, DOI 10.1016/0300-9084(93)90130-K
   MACFARLANE N, 1972, BIOCHEM J, V129, P1035, DOI 10.1042/bj1291035
   MALONEY PC, 1974, P NATL ACAD SCI USA, V71, P3896, DOI 10.1073/pnas.71.10.3896
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   MUIRHEAD H, 1986, EMBO J, V5, P475, DOI 10.1002/j.1460-2075.1986.tb04236.x
   RIOU JP, 1978, J BIOL CHEM, V253, P656
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SAKAI H, 1993, EUR J BIOCHEM, V211, P851, DOI 10.1111/j.1432-1033.1993.tb17618.x
   Sambrook J, 1989, MOL CLONING LAB MANU
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   TANAKA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1536, DOI 10.1271/bbb.59.1536
   THOMPSON J, 1979, J BACTERIOL, V140, P774, DOI 10.1128/JB.140.3.774-785.1979
   THOMPSON J, 1987, FEMS MICROBIOLOGY RE, V46, P2210
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   TUOMINEN FW, 1971, J BIOL CHEM, V246, P1746
   WAYGOOD EB, 1974, J BIOL CHEM, V249, P265
NR 29
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0958-6946
J9 INT DAIRY J
JI Int. Dairy J.
PY 2002
VL 12
IS 10
BP 821
EP 829
AR PII S0958-6946(02)00079-1
DI 10.1016/S0958-6946(02)00079-1
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA 603QL
UT WOS:000178571100004
DA 2021-01-25
ER

PT J
AU Walter, N
   Gehring, WJ
AF Walter, N
   Gehring, WJ
TI From transdetermination to the homeodomain at atomic resolution
SO INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
LA English
DT Editorial Material
ID EYELESS GENE; DROSOPHILA; ANTENNAPEDIA; EXPRESSION; COMPLEX
C1 SonntagsZeitung, Zurich, Switzerland.
RP Walter, N (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Walter, Nils/P-3163-2019
OI Walter, Nils/0000-0002-7301-1275
CR BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23
   BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   CARRASCO AE, 1984, CELL, V37, P409, DOI 10.1016/0092-8674(84)90371-4
   Desplan C, 1999, SCIENCE, V283, P799, DOI 10.1126/science.283.5403.799
   GARBER RL, 1983, EMBO J, V2, P2027, DOI 10.1002/j.1460-2075.1983.tb01696.x
   Gehring W, 1999, NATURE, V399, P521, DOI 10.1038/21057
   Gehring W.J., 1966, ARCH JULIUS KALAUSST, V41, P44
   GEHRING WJ, 1999, MASTER CONTROL GENES
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0
   McGinnis W, 1999, NATURE, V398, P301, DOI 10.1038/18595
   OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   SHEPHERD JCW, 1989, P NATL ACAD SCI USA, V86, P7520, DOI 10.1073/pnas.86.19.7520
NR 15
TC 2
Z9 2
U1 0
U2 0
PU U B C PRESS
PI BILBAO
PA UNIV BASQUE COUNTRY, EDITORIAL SERVICES, PO BOX 1397, E-48080 BILBAO,
   SPAIN
SN 0214-6282
J9 INT J DEV BIOL
JI Int. J. Dev. Biol.
PY 2002
VL 46
IS 1
SI SI
BP 29
EP 37
PG 9
WC Developmental Biology
SC Developmental Biology
GA 529UB
UT WOS:000174316800005
PM 11902685
DA 2021-01-25
ER

PT J
AU Burglin, TR
   Cassata, G
AF Burglin, TR
   Cassata, G
TI Loss and gain of domains during evolution of cut superclass homeobox
   genes
SO INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE homeobox gene; cut; ONECUT; CUX; evolution
ID HEPATOCYTE NUCLEAR FACTOR-6; CAENORHABDITIS-ELEGANS; ONECUT CLASS;
   PROTEIN; HOMEODOMAIN; HOMEOPROTEIN; SPECIFICITY; CONTAINS; TARGET;
   REPEAT
AB The cut superclass of homeobox genes has been divided into three classes: CUX, ONECUT and SATB. Given the various completed genomes, we have now made a comprehensive survey. We find that there are only two cut domain containing genes in Drosophila, one CUX and one ONECUT type. Caenorhabditis elegans has undergone an expansion of the ONECUT subclass genes and has a gene cluster with three ONECUT class genes, one of which has lost the cut domain. Two of these genes contain a conserved sequence motif, termed OCAM, which also occurs in another gene in C. elegans, this motif seems to be nematode specific. A recently uncovered C. elegans CUX gene has sequence conservation in its amino-terminus with vertebrate CUX proteins. Further, the 5' end of this gene containing the conserved region can undergo alternative splicing to give rise to a protein with a different carboxy-terminus lacking the cut- and homeodomain. This protein is conserved in its entirety with vertebrate genes termed CASP - which are also alternative splice products of the CUX genes - and with plant and fungal genes. The highly divergent SATB genes share a conserved amino terminal domain, COMPASS, with the Drosophila defective proventriculus gene and a C. elegans ORF. These two "COMPASS" family genes encode two highly divergent homeodomains, may be homologues of the SATB genes and thus probably belong to the cut superclass, too.
C1 Univ Basel, Biozentrum, Div Cell Biol, Basel, Switzerland.
RP Burglin, TR (corresponding author), Sodertorns Hogskola, Box 4101, SE-14104 Huddinge, Sweden.
EM thomas.burglin@biosci.ki.se
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   ANDRES V, 1992, DEVELOPMENT, V116, P321
   BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322
   Burglin Thomas R., 1994, P25
   Burglin TR, 1998, BIOINFORMATICS, V14, P751, DOI 10.1093/oxfordjournals.bioinformatics.a011055
   Burglin TR, 1998, DEV GENES EVOL, V208, P113, DOI 10.1007/s004270050161
   BURGLIN TR, 1995, BIODIVERSITY EVOLUTI, P291
   C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1089/dna.1997.16.663
   Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4
   Duboule D., 1994, GUIDEBOOK HOMEOBOX G
   Fuss B, 1998, MECH DEVELOP, V79, P83
   HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129
   Jacquemin P, 1999, J BIOL CHEM, V274, P2665, DOI 10.1074/jbc.274.5.2665
   Lannoy VJ, 1998, J BIOL CHEM, V273, P13552, DOI 10.1074/jbc.273.22.13552
   Lemaigre FP, 1996, P NATL ACAD SCI USA, V93, P9460, DOI 10.1073/pnas.93.18.9460
   Lievens PMJ, 1997, GENE, V197, P73
   NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852
   Nakagoshi H, 1998, GENE DEV, V12, P2724, DOI 10.1101/gad.12.17.2724
   NEUFELD EJ, 1992, NAT GENET, V1, P50, DOI 10.1038/ng0492-50
   QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8
   Rost B, 1996, METHOD ENZYMOL, V266, P525
   RUDDLE FH, 1994, ANNU REV GENET, V28, P423, DOI 10.1146/annurev.ge.28.120194.002231
   Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Tufarelli C, 1998, DEV BIOL, V200, P69, DOI 10.1006/dbio.1998.8950
   XU WG, 1995, CELL, V80, P639, DOI 10.1016/0092-8674(95)90518-9
NR 29
TC 41
Z9 51
U1 0
U2 5
PU UNIV BASQUE COUNTRY UPV-EHU PRESS
PI BILBAO
PA PO BOX 1397, BILBAO, BIZKAIA E-48080, SPAIN
SN 0214-6282
EI 1696-3547
J9 INT J DEV BIOL
JI Int. J. Dev. Biol.
PY 2002
VL 46
IS 1
SI SI
BP 115
EP 123
PG 9
WC Developmental Biology
SC Developmental Biology
GA 529UB
UT WOS:000174316800014
PM 11902672
DA 2021-01-25
ER

PT S
AU Engel, A
   Stahlberg, H
AF Engel, A
   Stahlberg, H
BE Zeuthen, T
   Stein, WD
TI Aquaglyceroporins: Channel proteins with a conserved core, multiple
   functions, and variable surfaces
SO INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 215:
   MOLECULAR MECHANISMS OF WATER TRANSPORT ACROSS BIOLOGICAL MEMBRANES
SE INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY
LA English
DT Review
DE AQP0; AQP1; AqpZ; GlpF; 2D-crystallization; atomic force microscopy;
   electron crystallography; sequence homology of aquaglyceroporins
ID MAJOR INTRINSIC PROTEIN; KIDNEY COLLECTING DUCT; MEMBRANE WATER CHANNEL;
   CELL CHIP28 PROTEIN; ESCHERICHIA-COLI; XENOPUS-OOCYTES; ELECTRON
   CRYSTALLOGRAPHY; MOLECULAR-CLONING; GLYCEROL CHANNEL; AQUAPORIN CHIP
C1 Univ Basel, Biozentrum, ME Muller Inst Microscop Struct Biol, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscop Struct Biol, CH-4056 Basel, Switzerland.
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
FU NATIONAL EYE INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [R01EY011239, R01EY011239, R01EY011239, R01EY011239,
   R01EY011239, R01EY011239, R01EY011239, R01EY011239, R01EY011239] Funding
   Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)
   [R01HL033991, R01HL033991, R01HL033991, R01HL048268, R01HL048268,
   R01HL033991, R01HL048268, R01HL033991, R01HL033991, R01HL033991,
   R01HL048268, R01HL048268, R01HL048268, R01HL033991, R01HL033991,
   R37HL048268, R01HL048268, R01HL033991, R37HL048268, R01HL033991,
   R01HL033991, R37HL048268, R01HL033991, R37HL048268, R37HL048268,
   R01HL033991, R37HL048268, R37HL048268, R37HL048268, R01HL033991,
   R01HL048268, R37HL048268, R01HL048268, R37HL048268, R37HL048268,
   R01HL033991, R01HL048268, R01HL048268, R01HL033991, R01HL033991] Funding
   Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [EY11239] Funding Source: Medline; NHLBI NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)
   [HL33991, HL48268] Funding Source: Medline
CR Agre P, 1997, SCIENCE, V275, P1490, DOI 10.1126/science.275.5305.1490
   Agre P, 2000, J AM SOC NEPHROL, V11, P764
   Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098
   Braun T, 2000, EMBO REP, V1, P183, DOI 10.1093/embo-reports/kvd022
   CALAMITA G, 1995, J BIOL CHEM, V270, P29063, DOI 10.1074/jbc.270.49.29063
   Chandy G, 1997, J MEMBRANE BIOL, V159, P29, DOI 10.1007/s002329900266
   Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517
   CHRISPEELS MJ, 1994, TRENDS BIOCHEM SCI, V19, P421, DOI 10.1016/0968-0004(94)90091-4
   Daniels MJ, 1999, J MOL BIOL, V294, P1337, DOI 10.1006/jmbi.1999.3293
   de Groot BL, 2000, J MOL BIOL, V300, P987, DOI 10.1006/jmbi.2000.3913
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Echevarria M, 1996, J BIOL CHEM, V271, P25079, DOI 10.1074/jbc.271.41.25079
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Finkelstein A., 1987, WATER MOVEMENT LIPID
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0
   Gerbeau P, 1999, PLANT J, V18, P577, DOI 10.1046/j.1365-313x.1999.00481.x
   GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9
   GUTIERREZ AM, 1995, J MEMBRANE BIOL, V143, P189
   Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796
   HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   Hille B, 1992, IONIC CHANNELS EXCIT
   Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782
   Ishibashi K, 1997, BIOCHEM BIOPH RES CO, V237, P714, DOI 10.1006/bbrc.1997.7219
   Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252
   ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269
   JAP BK, 1995, J MOL BIOL, V251, P413, DOI 10.1006/jmbi.1995.0444
   Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   Kuriyama H, 1997, BIOCHEM BIOPH RES CO, V241, P53, DOI 10.1006/bbrc.1997.7769
   KUSHMERICK C, 1995, EXP EYE RES, V61, P351, DOI 10.1016/S0014-4835(05)80129-0
   Kushmerick C, 1998, J MEMBRANE BIOL, V161, P9, DOI 10.1007/s002329900310
   Lagree V, 1998, J BIOL CHEM, V273, P33949, DOI 10.1074/jbc.273.51.33949
   Lagree V, 1999, J BIOL CHEM, V274, P6817, DOI 10.1074/jbc.274.11.6817
   Laize V, 1999, BIOCHEM BIOPH RES CO, V257, P139, DOI 10.1006/bbrc.1999.0425
   LeCaherec F, 1996, J CELL SCI, V109, P1285
   LeCaherec F, 1996, EUR J BIOCHEM, V241, P707, DOI 10.1111/j.1432-1033.1996.00707.x
   Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263
   Loo DDF, 1996, P NATL ACAD SCI USA, V93, P13367, DOI 10.1073/pnas.93.23.13367
   LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x
   MA TH, 1994, J BIOL CHEM, V269, P21845
   Marples D, 1999, AM J PHYSIOL-RENAL, V276, pF331
   Mathai JC, 1996, J BIOL CHEM, V271, P1309, DOI 10.1074/jbc.271.3.1309
   MAUREL C, 1995, EMBO J, V14, P3028, DOI 10.1002/j.1460-2075.1995.tb07305.x
   MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x
   MAUREL C, 1994, J BIOL CHEM, V269, P11869
   Meinild AK, 1998, J BIOL CHEM, V273, P32446, DOI 10.1074/jbc.273.49.32446
   MITRA AK, 1995, NAT STRUCT BIOL, V2, P726, DOI 10.1038/nsb0995-726
   Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177
   Modesto E, 1996, J MEMBRANE BIOL, V154, P239, DOI 10.1007/s002329900148
   MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777
   NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013
   Nollert P, 2001, FEBS LETT, V504, P112, DOI 10.1016/S0014-5793(01)02710-7
   Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120
   Pomes R, 1996, BIOPHYS J, V71, P19, DOI 10.1016/S0006-3495(96)79211-1
   PRESTIDGE BR, 1994, INT J RADIAT ONCOL, V28, P17, DOI 10.1016/0360-3016(94)90136-8
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110
   Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949
   Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031
   Rivers RL, 1997, J BIOL CHEM, V272, P16256, DOI 10.1074/jbc.272.26.16256
   Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489
   SAPAROV SM, 2001, J BIOL CHEM, V15, P15
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   SCHIEPEK G, 1995, PSYCHOTHERAPIE FORUM, V3, P1
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   Stahlberg H, 2000, J STRUCT BIOL, V132, P133, DOI 10.1006/jsbi.2000.4317
   Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685
   VANHOEK AN, 1995, BIOCHEMISTRY-US, V34, P2212, DOI 10.1021/bi00007a015
   VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   WALZ T, 1995, NAT STRUCT BIOL, V2, P730, DOI 10.1038/nsb0995-730
   Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512
   Walz T, 1996, J MOL BIOL, V264, P907, DOI 10.1006/jmbi.1996.0686
   Werten PJL, 2001, FEBS LETT, V504, P200, DOI 10.1016/S0014-5793(01)02703-X
   WHITE WB, 1997, P 12 INT C SPEL CHAU, V1, P89
   Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r
   Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140
   Yasui M, 1999, NATURE, V402, P184
   Yasui M, 1999, P NATL ACAD SCI USA, V96, P5808, DOI 10.1073/pnas.96.10.5808
   Yool AJ, 1996, SCIENCE, V273, P1216, DOI 10.1126/science.273.5279.1216
   ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042
   ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002
   Zeuthen T, 1999, J BIOL CHEM, V274, P21631, DOI 10.1074/jbc.274.31.21631
   ZHANG RB, 1993, BIOCHEMISTRY-US, V32, P2938, DOI 10.1021/bi00063a002
NR 96
TC 59
Z9 59
U1 1
U2 8
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0074-7696
BN 0-12-364619-7
J9 INT REV CYTOL
JI Int.Rev.Cytol.
PY 2002
VL 215
BP 75
EP 104
PG 30
WC Cell Biology
SC Cell Biology
GA BU26E
UT WOS:000175518600004
PM 11952238
DA 2021-01-25
ER

PT J
AU Markovic-Housley, Z
   Degano, M
   Lamba, D
   Susani, M
   Ferreira, F
   Scheiner, O
   Breiteneder, H
AF Markovic-Housley, Z
   Degano, M
   Lamba, D
   Susani, M
   Ferreira, F
   Scheiner, O
   Breiteneder, H
TI Crystal structure of a hypoallergenic isoform of the major birch pollen
   allergen Bet v 1 and its biological function
SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
LA English
DT Meeting Abstract
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Synchrotron Tieste, Trieste, Italy.
   CNR, Trieste, Italy.
   Adv Biol Syst, Vienna, Austria.
   Salzburg Univ, A-5020 Salzburg, Austria.
   Univ Vienna, Vienna, Austria.
RI Degano, Massimo/K-4669-2018; Lamba, Doriano/L-9808-2018; Lamba,
   Doriano/B-2961-2011
OI Degano, Massimo/0000-0002-0787-1883; Lamba, Doriano/0000-0001-6859-7868;
   Lamba, Doriano/0000-0001-6859-7868
NR 0
TC 2
Z9 3
U1 0
U2 3
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0091-6749
J9 J ALLERGY CLIN IMMUN
JI J. Allergy Clin. Immunol.
PD JAN
PY 2002
VL 109
IS 1
SU S
MA 483
BP S164
EP S164
DI 10.1016/S0091-6749(02)81619-0
PG 1
WC Allergy; Immunology
SC Allergy; Immunology
GA 519UX
UT WOS:000173744800482
DA 2021-01-25
ER

PT J
AU Ozbek, S
   Engel, U
   Engel, J
AF Ozbek, S
   Engel, U
   Engel, J
TI A switch in disulfide linkage during minicollagen assembly in hydra
   nematocysts or how to assemble a 150-bar-resistant structure
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop on Coiled-Coils, Collagen, and Co-Proteins
CY SEP 16-21, 2001
CL ALPBACH, AUSTRIA
ID COLLAGEN TYPE-IV; DOMAIN; PROTEIN; CLEAVAGE; BONDS
AB Hydra minicollagen, the shortest collagen known, is an important component of the nematocyst wall, which has a very high tensile strength. It has an unusual structure, with small and closely related Cys-rich domains at both ends of its chains. Three chains are trimerized by a central collagenous domain. Polyhydroxyproline helices connect the Cys-rich domains with the collagenous domain. The minicollagen precursor contains three internal disulfide bridges in each Cys-rich domain and no disulfide bridges between chains of the same trimeric molecule or between different molecules. Biochemical and structural evidence as well as confocal immunofluorescence microscopy points to disulfide-mediated assembly during maturation of nematocysts. (C) 2002 Elsevier Science (USA).
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany.
RP Ozbek, S (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Engel, Ulrike/E-5456-2014; Ozbek, Suat/D-3701-2014; Engel,
   Ulrike/AAO-7719-2020
OI Engel, Ulrike/0000-0002-6953-6845; Ozbek, Suat/0000-0003-2569-3942
CR Engel J, 1997, SCIENCE, V277, P1785, DOI 10.1126/science.277.5333.1785
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   FESSLER LI, 1993, DEVELOPMENT, V117, P1061
   GAILL F, 1991, J MOL BIOL, V221, P209, DOI 10.1016/0022-2836(91)80215-G
   HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186
   Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770
   Koch AW, 1998, J CELL SCI, V111, P1545
   KRAMER JM, 1994, FASEB J, V8, P329
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941
   Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404
   Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8
   SIEBOLD B, 1988, EUR J BIOCHEM, V176, P617, DOI 10.1111/j.1432-1033.1988.tb14321.x
   WANG WQ, 1995, GENE, V152, P195, DOI 10.1016/0378-1119(95)00644-L
   WEBER S, 1984, EUR J BIOCHEM, V139, P401, DOI 10.1111/j.1432-1033.1984.tb08019.x
   WEBER S, 1988, EUR J BIOCHEM, V175, P229, DOI 10.1111/j.1432-1033.1988.tb14188.x
NR 16
TC 16
Z9 16
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN-FEB
PY 2002
VL 137
IS 1-2
BP 11
EP 14
DI 10.1006/jsbi.2002.4436
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 566XL
UT WOS:000176453500003
PM 12064928
DA 2021-01-25
ER

PT J
AU Strelkov, SV
   Burkhard, P
AF Strelkov, SV
   Burkhard, P
TI Analysis of alpha-helical coiled coils with the program TWISTER reveals
   a structural mechanism for stutter compensation
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop on Coiled-Coils, Collagen, and Co-Proteins
CY SEP 16-21, 2001
CL ALPBACH, AUSTRIA
DE coiled coil; computer program; Crick parameters; heptad repeat; protein
   conformation; skips; stutters
ID CRYSTAL-STRUCTURE; PROTEIN; HEMAGGLUTININ; ZIPPER
AB alpha-Helical coiled coils represent a widespread protein structure motif distinguished by a seven-residue periodicity of apolar residues in the primary sequence. A characteristic "knobs-into-holes" packing of these residues into a hydrophobic core results in a superhelical, usually left-handed, rope of two or more alpha-helices. Such a geometry can be parameterized. For this purpose, a new computer program, TWISTER, was developed. With the three-dimensional coordinates as input, TWISTER uses an original algorithm to determine the local coiled-coil parameters as a function of residue number. In addition, heptad positions are assigned based on structural criteria. It is known that frequently encountered discontinuities in the heptad repeat, such as stutters and skips, can be tolerated within a continuous coiled coil but result in a local distortion of its geometry. This was explored in detail with the help of TWISTER for several two- and three-stranded coiled coils. Depending on the particular protein, stutters were found to be compensated locally by an unwinding of the superhelix, alpha-helical unwinding, or both. In the first case, there is often a local switch from a left-handed to a right-handed superhelix. In general, the geometrical distortion is confined to about two a-helical turns at either side of the stutter. Furthermore, stutters result in a local increase of the coiled-coil radius. (C) 2002 Elsevier Science (USA).
C1 Univ Basel, Biozentrum, Maurice E Muller Struct Biol, CH-4056 Basel, Switzerland.
RP Strelkov, SV (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sergei-v.strelkov@unibas.ch
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
CR Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Brown JH, 1996, PROTEINS, V26, P134
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   CRICK FHC, 1952, NATURE, V170, P882, DOI 10.1038/170882b0
   HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0
   Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962
   Lupas A, 1997, CURR OPIN STRUC BIOL, V7, P388, DOI 10.1016/S0959-440X(97)80056-5
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   SEO J, 1993, PROTEINS, V15, P223, DOI 10.1002/prot.340150302
   Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545
   WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0
NR 21
TC 197
Z9 199
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN-FEB
PY 2002
VL 137
IS 1-2
BP 54
EP 64
DI 10.1006/jsbi.2002.4454
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 566XL
UT WOS:000176453500008
PM 12064933
DA 2021-01-25
ER

PT J
AU Meier, M
   Lustig, A
   Aebi, U
   Burkhard, P
AF Meier, M
   Lustig, A
   Aebi, U
   Burkhard, P
TI Removing an interhelical salt bridge abolishes coiled-coil formation in
   a de novo designed peptide
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop on Coiled-Coils, Collagen, and Co-Proteins
CY SEP 16-21, 2001
CL ALPBACH, AUSTRIA
DE coiled coil; protein de novo design; ionic interactions; protein
   folding; protein oligomerization
ID CORTEXILLIN-I; DIMERIZATION; SPECIFICITY; STABILITY; DOMAIN; SITE
AB alpha-Helical coiled coils represent a common protein oligomerization motif that are mainly stabilized by hydrophobic interactions occurring along their coiled-coil interface, the so-called hydrophobic seam. We have recently de novo designed and optimized a series of two-heptad repeat long coiled-coil peptides which are further stabilized by a complex network of inter- and intrahelical salt bridges. Here we have extended the de novo design of such two heptad-repeat long peptides by removing the central and most important g-e' Arg to Glu (g-e'RE) ionic interhelical interaction and replacing these residues by alanine residues. The effect of the missing interhelical ionic interaction on coiled-coil formation and stability has been analyzed by CD spectroscopy, analytical ultracentrifugation, and X-ray crystallography. We show that the peptide, while being highly a-helical, is no longer able to form a parallel coiled-coil structure but rather assumes an octameric globular helical assembly devoid of any coiled-coil interactions. (C) 2002 Elsevier Science (USA).
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Phys Chem, CH-4056 Basel, Switzerland.
RP Burkhard, P (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM peter.burkhard@unibas.ch
RI Meier, Markus/F-2798-2011
OI Meier, Markus/0000-0003-1068-746X
CR Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   *CPP4, 1994, ACTA CRYSTALLOGR D, V50, P760
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   DELAFORTELLE E, 1997, METHODS ENZYMOLOG A, P277
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419
   Kohn WD, 1998, J MOL BIOL, V283, P993, DOI 10.1006/jmbi.1998.2125
   Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762
   Lavigne P, 1996, SCIENCE, V271, P1136, DOI 10.1126/science.271.5252.1136
   Lumb KJ, 1996, SCIENCE, V271, P1137, DOI 10.1126/science.271.5252.1137
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   McPherson A., 1982, PREPARATION ANAL PRO
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883
NR 18
TC 36
Z9 36
U1 1
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN-FEB
PY 2002
VL 137
IS 1-2
BP 65
EP 72
DI 10.1006/jsbi.2002.4467
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 566XL
UT WOS:000176453500009
PM 12064934
DA 2021-01-25
ER

PT J
AU Herrmann, H
   Wedig, T
   Porter, RM
   Lane, EB
   Aebi, U
AF Herrmann, H
   Wedig, T
   Porter, RM
   Lane, EB
   Aebi, U
TI Characterization of early assembly intermediates of recombinant human
   keratins
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop on Coiled-Coils, Collagen, and Co-Proteins
CY SEP 16-21, 2001
CL ALPBACH, AUSTRIA
DE assembly; intermediate filaments; keratins; electron microscopy;
   epidermolysis bullosa simplex (EBS)
ID FILAMENT-ASSOCIATED PROTEIN; CONSENSUS SEQUENCE MOTIF; IN-VITRO;
   COILED-COIL; ROD DOMAIN; POINT MUTATIONS; VIMENTIN; HEAD; EXPRESSION;
   DIMER
AB The intermediate filaments (IFs) form major structural elements of the cytoskeleton. In vitro analyses of these fibrous proteins reveal very different assembly properties for the nuclear and cytoplasmic IF proteins. However, keratins in particular; the largest and most heterogenous group of cytoplasmic IF proteins, have been difficult to analyze due to their rapid assembly dynamics under the near-physiological conditions used for other IF proteins. We show here that keratins, like other cytoplasmic IF proteins, go through a stage of assembling into full-width soluble complexes, i.e., "unit-length filaments" (ULFs). In contrast to other IF proteins, however, longitudinal annealing of keratin ULFs into long filaments quasi-coincides with their formation. In vitro assembly of IF proteins into filaments can be initiated by an increase of the ionic strength and/or lowering of the pH of the assembly buffer. We now document that 23-mer peptides from the head domains of various IF proteins can induce filament formation even under conditions of low salt and high pH. This suggests that the "heads" are involved in the formation and longitudinal association of the ULFs. Using a Tris-buffering protocol that causes formation of soluble oligomers at pH 9, the epidermal keratins K5/14 form less regular filaments and less efficiently than the simple epithelial keratins KS/18. In sodium phosphate buffers (pH 7.5), however, K5/14 were able to form long partially unraveled filaments which compacted into extended, regular filaments upon addition of 20 mM KCl. Applying the same assembly regimen to mutant K14 R125H demonstrated that mutations causing a severe disease phenotype and morphological filament abnormalities can form long; regular filaments with surprising efficiency an vitro. (C) 2002 Elsevier Science (USA).
C1 German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
   Univ Dundee, Sch Life Sci, Canc Res Campaign, Cell Struct Res Grp, Dundee DD1 5EH, Scotland.
   Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
RP Herrmann, H (corresponding author), German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
EM h.herrmann@dkfz.de
OI Porter, Rebecca/0000-0001-6748-0916
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293
   Clubb BH, 2000, BIOCHEM BIOPH RES CO, V273, P183, DOI 10.1006/bbrc.2000.2916
   CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3
   COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153
   COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y
   EICHNER R, 1985, ANN NY ACAD SCI, V455, P381, DOI 10.1111/j.1749-6632.1985.tb50424.x
   FRANKE WW, 1982, BIOL CELL, V46, P257
   Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   GEISLER N, 1993, J STRUCT BIOL, V110, P205, DOI 10.1006/jsbi.1993.1023
   Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995
   Grosberg AY, 1997, GIANT MOL
   HATZFELD M, 1994, J CELL SCI, V107, P1959
   HATZFELD M, 1992, J CELL BIOL, V116, P157, DOI 10.1083/jcb.116.1.157
   HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199
   HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517
   HENDERSON D, 1982, J MOL BIOL, V155, P173, DOI 10.1016/0022-2836(82)90444-2
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   HERRMANN H, 1993, J MOL BIOL, V234, P99, DOI 10.1006/jmbi.1993.1566
   Herrmann H, 1998, Subcell Biochem, V31, P319
   Hesse M, 2001, J CELL SCI, V114, P2569
   Hofmann I, 1997, EUR J CELL BIOL, V72, P122
   HOFMANN I, 1992, J CELL SCI, V101, P687
   Hofmann I, 2000, J CELL SCI, V113, P2471
   IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5
   Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x
   Karabinos A, 2000, EUR J CELL BIOL, V79, P17, DOI 10.1078/S0171-9335(04)70003-5
   KOUKLIS PD, 1992, J CELL SCI, V102, P31
   LANE EB, 1994, CURR OPIN GENET DEV, V4, P412, DOI 10.1016/0959-437X(94)90030-2
   LERSCH R, 1989, MOL CELL BIOL, V9, P3685, DOI 10.1128/MCB.9.9.3685
   LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197
   Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576
   MACK JW, 1993, J MOL BIOL, V232, P50, DOI 10.1006/jmbi.1993.1369
   MARCHUK D, 1985, P NATL ACAD SCI USA, V82, P1609, DOI 10.1073/pnas.82.6.1609
   Mehrani T, 2001, J BIOL CHEM, V276, P2088, DOI 10.1074/jbc.M007260200
   MEUCKE N, 2001, MOL BIOL CELL, V12, pA300
   MONTEIRO MJ, 1994, J CELL BIOL, V127, P1327, DOI 10.1083/jcb.127.5.1327
   MORLEY SN, 1995, J CELL SCI, V108, P3463
   Parry DAD, 2001, J BIOL CHEM, V276, P39253, DOI 10.1074/jbc.M104604200
   PARRY DAD, 1995, INTERMEDIATE FILAMEN, P1
   Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069
   SCHIWA M, 1986, CYTOSKELETON CELL BI, V13
   STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2
   STEINERT PM, 1991, J STRUCT BIOL, V107, P175, DOI 10.1016/1047-8477(91)90020-W
   STEINERT PM, 1990, J BIOL CHEM, V265, P8766
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881
   STEVEN AC, 1985, ANN NY ACAD SCI, V455, P371, DOI 10.1111/j.1749-6632.1985.tb50423.x
   STEVEN AC, 1982, P NATL ACAD SCI-BIOL, V79, P3101, DOI 10.1073/pnas.79.10.3101
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Wang J, 2000, EUR J CELL BIOL, V79, P478, DOI 10.1078/0171-9335-00069
   Wiche G, 1998, J CELL SCI, V111, P2477
   Winter H, 1997, J BIOL CHEM, V272, P32345, DOI 10.1074/jbc.272.51.32345
   Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200
NR 62
TC 88
Z9 89
U1 1
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN-FEB
PY 2002
VL 137
IS 1-2
BP 82
EP 96
DI 10.1006/jsbi.2002.4466
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 566XL
UT WOS:000176453500011
PM 12064936
DA 2021-01-25
ER

PT J
AU Smith, TA
   Strelkov, SV
   Burkhard, P
   Aebi, U
   Parry, DAD
AF Smith, TA
   Strelkov, SV
   Burkhard, P
   Aebi, U
   Parry, DAD
TI Sequence comparisons of intermediate filament chains: Evidence of a
   unique functional/structural role for coiled-coil segment 1A and linker
   L1
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT Workshop on Coiled-Coils, Collagen, and Co-Proteins
CY SEP 16-21, 2001
CL ALPBACH, AUSTRIA
DE alpha-helical stability; capping residues; coiled-coil segment; flexible
   hinge; intermediate filament sequences; linkers; swinging heads
ID INTRAHELICAL SALT BRIDGES; GCN4 LEUCINE-ZIPPER; AMINO-ACIDS; ROD DOMAIN;
   ATOMIC-STRUCTURE; ALPHA-HELIX; PROTEINS; PEPTIDES; STABILIZATION;
   DYNAMICS
AB A comprehensive analysis of the sequences of all types of intermediate filament chains has been undertaken with a particular emphasis on those of segment 1A and linker L1. This has been done to assess whether structural characteristics can be recognized in the sequences that would be consistent with the role of each region in the recently proposed "swinging head" hypothesis. The analyses show that linker L1 is the most flexible rod domain region, that it is the most elongated structure (on a per residue basis), and that it is the most variable region as regards sequence and length. Segment 1A has one of the two most highly conserved regions of sequence in the rod domain (the other being at the end of segment 2B), with seven particular residues conserved across all chain types: It also contains one of the very few potential interchain ionic interactions that could be conserved across all chain types. However, the aggregation of chains in segment 1A is specified less precisely overall by interchain ionic interactions than are the other coiled-coil segments. The apolar residue contents in positions a and d of the heptad substructure are the highest of any coiled-coil segment in the intermediate filament family. Segment 1A also displays an amino acid composition atypical of not only coiled-coil segments 1B and 2B, but indeed of two-stranded coiled coils in general. Nonetheless, molecular modeling based on the crystal structure of the monomeric 1A fragment from human vimentin shows that coiled-coil formation is plausible. The most extensive regions of apolar/aromatic residues lie at the C-terminal end of segment 2B in the helix termination motif and in segment 1A in and close to the helix initiation motif. The predicted stability of the individual a-helices in segment 1A is greater than in those comprising segments 1B and 2B, though potential intrachain ionic interactions are either lacking or are minimal in number. Analysis of the 1A sequence and those regions immediately N- and C-terminal to it has shown that the capping residues are near optimal close to the previously predicted ends, thus adding to the likely stability of the a-helical structure. However, a second terminating sequence is predicted in 1A (about 10 residues back from the C-terminus). This allows the possibility of some unwinding of the alpha-helical structure of 1A immediately adjacent to linker L1 when the head domains no longer stabilize the coiled-coil structure. All of these data are consistent with the concept of a flexible hinge at L1 and with the ability of the two a-helical coiled-coil strands to separate under appropriate conditions and partly unwind at their C-terminal ends to allow the head domains a greater degree of mobility, thus facilitating function. (C) 2002 Elsevier Science (USA).
C1 Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.
   Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
RP Parry, DAD (corresponding author), Massey Univ, Inst Fundamental Sci, Private Bag 11-222, Palmerston North, New Zealand.
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
CR BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843
   CONWAY JF, 1989, BIOL WOOL HAIR, P127
   CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P106
   CREWTHER WG, 1983, INT J BIOL MACROMOL, V5, P267, DOI 10.1016/0141-8130(83)90040-5
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   GEISLER N, 1993, J STRUCT BIOL, V110, P205, DOI 10.1006/jsbi.1993.1023
   GILL SR, 1990, J CELL BIOL, V111, P2005, DOI 10.1083/jcb.111.5.2005
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 1998, Subcell Biochem, V31, P319
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   HUBER R, 1979, NATURE, V280, P538, DOI 10.1038/280538a0
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   MANAVALAN P, 1978, NATURE, V275, P673, DOI 10.1038/275673a0
   MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898
   Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507
   ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Palliser CC, 2001, PROTEINS, V42, P243, DOI 10.1002/1097-0134(20010201)42:2<243::AID-PROT120>3.0.CO;2-B
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Parry DAD, 2002, J STRUCT BIOL, V137, P97, DOI 10.1006/jsbi.2002.4437
   PARRY DAD, 1995, INTERMEDIATE FILAMEN, P1
   PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824
   RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086
   STEINERT PM, 1993, BIOCHEMISTRY-US, V32, P10046, DOI 10.1021/bi00089a021
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Steinert PM, 1999, J BIOL CHEM, V274, P1657, DOI 10.1074/jbc.274.3.1657
   STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161
   Strelkov SV, 1998, ACTA CRYSTALLOGR D, V54, P805, DOI 10.1107/S0907444997018878
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   STRELKOV SV, 2002, IN PRESS J STRUCT BI
   SUNDARALINGAM M, 1985, P NATL ACAD SCI USA, V82, P7944, DOI 10.1073/pnas.82.23.7944
   Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545
   Wang H, 2000, J CELL BIOL, V151, P1459, DOI 10.1083/jcb.151.7.1459
   WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818
   Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539
   ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042
   ZHOU NE, 1994, PROTEIN PEPTIDE LETT, V1, P114
NR 45
TC 43
Z9 48
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JAN-FEB
PY 2002
VL 137
IS 1-2
BP 128
EP 145
DI 10.1006/jsbi.2002.4438
PG 18
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 566XL
UT WOS:000176453500015
PM 12064940
DA 2021-01-25
ER

PT J
AU Remigy, HW
   Hauska, G
   Muller, SA
   Tsiotis, G
AF Remigy, HW
   Hauska, G
   Muller, SA
   Tsiotis, G
TI The reaction centre from green sulphur bacteria: progress towards
   structural elucidation
SO PHOTOSYNTHESIS RESEARCH
LA English
DT Review
DE Chlorobium tepidum; green sulphur bacteria; reaction centre; scanning
   transmission electron microscopy
ID REACTION-CENTER COMPLEX; PHOTOSYNTHETIC REACTION-CENTER; TRANSMISSION
   ELECTRON-MICROSCOPY; LIMICOLA F THIOSULFATOPHILUM; SULFUR BACTERIUM;
   CHLOROBIUM-TEPIDUM; PHOTOSYSTEM-I; PROSTHECOCHLORIS-AESTUARII;
   BIOLOGICAL MACROMOLECULES; ANGSTROM RESOLUTION
AB The reaction centre (RC) of green sulphur bacteria is a FeS-type RC, as are the RCs of Photosystems I (PS I) of oxygenic photosynthetic organisms and of heliobacteria. The core domains of both green sulphur bacterial and heliobacterial RCs are considered to be homodimeric, in contrast to those of purple bacteria, PS I and Photosystem II (PS II). This paper briefly describes the techniques of electron microscopy and image processing suited to investigate the structure of these proteins. Recent advances in the study of the structure of the green sulphur bacterial RC, primarily achieved by the application of scanning transmission electron microscopy, are reviewed.
C1 Univ Crete, Dept Chem, Div Biochem, Iraklion 71409, Greece.
   Univ Basel, Biozentrum, ME Muller Inst Microscop Struct Biol, CH-4056 Basel, Switzerland.
   Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, D-93040 Regensburg, Germany.
RP Tsiotis, G (corresponding author), Univ Crete, Dept Chem, Div Biochem, POB 1470, Iraklion 71409, Greece.
EM tsiotis@chemistry.uoc.gr
CR BLANKENSHIP RE, 1995, ADV PHOTOSYNTH, V2, P399
   BREMER A, 1994, CELL BIOL LAB HDB, P126
   BRETAUDIERE JP, 1986, J MICROSC-OXFORD, V144, P1, DOI 10.1111/j.1365-2818.1986.tb04669.x
   BUTTNER M, 1992, P NATL ACAD SCI USA, V89, P8135, DOI 10.1073/pnas.89.17.8135
   DUBOCHET J, 1982, J MICROSC-OXFORD, V128, P219, DOI 10.1111/j.1365-2818.1982.tb04625.x
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   FEILER U, 1992, BIOCHEMISTRY-US, V31, P2608, DOI 10.1021/bi00124a022
   Feiler U., 1995, ANOXYGENIC PHOTOSYNT, P665
   Francke C, 1997, BIOCHEMISTRY-US, V36, P14167, DOI 10.1021/bi9716837
   Francke C, 1996, PHOTOSYNTH RES, V50, P71, DOI 10.1007/BF00018222
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Frankenberg N, 1996, PHOTOCHEM PHOTOBIOL, V64, P14, DOI 10.1111/j.1751-1097.1996.tb02415.x
   Fromme P, 1998, BBA-BIOENERGETICS, V1365, P175, DOI 10.1016/S0005-2728(98)00059-0
   GHOSH R, 1993, J MOL BIOL, V231, P501, DOI 10.1006/jmbi.1993.1298
   GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83
   GOLBECK JH, 1993, P NATL ACAD SCI USA, V90, P1642, DOI 10.1073/pnas.90.5.1642
   Griesbeck C, 1998, BBA-BIOENERGETICS, V1365, P285, DOI 10.1016/S0005-2728(98)00081-4
   HAGERBRAUN C, 1995, BIOCHEMISTRY-US, V34, P9617, DOI 10.1021/bi00029a039
   HagerBraun C, 1997, PHOTOSYNTH RES, V51, P127, DOI 10.1023/A:1005787209977
   Haschemyer RH, 1972, PRINCIPLES TECHNIQUE, V2, P101
   Hasler L, 1997, J STRUCT BIOL, V119, P273, DOI 10.1006/jsbi.1997.3889
   Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2
   HURT EC, 1984, FEBS LETT, V168, P149, DOI 10.1016/0014-5793(84)80225-2
   ILLINGER N, 1993, PHOTOSYNTH RES, V38, P111, DOI 10.1007/BF00015067
   Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000
   Karrasch S, 1996, J MOL BIOL, V262, P336, DOI 10.1006/jmbi.1996.0517
   KJAER B, 1994, PHOTOSYNTH RES, V41, P105, DOI 10.1007/BF02184150
   Kjaer B, 1998, BIOCHEMISTRY-US, V37, P3237, DOI 10.1021/bi973121t
   Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965
   KUSUMOTO N, 1994, PLANT CELL PHYSIOL, V35, P17
   Kusumoto N, 1999, BIOCHEMISTRY-US, V38, P12124, DOI 10.1021/bi990452s
   Li YF, 1997, J MOL BIOL, V271, P456, DOI 10.1006/jmbi.1997.1189
   LIEBL U, 1993, P NATL ACAD SCI USA, V90, P7124, DOI 10.1073/pnas.90.15.7124
   MATTHEWS BW, 1979, J MOL BIOL, V131, P259, DOI 10.1016/0022-2836(79)90076-7
   Muller SA, 1998, J STRUCT BIOL, V121, P219, DOI 10.1006/jsbi.1997.3953
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Neerken S, 1998, BIOCHEMISTRY-US, V37, P10792, DOI 10.1021/bi9806899
   NITSCHKE W, 1991, TRENDS BIOCHEM SCI, V16, P241, DOI 10.1016/0968-0004(91)90095-D
   Oh-Oka H, 1998, J PHYS CHEM B, V102, P8190, DOI 10.1021/jp981478g
   OHOKA H, 1993, PLANT CELL PHYSIOL, V34, P93
   OHOKA H, 1995, FEBS LETT, V365, P30, DOI 10.1016/0014-5793(95)00433-A
   OHOKA H, 1995, BIOCHEMISTRY-US, V34, P13091, DOI 10.1021/bi00040a021
   OKKELS JS, 1992, J BIOL CHEM, V267, P21139
   Olson JM, 1998, PHOTOCHEM PHOTOBIOL, V67, P61, DOI 10.1111/j.1751-1097.1998.tb05166.x
   Pascual A, 2000, ULTRAMICROSCOPY, V84, P85, DOI 10.1016/S0304-3991(00)00022-X
   Permentier HP, 2000, PHOTOSYNTH RES, V64, P27, DOI 10.1023/A:1026515027824
   Remigy HW, 1999, J MOL BIOL, V290, P851, DOI 10.1006/jmbi.1999.2925
   REMIGY HW, 1998, 11 INT C PHOT, P531
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   Schmidt KA, 1998, PHOTOSYNTH RES, V58, P57, DOI 10.1023/A:1006093627724
   Schubert WD, 1997, J MOL BIOL, V272, P741, DOI 10.1006/jmbi.1997.1269
   Tsiotis G, 1997, BBA-BIOENERGETICS, V1322, P163, DOI 10.1016/S0005-2728(97)00073-X
   Tsiotis G, 1999, EUR J BIOCHEM, V259, P320, DOI 10.1046/j.1432-1327.1999.00042.x
   VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4
   VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/S0304-3991(81)80197-0
   Vassiliev IR, 2000, BIOPHYS J, V78, P3160, DOI 10.1016/S0006-3495(00)76852-4
NR 60
TC 23
Z9 23
U1 0
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0166-8595
EI 1573-5079
J9 PHOTOSYNTH RES
JI Photosynth. Res.
PY 2002
VL 71
IS 1-2
BP 91
EP 98
DI 10.1023/A:1014963816574
PG 8
WC Plant Sciences
SC Plant Sciences
GA 548VB
UT WOS:000175409600010
PM 16228504
DA 2021-01-25
ER

PT J
AU Prescianotto-Baschong, C
   Riezman, H
AF Prescianotto-Baschong, C
   Riezman, H
TI Ordering of compartments in the yeast endocytic pathway
SO TRAFFIC
LA English
DT Article
DE carboxypeptidase Y; electron microscopy; endocytosis; endosomes;
   immunolabeling; Pep12p; positively charged nanogold; prevacuolar
   compartment; Saccharomyces cerevisiae; Tlg1p; vacuole
ID PROTEIN SORTING PATHWAYS; PREVACUOLAR COMPARTMENT;
   SACCHAROMYCES-CEREVISIAE; VACUOLAR; SYNTAXIN; TRAFFICKING; TRANSPORT;
   ENDOSOME; ATPASE; PEP12P
AB We have characterized the morphology of the yeast endocytic pathway leading from the plasma membrane to the vacuole by following the trafficking of positively charged nanogold in combination with compartment Identification using immunolocalization of t-SNARE proteins. The first endocytic compartment, termed the early/recycling endosome, contains the t-SNARE, Tig1p. The next compartment, the prevacuolar compartment, contains Pep12p. After transport to the prevacuolar compartment, where vacuolar enzymes are seen on their way to the vacuole, endocytic content is delivered to the late endosome and on to the vacuole, both of which are devoid of Pep12p immunolabel. Traffic to the prevacuolar compartment is reduced in strains mutant for the Rab5 homologs, Vps21p, Ypt52p, and Ypt53p and in vps27 mutant cells. On the other hand, traffic to the early recycling endosome is less dependent on Rab5 homologs and does not require Vps27p.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Riezman, H (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
OI Riezman, Howard/0000-0003-4680-9422
CR Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982
   Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820
   Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579
   Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277
   D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255
   Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x
   Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113
   HORAZDOVSKY BF, 1995, CURR OPIN CELL BIOL, V7, P544, DOI 10.1016/0955-0674(95)80012-3
   HORAZDOVSKY BF, 1994, EMBO J, V13, P1297, DOI 10.1002/j.1460-2075.1994.tb06382.x
   Huang KM, 1999, EMBO J, V18, P3897, DOI 10.1093/emboj/18.14.3897
   Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23
   Mulholland J, 1999, MOL BIOL CELL, V10, P799, DOI 10.1091/mbc.10.3.799
   Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7
   Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9
   Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356
   PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603
   Prescianotto-Baschong C, 1998, MOL BIOL CELL, V9, P173, DOI 10.1091/mbc.9.1.173
   RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389
   SINGERKRUGER B, 1995, J CELL SCI, V108, P3509
   SINGERKRUGER B, 1994, J CELL BIOL, V125, P283, DOI 10.1083/jcb.125.2.283
   TAN PK, 1993, J CELL BIOL, V123, P1707, DOI 10.1083/jcb.123.6.1707
   VANTUINEN E, 1987, J HISTOCHEM CYTOCHEM, V35, P327, DOI 10.1177/35.3.3546482
   Wendland B, 1998, CURR OPIN CELL BIOL, V10, P513, DOI 10.1016/S0955-0674(98)80067-7
   Wickner W, 2000, ANNU REV BIOCHEM, V69, P247, DOI 10.1146/annurev.biochem.69.1.247
   Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397
NR 25
TC 52
Z9 56
U1 0
U2 2
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 1398-9219
J9 TRAFFIC
JI Traffic
PD JAN
PY 2002
VL 3
IS 1
BP 37
EP 49
DI 10.1034/j.1600-0854.2002.30106.x
PG 13
WC Cell Biology
SC Cell Biology
GA 513VR
UT WOS:000173401400006
PM 11872141
OA Bronze
DA 2021-01-25
ER

PT J
AU Funato, K
   Riezman, H
AF Funato, K
   Riezman, H
TI Vesicular and nonvesicular transport of ceramide from ER to the Golgi
   apparatus in yeast
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
DE ceramide transport; sphingolipids; membrane contacts; secretion;
   Saccharomyces cerevisiae
ID SPHINGANINE N-ACYLTRANSFERASE; INOSITOL PHOSPHORYLCERAMIDE SYNTHASE;
   SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; INTERORGANELLE
   TRANSPORT; SPHINGOMYELIN SYNTHESIS; ALKALINE CERAMIDASE; SPHINGOID BASE;
   MEMBRANE; CELL
AB Transport and sorting of lipids must occur with specific mechanisms because the membranes of intracellular organelles differ in lipid composition even though most lipid biosynthesis begins in the ER. In yeast, ceramide is synthesized in the ER and transferred to the Golgi apparatus where inositolphosphorylceramide (IPC) is formed. These two facts imply that ceramide can be transported to the Golgi independent of vesicular traffic because IPC synthesis still continues when vesicular transport is blocked in sec mutants. Nonvesicular IPC synthesis in intact cells is not affected by ATP depletion. Using an in vitro assay that reconstitutes the nonvesicular pathway for transport of ceramide, we found that transport is temperature and cytosol dependent but energy independent. Preincubation of ER and Golgi fractions together at 4 degreesC, where ceramide transport does not occur, rendered the transport reaction membrane concentration independent, providing biochemical evidence that ER-Golgi membrane contacts stimulate ceramide transport. A cytosolic protease-sensitive factor is required after establishment of ER-Golgi contacts.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Riezman, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
OI Riezman, Howard/0000-0003-4680-9422
CR Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x
   BAI J, 1997, BIOCHEMISTRY-US, V23, P4977
   BAKER D, 1990, P NATL ACAD SCI USA, V87, P355, DOI 10.1073/pnas.87.1.355
   BANFIELD DK, 1994, J CELL BIOL, V127, P357, DOI 10.1083/jcb.127.2.357
   BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4
   Dickson RC, 1999, BBA-GEN SUBJECTS, V1426, P347, DOI 10.1016/S0304-4165(98)00135-4
   Emoto K, 1999, P NATL ACAD SCI USA, V96, P12400, DOI 10.1073/pnas.96.22.12400
   Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673
   Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200
   FUNATO K, 1992, BIOCHIM BIOPHYS ACTA, V1103, P198, DOI 10.1016/0005-2736(92)90087-3
   Futerman Anthony H., 1998, EMBO (European Molecular Biology Organization) Journal, V17, P6772, DOI 10.1093/emboj/17.23.6772
   Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2
   Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062
   Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704
   HAMBURGER D, 1995, J CELL BIOL, V129, P629, DOI 10.1083/jcb.129.3.629
   Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3
   Hashida-Okado T, 1998, FEBS LETT, V425, P117, DOI 10.1016/S0014-5793(98)00211-7
   HashidaOkado T, 1996, MOL GEN GENET, V251, P236
   HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751
   HORVATH A, 1994, EMBO J, V13, P3684
   Kok JW, 1998, BIOCHEM J, V333, P779, DOI 10.1042/bj3330779
   Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135
   Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267
   Liscum L, 1999, BBA-MOL CELL BIOL L, V1438, P19, DOI 10.1016/S1388-1981(99)00043-8
   MANDALA SM, 1995, J ANTIBIOT, V48, P349, DOI 10.7164/antibiotics.48.349
   MANDON EC, 1992, J BIOL CHEM, V267, P11144
   Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876
   Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200
   MCINTYRE JC, 1994, CURR TOP MEMBR, V40, P453, DOI 10.1016/S0070-2161(08)60992-2
   MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F
   MERRILL AH, 1993, J BIOL CHEM, V268, P27299
   MOREAU P, 1993, BIOCHIM BIOPHYS ACTA, V1146, P9, DOI 10.1016/0005-2736(93)90332-T
   MORELL P, 1970, J BIOL CHEM, V245, P342
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   Nishijima M, 1997, TRENDS CELL BIOL, V7, P324, DOI 10.1016/S0962-8924(97)01084-2
   PUOTI A, 1991, J CELL BIOL, V113, P515, DOI 10.1083/jcb.113.3.515
   Raggers RJ, 2000, TRAFFIC, V1, P226, DOI 10.1034/j.1600-0854.2000.010305.x
   Reggiori F, 1998, J BIOL CHEM, V273, P30550, DOI 10.1074/jbc.273.46.30550
   SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x
   Schneiter R, 1999, BIOESSAYS, V21, P1004, DOI 10.1002/(SICI)1521-1878(199912)22:1<1004::AID-BIES4>3.0.CO;2-Y
   Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741
   SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895
   Sutterlin C, 1997, J CELL SCI, V110, P2703
   TROTTER PJ, 1994, BBA-LIPID LIPID MET, V1213, P241, DOI 10.1016/0005-2760(94)00073-5
   van Meer G, 1998, TRENDS CELL BIOL, V8, P29, DOI 10.1016/S0962-8924(97)01196-3
   van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8
   Voelker DR, 2000, BBA-MOL CELL BIOL L, V1486, P97, DOI 10.1016/S1388-1981(00)00051-2
   VOELKER DR, 1993, J BIOL CHEM, V268, P7069
   WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124
   Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824
   Zhong WY, 1999, FEBS LETT, V463, P241, DOI 10.1016/S0014-5793(99)01633-6
NR 51
TC 134
Z9 135
U1 0
U2 8
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0021-9525
J9 J CELL BIOL
JI J. Cell Biol.
PD DEC 10
PY 2001
VL 155
IS 6
BP 949
EP 959
DI 10.1083/jcb.200105033
PG 11
WC Cell Biology
SC Cell Biology
GA 502EF
UT WOS:000172730200009
PM 11733544
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Hoepfner, D
   van den Berg, M
   Philippsen, P
   Tabak, HF
   Hettema, EH
AF Hoepfner, D
   van den Berg, M
   Philippsen, P
   Tabak, HF
   Hettema, EH
TI A role for Vps1p, actin, and the Myo2p motor in peroxisome abundance and
   inheritance in Saccharomyces cerevisiae
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
DE peroxisome inheritance; Vps1; fission; actin cytoskeleton; Myo2p
ID DYNAMIN-RELATED GTPASE; YEAST MYOSIN-V; BUDDING YEAST; CELL-CYCLE;
   SPINDLE ORIENTATION; MITOTIC SPINDLE; MATING-TYPE; MITOCHONDRIAL
   DIVISION; ORGANELLE INHERITANCE; ASTRAL MICROTUBULES
AB In vivo time-lapse microscopy reveals that the number of peroxisomes in Saccharomyces cerevisiae cells is fairly constant and that a subset of the organelles are targeted and segregated to the bud in a highly ordered, vectorial process. The dynamin-like protein Vps1p controls the number of peroxisomes, since in a vps1 Delta mutant only one or two giant peroxisomes remain. Analogous to the function of other dynamin-related proteins, Vps1p may be involved in a membrane fission event that is required for the regulation of peroxisome abundance. We found that efficient segregation of peroxisomes from mother to bud is dependent on the actin cytoskeleton, and active movement of peroxisomes along actin filaments is driven by the class V myosin motor protein, Myo2p: (a) peroxisomal dynamics always paralleled the polarity of the actin cytoskeleton, (b) double labeling of peroxisomes and actin cables revealed a close association between both, (c) depolymerization of the actin cytoskeleton abolished all peroxisomal movements, and (d) in cells containing thermosensitive alleles of MYO2, all peroxisome movement immediately stopped at the nonpermissive temperature. In addition, time-lapse videos showing peroxisome movement in wild-type and vps1 Delta cells suggest the existence of various levels of control involved in the partitioning of peroxisomes.
C1 Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands.
   Univ Basel, Biozentrum, Lehrstuhl Angew Mikrobiol, CH-4056 Basel, Switzerland.
RP Hoepfner, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biochem, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.
EM h.f.tabak@amc.uva.nl
CR ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934
   Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259
   Beach DL, 2000, CURR BIOL, V10, P1497, DOI 10.1016/S0960-9822(00)00837-X
   Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X
   BRETSCHER A, 1994, J CELL BIOL, V126, P821, DOI 10.1083/jcb.126.4.821
   Brocard C, 1997, EMBO J, V16, P5491, DOI 10.1093/emboj/16.18.5491
   Brown SS, 1997, CURR OPIN CELL BIOL, V9, P44, DOI 10.1016/S0955-0674(97)80150-0
   BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376
   BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975
   BYERS B, 1981, CYTOLOGY YEAST LIFE, P59
   Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629
   Catlett NL, 2000, CURR OPIN CELL BIOL, V12, P509, DOI 10.1016/S0955-0674(00)00124-1
   Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799
   Chen XYP, 1998, J CELL BIOL, V141, P1169, DOI 10.1083/jcb.141.5.1169
   CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/S0092-8674(05)80080-7
   COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2
   Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886
   Erdmann R, 1997, TRENDS CELL BIOL, V7, P400, DOI 10.1016/S0962-8924(97)01126-4
   Fink G., 1991, METHOD ENZYMOL, V194, P14
   FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405
   GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055
   Hettema EH, 1999, BBA-MOL CELL RES, V1451, P17, DOI 10.1016/S0167-4889(99)00087-7
   Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223
   Hettema EH, 1998, J CELL BIOL, V142, P421, DOI 10.1083/jcb.142.2.421
   Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4
   Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   HOWARD RJ, 1981, J CELL SCI, V48, P89
   HOWARD RJ, 1980, J CELL BIOL, V107, P1997
   HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H
   JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409
   JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539
   JONES EW, 1977, GENETICS, V85, P23
   Karpova TS, 2000, MOL BIOL CELL, V11, P1727, DOI 10.1091/mbc.11.5.1727
   KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922
   Knop M, 1998, EMBO J, V17, P3952, DOI 10.1093/emboj/17.14.3952
   LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421
   Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383
   Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687
   MCCONNELL SJ, 1993, SCIENCE, V260, P687, DOI 10.1126/science.8480179
   McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8
   MCNIVEN MA, 1986, J CELL BIOL, V103, P1547, DOI 10.1083/jcb.103.4.1547
   Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024
   Monosov EZ, 1996, J HISTOCHEM CYTOCHEM, V44, P581, DOI 10.1177/44.6.8666743
   Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367
   Nunnari J, 1996, CELL, V84, P389, DOI 10.1016/S0092-8674(00)81283-0
   Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333
   PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583
   Pastural E, 1997, NAT GENET, V16, P289, DOI 10.1038/ng0797-289
   PURDUE PE, 1994, J BIOL CHEM, V269, P30065
   Rapp S, 1996, ANN NY ACAD SCI, V804, P666, DOI 10.1111/j.1749-6632.1996.tb18659.x
   Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0
   RINDLER MJ, 1987, J CELL BIOL, V104, P231, DOI 10.1083/jcb.104.2.231
   ROGALSKI AA, 1984, J CELL BIOL, V99, P1101, DOI 10.1083/jcb.99.3.1101
   Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47
   ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U
   Sambrook J, 1989, MOL CLONING LAB MANU
   Santos B, 1997, J CELL BIOL, V136, P95, DOI 10.1083/jcb.136.1.95
   SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712
   Schliwa M., 1984, Cell and Muscle Motility, V5, P1
   Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791
   Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7
   Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699
   Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985
   Shepard KA, 1999, J CELL BIOL, V144, P711, DOI 10.1083/jcb.144.4.711
   Soues S, 1998, J CELL SCI, V111, P2809
   Steinberg G, 1998, FUNGAL GENET BIOL, V24, P161, DOI 10.1006/fgbi.1998.1058
   Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574
   Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399
   SULLIVAN DS, 1992, J CELL BIOL, V119, P379, DOI 10.1083/jcb.119.2.379
   Tabak HF, 1999, TRENDS CELL BIOL, V9, P447, DOI 10.1016/S0962-8924(99)01650-5
   Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015
   Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353
   Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993
   Titorenko VI, 1998, TRENDS BIOCHEM SCI, V23, P231, DOI 10.1016/S0968-0004(98)01226-2
   VALE RD, 1986, TRENDS BIOCHEM SCI, V11, P464, DOI 10.1016/0968-0004(86)90248-3
   van der Bliek AM, 2000, J CELL BIOL, V151, pF1, DOI 10.1083/jcb.151.2.F1
   van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1
   VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Waddle JA, 1996, J CELL BIOL, V132, P861, DOI 10.1083/jcb.132.5.861
   Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2
   WEISMAN LS, 1990, P NATL ACAD SCI USA, V87, P1076, DOI 10.1073/pnas.87.3.1076
   Wiemer EAC, 1997, J CELL BIOL, V136, P71, DOI 10.1083/jcb.136.1.71
   WILSBACH K, 1993, EMBO J, V12, P3049, DOI 10.1002/j.1460-2075.1993.tb05974.x
   Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797
   Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341
   Xu ZY, 1996, J CELL BIOL, V132, P787, DOI 10.1083/jcb.132.5.787
   Yaffe MP, 1999, NAT CELL BIOL, V1, pE149, DOI 10.1038/14101
   Yang HC, 1999, CURR BIOL, V9, P1111, DOI 10.1016/S0960-9822(99)80480-1
   Yin HW, 2000, NATURE, V406, P1013
NR 91
TC 244
Z9 248
U1 1
U2 14
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD DEC 10
PY 2001
VL 155
IS 6
BP 979
EP 990
DI 10.1083/jcb.200107028
PG 12
WC Cell Biology
SC Cell Biology
GA 502EF
UT WOS:000172730200012
PM 11733545
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Moore, C
   Leu, M
   Muller, U
   Brenner, HR
AF Moore, C
   Leu, M
   Muller, U
   Brenner, HR
TI Induction of multiple signaling loops by MuSK during neuromuscular
   synapse formation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID ACETYLCHOLINE-RECEPTOR; SKELETAL-MUSCLE; INNERVATED MUSCLE; SUBUNIT
   GENE; AGRIN; EXPRESSION; JUNCTION; NEUREGULIN; KINASE; SYSTEM
AB At the neuromuscular junction, two motor neuron-derived signals have been implicated in the regulation of synaptogenesis. Neuregulin-1 is thought to induce transcription of acetylcholine receptor (AChR) genes in subsynaptic muscle nuclei by activating ErbB receptors. Neural agrin aggregates AChRs by activating the receptor tyrosine kinase MUSK. Here, we show that these two signals act sequentially. Agrin, by activating MUSK, induces the synthesis and aggregation of both MUSK and ErbB receptors. ErbB acts downstream of MUSK in synapse formation. In this way, MUSK activation leads to the establishment of a neuregulin-1-dependent signaling complex that maintains MUSK, ErbB, and AChR expression at the synapse of electrically active muscle fibers.
C1 Univ Basel, Biozentrum, Pharmazentrum, Dept Physiol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Brenner, HR (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, Dept Physiol, Klingelbergstr 50, CH-4056 Basel, Switzerland.
CR Bezakova G, 2001, J CELL BIOL, V153, P1441, DOI 10.1083/jcb.153.7.1441
   Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936
   Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   Duclert A, 1996, J BIOL CHEM, V271, P17433, DOI 10.1074/jbc.271.29.17433
   Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429
   Freundlieb S, 1999, J GENE MED, V1, P4, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<4::AID-JGM4>3.0.CO;2-Y
   GAUTAM M, 1995, NATURE, V377, P195
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911
   Ip FCF, 2000, MOL CELL NEUROSCI, V16, P661, DOI 10.1006/mcne.2000.0892
   Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654
   Jones G, 1999, J NEUROSCI, V19, P3376
   KOIKE S, 1995, P NATL ACAD SCI USA, V92, P10624, DOI 10.1073/pnas.92.23.10624
   LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   MCMAHAN UJ, 1990, COLD SH Q B, V55, P407
   Meier T, 1997, J NEUROSCI, V17, P6534
   Meier T, 1998, J CELL BIOL, V141, P715, DOI 10.1083/jcb.141.3.715
   MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012
   PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0
   RIESE DJ, 1995, MOL CELL BIOL, V15, P5770
   Rimer M, 1998, MOL CELL NEUROSCI, V12, P1, DOI 10.1006/mcne.1998.0695
   Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703
   Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7
   Tzahar E, 1996, MOL CELL BIOL, V16, P5276
   VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9
   Weiss FU, 1997, J CELL PHYSIOL, V173, P187, DOI 10.1002/(SICI)1097-4652(199711)173:2<187::AID-JCP19>3.3.CO;2-R
   WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125
   Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
   Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131
   Young C, 1998, HISTOCHEM J, V30, P7, DOI 10.1023/A:1003206327367
   ZHU XJ, 1995, EMBO J, V14, P5842, DOI 10.1002/j.1460-2075.1995.tb00272.x
NR 36
TC 38
Z9 41
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 4
PY 2001
VL 98
IS 25
BP 14655
EP 14660
DI 10.1073/pnas.251291598
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 499NH
UT WOS:000172576900084
PM 11717400
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Friant, S
   Lombardi, R
   Schmelzle, T
   Hall, MN
   Riezman, H
AF Friant, S
   Lombardi, R
   Schmelzle, T
   Hall, MN
   Riezman, H
TI Sphingoid base signaling via Pkh kinases is required for endocytosis in
   yeast
SO EMBO JOURNAL
LA English
DT Article
DE endocytosis; PKH, PKC1 and PDK1 kinases; signaling pathway; sphingoid
   base
ID GPI-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; INTERNALIZATION STEP;
   ACTIN CYTOSKELETON; ACTIVATION; GENE; PDK1; INHIBITION; TRANSPORT; CELLS
AB In yeast, sphingoid base synthesis is required for the internalization step of endocytosis and organization of the actin cytoskeleton. We show that overexpression of either one of the two kinases Pkh1p or Pkh2p, that are homologous to mammalian 3-phosphoinositide-dependent kinase-1 (PDK1), can specifically suppress the sphingoid base synthesis requirement for endocytosis. Pkh1p and Pkh2p have an overlapping function because only a mutant with impaired function of both kinases is defective for endocytosis. Pkh1/2p kinases are activated in vitro by nanomolar concentrations of sphingoid base. These results suggest that Pkh1/2p kinases are part of a sphingoid base-mediated signaling pathway that is required for the internalization step of endocytosis. The Pkc1p kinase that is phosphorylated by Pkh1/2p kinases and plays a role in endocytosis was identified as one of the downstream effectors of this signaling cascade.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Riezman, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Howard.Riezman@unibas.ch
RI Friant, Sylvie/L-9244-2019; Friant, Sylvie/F-5409-2019
OI Friant, Sylvie/0000-0002-5412-6288; Friant, Sylvie/0000-0002-5412-6288;
   Riezman, Howard/0000-0003-4680-9422; Hall, Michael N/0000-0002-2998-0757
CR Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5
   ANTONSSON B, 1994, J BIOL CHEM, V269, P16821
   BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023
   Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137
   Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8
   Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575
   D'Hondt K, 2000, ANNU REV GENET, V34, P255, DOI 10.1146/annurev.genet.34.1.255
   DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533
   DULIC V, 1991, METHOD ENZYMOL, V194, P697
   Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834
   Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8
   Geli MI, 1998, J CELL SCI, V111, P1031
   HANNUN YA, 1986, J BIOL CHEM, V261, P2604
   HAWKINS PT, 1993, J BIOL CHEM, V268, P3374
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791
   HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x
   Inagaki M, 1999, MOL CELL BIOL, V19, P8344
   KING CC, 2000, J BIOL CHEM, V29, P29
   KUBLER E, 1993, EMBO J, V12, P2855, DOI 10.1002/j.1460-2075.1993.tb05947.x
   Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042
   LOMBARDI R, 2001, FRONTIERS MOL BIOL, V36, P218
   MCDONALD OB, 1991, J BIOL CHEM, V266, P21773
   MULLER G, 1995, EMBO J, V14, P1961, DOI 10.1002/j.1460-2075.1995.tb07188.x
   Munn AL, 1999, MOL BIOL CELL, V10, P3943, DOI 10.1091/mbc.10.11.3943
   MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373
   MUNN AL, 1995, MOL BIOL CELL, V6, P1721
   NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899
   Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707
   PUSHKAREVA MY, 1993, BIOCHEM J, V294, P699, DOI 10.1042/bj2940699
   PUSHKAREVA MY, 1992, J BIOL CHEM, V267, P15246
   RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55
   Riezman H, 1996, EXPERIENTIA, V52, P1033, DOI 10.1007/BF01952099
   ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28
   Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961
   SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712
   Sherman F, 1983, METHODS YEAST GENETI
   Skrzypek MS, 1998, J BIOL CHEM, V273, P2829, DOI 10.1074/jbc.273.5.2829
   Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710
   Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775
   Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000
   Sutterlin C, 1997, J CELL SCI, V110, P2703
   WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171
   Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824
NR 44
TC 135
Z9 138
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD DEC 3
PY 2001
VL 20
IS 23
BP 6783
EP 6792
DI 10.1093/emboj/20.23.6783
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 500LM
UT WOS:000172629100023
PM 11726514
OA Green Published
DA 2021-01-25
ER

PT J
AU Goldsbury, C
   Aebi, U
   Frey, P
AF Goldsbury, C
   Aebi, U
   Frey, P
TI A beta 1-40 assembly into fibrils involves multiple pathways:
   Implications for inhibition strategies
SO AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
LA English
DT Meeting Abstract
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4003 Basel, Switzerland.
   Novartis Pharma AG, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PARTHENON PUBLISHING GROUP
PI LANCASTER
PA RICHMOND HOUSE, WHITE CROSS, SOUTH ROAD, LANCASTER LA1 4XQ, ENGLAND
SN 1350-6129
J9 AMYLOID
JI Amyloid-J. Protein Fold. Disord.
PD DEC
PY 2001
VL 8
SU 2
BP 15
EP 16
PG 2
WC Biochemistry & Molecular Biology; Medicine, General & Internal;
   Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; General & Internal Medicine; Research
   & Experimental Medicine
GA 509ED
UT WOS:000173132100011
DA 2021-01-25
ER

PT J
AU Cardoso, I
   Goldsbury, C
   Aebi, U
   Saraiva, MJ
AF Cardoso, I
   Goldsbury, C
   Aebi, U
   Saraiva, MJ
TI Dynamics of TTR fibrils assembly: Leu55Pro fibrils formed at
   physiological pH versus WT fibrils produced by acidification
SO AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
LA English
DT Meeting Abstract
C1 Univ Porto, Amyloid Unit, Inst Mol & Cell Biol, P-4100 Oporto, Portugal.
   Univ Porto, Inst Biomed Sci Abel Salazar, Oporto, Portugal.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PARTHENON PUBLISHING GROUP
PI LANCASTER
PA RICHMOND HOUSE, WHITE CROSS, SOUTH ROAD, LANCASTER LA1 4XQ, ENGLAND
SN 1350-6129
J9 AMYLOID
JI Amyloid-J. Protein Fold. Disord.
PD DEC
PY 2001
VL 8
SU 2
BP 17
EP 17
PG 1
WC Biochemistry & Molecular Biology; Medicine, General & Internal;
   Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; General & Internal Medicine; Research
   & Experimental Medicine
GA 509ED
UT WOS:000173132100013
DA 2021-01-25
ER

PT J
AU Green, J
   Aebi, U
   Kistler, J
   Cooper, G
   Goldsbury, C
AF Green, J
   Aebi, U
   Kistler, J
   Cooper, G
   Goldsbury, C
TI Investigating early steps in human amylin fibril formation
SO AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
LA English
DT Meeting Abstract
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.
   Univ Auckland, Sch Med, Dept Med, Auckland, New Zealand.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU PARTHENON PUBLISHING GROUP
PI LANCASTER
PA RICHMOND HOUSE, WHITE CROSS, SOUTH ROAD, LANCASTER LA1 4XQ, ENGLAND
SN 1350-6129
J9 AMYLOID
JI Amyloid-J. Protein Fold. Disord.
PD DEC
PY 2001
VL 8
SU 2
BP 17
EP 17
PG 1
WC Biochemistry & Molecular Biology; Medicine, General & Internal;
   Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; General & Internal Medicine; Research
   & Experimental Medicine
GA 509ED
UT WOS:000173132100014
DA 2021-01-25
ER

PT J
AU Gladfelter, AS
   Pringle, JR
   Lew, DJ
AF Gladfelter, AS
   Pringle, JR
   Lew, DJ
TI The septin cortex at the yeast mother-bud neck
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID CORTICAL ACTIN CYTOSKELETON; CEREVISIAE CELL-CYCLE;
   SACCHAROMYCES-CEREVISIAE; BUDDING-YEAST; POLARIZED GROWTH;
   PROTEIN-KINASE; GENE-PRODUCT; SCHIZOSACCHAROMYCES-POMBE; MORPHOGENESIS
   CHECKPOINT; SUBCELLULAR-LOCALIZATION
AB A specialized cortical domain is organized by the septins at the necks of budding yeast cells. Recent findings suggest that this domain serves as a diffusion barrier and also as a local cell-shape sensor. We review these findings along with what is known about the organization of the septin cortex and its regulation during the cell cycle.
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA.
   Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.
RP Gladfelter, AS (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM daniel.lew@duke.edu
CR Adam JC, 2000, MOL BIOL CELL, V11, P3123, DOI 10.1091/mbc.11.9.3123
   Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119
   Amberg DC, 1997, MOL BIOL CELL, V8, P729
   Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399
   Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176
   Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X
   Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301
   Bloecher A, 2000, J CELL BIOL, V149, P125, DOI 10.1083/jcb.149.1.125
   Bouquin N, 2000, J CELL SCI, V113, P1435
   Boyne JR, 2000, J CELL SCI, V113, P4533
   Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567
   BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717
   Byers B., 1981, MOL BIOL YEAST SACCH, P59
   Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200
   Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709
   CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751
   CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767
   Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365
   Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975
   Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597
   Cid VJ, 2001, MICROBIOL-SGM, V147, P1437, DOI 10.1099/00221287-147-6-1437
   CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817
   DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75
   DeVirgilio C, 1996, MICROBIOL-SGM, V142, P2897, DOI 10.1099/13500872-142-10-2897
   Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886
   Epp JA, 1997, CURR BIOL, V7, P921, DOI 10.1016/S0960-9822(06)00411-8
   Fares H, 1996, J CELL BIOL, V132, P399, DOI 10.1083/jcb.132.3.399
   FARES H, 1995, MOL BIOL CELL, V6, P1843
   Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3
   Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605
   FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405
   Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737
   Frenz LM, 2000, J CELL SCI, V113, P3399
   GALE C, 2001, IN PRESS MOL BIOL CE, V12
   GLASFELTER AS, 2001, MOL BIOL CELL, V12, P1239
   Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1
   HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678
   Hales KG, 1999, CURR OPIN CELL BIOL, V11, P717, DOI 10.1016/S0955-0674(99)00042-3
   Halme A, 1996, CURR BIOL, V6, P570, DOI 10.1016/S0960-9822(02)00543-2
   Harkins HA, 2001, MOL BIOL CELL, V12, P2497, DOI 10.1091/mbc.12.8.2497
   HAYASHIBE M, 1973, J GEN APPL MICROBIOL, V19, P23, DOI 10.2323/jgam.19.23
   Hood JK, 2001, J CELL SCI, V114, P589
   Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981
   Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3
   Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341
   Kang PJ, 2001, SCIENCE, V292, P1376, DOI 10.1126/science.1060360
   Kartmann B, 2001, J CELL SCI, V114, P839
   KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535
   Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535
   Korinek WS, 2000, CURR BIOL, V10, P947, DOI 10.1016/S0960-9822(00)00626-6
   Le Goff X, 1999, MOL GEN GENET, V262, P163
   Lew DJ, 2000, CURR OPIN GENET DEV, V10, P47, DOI 10.1016/S0959-437X(99)00051-9
   LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739
   Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947
   Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355
   Lippincott J, 2001, J CELL SCI, V114, P1379
   Liu JH, 2000, J CELL SCI, V113, P1223
   Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000
   Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8
   Lord M, 2000, J CELL BIOL, V151, P1501, DOI 10.1083/jcb.151.7.1501
   MARCHANT R, 1968, J GEN MICROBIOL, V53, P163, DOI 10.1099/00221287-53-2-163
   Marcoux N, 2000, GENETICS, V156, P579
   Marston AL, 2001, CURR BIOL, V11, P803, DOI 10.1016/S0960-9822(01)00230-5
   McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2
   McMillan JN, 1999, MOL CELL BIOL, V19, P6929
   Mino A, 1998, BIOCHEM BIOPH RES CO, V251, P732, DOI 10.1006/bbrc.1998.9541
   Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039
   Moriya H, 1999, YEAST, V15, P481, DOI 10.1002/(SICI)1097-0061(199904)15:6<481::AID-YEA391>3.0.CO;2-M
   NEUFELD TP, 1994, CELL, V77, P371, DOI 10.1016/0092-8674(94)90152-X
   Nguyen TQ, 2000, J CELL SCI, V113, P3825
   Park HO, 1999, GENE DEV, V13, P1912, DOI 10.1101/gad.13.15.1912
   Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020
   Pringle JR, 1995, COLD SPRING HARB SYM, V60, P729, DOI 10.1101/SQB.1995.060.01.079
   Pruyne D, 2000, J CELL SCI, V113, P365
   Pruyne D, 2000, J CELL SCI, V113, P571
   Reiser V, 2000, NAT CELL BIOL, V2, P620
   Robinson LC, 1999, MOL BIOL CELL, V10, P1077, DOI 10.1091/mbc.10.4.1077
   Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777
   Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413
   Segal M, 2000, MOL BIOL CELL, V11, P3689, DOI 10.1091/mbc.11.11.3689
   SEICHERTOVA O, 1973, FOLIA MICROBIOL, V18, P207, DOI 10.1007/BF02872858
   Shannon KB, 1999, MOL BIOL CELL, V10, P283, DOI 10.1091/mbc.10.2.283
   Shulewitz MJ, 1999, MOL CELL BIOL, V19, P7123
   Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678
   Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000
   Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273
   Sreenivasan A, 1999, MOL CELL BIOL, V19, P7983
   Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821
   Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341
   Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8
   Trimble WS, 1999, J MEMBRANE BIOL, V169, P75, DOI 10.1007/s002329900519
   Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593
   Waddle JA, 1996, J CELL BIOL, V132, P861, DOI 10.1083/jcb.132.5.861
   Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300
   Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949
   Yoshida S, 2001, GENES GENET SYST, V76, P141, DOI 10.1266/ggs.76.141
   ZIMAN M, 1993, MOL BIOL CELL, V4, P1307
NR 97
TC 253
Z9 255
U1 0
U2 5
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD DEC
PY 2001
VL 4
IS 6
BP 681
EP 689
DI 10.1016/S1369-5274(01)00269-7
PG 9
WC Microbiology
SC Microbiology
GA 499DU
UT WOS:000172556400010
PM 11731320
DA 2021-01-25
ER

PT J
AU Tilgen, N
   Zorzato, F
   Halliger-Keller, B
   Muntoni, F
   Sewry, C
   Palmucci, LM
   Schneider, C
   Hauser, E
   Lehmann-Horn, F
   Muller, CR
   Treves, S
AF Tilgen, N
   Zorzato, F
   Halliger-Keller, B
   Muntoni, F
   Sewry, C
   Palmucci, LM
   Schneider, C
   Hauser, E
   Lehmann-Horn, F
   Muller, CR
   Treves, S
TI Identification of four novel mutations in the C-terminal membrane
   spanning domain of the ryanodine receptor 1: association with central
   core disease and alteration of calcium homeostasis
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MALIGNANT-HYPERTHERMIA SUSCEPTIBILITY; SKELETAL-MUSCLE; CA2+ RELEASE;
   SARCOPLASMIC-RETICULUM; CONGENITAL MYOPATHY; RYR1 GENE; CHANNEL; LOCUS;
   LOCALIZATION; RODS
AB The skeletal muscle ryanodine receptor gene (RYR1; OMIM 180901) on chromosome 19q13.1 encodes the skeletal muscle calcium release channel. To date, more than 25 missense mutations have been identified in RYR1 and are associated with central core disease (CCD; OMIM 117000) and/or the malignant hyperthermia susceptibility phenotype (MHS1; OMIM 145600). The majority of RYR1 mutations are clustered in the N-terminal hydrophilic domain of the protein. Only four mutations have been identified so far in the highly conserved C-terminal region encoding the luminal/transmembrane domain of the protein which forms the ion pore. Three of these mutations have been found to segregate with pure or mixed forms of CCD. We have screened the C-terminal domain of the RYR1 gene for mutations in 50 European patients, diagnosed clinically and/or histologically as having CCD. We have identified five missense mutations (four of them novel) in 13 index patients. The mutations cluster in exons 101 and 102 and replace amino acids which are conserved in all known vertebrate RYR genes. In order to study the functional effect of these mutations, we have immortalized B-lymphocytes from some of the patients and studied their [Ca2+](i) homeostasis. We show that lymphoblasts carrying the newly identified RYR1 mutations exhibit: (i) a release of calcium from intracellular stores in the absence of any pharmacological activators of RYR; (ii) significantly smaller thapsigargin-sensitive intracellular calcium stores, compared to lymphoblasts from control individuals; and (iii) a normal sensitivity of the calcium release to the RYR inhibitor dantrolene. Our data suggest the C-terminal domain of RYR1 as a hot spot for mutations leading to the CCD phenotype. If the functional alterations of mutated RYR channels observed in lymphoblastoid cells are also present in skeletal muscles this could explain the predominant symptom of CCD, i.e. chronic muscle weakness. Finally, the study of calcium homeostasis in lymphoblastoid cells naturally expressing RYR1 mutations offers a novel non-invasive approach to gain insights into the pathogenesis of MH and CCD.
C1 Univ Wurzburg, Biozentrum, Inst Humangenet, D-97074 Wurzburg, Germany.
   Kantonsspital, Dept Anaesthesie & Forsch, CH-4031 Basel, Switzerland.
   Univ Ferrara, Dipartimento Med Sperimentale & Diagnost, I-44100 Ferrara, Italy.
   Imperial Coll Sch Med, Dubovitz Neuromuscular Ctr, London W12 0NN, England.
   Univ Turin, Ctr Malattie Neuromuscolari Paolo Peirolo, I-10126 Turin, Italy.
   Univ Wurzburg, Neurol Klin, D-97080 Wurzburg, Germany.
   Univ Vienna, Kinderklin, A-1090 Vienna, Austria.
   Univ Ulm, Angew Physiol Abt, D-89069 Ulm, Germany.
RP Muller, CR (corresponding author), Univ Wurzburg, Biozentrum, Inst Humangenet, D-97074 Wurzburg, Germany.
OI Treves, Susan/0000-0002-0007-9631
FU TelethonFondazione Telethon [1259] Funding Source: Medline
CR Avila G, 2001, P NATL ACAD SCI USA, V98, P4215, DOI 10.1073/pnas.071048198
   Brown RL, 2000, HUM MOL GENET, V9, P1515, DOI 10.1093/hmg/9.10.1515
   Fessenden JD, 2000, BIOPHYS J, V79, P2509, DOI 10.1016/S0006-3495(00)76492-7
   Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3
   GREENFIELD JG, 1958, BRAIN, V81, P461, DOI 10.1093/brain/81.4.461
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   HAYASHI K, 1989, MUSCLE NERVE, V12, P95, DOI 10.1002/mus.880120203
   HerrmannFrank A, 1996, BBA-GEN SUBJECTS, V1289, P31, DOI 10.1016/0304-4165(95)00131-X
   ILES DE, 1994, HUM MOL GENET, V3, P969, DOI 10.1093/hmg/3.6.969
   ISAACS H, 1975, J NEUROL NEUROSUR PS, V38, P1177, DOI 10.1136/jnnp.38.12.1177
   Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D
   LARACH MG, 1994, ANESTHESIOLOGY, V80, P771, DOI 10.1097/00000542-199404000-00008
   Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9
   Lynch PJ, 1999, P NATL ACAD SCI USA, V96, P4164, DOI 10.1073/pnas.96.7.4164
   MACKENZIE AE, 1990, AM J HUM GENET, V46, P1082
   MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759
   McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D
   MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0
   MICKELSON JR, 1988, J BIOL CHEM, V263, P9310
   MIDDELTON LT, 1994, DIAGNOSTIC CRITERIA, P70
   Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454
   Monnier N, 2000, HUM MOL GENET, V9, P2599, DOI 10.1093/hmg/9.18.2599
   NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094
   ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766
   Paul-Pletzer K, 2001, BIOCHEMISTRY-US, V40, P531, DOI 10.1021/bi001502s
   Phillips MS, 1996, GENOMICS, V34, P24, DOI 10.1006/geno.1996.0238
   Robinson RL, 1997, HUM MOL GENET, V6, P953, DOI 10.1093/hmg/6.6.953
   Samso M, 1998, J STRUCT BIOL, V121, P172, DOI 10.1006/jsbi.1997.3955
   Scacheri PC, 2000, NEUROLOGY, V55, P1689, DOI 10.1212/WNL.55.11.1689
   SCHWEMMLE S, 1993, GENOMICS, V17, P205, DOI 10.1006/geno.1993.1302
   Sei Y, 1999, J BIOL CHEM, V274, P5995, DOI 10.1074/jbc.274.9.5995
   SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004
   SHY GM, 1956, BRAIN, V79, P160
   SUDBRAK R, 1995, AM J HUM GENET, V56, P684
   TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0
   Tong JF, 1999, J BIOL CHEM, V274, P693, DOI 10.1074/jbc.274.2.693
   Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332
   Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200
   ZORZATO F, 1990, J BIOL CHEM, V265, P2244
   ZORZATO F, 1993, MOL PHARMACOL, V44, P1192
NR 40
TC 105
Z9 108
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 1
PY 2001
VL 10
IS 25
BP 2879
EP 2887
DI 10.1093/hmg/10.25.2879
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 504QW
UT WOS:000172868200004
PM 11741831
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Baschong, W
   Suetterlin, R
   Laeng, RH
AF Baschong, W
   Suetterlin, R
   Laeng, RH
TI Control of autofluorescence of archival formaldehyde-fixed,
   paraffin-embedded tissue in confocal laser scanning microscopy (CLSM)
SO JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
LA English
DT Article
DE immunofluorescence; autofluorescence; background fluorescence; confocal
   laser scanning microscopy; paraffin sections; archival tissue;
   formaldehyde; bone marrow
ID IMMUNOFLUORESCENCE; FLUORESCENCE; COLLAGEN; FIXATION
AB Confocal laser scanning microscopy (CLSM) offers the advantage of quasi-theoretical resolution due to absence of interference with out-of-focus light. Prerequisites include minimal tissue autofluorescence, either intrinsic or induced by fixation and tissue processing, and minimal background fluorescence due to nonspecific binding of the fluorescent label. To eliminate or reduce autofluorescence, three different reagents, ammonia-ethanol, sodium borohydride, and Sudan Black B were tested on paraffin sections of archival formaldehyde-fixed tissue. Paraffin sections of biopsy specimens of human bone marrow, myocardium, and of bovine cartilage were compared by CLSM at 488-nm, 568-nm and 647-nm wavelengths with bone marrow frozen sections fixed either with formaldehyde or with glutaraldehyde. Autofluorescence of untreated sections related to both the specific type of tissue and to the tissue processing technique, including fixation. The reagents' effects also depended on the type of tissue and technique of tissue processing, including fixation, and so did the efficiency of the reagents tested. Therefore, no general recipe for the control of autofluorescence could be delineated. Ammonia-ethanol proved most efficient in archival bone marrow sections. Sudan Black B performed best on myocardium, and the combination of all three reagents proved most efficient on paraffin sections of cartilage and on frozen sections fixed in formaldehyde or glutaraldehyde. Sodium borohydride was required for the reduction of unwanted fluorescence in glutaraldehyde-fixed tissue. In formaldehyde-fixed tissue, however, sodium borohydride induced brilliant autofluorescence in erythrocytes that otherwise remained inconspicuous. Ammonia-ethanol is believed to reduce autofluorescence by improving the extraction of fluorescent molecules and by inactivating pH-sensitive fluorochromes. The efficiency of borohydride is related to its capacity of reducing aldehyde and keto-groups, thus changing the fluorescence of tissue constituents and especially of glutaraldehyde-derived condensates. Sudan Black B is suggested to mask fluorescent tissue components.
C1 Univ Basel, ME Muller Inst, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Oral Surg Radiol & Oral Med, Basel, Switzerland.
   Kantonsspital, Dept Pathol, Aarau, Switzerland.
RP Baschong, W (corresponding author), Univ Basel, ME Muller Inst, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
CR Banerjee B, 1999, J INVEST MED, V47, P326
   Baschong W, 1999, METHOD ENZYMOL, V307, P173
   Baschong W, 2001, MICRON, V32, P33, DOI 10.1016/S0968-4328(00)00025-1
   Baschong W, 1997, EUR J CELL BIOL, V72, P189
   Belichenko PV, 1996, J NEUROSCI METH, V69, P155, DOI 10.1016/S0165-0270(96)00035-0
   Brotchie D, 1999, J NEUROSCI METH, V87, P77, DOI 10.1016/S0165-0270(98)00168-X
   DELCASTILLO P, 1989, BASIC APPL HISTOCHEM, V33, P251
   EDWIN EE, 1981, J NEUROCHEM, V37, P1054, DOI 10.1111/j.1471-4159.1981.tb04497.x
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   JOHNSON TJA, 1987, EUR J CELL BIOL, V45, P160
   Kardasewitsch B., 1925, Z WISS MIKROSK, V42, P322
   KITTELBERGER R, 1989, ACTA HISTOCHEM, V86, P137, DOI 10.1016/S0065-1281(89)80082-0
   Liu SQ, 1997, HISTOCHEM CELL BIOL, V107, P267, DOI 10.1007/s004180050112
   Noonberg S B, 1992, Antisense Res Dev, V2, P303
   Romijn HJ, 1999, J HISTOCHEM CYTOCHEM, V47, P229, DOI 10.1177/002215549904700211
   Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601
   SMALL JV, 1978, J CELL SCI, V31, P393
   Southern LJ, 2000, J HEART VALVE DIS, V9, P241
   TEKOLA P, 1994, CYTOMETRY, V17, P191, DOI 10.1002/cyto.990170302
   VERBUNT RJAM, 1992, AM HEART J, V123, P208, DOI 10.1016/0002-8703(92)90767-P
NR 20
TC 183
Z9 189
U1 0
U2 29
PU HISTOCHEMICAL SOC INC
PI SEATTLE
PA UNIV WASHINGTON, DEPT BIOSTRUCTURE, BOX 357420, SEATTLE, WA 98195 USA
SN 0022-1554
J9 J HISTOCHEM CYTOCHEM
JI J. Histochem. Cytochem.
PD DEC
PY 2001
VL 49
IS 12
BP 1565
EP 1571
DI 10.1177/002215540104901210
PG 7
WC Cell Biology
SC Cell Biology
GA 509TT
UT WOS:000173166300010
PM 11724904
OA Bronze
DA 2021-01-25
ER

PT J
AU Goldsbury, C
   Aebi, U
   Frey, P
AF Goldsbury, C
   Aebi, U
   Frey, P
TI Pictures in molecular medicine visualizing the growth of Alzheimer's A
   beta amyloid-like fibrils
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Editorial Material
ID INHIBITORS
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel 70, Switzerland.
   Novartis Pharma AG, CH-4056 Basel, Switzerland.
RP Goldsbury, C (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel 70, Switzerland.
CR Findeis MA, 2000, BBA-MOL BASIS DIS, V1502, P76, DOI 10.1016/S0925-4439(00)00034-X
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259
   Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741
NR 5
TC 11
Z9 13
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
J9 TRENDS MOL MED
JI Trends Mol. Med
PD DEC
PY 2001
VL 7
IS 12
BP 582
EP 582
DI 10.1016/S1471-4914(01)02180-3
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 500FP
UT WOS:000172615700015
PM 11733223
DA 2021-01-25
ER

PT J
AU Dossenbach, C
   Rock, S
   Affolter, M
AF Dossenbach, C
   Rock, S
   Affolter, M
TI Specificity of FGF signaling in cell migration in Drosophila
SO DEVELOPMENT
LA English
DT Article
DE cell migration; FGF signaling; receptor tyrosine kinases; trachea;
   mesoderm; Drosophila
ID RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; MESODERMAL CELLS;
   TRACHEAL SYSTEM; HOMOLOG; PATHWAY; PROTEIN; ACTIVATION; BREATHLESS; RAS
AB We wanted to investigate the relationship between receptor tyrosine kinase (RTK) activated signaling pathways and the induction of cell migration. Using Drosophila tracheal and mesodermal cell migration as model systems, we find that the intracellular domain of the fibroblast growth factor receptors (FGFRs) Breathless (Btl) and Heartless (Htl) can be functionally replaced by the intracellular domains of Torso (Tor) and epidermal growth factor receptor (EGFR). These hybrid receptors can also rescue cell migration in the absence of Downstream of FGFR (Dof), a cytoplasmic protein essential for FGF signaling. These results demonstrate that tracheal and mesodermal cells respond during a specific time window to a receptor tyrosine kinase (RTK) signal with directed migration, independent of the presence or absence of Dof. We discuss our findings in the light of the recent findings that RTKs generate a generic signal that is interpreted in responding cells according to their developmental history.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
OI Affolter, Markus/0000-0002-5171-0016
CR AFFOLTER M, 1994, DEVELOPMENT, V120, P743
   Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183
   Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993
   Boube M, 2001, GENE DEV, V15, P1554, DOI 10.1101/gad.195501
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131
   Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0
   Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9
   Franch-Marro X, 2000, DEV BIOL, V227, P80, DOI 10.1006/dbio.2000.9890
   FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0
   Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019
   Ghiglione C, 1999, DEV BIOL, V205, P181, DOI 10.1006/dbio.1998.9102
   Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003
   Golembo M, 1996, DEVELOPMENT, V122, P223
   Greenwood S, 1997, DEVELOPMENT, V124, P4879
   Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402
   Guillemin K, 1996, DEVELOPMENT, V122, P1353
   Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312
   Halfar K, 2001, DEVELOPMENT, V128, P1687
   Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7
   Imam F, 1999, GENETICS, V152, P307
   KARPEN GH, 1992, GENETICS, V132, P737
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4
   Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912
   Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0
   MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8
   Michelson AM, 1998, DEVELOPMENT, V125, P4379
   Michelson AM, 1998, DEV GENET, V22, P212, DOI 10.1002/(SICI)1520-6408(1998)22:3<212::AID-DVG4>3.0.CO;2-9
   PERRIMON N, 1995, MOL REPROD DEV, V42, P515, DOI 10.1002/mrd.1080420421
   REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R
   REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428
   Rommel C, 1998, CURR OPIN GENET DEV, V8, P412, DOI 10.1016/S0959-437X(98)80111-1
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
   SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H
   Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/S0092-8674(00)00114-8
   SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   Shishido E, 1997, DEVELOPMENT, V124, P2119
   SHISHIDO E, 1993, DEVELOPMENT, V117, P751
   Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8
   SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Wilson R, 2000, PHILOS T ROY SOC B, V355, P891, DOI 10.1098/rstb.2000.0625
   Wolf C, 2000, GENE DEV, V14, P2140, DOI 10.1101/gad.180900
   Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0
NR 48
TC 31
Z9 31
U1 0
U2 2
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD NOV
PY 2001
VL 128
IS 22
BP 4563
EP 4572
PG 10
WC Developmental Biology
SC Developmental Biology
GA 499FC
UT WOS:000172559500016
PM 11714681
DA 2021-01-25
ER

PT J
AU Aspock, G
   Burglin, TR
AF Aspock, G
   Burglin, TR
TI The Caenorhabditis elegans Distal-less ortholog ceh-43 is required for
   development of the anterior hypodermis
SO DEVELOPMENTAL DYNAMICS
LA English
DT Article
DE ceh-43; homeobox; Distal-less; C. elegans; anterior closure;
   morphogenesis
ID EPIDERMAL MORPHOGENESIS; LIMB DEVELOPMENT; GENE; EXPRESSION; SYSTEM;
   EVOLUTION; SEQUENCE; ENCODES; CELL; FOREBRAIN
AB Homeobox genes of the Distal-less (Dll) class are expressed in developing appendages as well as in the central nervous system in invertebrates and vertebrates. Mutant analyses in mice and Drosophila have implicated these genes in outgrowth of structures, cell adhesion, cell migration, and cell fate decisions. We have investigated the expression and function of ceh-43, the Dll ortholog from the nematode Caenorhabditis elegans, by using gfp reporter constructs and double-stranded RNA-mediated interference (RNAi). Our results show that, as in the fly, the C. elegans Dll ortholog seems to play a role in cell adhesion. An antibody against the butterfly Distal-less homeodomain stains the nervous system of C. elegans embryos (Panganiban et al. [1997] Proc Natl Acad Sci USA. 94:5162-5166). GFP expression under the control of the ceh-43 promoter looks similar, although strong expression is primarily confined to the head hypodermis and to neuronal support cells. ceh43(RNAi) results in 100% lethality at embryonic or early larval stages. At the beginning of morphogenesis, ceh-43(RNAi) embryos start to lose cells through a hole in the head hypodermis. They either rupture anteriorly as elongation proceeds, or they elongate normally to threefold egg length with the pharynx not connected to the mouth. Elongated ceh-43(RNAi) animals die before or soon after hatching with a fluid-filled pseudocoel and large vacuoles. These phenotypes suggest a role for ceh-43 in development of adhesive properties in the head hypodermis that connects the epithelia of the skin and the digestive tract. Furthermore, possible defects in the excretory system may result at least in part from a requirement for ceh-43 in the CAN neurons where ceh-43::gfp is also expressed. (C) 2001 Wiley-Liss, Inc.
C1 Univ Basel, Biozentrum, Div Cell Biol, CH-4056 Basel, Switzerland.
RP Burglin, TR (corresponding author), Karolinska Inst, Sodertorns Hgsk, Dept Biosci, Box 4101,Alfred Nobels Alle 10, S-14104 Huddinge, Sweden.
EM thomas.burglin@biosci.ki.se
CR AKIMENKO MA, 1994, J NEUROSCI, V14, P3475
   Anderson C. A., 1997, REV GEN PSYCHOL, V1, P19, DOI [10.1037/1089-2680.1.1.19, DOI 10.1037/1089-2680.1.1.19]
   Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474
   Aspock G, 1999, GENOME RES, V9, P909, DOI 10.1101/gr.9.10.909
   Beanan MJ, 2000, DEV DYNAM, V218, P545, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1026>3.0.CO;2-B
   Beermann A, 2001, DEVELOPMENT, V128, P287
   Burglin TR, 2000, J MICROSC-OXFORD, V200, P75, DOI 10.1046/j.1365-2818.2000.00741.x
   Burglin TR, 1999, DEV GENES EVOL, V209, P629, DOI 10.1007/s004270050298
   BURGLIN TR, 1989, NATURE, V341, P239, DOI 10.1038/341239a0
   BURGLIN TR, 1995, BIODIVERSITY EVOLUTI, P291
   C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1089/dna.1997.16.663
   Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X
   Chin-Sang ID, 2000, TRENDS GENET, V16, P544, DOI 10.1016/S0168-9525(00)02143-0
   COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0
   Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297
   Ferrari D, 1999, DEV DYNAM, V216, P10, DOI 10.1002/(SICI)1097-0177(199909)216:1<10::AID-DVDY3>3.0.CO;2-A
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Forrester WC, 1997, DEVELOPMENT, V124, P1831
   Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517
   Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526
   Gorfinkiel N, 1997, GENE DEV, V11, P2259, DOI 10.1101/gad.11.17.2259
   HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9
   Holland ND, 1996, DEVELOPMENT, V122, P2911
   Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425
   Labouesse M, 1997, DEV DYNAM, V210, P19, DOI 10.1002/(SICI)1097-0177(199709)210:1<19::AID-AJA3>3.0.CO;2-4
   Mello C, 1995, METHOD CELL BIOL, V48, P451
   Merlo GR, 2000, INT J DEV BIOL, V44, P619
   Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6
   MORASSO MI, 1995, P NATL ACAD SCI USA, V92, P3968, DOI 10.1073/pnas.92.9.3968
   NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107
   Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162
   Panganiban G, 2000, DEV DYNAM, V218, P554, DOI 10.1002/1097-0177(200008)218:4<554::AID-DVDY1023>3.0.CO;2-#
   PRICE M, 1991, NATURE, V351, P748, DOI 10.1038/351748a0
   PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1
   Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556
   SATO T, 1984, DROSOPHILA INFORMATI, V60, P180
   Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509
   Simske JS, 2001, BIOESSAYS, V23, P12, DOI 10.1002/1521-1878(200101)23:1&lt;12::AID-BIES1003&gt;3.0.CO;2-R
   Stock DW, 1996, P NATL ACAD SCI USA, V93, P10858, DOI 10.1073/pnas.93.20.10858
   SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4
   SUNKEL CE, 1987, ROUX ARCH DEV BIOL, V196, P124, DOI 10.1007/BF00402034
   Thomas BL, 1997, DEVELOPMENT, V124, P4811
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305
   WilliamsMasson EM, 1997, DEVELOPMENT, V124, P2889
   Wood WB, 1988, NEMATODE CAENORHABDI
   WRIGHT KA, 1981, CAN J ZOOL, V59, P1952, DOI 10.1139/z81-266
NR 47
TC 14
Z9 16
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1058-8388
EI 1097-0177
J9 DEV DYNAM
JI Dev. Dyn.
PD NOV
PY 2001
VL 222
IS 3
BP 403
EP 409
DI 10.1002/dvdy.1201
PG 7
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA 489XT
UT WOS:000172018600008
PM 11747075
DA 2021-01-25
ER

PT J
AU Sass, HJ
   Musco, G
   Stahl, SJ
   Wingfield, PT
   Grzesiek, S
AF Sass, HJ
   Musco, G
   Stahl, SJ
   Wingfield, PT
   Grzesiek, S
TI An easy way to include weak alignment constraints into NMR structure
   calculations
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE orientation; protein; pseudo-inverse; residual tensorial coupling;
   structure calculation
ID ORIENTED MACROMOLECULES; DIPOLAR COUPLINGS
AB We have recently shown that an energy penalty for the incorporation of residual tensorial constraints into molecular structure calculations can be formulated without the explicit knowledge of the Saupe orientation tensor (Moltke and Grzesiek, J. Biomol. NMR, 1999, 15, 77-82). Here we report the implementation of such an algorithm into the program X-PLOR. The new algorithm is easy to use and has good convergence properties. The algorithm is used for the structure refinement of the HIV-1 Nef protein using 252 dipolar coupling restraints. The approach is compared to the conventional penalty function with explicit knowledge of the orientation tensor's amplitude and rhombicity. No significant differences are found with respect to speed, Ramachandran core quality or coordinate precision.
C1 Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Hosp San Raffaele, Dept Neurosci, Dept Biol & Technol Res, I-20132 Milan, Italy.
   NIAMSD, NIH, Bethesda, MD 20892 USA.
RP Sass, HJ (corresponding author), Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
EM Stephan.Grzesiek@unibas.ch
RI Musco, Giovanna/Q-2756-2019; musco, giovanna/I-7122-2012
OI musco, giovanna/0000-0002-0469-2994; Grzesiek,
   Stephan/0000-0003-1998-4225; Wingfield, Paul/0000-0002-9515-4752
CR Anderson E, 1999, LAPACK USERS GUIDE
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   Clore GM, 1998, J MAGN RESON, V133, P216, DOI 10.1006/jmre.1998.1419
   Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   GOLUB GH, 1973, SIAM J NUMER ANAL, V10, P413, DOI 10.1137/0710036
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754
   Moltke S, 1999, J BIOMOL NMR, V15, P77, DOI 10.1023/A:1008309630377
   Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   SAUPE A, 1964, Z NATURFORSCH PT A, VA 19, P161
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tjandra N, 1997, J MAGN RESON, V124, P512, DOI 10.1006/jmre.1996.1088
   Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732
   TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   Warren JJ, 2001, J MAGN RESON, V149, P271, DOI 10.1006/jmre.2001.2307
NR 22
TC 45
Z9 45
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD NOV
PY 2001
VL 21
IS 3
BP 275
EP 280
DI 10.1023/A:1012998006281
PG 6
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 496EM
UT WOS:000172383300008
PM 11775744
DA 2021-01-25
ER

PT J
AU Rosenbusch, JP
AF Rosenbusch, JP
TI Stability of membrane proteins: Relevance for the selection of
   appropriate methods for high-resolution structure determinations
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Review
DE crystallization; flexibility; membrane protein function; packing
   density; pliancy; secondary structure; stability; structure
   determination methods
ID NICOTINIC ACETYLCHOLINE-RECEPTOR; PHOTOSYNTHETIC REACTION-CENTER;
   LIGHT-HARVESTING COMPLEX; ESCHERICHIA-COLI; LACTOSE PERMEASE; ANGSTROM
   RESOLUTION; CRYSTAL-STRUCTURE; OUTER-MEMBRANE; CUBIC PHASES;
   LIPID-BILAYERS
AB High stability is a prominent characteristic of integral membrane proteins of known atomic structure. But rather than being an intrinsic property, it may be due to a selection exerted by biochemical procedures prior to structure determination, since solubilization results in the transient exposure of membrane proteins to solution conditions. This may cause structural perturbations that interfere with 3D crystallization and hence with X-ray analysis. This problem also affects the preparation of samples for electron crystallography and NMR studies and may account for the fact that high-resolution structures of representatives of whole groups, such as transport proteins and signal transducers, have not been elucidated so far by any method. A knowledge of the proportion of labile proteins among membrane proteins, and of the kinetics of their denaturation, is therefore necessary. Establishing stability profiles, developing methods to maintain lateral pressure, or preventing contact with water (or both) should prove significant in establishing the structures of conformationally flexible proteins. (C) 2001 Elsevier Science (USA).
C1 Univ Basel, Biozentrum, CH-4051 Basel, Switzerland.
RP Rosenbusch, JP (corresponding author), Univ Basel, Biozentrum, Klingelbregstr 70, CH-4051 Basel, Switzerland.
CR ALBERTSSON PA, 1973, BIOCHEMISTRY-US, V12, P2525, DOI 10.1021/bi00737a024
   ALTENDORF K, 1977, EUR J BIOCHEM, V73, P545, DOI 10.1111/j.1432-1033.1977.tb11349.x
   Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214
   ARYSTARKHOVA E, 1995, J BIOL CHEM, V270, P8785, DOI 10.1074/jbc.270.15.8785
   Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240
   Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028
   Barrantes FJ, 2000, J BIOL CHEM, V275, P37333, DOI 10.1074/jbc.M005246200
   Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X
   BLAUROCK AE, 1969, NATURE, V223, P906, DOI 10.1038/223906a0
   Bonhivers M, 2001, BIOCHEMISTRY-US, V40, P2606, DOI 10.1021/bi001725i
   Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279
   Bowie JU, 2001, CURR OPIN STRUC BIOL, V11, P397, DOI 10.1016/S0959-440X(00)00223-2
   Branden C-I, 1991, INTRO PROTEIN STRUCT
   Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011
   BROUILLETTE CG, 1987, BIOCHEMISTRY-US, V26, P7431, DOI 10.1021/bi00397a035
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1
   Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793
   Changeux JP, 2001, CURR OPIN NEUROBIOL, V11, P369, DOI 10.1016/S0959-4388(00)00221-X
   Chiu ML, 2000, ACTA CRYSTALLOGR D, V56, P781, DOI 10.1107/S0907444900004716
   CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7
   Cordone L, 1999, BIOPHYS J, V76, P1043, DOI 10.1016/S0006-3495(99)77269-3
   Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y
   Cotten M, 1997, BIOPHYS J, V73, P614, DOI 10.1016/S0006-3495(97)78097-4
   COWAN SW, 1994, SCIENCE, V264, P914, DOI 10.1126/science.8178151
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   Deber CM, 2001, PROTEIN SCI, V10, P212, DOI 10.1110/ps.30301
   DEISENHOFER J, 1995, J MOL BIOL, V246, P429, DOI 10.1006/jmbi.1994.0097
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Edwards AM, 2000, NAT STRUCT BIOL, V7, P970, DOI 10.1038/80751
   Egorova-Zachernyuk TA, 2001, J BIOMOL NMR, V19, P243, DOI 10.1023/A:1011235417465
   Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796
   EISELE JL, 1989, J MOL BIOL, V206, P209, DOI 10.1016/0022-2836(89)90533-0
   ENGELMAN DM, 1982, P NATL ACAD SCI USA, V77, P2023
   Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673
   Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298
   Fleming KG, 2000, CURR OPIN BIOTECH, V11, P67, DOI 10.1016/S0958-1669(99)00056-7
   Fleming PJ, 2000, J MOL BIOL, V299, P487, DOI 10.1006/jmbi.2000.3750
   Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Fu RQ, 2000, J BIOMOL NMR, V16, P261, DOI 10.1023/A:1008372508024
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   GOLDER WA, 1976, J CHROMATOGR, V123, P293, DOI 10.1016/S0021-9673(00)82197-4
   GOLDKORN T, 1983, P NATL ACAD SCI-BIOL, V80, P3322, DOI 10.1073/pnas.80.11.3322
   Griffiths JM, 2000, BIOCHEMISTRY-US, V39, P362, DOI 10.1021/bi991106d
   GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x
   Ha NC, 2000, NAT STRUCT BIOL, V7, P147
   HALTIA T, 1994, BIOCHEMISTRY-US, V33, P9731, DOI 10.1021/bi00198a044
   HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W
   HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Heremans K, 1998, BBA-PROTEIN STRUCT M, V1386, P353, DOI 10.1016/S0167-4838(98)00102-2
   HILL BC, 1988, BIOCHEMISTRY-US, V27, P4741, DOI 10.1021/bi00413a024
   Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993
   Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797
   Jayasinghe S, 2001, PROTEIN SCI, V10, P455, DOI 10.1110/ps.43501
   JUNG K, 1995, BIOCHEMISTRY-US, V34, P6272, DOI 10.1021/bi00019a003
   Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077
   Kaback HR, 1999, ACCOUNTS CHEM RES, V32, P805, DOI 10.1021/ar970256i
   Kaback HR, 1997, CURR OPIN STRUC BIOL, V7, P537, DOI 10.1016/S0959-440X(97)80119-4
   Karrasch S, 1996, J MOL BIOL, V262, P336, DOI 10.1006/jmbi.1996.0517
   Kikuchi J, 1999, BIOPOLYMERS, V49, P361, DOI 10.1002/(SICI)1097-0282(19990415)49:5<361::AID-BIP3>3.0.CO;2-4
   Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x
   Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390
   KONIG N, 1989, THESIS U BASEL BASEL
   KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0
   Kuhlbrandt W, 2000, NATURE, V406, P569, DOI 10.1038/35020654
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lambert O, 1999, J STRUCT BIOL, V126, P145, DOI 10.1006/jsbi.1999.4115
   Lamzin VS, 2000, NAT STRUCT BIOL, V7, P978, DOI 10.1038/80763
   Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j
   Le Novere N, 1999, BIOPHYS J, V76, P2329, DOI 10.1016/S0006-3495(99)77390-X
   Lemmon M.A., 1992, CURR OPIN STRUC BIOL, V2, P511
   Li SJ, 2001, BIOPHYS J, V81, P983, DOI 10.1016/S0006-3495(01)75756-6
   Lindblom G, 1996, CURR OPIN COLLOID IN, V1, P287, DOI 10.1016/S1359-0294(96)80017-3
   Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883
   Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   Luzzati V, 1997, CURR OPIN STRUC BIOL, V7, P661, DOI 10.1016/S0959-440X(97)80075-9
   Marassi FM, 1998, CURR OPIN STRUC BIOL, V8, P640, DOI 10.1016/S0959-440X(98)80157-7
   MARCHESI VT, 1972, P NATL ACAD SCI USA, V69, P1445, DOI 10.1073/pnas.69.6.1445
   Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3
   MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0
   MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x
   Methot N, 2001, J BIOL CHEM, V276, P23726, DOI 10.1074/jbc.M102101200
   MICHEL H, 1980, P NATL ACAD SCI-BIOL, V77, P1283, DOI 10.1073/pnas.77.3.1283
   MICHEL H, 1982, EMBO J, V1, P1267, DOI 10.1002/j.1460-2075.1982.tb00023.x
   MICHEL H, 1980, P NATL ACAD SCI-BIOL, V77, P338, DOI 10.1073/pnas.77.1.338
   MICHEL H, 2001, MEMBRANE PROTEINS KN
   Minke WE, 2000, ACTA CRYSTALLOGR D, V56, P795, DOI 10.1107/S090744490000514X
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721
   MORGAN DG, 1995, J MOL BIOL, V249, P88, DOI 10.1006/jmbi.1995.0282
   Mozhaev VV, 1996, PROTEINS, V24, P81, DOI 10.1002/(SICI)1097-0134(199601)24:1<81::AID-PROT6>3.0.CO;2-R
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Nagel G, 1998, BIOPHYS J, V74, P403, DOI 10.1016/S0006-3495(98)77797-5
   NEWMAN MJ, 1981, J BIOL CHEM, V256, P1804
   Nollert P, 1999, FEBS LETT, V457, P205, DOI 10.1016/S0014-5793(99)01014-5
   Nollert P, 2001, FEBS LETT, V504, P179, DOI 10.1016/S0014-5793(01)02747-8
   OIKAWA K, 1985, BIOCHEMISTRY-US, V24, P2843, DOI 10.1021/bi00333a005
   Ortells MO, 1996, PROTEIN ENG, V9, P51, DOI 10.1093/protein/9.1.51
   PAGE MGP, 1988, J BIOL CHEM, V263, P15897
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Pebay-Peyroula E, 2001, CURR OPIN STRUC BIOL, V11, P427, DOI 10.1016/S0959-440X(00)00228-1
   Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1
   Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c
   Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k
   PICOREL R, 1991, J AM CHEM SOC, V113, P2839, DOI 10.1021/ja00008a006
   Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x
   Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881
   POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7
   Pouny Y, 1998, BIOCHEMISTRY-US, V37, P15713, DOI 10.1021/bi981519z
   Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224
   Reat V, 1998, P NATL ACAD SCI USA, V95, P4970, DOI 10.1073/pnas.95.9.4970
   Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198
   Riek R, 1999, P NATL ACAD SCI USA, V96, P4918, DOI 10.1073/pnas.96.9.4918
   RIZZOLO LJ, 1978, BIOCHEMISTRY-US, V17, P4044, DOI 10.1021/bi00612a027
   ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019
   Rosenbusch JP, 2001, MICRON, V32, P75, DOI 10.1016/S0968-4328(00)00021-4
   ROSENBUSCH JP, 1977, SOLUBILIZATION LIPOP, P59
   ROST B, 1995, PROTEIN SCI, V4, P521
   Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100
   Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898
   RUMMEL G, 2002, METHODS RESULTS MEMB
   Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863
   Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775
   SANDERMANN H, 1978, FEBS LETT, V95, P107, DOI 10.1016/0014-5793(78)80062-3
   SASS HJ, 1989, J MOL BIOL, V209, P171, DOI 10.1016/0022-2836(89)90180-0
   SCHENKMAN S, 1984, J BIOL CHEM, V259, P7570
   SCHERTLER GFX, 1993, J MOL BIOL, V234, P156, DOI 10.1006/jmbi.1993.1570
   SCHINDLER H, 1978, P NATL ACAD SCI USA, V75, P3751, DOI 10.1073/pnas.75.8.3751
   SCHINDLER M, 1984, FEBS LETT, V173, P85, DOI 10.1016/0014-5793(84)81022-4
   SCHIRMER T, 1993, PROTEIN SCI, V2, P1361, DOI 10.1002/pro.5560020820
   Schwaiger M, 1998, EUR J BIOCHEM, V254, P610, DOI 10.1046/j.1432-1327.1998.2540610.x
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614
   Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9
   Tauc P, 1998, BIOPHYS J, V74, P1864, DOI 10.1016/S0006-3495(98)77896-8
   Templer RH, 1998, J PHYS CHEM B, V102, P7251, DOI 10.1021/jp972835a
   TOMMASSEN J, 1988, NATO ASI SER, P351
   TREUTLEIN H, 1992, P NATL ACAD SCI USA, V89, P75, DOI 10.1073/pnas.89.1.75
   Unger VM, 1997, NATURE, V389, P203
   VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0
   Vince JW, 1997, BBA-BIOMEMBRANES, V1326, P295, DOI 10.1016/S0005-2736(97)00033-3
   Vinogradova O, 1997, BIOPHYS J, V72, P2688, DOI 10.1016/S0006-3495(97)78912-4
   Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640
   WALIAN PJ, 1990, J MOL BIOL, V215, P429, DOI 10.1016/S0022-2836(05)80362-6
   Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420
   Watanabe M, 1997, BIOPHYS J, V72, P2094, DOI 10.1016/S0006-3495(97)78852-0
   Watts A, 1998, BBA-REV BIOMEMBRANES, V1376, P297, DOI 10.1016/S0304-4157(98)00012-4
   WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242
   Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798
   Wilson S, 1998, BRIT J PHARMACOL, V125, P1387, DOI 10.1038/sj.bjp.0702238
   WIRZ J, 1984, REVERSE MICELLES, P231
   Wu JH, 1998, J MOL BIOL, V282, P959, DOI 10.1006/jmbi.1998.2065
   Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604
   Zhou FX, 2000, NAT STRUCT BIOL, V7, P154
   Zhou YF, 2001, PROTEIN SCI, V10, P378, DOI 10.1110/ps.34201
   Zhuang JP, 1999, J STRUCT BIOL, V125, P63, DOI 10.1006/jsbi.1998.4059
   Zou XQ, 2001, BIOCHEMISTRY-US, V40, P5579, DOI 10.1021/bi010133c
NR 163
TC 66
Z9 68
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD NOV
PY 2001
VL 136
IS 2
BP 144
EP 157
DI 10.1006/jsbi.2001.4431
PG 14
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 531UU
UT WOS:000174436300008
PM 11886216
DA 2021-01-25
ER

PT J
AU Goldman, RD
   Khuon, S
   Yoon, M
   Helfand, BT
   Aebi, U
   Herrmann, H
AF Goldman, RD
   Khuon, S
   Yoon, M
   Helfand, BT
   Aebi, U
   Herrmann, H
TI The structure and function of intermediate filament proteins in the
   lamellipodia and ruffled membranes of cultured cells
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 Northwestern Univ, Sch Med, Chicago, IL 60611 USA.
   Univ Basel, Biozentrum, Basel, Switzerland.
   German Canc Res Ctr, Div Cell Biol A0100, D-6900 Heidelberg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2001
VL 12
SU S
MA 293
BP 54A
EP 54A
PG 1
WC Cell Biology
SC Cell Biology
GA 496AL
UT WOS:000172372500294
DA 2021-01-25
ER

PT J
AU Strelkov, SV
   Herrmann, H
   Geisler, N
   Zimbelmann, R
   Burkhard, P
   Aebi, U
AF Strelkov, SV
   Herrmann, H
   Geisler, N
   Zimbelmann, R
   Burkhard, P
   Aebi, U
TI Evolutionarily conserved alpha-helical segments 1A and 2B of the
   intermediate filament dimer: their atomic structures and role in
   filament assembly
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 Univ Basel, Biozentrum, M E Mueller Inst, Basel, Switzerland.
   German Canc Res Ctr, D-69120 Heidelberg, Germany.
   Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2001
VL 12
SU S
MA 297
BP 54A
EP 55A
PG 2
WC Cell Biology
SC Cell Biology
GA 496AL
UT WOS:000172372500298
DA 2021-01-25
ER

PT J
AU Herrmann, H
   Wedig, T
   Muecke, N
   Tran, S
   Langowski, J
   Steinert, P
   Burkhard, P
   Aebi, U
AF Herrmann, H
   Wedig, T
   Muecke, N
   Tran, S
   Langowski, J
   Steinert, P
   Burkhard, P
   Aebi, U
TI Molecular and Biophysical Characterization of "unit-length filaments"
   (ULFs) assembled from wild-type in comparison to a temperature-sensitive
   human vimentin
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 German Canc Res Ctr, D-69120 Heidelberg, Germany.
   NIH, Skin Biol Lab, Bethesda, MD USA.
   Univ Basel, Biozentrum, M E Mueller Inst, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2001
VL 12
SU S
MA 299
BP 55A
EP 55A
PG 1
WC Cell Biology
SC Cell Biology
GA 496AL
UT WOS:000172372500300
DA 2021-01-25
ER

PT J
AU Muecke, N
   Wedig, T
   Buerer, A
   Marekov, L
   Steinert, PM
   Langowski, J
   Aebi, U
   Herrmann, H
AF Muecke, N
   Wedig, T
   Buerer, A
   Marekov, L
   Steinert, PM
   Langowski, J
   Aebi, U
   Herrmann, H
TI Characterization of physiological "assembly-starter-units" of vimentin:
   The phosphate buffer system
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 German Canc Res Ctr, D-6900 Heidelberg, Germany.
   Univ Basel, Biozentrum, M E Mueller Inst, Basel, Switzerland.
   NIH, NIAMS, Bethesda, MD 20892 USA.
RI Langowski, Jorg/A-1843-2011
OI Langowski, Jorg/0000-0001-8600-0666
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2001
VL 12
SU S
MA 300
BP 55A
EP 55A
PG 1
WC Cell Biology
SC Cell Biology
GA 496AL
UT WOS:000172372500301
DA 2021-01-25
ER

PT J
AU Steinert, PM
   Muecke, N
   Buerer, A
   Aebi, U
   Marekov, L
   Herrmann, H
AF Steinert, PM
   Muecke, N
   Buerer, A
   Aebi, U
   Marekov, L
   Herrmann, H
TI Investigating the association state of headless intermediate filament
   proteins
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 NIH, NIAMS, Skin Biol Lab, Bethesda, MD 20892 USA.
   Univ Basel, Biozentrum, Div Biophys & Macromol, Basel, Switzerland.
   Univ Basel, Biozentrum, M E Mueller Inst, Basel, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Deutsch Krebsforschungszentrum, Div Cell Biol, Heidelberg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2001
VL 12
SU S
MA 298
BP 55A
EP 55A
PG 1
WC Cell Biology
SC Cell Biology
GA 496AL
UT WOS:000172372500299
DA 2021-01-25
ER

PT J
AU Fahrenkrog, B
   Sauder, U
   Ullman, KS
   Aebi, U
AF Fahrenkrog, B
   Sauder, U
   Ullman, KS
   Aebi, U
TI The nuclear pore complex towards a structure-based functional
   understanding of its central channel
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 European Mol Biol Lab, D-69117 Heidelberg, Germany.
   Univ Basel, Biozentrum, Maurice E Muller Inst High Resolut Electron M, CH-4003 Basel, Switzerland.
   Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2001
VL 12
SU S
MA 1258
BP 230A
EP 230A
PG 1
WC Cell Biology
SC Cell Biology
GA 496AL
UT WOS:000172372501256
DA 2021-01-25
ER

PT J
AU Fahrenkrog, B
   Duijts, A
   Borries, M
   Nassal, M
   Aebi, U
   Schoenenberger, CA
AF Fahrenkrog, B
   Duijts, A
   Borries, M
   Nassal, M
   Aebi, U
   Schoenenberger, CA
TI Challenging the size and function of the nuclear pore complex by
   recombinant hepatitis B virus capsids
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 European Mol Biol Lab, D-69117 Heidelberg, Germany.
   Univ Basel, ME Muller Inst Biomech, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Freiburg Klinikum, Dept Internal Med 2 Mol Biol, Freiburg, Germany.
   Univ Basel, ME Muller Inst Biomech, Bioctr, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2001
VL 12
SU S
MA 1262
BP 231A
EP 231A
PG 1
WC Cell Biology
SC Cell Biology
GA 496AL
UT WOS:000172372501260
DA 2021-01-25
ER

PT J
AU De Marco, V
   Burkhard, P
   Le Bot, N
   Vernos, I
   Hoenger, A
AF De Marco, V
   Burkhard, P
   Le Bot, N
   Vernos, I
   Hoenger, A
TI Analysis of heterodimer formation of Xklp3A/B, a kinesin-II from Xenopus
   laevis
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 European Mol Biol Lab, Struct Biol Programme, D-69117 Heidelberg, Germany.
   European Mol Biol Lab, Cell Biol & Biophys Programme, D-69117 Heidelberg, Germany.
   Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2001
VL 12
SU S
MA 2408
BP 437A
EP 437A
PG 1
WC Cell Biology
SC Cell Biology
GA 496AL
UT WOS:000172372502403
DA 2021-01-25
ER

PT J
AU Schorling, S
   Vallee, B
   Barz, WP
   Riezman, H
   Oesterhelt, D
AF Schorling, S
   Vallee, B
   Barz, WP
   Riezman, H
   Oesterhelt, D
TI Lag1p and Lac1p are essential for the acyl-CoA-dependent ceramide
   synthase reaction in Saccharomyces cerevisae
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; LONG-CHAIN BASES;
   ENDOPLASMIC-RETICULUM; ALKALINE CERAMIDASE; GOLGI TRANSPORT; SHUTTLE
   VECTORS; SUPPRESSOR GENE; HEAT-STRESS; YEAST; BIOSYNTHESIS
AB Lag1p and Lac1p are two homologous transmembrane proteins of the endoplasmic reticulum in Saccharomyces cerevisiae. Homologous genes have been found in a wide variety of eukaryotes. In yeast, both genes, LAC1 and LAG1, are required for efficient endoplasmic reticulum-to-Golgi transport of glycosylphosphatidylinositol-anchored proteins. In this study, we show that lag1 Delta lac1 Delta cells have reduced sphingolipid levels due to a block of the fumonisin B1-sensitive and acyl-CoA-dependent ceramide synthase reaction. The sphingolipid synthesis defect in lag1 Delta lac1 Delta A cells can be partially corrected by overexpression of YPC1 or YDC1, encoding ceramidases that have been reported to have acyl-CoA-independent ceramide synthesis activity. Quadruple mutant cells (lag1 Delta lac1 Delta ypc1 Delta ydc1 Delta) do not make any sphingolipids, but are still viable probably because they produce novel lipids. Moreover, lag1 Delta lac1 Delta cells are resistant to aureobasidin A, an inhibitor of the inositolphosphorylceramide synthase, suggesting that aureobasidin A may be toxic because it leads to increased ceramide levels. Based on these data, LAG1 and LAC1 are the first genes to be identified that are required for the fumonisin B1-sensitive and acyl-CoA-dependent ceramide synthase reaction.
C1 Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Riezman, H (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.
OI Riezman, Howard/0000-0003-4680-9422; Vallee,
   Beatrice/0000-0002-5161-354X
CR Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043
   BECKER GW, 1980, J BACTERIOL, V142, P747, DOI 10.1128/JB.142.3.747-754.1980
   Brandwagt BF, 2000, P NATL ACAD SCI USA, V97, P4961, DOI 10.1073/pnas.97.9.4961
   CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W
   CULBERTSON MR, 1975, GENETICS, V80, P23
   Dickson RC, 1999, BBA-MOL CELL BIOL L, V1438, P305, DOI 10.1016/S1388-1981(99)00068-2
   Dickson RC, 1998, ANNU REV BIOCHEM, V67, P27, DOI 10.1146/annurev.biochem.67.1.27
   Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196
   Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655
   HANSON BA, 1980, J LIPID RES, V21, P309
   HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x
   IGARASHI Y, 1989, BIOCHEM BIOPH RES CO, V164, P1411, DOI 10.1016/0006-291X(89)91827-5
   Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259
   KRAKOW JL, 1986, J BIOL CHEM, V261, P2147
   Lee TC, 1996, J BIOL CHEM, V271, P209, DOI 10.1074/jbc.271.1.209
   MANDALA SM, 1995, J ANTIBIOT, V48, P349, DOI 10.7164/antibiotics.48.349
   Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150
   Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690
   Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876
   Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200
   Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465
   MORELL P, 1970, J BIOL CHEM, V245, P342
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437
   Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809
   NAGIEC MM, 1993, J BIOL CHEM, V268, P22156
   NASMYTH KA, 1980, P NATL ACAD SCI-BIOL, V77, P2119, DOI 10.1073/pnas.77.4.2119
   PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992
   Perry DK, 1998, BBA-MOL CELL BIOL L, V1436, P233, DOI 10.1016/S0005-2760(98)00145-3
   PUOTI A, 1991, J CELL BIOL, V113, P515, DOI 10.1083/jcb.113.3.515
   Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087
   SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Skrzypek M, 1997, J BACTERIOL, V179, P1513, DOI 10.1128/jb.179.5.1513-1520.1997
   Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999
   Sutterlin C, 1997, J CELL SCI, V110, P2703
   WANG E, 1991, J BIOL CHEM, V266, P14486
   ZATZ M, 1981, J BIOL CHEM, V256, P28
NR 38
TC 197
Z9 201
U1 0
U2 3
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2001
VL 12
IS 11
BP 3417
EP 3427
DI 10.1091/mbc.12.11.3417
PG 11
WC Cell Biology
SC Cell Biology
GA 495TV
UT WOS:000172357200010
PM 11694577
OA Green Published
DA 2021-01-25
ER

PT J
AU Burkhard, P
   Dominici, P
   Borri-Voltattorni, C
   Jansonius, JN
   Malashkevich, VN
AF Burkhard, P
   Dominici, P
   Borri-Voltattorni, C
   Jansonius, JN
   Malashkevich, VN
TI Structural insight into Parkinson's disease treatment from
   drug-inhibited DOPA decarboxylase
SO NATURE STRUCTURAL BIOLOGY
LA English
DT Article
ID AMINO-ACID DECARBOXYLASE; O-ACETYLSERINE SULFHYDRYLASE; SITE-DIRECTED
   MUTAGENESIS; X-RAY ANALYSIS; ACTIVE-SITE; CONFORMATIONAL CHANGE;
   CRYSTAL-STRUCTURE; ASPARTATE-AMINOTRANSFERASE; ORNITHINE DECARBOXYLASE;
   3-DIMENSIONAL STRUCTURE
AB DOPA decarboxylase (DDC) is responsible for the synthesis of the key neurotransmitters dopamine and serotonin via decarboxylation of L-3,4-dihydroxyphenylalanine (L-DOPA) and L-5-hydroxy-tryptophan, respectively. DDC has been implicated in a number of clinic disorders, including Parkinson's disease and hypertension. Peripheral inhibitors of DDC are currently used to treat these diseases. We present the crystal structures of ligand-free DDC and its complex with the anti-Parkinson drug carbiDOPA. The inhibitor is bound to the enzyme by forming a hydrazone linkage with the cofactor, and its catechol ring is deeply buried in the active site cleft. The structures provide the molecular basis for the development of new inhibitors of DDC with better pharmacological characteristics.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Verona, Dipartimento Sci Neurol & Vis, Sez Chim Biol, I-37134 Verona, Italy.
   Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
RP Burkhard, P (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Peter.Burkhard@unibas.ch
CR Agid Y, 1998, LANCET, V351, P851, DOI 10.1016/S0140-6736(05)70285-3
   ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x
   AMINOFF MJ, 1994, WESTERN J MED, V161, P303
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bertoldi M, 2001, EUR J BIOCHEM, V268, P2975, DOI 10.1046/j.1432-1327.2001.02187.x
   Bertoldi M, 1999, J BIOL CHEM, V274, P5514, DOI 10.1074/jbc.274.9.5514
   Brannan T, 1996, J NEURAL TRANSM, V103, P1287, DOI 10.1007/BF01271189
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002
   Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   Diederich C, 1997, PHARMACOLOGY, V55, P109, DOI 10.1159/000139518
   Dominici P, 1997, PROTEIN SCI, V6, P2007, DOI 10.1002/pro.5560060921
   DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712
   Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074
   FETROW JS, 1995, FASEB J, V9, P708
   FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13658, DOI 10.1021/bi00212a034
   FORD GC, 1980, P NATL ACAD SCI-BIOL, V77, P2559, DOI 10.1073/pnas.77.5.2559
   Hennig M, 1997, P NATL ACAD SCI USA, V94, P4866, DOI 10.1073/pnas.94.10.4866
   Ishii S, 1998, PROTEIN SCI, V7, P1802, DOI 10.1002/pro.5560070816
   Ishii S, 1996, J BIOCHEM, V120, P369
   Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1
   JOHN RA, 1995, BBA-PROTEIN STRUCT M, V1248, P81, DOI 10.1016/0167-4838(95)00025-P
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636
   Kang UJ, 1998, MOVEMENT DISORD, V13, P59
   KATO H, 1994, BIOCHEMISTRY-US, V33, P4995, DOI 10.1021/bi00183a001
   KIRSCH JF, 1984, J MOL BIOL, V174, P497, DOI 10.1016/0022-2836(84)90333-4
   Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168
   LARSON EM, 1995, BIOCHEMISTRY-US, V34, P4531, DOI 10.1021/bi00014a005
   Leslie AGW, 1994, MOSFLM USERS GUIDE
   Malashkevich VN, 1999, J MOL BIOL, V294, P193, DOI 10.1006/jmbi.1999.3254
   Malashkevich VN, 1999, ACTA CRYSTALLOGR D, V55, P568, DOI 10.1107/S0907444998006283
   MALASHKEVICH VN, 1992, J MOL BIOL, V224, P1167, DOI 10.1016/0022-2836(92)90477-2
   Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265
   McPherson A., 1982, PREPARATION ANAL PRO
   MERRITT EA, 1997, RASTER3D PHOTOREALIS
   MOMANY C, 1995, J MOL BIOL, V252, P643, DOI 10.1006/jmbi.1995.0526
   MOMANY C, 1995, PROTEIN SCI, V4, P849
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Myers CS, 1998, MOL CHEM NEUROPATHOL, V33, P81, DOI 10.1007/BF02870183
   Nishino J, 1997, J BIOCHEM-TOKYO, V121, P604
   OPACKAJUFFRY J, 1995, MOVEMENT DISORD, V10, P241, DOI 10.1002/mds.870100302
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696
   Poupon A, 1999, PROTEINS, V37, P191, DOI 10.1002/(SICI)1097-0134(19991101)37:2<191::AID-PROT5>3.0.CO;2-4
   Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X
   TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040
   Tramonti A, 1998, J BIOL CHEM, V273, P1939, DOI 10.1074/jbc.273.4.1939
NR 51
TC 155
Z9 161
U1 0
U2 26
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1072-8368
J9 NAT STRUCT BIOL
JI Nat. Struct. Biol.
PD NOV
PY 2001
VL 8
IS 11
BP 963
EP 967
DI 10.1038/nsb1101-963
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 488AD
UT WOS:000171911100016
PM 11685243
DA 2021-01-25
ER

PT J
AU Van Gelder, P
   Dutzler, R
   Dumas, F
   Koebnik, R
   Schirmer, T
AF Van Gelder, P
   Dutzler, R
   Dumas, F
   Koebnik, R
   Schirmer, T
TI Sucrose transport through maltoporin mutants of Escherichia coli
SO PROTEIN ENGINEERING
LA English
DT Article
DE current fluctuation analysis; LamB; porin; ScrY; sugar transport
ID BACTERIOPHAGE-LAMBDA RECEPTOR; SITE-DIRECTED MUTAGENESIS;
   OUTER-MEMBRANE; SUGAR TRANSLOCATION; PORIN SCRY; MALTOSE TRANSPORT;
   ENTERIC BACTERIA; STRUCTURAL BASIS; MOLECULAR-BASIS; NOISE-ANALYSIS
AB Maltoporin (LamB) and sucrose porin (ScrY) reside in the bacterial outer membrane and facilitated the passive diffusion of maltodextrins and sucrose, respectively. To gain further insight into the determinants of solute specificity, LamB mutants were designed to allow translocation of sucrose, which hardly translocates through wild-type LamB. Three LamB mutants were studied. (a) Based on sequence and structure alignment of LamB with ScrY, two LamB triple mutants were generated (R109D, Y118D,D12IF; R109N,Y118D,D121F) to mimic the ScrY constriction. The crystal structure of the first of these mutants was determined to be 3.2 Angstrom and showed an increased ScrY-like cross-section except for D109 that protrudes into the channel. (b) Based on this crystal structure a double mutant was generated by truncation of the two residues that obstruct the channel most in LamB (R109A,Y118A). Analysis of liposome swelling and in vivo sugar uptake demonstrated substantial sucrose permeation through all mutants with the double alanine mutant performing best. The triple mutants did not show a well-defined binding site as indicated by sugar-induced ion current noise analysis, which can be explained by remaining steric interference as deduced from the crystal structure. Binding, however, was observed for the double mutant that had the obstructing residues truncated to alanines.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Microbiol, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 50, CH-4056 Basel, Switzerland.
RI Koebnik, Ralf/J-5627-2014
OI Koebnik, Ralf/0000-0002-4419-0542; Dumas, Fabrice/0000-0002-9164-4527
CR Andersen C, 1998, J MEMBRANE BIOL, V164, P263, DOI 10.1007/s002329900411
   ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385
   BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137
   Brunger A. T., 1992, X PLOR VERSION 3 1 S
   Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Dumas F, 2000, J BIOL CHEM, V275, P19747, DOI 10.1074/jbc.M000268200
   Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0
   Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37
   HARDESTY C, 1991, J BACTERIOL, V173, P449, DOI 10.1128/jb.173.2.449-456.1991
   JONES TA, 1993, VERSION 5 9 MANUAL
   KELLER TA, 1994, BIOCHEM BIOPH RES CO, V199, P767, DOI 10.1006/bbrc.1994.1295
   Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x
   LUCKEY M, 1980, P NATL ACAD SCI USA, V77, P165
   NEKOLLA S, 1994, BIOPHYS J, V66, P1388, DOI 10.1016/S0006-3495(94)80929-4
   NIKAIDO H, 1985, MICROBIOL REV, V49, P1
   NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121
   Otwinowski Z., 1993, DATA COLLECTION PROC, P56
   Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1016/S0378-1097(98)00151-7
   RANDALLH.L, 1973, J BACTERIOL, V116, P1436, DOI 10.1128/JB.116.3.1436-1446.1973
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948
   SCHMID K, 1991, MOL MICROBIOL, V5, P941, DOI 10.1111/j.1365-2958.1991.tb00769.x
   SCHMID K, 1988, MOL MICROBIOL, V2, P1, DOI 10.1111/j.1365-2958.1988.tb00001.x
   SCHULEIN K, 1995, MOL MICROBIOL, V17, P757, DOI 10.1111/j.1365-2958.1995.mmi_17040757.x
   SCHULEIN K, 1991, MOL MICROBIOL, V5, P2233, DOI 10.1111/j.1365-2958.1991.tb02153.x
   SZMELCMAN S, 1975, J BACTERIOL, V124, P112, DOI 10.1128/JB.124.1.112-118.1975
   SZMELCMAN S, 1976, EUR J BIOCHEM, V65, P13, DOI 10.1111/j.1432-1033.1976.tb10383.x
   Ulmke C, 1999, J BACTERIOL, V181, P1920, DOI 10.1128/JB.181.6.1920-1923.1999
   Van Gelder P, 2000, EUR J BIOCHEM, V267, P79, DOI 10.1046/j.1432-1327.2000.00960.x
   Wang YF, 1997, J MOL BIOL, V272, P56, DOI 10.1006/jmbi.1997.1224
NR 31
TC 10
Z9 11
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0269-2139
J9 PROTEIN ENG
JI Protein Eng.
PD NOV
PY 2001
VL 14
IS 11
BP 943
EP 948
DI 10.1093/protein/14.11.943
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 507TX
UT WOS:000173046500016
PM 11742115
OA Bronze
DA 2021-01-25
ER

PT J
AU Chiu, ML
   Viollier, PH
   Katoh, T
   Ramsden, JJ
   Thompson, CJ
AF Chiu, ML
   Viollier, PH
   Katoh, T
   Ramsden, JJ
   Thompson, CJ
TI Ligand-induced changes in the Streptomyces lividans TipAL protein imply
   an alternative mechanism of transcriptional activation for MerR-like
   proteins
SO BIOCHEMISTRY
LA English
DT Article
ID THIOSTREPTON-INDUCED GENE; PREDICTING COILED COILS; RNA-POLYMERASE; DNA;
   BINDING; RECOGNITION; EXPRESSION; PROMOTER; CONSTRUCTION; DOMAIN
AB TipAL is a Streptomyces transcriptional activator assigned to the MerR/SoxR family based both on homology within its putative DNA recognition domain and the fact that its operator binding sites lie within a region of its promoter normally occupied by RNA polymerase. The tipA gene is also independently translated as the C-terminal ligand-binding domain of TipAL (TipAS; residues 111-254). Both TipAS and TipAL share broad recognition specificity for cyclic thiopeptide antibiotics. The molecular mechanism by which TipAL catalyzes prokaryotic transcriptional activation at the tipA promoter (ptipA) in response to thiostrepton was studied using a combination of analytical ultracentrifugation (AU), circular dichroism (CD), optical waveguide lightmode, spectroscopy (OWLS; a sensitive in situ binding assay), and mutational analyses. AU showed that TipAL, but not TipAS, was a dimer in solution in the presence or absence of thiostrepton. This indicated that activation of TipAL by thiostrepton was not mediated by changes in multimerization and mapped the dimerization domain to its N-terminal 110 amino acids, presumably within amino acids predicted to form a coil-coil domain (residues 77-109). CD spectra showed that TipAL had more alpha -helical content than TipAS, probably because of the presence of the additional N-terminal region. The helicity of TipAL and TipAS both increased slightly after binding thiostrepton demonstrating conformation changes upon thiostrepton binding. OWLS experiments determined the overall binding constants via measurements of association and dissociation rates for both TipA proteins and RNA polymerase with ptipA. Thiostrepton slightly enhanced the rate of specific association of TipAL with ptipA, but drastically lowered the rate of dissociation from the binding site. TipAL-thiostrepton increased the affinity of RNA polymerase for ptipA more than 10-fold. In conjunction with genetic experiments, we propose that, while them are some similarities, the mechanism by which TipAL activates transcription is distinctly different from the established MerR/SoxR paradigm.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Thompson, CJ (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM charles-j.thompson@univas.ch
OI Viollier, Patrick/0000-0002-5249-9910; Chiu, Mark/0000-0001-6300-404X
CR AHMED M, 1994, J BIOL CHEM, V269, P28506
   ANSARI AZ, 1992, NATURE, V355, P87, DOI 10.1038/355087a0
   ANSARI AZ, 1995, NATURE, V374, P371
   Babcock MJ, 1997, GENE, V196, P31, DOI 10.1016/S0378-1119(97)00179-0
   Baranova NN, 1999, MOL MICROBIOL, V31, P1549, DOI 10.1046/j.1365-2958.1999.01301.x
   BARRINEAU P, 1984, Journal of Molecular and Applied Genetics, V2, P601
   BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259
   BUTTNER MJ, 1985, J MOL BIOL, V185, P177, DOI 10.1016/0022-2836(85)90189-5
   Caguiat JJ, 1999, J BACTERIOL, V181, P3462, DOI 10.1128/JB.181.11.3462-3471.1999
   Caslake LF, 1997, J BACTERIOL, V179, P1787, DOI 10.1128/jb.179.5.1787-1795.1997
   CHERVENKA CH, 1970, MANUAL METHODS ANAL
   Chiu ML, 1996, BIOCHEMISTRY-US, V35, P2332, DOI 10.1021/bi952073e
   Chiu ML, 1999, J BIOL CHEM, V274, P20578, DOI 10.1074/jbc.274.29.20578
   COMESS KM, 1994, BIOCHEMISTRY-US, V33, P4175, DOI 10.1021/bi00180a010
   FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x
   FRANTZ B, 1990, BIOCHEMISTRY-US, V29, P4747, DOI 10.1021/bi00472a001
   Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138
   Helmann J D, 1990, Adv Inorg Biochem, V8, P33
   HELMANN JD, 1990, SCIENCE, V247, P946, DOI 10.1126/science.2305262
   HELTZEL A, 1990, BIOCHEMISTRY-US, V29, P9572, DOI 10.1021/bi00493a011
   HIDALGO E, 1994, EMBO J, V13, P138, DOI 10.1002/j.1460-2075.1994.tb06243.x
   Hidalgo E, 1997, EMBO J, V16, P1056, DOI 10.1093/emboj/16.5.1056
   HIDALGO E, 1997, REGULATION GENE EXPR, P433
   HOLMES DJ, 1993, EMBO J, V12, P3183, DOI 10.1002/j.1460-2075.1993.tb05987.x
   Hopwood D.A., 1985, GENETIC MANIPULATION
   JAURIN B, 1984, GENE, V28, P83, DOI 10.1016/0378-1119(84)90090-8
   KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264
   KARLIN S, 1993, P NATL ACAD SCI USA, V90, P5873, DOI 10.1073/pnas.90.12.5873
   LANE D, 1992, MICROBIOL REV, V56, P509, DOI 10.1128/MMBR.56.4.509-528.1992
   LEVINE RJ, 1994, PRINCIPLES MED BIO A, V1, P37
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131
   MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X
   MURAKAMI T, 1989, J BACTERIOL, V171, P1459, DOI 10.1128/jb.171.3.1459-1466.1989
   MURAKAMI T, 1986, MOL GEN GENET, V205, P42, DOI 10.1007/BF02428031
   ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017
   PARKHILL J, 1990, NUCLEIC ACIDS RES, V18, P5157, DOI 10.1093/nar/18.17.5157
   PARKHILL J, 1993, EMBO J, V12, P413, DOI 10.1002/j.1460-2075.1993.tb05673.x
   RALSTON DM, 1990, P NATL ACAD SCI USA, V87, P3846, DOI 10.1073/pnas.87.10.3846
   RAMESH V, 1994, PROTEIN ENG, V7, P1053, DOI 10.1093/protein/7.8.1053
   Ramsden JJ, 1996, BIOCHEMISTRY-US, V35, P3746, DOI 10.1021/bi952158f
   Ramsden JJ, 2000, COLLOID SURFACE A, V173, P235
   RAMSDEN JJ, 1995, THIN SOLID FILMS, V254, P246, DOI 10.1016/0040-6090(94)06262-J
   RAMSDEN JJ, 1995, GLYCOCONJUGATE J, V12, P113, DOI 10.1007/BF00731354
   RAMSDEN JJ, 1995, J AM CHEM SOC, V117, P8511, DOI 10.1021/ja00138a003
   RAMSDEN JJ, 1993, BIOCHEMISTRY-US, V32, P523, DOI 10.1021/bi00053a017
   Sambrook J, 1989, MOL CLONING LAB MANU
   SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992
   TIEFENTHALER K, 1992, ADV BIOSENSORS, V2, P261
   Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310
   WARD JM, 1986, MOL GEN GENET, V203, P468, DOI 10.1007/BF00422072
   WEAST RC, 1981, HDB CHEM PHYSICS
   Zeng QD, 1998, BIOCHEMISTRY-US, V37, P15885, DOI 10.1021/bi9817562
   Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6
NR 54
TC 26
Z9 27
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD OCT 30
PY 2001
VL 40
IS 43
BP 12950
EP 12958
DI 10.1021/bi010328k
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 488XL
UT WOS:000171962100023
PM 11669632
DA 2021-01-25
ER

PT J
AU Hauska, G
   Schoedl, T
   Remigy, H
   Tsiotis, G
AF Hauska, G
   Schoedl, T
   Remigy, H
   Tsiotis, G
TI The reaction center of green sulfur bacteria
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Review
DE green sulfur bacteria; homodimeric P840 reaction center; FeS type
   reaction center; photosynthetic electron transport; energy transfer;
   bacteriochlorophyll protein; menaquinone; cytochrome; scanning
   transmission electron microscopy particle analysis
ID PHOTOSYNTHETIC REACTION-CENTER; REACTION-CENTER COMPLEX;
   BIOSYNTHETIC-PATHWAY MUTANTS; CENTER CORE COMPLEXES;
   ELECTRON-PARAMAGNETIC-RESONANCE; I REACTION-CENTER; PHOTOSYSTEM-I;
   PROSTHECOCHLORIS-AESTUARII; CHLOROBIUM-VIBRIOFORME; A(1) SITE
AB The composition of the P840-reaction center complex (RC), energy and electron transfer within the RC, as well as its topographical organization and interaction with other components in the membrane of green sulfur bacteria are presented, and compared to the FeS-type reaction centers of Photosystem I and of Heliobacteria. The core of the RC is homodimeric, since pscA is the only gene found in the genome of Chlorobium tepidum which resembles the genes psaA and -B for the heterodimeric core of Photosystem I. Functionally intact RC can be isolated from several species of green sulfur bacteria. It is generally composed of five subunits, PscA-D plus the BChl a-protein FMO. Functional cores, with PscA and PscB; only, can be isolated from Prostecochloris aestuarii. The PscA-dimer binds P840, a special pair of BChl a-molecules, the primary electron acceptor A(0), which is a Chl a-derivative and FeS-center F-X. An equivalent to the electron acceptor A, in Photosystem I, which is tightly bound phylloquinone acting between A(0) and F-X, is not required for forward electron transfer in the RC of green sulfur bacteria. This difference is reflected by different rates of electron transfer between A(0) and F-X in the two systems. The subunit PscB contains the two FeS-centers F-A and F-B. STEM particle analysis suggests that the core of the RC with PscA and PscB resembles the PsaAB/PsaC-core of the P700-reaction center in Photosystem 1. PscB may form a protrusion into the cytoplasmic space where reduction of ferredoxin occurs, with FMO trimers bound on both sides of this protrusion. Thus the subunit composition of the RC in vivo should be 2(FMO)(3)(PscA)(2)PscB(PScC)(2)PscD. Only 16 BChl a-, four Chl a-molecules and two carotenoids are bound to the RC-core, which is substantially less than its counterpart of Photosystem I, with 85 Chl a-molecules and 22 carotenoids. A total of 58 BChl a/RC are present in the membranes of green sulfur bacteria outside the chlorosomes, corresponding to two trimers of FMO (42 Bchl a) per RC (16 BChl a), The question whether the homodimeric RC is totally symmetric is still open. Furthermore, it is still unclear which cytochrome c is the physiological electron donor to P840(+). Also the way of NAD(+)-reduction is unknown, since a gene equivalent to ferredoxin-NADP(+) reductase is not present in the genome. (C) 2001 Elsevier Science B.V. All rights reserved.
C1 Univ Regensburg, Fak Biol & Vorklin Med, Lehrstuhl Zellbiol & Pflanzenphysiol, D-93040 Regensburg, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Microscop Struct Biol, CH-4056 Basel, Switzerland.
   Univ Crete, Dept Chem, Div Biochem, Iraklion 71409, Greece.
RP Hauska, G (corresponding author), Univ Regensburg, Fak Biol & Vorklin Med, Lehrstuhl Zellbiol & Pflanzenphysiol, D-93040 Regensburg, Germany.
EM guenther.hauska@biologie.uni-regensburg.de
CR ADMAN ET, 1973, J BIOL CHEM, V248, P3987
   Albouy D, 1997, BIOCHEMISTRY-US, V36, P1927, DOI 10.1021/bi962624g
   ALEXANDER B, 2000, 10 INT S PHOT PROK A, P155
   BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099
   Bialek-Bylka GE, 1998, PHOTOSYNTH RES, V58, P135, DOI 10.1023/A:1006112323144
   BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173
   BLANKENSHIP RE, 1995, ADV PHOTOSYNTH, V2, P399
   Brettel K, 1997, BBA-BIOENERGETICS, V1318, P322, DOI 10.1016/S0005-2728(96)00112-0
   Brettel K, 1998, BBA-BIOENERGETICS, V1363, P175, DOI 10.1016/S0005-2728(98)00010-3
   BRYANT DA, 1994, PHOTOSYNTH RES, V41, P27, DOI 10.1007/BF02184142
   BUTTNER M, 1992, P NATL ACAD SCI USA, V89, P8135, DOI 10.1073/pnas.89.17.8135
   Clayton RK, 1966, PHOTOCHEM PHOTOBIOL, V5, P669, DOI 10.1111/j.1751-1097.1966.tb05813.x
   DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0
   DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776
   DRACHEVA S, 1992, RES PHOTOSYNTHESIS, V1, P53
   FEILER U, 1995, BIOCHEMISTRY-US, V34, P11099, DOI 10.1021/bi00035a015
   FEILER U, 1995, ADV PHOTOSYNTH, V2, P665
   FIGUERAS JB, 2000, 10 INT S PHOT PROK B, P155
   Fischer N, 1997, BIOCHEMISTRY-US, V36, P93, DOI 10.1021/bi962244v
   FOWLER CF, 1971, P NATL ACAD SCI USA, V68, P2278, DOI 10.1073/pnas.68.9.2278
   Francke C, 1997, BIOCHEMISTRY-US, V36, P14167, DOI 10.1021/bi9716837
   Francke C, 1996, PHOTOSYNTH RES, V50, P71, DOI 10.1007/BF00018222
   Frankenberg N, 1996, PHOTOCHEM PHOTOBIOL, V64, P14, DOI 10.1111/j.1751-1097.1996.tb02415.x
   Frigaard NU, 1999, BBA-BIOENERGETICS, V1412, P108, DOI 10.1016/S0005-2728(99)00060-2
   Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5
   GOLBECK JH, 1991, CURR TOP BIOENERG, V16, P83
   Griesbeck C, 1998, BBA-BIOENERGETICS, V1365, P285, DOI 10.1016/S0005-2728(98)00081-4
   HAGERBRAUN C, 1995, BIOCHEMISTRY-US, V34, P9617, DOI 10.1021/bi00029a039
   HagerBraun C, 1997, PHOTOSYNTH RES, V51, P127, DOI 10.1023/A:1005787209977
   HAGERBRAUN C, 1999, PHOTOTROPHIC PROKARY, P169
   HAUSKA G, 1988, TRENDS BIOCHEM SCI, V13, P415, DOI 10.1016/0968-0004(88)90206-X
   Hauska G, 1996, ADV PHOTOSYNTH, V4, P377
   HURT EC, 1984, FEBS LETT, V168, P149, DOI 10.1016/0014-5793(84)80225-2
   ILLINGER N, 1993, PHOTOSYNTH RES, V38, P111, DOI 10.1007/BF00015067
   Itoh S, 2001, BBA-BIOENERGETICS, V1507, P115, DOI 10.1016/S0005-2728(01)00199-2
   Iwaki M, 1999, PLANT CELL PHYSIOL, V40, P1021, DOI 10.1093/oxfordjournals.pcp.a029483
   Johnson TW, 2000, J BIOL CHEM, V275, P8523, DOI 10.1074/jbc.275.12.8523
   Kjaer B, 1996, PHOTOSYNTH RES, V47, P33, DOI 10.1007/BF00017751
   KJAER B, 1994, PHOTOSYNTH RES, V41, P105, DOI 10.1007/BF02184150
   Kjaer B, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P3095
   Kjaer B, 1998, BIOCHEMISTRY-US, V37, P3237, DOI 10.1021/bi973121t
   KLEINHERENBRINK FAM, 1993, BIOCHIM BIOPHYS ACTA, V1142, P69, DOI 10.1016/0005-2728(93)90085-T
   KLUGHAMMER C, 1995, PHOTOSYNTH RES, V43, P27, DOI 10.1007/BF00029459
   KOBAYASHI M, 1991, BIOCHIM BIOPHYS ACTA, V1057, P89, DOI 10.1016/S0005-2728(05)80087-8
   Kobayashi M, 2000, PHOTOSYNTH RES, V63, P269, DOI 10.1023/A:1006480629059
   KUSAI K, 1973, BIOCHIM BIOPHYS ACTA, V325, P304, DOI 10.1016/0005-2728(73)90106-0
   KUSUMOTO N, 1994, PLANT CELL PHYSIOL, V35, P17
   Kusumoto N, 1999, BIOCHEMISTRY-US, V38, P12124, DOI 10.1021/bi990452s
   Leibl W, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL II, P191
   Li YF, 1997, J MOL BIOL, V271, P456, DOI 10.1006/jmbi.1997.1189
   LIEBL U, 1993, P NATL ACAD SCI USA, V90, P7124, DOI 10.1073/pnas.90.15.7124
   MATTHEWS BW, 1979, J MOL BIOL, V131, P259, DOI 10.1016/0022-2836(79)90076-7
   MEHARI T, 1995, J BIOL CHEM, V270, P28108
   MILLER M, 1992, BIOCHEMISTRY-US, V31, P4354, DOI 10.1021/bi00132a028
   Muhiuddin IP, 1999, BIOCHEMISTRY-US, V38, P7159, DOI 10.1021/bi982042u
   Neerken S, 1998, BIOCHEMISTRY-US, V37, P10792, DOI 10.1021/bi9806899
   Neerken S, 2000, BIOCHEMISTRY-US, V39, P3297, DOI 10.1021/bi992433o
   Neerken S, 1999, BIOCHEMISTRY-US, V38, P13216, DOI 10.1021/bi9910981
   NITSCHKE W, 1990, BIOCHEMISTRY-US, V29, P3834, DOI 10.1021/bi00468a005
   NITSCHKE W, 1987, FEBS LETT, V218, P283, DOI 10.1016/0014-5793(87)81062-1
   NITSCHKE W, 1995, ADV PHOTOSYNTH, V2, P775
   Noguchi T, 1996, BIOCHEMISTRY-US, V35, P15428, DOI 10.1021/bi9613638
   NUIJS AM, 1985, BIOCHIM BIOPHYS ACTA, V807, P24, DOI 10.1016/0005-2728(85)90049-0
   Oh-Oka H, 1998, BIOCHEMISTRY-US, V37, P12293, DOI 10.1021/bi9800799
   Oh-Oka H, 1998, J PHYS CHEM B, V102, P8190, DOI 10.1021/jp981478g
   OHOKA H, 1988, J BIOCHEM-TOKYO, V103, P962, DOI 10.1093/oxfordjournals.jbchem.a122394
   OhOka H, 1997, BIOCHEMISTRY-US, V36, P9267, DOI 10.1021/bi9701787
   OHOKA H, 1995, FEBS LETT, V365, P30, DOI 10.1016/0014-5793(95)00433-A
   OHOKA H, 1995, BIOCHEMISTRY-US, V34, P13091, DOI 10.1021/bi00040a021
   OKKELS JS, 1992, J BIOL CHEM, V267, P21139
   OKUMURA N, 1994, PHOTOSYNTH RES, V41, P125, DOI 10.1007/BF02184152
   Olson JM, 1998, PHOTOCHEM PHOTOBIOL, V67, P61, DOI 10.1111/j.1751-1097.1998.tb05166.x
   OLSON JM, 1973, BIOCHIM BIOPHYS ACTA, V292, P206, DOI 10.1016/0005-2728(73)90265-X
   OLSON JM, 1976, BROOKHAVEN SYM BIOL, V28, P238
   Ostafin AE, 1997, BBA-BIOENERGETICS, V1320, P195, DOI 10.1016/S0005-2728(97)00023-6
   Overmann J, 1997, ARCH MICROBIOL, V167, P302, DOI 10.1007/s002030050448
   Permentier HP, 2000, PHOTOSYNTH RES, V64, P27, DOI 10.1023/A:1026515027824
   PRINCE RC, 1976, BIOCHIM BIOPHYS ACTA, V423, P357, DOI 10.1016/0005-2728(76)90191-2
   Remigy HW, 1999, J MOL BIOL, V290, P851, DOI 10.1006/jmbi.1999.2925
   RIGBY SEJ, 1994, FEBS LETT, V350, P24, DOI 10.1016/0014-5793(94)00724-1
   RUSTANDI RR, 1992, BIOCHIM BIOPHYS ACTA, V1142, P69
   SAKURAGI Y, 1998, BIOCHIM BIOPHYS ACTA, V1413, P172
   Sakurai H, 1996, PHOTOCHEM PHOTOBIOL, V64, P5, DOI 10.1111/j.1751-1097.1996.tb02414.x
   Schmidt KA, 1998, PHOTOSYNTH RES, V58, P57, DOI 10.1023/A:1006093627724
   Schmidt KA, 2000, BIOCHEMISTRY-US, V39, P7212, DOI 10.1021/bi992861u
   SCHOEDER HU, 1986, FEBS LETT, V199, P23, DOI 10.1016/0014-5793(86)81216-9
   Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824
   SCHUTZ M, 1994, PHOTOSYNTH RES, V39, P163, DOI 10.1007/BF00029383
   Scott MP, 1997, EUR J BIOCHEM, V244, P454, DOI 10.1111/j.1432-1033.1997.00454.x
   Semenov AY, 2000, J BIOL CHEM, V275, P23429, DOI 10.1074/jbc.M000508200
   Seo D, 2001, BBA-BIOENERGETICS, V1503, P377, DOI 10.1016/S0005-2728(00)00245-0
   SETIF P, 1989, BIOCHEMISTRY-US, V28, P2689, DOI 10.1021/bi00432a049
   Setif P, 2001, BIOPHYS J, V81, P1208, DOI 10.1016/S0006-3495(01)75779-7
   SHAHAK Y, 1992, FEBS LETT, V299, P127, DOI 10.1016/0014-5793(92)80230-E
   SHAHAK Y, 1999, PHOTOTROPHIC PROKARY, P169
   SHUVALOV VA, 1986, BIOCHIM BIOPHYS ACTA, V851, P1, DOI 10.1016/0005-2728(86)90242-2
   SWARTHOFF T, 1979, BIOCHIM BIOPHYS ACTA, V548, P427, DOI 10.1016/0005-2728(79)90146-4
   TAKAHASHI Y, 1985, PHOTOSYNTH RES, V6, P183, DOI 10.1007/BF00032792
   TRONRUD DE, 1986, J MOL BIOL, V188, P443, DOI 10.1016/0022-2836(86)90167-1
   TROST JT, 1989, BIOCHEMISTRY-US, V28, P9898, DOI 10.1021/bi00452a003
   Tsiotis G, 1997, BBA-BIOENERGETICS, V1322, P163, DOI 10.1016/S0005-2728(97)00073-X
   TSIOTIS G, 2001, IN PRESS PHOTOSYNTH
   van Brederode ME, 1999, P NATL ACAD SCI USA, V96, P2054, DOI 10.1073/pnas.96.5.2054
   van der Est A, 1998, BBA-BIOENERGETICS, V1409, P87, DOI 10.1016/S0005-2728(98)00152-2
   VANDEMEENT EJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P356, DOI 10.1016/S0005-2728(05)80131-8
   VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X
   VASMEL H, 1983, BIOCHIM BIOPHYS ACTA, V725, P361, DOI 10.1016/0005-2728(83)90210-4
   Vassiliev IR, 2000, BIOPHYS J, V78, P3160, DOI 10.1016/S0006-3495(00)76852-4
   Vassiliev IR, 2001, BBA-BIOENERGETICS, V1507, P139, DOI 10.1016/S0005-2728(01)00197-9
   Vassilieva EV, 2001, BIOCHEMISTRY-US, V40, P464, DOI 10.1021/bi001917d
   Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724
   ZHOU WL, 1994, PHOTOSYNTH RES, V41, P89, DOI 10.1007/BF02184148
   ZIEGLER K, 1987, FEBS LETT, V217, P16, DOI 10.1016/0014-5793(87)81233-4
   ZIMMERMANN R, 1997, THESIS U REGENSBURG
   Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589
   Zybailov B, 2000, J BIOL CHEM, V275, P8531, DOI 10.1074/jbc.275.12.8531
NR 116
TC 114
Z9 117
U1 0
U2 33
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 1879-2650
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD OCT 30
PY 2001
VL 1507
IS 1-3
SI SI
BP 260
EP 277
DI 10.1016/S0005-2728(01)00200-6
PG 18
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 491CZ
UT WOS:000172091600017
PM 11687219
DA 2021-01-25
ER

PT J
AU Reichert, H
   Simeone, A
AF Reichert, H
   Simeone, A
TI Developmental genetics evidence for a monophyletic origin of the
   bilaterian brain
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE Hox genes; Otx; brain development; brain evolution; Drosophila;
   Urbilateria
ID NERVE CORD DEVELOPMENT; HUMAN OTX GENES; HOMEOBOX GENE; EMBRYONIC BRAIN;
   HALOCYNTHIA-RORETZI; EARLY NEUROGENESIS; ANIMAL PHYLOGENY; DROSOPHILA
   BRAIN; MAMMALIAN BRAIN; COLUMN IDENTITY
AB The widely held notion of an independent evolutionary origin of invertebrate and vertebrate brains is based on classical phylogenetic, neuroanatomical and embryological data. The interpretation of these data in favour of a polyphyletic origin of animals brains is currently being challenged by three fundamental findings that derive from comparative molecular, genetic and developmental analyses. First, modern molecular systematics indicates that none of the extant animals correspond to evolutionary intermediates between the protostomes and the deuterostomes, thus making it impossible to deduce the morphological organization of the ancestral bilaterian or its brain from living species. Second, recent molecular genetic evidence for the body axis inversion hypothesis now supports the idea that the basic body plan of vertebrates and invertebrates is similar but inverted, suggesting that the ventral nerve chord of protostome invertebrates is homologous to the dorsal nerve cord of deuterostome chordates. Third, a developmental genetic analysis of the molecular control elements involved in early embryonic brain patterning is uncovering the existence of structurally and functionally homologous genes that have comparable and interchangeable functions in key aspects of brain development in invertebrate and vertebrate model systems. All three of these findings are compatible with the hypothesis of a monophyletic origin of the bilaterian brain. Here we review these findings and consider their significance and implications for current thinking on the evolutionary origin of bilaterian brains. We also preview the impact of comparative functional genomic analyses on our understanding of brain evolution.
C1 Univ Basel, Inst Zool, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
   Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 9RT, England.
RP Reichert, H (corresponding author), Univ Basel, Inst Zool, Biozentrum Pharmazentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Heinrich.Reichert@unibas.ch
RI Simeone, Antonio/ABG-5269-2020
OI Simeone, Antonio/0000-0003-2693-9836
CR ACAMPORA D, 1995, DEVELOPMENT, V121, P3279
   Acampora D, 1998, DEVELOPMENT, V125, P1691
   Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218
   Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453
   Adoutte A, 1999, TRENDS GENET, V15, P104, DOI 10.1016/S0168-9525(98)01671-0
   Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0
   Ang SL, 1996, DEVELOPMENT, V122, P243
   Arendt D, 1999, DEVELOPMENT, V126, P2309
   BALL HL, 1995, LETT PEPT SCI, V2, P49, DOI 10.1007/BF00122923
   BARNES RSK, 1993, INVERTEBRATES
   Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168
   Briscoe J, 1999, NATURE, V398, P622
   Brusca R.C., 1990, INVERTEBRATES
   Bullock TH, 1965, STRUCTURE FUNCTION N
   Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483
   Campbell N.A., 1999, BIOLOGY
   Chan YM, 1999, CURR OPIN NEUROBIOL, V9, P582, DOI 10.1016/S0959-4388(99)00017-3
   Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613
   COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0
   Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5
   de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631
   DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0
   Gavalas A, 1998, DEVELOPMENT, V125, P1123
   Gee H., 1996, BACKBONE VIEWS ORIGI
   Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.0.CO;2-R
   Geoffroy St-Hilaire E., 1822, MEM MUS HIST NAT, V9, P89
   Gionti M, 1998, DEV GENES EVOL, V207, P515, DOI 10.1007/s004270050142
   Graham A, 2000, CURR BIOL, V10, pR36, DOI 10.1016/S0960-9822(99)00255-9
   HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451
   Hanks MC, 1998, DEVELOPMENT, V125, P4521
   Hartmann B, 1998, MOL CELL NEUROSCI, V12, P194, DOI 10.1006/mcne.1998.0716
   Hartmann B, 2000, MECH DEVELOP, V90, P143, DOI 10.1016/S0925-4773(99)00237-3
   Hirth F, 1999, BIOESSAYS, V21, P677, DOI 10.1002/(SICI)1521-1878(199908)21:8<677::AID-BIES7>3.0.CO;2-8
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034
   HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0
   Hyman L. H., 1940, INVERTEBRATES, P726
   Jungbluth S, 1999, DEVELOPMENT, V126, P2751
   KATSUYAMA Y, 1995, DEVELOPMENT, V121, P3197
   Kaufman T C, 1990, Adv Genet, V27, P309
   Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129
   Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8
   Leemans R, 2000, P NATL ACAD SCI USA, V97, P12138, DOI 10.1073/pnas.210066997
   Leemans R, 2001, GENOME BIOL, V2
   Leuzinger S, 1998, DEVELOPMENT, V125, P1703
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   LI YB, 1994, MECH DEVELOP, V48, P229, DOI 10.1016/0925-4773(94)90062-0
   Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109
   MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646
   McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   MERCIER P, 1995, INT J DEV BIOL, V39, P559
   Nagao T, 1998, P NATL ACAD SCI USA, V95, P3737, DOI 10.1073/pnas.95.7.3737
   Nauta W. J. H., 1986, FUNDAMENTAL NEUROANA
   Nielsen C., 1995, ANIMAL EVOLUTION INT
   Oelgeschlager M, 2000, NATURE, V405, P757
   PANNESE M, 1995, DEVELOPMENT, V121, P707
   Pellegrini M, 1996, DEVELOPMENT, V122, P3893
   PURVES WK, 1997, LIFE SCI BIOL
   Qiu MS, 1996, DEV BIOL, V178, P174, DOI 10.1006/dbio.1996.0207
   Reichert H, 1999, CURR OPIN NEUROBIOL, V9, P589, DOI 10.1016/S0959-4388(99)00002-1
   Reichert H, 1997, TRENDS NEUROSCI, V20, P258, DOI 10.1016/S0166-2236(96)01034-X
   Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204
   Sasai Y, 1997, DEV BIOL, V182, P5, DOI 10.1006/dbio.1996.8445
   Scott MP, 2000, CELL, V100, P27, DOI 10.1016/S0092-8674(00)81681-5
   SIEWING R, 1985, LEHRBUCH ZOOLOGIE, V2
   Simeone A, 1998, EMBO J, V17, P6790, DOI 10.1093/emboj/17.23.6790
   SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0
   Studer M, 1998, DEVELOPMENT, V125, P1025
   THERIANOS S, 1995, DEVELOPMENT, V121, P3849
   Ueki T, 1998, DEV GENES EVOL, V208, P223, DOI 10.1007/s004270050176
   Umesono Y, 1999, DEV GENES EVOL, V209, P31, DOI 10.1007/s004270050224
   WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801
   Wada S, 1996, MECH DEVELOP, V60, P59, DOI 10.1016/S0925-4773(96)00600-4
   Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591
   Williams NA, 1998, MOL BIOL EVOL, V15, P600, DOI 10.1093/oxfordjournals.molbev.a025961
   WOLPERT L, 1998, PRINCIPLES DEV
   Yoshida M, 1997, DEVELOPMENT, V124, P101
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475
NR 81
TC 48
Z9 50
U1 0
U2 1
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD OCT 29
PY 2001
VL 356
IS 1414
BP 1533
EP 1544
DI 10.1098/rstb.2001.0972
PG 12
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 486ZV
UT WOS:000171850000003
PM 11604121
OA Green Published
DA 2021-01-25
ER

PT J
AU Handschin, C
   Podvinec, M
   Looser, R
   Amherd, R
   Meyer, UA
AF Handschin, C
   Podvinec, M
   Looser, R
   Amherd, R
   Meyer, UA
TI Multiple enhancer units mediate drug induction of CYP2H1 by
   xenobiotic-sensing orphan nuclear receptor chicken xenobiotic receptor
SO MOLECULAR PHARMACOLOGY
LA English
DT Article
ID CONSTITUTIVE ANDROSTANE RECEPTOR; PHENOBARBITAL RESPONSE UNIT; PREGNANE
   X RECEPTOR; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; CAR; BINDING;
   LOCALIZATION; FACTOR-1; ELEMENTS
AB Binding of nuclear receptors to drug-responsive enhancer units mediates transcriptional activation of cytochromes P-450 (P-450) by drugs and xenobiotics. In previous studies, a 264-base-pair (bp) phenobarbital-responsive enhancer unit (PBRU) located at -1671 to -1408 upstream of the chicken CYP2H1 transcriptional start-site increased gene expression when activated by the chicken xenobiotic-sensing orphan nuclear receptor CXR. In extension of these studies, we now have functionally analyzed a second distal drug-responsive element and delimited a 643- and a 240-bp PBRU located between 5 and 6 kilobases upstream of the transcriptional start site of CYP2H1. Both PBRUs were activated by CXR after treatment with different drugs. A nuclear receptor binding site, a direct repeat-4 (DR-4) hexamer repeat, was identified on the 240-bp PBRU. Site-directed mutagenesis of this DR-4 abolished activity in reporter gene assays in the chicken hepatoma cells leghorn male hepatoma as well as transactivation of the 240-bp PBRU by CXR in CV-1 cells. CXR bound to this PBRU in electromobility shift assays and the complex remained unaffected by unlabeled 240-bp PBRU with a mutated DR-4. In cross-species experiments, both the human xenobiotic-sensing nuclear receptors pregnane X receptor and constitutive androstane receptor bound to this element, suggesting sequence conservation between chicken and mammalian PBRUs and between the DNA binding domains of these receptors. Of two orphan nuclear receptors involved in cholesterol and bile acid homeostasis, only chicken liver X receptor (LXR) but not chicken farnesoid X receptor bound to the 240-bp PBRU. These results suggest that CYP2H1 induction is explained by the combined effect of multiple distal enhancer elements interacting with multiple transcription factors, including CXR and LXR.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM urs-a.meyer@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR Dogra SC, 1999, MOL PHARMACOL, V55, P14
   Frueh FW, 1997, MOL PHARMACOL, V51, P363
   Goodwin B, 1999, MOL PHARMACOL, V56, P1329
   HAHN CN, 1991, J BIOL CHEM, V266, P17031
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Honkakoski P, 1997, J BIOL CHEM, V272, P14943, DOI 10.1074/jbc.272.23.14943
   Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   Honkakoski P, 1998, J BIOCHEM MOL TOXIC, V12, P3
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Kemper B, 1998, PROG NUCLEIC ACID RE, V61, P25, DOI 10.1016/S0079-6603(08)60824-7
   Kim J, 2001, J BIOL CHEM, V276, P7559, DOI 10.1074/jbc.M008090200
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Lu TH, 2000, MOL CELL BIOCHEM, V209, P17, DOI 10.1023/A:1007025505842
   Luc PV, 1996, BIOCHEM PHARMACOL, V51, P345, DOI 10.1016/0006-2952(95)02190-6
   MATTSCHOSS LA, 1986, J BIOL CHEM, V261, P9438
   Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   Paquet Y, 2000, J BIOL CHEM, V275, P38427, DOI 10.1074/jbc.M005776200
   Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Savas U, 1999, MOL PHARMACOL, V56, P851
   Schuetz EG, 2000, DRUG METAB DISPOS, V28, P268
   Sommer A, 2000, FEBS LETT, V474, P146, DOI 10.1016/S0014-5793(00)01566-0
   Stoltz C, 1999, BIOCHEM PHARMACOL, V57, P1073, DOI 10.1016/S0006-2952(98)00367-0
   Stoltz C, 1998, J BIOL CHEM, V273, P8528, DOI 10.1074/jbc.273.14.8528
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Takahashi Y, 1997, J BIOL CHEM, V272, P30025, DOI 10.1074/jbc.272.48.30025
   TROTTIER E, 1995, GENE, V158, P263, DOI 10.1016/0378-1119(94)00916-G
   WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316
   Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116
   Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800
   Zelko I, 2000, BIOCHEM BIOPH RES CO, V277, P1, DOI 10.1006/bbrc.2000.3557
NR 36
TC 22
Z9 22
U1 0
U2 2
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0026-895X
EI 1521-0111
J9 MOL PHARMACOL
JI Mol. Pharmacol.
PD OCT
PY 2001
VL 60
IS 4
BP 681
EP 689
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 477LJ
UT WOS:000171284800008
PM 11562429
DA 2021-01-25
ER

PT J
AU Knutti, D
   Kralli, A
AF Knutti, D
   Kralli, A
TI PGC-1, a versatile coactivator
SO TRENDS IN ENDOCRINOLOGY AND METABOLISM
LA English
DT Review
ID ACTIVATED RECEPTOR-ALPHA; BROWN ADIPOSE-TISSUE; RNA-POLYMERASE-II;
   ADAPTIVE THERMOGENESIS; GENE-EXPRESSION; THYROID-HORMONE; MITOCHONDRIAL
   BIOGENESIS; GAMMA COACTIVATOR-1; NUCLEAR RECEPTORS; TRANSCRIPTION
AB PGC-1 was originally identified as a transcriptional coactivator of the nuclear receptor PPAR gamma. The expression pattern and induction by exposure to cold have implicated PGC-1 in the regulation of energy metabolism and adaptive thermogenesis. Remarkably, PGC-1 overexpression can induce mitochondrial biogenesis and functions. Recent studies show that PGC-1 regulates the activity of several nuclear receptors and other transcription factors, and thus acts in a broader context than previously anticipated. Furthermore, PGC-1 displays the striking ability to interact with components of the splicing machinery. PGC-1 could therefore allow coordinated regulation of transcription and splicing in response to signals relaying metabolic needs. These novel findings are discussed in the context of the proposed physiological functions of PGC-1.
C1 Univ Basel, Div Biochem, Biozentrum, CH-4056 Basel, Switzerland.
RP Knutti, D (corresponding author), Univ Basel, Div Biochem, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Blencowe BJ, 1999, BIOCHEM CELL BIOL, V77, P277, DOI 10.1139/bcb-77-4-277
   Branco M, 1999, AM J PHYSIOL-ENDOC M, V276, pE179
   Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640
   Butow RA, 1999, CURR BIOL, V9, pR767, DOI 10.1016/S0960-9822(00)80008-1
   Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483
   Chen SL, 2000, GENE DEV, V14, P1209
   Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X
   Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456
   Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009
   Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977
   Ezaki O, 1997, BIOCHEM BIOPH RES CO, V241, P1, DOI 10.1006/bbrc.1997.7587
   Fukuhara K, 1996, J NEUROENDOCRINOL, V8, P533, DOI 10.1046/j.1365-2826.1996.04877.x
   Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5
   Ge H, 1998, MOL CELL, V2, P751, DOI 10.1016/S1097-2765(00)80290-7
   Glass CK, 2000, GENE DEV, V14, P121
   Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134
   Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960
   Hallier M, 1998, J BIOL CHEM, V273, P4838, DOI 10.1074/jbc.273.9.4838
   HIMMSHAGEN J, 1990, FASEB J, V4, P2890
   Hirose Y, 2000, GENE DEV, V14, P1415
   Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Kersten S, 2000, NATURE, V405, P421
   Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000
   Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698
   Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   LEMBERGER T, 1994, J BIOL CHEM, V269, P24527
   Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473
   Lowell BB, 2000, NATURE, V404, P652
   Lowell BB, 1998, CURR BIOL, V8, pR517, DOI 10.1016/S0960-9822(07)00336-3
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9
   MORISCOT A, 1993, AM J PHYSIOL, V265, pE81
   Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4
   Powers CA, 1998, MOL ENDOCRINOL, V12, P4, DOI 10.1210/mend.12.1.0043
   Proudfoot N, 2000, TRENDS BIOCHEM SCI, V25, P290, DOI 10.1016/S0968-0004(00)01591-7
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568
   Robyr D, 2000, MOL ENDOCRINOL, V14, P329, DOI 10.1210/me.14.3.329
   Rosen ED, 2000, GENE DEV, V14, P1293
   Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55
   SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x
   Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481
   SOBOLL S, 1993, BIOCHIM BIOPHYS ACTA, V1144, P1, DOI 10.1016/0005-2728(93)90024-A
   Soumano K, 2000, MOL CELL ENDOCRINOL, V165, P7, DOI 10.1016/S0303-7207(00)00276-8
   STRACK AM, 1995, AM J PHYSIOL-REG I, V268, pR183
   TEHEREPANOVA I, 2000, J BIOL CHEM, V275, P16302
   Uranishi H, 2001, J BIOL CHEM, V276, P13395, DOI 10.1074/jbc.M011176200
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703
   WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761
   Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160
NR 56
TC 231
Z9 245
U1 0
U2 14
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1043-2760
J9 TRENDS ENDOCRIN MET
JI Trends Endocrinol. Metab.
PD OCT
PY 2001
VL 12
IS 8
BP 360
EP 365
DI 10.1016/S1043-2760(01)00457-X
PG 6
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 475FW
UT WOS:000171152500006
PM 11551810
DA 2021-01-25
ER

PT J
AU Moll, J
   Barzaghi, P
   Lin, S
   Bezakova, G
   Lochmuller, H
   Engvall, E
   Muller, U
   Ruegg, MA
AF Moll, J
   Barzaghi, P
   Lin, S
   Bezakova, G
   Lochmuller, H
   Engvall, E
   Muller, U
   Ruegg, MA
TI An agrin minigene rescues dystrophic symptoms in a mouse model for
   congenital muscular dystrophy
SO NATURE
LA English
DT Article
ID CREATINE-KINASE GENE; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX;
   BASEMENT-MEMBRANE; SKELETAL-MUSCLE; LAMININ; MICE; EXPRESSION;
   DIFFERENTIATION; DYSTROGLYCAN
AB Congenital muscular dystrophy is a heterogeneous and severe, progressive muscle-wasting disease that frequently leads to death in early childhood(1,2). Most cases of congenital muscular dystrophy are caused by mutations in LAMA2, the gene encoding the alpha2 chain of the main laminin isoforms expressed by muscle fibres. Muscle fibre deterioration in this disease is thought to be caused by the failure to form the primary laminin scaffold, which is necessary for basement membrane structure(3), and the missing interaction between muscle basement membrane and the dystrophin-glycoprotein complex (DGC)(4) or the integrins(5). With the aim to restore muscle function in a mouse model for this disease, we have designed a minigene of agrin, a protein known for its role in the formation of the neuromuscular junction(6). Here we show that this mini-agrin-which binds to basement membrane(7) and to alpha -dystroglycan(8), a member of the DGC-amends muscle pathology by a mechanism that includes agrin-mediated stabilization of alpha -dystroglycan and the laminin alpha5 chain. Our data provides in vivo evidence that a non-homologous protein in combination with rational protein design can be used to devise therapeutic tools that may restore muscle function in human muscular dystrophies.
C1 Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   Univ Munich, Genzentrum Munich, D-81377 Munich, Germany.
   Burnham Inst, La Jolla, CA 92037 USA.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Lochmuller, Hanns/0000-0003-2324-8001
CR Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5
   Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Cote PD, 1999, NAT GENET, V23, P338
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335
   ERVASTI JM, 1991, J BIOL CHEM, V266, P9161
   Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600
   Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0
   Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926
   IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0
   JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855
   Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705
   MACPIKE AD, 1976, P SOC EXP BIOL MED, V151, P670, DOI 10.3181/00379727-151-39283
   Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318
   Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x
   Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q
   Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507
   Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244
   Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5
   SCHULZE B, 1995, EUR J BIOCHEM, V231, P551, DOI 10.1111/j.1432-1033.1995.tb20731.x
   Sorokin LM, 1997, DEV DYNAM, V210, P446, DOI 10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G
   STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896
   SUNADA Y, 1994, J BIOL CHEM, V269, P13729
   Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200
   TOME FMS, 1998, NEUROMUSCULAR DISORD, P21
   Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2
   XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297
   XU H, 1994, P NATL ACAD SCI USA, V91, P5572, DOI 10.1073/pnas.91.12.5572
NR 30
TC 168
Z9 170
U1 0
U2 3
PU MACMILLAN PUBLISHERS LTD
PI LONDON
PA PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD SEP 20
PY 2001
VL 413
IS 6853
BP 302
EP 307
DI 10.1038/35095054
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 473KB
UT WOS:000171040500038
PM 11565031
DA 2021-01-25
ER

PT J
AU Crespo, JL
   Daicho, K
   Ushimaru, T
   Hall, MN
AF Crespo, JL
   Daicho, K
   Ushimaru, T
   Hall, MN
TI The GATA transcription factors GLN3 and GAT1 link TOR to salt stress in
   Saccharomyces cerevisiae
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PHOSPHATIDYLINOSITOL KINASE HOMOLOG; NITROGEN CATABOLITE REPRESSION;
   REGULATES GENE-EXPRESSION; SIGNALING PATHWAY; ION HOMEOSTASIS;
   PHOSPHATASE CALCINEURIN; PLASMA-MEMBRANE; ENA1 GENE; YEAST; RAPAMYCIN
AB One of the most recent functions assigned to the TOR signaling pathway in yeast is the coordination of the transcription of genes involved in nutrient utilization. Here we show that transcription of ENA1, a gene encoding a lithium and sodium ion transporter essential for salt tolerance in yeast, is controlled by the TOR signaling pathway. First, ENA1 expression is strongly induced under TOR-inactivating conditions. Second, the absence of the TOR-controlled GATA transcription factors GLN3 and GAT1 results in reduced basal and salt-induced expression of ENA1 Third, a gln3 gat1 mutant displays a pronounced sensitivity to high concentrations of lithium and sodium. Fourth, TOR1, similar to ENA1, is required for growth under saline stress conditions. In summary, our results suggest that TOR plays a role in the general response to saline stress by regulating the transcription of ENA1 via GLN3 and GAT1.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
   Shizuoka Univ, Fac Sci, Dept Biol, Shizuoka 4228529, Japan.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
RI Crespo, Jose L/L-3977-2014
OI Crespo, Jose L/0000-0003-3514-1025; Hall, Michael N/0000-0002-2998-0757
CR Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x
   Ausubel F.M., 1998, CURRENT PROTOCOLS MO
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   Chan TF, 2001, J BIOL CHEM, V276, P6463, DOI 10.1074/jbc.M008162200
   Cox KH, 1999, YEAST, V15, P703, DOI 10.1002/(SICI)1097-0061(19990615)15:8<703::AID-YEA413>3.0.CO;2-Z
   Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408
   GALLWITZ D, 1980, P NATL ACAD SCI-BIOL, V77, P2546, DOI 10.1073/pnas.77.5.2546
   GARCIADEBLAS B, 1993, MOL GEN GENET, V236, P363, DOI 10.1007/BF00277134
   Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241
   GOFFEAU A, 1981, BIOCHIM BIOPHYS ACTA, V639, P197, DOI 10.1016/0304-4173(81)90010-0
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983
   Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Marquez JA, 1996, FEBS LETT, V382, P89, DOI 10.1016/0014-5793(96)00157-3
   Masuda CA, 2000, J BIOL CHEM, V275, P30957, DOI 10.1074/jbc.M004869200
   Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445
   Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X
   MENDOZA I, 1994, J BIOL CHEM, V269, P8792
   MORI K, 1993, CELL, V74, P743
   Mulet JM, 1999, MOL CELL BIOL, V19, P3328
   Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963
   Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Proft M, 1999, MOL CELL BIOL, V19, P537
   Rios G, 1997, YEAST, V13, P515, DOI 10.1002/(SICI)1097-0061(199705)13:6<515::AID-YEA102>3.3.CO;2-O
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   STAN R, 1994, J BIOL CHEM, V269, P32027
   STANBROUGH M, 1995, P NATL ACAD SCI USA, V92, P9450, DOI 10.1073/pnas.92.21.9450
   Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432
   ter Schure EG, 2000, FEMS MICROBIOL REV, V24, P67, DOI 10.1016/S0168-6445(99)00030-3
   Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200
   WIELAND J, 1995, EMBO J, V14, P3870, DOI 10.1002/j.1460-2075.1995.tb00059.x
   Withee JL, 1998, GENETICS, V149, P865
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
NR 42
TC 72
Z9 73
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 14
PY 2001
VL 276
IS 37
BP 34441
EP 34444
DI 10.1074/jbc.M103601200
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 473DK
UT WOS:000171024600013
PM 11457832
OA Other Gold
DA 2021-01-25
ER

PT J
AU Stolz, M
   Stoffler, D
   Goldsbury, C
   Green, J
   Baschong, W
   Aebi, U
AF Stolz, M
   Stoffler, D
   Goldsbury, C
   Green, J
   Baschong, W
   Aebi, U
TI Watching biomolecules at work by time-lapse atomic force microscopy
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0022-3042
J9 J NEUROCHEM
JI J. Neurochem.
PD SEP
PY 2001
VL 78
SU 1
BP 111
EP 111
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 469AF
UT WOS:000170789800390
DA 2021-01-25
ER

PT J
AU Murphy, MP
   Leuenberger, D
   Curran, SP
   Oppliger, W
   Koehler, CM
AF Murphy, MP
   Leuenberger, D
   Curran, SP
   Oppliger, W
   Koehler, CM
TI The essential function of the small Tim proteins in the TIM22 import
   pathway does not depend on formation of the soluble 70-kilodalton
   complex
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID ADP ATP CARRIER; MITOCHONDRIAL INTERMEMBRANE SPACE; BLUE NATIVE
   ELECTROPHORESIS; MEDIATES INSERTION; TRANSLOCATION; MEMBRANE; COMPONENT;
   SUBUNIT
AB The TIM22 protein import pathway of the yeast mitochondrion contains several components, including a family of five proteins (Tim8p, -9p, -10p, -12p, and -13p [Tim, for translocase of inner membrane]) that are located in the intermembrane space and are 25% identical. Tim9p and Tim10p have dual roles in mediating the import of inner membrane proteins. Like the Tim8p-Tim13p complex, the Tim9p-Tim10p complex functions as a putative chaperone to guide hydrophobic precursors across the intermembrane space. Like membrane-associated Tim12p, they are members of the Tim18p-Tim22p-Tim54p membrane complex that mediates precursor insertion into the membrane. To understand the role of this family in protein import, we have used a genetic approach to manipulate the complement of the small Tim proteins. A strain has been constructed that lacks the 70-kDa soluble Tim8p-Tim13p and Tim9p-Tim10p complexes in the intermembrane space. Instead, a functional version of Tim9p (Tim9(S67C)p), identified as a second-site suppressor of a conditional tim10 mutant, maintains viability. Characterization of this strain revealed that Tim9(S67C)p and Tim10p were tightly associated with the inner membrane, the soluble 70-kDa Tim8p-Tim13p and Tim9p-Tim10p complexes were not detectable, and the rate of protein import into isolated mitochondria proceeded at a slower rate. An arrested translocation intermediate bound to Tim9(S67C)p was located in the intermembrane space, associated with the inner membrane. We suggest that the 70-kDa complexes facilitate import, similar to the outer membrane receptors of the TOM (hetero-oligomeric translocase of the outer membrane) complex, and the essential role of Tim9p and Tim10p may be to mediate protein insertion in the inner membrane with the TIM22 complex.
C1 Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.
   MRC Wellcome, Dunn Human Nutr Unit, Cambridge CB2 2XY, England.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 951569, Los Angeles, CA 90095 USA.
EM koehler@chem.ucla.edu
RI Murphy, Michael P/C-2120-2009
OI Murphy, Michael P/0000-0003-1115-9618
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [1R01GM61721-01, R01 GM061721] Funding Source:
   Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM061721, R01GM061721, R01GM061721, R01GM061721, R01GM061721,
   R01GM061721, R01GM061721, R01GM061721, R01GM061721, R01GM061721,
   R01GM061721, R01GM061721, R01GM061721, R01GM061721, R01GM061721,
   R01GM061721, R01GM061721, R01GM061721, R01GM061721, R01GM061721] Funding
   Source: NIH RePORTER
CR Adam A, 1999, EMBO J, V18, P313, DOI 10.1093/emboj/18.2.313
   Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0
   Davis AJ, 2000, J CELL BIOL, V150, P1271, DOI 10.1083/jcb.150.6.1271
   Dekker PJT, 1996, BIOL CHEM, V377, P535
   Endres M, 1999, EMBO J, V18, P3214, DOI 10.1093/emboj/18.12.3214
   GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K
   Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2
   Guthrie C., 1991, GUIDE YEAST GENETICS, V194
   Haucke V, 1997, EMBO J, V16, P4560, DOI 10.1093/emboj/16.15.4560
   Jarosch E, 1996, J BIOL CHEM, V271, P17219, DOI 10.1074/jbc.271.29.17219
   Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103
   Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663
   Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0
   Koehler CM, 2000, MOL CELL BIOL, V20, P1187, DOI 10.1128/MCB.20.4.1187-1193.2000
   Koehler CM, 1998, EMBO J, V17, P6477, DOI 10.1093/emboj/17.22.6477
   Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369
   Koehler CM, 1999, P NATL ACAD SCI USA, V96, P2141, DOI 10.1073/pnas.96.5.2141
   Leuenberger D, 1999, EMBO J, V18, P4816, DOI 10.1093/emboj/18.17.4816
   Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863
   Palmieri F, 1996, BBA-BIOENERGETICS, V1275, P127, DOI 10.1016/0005-2728(96)00062-X
   PFANNER N, 1987, J BIOL CHEM, V262, P7528
   Pfanner N, 1998, CURR BIOL, V8, pR262, DOI 10.1016/S0960-9822(98)70168-X
   ROSPERT S, 1994, J BIOL CHEM, V269, P17279
   Rospert S, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P277
   RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6
   Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619
   SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136
   YAFFE MP, 1985, EMBO J, V4, P2069, DOI 10.1002/j.1460-2075.1985.tb03893.x
NR 33
TC 30
Z9 34
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD SEP
PY 2001
VL 21
IS 18
BP 6132
EP 6138
DI 10.1128/MCB.21.18.6132-6138.2001
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 466AN
UT WOS:000170622300005
PM 11509656
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Goder, V
   Spiess, M
AF Goder, V
   Spiess, M
TI Topogenesis of membrane proteins: determinants and dynamics
SO FEBS LETTERS
LA English
DT Article; Proceedings Paper
CT Conference on Structure, Dynamics and Function of Proteins in Biological
   Membranes
CY MAR 13-17, 2001
CL MONTE VERITA, SWITZERLAND
DE endoplasmic reticulum; glycosylation; signal recognition particle;
   signal sequence
ID ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL RECOGNITION PARTICLE; POSITIVELY
   CHARGED RESIDUES; NASCENT SECRETORY PROTEINS; ER MEMBRANE; SEQUENCE
   RECOGNITION; ELONGATION ARREST; ESCHERICHIA-COLI; AMINO-ACIDS;
   TRANSMEMBRANE ORIENTATION
AB For targeting and integration of proteins into the mammalian endoplasmic reticulum, two types of signals can be distinguished: those that translocate their C-terminal sequence (cleavable signals and signal-anchors) and those that translocate their N-terminus (reverse signal-anchors). In addition to the well established effect of flanking charges, also the length and hydrophobicity of the apolar core of the signal as well as protein folding and glycosylation contribute to orienting the signal in the translocon. In multi-spanning membrane proteins, topogenic determinants are distributed throughout the sequence and may even compete with each other. During topogenesis, segments of up to 60 residues may move back and forth through the translocon, emphasizing unexpected dynamic aspects of topogenesis. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Goder, Veit/F-8092-2016
OI Goder, Veit/0000-0003-0854-4873; Spiess, Martin/0000-0001-7139-0550
CR ANDREWS DW, 1992, J BIOL CHEM, V267, P7761
   BELTZER JP, 1991, J BIOL CHEM, V266, P973
   BIBI E, 1991, P NATL ACAD SCI USA, V88, P7271, DOI 10.1073/pnas.88.16.7271
   BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496
   Bui N, 1999, BIOL CHEM, V380, P135, DOI 10.1515/BC.1999.021
   Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x
   Eusebio A, 1998, EXP CELL RES, V241, P181, DOI 10.1006/excr.1998.4042
   Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338
   Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119
   GALLUSSER A, 1990, EMBO J, V9, P2723, DOI 10.1002/j.1460-2075.1990.tb07459.x
   Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257
   Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704
   GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7
   Harley CA, 1996, J BIOL CHEM, V271, P24625, DOI 10.1074/jbc.271.40.24625
   Hatsuzawa K, 1997, J BIOCHEM-TOKYO, V121, P270
   Hegde RS, 1996, CELL, V85, P217, DOI 10.1016/S0092-8674(00)81098-3
   Hegde RS, 1998, CELL, V92, P621, DOI 10.1016/S0092-8674(00)81130-7
   HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.biochem.60.1.717
   HIGH S, 1991, J CELL BIOL, V113, P229, DOI 10.1083/jcb.113.2.229
   HIGH S, 1993, J BIOL CHEM, V268, P26745
   Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799
   JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5
   KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x
   LIPP J, 1989, J CELL BIOL, V109, P2013, DOI 10.1083/jcb.109.5.2013
   Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645
   MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5
   Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164
   MCGOVERN K, 1991, J BIOL CHEM, V266, P20870
   Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550
   MONIER S, 1988, J CELL BIOL, V107, P457, DOI 10.1083/jcb.107.2.457
   MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x
   Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355
   PARKS GD, 1993, J BIOL CHEM, V268, P19101
   PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U
   Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9
   Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6
   Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200
   SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16
   Sato M, 1998, J BIOL CHEM, V273, P25203, DOI 10.1074/jbc.273.39.25203
   Sato M, 1999, J BIOL CHEM, V274, P24721, DOI 10.1074/jbc.274.35.24721
   SATO T, 1990, EMBO J, V9, P2391, DOI 10.1002/j.1460-2075.1990.tb07414.x
   Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8
   SPIESS M, 1995, FEBS LETT, V369, P76, DOI 10.1016/0014-5793(95)00551-J
   Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881
   SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738
   SZCZESNASKORUPA E, 1989, J CELL BIOL, V108, P1237, DOI 10.1083/jcb.108.4.1237
   TOMILO M, 1994, J BIOL CHEM, V269, P32016
   Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214
   Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504
   vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261
   VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C
   VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x
   VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0
   Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555
   Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420
   WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511
   Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583
   WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617
   Young BP, 2001, EMBO J, V20, P262, DOI 10.1093/emboj/20.1.262
NR 59
TC 128
Z9 130
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD AUG 31
PY 2001
VL 504
IS 3
SI SI
BP 87
EP 93
DI 10.1016/S0014-5793(01)02712-0
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 472HG
UT WOS:000170977600002
PM 11532438
OA Bronze
DA 2021-01-25
ER

PT J
AU Stahlberg, H
   Fotiadis, D
   Scheuring, S
   Remigy, H
   Braun, T
   Mitsuoka, K
   Fujiyoshi, Y
   Engel, A
AF Stahlberg, H
   Fotiadis, D
   Scheuring, S
   Remigy, H
   Braun, T
   Mitsuoka, K
   Fujiyoshi, Y
   Engel, A
TI Two-dimensional crystals: a powerful approach to assess structure,
   function and dynamics of membrane proteins
SO FEBS LETTERS
LA English
DT Article; Proceedings Paper
CT Conference on Structure, Dynamics and Function of Proteins in Biological
   Membranes
CY MAR 13-17, 2001
CL MONTE VERITA, SWITZERLAND
DE two-dimensional crystallization; electron crystallography; atomic force
   microscopy
ID ATOMIC-FORCE MICROSCOPY; LIGHT-HARVESTING COMPLEX; ELECTRON
   CRYSTALLOGRAPHY; 3-DIMENSIONAL STRUCTURE; ANGSTROM RESOLUTION; WATER
   CHANNEL; CRYSTALLIZATION; BACTERIORHODOPSIN; TOPOGRAPHS; MICELLE
AB Electron crystallography and atomic force microscopy allow the study of two-dimensional membrane protein crystals. While electron crystallography provides atomic scale three-dimensional density maps, atomic force microscopy gives insight into the surface structure and dynamics at sub-nanometer resolution. Importantly, the membrane protein studied is in its native environment and its function can be assessed directly. The approach allows both the atomic structure of the membrane protein and the dynamics of its surface to be analyzed. In this way, the function-related conformational changes can be assessed, thus providing a detailed insight on the molecular mechanisms of essential biological processes. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
RI Fujiyoshi, Yoshinori/E-5989-2012; Scheuring, Simon/L-9843-2018;
   Stahlberg, Henning/H-1868-2011
OI Fujiyoshi, Yoshinori/0000-0002-8070-1493; Scheuring,
   Simon/0000-0003-3534-069X; Stahlberg, Henning/0000-0002-1185-4592
CR Auer M, 1998, NATURE, V392, P840
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   DOWNING KH, 1991, SCIENCE, V251, P53, DOI 10.1126/science.1846047
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   EGELHAAF SU, 1994, J PHYS CHEM-US, V98, P8560, DOI 10.1021/j100085a041
   Fernandez C, 2001, FEBS LETT, V504, P173, DOI 10.1016/S0014-5793(01)02742-9
   FUJIYOSHI Y, 1991, ULTRAMICROSCOPY, V38, P241, DOI 10.1016/0304-3991(91)90159-4
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Heymann JB, 1999, J STRUCT BIOL, V128, P243, DOI 10.1006/jsbi.1999.4180
   Hunte C, 2001, FEBS LETT, V504, P126, DOI 10.1016/S0014-5793(01)02744-2
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Krebs A, 1998, J MOL BIOL, V282, P991, DOI 10.1006/jmbi.1998.2070
   KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0
   Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X
   Li HL, 1997, NAT STRUCT BIOL, V4, P263, DOI 10.1038/nsb0497-263
   Luecke H, 2000, BBA-BIOENERGETICS, V1460, P133, DOI 10.1016/S0005-2728(00)00135-3
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465
   Nollert P, 2001, FEBS LETT, V504, P179, DOI 10.1016/S0014-5793(01)02747-8
   PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676
   PUTMAN CAJ, 1994, APPL PHYS LETT, V64, P2454, DOI 10.1063/1.111597
   Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   Ringler P, 2000, PRACT APPROACH SER, P229
   SCHABERT FA, 1994, BIOPHYS J, V67, P2394, DOI 10.1016/S0006-3495(94)80726-X
   Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029
   SCHEURING S, 2001, IN PRESS EUR BIOPHYS
   Stahlberg H, 2000, J STRUCT BIOL, V132, P133, DOI 10.1006/jsbi.2000.4317
   Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176
   Vonck J, 2000, ULTRAMICROSCOPY, V85, P123, DOI 10.1016/S0304-3991(00)00052-8
   WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WEISENHORN AL, 1989, APPL PHYS LETT, V54, P2651, DOI 10.1063/1.101024
   Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534
   Zhuang JP, 1999, J STRUCT BIOL, V125, P63, DOI 10.1006/jsbi.1998.4059
NR 42
TC 64
Z9 74
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD AUG 31
PY 2001
VL 504
IS 3
SI SI
BP 166
EP 172
DI 10.1016/S0014-5793(01)02746-6
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 472HG
UT WOS:000170977600013
PM 11532449
DA 2021-01-25
ER

PT J
AU Nollert, P
   Qiu, H
   Caffrey, M
   Rosenbusch, JP
   Landau, EM
AF Nollert, P
   Qiu, H
   Caffrey, M
   Rosenbusch, JP
   Landau, EM
TI Molecular mechanism for the crystallization of bacteriorhodopsin in
   lipidic cubic phases
SO FEBS LETTERS
LA English
DT Article; Proceedings Paper
CT Conference on Structure, Dynamics and Function of Proteins in Biological
   Membranes
CY MAR 13-17, 2001
CL MONTE VERITA, SWITZERLAND
DE crystallization; bacteriorhodopsin; lipidic cubic phases
ID MEMBRANE-PROTEIN CRYSTALLIZATION; X-RAY-STRUCTURE; 2D-ARRAY FORMATION;
   ENERGY FUNCTION; MESOPHASES; TRANSPORT; EQUILIBRIUM; TRANSITIONS;
   CRYSTALS; LAMELLAR
AB Crystals of transmembrane proteins may be grown from detergent solutions or in a matrix of membranous lipid bilayers existing in a liquid crystalline state and forming a cubic phase (in cubo). While crystallization in micellar solutions appears analogous to that for soluble proteins, crystallization in lipidic matrices is poorly understood. As this method was shown to be applicable to several membrane proteins, understanding its mechanism will facilitate a rational design of crystallization, minimizing the laborious screening of a large number of parameters. Using polarization microscopy and low-angle X-ray diffraction, experimental evidence is provided to support a mechanistic model for the in cubo crystallization of bacteriorhodopsin in a lipid matrix. Membrane proteins are thought to reside in curved lipid bilayers, to diffuse into patches of lower curvature and to incorporate into lattices which associate to form highly ordered three-dimensional crystals. Critical testing of this model is necessary to generalize it to other membrane proteins. (C) 2001 Published by Elsevier Science BY. on behalf of the Federation of European Biochemical Societies.
C1 Univ Texas, Dept Physiol & Biophys, Med Branch, Membrane Prot Lab, Galveston, TX 77555 USA.
   Univ Texas, Dept Physiol & Biophys, Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA.
   Ohio State Univ, Columbus, OH 43210 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.
RP Landau, EM (corresponding author), Univ Texas, Dept Physiol & Biophys, Med Branch, Membrane Prot Lab, 301 Univ Blvd, Galveston, TX 77555 USA.
EM emlandau@utmb.edu
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM056969,
   R01GM056969, R01GM056969, R01GM056969] Funding Source: NIH RePORTER;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM 56969, GM 61060] Funding Source: Medline
CR Ai X, 2000, BIOPHYS J, V79, P394, DOI 10.1016/S0006-3495(00)76301-6
   Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X
   BenTal N, 1996, BIOPHYS J, V70, P1803, DOI 10.1016/S0006-3495(96)79744-8
   Blanton TN, 1995, POWDER DIFFR, V10, P91, DOI DOI 10.1017/S0885715600014421
   Briggs J, 1996, J PHYS II, V6, P723, DOI 10.1051/jp2:1996208
   Caffrey M, 2000, CURR OPIN STRUC BIOL, V10, P486, DOI 10.1016/S0959-440X(00)00119-6
   Charitat T, 1997, J PHYS II, V7, P15, DOI 10.1051/jp2:1997112
   Chen AH, 1998, CHEM PHYS LIPIDS, V95, P11, DOI 10.1016/S0009-3084(98)00060-7
   Chiu ML, 2000, ACTA CRYSTALLOGR D, V56, P781, DOI 10.1107/S0907444900004716
   CHOU T, 2001, IN PRESS BIOPHYS J
   CHUNG H, 1994, NATURE, V368, P224, DOI 10.1038/368224a0
   CLERC M, 1991, J PHYS II, V1, P1263
   Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623
   Heberle J, 1998, J MOL BIOL, V281, P587, DOI 10.1006/jmbi.1998.1970
   Hyde ST, 1997, LANGMUIR, V13, P842, DOI 10.1021/la9605347
   JACKSON MB, 1978, BIOCHEMISTRY-US, V17, P4470, DOI 10.1021/bi00614a017
   Kim KS, 1998, BIOPHYS J, V75, P2274, DOI 10.1016/S0006-3495(98)77672-6
   Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390
   Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532
   LOEWEN M, 2000, CRC METH SIG TRANS, P365
   Luecke H, 2000, J MOL BIOL, V300, P1237, DOI 10.1006/jmbi.2000.3884
   Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255
   Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   LUECKE H, 2001, IN PRESS SCIENCE
   Lustig A, 2000, BBA-BIOMEMBRANES, V1464, P199, DOI 10.1016/S0005-2736(99)00254-0
   Marelja S., 1976, BIOCHIM BIOPHYS ACTA, V455, P1
   Mariani P, 1996, PHYS REV E, V54, P5840, DOI 10.1103/PhysRevE.54.5840
   Nollert P, 1998, BIOCHEM SOC T, V26, P709, DOI 10.1042/bst0260709
   Nollert P, 1999, FEBS LETT, V457, P205, DOI 10.1016/S0014-5793(99)01014-5
   NOLLERT P, 2001, G PROTEIN PATHWAYS M
   ODELL E, 1994, LECT MATH LIFE SCI, V24, P23
   Pebay-Peyroula E, 2000, BBA-BIOENERGETICS, V1460, P119, DOI 10.1016/S0005-2728(00)00134-1
   PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676
   Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X
   Royant A, 2000, NATURE, V406, P645, DOI 10.1038/35020599
   ROYANT A, 2001, IN PRESS P NATL ACAD
   Rummel G, 1998, J STRUCT BIOL, V121, P82, DOI 10.1006/jsbi.1997.3952
   Sabra MC, 1998, BIOPHYS J, V75, P1180, DOI 10.1016/S0006-3495(98)74037-8
   Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607
   SIEGEL DP, 1986, CHEM PHYS LIPIDS, V42, P279, DOI 10.1016/0009-3084(86)90087-3
   STERNBERG B, 1992, BIOCHIM BIOPHYS ACTA, V1108, P21, DOI 10.1016/0005-2736(92)90110-8
   Templer RH, 1998, CURR OPIN COLLOID IN, V3, P255, DOI 10.1016/S1359-0294(98)80069-1
   Templer RH, 1998, J PHYS CHEM B, V102, P7262, DOI 10.1021/jp972837v
   Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420
   WATTS A, 1995, BIOPHYS CHEM, V55, P137, DOI 10.1016/0301-4622(94)00147-C
   WATTS A, 1995, BIOPHYS CHEM, V56, P41, DOI 10.1016/0301-4622(95)00013-N
   ZHU T, 1993, BIOPHYS J, V65, P939, DOI 10.1016/S0006-3495(93)81108-1
NR 48
TC 95
Z9 98
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD AUG 31
PY 2001
VL 504
IS 3
SI SI
BP 179
EP 186
DI 10.1016/S0014-5793(01)02747-8
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 472HG
UT WOS:000170977600015
PM 11532451
DA 2021-01-25
ER

PT J
AU Werten, PJL
   Hasler, L
   Koenderink, JB
   Klaassen, CHW
   de Grip, WJ
   Engel, A
   Deen, PMT
AF Werten, PJL
   Hasler, L
   Koenderink, JB
   Klaassen, CHW
   de Grip, WJ
   Engel, A
   Deen, PMT
TI Large-scale purification of functional recombinant human aquaporin-2
SO FEBS LETTERS
LA English
DT Article; Proceedings Paper
CT Conference on Structure, Dynamics and Function of Proteins in Biological
   Membranes
CY MAR 13-17, 2001
CL MONTE VERITA, SWITZERLAND
DE baculovirus; insect cell; expression; stopped-flow analysis; structural
   analysis
ID NEPHROGENIC DIABETES-INSIPIDUS; WATER-BALANCE DISORDERS; INTRINSIC
   PROTEIN MIP; 3-DIMENSIONAL STRUCTURE; CHANNEL PROTEINS; RENAL
   AQUAPORINS; EXPRESSION; PATHOPHYSIOLOGY; PHYSIOLOGY; KIDNEY
AB The homotetrameric aquaporin-2 (AQP2) water channel is essential for the concentration of urine and of critical importance in diseases with water dysregulation, such as nephrogenic diabetes insipidus, congestive heart failure, liver cirrhosis and pre-eclampsia. The structure of human AQP2 is a prerequisite for understanding its function and for designing specific blockers. To obtain sufficient amounts of AQP2 for structural analyses, we have expressed recombinant his-tagged human AQP2 (HT-AQP2) in the baculovirus/insect cell system. Using the protocols outlined in this study, 0.5 mg of pure HT-AQP2 could be obtained per liter of bioreactor culture. HT-AQP2 had retained its homotetrameric structure and exhibited a single channel water permeability of 0.93 +/- 0.03 x 10(-13) cm(3)/s, similar to that of other AQPs. Thus, the baculovirus/insect cell system allows large-scale expression of functional recombinant human AQP2 that is suitable for structural studies. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Univ Nijmegen, Dept Cell Physiol, Nijmegen, Netherlands.
   Univ Basel, Biozentrum, ME Muller Inst, Basel, Switzerland.
   Univ Nijmegen, Dept Biochem, Nijmegen, Netherlands.
RP Deen, PMT (corresponding author), Univ Nijmegen, Dept Cell Physiol, Nijmegen, Netherlands.
EM peterd@sci.kun.nl
RI Koenderink, Jan/N-3578-2014; Deen, Peter/B-9854-2013; Deen,
   P.M.T./H-8023-2014; de Grip, W.J./L-4335-2015
OI Deen, Peter/0000-0002-7868-4655; Deen, P.M.T./0000-0002-7868-4655; de
   Grip, W.J./0000-0001-7637-4920
CR Agre P, 2000, J AM SOC NEPHROL, V11, P764
   ASAHINA Y, 1995, HEPATOLOGY, V21, P169, DOI 10.1016/0270-9139(95)90425-5
   Braun T, 2000, EMBO REP, V1, P183, DOI 10.1093/embo-reports/kvd022
   BROWN D, 1995, HISTOCHEM CELL BIOL, V104, P1, DOI 10.1007/BF01464780
   Daniels MJ, 1999, J MOL BIOL, V294, P1337, DOI 10.1006/jmbi.1999.3293
   Deen PMT, 1997, J AM SOC NEPHROL, V8, P1493
   DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920
   Deen PMT, 1998, CURR OPIN CELL BIOL, V10, P435, DOI 10.1016/S0955-0674(98)80055-0
   Deen PMT, 1998, CURR OPIN NEPHROL HY, V7, P37
   DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421
   Fernandez-Llama P, 1999, J AM SOC NEPHROL, V10, P1950
   FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0
   Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   Jonassen TEN, 1998, AM J PHYSIOL-RENAL, V275, pF216
   Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394
   KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2
   King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6
   KISTLER J, 1994, J CELL BIOL, V126, P1047, DOI 10.1083/jcb.126.4.1047
   Klaassen CHW, 1999, BIOCHEM J, V342, P293, DOI 10.1042/0264-6021:3420293
   Knepper MA, 1997, CURR OPIN NEPHROL HY, V6, P367
   LAMPE PD, 1990, EUR J BIOCHEM, V194, P541, DOI 10.1111/j.1432-1033.1990.tb15650.x
   Mulders SM, 1998, J CLIN INVEST, V102, P57, DOI 10.1172/JCI2605
   Nielsen S, 1998, CURR OPIN NEPHROL HY, V7, P509, DOI 10.1097/00041552-199809000-00005
   Nielsen S, 1997, P NATL ACAD SCI USA, V94, P5450, DOI 10.1073/pnas.94.10.5450
   Nielsen S, 1999, J AM SOC NEPHROL, V10, P647
   PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060
   PEARSON JF, 1992, BRIT J HOSP MED, V48, P47
   Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031
   Schrier RW, 1998, P ASSOC AM PHYSICIAN, V110, P407
   Schrier RW, 1998, MOL GENET METAB, V65, P255, DOI 10.1006/mgme.1998.2765
   Schulein R, 1997, PROTEIN ENG, V10, P707, DOI 10.1093/protein/10.6.707
   SMITH BL, 1991, J BIOL CHEM, V266, P6407
   STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9
   Sui HX, 2000, ACTA CRYSTALLOGR D, V56, P1198, DOI 10.1107/S0907444900008143
   van Os CH, 1998, NEPHROL DIAL TRANSPL, V13, P1645, DOI 10.1093/ndt/13.7.1645
   VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512
   Xu Linjing, 1998, Medicine and Science in Sports and Exercise, V30, P1230, DOI 10.1097/00005768-199808000-00008
   Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r
NR 42
TC 29
Z9 30
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD AUG 31
PY 2001
VL 504
IS 3
SI SI
BP 200
EP 205
DI 10.1016/S0014-5793(01)02703-X
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 472HG
UT WOS:000170977600018
PM 11532454
OA Bronze
DA 2021-01-25
ER

PT J
AU Muller, DJ
   Dencher, NA
   Meier, T
   Dimroth, P
   Suda, K
   Stahlberg, H
   Engel, A
   Seelert, H
   Matthey, U
AF Muller, DJ
   Dencher, NA
   Meier, T
   Dimroth, P
   Suda, K
   Stahlberg, H
   Engel, A
   Seelert, H
   Matthey, U
TI ATP synthase: constrained stoichiometry of the transmembrane rotor
SO FEBS LETTERS
LA English
DT Article; Proceedings Paper
CT Conference on Structure, Dynamics and Function of Proteins in Biological
   Membranes
CY MAR 13-17, 2001
CL MONTE VERITA, SWITZERLAND
DE atomic force microscopy; ATP synthase; structural assembly; molecular
   interaction
ID LIGHT-HARVESTING COMPLEX; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN
   COMPLEXES; ATOMIC-FORCE MICROSCOPE; C-SUBUNIT OLIGOMER;
   ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PURPLE MEMBRANE; F-ATPASE;
   PURIFICATION
AB Recent structural data suggest that the number of identical subunits (c or III) assembled into the cation-powered rotor of F1F0 ATP synthase depends on the biological origin. Atomic force microscopy allowed individual subunits of the cylindrical transmembrane rotors from spinach chloroplast and from Ilyobacter tartaricus ATP synthase to be directly visualized in their native-like environment. Occasionally, individual rotors exhibit structural gaps of the size of one or more subunits. Complete rotors and arch-shaped fragments of incomplete rotors revealed the same diameter within one ATP synthase species. These results suggest the rotor diameter and stoichiometry to be determined by the shape of the subunits and their nearest neighbor interactions. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Tech Univ Darmstadt, Dept Chem, D-64287 Darmstadt, Germany.
   ETH Zurich, Inst Microbiol, CH-8092 Zurich, Switzerland.
RP Muller, DJ (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
RI Dencher, Norbert/G-6640-2014; Stahlberg, Henning/H-1868-2011
OI Muller, Daniel J/0000-0003-3075-0665; Stahlberg,
   Henning/0000-0002-1185-4592
CR ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Ferguson SJ, 2000, CURR BIOL, V10, pR804, DOI 10.1016/S0960-9822(00)00765-X
   Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055
   Heymann JB, 1999, J STRUCT BIOL, V128, P243, DOI 10.1006/jsbi.1999.4180
   Junge W, 1999, P NATL ACAD SCI USA, V96, P4735, DOI 10.1073/pnas.96.9.4735
   Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9
   KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0
   Moller C, 2000, J MOL BIOL, V301, P869, DOI 10.1006/jmbi.2000.3995
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 1999, J MOL BIOL, V285, P1903, DOI 10.1006/jmbi.1998.2441
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Neff D, 1999, BIOCHEM BIOPH RES CO, V259, P569, DOI 10.1006/bbrc.1999.0820
   Neumann S, 1998, J BACTERIOL, V180, P3312, DOI 10.1128/JB.180.13.3312-3316.1998
   Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0
   Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8
   Poetsch A, 2000, BBA-BIOMEMBRANES, V1466, P339, DOI 10.1016/S0005-2736(00)00191-7
   Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051
   Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0
   Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Schemidt RA, 1998, J BACTERIOL, V180, P3205, DOI 10.1128/JB.180.12.3205-3208.1998
   Seelert H, 2000, NATURE, V405, P418
   Seelert H, 2000, BIOCHEM J, V346, P41, DOI 10.1042/0264-6021:3460041
   STAHLBERG H, 2001, EMBO REP, V21, P1
   Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700
   Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0
   Wilkens S, 1997, NAT STRUCT BIOL, V4, P198, DOI 10.1038/nsb0397-198
   WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961
NR 32
TC 55
Z9 61
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD AUG 31
PY 2001
VL 504
IS 3
SI SI
BP 219
EP 222
DI 10.1016/S0014-5793(01)02708-9
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 472HG
UT WOS:000170977600021
PM 11532457
OA Bronze
DA 2021-01-25
ER

PT J
AU Royant, A
   Nollert, P
   Edman, K
   Neutze, R
   Landau, EM
   Pebay-Peyroula, E
   Navarro, J
AF Royant, A
   Nollert, P
   Edman, K
   Neutze, R
   Landau, EM
   Pebay-Peyroula, E
   Navarro, J
TI X-ray structure of sensory rhodopsin II at 2.1-angstrom resolution
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID LIPIDIC CUBIC PHASES; PHARAONIS PHOBORHODOPSIN; ANGSTROM RESOLUTION;
   NATRONOBACTERIUM-PHARAONIS; ESCHERICHIA-COLI; BACTERIORHODOPSIN;
   PROTEIN; HALORHODOPSIN; PHOTOCYCLE; TRANSDUCER
AB Sensory rhodopsins (SRs) belong to a subfamily of heptahelical transmembrane proteins containing a retinal chromophore. These photoreceptors mediate the cascade of vision in animal eyes and phototaxis in archaebacteria and unicellular flagellated algae. Signal transduction by these photoreceptors occurs by means of transducer proteins. The two archaebacterial sensory rhodopsins SRI and SRII are coupled to the membrane-bound HtrI and HtrII transducer proteins. Activation of these proteins initiates phosphorylation cascades that modulate the flagellar motors, resulting in either attractant (SRI) or repellent (SRII) phototaxis. In addition, transducer-free SRI and SRII were shown to operate as proton pumps, analogous to bacteriorhodopsin. Here, we present the x-ray structure of SRII from Natronobacterium pharaonis (pSRII) at 2.1-Angstrom resolution, revealing a unique molecular architecture of the retinal-binding pocket. in particular, the structure of pSRII exhibits a largely unbent conformation of the retinal (as compared with bacteriorhodopsin and halorhodopsin), a hydroxyl group of Thr-204 in the vicinity of the Schiff base, and an outward orientation of the guanidinium group of Arg-72. Furthermore, the structure reveals a putative chloride ion that is coupled to the Schiff base by means of a hydrogen-bond network and a unique, positively charged surface patch for a probable interaction with HtrII. The high-resolution structure of pSRII provides a structural basis to elucidate the mechanisms of phototransduction and color tuning.
C1 Univ Texas, Med Branch, Membrane Prot Lab, Dept Physiol & Biophys, Galveston, TX 77555 USA.
   Univ Texas, Med Branch, Sealy Ctrs Struct Biol & Mol Sci, Galveston, TX 77555 USA.
   Univ Grenoble 1, Commissariat Energie Atom, Unite Mixte Rech 5075,CNRS, Inst Biol Struct, F-38027 Grenoble, France.
   European Synchrotron Radiat Facil, F-38043 Grenoble, France.
   Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Uppsala, Ctr Biomed, Dept Biochem, S-75123 Uppsala, Sweden.
   Chalmers Univ Technol, Dept Mol Biotechnol, S-40530 Gothenburg, Sweden.
RP Navarro, J (corresponding author), Univ Texas, Med Branch, Membrane Prot Lab, Dept Physiol & Biophys, 301 Univ Blvd, Galveston, TX 77555 USA.
RI Royant, Antoine/G-3684-2012; Marques, Jorge Teixeira/A-9961-2018;
   Tavares, Paula/W-4275-2017; Neutze, Richard/A-7573-2010
OI Royant, Antoine/0000-0002-1919-8649; Marques, Jorge
   Teixeira/0000-0003-0381-6374; Tavares, Paula/0000-0002-6955-3389;
   Neutze, Richard/0000-0003-0986-6153; Navarro, Javier/0000-0001-7098-4373
CR [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760
   Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5
   Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133
   GREENHALGH DA, 1993, J BIOL CHEM, V268, P20305
   Hohenfeld IP, 1999, FEBS LETT, V442, P198, DOI 10.1016/S0014-5793(98)01659-7
   Iwamoto M, 1999, BIOPHYS CHEM, V79, P187, DOI 10.1016/S0301-4622(99)00054-X
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2
   Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390
   Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P55
   PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676
   Sasaki J, 2000, BBA-BIOENERGETICS, V1460, P230, DOI 10.1016/S0005-2728(00)00142-0
   Schmies G, 2000, BIOPHYS J, V78, P967, DOI 10.1016/S0006-3495(00)76654-9
   SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036
   Shimono K, 2000, BIOPHYS CHEM, V87, P225, DOI 10.1016/S0301-4622(00)00195-2
   Shimono K, 2000, PHOTOCHEM PHOTOBIOL, V72, P141
   Spudich JL, 1998, MOL MICROBIOL, V28, P1051, DOI 10.1046/j.1365-2958.1998.00859.x
   Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365
   Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614
   SUBRAMANIAM S, 1993, EMBO J, V12, P1
   Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008
   Zhang XN, 1999, P NATL ACAD SCI USA, V96, P857, DOI 10.1073/pnas.96.3.857
NR 29
TC 231
Z9 236
U1 0
U2 13
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 28
PY 2001
VL 98
IS 18
BP 10131
EP 10136
DI 10.1073/pnas.181203898
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 468BJ
UT WOS:000170738000023
PM 11504917
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Hellstern, S
   Pegoraro, S
   Karim, CB
   Lustig, A
   Thomas, DD
   Moroder, L
   Engel, J
AF Hellstern, S
   Pegoraro, S
   Karim, CB
   Lustig, A
   Thomas, DD
   Moroder, L
   Engel, J
TI Sarcolipin, the shorter homologue of phospholamban, forms oligomeric
   structures in detergent micelles and in liposomes
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CARDIAC SARCOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN;
   CIRCULAR-DICHROISM; MEMBRANE-PROTEINS; HIGH-RESOLUTION; LIPID BILAYERS;
   CA-ATPASE; CA2+-ATPASE; PHOSPHORYLATION; MECHANISM
AB The human 31-amino acid integral membrane protein sarcolipin (SLN), which regulates the sarcoplasmic reticulum Ca-ATPase in fast-twitch skeletal muscle, was chemically synthesized. Appropriate synthesis and purification strategies were used to achieve high purity and satisfactory yields of this hydrophobic and poorly soluble protein. Structural and functional properties of SIN were analyzed and compared with the homologous region of human phospholamban (PLB) comprising residues Ala(24)-Leu(52) (PLB(24-52)), the regulatory protein of the cardiac sarcoplasmic reticulum Ca-ATPase. Circular dichroism spectroscopy showed that SLN is a predominantly alpha -helical protein and that the secondary structure is highly resistant to SDS and thermal denaturation. In this respect SLN is remarkably similar to PLB-(24-52). However, SLN is monomeric in SDS gels, whereas PLB-(24-52) shows a monomer-pentamer equilibrium typical for native PLB. Analytical ultracentrifugation experiments revealed that SLN oligomerizes in the presence of the nonionic detergents octylpolyoxyethylene and octyl glucoside in a concentration-dependent manner. No plateau was observed, and a pentameric state was only reached at much higher protein concentrations compared with PLB-(24-52). Chemical cross-linking showed that also in liposomes SLN has the ability to self-associate to oligomers. PLB-(24-52) specifically oligomerized to pentamers in the presence of octylpolyoxyethylene as well as in liposomes at low protein concentrations. In the presence of octylpolyoxyethylene pentamers were the main oligomeric species, whereas in liposomes monomers and dimers were predominant. Increasing the protein concentration led to self-association of PLB-(24-52) pentamers in the presence of octylpolyoxyethylene. Functional reconstitution of Ca-ATPase with PLB-(24-52) and SLN in liposomes showed that both proteins regulate the Ca-ATPase in a similar manner.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Thomas, David D/B-4257-2012
OI Karim, Christine/0000-0002-7321-7695; Thomas, David
   D./0000-0002-8822-2040; Moroder, Luis/0000-0001-9570-5713
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM027906,
   R01GM027906, R01GM027906, R01GM027906, R01GM027906, R01GM027906,
   R01GM027906, R01GM027906, R01GM027906, R01GM027906, R01GM027906,
   R01GM027906, R01GM027906, R01GM027906, R01GM027906, R01GM027906,
   R01GM027906, R01GM027906, R01GM027906, R01GM027906, R01GM027906,
   R01GM027906, R01GM027906, R01GM027906, R01GM027906, R01GM027906,
   R01GM027906, R01GM027906, R01GM027906, R01GM027906, R01GM027906,
   R01GM027906, R01GM027906, R01GM027906] Funding Source: NIH RePORTER;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM27906] Funding Source: Medline
CR ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154
   Arkin IT, 1997, ANNU REV BIOPH BIOM, V26, P157, DOI 10.1146/annurev.biophys.26.1.157
   ARKIN IT, 1995, J MOL BIOL, V248, P824, DOI 10.1006/jmbi.1995.0263
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q
   FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6
   Frank S, 2000, BIOCHEMISTRY-US, V39, P6825, DOI 10.1021/bi0000972
   HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106
   Hughes G, 1996, BIOCHEM J, V318, P973, DOI 10.1042/bj3180973
   JONES LR, 1985, J BIOL CHEM, V260, P7721
   Karim CB, 1998, BIOCHEMISTRY-US, V37, P12074, DOI 10.1021/bi980642n
   Karim CB, 2000, BIOCHEMISTRY-US, V39, P10892, DOI 10.1021/bi0003543
   Kimura Y, 1996, J BIOL CHEM, V271, P21726, DOI 10.1074/jbc.271.36.21726
   KOVACS RJ, 1988, J BIOL CHEM, V263, P18364
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE
   Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734
   Lustig A, 2000, BBA-BIOMEMBRANES, V1464, P199, DOI 10.1016/S0005-2736(99)00254-0
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   Mayer EJ, 1996, J BIOL CHEM, V271, P1669, DOI 10.1074/jbc.271.3.1669
   Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1
   MUTTER M, 1995, PEPTIDE RES, V8, P145
   Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967
   Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   PARK K, 1992, PROTEIN SCI, V1, P1032, DOI 10.1002/pro.5560010809
   PEGORARO S, 2000, P 16 AM AM PEPT S
   REDDY LG, 1995, J BIOL CHEM, V270, P9390, DOI 10.1074/jbc.270.16.9390
   Reddy LG, 1999, J BIOL CHEM, V274, P7649, DOI 10.1074/jbc.274.12.7649
   Rosenbusch JP, 2001, MICRON, V32, P75, DOI 10.1016/S0968-4328(00)00021-4
   SASAKI T, 1992, J BIOL CHEM, V267, P1674
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SHIRE SJ, 1994, MODERN ANAL ULTRACEN, V14, P276
   SIMMERMAN HKB, 1989, BIOCHIM BIOPHYS ACTA, V997, P322, DOI 10.1016/0167-4838(89)90203-3
   Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941
   Simmerman HKB, 1998, PHYSIOL REV, V78, P921
   SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333
   Stokes DL, 1997, CURR OPIN STRUC BIOL, V7, P550, DOI 10.1016/S0959-440X(97)80121-2
   STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7
   Torres J, 2000, J MOL BIOL, V300, P677, DOI 10.1006/jmbi.2000.3885
   VORHERR T, 1993, PROTEIN SCI, V2, P339
   WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8
   WEGENER AD, 1989, J BIOL CHEM, V264, P11468
NR 43
TC 52
Z9 54
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 17
PY 2001
VL 276
IS 33
BP 30845
EP 30852
DI 10.1074/jbc.M102495200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 463JG
UT WOS:000170472900036
PM 11413134
OA Bronze
DA 2021-01-25
ER

PT J
AU Corps, E
   Carter, C
   Karecla, P
   Ahrens, T
   Evans, P
   Kilshaw, P
AF Corps, E
   Carter, C
   Karecla, P
   Ahrens, T
   Evans, P
   Kilshaw, P
TI Recognition of E-cadherin by integrin alpha(E)beta(7) - Requirement for
   cadherin dimerization and implications for cadherin and integrin
   function
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CELL-ADHESION; INTRAEPITHELIAL LYMPHOCYTES; (CD103)-DEFICIENT MICE;
   CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; CALCIUM-BINDING; TERMINAL DOMAIN;
   UVOMORULIN; SITE; HOMOASSOCIATION
AB We have investigated the importance of dimerization of E-cadherin in the heterophilic adhesive interaction between E-cadherin and integrin alpha (E)beta (7). Dimerization of cadherin molecules in parallel alignment is known to be essential for homophilic adhesion and has been attributed to Ca2+-dependent interactions in the domain 1-2 junction or to cross-intercalation of Trp2 from one molecule to the other. We have disrupted either or both of these proposed mechanisms by point mutations in E-cadherin-Fc and have tested the modified proteins for alpha (E)beta (7)-mediated cell adhesion. Prevention of Trp2 intercalation had no adverse effect on integrin-mediated adhesion, whereas disruption of Ca2+ binding permitted adhesion but with reduced efficiency. Both modifications in combination abolished recognition by alpha (E)beta (7). In EGTA, alpha (E)beta (7) adhered to wild type E-cadherin but not to the Trp2 deletion mutant. Independent evidence that the mutations prevented either or both mechanisms for dimerization is presented. The data show that dimerization is required for recognition by alpha (E)beta (7) and that it can take place by either of two mechanisms. Implications for the roles of the alpha (E) and beta (7) integrin subunits in ligand binding and for Trp2 and Ca2+ in the assembly of cadherin complexes are discussed.
C1 Babraham Inst, Mol Immunol Programme, Cambridge CB2 4AT, England.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Kilshaw, P (corresponding author), Babraham Inst, Mol Immunol Programme, Cambridge CB2 4AT, England.
CR Alattia JR, 1997, FEBS LETT, V417, P405, DOI 10.1016/S0014-5793(97)01333-1
   ANDREW DP, 1994, J IMMUNOL, V153, P3847
   Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697
   Beagley KW, 1998, CRIT REV IMMUNOL, V18, P237, DOI 10.1615/CritRevImmunol.v18.i3.40
   Berg RW, 1999, IMMUNOL CELL BIOL, V77, P337, DOI 10.1046/j.1440-1711.1999.00832.x
   Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487
   Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134
   CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0
   Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837
   Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i
   GONZALEZ AL, 1995, TRENDS GENET, V11, P216, DOI 10.1016/S0168-9525(00)89051-4
   Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197
   Higgins JMG, 2000, J BIOL CHEM, V275, P25652, DOI 10.1074/jbc.M001228200
   Huber O, 1999, J CELL SCI, V112, P4415
   Karecla PI, 1996, J BIOL CHEM, V271, P30909, DOI 10.1074/jbc.271.48.30909
   KARECLA PI, 1995, EUR J IMMUNOL, V25, P852, DOI 10.1002/eji.1830250333
   KILSHAW PJ, 1988, IMMUNOL LETT, V18, P149, DOI 10.1016/0165-2478(88)90056-9
   Kitagawa M, 2000, BIOCHEM BIOPH RES CO, V271, P358, DOI 10.1006/bbrc.2000.2636
   Klingelhofer J, 2000, J CELL SCI, V113, P2829
   Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624
   Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398
   Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598
   Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0
   Nakashima A, 1999, J NEURAL TRANSM, V106, P819, DOI 10.1007/s007020050202
   OZAWA M, 1990, MECH DEVELOP, V33, P49, DOI 10.1016/0925-4773(90)90134-8
   Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166
   OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A
   Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605
   OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645
   Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738
   PURZONMCLAUGHLI.W, 2000, J BIOL CHEM, V275, P7795
   Schon MP, 2000, J IMMUNOL, V165, P6583, DOI 10.4049/jimmunol.165.11.6583
   Schon MP, 1999, J IMMUNOL, V162, P6641
   Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579
   SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0
   SIRAYOSHI Y, 1986, CELL STRUCT FUNCT, V11, P245
   Strauch UG, 2001, J IMMUNOL, V166, P3506, DOI 10.4049/jimmunol.166.5.3506
   Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542
   Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1
   Taraszka KS, 2000, J EXP MED, V191, P1555, DOI 10.1084/jem.191.9.1555
   Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128
   Tidswell M, 1997, J IMMUNOL, V159, P1497
   Tolosa E, 1996, J IMMUNOL METHODS, V192, P165, DOI 10.1016/0022-1759(96)00042-7
   Troyanovsky RB, 1999, J CELL SCI, V112, P4379
   Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G
   WEARNE SJ, 1990, FEBS LETT, V263, P23, DOI 10.1016/0014-5793(90)80696-G
   Zang Q, 2000, J BIOL CHEM, V275, P22202, DOI 10.1074/jbc.M002883200
NR 47
TC 22
Z9 23
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD AUG 17
PY 2001
VL 276
IS 33
BP 30862
EP 30870
DI 10.1074/jbc.M101712200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 463JG
UT WOS:000170472900038
PM 11413131
OA Bronze
DA 2021-01-25
ER

PT J
AU Dozier, C
   Kagoshima, H
   Niklaus, G
   Cassata, G
   Burglin, TR
AF Dozier, C
   Kagoshima, H
   Niklaus, G
   Cassata, G
   Burglin, TR
TI The Caenorhabditis elegans Six/sine oculis class homeobox gene ceh-32 is
   required for head morphogenesis
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE ceh-32; homeobox gene; Six/so class; Caenorhabditis elegans; head
   morphogenesis; vab-3; Pax-6
ID SINE OCULIS; C-ELEGANS; EYE DEVELOPMENT; TRANSCRIPTION FACTOR;
   VERTEBRATE MUSCLE; ESCHERICHIA-COLI; PAIRED DOMAIN; TARGET GENES;
   DROSOPHILA; EXPRESSION
AB Caenorhabditis elegans has four members of the Six/sine oculis class of homeobox genes, ceh-32, ceh-33, ceh-34, and ceh-35. Proteins encoded by this gene family are transcription factors sharing two conserved domains, the homeodomain and the Six/sine oculis domain, both involved in DNA binding. ceh-32 expression was detected during embryogenesis in hypodermal and neuronal precursor cells and later in descendants of these cells as well as in gonadal sheath cells. RNAi inactivation studies suggest that ceh-32 plays a role in head morphogenesis, like vab-3, the C. elegans Pax-6 orthologue. ceh-32 and vab-3 are coexpressed in head hypodermal cells and ceh-32 mRNA levels are reduced in vab-3 mutants. Moreover, ectopic expression of VAB-3 in transgenic worms is able to induce ceh-32 ectopically. In addition, we demonstrate that VAB-3 is able to bind directly to the ceh-32 upstream regulatory region in vitro and to activate reporter gene transcription in a yeast one-hybrid system. Out results suggest that VAB-3 acts upstream of ceh-32 during head morphogenesis and directly induces ceh-32. Thus, ceh-32 appears to be the first target gene of VAB-3 identified so far. (C) 2001 Academic Press.
C1 Univ Basel, Biozentrum, Div Cell Biol, CH-4056 Basel, Switzerland.
RP Burglin, TR (corresponding author), Karolinska Inst, Dept Biosci, Sodertorns Hogskola, Box 4101,Alfred Nobels Alle 10, SE-14104 Huddinge, Sweden.
EM thomas.burglin@biosci.ki.se
RI DOZIER, Christine/P-1539-2014
CR Aspock G, 1999, GENOME RES, V9, P909, DOI 10.1101/gr.9.10.909
   Baum PD, 1997, NEURON, V19, P51, DOI 10.1016/S0896-6273(00)80347-5
   BURGLIN TR, 1995, BIODIVERSITY EVOLUTI, P291
   Cassata G, 1998, GENE, V212, P127, DOI 10.1016/S0378-1119(98)00137-1
   Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4
   Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X
   CHISHOLM AD, 1995, NATURE, V377, P52, DOI 10.1038/377052a0
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CZERNY T, 1995, MOL CELL BIOL, V15, P2858
   DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387
   Duncan MK, 1997, MAMM GENOME, V8, P479, DOI 10.1007/s003359900480
   EPSTEIN J, 1994, J BIOL CHEM, V269, P8355
   FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Fire A., 1992, GENETIC ANAL TECHNIQ, V9, P5
   George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9
   GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463
   GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z
   Halder G, 1998, DEVELOPMENT, V125, P2181
   Harris SE, 2000, NUCLEIC ACIDS RES, V28, P1871, DOI 10.1093/nar/28.9.1871
   Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231
   Hobert O, 1999, TRENDS GENET, V15, P214, DOI 10.1016/S0168-9525(99)01731-X
   Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I
   Kawakami K, 1996, NUCLEIC ACIDS RES, V24, P303, DOI 10.1093/nar/24.2.303
   Kozmik Z, 1999, DEV GENES EVOL, V209, P537, DOI 10.1007/s004270050286
   MASTICK GS, 1995, GENETICS, V139, P349
   McCarter J, 1997, DEV BIOL, V181, P121, DOI 10.1006/dbio.1996.8429
   Mello C, 1995, METHOD CELL BIOL, V48, P451
   MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Ohto H, 1999, MOL CELL BIOL, V19, P6815
   Oka T, 1997, J BIOL CHEM, V272, P24387, DOI 10.1074/jbc.272.39.24387
   Oliver G, 1995, DEVELOPMENT, V121, P4045
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Pineda D, 2000, P NATL ACAD SCI USA, V97, P4525, DOI 10.1073/pnas.97.9.4525
   Relaix F, 1999, GENE DEV, V13, P3171, DOI 10.1101/gad.13.24.3171
   Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033
   Seimiya M, 2000, DEVELOPMENT, V127, P1879
   Seo HC, 1998, MECH DEVELOP, V73, P45, DOI 10.1016/S0925-4773(98)00028-8
   Seo HC, 1999, MECH DEVELOP, V83, P127, DOI 10.1016/S0925-4773(99)00045-3
   Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Treisman JE, 1999, BIOESSAYS, V21, P843, DOI 10.1002/(SICI)1521-1878(199910)21:10<843::AID-BIES6>3.3.CO;2-A
   YASUKAWA T, 1995, J BIOL CHEM, V270, P25328, DOI 10.1074/jbc.270.43.25328
   ZHANG YH, 1995, NATURE, V377, P55, DOI 10.1038/377055a0
   Zhang YH, 1998, MECH DEVELOP, V78, P179, DOI 10.1016/S0925-4773(98)00171-3
NR 46
TC 31
Z9 37
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD AUG 15
PY 2001
VL 236
IS 2
BP 289
EP 303
DI 10.1006/dbio.2001.0325
PG 15
WC Developmental Biology
SC Developmental Biology
GA 463VF
UT WOS:000170497400003
PM 11476572
DA 2021-01-25
ER

PT J
AU Choi, S
   Qiu, J
   Storici, P
   Schirmer, T
   Silverman, RB
AF Choi, S
   Qiu, J
   Storici, P
   Schirmer, T
   Silverman, RB
TI Inactivation of gamma-aminobutyric acid aminotransferase by
   conformationally-rigid analogs.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG
PY 2001
VL 222
MA 239-BIOL
BP U154
EP U155
PN 1
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 467ET
UT WOS:000170690000753
DA 2021-01-25
ER

PT J
AU Pebay-Peyroula, E
   Rosenbusch, JP
AF Pebay-Peyroula, E
   Rosenbusch, JP
TI High-resolution structures and dynamics of membrane protein-lipid
   complexes: a critique
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Review
ID CYTOCHROME-C-OXIDASE; ESCHERICHIA-COLI; ANGSTROM RESOLUTION; OMPF PORIN;
   PHOSPHOTRANSFERASE SYSTEM; CONFORMATIONAL-CHANGES; NEUTRON-SCATTERING;
   CRYSTAL-STRUCTURES; BACTERIORHODOPSIN; TRANSPORT
AB Crystallographic analysis of lipidic components in complex with membrane proteins reveals molecules exhibiting well-ordered polar or hydrophobic moieties in contact with protein. As dynamic methods indicate high exchange rates, the interpretation of structural data requires a detailed knowledge of the specificity, affinity and cooperativity of lipid binding.
C1 Univ Grenoble 1, CNRS, CEA, UMR 5075,IBS, F-38027 Grenoble 1, France.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pebay-Peyroula, E (corresponding author), Univ Grenoble 1, CNRS, CEA, UMR 5075,IBS, F-38027 Grenoble 1, France.
CR Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X
   Bezrukov SM, 2000, J MEMBRANE BIOL, V174, P1, DOI 10.1007/s002320001026
   BUEHLER LK, 1991, J BIOL CHEM, V266, P24446
   Bystrom T, 2000, BBA-BIOMEMBRANES, V1509, P335, DOI 10.1016/S0005-2736(00)00316-3
   Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1
   Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199
   EISELE JL, 1990, J BIOL CHEM, V265, P10217
   Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673
   Ferguson AD, 2000, STRUCTURE, V8, P585
   Fyfe PK, 2001, TRENDS BIOCHEM SCI, V26, P106, DOI 10.1016/S0968-0004(00)01746-1
   GARAVITO RM, 1983, J MOL BIOL, V164, P313, DOI 10.1016/0022-2836(83)90079-7
   Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328
   Heberle J, 1998, J MOL BIOL, V281, P587, DOI 10.1006/jmbi.1998.1970
   HOLZENBURG A, 1989, BIOCHEMISTRY-US, V28, P4187, DOI 10.1021/bi00436a010
   Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956
   IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0
   Joshi MK, 1998, BIOCHEMISTRY-US, V37, P14463, DOI 10.1021/bi980965j
   Jost P C, 1980, Ann N Y Acad Sci, V348, P391, DOI 10.1111/j.1749-6632.1980.tb21315.x
   KATES M, 1993, BIOCHIM BIOPHYS ACTA, V1169, P46, DOI 10.1016/0005-2760(93)90080-S
   Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390
   Kuhlbrandt W, 2000, NATURE, V406, P569, DOI 10.1038/35020654
   KUNDIG W, 1971, J BIOL CHEM, V246, P1407
   Lague P, 2000, BIOPHYS J, V79, P2867, DOI 10.1016/S0006-3495(00)76524-6
   Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   McAuley KE, 1999, P NATL ACAD SCI USA, V96, P14706, DOI 10.1073/pnas.96.26.14706
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Muller DJ, 2000, BBA-BIOENERGETICS, V1460, P27, DOI 10.1016/S0005-2728(00)00127-4
   PEBAYPEYROULA E, 1995, STRUCTURE, V3, P1051, DOI 10.1016/S0969-2126(01)00241-6
   Penel S, 1998, BIOCHIMIE, V80, P543, DOI 10.1016/S0300-9084(00)80019-X
   QIAN MX, 1995, PROTEIN SCI, V4, P747
   RAND RP, 1993, BIOCHEMISTRY-US, V32, P5925, DOI 10.1021/bi00074a001
   Rohwer JM, 2000, J BIOL CHEM, V275, P34909, DOI 10.1074/jbc.M002461200
   ROSENBERG B, 1980, NUCLEIC ACID METAL I, V1, P1
   Rummel G, 1998, J STRUCT BIOL, V121, P82, DOI 10.1006/jsbi.1997.3952
   Sato H, 1999, ACTA CRYSTALLOGR D, V55, P1251, DOI 10.1107/S090744499900503X
   SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213
   SCHINDLER H, 1981, P NATL ACAD SCI-BIOL, V78, P2302, DOI 10.1073/pnas.78.4.2302
   SEELIG A, 1977, BIOCHEMISTRY-US, V16, P45, DOI 10.1021/bi00620a008
   Spencer RH, 1999, CURR OPIN STRUC BIOL, V9, P448, DOI 10.1016/S0959-440X(99)80063-3
   STEVEN AC, 1977, J CELL BIOL, V72, P292, DOI 10.1083/jcb.72.2.292
   Subramaniam S, 2000, BBA-BIOENERGETICS, V1460, P157, DOI 10.1016/S0005-2728(00)00136-5
   Tarek M, 2000, BIOPHYS J, V79, P3244, DOI 10.1016/S0006-3495(00)76557-X
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   VIITANEN P, 1984, P NATL ACAD SCI-BIOL, V81, P1629, DOI 10.1073/pnas.81.6.1629
   VOGT TCB, 1994, BIOCHEMISTRY-US, V33, P2063, DOI 10.1021/bi00174a012
   Weik M, 1998, MOL CELL, V1, P411, DOI 10.1016/S1097-2765(00)80041-6
   Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c
   Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604
NR 52
TC 34
Z9 34
U1 0
U2 2
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD AUG
PY 2001
VL 11
IS 4
BP 427
EP 432
DI 10.1016/S0959-440X(00)00228-1
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 462RK
UT WOS:000170433400007
PM 11495734
DA 2021-01-25
ER

PT J
AU Meier, M
   Janosik, M
   Kery, V
   Kraus, JP
   Burkhard, P
AF Meier, M
   Janosik, M
   Kery, V
   Kraus, JP
   Burkhard, P
TI Structure of human cystathionine beta-synthase: a unique pyridoxal 5
   '-phosphate-dependent heme protein
SO EMBO JOURNAL
LA English
DT Article
DE cystathionine beta-synthase; cysteine biosynthesis; heme protein;
   pyridoxal 5 '-phosphate; X-ray crystal structure
ID O-ACETYLSERINE SULFHYDRYLASE; SALMONELLA-TYPHIMURIUM; 3-DIMENSIONAL
   STRUCTURE; TRYPTOPHAN SYNTHASE; CRYSTAL-STRUCTURE; HOMOCYSTINURIA;
   BINDING; TRANSSULFURATION; DEAMINASE; LIGAND
AB Cystathionine beta -synthase (CBS) is a unique heme-containing enzyme that catalyzes a pyridoxal 5 ' -phosphate (PLP)-dependent condensation of serine and homocysteine to give cystathionine. Deficiency of CBS leads to homocystinuria, an inherited disease of sulfur metabolism characterized by increased levels of the toxic metabolite homocysteine. Here we present the X-ray crystal structure of a truncated form of the enzyme. CBS shares the same fold with O-acetylserine sulfhydrylase but it contains an additional N-terminal heme binding site. This heme binding motif together with a spatially adjacent oxidoreductase active site motif could explain the regulation of its enzyme activity by redox changes.
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Colorado, Sch Med, Dept Pediat, Denver, CO 80262 USA.
   Univ Colorado, Sch Med, Dept Cellular & Struct Biol, Denver, CO 80262 USA.
RP Burkhard, P (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Meier, Markus/F-2798-2011
OI Meier, Markus/0000-0003-1068-746X
CR ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x
   [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760
   Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Bruno S, 2001, J BIOL CHEM, V276, P16, DOI 10.1074/jbc.C000588200
   Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109
   Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002
   Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037
   Christen P, 1985, TRANSAMINASES
   Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3
   HYDE CC, 1988, J BIOL CHEM, V263, P17857
   Janosik M, 2001, ACTA CRYSTALLOGR D, V57, P289, DOI 10.1107/S0907444900017893
   Jhee KH, 2000, BIOCHEMISTRY-US, V39, P10548, DOI 10.1021/bi001020g
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kery V, 1999, BIOCHEMISTRY-US, V38, P2716, DOI 10.1021/bi981808n
   Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723
   KERY V, 1994, J BIOL CHEM, V269, P25283
   Kraus JP, 1999, HUM MUTAT, V13, P362
   KRAUS JP, 1994, J INHERIT METAB DIS, V17, P383, DOI 10.1007/BF00711354
   Maclean KN, 2000, J INORG BIOCHEM, V81, P161, DOI 10.1016/S0162-0134(00)00100-8
   MUDD SH, 2001, METABOLIC MOL BASES, V1, P2007
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Ojha S, 2000, BIOCHEMISTRY-US, V39, P10542, DOI 10.1021/bi000831h
   OMURA T, 1984, J BIOCHEM-TOKYO, V96, P1491, DOI 10.1093/oxfordjournals.jbchem.a134978
   POULOS TL, 1987, HEME ENZYME CRYSTAL
   Schneider TR, 1998, BIOCHEMISTRY-US, V37, P5394, DOI 10.1021/bi9728957
   Shan XY, 2001, HUM MOL GENET, V10, P635, DOI 10.1093/hmg/10.6.635
   SKOVBY F, 1984, J BIOL CHEM, V259, P583
   SWAROOP M, 1992, J BIOL CHEM, V267, P11455
   Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179
   Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t
   Yao M, 2000, J BIOL CHEM, V275, P34557, DOI 10.1074/jbc.M004681200
   Yap S, 2000, SEMIN THROMB HEMOST, V26, P335, DOI 10.1055/s-2000-8100
   Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v
NR 34
TC 230
Z9 236
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0261-4189
J9 EMBO J
JI Embo J.
PD AUG 1
PY 2001
VL 20
IS 15
BP 3910
EP 3916
DI 10.1093/emboj/20.15.3910
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 462DZ
UT WOS:000170406600003
PM 11483494
OA Green Published
DA 2021-01-25
ER

PT J
AU Fuhrmann, O
   Arvand, M
   Gohler, A
   Schmid, M
   Krull, M
   Hippenstiel, S
   Seybold, J
   Dehio, C
   Suttorp, N
AF Fuhrmann, O
   Arvand, M
   Gohler, A
   Schmid, M
   Krull, M
   Hippenstiel, S
   Seybold, J
   Dehio, C
   Suttorp, N
TI Bartonella henselae induces NF-kappa B-dependent upregulation of
   adhesion molecules in cultured human endothelial cells: Possible role of
   outer membrane proteins as pathogenic factors
SO INFECTION AND IMMUNITY
LA English
DT Article
ID CAT-SCRATCH DISEASE; E-SELECTIN; BACILLARY ANGIOMATOSIS;
   ESCHERICHIA-COLI; IN-VITRO; ROCHALIMAEA-HENSELAE; GENE; IDENTIFICATION;
   PROLIFERATION; NEUTROPHIL
AB The endothelium is a specific target for Bartonella henselae, and endothelial cell infection represents an important step in the pathogenesis of cat scratch disease and bacillary angiomatosis. Mechanisms of Bartonella-endothelial cell interaction as well as signaling pathways involved in target cell activation were analyzed. B. henselae strain Berlin-1, isolated from bacillary angiomatosis lesions of a human immunodeficiency virus-infected patient, potently stimulated human umbilical cord vein endothelial cells (HUVEC), as determined by NF-kappaB activation and enhanced adhesion molecule expression. These effects were accompanied by increased PMN rolling on and adhesion to infected endothelial cell monolayers, as measured in a parallel-plate flow chamber assay. Monoclonal antibodies against E-selectin significantly reduced PMN rolling and adhesion. In our hands, B. henselae Berlin-1 was substantially more active than the typing strain B. henselae ATCC 49882. E-selectin and ICAM-1 upregulation occurred for up to 9 days, as verified by Northern blotting and cell surface enzyme-linked immunosorbent assay. Induction of adhesion molecules was mediated via NF-kappaB activation and could be blocked by a specific NF-kappaB inhibitor. Additional studies indicated that B. henselae-induced effects did not require living bacteria or Bartonella lipopolysaccharides. Exposure of HUVEC to purified B. henselae outer membrane proteins (OMPs), however, reproduced all aspects of endothelial cell activation. In conclusion, B. henselae, the causative agent of cat scratch disease and. bacillary angiomatosis, infects and activates endothelial cells. B. henselae OMPs are sufficient to induce NF-kappaB activation and adhesion molecule expression followed by enhanced rolling and adhesion of leukocytes. These observations identify important new properties of B. henselae, demonstrating its capacity to initiate a cascade of events culminating in a proinflammatory phenotype of infected endothelial cells.
C1 Humboldt Univ, Charite, Med Klin MS Infektiol, Dept Internal Med Infect Dis, D-13353 Berlin, Germany.
   Free Univ Berlin, Univ Hosp Benjamin Franklin, Inst Infect Dis, D-12203 Berlin, Germany.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Suttorp, N (corresponding author), Humboldt Univ, Charite, Med Klin MS Infektiol, Dept Internal Med Infect Dis, Campus Virchow Klinikum,Augustenburger Pl 1, D-13353 Berlin, Germany.
EM norbert.suttorp@charite.de
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Schmid, Michael/0000-0002-3445-0013
CR ABBASI S, 1995, PEDIATR INFECT DIS J, V14, P547, DOI 10.1097/00006454-199506000-00014
   Anderson BE, 1997, CLIN MICROBIOL REV, V10, P203, DOI 10.1128/CMR.10.2.203
   Arvand M, 1998, CLIN INFECT DIS, V26, P1296, DOI 10.1086/516348
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P163, DOI 10.1097/00006454-199702000-00002
   BATTERMAN HJ, 1995, INFECT IMMUN, V63, P4553, DOI 10.1128/IAI.63.11.4553-4556.1995
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Breathnach AS, 1997, HEART, V77, P474, DOI 10.1136/hrt.77.5.474
   Brouqui P, 1996, RES MICROBIOL, V147, P719, DOI 10.1016/S0923-2508(97)85119-4
   Burgess AWO, 1998, MICROB PATHOGENESIS, V25, P157, DOI 10.1006/mpat.1998.0223
   Burgess AWO, 2000, MICROB PATHOGENESIS, V29, P73, DOI 10.1006/mpat.2000.0366
   CANIZA MA, 1995, CLIN INFECT DIS, V20, P1505, DOI 10.1093/clinids/20.6.1505
   CARLOS TM, 1994, BLOOD, V84, P2068
   CHAN JKC, 1991, AM J SURG PATHOL, V15, P430, DOI 10.1097/00000478-199105000-00002
   CHEN CC, 1995, AGENT ACTION SUPPL, V47, P135
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996
   COLLINS T, 1991, J BIOL CHEM, V266, P2466
   CONLEY T, 1994, J LAB CLIN MED, V124, P521
   Dehio C, 1999, CURR OPIN MICROBIOL, V2, P78, DOI 10.1016/S1369-5274(99)80013-7
   Dehio C, 1997, J CELL SCI, V110, P2141
   FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973
   GARCIA FU, 1990, AM J PATHOL, V136, P1125
   Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x
   Issekutz AC, 1999, J LEUKOCYTE BIOL, V65, P117
   Jacobs RF, 1998, CLIN INFECT DIS, V26, P80, DOI 10.1086/516256
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U
   Koehler JE, 1997, NEW ENGL J MED, V337, P1876, DOI 10.1056/NEJM199712253372603
   KOEHLER JE, 1994, JAMA-J AM MED ASSOC, V271, P531, DOI 10.1001/jama.271.7.531
   KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303
   Krull M, 1999, J IMMUNOL, V162, P4834
   Krull M, 1996, J IMMUNOL, V157, P4133
   LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D
   LEWIS H, 1994, MOL CELL BIOL, V14, P5701, DOI 10.1128/MCB.14.9.5701
   Ley K, 1998, CIRC RES, V83, P287, DOI 10.1161/01.RES.83.3.287
   Lingwood CA, 1999, BBA-MOL BASIS DIS, V1455, P375, DOI 10.1016/S0925-4439(99)00062-9
   Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315
   Maurin M, 1997, EUR J CLIN MICROBIOL, V16, P487, DOI 10.1007/BF01708232
   Minnick MF, 1996, TRENDS MICROBIOL, V4, P343, DOI 10.1016/0966-842X(96)10055-X
   Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090
   Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707
   PRASADARAO NV, 1993, J BIOL CHEM, V268, P10356
   Reed JB, 1998, OPHTHALMOLOGY, V105, P459, DOI 10.1016/S0161-6420(98)93028-7
   Scheuerpflug I, 1999, INFECT IMMUN, V67, P834, DOI 10.1128/IAI.67.2.834-843.1999
   SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820
   Schwarzer N, 1998, J IMMUNOL, V161, P3010
   Sriramarao P, 1996, J IMMUNOL, V157, P4672
   VORABERGER G, 1991, J IMMUNOL, V147, P2777
   WELCH DF, 1993, J CLIN MICROBIOL, V31, P2381, DOI 10.1128/JCM.31.9.2381-2386.1993
   WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464, DOI 10.1128/MCB.14.10.6464
NR 50
TC 59
Z9 62
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD AUG
PY 2001
VL 69
IS 8
BP 5088
EP 5097
DI 10.1128/IAI.69.8.5088-5097.2001
PG 10
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 456UP
UT WOS:000170100900050
PM 11447190
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Murata, K
   Mitsuoka, K
   Hirai, T
   Walz, T
   Agre, P
   Heymann, JB
   Engel, A
   Fujiyoshi, Y
AF Murata, K
   Mitsuoka, K
   Hirai, T
   Walz, T
   Agre, P
   Heymann, JB
   Engel, A
   Fujiyoshi, Y
TI Molecular basis of water selectivity on aquaporin-1
SO KIDNEY INTERNATIONAL
LA English
DT Meeting Abstract
C1 Kyoto Univ, Fac Sci, Dept Biophys, Kyoto 606, Japan.
   Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA.
   Johns Hopkins Univ, Sch Med, Dept Biol Chem & Med, Baltimore, MD USA.
   Univ Basel, ME Muller Inst Microscop Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Inst Physiol, Okazaki, Aichi, Japan.
RI Fujiyoshi, Yoshinori/E-5989-2012; Heymann, Bernard/F-6825-2011; Hirai,
   Teruhisa/G-2105-2015; Heymann, Bernard/H-8265-2019
OI Fujiyoshi, Yoshinori/0000-0002-8070-1493; Hirai,
   Teruhisa/0000-0002-2114-8149; Heymann, Bernard/0000-0002-8872-5326
CR de Groot BL, 2000, J MOL BIOL, V300, P987, DOI 10.1006/jmbi.2000.3913
   Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Mitsuoka K, 1999, J STRUCT BIOL, V128, P34, DOI 10.1006/jsbi.1999.4177
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
NR 5
TC 1
Z9 1
U1 0
U2 2
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0085-2538
J9 KIDNEY INT
JI Kidney Int.
PD AUG
PY 2001
VL 60
IS 2
BP 399
EP 399
DI 10.1046/j.1523-1755.2001.00821-5.x
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA 455AW
UT WOS:000170006200006
DA 2021-01-25
ER

PT J
AU Schaerer, F
   Morgan, G
   Winey, M
   Philippsen, P
AF Schaerer, F
   Morgan, G
   Winey, M
   Philippsen, P
TI Cnm67p is a spacer protein of the Saccharomyces cerevisiae spindle pole
   body outer plaque
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID GAMMA-TUBULIN COMPLEX; HIGH-EFFICIENCY TRANSFORMATION; YEAST SPINDLE;
   CELL-CYCLE; MITOTIC SPINDLE; NUCLEAR MIGRATION; MICROTUBULE
   ORGANIZATION; ASTRAL MICROTUBULES; SPB DUPLICATION; BUDDING YEAST
AB In Saccharomyces cerevisiae, the spindle pole body (SPB) is the functional homolog of the mammalian centrosome, responsible for the organization of the tubulin cytoskeleton. Cytoplasmic (astral) microtubules essential for the proper segregation of the nucleus into the daughter cell are attached at the outer plaque on the SPB cytoplasmic face. Previously, it has been shown that Cnm67p is an integral component of this structure; cells deleted for CNM67 are lacking the SPB outer plaque and thus experience severe nuclear migration defects. With the use of partial deletion mutants of CNM67, we show that the N- and C-terminal domains of the protein are important for nuclear migration. The C terminus, not the N terminus, is essential for Cnm67p localization to the SPB. On the other hand, only the N terminus is subject to protein phosphorylation of a yet unknown function. Electron microscopy of SPB serial thin sections reveals that deletion of the N- or C-terminal domains disturbs outer plaque formation, whereas mutations in the central coiled-coil domain of Cnm67p change the distance between the SPB core and the outer plaque. We conclude that Cnm67p is the protein that connects the outer plaque to the central plaque embedded in the nuclear envelope, adjusting the space between them by the length of its coiled-coil.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Colorado, MCD Biol, Boulder, CO 80309 USA.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM Peter.Philippsen@unibas.ch
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM051312,
   R01GM051312, R01GM051312, R01GM051312, R01GM051312, R01GM051312,
   R01GM051312, R01GM051312, R01GM051312, R01GM051312, R01GM051312,
   R01GM051312, R01GM051312, R01GM051312, R01GM051312, R01GM051312,
   R01GM051312, R01GM051312, R01GM051312, R01GM051312, R01GM051312,
   R01GM051312, R01GM051312] Funding Source: NIH RePORTER; NIGMS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM051312, GM-51312] Funding Source:
   Medline
CR Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809
   Brachat A, 1998, MOL BIOL CELL, V9, P977, DOI 10.1091/mbc.9.5.977
   Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0
   BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975
   Byers B., 1981, MOL BIOL YEAST SACCH, P59
   Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629
   Chen XYP, 1998, J CELL BIOL, V141, P1169, DOI 10.1083/jcb.141.5.1169
   Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303
   Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041
   DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023
   Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887
   DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127
   Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205
   ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172
   FARKASOVSKY M, 1995, J CELL BIOL, V131, P1003, DOI 10.1083/jcb.131.4.1003
   Francis SE, 2000, CURR TOP DEV BIOL, V49, P105
   Friedman DB, 1996, J CELL BIOL, V132, P903, DOI 10.1083/jcb.132.5.903
   Gruneberg U, 2000, EMBO J, V19, P6475, DOI 10.1093/emboj/19.23.6475
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   HORVATH A, 1994, YEAST, V10, P1305, DOI 10.1002/yea.320101007
   HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997
   HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H
   KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231
   KILMARTIN JV, 1993, J CELL BIOL, V123, P1175, DOI 10.1083/jcb.123.5.1175
   KILMARTIN JV, 1994, CURR OPIN CELL BIOL, V6, P50, DOI 10.1016/0955-0674(94)90115-5
   Knop M, 1998, EMBO J, V17, P3952, DOI 10.1093/emboj/17.14.3952
   Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550
   Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985
   Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096
   Lupas A, 1996, METHOD ENZYMOL, V266, P513
   Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377
   Miller RK, 1999, J CELL BIOL, V144, P963, DOI 10.1083/jcb.144.5.963
   MIRZAYAN C, 1992, J CELL BIOL, V116, P1319, DOI 10.1083/jcb.116.6.1319
   MOENS PB, 1971, J CELL BIOL, V50, P344, DOI 10.1083/jcb.50.2.344
   Newman JRS, 2000, P NATL ACAD SCI USA, V97, P13203, DOI 10.1073/pnas.97.24.13203
   O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017
   PALAZZO RE, 2000, CENTROSOME CELL REPL
   PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583
   Pereira G, 1997, J CELL SCI, V110, P295
   Pereira G, 1999, EMBO J, V18, P4180, DOI 10.1093/emboj/18.15.4180
   Pereira G, 1998, MOL BIOL CELL, V9, P775, DOI 10.1091/mbc.9.4.775
   ROUT MP, 1990, J CELL BIOL, V111, P1913, DOI 10.1083/jcb.111.5.1913
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schaerer-Brodbeck C, 2000, BIOL CHEM, V381, P815, DOI 10.1515/BC.2000.104
   SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712
   Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985
   SIKORSKI RS, 1989, GENETICS, V122, P19
   SNYDER M, 1994, CHROMOSOMA, V103, P369, DOI 10.1007/BF00362281
   Soues S, 1998, J CELL SCI, V111, P2809
   Stirling DA, 1996, BIOCHEM BIOPH RES CO, V222, P236, DOI 10.1006/bbrc.1996.0728
   SULLIVAN DS, 1992, J CELL BIOL, V119, P379, DOI 10.1083/jcb.119.2.379
   Sundberg HA, 1997, MOL BIOL CELL, V8, P2575, DOI 10.1091/mbc.8.12.2575
   Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967
   WINEY M, 1993, TRENDS GENET, V9, P300, DOI 10.1016/0168-9525(93)90247-F
   WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
NR 60
TC 41
Z9 42
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD AUG
PY 2001
VL 12
IS 8
BP 2519
EP 2533
DI 10.1091/mbc.12.8.2519
PG 15
WC Cell Biology
SC Cell Biology
GA 467QU
UT WOS:000170715900020
PM 11514632
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Stetefeld, J
   Jenny, M
   Schulthess, T
   Landwehr, R
   Schumacher, B
   Frank, S
   Ruegg, MA
   Engel, J
   Kammerer, RA
AF Stetefeld, J
   Jenny, M
   Schulthess, T
   Landwehr, R
   Schumacher, B
   Frank, S
   Ruegg, MA
   Engel, J
   Kammerer, RA
TI The laminin-binding domain of agrin is structurally related to N-TIMP-1
SO NATURE STRUCTURAL BIOLOGY
LA English
DT Article
ID HUMAN TISSUE INHIBITOR; AMINO-TERMINAL DOMAIN; MATRIX
   METALLOPROTEINASES; NEUROMUSCULAR-JUNCTION; SYNAPTIC DIFFERENTIATION;
   ESCHERICHIA-COLI; TIMP-1; ISOFORMS; SITE; REPLACEMENT
AB Agrin is the key organizer of postsynaptic differentiation at the neuromuscular junction. This organization activity requires the binding of agrin to the synaptic basal lamina. Binding is conferred by the N-terminal agrin (NtA) domain, which mediates a high-affinity interaction with the coiled coil domain of laminins. Here, we report the crystal structure of chicken NtA at 1.6 Angstrom resolution. The structure reveals that NtA harbors an oligosaccharide/oligonucleotide-binding fold with several possible sites for the interaction with different ligands. A high structural similarity of NtA with the protease inhibition domain in tissue inhibitor of metallo-proteinases-1 (TIMP- 1) supports the idea of additional functions of agrin besides synaptogenic activity.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, CH-4056 Basel, Switzerland.
   Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Stetefeld, Joerg/H-7630-2017; Ruegg, Markus/X-7256-2019
OI Stetefeld, Joerg/0000-0003-1478-3248; Ruegg, Markus/0000-0002-4974-9384;
   Kammerer, Richard/0000-0003-4570-5197
CR [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760
   Bode W, 2000, BBA-PROTEIN STRUCT M, V1477, P241, DOI 10.1016/S0167-4838(99)00276-9
   Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   BUDISA N, 1995, EUR J BIOCHEM, V230, P788
   Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   Caterina NCM, 1997, J BIOL CHEM, V272, P32141, DOI 10.1074/jbc.272.51.32141
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335
   Denzer AJ, 1997, CELL TISSUE RES, V290, P357, DOI 10.1007/s004410050941
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995
   HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600
   Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3
   Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086
   Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762
   Leslie AGW, 1994, MOSFLM USERS GUIDE
   Meng Q, 1999, J BIOL CHEM, V274, P10184, DOI 10.1074/jbc.274.15.10184
   MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001
   MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457
   Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5
   Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839
   TURK D, 1992, THESIS TU MUNCHEN MU
   Wu B, 2000, J MOL BIOL, V295, P257, DOI 10.1006/jmbi.1999.3362
NR 30
TC 40
Z9 41
U1 0
U2 0
PU NATURE AMERICA INC
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1072-8368
J9 NAT STRUCT BIOL
JI Nat. Struct. Biol.
PD AUG
PY 2001
VL 8
IS 8
BP 705
EP 709
DI 10.1038/90422
PG 5
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 457LV
UT WOS:000170139500020
PM 11473262
DA 2021-01-25
ER

PT J
AU Choi, S
   Qiu, J
   Storici, P
   Schirmer, T
   Silverman, RB
AF Choi, S
   Qiu, J
   Storici, P
   Schirmer, T
   Silverman, RB
TI Inactivation of gamma-aminobutyric acid aminotransferase by
   conformationally-rigid analogues.
SO BIOCHEMISTRY
LA English
DT Meeting Abstract
C1 Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.
   Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUL 24
PY 2001
VL 40
IS 29
MA 244
BP 8661
EP 8661
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 455ZG
UT WOS:000170057200266
DA 2021-01-25
ER

PT J
AU Bieri, O
   Kiefhaber, T
AF Bieri, O
   Kiefhaber, T
TI Origin of apparent fast and non-exponential kinetics of lysozyme folding
   measured in pulsed hydrogen exchange experiments
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; hydrogen/deuterium exchange; folding intermediates;
   lysozyme; non-exponential kinetics
ID AMIDE PROTON-EXCHANGE; RIBONUCLEASE-A; HEN LYSOZYME; NATIVE-STATE;
   STRUCTURAL-CHARACTERIZATION; CYTOCHROME-C; INTERMEDIATE; PATHWAY; NMR;
   PEPTIDE
AB Folding of lysozyme at pH 5.2 is a complex processes. After rapid collapse (< 1 ms) kinetic partitioning into a slow and fast folding pathway occurs. The fast pathway leads directly to the native structure (N), whereas the slow pathway goes through a partially folded intermediate (I(1)) with native-like secondary structure in the cc-domain. This mechanism is in agreement with data from a large number of spectroscopic probes, from changes in the radius of gyration and from measurements on the time-course of the populations of the different species. Results from pulsed hydrogen exchange experiments, in contrast, revealed that the secondary structure of I(1) and of N is formed significantly faster than changes in spectroscopic properties occur and showed large variations in the protection kinetics of individual amide sites. We investigated the molecular origin of the rapid amide protection by quantitatively simulating all kinetic processes during the pulse-labeling experiments. Absorbance and fluorescence-detected folding kinetics showed that the early events in lysozyme folding are accelerated under exchange conditions (pH 9.2) and that a change in folding mechanism occurs due to the transient population of an additional intermediate (I(1)). This leads to kinetic competition between exchange and folding during the exchange pulse and to incomplete labeling of amide sites with slow intrinsic exchange rates. As a result, apparently faster and non-exponential kinetics of amide protection are measured in the labeling experiments. Our results further suggest that collapsed lysozyme (C) and I(1) have five and ten-times reduced free exchange rates, respectively, due to limited solvent accessibility. (C) 2001 Academic Press.
C1 Univ Basel, Biozentrum, Biophys Chem Abt, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Biophys Chem Abt, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010
CR Arrington CB, 1997, BIOCHEMISTRY-US, V36, P8686, DOI 10.1021/bi970872m
   BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110
   BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079
   Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0
   Behlke J, 1999, BIOPHYS CHEM, V76, P13, DOI 10.1016/S0301-4622(98)00212-9
   Bieri O, 1999, BIOCHEMISTRY-US, V38, P12460, DOI 10.1021/bi9909703
   BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302
   BYCROFT M, 1990, NATURE, V346, P488, DOI 10.1038/346488a0
   Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782
   CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111
   Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10
   Forsythe G.E., 1977, COMPUTER METHODS MAT
   Gladwin ST, 1996, FOLD DES, V1, P407, DOI 10.1016/S1359-0278(96)00057-0
   HILL TL, 1997, FREE ENERGY TRANSDUC
   HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495
   ITZHAKI LS, 1994, BIOCHEMISTRY-US, V33, P5212, DOI 10.1021/bi00183a026
   JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001
   JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610
   KIEFHABER T, 1995, P NATL ACAD SCI USA, V92, P9029, DOI 10.1073/pnas.92.20.9029
   KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631
   KIM PS, 1980, BIOCHEMISTRY-US, V19, P6124, DOI 10.1021/bi00567a027
   Kulkarni SK, 1999, PROTEIN SCI, V8, P35
   KUWAJIMA K, 1985, BIOCHEMISTRY-US, V24, P874, DOI 10.1021/bi00325a010
   LINDERSTROMLANG KU, 1955, CHEM SOC SPEC PUBL, V2, P1
   Matagne A, 1998, J MOL BIOL, V277, P997, DOI 10.1006/jmbi.1998.1657
   MAYO SL, 1993, SCIENCE, V262, P873, DOI 10.1126/science.8235609
   MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611
   MIRANKER A, 1991, NATURE, V349, P633, DOI 10.1038/349633a0
   MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003
   Morozova-Roche LA, 1999, J MOL BIOL, V289, P1055, DOI 10.1006/jmbi.1999.2741
   PTITSYN OB, 1991, FEBS LETT, V285, P176, DOI 10.1016/0014-5793(91)80799-9
   PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7
   RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0
   RODER H, 1986, Proteins Structure Function and Genetics, V1, P34, DOI 10.1002/prot.340010107
   RODER H, 1988, NATURE, V335, P700, DOI 10.1038/335700a0
   ROSA JJ, 1979, J MOL BIOL, V133, P399, DOI 10.1016/0022-2836(79)90400-5
   SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013
   SCHMID FX, 1979, J MOL BIOL, V135, P199, DOI 10.1016/0022-2836(79)90347-4
   Segel DJ, 1999, J MOL BIOL, V288, P489, DOI 10.1006/jmbi.1999.2703
   TANFORD C, 1972, BIOCHEMISTRY-US, V11, P2192, DOI 10.1021/bi00761a029
   THIRUMALAI D, 1994, NATO ADV SCI INST SE, V325, P115
   UDGAONKAR JB, 1990, P NATL ACAD SCI USA, V87, P8197, DOI 10.1073/pnas.87.21.8197
   UDGAONKAR JB, 1988, NATURE, V335, P694, DOI 10.1038/335694a0
   VARLEY P, 1993, SCIENCE, V260, P1110, DOI 10.1126/science.8493553
   WAGNER G, 1982, J MOL BIOL, V160, P343, DOI 10.1016/0022-2836(82)90180-2
   Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030
   WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447
NR 47
TC 34
Z9 34
U1 0
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 20
PY 2001
VL 310
IS 4
BP 919
EP 935
DI 10.1006/jmbi.2001.4804
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 454RJ
UT WOS:000169985300019
PM 11453698
DA 2021-01-25
ER

PT J
AU Gadal, O
   Strauss, D
   Braspenning, J
   Hoepfner, D
   Petfalski, E
   Philippsen, P
   Tollervey, D
   Hurt, E
AF Gadal, O
   Strauss, D
   Braspenning, J
   Hoepfner, D
   Petfalski, E
   Philippsen, P
   Tollervey, D
   Hurt, E
TI A nuclear AAA-type ATPase (Rix7p) is required for biogenesis and nuclear
   export of 60S ribosomal subunits
SO EMBO JOURNAL
LA English
DT Article
DE AAA ATPase; nuclear transport; ribosomal biogenesis; ribosomal export
ID MESSENGER-RNA EXPORT; PROTEIN; TRANSPORT; COMPLEX; NUCLEOPORINS;
   PARTICLES; BINDING; MEX67P; NMD3P; GENE
AB Ribosomal precursor particles are assembled in the nucleolus before export into the cytoplasm. Using a visual assay for nuclear accumulation of 60S subunits, we have isolated several conditional-lethal strains with defects in ribosomal export (rix mutants). Here we report the characterization of a mutation in an essential gene, RIX7, which encodes a novel member of the AAA ATPase superfamily. The rix7-1 temperature-sensitive allele carries a point mutation that causes defects in pre-rRNA processing, biogenesis of 60S ribosomal subunits, and their subsequent export into the cytoplasm. Rix7p, which associates with 60S ribosomal precursor particles, localizes throughout the nucleus in exponentially growing cells, but concentrates in the nucleolus in stationary phase cells. When cells resume growth upon shift to fresh medium, Rix7p-green fluorescent protein exhibits a transient perinuclear location. We propose that a nuclear AAA ATPase is required for restructuring nucleoplasmic 60S pre-ribosomal particles to make them competent for nuclear export.
C1 Biochem Zentrum Heidelberg, BZH, D-69120 Heidelberg, Germany.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland.
RP Hurt, E (corresponding author), Biochem Zentrum Heidelberg, BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.
EM cg5@ix.urz.uni-heidelberg.de
RI Tollervey, David/AAR-6662-2020; Ed Hurt, Dr./AAE-8874-2019; Gadal,
   Olivier/A-4731-2008
OI Tollervey, David/0000-0003-2894-2772; Ed Hurt, Dr./0000-0002-4535-8255;
   Gadal, Olivier/0000-0001-9421-0831
CR AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173
   Dechampesme AM, 1999, J CELL BIOL, V145, P1369, DOI 10.1083/jcb.145.7.1369
   Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2
   Eisinger DP, 1997, MOL CELL BIOL, V17, P5136, DOI 10.1128/MCB.17.9.5136
   Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001
   Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088
   GermainLee EL, 1997, GENOMICS, V44, P22, DOI 10.1006/geno.1997.4856
   Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374
   Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057
   Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389
   KADOWAKI T, 1992, P NATL ACAD SCI USA, V89, P2312, DOI 10.1073/pnas.89.6.2312
   Kressler D, 1999, MOL CELL BIOL, V19, P7897
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Maniatis T, 1982, MOL CLONING LAB MANU
   Neuwald AF, 1999, GENOME RES, V9, P27
   Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826
   Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366
   Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256
   Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2
   Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0
   Stage-Zimmermann T, 2000, MOL BIOL CELL, V11, P3777, DOI 10.1091/mbc.11.11.3777
   Sun X, 1998, J CELL BIOL, V142, P1181, DOI 10.1083/jcb.142.5.1181
   TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x
   TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F
   TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4
   Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13
   van Beekvelt CA, 2000, J MOL BIOL, V296, P7, DOI 10.1006/jmbi.1999.3432
   Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261
   WOOLFORD JL, 1991, ADV GENET, V29, P63, DOI 10.1016/S0065-2660(08)60107-8
   Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X
NR 32
TC 74
Z9 75
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JUL 16
PY 2001
VL 20
IS 14
BP 3695
EP 3704
DI 10.1093/emboj/20.14.3695
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 457RA
UT WOS:000170149500011
PM 11447111
OA Green Published
DA 2021-01-25
ER

PT J
AU Meyer, UA
AF Meyer, UA
TI Genomics and the prediction of xenobiotic toxicity
SO TOXICOLOGY
LA English
DT Meeting Abstract
C1 Univ Basel, Biozentrum, Basel, Switzerland.
CR Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD JUL 8
PY 2001
VL 164
IS 1-3
SU S
BP 34
EP 34
PG 1
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 452ZA
UT WOS:000169888500099
DA 2021-01-25
ER

PT J
AU Affolter, M
   Marty, T
   Vigano, MA
   Jazwinska, A
AF Affolter, M
   Marty, T
   Vigano, MA
   Jazwinska, A
TI Nuclear interpretation of Dpp signaling in Drosophila
SO EMBO JOURNAL
LA English
DT Review
DE Dpp; morphogen gradient; nuclear signaling; selector proteins; TGF beta
ID WING IMAGINAL DISCS; DNA-BINDING PROTEIN; TRANSCRIPTION FACTOR;
   SYNERGISTIC ACTIVATION; MORPHOGEN GRADIENT; TARGET GENES; BRINKER;
   SCHNURRI; MAD; TRANSDUCTION
AB Signaling by Decapentaplegic (Dpp), a member of the TGF beta superfamily of signaling molecules similar to vertebrate BMP2 and BMP4, has been implicated in many developmental processes in Drosophila melanogaster, Notably, Dpp acts as a long-range morphogen during imaginal disc growth and patterning, Genetic approaches led to the identification of a number of gene products that constitute the core signaling pathway. In addition to the ligand-activated heteromeric receptor complex and the signal-transducing intracellular Smad proteins, Dpp signaling requires two nuclear proteins, Schnurri (Shn) and Brinker (Brk), to prime cells for Dpp responsiveness. A complex interplay between the nuclear factors involved in Dpp signaling appears to control the transcriptional readout of the Dpp morphogen gradient. It remains to be seen whether similar molecular mechanisms operate in the nucleus in vertebrate systems.
C1 Univ Basel, Abt Zellbiol, Biozentrum, CH-4026 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Abt Zellbiol, Biozentrum, Klingelbergstr 70, CH-4026 Basel, Switzerland.
RI Jazwinska, Anna/M-8705-2016
OI Jazwinska, Anna/0000-0003-3881-9284; Affolter,
   Markus/0000-0002-5171-0016; vigano, maria alessandra/0000-0003-2009-0384
CR ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1
   Ashe HL, 2000, DEVELOPMENT, V127, P3305
   Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5
   Certel K, 2000, DEVELOPMENT, V127, P3173
   Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0
   Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144
   Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901
   Dorfman R, 2001, DEVELOPMENT, V128, P965
   Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2
   FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29
   GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5
   Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402
   Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052
   Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900
   Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7
   Jazwinska A, 1999, DEVELOPMENT, V126, P3323
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1
   Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906
   Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200
   Lecuit T, 1996, NATURE, V382, P93, DOI 10.1038/382093a0
   Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5
   Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Muller B, 2000, DEVELOPMENT, V127, P2999
   Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9
   Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5
   Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7
   Nishita M, 2000, NATURE, V403, P781
   NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156
   Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8
   Podos SD, 1999, TRENDS GENET, V15, P396, DOI 10.1016/S0168-9525(99)01854-5
   Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282
   RAFTERY LA, 1995, GENETICS, V139, P241
   Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401
   Ryoo HD, 1999, DEVELOPMENT, V126, P5137
   Saller E, 2001, EMBO REP, V2, P298, DOI 10.1093/embo-reports/kve068
   SEKELSKY JJ, 1995, GENETICS, V139, P1347
   Shi YG, 2001, BIOESSAYS, V23, P223, DOI 10.1002/1521-1878(200103)23:3<223::AID-BIES1032>3.3.CO;2-L
   Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162
   SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4
   STAEHLINGHAMPTON K, 1995, DEVELOPMENT, V121, P3393
   Szuts D, 1998, GENE DEV, V12, P2022, DOI 10.1101/gad.12.13.2022
   Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7
   Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9
   Torres-Vazquez J, 2001, DEVELOPMENT, V128, P1657
   Udagawa Y, 2000, GENES CELLS, V5, P359, DOI 10.1046/j.1365-2443.2000.00328.x
   Waltzer L, 1998, NATURE, V395, P521
   Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354
   Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201
NR 52
TC 85
Z9 89
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0261-4189
J9 EMBO J
JI Embo J.
PD JUL 2
PY 2001
VL 20
IS 13
BP 3298
EP 3305
DI 10.1093/emboj/20.13.3298
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 451LN
UT WOS:000169803700002
PM 11432817
OA Green Published
DA 2021-01-25
ER

PT J
AU Vohradsky, J
   Ramsden, JJ
AF Vohradsky, J
   Ramsden, JJ
TI Genome resource utilization during prokaryotic development
SO FASEB JOURNAL
LA English
DT Article
DE gene expression; proteome
ID STATISTICAL-ANALYSES
AB The distributions of synthesis rates of expressed proteins in a liquid batch culture of the prokaryote S. coelicolor during 3 days' growth have been analyzed by using a law governing the relation between the synthesis rates and the corresponding ranks in a list of rates (the so-called simplified canonical law, scl), which we have found previously to characterize the distribution of prokaryotic protein expression. The scl remains valid throughout development and the two parameters of the distribution, theta and rho, evolve in a highly characteristic and revealing way. theta is a measure of the degree to which available genomic resources are used, in the sense of exploiting their potential diversity. The passage from one developmental phase to another is marked by a sharp peak in theta, as these resources are fully mobilized to deal with a crisis (i.e., exhaustion of the habitual food supply). This is followed by an even more pronounced trough, as the organism briefly focuses its resources on synthesizing just those proteins most essential for survival, especially those hitherto unavailable and needed for metabolizing the new nutrient source. The parameter rho indicates redundancy among the most abundantly expressed proteins: higher rho corresponds to more diversity; i.e., less duplication of function, hence less robustness. This parameter is relatively steady throughout the development of the culture, except for a pronounced peak during the developmental phase transition. This corresponds to the "emergency mode" characterized by extremely low theta, during which a minimum repertoire of proteins is expressed.
C1 Univ Basel, Biozentrum, Dept Microbiol, Basel, Switzerland.
   Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic.
   Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
   Inst Adv Study, Collegium Basilea, Basel, Switzerland.
RP Ramsden, JJ (corresponding author), Hochstr 51, CH-4053 Basel, Switzerland.
EM J.Ramsden@unibas.ch
CR GARRELS JI, 1989, J BIOL CHEM, V264, P5269
   HOLT TG, 1992, MOL MICROBIOL, V6, P969, DOI 10.1111/j.1365-2958.1992.tb02163.x
   Jollife I.T., 1986, PRINCIPAL COMPONENT
   Mandelbrot B. B., 1952, PUBL I STAT U PARIS, V2, P1
   Mandelbrot B, 1954, WORD, V10, P1
   Neumann T, 1996, MICROBIOL-UK, V142, P1953, DOI 10.1099/13500872-142-8-1953
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   PUGLIA AM, 1995, MOL MICROBIOL, V17, P737, DOI 10.1111/j.1365-2958.1995.mmi_17040737.x
   Ramsden JJ, 1998, PHYS REV E, V58, P7777, DOI 10.1103/PhysRevE.58.7777
   Ramsden JJ, 2000, PHYSICA A, V277, P220, DOI 10.1016/S0378-4371(99)00572-5
   SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x
   VanBogelen R A, 1995, Biotechnol Annu Rev, V1, P69, DOI 10.1016/S1387-2656(08)70048-6
   Vohradsky J, 1997, ELECTROPHORESIS, V18, P1418, DOI 10.1002/elps.1150180817
   Vohradsky J, 2000, J BACTERIOL, V182, P4979, DOI 10.1128/JB.182.17.4979-4986.2000
   Wilkins MR, 1997, PROTEOME RES NEW FRO
NR 15
TC 12
Z9 13
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JUL
PY 2001
VL 15
IS 9
BP 2054
EP +
DI 10.1096/fj.00-0889fje
PG 12
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 460PV
UT WOS:000170318500011
PM 11511523
DA 2021-01-25
ER

PT J
AU Dehio, C
   Lanz, C
   Pohl, R
   Behrens, P
   Bermond, D
   Piemont, Y
   Pelz, K
   Sander, A
AF Dehio, C
   Lanz, C
   Pohl, R
   Behrens, P
   Bermond, D
   Piemont, Y
   Pelz, K
   Sander, A
TI Bartonella schoenbuchii sp nov., isolated from the blood of wild roe
   deer
SO INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
LA English
DT Article
DE Bartonella schoenbuchii; roe deer; zoonoses
ID CAT-SCRATCH DISEASE; VINSONII SUBSP BERKHOFFII; CITRATE SYNTHASE GENE;
   BORRELIA-BURGDORFERI; EXPANDING SPECTRUM; DOMESTIC CATS; COMB-NOV;
   HENSELAE; CLARRIDGEIAE; ROCHALIMAEA
AB The genus Bartonella comprises two human-specific pathogens and a growing number of zoonotic or animal-specific species. Domesticated as well as wild mammals can serve as reservoir hosts for the zoonotic agents and transmission to humans may occur by blood sucking arthropods or by direct blood to blood contact. Humans may come into intimate contact with free-ranging mammals during hunting, especially during evisceration with bare hands, when accidental blood to blood contact frequently occurs. The objective of this work was to determine the presence and the polymorphism of Bartonella strains in wild roe deer (Capreolus capreolus) as the most widely spread game in Western Europe. We report the isolation of four Bartonella strains from the blood of five roe deer. These strains carry polar flagella similar to Bartonella bacilliformis and Bartonella clarridgeiae, Based on their phenotypic and genotypic characteristics, three of the four roe deer isolates were different and they were all distinct from previously described Bartonella species. They can be distinguished from each other and from other Bartonella species by their protein profile, ERIC-PCR pattern, 16S rRNA and citrate synthase (gltA) gene sequences, as well as by whole DNA-DNA hybridization. In spite of their considerable heterogeneity, all four strains fulfil the criteria for belonging to a single new species. The name Bartonella schoenbuchii is proposed for this new species. The type strain R1(T) of Bartonella schoenbuchii has been deposited in the National Collection of Type Cultures as NCTC 13165(T) and the Deutsche Sammlung von Mikroorganismen und Zellkulturen as DSM 13525(T).
C1 Univ Basel, Biozentrum, Abt Mol Mikrobiol, CH-4056 Basel, Switzerland.
   Max Planck Inst Biol, Infekt Biol Abt, D-7400 Tubingen, Germany.
   Staatl Forstamt Tubingen Bebenhausen, Tubingen, Germany.
   Veterinaramt Tubingen, Tubingen, Germany.
   Univ Strasbourg, Univ Louis Pasteur Hop, Fac Med, Inst Bacteriol, Strasbourg, France.
   Univ Freiburg, Inst Med Mikrobiol & Hyg, Freiburg, Germany.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Abt Mol Mikrobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR Bass JW, 1997, PEDIATR INFECT DIS J, V16, P163, DOI 10.1097/00006454-199702000-00002
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P2, DOI 10.1097/00006454-199701000-00003
   Birtles RJ, 1996, INT J SYST BACTERIOL, V46, P891, DOI 10.1099/00207713-46-4-891
   BIRTLES RJ, 1995, INT J SYST BACTERIOL, V45, P1, DOI 10.1099/00207713-45-1-1
   BRENNER DJ, 1993, INT J SYST BACTERIOL, V43, P777, DOI 10.1099/00207713-43-4-777
   BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P1133, DOI 10.1128/JCM.15.6.1133-1140.1982
   Chang CC, 2000, EMERG INFECT DIS, V6, P306, DOI 10.3201/eid0603.000313
   CHAPIN KC, 2000, MANUAL CLIN MICROBIO, P1674
   DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993
   Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1
   Ellis BA, 1999, J INFECT DIS, V180, P220, DOI 10.1086/314824
   Fussenegger M, 1996, MOL MICROBIOL, V19, P1357, DOI 10.1111/j.1365-2958.1996.tb02479.x
   Gurfield AN, 1997, J CLIN MICROBIOL, V35, P2120, DOI 10.1128/JCM.35.8.2120-2123.1997
   Heller R, 1997, J CLIN MICROBIOL, V35, P1327, DOI 10.1128/JCM.35.6.1327-1331.1997
   Heller R, 1999, INT J SYST BACTERIOL, V49, P283, DOI 10.1099/00207713-49-1-283
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Kerkhoff FT, 1999, J CLIN MICROBIOL, V37, P4034, DOI 10.1128/JCM.37.12.4034-4038.1999
   Kordick DL, 1997, J CLIN MICROBIOL, V35, P1813, DOI 10.1128/JCM.35.7.1813-1818.1997
   Kordick DL, 1996, INT J SYST BACTERIOL, V46, P704, DOI 10.1099/00207713-46-3-704
   KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MILLER L, 1985, BACTERIAL IDENIFICAT
   NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995
   Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   RODRIGUEZBARRADAS MC, 1995, J CLIN MICROBIOL, V33, P1089, DOI 10.1128/JCM.33.5.1089-1093.1995
   Roux V, 2000, J CLIN MICROBIOL, V38, P1698, DOI 10.1128/JCM.38.4.1698-1700.2000
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Sander A, 1998, CONTRIB MICROBIOL, V1, P98
   Sander A, 1997, J CLIN MICROBIOL, V35, P584, DOI 10.1128/JCM.35.3.584-587.1997
   Sander A, 1998, J CLIN MICROBIOL, V36, P2973, DOI 10.1128/JCM.36.10.2973-2981.1998
   Sander A, 1998, SCAND J INFECT DIS, V30, P387, DOI 10.1080/00365549850160693
   Schouls LM, 1999, J CLIN MICROBIOL, V37, P2215, DOI 10.1128/JCM.37.7.2215-2222.1999
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823
   WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463
   Welch DF, 1999, J CLIN MICROBIOL, V37, P2598, DOI 10.1128/JCM.37.8.2598-2601.1999
NR 37
TC 80
Z9 85
U1 0
U2 2
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 1466-5026
EI 1466-5034
J9 INT J SYST EVOL MICR
JI Int. J. Syst. Evol. Microbiol.
PD JUL
PY 2001
VL 51
BP 1557
EP 1565
DI 10.1099/00207713-51-4-1557
PN 4
PG 9
WC Microbiology
SC Microbiology
GA 454HE
UT WOS:000169966500040
PM 11491358
OA Bronze
DA 2021-01-25
ER

PT J
AU Alexandrescu, AT
   Maciejewski, MW
   Ruegg, MA
   Engel, J
   Kammerer, RA
AF Alexandrescu, AT
   Maciejewski, MW
   Ruegg, MA
   Engel, J
   Kammerer, RA
TI Letter to the Editor: H-1, C-13 and N-15 backbone assignments for the
   C-terminal globular domain of agrin
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Letter
DE AChR clustering; calcium binding; neuromuscular junction; synapse
   development
ID VERTEBRATE NEUROMUSCULAR-JUNCTION; LAMININ G-LIKE; BINDING
C1 Univ Connecticut, MCB, Storrs, CT 06269 USA.
   Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06032 USA.
   Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.
RP Alexandrescu, AT (corresponding author), Univ Connecticut, MCB, Storrs, CT 06269 USA.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Kammerer, Richard/0000-0003-4570-5197
CR Beckmann G, 1998, J MOL BIOL, V275, P725, DOI 10.1006/jmbi.1997.1510
   Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335
   Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3
   Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5
   Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389
   Wiltscheck R, 1997, PROTEIN SCI, V6, P1734, DOI 10.1002/pro.5560060814
NR 6
TC 4
Z9 4
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0925-2738
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD JUL
PY 2001
VL 20
IS 3
BP 295
EP 296
DI 10.1023/A:1011256008944
PG 2
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 456AW
UT WOS:000170060800012
PM 11519755
DA 2021-01-25
ER

PT J
AU Koesling, J
   Aebischer, T
   Falch, C
   Schulein, R
   Dehio, C
AF Koesling, J
   Aebischer, T
   Falch, C
   Schulein, R
   Dehio, C
TI Cutting edge: Antibody-mediated cessation of hemotropic infection by the
   intraerythrocytic mouse pathogen Bartonella grahamii
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID CAT-SCRATCH DISEASE; SALMONELLA-TYPHIMURIUM; PROTECTIVE IMMUNITY;
   EXPANDING SPECTRUM; HENSELAE; HOST; MICE; LYMPHOCYTES; PATIENT
AB The genus Bartonella includes important human-specific and zoonotic pathogens which cause intraerythrocytic. bacteremia in their mammalian reservoir host(s). It is accepted that cellular immunity plays a decisive role in the host's defense against most intracellular bacteria. Bartonella sp. infection in the immunocompetent host typically leads to immunity against homologous challenge. The basis of this immunity, be it cellular or humoral, is unclear. In this study, the course of Bartonella grahamii bacteremia in immunocompetent and immunocompromised mice was compared. In immunocompetent hosts, the bacteremia is transient and induces a strong humoral immune response. In contrast, bacteremia persists in immunocompromised B and T cell-deficient mice. Immune serum transfer beginning with day 6 postinfection to B cell-deficient mice unable to produce Igs converted the persistent bacteremia to a transient course indistinguishable from that of immunocompetent animals. These data demonstrate an essential role for specific Abs in abrogating the intraerythrocytic bacteremia of B. grahamii in mice.
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
   Max Planck Inst Infect Biol, Dept Biol Mol, Berlin, Germany.
   Max Planck Inst Biol, Dept Infect Biol, D-7400 Tubingen, Germany.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Aebischer, Toni/0000-0002-4875-8457
CR Arvand M, 1998, CLIN INFECT DIS, V27, P1533, DOI 10.1086/517738
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P163, DOI 10.1097/00006454-199702000-00002
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P2, DOI 10.1097/00006454-199701000-00003
   BIRTLES RJ, 1994, ANN TROP MED PARASIT, V88, P317, DOI 10.1080/00034983.1994.11812872
   Birtles RJ, 1996, INT J SYST BACTERIOL, V46, P891, DOI 10.1099/00207713-46-4-891
   BIRTLES RJ, 1995, INT J SYST BACTERIOL, V45, P1, DOI 10.1099/00207713-45-1-1
   Brieland JK, 1996, J IMMUNOL, V157, P5002
   Casadevall A, 1998, TRENDS MICROBIOL, V6, P102, DOI 10.1016/S0966-842X(98)01208-6
   Choudhury A, 1997, PARASITOL RES, V83, P746, DOI 10.1007/s004360050334
   CLOECKAERT A, 1992, INFECT IMMUN, V60, P312, DOI 10.1128/IAI.60.1.312-315.1992
   Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1
   DUNBAR BS, 1990, METHOD ENZYMOL, V182, P663
   EISENSTEIN TK, 1984, J INFECT DIS, V150, P425, DOI 10.1093/infdis/150.3.425
   Gomez-Duarte OG, 1998, VACCINE, V16, P460, DOI 10.1016/S0264-410X(97)00247-8
   Guptill L, 1999, VET IMMUNOL IMMUNOP, V71, P233, DOI 10.1016/S0165-2427(99)00104-X
   Guptill L, 1997, J INFECT DIS, V176, P206, DOI 10.1086/514026
   Karem KL, 1999, IMMUNOLOGY, V97, P352, DOI 10.1046/j.1365-2567.1999.00750.x
   Kerkhoff FT, 1999, J CLIN MICROBIOL, V37, P4034, DOI 10.1128/JCM.37.12.4034-4038.1999
   Kosoy MY, 1999, J WILDLIFE DIS, V35, P275, DOI 10.7589/0090-3558-35.2.275
   LANE FC, 1972, J EXP MED, V135, P1104, DOI 10.1084/jem.135.5.1104
   Matsumoto S, 1999, VACCINE, V18, P832, DOI 10.1016/S0264-410X(99)00326-6
   MIKI K, 1964, J EXP MED, V120, P93, DOI 10.1084/jem.120.1.93
   Mittrucker HW, 2000, J IMMUNOL, V164, P1648, DOI 10.4049/jimmunol.164.4.1648
   Mota MM, 1998, INFECT IMMUN, V66, P4080
   Pappalardo BL, 2000, VET IMMUNOL IMMUNOP, V75, P43, DOI 10.1016/S0165-2427(00)00182-3
   RAYNAFARJE C, 1961, BLOOD, V17, P562
   Regnery RL, 1997, AM J VET RES, V58, P803
   Regnery RL, 1996, AM J VET RES, V57, P1714
   Schaible U E, 1999, Adv Immunol, V71, P267
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688
NR 31
TC 47
Z9 49
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD JUL 1
PY 2001
VL 167
IS 1
BP 11
EP 14
DI 10.4049/jimmunol.167.1.11
PG 4
WC Immunology
SC Immunology
GA 471VJ
UT WOS:000170949100003
PM 11418625
OA Bronze
DA 2021-01-25
ER

PT J
AU Bachinger, HP
   Engel, J
AF Bachinger, HP
   Engel, J
TI Thermodynamic vs. kinetic stability of collagen triple helices
SO MATRIX BIOLOGY
LA English
DT Letter
ID DEPENDENCE; HYSTERESIS
C1 Shriners Hosp Children, Dept Biochem & Mol Biol, Res Ctr, Portland, OR 97201 USA.
   Univ Basel, Biozentrum, Biophys Chem Abt, Basel, Switzerland.
RP Bachinger, HP (corresponding author), Shriners Hosp Children, Dept Biochem & Mol Biol, Res Ctr, Portland, OR 97201 USA.
CR Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   DAVIS JM, 1993, J BIOL CHEM, V268, P25965
   Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8
   GO N, 1973, BIOPOLYMERS, V12, P1927, DOI 10.1002/bip.1973.360120818
   KOBAYASHI Y, 1970, BIOPOLYMERS, V9, P415, DOI 10.1002/bip.1970.360090404
   PIEZ KA, 1970, BIOCHEMISTRY-US, V9, P4134, DOI 10.1021/bi00823a016
NR 7
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0945-053X
J9 MATRIX BIOL
JI Matrix Biol.
PD JUL
PY 2001
VL 20
IS 4
BP 267
EP 269
DI 10.1016/S0945-053X(01)00138-X
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 467MY
UT WOS:000170709400006
DA 2021-01-25
ER

PT J
AU Eiselt, R
   Domanski, TL
   Zibat, A
   Mueller, R
   Presecan-Siedel, E
   Hustert, E
   Zanger, UM
   Brockmoller, J
   Klenk, HP
   Meyer, UA
   Khan, KK
   He, YA
   Halpert, JR
   Wojnowski, L
AF Eiselt, R
   Domanski, TL
   Zibat, A
   Mueller, R
   Presecan-Siedel, E
   Hustert, E
   Zanger, UM
   Brockmoller, J
   Klenk, HP
   Meyer, UA
   Khan, KK
   He, YA
   Halpert, JR
   Wojnowski, L
TI Identification and functional characterization of eight CYP3A4 protein
   variants
SO PHARMACOGENETICS
LA English
DT Article
DE CYP3A; CYP3A4; protein variant; drug metabolism; steroid metabolism
ID HUMAN CYTOCHROME-P450 3A4; HUMAN-LIVER; NIFEDIPINE OXIDASE; ALLELIC
   VARIANT; SUBSTRATE-SPECIFICITY; CATALYTIC ACTIVITY; GENETIC VARIANT;
   SITE; METABOLISM; EXPRESSION
AB The genetic component of the inter-individual variability in CYP3A4 activity has been estimated to be between 60% and 90%, but the underlying genetic factors remain largely unknown. A study of 213 Middle and Western European DNA samples resulted in the identification of 18 new CYP3A4 variants, including eight protein variants, A total of 7.5% of the population studied was found to be heterozygous for one of these variants, in a bacterial heterologous expression system, two mutants, R130Q and P416L, did not result in detectable P450 holoprotein. One mutant, T363M, expressed at significantly lower levels than wild-type CYP3A4, G56D, V170I, D174H and M445T were not significantly different when compared with wild-type CYP3A4 in expression or steroid hydroxylase activity, L373F displayed a significantly altered testosterone metabolite profile and a four-fold increase in the K-m value for 1'-OH midazolam formation. The results suggest a limited contribution of CYP3A4 protein variants to the inter-individual variability of CYP3A4 activity in Caucasians, Some variants may, however, play a role in the atypical response to drugs or altered sensitivity to carcinogens. Pharmacogenetics 11:447-458 (C) 2001 Lippincott Williams & Wilkins.
C1 EPIDAUROS Biotechnol AG, D-82347 Bernried, Germany.
   Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77550 USA.
   Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.
   Humboldt Univ, Univ Med Ctr Charite, Inst Clin Pharmacol, Berlin, Germany.
   Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4003 Basel, Switzerland.
RP Wojnowski, L (corresponding author), EPIDAUROS Biotechnol AG, Neuland 1, D-82347 Bernried, Germany.
EM leszek.wojnowski@epidauros.com
RI Zanger, Ulrich M./A-9364-2012
OI Zanger, Ulrich M./0000-0002-5276-2002
FU NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS)
   [P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676, P30ES006676, P30ES006676,
   P30ES006676, P30ES006676, P30ES006676] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM054995,
   R01GM054995, R37GM054995, R01GM054995, R37GM054995, R37GM054995,
   R37GM054995, R37GM054995, R37GM054995, R37GM054995, R01GM054995,
   R37GM054995, R37GM054995, R37GM054995, R01GM054995, R37GM054995,
   R01GM054995, R01GM054995, R01GM054995, R37GM054995, R01GM054995] Funding
   Source: NIH RePORTER; NIEHS NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Environmental Health Sciences (NIEHS) [ESO6676] Funding
   Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [GM54995] Funding Source: Medline
CR AOYAMA T, 1989, J BIOL CHEM, V264, P10388
   Ball SE, 1999, CLIN PHARMACOL THER, V66, P288, DOI 10.1016/S0009-9236(99)70037-8
   BEAUNE PH, 1986, P NATL ACAD SCI USA, V83, P8064, DOI 10.1073/pnas.83.21.8064
   BORK RW, 1989, J BIOL CHEM, V264, P910
   Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036
   CIACCIO PJ, 1989, ARCH BIOCHEM BIOPHYS, V271, P284, DOI 10.1016/0003-9861(89)90279-8
   Crespi CL, 1997, PHARMACOGENETICS, V7, P203, DOI 10.1097/00008571-199706000-00005
   Daly AK, 1998, TOXICOL LETT, V103, P143, DOI 10.1016/S0378-4274(98)00299-9
   Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585
   Domanski TL, 1998, ARCH BIOCHEM BIOPHYS, V350, P223, DOI 10.1006/abbi.1997.0525
   Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487
   Felix CA, 1998, P NATL ACAD SCI USA, V95, P13176, DOI 10.1073/pnas.95.22.13176
   Gellner K, 2001, PHARMACOGENETICS, V11, P111, DOI 10.1097/00008571-200103000-00002
   GONZALEZ FJ, 1988, DNA-J MOLEC CELL BIO, V7, P79, DOI 10.1089/dna.1988.7.79
   GORSKI JC, 1994, BIOCHEM PHARMACOL, V47, P1643
   Haining RL, 1996, ARCH BIOCHEM BIOPHYS, V333, P447, DOI 10.1006/abbi.1996.0414
   Halushka MK, 1999, NAT GENET, V22, P239
   Harlow GR, 1997, J BIOL CHEM, V272, P5396, DOI 10.1074/jbc.272.9.5396
   Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636
   HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4
   HASHIMOTO H, 1993, EUR J BIOCHEM, V218, P585, DOI 10.1111/j.1432-1033.1993.tb18412.x
   He YA, 1997, BIOCHEMISTRY-US, V36, P8831, DOI 10.1021/bi970182i
   Henry SH, 1999, SCIENCE, V286, P2453, DOI 10.1126/science.286.5449.2453
   Khan KK, 2000, ARCH BIOCHEM BIOPHYS, V373, P335, DOI 10.1006/abbi.1999.1578
   KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005
   Lewis DFV, 1996, XENOBIOTICA, V26, P1067
   Lewis DFV, 1998, MUTAT RES-REV MUTAT, V410, P245, DOI 10.1016/S1383-5742(97)00040-9
   Li AP, 1995, TOXICOLOGY, V104, P1, DOI 10.1016/0300-483X(95)03155-9
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001
   Paolini M, 1999, NATURE, V398, P760, DOI 10.1038/19655
   Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913
   PEYRONNEAU MA, 1993, EUR J BIOCHEM, V218, P355, DOI 10.1111/j.1432-1033.1993.tb18384.x
   Rebbeck TR, 1998, J NATL CANCER I, V90, P1225, DOI 10.1093/jnci/90.16.1225
   REBBECK TR, 1999, JNCI-J NATL CANCER I, V16, P1082
   RETTIE AE, 1994, PHARMACOGENETICS, V4, P39, DOI 10.1097/00008571-199402000-00005
   Roussel F, 2000, ARCH BIOCHEM BIOPHYS, V374, P269, DOI 10.1006/abbi.1999.1599
   Sata F, 2000, CLIN PHARMACOL THER, V67, P48, DOI 10.1067/mcp.2000.104391
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   SullivanKlose TH, 1996, PHARMACOGENETICS, V6, P341, DOI 10.1097/00008571-199608000-00007
   Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389
   Touw D. J., 1997, Drug Metabolism and Drug Interactions, V14, P55
   Wang HF, 1998, BIOCHEMISTRY-US, V37, P12536, DOI 10.1021/bi980895g
   Westlind A, 1999, BIOCHEM BIOPH RES CO, V259, P201, DOI 10.1006/bbrc.1999.0752
   Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6
   Zheng YM, 1998, BIOCHEMISTRY-US, V37, P12847, DOI 10.1021/bi981280m
NR 47
TC 172
Z9 190
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0960-314X
J9 PHARMACOGENETICS
JI Pharmacogenetics
PD JUL
PY 2001
VL 11
IS 5
BP 447
EP 458
DI 10.1097/00008571-200107000-00008
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
GA 454QR
UT WOS:000169983700008
PM 11470997
DA 2021-01-25
ER

PT J
AU Taschner, N
   Muller, SA
   Alumella, VR
   Goldie, KN
   Drake, AF
   Aebi, U
   Arvinte, T
AF Taschner, N
   Muller, SA
   Alumella, VR
   Goldie, KN
   Drake, AF
   Aebi, U
   Arvinte, T
TI Modulation of antigenicity related to changes in antibody flexibility
   upon lyophilization
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE antibody flexibility; lyophilization effects; scanning transmission
   electron microscopy
ID MONOCLONAL-ANTIBODY; 3-DIMENSIONAL STRUCTURE; SEGMENTAL FLEXIBILITY;
   HUMAN-IMMUNOGLOBULIN; MOLECULE; FLUORESCENCE; TRYPTOPHAN; IMAGES;
   ADENOCARCINOMA; SPECTROSCOPY
AB Lyophilization is frequently used to increase the shelf-life of biopharmaceuticals containing antibodies. A case in which an anti-idiotypic antibody, MMA 383, substantially lost its in vivo immunogenic properties although the protein was not degraded, is investigated. The scanning transmission electron microscope allowed the MMA 383 Fab and Pc moieties to be resolved. By averaging the single antibodies, the angle between the Fab moieties can be calculated. Non-lyophilized antibodies displayed a wider range of shapes than their reconstituted, lyophilized counterparts. Accordingly, the angle between the two Fab fragments varied more, indicating greater flexibility. The tryptophan steady-state fluorescence intensity, steady-state fluorescence anisotropy and fluorescence Lifetime, were smaller for the lyophilized antibodies. These were also more resistant towards thermal denaturation/aggregation. Circular dichroism spectra detected temperpture-dependent differences between the two antibody types in the 236 nm region. The subtle but reproducible structural changes induced by lyophilization may be related to the loss of in vivo immunogenic properties. (C) 2001 Academic Press.
C1 Novartis Pharma AG, Biotechnol Dev & Prod, CH-4002 Basel, Switzerland.
   Univ Basel, Biozentrum, Inst Microscopy, CH-4056 Basel, Switzerland.
   European Mol Biol Lab, D-69117 Heidelberg, Germany.
   Kings Coll London, Dept Pharm, London SE1 8WA, England.
RP Arvinte, T (corresponding author), Novartis Pharma AG, Biotechnol Dev & Prod, CH-4002 Basel, Switzerland.
EM tudor.arvinte@pharma.novartis.com
CR ARVINTE T, 1995, Patent No. 0665019
   AZUMI T, 1962, J CHEM PHYS, V37, P2413, DOI 10.1063/1.1733019
   BLASZCZYKTHURIN M, 1987, J BIOL CHEM, V262, P372
   BRETAUDIERE JP, 1986, J MICROSC-OXFORD, V144, P1, DOI 10.1111/j.1365-2818.1986.tb04669.x
   BURTON DR, 1990, TRENDS BIOCHEM SCI, V15, P64, DOI 10.1016/0968-0004(90)90178-E
   CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P463
   Chang BS, 1996, J PHARM SCI, V85, P1325, DOI 10.1021/js960080y
   Chen B, 1999, J PHARM SCI-US, V88, P477, DOI 10.1021/js980273g
   Deshpande PP, 1997, NATURE, V387, P164, DOI 10.1038/387164a0
   FEINSTEI.A, 1965, NATURE, V205, P147, DOI 10.1038/205147a0
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   GIETZ U, 1997, THESIS ETH ZURICH
   GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271
   Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508
   HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0
   Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+
   HIDER RC, 1988, BIOPOLYMERS, V27, P113, DOI 10.1002/bip.360270109
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   LAKOWICZ JR, 1985, BIOCHEMISTRY-US, V24, P376, DOI 10.1021/bi00323a021
   Malik K. M., 1997, THESIS KINGS COLL LO
   MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1
   Nishimoto E, 1998, BIOCHEMISTRY-US, V37, P5599, DOI 10.1021/bi9718651
   NORDMANN AP, 1996, THESIS COLL U LONDON
   NUDELMAN E, 1986, J BIOL CHEM, V261, P1247
   Pai LH, 1996, NAT MED, V2, P350, DOI 10.1038/nm0396-350
   ROBBINS RJ, 1980, J AM CHEM SOC, V102, P6271, DOI 10.1021/ja00540a016
   ROMANS DG, 1977, P NATL ACAD SCI USA, V74, P2531, DOI 10.1073/pnas.74.6.2531
   Roux KH, 1997, J IMMUNOL, V159, P3372
   SARMA R, 1982, J APPL CRYSTALLOGR, V15, P476, DOI 10.1107/S002188988201245X
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   SIEGALL CB, 1995, SEMIN CANCER BIOL, V6, P289, DOI 10.1006/scbi.1995.0037
   SILIGARDI G, 1992, EUR J BIOCHEM, V206, P23, DOI 10.1111/j.1432-1033.1992.tb16897.x
   SILVERTON EW, 1977, P NATL ACAD SCI USA, V74, P5140, DOI 10.1073/pnas.74.11.5140
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   STEPLEWSKI Z, 1990, HYBRIDOMA, V9, P201, DOI 10.1089/hyb.1990.9.201
   VALENTINE RC, 1967, J MOL BIOL, V27, P615, DOI 10.1016/0022-2836(67)90063-0
   VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4
   VOS K, 1987, EUR J BIOCHEM, V165, P55, DOI 10.1111/j.1432-1033.1987.tb11193.x
   WAWRZYNCZAK EJ, 1988, BIOPHYS CHEM, V31, P301, DOI 10.1016/0301-4622(88)80036-X
   YGUERABIDE J, 1970, J MOL BIOL, V51, P573, DOI 10.1016/0022-2836(70)90009-4
NR 40
TC 25
Z9 26
U1 3
U2 15
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUN 29
PY 2001
VL 310
IS 1
BP 169
EP 179
DI 10.1006/jmbi.2001.4736
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 448JN
UT WOS:000169623900012
PM 11419944
DA 2021-01-25
ER

PT J
AU Brett, W
   Mandinova, A
   Remppis, A
   Sauder, U
   Ruter, F
   Heizmann, CW
   Aebi, U
   Zerkowski, HR
AF Brett, W
   Mandinova, A
   Remppis, A
   Sauder, U
   Ruter, F
   Heizmann, CW
   Aebi, U
   Zerkowski, HR
TI Translocation of S100A1 calcium binding protein during heart surgery
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Ca2+-binding proteins; cardioplegia; cardiopulmonary bypass;
   cardiomyocytes; ischemia-reperfusion; laser scanning microscopy; S100
   proteins
ID CARDIAC TROPONIN-T; ACUTE MYOCARDIAL-INFARCTION; STUNNED MYOCARDIUM;
   CA2+; MUSCLE; MICROSCOPY; MECHANISMS; EXPRESSION; RYANODINE; SERUM
AB Myocardial ischemia during cardiopulmonary bypass terminated by reperfusion generally leads to different degrees of damage of the cardiomyocytes induced by transient cytosolic Ca2+ overload. Recently, much attention has been paid to the role of heart-specific Ca2+-binding proteins in the pathogenesis of myocardial ischemia-reperfusion injury. S100A1 is a heart-specific EF-hand Ca2+-binding protein that is directly involved in a variety of Ca2+-mediated functions in myocytes. The aim of our study was to investigate the localization and translocation of S100A1 in the human heart under normal (baseline) conditions and after prolonged ischemia and reperfusion of the myocardium. Our data suggest that S100A1 is directly involved in the transient perioperative myocardial damage caused by ischemia during open heart surgery in humans. Given its role in the contractile function of muscle cells, this S100 protein could be an important "intracellular link" in ischemia-reperfusion injury of the heart. (C) 2001 Academic Press.
C1 Univ Basel, Kantonsspital, Div Cardiothorac Surg, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland.
   Univ Lubeck, Div Cardiol, Dept Internal Med 2, D-23538 Lubeck, Germany.
   Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland.
RP Brett, W (corresponding author), Univ Basel, Kantonsspital, Div Cardiothorac Surg, Spitalstr 21, CH-4031 Basel, Switzerland.
CR Baschong W, 1997, EUR J CELL BIOL, V72, P189
   Bolli R, 1999, PHYSIOL REV, V79, P609
   Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0
   Ehlermann P, 2000, BBA-MOL BASIS DIS, V1500, P249, DOI 10.1016/S0925-4439(99)00106-4
   Gao WD, 1996, CIRCULATION, V94, P2597, DOI 10.1161/01.CIR.94.10.2597
   Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172
   HEIZMANN CW, 2001, IN PRESS ENCY MOL ME
   HEIZMANN CW, 2001, METHODS MOL BIOL CAL, V1, P688
   Ilg EC, 1996, INT J CANCER, V68, P325, DOI 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.3.CO;2-0
   Ivanenkov VV, 1996, BIOCHEM BIOPH RES CO, V221, P46, DOI 10.1006/bbrc.1996.0542
   KATUS HA, 1989, J MOL CELL CARDIOL, V21, P1349, DOI 10.1016/0022-2828(89)90680-9
   KATUS HA, 1991, AM J CARDIOL, V67, P1360, DOI 10.1016/0002-9149(91)90466-X
   Kiewitz R, 2000, BIOCHEM BIOPH RES CO, V274, P865, DOI 10.1006/bbrc.2000.3229
   Kiewitz R, 2000, BBA-MOL CELL RES, V1498, P207, DOI 10.1016/S0167-4889(00)00097-5
   Landar A, 1998, BIOCHEMISTRY-US, V37, P17429, DOI 10.1021/bi9817921
   MACO B, 2001, IN PRESS PHYS REV
   Mandinova A, 1998, J CELL SCI, V111, P2043
   MESSERLI JM, 1993, HISTOCHEMISTRY, V100, P193, DOI 10.1007/BF00269092
   MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7
   Nicol RL, 2000, ANNU REV GENOM HUM G, V1, P179, DOI 10.1146/annurev.genom.1.1.179
   PATEL B, 1988, ANN INTERN MED, V108, P626, DOI 10.7326/0003-4819-108-4-626
   PEDROCCHI M, 1994, BIOCHEMISTRY-US, V33, P6732, DOI 10.1021/bi00187a045
   Pieske B, 1999, CIRC RES, V85, P38
   REMPPIS A, 1994, BRIT HEART J, V71, P242
   Remppis A, 1996, BBA-MOL CELL RES, V1313, P253, DOI 10.1016/0167-4889(96)00097-3
   ROBERTS AJ, 1981, J THORAC CARDIOV SUR, V81, P69
   Ros JAR, 1999, J CARDIOVASC SURG, V40, P203
   Schindewolf U, 1996, BER BUNSEN PHYS CHEM, V100, P1
   Schlotthauer K, 1998, J MOL CELL CARDIOL, V30, P1285, DOI 10.1006/jmcc.1998.0690
   SMALL JV, 1978, J CELL SCI, V31, P393
   Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w
   USUI A, 1994, J NEUROL SCI, V123, P134, DOI 10.1016/0022-510X(94)90215-1
NR 32
TC 12
Z9 12
U1 0
U2 0
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUN 15
PY 2001
VL 284
IS 3
BP 698
EP 703
DI 10.1006/bbrc.2001.4996
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 443WR
UT WOS:000169365800025
PM 11396958
DA 2021-01-25
ER

PT J
AU Dichtl, B
   Keller, W
AF Dichtl, B
   Keller, W
TI Recognition of polyadenylation sites in yeast pre-mRNAs by cleavage and
   polyadenylation factor
SO EMBO JOURNAL
LA English
DT Article
DE mRNA; polyadenylation signals; pre-mRNA 3 '-end processing; RNA-protein
   interactions
ID RNA 3'-END FORMATION; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE;
   SPECIFICITY FACTOR; BINDING PROTEIN; EFFICIENCY; SUBUNIT;
   IDENTIFICATION; SEPARATION; COMPONENTS
AB Recognition of poly(A) sites in yeast pre-mRNAs is poorly understood, Employing an in vitro cleavage system with cleavage and polyadenylation factor (CPF) and cleavage factor IA we show that the efficiency and positioning elements are dispensable for poly(A)-site recognition within a short CYC1 substrate in vitro. Instead, U-rich elements immediately upstream and downstream of the poly(A) site mediate cleavage-site recognition within CYC1 and ADH1 pre-mRNAs, These elements act in concert with the poly(A) site to produce multiple recognition sites for the processing machinery, since combinations of mutations within these elements were most effective in cleavage inhibition. Intriguingly, introduction of a U-rich element downstream of the GAL7 poly(A) site strongly enhanced cleavage, underscoring the importance of downstream sequences in general, RNA-binding analyses demonstrate that cleavage depends on the recognition of the poly(A)-site region by CPF, Consistent with in vitro results, mutation of sequences upstream and downstream of the poly(A) site affected 3'-end formation in vivo. A model for yeast pre-mRNA cleavage-site recognition outlines an unanticipated high conservation of yeast and mammalian 3'-end processing mechanisms.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Keller, W (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
EM walter.keller@unibas.ch
OI Dichtl, Bernhard/0000-0001-5514-4982
CR Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778
   BUTLER JS, 1988, SCIENCE, V242, P1270, DOI 10.1126/science.2848317
   CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391
   CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470
   Chen SX, 1998, NUCLEIC ACIDS RES, V26, P4965, DOI 10.1093/nar/26.21.4965
   COLLART MA, 1994, CURRENT PROTOCOLS MO
   Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218
   GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425
   Graber JH, 1999, NUCLEIC ACIDS RES, V27, P888, DOI 10.1093/nar/27.3.888
   Guo ZJ, 1996, TRENDS BIOCHEM SCI, V21, P477, DOI 10.1016/S0968-0004(96)10057-8
   Guo ZJ, 1996, MOL CELL BIOL, V16, P2772
   HEIDMANN S, 1992, MOL CELL BIOL, V12, P4215, DOI 10.1128/MCB.12.9.4215
   HYMAN LE, 1991, MOL CELL BIOL, V11, P2004, DOI 10.1128/MCB.11.4.2004
   Kessler MM, 1996, J BIOL CHEM, V271, P27167, DOI 10.1074/jbc.271.43.27167
   Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545
   MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647
   Minvielle-Sebastia L, 1998, EMBO J, V17, P7454, DOI 10.1093/emboj/17.24.7454
   MINVIELLESEBASTIA L, 1991, MOL CELL BIOL, V11, P3075, DOI 10.1128/MCB.11.6.3075
   MINVIELLESEBASTIA L, 1994, SCIENCE, V266, P1702, DOI 10.1126/science.7992054
   MURTHY KGK, 1995, GENE DEV, V9, P2672, DOI 10.1101/gad.9.21.2672
   Ohnacker M, 2000, EMBO J, V19, P37, DOI 10.1093/emboj/19.1.37
   Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196
   STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z
   TAKAGAKI Y, 1994, NATURE, V372, P471, DOI 10.1038/372471a0
   TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x
   Valentini SR, 1999, RNA, V5, P272, DOI 10.1017/S1355838299981633
   Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907
   ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2
   Zhao J, 1997, J BIOL CHEM, V272, P10831
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
NR 30
TC 57
Z9 58
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JUN 15
PY 2001
VL 20
IS 12
BP 3197
EP 3209
DI 10.1093/emboj/20.12.3197
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 445GP
UT WOS:000169450000022
PM 11406596
OA Green Published
DA 2021-01-25
ER

PT J
AU Panne, D
   Muller, SA
   Wirtz, S
   Engel, A
   Bickle, TA
AF Panne, D
   Muller, SA
   Wirtz, S
   Engel, A
   Bickle, TA
TI The McrBC restriction endonuclease assembles into a ring structure in
   the presence of G nucleotides
SO EMBO JOURNAL
LA English
DT Article
DE AAA(+) protein family; GTP; GTPase; McrBC restriction; scanning
   transmission electron microscopy
ID ESCHERICHIA-COLI K-12; TRANSMISSION ELECTRON-MICROSCOPY; DNA; GTP;
   REGION; ORGANIZATION; RECOGNITION; PROTEASOME; CHAPERONE; SEQUENCE
AB McrBC from Escherichia coli K-12 is a restriction enzyme that belongs to the family of AAA(+) proteins and cuts DNA containing modified cytosines, Two proteins are expressed from the mcrB gene: a full-length version, McrB(L), and a short version, McrB(S). McrB(L) binds specifically to the methylated recognition site and is, therefore, the DNA-binding moiety of the McrBC endonuclease, McrB(S) is devoid of DNA-binding activity. We observed that the quaternary structure of the endonuclease depends on binding of the cofactors, In gel filtration experiments, McrB(L) and McrB(S) form high molecular weight oligomers in the presence of Mg2+ and GTP, GDP or GTP-gamma -S. Oligomerization did not require the presence of DNA and was independent of GTP hydrolysis. Electron micrographs of negatively stained McrB(L) and McrB(S) revealed ring-shaped particles with a central channel. Mass analysis by scanning transmission electron microscopy indicates that McrB(L) and McrB(S) form single heptameric rings as well as tetradecamers, In the presence of McrC, a subunit that is essential for DNA cleavage, the tetradecameric species was the major form of the endonuclease.
C1 Univ Basel, Biozentrum, Dept Microbiol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Bickle, TA (corresponding author), Univ Basel, Biozentrum, Dept Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM thomas-a.bickle@unibas.ch
RI Panne, Daniel/I-8368-2017
OI Panne, Daniel/0000-0001-9158-5507
CR ARBER W, 1965, J MOL BIOL, V11, P247, DOI 10.1016/S0022-2836(65)80055-9
   Beary TP, 1997, J BACTERIOL, V179, P7768, DOI 10.1128/jb.179.24.7768-7775.1997
   BERTANI G, 1953, J BACTERIOL, V65, P113, DOI 10.1128/JB.65.2.113-121.1953
   BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993
   Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043
   CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710
   DILA D, 1990, J BACTERIOL, V172, P4888, DOI 10.1128/jb.172.9.4888-4900.1990
   DUSSOIX D, 1962, J MOL BIOL, V5, P37, DOI 10.1016/S0022-2836(62)80059-X
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   Fouts ET, 1999, J BIOL CHEM, V274, P4447, DOI 10.1074/jbc.274.7.4447
   Gast FU, 1997, BIOL CHEM, V378, P975, DOI 10.1515/bchm.1997.378.9.975
   Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135
   KRUGER T, 1992, GENE, V114, P1, DOI 10.1016/0378-1119(92)90700-Y
   KRUGER T, 1995, EMBO J, V14, P2661, DOI 10.1002/j.1460-2075.1995.tb07264.x
   LURIA SE, 1952, J BACTERIOL, V64, P557, DOI 10.1128/JB.64.4.557-569.1952
   MASTRANGELO IA, 1989, NATURE, V338, P658, DOI 10.1038/338658a0
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Neuwald AF, 1999, GENOME RES, V9, P27
   Pamnani V, 1997, FEBS LETT, V404, P263, DOI 10.1016/S0014-5793(97)00138-5
   Panne D, 1998, EMBO J, V17, P5477, DOI 10.1093/emboj/17.18.5477
   Panne D, 1999, J MOL BIOL, V290, P49, DOI 10.1006/jmbi.1999.2894
   Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9
   PATEL SS, 1993, J BIOL CHEM, V268, P10668
   Pieper U, 1997, J MOL BIOL, V272, P190, DOI 10.1006/jmbi.1997.1228
   RALEIGH EA, 1992, MOL MICROBIOL, V6, P1079, DOI 10.1111/j.1365-2958.1992.tb01546.x
   RALEIGH EA, 1986, P NATL ACAD SCI USA, V83, P9070, DOI 10.1073/pnas.83.23.9070
   REHAKRANTZ LJ, 1978, J BIOL CHEM, V253, P4043
   REVEL HR, 1983, BACTERIOPHAGE T, V4, P156
   ROBERTS RJ, 1993, NUCLEASES, P439
   Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133
   ROSS TK, 1989, J BACTERIOL, V171, P1974, DOI 10.1128/jb.171.4.1974-1981.1989
   ROSS TK, 1989, MOL GEN GENET, V216, P402, DOI 10.1007/BF00334382
   ROSS TK, 1987, J BACTERIOL, V169, P1757, DOI 10.1128/jb.169.4.1757-1759.1987
   STASIAK A, 1994, P NATL ACAD SCI USA, V91, P7618, DOI 10.1073/pnas.91.16.7618
   Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7
   Stewart FJ, 1998, BIOL CHEM, V379, P611
   Stewart FJ, 2000, J MOL BIOL, V298, P611, DOI 10.1006/jmbi.2000.3697
   SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A
   Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589
NR 39
TC 24
Z9 24
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JUN 15
PY 2001
VL 20
IS 12
BP 3210
EP 3217
DI 10.1093/emboj/20.12.3210
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 445GP
UT WOS:000169450000023
PM 11406597
OA Green Published
DA 2021-01-25
ER

PT J
AU Klopfenstein, DR
   Klumperman, J
   Lustig, A
   Kammerer, RA
   Oorschot, V
   Hauri, HP
AF Klopfenstein, DR
   Klumperman, J
   Lustig, A
   Kammerer, RA
   Oorschot, V
   Hauri, HP
TI Subdomain-specific localization of CLIMP-63 (p63) in the endoplasmic
   reticulum is mediated by its luminal alpha-helical segment
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
DE coiled coils; CLIMP-63 (p63); endoplasmic reticulum; green fluorescent
   protein; microtubule-binding membrane protein
ID GOLGI INTERMEDIATE COMPARTMENT; MEMBRANE-PROTEIN; COILED-COILS;
   SUBCELLULAR-LOCALIZATION; INTRACELLULAR-TRANSPORT; LIVING CELLS;
   QUICK-FREEZE; NUCLEAR; PATHWAY; PALMITOYLATION
AB The microtubule-binding integral 63 kD cytoskeleton-linking membrane protein (CLIMP-63; former name, p63) of the rough endoplasmic reticulum (ER) is excluded from the nuclear envelope. We studied the mechanism underlying this ER subdomain-specific localization by mutagenesis and structural analysis. Deleting the luminal but not cytosolic segment of CLIMP-63 abrogated subdomain-specific localization, as visualized by confocal microscopy in living cells and by immunoelectron microscopy using ultrathin cryosections. Photobleaching/recovery analysis revealed that the luminal segment determines restricted diffusion and immobility of the protein. The recombinant full-length luminal segment of CLIMP-63 formed a-helical 91-nm long rod-like structures as evident by circular dichroism spectroscopy and electron microscopy. In the analytical ultracentrifuge, the luminal segment sedimented at 25.7 S, indicating large complexes. The complexes most likely arose by electrostatic interactions of individual highly charged coiled coils. The findings indicate that the luminal segment of CLIMP-63 is necessary and sufficient for oligomerization into cc-helical complexes that prevent nuclear envelope localization. Concentration of CLIMP-63 into patches may enhance microtubule binding on the cytosolic side and contribute to ER morphology by the formation of a protein scaffold in the lumen of the ER.
C1 Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Utrecht, Med Ctr, Ctr Biomed Genet,Inst Biomembranes, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
OI Kammerer, Richard/0000-0003-4570-5197
CR Abumuhor IA, 1998, J STRUCT BIOL, V123, P187, DOI 10.1006/jsbi.1998.4040
   Adam SA, 1999, CURR OPIN CELL BIOL, V11, P402, DOI 10.1016/S0955-0674(99)80056-8
   Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258
   Bastos R, 1995, INT REV CYTOL, V162B, P257
   Baumann O, 1998, CELL MOTIL CYTOSKEL, V41, P74, DOI 10.1002/(SICI)1097-0169(1998)41:1<74::AID-CM7>3.0.CO;2-F
   Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459
   CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027
   Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797
   Csermely P, 1995, BBA-REV BIOMEMBRANES, V1241, P425, DOI 10.1016/0304-4157(95)00015-1
   CULLEN BR, 1987, METHOD ENZYMOL, V152, P692
   DESCHUYTENEER M, 1988, J BIOL CHEM, V263, P2452
   Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193
   ELLINGER A, 1992, J HISTOCHEM CYTOCHEM, V40, P919, DOI 10.1177/40.7.1607641
   FRASER RDB, 1964, J MOL BIOL, V10, P147, DOI 10.1016/S0022-2836(64)80034-6
   GOTOW T, 1989, CELL TISSUE RES, V256, P53
   HAURI HP, 1997, HDB PHYSIOL 14, P605
   Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602
   Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7
   Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Kohn WD, 1997, J MOL BIOL, V267, P1039, DOI 10.1006/jmbi.1997.0930
   LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679
   Lippincott-Schwartz J, 1999, METHOD CELL BIOL, V58, P261
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   Lupas A, 1996, METHOD ENZYMOL, V266, P513
   Mancini MA, 1996, J CELL BIOCHEM, V62, P158, DOI 10.1002/(SICI)1097-4644(199608)62:2<158::AID-JCB3>3.3.CO;2-M
   Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265
   MCLACHLAN AD, 1975, J MOL BIOL, V98, P293, DOI 10.1016/S0022-2836(75)80119-7
   MUNDY DI, 1992, J CELL BIOL, V116, P135, DOI 10.1083/jcb.116.1.135
   MUNDY DI, 1995, BIOCHEM SOC T, V23, P572, DOI 10.1042/bst0230572
   Pahl HL, 1999, PHYSIOL REV, V79, P683
   Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7
   Rolls MM, 1999, J CELL BIOL, V146, P29, DOI 10.1083/jcb.146.1.29
   SCHWEIZER A, 1995, J CELL SCI, V108, P2477
   SCHWEIZER A, 1994, J CELL BIOL, V126, P25, DOI 10.1083/jcb.126.1.25
   SCHWEIZER A, 1993, J CELL SCI, V104, P671
   SCHWEIZER A, 1995, J BIOL CHEM, V270, P9638, DOI 10.1074/jbc.270.16.9638
   SCHWEIZER A, 1993, J CELL SCI, V104, P685
   Senda T, 1998, ANAT REC, V251, P339
   Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57
   Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7
   Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1
   SITIA R, 1992, MOL BIOL CELL, V3, P1067
   Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9
   SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123
   SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800
   Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Szczesna-Skorupa E, 1998, P NATL ACAD SCI USA, V95, P14793, DOI 10.1073/pnas.95.25.14793
   Talcott B, 1999, TRENDS CELL BIOL, V9, P312, DOI 10.1016/S0962-8924(99)01608-6
   VERTEL BM, 1989, J CELL BIOL, V109, P1827, DOI 10.1083/jcb.109.4.1827
   Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9
   Weibel ER, 1979, STEREOLOGICAL METHOD, V1
NR 54
TC 85
Z9 87
U1 0
U2 1
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0021-9525
J9 J CELL BIOL
JI J. Cell Biol.
PD JUN 11
PY 2001
VL 153
IS 6
BP 1287
EP 1299
DI 10.1083/jcb.153.6.1287
PG 13
WC Cell Biology
SC Cell Biology
GA 443AX
UT WOS:000169318100015
PM 11402071
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Shneider, MM
   Boudko, SP
   Lustig, A
   Mesyanzhinov, VV
AF Shneider, MM
   Boudko, SP
   Lustig, A
   Mesyanzhinov, VV
TI Properties of bacteriophage T4 baseplate protein encoded by gene 8
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE bacteriophage T4; baseplate; gene product 8; CD spectroscopy; alpha/beta
   proteins
ID SECONDARY STRUCTURE; CIRCULAR-DICHROISM; TAIL; GENE-PRODUCT-9;
   MORPHOGENESIS
AB Gene product 8 (gp8, 344 amino acids per monomer) of bacteriophage T4 is one of the baseplate structural proteins. We constructed an expression vector of gp8 acid developed a method for purification of recombinant protein. CD spectroscopy showed that gp8 is an alpha/beta type structural protein. Its polypeptide chain consists of nearly 40% beta -structure and 15% alpha -helix. These data agree with results of prediction of secondary structure based on the amino acid sequence of the protein. The sedimentation coefficient under standard conditions (S-20,S-w) is 4.6S. Analytical ultracentrifugation results demonstrated that gp8 in solution has two types of oligomers-dimer and tetramer. The tetramer of gp8 may be included in the wedge (1/6 of the baseplate), and the dimer may be an intermediate product of association.
C1 Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117871, Russia.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Shneider, MM (corresponding author), Shemyakin & Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117871, Russia.
RI Shneider, Mikhail/AAL-6817-2020
OI Shneider, Mikhail/0000-0002-3768-3541
CR CROWTHER RA, 1977, J MOL BIOL, V116, P489, DOI 10.1016/0022-2836(77)90081-X
   EFIMOV VP, 1990, NUCLEIC ACIDS RES, V18, P5313, DOI 10.1093/nar/18.17.5313
   Ferguson PL, 2000, J MOL BIOL, V297, P99, DOI 10.1006/jmbi.2000.3551
   KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X
   KIKUCHI Y, 1975, J MOL BIOL, V99, P645, DOI 10.1016/S0022-2836(75)80178-1
   Kostyuchenko VA, 1999, STRUCTURE, V7, P1213, DOI 10.1016/S0969-2126(00)80055-6
   Leiman PG, 2000, J MOL BIOL, V301, P975, DOI 10.1006/jmbi.2000.3989
   Navruzbekov GA, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1266
   PLISHKER MF, 1988, J VIROL, V62, P400, DOI 10.1128/JVI.62.2.400-406.1988
   PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006
   PTITSYN OB, 1983, BIOPOLYMERS, V22, P15, DOI 10.1002/bip.360220105
   Sambrook J, 1989, MOL CLONING LAB MANU
   SREERAMA N, 1994, J MOL BIOL, V242, P497, DOI 10.1006/jmbi.1994.1597
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P60
   VENYAMINOV SY, 1994, ANAL BIOCHEM, V222, P176, DOI 10.1006/abio.1994.1470
   WATTS NRM, 1990, J VIROL, V64, P143, DOI 10.1128/JVI.64.1.143-154.1990
   WATTS NRM, 1989, J VIROL, V63, P2427, DOI 10.1128/JVI.63.6.2427-2436.1989
   Zhao L, 2000, BBA-PROTEIN STRUCT M, V1479, P286, DOI 10.1016/S0167-4838(00)00015-7
NR 18
TC 6
Z9 6
U1 0
U2 2
PU CONSULTANTS BUREAU
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0006-2979
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD JUN
PY 2001
VL 66
IS 6
BP 693
EP 697
DI 10.1023/A:1010271701204
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 453WF
UT WOS:000169938900015
PM 11421820
DA 2021-01-25
ER

PT J
AU Levy-Rimler, G
   Viitanen, P
   Weiss, C
   Sharkia, R
   Greenberg, A
   Niv, A
   Lustig, A
   Delarea, Y
   Azem, A
AF Levy-Rimler, G
   Viitanen, P
   Weiss, C
   Sharkia, R
   Greenberg, A
   Niv, A
   Lustig, A
   Delarea, Y
   Azem, A
TI The effect of nucleotides and mitochondrial chaperonin 10 on the
   structure and chaperone activity of mitochondrial chaperonin 60
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE chaperonin; mitochondrial folding; cpn60; cpn10; hsp60
ID FOLDING IN-VIVO; SINGLE-RING; ANALYTICAL ULTRACENTRIFUGATION; YEAST
   MITOCHONDRIA; PROTEIN; GROEL; CHLOROPLAST; PLANT; HEAT-SHOCK-PROTEIN-60;
   RECONSTITUTION
AB Mitochondrial chaperonins are necessary for the folding of newly imported and stress-denatured mitochondrial proteins. The goal of this study was to investigate the structure and function of the mammalian mitochondrial chaperonin system. We present evidence that the 60 kDa chaperonin (mt-cpn60) exists in solution in dynamic equilibrium between monomers, heptameric single rings and double-ringed tetradecamers. In the presence of ATP and the 10 kDa cochaperonin (mt-cpn10), the formation of a double ring is favored. ADP at very high concentrations does not inhibit malate dehydrogenase refolding or ATP hydrolysis by mt-cpn60 in the presence of mt-cpn10. We propose that the cis (mt-cpn60)(14).nuleotide.(mt-cpn10)(7) complex is not a stable species and does not bind ADP effectively at its trans binding site.
C1 Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.
   Dupont Co, Expt Stn, Dept Cent Res & Dev, Div Mol Biol, Wilmington, DE USA.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Azem, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.
CR AGSTERIBBE E, 1993, BIOCHEM BIOPH RES CO, V193, P146, DOI 10.1006/bbrc.1993.1602
   AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553
   Azem A, 1995, P NATL ACAD SCI USA, V92, P12021, DOI 10.1073/pnas.92.26.12021
   Ben-Zvi AP, 1998, P NATL ACAD SCI USA, V95, P15275, DOI 10.1073/pnas.95.26.15275
   Briones P, 1997, J INHERIT METAB DIS, V20, P569, DOI 10.1023/A:1005303008439
   Carrascosa JL, 2001, MICRON, V32, P43, DOI 10.1016/S0968-4328(00)00027-5
   CHANT ID, 1995, BRIT J HAEMATOL, V90, P163, DOI 10.1111/j.1365-2141.1995.tb03395.x
   CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0
   Diamant S, 1998, BIOCHEMISTRY-US, V37, P9688, DOI 10.1021/bi980338u
   Dickson R, 2000, J BIOL CHEM, V275, P11829, DOI 10.1074/jbc.275.16.11829
   Ellis RJ, 1999, CURR BIOL, V9, pR352
   HALLBERG EM, 1993, MOL CELL BIOL, V13, P3050, DOI 10.1128/MCB.13.5.3050
   Hallberg R L, 1990, Semin Cell Biol, V1, P37
   HARTMAN DJ, 1993, P NATL ACAD SCI USA, V90, P2276, DOI 10.1073/pnas.90.6.2276
   Hensley P, 1996, STRUCTURE, V4, P367, DOI 10.1016/S0969-2126(96)00042-1
   Horst M, 1996, PROTEIN SCI, V5, P759
   HUCKRIEDE A, 1995, VIRCHOWS ARCH, V427, P159
   Knowlton AA, 1998, J MOL CELL CARDIOL, V30, P811, DOI 10.1006/jmcc.1998.0646
   Lorimer GH, 1996, FASEB J, V10, P5
   Lu W, 1998, J Tongji Med Univ, V18, P145
   Lustig A, 2000, BBA-BIOMEMBRANES, V1464, P199, DOI 10.1016/S0005-2736(99)00254-0
   Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3
   Nielsen KL, 1999, J BACTERIOL, V181, P5871, DOI 10.1128/JB.181.18.5871-5875.1999
   Rospert S, 1996, EMBO J, V15, P764, DOI 10.1002/j.1460-2075.1996.tb00412.x
   Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4
   SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554
   Schuster TM, 1996, CURR OPIN STRUC BIOL, V6, P650, DOI 10.1016/S0959-440X(96)80032-7
   Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581
   TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555
   TODD MJ, 1995, BIOCHEMISTRY-US, V34, P14932, DOI 10.1021/bi00045a038
   Viitanen PV, 1998, METHOD ENZYMOL, V290, P218, DOI 10.1016/S0076-6879(98)90021-0
   Viitanen PV, 1998, METHOD ENZYMOL, V290, P203, DOI 10.1016/S0076-6879(98)90020-9
   VIITANEN PV, 1992, J BIOL CHEM, V267, P695
   VIITANEN PV, 1995, J BIOL CHEM, V270, P18158, DOI 10.1074/jbc.270.30.18158
   Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3
   WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5
   YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001
   Yifrach O, 2000, P NATL ACAD SCI USA, V97, P1521, DOI 10.1073/pnas.040449997
NR 38
TC 74
Z9 77
U1 0
U2 6
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD JUN
PY 2001
VL 268
IS 12
BP 3465
EP 3472
DI 10.1046/j.1432-1327.2001.02243.x
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 445TF
UT WOS:000169474100013
PM 11422376
OA Bronze
DA 2021-01-25
ER

PT J
AU Shanshiashvili, L
   Suknidze, N
   Pichkhadze, B
   Machaidze, G
   Ramsden, J
   Mikeladze, D
AF Shanshiashvili, L
   Suknidze, N
   Pichkhadze, B
   Machaidze, G
   Ramsden, J
   Mikeladze, D
TI Human T-cell response to myelin basic protein C8 isoform and its tryptic
   peptide fragments
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Meeting Abstract
C1 Georgian Acad Sci, Inst Physiol, GE-380060 Tbilisi, Georgia.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Basel, Inst Inorgan Chem, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JUN
PY 2001
VL 77
SU 1
MA P0461
BP 52
EP 52
PG 1
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 441RL
UT WOS:000169243300182
DA 2021-01-25
ER

PT J
AU Gerber, AP
   Keller, W
AF Gerber, AP
   Keller, W
TI RNA editing by base deamination: more enzymes, more targets, more
   mysteries
SO TRENDS IN BIOCHEMICAL SCIENCES
LA English
DT Review
ID B MESSENGER-RNA; DSRNA-ADENOSINE-DEAMINASE; CYTIDINE DEAMINASE;
   PHYLOGENETIC ANALYSIS; MOLECULAR-CLONING; Z-DNA; DROSOPHILA; BINDING;
   INOSINE; ADAR1
AB The posttranscriptional modification of messenger RNA precursors (pre-mRNAs) by base deamination can profoundly alter the physiological function of the encoded proteins. The recent identification of tRNA-specific adenosine deaminases (ADATs) has led to the suggestion that these enzymes, as well as the cytidine and adenosine deaminases acting on pre-mRNAs (CDARs and ADARs), belong to a superfamily of RNA-dependent deaminases. This superfamily might have evolved from an ancient cytidine deaminase, This article reviews the reactions catalysed by these enzymes and discusses their evolutionary relationships.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4055 Basel, Switzerland.
RP Gerber, AP (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4055 Basel, Switzerland.
EM walter.keller@unibas.ch
CR Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056
   Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921
   Auxilien S, 1996, J MOL BIOL, V262, P437, DOI 10.1006/jmbi.1996.0527
   Bass BL, 1997, RNA, V3, P947
   Blanc V, 2001, J BIOL CHEM, V276, P10272, DOI 10.1074/jbc.M006435200
   Bourara K, 2000, SCIENCE, V289, P1564, DOI 10.1126/science.289.5484.1564
   BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677
   Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0
   Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170
   Chester A, 2000, BBA-GENE STRUCT EXPR, V1494, P1, DOI 10.1016/S0167-4781(00)00219-0
   George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621
   Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780
   Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146
   Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324
   Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499
   Grosjean H, 1996, BIOCHIMIE, V78, P488, DOI 10.1016/0300-9084(96)84755-9
   Hanrahan CJ, 2000, GENETICS, V155, P1149
   Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421
   Hersberger M, 1999, J BIOL CHEM, V274, P34590, DOI 10.1074/jbc.274.49.34590
   Higuchi M, 2000, NATURE, V406, P78
   Hirose T, 2001, EMBO J, V20, P1144, DOI 10.1093/emboj/20.5.1144
   Hough RF, 1999, NUCLEIC ACIDS RES, V27, P3424, DOI 10.1093/nar/27.17.3424
   Hough RF, 1997, RNA, V3, P356
   Kawakubo K, 2000, GENE, V258, P165, DOI 10.1016/S0378-1119(00)00368-1
   Keegan LP, 2000, MOL CELL BIOL, V20, P825, DOI 10.1128/MCB.20.3.825-833.2000
   Keller W, 1999, FEBS LETT, V452, P71, DOI 10.1016/S0014-5793(99)00590-6
   Lehmann KA, 1999, J MOL BIOL, V291, P1, DOI 10.1006/jmbi.1999.2914
   Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200
   Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925
   Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.3.CO;2-S
   Maas S, 1999, P NATL ACAD SCI USA, V96, P8895, DOI 10.1073/pnas.96.16.8895
   Maas S, 2000, GENE, V243, P59, DOI 10.1016/S0378-1119(99)00562-4
   Madsen P, 1999, J INVEST DERMATOL, V113, P162, DOI 10.1046/j.1523-1747.1999.00682.x
   MARCHFELDER A, 1998, MODIFICATION EDITING, P307
   Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000
   Morse DP, 1999, P NATL ACAD SCI USA, V96, P6048, DOI 10.1073/pnas.96.11.6048
   Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Navaratnam N, 1998, J MOL BIOL, V275, P695, DOI 10.1006/jmbi.1997.1506
   NAVARATNAM N, 1995, CELL, V81, P187, DOI 10.1016/0092-8674(95)90328-3
   Ohman M, 2000, RNA, V6, P687, DOI 10.1017/S1355838200000200
   Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0
   Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248
   PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376
   Patton DE, 1997, NEURON, V19, P711, DOI 10.1016/S0896-6273(00)80383-9
   Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120
   Polson AG, 1996, NATURE, V380, P454
   Reenan RA, 2000, NEURON, V25, P139, DOI 10.1016/S0896-6273(00)80878-8
   Reenan RA, 2001, TRENDS GENET, V17, P53, DOI 10.1016/S0168-9525(00)02169-7
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992
   Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841
   Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3
   Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x
   Simpson L, 2000, P NATL ACAD SCI USA, V97, P6986, DOI 10.1073/pnas.97.13.6986
   Smith LA, 1996, J NEUROSCI, V16, P7868
   Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765
NR 57
TC 154
Z9 157
U1 0
U2 15
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0968-0004
EI 1362-4326
J9 TRENDS BIOCHEM SCI
JI Trends Biochem.Sci.
PD JUN
PY 2001
VL 26
IS 6
BP 376
EP 384
DI 10.1016/S0968-0004(01)01827-8
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 444VH
UT WOS:000169420400016
PM 11406411
DA 2021-01-25
ER

PT J
AU Frank, S
   Kammerer, RA
   Mechling, D
   Schulthess, T
   Landwehr, R
   Bann, J
   Guo, Y
   Lustig, A
   Bachinger, HP
   Engel, J
AF Frank, S
   Kammerer, RA
   Mechling, D
   Schulthess, T
   Landwehr, R
   Bann, J
   Guo, Y
   Lustig, A
   Bachinger, HP
   Engel, J
TI Stabilization of short collagen-like triple helices by protein
   engineering
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE collagen-like peptides; folden; oligomerization domain; stabilization;
   protein engineering
ID CIS-TRANS ISOMERIZATION; PEPTIDE-BONDS; CONVERSION; DOMAIN; MODEL
AB Recombinant expression of collagens and fragments of collagens is often difficult, as their biosynthesis requires specific post-translational enzymes, in particular prolyl 4-hydroxylase. Although the use of hydroxyproline-deficient variants offers one possibility to overcome this difficulty, these proteins usually differ markedly in stability when compared with the hydroxyproline-containing analogs. Here, we report a method to stabilize collagen-like peptides by fusing them to the N terminus of the bacteriophage T4 fibritin foldon domain. The isolated foldon domain and the chimeric protein (GlyProPro)(10)foldon were expressed in a soluble form in Escherichia coli. The recombinant proteins and the synthetic (ProProGly)(10) peptide were characterized by circular dichroism (CD) spectroscopy, differential scanning calorimetry, and analytical ultracentrifugation. We show that the foldon domain, which comprises only 27 amino acid residues, forms an obligatory trimer with a high degree of thermal stability. The CD thermal unfolding profiles recorded from foldon are monophasic and completely reversible upon cooling. Similar Van't Hoff and calorimertic enthalpy values of trimer formation indicated a cooperative all-or-none transition. As reported previously, (ProProGly)(10) peptides form collagen triple helices of only moderate stability. When fused to the foldon domain, however, triple helix formation of (GlyProPro)(10) is concentration independent, and the midpoint temperature of the triple helix unfolding is significantly increased. The stabilizing function of the trimeric foldon domain is explained by the close vicinity of its N termini, which induce a high local concentration in the range of 1 M for the C termini of the collagen-like-peptide. Collagen-foldon fusion proteins should be potentially useful to study receptor-collagen interactions. (C) 2001 Academic Press.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Shriners Hosp Children, Res Ctr, Portland, OR 97201 USA.
   Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RI Guo, Yuan/B-1319-2018
OI Guo, Yuan/0000-0003-4607-7356; Kammerer, Richard/0000-0003-4570-5197
CR BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x
   BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x
   BARTSCH H.-J., 1982, TASCHENBUCH MATHEMAT, P66
   BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x
   Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   GERMANN HP, 1988, BIOPOLYMERS, V27, P157, DOI 10.1002/bip.360270112
   GO N, 1973, BIOPOLYMERS, V12, P1927, DOI 10.1002/bip.1973.360120818
   Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602
   LABOURDETTE L, 1993, FEBS LETT, V320, P211, DOI 10.1016/0014-5793(93)80588-L
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   Plotnikov VV, 1997, ANAL BIOCHEM, V250, P237, DOI 10.1006/abio.1997.2236
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Van Holde K. E., 1985, PHYSICAL BIOCH, P93
NR 20
TC 145
Z9 154
U1 2
U2 43
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 18
PY 2001
VL 308
IS 5
BP 1081
EP 1089
DI 10.1006/jmbi.2001.4644
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 437VP
UT WOS:000169014500018
PM 11352592
DA 2021-01-25
ER

PT J
AU Affolter, M
   Mann, R
AF Affolter, M
   Mann, R
TI Development - Legs, eyes, or wings - Selectors and signals make the
   difference
SO SCIENCE
LA English
DT Editorial Material
ID TRANSCRIPTION FACTORS; PROTEINS ACT; DROSOPHILA; DPP
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
OI Affolter, Markus/0000-0002-5171-0016
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM054510] Funding Source: Medline;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510] Funding
   Source: NIH RePORTER
CR Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0
   Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9
   Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402
   Guss KA, 2001, SCIENCE, V292, P1164, DOI 10.1126/science.1058312
   Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900
   Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7
   Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000
   Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243
   Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5
   Szuts D, 1998, GENE DEV, V12, P2022, DOI 10.1101/gad.12.13.2022
   Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0
   Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354
NR 12
TC 22
Z9 27
U1 0
U2 2
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD MAY 11
PY 2001
VL 292
IS 5519
BP 1080
EP 1081
DI 10.1126/science.1060856
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 431AF
UT WOS:000168609200036
PM 11352058
DA 2021-01-25
ER

PT J
AU Schulein, R
   Seubert, A
   Gille, C
   Lanz, C
   Hansmann, Y
   Piemont, Y
   Dehio, C
AF Schulein, R
   Seubert, A
   Gille, C
   Lanz, C
   Hansmann, Y
   Piemont, Y
   Dehio, C
TI Invasion and persistent intracellular colonization of erythrocytes: A
   unique parasitic strategy of the emerging pathogen Bartonella
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE Bartonella; erythrocyte parasitism; flow cytometry; GFP; whole blood
   biotinylation
ID GREEN FLUORESCENT PROTEIN; EXPERIMENTAL-INFECTION; FREE CATS; HENSELAE;
   DISEASE; BACILLIFORMIS; RATS; EXPRESSION; BACTEREMIA; MEMBRANES
AB The expanding genus Bartonella includes zoonotic and human-specific pathogens that can cause a wide range of clinical manifestations. A productive infection allowing bacterial transmission by blood-sucking arthropods is marked by an intraerythrocytic bacteremia that occurs exclusively in specific human or animal reservoir hosts. Incidental human infection by animal-adapted bartonellae can cause disease without evidence for erythrocyte parasitism. A better understanding of the intraerythrocytic lifestyle of bartonellae may permit the design of strategies to control the reservoir and transmittable stages of these emerging pathogens. We have dissected the process of Bartonella erythrocyte parasitism in experimentally infected animals using a novel approach for tracking blood infections based on flow cytometric quantification of green fluorescent protein-expressing bacteria during their interaction with in vivo-biotinylated erythrocytes. Bacteremia onset occurs several days after inoculation by a synchronous wave of bacterial invasion into mature erythrocytes. Intracellular bacteria replicate until reaching a stagnant number, which is sustained for the remaining life span of the infected erythrocyte. The initial wave of erythrocyte infection is followed by reinfection waves occurring at intervals of several days. Our findings unravel a unique bacterial persistance strategy adapted to non-hemolytic intracellular colonization of erythrocytes that preserves the pathogen for efficient transmission by blood-sucking arthropods.
C1 Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
   Max Planck Inst Biol, Dept Infect Biol, D-72076 Tubingen, Germany.
   Univ Strasbourg 1, Fac Med, Inst Bacteriol, F-67000 Strasbourg, France.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Dept Mol Microbiol, Klingelbergerstr 70, CH-4056 Basel, Switzerland.
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Seubert, Anja/0000-0003-3321-9140
CR Abbott RC, 1997, COMP IMMUNOL MICROB, V20, P41, DOI 10.1016/S0147-9571(96)00025-2
   Anderson BE, 1997, CLIN MICROBIOL REV, V10, P203, DOI 10.1128/CMR.10.2.203
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P2, DOI 10.1097/00006454-199701000-00003
   Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9
   BENSON LA, 1986, INFECT IMMUN, V54, P347, DOI 10.1128/IAI.54.2.347-353.1986
   Breitschwerdt EB, 2000, CLIN MICROBIOL REV, V13, P428, DOI 10.1128/CMR.13.3.428-438.2000
   Brouqui P, 1999, NEW ENGL J MED, V340, P184, DOI 10.1056/NEJM199901213400303
   Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0
   DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993
   Dehio C, 1999, CURR OPIN MICROBIOL, V2, P78, DOI 10.1016/S1369-5274(99)80013-7
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio Christoph, 1999, Trends in Microbiology, V7, P226, DOI 10.1016/S0966-842X(99)01523-1
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990
   Ellis BA, 1999, J INFECT DIS, V180, P220, DOI 10.1086/314824
   GARCIACACERES U, 1991, AM J CLIN PATHOL, V95, pS58
   Guptill L, 1999, VET IMMUNOL IMMUNOP, V71, P233, DOI 10.1016/S0165-2427(99)00104-X
   Guptill L, 1997, J INFECT DIS, V176, P206, DOI 10.1086/514026
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Hendrix LR, 2000, FEMS MICROBIOL LETT, V182, P119, DOI 10.1111/j.1574-6968.2000.tb08884.x
   HOFFMANNFEZER G, 1991, ANN HEMATOL, V63, P214, DOI 10.1007/BF01703446
   Iwaki-Egawa S, 1997, FEMS MICROBIOL LETT, V157, P207, DOI 10.1111/j.1574-6968.1997.tb12775.x
   Jackson LA, 1996, J INFECT DIS, V173, P1023, DOI 10.1093/infdis/173.4.1023
   Kerkhoff FT, 1999, J CLIN MICROBIOL, V37, P4034, DOI 10.1128/JCM.37.12.4034-4038.1999
   KORDICK DL, 1995, J CLIN MICROBIOL, V33, P1655, DOI 10.1128/JCM.33.6.1655-1656.1995
   Kordick DL, 1997, AM J VET RES, V58, P492
   Kordick DL, 1997, J CLIN MICROBIOL, V35, P1813, DOI 10.1128/JCM.35.7.1813-1818.1997
   Kosoy MY, 1999, J WILDLIFE DIS, V35, P275, DOI 10.7589/0090-3558-35.2.275
   O'Reilly KL, 1999, INFECT IMMUN, V67, P3066
   QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6
   RAYNAFARJE C, 1961, BLOOD, V17, P562
   Regnery RL, 1996, AM J VET RES, V57, P1714
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCHULTZ MG, 1968, AM J TROP MED HYG, V17, P503, DOI 10.4269/ajtmh.1968.17.503
   Sinnis P, 1997, TRENDS MICROBIOL, V5, P52, DOI 10.1016/S0966-842X(97)84657-4
   Weinman D, 1937, P SOC EXP BIOL MED, V37, P596
   XU YH, 1995, BBA-BIOMEMBRANES, V1234, P173, DOI 10.1016/0005-2736(94)00271-P
NR 37
TC 126
Z9 133
U1 0
U2 9
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PD MAY 7
PY 2001
VL 193
IS 9
BP 1077
EP 1086
DI 10.1084/jem.193.9.1077
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 432DX
UT WOS:000168677900010
PM 11342592
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Barfield, M
   Dingley, AJ
   Feigon, J
   Grzesiek, S
AF Barfield, M
   Dingley, AJ
   Feigon, J
   Grzesiek, S
TI A DFT study of the interresidue dependencies of scalar J-coupling and
   magnetic shielding in the hydrogen-bonding regions of a DNA tripler
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID CONSISTENT PERTURBATION-THEORY; SPIN-SPIN COUPLINGS; ACID BASE-PAIRS;
   CHEMICAL-SHIFT; NMR; CONSTANTS; N-15; RESONANCE; RELAXATION; TENSORS
AB Scalar coupling constants and magnetic shieldings in the imino hydrogen-bonding region of Hoogsteen-Watson-Crick T A-T and Ct G-C triplets have been calculated as a function of the distance between proton donor and acceptor nitrogen atoms. The Fermi contact contributions to (h2)J(N-15-H . . . N-15), (1)J(N-15-H-1), and (h1)J(H-1 . . . N-15) were computed using density functional theory/finite perturbation theory (DFT/ FPT) methods for the full base triplets at the unrestricted B3PW91/6-311G** level. Chemical shifts B(H-1) and delta(N-15) were obtained at the same level using the gauge including atomic orbital (GIAO) method for magnetic shielding. All three scalar couplings and all three chemical shifts are strongly interrelated and exhibit monotonic changes with base pair separation. These correlations are in conformity with experimental data for a 32-nucleotide DNA tripler. The results suggest that both chemical shifts and coupling constants can be used to gain information on H-bond donor-acceptor distances in nucleic acids. In addition to the DFT/FPT calculations, a simple three-orbital model of the N-H H bond and a sum-over-states analysis is presented. This model reproduces the basic features of the H-bond coupling effect. In accordance with this model and the DFT calculations, a positive sign for the (h2)J(NN) coupling is determined from an E.COSY experiment.
C1 Univ Arizona, Dept Chem, Tucson, AZ 85721 USA.
   Univ Dusseldorf, Inst Biol Phys, D-40225 Dusseldorf, Germany.
   Univ Calif Los Angeles, Dept Biochem & Chem, Los Angeles, CA 90095 USA.
   Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
RP Barfield, M (corresponding author), Univ Arizona, Dept Chem, Tucson, AZ 85721 USA.
EM Barfield@u.arizona.edu; Stephan.Grzesiek@unibas.ch
RI Dingley, Andrew/G-6427-2013
OI Dingley, Andrew/0000-0002-6838-5803; Grzesiek,
   Stephan/0000-0003-1998-4225
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM37254, GM48123] Funding Source: Medline;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM037254,
   R01GM037254, R01GM037254, R01GM037254, R01GM037254, R01GM037254,
   R01GM037254, R01GM037254, R01GM037254, R01GM037254, R01GM037254,
   R01GM037254, R01GM037254, R01GM037254, R01GM037254, R01GM037254,
   R01GM037254, R01GM037254, R01GM037254, R01GM037254, R01GM037254,
   R01GM037254, R01GM037254, R01GM037254, R01GM037254] Funding Source: NIH
   RePORTER
CR BARFIELD M, 1973, CHEM REV, V73, P53, DOI 10.1021/cr60281a004
   BARFIELD M, 1965, ADV MAGN RESON, V1, P149
   Becke AD, 1996, CAN J CHEM, V74, P995, DOI 10.1139/v96-110
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   BECKER ED, 1996, ENCY NUCL MAGNETIC R, P2400
   Benedict H, 2000, J AM CHEM SOC, V122, P1979, DOI 10.1021/ja9907461
   Contreras RH, 2000, ANNU REP NMR SPECTRO, V41, P55, DOI 10.1016/S0066-4103(00)41009-4
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   COULSON CA, 1947, PROC R SOC LON SER-A, V191, P39, DOI 10.1098/rspa.1947.0102
   Czernek J, 2000, J MAGN RESON, V145, P142, DOI 10.1006/jmre.2000.2091
   de Azua MCR, 1998, J MOL STRUC-THEOCHEM, V433, P141, DOI 10.1016/S0166-1280(98)00020-7
   Del Bene JE, 2000, J AM CHEM SOC, V122, P3560, DOI 10.1021/ja994312h
   Dingley AJ, 1999, J AM CHEM SOC, V121, P6019, DOI 10.1021/ja9908321
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   DITCHFIELD R, 1974, MOL PHYS, V27, P789, DOI 10.1080/00268977400100711
   EMSLEY JW, 1966, HIGH RESOLUTION NUCL, V2
   Facelli JC, 1998, J BIOMOL STRUCT DYN, V16, P619, DOI 10.1080/07391102.1998.10508274
   Fierman M, 2000, ORG LETT, V2, P2077, DOI 10.1021/ol0060679
   Frisch M. J., 1995, GAUSSIAN 94 REVISION
   FUKUI H, 2000, 29 CHEM SOC LOND
   Galasso V, 1998, INT J QUANTUM CHEM, V70, P313, DOI 10.1002/(SICI)1097-461X(1998)70:2<313::AID-QUA7>3.3.CO;2-1
   Golubev NS, 1999, CHEM-EUR J, V5, P492, DOI 10.1002/(SICI)1521-3765(19990201)5:2<492::AID-CHEM492>3.0.CO;2-I
   GRIFFEY RH, 1987, Q REV BIOPHYS, V19, P51, DOI 10.1017/S0033583500004029
   Hehre WJ, 1986, AB INITIO MOL ORBITA
   Hobza P, 1999, CHEM REV, V99, P3247, DOI 10.1021/cr9800255
   Hu JZ, 1998, J AM CHEM SOC, V120, P9863, DOI 10.1021/ja9816786
   JAMESON CJ, 2000, 29 CHEM SOC LOND
   KEARNS DR, 1973, ANN NY ACAD SCI, V222, P324, DOI 10.1111/j.1749-6632.1973.tb15271.x
   KEARNS DR, 1971, J MOL BIOL, V61, P265, DOI 10.1016/0022-2836(71)90224-5
   Kettani A, 2000, J MOL BIOL, V297, P627, DOI 10.1006/jmbi.2000.3524
   KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133
   KOOLE LH, 1986, J CHEM SOC CHEM COMM, P362, DOI 10.1039/c39860000362
   KUTZELNIGG W, 1990, NMR BASIC PRINCIPLES, V23, P165, DOI DOI 10.1007/978-3-642-75932-1
   LAFORGUE A, 1949, J CHIM PHYS PCB, V46, P568, DOI 10.1051/jcp/1949460568
   LITCHMAN WM, 1969, J CHEM PHYS, V50, P1031, DOI 10.1063/1.1671085
   Majumdar A, 1999, J BIOMOL NMR, V14, P67, DOI 10.1023/A:1008335502416
   March NH, 1992, ELECT DENSITY THEORY
   Mason J., 1987, MULTINUCLEAR NMR, P335
   MOORE PB, 1995, ACCOUNTS CHEM RES, V28, P251, DOI 10.1021/ar00054a002
   Mueller U, 1999, RNA, V5, P670, DOI 10.1017/S1355838299982304
   MULLIKEN RS, 1949, J CHEM PHYS, V17, P1248, DOI 10.1063/1.1747150
   MULLIKEN RS, 1949, J CHIM PHYS PCB, V46, P497, DOI 10.1051/jcp/1949460497
   Onak T, 1999, J AM CHEM SOC, V121, P2850, DOI 10.1021/ja9841097
   Parr R., 1989, DENSITY FUNCTIONAL T
   Pauling L., 1960, NATURE CHEM BOND, P89
   Pecul M, 2000, J PHYS CHEM A, V104, P8105, DOI 10.1021/jp001251x
   Pecul M, 2000, J CHEM PHYS, V112, P7930, DOI 10.1063/1.481394
   Perera SA, 2000, J AM CHEM SOC, V122, P1231, DOI 10.1021/ja993275r
   Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366
   Pervushin K, 2000, J BIOMOL NMR, V16, P39, DOI 10.1023/A:1008367405025
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   POPLE JA, 1968, J CHEM PHYS, V49, P2960, DOI 10.1063/1.1670536
   POPLE JA, 1964, MOL PHYS, V8, P1, DOI 10.1080/00268976400100011
   POPLE JA, 1964, MOL PHYS, V7, P269, DOI 10.1080/00268976300101031
   POULTER CD, 1979, TETRAHEDRON LETT, P755
   Scheurer C, 1999, J AM CHEM SOC, V121, P8661, DOI 10.1021/ja9917417
   SCHINDLER M, 1988, J AM CHEM SOC, V110, P6623, DOI 10.1021/ja00228a005
   Shenderovich IG, 1998, BER BUNSEN PHYS CHEM, V102, P422, DOI 10.1002/bbpc.19981020322
   STEINER T, 1995, J CHEM SOC CHEM COMM, P1331, DOI 10.1039/c39950001331
   Stofer E, 1999, J AM CHEM SOC, V121, P9503, DOI 10.1021/ja991092z
   Tarkoy M, 1998, BIOCHEMISTRY-US, V37, P5810, DOI 10.1021/bi9728102
   WANG C, 1991, J AM CHEM SOC, V113, P1448, DOI 10.1021/ja00004a075
   WANG Y, 1991, PHYS REV B, V44, P13298, DOI 10.1103/PhysRevB.44.13298
   Wigglesworth RD, 1997, MOL PHYS, V92, P77, DOI 10.1080/002689797170635
   Wijmenga SS, 1997, J BIOMOL NMR, V10, P337, DOI 10.1023/A:1018348123074
   WITANOWSKI M, 1993, ANNU REP NMR SPECTRO, V25, P88
   Xu XP, 2000, J PHYS CHEM B, V104, P5641, DOI 10.1021/jp0007538
   Zhang XH, 1998, J AM CHEM SOC, V120, P6625, DOI 10.1021/ja9738384
NR 69
TC 109
Z9 109
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
EI 1520-5126
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAY 2
PY 2001
VL 123
IS 17
BP 4014
EP 4022
DI 10.1021/ja003781c
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 428CC
UT WOS:000168442700019
PM 11457152
DA 2021-01-25
ER

PT J
AU Schuurmans, MM
   Hoffmann, F
   Lindberg, RL
   Meyer, UA
AF Schuurmans, MM
   Hoffmann, F
   Lindberg, RL
   Meyer, UA
TI Zinc mesoporphyrin represses induced hepatic 5-aminolevulinic acid
   synthase and reduces heme oxygenase activity in a mouse model of acute
   hepatic porphyria
SO HEPATOLOGY
LA English
DT Article
ID DELTA-AMINOLEVULINATE SYNTHASE; TIN-PROTOPORPHYRIN; CLINICAL
   IMPLICATIONS; BILIRUBIN PRODUCTION; TISSUE DISTRIBUTION; TERM NEWBORNS;
   METALLOPORPHYRINS; ARGINATE; INHIBITORS; RATS
AB Zinc mesoporphyrin (ZnMP) is a potent inhibitor of heme oxygenase (HO) and represses 5-aminolevulinic acid synthase (ALAS), These properties make it a potential candidate for treatment of inducible acute hepatic porphyrias, diseases characterized by neurovisceral symptoms, and massive ALAS induction. Effects of intraperitoneal ZnMP (2.5-10 mu mol/kg/d) and heme arginate (3-6 mg/kg/d) on plasma levels of 5-aminolevulinic acid (ALA), on messenger RNA (mRNA), and activity of hepatic ALAS and HO were studied in porphobilinogen deaminase-deficient mice treated with phenobarbital (100 mg/kg/d) to induce ALAS. ZnMP (5 mu mol/kg/d) led to a significant reduction of plasma ALA levels to 31% of controls (P < .01) by lowering the activity of hepatic mitochondrial and cytosolic ALAS to 29% and 25% of controls, respectively (P < .03). ZnMP decreased the mRNA levels of hepatic ALAS to 53% (P < .03) of controls and this repression was more pronounced than that achieved with heme arginate, In contrast to heme arginate, ZnMP led to a significant reduction of HO activity, We conclude that the combined effect of ZnMP on highly induced ALAS and on HO may be of potential benefit for human acute hepatic porphyrias and therefore merits further in vivo investigations addressing questions raised by this study.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
OI Schuurmans, Mace M./0000-0001-5404-7566
CR BERI R, 1993, DRUG METAB REV, V25, P49, DOI 10.3109/03602539308993973
   BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1050
   BONKOVSKY HL, 1993, GASTROENTEROLOGY, V105, P590, DOI 10.1016/0016-5085(93)90739-Y
   Bundock EA, 1996, PHARMACOLOGY, V52, P187, DOI 10.1159/000139383
   Cable EE, 1996, EUR J BIOCHEM, V240, P112, DOI 10.1111/j.1432-1033.1996.0112h.x
   CABLE EE, 1993, HEPATOLOGY, V18, P119, DOI 10.1002/hep.1840180119
   CABLE EE, 1994, J CLIN INVEST, V94, P649, DOI 10.1172/JCI117381
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DOVER SB, 1993, GASTROENTEROLOGY, V105, P500, DOI 10.1016/0016-5085(93)90726-S
   DOVER SB, 1991, LANCET, V338, P263, DOI 10.1016/0140-6736(91)90411-H
   Elder GH, 1997, LANCET, V349, P1613, DOI 10.1016/S0140-6736(96)09070-8
   GALBRAITH RA, 1985, J CLIN INVEST, V76, P2436, DOI 10.1172/JCI112259
   GALBRAITH RA, 1989, HEPATOLOGY, V9, P882, DOI 10.1002/hep.1840090616
   HINTZ SR, 1990, DEV PHARMACOL THERAP, V14, P187, DOI 10.1159/000480917
   KAPPAS A, 1988, PEDIATRICS, V81, P485
   LINCOLN BC, 1988, ANAL BIOCHEM, V170, P485, DOI 10.1016/0003-2697(88)90662-8
   Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195
   Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lutton JD, 1997, P NATL ACAD SCI USA, V94, P1432, DOI 10.1073/pnas.94.4.1432
   Lutton JD, 1999, PHARMACOLOGY, V58, P44, DOI 10.1159/000028267
   MARK JA, 1992, PEDIATR RES, V32, P324, DOI 10.1203/00006450-199209000-00016
   Martinez JC, 1999, PEDIATRICS, V103, P1, DOI 10.1542/peds.103.1.1
   MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2
   Meyer UA, 1998, SEMIN LIVER DIS, V18, P43, DOI 10.1055/s-2007-1007139
   MUSTAJOKI P, 1993, ARCH INTERN MED, V153, P2004
   MUSTAJOKI P, 1989, SEMIN HEMATOL, V26, P1
   POLAND A, 1972, SCIENCE, V179, P476
   RUSSO SM, 1995, J PHARMACOL EXP THER, V272, P766
   RUSSO SM, 1994, EUR J CLIN INVEST, V24, P406, DOI 10.1111/j.1365-2362.1994.tb02184.x
   SAMBROOK J, 1989, NATURE, V342, P224, DOI 10.1038/342224a0
   Shan Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P219, DOI 10.1006/abbi.2000.1921
   TENHUNEN R, 1969, J BIOL CHEM, V244, P6388
   TENHUNEN R, 1987, J PHARM PHARMACOL, V39, P780, DOI 10.1111/j.2042-7158.1987.tb05119.x
   Tenhunen R, 1998, SEMIN LIVER DIS, V18, P53, DOI 10.1055/s-2007-1007140
   TOKOLA O, 1987, PHARMACOL TOXICOL, V61, P75, DOI 10.1111/j.1600-0773.1987.tb01778.x
   TOMOKUNI K, 1993, CLIN CHEM, V39, P169
   VALAES T, 1994, PEDIATRICS, V93, P1
   VREMAN HJ, 1993, PEDIATR RES, V33, P195
   Vreman HJ, 1996, CAN J PHYSIOL PHARM, V74, P278, DOI 10.1139/cjpp-74-3-278
NR 40
TC 15
Z9 15
U1 0
U2 2
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD MAY
PY 2001
VL 33
IS 5
BP 1217
EP 1222
DI 10.1053/jhep.2001.24170
PG 6
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 426RW
UT WOS:000168363000026
PM 11343251
OA Bronze
DA 2021-01-25
ER

EF